PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Basavanna, S; Chimalapati, S; Maqbool, A; Rubbo, B; Yuste, J; Wilson, RJ; Hosie, A; Ogunniyi, AD; Paton, JC; Thomas, G; Brown, JS				Basavanna, Shilpa; Chimalapati, Suneeta; Maqbool, Abbas; Rubbo, Bruna; Yuste, Jose; Wilson, Robert J.; Hosie, Arthur; Ogunniyi, Abiodun D.; Paton, James C.; Thomas, Gavin; Brown, Jeremy S.			The Effects of Methionine Acquisition and Synthesis on Streptococcus Pneumoniae Growth and Virulence	PLOS ONE			English	Article							POTD PROTECTS MICE; ABC TRANSPORTER; IRON UPTAKE; IDENTIFICATION; GENES; IMMUNIZATION; PROTEINS; LIPOPROTEINS; METABOLISM; INFECTION	Bacterial pathogens need to acquire nutrients from the host, but for many nutrients their importance during infection remain poorly understood. We have investigated the importance of methionine acquisition and synthesis for Streptococcus pneumoniae growth and virulence using strains with gene deletions affecting a putative methionine ABC transporter lipoprotein (Sp_0149, metQ) and/or methionine biosynthesis enzymes (Sp_0585 - Sp_0586, metE and metF). Immunoblot analysis confirmed MetQ was a lipoprotein and present in all S. pneumoniae strains investigated. However, vaccination with MetQ did not prevent fatal S. pneumoniae infection in mice despite stimulating a strong specific IgG response. Tryptophan fluorescence spectroscopy and isothermal titration calorimetry demonstrated that MetQ has both a high affinity and specificity for L-methionine with a K-D of similar to 25 nM, and a Delta metQ strain had reduced uptake of C-14-methionine. Growth of the Delta metQ/Delta metEF strain was greatly impaired in chemically defined medium containing low concentrations of methionine and in blood but was partially restored by addition of high concentrations of exogenous methionine. Mixed infection models showed no attenuation of the Delta metQ, Delta metEF and Delta metQ/Delta metEF strains in their ability to colonise the mouse nasopharnyx. In a mouse model of systemic infection although significant infection was established in all mice, there were reduced spleen bacterial CFU after infection with the Delta metQ/Delta metEF strain compared to the wild-type strain. These data demonstrate that Sp_0149 encodes a high affinity methionine ABC transporter lipoprotein and that Sp_0585 - Sp_0586 are likely to be required for methionine synthesis. Although Sp_0149 and Sp_0585 - Sp_0586 make a contribution towards full virulence, neither was essential for S. pneumoniae survival during infection.	[Basavanna, Shilpa] Univ Texas Houston, Sch Med, Dept Microbiol & Mol Genet, Houston, TX USA; [Chimalapati, Suneeta; Rubbo, Bruna; Wilson, Robert J.; Brown, Jeremy S.] UCL, Rayne Inst, Sch Med, Ctr Inflammat & Tissue Repair,Dept Med, London, England; [Maqbool, Abbas; Thomas, Gavin] Univ York, Dept Biol, Area 10, York YO10 5DD, N Yorkshire, England; [Yuste, Jose] CSIC, Ctr Invest Biol, Madrid, Spain; [Yuste, Jose] Enfermedades Resp CIBERES, Madrid, Spain; [Hosie, Arthur] Univ Bedfordshire, Div Sci, Luton, Beds, England; [Ogunniyi, Abiodun D.; Paton, James C.] Univ Adelaide, Sch Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA, Australia	University of Texas System; University of Texas Health Science Center Houston; University of London; King's College London; University College London; UCL Medical School; University of York - UK; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Bedfordshire; University of Adelaide	Brown, JS (corresponding author), UCL, Rayne Inst, Sch Med, Ctr Inflammat & Tissue Repair,Dept Med, London, England.	jeremy.brown@ucl.ac.uk	Thomas, Gavin H/E-5753-2011; YUSTE, JOSE/ABG-9851-2020; Hosie, Arthur/J-9615-2012; Maqbool, Abbas/AAA-9052-2020; Maqbool, Abbas/G-3191-2016	Thomas, Gavin H/0000-0002-9763-1313; Hosie, Arthur/0000-0002-1327-7901; Brown, Jeremy/0000-0002-5650-5361; Maqbool, Abbas/0000-0002-6189-5560; YUSTE, JOSE/0000-0001-7996-0837; Ogunniyi, Abiodun/0000-0001-9308-5629	Department of Health's NIHR Biomedical Research Centre's funding scheme; British Lung Foundation [P05/3]; Wellcome Trust [076442]; UCL Charities funding	Department of Health's NIHR Biomedical Research Centre's funding scheme(National Institute for Health Research (NIHR)); British Lung Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); UCL Charities funding	This work was undertaken at UCLH/UCL, which received a proportion of funding from the Department of Health's NIHR Biomedical Research Centre's funding scheme, and was supported by the UCL Charities funding and grants from the British Lung Foundation (P05/3) and the Wellcome Trust (grant reference 076442). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo MT, 2009, FEMS IMMUNOL MED MIC, V55, P346, DOI 10.1111/j.1574-695X.2008.00518.x; Basavanna S, 2009, INFECT IMMUN, V77, P3412, DOI 10.1128/IAI.01543-08; Bayle L, 2011, MOL MICROBIOL, V82, P904, DOI 10.1111/j.1365-2958.2011.07862.x; Beuzon CR, 2001, MICROBES INFECT, V3, P1345, DOI 10.1016/S1286-4579(01)01496-4; Brown JS, 2002, INFECT IMMUN, V70, P4389, DOI 10.1128/IAI.70.8.4389-4398.2002; Brown JS, 2001, MOL MICROBIOL, V40, P572, DOI 10.1046/j.1365-2958.2001.02414.x; Brown JS, 2001, INFECT IMMUN, V69, P6702, DOI 10.1128/IAI.69.11.6702-6706.2001; Bryan JD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-607; CHU J, 1985, ARCH BIOCHEM BIOPHYS, V239, P467, DOI 10.1016/0003-9861(85)90713-1; Darwin AJ, 2005, CURR ISSUES MOL BIOL, V7; den Hengst CD, 2006, J BACTERIOL, V188, P3280, DOI 10.1128/JB.188.9.3280-3289.2006; Ejim LJ, 2004, INFECT IMMUN, V72, P3310, DOI 10.1128/IAI.72.6.3310-3314.2004; Fontecave M, 2004, TRENDS BIOCHEM SCI, V29, P243, DOI 10.1016/j.tibs.2004.03.007; Garmory HS, 2004, INFECT IMMUN, V72, P6757, DOI 10.1128/IAI.72.12.6757-6763.2004; GREENE RC, 1996, ESCHERICHIA COLI SAL, P542; Hill CE, 2003, VET MICROBIOL, V96, P189, DOI 10.1016/S0378-1135(03)00212-8; Himpsl SD, 2008, J MED MICROBIOL, V57, P1068, DOI 10.1099/jmm.0.2008/002071-0; Hullo MF, 2004, RES MICROBIOL, V155, P80, DOI 10.1016/j.resmic.2003.11.008; Johnston JW, 2004, INFECT IMMUN, V72, P5858, DOI 10.1128/IAI.72.10.5858-5867.2004; Jomaa M, 2005, INFECT IMMUN, V73, P6852, DOI 10.1128/IAI.73.10.6852-6859.2005; Jomaa M, 2006, VACCINE, V24, P5133, DOI 10.1016/j.vaccine.2006.04.012; Khandavilli S, 2008, MOL MICROBIOL, V67, P541, DOI 10.1111/j.1365-2958.2007.06065.x; Kovaleva GY, 2007, FEMS MICROBIOL LETT, V276, P207, DOI 10.1111/j.1574-6968.2007.00934.x; Lau GW, 2001, MOL MICROBIOL, V40, P555, DOI 10.1046/j.1365-2958.2001.02335.x; Lei BF, 2004, J INFECT DIS, V189, P79, DOI 10.1086/380491; Lestrate P, 2000, MOL MICROBIOL, V38, P543, DOI 10.1046/j.1365-2958.2000.02150.x; Maqbool A, 2011, J BIOL CHEM, V286, P31512, DOI 10.1074/jbc.M111.267179; Mei JM, 1997, MOL MICROBIOL, V26, P399, DOI 10.1046/j.1365-2958.1997.5911966.x; Merlin C, 2002, J BACTERIOL, V184, P5513, DOI 10.1128/JB.184.19.5513-5517.2002; Novak R, 1999, J BACTERIOL, V181, P1126, DOI 10.1128/JB.181.4.1126-1133.1999; Ogunniyi AD, 2012, INFECT IMMUN, V80, P3268, DOI 10.1128/IAI.00295-12; Ogunniyi AD, 2002, MICROBIOL-SGM, V148, P2045, DOI 10.1099/00221287-148-7-2045; Ravanel S, 1998, P NATL ACAD SCI USA, V95, P7805, DOI 10.1073/pnas.95.13.7805; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; SAMBROOK J, 1989, MOL CLONING LAB CLON; Severi E, 2005, MOL MICROBIOL, V58, P1173, DOI 10.1111/j.1365-2958.2005.04901.x; Shah P, 2006, INFECT IMMUN, V74, P5888, DOI 10.1128/IAI.00553-06; Shah P, 2009, EXP BIOL MED, V234, P403, DOI 10.3181/0809-RM-269; Shelver D, 2003, J BACTERIOL, V185, P6592, DOI 10.1128/JB.185.22.6592-6599.2003; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; Sperandio B, 2007, J BACTERIOL, V189, P7032, DOI 10.1128/JB.00703-07; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Thomas GH, 2006, MICROBIOL-SGM, V152, P187, DOI 10.1099/MIC.0.28334-0; Tomasz A, 1964, 64 GEN M AM SOC MICR; Webb AJ, 2008, J BACTERIOL, V190, P168, DOI 10.1128/JB.01509-07; Yuste J, 2006, J IMMUNOL, V176, P6112, DOI 10.4049/jimmunol.176.10.6112; Yuste J, 2010, INFECT IMMUN, V78, P283, DOI 10.1128/IAI.00541-09	47	46	46	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e49638	10.1371/journal.pone.0049638	http://dx.doi.org/10.1371/journal.pone.0049638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349662	Green Published, Green Submitted, gold			2022-12-25	WOS:000314019100004
J	Graziano, A; Foffani, G; Knudsen, EB; Shumsky, J; Moxon, KA				Graziano, Alessandro; Foffani, Guglielmo; Knudsen, Eric B.; Shumsky, Jed; Moxon, Karen A.			Passive Exercise of the Hind Limbs after Complete Thoracic Transection of the Spinal Cord Promotes Cortical Reorganization	PLOS ONE			English	Article							PRIMARY SOMATOSENSORY CORTEX; CENTRAL-NERVOUS-SYSTEM; FUNCTIONAL REORGANIZATION; VOLUNTARY EXERCISE; ADENYLYL-CYCLASE; H-REFLEX; NEUROPATHIC PAIN; MOTOR CORTEX; INJURY; PLASTICITY	Physical exercise promotes neural plasticity in the brain of healthy subjects and modulates pathophysiological neural plasticity after sensorimotor loss, but the mechanisms of this action are not fully understood. After spinal cord injury, cortical reorganization can be maximized by exercising the non-affected body or the residual functions of the affected body. However, exercise per se also produces systemic changes - such as increased cardiovascular fitness, improved circulation and neuroendocrine changes - that have a great impact on brain function and plasticity. It is therefore possible that passive exercise therapies typically applied below the level of the lesion in patients with spinal cord injury could put the brain in a more plastic state and promote cortical reorganization. To directly test this hypothesis, we applied passive hindlimb bike exercise after complete thoracic transection of the spinal cord in adult rats. Using western blot analysis, we found that the level of proteins associated with plasticity - specifically ADCY1 and BDNF - increased in the somatosensory cortex of transected animals that received passive bike exercise compared to transected animals that received sham exercise. Using electrophysiological techniques, we then verified that neurons in the deafferented hindlimb cortex increased their responsiveness to tactile stimuli delivered to the forelimb in transected animals that received passive bike exercise compared to transected animals that received sham exercise. Passive exercise below the level of the lesion, therefore, promotes cortical reorganization after spinal cord injury, uncovering a brain-body interaction that does not rely on intact sensorimotor pathways connecting the exercised body parts and the brain.	[Foffani, Guglielmo; Knudsen, Eric B.; Moxon, Karen A.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Graziano, Alessandro] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19104 USA; [Shumsky, Jed; Moxon, Karen A.] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19104 USA; [Foffani, Guglielmo] Hosp Nacl Paraplejicos, Serv Salud Castilla La Mancha, Toledo, Spain	Drexel University; Drexel University; Drexel University; Hospital Nacional de Paraplejicos	Graziano, A (corresponding author), Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19104 USA.	Alessandro.Graziano@DrexelMed.edu	Moxon, Karen/K-7407-2012; Foffani, Guglielmo/ABD-5897-2020	Moxon, Karen/0000-0002-5790-097X; Foffani, Guglielmo/0000-0001-7289-6668	Neilsen Foundation [36206]; National Institutes of Health [P01 NS 055976, R01 NS05741]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS055976] Funding Source: NIH RePORTER	Neilsen Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grant 36206 from the Neilsen Foundation and grants P01 NS 055976 and R01 NS05741 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Majid RM, 1998, NAT GENET, V19, P289, DOI 10.1038/980; Aguilar J, 2010, J NEUROSCI, V30, P7528, DOI 10.1523/JNEUROSCI.0379-10.2010; Ang ET, 2007, CURR MED CHEM, V14, P2564, DOI 10.2174/092986707782023280; Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105; Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; Bowes C, 2012, P NATL ACAD SCI USA, V109, P2595, DOI 10.1073/pnas.1121604109; CALFORD MB, 1988, NATURE, V332, P446, DOI 10.1038/332446a0; CHAPIN JK, 1984, J COMP NEUROL, V229, P199, DOI 10.1002/cne.902290206; Conner JM, 2005, NEURON, V46, P173, DOI 10.1016/j.neuron.2005.03.003; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; de Mello MT, 2004, SPINAL CORD, V42, P218, DOI 10.1038/sj.sc.3101575; Endo T, 2007, BRAIN, V130, P2951, DOI 10.1093/brain/awm237; Engineer ND, 2011, NATURE, V470, P101, DOI 10.1038/nature09656; ERZURUMLU RS, 1990, J COMP NEUROL, V292, P443, DOI 10.1002/cne.902920310; Faggin BM, 1997, P NATL ACAD SCI USA, V94, P9428, DOI 10.1073/pnas.94.17.9428; Faghri P D, 1997, IEEE Trans Rehabil Eng, V5, P62, DOI 10.1109/86.559350; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Felix MS, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00045; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; Friedberg MH, 1999, J NEUROPHYSIOL, V81, P2243, DOI 10.1152/jn.1999.81.5.2243; Fumagalli F, 2009, NEUROSCIENCE, V159, P936, DOI 10.1016/j.neuroscience.2009.01.030; Ghosh A, 2012, CEREB CORTEX, V22, P1309, DOI 10.1093/cercor/bhr191; Ghosh A, 2010, NAT NEUROSCI, V13, P97, DOI 10.1038/nn.2448; Ghosh A, 2009, J NEUROSCI, V29, P12210, DOI 10.1523/JNEUROSCI.1828-09.2009; Girgis J, 2007, BRAIN, V130, P2993, DOI 10.1093/brain/awm245; Gomez-Pinilla F, 2002, J NEUROPHYSIOL, V88, P2187, DOI 10.1152/jn.00152.2002; Gomez-Pinilla F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032298; Graziano A, 2009, J NEUROSCI, V29, P3738, DOI 10.1523/JNEUROSCI.5388-08.2009; Green JB, 1998, NEUROLOGY, V50, P1115, DOI 10.1212/WNL.50.4.1115; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; HANGARTNER TN, 1994, J REHABIL RES DEV, V31, P50; Hoffman LR, 2007, PHYS THER, V87, P208, DOI 10.2522/ptj.20050365; House DRC, 2011, NEURON, V72, P819, DOI 10.1016/j.neuron.2011.09.008; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Hutchinson KJ, 2004, BRAIN, V127, P1403, DOI 10.1093/brain/awh160; Inoue H, 2007, P NATL ACAD SCI USA, V104, P14430, DOI 10.1073/pnas.0700901104; JAIN N, 1995, J NEUROPHYSIOL, V73, P1537, DOI 10.1152/jn.1995.73.4.1537; Jain N, 1997, NATURE, V386, P495, DOI 10.1038/386495a0; Jain N, 2008, J NEUROSCI, V28, P11042, DOI 10.1523/JNEUROSCI.2334-08.2008; Ji B, 2006, MOL CELL NEUROSCI, V33, P311, DOI 10.1016/j.mcn.2006.08.003; Jones EG, 2000, ANNU REV NEUROSCI, V23, P1, DOI 10.1146/annurev.neuro.23.1.1; Jones EG, 1998, SCIENCE, V282, P1121, DOI 10.1126/science.282.5391.1121; JULIANO SL, 1991, P NATL ACAD SCI USA, V88, P780, DOI 10.1073/pnas.88.3.780; Kaas JH, 2000, PROG BRAIN RES, V128, P173; Kao T, 2011, J NEUROPHYSIOL, V106, P2662, DOI 10.1152/jn.01017.2010; Kao T, 2009, J NEUROSCI, V29, P7549, DOI 10.1523/JNEUROSCI.2474-08.2009; Keck T, 2011, NEURON, V71, P869, DOI 10.1016/j.neuron.2011.06.034; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kiser TS, 2005, J SPINAL CORD MED, V28, P241, DOI 10.1080/10790268.2005.11753818; Klit H, 2009, LANCET NEUROL, V8, P857, DOI 10.1016/S1474-4422(09)70176-0; Knikou M, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/254948; Lauer RT, 2011, SPINAL CORD, V49, P917, DOI 10.1038/sc.2011.19; Leergaard TB, 2004, J COMP NEUROL, V478, P306, DOI 10.1002/cne.20289; Li XY, 2010, SCIENCE, V330, P1400, DOI 10.1126/science.1191792; Lopes JP, 2011, PROG NEUROBIOL, V94, P49, DOI 10.1016/j.pneurobio.2011.03.006; Lotze M, 1999, NAT NEUROSCI, V2, P501, DOI 10.1038/9145; Lu HC, 2003, NAT NEUROSCI, V6, P939, DOI 10.1038/nn1106; Maier DL, 1999, P NATL ACAD SCI USA, V96, P9397, DOI 10.1073/pnas.96.16.9397; Marik SA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000395; Mendonca HR, 2010, NEUROSCI LETT, V477, P23, DOI 10.1016/j.neulet.2010.04.027; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Mizutani K, 2011, BRAIN RES, V1416, P61, DOI 10.1016/j.brainres.2011.08.012; Moore CI, 2000, P NATL ACAD SCI USA, V97, P14703, DOI 10.1073/pnas.250348997; Mosyak L, 2006, J BIOL CHEM, V281, P36378, DOI 10.1074/jbc.M607314200; Moxon KA, 2008, NEUROSCIENCE, V156, P1083, DOI 10.1016/j.neuroscience.2008.08.009; Nicol X, 2006, J NEUROSCI, V26, P862, DOI 10.1523/JNEUROSCI.3385-05.2006; Nishimura Y, 2007, SCIENCE, V318, P1150, DOI 10.1126/science.1147243; Nothias JM, 2005, NEUROREHAB NEURAL RE, V19, P296, DOI 10.1177/1545968305281209; Paxinos G., 1986, RAT BRAIN STEREOTAXI, pxxvi; Petrinovic MM, 2010, DEVELOPMENT, V137, P2539, DOI 10.1242/dev.048371; Phadke CP, 2009, ARCH PHYS MED REHAB, V90, P1218, DOI 10.1016/j.apmr.2009.01.022; Phillips AA, 2011, SPINAL CORD, V49, P702, DOI 10.1038/sc.2010.193; Phillips WT, 1998, CURR PROB CARDIOLOGY, V23, P649; PONS TP, 1991, SCIENCE, V252, P1857, DOI 10.1126/science.1843843; Ravary A, 2003, J NEUROSCI, V23, P2228; Rayegani Seyed Mansoor, 2011, Front Neurol, V2, P39, DOI 10.3389/fneur.2011.00039; Seifert T, 2011, PROG NEUROBIOL, V95, P406, DOI 10.1016/j.pneurobio.2011.09.008; Simoes EL, 2012, J NEUROSCI, V32, P3211, DOI 10.1523/JNEUROSCI.4592-11.2012; Skinner RD, 1996, BRAIN RES, V729, P127, DOI 10.1016/0006-8993(96)00556-2; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Thomas SL, 2005, J NEUROPHYSIOL, V94, P2844, DOI 10.1152/jn.00532.2005; TWIST DJ, 1992, AM J PHYS MED REHAB, V71, P156, DOI 10.1097/00002060-199206000-00006; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Vaynman S, 2005, NEUROREHAB NEURAL RE, V19, P283, DOI 10.1177/1545968305280753; Viswanath V, 2000, P NATL ACAD SCI USA, V97, P2270, DOI 10.1073/pnas.030365297; WALL PD, 1971, NATURE, V232, P542, DOI 10.1038/232542a0; Wang HB, 2004, NAT NEUROSCI, V7, P635, DOI 10.1038/nn1248; Wei F, 2002, NEURON, V36, P713, DOI 10.1016/S0896-6273(02)01019-X; Wei HF, 2011, NEUROSCI LETT, V500, P187, DOI 10.1016/j.neulet.2011.06.029; Welker E, 1996, SCIENCE, V271, P1864, DOI 10.1126/science.271.5257.1864; Winchester P, 2005, NEUROREHAB NEURAL RE, V19, P313, DOI 10.1177/1545968305281515; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; Wrigley PJ, 2009, PAIN, V141, P52, DOI 10.1016/j.pain.2008.10.007; Yague JG, 2011, EXP NEUROL, V227, P252, DOI 10.1016/j.expneurol.2010.11.011; Yamahachi H, 2009, NEURON, V64, P719, DOI 10.1016/j.neuron.2009.11.026; Zhu HC, 2012, BRAIN RES B	99	30	32	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54350	10.1371/journal.pone.0054350	http://dx.doi.org/10.1371/journal.pone.0054350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349859	gold, Green Published, Green Submitted			2022-12-25	WOS:000314019100059
J	Vincent, K; Tauskela, JS; Mealing, GA; Thivierge, JP				Vincent, Kathleen; Tauskela, Joseph S.; Mealing, Geoffrey A.; Thivierge, Jean-Philippe			Altered Network Communication Following a Neuroprotective Drug Treatment	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; SMALL-WORLD; CONNECTIVITY; PLASTICITY; POPULATION; TOPOLOGY; DYNAMICS; BRAIN; MODEL	Preconditioning is defined as a range of stimuli that allow cells to withstand subsequent anaerobic and other deleterious conditions. While cell protection under preconditioning is well established, this paper investigates the influence of neuroprotective preconditioning drugs, 4-aminopyridine and bicuculline (4-AP/bic), on synaptic communication across a broad network of in vitro rat cortical neurons. Using a permutation test, we evaluated cross-correlations of extracellular spiking activity across all pairs of recording electrodes on a 64-channel multielectrode array. The resulting functional connectivity maps were analyzed in terms of their graph-theoretic properties. A small-world effect was found, characterized by a functional network with high clustering coefficient and short average path length. Twenty-four hours after exposure to 4-AP/bic, small-world properties were comparable to control cultures that were not treated with the drug. Four hours following drug washout, however, the density of functional connections increased, while path length decreased and clustering coefficient increased. These alterations in functional connectivity were maintained at four days post-washout, suggesting that 4-AP/bic preconditioning leads to long-term effects on functional networks of cortical neurons. Because of their influence on communication efficiency in neuronal networks, alterations in small-world properties hold implications for information processing in brain systems. The observed relationship between density, path length, and clustering coefficient is captured by a phenomenological model where connections are added randomly within a spatially-embedded network. Taken together, results provide information regarding functional consequences of drug therapies that are overlooked in traditional viability studies and present the first investigation of functional networks under neuroprotective preconditioning.	[Vincent, Kathleen; Thivierge, Jean-Philippe] Univ Ottawa, Sch Psychol, Ottawa, ON K1N 6N5, Canada; [Tauskela, Joseph S.; Mealing, Geoffrey A.] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	University of Ottawa; National Research Council Canada	Thivierge, JP (corresponding author), Univ Ottawa, Sch Psychol, Ottawa, ON K1N 6N5, Canada.	jthivier@uottawa.ca		Vincent, Kathleen/0000-0001-6098-9998	NAKFI Keck Future Initiatives; National Research Council Canada	NAKFI Keck Future Initiatives; National Research Council Canada	This research was supported by a grant to J.P.T. from the NAKFI Keck Future Initiatives and intramural funding from the National Research Council Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; AERTSEN AMHJ, 1985, BRAIN RES, V340, P341, DOI 10.1016/0006-8993(85)90931-X; Bettencourt LMA, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021915; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; Cadotte AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003355; Chen J, 1997, NEUROLOGY, V48, P306, DOI 10.1212/WNL.48.2.306; Chiappalone M, 2003, BIOSENS BIOELECTRON, V18, P627, DOI 10.1016/S0956-5663(03)00041-1; Cramer H., 1946, MATH METHODS STAT; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; Gerhard F, 2011, FRONT COMPUT NEUROSC, V5, P1, DOI [10.3389/fncom.2011.00004, 10.3389/fncom.2011.00023]; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Jimbo Y, 1999, BIOPHYS J, V76, P670, DOI 10.1016/S0006-3495(99)77234-6; Keppel G, 1991, DESIGN ANAL RES HDB; Kleinberg J., 2000, Proceedings of the Thirty Second Annual ACM Symposium on Theory of Computing, P163, DOI 10.1145/335305.335325; Kleinberg JM, 2000, NATURE, V406, P845, DOI 10.1038/35022643; Koulakov AA, 2009, J NEUROSCI, V29, P3685, DOI 10.1523/JNEUROSCI.4500-08.2009; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Novellino Antonio, 2010, Advances in Artificial Intelligence, DOI 10.1155/2010/209254; PerezPinzon MA, 1996, NEUROSCIENCE, V75, P687; Reijneveld JC, 2007, CLIN NEUROPHYSIOL, V118, P2317, DOI 10.1016/j.clinph.2007.08.010; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Srinivas KV, 2007, EUR J NEUROSCI, V25, P3276, DOI 10.1111/j.1460-9568.2007.05559.x; Tauskela JS, 2008, J BIOL CHEM, V283, P34667, DOI 10.1074/jbc.M805624200; Thivierge JP, 2007, TRENDS NEUROSCI, V30, P251, DOI 10.1016/j.tins.2007.04.004; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; van Pelt J, 2005, PROG BRAIN RES, V147, P173, DOI 10.1016/S0079-6123(04)47013-7; Vincent K, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00086; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	32	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54478	10.1371/journal.pone.0054478	http://dx.doi.org/10.1371/journal.pone.0054478			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349901	Green Published, gold, Green Submitted			2022-12-25	WOS:000314019100072
J	Fischer, S; Kittler, S; Klein, G; Glunder, G				Fischer, Samuel; Kittler, Sophie; Klein, Guenter; Gluender, Gerhard			Microplate-Test for the Rapid Determination of Bacteriophage-Susceptibility of Campylobacter Isolates-Development and Validation	PLOS ONE			English	Article							HOST-RANGE; JEJUNI; PHAGE; INFECTION; COLI; IDENTIFICATION	A simple susceptibility test using 800 isolates of one Campylobacter strain with different degrees of susceptibility and four bacteriophages of the British phage typing scheme was developed and examined for its suitability. The test presented is economically cheaper and less time consuming than the conventional agar overlay plate assay and therefore enables the monitoring of changes in the susceptibility pattern during phage therapy under practical field conditions. The main objective of this study was to compare the simplified test with the conventional agar overlay plate assay. The conventional test describes for a population of Campylobacter: i. the rate of resistant isolates (0 plaques) and ii. the degree of susceptibility, also called relative efficiency of plating (EOP), for the remaining isolates. The simplified test divides the isolates into four susceptibility ranks, which are easily distinguishable to the naked eye. Ten Campylobacter isolates out of each rank were subjected to the conventional method for validation of the simplified test. Each resistance rank contained isolates showing certain degrees of susceptibility, reflecting decreasing susceptibility by an increase of the rank. Thus, the simplified test correlated well with the conventional method. Nevertheless, it can be suggested for a clear cut to summarise the first thee ranks as "high susceptible'' and to mark out the fourth rank as reduced susceptible. Further test improvements will enable the monitoring of the degree of susceptibility and potentially also of resistance during phage therapy in the field. To ensure a long-lasting successful use of phage therapy, further studies on both the loss of susceptibility and the development of resistance of Campylobacter against phages combined with their impact on phage therapy will be necessary.	[Fischer, Samuel; Gluender, Gerhard] Univ Vet Med, Clin Poultry, Hannover, Lower Saxony, Germany; [Kittler, Sophie; Klein, Guenter] Univ Vet Med, Inst Food Qual & Food Safety, Hannover, Lower Saxony, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Fischer, S (corresponding author), Univ Vet Med, Clin Poultry, Hannover, Lower Saxony, Germany.	samuel.fischer@tiho-hannover.de	Klein, Günter/G-5321-2013	Klein, Günter/0000-0003-1931-2701	Clinic For Poultry	Clinic For Poultry	Work was funded through own recources of the Clinic For Poultry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedon ST, 2012, BACTERIOPHAGE, V2, P1; Abedon S, 2011, ADV APPL MICROBIOL, V77, P1, DOI 10.1016/B978-0-12-387044-5.00001-7; Abedon Stephen T, 2011, Bacteriophage, V1, P179; Abedon Stephen T., 2009, V501, P161, DOI 10.1007/978-1-60327-164-6_17; Al-Attar S, 2011, BIOL CHEM, V392, P277, DOI 10.1515/BC.2011.042; Atterbury RJ, 2003, APPL ENVIRON MICROB, V69, P6302, DOI 10.1128/AEM.69.10.6302-6306.2003; Atterbury RJ, 2003, APPL ENVIRON MICROB, V69, P4511, DOI 10.1128/AEM.69.8.4511-4518.2003; BfR, 2009, GRUNDL ZUM VORK CAMP; Carrillo CL, 2005, APPL ENVIRON MICROB, V71, P6554, DOI 10.1128/AEM.71.11.6554-6563.2005; Carvalho CM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-232; Coffey B, 2010, ANNU REV FOOD SCI T, V1, P449, DOI 10.1146/annurev.food.102308.124046; Connerton PL, 2004, APPL ENVIRON MICROB, V70, P3877, DOI 10.1128/AEM.70.7.3877-3883.2004; El-Shibiny A, 2009, J FOOD PROTECT, V72, P733, DOI 10.4315/0362-028X-72.4.733; European Food Safety Authority, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1503; Eurosurveillance Editorial Team, 2012, EUROSURVEILLANCE, V17, P21; Frost JA, 1999, EPIDEMIOL INFECT, V123, P47, DOI 10.1017/S095026889900254X; Gillespie IA, 2002, EMERG INFECT DIS, V8, P937, DOI 10.3201/eid0809.010817; Glunder G, 1998, P 1 INT S TURK DIS 1, P307; GRAJEWSKI BA, 1985, J CLIN MICROBIOL, V22, P13, DOI 10.1128/JCM.22.1.13-18.1985; Hanlon GW, 2007, INT J ANTIMICROB AG, V30, P118, DOI 10.1016/j.ijantimicag.2007.04.006; Hansen VM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-90; Hirsch K, 2010, DEV STRATEGIES MINIM; Hyman P, 2010, ADV APPL MICROBIOL, V70, P217, DOI 10.1016/S0065-2164(10)70007-1; Guenter K, 2007, ANTON LEEUW INT J G, V92, P267, DOI 10.1007/s10482-007-9157-3; Kutter Elizabeth, 2009, V501, P141, DOI 10.1007/978-1-60327-164-6_14; Lammerding AM, 2000, INT J FOOD MICROBIOL, V58, P147, DOI 10.1016/S0168-1605(00)00269-5; Lindqvist R, 2001, EMERG INFECT DIS, V7, P588; Marshall SM, 1999, J CLIN MICROBIOL, V37, P4158, DOI 10.1128/JCM.37.12.4158-4160.1999; Pichard K, 1998, LEBENSMITTELMIKROBIO; Rosenquist H, 2003, INT J FOOD MICROBIOL, V83, P87, DOI 10.1016/S0168-1605(02)00317-3; Samuel MC, 2004, CLIN INFECT DIS, V38, pS165, DOI 10.1086/381583; Scott AE, 2007, PLOS PATHOG, V3, P1142, DOI 10.1371/journal.ppat.0030119; Shane SM, 2000, REV SCI TECH OIE, V19, P376, DOI 10.20506/rst.19.2.1224; Sorensen MCH, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00011; Sorensen MCH, 2011, J BACTERIOL, V193, P6742, DOI 10.1128/JB.05276-11; Wagenaar JA, 2005, VET MICROBIOL, V109, P275, DOI 10.1016/j.vetmic.2005.06.002	36	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53899	10.1371/journal.pone.0053899	http://dx.doi.org/10.1371/journal.pone.0053899			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349761	Green Submitted, Green Published, gold			2022-12-25	WOS:000313738900026
J	Genung, MA; Bailey, JK; Schweitzer, JA				Genung, Mark A.; Bailey, Joseph K.; Schweitzer, Jennifer A.			The Afterlife of Interspecific Indirect Genetic Effects: Genotype Interactions Alter Litter Quality with Consequences for Decomposition and Nutrient Dynamics	PLOS ONE			English	Article							EVOLUTIONARY CONSEQUENCES; ECOSYSTEM GENETICS; SOLIDAGO-ALTISSIMA; TRIFOLIUM-REPENS; COMMUNITY; DIVERSITY; NITROGEN; DETERMINANTS; BIODIVERSITY; INTEGRATION	Aboveground-belowground linkages are recognized as divers of community dynamics and ecosystem processes, but the impacts of plant-neighbor interactions on these linkages are virtually unknown. Plant-neighbor interactions are a type of interspecific indirect genetic effect (IIGE) if the focal plant's phenotype is altered by the expression of genes in a neighboring heterospecific plant, and IIGEs could persist after plant senescence to affect ecosystem processes. This perspective can provide insight into how plant-neighbor interactions affect evolution, as IIGEs are capable of altering species interactions and community composition over time. Utilizing genotypes of Solidago altissima and Solidago gigantea, we experimentally tested whether IIGEs that had affected living focal plants would affect litter decomposition rate, as well as nitrogen (N) and phosphorous (P) dynamics after the focal plant senesced. We found that species interactions affected N release and genotype interactions affected P immobilization. From a previous study we knew that neighbor genotype influenced patterns of biomass allocation for focal plants. Here we extend those previous results to show that these changes in biomass allocation altered litter quality, that then altered rates of decomposition and nutrient cycling. Our results provide insights into above- and belowground linkages by showing that, through their effects on plant litter quality (e.g., litter lignin: N), IIGEs can have afterlife effects, tying plant-neighbor interactions to ecosystem processes. This holistic approach advances our understanding of decomposition and nutrient cycling by showing that evolutionary processes (i.e., IIGEs) can influence ecosystem functioning after plant senescence. Because plant traits are determined by the combined effects of genetic and environmental influences, and because these traits are known to affect decomposition and nutrient cycling, we suggest that ecosystem processes can be described as gene-less products of genetic interactions among the species comprising ecological communities.	[Genung, Mark A.; Bailey, Joseph K.; Schweitzer, Jennifer A.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Genung, MA (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	mgenung@utk.edu		Genung, Mark/0000-0002-9383-667X	Department of Ecology and Evolutionary Biology at the University of Tennessee; National Science Foundation [DEB-0743437]; Australian Research Council [FT0991727]	Department of Ecology and Evolutionary Biology at the University of Tennessee; National Science Foundation(National Science Foundation (NSF)); Australian Research Council(Australian Research Council)	The Department of Ecology and Evolutionary Biology at the University of Tennessee, the National Science Foundation (DEB-0743437) and The Australian Research Council (FT0991727) provided financial support to the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARSSEN LW, 1985, J ECOL, V73, P605, DOI 10.2307/2260497; ABRAHAMSON WG, 1991, AM J BOT, V78, P1508, DOI 10.2307/2444976; Abrahamson WG, 2005, PLANT ECOL, V177, P43, DOI 10.1007/s11258-005-2069-2; Abrahamson WG, 1997, MONOGRAPHS POPULATIO, V29; Bailey JK, 2009, PHILOS T R SOC B, V364, P1607, DOI 10.1098/rstb.2008.0336; Bardgett R.D., 2010, ABOVEGROUND BELOWGRO; BLAIR JM, 1992, BIOL FERT SOILS, V12, P241, DOI 10.1007/BF00336039; BLAIR JM, 1990, ECOLOGY, V71, P1976, DOI 10.2307/1937606; Bossdorf O, 2009, OIKOS, V118, P1541, DOI 10.1111/j.1600-0706.2009.17559.x; Briones MJI, 1996, SOIL BIOL BIOCHEM, V28, P1381, DOI 10.1016/S0038-0717(96)00158-7; CALDWELL M, 1995, AMBIO, V24, P166; CARACO T, 1991, ECOLOGY, V72, P81, DOI 10.2307/1938904; Chapman SK, 2010, OECOLOGIA, V162, P763, DOI 10.1007/s00442-009-1498-3; CHOUDHURY D, 1988, OIKOS, V51, P389, DOI 10.2307/3565324; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Dawkins R., 1982, pi; Findlay S, 1996, ECOL APPL, V6, P269, DOI 10.2307/2269570; Finzi AC, 1998, FOREST ECOL MANAG, V105, P129, DOI 10.1016/S0378-1127(97)00277-6; Fridley JD, 2007, J ECOL, V95, P908, DOI 10.1111/j.1365-2745.2007.01256.x; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Genung MA, 2012, ECOL LETT, V15, P65, DOI 10.1111/j.1461-0248.2011.01710.x; Genung MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008711; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; Hansen RA, 1998, APPL SOIL ECOL, V9, P17, DOI 10.1016/S0929-1393(98)00048-1; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; HOBBIE SE, 1992, TRENDS ECOL EVOL, V7, P336, DOI 10.1016/0169-5347(92)90126-V; MADDOX GD, 1987, OECOLOGIA, V72, P8, DOI 10.1007/BF00385037; Madritch M, 2006, ECOSYSTEMS, V9, P528, DOI 10.1007/s10021-006-0008-2; Madritch MD, 2011, OIKOS, V120, P1696, DOI 10.1111/j.1600-0706.2011.19195.x; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; Moya-Larano J, 2012, TRENDS ECOL EVOL, V27, P139, DOI 10.1016/j.tree.2011.11.013; OBRIEN WJ, 1974, ECOLOGY, V55, P135, DOI 10.2307/1934626; PARKINSON JA, 1975, COMMUN SOIL SCI PLAN, V6, P1, DOI 10.1080/00103627509366539; Schweitzer JA, 2005, ECOLOGY, V86, P2834, DOI 10.1890/04-1955; Shuster SM, 2006, EVOLUTION, V60, P991, DOI 10.1111/j.0014-3820.2006.tb01177.x; Thompson J. N., 2005, INTERSPEC INTERACT; TILMAN D, 1982, ANNU REV ECOL SYST, V13, P349, DOI 10.1146/annurev.es.13.110182.002025; TURKINGTON R, 1979, J ECOL, V67, P245, DOI 10.2307/2259348; Van der Putten WH, 2001, TRENDS ECOL EVOL, V16, P547, DOI 10.1016/S0169-5347(01)02265-0; Wade MJ, 2007, NAT REV GENET, V8, P185, DOI 10.1038/nrg2031; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wardle DA, 2003, SOIL BIOL BIOCHEM, V35, P827, DOI 10.1016/S0038-0717(03)00118-4; Wardle DA, 1997, OIKOS, V79, P247, DOI 10.2307/3546010; Wardle DA, 2002, FUNCT ECOL, V16, P585, DOI 10.1046/j.1365-2435.2002.00659.x; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Whitham TG, 2012, TRENDS PLANT SCI, V17, P271, DOI 10.1016/j.tplants.2012.01.005; WIEDER RK, 1982, ECOLOGY, V63, P1636, DOI 10.2307/1940104; Wolf JB, 1998, TRENDS ECOL EVOL, V13, P64, DOI 10.1016/S0169-5347(97)01233-0	49	23	23	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53718	10.1371/journal.pone.0053718	http://dx.doi.org/10.1371/journal.pone.0053718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349735	gold, Green Published, Green Submitted			2022-12-25	WOS:000313738900017
J	Estallo, EL; Mas, G; Vergara-Cid, C; Lanfri, MA; Luduena-Almeida, F; Scavuzzo, CM; Introini, MV; Zaidenberg, M; Almiron, WR				Lilia Estallo, Elizabet; Mas, Guillermo; Vergara-Cid, Carolina; Alberto Lanfri, Mario; Luduena-Almeida, Francisco; Marcelo Scavuzzo, Carlos; Virginia Introini, Maria; Zaidenberg, Mario; Ricardo Almiron, Walter			Spatial Patterns of High Aedes aegypti Oviposition Activity in Northwestern Argentina	PLOS ONE			English	Article							BUENOS-AIRES; DENGUE; EPIDEMIOLOGY; DIPTERA	Background: was to analyze the spatial patterns of high Aedes aegypti oviposition activity in San Ramon de la Nueva Oran, northwestern Argentina. The location of clusters as hot spot areas should help control programs to identify priority areas and allocate their resources more effectively. Methodology: Oviposition activity was detected in Oran City (Salta province) using ovitraps, weekly replaced (October 2005-2007). Spatial autocorrelation was measured with Moran's Index and depicted through cluster maps to identify hot spots. Total egg numbers were spatially interpolated and a classified map with Ae. aegypti high oviposition activity areas was performed. Potential breeding and resting (PBR) sites were geo-referenced. A logistic regression analysis of interpolated egg numbers and PBR location was performed to generate a predictive mapping of mosquito oviposition activity. Principal Findings: Both cluster maps and predictive map were consistent, identifying in central and southern areas of the city high Ae. aegypti oviposition activity. A logistic regression model was successfully developed to predict Ae. aegypti oviposition activity based on distance to PBR sites, with tire dumps having the strongest association with mosquito oviposition activity. A predictive map reflecting probability of oviposition activity was produced. The predictive map delimitated an area of maximum probability of Ae. aegypti oviposition activity in the south of Oran city where tire dumps predominate. The overall fit of the model was acceptable (ROC = 0.77), obtaining 99% of sensitivity and 75.29% of specificity. Conclusions: Distance to tire dumps is inversely associated with high mosquito activity, allowing us to identify hot spots. These methodologies are useful for prevention, surveillance, and control of tropical vector borne diseases and might assist National Health Ministry to focus resources more effectively.	[Lilia Estallo, Elizabet; Luduena-Almeida, Francisco; Ricardo Almiron, Walter] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Ctr Invest Entomol Cordoba, Inst Invest Biol & Tecnol,CONICET, RA-5000 Cordoba, Argentina; [Mas, Guillermo] INTA EEA San Luis, Villa Mercedes, San Luis, Argentina; [Vergara-Cid, Carolina] Univ Nacl Cordoba, Fac Ciencias Med, Inst Virol Dr JM Vanella, RA-5000 Cordoba, Argentina; [Alberto Lanfri, Mario; Marcelo Scavuzzo, Carlos] Ctr Espacial Teofilo Tabanera, Comis Nacl Actividades Espaciales CONAE, Inst Altos Estudios Espaciales Mario Gulich, Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Instituto Nacional de Tecnologia Agropecuaria (INTA); National University of Cordoba	Estallo, EL (corresponding author), Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Ctr Invest Entomol Cordoba, Inst Invest Biol & Tecnol,CONICET, Ciudad Univ, RA-5000 Cordoba, Argentina.	eelizabet@gmail.com	scavuzzo, carlos marcelo/M-9829-2015	carlos marcelo, scavuzzo/0000-0003-0905-6361; Vergara Cid, Carolina/0000-0003-0221-8620; Estallo, Elizabet/0000-0002-6723-6929	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); SECYT - Universidad Nacional de Cordoba; FONCYT - Fondo Nacional de Ciencia y Tecnica [PICT 38060]; REd Latinoamericana de COntrol de Vectores (RELCOV) Ministerio de Salud de La Nacion; programa VIGIA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); SECYT - Universidad Nacional de Cordoba(Secretaria de Ciencia y Tecnologia (SECYT)); FONCYT - Fondo Nacional de Ciencia y Tecnica; REd Latinoamericana de COntrol de Vectores (RELCOV) Ministerio de Salud de La Nacion; programa VIGIA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), SECYT - Universidad Nacional de Cordoba, FONCYT (PICT 38060) - Fondo Nacional de Ciencia y Tecnica, REd Latinoamericana de COntrol de Vectores (RELCOV) Ministerio de Salud de La Nacion, programa VIGIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almiron Walter R, 2003, Rev Fac Cien Med Univ Nac Cordoba, V60, P37; [Anonymous], 2006, IDR AND; [Anonymous], 2007, KEY CONCEPTS TECHNIQ; [Anonymous], ARCVIEW 3 2; Anosike JC, 2007, ANN AGR ENV MED, V14, P31; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Anselin L., 2019, GEODA WORKBOOK; Aviles G, 1999, EMERG INFECT DIS, V5, P575, DOI 10.3201/eid0504.990424; Barrera R, 2011, AM J TROP MED HYG, V85, P1087, DOI 10.4269/ajtmh.2011.11-0381; Brooker S, 2006, EMERG INFECT DIS, V12, P1600, DOI 10.3201/eid1210.060051; Carbajo AE, 2004, MEDICINA-BUENOS AIRE, V64, P231; Christophers S., 1960, YELLOW FEVER MOSQUIT; Di Rienzo J., INFOSTAT VERSION 201; Eisen L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000411; Focks Dana A., 1999, American Entomologist, V45, P173; Getis A, 2003, AM J TROP MED HYG, V69, P494, DOI 10.4269/ajtmh.2003.69.494; Graham AJ, 2004, ACTA TROP, V91, P219, DOI 10.1016/j.actatropica.2004.05.001; King RJ, 2004, EMERG INFECT DIS, V10, P598, DOI 10.3201/eid1004.030241; Mangudo C, 2010, 7 JORN REG MOSQ, P37; Marquetti María del Carmen, 2005, Rev Cubana Med Trop, V57, P159; Ministerio de Salud de la Nacion, 2009, PLAN NAC PREV CONTR; MOORE CG, 1978, AM J TROP MED HYG, V27, P1225, DOI 10.4269/ajtmh.1978.27.1225; Naish S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025688; Natiello M, 2008, EMERG INFECT DIS, V14, P1498, DOI 10.3201/eid1409.080143; OPS, 1990, ORG PANAMERICANA SAL, V524, P1; Pérez Martínez Teresita Tamara, 2003, Rev Cubana Salud Pública, V29, P0; Reiter P., 2001, GUIDELINES ASSESSING; Rodhain Francois, 1997, P45; Duenas JCR, 2009, J MED ENTOMOL, V46, P1344, DOI 10.1603/033.046.0613; Ryan PA, 2004, J MED ENTOMOL, V41, P1143, DOI 10.1603/0022-2585-41.6.1143; Schweigmann N., 1997, Entomologia y Vectores, V4, P185; Sciarretta A, 2010, B ENTOMOL RES, V100, P661, DOI 10.1017/S0007485309990733; Service M. W., 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P681; Stein M, 2002, REV SAUDE PUBL, V36, P627, DOI 10.1590/S0034-89102002000600013; Stein M, 2011, MEM I OSWALDO CRUZ, V106, P400, DOI 10.1590/S0074-02762011000400004; TINKER MILTON E., 1964, MOSQUITO NEWS, V24, P426	36	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54167	10.1371/journal.pone.0054167	http://dx.doi.org/10.1371/journal.pone.0054167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349813	gold, Green Published, Green Submitted			2022-12-25	WOS:000313738900047
J	Kristensen, JM; Larsen, S; Helge, JW; Dela, F; Wojtaszewski, JFP				Kristensen, Jonas M.; Larsen, Steen; Helge, Jorn W.; Dela, Flemming; Wojtaszewski, Jorgen F. P.			Two Weeks of Metformin Treatment Enhances Mitochondrial Respiration in Skeletal Muscle of AMPK Kinase Dead but Not Wild Type Mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GLUCOSE-UPTAKE; COMPLEX-I; RAT-LIVER; INSULIN; EXERCISE; EXPRESSION; BIOGENESIS; AMPK-ALPHA-2; MECHANISM	Metformin is used as an anti-diabetic drug. Metformin ameliorates insulin resistance by improving insulin sensitivity in liver and skeletal muscle. Reduced mitochondrial content has been reported in type 2 diabetic muscles and it may contribute to decreased insulin sensitivity characteristic for diabetic muscles. The molecular mechanism behind the effect of metformin is not fully clarified but inhibition of complex I in the mitochondria and also activation of the 5'AMP activated protein kinase (AMPK) has been reported in muscle. Furthermore, both AMPK activation and metformin treatment have been associated with stimulation of mitochondrial function and biogenesis. However, a causal relationship in skeletal muscle has not been investigated. We hypothesized that potential effects of in vivo metformin treatment on mitochondrial function and protein expressions in skeletal muscle are dependent upon AMPK signaling. We investigated this by two weeks of oral metformin treatment of muscle specific kinase dead alpha(2) (KD) AMPK mice and wild type (WT) littermates. We measured mitochondrial respiration and protein activity and expressions of key enzymes involved in mitochondrial carbohydrate and fat metabolism and oxidative phosphorylation. Mitochondrial respiration, HAD and CS activity, PDH and complex I-V and cytochrome c protein expression were all reduced in AMPK KD compared to WT tibialis anterior muscles. Surprisingly, metformin treatment only enhanced respiration in AMPK KD mice and thereby rescued the respiration defect compared to the WT mice. Metformin did not influence protein activities or expressions in either WT or AMPK KD mice. We conclude that two weeks of in vivo metformin treatment enhances mitochondrial respiration in the mitochondrial deficient AMPK KD but not WT mice. The improvement seems to be unrelated to AMPK, and does not involve changes in key mitochondrial proteins.	[Kristensen, Jonas M.; Wojtaszewski, Jorgen F. P.] Univ Copenhagen, Dept Nutr Exercise & Sport Sci, August Krogh Ctr, Sect Mol Physiol Grp, DK-1168 Copenhagen, Denmark; [Larsen, Steen; Helge, Jorn W.; Dela, Flemming] Univ Copenhagen, Xlab, Ctr Hlth Aging, Dept Biomed Sci,Fac Hlth Sci, DK-1168 Copenhagen, Denmark; [Kristensen, Jonas M.] Univ So Denmark, Inst Clin Res, Sect Mol Diabet & Metab, Endocrinol Res Unit, Odense, Denmark	University of Copenhagen; University of Copenhagen; University of Southern Denmark	Kristensen, JM (corresponding author), Univ Copenhagen, Dept Nutr Exercise & Sport Sci, August Krogh Ctr, Sect Mol Physiol Grp, DK-1168 Copenhagen, Denmark.	jmkristensen@ifi.ku.dk	Helge, Jørn Wulff/I-7096-2012; Larsen, Steen/L-2069-2013; Dela, Flemming/B-3239-2008; Wojtaszewski, Jørgen FP/P-6583-2014; Dela, Flemming/AAU-1691-2021; Kristensen, Jonas/A-3249-2017	Helge, Jørn Wulff/0000-0001-9724-5423; Dela, Flemming/0000-0001-9970-9535; Wojtaszewski, Jørgen FP/0000-0001-9785-6830; Dela, Flemming/0000-0001-9970-9535; wojtaszewski, jorgen/0000-0001-8185-3408; Larsen, Steen/0000-0002-5170-4337; Kristensen, Jonas/0000-0002-8296-975X	Danish Medical Research Council; Novo Nordisk Foundation; Danish Diabetes Association; Lundbeck Foundation; Nordea Foundation; Danish Ministry of Science, Technology and Innovation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Diabetes Association; Lundbeck Foundation(Lundbeckfonden); Nordea Foundation; Danish Ministry of Science, Technology and Innovation	The study was supported by: Danish Medical Research Council; The Novo Nordisk Foundation; The Danish Diabetes Association; The Lundbeck Foundation; The Nordea Foundation. Danish Ministry of Science, Technology and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguer C, 2010, DIABETOLOGIA, V53, P1151, DOI 10.1007/s00125-010-1708-x; Al-Khalili L, 2005, DIABETOLOGIA, V48, P1173, DOI 10.1007/s00125-005-1741-3; BAILEY CJ, 1986, DIABETES METAB, V12, P212; Bamford JA, 2003, CAN J PHYSIOL PHARM, V81, P1072, DOI 10.1139/Y03-110; Batandier C, 2006, J BIOENERG BIOMEMBR, V38, P33, DOI 10.1007/s10863-006-9003-8; Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340; Bikman BT, 2010, J OBES, V2010, DOI 10.1155/2010/970865; Bland ML, 2011, SCIENCE, V332, P1387, DOI 10.1126/science.1208444; Borst SE, 2001, LIFE SCI, V69, P1497, DOI 10.1016/S0024-3205(01)01225-5; Borst SE, 2000, LIFE SCI, V67, P165, DOI 10.1016/S0024-3205(00)00612-3; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Brown JD, 2011, ACTA PHYSIOL, V201, P457, DOI 10.1111/j.1748-1716.2010.02226.x; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; Carvalho C, 2008, MOL CELL BIOCHEM, V308, P75, DOI 10.1007/s11010-007-9614-3; Cusi K, 1998, DIABETES REV, V6, P89; Dzamko N, 2008, J PHYSIOL-LONDON, V586, P5819, DOI 10.1113/jphysiol.2008.159814; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Garcia-Roves PM, 2008, J BIOL CHEM, V283, P35724, DOI 10.1074/jbc.M805078200; Graham GG, 2011, CLIN PHARMACOKINET, V50, P81, DOI 10.2165/11534750-000000000-00000; Halimi S, 2006, DIABETES METAB, V32, P555, DOI 10.1016/S1262-3636(07)70309-9; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Hardie DG, 2006, GASTROENTEROLOGY, V131, P973, DOI 10.1053/j.gastro.2006.07.032; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hojlund K, 2004, AM J PHYSIOL-ENDOC M, V286, pE239, DOI 10.1152/ajpendo.00326.2003; Holloszy JO, 2008, J PHYSIOL PHARMACOL, V59, P5; Holloszy JO, 2009, AM J CLIN NUTR, V89, p463S, DOI 10.3945/ajcn.2008.26717C; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Hou XG, 2010, BIOCHEM BIOPH RES CO, V396, P199, DOI 10.1016/j.bbrc.2010.04.017; Irving BA, 2011, J CLIN ENDOCR METAB, V96, pE1137, DOI 10.1210/jc.2010-2863; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V292, pE1308, DOI 10.1152/ajpendo.00456.2006; Jorgensen SB, 2005, FASEB J, V19, P1146, DOI 10.1096/fj.04-3144fje; Jorgensen SB, 2006, AM J PHYSL ENDOCRINO; Jorgensen SB, 2007, AM J PHYSIOL-ENDOC M, V292, pE331, DOI 10.1152/ajpendo.00243.2006; Joseph AM, 2006, ESSAYS BIOCHEM, V42, P13, DOI 10.1042/bse0420013; Kane DA, 2010, FREE RADICAL BIO MED, V49, P1082, DOI 10.1016/j.freeradbiomed.2010.06.022; Klein DK, 2007, AM J PHYSIOL-ENDOC M, V293, pE1242, DOI 10.1152/ajpendo.00382.2007; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Larsen S, 2012, ACTA PHYSIOL, V205, P314, DOI 10.1111/j.1748-1716.2011.02399.x; Larsen S, 2012, DIABETOLOGIA, V55, P443, DOI 10.1007/s00125-011-2340-0; Larsen S, 2011, DIABETOLOGIA, V54, P1427, DOI 10.1007/s00125-011-2098-4; Lee-Young RS, 2009, J BIOL CHEM, V284, P23925, DOI 10.1074/jbc.M109.021048; Leick L, 2010, AM J PHYSIOL-ENDOC M, V299, pE456, DOI 10.1152/ajpendo.00648.2009; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Luna V, 2006, DIABETOLOGIA, V49, P375, DOI 10.1007/s00125-005-0112-4; Maarbjerg SJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE924, DOI 10.1152/ajpendo.90653.2008; Moreira PI, 2011, HANDB EXP PHARMACOL, V203, P331, DOI 10.1007/978-3-642-17214-4_14; Mortensen B, 2009, AM J PHYSIOL-ENDOC M, V297, pE956, DOI 10.1152/ajpendo.00058.2009; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Musi N, 2001, DIABETES, V50, P921, DOI 10.2337/diabetes.50.5.921; Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; PENICAUD L, 1989, BIOCHEM J, V262, P881, DOI 10.1042/bj2620881; Pilegaard H, 2006, DIABETES, V55, P3020, DOI 10.2337/db06-0152; Putman CT, 2003, J PHYSIOL-LONDON, V551, P169, DOI 10.1113/jphysiol.2003.04069; Rabol R, 2006, APPL PHYSIOL NUTR ME, V31, P675, DOI 10.1139/h06-071; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Sriwijitkamol A, 2007, DIABETES, V56, P836, DOI 10.2337/db06-1119; Stephenne X, 2011, DIABETOLOGIA, V54, P3101, DOI 10.1007/s00125-011-2311-5; Stumvoll M, 2007, ENDOCR RES, V32, P39, DOI 10.1080/07435800701743828; Suwa M, 2006, J APPL PHYSL; Thomson M, 2007, AM J PHYSIOL-ENDOC M, V292, pE196, DOI 10.1152/ajpendo.00366.2006; Thomson DM, 2010, J APPL PHYSIOL, V108, P1775, DOI 10.1152/japplphysiol.01293.2009; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; Williams DB, 2009, AM J PHYSIOL-ENDOC M, V296, pE1400, DOI 10.1152/ajpendo.90913.2008; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Wojtaszewski JFP, 2005, J PHYSIOL-LONDON, V564, P563, DOI 10.1113/jphysiol.2005.082669; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zhang L, 2007, AM J PHYSL HEART CIR; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	78	42	43	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53533	10.1371/journal.pone.0053533	http://dx.doi.org/10.1371/journal.pone.0053533			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341947	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400047
J	Stech, M; Veldman, S; Larrain, J; Munoz, J; Quandt, D; Hassel, K; Kruijer, H				Stech, Michael; Veldman, Sarina; Larrain, Juan; Munoz, Jesus; Quandt, Dietmar; Hassel, Kristian; Kruijer, Hans			Molecular Species Delimitation in the Racomitrium canescens Complex (Grimmiaceae) and Implications for DNA Barcoding of Species Complexes in Mosses	PLOS ONE			English	Article							CRYPTIC SPECIATION; EVOLUTION; BRYOPHYTA; TAXONOMY; CIRCUMSCRIPTIONS; CLASSIFICATION; BIOGEOGRAPHY; LEJEUNEACEAE; PHYLOGENY; INFERENCE	In bryophytes a morphological species concept is still most commonly employed, but delimitation of closely related species based on morphological characters is often difficult. Here we test morphological species circumscriptions in a species complex of the moss genus Racomitrium, the R. canescens complex, based on variable DNA sequence markers from the plastid (rps4-trnT-trnL region) and nuclear (nrITS) genomes. The extensive morphological variability within the complex has led to different opinions about the number of species and intraspecific taxa to be distinguished. Molecular phylogenetic reconstructions allowed to clearly distinguish all eight currently recognised species of the complex plus a ninth species that was inferred to belong to the complex in earlier molecular analyses. The taxonomic significance of intraspecific sequence variation is discussed. The present molecular data do not support the division of the R. canescens complex into two groups of species (subsections or sections). Most morphological characters, albeit being in part difficult to apply, are reliable for species identification in the R. canescens complex. However, misidentification of collections that were morphologically intermediate between species questioned the suitability of leaf shape as diagnostic character. Four partitions of the molecular markers (rps4-trnT, trnT-trnL, ITS1, ITS2) that could potentially be used for molecular species identification (DNA barcoding) performed almost equally well concerning amplification and sequencing success. Of these, ITS1 provided the highest species discrimination capacity and should be considered as a DNA barcoding marker for mosses, especially in complexes of closely related species. Molecular species identification should be complemented by redefining morphological characters, to develop a set of easy-to-use molecular and non-molecular identification tools for improving biodiversity assessments and ecological research including mosses.	[Stech, Michael; Veldman, Sarina; Kruijer, Hans] Leiden Univ, Naturalis Biodivers Ctr, Sect Natl Herbarium Netherlands, Leiden, Netherlands; [Larrain, Juan] Univ Concepcion, Dept Bot, Concepcion, Chile; [Munoz, Jesus] Consejo Super Invest Cient RJB CSIC, Real Jardin Bot, Madrid, Spain; [Munoz, Jesus] Univ Tecnol Indoamer, Ctr Invest Biodiversidad & Cambio Climat, Quito, Ecuador; [Quandt, Dietmar] Univ Bonn, Nees Inst Plant Biodivers, Bonn, Germany; [Hassel, Kristian] Norwegian Univ Sci & Technol, Museum Nat Hist & Archaeol, N-7034 Trondheim, Norway	Leiden University; Leiden University - Excl LUMC; Naturalis Biodiversity Center; Universidad de Concepcion; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; University of Bonn; Norwegian University of Science & Technology (NTNU)	Stech, M (corresponding author), Leiden Univ, Naturalis Biodivers Ctr, Sect Natl Herbarium Netherlands, Leiden, Netherlands.	michael.stech@naturalis.nl	Quandt, Dietmar/F-1821-2010; Munoz, Jesus/B-7809-2008; Hassel, Kristian/AAD-7241-2022	Quandt, Dietmar/0000-0003-4304-6028; Hassel, Kristian/0000-0002-1906-8166; Kruijer, Hans/0000-0002-6768-5230; Larrain, Juan B./0000-0002-9423-6561; Munoz, Jesus/0000-0002-9266-2268	European Centre for Arctic Environmental Research [ARCFAC-026129-2008-31, ARCFAC-026129-2009-123]; Dutch Organization for Scientific Research (NWO) [ALW-NAP/08-01]; Ministry of Science and Technology of Spain [CGL2009-09530-BOS]	European Centre for Arctic Environmental Research; Dutch Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Ministry of Science and Technology of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	MS and HK received financial support from the European Centre for Arctic Environmental Research (projects ARCFAC-026129-2008-31, ARCFAC-026129-2009-123) and the Dutch Organization for Scientific Research (NWO, project ALW-NAP/08-01). JM received financial support from the Ministry of Science and Technology of Spain (grant CGL2009-09530-BOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell D, 2012, MOL ECOL RESOUR, V12, P36, DOI 10.1111/j.1755-0998.2011.03053.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Drummond A.J., 2007, TRACER VERSION 15; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Frisvoll A. A., 1983, GUNNERIA, V41, P1; Gao C, 2003, MOSS FLORA CHINA, V3; Hedenas L, 2011, TAXON, V60, P1596, DOI 10.1002/tax.606005; HEINONEN K, 1971, Annales Botanici Fennici, V8, P142; Heinrichs J, 2009, MOL PHYLOGENET EVOL, V53, P113, DOI 10.1016/j.ympev.2009.05.032; Hernandez-Maqueda R, 2008, MOL PHYLOGENET EVOL, V46, P863, DOI 10.1016/j.ympev.2007.12.017; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hollingsworth PM, 2009, P NATL ACAD SCI USA, V106, P12794, DOI 10.1073/pnas.0905845106; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huttunen S, 2010, TAXON, V59, P791, DOI 10.1002/tax.593010; Korotkova N, 2011, AM J BOT, V98, P1549, DOI 10.3732/ajb.1000502; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Larrain J, 2011, THESIS U CONCEPCION; Larrain J, 2011, BRYOLOGIST, V114, P732, DOI 10.1639/0007-2745-114.4.732; Liu Y, 2011, TAXON, V60, P185, DOI 10.1002/tax.601016; Liu Y, 2010, J SYST EVOL, V48, P36, DOI 10.1111/j.1759-6831.2009.00063.x; Muller K, 2004, MOL PHYLOGENET EVOL, V31, P780, DOI 10.1016/j.ympev.2003.12.006; Muller Kai, 2005, Appl Bioinformatics, V4, P65; Noguchi A., 1974, J HATTORI BOT LAB, V38, P337; Nuin PAS., 2005, MTGUI SIMPLE INTERFA; Ochyra R., 2003, BIODIVERSITY POLAND, V3, P1; Ochyra R, 2007, FLORA N AM, V27, P285; Pennisi E, 2007, SCIENCE, V318, P190, DOI 10.1126/science.318.5848.190; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Quandt D, 2005, MOL PHYLOGENET EVOL, V36, P429, DOI 10.1016/j.ympev.2005.03.014; Qut D., 2006, PHYDE PHYLOGENETIC D; Shaw A. J., 2009, BRYOPHYTE BIOL; Shaw AJ, 2001, J BIOGEOGR, V28, P253; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Stech M, 2004, MONOG SYST BOTAN, V98, P415; Stech M, 2005, TAXON, V54, P377, DOI 10.2307/25065366; Stech M, 1999, J BRYOL, V21, P191, DOI 10.1179/jbr.1999.21.3.191; Stech M, 2008, NOVA HEDWIGIA, V86, P1, DOI 10.1127/0029-5035/2008/0086-0001; Stech M, 2011, TAXON, V60, P79, DOI 10.1002/tax.601007; Stech M, 2010, PHYTOTAXA, V9, P196; Stenoien HK, 2008, J EVOLUTION BIOL, V21, P566, DOI 10.1111/j.1420-9101.2007.01479.x; Sukkharak P, 2011, TAXON, V60, P1607, DOI 10.1002/tax.606006; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Vanderpoorten A, 2006, PLANT GENOME BIODI B, P385; Vanderpoorten A, 2010, PHYTOTAXA, V9, P229; VITT DH, 1993, NOVA HEDWIGIA, V57, P457; Yao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013102	50	32	34	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53134	10.1371/journal.pone.0053134	http://dx.doi.org/10.1371/journal.pone.0053134			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341927	gold, Green Published, Green Submitted			2022-12-25	WOS:000314759400032
J	Swartz, TD; Sakar, Y; Duca, FA; Covasa, M				Swartz, Timothy D.; Sakar, Yassine; Duca, Frank A.; Covasa, Mihai			Preserved adiposity in the Fischer 344 rat devoid of gut microbiota	FASEB JOURNAL			English	Article						germ-free; nutrient-receptor; FIAF; lipogenesis; metabolism	DIET-INDUCED OBESITY; FATTY-ACID RECEPTOR; ENTEROENDOCRINE CELLS; SECRETION; GPR43; SIZE; METABOLISM; RESISTANCE; GERMFREE; MICE	The gut microbiota is implicated in host metabolism and energy regulation. Germ-free (GF) C57BL/6 mice display decreased adiposity, an effect associated with increased intestinal fasting-induced adipose factor (FIAF) and decreased hepatic lipogenesis. However, whether the altered metabolism observed in the absence of gut microbiota extends to other species, commonly used to examine energy metabolism, is unknown. Thus, we used the GF Fischer 344 rat to examine adiposity and associated alterations in intestinal nutrient chemoreceptors, gut peptide levels, and FIAF expression, as well as markers of hepatic and adipose lipogenesis and adipogenesis. We found that GF rats displayed similar body weights and adiposity relative to controls. GF state was associated with up-regulation of intestinal and hepatic FIAF, decreased expression of hepatic FAS, ACC-1, and SREBP, and increased pAMPK and pACC. However, GF rats displayed reduced adipocyte FIAF, increased lipogenic enzymes, and decreased pAMPK, accompanied by an increase in adipocyte size. These findings show that, despite increased intestinal FIAF and reduced hepatic lipogenesis, adiposity is preserved in the Fisher 344 GF rat, unlike the C57Bl/6J GF mouse, with a shift in increased adipocyte lipogenesis. This also demonstrates that adipose, rather than intestinal, FIAF may have a more prominent role in adiposity.-Swartz, T. D., Sakar, Y., Duca, F. A., Covasa, M. Preserved adiposity in the Fischer 344 rat devoid of gut microbiota. FASEB J. 27, 1701-1710 (2013). www.fasebj.org	[Swartz, Timothy D.; Sakar, Yassine; Duca, Frank A.; Covasa, Mihai] INRA, Ctr Rech Jouy En Josas, UMR 1319, Microbiol Alimentat Serv Sante MICALIS, F-78350 Jouy En Josas, France; [Swartz, Timothy D.; Duca, Frank A.] Univ Paris 06, Doctoral Sch Physiol & Pathophysiol, Paris, France; [Covasa, Mihai] Western Univ Hlth Sci, Coll Osteopath Med, Dept Basic Med Sci, Pomona, CA USA; [Covasa, Mihai] Univ Suceava, Dept Human Hlth & Dev, Suceava, Romania	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Western University of Health Sciences; Stefan cel Mare University of Suceava	Covasa, M (corresponding author), INRA, Ctr Rech Jouy En Josas, UMR 1319, MICALIS, F-78350 Jouy En Josas, France.	mcovasa@jouy.inra.fr		Swartz, Timothy/0000-0002-9801-8756	Institut National de Recherche Agronomique through a scientific package	Institut National de Recherche Agronomique through a scientific package	The authors thank Fabienne Devime for her technical assistance, Fatima Joly for the husbandry of the Fisher 344 GF rats, and the Animalerie Axenique de Micalis (ANAXEM) team for their assistance in the GF facilities. The study was supported by Institut National de Recherche Agronomique through a scientific package to M. C. The authors declare no conflicts of interest.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bastie C, 2000, J BIOL CHEM, V275, P38768, DOI 10.1074/jbc.M006450200; Cherbuy C, 2010, AM J PHYSIOL-GASTR L, V299, pG348, DOI 10.1152/ajpgi.00384.2009; de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010; Duca FA, 2013, INT J OBESITY, V37, P375, DOI 10.1038/ijo.2012.45; Duca FA, 2012, BR J NUTR, P1; Duca FA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039748; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; Fleissner CK, 2010, BRIT J NUTR, V104, P919, DOI 10.1017/S0007114510001303; Hayes MR, 2009, ENDOCRINOLOGY, V150, P2654, DOI 10.1210/en.2008-1479; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Jernas M, 2006, FASEB J, V20, P1540, DOI 10.1096/fj.05-5678fje; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Karaki S, 2006, CELL TISSUE RES, V324, P353, DOI 10.1007/s00441-005-0140-x; Karaki SI, 2008, J MOL HISTOL, V39, P135, DOI 10.1007/s10735-007-9145-y; KAWAI Y, 1981, MECH AGEING DEV, V16, P149, DOI 10.1016/0047-6374(81)90091-9; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Lin Zhi-jian, 2009, Chinese Medical Sciences Journal, V24, P191; Liou AP, 2011, AM J PHYSIOL-GASTR L, V300, pG538, DOI 10.1152/ajpgi.00342.2010; Liou AP, 2011, GASTROENTEROLOGY, V140, P903, DOI 10.1053/j.gastro.2010.10.012; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Rabot S, 2010, FASEB J, V24, P4948, DOI 10.1096/fj.10-164921; Ruttimann EB, 2010, PHYSIOL BEHAV, V100, P291, DOI 10.1016/j.physbeh.2010.02.022; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Tanaka T, 2008, N-S ARCH PHARMACOL, V377, P515, DOI 10.1007/s00210-007-0250-y; Tazoe H, 2008, J PHYSIOL PHARMACOL, V59, P251; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Weyer C, 2000, DIABETOLOGIA, V43, P1498, DOI 10.1007/s001250051560; Williams DL, 2006, DIABETES, V55, P3387, DOI 10.2337/db06-0558; Williams DL, 2009, ENDOCRINOLOGY, V150, P1680, DOI 10.1210/en.2008-1045; WOSTMANN BS, 1983, LAB ANIM SCI, V33, P46	33	12	15	2	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2013	27	4					1701	1710		10.1096/fj.12-221689	http://dx.doi.org/10.1096/fj.12-221689			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23349551				2022-12-25	WOS:000316940800039
J	Lee, CH; Lee, M; Kang, HJ; Kim, DH; Kang, YH; Bae, SH; Seo, YS				Lee, Chul-Hwan; Lee, Miju; Kang, Hyo-Jin; Kim, Do-Hyung; Kang, Young-Hoon; Bae, Sung-Ho; Seo, Yeon-Soo			The N-terminal 45-kDa Domain of Dna2 Endonuclease/Helicase Targets the Enzyme to Secondary Structure DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OKAZAKI FRAGMENT MATURATION; STALLED REPLICATION FORKS; CELL NUCLEAR ANTIGEN; BREAK END RESECTION; ESSENTIAL IN-VIVO; SACCHAROMYCES-CEREVISIAE; POLYMERASE-DELTA; S-PHASE; FISSION YEAST; FLAP ENDONUCLEASE-1	The removal of initiating primers from the 5'-ends of each Okazaki fragment, required for the generation of contiguous daughter strands, can be catalyzed by the combined action of DNA polymerase delta and Fen1. When the flaps generated by displacement of DNA synthesis activity of polymerase delta become long enough to bind replication protein A or form hairpin structures, the helicase/endonuclease enzyme, Dna2, becomes critical because of its ability to remove replication protein A-coated or secondary structure flaps. In this study, we show that the N-terminal 45-kDa domain of Dna2 binds hairpin structures, allowing the enzyme to target secondary structure flap DNA. We found that this activity was essential for the efficient removal of hairpin flaps by the endonuclease activity of Dna2 with the aid of its helicase activity. Thus, the efficient removal of hairpin structure flaps requires the coordinated action of all three functional domains of Dna2. We also found that deletion of the N-terminal 45-kDa domain of Dna2 led to a partial loss of the intra-S-phase checkpoint function and an increased rate of homologous recombination in yeast. We discuss the potential roles of the N-terminal domain of Dna2 in the maintenance of genomic stability.	[Lee, Chul-Hwan; Lee, Miju; Kang, Hyo-Jin; Kim, Do-Hyung; Kang, Young-Hoon; Seo, Yeon-Soo] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Bae, Sung-Ho] Inha Univ, Dept Biol Sci, Inchon 402751, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Inha University	Seo, YS (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	yeonsooseo@kaist.ac.kr	Seo, Yeonsoo/C-1605-2011; Bae, Sung-Ho/AAK-7350-2020	Lee, Chul-Hwan/0000-0003-0643-0100	Korean Ministry of Education, Science and Technology	Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant from the Korean Ministry of Education, Science and Technology (to Y.-S.S.).	Bae KH, 2003, NUCLEIC ACIDS RES, V31, P3006, DOI 10.1093/nar/gkg422; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2002, J BIOL CHEM, V277, P26632, DOI 10.1074/jbc.M111026200; Bae SH, 2001, NUCLEIC ACIDS RES, V29, P3069, DOI 10.1093/nar/29.14.3069; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; BRILL SJ, 1989, NATURE, V342, P92, DOI 10.1038/342092a0; Budd ME, 2005, PLOS GENET, V1, P634, DOI 10.1371/journal.pgen.0010061; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Chen XF, 2011, NAT STRUCT MOL BIOL, V18, P1015, DOI 10.1038/nsmb.2105; Formosa T, 1998, MOL GEN GENET, V257, P461, DOI 10.1007/s004380050670; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; Hu JZ, 2012, CELL, V149, P1221, DOI 10.1016/j.cell.2012.04.030; Jin YH, 2003, J BIOL CHEM, V278, P1626, DOI 10.1074/jbc.M209803200; Johansson E, 2004, J BIOL CHEM, V279, P1907, DOI 10.1074/jbc.M310362200; Kang HY, 2000, GENETICS, V155, P1055; Kang YH, 2010, CRIT REV BIOCHEM MOL, V45, P71, DOI 10.3109/10409230903578593; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Kao HI, 2003, CRIT REV BIOCHEM MOL, V38, P433, DOI 10.1080/10409230390259382; Lee KH, 2000, NUCLEIC ACIDS RES, V28, P2873, DOI 10.1093/nar/28.15.2873; Lew DJ, 2003, CURR OPIN CELL BIOL, V15, P648, DOI 10.1016/j.ceb.2003.09.001; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Maga G, 2001, P NATL ACAD SCI USA, V98, P14298, DOI 10.1073/pnas.251193198; Marchetti MA, 2002, P NATL ACAD SCI USA, V99, P7472, DOI 10.1073/pnas.112702399; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; NEWLON CS, 1993, COLD SPRING HARB SYM, V58, P415, DOI 10.1101/SQB.1993.058.01.048; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Onoda F, 2004, DNA REPAIR, V3, P429, DOI 10.1016/j.dnarep.2003.12.007; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; PODUST VN, 1993, NUCLEIC ACIDS RES, V21, P841, DOI 10.1093/nar/21.4.841; Redon C, 2003, EMBO REP, V4, P678, DOI 10.1038/sj.embor.embor871; Reynolds N, 2000, EMBO J, V19, P1108, DOI 10.1093/emboj/19.5.1108; Rossi ML, 2008, J BIOL CHEM, V283, P27483, DOI 10.1074/jbc.M804550200; Rossi ML, 2006, J BIOL CHEM, V281, P26051, DOI 10.1074/jbc.M604805200; Ryu GH, 2004, NUCLEIC ACIDS RES, V32, P4205, DOI 10.1093/nar/gkh720; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Segurado M, 2009, BIOL CELL, V101, P617, DOI 10.1042/BC20090053; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; SIKORSKI RS, 1989, GENETICS, V122, P19; Spiro C, 1999, MOL CELL, V4, P1079, DOI 10.1016/S1097-2765(00)80236-1; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tanaka H, 2004, NUCLEIC ACIDS RES, V32, P6367, DOI 10.1093/nar/gkh963; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; WAHL GM, 1979, P NATL ACAD SCI USA, V76, P3683, DOI 10.1073/pnas.76.8.3683; Yabuki N, 2002, GENES CELLS, V7, P781, DOI 10.1046/j.1365-2443.2002.00559.x; Zegerman P, 2010, NATURE, V467, P474, DOI 10.1038/nature09373; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zuo SJ, 2000, J BIOL CHEM, V275, P5153, DOI 10.1074/jbc.275.7.5153	55	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9468	9481		10.1074/jbc.M112.418715	http://dx.doi.org/10.1074/jbc.M112.418715			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23344960	Green Published, hybrid			2022-12-25	WOS:000316862200063
J	Canning, P; Cooper, CDO; Krojer, T; Murray, JW; Pike, ACW; Chaikuad, A; Keates, T; Thangaratnarajah, C; Hojzan, V; Marsden, BD; Gileadi, O; Knapp, S; von Delft, F; Bullock, AN				Canning, Peter; Cooper, Christopher D. O.; Krojer, Tobias; Murray, James W.; Pike, Ashley C. W.; Chaikuad, Apirat; Keates, Tracy; Thangaratnarajah, Chancievan; Hojzan, Viktorija; Marsden, Brian D.; Gileadi, Opher; Knapp, Stefan; von Delft, Frank; Bullock, Alex N.			Structural Basis for Cul3 Protein Assembly with the BTB-Kelch Family of E3 Ubiquitin Ligases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITORS; PROTEASOMAL DEGRADATION; CRYSTAL-STRUCTURE; COMPLEX REVEALS; DLG MOTIFS; ACTIVATION; DOMAIN; KEAP1; SCF; MUTATIONS	Cullin-RING ligases are multisubunit E3 ubiquitin ligases that recruit substrate-specific adaptors to catalyze protein ubiquitylation. Cul3-based Cullin-RING ligases are uniquely associated with BTB adaptors that incorporate homodimerization, Cul3 assembly, and substrate recognition into a single multidomain protein, of which the best known are BTB-BACK-Kelch domain proteins, including KEAP1. Cul3 assembly requires a BTB protein "3-box" motif, analogous to the F-box and SOCS box motifs of other Cullin-based E3s. To define the molecular basis for this assembly and the overall architecture of the E3, we determined the crystal structures of the BTB-BACK domains of KLHL11 both alone and in complex with Cul3, along with the Kelch domain structures of KLHL2 (Mayven), KLHL7, KLHL12, and KBTBD5. We show that Cul3 interaction is dependent on a unique N-terminal extension sequence that packs against the 3-box in a hydrophobic groove centrally located between the BTB and BACK domains. Deletion of this N-terminal region results in a 30-fold loss in affinity. The presented data offer a model for the quaternary assembly of this E3 class that supports the bivalent capture of Nrf2 and reveals potential new sites for E3 inhibitor design.	[Canning, Peter; Cooper, Christopher D. O.; Krojer, Tobias; Murray, James W.; Pike, Ashley C. W.; Chaikuad, Apirat; Keates, Tracy; Thangaratnarajah, Chancievan; Hojzan, Viktorija; Marsden, Brian D.; Gileadi, Opher; Knapp, Stefan; von Delft, Frank; Bullock, Alex N.] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England	University of Oxford	Bullock, AN (corresponding author), Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England.	alex.bullock@sgc.ox.ac.uk	Cooper, Christopher/E-8392-2013; Krojer, Tobias/ABE-3829-2021; Gileadi, Opher/F-1105-2013; Knapp, Stefan/AAG-2347-2019; Cooper, Chris/G-9982-2014	Gileadi, Opher/0000-0001-6886-898X; Knapp, Stefan/0000-0001-5995-6494; Cooper, Chris/0000-0002-9197-8041; Thangaratnarajah, Chancievan/0000-0002-0279-6642; von Delft, Frank/0000-0003-0378-0017; Krojer, Tobias/0000-0003-0661-0814; Chaikuad, Apirat/0000-0003-1120-2209; Canning, Peter/0000-0001-9678-4169; Murray, James/0000-0002-8897-0161	Canadian Institutes for Health Research; Genome Canada; GlaxoSmithKline; Lilly Canada; Novartis Research Foundation; Pfizer; Takeda; AbbVie; Canada Foundation for Innovation; Ontario Ministry of Economic Development and Innovation; Wellcome Trust [092809/Z/10/Z]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Lilly Canada(Eli Lilly); Novartis Research Foundation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); AbbVie(AbbVie); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Ministry of Economic Development and Innovation; Wellcome Trust(Wellcome TrustEuropean Commission)	The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, Genome Canada, GlaxoSmithKline, Lilly Canada, the Novartis Research Foundation, Pfizer, Takeda, AbbVie, the Canada Foundation for Innovation, the Ontario Ministry of Economic Development and Innovation, and Wellcome Trust Grant 092809/Z/10/Z.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahmad KF, 1998, P NATL ACAD SCI USA, V95, P12123, DOI 10.1073/pnas.95.21.12123; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Bricogne G., 2011, BUSTER VERSION 2 10; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Buckley DL, 2012, ANGEW CHEM INT EDIT, V51, P11463, DOI 10.1002/anie.201206231; Bullock AN, 2007, STRUCTURE, V15, P1493, DOI 10.1016/j.str.2007.09.016; Cerchietti LC, 2010, CANCER CELL, V17, P400, DOI 10.1016/j.ccr.2009.12.050; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Choi JH, 2000, BIOINFORMATICS, V16, P1056, DOI 10.1093/bioinformatics/16.11.1056; Cirak S, 2010, BRAIN, V133, P2123, DOI 10.1093/brain/awq108; Cowtan K, 2008, ACTA CRYSTALLOGR D, V64, P83, DOI 10.1107/S0907444907033938; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Errington WJ, 2012, STRUCTURE, V20, P1141, DOI 10.1016/j.str.2012.04.009; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Friedman JS, 2009, AM J HUM GENET, V84, P792, DOI 10.1016/j.ajhg.2009.05.007; Gray CH, 2009, J BIOL CHEM, V284, P30498, DOI 10.1074/jbc.M109.023259; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Li T, 2005, METHOD ENZYMOL, V398, P125, DOI 10.1016/S0076-6879(05)98012-9; Li XC, 2004, J BIOL CHEM, V279, P54750, DOI 10.1074/jbc.M410073200; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ogura T, 2010, P NATL ACAD SCI USA, V107, P2842, DOI 10.1073/pnas.0914036107; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Prag S, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-42; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Rondou P, 2008, J BIOL CHEM, V283, P11083, DOI 10.1074/jbc.M708473200; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Stogios PJ, 2004, TRENDS BIOCHEM SCI, V29, P634, DOI 10.1016/j.tibs.2004.10.003; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Tong KI, 2007, MOL CELL BIOL, V27, P7511, DOI 10.1128/MCB.00753-07; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu L, 2012, CHEM BIOL, V19, P1515, DOI 10.1016/j.chembiol.2012.09.015; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010	68	175	185	2	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7803	7814		10.1074/jbc.M112.437996	http://dx.doi.org/10.1074/jbc.M112.437996			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23349464	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000316455300035
J	Kierans, C; Padilla-Altamira, C; Garcia-Garcia, G; Ibarra-Hernandez, M; Mercado, FJ				Kierans, Ciara; Padilla-Altamira, Cesar; Garcia-Garcia, Guillermo; Ibarra-Hernandez, Margarita; Mercado, Francisco J.			When Health Systems Are Barriers to Health Care: Challenges Faced by Uninsured Mexican Kidney Patients	PLOS ONE			English	Article							STAGE RENAL-DISEASE; REPLACEMENT THERAPY; DIALYSIS; END; INSURANCE; JALISCO; BURDEN; EQUITY; REFORM	Background: Chronic Kidney Disease disproportionately affects the poor in Low and Middle Income Countries (LMICs). Mexico exemplifies the difficulties faced in supporting Renal Replacement Therapy (RRT) and providing equitable patient care, despite recent attempts at health reform. The objective of this study is to document the challenges faced by uninsured, poor Mexican families when attempting to access RRT. Methods: The article takes an ethnographic approach, using interviewing and observation to generate detailed accounts of the problems that accompany attempts to secure care. The study, based in the state of Jalisco, comprised interviews with patients, their caregivers, health and social care professionals, among others. Observations were carried out in both clinical and social settings. Results: In the absence of organised health information and stable pathways to renal care, patients and their families work extraordinarily hard and at great expense to secure care in a mixed public-private healthcare system. As part of this work, they must navigate challenging health and social care environments, negotiate treatments and costs, resource and finance healthcare and manage a wide range of formal and informal health information. Conclusions: Examining commonalities across pathways to adequate healthcare reveals major failings in the Mexican system. These systemic problems serve to reproduce and deepen health inequalities. A system, in which the costs of renal care are disproportionately borne by those who can least afford them, faces major difficulties around the sustainability and resourcing of RRTs. Attempts to increase access to renal therapies, therefore, need to take into account the complex social and economic demands this places on those who need access most. This paper further shows that ethnographic studies of the concrete ways in which healthcare is accessed in practice provide important insights into the plight of CKD patients and so constitute an important source of evidence in that effort.	[Kierans, Ciara; Padilla-Altamira, Cesar] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England; [Garcia-Garcia, Guillermo; Ibarra-Hernandez, Margarita] Univ Guadalajara, Hlth Sci Ctr, Hosp 278, Div Nephrol,Hosp Civil Guadalajara, Guadalajara 44430, Jalisco, Mexico; [Mercado, Francisco J.] Univ Guadalajara, CUCS, Depto Salud Publ, Guadalajara 44430, Jalisco, Mexico	University of Liverpool; Universidad de Guadalajara; Universidad de Guadalajara	Kierans, C (corresponding author), Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England.	c.kierans@liv.ac.uk		Garcia Garcia, Guillermo/0000-0003-0558-0035; Kierans, Ciara/0000-0001-7268-4438	Darwin Initiative [14-032]; Cambridge Conservation Initiative [CCI 05/10/006]; Leverhulme Trust [F/01 503/B]	Darwin Initiative; Cambridge Conservation Initiative; Leverhulme Trust(Leverhulme Trust)	This work was supported by grants from The Darwin Initiative (14-032), The Cambridge Conservation Initiative (CCI 05/10/006) and The Leverhulme Trust (F/01 503/B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gutierrez-Padilla JA, 2010, AM J KIDNEY DIS, V55, P474, DOI 10.1053/j.ajkd.2009.07.023; Amato DK, 2005, KIDNEY INT, V68, pS11, DOI 10.1111/j.1523-1755.2005.09702.x; [Anonymous], 2012, LANCET, V380, P76, DOI 10.1016/S0140-6736(12)61158-1; Aviles-Gomez R, 2006, ETHNIC DIS, V16; Ayodele OE, 2010, ADV CHRONIC KIDNEY D, V17, P215, DOI 10.1053/j.ackd.2010.02.001; Barsoum RS, 2003, KIDNEY INT, V63, P111, DOI 10.1046/j.1523-1755.63.s83.23.x; Barsoum RS, 2002, ARTIF ORGANS, V26, P737, DOI 10.1046/j.1525-1594.2002.07061.x; Becker Howard, 1961, BOYS WHITE STUDENT C; Bello AK, 2005, KIDNEY INT, V68, pS11, DOI 10.1111/j.1523-1755.2005.09802.x; Consejo Estatal de Poplacion Jalisco, 2011, DIEZ PROBL POBL JAL; Corbin J M, 1991, Sch Inq Nurs Pract, V5, P155; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; Laurell AC, 2010, SALUD COLECT, V6, P137, DOI 10.18294/sc.2010.362; Cueto-Manzano AM, 2007, PERITON DIALYSIS INT, V27, P142; Eibenschutz Catalina, 2008, Rev. salud pública, V10, P119; Frenk J, 2006, LANCET, V368, P954, DOI 10.1016/S0140-6736(06)69376-8; Frenk J, 2006, LANCET, V368, P1524, DOI 10.1016/S0140-6736(06)69564-0; Gakidou E, 2006, LANCET, V368, P1920, DOI 10.1016/S0140-6736(06)69568-8; Garcia-Diaz R, 2011, J HEALTH ECON, V30, P707, DOI 10.1016/j.jhealeco.2011.04.003; Garcia-Garcia G, 2005, KIDNEY INT, V68, pS58, DOI 10.1111/j.1523-1755.2005.09710.x; Garcia-Garcia G, 2007, J AM SOC NEPHROL, V18, P1922, DOI 10.1681/ASN.2006121388; Garcia-Garcia G, 2010, SEMIN NEPHROL, V30, P3, DOI 10.1016/j.semnephrol.2009.10.001; Goffman E, 1961, ENCOUNTERS 2 STUDIES; Gonzalez-Pier E, 2006, LANCET, V368, P1608, DOI 10.1016/S0140-6736(06)69567-6; Homedes N, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000124; Kher V, 2002, KIDNEY INT, V62, P350, DOI 10.1046/j.1523-1755.2002.00426.x; Knaul FM, 2006, LANCET, V368, P1828, DOI 10.1016/S0140-6736(06)69565-2; Lakin JM, 2010, J HEALTH POLIT POLIC, V35, P313, DOI 10.1215/03616878-2010-002; Latour Bruno, 1987, SCI ACTION FOLLOW SC; Laurell AC, 2011, CIENCIA SAUDE COLETI, V16, P2796; Laurell AC, 2007, INT J HEALTH SERV, V37, P515, DOI 10.2190/0133-572V-564N-4831; Lopez-Cervantes M., 2010, ENFERMEDAD RENAL CRO; Lozano R, 2006, LANCET, V368, P1729, DOI 10.1016/S0140-6736(06)69566-4; Lustig N, 2007, REV NEXOS, V358; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Mendez-Duran A, 2010, DIALISIS TRASPL, V31, P7, DOI DOI 10.1016/S1886-2845(10)70004-7; Moosa MR, 2006, KIDNEY INT, V70, P1107, DOI 10.1038/sj.ki.5001750; Nugent RA, 2011, NEPHRON CLIN PRACT, V118, pC269, DOI 10.1159/000321382; Paniagua R, 2007, PERITON DIALYSIS INT, V27, P405; Sosa-Rubi SG, 2011, SALUD PUBLICA MEXICO, V53, pS425; Tamez González Silvia, 2005, Rev. Mex. Sociol, V67, P321; Tamez Gonzalez Silvia, 2008, Rev Salud Publica (Bogota), V10 Suppl, P133; Urbina M, 2008, SISTEMA PROTECCION S; Victora CG, 2009, LANCET, V373, P1404, DOI 10.1016/S0140-6736(09)60564-X; Wacquant Loic, 2003, ETHNOGRAPHY, V4, P5; White SL, 2008, B WORLD HEALTH ORGAN, V86, P229, DOI 10.2471/BLT.07.041715; Whitehead M, 2001, LANCET, V358, P833, DOI 10.1016/S0140-6736(01)05975-X	47	58	62	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54380	10.1371/journal.pone.0054380	http://dx.doi.org/10.1371/journal.pone.0054380			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077HS	23349868	Green Submitted, Green Published, gold			2022-12-25	WOS:000314019100063
J	Tzitzilonis, C; Eichmann, C; Maslennikov, I; Choe, S; Riek, R				Tzitzilonis, Christos; Eichmann, Cedric; Maslennikov, Innokentiy; Choe, Senyon; Riek, Roland			Detergent/Nanodisc Screening for High-Resolution NMR Studies of an Integral Membrane Protein Containing a Cytoplasmic Domain	PLOS ONE			English	Article							BILAYER NANODISCS; ACTIVE PEPTIDES; RHODANESE; DYNAMICS	Because membrane proteins need to be extracted from their natural environment and reconstituted in artificial milieus for the 3D structure determination by X-ray crystallography or NMR, the search for membrane mimetic that conserve the native structure and functional activities remains challenging. We demonstrate here a detergent/nanodisc screening study by NMR of the bacterial alpha-helical membrane protein YgaP containing a cytoplasmic rhodanese domain. The analysis of 2D [N-15,H-1]-TROSY spectra shows that only a careful usage of low amounts of mixed detergents did not perturb the cytoplasmic domain while solubilizing in parallel the transmembrane segments with good spectral quality. In contrast, the incorporation of YgaP into nanodiscs appeared to be straightforward and yielded a surprisingly high quality [N-15,H-1]-TROSY spectrum opening an avenue for the structural studies of a helical membrane protein in a bilayer system by solution state NMR.	[Tzitzilonis, Christos; Eichmann, Cedric; Riek, Roland] ETH Honggerberg, Swiss Fed Inst Technol, Phys Chem Lab, CH-8093 Zurich, Switzerland; [Tzitzilonis, Christos; Maslennikov, Innokentiy; Choe, Senyon; Riek, Roland] Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Salk Institute	Riek, R (corresponding author), ETH Honggerberg, Swiss Fed Inst Technol, Phys Chem Lab, CH-8093 Zurich, Switzerland.	roland.riek@phys.chem.ethz.ch	Eichmann, Cédric/U-1360-2018; Maslennikov, Innokentiy/I-2524-2012	Eichmann, Cédric/0000-0002-8476-1936; Maslennikov, Innokentiy/0000-0003-4292-5821				Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Billeter M, 1995, J BIOMOL NMR, V5, P1; Brewer KD, 2011, P NATL ACAD SCI USA, V108, P12723, DOI 10.1073/pnas.1105128108; Cipollone R, 2008, J MOL MICROB BIOTECH, V15, P199, DOI 10.1159/000121331; Columbus L, 2009, J AM CHEM SOC, V131, P7320, DOI 10.1021/ja808776j; Gluck JM, 2009, J AM CHEM SOC, V131, P12060, DOI 10.1021/ja904897p; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; Gueune H, 2008, APPL ENVIRON MICROB, V74, P1954, DOI 10.1128/AEM.02294-07; GUNTERT P, 1992, J BIOMOL NMR, V2, P619, DOI 10.1007/BF02192850; Kawai T, 2011, FEBS LETT, V585, P3533, DOI 10.1016/j.febslet.2011.10.015; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Li HW, 2008, BIOCHEMISTRY-US, V47, P4377, DOI 10.1021/bi800039n; Lyukmanova EN, 2008, J AM CHEM SOC, V130, P2140, DOI 10.1021/ja0777988; Maslennikov I, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-74; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Raschle T, 2010, CURR OPIN STRUC BIOL, V20, P471, DOI 10.1016/j.sbi.2010.05.006; Raschle T, 2009, J AM CHEM SOC, V131, P17777, DOI 10.1021/ja907918r; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Sambrook J., 2002, MOL CLONING LAB MANU; Savage DF, 2007, PROTEIN SCI, V16, P966, DOI 10.1110/ps.062696307; Shenkarev ZO, 2009, BIOCHEMISTRY-MOSCOW+, V74, P756, DOI 10.1134/S0006297909070086; Shenkarev ZO, 2010, J AM CHEM SOC, V132, P5628, DOI 10.1021/ja9097498; Shih AY, 2005, BIOPHYS J, V88, P548, DOI 10.1529/biophysj.104.046896; Tate CG, 2010, METHODS MOL BIOL, V601, P187, DOI 10.1007/978-1-60761-344-2_12; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Yu TY, 2012, BBA-BIOMEMBRANES, V1818, P1562, DOI 10.1016/j.bbamem.2011.11.012	27	34	34	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54378	10.1371/journal.pone.0054378	http://dx.doi.org/10.1371/journal.pone.0054378			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349867	Green Published, Green Submitted, gold			2022-12-25	WOS:000314019100062
J	Shiau, MY; Fan, LC; Yang, SC; Tsao, CH; Lee, H; Cheng, YW; Lai, LC; Chang, YH				Shiau, Ming-Yuh; Fan, Li-Ching; Yang, Shun-Chun; Tsao, Chang-Hui; Lee, Huei; Cheng, Ya-Wen; Lai, Li-Chuan; Chang, Yih-Hsin			Human Papillomavirus Up-Regulates MMP-2 and MMP-9 Expression and Activity by Inducing Interleukin-8 in Lung Adenocarcinomas	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HUMAN-MELANOMA CELLS; TUMOR ANGIOGENESIS; TYPE-16 E6; MATRIX-METALLOPROTEINASE; PROMOTES ANGIOGENESIS; MCL-1 EXPRESSION; PATIENT SURVIVAL; DOWN-REGULATION; SERUM LEVELS	Human papillomavirus (HPV) infection is associated with non-smoking female lung cancer. Our previous report demonstrated that HPV 16 promotes lung tumor cell progression by up-regulating interleukin-17 (IL-17). IL-17 and its downstream signaling mediator, interleukin-8 (IL-8), have been implicated to modulate a variety of pro-angiogenic factors and play important roles in tumor angiogenesis and metastasis. Accordingly, we hypothesized that HPV infection may potentiate tumorigenic and metastatic characteristics of the infected cells through IL-8. The goal of the present study was to determine whether HPV infection in lung adenocarcinoma cells can promote the expression of IL-8 and metalloproteinases (MMPs) to make the transformed cells equipped with angiogenic and metastatic characteristics. The expression of IL-8 and MMPs in HPV 16 E6-transfected H1299 cells was analyzed to examine the hypothesis. HPV 16 E6 up-regulates pro-angiogenic MMP-2 and MMP-9 through inducing IL-8 expression in lung cancer cells. The results indicate that, in addition to cell proliferation-related machinery, HPV infection promotes the expression and activities of angiogenic and metastatic molecules in lung adenocarcinoma cells. The cytokines induced by HPV infection may work together to confer the malignant and tumorigenic potentials on the infected cells by promoting machineries of growth, angiogenic and metastatic characteristics.	[Shiau, Ming-Yuh] Hungkuang Univ, Taichung, Taiwan; [Fan, Li-Ching] Chung Shan Med Univ, Inst Med & Mol Toxicol, Taichung, Taiwan; [Yang, Shun-Chun; Lai, Li-Chuan] Chung Shan Med Univ, Sch Med Lab & Biotechnol, Taichung, Taiwan; [Tsao, Chang-Hui] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Lee, Huei; Cheng, Ya-Wen] Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan; [Chang, Yih-Hsin] Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei 112, Taiwan	Hungkuang University; Chung Shan Medical University; Chung Shan Medical University; National Defense Medical Center; Taipei Medical University; National Yang Ming Chiao Tung University	Chang, YH (corresponding author), Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei 112, Taiwan.	cyh@ym.edu.tw			National Science Council, Taiwan, Republic of China [NSC98-2320-B-010-034-MY3, NSC101-2320-B-010-052-MY3, NSC100-2320-B-241-003]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported in part by grants from the National Science Council, Taiwan, Republic of China (NSC98-2320-B-010-034-MY3, NSC101-2320-B-010-052-MY3 and NSC100-2320-B-241-003). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberg AJ, 2003, CHEST, V123, p21S, DOI 10.1378/chest.123.1_suppl.21S; Arenberg DA, 1996, J CLIN INVEST, V97, P2792, DOI 10.1172/JCI118734; Atkinson JJ, 2003, AM J RESP CELL MOL, V28, P12, DOI 10.1165/rcmb.2002-0166TR; Bequet-Romero M, 2000, BIOCHEM BIOPH RES CO, V277, P55, DOI 10.1006/bbrc.2000.3628; Chang YH, 2010, CANCER-AM CANCER SOC, V116, P4800, DOI 10.1002/cncr.25224; Chen JJW, 2003, CLIN CANCER RES, V9, P729; Cheng YW, 2008, CLIN CANCER RES, V14, P4705, DOI 10.1158/1078-0432.CCR-07-4675; Cheng YW, 2007, CANCER RES, V67, P10686, DOI 10.1158/0008-5472.CAN-07-1461; Cheng YW, 2001, CANCER RES, V61, P2799; D'Amico Thomas A, 2004, Semin Thorac Cardiovasc Surg, V16, P13; Evander M, 1997, J VIROL, V71, P2449, DOI 10.1128/JVI.71.3.2449-2456.1997; Folkman J, 1976, Int Rev Exp Pathol, V16, P207; Garzetti GG, 1998, CANCER-AM CANCER SOC, V82, P886, DOI 10.1002/(SICI)1097-0142(19980301)82:5<886::AID-CNCR13>3.0.CO;2-X; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Herbst RS, 2005, J CLIN ONCOL, V23, P3243, DOI 10.1200/JCO.2005.18.853; Hsieh HG, 2002, CYTOKINE, V19, P159, DOI 10.1006/cyto.2002.1952; Hu MW, 2004, SURGERY, V135, P87, DOI 10.1016/S0039-6060(03)00347-7; Huang SM, 2002, J VIROL, V76, P8710, DOI 10.1128/JVI.76.17.8710-8721.2002; Inoue K, 2000, CLIN CANCER RES, V6, P2104; Laan M, 2002, CURR PHARM DESIGN, V8, P1855, DOI 10.2174/1381612023393864; Leuenroth SJ, 2000, J LEUKOCYTE BIOL, V68, P158; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Li G, 2011, CANCER LETT, V311, P160, DOI 10.1016/j.canlet.2011.07.012; Lopez-Ocejo O, 2000, ONCOGENE, V19, P4611, DOI 10.1038/sj.onc.1203817; Luca M, 1997, AM J PATHOL, V151, P1105; Masuya D, 2001, CANCER, V92, P2628, DOI 10.1002/1097-0142(20011115)92:10<2628::AID-CNCR1616>3.0.CO;2-F; Mian BM, 2003, CLIN CANCER RES, V9, P3167; Moulding DA, 1998, BLOOD, V92, P2495, DOI 10.1182/blood.V92.7.2495.2495_2495_2502; Mulayim N, 2004, FERTIL STERIL, V81, P904, DOI 10.1016/j.fertnstert.2003.11.015; Nor JE, 2001, CANCER RES, V61, P2183; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Orditura M, 2002, J INTERF CYTOK RES, V22, P1129, DOI 10.1089/10799900260442557; Peng PL, 2006, TOXICOL APPL PHARM, V214, P8, DOI 10.1016/j.taap.2005.11.010; Pillai MR, 2000, EXP MOL PATHOL, V69, P233, DOI 10.1006/exmp.2000.2335; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Shijubo N, 2003, MICROSC RES TECHNIQ, V60, P186, DOI 10.1002/jemt.10257; SINGH RK, 1994, CANCER RES, V54, P3242; Singh RK, 2000, EXP HEMATOL, V28, P499, DOI 10.1016/S0301-472X(00)00145-4; SMITH DR, 1994, J EXP MED, V179, P1409, DOI 10.1084/jem.179.5.1409; Smola-Hess S, 2005, J GEN VIROL, V86, P1291, DOI 10.1099/vir.0.80551-0; Tjalma WA, 2001, EUR J OBSTET GYN R B, V97, P223, DOI 10.1016/S0301-2115(00)00541-8; Toussaint-Smith E, 2004, ONCOGENE, V23, P2988, DOI 10.1038/sj.onc.1207442; UEDA T, 1994, J GASTROENTEROL, V29, P423, DOI 10.1007/BF02361238; Van den Steen PE, 2000, BLOOD, V96, P2673, DOI 10.1182/blood.V96.8.2673.h8002673_2673_2681; Wang JY, 1996, J INTERF CYTOK RES, V16, P53, DOI 10.1089/jir.1996.16.53; Yuan A, 2000, AM J RESP CRIT CARE, V162, P1957, DOI 10.1164/ajrccm.162.5.2002108; Zhu YM, 2004, BRIT J CANCER, V91, P1970, DOI 10.1038/sj.bjc.6602227	47	38	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54423	10.1371/journal.pone.0054423	http://dx.doi.org/10.1371/journal.pone.0054423			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349885	Green Published, Green Submitted, gold			2022-12-25	WOS:000313943000036
J	Trognitz, B; Cros, E; Assemat, S; Davrieux, F; Forestier-Chiron, N; Ayestas, E; Kuant, A; Scheldeman, X; Hermann, M				Trognitz, Bodo; Cros, Emile; Assemat, Sophie; Davrieux, Fabrice; Forestier-Chiron, Nelly; Ayestas, Eusebio; Kuant, Aldo; Scheldeman, Xavier; Hermann, Michael			Diversity of Cacao Trees in Waslala, Nicaragua: Associations between Genotype Spectra, Product Quality and Yield Potential	PLOS ONE			English	Article							THEOBROMA-CACAO	The sensory quality and the contents of quality-determining chemical compounds in unfermented and fermented cocoa from 100 cacao trees (individual genotypes) representing groups of nine genotype spectra (GG), grown at smallholder plantings in the municipality of Waslala, Nicaragua, were evaluated for two successive harvest periods. Cocoa samples were fermented using a technique mimicking recommended on-farm practices. The sensory cocoa quality was assessed by experienced tasters, and seven major chemical taste compounds were quantified by near infrared spectrometry (NIRS). The association of the nine, partially admixed, genotype spectra with the analytical and sensory quality parameters was tested. The individual parameters were analyzed as a function of the factors GG and harvest (including the date of fermentation), individual trees within a single GG were used as replications. In fermented cocoa, significant GG-specific differences were observed for methylxanthines, theobromine-to-caffeine (T/C) ratio, total fat, procyanidin B5 and epicatechin, as well as the sensory attributes global score, astringency, and dry fruit aroma, but differences related to harvest were also apparent. The potential cocoa yield was also highly determined by the individual GG, although there was significant tree-to-tree variation within every single GG. Non-fermented samples showed large harvest-to-harvest variation of their chemical composition, while differences between GG were insignificant. These results suggest that selection by the genetic background, represented here by groups of partially admixed genotype spectra, would be a useful strategy toward enhancing quality and yield of cocoa in Nicaragua. Selection by the GG within the local, genetically segregating populations of seed-propagated cacao, followed by clonal propagation of best-performing individuals of the selected GG could be a viable alternative to traditional propagation of cacao by seed from open pollination. Fast and gentle air-drying of the fermented beans and their permanent dry storage were an efficient and comparatively easy precondition for high cocoa quality.	[Trognitz, Bodo] AIT Austrian Inst Technol, Dept Hlth & Environm, Tulln, Austria; [Trognitz, Bodo] CSF Campus Sci Support Facil, Plant Growth & Phenotyping Facil, Vienna, Austria; [Cros, Emile; Assemat, Sophie; Davrieux, Fabrice; Forestier-Chiron, Nelly] CIRAD Ctr Cooperat Int Rech Agron Dev, Dept Persyst Performances Syst Prod & Transformat, Montpellier, France; [Ayestas, Eusebio] Univ Nacl Agr, Fac Agron, Managua, Nicaragua; [Kuant, Aldo] Pro Mundo Humano, Waslala, Nicaragua; [Scheldeman, Xavier; Hermann, Michael] Biovers Int, Reg Off Amer, Cali, Colombia; [Hermann, Michael] Crops Future, Serdang, Malaysia	CIRAD; Alliance; Bioversity International	Trognitz, B (corresponding author), AIT Austrian Inst Technol, Dept Hlth & Environm, Tulln, Austria.	bodo.trognitz@ait.ac.at	Scheldeman, Xavier/AAF-7960-2021; Scheldeman, Xavier/ABE-9909-2021	Scheldeman, Xavier/0000-0001-7967-7361	Austrian Development Agency, ADA [2006/05]; Bioversity International; Austrian Institute of Technology, AIT [1.U4.00077]	Austrian Development Agency, ADA; Bioversity International; Austrian Institute of Technology, AIT	This study was conducted in the framework of a research and development project entitled "Sustainable futures for indigenous smallholders in Nicaragua: harnessing the high value potential of native cacao diversity" funded by the Austrian Development Agency, ADA (http://www.entwicklung.at/en/), Project reference No. 2006/05, Bioversity International (www.bioversityinternational.org), and the Austrian Institute of Technology, AIT (1.U4.00077) (http://www.ait.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The publication content is solely the responsibility of the authors and does not necessarily represent the official views of ADA, Bioversity or AIT. The project aims at assisting farmers in Waslala to make a gradual transition from their current production of only average-quality cocoa to the production of differentiated high-value cocoa based on the improved use of cacao biodiversity, choice of locality and appropriate post-harvest procedures.	BARNES RJ, 1989, APPL SPECTROSC, V43, P772, DOI 10.1366/0003702894202201; Bonvehi JS, 2000, EUR FOOD RES TECHNOL, V210, P189; CLAPPERTON J, 1994, TROP AGR, V71, P303; Clapperton J. F., 1994, Cocoa Growers' Bulletin, P47; Davrieux F, 2007, P 12 INT C NEAR INFR, P382; Elwers S., 2008, THESIS; Elwers S, 2010, J APPL BOT FOOD QUAL, V83, P182; Figueira A, 1997, TROP AGR, V74, P132; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2010, DOCUMENTATION STRUCT, P15; Robbins RJ, 2012, J AOAC INT, V95, P1153, DOI 10.5740/jaoacint.12-162; SAS Institute Inc, 1989, SAS STAT USERS GUIDE; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Stark T, 2006, J AGR FOOD CHEM, V54, P5530, DOI 10.1021/jf0608726; Trognitz B, 2012, PLOS ONE; Trognitz B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016056; Wintgens JN, 1992, 2ND INTL CONGR COCOA; Wood GAR, 1985, TROPICAL AGRICULTURE; YOUNG AM, 1994, THE CHOCOLATE TREE A	20	25	25	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54079	10.1371/journal.pone.0054079	http://dx.doi.org/10.1371/journal.pone.0054079			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349790	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872800024
J	Hayes, S; Kamma-Lorger, CS; Boote, C; Young, RD; Quantock, AJ; Rost, A; Khatib, Y; Harris, J; Yagi, N; Terrill, N; Meek, KM				Hayes, Sally; Kamma-Lorger, Christina S.; Boote, Craig; Young, Robert D.; Quantock, Andrew J.; Rost, Anika; Khatib, Yasmeen; Harris, Jonathan; Yagi, Naoto; Terrill, Nicholas; Meek, Keith M.			The Effect of Riboflavin/UVA Collagen Cross-linking Therapy on the Structure and Hydrodynamic Behaviour of the Ungulate and Rabbit Corneal Stroma	PLOS ONE			English	Article							X-RAY-DIFFRACTION; ULTRAVIOLET-A; FIBRILS; PROTEOGLYCANS; TRANSPARENCY; PRESERVATION; SCATTERING; GLYCATION; KERATITIS; HYDRATION	Purpose: To examine the effect of riboflavin/UVA corneal crosslinking on stromal ultrastructure and hydrodynamic behaviour. Methods: One hundred and seventeen enucleated ungulate eyes (112 pig and 5 sheep) and 3 pairs of rabbit eyes, with corneal epithelium removed, were divided into four treatment groups: Group 1 (28 pig, 2 sheep and 3 rabbits) were untreated; Group 2 (24 pig) were exposed to UVA light (3.04 mW/cm(2)) for 30 minutes and Group 3 (29 pig) and Group 4 (31 pig, 3 sheep and 3 rabbits) had riboflavin eye drops applied to the corneal surface every 5 minutes for 35 minutes. Five minutes after the initial riboflavin instillation, the corneas in Group 4 experienced a 30 minute exposure to UVA light (3.04 mW/cm(2)). X-ray scattering was used to obtain measurements of collagen interfibrillar spacing, spatial order, fibril diameter, D-periodicity and intermolecular spacing throughout the whole tissue thickness and as a function of tissue depth in the treated and untreated corneas. The effect of each treatment on the hydrodynamic behaviour of the cornea (its ability to swell in saline solution) and its resistance to enzymatic digestion were assessed using in vitro laboratory techniques. Results: Corneal thickness decreased significantly following riboflavin application (p<0.01) and also to a lesser extent after UVA exposure (p<0.05). With the exception of the spatial order factor, which was higher in Group 4 than Group 1 (p<0.01), all other measured collagen parameters were unaltered by cross-linking, even within the most anterior 300 microns of the cornea. The cross-linking treatment had no effect on the hydrodynamic behaviour of the cornea but did cause a significant increase in its resistance to enzymatic digestion. Conclusions: It seems likely that cross-links formed during riboflavin/UVA therapy occur predominantly at the collagen fibril surface and in the protein network surrounding the collagen.	[Hayes, Sally; Kamma-Lorger, Christina S.; Boote, Craig; Young, Robert D.; Quantock, Andrew J.; Rost, Anika; Khatib, Yasmeen; Harris, Jonathan; Meek, Keith M.] Cardiff Univ, Sch Optometry & Vis Sci, Struct Biophys Res Grp, Cardiff CF10 3AX, S Glam, Wales; [Yagi, Naoto] Japan Synchrotron Radiat Res Inst, Kobe, Hyogo, Japan; [Terrill, Nicholas] Diamond Light Source, Didcot, Oxon, England	Cardiff University; Japan Synchrotron Radiation Research Institute; Diamond Light Source	Meek, KM (corresponding author), Cardiff Univ, Sch Optometry & Vis Sci, Struct Biophys Res Grp, Cardiff CF10 3AX, S Glam, Wales.	meekkm@cf.ac.uk	Terrill, Nick J/D-2639-2017	Terrill, Nick J/0000-0002-8783-1282; Young, Robert D./0000-0002-1452-6682; Hayes, Sally/0000-0001-8550-0108; Boote, Craig/0000-0003-0348-6547	5-year Medical Research Council Grant [G06007]; Science and Technology Facilities Council Grant [SM-1536]; MRC [MR/K000837/1, G0600755] Funding Source: UKRI; Medical Research Council [G0600755, MR/K000837/1] Funding Source: researchfish	5-year Medical Research Council Grant; Science and Technology Facilities Council Grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a 5-year Medical Research Council Grant (G0600755) and a Science and Technology Facilities Council Grant (SM-1536). Keith Meek is a Royal Society-Wolfson Research Merit Award Holder. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Blanco T, 2008, ARVO FORT LAUDERDALE, P3911; Boote C, 2003, INVEST OPHTH VIS SCI, V44, P2941, DOI 10.1167/iovs.03-0131; Bottos KM, 2010, CORNEA, V29, P789, DOI 10.1097/ICO.0b013e3181bd9f12; Brummer G, 2011, INVEST OPHTH VIS SCI, V52, P6363, DOI 10.1167/iovs.11-7585; CRAIG AS, 1981, J ULTRA MOL STRUCT R, V74, P232, DOI 10.1016/S0022-5320(81)80081-0; CRAIG AS, 1986, J ULTRA MOL STRUCT R, V96, P172, DOI 10.1016/0889-1605(86)90018-2; Faber C, 2008, SCAND J LAB ANIM SCI, V35, P39; FRATZL P, 1993, BIOPHYS J, V64, P1210, DOI 10.1016/S0006-3495(93)81487-5; FULLWOOD NJ, 1993, J MICROSC-OXFORD, V169, P53, DOI 10.1111/j.1365-2818.1993.tb03277.x; FULLWOOD NJ, 1994, J MOL BIOL, V236, P749, DOI 10.1006/jmbi.1994.1187; Ghanem RC, 2010, J CATARACT REFR SURG, V36, P273, DOI 10.1016/j.jcrs.2009.07.041; Gharaee H, 2011, MIDDLE EAST AFR J OP, V18, P58, DOI 10.4103/0974-9233.75889; HART RW, 1969, J OPT SOC AM, V59, P766, DOI 10.1364/JOSA.59.000766; Hayes S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022405; Iseli HP, 2008, CORNEA, V27, P590, DOI 10.1097/ICO.0b013e318169d698; KIKKAWA Y, 1970, INVEST OPHTH VISUAL, V9, P735; Krueger RR, 2008, J REFRACT SURG, V24, pS730, DOI 10.3928/1081597X-20080901-17; LEE D, 1981, CURR EYE RES, V1, P457, DOI 10.3109/02713688109019986; Lewis PN, 2010, STRUCTURE, V18, P239, DOI 10.1016/j.str.2009.11.013; Makdoumi K, 2012, GRAEF ARCH CLIN EXP, V250, P95, DOI 10.1007/s00417-011-1754-1; Malik NS, 1996, AGE AGEING, V25, P279, DOI 10.1093/ageing/25.4.279; MALIK NS, 1992, BIOCHIM BIOPHYS ACTA, V1138, P222, DOI 10.1016/0925-4439(92)90041-K; MALIK NS, 1994, BIOCHEM BIOPH RES CO, V199, P683, DOI 10.1006/bbrc.1994.1282; MAROUDAS A, 1991, BIOCHIM BIOPHYS ACTA, V1073, P285, DOI 10.1016/0304-4165(91)90133-2; MAURICE DM, 1957, J PHYSIOL-LONDON, V136, P263, DOI 10.1113/jphysiol.1957.sp005758; MEEK KM, 1991, BIOPHYS J, V60, P467, DOI 10.1016/S0006-3495(91)82073-2; Meek KM, 2001, PROG RETIN EYE RES, V20, P95, DOI 10.1016/S1350-9462(00)00016-1; Meek KM, 2008, ARVO FORT LAUDERDALE, P3913; Muller LJ, 2001, BRIT J OPHTHALMOL, V85, P437, DOI 10.1136/bjo.85.4.437; Rahman I, 2009, EYE, V23, P1288, DOI 10.1038/eye.2008.305; Raiskup-Wolf F, 2008, J CATARACT REFR SURG, V34, P796, DOI 10.1016/j.jcrs.2007.12.039; RAWE IM, 1994, BIOPHYS J, V67, P1743, DOI 10.1016/S0006-3495(94)80648-4; SCOTT JE, 1988, BIOCHEM J, V252, P313, DOI 10.1042/bj2520313; SCOTT JE, 1992, J ANAT, V180, P155; Seiler T, 2006, CORNEA, V25, P1057, DOI 10.1097/01.ico.0000225720.38748.58; SLACK JW, 1992, CORNEA, V11, P204; Spoerl E, 2004, CURR EYE RES, V29, P35, DOI 10.1080/02713680490513182; Spoerl E, 2004, OPHTHALMOLOGICA, V218, P136, DOI 10.1159/000076150; Spoerl E, 2012, FORT LAUDER IN PRESS; TWERSKY V, 1975, J OPT SOC AM, V65, P524, DOI 10.1364/JOSA.65.000524; VANHORN DL, 1975, ARCH OPHTHALMOL-CHIC, V93, P275, DOI 10.1001/archopht.1975.01010020285007; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200; Wollensak G, 2004, CORNEA, V23, P503, DOI 10.1097/01.ico.0000105827.85025.7f; Wollensak G, 2004, CORNEA, V23, P43, DOI 10.1097/00003226-200401000-00008; Wollensak G, 2011, BRIT J OPHTHALMOL, V95, P876, DOI 10.1136/bjo.2010.190843; Wollensak G, 2003, J CATARACT REFR SURG, V29, P1780, DOI 10.1016/S0886-3350(03)00407-3; Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1; Wollensak G, 2007, J CATARACT REFR SURG, V33, P516, DOI 10.1016/j.jcrs.2006.11.015; Wollensak G, 2009, OPHTHALMIC RES, V41, P114, DOI 10.1159/000187630; WORTHINGTON CR, 1985, INT J BIOL MACROMOL, V7, P2, DOI 10.1016/0141-8130(85)90057-1; Zhang YT, 2011, J BIOL CHEM, V286, P13011, DOI 10.1074/jbc.M110.169813	51	120	124	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e52860	10.1371/journal.pone.0052860	http://dx.doi.org/10.1371/journal.pone.0052860			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349690	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000313738900006
J	Ciantar, J; Finch, E; Copland, DA				Ciantar, Jessica; Finch, Emma; Copland, David A.			Hand Movement Effects on Word Learning and Retrieval in Adults	PLOS ONE			English	Article							CONCURRENT TASK-PERFORMANCE; SHORT-TERM-MEMORY; DIVIDED ATTENTION; EXPLAINING MATH; LANGUAGE; APHASIA; OBJECTS; INTERFERENCE; ACQUISITION; GESTURE	The present study investigated the effect of performing an intentional non-meaningful hand movement on subsequent lexical acquisition and retrieval in healthy adults. Twenty-five right-handed healthy individuals were required to learn the names (2-syllable legal nonwords) for a series of unfamiliar objects. Participants also completed a familiar picture naming task to investigate the effects of the intentional non-meaningful movement on lexical retrieval. Results revealed that performing this hand movement immediately before linguistic tasks interfered with both new word learning and familiar picture naming when compared with no movement. These results extend previous findings of dual task interference effects in healthy individuals, suggesting that complex, non-meaningful, hand movements can also interfere with subsequent lexical acquisition and retrieval.	[Ciantar, Jessica; Finch, Emma; Copland, David A.] Univ Queensland, Div Speech Pathol, Brisbane, Qld, Australia; [Finch, Emma] Princess Alexandra Hosp, Speech Pathol Dept, Brisbane, Qld 4102, Australia; [Finch, Emma] Queensland Hlth, Ctr Functioning & Hlth Res, Brisbane, Qld, Australia; [Copland, David A.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia	University of Queensland; Queensland Health; University of Queensland	Finch, E (corresponding author), Univ Queensland, Div Speech Pathol, Brisbane, Qld, Australia.	e.whiting@uq.edu.au	Copland, David A/F-1409-2010; Finch, Emma/B-3067-2011; Copland, David/AAE-5334-2020	Copland, David A/0000-0002-2257-4270; Finch, Emma/0000-0002-9690-8165; Copland, David/0000-0002-2257-4270				Baddeley A, 1998, PSYCHOL REV, V105, P158, DOI 10.1037/0033-295X.105.1.158; Basso A, 2001, BRAIN LANG, V77, P45, DOI 10.1006/brln.2000.2422; Breitenstein C, 2004, RESTOR NEUROL NEUROS, V22, P445; Breitenstein C, 2004, NEUROPSYCHOPHARMACOL, V29, P1704, DOI 10.1038/sj.npp.1300464; Breitenstein C, 2002, J NEUROSCI METH, V114, P173, DOI 10.1016/S0165-0270(01)00525-8; Caroselli JS, 1997, NEUROPSYCHOLOGIA, V35, P457; Carson DH, 1968, CORTEX, V4, P92; Conway CM, 2007, J DEAF STUD DEAF EDU, V12, P317, DOI 10.1093/deafed/enm019; Conway CM, 2010, COGNITION, V114, P356, DOI 10.1016/j.cognition.2009.10.009; Cook SW, 2012, LANG COGNITIVE PROC, V27, P594, DOI 10.1080/01690965.2011.567074; Cornelissen K, 2004, BRAIN LANG, V89, P617, DOI 10.1016/j.bandl.2003.12.007; Craik FIM, 1996, J EXP PSYCHOL GEN, V125, P159, DOI 10.1037/0096-3445.125.2.159; Crosson B, 2005, J COGNITIVE NEUROSCI, V17, P392, DOI 10.1162/0898929053279487; Crosson B, 2007, J INT NEUROPSYCH SOC, V13, P582, DOI 10.1017/S1355617707070737; Filoteo JV, 2010, PSYCHOL SCI, V21, P415, DOI 10.1177/0956797610362646; Goldin-Meadow S, 2001, PSYCHOL SCI, V12, P516, DOI 10.1111/1467-9280.00395; Guez J, 2006, EUR J COGN PSYCHOL, V18, P874, DOI 10.1080/09541440500485854; Gupta P, 1997, BRAIN LANG, V59, P267, DOI 10.1006/brln.1997.1819; Gupta P, 2003, Q J EXP PSYCHOL-A, V56, P1213, DOI 10.1080/02724980343000071; Heilman K, 2003, CLIN NEUROPSYCHOLOGY, P296, DOI DOI 10.1016/J.NEUR0PSYCHOLOGIA.2011.09.030; Hiscock M, 1995, BRAIN COGNITION, V29, P307, DOI 10.1006/brcg.1995.1284; Kelly SD, 2009, LANG COGNITIVE PROC, V24, P313, DOI 10.1080/01690960802365567; Kiefer M, 2005, NEUROPSYCHOLOGY, V19, P332, DOI 10.1037/0894-4105.19.3.332; Laine M, 2003, BRAIN LANG, V87, P128, DOI 10.1016/S0093-934X(03)00232-3; Laine M, 2010, LANG LEARN, V60, P25, DOI 10.1111/j.1467-9922.2010.00599.x; LOMAS J, 1980, NEUROPSYCHOLOGIA, V18, P141, DOI 10.1016/0028-3932(80)90060-3; LOMAS J, 1976, NEUROPSYCHOLOGIA, V14, P23, DOI 10.1016/0028-3932(76)90004-X; Martin N, 2004, COGN NEUROPSYCHOL, V21, P213, DOI 10.1080/02643290342000447; McCafferty SG, 2002, MOD LANG J, V86, P192, DOI 10.1111/1540-4781.00144; MCFARLAND K, 1982, NEUROPSYCHOLOGIA, V20, P365, DOI 10.1016/0028-3932(82)90112-9; MCFARLAND K, 1982, NEUROPSYCHOLOGIA, V20, P383, DOI 10.1016/0028-3932(82)90038-0; Medland SE, 2002, NEUROPSYCHOLOGIA, V40, P1233, DOI 10.1016/S0028-3932(01)00228-7; Meinzer M, 2011, NEUROREHAB NEURAL RE, V25, P178, DOI 10.1177/1545968310376577; Naveh-Benjamin M, 2006, MEM COGNITION, V34, P90, DOI 10.3758/BF03193389; Naveh-Benjamin M, 2005, J EXP PSYCHOL LEARN, V31, P520, DOI 10.1037/0278-7393.31.3.520; Naveh-Benjamin M, 2007, CAN J EXP PSYCHOL, V61, P1, DOI 10.1037/cjep2007001; Nemeth D, 2012, CEREBRAL CORTEX; Nemeth D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017577; Ping R, 2010, COGNITIVE SCI, V34, P602, DOI 10.1111/j.1551-6709.2010.01102.x; *PSYCH SOFTW TOOLS, 2002, E PRIM VERS 1 1 COMP; Rastle K, 2002, Q J EXP PSYCHOL-A, V55, P1339, DOI 10.1080/02724980244000099; Richards K, 2002, J REHABIL RES DEV, V39, P445; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Szekely A, 2004, J MEM LANG, V51, P247, DOI 10.1016/j.jml.2004.03.002; Tikofsky R S, 1971, Cortex, V7, P106; Wagner SM, 2004, J MEM LANG, V50, P395, DOI 10.1016/j.jml.2004.01.002; Whiting E, 2007, INT J NEUROPSYCHOPH, V10, P805, DOI 10.1017/S1461145706007516; Whiting E, 2008, BRAIN LANG, V104, P254, DOI 10.1016/j.bandl.2007.03.003	48	1	2	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53861	10.1371/journal.pone.0053861	http://dx.doi.org/10.1371/journal.pone.0053861			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072OV	23342020	Green Published, gold, Green Submitted			2022-12-25	WOS:000313682700052
J	Mortuza, R; Chen, SL; Feng, BA; Sen, S; Chakrabarti, S				Mortuza, Rokhsana; Chen, Shali; Feng, Biao; Sen, Subhrojit; Chakrabarti, Subrata			High Glucose Induced Alteration of SIRTs in Endothelial Cells Causes Rapid Aging in a p300 and FOXO Regulated Pathway	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; EXPRESSION; PROTEIN; ACETYLATION; BIOCHEMISTRY; DIVERSITY; INSULIN; STRESS; HEALTH	In diabetes, some of the cellular changes are similar to aging. We hypothesized that hyperglycemia accelerates aging-like changes in the endothelial cells (ECs) and tissues leading to structural and functional damage. We investigated glucose-induced aging in 3 types of ECs using senescence associated beta-gal (SA beta-gal) staining and cell morphology. Alterations of sirtuins (SIRTs) and their downstream mediator FOXO and oxidative stress were investigated. Relationship of such alteration with histone acetylase (HAT) p300 was examined. Similar examinations were performed in tissues of diabetic animals. ECs in high glucose (HG) showed evidence of early senescence as demonstrated by increased SA beta-gal positivity and reduced replicative capacities. These alterations were pronounced in microvascular ECs. They developed an irregular and hypertrophic phenotype. Such changes were associated with decreased SIRT (1-7) mRNA expressions. We also found that p300 and SIRT1 regulate each other in such process, as silencing one led to increase of the others' expression. Furthermore, HG caused reduction in FOXO1's DNA binding ability and antioxidant target gene expressions. Chemically induced increased SIRT1 activity and p300 knockdown corrected these abnormalities slowing aging-like changes. Diabetic animals showed increased cellular senescence in renal glomerulus and retinal blood vessels along with reduced SIRT1 mRNA expressions in these tissues. Data from this study demonstrated that hyperglycemia accelerates aging-like process in the vascular ECs and such process is mediated via downregulation of SIRT1, causing reduction of mitochondrial antioxidant enzyme in a p300 and FOXO1 mediated pathway.	[Mortuza, Rokhsana; Chen, Shali; Feng, Biao; Sen, Subhrojit; Chakrabarti, Subrata] Univ Western Ontario, Dept Pathol, Schulich Sch Med & Dent, London, ON, Canada	Western University (University of Western Ontario)	Chakrabarti, S (corresponding author), Univ Western Ontario, Dept Pathol, Schulich Sch Med & Dent, London, ON, Canada.	subrata.chakrabarti@schulich.uwo.ca		Chakrabarti, Subrata/0000-0002-0208-1401	Canadian Diabetes Association; Heart and Stroke Foundation of Canada	Canadian Diabetes Association; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This study was supported by grants from the Canadian Diabetes Association and the Heart and Stroke Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2007, GASTROENTEROLOGY, V132, P1434, DOI 10.1053/j.gastro.2007.01.033; Adams JD, 2007, LETT DRUG DES DISCOV, V4, P44; Anderson RM, 2009, TOXICOL PATHOL, V37, P47, DOI 10.1177/0192623308329476; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen S.Y, 2003, FLORA YUNNAN, V14, P1; Chen SL, 2010, AM J PHYSIOL-ENDOC M, V298, pE127, DOI 10.1152/ajpendo.00432.2009; Chi JT, 2003, P NATL ACAD SCI USA, V100, P10623, DOI 10.1073/pnas.1434429100; Daitoku H, 2011, BBA-MOL CELL RES, V1813, P1954, DOI 10.1016/j.bbamcr.2011.03.001; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Feng BA, 2011, DIABETES, V60, P2975, DOI 10.2337/db11-0478; Finkenzeller G, 2009, CELL PROLIFERAT, V42, P498, DOI 10.1111/j.1365-2184.2009.00610.x; Fontana L, 2007, JAMA-J AM MED ASSOC, V297, P986, DOI 10.1001/jama.297.9.986; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Gerrits PO, 2010, NEUROSCI RES, V67, P267, DOI 10.1016/j.neures.2010.04.010; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Han L, 2012, NUCLEIC ACIDS RES, V38, P7458; Hendrickx J, 2004, PHYSIOL GENOMICS, V19, P198, DOI 10.1152/physiolgenomics.00143.2004; Jang YC, 2009, EXP GERONTOL, V44, P256, DOI 10.1016/j.exger.2008.12.006; Kaur H, 2006, DIABETES, V55, P3104, DOI 10.2337/db06-0519; Khan Zia A., 2006, Current Vascular Pharmacology, V4, P45, DOI 10.2174/157016106775203081; Kloet DEA, 2011, BBA-MOL CELL RES, V1813, P1926, DOI 10.1016/j.bbamcr.2011.04.003; Kousteni S, 2011, J BONE MINER RES, V26, P912, DOI 10.1002/jbmr.306; Malik AI, 2011, GENE, V485, P114, DOI 10.1016/j.gene.2011.06.014; Matsui-Hirai H, 2011, J PHARMACOL EXP THER, V337, P591, DOI 10.1124/jpet.110.177584; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Mozaffarian D, 2009, ARCH INTERN MED, V169, P798, DOI 10.1001/archinternmed.2009.21; Nakagawa T, 2009, AGING-US, V1, P578, DOI 10.18632/aging.100062; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Ozden O, 2011, AGING-US, V3, P102, DOI 10.18632/aging.100291; Patlak Margie, 2002, FASEB Journal, V16, P1853, DOI 10.1096/fj.02-0974bkt; Rajendran R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/368276; Rao KS, 2009, INDIAN J BIOCHEM BIO, V46, P9; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rother KI, 2007, NEW ENGL J MED, V356, P1499, DOI 10.1056/NEJMp078030; Sangaralingham SJ, 2011, AM J PHYSIOL-RENAL, V301, pF943, DOI 10.1152/ajprenal.00170.2011; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Sen S, 2012, PHYTOMEDICINE, V19, P494, DOI 10.1016/j.phymed.2012.01.001; Smith JR, 2007, INVEST OPHTH VIS SCI, V48, P2676, DOI 10.1167/iovs.06-0598; Sosa MAG, 2010, AM J PATHOL, V176, P353, DOI 10.2353/ajpath.2010.090482; Taylor DM, 2008, CELL MOL LIFE SCI, V65, P4000, DOI 10.1007/s00018-008-8357-y; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Wu YX, 2010, CAN J PHYSIOL PHARM, V88, P607, DOI 10.1139/Y10-033; Yamamoto H, 2007, MOL ENDOCRINOL, V21, P1745, DOI 10.1210/me.2007-0079	45	130	141	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54514	10.1371/journal.pone.0054514	http://dx.doi.org/10.1371/journal.pone.0054514			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342163	Green Submitted, Green Published, gold			2022-12-25	WOS:000313682700120
J	Pan, D; Marcato, P; Ahn, DG; Gujar, S; Pan, LZ; Shmulevitz, M; Lee, PWK				Pan, Da; Marcato, Paola; Ahn, Dae-Gyun; Gujar, Shashi; Pan, Lu-Zhe; Shmulevitz, Maya; Lee, Patrick W. K.			Activation of p53 by Chemotherapeutic Agents Enhances Reovirus Oncolysis	PLOS ONE			English	Article							NF-KAPPA-B; APOPTOTIC RESPONSE; PHASE-I; CANCER; THERAPY; CYTOTOXICITY; PROMOTES; ARREST; SPREAD; TRIAL	Mammalian reovirus is a benign virus that possesses the natural ability to preferentially infect and kill cancer cells (reovirus oncolysis). Reovirus exploits aberrant Ras signalling in many human cancers to promote its own replication and spread. In vitro and in vivo studies using reovirus either singly or in combination with anti-cancer drugs have shown very encouraging results. Presently, a number of reovirus combination therapies are undergoing clinical trials for a variety of cancers. Previously we showed that accumulation of the tumor suppressor protein p53 by Nutlin-3a (a specific p53 stabilizer) enhanced reovirus-induced apoptosis, and resulted in significantly higher levels of reovirus dissemination. In this study, we examined the role of p53 in combination therapies involving reovirus and chemotherapeutic drugs. We showed that sublethal concentrations of traditional chemotherapy drugs actinomycin D or etoposide, but not doxorubicin, enhanced reovirus-induced apoptosis in a p53-dependent manner. Furthermore, NF-kappa B activation and expression of p53-target genes (p21 and bax) were important for the p53-dependent enhancement of cell death. Our results show that p53 status affects the efficacy of combination therapy involving reovirus. Choosing the right combination partner for reovirus and a low dosage of the drug may help to both enhance reovirus-induced cancer elimination and reduce drug toxicity.	[Pan, Da; Ahn, Dae-Gyun; Gujar, Shashi; Pan, Lu-Zhe; Lee, Patrick W. K.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Marcato, Paola; Lee, Patrick W. K.] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Shmulevitz, Maya] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada	Dalhousie University; Dalhousie University; University of Alberta	Lee, PWK (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada.	patrick.lee@dal.ca	; Ahn, Dae-Gyun/L-7106-2015	Shmulevitz, Maya/0000-0002-8627-068X; Marcato, Paola/0000-0001-8619-283X; Gujar, Shashi/0000-0002-5427-0829; Ahn, Dae-Gyun/0000-0001-8251-8820	Canadian Institutes for Health Research (CIHR); Cancer Research Training Program (CRTP) through Dalhousie University; Alberta Heritage Foundation for Medical Research; CRTP	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cancer Research Training Program (CRTP) through Dalhousie University; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); CRTP	This work was supported by an operating grant from the Canadian Institutes for Health Research (CIHR) (P.W.K Lee), doctoral scholarships from the Cancer Research Training Program (CRTP) through Dalhousie University (D. Pan), and postdoctoral fellowships from the Alberta Heritage Foundation for Medical Research (P. Marcato) and CRTP (P. Marcato and S. Gujar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain T, 2002, BLOOD, V100, P4146, DOI 10.1182/blood-2002-02-0503; Bagnyukova T, 2010, CANCER BIOL THER, V10, P843, DOI 10.4161/cbt.10.9.13738; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Berard Alicia, 2009, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/9780471729259.mc15c01s14; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chang PY, 2006, MOL CANCER RES, V4, P101, DOI 10.1158/1541-7786.MCR-05-0259; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Coffey MC, 1998, SCIENCE, V282, P1332, DOI 10.1126/science.282.5392.1332; Dey A, 2008, BRIT J CANCER, V98, P4, DOI 10.1038/sj.bjc.6604098; DUNCAN MR, 1978, J VIROL, V28, P444, DOI 10.1128/JVI.28.2.444-449.1978; Forsyth P, 2008, MOL THER, V16, P627, DOI 10.1038/sj.mt.6300403; Gollamudi R, 2010, INVEST NEW DRUG, V28, P641, DOI 10.1007/s10637-009-9279-8; Harrington KJ, 2010, CYTOKINE GROWTH F R, V21, P91, DOI 10.1016/j.cytogfr.2010.02.006; Harrington KJ, 2010, CLIN CANCER RES, V16, P3067, DOI 10.1158/1078-0432.CCR-10-0054; Harrison C, 2012, NAT REV DRUG DISCOV, V11, DOI 10.1038/nrd3782; HASHIRO G, 1977, ARCH VIROL, V54, P307, DOI 10.1007/BF01314776; Hingorani P, 2011, CANCER-AM CANCER SOC, V117, P1764, DOI 10.1002/cncr.25741; Hirasawa K, 2002, CANCER RES, V62, P1696; Karapanagiotou EM, 2012, CLIN CANCER RES, V18, P2080, DOI 10.1158/1078-0432.CCR-11-2181; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Lolkema MP, 2011, CLIN CANCER RES, V17, P581, DOI 10.1158/1078-0432.CCR-10-2159; Marcato P, 2007, MOL THER, V15, P1522, DOI 10.1038/sj.mt.6300179; Marcato P, 2009, MOL THER, V17, P972, DOI 10.1038/mt.2009.58; Mendez II, 2000, J VIROL METHODS, V90, P59, DOI 10.1016/S0166-0934(00)00217-2; Norman KL, 2002, HUM GENE THER, V13, P641, DOI 10.1089/10430340252837233; Pan D, 2011, BRIT J CANCER, V105, P1012, DOI 10.1038/bjc.2011.325; Pandha HS, 2009, CLIN CANCER RES, V15, P6158, DOI 10.1158/1078-0432.CCR-09-0796; Shmulevitz M, 2010, CANCER RES, V70, P4912, DOI 10.1158/0008-5472.CAN-09-4676; SMITH RE, 1969, VIROLOGY, V39, P791, DOI 10.1016/0042-6822(69)90017-8; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Strong JE, 1998, EMBO J, V17, P3351, DOI 10.1093/emboj/17.12.3351; Thirukkumaran CM, 2010, CANCER RES, V70, P2435, DOI 10.1158/0008-5472.CAN-09-2408; Twigger K, 2008, CLIN CANCER RES, V14, P912, DOI 10.1158/1078-0432.CCR-07-1400; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Vidal L, 2008, CLIN CANCER RES, V14, P7127, DOI 10.1158/1078-0432.CCR-08-0524; Wuerzberger-Davis SM, 2005, MOL CANCER RES, V3, P345, DOI 10.1158/1541-7786.MCR-05-0028; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Yu X, 2012, CANCER CELL, V21, P614, DOI 10.1016/j.ccr.2012.03.042; Zhang GH, 1997, BIOTECHNIQUES, V23, P525, DOI 10.2144/97233pf01; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989	40	16	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							Citation: e54006	10.1371/journal.pone.0054006	http://dx.doi.org/10.1371/journal.pone.0054006			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342061	Green Published, gold, Green Submitted			2022-12-25	WOS:000313682700075
J	Varzari, A; Kharkov, V; Nikitin, AG; Raicu, F; Simonova, K; Stephan, W; Weiss, EH; Stepanov, V				Varzari, Alexander; Kharkov, Vladimir; Nikitin, Alexey G.; Raicu, Florina; Simonova, Kseniya; Stephan, Wolfgang; Weiss, Elisabeth H.; Stepanov, Vadim			Paleo-Balkan and Slavic Contributions to the Genetic Pool of Moldavians: Insights from the Y Chromosome	PLOS ONE			English	Article							LINEAGES; POPULATIONS; REVEALS; E-M78; DNA	Moldova has a rich historical and cultural heritage, which may be reflected in the current genetic makeup of its population. To date, no comprehensive studies exist about the population genetic structure of modern Moldavians. To bridge this gap with respect to paternal lineages, we analyzed 37 binary and 17 multiallelic (STRs) polymorphisms on the non-recombining portion of the Y chromosome in 125 Moldavian males. In addition, 53 Ukrainians from eastern Moldova and 54 Romanians from the neighboring eastern Romania were typed using the same set of markers. In Moldavians, 19 Y chromosome haplogroups were identified, the most common being I-M423 (20.8%), R-M17* (17.6%), R-M458 (12.8%), E-v13 (8.8%), R-M269* and R-M412* (both 7.2%). In Romanians, 14 haplogroups were found including I-M423 (40.7%), R-M17* (16.7%), R-M405 (7.4%), E-v13 and R-M412* (both 5.6%). In Ukrainians, 13 haplogroups were identified including R-M17 (34.0%), I-M423 (20.8%), R-M269* (9.4%), N-M178, R-M458 and R-M73 (each 5.7%). Our results show that a significant majority of the Moldavian paternal gene pool belongs to eastern/central European and Balkan/eastern Mediterranean Y lineages. Phylogenetic and AMOVA analyses based on Y-STR loci also revealed that Moldavians are close to both eastern/central European and Balkan-Carpathian populations. The data correlate well with historical accounts and geographical location of the region and thus allow to hypothesize that extant Moldavian paternal genetic lineages arose from extensive recent admixture between genetically autochthonous populations of the Balkan-Carpathian zone and neighboring Slavic groups.	[Varzari, Alexander] Phthisiopneumol Inst Chiril Draganiuc, Kishinev, Moldova; [Varzari, Alexander; Kharkov, Vladimir; Simonova, Kseniya; Stepanov, Vadim] Russian Acad Med Sci, Res Inst Med Genet, Tomsk, Russia; [Varzari, Alexander; Stephan, Wolfgang; Weiss, Elisabeth H.] Univ Munich, Dept Biol 2, Planegg Martinsried, Germany; [Nikitin, Alexey G.] Grand Valley State Univ, Dept Biol, Allendale, MI 49401 USA; [Raicu, Florina] Romanian Acad, Anthropol Res Ctr Francisc Rainer, Bucharest, Romania; [Raicu, Florina] Carol Davila Univ Med & Pharm, Fac Med, Genet Chair, Bucharest, Romania; [Stepanov, Vadim] Genomnaya Diagnost Ltd, Tomsk, Russia	Russian Academy of Medical Sciences; Russian Academy of Sciences; Tomsk National Research Medical Center; Research Institute of Medical Genetics - Tomsk; University of Munich; Grand Valley State University; Romanian Academy of Sciences; Carol Davila University of Medicine & Pharmacy	Varzari, A (corresponding author), Phthisiopneumol Inst Chiril Draganiuc, Kishinev, Moldova.	varsahr@yahoo.com	Вагайцева, Ксения/A-7894-2014; Stepanov, Vadim/G-4320-2013; Kharkov, Vladimir/A-7884-2014; Vagaytseva, Kseniya/GZL-0221-2022; Stepanov, Vadim A./N-7657-2014; Stephan, Wolfgang/GOV-6503-2022; Nikitin, Alexey G/I-2651-2019; Raicu, Florina/A-4531-2011	Вагайцева, Ксения/0000-0003-4877-9749; Stepanov, Vadim/0000-0002-5166-331X; Kharkov, Vladimir/0000-0002-1679-2212; Vagaytseva, Kseniya/0000-0003-4877-9749; Nikitin, Alexey G/0000-0002-3897-4607; 	Russian Ministry of Science and Education [16.512.11.2033, 11.519.11.2036, P321]; DAAD	Russian Ministry of Science and Education(Ministry of Education and Science, Russian Federation); DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by the Russian Ministry of Science and Education (contracts # 16.512.11.2033, 11.519.11.2036 and P321). AV was supported by a DAAD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ayub Q, 2000, Nucleic Acids Res, V28, pe8, DOI 10.1093/nar/28.2.e8; Balanovsky O, 2008, AM J HUM GENET, V82, P236, DOI 10.1016/j.ajhg.2007.09.019; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Battaglia V, 2009, EUR J HUM GENET, V17, P820, DOI 10.1038/ejhg.2008.249; Bosch E, 2006, ANN HUM GENET, V70, P459, DOI 10.1111/j.1469-1809.2005.00251.x; Butler JM, 2002, FORENSIC SCI INT, V129, P10, DOI 10.1016/S0379-0738(02)00195-0; Cruciani F, 2007, MOL BIOL EVOL, V24, P1300, DOI 10.1093/molbev/msm049; Cruciani F, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9445; Csanyi B, 2008, ANN HUM GENET, V72, P519, DOI 10.1111/j.1469-1809.2008.00440.x; deKnijff P, 1997, INT J LEGAL MED, V110, P134, DOI 10.1007/s004140050052; Dergachev V, 2000, J INDO-EUR STUD, V28, P257; Dumitrescu VL, 1982, PREHISTORY BALKANS M, P1; Ellis N, 2002, GENOME RES, V12, P339; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Flores C, 2003, ANN HUM GENET, V67, P138, DOI 10.1046/j.1469-1809.2003.00015.x; Fyodorov GB, 1999, STRATUM PLUS, V5, P14; Garasanin M, 1982, PREHISTORY BALKANS M, P75; Gimbutas, 1973, J INDOEUROPEAN STUDI, V1, P163; Guboglo MN, 2010, MOLDAVIANS; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Hurles ME, 1998, AM J HUM GENET, V63, P1793, DOI 10.1086/302147; Hurles ME, 1999, AM J HUM GENET, V67, P1055; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Karafet TM, 2002, HUM BIOL, V74, P761, DOI 10.1353/hub.2003.0006; Kasuba M, 2010, ISTORIA MOLDOVEI EPO, P313; Kayser M, 1997, INT J LEGAL MED, V110, P125, DOI 10.1007/s004140050051; Khar'kov V N, 2011, Mol Biol (Mosk), V45, P446; KHARKOV NV, 2005, RUSS J GENET, V41, P938; Kharkov VN, 2007, RUSS J GENET+, V43, P551, DOI 10.1134/S1022795407050110; Kharkov VN, 2004, RUSS J GENET+, V40, P326, DOI 10.1023/B:RUGE.0000021635.80528.2f; Klepper N, 2002, ROMANIA ILLUSTRATED; Larina O, 2010, ISTORIA MOLDOVEI EPO, P177; MATHIAS N, 1994, HUM MOL GENET, V3, P115, DOI 10.1093/hmg/3.1.115; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Myres NM, 2007, CROAT MED J, V48, P450; Myres NM, 2011, EUR J HUM GENET, V19, P95, DOI 10.1038/ejhg.2010.146; Nasidze I, 2007, ANN HUM GENET, V71, P379, DOI 10.1111/j.1469-1809.2006.00330.x; Renfrew AC, 1987, ARCHAEOLOGY LANGUAGE; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Russev ND, 1999, STRATUM PLUS, V5, P379; Sedov VV, 2002, SLAVS HIST ARCHAEOLO; Shchukin MB, 1989, ROME BARBARIANS CENT; Sims LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005792; Stefan M, 2001, EUR J HUM GENET, V9, P27, DOI 10.1038/sj.ejhg.5200580; Underhill PA, 2010, EUR J HUM GENET, V18, P479, DOI 10.1038/ejhg.2009.194; Varsahr A. M., 2006, Anthropologischer Anzeiger, V64, P51; Varzari A, 2007, J HUM GENET, V52, P308, DOI 10.1007/s10038-007-0113-x; Varzari A, 2009, AM J HUM BIOL, V21, P326, DOI 10.1002/ajhb.20863; Zbenovich VG, 1996, J WORLD PREHIST, V10, P199, DOI 10.1007/BF02221076; Zerjal T, 1997, AM J HUM GENET, V60, P1174	51	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53731	10.1371/journal.pone.0053731	http://dx.doi.org/10.1371/journal.pone.0053731			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341985	Green Published, Green Submitted, gold			2022-12-25	WOS:000313682700040
J	Gajiwala, KS; Maegley, K; Ferre, R; He, YA; Yu, X				Gajiwala, Ketan S.; Maegley, Karen; Ferre, RoseAnn; He, You-Ai; Yu, Xiu			Ack1: Activation and Regulation by Allostery	PLOS ONE			English	Article							TYROSINE KINASE ACK1; GROWTH-FACTOR RECEPTOR; CDC42-ASSOCIATED KINASE; CRYSTAL-STRUCTURE; EGF RECEPTOR; SH3 DOMAINS; MECHANISM; SRC; SPECIFICITY; BINDING	The non-receptor tyrosine kinase Ack1 belongs to a unique multi-domain protein kinase family, Ack. Ack is the only family of SH3 domain containing kinases to have an SH3 domain following the kinase domain; others have their SH3 domains preceding the kinase domain. Previous reports have suggested that Ack1 does not require phosphorylation for activation and the enzyme activity of the isolated kinase domain is low relative to other kinases. It has been shown to dimerize in the cellular environment, which augments its enzyme activity. The molecular mechanism of activation, however, remains unknown. Here we present structural and biochemical data on Ack1 kinase domain, and kinase domain+SH3 domain that suggest that Ack1 in its monomeric state is autoinhibited, like EGFR and CDK. The activation of the kinase domain may require N-lobe mediated symmetric dimerization, which may be facilitated by the N-terminal SAM domain. Results presented here show that SH3 domain, unlike in Src family tyrosine kinases, does not directly control the activation state of the enzyme. Instead we speculate that the SH3 domain may play a regulatory role by facilitating binding of the MIG6 homologous region to the kinase domain. We postulate that features of Ack1 activation and regulation parallel those of receptor tyrosine kinase EGFR with some interesting differences.	[Gajiwala, Ketan S.; Ferre, RoseAnn; He, You-Ai; Yu, Xiu] Pfizer Worldwide Res & Dev, Canc Struct Biol Oncol Med Chem, San Diego, CA USA; [Maegley, Karen] Pfizer Worldwide Res & Dev, Oncol Res Unit, San Diego, CA USA	Pfizer; Pfizer	Gajiwala, KS (corresponding author), Pfizer Worldwide Res & Dev, Canc Struct Biol Oncol Med Chem, San Diego, CA USA.	Ketan.gajiwala@pfizer.com			Pfizer	Pfizer(Pfizer)	Funding for this research was provided by Pfizer, and all authors are paid employees of the company. However, the study was designed, data collected and analyzed, and the manuscript prepared exclusively by the authors of this work.	Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Chan W, 2011, BIOCHEM J, V435, P355, DOI 10.1042/BJ20102156; Eisenmann KM, 1999, NAT CELL BIOL, V1, P507, DOI 10.1038/70302; Endres NF, 2011, CURR OPIN STRUCT BIO; Galisteo ML, 2006, P NATL ACAD SCI USA, V103, P9796, DOI 10.1073/pnas.0603714103; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kopecky DJ, 2008, BIOORG MED CHEM LETT, V18, P6352, DOI 10.1016/j.bmcl.2008.10.092; Kristensen O, 2006, EMBO J, V25, P785, DOI 10.1038/sj.emboj.7600982; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Lougheed JC, 2004, J BIOL CHEM, V279, P44039, DOI 10.1074/jbc.M406703200; Mahajan NP, 2005, CANCER RES, V65, P10514, DOI 10.1158/0008-5472.CAN-05-1127; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; Massenet C, 2005, J BIOL CHEM, V280, P13752, DOI 10.1074/jbc.M412897200; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; MUSACCHIO A, 1992, NATURE, V359, P851, DOI 10.1038/359851a0; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Prieto-Echagile V., 2011, J SIGNAL TRANSDUCT, V2011; Prieto-Echague V, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-42; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; van der Horst EH, 2005, P NATL ACAD SCI USA, V102, P15901, DOI 10.1073/pnas.0508014102; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yeow-Fong L, 2005, FEBS LETT, V579, P5040, DOI 10.1016/j.febslet.2005.07.093; Yokoyama N, 2005, J BIOL CHEM, V280, P42219, DOI 10.1074/jbc.M506996200; Yokoyama N, 2003, J BIOL CHEM, V278, P47713, DOI 10.1074/jbc.M306716200; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998	34	13	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53994	10.1371/journal.pone.0053994	http://dx.doi.org/10.1371/journal.pone.0053994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342057	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400109
J	Loening, NM; Wilson, ZN; Zobel-Thropp, PA; Binford, GJ				Loening, Nikolaus M.; Wilson, Zachary N.; Zobel-Thropp, Pamela A.; Binford, Greta J.			Solution Structures of Two Homologous Venom Peptides from Sicarius dolichocephalus	PLOS ONE			English	Article							NMR CHEMICAL-SHIFTS; INSECTICIDAL NEUROTOXINS; CYSTINE KNOT; SPIDERS; DISCOVERY; TOXINS; IDENTIFICATION; POLYPEPTIDES; LOXOSCELES; ASSIGNMENT	We present solution-state NMR structures for two putative venom peptides from Sicarius dolichocephalus. These peptides were identified from cDNA libraries created from venom gland mRNA and then recombinantly expressed. They are the first structures from any species of Sicarius spiders, and the first peptide structures for any haplogyne spiders. These peptides are homologous to one another, and while they have at most only 20% sequence identity with known venom peptides their structures follow the inhibitor cystine knot motif that has been found in a broad range of venom peptides.	[Loening, Nikolaus M.; Wilson, Zachary N.] Lewis & Clark Coll, Dept Chem, Portland, OR 97219 USA; [Zobel-Thropp, Pamela A.; Binford, Greta J.] Lewis & Clark Coll, Dept Biol, Portland, OR 97219 USA		Loening, NM (corresponding author), Lewis & Clark Coll, Dept Chem, Portland, OR 97219 USA.	loening@lclark.edu		Loening, Nikolaus/0000-0002-5074-6906; Wilson, Zachary/0000-0003-4269-4058	National Institute of General Medical Sciences [R15GM085733, R15GM097696]; National Science Foundation [IOB-0546858]; John S. Rogers Science Research Program at Lewis Clark College; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM085733, R15GM097696] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); John S. Rogers Science Research Program at Lewis Clark College; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	N.M.L. was supported by Award Number R15GM085733 from the National Institute of General Medical Sciences. G.J.B and P.A.Z were supported by Award Number R15GM097696 from the National Institute of General Medical Sciences and CAREER Award IOB-0546858 from the National Science Foundation. Z.N.W. acknowledges support from the John S. Rogers Science Research Program at Lewis & Clark College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Binford GJ, 2003, COMP BIOCHEM PHYS B, V135, P25, DOI 10.1016/S1096-4959(03)00045-9; Binford GJ, 2008, MOL PHYLOGENET EVOL, V49, P538, DOI 10.1016/j.ympev.2008.08.003; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; de Castro CS, 2004, TOXICON, V44, P273, DOI 10.1016/j.toxicon.2004.05.028; Escoubas P, 2004, TOXICON, V43, P555, DOI 10.1016/j.toxicon.2004.02.007; Escoubas P, 2009, EXPERT REV PROTEOMIC, V6, P221, DOI 10.1586/EPR.09.45; Herzig V, 2011, NUCLEIC ACIDS RES, V39, pD653, DOI 10.1093/nar/gkq1058; Jensen JE, 2009, TOXICON, V54, P56, DOI 10.1016/j.toxicon.2009.03.014; King GF, 2002, J TOXICOL-TOXIN REV, V21, P359, DOI 10.1081/TXR-120014409; King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020; Kozlov S, 2005, PROTEINS, V59, P131, DOI 10.1002/prot.20390; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; Liang SP, 1999, J PROTEIN CHEM, V18, P619, DOI 10.1023/A:1020693920990; Liu Q, 2006, J BIOL CHEM, V281, P32861, DOI 10.1074/jbc.M606365200; MADDISON D. R., 2005, MACCLADE 4 ANAL PHYL; Murakami MT, 2005, J BIOL CHEM, V280, P13658, DOI 10.1074/jbc.M412437200; Nilges M, 2008, STRUCTURE, V16, P1305, DOI 10.1016/j.str.2008.07.008; Norton RS, 1998, TOXICON, V36, P1573, DOI 10.1016/S0041-0101(98)00149-4; Ostrow KL, 2003, TOXICON, V42, P263, DOI 10.1016/S0041-0101(03)00141-7; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Platnick N. I., 1991, AM MUS NOVIT, V3016, P1; Platnick N.I., 2012, WORLD SPIDER CATALOG; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Schanda P, 2006, J AM CHEM SOC, V128, P9042, DOI 10.1021/ja062025p; Selden PA, 2010, BIOL REV, V85, P171, DOI 10.1111/j.1469-185X.2009.00099.x; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sollod BL, 2005, PEPTIDES, V26, P131, DOI 10.1016/j.peptides.2004.07.016; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang XH, 2000, NAT STRUCT BIOL, V7, P505, DOI 10.1038/75921; Wang XH, 2001, J BIOL CHEM, V276, P40306, DOI 10.1074/jbc.M105206200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Zhang YQ, 2010, ZOOLOGY, V113, P10, DOI 10.1016/j.zool.2009.04.001	38	5	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54401	10.1371/journal.pone.0054401	http://dx.doi.org/10.1371/journal.pone.0054401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342149	Green Submitted, Green Published, gold			2022-12-25	WOS:000314759400159
J	Athavale, SS; Gossett, JJ; Bowman, JC; Hud, NV; Williams, LD; Harvey, SC				Athavale, Shreyas S.; Gossett, J. Jared; Bowman, Jessica C.; Hud, Nicholas V.; Williams, Loren Dean; Harvey, Stephen C.			In Vitro Secondary Structure of the Genomic RNA of Satellite Tobacco Mosaic Virus	PLOS ONE			English	Article							SHAPE CHEMISTRY; CONSTRAINTS; TRANSCRIPTS; PREDICTION; RESOLUTION; IONS	Satellite tobacco mosaic virus (STMV) is a T = 1 icosahedral virus with a single-stranded RNA genome. It is widely accepted that the RNA genome plays an important structural role during assembly of the STMV virion. While the encapsidated form of the RNA has been extensively studied, less is known about the structure of the free RNA, aside from a purported tRNA-like structure at the 3' end. Here we use selective 2'-hydroxyl acylation analyzed by primer extension (SHAPE) analysis to examine the secondary structure of in vitro transcribed STMV RNA. The predicted secondary structure is unusual in the sense that it is highly extended, which could be significant for protecting the RNA from degradation. The SHAPE data are also consistent with the previously predicted tRNA-like fold at the 3' end of the molecule, which is also known to hinder degradation. Our data are not consistent with the secondary structure proposed for the encapsidated RNA by Schroeder et al., suggesting that, if the Schroeder structure is correct, either the RNA is packaged as it emerges from the replication complex, or the RNA undergoes extensive refolding upon encapsidation. We also consider the alternative, i.e., that the structure of the encapsidated STMV RNA might be the same as the in vitro structure presented here, and we examine how this structure might be organized in the virus. This possibility is not rigorously ruled out by the available data, so it remains open to examination by experiment.	[Athavale, Shreyas S.; Gossett, J. Jared; Harvey, Stephen C.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Bowman, Jessica C.; Hud, Nicholas V.; Williams, Loren Dean; Harvey, Stephen C.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Gossett, J. Jared] Georgia Inst Technol, Sch Computat Sci & Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Harvey, SC (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	steve.harvey@biology.gatech.edu	Hud, Nicholas V/T-7017-2017	Hud, Nicholas/0000-0001-7711-6472; Bowman, Jessica/0000-0002-6219-2680	National Institutes of Health [GM 70785]; NASA Astrobiology Institute [NNA09DA78A]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070785] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NASA Astrobiology Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by grant GM 70785 to SCH from the National Institutes of Health (URL: www.nih.gov) and by grant NNA09DA78A to LDW from the NASA Astrobiology Institute (URL: astrobiology.nasa.gov/nai). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athavale SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038024; Athavale SS, 2012, RNA, V18, P752, DOI 10.1261/rna.030692.111; Bindewald E, 2011, RNA, V17, P1688, DOI 10.1261/rna.2640111; Bowman JC, 2012, CURR OPIN STRUC BIOL, V22, P262, DOI 10.1016/j.sbi.2012.04.006; Brion P, 1997, ANNU REV BIOPH BIOM, V26, P113, DOI 10.1146/annurev.biophys.26.1.113; Choi YG, 2002, P NATL ACAD SCI USA, V99, P655, DOI 10.1073/pnas.022618199; Cordero P, 2012, BIOCHEMISTRY-US, V51, P7037, DOI 10.1021/bi3008802; Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106; Dodds JA, 1998, ANNU REV PHYTOPATHOL, V36, P295, DOI 10.1146/annurev.phyto.36.1.295; Draper DE, 2008, BIOPHYS J, V95, P5489, DOI 10.1529/biophysj.108.131813; Dreher TW, 1999, ANNU REV PHYTOPATHOL, V37, P151, DOI 10.1146/annurev.phyto.37.1.151; FELDEN B, 1994, NUCLEIC ACIDS RES, V22, P2882, DOI 10.1093/nar/22.15.2882; GALLIE DR, 1991, NUCLEIC ACIDS RES, V19, P5031, DOI 10.1093/nar/19.18.5031; Gossele V, 2002, PLANT J, V32, P859, DOI 10.1046/j.1365-313X.2002.01471.x; GULTYAEV AP, 1994, J GEN VIROL, V75, P2851, DOI 10.1099/0022-1317-75-10-2851; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Kladwang W, 2011, BIOCHEMISTRY-US, V50, P8049, DOI [10.1021/bi4200524n, 10.1021/bi200524n]; Kuznetsov YG, 2010, NUCLEIC ACIDS RES, V38, P8284, DOI 10.1093/nar/gkq662; Larson SB, 1998, J MOL BIOL, V277, P37, DOI 10.1006/jmbi.1997.1570; Larson SB, 2001, CURR OPIN STRUC BIOL, V11, P59, DOI 10.1016/S0959-440X(00)00166-4; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; McGinnis JL, 2012, J AM CHEM SOC, V134, P6617, DOI 10.1021/ja2104075; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; MIRKOV TE, 1989, VIROLOGY, V170, P139, DOI 10.1016/0042-6822(89)90361-9; MIRKOV TE, 1990, VIROLOGY, V179, P395, DOI 10.1016/0042-6822(90)90307-D; Mortimer SA, 2008, J AM CHEM SOC, V130, P16178, DOI 10.1021/ja8061216; RAO ALN, 1989, P NATL ACAD SCI USA, V86, P5335, DOI 10.1073/pnas.86.14.5335; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; ROUTH G, 1995, VIROLOGY, V212, P121, DOI 10.1006/viro.1995.1460; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; Schneemann A, 2006, ANNU REV MICROBIOL, V60, P51, DOI 10.1146/annurev.micro.60.080805.142304; Schroeder SJ, 2011, BIOPHYS J, V101, P167, DOI 10.1016/j.bpj.2011.05.053; Soll D, 1995, TRNA STRUCTURE BIOSY, Vxiii; Vicens Q, 2007, RNA, V13, P536, DOI 10.1261/rna.400207; Wang MB, 2004, P NATL ACAD SCI USA, V101, P3275, DOI 10.1073/pnas.0400104101; Wilkinson KA, 2005, J AM CHEM SOC, V127, P4659, DOI 10.1021/ja0436749; Wilkinson KA, 2009, RNA, V15, P1314, DOI 10.1261/rna.1536209; Xu WX, 2012, MOL PLANT PATHOL, V13, P666, DOI 10.1111/j.1364-3703.2011.00776.x; Yoffe AM, 2008, P NATL ACAD SCI USA, V105, P16153, DOI 10.1073/pnas.0808089105; Zeng YY, 2012, J STRUCT BIOL, V180, P110, DOI 10.1016/j.jsb.2012.06.008	40	21	21	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54384	10.1371/journal.pone.0054384	http://dx.doi.org/10.1371/journal.pone.0054384			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349871	gold, Green Published, Green Submitted			2022-12-25	WOS:000314019100064
J	Samaniego, S; Marcu, KB				Samaniego, Sylvia; Marcu, Kenneth B.			IKK beta in Myeloid Cells Controls the Host Response to Lethal and Sublethal Francisella tularensis LVS Infection	PLOS ONE			English	Article							LIVE-VACCINE-STRAIN; NF-KAPPA-B; INNATE IMMUNE-RESPONSE; ALTERNATIVE ACTIVATION; INFLAMMATORY RESPONSES; INTRACELLULAR PATHOGEN; MACROPHAGE ACTIVATION; MURINE MACROPHAGES; DEFENSE MECHANISMS; REACTIVE NITROGEN	Background: The NF-kappa B activating kinases, IKK alpha and IKK beta, are key regulators of inflammation and immunity in response to infection by a variety of pathogens. Both IKK alpha and IKK beta have been reported to modulate either pro- or anti- inflammatory programs, which may be specific to the infectious organism or the target tissue. Here, we analyzed the requirements for the IKKs in myeloid cells in vivo in response to Francisella tularensis Live Vaccine Strain (Ft. LVS) infection. Methods and Principal Findings: In contrast to prior reports in which conditional deletion of IKK beta in the myeloid lineage promoted survival and conferred resistance to an in vivo group B streptococcus infection, we show that mice with a comparable conditional deletion (IKK beta cKO) succumb more rapidly to lethal Ft. LVS infection and are unable to control bacterial growth at sublethal doses. Flow cytometry analysis of hepatic non-parenchymal cells from infected mice reveals that IKK beta inhibits M1 classical macrophage activation two days post infection, which has the collateral effect of suppressing IFN-gamma(+) CD8(+) T cells. Despite this early enhanced inflammation, IKK beta cKO mice are unable to control infection; and this coincides with a shift toward M2a polarized macrophages. In comparison, we find that myeloid IKK beta is dispensable for survival and bacterial control. However, both IKK alpha and IKK beta have effects on hepatic granuloma development. IKK alpha cKO mice develop fewer, but well-contained granulomas that accumulate excess necrotic cells after 9 days of infection; while IKK beta cKO mice develop numerous micro-granulomas that are less well contained. Conclusions: Taken together our findings reveal that unlike IKK alpha, IKK beta has multiple, contrasting roles in this bacterial infection model by acting in an anti-inflammatory capacity at early times towards sublethal Ft. LVS infection; but in spite of this, macrophage IKK beta is also a critical effector for host survival and efficient pathogen clearance.	[Samaniego, Sylvia; Marcu, Kenneth B.] SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA; [Samaniego, Sylvia; Marcu, Kenneth B.] SUNY Stony Brook, Biochem & Cell Biol Dept, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Samaniego, S (corresponding author), SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA.	sysamani@gmail.com; kenneth.marcu@stonybrook.edu	Samaniego, Sylvia/M-3167-2014	Samaniego, Sylvia/0000-0002-1076-5459	National Institutes of Health [GM066882]; Boehringer Ingelheim Pharmaceuticals, Inc.; NCI through the Genetics Graduate Program of Stony Brook University [5 T32 CA009176]; NATIONAL CANCER INSTITUTE [T32CA009176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066882] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Pharmaceuticals, Inc.(Boehringer Ingelheim); NCI through the Genetics Graduate Program of Stony Brook University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM066882 and a research contract from Boehringer Ingelheim Pharmaceuticals, Inc. both awarded to KBM. NCI training grant 5 T32 CA009176 awarded to SS through the Genetics Graduate Program of Stony Brook University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abplanalp AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007920; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; ANTHONY LSD, 1991, INFECT IMMUN, V59, P3291, DOI 10.1128/IAI.59.9.3291-3296.1991; Ashida H, 2011, J CELL BIOL, V195, P931, DOI 10.1083/jcb.201108081; Baron SD, 2007, INFECT IMMUN, V75, P2152, DOI 10.1128/IAI.01606-06; Ben Nasr A, 2008, J LEUKOCYTE BIOL, V84, P77, DOI 10.1189/jlb.0807526; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; Bokhari SM, 2008, INFECT IMMUN, V76, P1379, DOI 10.1128/IAI.00745-07; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Bosio CM, 2005, J IMMUNOL, V175, P6792, DOI 10.4049/jimmunol.175.10.6792; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Chariot A, 2009, TRENDS CELL BIOL, V19, P404, DOI 10.1016/j.tcb.2009.05.006; Chen WX, 2005, IMMUNOL LETT, V97, P151, DOI 10.1016/j.imlet.2004.10.001; Chen WX, 2003, VACCINE, V21, P3690, DOI 10.1016/S0264-410X(03)00386-4; Chiavolini D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011156; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Clay CD, 2008, J IMMUNOL, V181, P5568, DOI 10.4049/jimmunol.181.8.5568; Clemens DL, 2005, INFECT IMMUN, V73, P5892, DOI 10.1128/IAI.73.9.5892-5902.2005; Cole LE, 2007, INFECT IMMUN, V75, P4127, DOI 10.1128/IAI.01868-06; Cole LE, 2006, J IMMUNOL, V176, P6888, DOI 10.4049/jimmunol.176.11.6888; Collazo CM, 2006, MICROBES INFECT, V8, P779, DOI 10.1016/j.micinf.2005.09.014; Conlan JW, 2008, MOL IMMUNOL, V45, P2962, DOI 10.1016/j.molimm.2008.01.022; Conlan JW, 2005, VACCINE, V23, P2477, DOI 10.1016/j.vaccine.2004.10.034; CONLAN JW, 1992, INFECT IMMUN, V60, P5164, DOI 10.1128/IAI.60.12.5164-5171.1992; Conlan JW, 2003, MICROB PATHOGENESIS, V34, P239, DOI 10.1016/S0882-4010(03)00046-9; CONLAN JW, 1994, INFECT IMMUN, V62, P5603, DOI 10.1128/IAI.62.12.5603-5607.1994; Duenas AI, 2006, INT IMMUNOL, V18, P785, DOI 10.1093/intimm/dxl015; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; ELKINS KL, 1993, INFECT IMMUN, V61, P823, DOI 10.1128/IAI.61.3.823-829.1993; Fong CHY, 2008, J EXP MED, V205, P1269, DOI 10.1084/jem.20080124; Foo SY, 2010, MUCOSAL IMMUNOL, V3, P537, DOI 10.1038/mi.2010.52; Forestal CA, 2003, J IMMUNOL, V171, P2563, DOI 10.4049/jimmunol.171.5.2563; Fortier A H, 1994, Immunol Ser, V60, P349; FORTIER AH, 1992, INFECT IMMUN, V60, P817, DOI 10.1128/IAI.60.3.817-825.1992; FORTIER AH, 1991, INFECT IMMUN, V59, P2922, DOI 10.1128/IAI.59.9.2922-2928.1991; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; GOLOVLIOV I, 1995, INFECT IMMUN, V63, P534, DOI 10.1128/IAI.63.2.534-538.1995; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hall JD, 2006, INFECT IMMUN, P01254; Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08; Hong KJ, 2007, INFECT IMMUN, V75, P5338, DOI 10.1128/IAI.00561-07; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Katz J, 2006, INFECT IMMUN, V74, P2809, DOI 10.1128/IAI.74.5.2809-2816.2006; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Lawrence T, 2010, INT J BIOCHEM CELL B, V42, P519, DOI 10.1016/j.biocel.2009.12.016; LEIBY DA, 1992, INFECT IMMUN, V60, P84, DOI 10.1128/IAI.60.1.84-89.1992; Li HF, 2006, J LEUKOCYTE BIOL, V80, P766, DOI 10.1189/jlb.0406294; Li QT, 2005, P NATL ACAD SCI USA, V102, P12425, DOI 10.1073/pnas.0505997102; Lindgren H, 2004, INFECT IMMUN, V72, P7172, DOI 10.1128/IAI.72.12.7172-7182.2004; Liu F, 2012, IMMUNOL REV, V246, P239, DOI 10.1111/j.1600-065X.2012.01107.x; Lyons CR, 2007, ANN NY ACAD SCI, V1105, P238, DOI 10.1196/annals.1409.003; Mancuso G, 2004, J IMMUNOL, V172, P6324, DOI 10.4049/jimmunol.172.10.6324; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; McCaffrey RL, 2006, J LEUKOCYTE BIOL, V80, P1224, DOI 10.1189/jlb.0406287; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Neyt K, 2012, TRENDS IMMUNOL, V33, P297, DOI 10.1016/j.it.2012.04.006; Parsa KVL, 2008, MOL IMMUNOL, V45, P3428, DOI 10.1016/j.molimm.2008.04.006; Penzo M, 2010, J IMMUNOL, V184, P4497, DOI 10.4049/jimmunol.0903131; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Rasmussen JW, 2006, INFECT IMMUN, V74, P6590, DOI 10.1128/IAI.00868-06; SANDSTROM G, 1988, INFECT IMMUN, V56, P1194; Santic M, 2005, CELL MICROBIOL, V7, P969, DOI 10.1111/j.1462-5822.2005.00526.x; Santic M, 2006, TRENDS MICROBIOL, V14, P37, DOI 10.1016/j.tim.2005.11.008; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Shirey KA, 2008, J IMMUNOL, V181, P4159, DOI 10.4049/jimmunol.181.6.4159; SJOSTEDT A, 1994, INFECT IMMUN, V62, P2779; Telepnev M, 2005, MICROB PATHOGENESIS, V38, P239, DOI 10.1016/j.micpath.2005.02.003; Telepnev M, 2003, CELL MICROBIOL, V5, P41, DOI 10.1046/j.1462-5822.2003.00251.x; Timmer AM, 2008, J EXP MED, V205, P1255, DOI 10.1084/jem.20081056; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vinogradov E, 2002, EUR J BIOCHEM, V269, P6112, DOI 10.1046/j.1432-1033.2002.03321.x; Yee D, 1996, J IMMUNOL, V157, P5042	75	3	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54124	10.1371/journal.pone.0054124	http://dx.doi.org/10.1371/journal.pone.0054124			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349802	Green Published, gold, Green Submitted			2022-12-25	WOS:000314019100046
J	Baiamonte, BA; Lee, FA; Brewer, ST; Spano, D; LaHoste, GJ				Baiamonte, Brandon A.; Lee, Franklin A.; Brewer, Steve T.; Spano, Daniela; LaHoste, Gerald J.			Attenuation of Rhes Activity Significantly Delays the Appearance of Behavioral Symptoms in a Mouse Model of Huntington's Disease	PLOS ONE			English	Article							MUTANT-HUNTINGTIN; CAG REPEATS; HD GENE; PATHOGENESIS; MECHANISMS; PROTEIN	Huntington's disease (HD) is a neuropsychiatric disorder characterized by choreiform movement of the limbs, cognitive disability, psychosis and dementia. It is invariably associated with an abnormally long CAG expansion within the IT15 gene on human chromosome 4. Although the mutant huntingtin protein is ubiquitously expressed in HD patients, cellular degeneration occurs predominantly in neurons within the corpus striatum and cerebral cortex. The Ras homolog Rhes is expressed very selectively in the precise brain areas affected by HD. Recent in vitro work suggests that Rhes may be a cofactor with mutant huntingtin in cell death. The objective of the present study was to examine whether the inhibition of Rhes would attenuate or delay the symptoms of HD in vivo. We used a transgenic mouse model of HD crossed with Rhes knockout mice to show that the behavioral symptoms of HD are regulated by Rhes. HD+/Rhes(-/-) mice showed significantly delayed expression of HD-like symptoms in this in vivo model. Drugs that block or inhibit the actions of Rhes may be useful as the first treatments for HD.	[Baiamonte, Brandon A.; Lee, Franklin A.; Brewer, Steve T.; LaHoste, Gerald J.] Univ New Orleans, Dept Psychol, Appl Biopsychol Program, New Orleans, LA 70148 USA; [Spano, Daniela] Univ Naples Federico II, Dipartimento Biochem & Biotecnol Med, Naples, Italy; [Spano, Daniela] CEINGE Biotecnol Avanzate, Naples, Italy	University of Louisiana System; University of New Orleans; University of Naples Federico II; CEINGE Biotecnologie Avanzate	LaHoste, GJ (corresponding author), Univ New Orleans, Dept Psychol, Appl Biopsychol Program, New Orleans, LA 70148 USA.	glahoste@uno.edu		Spano, Daniela/0000-0003-3567-6492				ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Falk JD, 1999, J NEUROSCI RES, V57, P782, DOI 10.1002/(SICI)1097-4547(19990915)57:6<782::AID-JNR3>3.0.CO;2-9; Gil JM, 2008, EUR J NEUROSCI, V27, P2803, DOI 10.1111/j.1460-9568.2008.06310.x; Harrison LM, 2006, NEUROSCIENCE, V137, P483, DOI 10.1016/j.neuroscience.2005.08.017; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huntington G., 1872, MED SURGICAL REPORTE, V26, P320; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kuemmerle S, 1999, ANN NEUROL, V46, P842; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; Lin X, 2003, J BIOL CHEM, V278, P31043, DOI 10.1074/jbc.C300112200; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Pineda JR, 2005, J NEUROCHEM, V93, P1057, DOI 10.1111/j.1471-4159.2005.03047.x; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; Sathasivam K, 1997, HUM GENET, V99, P692, DOI 10.1007/s004390050432; Spalding JF, 1982, ENERGY CITATIONS DAT; Spano D, 2004, MOL CELL BIOL, V24, P5788, DOI 10.1128/MCB.24.13.5788-5796.2004; Stack EC, 2005, J COMP NEUROL, V490, P354, DOI 10.1002/cne.20680; Steffan JS, 2010, CELL CYCLE, V9, P3401, DOI [10.4161/cc.9.17.12718, 10.4161/cc.9.17.12671]; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Subramaniam S, 2010, J BIOL CHEM, V285, P20428, DOI 10.1074/jbc.C110.127191; Subramaniam S, 2009, SCIENCE, V324, P1327, DOI 10.1126/science.1172871; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	29	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e53606	10.1371/journal.pone.0053606	http://dx.doi.org/10.1371/journal.pone.0053606			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349722	gold, Green Published, Green Submitted			2022-12-25	WOS:000313943000014
J	Hoesein, FAAM; Wauters, E; Janssens, W; Groen, HJM; Smolonska, J; Wijmenga, C; Postma, DS; Boezen, HM; De Jong, PA; Decramer, M; Lammers, JWJ; Lambrechts, D; Zanen, P				Hoesein, Firdaus A. A. Mohamed; Wauters, Els; Janssens, Wim; Groen, Harry J. M.; Smolonska, Joanna; Wijmenga, Cisca; Postma, Dirkje S.; Boezen, H. Marike; De Jong, Pim A.; Decramer, Marc; Lammers, Jan-Willem J.; Lambrechts, Diether; Zanen, Pieter			Variants in the 15q24/25 Locus Associate with Lung Function Decline in Active Smokers	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; GENOME-WIDE ASSOCIATION; NICOTINE DEPENDENCE; SUSCEPTIBILITY LOCUS; EPITHELIAL-CELLS; CANCER; SMOKING; SUBUNIT; GENES; 15Q25.1	Genetic variation in nicotinic acetylcholine receptor subunit genes (nAChRs) is associated with lung function level and chronic obstructive pulmonary disease (COPD). It is unknown whether these variants also predispose to an accelerated lung function decline. We investigated the association of nAChR susceptibility variants with lung function decline and COPD severity. The rs1051730 and rs8034191 variants were genotyped in a population-based cohort of 1,226 heavy smokers (COPACETIC) and in an independent cohort of 883 heavy smokers, of which 653 with COPD of varying severity (LEUVEN). Participants underwent pulmonary function tests at baseline. Lung function decline was assessed over a median follow-up of 3 years in COPACETIC. Current smokers homozygous for the rs1051730 A-allele or rs8034191 G-allele had significantly greater FEV1/FVC decline than homozygous carriers of wild-type alleles (3.3% and 4.3%, p = 0.026 and p = 0.009, respectively). In the LEUVEN cohort, rs1051730 AA-carriers and rs8034191 GG-carriers had a two-fold increased risk to suffer from COPD GOLD IV (OR 2.29, 95% confidence interval [CI] = 1.11-4.75; p = 0.025 and OR = 2.42, 95% [CI] = 1.18-4.95; p = 0.016, respectively). The same risk alleles conferred, respectively, a five-and four-fold increased risk to be referred for lung transplantation because of end-stage COPD (OR = 5.0, 95% [CI] = 1.68-14.89; p = 0.004 and OR = 4.06, 95% [CI] = 1.39-11.88; p = 0.010). In Europeans, variants in nAChRs associate with an accelerated lung function decline in current smokers and with clinically relevant COPD.	[Hoesein, Firdaus A. A. Mohamed; Lammers, Jan-Willem J.; Zanen, Pieter] Univ Med Ctr, Div Heart & Lungs, Dept Resp Med, Utrecht, Netherlands; [Wauters, Els; Janssens, Wim; Decramer, Marc] Katholieke Univ Leuven, Div Resp, Univ Hosp Gasthuisberg, Louvain, Belgium; [Wauters, Els; Lambrechts, Diether] VIB, Vesalius Res Ctr, Louvain, Belgium; [Wauters, Els; Lambrechts, Diether] Katholieke Univ Leuven, Vesalius Res Ctr, Louvain, Belgium; [Groen, Harry J. M.; Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands; [Smolonska, Joanna; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Boezen, H. Marike] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [De Jong, Pim A.] Univ Med Ctr, Dept Radiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; KU Leuven; University Hospital Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Groningen; University of Groningen; University of Groningen; Utrecht University; Utrecht University Medical Center	Hoesein, FAAM (corresponding author), Univ Med Ctr, Div Heart & Lungs, Dept Resp Med, Utrecht, Netherlands.	fmohamedhoesein@gmail.com	Wijmenga, Cisca/AAE-7719-2019; Wijmenga, Cisca/D-2173-2009; de Jong, Pim A/G-7220-2014; Lambrechts, Diether/AAJ-3167-2020; Groen, Harry/AAP-2242-2021	Wijmenga, Cisca/0000-0002-5635-1614; de Jong, Pim A/0000-0003-4840-6854; Lambrechts, Diether/0000-0002-3429-302X; Groen, Harry J.M./0000-0002-2978-5265; zanen, pieter/0000-0002-5318-8276; Wauters, Els/0000-0002-0115-0030; Janssens, Wim/0000-0003-1830-2982	Vlaamse Liga tegen Kanker (VLK); Fund for Scientific Research Flanders (FWO); European Union [201379, COPACETIC]; Zorg Onderzoek Nederland-Medische Wetenschappen; KWF Kankerbestrijding; Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen; Siemens Germany; G. Ph. Verhagen Stichting; Rotterdam Oncologic Thoracic Steering Committee; Erasmus Trust; Stichting tegen Kanker; AstraZeneca; GSK; Nycomed; Chiesi; Boehringer Ingelheim	Vlaamse Liga tegen Kanker (VLK); Fund for Scientific Research Flanders (FWO)(FWO); European Union(European Commission); Zorg Onderzoek Nederland-Medische Wetenschappen; KWF Kankerbestrijding(KWF Kankerbestrijding); Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen; Siemens Germany(Siemens AG); G. Ph. Verhagen Stichting; Rotterdam Oncologic Thoracic Steering Committee; Erasmus Trust; Stichting tegen Kanker; AstraZeneca(AstraZeneca); GSK(GlaxoSmithKline); Nycomed; Chiesi(Chiesi Pharmaceuticals Inc); Boehringer Ingelheim(Boehringer Ingelheim)	Supported by the Vlaamse Liga tegen Kanker (VLK) (E. W), the Fund for Scientific Research Flanders (FWO) (W. J. and E. W) and a European Union FP7 grant (201379, COPACETIC) (F. M. H., P. Z., H. J. M. G., D. S. P., C. W., J. S. and J. L.). NELSON was funded by 'Zorg Onderzoek Nederland-Medische Wetenschappen, KWF Kankerbestrijding, Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen, Siemens Germany, G. Ph. Verhagen Stichting, Rotterdam Oncologic Thoracic Steering Committee, Erasmus Trust Fund, Stichting tegen Kanker (P. A. J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DS Postma received funding for research from AstraZeneca, GSK, Nycomed. Travel to ERS or ATS has been partially funded by AstraZeneca, GSK, Chiesi, Nycomed. DS Postma has been consultant to AstraZeneca, Boehringer Ingelheim, Chiesi, GSK, Nycomed, TEVA. W Janssens has been consultant and received travel grants from Boehringer Ingelheim, Astra Zeneca, Nycomed. All the other authors state that they have no conflicts of interests. The above commercial funding was not for this specific study. This study was, however, funded by 'Zorg Onderzoek Nederland-Medische Wetenschappen, KWF Kankerbestrijding, Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen, Siemens Germany, G. Ph. Verhagen Stichting, Rotterdam Oncologic Thoracic Steering Committee, Erasmus Trust Fund, Stichting tegen Kanker. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Bierut LJ, 2009, DRUG ALCOHOL DEPEN, V104, pS64, DOI 10.1016/j.drugalcdep.2009.06.003; Caporaso N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004653; Castaldi PJ, 2011, AM J RESP CELL MOL, V45, P1147, DOI 10.1165/rcmb.2011-0055OC; Demeo DL, 2009, AM J HUM GENET, V85, P493, DOI 10.1016/j.ajhg.2009.09.004; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Fu XW, 2009, AM J RESP CELL MOL, V41, P93, DOI 10.1165/rcmb.2008-0352OC; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Janssens W, 2010, AM J RESP CRIT CARE, V182, P163, DOI 10.1164/rccm.200905-0767OC; Janssens W, 2010, THORAX, V65, P215, DOI 10.1136/thx.2009.120659; Lambrechts D, 2010, AM J RESP CRIT CARE, V181, P486, DOI 10.1164/rccm.200909-1364OC; Le Marchand L, 2008, CANCER RES, V68, P9137, DOI 10.1158/0008-5472.CAN-08-2271; Li MD, 2008, HUM GENET, V123, P119, DOI 10.1007/s00439-008-0473-0; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Paliwal A, 2010, CANCER RES, V70, P2779, DOI 10.1158/0008-5472.CAN-09-4550; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Pillai SG, 2010, AM J RESP CRIT CARE, V182, P1498, DOI 10.1164/rccm.201002-0151OC; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Silverman EK, 2009, NEW ENGL J MED, V360, P2749, DOI 10.1056/NEJMcp0900449; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Trulock EP, 2007, J HEART LUNG TRANSPL, V26, P782, DOI 10.1016/j.healun.2007.06.003; van den Bergh KAM, 2010, BRIT J CANCER, V102, P27, DOI 10.1038/sj.bjc.6605459; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang JA, 2010, CANCER-AM CANCER SOC, V116, P3458, DOI 10.1002/cncr.25085; Wilk JB, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S8; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; Zhou H, 2012, J HUM GENET IN PRESS	34	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e53219	10.1371/journal.pone.0053219	http://dx.doi.org/10.1371/journal.pone.0053219			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349703	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872800007
J	Gupta, V; Vinay, DG; Sovio, U; Rafiq, S; Kumar, MVK; Janipalli, CS; Evans, D; Mani, KR; Sandeep, MN; Taylor, A; Kinra, S; Sullivan, R; Bowen, L; Timpson, N; Smith, GD; Dudbridge, F; Prabhakaran, D; Ben-Shlomo, Y; Reddy, KS; Ebrahim, S; Chandak, GR				Gupta, Vipin; Vinay, Donipadi Guru; Sovio, Ulla; Rafiq, Sajjad; Kumar, Madamchetty Venkata Kranthi; Janipalli, Charles Spurgeon; Evans, David; Mani, Kulathu Radha; Sandeep, Madana Narasimha; Taylor, Amy; Kinra, Sanjay; Sullivan, Ruth; Bowen, Liza; Timpson, Nicholas; Smith, George Davey; Dudbridge, Frank; Prabhakaran, Dorairaj; Ben-Shlomo, Yoav; Reddy, Kolli Srinath; Ebrahim, Shah; Chandak, Giriraj Ratan		Indian Migration Study Grp	Association Study of 25 Type 2 Diabetes Related Loci with Measures of Obesity in Indian Sib Pairs	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; METABOLIC TRAITS; GENETIC-VARIANTS; FTO GENE; RISK; METAANALYSIS; INDIVIDUALS; REPLICATION; LINKAGE	Obesity is an established risk factor for type 2 diabetes (T2D) and they are metabolically related through the mechanism of insulin resistance. In order to explore how common genetic variants associated with T2D correlate with body mass index (BMI), we examined the influence of 25 T2D associated loci on obesity risk. We used 5056 individuals (2528 sib-pairs) recruited in Indian Migration Study and conducted within sib-pair analysis for six obesity phenotypes. We found associations of variants in CXCR4 (rs932206) and HHEX (rs5015480) with higher body mass index (BMI) (b = 0.13, p = 0.001) and (beta = 0.09, p = 0.002), respectively and weight (beta = 0.13, p = 0.001) and (beta = 0.09, p = 0.001), respectively. CXCR4 variant was also strongly associated with body fat (beta = 0.10, p = 0.0004). In addition, we demonstrated associations of CXCR4 and HHEX with overweight/obesity (OR = 1.6, p = 0.003) and (OR = 1.4, p = 0.002), respectively, in 1333 sib-pairs (2666 individuals). We observed marginal evidence of associations between variants at six loci (TCF7L2, NGN3, FOXA2, LOC646279, FLJ3970 and THADA) and waist hip ratio (WHR), BMI and/or overweight which needs to be validated in larger set of samples. All the above findings were independent of daily energy consumption and physical activity level. The risk score estimates based on eight significant loci (including nominal associations) showed associations with WHR and body fat which were independent of BMI. In summary, we establish the role of T2D associated loci in influencing the measures of obesity in Indian population, suggesting common underlying pathophysiology across populations.	[Gupta, Vipin; Reddy, Kolli Srinath; Ebrahim, Shah] Publ Hlth Fdn India, S Asia Network Chron Dis, New Delhi, India; [Vinay, Donipadi Guru; Kumar, Madamchetty Venkata Kranthi; Janipalli, Charles Spurgeon; Mani, Kulathu Radha; Sandeep, Madana Narasimha; Chandak, Giriraj Ratan] CSIC, CCMB, Hyderabad, Andhra Pradesh, India; [Sovio, Ulla; Kinra, Sanjay; Sullivan, Ruth; Bowen, Liza; Dudbridge, Frank; Ebrahim, Shah] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Rafiq, Sajjad] Univ Southampton, Southampton, Hants, England; [Evans, David; Taylor, Amy; Timpson, Nicholas; Smith, George Davey; Ben-Shlomo, Yoav] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Evans, David; Taylor, Amy; Timpson, Nicholas; Smith, George Davey] Univ Bristol, MRC, Ctr Causal Analyses Translat Epidemiol, Bristol, Avon, England; [Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India	Public Health Foundation of India; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); University of London; London School of Hygiene & Tropical Medicine; University of Southampton; University of Bristol; University of Bristol	Gupta, V (corresponding author), Publ Hlth Fdn India, S Asia Network Chron Dis, New Delhi, India.	udaiig@gmail.com; chandakgrc@ccmb.res.in	Sovio, Ulla/H-8532-2019; Bowen, Liza/AAA-5502-2019; Davey Smith, George/A-7407-2013; Gupta, Vipin/D-1704-2014; Prabhakaran, Dorairaj/B-4147-2011; Timpson, Nicholas John/O-7548-2015; Fox, Laura J/C-6249-2016; Attrill, Lauren/V-1688-2018; Ben-Shlomo, Yoav/ABD-2004-2021; Evans, David/H-6325-2013	Sovio, Ulla/0000-0002-0799-1105; Davey Smith, George/0000-0002-1407-8314; Gupta, Vipin/0000-0002-0607-5543; Prabhakaran, Dorairaj/0000-0002-3172-834X; Timpson, Nicholas John/0000-0002-7141-9189; Ben-Shlomo, Yoav/0000-0001-6648-3007; Evans, David/0000-0003-0663-4621; Bowen, Liza/0000-0001-8318-8421; Reddy, K Srinath/0000-0003-3416-3548; Chandak, Giriraj Ratan/0000-0002-3095-9453; Rafiq, Sajjad/0000-0003-4873-4540	Wellcome Trust [GR070797MF, 083541/Z/07/Z]; Wellcome Trust Sabbatical Award [089645/Z/09/Z]; MRC [G1000718] Funding Source: UKRI; Medical Research Council [G1000718] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Wellcome Trust Sabbatical Award(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Indian Migration Study was funded by the Wellcome Trust (grant number GR070797MF). The genetic work was funded by a project grant from the Wellcome Trust (083541/Z/07/Z). GDS was supported by a Wellcome Trust Sabbatical Award (089645/Z/09/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson P, 2004, SCIENCE, V304, P1413, DOI 10.1126/science.304.5676.1413; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Aulchenko YS, 2007, DIABETES, V56, P3020, DOI 10.2337/db07-0338; Been LF, 2010, OBESITY, V18, P425, DOI 10.1038/oby.2009.254; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boffetta P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019930; Bowen L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014822; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; Freathy RM, 2008, DIABETES, V57, P1419, DOI 10.2337/db07-1466; Freathy RM, 2009, DIABETES, V58, P1428, DOI 10.2337/db08-1739; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; Gregg EW, 2004, DIABETES CARE, V27, P2806, DOI 10.2337/diacare.27.12.2806; Gupta V, 2012, DIABETOLOGIA, V55, P349, DOI 10.1007/s00125-011-2355-6; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Janipalli CS, 2012, DIABETIC MED, V29, P121, DOI 10.1111/j.1464-5491.2011.03438.x; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Laird NM, 2006, NAT REV GENET, V7, P385, DOI 10.1038/nrg1839; Li S, 2011, DIABETOLOGIA, V54, P776, DOI 10.1007/s00125-011-2044-5; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Pecioska S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008541; Puigserver P, 2006, NAT MED, V12, P38, DOI 10.1038/nm0106-38; PURCELL S, 2003, BIOINFORMATICS, V19, P149, DOI [DOI 10.1093/BIOINFORMATICS/19.1.149, 10.1093/bioinformatics/19.1.149]; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramya K., 2011, DIABETES TECHNOL THE, V13, P33, DOI DOI 10.1089/dia.2010.0071; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Tabassum R, 2008, J HUM GENET, V53, P957, DOI 10.1007/s10038-008-0335-6; Tabassum R, 2012, DIABETES, V61, P626, DOI 10.2337/db11-1501; Taylor AE, 2011, J OBES, V2011, DOI 10.1155/2011/307542; Timpson NJ, 2008, AM J CLIN NUTR, V88, P971, DOI 10.1093/ajcn/88.4.971; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang X, 2009, DIABETOLOGIA, V52, P2578, DOI 10.1007/s00125-009-1524-3; WHO, 2004, LANCET, V363, P902; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhao JH, 2010, DIABETES, V59, P751, DOI 10.2337/db09-0972	41	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53944	10.1371/journal.pone.0053944	http://dx.doi.org/10.1371/journal.pone.0053944			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349771	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000313738900029
J	Maltby, R; Leatham-Jensen, MP; Gibson, T; Cohen, PS; Conway, T				Maltby, Rosalie; Leatham-Jensen, Mary P.; Gibson, Terri; Cohen, Paul S.; Conway, Tyrrell			Nutritional Basis for Colonization Resistance by Human Commensal Escherichia coli Strains HS and Nissle 1917 against E. coli O157:H7 in the Mouse Intestine	PLOS ONE			English	Article							ULCERATIVE-COLITIS; CARBON NUTRITION; IN-VITRO; MODELS; STREPTOMYCIN; MICROBIOTA; VIRULENCE; MUTANTS; ENTEROTOXINS; RESPIRATION	Escherichia coli is a single species consisting of many biotypes, some of which are commensal colonizers of mammals and others that cause disease. Humans are colonized on average with five commensal biotypes, and it is widely thought that the commensals serve as a barrier to infection by pathogens. Previous studies showed that a combination of three pre-colonized commensal E. coli strains prevents colonization of E. coli O157:H7 in a mouse model (Leatham, et al., 2010, Infect Immun 77: 2876-7886). The commensal biotypes included E. coli HS, which is known to successfully colonize humans at high doses with no adverse effects, and E. coli Nissle 1917, a human commensal strain that is used in Europe as a preventative of traveler's diarrhea. We hypothesized that commensal biotypes could exert colonization resistance by consuming nutrients needed by E. coli O157: H7 to colonize, thus preventing this first step in infection. Here we report that to colonize streptomycin-treated mice E. coli HS consumes six of the twelve sugars tested and E. coli Nissle 1917 uses a complementary yet divergent set of seven sugars to colonize, thus establishing a nutritional basis for the ability of E. coli HS and Nissle 1917 to occupy distinct niches in the mouse intestine. Together these two commensals use the five sugars previously determined to be most important for colonization of E. coli EDL933, an O157:H7 strain. As predicted, the two commensals prevented E. coli EDL933 colonization. The results support a model in which invading pathogenic E. coli must compete with the gut microbiota to obtain the nutrients needed to colonize and establish infection; accordingly, the outcome of the challenge is determined by the aggregate capacity of the native microbiota to consume the nutrients required by the pathogen.	[Maltby, Rosalie; Gibson, Terri; Conway, Tyrrell] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA; [Leatham-Jensen, Mary P.; Cohen, Paul S.] Univ Rhode Isl, Dept Cell & Mol Biol, Kingston, RI 02881 USA	University of Oklahoma System; University of Oklahoma - Norman; University of Rhode Island	Conway, T (corresponding author), Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA.	tconway@ou.edu		Maltby, Rosalie/0000-0002-7278-9544	Public Health Service [AI48945, GM095370]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI048945, R01AI048945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095370] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by Public Health Service grants AI48945 and GM095370 to TC and PSC. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, MMWR RECOMM REP, V60, P1762; [Anonymous], 2009, NAT DIG DIS INF; APPERLOORENKEMA HZ, 1990, EPIDEMIOL INFECT, V105, P355, DOI 10.1017/S0950268800047944; Araya M, 2001, JOINT FAO WHO EXPERT; Autieri SM, 2007, INFECT IMMUN, V75, P5465, DOI 10.1128/IAI.00822-07; BARKULIS IL, 1953, J BACTERIOL, V65, P337, DOI 10.1128/JB.65.3.337-343.1953; Besselink MGH, 2008, LANCET, V371, P651, DOI 10.1016/S0140-6736(08)60207-X; Bjarnason A, 2008, LANCET, V372, P114, DOI 10.1016/S0140-6736(08)61028-4; Bleich A, 2008, INT J EXP PATHOL, V89, P45, DOI 10.1111/j.1365-2613.2007.00560.x; Bryan A, 2006, INFECT IMMUN, V74, P1072, DOI 10.1128/IAI.74.2.1072-1083.2006; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fabich AJ, 2008, INFECT IMMUN, V76, P1143, DOI 10.1128/IAI.01386-07; FORMAL SB, 1971, ANN NY ACAD SCI, V176, P190, DOI 10.1111/j.1749-6632.1971.tb35004.x; FORMAL SB, 1958, J BACTERIOL, V75, P604, DOI 10.1128/JB.75.5.604-610.1958; Frank DN, 2008, CURR OPIN GASTROEN, V24, P4, DOI 10.1097/MOG.0b013e3282f2b0e8; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Franklin T.J., 2005, BIOCH MOL BIOL ANTIM, P121; FRETER R, 1983, INFECT IMMUN, V39, P666, DOI 10.1128/IAI.39.2.666-675.1983; FRETER R, 1983, INFECT IMMUN, V39, P676, DOI 10.1128/IAI.39.2.676-685.1983; FRETER R, 1983, REV INFECT DIS, V5, pS647; FRETER R, 1983, INFECT IMMUN, V39, P686, DOI 10.1128/IAI.39.2.686-703.1983; FRETER R, 1983, INFECT IMMUN, V39, P60, DOI 10.1128/IAI.39.1.60-84.1983; Gronbach K, 2010, INFECT IMMUN, V78, P3036, DOI 10.1128/IAI.00218-10; HENRY RJ, 1949, J BACTERIOL, V57, P447, DOI 10.1128/JB.57.4.447-451.1949; Hentges D., 1984, MICROECOL THER, V14, P53; Jones SA, 2008, INFECT IMMUN, V76, P2531, DOI 10.1128/IAI.00096-08; Jones SA, 2007, INFECT IMMUN, V75, P4891, DOI 10.1128/IAI.00484-07; Jones SA, 2011, INFECT IMMUN, V79, P4218, DOI 10.1128/IAI.05395-11; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Lapaquette P, 2010, CELL MICROBIOL, V12, P99, DOI 10.1111/j.1462-5822.2009.01381.x; Leatham MP, 2009, INFECT IMMUN, V77, P2876, DOI 10.1128/IAI.00059-09; Leatham MP, 2005, INFECT IMMUN, V73, P8039, DOI 10.1128/IAI.73.12.8039-8049.2005; Leatham-Jensen MP, 2012, INFECT IMMUN, V80, P1716, DOI 10.1128/IAI.06193-11; LeDoux D, 2006, INT J STD AIDS, V17, P280, DOI 10.1258/095646206776253507; LEVINE MM, 1978, LANCET, V1, P1119; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Miranda RL, 2004, INFECT IMMUN, V72, P1666, DOI 10.1128/IAI.72.3.1666-1676.2004; Murphy KC, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-11; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; NATARO JP, 1995, J INFECT DIS, V171, P465, DOI 10.1093/infdis/171.2.465; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Nell S, 2010, NAT REV MICROBIOL, V8, P564, DOI 10.1038/nrmicro2403; NISSLE A, 1951, Z Klin Med, V2, P68; PAINE TF, 1953, SCIENCE, V118, P73, DOI 10.1126/science.118.3055.73; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Peekhaus N, 1998, J BACTERIOL, V180, P3495, DOI 10.1128/JB.180.14.3495-3502.1998; Plumbridge J, 2009, J BACTERIOL, V191, P5641, DOI 10.1128/JB.00448-09; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Rembacken BJ, 1999, LANCET, V354, P635, DOI 10.1016/S0140-6736(98)06343-0; ROBINSBROWNE RM, 1982, INFECT IMMUN, V38, P798, DOI 10.1128/IAI.38.2.798-801.1982; Schultz M, 2008, INFLAMM BOWEL DIS, V14, P1012, DOI 10.1002/ibd.20377; Schumann S, 2011, APPL ENVIRON MICROB; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Stecher B, 2011, CURR OPIN MICROBIOL, V14, P82, DOI 10.1016/j.mib.2010.10.003; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Swallow DM, 2003, ANNU REV GENET, V37, P197, DOI 10.1146/annurev.genet.37.110801.143820; Tilman D., 1982, Monographs in Population Biology, pi; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; UMBREIT WW, 1949, J BIOL CHEM, V177, P703; WELLS CL, 1987, INFECT IMMUN, V55, P2689, DOI 10.1128/IAI.55.11.2689-2694.1987; Zyrek AA, 2007, CELL MICROBIOL, V9, P804, DOI 10.1111/j.1462-5822.2006.00836.x	64	145	149	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53957	10.1371/journal.pone.0053957	http://dx.doi.org/10.1371/journal.pone.0053957			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349773	Green Published, gold			2022-12-25	WOS:000313738900030
J	Agnarson, AM; Levira, F; Masanja, H; Ekstrom, AM; Thorson, A				Agnarson, Abela Mpobela; Levira, Francis; Masanja, Honorati; Ekstrom, Anna Mia; Thorson, Anna			Antiretroviral Treatment Knowledge and Stigma-Implications for Programs and HIV Treatment Interventions in Rural Tanzanian Populations	PLOS ONE			English	Article							LATENT CLASS ANALYSIS; 5 AFRICAN COUNTRIES; SOUTH-AFRICA; HIV/AIDS STIGMA; PEOPLE; CARE; RESPONSES; PATTERNS; THERAPY; SCALE	Objective: To analyse antiretroviral treatment (ART) knowledge and HIV- and ART-related stigma among the adult population in a rural Tanzanian community. Design: Population-based cross-sectional survey of 694 adults (15-49 years of age). Methods: Latent class analysis (LCA) categorized respondents' levels of ART knowledge and of ART-related stigma. Multinomial logistic regression assessed the association between the levels of ART knowledge and HIV- and ART-related stigma, while controlling for the effects of age, gender, education, marital status and occupation. Results: More than one-third of men and women in the study reported that they had never heard of ART. Among those who had heard of ART, 24% were east informed about ART, 8% moderately informed, and 68% highly informed. Regarding ART-related stigma, 28% were least stigmatizing, 41% moderately stigmatizing, and 31% highly stigmatizing toward persons taking ART. Respondents that had at least primary education were more likely to have high levels of knowledge about ART (OR 3.09, 95% CI 1.61-5.94). Participants highly informed about ART held less HIV- and ART-related stigma towards ART patients (OR 0.26, 95% CI 0.09-0.74). Conclusion: The lack of ART knowledge is broad, and there is a strong association between ART knowledge and individual education level. These are relevant findings for both HIV prevention and HIV treatment program interventions that address ART-related stigma across the entire spectrum of the community.	[Agnarson, Abela Mpobela; Ekstrom, Anna Mia; Thorson, Anna] Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth IHCAR, Stockholm, Sweden; [Levira, Francis; Masanja, Honorati] Ifakara Hlth Inst, Dar Es Salaam, Tanzania	Karolinska Institutet; Ifakara Health Institute	Agnarson, AM (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth IHCAR, Stockholm, Sweden.	abela.agnarson@ki.se	Ekström, Anna Mia/H-6901-2013	Thorson, Anna/0000-0002-8703-6561; Levira, Francis/0000-0002-7063-2447	Sida/SAREC (Swedish International Development Cooperation Agency); European Community	Sida/SAREC (Swedish International Development Cooperation Agency); European Community(European Commission)	Sida/SAREC (Swedish International Development Cooperation Agency) is especially appreciated for providing financial support to the study (http://www.sida.se). This research is part of the Effects of Antiretrovirals for HIV on African Health Systems project, Maternal and Child Health (ARVMAC), and was in part supported by the European Community's FP6 funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarson AM, 2010, TROP MED INT HEALTH, V15, P1000, DOI 10.1111/j.1365-3156.2010.02587.x; Amuri M, 2011, AIDS CARE, V23, P378, DOI 10.1080/09540121.2010.507739; Chopra M, 2006, AIDS, V20, P1975, DOI 10.1097/01.aids.0000247120.12327.6b; Cornell M, 2011, TROP MED INT HEALTH, V16, P828, DOI 10.1111/j.1365-3156.2011.02767.x; de Walque D, 2010, ANTIRETROVIRAL THERA; Dennis ML, 2001, EVAL PROGRAM PLANN, V24, P187, DOI 10.1016/s0149-7189(01)00014-3; Dlamini PS, 2009, AIDS PATIENT CARE ST, V23, P377, DOI 10.1089/apc.2008.0164; Ezekiel MJ, 2009, SOC SCI MED; Genberg BL, 2008, AIDS BEHAV, V12, P772, DOI 10.1007/s10461-007-9340-6; Hutchinson PL, 2007, AIDS EDUC PREV, V19, P489, DOI 10.1521/aeap.2007.19.6.489; ICRW/USAID, 2005, WORK REP MEAS HIV ST; International Development Research C Network I, 2002, POP HLTH DEV COUNTR, V1; Kalichman SC, 2005, AIDS BEHAV, V9, P135, DOI 10.1007/s10461-005-3895-x; Kattumuri R, 2003, INT J STD AIDS, V14, P552, DOI 10.1258/095646203767869174; Kranzer K, 2010, JAIDS-J ACQ IMM DEF, V55, pE17, DOI 10.1097/QAI.0b013e3181f275fd; Kudel I, 2006, J GEN INTERN MED, V21, pS48, DOI 10.1111/j.1525-1497.2006.00645.x; Lanza ST, 2007, STRUCT EQU MODELING, V14, P671, DOI 10.1080/10705510701575602; Larsson EC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-769; Link BG, 2006, LANCET, V367, P528, DOI 10.1016/S0140-6736(06)68184-1; Link BG, 2001, PSYCHIATR SERV, V52, P1621, DOI 10.1176/appi.ps.52.12.1621; Macro, 2002, HOUS BUDG SURV 2000; Makoae LN, 2009, AIDS CARE, V21, P1357, DOI 10.1080/09540120902862576; Messer LC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-504; Muhamadi L, 2010, HEALTH POLICY, V97, P187, DOI 10.1016/j.healthpol.2010.06.003; *NAT BUR STAT TANZ, 2008, TANZ HIV AIDS MAL IN; Nyblade Laura C, 2006, Psychol Health Med, V11, P335, DOI 10.1080/13548500600595178; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Ochieng-Ooko V, 2010, B WORLD HEALTH ORGAN, V88, P681, DOI 10.2471/BLT.09.064329; Pharris A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-705; Rosenburg N, 2012, J ASSOC NURSE AIDS C, V23, P170, DOI 10.1016/j.jana.2011.09.003; Roura M, 2008, SEX TRANSM INFECT; Rumisha S.F., 2006, TANZANIA HLTH RES B, V8, P101; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Somi G, 2012, LOW MORTALITY RISK; URT, 2003, GUID FORM AIDS COM L; WHO-UNAIDS, 2010, UNAIDS REP GLOB AIDS	36	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53993	10.1371/journal.pone.0053993	http://dx.doi.org/10.1371/journal.pone.0053993			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072OV	23342056	Green Published, gold			2022-12-25	WOS:000313682700071
J	Benoit, J; Adnet, S; El Mabrouk, E; Khayati, H; Ali, MB; Marivaux, L; Merzeraud, G; Merigeaud, S; Vianey-Liaud, M; Tabuce, R				Benoit, Julien; Adnet, Sylvain; El Mabrouk, Essid; Khayati, Hayet; Ali, Mustapha Ben Haj; Marivaux, Laurent; Merzeraud, Gilles; Merigeaud, Samuel; Vianey-Liaud, Monique; Tabuce, Rodolphe			Cranial Remain from Tunisia Provides New Clues for the Origin and Evolution of Sirenia (Mammalia, Afrotheria) in Africa	PLOS ONE			English	Article							NUMIDOTHERIUM-KOHOLENSE; EAR REGION; EOCENE; PROBOSCIDEA; ANATOMY	Sea cows (manatees, dugongs) are the only living marine mammals to feed solely on aquatic plants. Unlike whales or dolphins (Cetacea), the earliest evolutionary history of sirenians is poorly documented, and limited to a few fossils including skulls and skeletons of two genera composing the stem family of Prorastomidae (Prorastomus and Pezosiren). Surprisingly, these fossils come from the Eocene of Jamaica, while stem Hyracoidea and Proboscidea - the putative sister-groups to Sirenia - are recorded in Africa as early as the Late Paleocene. So far, the historical biogeography of early Sirenia has remained obscure given this paradox between phylogeny and fossil record. Here we use X-ray microtomography to investigate a newly discovered sirenian petrosal from the Eocene of Tunisia. This fossil represents the oldest occurrence of sirenians in Africa. The morphology of this petrosal is more primitive than the Jamaican prorastomids' one, which emphasizes the basal position of this new African taxon within the Sirenia clade. This discovery testifies to the great antiquity of Sirenia in Africa, and therefore supports their African origin. While isotopic analyses previously suggested sirenians had adapted directly to the marine environment, new paleoenvironmental evidence suggests that basal-most sea cows were likely restricted to fresh waters.	[Benoit, Julien; Adnet, Sylvain; Marivaux, Laurent; Vianey-Liaud, Monique; Tabuce, Rodolphe] Univ Montpellier 2, Inst Sci Evolut, Montpellier, France; [El Mabrouk, Essid; Khayati, Hayet; Ali, Mustapha Ben Haj] Off Natl Mines, Tunis, Tunisia; [Merigeaud, Samuel] CHU Montpellier, Hop Lapeyronie, Serv Imagerie Med, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Office National des Mines; Universite de Montpellier; CHU de Montpellier	Benoit, J (corresponding author), Univ Montpellier 2, Inst Sci Evolut, Montpellier, France.	Julien.benoit@univ-montp2.fr		Tabuce, Rodolphe/0000-0002-4713-3981; Benoit, Julien/0000-0001-5378-3940	Agence nationale de la recherche (ANR) (Conseil Europeen de la Recherche (ERC) programme Palasiafrica [ANR-08-JCJC-0017-01]	Agence nationale de la recherche (ANR) (Conseil Europeen de la Recherche (ERC) programme Palasiafrica(French National Research Agency (ANR))	This work has been conducted with the support of the Agence nationale de la recherche (ANR) (Conseil Europeen de la Recherche (ERC) programme Palasiafrica (ANR-08-JCJC-0017-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel O., 1913, Palaeontographica Stuttgart, V59, P289; Adaci M, 2007, CR PALEVOL, V6, P535, DOI 10.1016/j.crpv.2007.09.001; Badiola A, 2011, INT SENCK C 22, P22; Beatty BL, 2010, NEUES JAHRB GEOL P-A, V258, P185, DOI 10.1127/0077-7749/2010/0095; Benoit J, 2012, J SYST PALE IN PRESS; CIFELLI RL, 1982, J PALEONTOL, V56, P795; Clementz MT, 2006, J VERTEBR PALEONTOL, V26, P355, DOI 10.1671/0272-4634(2006)26[355:IRFEWA]2.0.CO;2; Clementz MT, 2003, PALEOBIOLOGY, V29, P506, DOI 10.1666/0094-8373(2003)029<0506:APPTHA>2.0.CO;2; COURT N, 1994, ZOOL J LINN SOC-LOND, V112, P13, DOI 10.1006/zjls.1994.1032; Court N., 1990, Journal of Vertebrate Paleontology, V10, P170; COURT N, 1994, ZOOL J LINN SOC-LOND, V111, P297, DOI 10.1111/j.1096-3642.1994.tb01487.x; COURT N, 1992, LETHAIA, V25, P211, DOI 10.1111/j.1502-3931.1992.tb01385.x; Court Nicholas, 1993, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V226, P125; Domning D.P., 1982, Smithsonian Contributions to Paleobiology, P1; Domning Daryl P., 2010, P147; Domning Daryl P., 1994, Proceedings of the San Diego Society of Natural History, V29, P177; Domning DP, 2001, NATURE, V413, P625, DOI 10.1038/35098072; Domning DP, 2012, SIRENIA DUGONGS MANA, DOI 101002/9780470015902a0001576pub3; Ekdale EG, 2009, THESIS U TEXAS AUSTI; Ekdale EG, 2011, J MORPHOL, V272, P452, DOI 10.1002/jmor.10924; Fischer MS, 1993, MAMMAL PHYLOGENY, P217; Gaeth AP, 1999, P NATL ACAD SCI USA, V96, P5555, DOI 10.1073/pnas.96.10.5555; Gheerbrant E, 2005, GEODIVERSITAS, V27, P239; Gheerbrant Emmanuel, 2005, P84; Gheerbrant E, 2009, P NATL ACAD SCI USA, V106, P10717, DOI 10.1073/pnas.0900251106; Gingerich PD., 1994, CONTRIBUTIONS MUSEUM, V29, P41; Hartenberger JL, 2001, T GEOBIOL, V18, P237; Hautier L, 2012, J VERTEBR PALEONTOL, V32, P1218, DOI 10.1080/02724634.2012.687421; KETTEN DR, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P717; KETTEN DR, 1992, MARINE MAMMAL SENSORY SYSTEMS, P77; Liu AGSC, 2008, P NATL ACAD SCI USA, V105, P5786, DOI 10.1073/pnas.0800884105; Luo Z., 1999, U MICHIGAN PAPERS PA, V31, P1; MCCOY ED, 1976, SYST ZOOL, V25, P201, DOI 10.2307/2412488; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Novacek M.J., 1987, American Museum Novitates, P1; Robineau D., 1969, Memoires du Museum Nationale d'Histoire Naturelle Paris (Zool), V60, P1; Ruf I, 2009, J ANAT, V214, P679, DOI 10.1111/j.1469-7580.2009.01059.x; Sagne C, 2001, THESIS MUSEUM NATL H; Samonds KE, 2009, J VERTEBR PALEONTOL, V29, P1233, DOI 10.1671/039.029.0417; SAVAGE RJG, 1976, SYST ZOOL, V25, P344, DOI 10.2307/2412509; SAVAGE RJG, 1994, J VERTEBR PALEONTOL, V14, P427, DOI 10.1080/02724634.1994.10011569; SEGALL W, 1970, Fieldiana Zoology, V51, P169; Sickenberg O., 1934, Memoires du Musee Histoire Naturelle Belgique, V63, P1; Spoor F, 2008, SENSORY EVOLUTION ON THE THRESHOLD: ADAPTATIONS IN SECONDARILY AQUATIC VERTEBRATES, P257; Stanhope MJ, 1998, P NATL ACAD SCI USA, V95, P9967, DOI 10.1073/pnas.95.17.9967; Tabuce R, 2008, MAMMALIA, V72, P2, DOI 10.1515/MAMM.2008.004; Thewissen J. G. M., 2000, Journal of Vertebrate Paleontology, V20, p73A; Zalmout IS, 2008, THESIS U MICHIGAN AN	48	49	50	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54307	10.1371/journal.pone.0054307	http://dx.doi.org/10.1371/journal.pone.0054307			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342128	Green Submitted, Green Published, gold			2022-12-25	WOS:000313682700105
J	Chan, ST; Yang, NC; Huang, CS; Liao, JW; Yeh, SL				Chan, Shu-Ting; Yang, Nae-Cherng; Huang, Chin-Shiu; Liao, Jiunn-Wang; Yeh, Shu-Lan			Quercetin Enhances the Antitumor Activity of Trichostatin A through Upregulation of p53 Protein Expression In Vitro and In Vivo	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; CELL-CYCLE ARREST; LUNG-CANCER-CELLS; APOPTOSIS; MITOCHONDRIA; HYPERACETYLATION; SUPPRESSES; MODULATION; ACTIVATION; INDUCTION	This study investigated the effects of quercetin on the anti-tumor effect of trichostatin A (TSA), a novel anticancer drug, in vitro and in vivo and the possible mechanisms of these effects in human lung cancer cells. We first showed that quercetin (5 mu M) significantly increased the growth arrest and apoptosis in A549 cells (expressing wild-type p53) induced by 25 ng/mL of (82.5 nM) TSA at 48 h by about 25% and 101%, respectively. However, such enhancing effects of quercetin (5 mu M) were not significant in TSA-exposed H1299 cells (a p53 null mutant) or were much lower than in A549 cells. In addition, quercetin significantly increased TSA-induced p53 expression in A549 cells. Transfection of p53 siRNA into A549 cells significantly but not completely diminished the enhancing effects of quercetin on TSA-induced apoptosis. Furthermore, we demonstrated that quercetin enhanced TSA-induced apoptosis through the mitochondrial pathway. Transfection of p53 siRNA abolished such enhancing effects of quercetin. However, quercetin increased the acetylation of histones H3 and H4 induced by TSA in A549 cells, even with p53 siRNA transfection as well as in H1299 cells. In a xenograft mouse model of lung cancer, quercetin enhanced the antitumor effect of TSA. Tumors from mice treated with TSA in combination with quercetin had higher p53 and apoptosis levels than did those from control and TSA-treated mice. These data indicate that regulation of the expression of p53 by quercetin plays an important role in enhancing TSA-induced apoptosis in A549 cells. However, p53-independent mechanisms may also contribute to the enhancing effect of quercetin.	[Chan, Shu-Ting; Yang, Nae-Cherng; Yeh, Shu-Lan] Chung Shan Med Univ, Dept Nutr Sci, Taichung, Taiwan; [Huang, Chin-Shiu] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan; [Liao, Jiunn-Wang] Natl Chung Hsing Univ, Coll Vet Med, Grad Inst Vet Pathol, Taichung 40227, Taiwan; [Yeh, Shu-Lan] Chung Shan Med Univ Hosp, Dept Nutr, Taichung, Taiwan	Chung Shan Medical University; Asia University Taiwan; National Chung Hsing University; Chung Shan Medical University; Chung Shan Medical University Hospital	Yeh, SL (corresponding author), Chung Shan Med Univ, Dept Nutr Sci, Taichung, Taiwan.	suzyyeh@csmu.edu.tw		Liao, Jiunn-Wang/0000-0001-7374-1203	National Science Council, Republic of China [NSC-99-2320-B-040-006-MY3]	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by grants (NSC-99-2320-B-040-006-MY3) from the National Science Council, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral JD, 2010, DISCOV MED, V9, P145; Ashcroft M, 1999, ONCOGENE, V18, P7637, DOI 10.1038/sj.onc.1203012; Beniston RG, 2001, CARCINOGENESIS, V22, P1069, DOI 10.1093/carcin/22.7.1069; Bouvard V, 2000, ONCOGENE, V19, P649, DOI 10.1038/sj.onc.1203366; Cantor JP, 2007, INT J CANCER, V120, P24, DOI 10.1002/ijc.22073; Chan ST, 2012, J NUTR BIOCHEM, V23, P179, DOI 10.1016/j.jnutbio.2010.11.014; Chang J, 2012, BRIT J CANCER, V106, P116, DOI 10.1038/bjc.2011.532; Chen J, 2005, PHARMAZIE, V60, P856; Choi YH, 2005, INT J ONCOL, V27, P473; Chou CC, 2010, ARCH PHARM RES, V33, P1181, DOI 10.1007/s12272-010-0808-y; de Boer VCJ, 2005, J NUTR, V135, P1718, DOI 10.1093/jn/135.7.1718; de Kok TM, 2008, EUR J NUTR, V47, P51, DOI 10.1007/s00394-008-2006-y; Divisi Duilio, 2006, Acta Biomed, V77, P118; Dokmanovic M, 2005, J CELL BIOCHEM, V96, P293, DOI 10.1002/jcb.20532; Gahr S, 2008, ONCOL REP, V20, P1249, DOI 10.3892/or_00000137; Ganslmayer M, 2004, ONCOL REP, V11, P943; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Henderson C, 2003, J BIOL CHEM, V278, P12579, DOI 10.1074/jbc.M213093200; Hsu HS, 2011, CANCER-AM CANCER SOC, V117, P1516, DOI 10.1002/cncr.25599; Jia J, 2008, PHARMAZIE, V63, P379, DOI 10.1691/ph.2008.7693; Karagiannis TC, 2010, AGING-US, V2, P659, DOI 10.18632/aging.100203; Kim HR, 2006, EXP MOL MED, V38, P616, DOI 10.1038/emm.2006.73; Lamson D W, 2000, Altern Med Rev, V5, P196; Lee E, 1996, FEBS LETT, V395, P183, DOI 10.1016/0014-5793(96)01033-2; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mai ZM, 2007, CARCINOGENESIS, V28, P1217, DOI 10.1093/carcin/bgm004; MIYASHITA T, 1995, CELL, V80, P293; Ocker M, 2007, INT J BIOCHEM CELL B, V39, P1367, DOI 10.1016/j.biocel.2007.03.001; Pfahl M, 1998, Expert Opin Investig Drugs, V7, P601, DOI 10.1517/13543784.7.4.601; Platta CS, 2007, J SURG RES, V142, P219, DOI 10.1016/j.jss.2006.12.555; Priyadarsini RV, 2010, EUR J PHARMACOL, V649, P84, DOI 10.1016/j.ejphar.2010.09.020; Ramos-Vara JA, 2005, VET PATHOL, V42, P405, DOI 10.1354/vp.42-4-405; Reed JC, 1998, BBA-BIOENERGETICS, V1366, P127, DOI 10.1016/S0005-2728(98)00108-X; Roos WP, 2012, CANC LETT; Samuel T, 2012, ANTICANCER RES, V32, P61; Seo SK, 2011, J THORAC ONCOL, V6, P1313, DOI 10.1097/JTO.0b013e318220caff; Shiau RJ, 2010, EUR J NUTR, V49, P19, DOI 10.1007/s00394-009-0044-8; Shu LM, 2011, AAPS J, V13, P606, DOI 10.1208/s12248-011-9300-y; Soengas MS, 1999, SCIENCE, V284, P156, DOI 10.1126/science.284.5411.156; Staedler D, 2011, CANCER CHEMOTH PHARM, V68, P1161, DOI 10.1007/s00280-011-1596-x; Tanigawa S, 2008, BIOSCI BIOTECH BIOCH, V72, P797, DOI 10.1271/bbb.70680; Thangasamy T, 2007, NUTR CANCER, V59, P258, DOI 10.1080/01635580701499545; Wang X, 2011, MOL CARCINOG; Xavier CPR, 2011, CANCER CHEMOTH PHARM, V68, P1449, DOI 10.1007/s00280-011-1641-9; Zhu WG, 2001, CANCER RES, V61, P1327; Zuckerman V, 2009, J PATHOL, V219, P3, DOI 10.1002/path.2584	47	72	74	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54255	10.1371/journal.pone.0054255	http://dx.doi.org/10.1371/journal.pone.0054255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342112	gold, Green Published, Green Submitted			2022-12-25	WOS:000313682700098
J	Conklin, JR; Battley, PF; Potter, MA				Conklin, Jesse R.; Battley, Phil F.; Potter, Murray A.			Absolute Consistency: Individual versus Population Variation in Annual-Cycle Schedules of a Long-Distance Migrant Bird	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; STOPOVER ECOLOGY; NEW-ZEALAND; MIGRATION; MOLT; ARRIVAL; NORTH; CONSEQUENCES; STRATEGIES; DEPARTURE	Flexibility in scheduling varies throughout an organism's annual cycle, reflecting relative temporal constraints and fitness consequences among life-history stages. Time-selection can act at different scales, either by limiting the range of alternative strategies in the population, or by increasing the precision of individual performance. We tracked individual bar-tailed godwits Limosa lapponica baueri for two full years (including direct observation during non-breeding seasons in New Zealand and geolocator tracking of round-trip migrations to Alaska) to present a full annual-cycle view of molt, breeding, and migration schedules. At both population and individual scales, temporal variation was greater in post-breeding than pre-breeding stages, and greater in molts than in movements, but schedules did not tighten across successive stages of migration toward the breeding grounds. In general, individual godwits were quite consistent in timing of events throughout the year, and repeatability of pre-breeding movements was particularly high (r = 0.82-0.92). However, we demonstrate that r values misrepresent absolute consistency by confounding inter- and intra-individual variation; the biological significance of r values can only be understood when these are considered separately. By doing so, we show that some stages have considerable tolerance for alternative strategies within the population, whereas scheduling of northbound migratory movements was similar for all individuals. How time-selection simultaneously shapes both individual and population variation is central to understanding and predicting adaptive phenological responses to environmental change.	[Conklin, Jesse R.; Battley, Phil F.; Potter, Murray A.] Massey Univ, Inst Nat Resources, Ecol Grp, Palmerston North, New Zealand	Massey University	Conklin, JR (corresponding author), Univ Groningen, Anim Ecol Grp, Groningen, Netherlands.	conklin.jesse@gmail.com	Battley, Philip/AAI-1443-2021	Battley, Philip/0000-0002-8590-8098; Potter, Murray/0000-0002-0246-8294	David and Lucile Packard Foundation through the Pacific Shorebird Migration Project; Marsden Fund grant; Department of Conservation Research and Development [3739-01, 3599]	David and Lucile Packard Foundation through the Pacific Shorebird Migration Project; Marsden Fund grant(Royal Society of New ZealandMarsden Fund (NZ)); Department of Conservation Research and Development	This project was supported by the David and Lucile Packard Foundation through the Pacific Shorebird Migration Project, and by a Marsden Fund grant administered by The Royal Society of New Zealand to P. Battley. Color-banding was conducted under Department of Conservation Research and Development contracts 3739-01 and 3599. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 2006, ANIM BEHAV, V71, P555, DOI 10.1016/j.anbehav.2005.05.016; Alerstam T, 1990, BIRD MIGRATION PHYSL, P331, DOI [DOI 10.1007/978-3-642-74542-3_22., 10.1007/978-3-642-74542-3_22]; Barshep Y, 2011, ARDEA, V99, P43, DOI 10.5253/078.099.0106; Battley PF, 2004, IBIS, V146, P46, DOI 10.1111/j.1474-919X.2004.00210.x; Battley PF, 2012, J AVIAN BIOL, V43, P21, DOI 10.1111/j.1600-048X.2011.05473.x; Battley PF, 2006, BIOL LETTERS, V2, P517, DOI 10.1098/rsbl.2006.0535; Becker WA, 1984, A MANUAL OF QUANTITA; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Bety J, 2004, BEHAV ECOL SOCIOBIOL, V57, P1, DOI 10.1007/s00265-004-0840-3; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Catry P, 1999, OIKOS, V84, P473, DOI 10.2307/3546426; Conklin JR, 2012, J AVIAN BIOL, V43, P252, DOI 10.1111/j.1600-048X.2012.05606.x; Conklin JR, 2011, EMU, V111, P330, DOI 10.1071/MU11011; Conklin JR, 2011, BEHAV ECOL, V22, P854, DOI 10.1093/beheco/arr054; Conklin JR, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1072; Conklin JR, 2011, THESIS; Dawson A, 2000, P ROY SOC B-BIOL SCI, V267, P2093, DOI 10.1098/rspb.2000.1254; Dawson A, 2008, PHILOS T R SOC B, V363, P1621, DOI 10.1098/rstb.2007.0004; Dawson A, 2006, GEN COMP ENDOCR, V147, P314, DOI 10.1016/j.ygcen.2006.02.001; Dohm MR, 2002, FUNCT ECOL, V16, P273; Drent R, 2003, OIKOS, V103, P274, DOI 10.1034/j.1600-0706.2003.12274.x; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Eichhorn G, 2006, ARDEA, V94, P667; Farmer AH, 1999, ECOLOGY, V80, P2566, DOI 10.2307/177241; Fox J., 2010, GEOLOCATOR MANUAL VE; FRANSSON T, 1995, J AVIAN BIOL, V26, P39, DOI 10.2307/3677211; Gill RE, 2009, P ROY SOC B-BIOL SCI, V276, P447, DOI 10.1098/rspb.2008.1142; Gwinner E, 1996, IBIS, V138, P47, DOI 10.1111/j.1474-919X.1996.tb04312.x; HAHN TP, 1992, ORNIS SCAND, V23, P314, DOI 10.2307/3676655; Harrison XA, 2011, J ANIM ECOL, V80, P4, DOI 10.1111/j.1365-2656.2010.01740.x; Helm B., 2006, ACTA ZOOL SIN S, V52, P703; HOLMGREN N, 1995, EVOL ECOL, V9, P354, DOI 10.1007/BF01237759; Jacobs JD, 2000, CONDOR, V102, P35, DOI 10.1650/0010-5422(2000)102[0035:ECOLCS]2.0.CO;2; Kokko H, 1999, J ANIM ECOL, V68, P940, DOI 10.1046/j.1365-2656.1999.00343.x; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Liechti F, 2006, J ORNITHOL, V147, P202, DOI 10.1007/s10336-006-0061-9; Lourenco PM, 2011, J ORNITHOL, V152, P1023, DOI 10.1007/s10336-011-0692-3; LYONS JE, 1995, CONDOR, V97, P427, DOI 10.2307/1369028; Madsen J, 2001, ARDEA, V89, P43; Marra PP, 2005, OECOLOGIA, V142, P307, DOI 10.1007/s00442-004-1725-x; McCaffery B. J., 2001, BIRDS N AM; McNamara JM, 1998, J AVIAN BIOL, V29, P416, DOI 10.2307/3677160; Mitchell GW, 2012, IBIS, V154, P325, DOI 10.1111/j.1474-919X.2012.01212.x; MOLLER AP, 1994, BEHAV ECOL SOCIOBIOL, V35, P115, DOI 10.1007/BF00171501; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; NOSKOV G. A., 1999, P 22 INT ORN C DURB, P544; Nussey DH, 2005, SCIENCE, V310, P304, DOI 10.1126/science.1117004; Pulido F, 2007, CLIM RES, V35, P5, DOI 10.3354/cr00711; REES EC, 1989, ANIM BEHAV, V38, P384, DOI 10.1016/S0003-3472(89)80031-4; Smith PA, 2010, J AVIAN BIOL, V41, P292, DOI 10.1111/j.1600-048X.2009.04815.x; Studds CE, 2007, CLIM RES, V35, P115, DOI 10.3354/cr00718; Studds CE, 2011, P ROY SOC B-BIOL SCI, V278, P3437, DOI 10.1098/rspb.2011.0332; Vardanis Y, 2011, BIOL LETTERS, V7, P502, DOI 10.1098/rsbl.2010.1180; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warnock N, 2004, CAN J ZOOL, V82, P1687, DOI 10.1139/Z04-154; Warnock N, 1998, CONDOR, V100, P456, DOI 10.2307/1369711; Weber TP, 1998, EVOL ECOL, V12, P377, DOI 10.1023/A:1006560420310	57	96	101	2	136	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54535	10.1371/journal.pone.0054535	http://dx.doi.org/10.1371/journal.pone.0054535			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342168	gold, Green Published, Green Submitted			2022-12-25	WOS:000313682700123
J	Ellwood, ER; Temple, SA; Primack, RB; Bradley, NL; Davis, CC				Ellwood, Elizabeth R.; Temple, Stanley A.; Primack, Richard B.; Bradley, Nina L.; Davis, Charles C.			Record-Breaking Early Flowering in the Eastern United States	PLOS ONE			English	Article							CLIMATE-CHANGE; PHENOLOGICAL RESPONSES; TEMPERATURE; PLANT; IMPACTS; SUCCESS; TIMES; DATES	Flowering times are well-documented indicators of the ecological effects of climate change and are linked to numerous ecosystem processes and trophic interactions. Dozens of studies have shown that flowering times for many spring-flowering plants have become earlier as a result of recent climate change, but it is uncertain if flowering times will continue to advance as temperatures rise. Here, we used long-term flowering records initiated by Henry David Thoreau in 1852 and Aldo Leopold in 1935 to investigate this question. Our analyses demonstrate that record-breaking spring temperatures in 2010 and 2012 in Massachusetts, USA, and 2012 in Wisconsin, USA, resulted in the earliest flowering times in recorded history for dozens of spring-flowering plants of the eastern United States. These dramatic advances in spring flowering were successfully predicted by historical relationships between flowering and spring temperature spanning up to 161 years of ecological change. These results demonstrate that numerous temperate plant species have yet to show obvious signs of physiological constraints on phenological advancement in the face of climate change.	[Ellwood, Elizabeth R.; Primack, Richard B.] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Temple, Stanley A.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI USA; [Temple, Stanley A.; Bradley, Nina L.] Aldo Leopold Fdn, Baraboo, WI USA; [Davis, Charles C.] Harvard Univ Herbaria, Dept Organism & Evolutionary Biol, Cambridge, MA USA	Boston University; University of Wisconsin System; University of Wisconsin Madison; Harvard University	Ellwood, ER (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	eellwood@bu.edu; satemple@wisc.edu; primack@bu.edu; cdavis@oeb.harvard.edu		Ellwood, Elizabeth/0000-0003-1602-1917	National Science Foundation Grant Assembling the Tree of Life (AToL) [EF 04-31242]; National Science Foundation [DEB-0842749]; Division Of Environmental Biology [0842749] Funding Source: National Science Foundation	National Science Foundation Grant Assembling the Tree of Life (AToL); National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	CCD: National Science Foundation Grant Assembling the Tree of Life (AToL) EF 04-31242; RBP: National Science Foundation Grant DEB-0842749. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J., 1975, STAT PREDICTION ANAL; Amano T, 2010, P ROY SOC B-BIOL SCI, V277, P2451, DOI 10.1098/rspb.2010.0291; Anderson JT, 2012, P ROY SOC B-BIOL SCI, V279, P3843, DOI 10.1098/rspb.2012.1051; Beaubien E, 2011, BIOSCIENCE, V61, P514, DOI 10.1525/bio.2011.61.7.6; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; Bradley NL, 1999, P NATL ACAD SCI USA, V96, P9701, DOI 10.1073/pnas.96.17.9701; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; Cook BI, 2012, P NATL ACAD SCI USA, V109, P9000, DOI 10.1073/pnas.1118364109; Doi H, 2010, GLOBAL CHANGE BIOL, V16, P373, DOI 10.1111/j.1365-2486.2009.01993.x; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Forrest JRK, 2011, ECOL MONOGR, V81, P469, DOI 10.1890/10-1885.1; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gimenez-Benavides L, 2007, NEW PHYTOL, V173, P367, DOI 10.1111/j.1469-8137.2006.01932.x; INOUYE DW, 1991, AM J BOT, V78, P997, DOI 10.2307/2445179; LEOPOLD A, 1947, ECOL MONOGR, V17, P81, DOI 10.2307/1948614; Leopold A., 1949, S COUNTY ALMANAC; McEwan RW, 2011, PLANT ECOL, V212, P55, DOI 10.1007/s11258-010-9801-2; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Miller-Rushing AJ, 2008, ECOLOGY, V89, P332, DOI 10.1890/07-0068.1; Morin X, 2010, NEW PHYTOL, V186, P900, DOI 10.1111/j.1469-8137.2010.03252.x; New England Regional Assessment Group, 2001, NEW ENGLAND REGIONAL; Nielsen CCN, 2009, FORESTRY, V82, P43, DOI 10.1093/forestry/cpn048; NOAA National Climatic Data Center, 2012, STAT CLIM NAT OV MAR; Norby RJ, 2003, GLOBAL CHANGE BIOL, V9, P1792, DOI 10.1111/j.1365-2486.2003.00714.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Polgar CA, 2011, NEW PHYTOL, V191, P926, DOI 10.1111/j.1469-8137.2011.03803.x; Post E, 2008, PHILOS T R SOC B, V363, P2369, DOI 10.1098/rstb.2007.2207; PRIMACK RB, 1987, ANNU REV ECOL SYST, V18, P409, DOI 10.1146/annurev.ecolsys.18.1.409; Primack RB, 2012, BIOSCIENCE, V62, P170, DOI 10.1525/bio.2012.62.2.10; R Core Development Team, 2008, R LANG ENV STAT COMP; Schwartz MD, 2010, INT J CLIMATOL, V30, P1595, DOI 10.1002/joc.2014; Schwartz MD, 2000, INT J CLIMATOL, V20, P929, DOI 10.1002/1097-0088(20000630)20:8&lt;929::AID-JOC557&gt;3.0.CO;2-5; Sparks TH, 2000, INT J BIOMETEOROL, V44, P82, DOI 10.1007/s004840000049; Thoreau H. D., 1854, WALDEN LIFE WOODS; Tryjanowski P, 2006, CLIM RES, V32, P89, DOI 10.3354/cr032089; Willis CG, 2008, P NATL ACAD SCI USA, V105, P17029, DOI 10.1073/pnas.0806446105; Willis CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008878; Wisconsin Initiative on Climate Change Impacts, 2011, WISC CHANG CLIM IMP; Wolkovich EM, 2012, NATURE, V485, P494, DOI 10.1038/nature11014; Wright SD, 2008, VANISHING PRESENT, P42	44	109	115	0	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53788	10.1371/journal.pone.0053788	http://dx.doi.org/10.1371/journal.pone.0053788			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342001	Green Published, Green Submitted, gold			2022-12-25	WOS:000313682700045
J	Laskar, BA; Bhattacharjee, MJ; Dhar, B; Mahadani, P; Kundu, S; Ghosh, SK				Laskar, Boni A.; Bhattacharjee, Maloyjo J.; Dhar, Bishal; Mahadani, Pradosh; Kundu, Shantanu; Ghosh, Sankar K.			The Species Dilemma of Northeast Indian Mahseer (Actinopterygii: Cyprinidae): DNA Barcoding in Clarifying the Riddle	PLOS ONE			English	Article							FISHES; TOR; DIVERSITY; TELEOSTEI	Background: The taxonomic validity of Northeast Indian endemic Mahseer species, Tor progeneius and Neolissochilus hexastichus, has been argued repeatedly. This is mainly due to disagreements in recognizing the species based on morphological characters. Consequently, both the species have been concealed for many decades. DNA barcoding has become a promising and an independent technique for accurate species level identification. Therefore, utilization of such technique in association with the traditional morphotaxonomic description can resolve the species dilemma of this important group of sport fishes. Methodology/Principal Findings: Altogether, 28 mahseer specimens including paratypes were studied from different locations in Northeast India, and 24 morphometric characters were measured invariably. The Principal Component Analysis with morphometric data revealed five distinct groups of sample that were taxonomically categorized into 4 species, viz., Tor putitora, T. progeneius, Neolissochilus hexagonolepis and N. hexastichus. Analysis with a dataset of 76 DNA barcode sequences of different mahseer species exhibited that the queries of T. putitora and N. hexagonolepis clustered cohesively with the respective conspecific database sequences maintaining 0.8% maximum K2P divergence. The closest congeneric divergence was 3 times higher than the mean conspecific divergence and was considered as barcode gap. The maximum divergence among the samples of T. progeneius and T. putitora was 0.8% that was much below the barcode gap, indicating them being synonymous. The query sequences of N. hexastichus invariably formed a discrete and a congeneric clade with the database sequences and maintained the interspecific divergence that supported its distinct species status. Notably, N. hexastichus was encountered in a single site and seemed to be under threat. Conclusion: This study substantiated the identification of N. hexastichus to be a true species, and tentatively regarded T. progeneius to be a synonym of T. putitora. It would guide the conservationists to initiate priority conservation of N. hexastichus and T. putitora.	[Laskar, Boni A.; Bhattacharjee, Maloyjo J.; Dhar, Bishal; Mahadani, Pradosh; Kundu, Shantanu; Ghosh, Sankar K.] Assam Univ, Dept Biotechnol, Silchar, Assam, India	Assam University	Ghosh, SK (corresponding author), Assam Univ, Dept Biotechnol, Silchar, Assam, India.	drsankarghosh@gmail.com	Kundu, Dr. Shantanu/AAX-1130-2020	Kundu, Dr. Shantanu/0000-0002-5488-4433; Dhar, Bishal/0000-0001-9268-4662	fellowship (DBT-RA) from the Department of Biotechnology, Government of India	fellowship (DBT-RA) from the Department of Biotechnology, Government of India	BAL has received a fellowship (DBT-RA) from the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; April J, 2011, P NATL ACAD SCI USA, V108, P10602, DOI 10.1073/pnas.1016437108; Avise John C., 1994, pi; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bagra Kenjum, 2009, Check List, V5, P330; Bhattacharjee MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049950; Byrkjedal I, 2007, J FISH BIOL, V71, P111, DOI 10.1111/j.1095-8649.2007.01550.x; CLARE EB, 2006, MOL ECOL NOTES, V7, P184; Day F, 1878, FISHES INDIA BEING N, V1-2; Day F, 1878, FISHES INDIA BEING N, VII; Desai VR, 1822, SYNOPSIS BIOL DATA T, V158; Devi RK, 1997, CHECK LIST NATIVE FR; Doi Atsushi, 1997, Japanese Journal of Ichthyology, V44, P1; Eschmeyer WN, 2012, CATALOG FISHES; FAO, 2006, FAO NEWSLETTER; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Hamilton F., 1822, ACCOUNT FISHES FOUND; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hora S. L., 1936, REC INDIAN MUS, V38, P328; Hora SL, 1941, J BOMBAY NATURAL HIS, V12, P526; IUCN, 2012, IUCN RED LIST THREAT; Jayaram KC., 1999, FRESHWATER FISHES IN; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; McClelland J, 1939, INDIAN CYPRINIDAE, V19, P217; McDonald J. A., 1948, CIRCUMVENTING MAHSEE; Menon A. G. K., 1992, J BOMBAY NAT HIST SO, V89, P244; Mohindra Vindhya, 2007, Acta Zoologica Sinica, V53, P725; Molur S, 1998, WORKSH CONS ASS MAN; Nautiyal P, 2006, CURR SCI INDIA, V91, P1604; Nguyen TTT, 2008, FRESHWATER BIOL, V53, P924, DOI 10.1111/j.1365-2427.2007.01948.x; Oo W., 2002, FAO Fisheries Technical Paper, P71; Rainboth W., 1996, FISHES CAMBODIAN MEK; RAINBOTH W J, 1985, Beaufortia, V35, P25; Roberts TR, 1999, RAFFLES B ZOOL, V47, P225; Sambrook J., 2001, MOL CLONING LAB MANU; Sen T.K., 1982, Records of the Zoological Survey of India Occasional Paper, P1; Singh M, 2009, GENOME, V52, P783, DOI [10.1139/G09-052, 10.1139/g09-052]; Smith Andrew, 2005, FISH AQ TOP RECR FIS; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Talwar P.K., 1991, P1; Talwar P K, 1991, INLAND FISHES INDIA, V2, P1158; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Thomas HS, 1897, ROD INDIA; Thompson JD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0203S00; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Yang L, 2010, ZOOL SCR, V39, P527, DOI 10.1111/j.1463-6409.2010.00443.x; Zhang DX, 1996, TRENDS ECOL EVOL, V11, P247, DOI 10.1016/0169-5347(96)10031-8	50	39	42	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53704	10.1371/journal.pone.0053704	http://dx.doi.org/10.1371/journal.pone.0053704			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341979	Green Published, gold, Green Submitted			2022-12-25	WOS:000313682700036
J	Burcharth, J; Pedersen, M; Bisgaard, T; Pedersen, C; Rosenberg, J				Burcharth, Jakob; Pedersen, Michael; Bisgaard, Thue; Pedersen, Carsten; Rosenberg, Jacob			Nationwide Prevalence of Groin Hernia Repair	PLOS ONE			English	Article							INGUINAL-HERNIA	Introduction: Groin hernia repair is a commonly performed surgical procedure in the western world but large-scaled epidemiologic data are sparse. Large-scale data on the occurrence of groin hernia repair may provide further understanding to the pathophysiology of groin hernia development. This study was undertaken to investigate the age and gender dependent prevalence of groin hernia repair. Methods: In a nationwide register-based study, using data from the Civil Registration System covering all Danish citizens, we established a population-based cohort of all people living in Denmark on December 31st, 2010. Within this population all groin hernia repairs during the past 5 years were identified using data from the ICD 10th edition in the Danish National Hospital Register. Results: The study population covered n = 5,639,885 persons. During the five years study period 46,717 groin hernia repairs were performed (88.6% males, 11.4% females). Inguinal hernias comprised 97% of groin hernia repairs (90.2% males, 9.8% females) and femoral hernias 3% of groin hernia repairs (29.8% males, 70.2% females). Patients between 0-5 years and 75-80 years constituted the two dominant groups for inguinal hernia repair. In contrast, the age-specific prevalence of femoral hernia repair increased steadily throughout life peaking at age 80-90 years in both men and women. Conclusion: The age distribution of inguinal hernia repair is bimodal peaking at early childhood and old age, whereas the prevalence of femoral hernia repair increased steadily throughout life. This information can be used to formulate new hypotheses regarding disease etiology with regard to age and gender specifications.	[Burcharth, Jakob; Rosenberg, Jacob] Univ Copenhagen, Herlev Hosp, Dept Surg, Ctr Perioperat Optimizat, DK-2730 Herlev, Denmark; [Pedersen, Michael; Pedersen, Carsten] Univ Aarhus, Natl Ctr Register Based Res, Aarhus, Denmark; [Bisgaard, Thue] Univ Copenhagen, Koge Hosp, Dept Surg, Koge, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Aarhus University; University of Copenhagen	Burcharth, J (corresponding author), Univ Copenhagen, Herlev Hosp, Dept Surg, Ctr Perioperat Optimizat, DK-2730 Herlev, Denmark.	jakobburcharth@gmail.com	Burcharth, Jakob/S-9147-2019; Pedersen, Carsten Bøcker/B-8441-2013	Burcharth, Jakob/0000-0001-8367-7831; Pedersen, Carsten Bøcker/0000-0003-2077-8533; Rosenberg, Jacob/0000-0002-0063-1086				ABRAMSON JH, 1978, J EPIDEMIOL COMMUN H, V32, P59, DOI 10.1136/jech.32.1.59; Akin M L, 1997, J R Army Med Corps, V143, P101; Al-Shanafey S, 1999, J PEDIATR SURG, V34, P1104, DOI 10.1016/S0022-3468(99)90576-6; Andersen TF, 1999, DAN MED BULL, V46, P263; Bay-Nielsen M, 2001, LANCET, V358, P1124, DOI 10.1016/S0140-6736(01)06251-1; Dabbas Natalie, 2011, JRSM Short Rep, V2, P5, DOI 10.1258/shorts.2010.010071; Ein SH, 2006, J PEDIATR SURG, V41, P980, DOI 10.1016/j.jpedsurg.2006.01.020; Fitzgibbons RJ, 2006, JAMA-J AM MED ASSOC, V295, P285, DOI 10.1001/jama.295.3.285; Kingsnorth A, 2003, LANCET, V362, P1561, DOI 10.1016/S0140-6736(03)14746-0; Kingsworth A., 2000, BAILEY LOVE SHORT PR, V23, P1149; Nilsson H, 2007, ANN SURG, V245, P656, DOI 10.1097/01.sla.0000251364.32698.4b; Nilsson JR, 1937, SURG GYNECOL OBSTET, V64, P400; Pedersen CB, 2006, DAN MED BULL, V53, P441; Phillips W, 2004, HLTH CARE NEEDS ASSE; Rutkow IM, 2003, SURG CLIN N AM, V83, P1045, DOI 10.1016/S0039-6109(03)00132-4; Sandblom G, 1999, HERNIA, V3, P131; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID, P1609; van Wessem K J P, 2003, Hernia, V7, P76; Zimmerman L, 1967, ANATOMY SURG HERNIA	19	107	114	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54367	10.1371/journal.pone.0054367	http://dx.doi.org/10.1371/journal.pone.0054367			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342139	Green Published, gold			2022-12-25	WOS:000314759400154
J	Chlystun, M; Campanella, M; Law, AL; Duchen, MR; Fatimathas, L; Levine, TP; Gerke, V; Moss, SE				Chlystun, Marcin; Campanella, Michelangelo; Law, Ah-Lai; Duchen, Michael R.; Fatimathas, Lux; Levine, Tim P.; Gerke, Volker; Moss, Stephen E.			Regulation of Mitochondrial Morphogenesis by Annexin A6	PLOS ONE			English	Article							DYNAMIN-RELATED PROTEIN-1; CA2+; CALCIUM; DRP1; FISSION; KINASE; VI; ASSOCIATION; BAX; PHOSPHORYLATION	Mitochondrial homeostasis is critical in meeting cellular energy demands, shaping calcium signals and determining susceptibility to apoptosis. Here we report a role for anxA6 in the regulation of mitochondrial morphogenesis, and show that in cells lacking anxA6 mitochondria are fragmented, respiration is impaired and mitochondrial membrane potential is reduced. In fibroblasts from AnxA6(-/-) mice, mitochondrial Ca2+ uptake is reduced and cytosolic Ca2+ transients are elevated. These observations led us to investigate possible interactions between anxA6 and proteins with roles in mitochondrial fusion and fission. We found that anxA6 associates with Drp1 and that mitochondrial fragmentation in AnxA6(-/-) fibroblasts was prevented by the Drp1 inhibitor mdivi-1. In normal cells elevation of intracellular Ca2+ disrupted the interaction between anxA6 and Drp1, displacing anxA6 to the plasma membrane and promoting mitochondrial fission. Our results suggest that anxA6 inhibits Drp1 activity, and that Ca2+-binding to anxA6 relieves this inhibition to permit Drp1-mediated mitochondrial fission.	[Chlystun, Marcin; Law, Ah-Lai; Fatimathas, Lux; Levine, Tim P.; Moss, Stephen E.] UCL, Inst Ophthalmol, Dept Cell Biol, London, England; [Campanella, Michelangelo] Univ London Royal Vet Coll, Dept Comparat Biomed Sci, London, England; [Duchen, Michael R.] UCL, Dept Cell & Dev Biol, Mitochondrial Biol Grp, London, England; [Gerke, Volker] Univ Munster, Inst Med Biochem, D-48149 Munster, Germany; [Campanella, Michelangelo; Duchen, Michael R.] UCL, Consortium Mitochondrial Res CfMR, London, England	University of London; University College London; University of London; University of London Royal Veterinary College; University of London; University College London; University of Munster; University of London; University College London	Moss, SE (corresponding author), UCL, Inst Ophthalmol, Dept Cell Biol, London, England.	s.moss@ucl.ac.uk	duchen, michael/A-2116-2009	duchen, michael/0000-0003-2548-4294; Levine, Timothy/0000-0002-7231-0775	Biotechnology and Biological Sciences Research Council (BBSRC); Wellcome Trust; DFG; Marie Curie Actions; Biotechnology and Biological Sciences Research Council [BB/D018099/1, BB/I013695/1] Funding Source: researchfish; Medical Research Council [MR/K000608/1] Funding Source: researchfish; BBSRC [BB/D018099/1, BB/I013695/1] Funding Source: UKRI; MRC [MR/K000608/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); DFG(German Research Foundation (DFG)); Marie Curie Actions(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Biotechnology and Biological Sciences Research Council (BBSRC), Wellcome Trust and the DFG. The authors also thank Marie Curie Actions for support to M. Campanella. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benz J, 1997, BIOL CHEM, V378, P177; Borthwick LA, 2007, MOL BIOL CELL, V18, P3388, DOI 10.1091/mbc.E07-02-0126; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Campanella M, 2009, BBA-BIOENERGETICS, V1787, P393, DOI 10.1016/j.bbabio.2009.02.023; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Cubells L, 2007, TRAFFIC, V8, P1568, DOI 10.1111/j.1600-0854.2007.00640.x; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; DEMURCIA G, 1995, TRENDS CELL BIOL, V5, P78, DOI 10.1016/S0962-8924(00)88951-5; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Duchen MR, 2000, CELL CALCIUM, V28, P339, DOI 10.1054/ceca.2000.0170; Fleet A, 1999, BIOCHEM BIOPH RES CO, V260, P540, DOI 10.1006/bbrc.1999.0915; Francia G, 1996, CANCER RES, V56, P3855; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Grewal T, 2006, BIOESSAYS, V28, P1211, DOI 10.1002/bies.20503; GunteskiHamblin AM, 1996, AM J PHYSIOL-HEART C, V270, pH1091, DOI 10.1152/ajpheart.1996.270.3.H1091; Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164; Hanson CJ, 2008, CELL CALCIUM, V44, P324, DOI 10.1016/j.ceca.2008.01.003; Hawkins TE, 2002, P NATL ACAD SCI USA, V99, P8054, DOI 10.1073/pnas.132598099; Hawkins TE, 2000, CELL BIOCHEM BIOPHYS, V33, P275, DOI 10.1385/CBB:33:3:275; Hawkins TE, 1999, MOL CELL BIOL, V19, P8028; Hayes MJ, 2004, J BIOL CHEM, V279, P14157, DOI 10.1074/jbc.M313025200; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Mandal M, 1998, ONCOGENE, V17, P999, DOI 10.1038/sj.onc.1202020; McKenzie M, 2007, J BIOL CHEM, V282, P36845, DOI 10.1074/jbc.M704158200; Men XL, 2009, INT J BIOCHEM CELL B, V41, P879, DOI 10.1016/j.biocel.2008.08.031; Monastyrskaya K, 2007, CELL CALCIUM, V41, P207, DOI 10.1016/j.ceca.2006.06.008; Monastyrskaya K, 2009, J BIOL CHEM, V284, P17227, DOI 10.1074/jbc.M109.004457; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; Moss SE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-219; Nelsestuen GL, 1999, CURR OPIN STRUC BIOL, V9, P433, DOI 10.1016/S0959-440X(99)80060-8; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Potez S, 2011, J BIOL CHEM, V286, P17982, DOI 10.1074/jbc.M110.187625; Rescher U, 2004, J CELL SCI, V117, P3473, DOI 10.1242/jcs.01208; SHADLE PJ, 1985, J BIOL CHEM, V260, P6354; Smith DL, 2002, MOL CELL PROTEOMICS, V1, P876, DOI 10.1074/mcp.M200035-MCP200; Song GJ, 2002, FASEB J, V16, P622, DOI 10.1096/fj.01-0892fje; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; Tanaka A, 2008, MOL CELL, V29, P409, DOI 10.1016/j.molcel.2008.02.005; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Westermann B, 2008, J BIOL CHEM, V283, P13501, DOI 10.1074/jbc.R800011200; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zhao J, 2011, EMBO J, V30, P2762, DOI 10.1038/emboj.2011.198	52	40	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53774	10.1371/journal.pone.0053774	http://dx.doi.org/10.1371/journal.pone.0053774			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341998	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400080
J	Coffey, CM; Solleveld, PA; Fang, J; Roberts, AK; Hong, SK; Dawid, IB; Laverriere, CE; Glasgow, E				Coffey, Caitrin M.; Solleveld, Patricia A.; Fang, Joyce; Roberts, Antonia K.; Hong, Sung-Kook; Dawid, Igor B.; Laverriere, Caroline E.; Glasgow, Eric			Novel Oxytocin Gene Expression in the Hindbrain Is Induced by Alcohol Exposure: Transgenic Zebrafish Enable Visualization of Sensitive Neurons	PLOS ONE			English	Article							OPITZ-KAVEGGIA-SYNDROME; SPECTRUM DISORDERS; ETHANOL EXPOSURE; LARVAL ZEBRAFISH; BRAIN-STEM; HOPA(12BP) POLYMORPHISM; SEROTONERGIC NEURONS; BEHAVIORAL FEATURES; PRENATAL ETHANOL; AREA POSTREMA	Background: Fetal Alcohol Spectrum Disorders (FASD) are a collection of disorders resulting from fetal ethanol exposure, which causes a wide range of physical, neurological and behavioral deficits including heightened susceptibility for alcoholism and addictive disorders. While a number of mechanisms have been proposed for how ethanol exposure disrupts brain development, with selective groups of neurons undergoing reduced proliferation, dysfunction and death, the induction of a new neurotransmitter phenotype by ethanol exposure has not yet been reported. Principal Findings: The effects of embryonic and larval ethanol exposure on brain development were visually monitored using transgenic zebrafish expressing cell-specific green fluorescent protein (GFP) marker genes. Specific subsets of GFP-expressing neurons were highly sensitive to ethanol exposure, but only during defined developmental windows. In the med12 mutant, which affects the Mediator co-activator complex component Med12, exposure to lower concentrations of ethanol was sufficient to reduce GFP expression in transgenic embryos. In transgenic embryos and larva containing GFP driven by an oxytocin-like (oxtl) promoter, ethanol exposure dramatically up-regulated GFP expression in a small group of hindbrain neurons, while having no effect on expression in the neuroendocrine preoptic area. Conclusions: Alcohol exposure during limited embryonic periods impedes the development of specific, identifiable groups of neurons, and the med12 mutation sensitizes these neurons to the deleterious effects of ethanol. In contrast, ethanol exposure induces oxtl expression in the hindbrain, a finding with profound implications for understanding alcoholism and other addictive disorders.	[Coffey, Caitrin M.; Solleveld, Patricia A.; Fang, Joyce; Roberts, Antonia K.; Laverriere, Caroline E.; Glasgow, Eric] Georgetown Univ, Med Ctr, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [Hong, Sung-Kook; Dawid, Igor B.] Eunice Kennedy Shriver Natl Inst Child & Human De, Mol Genet Lab, Program Genom Differentiat, NIH, Bethesda, MD USA; [Hong, Sung-Kook] NHGRI, Mol Genet Branch, NIH, Bethesda, MD 20892 USA	Georgetown University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Glasgow, E (corresponding author), Georgetown Univ, Med Ctr, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA.	eg239@georgetown.edu		Glasgow, Eric/0000-0001-7729-3954	National Cancer Institue [P30-CA051008]; National Institute of Child Health and Human Development, United States National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008809] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER	National Cancer Institue(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Child Health and Human Development, United States National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was partially funded by National Cancer Institue grant P30-CA051008, and by the Intramural Research Program of the National Institute of Child Health and Human Development, United States National Institutes of Health. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL EL, 1986, LANCET, V2, P1222; Alati R, 2006, ARCH GEN PSYCHIAT, V63, P1009, DOI 10.1001/archpsyc.63.9.1009; Ali Shaukat, 2011, PLoS One, V6, pe20037, DOI 10.1371/journal.pone.0020037; Amsterdam A, 2005, DEV DYNAM, V234, P255, DOI 10.1002/dvdy.20541; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Baer JS, 2003, ARCH GEN PSYCHIAT, V60, P377, DOI 10.1001/archpsyc.60.4.377; Barbier E, 2008, NEUROPHARMACOLOGY, V55, P1199, DOI 10.1016/j.neuropharm.2008.07.030; Barr HM, 2006, AM J PSYCHIAT, V163, P1061, DOI 10.1176/appi.ajp.163.6.1061; Baskerville TA, 2010, CNS NEUROSCI THER, V16, pe92, DOI 10.1111/j.1755-5949.2010.00154.x; Bennett B, 2006, TRENDS GENET, V22, P367, DOI 10.1016/j.tig.2006.05.005; Blader P, 1998, DEV BIOL, V201, P185, DOI 10.1006/dbio.1998.8995; Bonthius DJ, 2003, DEV BRAIN RES, V140, P15, DOI 10.1016/S0165-3806(02)00549-7; Burd L, 2007, INT J DISABIL HUM DE, V6, P383; Buske C, 2011, NEUROTOXICOL TERATOL, V33, P698, DOI 10.1016/j.ntt.2011.05.009; Caldeira JC, 2004, J NEUROCHEM, V90, P1530, DOI 10.1111/j.1471-4159.2004.02686.x; Carvan MJ, 2004, NEUROTOXICOL TERATOL, V26, P757, DOI 10.1016/j.ntt.2004.06.016; Choo BG, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-5; Chotro MG, 2007, NEUROSCI BIOBEHAV R, V31, P181, DOI 10.1016/j.neubiorev.2006.06.021; Davis K, 2011, J DEV PHYS DISABIL, V23, P143, DOI 10.1007/s10882-010-9204-2; Dikranian K, 2005, DEV BRAIN RES, V155, P1, DOI 10.1016/j.devbrainres.2004.11.005; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Eaton JL, 2006, DEV DYNAM, V235, P2071, DOI 10.1002/dvdy.20848; Echevarria DJ, 2011, REV NEUROSCIENCE, V22, P85, DOI 10.1515/RNS.2011.010; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; Emiliano ABF, 2007, NEUROPSYCHOPHARMACOL, V32, P977, DOI 10.1038/sj.npp.1301206; Fernandes Y, 2009, ALCOHOL CLIN EXP RES, V33, P601, DOI 10.1111/j.1530-0277.2008.00874.x; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Fitzgerald DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024364; FurutaniSeiki M, 1996, DEVELOPMENT, V123, P229; GALLO M, 1990, PHARMACOL BIOCHEM BE, V35, P543, DOI 10.1016/0091-3057(90)90287-R; Gohlke JM, 2008, ALCOHOL RES HEALTH, V31, P76; Goodlett CR, 2005, EXP BIOL MED, V230, P394, DOI 10.1177/15353702-0323006-07; Graham JM, 2010, AM J MED GENET C, V154C, P477, DOI 10.1002/ajmg.c.30284; Hayes UL, 2005, PHYSIOL BEHAV, V84, P147, DOI 10.1016/j.physbeh.2004.11.001; Heaton MB, 2003, DEV BRAIN RES, V145, P249, DOI 10.1016/j.devbrainres.2003.08.005; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Hong SK, 2005, P NATL ACAD SCI USA, V102, P18473, DOI 10.1073/pnas.0509457102; Hong SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019076; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; Ikonomidou C, 2011, ANTIOXID REDOX SIGN, V14, P1535, DOI 10.1089/ars.2010.3581; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; Johnstone LE, 2006, CELL METAB, V4, P313, DOI 10.1016/j.cmet.2006.08.003; Kane MA, 2010, FASEB J, V24, P823, DOI 10.1096/fj.09-141572; Kastenhuber E, 2010, J COMP NEUROL, V518, P439, DOI 10.1002/cne.22214; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kawakami K, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-105; Kily LJM, 2008, J EXP BIOL, V211, P1623, DOI 10.1242/jeb.014399; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kurta A, 2010, DOSE-RESPONSE, V8, P527, DOI 10.2203/dose-response.10-008.Palestis; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lebel C, 2011, NEUROPSYCHOL REV, V21, P102, DOI 10.1007/s11065-011-9163-0; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; MacDonald K, 2010, HARVARD REV PSYCHIAT, V18, P1, DOI 10.3109/10673220903523615; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Mattson SN, 2011, NEUROPSYCHOL REV, V21, P81, DOI 10.1007/s11065-011-9167-9; May PA, 2009, DEV DISABIL RES REV, V15, P176, DOI 10.1002/ddrr.68; McGregor IS, 2008, BRIT J PHARMACOL, V154, P358, DOI 10.1038/bjp.2008.132; McLean DL, 2004, J COMP NEUROL, V480, P38, DOI 10.1002/cne.20280; McMurray MS, 2008, NEUROTOXICOL TERATOL, V30, P475, DOI 10.1016/j.ntt.2008.07.001; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; MILLER MW, 1986, SCIENCE, V233, P1308, DOI 10.1126/science.3749878; Tong M, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/213286; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; Philiber RA, 2007, PHARMACOGENOMICS, V8, P909, DOI 10.2217/14622416.8.8.909; Philibert RA, 2006, PSYCHIAT GENET, V16, P73, DOI 10.1097/01.ypg.0000194443.81813.f0; Philibert RA, 2007, AM J MED GENET B, V144B, P743, DOI 10.1002/ajmg.b.30489; Picker A, 2002, DEVELOPMENT, V129, P3227; Price CJ, 2008, NEUROSCIENTIST, V14, P182, DOI 10.1177/1073858407311100; Riley EP, 2011, NEUROPSYCHOL REV, V21, P73, DOI 10.1007/s11065-011-9166-x; Rinkwitz S, 2011, PROG NEUROBIOL, V93, P231, DOI 10.1016/j.pneurobio.2010.11.003; Risheg H, 2007, NAT GENET, V39, P451, DOI 10.1038/ng1992; Robles E, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00001; Rump P, 2011, CLIN GENET, V79, P183, DOI 10.1111/j.1399-0004.2010.01449.x; Sarnyai Z, 2011, ADDICT BIOL, V16, P199, DOI 10.1111/j.1369-1600.2011.00332.x; Scantamburlo G, 2009, ANN ENDOCRINOL-PARIS, V70, P449, DOI 10.1016/j.ando.2009.09.002; Schwartz CE, 2007, J MED GENET, V44, P472, DOI 10.1136/jmg.2006.048637; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Scott EK, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.013.2009; Sorensen HJ, 2011, ALCOHOL CLIN EXP RES, V35, P1315, DOI 10.1111/j.1530-0277.2011.01467.x; Sowell ER, 2001, NEUROLOGY, V57, P235, DOI 10.1212/WNL.57.2.235; Thiele TE, 1996, ALCOHOL CLIN EXP RES, V20, P1023, DOI 10.1111/j.1530-0277.1996.tb01941.x; Unger JL, 2003, GENE EXPR PATTERNS, V3, P105, DOI 10.1016/S1567-133X(02)00064-9; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Warren KR, 2005, BIRTH DEFECTS RES A, V73, P195, DOI 10.1002/bdra.20125; Westerfield M, 1995, ZEBRAFISH BOOK; Williams SK, 2009, NEUROTOXICOL TERATOL, V31, P291, DOI 10.1016/j.ntt.2009.06.001; Xu J, 2003, J BIOL CHEM, V278, P26929, DOI 10.1074/jbc.M300401200; Yoshida M, 2009, J NEUROSCI, V29, P2259, DOI 10.1523/JNEUROSCI.5593-08.2009; Young KA, 2011, NEUROSCI BIOBEHAV R, V35, P498, DOI 10.1016/j.neubiorev.2010.06.004; Youngentob SL, 2009, P NATL ACAD SCI USA, V106, P5359, DOI 10.1073/pnas.0809804106	91	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53991	10.1371/journal.pone.0053991	http://dx.doi.org/10.1371/journal.pone.0053991			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342055	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400108
J	Malli, F; Koutsokera, A; Paraskeva, E; Zakynthinos, E; Papagianni, M; Makris, D; Tsilioni, I; Molyvdas, PA; Gourgoulianis, KI; Daniil, Z				Malli, Foteini; Koutsokera, Angela; Paraskeva, Efrosini; Zakynthinos, Epaminondas; Papagianni, Maria; Makris, Dimosthenes; Tsilioni, Irene; Molyvdas, Paschalis Adam; Gourgoulianis, Konstantinos I.; Daniil, Zoe			Endothelial Progenitor Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis: An Evolving Concept	PLOS ONE			English	Article							ACUTE LUNG INJURY; ARTERIAL-HYPERTENSION; PRESSURE; DISEASE; SURVIVAL; EFFICACY	Background: Idiopathic pulmonary fibrosis (IPF) has been associated with abnormal vascular remodeling. Bone marrow derived endothelial progenitor cells (EPCs) are considered to possess lung tissue repair and vascular remodeling properties. Objectives: The study aimed to assess early EPCs levels and EPCs endogenous vascular endothelial growth factor (VEGF) expression in IPF. In order to examine alterations in the mobilization of EPCs from the bone marrow we measured plasma VEGF. Main Results: Twenty-three patients with IPF and fifteen healthy subjects were included. The number of early EPCs colonies was markedly reduced in IPF patients vs controls (6.00 +/- 6.49 vs 49.68 +/- 16.73, respectively, p<0.001). EPCs were further decreased in patients presenting systolic pulmonary arterial pressure (sPAP)>= 35 mmHg. The number of colonies per well correlated negatively with P(A-a)O2 (r = -0.750, p<0.001). Additionally, VEGF mRNA levels were significantly increased in IPF patients. There were no differences observed in VEGF plasma levels in IPF patients when compared to controls. Conclusions: The current data suggest that inadequate levels of early EPCs may potentially contribute to suppressed repair and recovery of the damaged pulmonary endothelium and thereby may drive the sequence of events in profibrogenic direction. Increased VEGFmRNA levels in the clinical context of IPF may represent a compensatory mechanism to overcome reduced EPCs levels.	[Malli, Foteini; Koutsokera, Angela; Tsilioni, Irene; Gourgoulianis, Konstantinos I.; Daniil, Zoe] Univ Thessaly, Dept Resp Med, Sch Med, Larisa, Greece; [Paraskeva, Efrosini; Papagianni, Maria; Molyvdas, Paschalis Adam] Univ Thessaly, Dept Physiol, Sch Med, Larisa, Greece; [Zakynthinos, Epaminondas; Makris, Dimosthenes] Univ Thessaly, Dept Crit Care Med, Sch Med, Larisa, Greece	University of Thessaly; University of Thessaly; University of Thessaly	Daniil, Z (corresponding author), Univ Thessaly, Dept Resp Med, Sch Med, Larisa, Greece.	zdaniil@med.uth.gr	Papagianni, Maria/AGC-9926-2022; MAKRIS, DEMOSTHENES/J-5953-2015; Koutsokera, Angela/H-8540-2019; Paraskeva, Efrosyni/E-6449-2015; Zakynthinos, Epameinondas/N-9024-2019	MAKRIS, DEMOSTHENES/0000-0003-1951-6421; Koutsokera, Angela/0000-0003-1227-1679; Paraskeva, Efrosyni/0000-0002-1312-0322; 	Hellenic Thoracic Society	Hellenic Thoracic Society	This work was supported by a grant from the Hellenic Thoracic Society to FM and ZD. The funders of the study had no role in study design, data collection, data analysis, decision to publish, data interpretation, or the preparation of the manuscript.	Akita T, 2003, LAB INVEST, V83, P65, DOI 10.1097/01.LAB.0000050761.67879.E4; Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Avouac J, 2008, ARTHRITIS RHEUM-US, V58, P3550, DOI 10.1002/art.23968; Barst R. J., 2004, J AM COLL CARDIOL S, V43, P40, DOI DOI 10.1016/j.jacc.2004.02.032; Bjoraker JA, 1998, AM J RESP CRIT CARE, V157, P199, DOI 10.1164/ajrccm.157.1.9704130; Burnham EL, 2005, AM J RESP CRIT CARE, V172, P854, DOI 10.1164/rccm.200410-1325OC; Corte TJ, 2009, SARCOIDOSIS VASC DIF, V26, P7; CURRIE PJ, 1985, J AM COLL CARDIOL, V6, P750, DOI 10.1016/S0735-1097(85)80477-0; Diller GP, 2008, CIRCULATION, V117, P3020, DOI 10.1161/CIRCULATIONAHA.108.769646; Fadini GP, 2010, EUR RESPIR J, V35, P418, DOI 10.1183/09031936.00112809; Fadini GP, 2007, SARCOIDOSIS VASC DIF, V24, P85; Fadini GP, 2007, AM J RESP CRIT CARE, V176, P724, DOI 10.1164/ajrccm.176.7.724a; Fadini GP, 2006, STEM CELLS, V24, P1806, DOI 10.1634/stemcells.2005-0440; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; FERRARA N, 1992, ENDOCR REV, V13, P18, DOI 10.1210/er.13.1.18; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; HIMELMAN RB, 1989, CIRCULATION, V79, P863, DOI 10.1161/01.CIR.79.4.863; Ito H, 1999, CANCER RES, V59, P5875; Joppa P, 2006, CHEST, V130, P326, DOI 10.1378/chest.130.2.326; Lam CF, 2008, ANESTHESIOLOGY, V108, P392, DOI 10.1097/ALN.0b013e318164ca64; Mao M, 2010, SHOCK, V34, P196, DOI 10.1097/SHK.0b013e3181d49457; Nathan SD, 2007, AM J RESP CRIT CARE, V175, P875, DOI 10.1164/rccm.200608-1153CC; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Strieter RM, 2009, CHEST, V136, P1364, DOI 10.1378/chest.09-0510; Travis W.D., 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003; Yamada M, 2005, THORAX, V60, P410, DOI 10.1136/thx.2004.034058; YOCK PG, 1984, CIRCULATION, V70, P657, DOI 10.1161/01.CIR.70.4.657; Zammaretti P, 2005, INT J BIOCHEM CELL B, V37, P493, DOI 10.1016/j.biocel.2004.06.018; Zhao YDD, 2005, CIRC RES, V96, P442, DOI 10.1161/01.RES.0000157672.70560.7b; Zhu JH, 2008, RESP MED, V102, P1073, DOI 10.1016/j.rmed.2007.12.030	31	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53658	10.1371/journal.pone.0053658	http://dx.doi.org/10.1371/journal.pone.0053658			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341966	gold, Green Submitted, Green Published			2022-12-25	WOS:000314759400060
J	Murase, K; Mori, K; Yoshimura, C; Aihara, K; Chihara, Y; Azuma, M; Harada, Y; Toyama, Y; Tanizawa, K; Handa, T; Hitomi, T; Oga, T; Mishima, M; Chin, K				Murase, Kimihiko; Mori, Kiyoshi; Yoshimura, Chikara; Aihara, Kensaku; Chihara, Yuichi; Azuma, Masanori; Harada, Yuka; Toyama, Yoshiro; Tanizawa, Kiminobu; Handa, Tomohiro; Hitomi, Takefumi; Oga, Toru; Mishima, Michiaki; Chin, Kazuo			Association between Plasma Neutrophil Gelatinase Associated Lipocalin Level and Obstructive Sleep Apnea or Nocturnal Intermittent Hypoxia	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; INSULIN-RESISTANCE; NGAL; IDENTIFICATION; OBESITY; EXPRESSION; BIOMARKER; MARKER	Background: Both obstructive sleep apnea (OSA) and a novel lipocalin, neutrophil gelatinase associated lipocalin (Ngal), have been reported to be closely linked with cardiovascular disease and loss of kidney function through chronic inflammation. However, the relationship between OSA and Ngal has never been investigated. Objectives: To evaluate the relationship between Ngal and OSA in clinical practice. Methods: In 102 patients, polysomnography was performed to diagnose OSA and plasma Ngal levels were measured. The correlations between Ngal levels and OSA severity and other clinical variables were evaluated. Of the 46 patients who began treatment with continuous positive airway pressure (CPAP), Ngal levels were reevaluated after three months of treatment in 25 patients. Results: The Ngal level correlated significantly with OSA severity as determined by the apnea hypopnea index (r = 0.24, p = 0.01) and 4% oxygen desaturation index (ODI) (r = 0.26, p = 0.01). Multiple regression analysis showed that the Ngal level was associated with 4% ODI independently of other clinical variables. Compliance was good in 13 of the 25 patients who used CPAP. Although the OSA (4% ODI: 33.1 +/- 16.7 to 1.1 +/- 1.9/h, p<0.01) had significantly improved in those with good compliance, the Ngal levels were not significantly changed (60.5 +/- 18.1 before CPAP vs 64.2 +/- 13.9 ng/ml after CPAP, p = 0.27). Conclusions: Plasma Ngal levels were positively associated with the severity of OSA. However, the contribution rate of OSA to systemic Ngal secretion was small and changes in Ngal levels appeared to be influenced largely by other confounding factors. Therefore, it does not seem reasonable to use the Ngal level as a specific biomarker of OSA in clinical practice.	[Murase, Kimihiko; Aihara, Kensaku; Azuma, Masanori; Harada, Yuka; Toyama, Yoshiro; Tanizawa, Kiminobu; Handa, Tomohiro; Mishima, Michiaki] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan; [Mori, Kiyoshi] Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Kyoto, Japan; [Yoshimura, Chikara; Hitomi, Takefumi; Oga, Toru; Chin, Kazuo] Kyoto Univ, Grad Sch Med, Dept Resp Care & Sleep Control Med, Kyoto, Japan; [Chihara, Yuichi] Red Cross Otsu Hosp, Dept Resp Med, Shiga, Japan	Kyoto University; Kyoto University; Kyoto University	Chin, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Resp Care & Sleep Control Med, Kyoto, Japan.	chink@kuhp.kyoto-u.ac.jp	Tanizawa, Kiminobu/GPC-4728-2022; Mori, Kiyoshi/N-1267-2014; Aihara, Kensaku/AAB-9889-2021; Chihara, Yuichi/AAK-3397-2020	Mori, Kiyoshi/0000-0002-7285-8351; Tanizawa, Kiminobu/0000-0002-5719-0744	Japanese Ministry of Education, Culture, Sports, Science and Technology; Respiratory Failure Research Group from the Ministry of Health, Labor and Welfare of Japan	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Respiratory Failure Research Group from the Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was partly supported by grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology, Respiratory Failure Research Group from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019029; Bao GH, 2010, NAT CHEM BIOL, V6, P602, DOI [10.1038/nchembio.402, 10.1038/NCHEMBIO.402]; Bolignano D, 2009, CLIN J AM SOC NEPHRO, V4, P337, DOI 10.2215/CJN.03530708; Choi KM, 2009, CLIN ENDOCRINOL, V70, P569, DOI 10.1111/j.1365-2265.2008.03374.x; Collen J, 2009, CHEST, V135, P704, DOI 10.1378/chest.08-2182; Daniels LB, 2012, J AM COLL CARDIOL, V59, P1101, DOI 10.1016/j.jacc.2011.11.046; Drager LF, 2011, CHEST, V140, P534, DOI 10.1378/chest.10-2223; Fassett RG, 2012, NEPHROL DIAL TRANSPL, V27, P182, DOI 10.1093/ndt/gfr193; Giaginis C, 2010, CLIN CHEM LAB MED, V48, P1035, DOI 10.1515/CCLM.2010.211; Hemdahl AL, 2006, ARTERIOSCL THROM VAS, V26, P136, DOI 10.1161/01.ATV.0000193567.88685.f4; Iber C., 2007, AASM MANUAL SCORING; Jayaraman A, 2005, BIOTECHNOL BIOENG, V91, P502, DOI 10.1002/bit.20535; Jiang W, 2008, BLOOD CELL MOL DIS, V41, P169, DOI 10.1016/j.bcmd.2008.04.006; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Kohler M, 2010, NAT REV CARDIOL, V7, P677, DOI 10.1038/nrcardio.2010.145; LIU QS, 1995, J BIOL CHEM, V270, P22565, DOI 10.1074/jbc.270.38.22565; Liu XW, 2011, EUR J ENDOCRINOL, V165, P805, DOI 10.1530/EJE-11-0660; Makino S, 2009, HORM METAB RES, V41, P221, DOI 10.1055/s-0028-1100411; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Nakayama-Ashida Y, 2008, SLEEP, V31, P419, DOI 10.1093/sleep/31.3.419; Nena E, 2010, RESPIRATION, V80, P517, DOI 10.1159/000295903; Nicholl DDM, 2012, CHEST, V141, P1422, DOI 10.1378/chest.11-1809; Niigaki M, 2013, J GASTROENTEROL, V48, P463, DOI 10.1007/s00535-012-0671-3; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Ronco C, 2007, CRIT CARE, V11, DOI 10.1186/cc6162; Ryan S, 2005, CIRCULATION, V112, P2660, DOI 10.1161/CIRCULATIONAHA.105.556746; Viau A, 2010, J CLIN INVEST, V120, P4065, DOI 10.1172/JCI42004; Wallenius V, 2011, EXP CLIN ENDOCR DIAB, V119, P75, DOI 10.1055/s-0030-1265212; Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yndestad A, 2009, EUR HEART J, V30, P1229, DOI 10.1093/eurheartj/ehp088; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	35	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54184	10.1371/journal.pone.0054184	http://dx.doi.org/10.1371/journal.pone.0054184			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342100	Green Submitted, Green Published, gold			2022-12-25	WOS:000314759400130
J	Xu, YD; Qian, CX				Xu, Yidong; Qian, Chunxiang			Application of Gurson-Tvergaard-Needleman Constitutive Model to the Tensile Behavior of Reinforcing Bars with Corrosion Pits	PLOS ONE			English	Article							INDUCED CRACKING; VOID NUCLEATION; STRESS; EVOLUTION; FRACTURE	Based on meso-damage mechanics and finite element analysis, the aim of this paper is to describe the feasibility of the Gurson-Tvergaard-Needleman (GTN) constitutive model in describing the tensile behavior of corroded reinforcing bars. The orthogonal test results showed that different fracture pattern and the related damage evolution process can be simulated by choosing different material parameters of GTN constitutive model. Compared with failure parameters, the two constitutive parameters are significant factors affecting the tensile strength. Both the nominal yield and ultimate tensile strength decrease markedly with the increase of constitutive parameters. Combining with the latest data and trial-and-error method, the suitable material parameters of GTN constitutive model were adopted to simulate the tensile behavior of corroded reinforcing bars in concrete under carbonation environment attack. The numerical predictions can not only agree very well with experimental measurements, but also simplify the finite element modeling process.	[Xu, Yidong; Qian, Chunxiang] Southeast Univ, Sch Mat Sci & Engn, Nanjing, Jiangsu, Peoples R China; [Xu, Yidong] Zhejiang Univ, Ningbo Inst Technol, Res Ctr Green Bldg Mat & Waste Resources Reuse, Ningbo, Zhejiang, Peoples R China	Southeast University - China; Zhejiang University	Qian, CX (corresponding author), Southeast Univ, Sch Mat Sci & Engn, Nanjing, Jiangsu, Peoples R China.	30397604@163.com	徐, 亦冬/J-6680-2019	徐, 亦冬/0000-0003-3756-032X; Qian, Chunxiang/0000-0002-7547-5890	National Key Basic Research and Development Plan of China (973 Program) [2009CB623203]; National Natural Science Foundation of China [51008276]; Ningbo Scientific and technological innovation teams of safety and durability in coastal structures [2011B81005]	National Key Basic Research and Development Plan of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ningbo Scientific and technological innovation teams of safety and durability in coastal structures	(1) National Key Basic Research and Development Plan of China (973 Program) 2009CB623203, (2) National Natural Science Foundation of China 51008276, (3) Ningbo Scientific and technological innovation teams of safety and durability in coastal structures 2011B81005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almusallam AA, 2001, CONSTR BUILD MATER, V15, P361, DOI 10.1016/S0950-0618(01)00009-5; [安琳 An Lin], 2005, [东南大学学报. 自然科学版, Journal of southeast university. Natural science edition], V35, P940; Apostolopoulos CA, 2006, CONSTR BUILD MATER, V20, P782, DOI 10.1016/j.conbuildmat.2005.01.065; Bai Y, 2010, T NONFERR METAL SOC, V20, P1392, DOI 10.1016/S1003-6326(09)60310-1; Beardsmore D, 2006, ASME PVP DIV C VANC; Benseddiq N, 2008, INT J PRES VES PIP, V85, P219, DOI 10.1016/j.ijpvp.2007.09.003; Cerit M, 2009, ENG FAIL ANAL, V16, P2467, DOI 10.1016/j.engfailanal.2009.04.004; CHU CC, 1980, J ENG MATER-T ASME, V102, P249, DOI 10.1115/1.3224807; Du YG, 2005, MAG CONCRETE RES, V57, P407, DOI 10.1680/macr.2005.57.7.407; Du YG, 2005, MAG CONCRETE RES, V57, P135, DOI 10.1680/macr.57.3.135.60482; [范颖芳 Fan Yingfang], 2003, [建筑材料学报, Journal of building materials], V6, P248; GURSON AL, 1977, J ENG MATER-T ASME, V99, P2, DOI 10.1115/1.3443401; Horner DA, 2011, CORROS SCI, V53, P3466, DOI 10.1016/j.corsci.2011.05.050; Mullard JA, 2011, ACI STRUCT J, V108, P71; Turnbull A, 2010, CORROS SCI, V52, P1492, DOI 10.1016/j.corsci.2009.12.004; Turnbull A, 2009, ENG FRACT MECH, V76, P633, DOI 10.1016/j.engfracmech.2008.09.004; TVERGAARD V, 1984, ACTA METALL MATER, V32, P157, DOI 10.1016/0001-6160(84)90213-X; Vu K, 2005, ACI STRUCT J, V102, P719; Xu YD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029956; Yu HH, 2007, INT J BIOL MACROMOL, V40, P276, DOI 10.1016/j.ijbiomac.2006.06.020; Zhang RJ, 2010, CEMENT CONCRETE RES, V40, P415, DOI 10.1016/j.cemconres.2009.09.026; Zhang WP, 2012, CONSTR BUILD MATER, V34, P409, DOI 10.1016/j.conbuildmat.2012.02.071; Zhang ZL, 2000, ENG FRACT MECH, V67, P155, DOI 10.1016/S0013-7944(00)00055-2; Zhao YX, 2012, CORROS SCI, V55, P385, DOI 10.1016/j.corsci.2011.11.002; Zhao YX, 2011, CORROS SCI, V53, P3388, DOI 10.1016/j.corsci.2011.06.018	25	5	5	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54368	10.1371/journal.pone.0054368	http://dx.doi.org/10.1371/journal.pone.0054368			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342140	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400155
J	Castanera, D; Vila, B; Razzolini, NL; Falkingham, PL; Canudo, JI; Manning, PL; Galobart, A				Castanera, Diego; Vila, Bernat; Razzolini, Novella L.; Falkingham, Peter L.; Canudo, Jose I.; Manning, Phillip L.; Galobart, Angel			Manus Track Preservation Bias as a Key Factor for Assessing Trackmaker Identity and Quadrupedalism in Basal Ornithopods	PLOS ONE			English	Article							DINOSAUR FOOTPRINTS; ORNITHISCHIA ORNITHOPODA; ICHNOLOGICAL EVIDENCE	Background: The Las Cerradicas site (Tithonian-Berriasian), Teruel, Spain, preserves at least seventeen dinosaur trackways, some of them formerly attributed to quadrupedal ornithopods, sauropods and theropods. The exposure of new track evidence allows a more detailed interpretation of the controversial tridactyl trackways as well as the modes of locomotion and taxonomic affinities of the trackmakers. Methodology/Principal Findings: Detailed stratigraphic analysis reveals four different levels where footprints have been preserved in different modes. Within the tridactyl trackways, manus tracks are mainly present in a specific horizon relative to surface tracks. The presence of manus tracks is interpreted as evidence of an ornithopod trackmaker. Cross-sections produced from photogrammetric digital models show different depths of the pes and manus, suggesting covariance in loading between the forelimbs and the hindlimbs. Conclusions/Significance: Several features (digital pads, length/width ratio, claw marks) of some ornithopod pes tracks from Las Cerradicas are reminiscent of theropod pedal morphology. This morphological convergence, combined with the shallow nature of the manus tracks, which reduces preservation potential, opens a new window into the interpretation of these tridactyl tracks. Thus, trackmaker assignations during the Jurassic-Cretaceous interval of purported theropod trackways may potentially represent ornithopods. Moreover, the Las Cerradicas trackways are further evidence for quadrupedalism among some basal small-to medium-sized ornithopods from this time interval.	[Castanera, Diego; Vila, Bernat; Canudo, Jose I.] Univ Zaragoza, Fac Ciencias, Grp Aragosaurus IUCA, E-50009 Zaragoza, Spain; [Vila, Bernat; Razzolini, Novella L.; Galobart, Angel] Inst Catala Paleontol Miquel Crusafont, Barcelona, Spain; [Falkingham, Peter L.] Univ London Royal Vet Coll, Dept Comparat Biomed Sci Struct & Mot Lab, London, England; [Falkingham, Peter L.] Brown Univ, Div Biol & Med, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Manning, Phillip L.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester, Lancs, England; [Manning, Phillip L.] Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA	University of Zaragoza; Institut Catala de Paleontologia Miquel Crusafont (ICP); University of London; University of London Royal Veterinary College; Brown University; University of Manchester; University of Pennsylvania	Castanera, D (corresponding author), Univ Zaragoza, Fac Ciencias, Grp Aragosaurus IUCA, E-50009 Zaragoza, Spain.	dcastanera@unizar.es	CASTANERA, DIEGO/AAH-5598-2019; VILA, BERNAT/AAA-7367-2021; Manning, Phillip/F-9966-2011; Falkingham, Peter/C-7656-2014; Galobart, Àngel À/H-5024-2011	CASTANERA, DIEGO/0000-0003-3950-1630; VILA, BERNAT/0000-0002-5935-1732; Manning, Phillip/0000-0002-7161-6246; Falkingham, Peter/0000-0003-1856-8377; Galobart, Àngel À/0000-0003-1508-4561; Canudo Sanagustin, Jose Ignacio/0000-0003-1732-9155	FPU grant from the Spanish Ministry of Education [AP2008-01340]; Ministry of Science and Innovation (Subprograma Juan de la Cierva (MICINN-JDC)); Marie Curie International outgoing Fellowship within the 7th European Framework Programme	FPU grant from the Spanish Ministry of Education(German Research Foundation (DFG)); Ministry of Science and Innovation (Subprograma Juan de la Cierva (MICINN-JDC)); Marie Curie International outgoing Fellowship within the 7th European Framework Programme	DC was supported by a FPU grant from the Spanish Ministry of Education (AP2008-01340). BV acknowledges support from the Ministry of Science and Innovation (Subprograma Juan de la Cierva (MICINN-JDC) 2011). PLF was supported by a Marie Curie International outgoing Fellowship within the 7th European Framework Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcal?, 2012, FUNDAMENTAL, P219; Alcal?, 2012, FUNDAMENTAL, P215; ALEXANDER RM, 1976, NATURE, V261, P129, DOI 10.1038/261129a0; Avanzini M, 2012, LETHAIA, V45, P238, DOI 10.1111/j.1502-3931.2011.00276.x; Barco Jose Luis, 2006, Ichnos, V13, P237, DOI 10.1080/10420940600843682; Barrett PM, 2011, SPEC PAP PALAEONTOL, P131, DOI 10.1111/j.1475-4983.2011.01076.x; Bates KT, 2008, J GEOL SOC LONDON, V165, P115, DOI 10.1144/0016-76492007-033; Canudo J.I., 2005, Geogaceta, V38, P39; Canudo JI, 2012, GEOL MAG, V149, P252, DOI 10.1017/S0016756811000732; Castanera D, J IBERIAN G IN PRESS; Castanera D, 2012, LETHAIA, V45, P476, DOI 10.1111/j.1502-3931.2012.00304.x; Castanera D, 2011, PALAEOGEOGR PALAEOCL, V310, P227, DOI 10.1016/j.palaeo.2011.07.015; Cobos A, 2011, THESIS U PAIS VASCO; D'Orazi Porchetti S., 2008, STUDI TRENTINI SCI N, V83, P277; Dall Vecchia Fabio M., 2000, Memorie di Scienze Geologiche, V52, P227; Diaz-Martinez I, 2012, FUNDAMENTAL, V20, P63; Diedrich Cajus, 2004, Ichnos, V11, P215, DOI 10.1080/10420940490444924; Falkingham PL, 2012, J GEOL SOC LONDON, V169, P365, DOI 10.1144/0016-76492011-019; Falkingham PL, 2011, J R SOC INTERFACE, V8, P1142, DOI 10.1098/rsif.2010.0634; Falkingham PL, 2011, BIOL LETTERS, V7, P142, DOI 10.1098/rsbl.2010.0403; Falkingham PL, 2010, PALAIOS, V25, P356, DOI 10.2110/palo.2009.p09-164r; Falkingham PL, 2012, PALAEONTOL ELECTRON, V15; Farlow James O., 1993, Bulletin of the New Mexico Museum of Natural History and Science, V3, P123; Farlow James O., 1997, P519; FUENTES VIDARTE C., 1998, ESTUD GEOL-MADRID, V54, P147, DOI DOI 10.3989/EGEOL.98543-4213; HEINRICH RE, 1993, ZOOL J LINN SOC-LOND, V108, P179, DOI 10.1111/j.1096-3642.1993.tb00294.x; Hornung JJ, 2012, PALAEONTOL Z, V86, P231, DOI 10.1007/s12542-012-0131-7; Instituto de Estudios Turolenses, 2009, 2 JORN PAL GALV HOM, P85; Jackson SJ, 2009, PALAIOS, V24, P222, DOI 10.2110/palo.2007.p07-070r; Le Loeuff J, 2002, C R PALEVOL, V1, P287, DOI 10.1016/S1631-0683(02)00037-4; Leonardi G, 1997, REV SOC GEOLOGICA ES, V10, P341; Leonardi G., 1994, ANNOTATED ATLAS S AM; Lingham-Soliar T, 2003, NATURWISSENSCHAFTEN, V90, P572, DOI 10.1007/s00114-003-0477-5; LOCKLEY M. G, 1991, TRACKING DINOSAURS N; Lockley Martin, 1998, Modern Geology, V23, P317; Lockley Martin G., 2001, P428; Lockley MG, 2009, GEOL SOC SPEC PUBL, V315, P255, DOI 10.1144/SP315.18; Lockley MG, 2009, GEOL Q, V53, P415; Lockley Martin G., 2000, Gaia (Lisboa), V15, P339; LOCKLEY MG, 1986, GEOL SOC AM BULL, V97, P1163, DOI 10.1130/0016-7606(1986)97<1163:NALDTS>2.0.CO;2; Lockley MG, 1999, PALAEOGEOGR PALAEOCL, V150, P25, DOI 10.1016/S0031-0182(99)00005-X; Lockley MG, 2009, ACT 4 JORN INT PAL D, P121; Lockley MG, 2004, ICHNOS, V11, P262, DOI [DOI 10.1080/10420940490428805, 10.1080/10420940490428805]; Maidment SCR, ACTA PALEON IN PRESS; Maidment SCR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036904; Manning PL, 2004, GEOL SOC SPEC PUBL, V228, P93, DOI 10.1144/GSL.SP.2004.228.01.06; MARTY D., 2008, GEOFOCUS, V21, P1; Marty D, 2009, ICHNOS, V16, P127, DOI 10.1080/10420940802471027; Mateus Octavio, 2008, Oryctos, V8, P47; Matsukawa M, 1997, CRETACEOUS RES, V18, P603, DOI 10.1006/cres.1997.0075; Matsukawa Masaki, 2005, Ichnos, V12, P201, DOI 10.1080/10420940591009231; Meyer Christian A., 2003, Ichnos, V10, P221, DOI 10.1080/10420940390256186; Milan J, 2006, PALAEOGEOGR PALAEOCL, V231, P253, DOI 10.1016/j.palaeo.2004.12.022; Moratalla J.J., 1992, Journal of Vertebrate Paleontology, V12, P150; Moratalla J.J., 1997, REV ESPANOLA PALEONT, V12, P185; MORATALLA JJ, 1988, GEOBIOS-LYON, V21, P395, DOI 10.1016/S0016-6995(88)80042-1; Moratalla Jose J., 1994, Ichnos, V3, P89; Moreno K, 2007, J MORPHOL, V268, P50, DOI 10.1002/jmor.10498; Norman D.B., 1986, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V56, P281; Olsen P.E., 1986, P61; Ortega F., 2006, Estudios Geologicos (Madrid), V62, P219; Pascual-Arribas Carlos, 2009, Studia Geologica Salmanticensia, V45, P105; Perez-Lorente Felix, 1997, Ichnos, V5, P109; Romilio A, 2011, CRETACEOUS RES, V32, P135, DOI 10.1016/j.cretres.2010.11.003; Royo-Torres R, 2009, PALAEONTOLOGY, V52, P1009, DOI 10.1111/j.1475-4983.2009.00898.x; Ruiz-Omenaca JI, 2011, ESTUD GEOL-MADRID, V67, P83, DOI 10.3989/egeol.40276.124; Sanchez-Hernandez B, 2007, PALAEOGEOGR PALAEOCL, V249, P180, DOI 10.1016/j.palaeo.2007.01.009; Santos VF, CRETACEOUS IN PRESS, P1; STERNBERG C.H., 1932, NATL MUSEUM CANADA B, P59; Taquet, 1984, ORME DINOSAURI, P165; Thulborn T., 1990, DINOSAUR TRACKS; Wright JL, 1999, SP PALAEONT, P209	72	40	42	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54177	10.1371/journal.pone.0054177	http://dx.doi.org/10.1371/journal.pone.0054177			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349817	Green Accepted, Green Published, gold			2022-12-25	WOS:000314019100048
J	Eiler, A; Drakare, S; Bertilsson, S; Pernthaler, J; Peura, S; Rofner, C; Simek, K; Yang, Y; Znachor, P; Lindstrom, ES				Eiler, Alexander; Drakare, Stina; Bertilsson, Stefan; Pernthaler, Jakob; Peura, Sari; Rofner, Carina; Simek, Karel; Yang, Yang; Znachor, Petr; Lindstrom, Eva S.			Unveiling Distribution Patterns of Freshwater Phytoplankton by a Next Generation Sequencing Based Approach	PLOS ONE			English	Article							AUTOTROPHIC PICOPLANKTON; MICROBIAL DIVERSITY; RNA; MARINE; BACTERIAL; SEA; DNA; COMMUNITIES; ANABAENA; REVEALS	The recognition and discrimination of phytoplankton species is one of the foundations of freshwater biodiversity research and environmental monitoring. This step is frequently a bottleneck in the analytical chain from sampling to data analysis and subsequent environmental status evaluation. Here we present phytoplankton diversity data from 49 lakes including three seasonal surveys assessed by next generation sequencing (NGS) of 16S ribosomal RNA chloroplast and cyanobacterial gene amplicons and also compare part of these datasets with identification based on morphology. Direct comparison of NGS to microscopic data from three time-series showed that NGS was able to capture the seasonality in phytoplankton succession as observed by microscopy. Still, the PCR-based approach was only semi-quantitative, and detailed NGS and microscopy taxa lists had only low taxonomic correspondence. This is probably due to, both, methodological constraints and current discrepancies in taxonomic frameworks. Discrepancies included Euglenophyta and Heterokonta that were scarce in the NGS but frequently detected by microscopy and Cyanobacteria that were in general more abundant and classified with high resolution by NGS. A deep-branching taxonomically unclassified cluster was frequently detected by NGS but could not be linked to any group identified by microscopy. NGS derived phytoplankton composition differed significantly among lakes with different trophic status, showing that our approach can resolve phytoplankton communities at a level relevant for ecosystem management. The high reproducibility and potential for standardization and parallelization makes our NGS approach an excellent candidate for simultaneous monitoring of prokaryotic and eukaryotic phytoplankton in inland waters.	[Eiler, Alexander; Bertilsson, Stefan; Rofner, Carina; Lindstrom, Eva S.] Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden; [Drakare, Stina] Swedish Univ Agr Sci, Uppsala, Sweden; [Pernthaler, Jakob] Inst Plant Biol, Limnol Stn, Kilchberg, Switzerland; [Peura, Sari] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Simek, Karel; Znachor, Petr] Acad Sci Czech Republ, Inst Hydrobiol, Vvi, Ctr Biol, Ceske Budejovice, Czech Republic; [Yang, Yang] Uppsala Univ, Erken Lab, Norrtalje, Sweden	Uppsala University; Swedish University of Agricultural Sciences; University of Jyvaskyla; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Uppsala University	Eiler, A (corresponding author), Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden.	alexander.eiler@ebc.uu.se	Eiler, Alexander/V-9220-2017; LindstrÃm, Eva/H-5930-2016; Šimek, Karel/AAB-1956-2021; Drakare, Stina/D-4532-2016; Znachor, Petr/F-8901-2014; Znachor, Petr/AAH-5088-2020; Simek, Karel/F-8930-2014; Drakare, Stina/ABF-1259-2020; Znachor, Petr/AAC-2289-2021	Eiler, Alexander/0000-0001-9916-9567; LindstrÃm, Eva/0000-0001-8920-3071; Šimek, Karel/0000-0002-7058-9063; Drakare, Stina/0000-0002-7389-2105; Drakare, Stina/0000-0002-7389-2105; Znachor, Petr/0000-0002-9356-5996; Peura, Sari/0000-0003-3892-8157	Swedish foundation for strategic research; Swedish Research Council; Czech Grant Agency [206/08/0015]	Swedish foundation for strategic research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Czech Grant Agency(Grant Agency of the Czech Republic)	This work was supported by the Swedish foundation for strategic research (grant to AE), the Swedish Research Council (separate grants to ESL and SB) and the Czech Grant Agency (grant 206/08/0015 to KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Andersson AF, 2010, ISME J, V4, P171, DOI 10.1038/ismej.2009.108; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Bell T, 2001, LIMNOL OCEANOGR, V46, P1243, DOI 10.4319/lo.2001.46.5.1243; Bolhuis H, 2011, ISME J, V5, P1701, DOI [10.1038/Ismej.2011.52, 10.1038/ismej.2011.52]; Capblancq J., 1994, P9; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Diez B, 2001, APPL ENVIRON MICROB, V67, P2932, DOI 10.1128/AEM.67.7.2932-2941.2001; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eiler A, 2012, ISME J, V6, P330, DOI 10.1038/ismej.2011.113; Galand PE, 2009, ISME J, V3, P860, DOI 10.1038/ismej.2009.23; Galluzzi L, 2004, APPL ENVIRON MICROB, V70, P1199, DOI 10.1128/AEM.70.2.1199-1206.2004; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Gugger M, 2002, INT J SYST EVOL MICR, V52, P1867, DOI 10.1099/ijs.0.02270-0; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Joo S, 2010, J MICROBIOL METH, V81, P61, DOI 10.1016/j.mimet.2010.01.025; Leliaert F, 2012, CRIT REV PLANT SCI, V31, P1, DOI 10.1080/07352689.2011.615705; Llewellyn CA, 2000, MAR ECOL PROG SER, V193, P33, DOI 10.3354/meps193033; Logares R, 2012, ISME J; Logares R, 2012, ISME J, V6, P1823, DOI 10.1038/ismej.2012.36; Logue JB, 2012, ISME J, V6, P1127, DOI 10.1038/ismej.2011.184; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; LUND J. W. G., 1958, HYDROBIOLOGIA, V11, P143, DOI 10.1007/BF00007865; Lundin D, 2012, ENV MICROBIOL REP, V4, P367, DOI 10.1111/j.1758-2229.2012.00345.x; MALONE TC, 1971, LIMNOL OCEANOGR, V16, P633, DOI 10.4319/lo.1971.16.4.0633; Martin-Laurent F, 2001, APPL ENVIRON MICROB, V67, P2354, DOI 10.1128/AEM.67.5.2354-2359.2001; Martinez-Garcia M, 2012, ISME J, V6, P703, DOI 10.1038/ismej.2011.126; Massana R, 2002, APPL ENVIRON MICROB, V68, P4554, DOI 10.1128/AEM.68.9.4554-4558.2002; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Medlin LK, 2006, MICROB ECOL, V52, P53, DOI 10.1007/s00248-005-0062-x; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; NGANDO TS, 1991, ARCH PROTISTENKD, V140, P109, DOI 10.1016/S0003-9365(11)80179-X; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Olrik K, 1998, 4860 SWED EPA 1; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Pawlowski J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001419; Peura S, 2012, ISME J, V6, P1640, DOI 10.1038/ismej.2012.21; Posch T, 2012, NATURE CLIMATE CHANG, V8, DOI 101038/nclimate1581; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; R Development Core Team, 2011, R LANG ENV STAT COMP, P2630; Schallenberg M, 2001, FRESHWATER BIOL, V46, P27, DOI 10.1046/j.1365-2427.2001.00647.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; SOMMER U, 1985, LIMNOL OCEANOGR, V30, P335, DOI 10.4319/lo.1985.30.2.0335; STOCKNER JG, 1991, INT REV GES HYDROBIO, V76, P483, DOI 10.1002/iroh.19910760402; Stoeck T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-72; Theriot EC, 2010, PLANT ECOL EVOL, V143, P278, DOI 10.5091/plecevo.2010.418; Treusch AH, 2012, ISME J, V6, P481, DOI 10.1038/ismej.2011.117; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zapomelova E, 2009, J PHYCOL, V45, P1363, DOI 10.1111/j.1529-8817.2009.00758.x; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006; Zimmermann J, 2011, ORG DIVERS EVOL, V11, P173, DOI 10.1007/s13127-011-0050-6	55	81	88	2	168	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53516	10.1371/journal.pone.0053516	http://dx.doi.org/10.1371/journal.pone.0053516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349714	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000314019100023
J	Nobrega, C; Nascimento-Ferreira, I; Onofre, I; Albuquerque, D; Hirai, H; Deglon, N; de Almeida, LP				Nobrega, Clevio; Nascimento-Ferreira, Isabel; Onofre, Isabel; Albuquerque, David; Hirai, Hirokazu; Deglon, Nicole; de Almeida, Luis Pereira			Silencing Mutant Ataxin-3 Rescues Motor Deficits and Neuropathology in Machado-Joseph Disease Transgenic Mice	PLOS ONE			English	Article							POLYGLUTAMINE-INDUCED NEURODEGENERATION; SPINOCEREBELLAR ATAXIA; MOUSE MODEL; EXPANDED POLYGLUTAMINE; RAT MODEL; INTRANUCLEAR INCLUSIONS; CEREBELLAR DYSFUNCTION; NUCLEAR-LOCALIZATION; CAG REPEATS; IN-VITRO	Machado-Joseph disease (MJD) or spinocerebellar ataxia type 3 (SCA3) is an autosomal dominantly-inherited neurodegenerative disorder caused by the over-repetition of a CAG codon in the MJD1 gene. This expansion translates into a polyglutamine tract that confers a toxic gain-of-function to the mutant protein - ataxin-3, leading to neurodegeneration in specific brain regions, with particular severity in the cerebellum. No treatment able to modify the disease progression is available. However, gene silencing by RNA interference has shown promising results. Therefore, in this study we investigated whether lentiviral-mediated allele-specific silencing of the mutant ataxin-3 gene, after disease onset, would rescue the motor behavior deficits and neuropathological features in a severely impaired transgenic mouse model of MJD. For this purpose, we injected lentiviral vectors encoding allele-specific silencing-sequences (shAtx3) into the cerebellum of diseased transgenic mice expressing the targeted C-variant of mutant ataxin-3 present in 70% of MJD patients. This variation permits to discriminate between the wild-type and mutant forms, maintaining the normal function of the wild-type allele and silencing only the mutant form. Quantitative analysis of rotarod performance, footprint and activity patterns revealed significant and robust alleviation of gait, balance (average 3-fold increase of rotarod test time), locomotor and exploratory activity impairments in shAtx3-injected mice, as compared to control ones injected with shGFP. An important improvement of neuropathology was also observed, regarding the number of intranuclear inclusions, calbindin and DARPP-32 immunoreactivity, fluorojade B and Golgi staining and molecular and granular layers thickness. These data demonstrate for the first time the efficacy of gene silencing in blocking the MJD-associated motor-behavior and neuropathological abnormalities after the onset of the disease, supporting the use of this strategy for therapy of MJD.	[Nobrega, Clevio; Nascimento-Ferreira, Isabel; Onofre, Isabel; de Almeida, Luis Pereira] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Nascimento-Ferreira, Isabel; Onofre, Isabel; de Almeida, Luis Pereira] Univ Coimbra, Fac Pharm, Coimbra, Portugal; [Albuquerque, David] Univ Coimbra, Fac Sci & Technol, Coimbra, Portugal; [Hirai, Hirokazu] Gunma Univ, Grad Sch Med, Dept Neurophysiol, Maebashi, Gunma 371, Japan; [Deglon, Nicole] Univ Lausanne Hosp, Dept Clin Neurosci, Lab Cellular & Mol Neurotherapies, Lausanne, Switzerland	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Gunma University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	de Almeida, LP (corresponding author), Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal.	luispa@ci.uc.pt	Deglon, Nicole/A-2265-2012; de Almeida, Luis Pereira/A-4605-2009; de Almeida, Luis Pereira/O-8196-2019; Nobrega, Clévio/M-6047-2013; Hirai, Hirokazu/ABP-1143-2022; Albuquerque, David/S-5586-2017	Deglon, Nicole/0000-0003-4475-9476; de Almeida, Luis Pereira/0000-0001-5831-3307; de Almeida, Luis Pereira/0000-0001-5831-3307; Nobrega, Clévio/0000-0002-8312-5292; Hirai, Hirokazu/0000-0002-0721-4293; Albuquerque, David/0000-0001-8899-9020; Onofre, Isabel/0000-0002-4937-448X	Portuguese Foundation for Science and Technology [PTDC/SAU-NEU/099307/2008, PTDC/SAU-FAR/116535/2010]; Center for Science and Technology of Madeira; National Ataxia Foundation; Richard Chin and Lily Lock Machado-Joseph disease Research Fund	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Center for Science and Technology of Madeira; National Ataxia Foundation; Richard Chin and Lily Lock Machado-Joseph disease Research Fund	This work was supported by the Portuguese Foundation for Science and Technology (grants PTDC/SAU-NEU/099307/2008 and PTDC/SAU-FAR/116535/2010 and fellowships to CN, INF, IO and DA), the Center for Science and Technology of Madeira (CN), the National Ataxia Foundation and the Richard Chin and Lily Lock Machado-Joseph disease Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves S, 2008, HUM MOL GENET, V17, P2071, DOI 10.1093/hmg/ddn106; Alves S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003341; Bichelmeier U, 2007, J NEUROSCI, V27, P7418, DOI 10.1523/JNEUROSCI.4540-06.2007; Boudreau RL, 2009, MOL THER, V17, P1053, DOI 10.1038/mt.2009.17; Boy J, 2010, NEUROBIOL DIS, V37, P284, DOI 10.1016/j.nbd.2009.08.002; Boy J, 2009, HUM MOL GENET, V18, P4282, DOI 10.1093/hmg/ddp381; Cemal CK, 2002, HUM MOL GENET, V11, P1075, DOI 10.1093/hmg/11.9.1075; Chen X, 2008, J NEUROSCI, V28, P12713, DOI 10.1523/JNEUROSCI.3909-08.2008; Chou AH, 2008, NEUROBIOL DIS, V31, P89, DOI 10.1016/j.nbd.2008.03.011; Clark HB, 1997, J NEUROSCI, V17, P7385; de Almeida LP, 2001, NEUROBIOL DIS, V8, P433, DOI 10.1006/nbdi.2001.0388; DiFiglia M, 2007, P NATL ACAD SCI USA, V104, P17204, DOI 10.1073/pnas.0708285104; Durr A, 1996, ANN NEUROL, V39, P490, DOI 10.1002/ana.410390411; FOWLER HL, 1984, ARCH NEUROL-CHICAGO, V41, P921, DOI 10.1001/archneur.1984.04050200027013; Friedland DR, 2006, J NEUROSCI METH, V150, P90, DOI 10.1016/j.jneumeth.2005.06.004; Gaspar C, 1996, HUM GENET, V98, P620, DOI 10.1007/s004390050270; Gaspar C, 2001, AM J HUM GENET, V68, P523, DOI 10.1086/318184; Goti D, 2004, J NEUROSCI, V24, P10266, DOI 10.1523/JNEUROSCI.2734-04.2004; Hadj-Sahraoui N, 2001, DEV BRAIN RES, V126, P201, DOI 10.1016/S0165-3806(01)00095-5; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Hu JX, 2009, NAT BIOTECHNOL, V27, P478, DOI 10.1038/nbt.1539; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Ito M, 2002, ANN NY ACAD SCI, V978, P273, DOI 10.1111/j.1749-6632.2002.tb07574.x; Jardim LB, 2001, J NEUROL, V248, P870, DOI 10.1007/s004150170072; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Koeppen AH, 2005, CEREBELLUM, V4, P62, DOI 10.1080/14734220510007950; Lombardi MS, 2009, EXP NEUROL, V217, P312, DOI 10.1016/j.expneurol.2009.03.004; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; Munoz E, 2002, J NEUROL SCI, V200, P19, DOI 10.1016/S0022-510X(02)00110-7; Nakamura K, 2001, HUM MOL GENET, V10, P1441, DOI 10.1093/hmg/10.14.1441; Nascimento-Ferreira I, 2011, BRAIN, V134, P1400, DOI 10.1093/brain/awr047; Oue M, 2009, BRAIN RES, V1255, P9, DOI 10.1016/j.brainres.2008.12.014; Pfister EL, 2009, CURR BIOL, V19, P774, DOI 10.1016/j.cub.2009.03.030; Rodrigues AJ, 2010, BBA-MOL CELL RES, V1803, P1154, DOI 10.1016/j.bbamcr.2010.07.004; Rodriguez-Lebron E, 2005, MOL THER, V12, P618, DOI 10.1016/j.ymthe.2005.05.006; Schmidt T, 1998, BRAIN PATHOL, V8, P669, DOI 10.1111/j.1750-3639.1998.tb00193.x; Schmitt I, 2007, BIOCHEM BIOPH RES CO, V362, P734, DOI 10.1016/j.bbrc.2007.08.062; Scholefield J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007232; SCHOLS L, 1995, HUM MOL GENET, V4, P1001, DOI 10.1093/hmg/4.6.1001; Shakkottai VG, 2011, J NEUROSCI, V31, P13002, DOI 10.1523/JNEUROSCI.2789-11.2011; Silva-Fernandes A, 2010, NEUROBIOL DIS, V40, P163, DOI 10.1016/j.nbd.2010.05.021; Silveira I, 1998, AM J MED GENET, V81, P134, DOI 10.1002/(SICI)1096-8628(19980328)81:2<134::AID-AJMG3>3.0.CO;2-W; Simoes AT, 2012, BRAIN, V135, P2428, DOI 10.1093/brain/aws177; SUDARSKY L, 1995, CLIN NEUROSCI, V3, P17; Torashima T, 2008, EMBO REP, V9, P393, DOI 10.1038/embor.2008.31; van Alfen N, 2001, ANN NEUROL, V49, P805, DOI 10.1002/ana.1089; van Bilsen PHJ, 2008, HUM GENE THER, V19, P710, DOI 10.1089/hum.2007.116; Wullner U, 2005, ARCH NEUROL-CHICAGO, V62, P1280, DOI 10.1001/archneur.62.8.1280; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Yoshizawa T, 2000, HUM MOL GENET, V9, P69, DOI 10.1093/hmg/9.1.69; Zhang CZ, 2006, J BIOSCIENCES, V31, P55, DOI 10.1007/BF02705235; Zhang S, 2009, DIS MODEL MECH, V2, P247, DOI 10.1242/dmm.000653; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zu T, 2004, J NEUROSCI, V24, P8853, DOI 10.1523/JNEUROSCI.2978-04.2004	55	85	86	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e52396	10.1371/journal.pone.0052396	http://dx.doi.org/10.1371/journal.pone.0052396			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349684	Green Published, gold, Green Submitted			2022-12-25	WOS:000314019100011
J	Salati, S; Lisignoli, G; Manferdini, C; Pennucci, V; Zini, R; Bianchi, E; Norfo, R; Facchini, A; Ferrari, S; Manfredini, R				Salati, Simona; Lisignoli, Gina; Manferdini, Cristina; Pennucci, Valentina; Zini, Roberta; Bianchi, Elisa; Norfo, Ruggiero; Facchini, Andrea; Ferrari, Sergio; Manfredini, Rossella			Co-Culture of Hematopoietic Stem/Progenitor Cells with Human Osteblasts Favours Mono/Macrophage Differentiation at the Expense of the Erythroid Lineage	PLOS ONE			English	Article							STEM-CELL; BONE-MARROW; PROGENITOR CELLS; PERIPHERAL-BLOOD; SELF-RENEWAL; NICHE; TWIST; OSTEOBLASTS; PROLIFERATION; ENGRAFTMENT	Hematopoietic stem cells (HSCs) are located in the bone marrow in a specific microenvironment referred as the hematopoietic stem cell niche, where HSCs interact with a variety of stromal cells. Though several components of the stem cell niche have been identified, the regulatory mechanisms through which such components regulate the stem cell fate are still unknown. In order to address this issue, we investigated how osteoblasts (OBs) can affect the molecular and functional phenotype of Hematopoietic Stem/Progenitor Cells (HSPCs) and vice versa. For this purpose, human CD34+ cells were cultured in direct contact with primary human OBs. Our data showed that CD34+ cells cultured with OBs give rise to higher total cell numbers, produce more CFUs and maintain a higher percentage of CD34+CD38-cells compared to control culture. Moreover, clonogenic assay and long-term culture results showed that co-culture with OBs induces a strong increase in mono/macrophage precursors coupled to a decrease in the erythroid ones. Finally, gene expression profiling (GEP) allowed us to study which signalling pathways were activated in the hematopoietic cell fraction and in the stromal cell compartment after coculture. Such analysis allowed us to identify several cytokine-receptor networks, such as WNT pathway, and transcription factors, as TWIST1 and FOXC1, that could be activated by co-culture with OBs and could be responsible for the biological effects reported above. Altogether our results indicate that OBs are able to affect HPSCs on 2 different levels: on one side, they increase the immature progenitor pool in vitro, on the other side, they favor the expansion of the mono/macrophage precursors at the expense of the erythroid lineage.	[Salati, Simona; Pennucci, Valentina; Zini, Roberta; Bianchi, Elisa; Norfo, Ruggiero; Manfredini, Rossella] Univ Modena & Reggio Emilia, Ctr Regenerat Med Stefano Ferrari, Modena, Italy; [Lisignoli, Gina; Manferdini, Cristina; Facchini, Andrea] Ist Ortoped Rizzoli, SC Lab Immunoreumatol & Rigeneraz Tissutale, Bologna, Italy; [Lisignoli, Gina; Manferdini, Cristina; Facchini, Andrea] Ist Ortoped Rizzoli, Lab RAMSES, Bologna, Italy; [Facchini, Andrea] Univ Bologna, Dipartimento Sci Med & Chirurg, Bologna, Italy; [Ferrari, Sergio] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy	Universita di Modena e Reggio Emilia; IRCCS Istituto Ortopedico Rizzoli; IRCCS Istituto Ortopedico Rizzoli; University of Bologna; Universita di Modena e Reggio Emilia	Manfredini, R (corresponding author), Univ Modena & Reggio Emilia, Ctr Regenerat Med Stefano Ferrari, Modena, Italy.	rossella.manfredini@unimore.it	Lisignoli, Gina/K-4384-2016; Salati, Simona/J-2344-2012; Zini, Roberta/I-6734-2012; Manfredini, Rossella/C-5625-2015; Bianchi, Elisa/F-2242-2015; manferdini, cristina/K-2680-2018; Ferrari, Sergio/A-1110-2010	Lisignoli, Gina/0000-0003-2837-9967; Salati, Simona/0000-0002-8072-1128; Zini, Roberta/0000-0001-6657-0864; Manfredini, Rossella/0000-0003-0660-6110; Bianchi, Elisa/0000-0002-6110-5944; manferdini, cristina/0000-0002-6648-6061; Ferrari, Sergio/0000-0002-4822-2521; Norfo, Ruggiero/0000-0002-9485-6285	Italian Ministry of University Research [RBAP11CZLK_ 002]; Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano); Special Program Molecular Clinical Oncology [10005, 561000]; AIRC project [12055]	Italian Ministry of University Research(Ministry of Education, Universities and Research (MIUR)); Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano)(Fondazione AIRC per la ricerca sul cancro); Special Program Molecular Clinical Oncology; AIRC project(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Italian Ministry of University & Research (FIRB Project 2011, project number #RBAP11CZLK_ 002, http://www.istruzione.it/web/ricerca/firb), Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano, http://www.airc.it/english/obiettivi-risultati-english.asp), project number #10005 "Special Program Molecular Clinical Oncology 561000" to AGIMM (AIRC-Gruppo Italiano Malattie Mieloproliferative, http://www.progettoagimm.it), AIRC project number #12055, and Project "Tecnopolo" (Regione Emilia Romagna, http://www.aster.it/tiki-index.php? page = TecnopoloMo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstee DJ, 2011, VOX SANG, V100, P140, DOI 10.1111/j.1423-0410.2010.01388.x; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Bianchi E, 2010, BLOOD, V116, pE99, DOI 10.1182/blood-2009-08-238311; Bloushtain-Qimron N, 2008, P NATL ACAD SCI USA, V105, P14076, DOI 10.1073/pnas.0805206105; Bono P, 2001, MOL BIOL CELL, V12, P891, DOI 10.1091/mbc.12.4.891; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cashman JD, 1999, BLOOD, V93, P481, DOI 10.1182/blood.V93.2.481.402k20_481_487; Chitteti BR, 2010, BLOOD, V115, P3239, DOI 10.1182/blood-2009-09-246173; Dea V, 2004, BLOOD, V103, P3258; Dormady SP, 2000, P NATL ACAD SCI USA, V97, P12260, DOI 10.1073/pnas.97.22.12260; Elias MC, 2005, NEOPLASIA, V7, P824, DOI 10.1593/neo.04352; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Hosokawa K, 2010, BLOOD, V116, P554, DOI 10.1182/blood-2009-05-224857; Hosokawa K, 2010, CELL STEM CELL, V6, P194, DOI 10.1016/j.stem.2009.04.013; Jung Y, 2005, CYTOKINE, V32, P155, DOI 10.1016/j.cyto.2005.09.001; Katoh M, 2004, INT J ONCOL, V25, P1495; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Li XA, 2010, BLOOD, V116, P2304, DOI 10.1182/blood-2009-09-242313; Lisignoli G, 2006, J CELL PHYSIOL, V206, P78, DOI 10.1002/jcp.20435; Majka M, 2001, BLOOD, V97, P3075, DOI 10.1182/blood.V97.10.3075; Manferdini C, J CELL PHYSL, V226, P2675; Manfredini R, 2005, STEM CELLS, V23, P496, DOI 10.1634/stemcells.2004-0265; MARUSIC A, 1993, J BONE MINER RES, V8, P617; Mayer DCG, 2009, P NATL ACAD SCI USA, V106, P5348, DOI 10.1073/pnas.0900878106; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; Moll NM, 2010, EXPERT REV HEMATOL, V3, P315, DOI 10.1586/EHM.10.16; Nakata Y, 2006, BLOOD, V107, P4234, DOI 10.1182/blood-2005-08-3343; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Ottersbach K, 2006, BLOOD, V107, P1284, DOI 10.1182/blood-2005-08-3112; Pelus LM, 2006, EXP HEMATOL, V34, P1010, DOI 10.1016/j.exphem.2006.04.004; Ross EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002338; Salati S, 2008, STEM CELLS, V26, P950, DOI 10.1634/stemcells.2007-0597; Shiota M, 2008, ONCOGENE, V27, P5543, DOI 10.1038/onc.2008.176; Staal FJT, 2005, NAT REV IMMUNOL, V5, P21, DOI 10.1038/nri1529; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Taichman RS, 1996, BLOOD, V87, P518, DOI 10.1182/blood.V87.2.518.bloodjournal872518; TAICHMAN RS, 1994, J EXP MED, V179, P1677, DOI 10.1084/jem.179.5.1677; Terauchi M, 2007, CLIN EXP METASTAS, V24, P329, DOI 10.1007/s10585-007-9070-1; Weber JM, 2010, BONE, V46, P281, DOI 10.1016/j.bone.2009.08.007; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhang XM, 2007, INT J CANCER, V120, P1891, DOI 10.1002/ijc.22489; Zhang YQ, 2007, PATHOLOGY, V39, P470, DOI 10.1080/00313020701570053	44	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53496	10.1371/journal.pone.0053496	http://dx.doi.org/10.1371/journal.pone.0053496			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349713	Green Published, Green Submitted, gold			2022-12-25	WOS:000314019100022
J	Tang, HB; Ming, ZP; Liu, R; Xiong, T; Grevelding, CG; Dong, HF; Jiang, MS				Tang, Hongbin; Ming, Zhenping; Liu, Rong; Xiong, Tao; Grevelding, Christoph G.; Dong, Huifeng; Jiang, Mingsen			Development of Adult Worms and Granulomatous Pathology Are Collectively Regulated by T- and B-Cells in Mice Infected with Schistosoma japonicum	PLOS ONE			English	Article							HOST-PARASITE RELATIONSHIP; BLOOD FLUKE DEVELOPMENT; MURINE SCHISTOSOMIASIS; MANSONI; RESPONSES; IL-10; MODULATION; MOUSE; HYPERSENSITIVITY; INDUCTION	Schistosoma blood flukes, which cause schistosomiasis affecting 200 million people in the world, are dependent on signals from host CD4(+) T cells to facilitate parasite growth and development in the mammalian host and to induce Th2-biased inflammatory granulomas. B cells, however, are reported to down-regulate granulomatous pathology in schistosomiasis, but not to affect the development of blood flukes together with CD4(+) T lymphocytes. Thus it is not clear whether B cells mediate parasite development, reproduction and egg granuloma formation of schistosomes without the help of CD4(+) T lymphocytes. Using mice that have severe combined immunodeficiency (scid) and mice lacking T cells (nude), we found that the absence of B cells can more seriously hamper the development and paring of adult worms, but granuloma formation of Schistosoma japonicum in scid mice was not down-regulated comparing with that in nude mice. The level of IL-10 in the sera of nude mice was significantly higher than of scid mice at 43 days post infection (p.i.). Thus multiple mechanisms of immune modulation seem to be involved in parasite development and reproduction by helminth-induced regulatory B cells. Our findings have significance for understanding the molecular connections between schistosomes and T- and B-cells, indicating that more research is needed to develop efficient vaccine-based therapies for schistosomiasis.	[Tang, Hongbin] Wuhan Univ, Sch Med, Lab Anim Ctr, Wuhan 430072, Peoples R China; [Ming, Zhenping; Liu, Rong; Xiong, Tao; Dong, Huifeng; Jiang, Mingsen] Wuhan Univ, Sch Basic Med Sci, Dept Med Parasitol, Wuhan 430072, Peoples R China; [Grevelding, Christoph G.] Univ Giessen, Inst Parasitol, D-35390 Giessen, Germany	Wuhan University; Wuhan University; Justus Liebig University Giessen	Dong, HF (corresponding author), Wuhan Univ, Sch Basic Med Sci, Dept Med Parasitol, Wuhan 430072, Peoples R China.	hfdong@whu.edu.cn; msjiang@whu.edu.cn	Liu, Rong/ABE-3102-2020	Liu, Rong/0000-0003-2561-348X	national natural science foundation of china [30872202]	national natural science foundation of china(National Natural Science Foundation of China (NSFC))	This work is financially supported by the national natural science foundation of china awarded #30872202. http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE T, 1984, J IMMUNOL, V132, P2084; AMIRI P, 1992, NATURE, V356, P604, DOI 10.1038/356604a0; Amu S, 2010, J ALLERGY CLIN IMMUN, V125, P1114, DOI 10.1016/j.jaci.2010.01.018; Blank RB, 2006, J INFECT DIS, V194, P1609, DOI 10.1086/508896; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Burdin N, 1997, METHODS, V11, P98, DOI 10.1006/meth.1996.0393; BYRAM JE, 1977, AM J TROP MED HYG, V26, P944, DOI 10.4269/ajtmh.1977.26.944; BYRAM JE, 1979, AM J TROP MED HYG, V28, P274, DOI 10.4269/ajtmh.1979.28.274; Cheever AW, 1999, INFECT IMMUN, V67, P2201, DOI 10.1128/IAI.67.5.2201-2208.1999; Chen PH, 1995, CULTIVATION IN VITRO, P277; Cheng YL, 2008, PARASITOL RES, V102, P1129, DOI 10.1007/s00436-008-0880-0; CHENSUE SW, 1981, J IMMUNOL, V127, P363; CHENSUE SW, 1993, J IMMUNOL, V151, P1391; CHENSUE SW, 1994, CLIN EXP IMMUNOL, V98, P395, DOI 10.1111/j.1365-2249.1994.tb05503.x; CUSTER RP, 1985, AM J PATHOL, V120, P464; Davies SJ, 2001, SCIENCE, V294, P1358, DOI 10.1126/science.1064462; DOENHOFF M, 1978, IMMUNOLOGY, V35, P771; DOENHOFF MJ, 1987, T ROY SOC TROP MED H, V81, P947, DOI 10.1016/0035-9203(87)90360-9; Duddy ME, 2004, J IMMUNOL, V172, P3422, DOI 10.4049/jimmunol.172.6.3422; Fairfax KC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002490; Falcao PL, 1998, PARASITE IMMUNOL, V20, P447, DOI 10.1046/j.1365-3024.1998.00166.x; FloresVillanueva PO, 1996, J IMMUNOL, V156, P3315; Harris N, 2011, TRENDS IMMUNOL, V32, P80, DOI 10.1016/j.it.2010.11.005; HARRISON RA, 1983, PARASITOLOGY, V86, P429, DOI 10.1017/S0031182000050629; Jankovic D, 1998, J EXP MED, V187, P619, DOI 10.1084/jem.187.4.619; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Lamb EW, 2007, INT J PARASITOL, V37, P405, DOI 10.1016/j.ijpara.2006.11.001; Lamb EW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000892; Mangan NE, 2004, J IMMUNOL, V173, P6346, DOI 10.4049/jimmunol.173.10.6346; Mizoguchi A, 2006, J IMMUNOL, V176, P705, DOI 10.4049/jimmunol.176.2.705; MOLONEY NA, 1982, PARASITE IMMUNOL, V4, P431, DOI 10.1111/j.1365-3024.1982.tb00454.x; Montesano MA, 1997, J IMMUNOL, V158, P3800; PEARCE EJ, 1991, J EXP MED, V173, P159, DOI 10.1084/jem.173.1.159; PHILLIPS SM, 1977, J IMMUNOL, V118, P594; RUPPEL A, 1990, PARASITOLOGY, V101, P23, DOI 10.1017/S0031182000079701; Smits HH, 2007, J ALLERGY CLIN IMMUN, V120, P932, DOI 10.1016/j.jaci.2007.06.009; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Velupillai P, 1997, J IMMUNOL, V158, P338; VELUPILLAI P, 1994, P NATL ACAD SCI USA, V91, P18, DOI 10.1073/pnas.91.1.18; VILLANUEVA POF, 1994, J IMMUNOL, V153, P5190; Wilson MS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002171; Wolowczuk I, 1999, INFECT IMMUN, V67, P4183, DOI 10.1128/IAI.67.8.4183-4190.1999	42	25	28	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54432	10.1371/journal.pone.0054432	http://dx.doi.org/10.1371/journal.pone.0054432			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349889	gold, Green Submitted, Green Published			2022-12-25	WOS:000314019100067
J	Yu, X; Lv, JJ; Zhu, YZ; Duan, LP; Ma, LQ				Yu, Xue; Lv, Jiajun; Zhu, Yunzhen; Duan, Liping; Ma, Lanqing			Homocysteine Inhibits Hepatocyte Proliferation via Endoplasmic Reticulum Stress	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL-CELLS; METHIONINE METABOLISM; MURINE MODEL; HYPERHOMOCYSTEINEMIA; APOPTOSIS; DEATH; LIVER; MICE; EXPRESSION; TRB3	Homocysteine is an independent risk factor for coronary, cerebral, and peripheral vascular diseases. Recent studies have shown that levels of homocysteine are elevated in patients with impaired hepatic function, but the precise role of homocysteine in the development of hepatic dysfunction is unclear. In this study, we examined the effect of homocysteine on hepatocyte proliferation in vitro. Our results demonstrated that homocysteine inhibited hepatocyte proliferation by up-regulating protein levels of p53 as well as mRNA and protein levels of p21(Cip1) in primary cultured hepatocytes. Homocysteine induced cell growth arrest in p53-positive hepatocarcinoma cell line HepG2, but not in p53-null hepatocarcinoma cell line Hep3B. A p53 inhibitor pifithrin-alpha inhibited the expression of p21(Cip1) and attenuated homocysteine-induced cell growth arrest. Homocysteine induced TRB3 expression via endoplasmic reticulum stress pathway, resulting in Akt dephosphorylation. Knock-down of endogenous TRB3 significantly suppressed the inhibitory effect of homocysteine on cell proliferation and the phosphorylation of Akt. LiCl reversed homocysteine-mediated cell growth arrest by inhibiting TRB3-mediated Akt dephosphorylation. These results demonstrate that both TRB3 and p21(Cip1) are critical molecules in the homocysteine signaling cascade and provide a mechanistic explanation for impairment of liver regeneration in hyperhomocysteinemia.	[Yu, Xue] Beijing Hosp, Minist Hlth, Dept Cardiol, Beijing, Peoples R China; [Lv, Jiajun; Zhu, Yunzhen; Duan, Liping; Ma, Lanqing] Kunming Med Univ, Affiliated Hosp 1, Dept Digest Dis, Kunming, Yunnan, Peoples R China	Beijing Hospital; Kunming Medical University	Ma, LQ (corresponding author), Kunming Med Univ, Affiliated Hosp 1, Dept Digest Dis, Kunming, Yunnan, Peoples R China.	mlq6006@yahoo.cn			National Natural Science Foundation of China [81160060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant (81160060) from the National Natural Science Foundation of China (to LM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinolfi LE, 2005, HEPATOLOGY, V41, P995, DOI 10.1002/hep.20664; Akasaka K, 2005, J VASC SURG, V41, P517, DOI 10.1016/j.jvs.2004.12.043; Avila MA, 2000, J HEPATOL, V33, P907, DOI 10.1016/S0168-8278(00)80122-1; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Chalecka-Franaszek E, 1999, P NATL ACAD SCI USA, V96, P8745, DOI 10.1073/pnas.96.15.8745; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Halsted CH, 2002, P NATL ACAD SCI USA, V99, P10072, DOI 10.1073/pnas.112336399; He L, 2007, MOL ENDOCRINOL, V21, P2541, DOI 10.1210/me.2007-0036; Ji C, 2005, ALCOHOL CLIN EXP RES, V29, P1496, DOI 10.1097/01.alc.0000174691.03751.11; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kim AJ, 2005, J CELL SCI, V118, P89, DOI 10.1242/jcs.01562; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kruman II, 2000, J NEUROSCI, V20, P6920, DOI 10.1523/JNEUROSCI.20-18-06920.2000; Liu WH, 2010, AM J PATHOL, V177, P2357, DOI 10.2353/ajpath.2010.091131; Liu WJ, 2011, AM J PATHOL, V178, P1489, DOI 10.1016/j.ajpath.2010.12.052; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Mikael LG, 2006, CIRC RES, V98, P564, DOI 10.1161/01.RES.0000204825.66410.0b; Namekata K, 2004, J BIOL CHEM, V279, P52961, DOI 10.1074/jbc.M406820200; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Outinen PA, 1999, BLOOD, V94, P959, DOI 10.1182/blood.V94.3.959.415k20_959_967; Robert K, 2005, GASTROENTEROLOGY, V128, P1405, DOI 10.1053/j.gastro.2005.02.034; Sakuta H, 2005, ALCOHOL, V37, P73, DOI 10.1016/j.alcohol.2005.12.005; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Suhara T, 2004, HYPERTENSION, V43, P1208, DOI 10.1161/01.HYP.0000127914.94292.76; Thambyrajah J, 2000, EUR HEART J, V21, P967, DOI 10.1053/euhj.1999.1914; VARELAMOREIRAS G, 1995, HEPATOLOGY, V22, P1310, DOI 10.1016/0270-9139(95)90644-4; Vitvitsky V, 2004, AM J PHYSIOL-REG I, V287, pR39, DOI 10.1152/ajpregu.00036.2004; Wang XZ, 1998, EMBO J, V17, P3619, DOI 10.1093/emboj/17.13.3619; Weinberg WC, 2002, CRIT REV ORAL BIOL M, V13, P453, DOI 10.1177/154411130201300603; Welch GN, 1998, NEW ENGL J MED, V338, P1042, DOI 10.1056/NEJM199804093381507; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Xu D, 2000, FEBS LETT, V470, P20, DOI 10.1016/S0014-5793(00)01278-3; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yu X, 2009, ACTA BIOCH BIOPH SIN, V41, P1027, DOI 10.1093/abbs/gmp097; Zhang C, 2001, J BIOL CHEM, V276, P35867, DOI 10.1074/jbc.M100747200; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; Zou CG, 2005, ANTIOXID REDOX SIGN, V7, P547, DOI 10.1089/ars.2005.7.547	42	11	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54265	10.1371/journal.pone.0054265	http://dx.doi.org/10.1371/journal.pone.0054265			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349842	Green Published, Green Submitted, gold			2022-12-25	WOS:000314019100053
J	Colombara, DV; Cowgill, KD; Faruque, ASG				Colombara, Danny V.; Cowgill, Karen D.; Faruque, Abu S. G.			Risk Factors for Severe Cholera among Children under Five in Rural and Urban Bangladesh, 2000-2008: A Hospital-Based Surveillance Study	PLOS ONE			English	Article							BREAST-MILK; INFECTION; DIARRHEA; ANTIBODIES; INFANTS; DISEASE; TRIAL; DHAKA	Background: Children under five bear the largest cholera burden. We therefore sought to identify modifiable risk factors among Bangladeshi children. Methodology/Principal Findings: We used multivariate Poisson regression to assess risk factors for severe cholera among diarrheal patients presenting at hospitals in Matlab (rural) and Dhaka (urban), Bangladesh. Risk increased with age. Compared to those under one, rural and urban four-year-olds had adjusted risk ratios (aRR) of 4.17 (95% confidence interval (CI) 2.43-7.15) and 6.32 (95% CI: 4.63-8.63), respectively. Breastfeeding halved the risk in both rural (aRR = 0.49, 95% CI: 0.35-0.67) and urban (aRR = 0.51, 95% CI: 0.41-0.62) settings. Rural children's risk decreased with maternal education (P-trend: <0.001) and increased among those with a family member with diarrhea in the past week (aRR = 1.61, 95% CI: 1.22-2.14) and those with prior vitamin A supplementation (aRR = 1.65, 95% CI: 1.12-2.43). Urban children whose mothers daily (aRR = 0.41, 95% CI: 0.21-0.79) or occasionally (aRR = 0.55, 95% CI: 0.36-0.84) read a newspaper experienced reduced risk. Urban children from households with incomes between 34-84 USD/month had a 30% increased risk compared to those from households with incomes >84 USD/month. Conclusion/Significance: Increasing age, lower socioeconomic status, and lack of breastfeeding are key correlates of increased risk for cholera hospitalization among those under five in rural and urban Bangladesh. In addition, having a family member with diarrhea in the past week was associated with increased risk among rural children. Continued attention should be directed to the promotion of breastfeeding. Further research is needed to elucidate the relationship between maternal education and cholera risk. Renewed research regarding the use of chemoprophylaxis among family members of cholera cases may be warranted in rural endemic settings.	[Colombara, Danny V.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Cowgill, Karen D.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Cowgill, Karen D.] Seattle Univ, Coll Nursing, Seattle, WA 98122 USA; [Faruque, Abu S. G.] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle University; International Centre for Diarrhoeal Disease Research (ICDDR)	Colombara, DV (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	dvc2@uw.edu	Colombara, Danny/H-7202-2015	Colombara, Danny/0000-0002-5237-1300; Cowgill, Karen/0000-0002-4188-3757	Washington Global Health Alliance travel grant; National Institutes of Health Office of the Director; Fogarty International Center; Office of AIDS Research, National Cancer Center, National Eye Institute, National Heart, Blood, and Lung Institute; National Institute of Dental and Craniofacial Research; National Institute On Drug Abuse; National Institute of Mental Health; National Institute of Allergy and Infectious Diseases; National Institutes of Health Office of Women's Health and Research through the Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University [R24 TW007988]; National Cancer Institute [R25 CA94880]; American Relief and Recovery Act; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R25CA094880] Funding Source: NIH RePORTER	Washington Global Health Alliance travel grant; National Institutes of Health Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Office of AIDS Research, National Cancer Center, National Eye Institute, National Heart, Blood, and Lung Institute; National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute On Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health Office of Women's Health and Research through the Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Relief and Recovery Act; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Washington Global Health Alliance travel grant [2009 to DVC (http://www.wghalliance.org/)]; the National Institutes of Health Office of the Director, Fogarty International Center, Office of AIDS Research, National Cancer Center, National Eye Institute, National Heart, Blood, and Lung Institute, National Institute of Dental and Craniofacial Research, National Institute On Drug Abuse, National Institute of Mental Health, National Institute of Allergy and Infectious Diseases, and National Institutes of Health Office of Women's Health and Research through the Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University [grant number R24 TW007988 to DVC (https://fogartyscholars.org/)]; the National Cancer Institute [grant number R25 CA94880 to DVC (http://www.cancer.gov/)]; and the American Relief and Recovery Act. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; Ali M, 2011, J INFECT DIS, V204, P912, DOI 10.1093/infdis/jir416; BLAKE PA, 1993, J INFECT DIS, V167, P627, DOI 10.1093/infdis/167.3.627; Chowdhury F, 2008, PEDIATR INFECT DIS J, V27, P986, DOI 10.1097/INF.0b013e3181783adf; CLEMENS JD, 1990, AM J EPIDEMIOL, V131, P400, DOI 10.1093/oxfordjournals.aje.a115515; Giashuddin MS, 2004, INDIAN J MED RES, V119, P267; Giebultowicz S, 2011, HEALTH PLACE, V17, P490, DOI 10.1016/j.healthplace.2010.12.004; GLASS RI, 1986, ACTA PAEDIATR SCAND, V75, P713, DOI 10.1111/j.1651-2227.1986.tb10279.x; GLASS RI, 1983, NEW ENGL J MED, V308, P1389, DOI 10.1056/NEJM198306093082304; GLASS RI, 1985, AM J EPIDEMIOL, V121, P791, DOI 10.1093/oxfordjournals.aje.a114050; GLASS RI, 1982, AM J EPIDEMIOL, V116, P959, DOI 10.1093/oxfordjournals.aje.a113498; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; GUERRANT RL, 1983, J INFECT DIS, V148, P986, DOI 10.1093/infdis/148.6.986; GUNN RA, 1979, LANCET, V2, P730; Haider R, 2000, LANCET, V356, P1643, DOI 10.1016/S0140-6736(00)03159-7; Harris JB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000221; Kay B, 1994, VIBRIO CHOLERAE CHOL, P3; LEVINE RJ, 1976, LANCET, V2, P86; Mccarthy N, 1999, CASE CASE COMP STUDY, P764; Mitra AK, 2000, J HEALTH POPUL NUTR, V18, P151; MOSLEY WH, 1968, B WORLD HEALTH ORGAN, V38, P335; O'Reilly CE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001256; PALMER DL, 1976, J INFECT DIS, V134, P8, DOI 10.1093/infdis/134.1.8; Qureshi K, 2006, PEDIATR INFECT DIS J, V25, P1163, DOI 10.1097/01.inf.0000246977.58697.a5; Rahman KM, 2009, J HEALTH POPUL NUTR, V27, P733; Reveiz L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027060; Rowe PC, 1994, EPIDEMIC ESCHERICHIA, P1; Schwartz BS, 2006, AM J TROP MED HYG, V74, P1067, DOI 10.4269/ajtmh.2006.74.1067; Sinclair D, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008603.pub2; Strand TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036436; Weil AA, 2009, CLIN INFECT DIS, V49, P1473, DOI 10.1086/644779; WHO, 1987, PROGR CONTR DIARRH D; WHO/UNICEF Joint Monitoring Programme for Water Supply and Sanitation, 2010, TYP DRINK WAT SOURC; Wilson Nick, 2008, Epidemiol Perspect Innov, V5, P6, DOI 10.1186/1742-5573-5-6; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	35	15	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54395	10.1371/journal.pone.0054395	http://dx.doi.org/10.1371/journal.pone.0054395			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349875	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872800049
J	Lang, R; Liu, GH; Shi, YG; Bharadwaj, S; Leng, XY; Zhou, XB; Liu, H; Atala, A; Zhang, YY				Lang, Ren; Liu, Guihua; Shi, Yingai; Bharadwaj, Shantaram; Leng, Xiaoyan; Zhou, Xiaobo; Liu, Hong; Atala, Anthony; Zhang, Yuanyuan			Self-Renewal and Differentiation Capacity of Urine-Derived Stem Cells after Urine Preservation for 24 Hours	PLOS ONE			English	Article							ORGAN PRESERVATION; TISSUE; CRYOPRESERVATION; BIOLOGY; GROWTH	Despite successful approaches to preserve organs, tissues, and isolated cells, the maintenance of stem cell viability and function in body fluids during storage for cell distribution and transportation remains unexplored. The aim of this study was to characterize urine-derived stem cells (USCs) after optimal preservation of urine specimens for up to 24 hours. A total of 415 urine specimens were collected from 12 healthy men (age range 20-54 years old). About 6x10(4) cells shed off from the urinary tract system in 24 hours. At least 100 USC clones were obtained from the stored urine specimens after 24 hours and maintained similar biological features to fresh USCs. The stored USCs had a "rice grain" shape in primary culture, and expressed mesenchymal stem cell surface markers, high telomerase activity, and normal karyotypes. Importantly, the preserved cells retained bipotent differentiation capacity. Differentiated USCs expressed myogenic specific proteins and contractile function when exposed to myogenic differentiation medium, and they expressed urothelial cell-specific markers and barrier function when exposed to urothelial differentiation medium. These data demonstrated that up to 75% of fresh USCs can be safely persevered in urine for 24 hours and that these cells stored in urine retain their original stem cell properties, indicating that preserved USCs could be available for potential use in cell-based therapy or clinical diagnosis.	[Lang, Ren] Capital Med Univ, Beijing Chaoyang Hosp, Dept Hepatobiliary Surg, Beijing, Peoples R China; [Lang, Ren; Liu, Guihua; Shi, Yingai; Bharadwaj, Shantaram; Atala, Anthony; Zhang, Yuanyuan] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC USA; [Leng, Xiaoyan] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Zhou, Xiaobo] Methodist Hosp, Radiol Translat Biol Dept, Res Inst, Houston, TX 77030 USA; [Liu, Hong] Univ Oklahoma, Ctr Bioengn, Norman, OK 73019 USA; [Liu, Hong] Univ Oklahoma, Sch Elect & Comp Engn, Norman, OK 73019 USA	Capital Medical University; Wake Forest University; Wake Forest University; The Methodist Hospital System; The Methodist Hospital - Houston; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman	Zhang, YY (corresponding author), Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC USA.	yzhang@wakehealth.edu	zhang, yuanyuan/GYA-4428-2022; guihua, liu/B-1060-2012	Atala, Anthony/0000-0001-8186-2160				Bharadwaj S, 2009, J TISSUE ENG REGEN M, V6, pS293; Bharadwaj S, 2011, TISSUE ENG PT A, V17, P2123, DOI [10.1089/ten.TEA.2010.0637, 10.1089/ten.tea.2010.0637]; Bharadwaj S, 2010, J UROLOGY, V183, pE681, DOI 10.1016/j.juro.2010.02.1671; Bodin A, 2010, BIOMATERIALS, V31, P8889, DOI 10.1016/j.biomaterials.2010.07.108; DEBOER WI, 1994, J HISTOCHEM CYTOCHEM, V42, P277, DOI 10.1177/42.2.7507144; Fridell JA, 2009, CLIN TRANSPLANT, V23, P305, DOI 10.1111/j.1399-0012.2008.00952.x; Guibert EE, 2011, TRANSFUS MED HEMOTH, V38, P125, DOI 10.1159/000327033; Hoath SB, 2003, J INVEST DERMATOL, V121, P1440, DOI 10.1046/j.1523-1747.2003.12606.x; Hung SC, 2002, STEM CELLS, V20, P249, DOI 10.1634/stemcells.20-3-249; Huss R, 2000, STEM CELLS, V18, P1, DOI 10.1634/stemcells.18-1-1; Isachenko E, 2003, EUR J OBSTET GYN R B, V108, P186, DOI 10.1016/S0301-2115(02)00465-7; Jiang SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003812; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Kreft ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038509; Kropp BP, 1999, J UROLOGY, V162, P1779, DOI 10.1016/S0022-5347(05)68237-7; Luder Hans U, 2012, Methods Mol Biol, V887, P81, DOI 10.1007/978-1-61779-860-3_9; Muhlbacher F, 1999, TRANSPLANT P, V31, P2069, DOI 10.1016/S0041-1345(99)00265-1; Nakanishi W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042319; Pellettieri J, 2007, ANNU REV GENET, V41, P83, DOI 10.1146/annurev.genet.41.110306.130244; Penny J, 2012, FRONT BIOSCI-LANDMRK, V17, P892, DOI 10.2741/3963; Poglio S, 2010, STEM CELLS, V28, P2065, DOI 10.1002/stem.523; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Rubio D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001398; Tee JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005880; Tian H, 2010, TISSUE ENG PT A, V16, P1769, DOI [10.1089/ten.tea.2009.0625, 10.1089/ten.TEA.2009.0625]; Tian H, 2010, BIOMATERIALS, V31, P870, DOI 10.1016/j.biomaterials.2009.10.001; WIGLEY CB, 1976, J CELL SCI, V20, P149; Wu SF, 2011, J UROLOGY, V186, P640, DOI 10.1016/j.juro.2011.03.152; Wu SF, 2011, BIOMATERIALS, V32, P1317, DOI 10.1016/j.biomaterials.2010.10.006; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; ZAHEER HA, 1994, STEM CELLS, V12, P180, DOI 10.1002/stem.5530120206; Zhang YY, 2008, J UROLOGY, V180, P2226, DOI 10.1016/j.juro.2008.07.023; Zuk PA, 2010, MOL BIOL CELL, V21, P1783, DOI 10.1091/mbc.E09-07-0589	34	82	96	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e53980	10.1371/journal.pone.0053980	http://dx.doi.org/10.1371/journal.pone.0053980			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349776	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872800020
J	Sham, D; Wesley, UV; Hristova, M; van der Vliet, A				Sham, Derek; Wesley, Umadevi V.; Hristova, Milena; van der Vliet, Albert			ATP-Mediated Transactivation of the Epidermal Growth Factor Receptor in Airway Epithelial Cells Involves DUOX1-Dependent Oxidation of Src and ADAM17	PLOS ONE			English	Article							C-SRC; P2Y(2) RECEPTOR; TYROSINE KINASE; NADPH OXIDASES; WOUND REPAIR; ACTIVATION; REDOX; PHOSPHORYLATION; EXPRESSION; RESPONSES	The respiratory epithelium is subject to continuous environmental stress and its responses to injury or infection are largely mediated by transactivation of the epidermal growth factor receptor (EGFR) and downstream signaling cascades. Based on previous studies indicating involvement of ATP-dependent activation of the NADPH oxidase homolog DUOX1 in epithelial wound responses, the present studies were performed to elucidate the mechanisms by which DUOX1-derived H2O2 participates in ATP-dependent redox signaling and EGFR transactivation. ATP-mediated EGFR transactivation in airway epithelial cells was found to involve purinergic P2Y(2) receptor stimulation, and both ligand-dependent mechanisms as well as ligand-independent EGFR activation by the non-receptor tyrosine kinase Src. Activation of Src was also essential for ATP-dependent activation of the sheddase ADAM17, which is responsible for liberation and activation of EGFR ligands. Activation of P2Y(2)R results in recruitment of Src and DUOX1 into a signaling complex, and transient siRNA silencing or stable shRNA transfection established a critical role for DUOX1 in ATP-dependent activation of Src, ADAM17, EGFR, and downstream wound responses. Using thiol-specific biotin labeling strategies, we determined that ATP-dependent EGFR transactivation was associated with DUOX1-dependent oxidation of cysteine residues within Src as well as ADAM17. In aggregate, our findings demonstrate that DUOX1 plays a central role in overall epithelial defense responses to infection or injury, by mediating oxidative activation of Src and ADAM17 in response to ATP-dependent P2Y(2)R activation as a proximal step in EGFR transactivation and downstream signaling.	[Sham, Derek; Hristova, Milena; van der Vliet, Albert] Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA; [Wesley, Umadevi V.] Univ Vermont, Coll Med, Dept Microbiol & Mol Genet, Burlington, VT USA; [Wesley, Umadevi V.] Univ Vermont, Vermont Lung Ctr, Burlington, VT USA	University of Vermont; University of Vermont; University of Vermont	van der Vliet, A (corresponding author), Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA.	Albert.van-der-Vliet@uvm.edu			National Institutes of Health [R01 HL085646]; Department of Pathology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Pathology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a research grant from the National Institutes of Health to AvdV (R01 HL085646), and by a Fellowship from the Department of Pathology to DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2006, FREE RADICAL BIO MED, V41, P29, DOI 10.1016/j.freeradbiomed.2006.03.004; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Bae YS, 2010, TRENDS IMMUNOL, V31, P278, DOI 10.1016/j.it.2010.05.003; Belete HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027469; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Block ER, 2011, CELL SIGNAL, V23, P2051, DOI 10.1016/j.cellsig.2011.07.021; Boots AW, 2009, J BIOL CHEM, V284, P17858, DOI 10.1074/jbc.M809761200; Boucher I, 2007, EXP EYE RES, V85, P130, DOI 10.1016/j.exer.2007.03.009; Boucher I, 2010, AM J PHYSIOL-CELL PH, V299, pC411, DOI 10.1152/ajpcell.00100.2009; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Burgel PR, 2008, EUR RESPIR J, V32, P1068, DOI 10.1183/09031936.00172007; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Davis CW, 2008, ANNU REV PHYSIOL, V70, P487, DOI 10.1146/annurev.physiol.70.113006.100638; Davis FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023464; De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200; Doedens JR, 2003, BIOCHEM BIOPH RES CO, V308, P331, DOI 10.1016/S0006-291X(03)01381-0; Donepudi M, 2008, CELL SIGNAL, V20, P1359, DOI 10.1016/j.cellsig.2008.03.007; Douillet CD, 2006, AM J PHYSIOL-LUNG C, V291, pL734, DOI 10.1152/ajplung.00389.2005; Filosto S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023240; Fomenko DE, 2011, P NATL ACAD SCI USA, V108, P2729, DOI 10.1073/pnas.1010721108; Forteza R, 2005, AM J RESP CELL MOL, V32, P462, DOI 10.1165/rcmb.2004-0302OC; Gattas MV, 2009, FREE RADICAL BIO MED, V47, P1450, DOI 10.1016/j.freeradbiomed.2009.08.017; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Giannoni E, 2010, FREE RADICAL BIO MED, V49, P516, DOI 10.1016/j.freeradbiomed.2010.04.025; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; Gutsche M, 2009, J BIOL CHEM, V284, P31532, DOI 10.1074/jbc.M109.059246; Harper RW, 2005, FEBS LETT, V579, P4911, DOI 10.1016/j.febslet.2005.08.002; Joo JH, 2012, ANTIOXID REDOX SIGN, V16, P57, DOI 10.1089/ars.2011.3898; Juarez MT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002424; Kato A, 2007, CURR OPIN IMMUNOL, V19, P711, DOI 10.1016/j.coi.2007.08.004; Kemble DJ, 2009, P NATL ACAD SCI USA, V106, P5070, DOI 10.1073/pnas.0806117106; Khan EM, 2006, J BIOL CHEM, V281, P14486, DOI 10.1074/jbc.M509332200; Koff JL, 2008, AM J PHYSL LUNG CELL; Koff JL, 2006, J IMMUNOL, V177, P8693, DOI 10.4049/jimmunol.177.12.8693; Lazarowski ER, 2009, CURR OPIN PHARMACOL, V9, P262, DOI 10.1016/j.coph.2009.02.004; Linderholm AL, 2010, AM J PHYSIOL-LUNG C, V299, pL215, DOI 10.1152/ajplung.00015.2010; Liu J, 2004, J BIOL CHEM, V279, P8212, DOI 10.1074/jbc.M312230200; Luxen S, 2009, J CELL SCI, V122, P1238, DOI 10.1242/jcs.044123; Maretzky T, 2011, ONCOGENE, V30, P611, DOI 10.1038/onc.2010.443; McCarthy SM, 2008, BIOCHEMISTRY-US, V47, P5832, DOI 10.1021/bi702496v; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Moro L, 2002, J BIOL CHEM, V277, P9405, DOI 10.1074/jbc.M109101200; Moskwa P, 2007, AM J RESP CRIT CARE, V175, P174, DOI 10.1164/rccm.200607-1029OC; Myers TJ, 2009, MOL BIOL CELL, V20, P5236, DOI 10.1091/mbc.E08-12-1256; Norambuena A, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.081166; Ohtsu H, 2006, AM J PHYSIOL-CELL PH, V291, pC1, DOI 10.1152/ajpcell.00620.2005; Okutani D, 2006, AM J PHYSIOL-LUNG C, V291, pL129, DOI 10.1152/ajplung.00261.2005; Paulsen CE, 2012, NAT CHEM BIOL, V8, P57, DOI 10.1038/nchembio.736; Peterson TS, 2010, MOL NEUROBIOL, V41, P356, DOI 10.1007/s12035-010-8115-7; Puchelle Edith, 2006, Proc Am Thorac Soc, V3, P726, DOI 10.1513/pats.200605-126SF; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; Ratchford AM, 2010, J BIOL CHEM, V285, P7545, DOI 10.1074/jbc.M109.078170; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Senga T, 2008, CANCER SCI, V99, P571, DOI 10.1111/j.1349-7006.2007.00714.x; Seong JH, 2009, CHEM BIOL, V16, P48, DOI 10.1016/j.chembiol.2008.11.007; Shao MXG, 2005, P NATL ACAD SCI USA, V102, P767, DOI 10.1073/pnas.0408932102; Tschumperlin DJ, 2004, NATURE, V429, P83, DOI 10.1038/nature02543; van der Hoeven R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002453; van der Vliet A, 2008, FREE RADICAL BIO MED, V44, P938, DOI 10.1016/j.freeradbiomed.2007.11.016; Vermeer PD, 2003, NATURE, V422, P322, DOI 10.1038/nature01440; Vermeer PD, 2006, J BIOL CHEM, V281, P1725, DOI 10.1074/jbc.M506933200; Wang LF, 2011, AM J PHYSIOL-CELL PH, V301, pC171, DOI 10.1152/ajpcell.00363.2010; Wang Y, 2009, J IMMUNOL, V182, P2449, DOI 10.4049/jimmunol.0802770; Wesley UV, 2007, J BIOL CHEM, V282, P3213, DOI 10.1074/jbc.M606533200; Willems SH, 2010, BIOCHEM J, V428, P439, DOI 10.1042/BJ20100179; Yoo SK, 2012, J CELL BIOL, V199, P225, DOI 10.1083/jcb.201203154; Yoo SK, 2011, NATURE, V480, P109, DOI 10.1038/nature10632; Yu M, 2011, J IMMUNOL, V186, P1180, DOI 10.4049/jimmunol.1001499; Zhougang SG, 2004, AM J PHYSIOL-RENAL, V286, pF858, DOI 10.1152/ajprenal.00282.2003	74	57	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54391	10.1371/journal.pone.0054391	http://dx.doi.org/10.1371/journal.pone.0054391			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349873	Green Submitted, gold, Green Published			2022-12-25	WOS:000313872800048
J	Cuntz, U; Enck, P; Fruhauf, E; Lehnert, P; Riepl, RL; Fichter, MM; Otto, B				Cuntz, Ulrich; Enck, Paul; Fruehauf, Erich; Lehnert, Peter; Riepl, Rudolf L.; Fichter, Manfred M.; Otto, Baerbel			Cholecystokinin Revisited: CCK and the Hunger Trap in Anorexia Nervosa	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; EXOCRINE PANCREATIC-SECRETION; FOOD-INTAKE; PLASMA CHOLECYSTOKININ; GASTROINTESTINAL PEPTIDES; EATING-DISORDERS; BULIMIA-NERVOSA; BODY-WEIGHT; SATIETY; RELEASE	Objective: Despite a number of studies in the past decades, the role of Cholecystokinin (CCK) in anorexia nervosa (AN) has remained uncertain. In this study a highly specific assay for the biologically active part of CCK was used in patients with bulimic as well as with the restricting type of AN who were followed over the course of weight gain. Methods: Ten patients with restricting and 13 with bulimic AN were investigated upon admission (T0), after a weight gain of at least 2 kg on two consecutive weighting dates (T1), and during the last week before discharge (T2) from inpatient treatment in a specialized clinic. Blood samples were drawn under fasting conditions and 20 and 60 minutes following a standard meal (250 kcal). Data were compared to those of eight controls matched for sex and age. Gastrointestinal complaints of patients were measured by a questionnaire at each of the follow-up time points. Results: At admission, AN patients exhibited CCK-levels similar to controls both prior to and after a test meal. Pre and post-meal CCK levels increased significantly after an initial weight gain but decreased again with further weight improvement. CCK release was somewhat lower in bulimic than in restricting type AN but both subgroups showed a similar profile. There was no significant association of CCK release to either initial weight or BMI, or their changes, but CCK levels at admission predicted gastrointestinal symptom improvement during therapy. Conclusions: Normal CCK profiles in AN at admission indicates hormonal responses adapted to low food intake while change of eating habits and weight gain results in initially increased CCK release (counteracting the attempts to alter eating behavior) that returns towards normal levels with continuous therapy.	[Cuntz, Ulrich; Fruehauf, Erich; Fichter, Manfred M.] Klin Roseneck, Ctr Behav Med, Prien Am Chiemsee, Germany; [Cuntz, Ulrich] Paracelsus Med Univ, Salzburg, Austria; [Enck, Paul; Riepl, Rudolf L.] Univ Hosp, Dept Internal Med Psychosomat Med & Psychotherapy, Tubingen, Germany; [Lehnert, Peter; Otto, Baerbel] Univ Clin Munich, Med Dept Innenstadt, Munich, Germany	Paracelsus Private Medical University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich	Enck, P (corresponding author), Univ Hosp, Dept Internal Med Psychosomat Med & Psychotherapy, Tubingen, Germany.	paul.enck@uni-tuebingen.de		Cuntz, Ulrich/0000-0002-2394-9935				American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT; BALLINGER A, 1995, CLIN SCI, V89, P375, DOI 10.1042/cs0890375; BALLINGER AB, 1994, GASTROENTEROLOGY, V107, P1913, DOI 10.1016/0016-5085(94)90856-7; Baranowska B, 2000, DIABETES OBES METAB, V2, P99, DOI 10.1046/j.1463-1326.2000.00070.x; CHAMI TN, 1995, AM J GASTROENTEROL, V90, P88; Chowdhury P, 2001, ANN CLIN LAB SCI, V31, P376; de Krom M, 2006, PSYCHIAT GENET, V16, P239, DOI 10.1097/01.ypg.0000242197.59020.2e; Devlin MJ, 1997, AM J CLIN NUTR, V65, P114, DOI 10.1093/ajcn/65.1.114; Enck P, 2009, NEUROGASTROENT MOTIL, V21, P52, DOI 10.1111/j.1365-2982.2008.01182.x; Fujimoto S, 1997, BIOL PSYCHIAT, V41, P1068, DOI 10.1016/S0006-3223(97)00044-9; GERACIOTI TD, 1992, AM J PSYCHIAT, V149, P958; GIBBS J, 1973, J COMP PHYSIOL PSYCH, V84, P488, DOI 10.1037/h0034870; GIBBS J, 1976, AM J PHYSIOL, V230, P15, DOI 10.1152/ajplegacy.1976.230.1.15; Giel KE, 2011, BIOL PSYCHIAT, V69, P661, DOI 10.1016/j.biopsych.2010.09.047; Giel KE, 2012, PSYCHIAT RE IN PRESS; GREEN GM, 1986, AM J PHYSIOL, V251, pG70, DOI 10.1152/ajpgi.1986.251.1.G70; HARTY RF, 1991, REGUL PEPTIDES, V36, P141, DOI 10.1016/0167-0115(91)90202-R; KANAYAMA S, 1991, GASTROENTEROLOGY, V100, P909, DOI 10.1016/0016-5085(91)90263-K; Keifer Ekaterina, 2010, Eat Disord, V18, P302, DOI 10.1080/10640266.2010.490120; Kopin AS, 1999, J CLIN INVEST, V103, P383, DOI 10.1172/JCI4901; LAMERS CBHW, 1995, BRIT J HOSP MED, V53, P113; Leibbrand R, 2002, INT J BEHAV MED, V9, P155, DOI 10.1207/S15327558IJBM0902_06; LIEVERSE RJ, 1993, INT J OBESITY, V17, P177; LIEVERSE RJ, 1994, GASTROENTEROLOGY, V106, P1451, DOI 10.1016/0016-5085(94)90397-2; MAOUYO D, 1995, AM J PHYSIOL-GASTR L, V268, pG251, DOI 10.1152/ajpgi.1995.268.2.G251; Matson CA, 2000, AM J PHYSIOL-REG I, V278, pR882, DOI 10.1152/ajpregu.2000.278.4.R882; Matson CA, 1997, PEPTIDES, V18, P1275, DOI 10.1016/S0196-9781(97)00138-1; Moran TH, 2000, NUTRITION, V16, P858, DOI 10.1016/S0899-9007(00)00419-6; Moran TH, 1998, AM J PHYSIOL-REG I, V274, pR618, DOI 10.1152/ajpregu.1998.274.3.R618; Munsch S, 2009, PHYSIOL BEHAV, V97, P14, DOI 10.1016/j.physbeh.2009.01.015; NIEDERAU C, 1992, GASTROENTEROLOGY, V102, P1889, DOI 10.1016/0016-5085(92)90310-U; PHILIPP E, 1991, LIFE SCI, V48, P2443, DOI 10.1016/0024-3205(91)90379-P; PIRKE KM, 1994, INT J EAT DISORDER, V15, P63, DOI 10.1002/1098-108X(199401)15:1&lt;63::AID-EAT2260150108&gt;3.0.CO;2-V; Probst M, 1996, BRIT J NUTR, V76, P639, DOI 10.1079/BJN19960072; Riepl R L, 1997, Eur J Med Res, V2, P23; Riepl RL, 1996, ITAL J GASTROENTEROL, V28, P421; Sjolund K, 1996, SCAND J GASTROENTERO, V31, P1110, DOI 10.3109/00365529609036895; Strum K, 2003, J CLIN ENDOCR METAB, V88, P3747, DOI 10.1210/jc.2002-021656; Tang TN, 1998, J PSYCHOSOM RES, V45, P171, DOI 10.1016/S0022-3999(97)00300-0; Tomasik PJ, 2004, J PEDIATR ENDOCR MET, V17, P1623; WALDHOLTZ BD, 1990, GASTROENTEROLOGY, V98, P1415, DOI 10.1016/0016-5085(90)91070-M; Wittorf A, 2012, COGN NEUROPSYCHIATRY, V17, P262, DOI 10.1080/13546805.2011.633749	42	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54457	10.1371/journal.pone.0054457	http://dx.doi.org/10.1371/journal.pone.0054457			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349895	gold, Green Published, Green Submitted			2022-12-25	WOS:000313738900069
J	Dreschers, S; Gille, C; Haas, M; Grosse-Ophoff, J; Schneider, M; Leiber, A; Buhring, HJ; Orlikowsky, TW				Dreschers, Stephan; Gille, Christian; Haas, Martin; Grosse-Ophoff, Julia; Schneider, Marion; Leiber, Anja; Buehring, Hans-Joerg; Orlikowsky, Thorsten W.			Infection-induced Bystander-Apoptosis of Monocytes Is TNF-alpha-mediated	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; CELL-DEATH; ESCHERICHIA-COLI; DENDRITIC CELLS; NEONATAL SEPSIS; CORD BLOOD; MACROPHAGES; PHAGOCYTOSIS; LIPOPOLYSACCHARIDE	Phagocytosis induced cell death (PICD) is crucial for controlling phagocyte effector cells, such as monocytes, at sites of infection, and essentially contributes to termination of inflammation. Here we tested the hypothesis, that during PICD bystander apoptosis of non-phagocyting monocytes occurs, that apoptosis induction is mediated via tumor necrosis factor-alpha (TNF-alpha and that TNF-alpha secretion and -signalling is causal. Monocytes were infected with Escherichia coli (E. coli), expressing green fluorescent protein (GFP), or a pH-sensitive Eos-fluorescent protein (EOS-FP). Monocyte phenotype, phagocytic activity, apoptosis, TNF-receptor (TNFR)-1, -2-expression and TNF-alpha production were analyzed. Apoptosis occured in phagocyting and non-phagocyting, bystander monocytes. Bacterial transport to the phagolysosome was no prerequisite for apoptosis induction, and desensitized monocytes from PICD, as confirmed by EOS-FP expressing E. coli. Co-cultivation with non-infected carboxyfluorescein-succinimidyl-ester- (CFSE-) labelled monocytes resulted in significant apoptotic cell death of non-infected bystander monocytes. This process required protein de-novo synthesis and still occurred in a diminished way in the absence of cell-cell contact. E. coli induced a robust TNF-alpha production, leading to TNF-mediated apoptosis in monocytes. Neutralization with an anti-TNF-alpha antibody reduced monocyte bystander apoptosis significantly. In contrast to TNFR2, the pro-apoptotic TNFR1 was down-regulated on the monocyte surface, internalized 30 min. p.i. and led to apoptosis predominantly in monocytes without phagocyting bacteria by themselves. Our results suggest, that apoptosis of bystander monocytes occurs after infection with E. coli via internalization of TNFR1, and indicate a relevant role for TNF-alpha. Modifying monocyte apoptosis in sepsis may be a future therapeutic option.	[Dreschers, Stephan; Haas, Martin; Grosse-Ophoff, Julia; Orlikowsky, Thorsten W.] Univ Childrens Hosp, Dept Neonatol, Aachen, Germany; [Gille, Christian; Leiber, Anja] Univ Childrens Hosp, Dept Neonatol, Tubingen, Germany; [Schneider, Marion] Univ Hosp, Dept Expt Anesthesiol, Ulm, Germany; [Buehring, Hans-Joerg] Univ Hosp, FACS Core Facil, Tubingen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ulm University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Orlikowsky, TW (corresponding author), Univ Childrens Hosp, Dept Neonatol, Aachen, Germany.	torlikowsky@ukaachen.de	Gille, Christian/AAC-1883-2020					Brocklehurst P, 2011, NEW ENGL J MED, V365, P1201, DOI 10.1056/NEJMoa1100441; Cai BL, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/642462; Currie AJ, 2011, INFECT IMMUN, V79, P1588, DOI 10.1128/IAI.00535-10; del Fresno C, 2009, J IMMUNOL, V182, P6494, DOI 10.4049/jimmunol.0803350; Dhiman R, 2008, BBA-GEN SUBJECTS, V1780, P733, DOI 10.1016/j.bbagen.2007.12.010; Ebach DR, 2005, SHOCK, V23, P311, DOI 10.1097/01.shk.0000157301.87051.77; Eissner G, 2000, J IMMUNOL, V164, P6193, DOI 10.4049/jimmunol.164.12.6193; Eissner G, 2004, CYTOKINE GROWTH F R, V15, P353, DOI 10.1016/j.cytogfr.2004.03.011; Fortier A, 2009, INFECT IMMUN, V77, P4794, DOI 10.1128/IAI.01546-08; Frankenberg T, 2008, EUR J IMMUNOL, V38, P204, DOI 10.1002/eji.200737379; Garg AK, 2002, MOL IMMUNOL, V29, P497; Gille C, 2009, CYTOM PART B-CLIN CY, V76B, P271, DOI 10.1002/cyto.b.20474; Gille C, 2008, PEDIATR RES, V63, P33, DOI 10.1203/PDR.0b013e31815b8e9f; Gille C, 2007, J LIPID RES, V48, P307, DOI 10.1194/jlr.M600451-JLR200; Gille C, 2012, CYTOM PART B-CLIN CY, V82B, P26, DOI 10.1002/cyto.b.20609; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Kapetanovic R, 2011, AM J PHYSIOL-CELL PH, V300, pC850, DOI 10.1152/ajpcell.00187.2010; Kirchner S, 2004, CYTOKINE, V28, P67, DOI 10.1016/j.cyto.2004.06.008; Kitamura M, 1999, EUR J IMMUNOL, V29, P1647; Morelli AE, 2010, APOPTOSIS, V15, P1083, DOI 10.1007/s10495-010-0469-9; Nadel S, 2007, LANCET, V369, P836, DOI 10.1016/S0140-6736(07)60411-5; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Nienhaus GU, 2006, PHOTOCHEM PHOTOBIOL, V82, P351, DOI 10.1562/2005-05-19-RA-533; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Quevedo-Diaz MA, 2010, J LEUKOCYTE BIOL, V88, P675, DOI 10.1189/jlb.1009674; Ruckdeschel K, 1998, J EXP MED, V187, P1069, DOI 10.1084/jem.187.7.1069; Salazar JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000444; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Scherubl Christoph, 2005, J Inflamm (Lond), V2, P7, DOI 10.1186/1476-9255-2-7; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Spasojevic I, 2012, CRIT CARE, V16, DOI 10.1186/cc11183; TRACEY KJ, 1993, ANNU REV CELL BIOL, V9, P317, DOI 10.1146/annurev.cb.09.110193.001533; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Volling K, 2011, CELL MICROBIOL; Wang P, 2009, CELL DEATH DIFFER, V16, P1192, DOI 10.1038/cdd.2009.51; Webster SJ, 2010, J IMMUNOL, V185, P2968, DOI 10.4049/jimmunol.1000805; Wiedenmann J, 2006, EXPERT REV PROTEOMIC, V3, P361, DOI 10.1586/14789450.3.3.361	40	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53589	10.1371/journal.pone.0053589	http://dx.doi.org/10.1371/journal.pone.0053589			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349721	Green Published, gold, Green Submitted			2022-12-25	WOS:000313738900013
J	Casson, L; Howell, L; Mathews, LA; Ferrer, M; Southall, N; Guha, R; Keller, JM; Thomas, C; Siskind, LJ; Beverly, LJ				Casson, Lavona; Howell, Lauren; Mathews, Lesley A.; Ferrer, Marc; Southall, Noel; Guha, Rajarshi; Keller, Jonathan M.; Thomas, Craig; Siskind, Leah J.; Beverly, Levi J.			Inhibition of Ceramide Metabolism Sensitizes Human Leukemia Cells to Inhibition of BCL2-Like Proteins	PLOS ONE			English	Article							DAUNORUBICIN-INDUCED APOPTOSIS; BCL-2 FAMILY PROTEINS; BH3 MIMETIC ABT-737; GLUCOSYLCERAMIDE SYNTHASE; SPHINGOSINE KINASE; IN-VITRO; PATHWAY; BAX; RESISTANCE; EXPRESSION	The identification of novel combinations of effective cancer drugs is required for the successful treatment of cancer patients for a number of reasons. First, many "cancer specific" therapeutics display detrimental patient side-effects and second, there are almost no examples of single agent therapeutics that lead to cures. One strategy to decrease both the effective dose of individual drugs and the potential for therapeutic resistance is to combine drugs that regulate independent pathways that converge on cell death. BCL2-like family members are key proteins that regulate apoptosis. We conducted a screen to identify drugs that could be combined with an inhibitor of anti-apoptotic BCL2-like proteins, ABT-263, to kill human leukemia cells lines. We found that the combination of D,L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) hydrochloride, an inhibitor of glucosylceramide synthase, potently synergized with ABT-263 in the killing of multiple human leukemia cell lines. Treatment of cells with PDMP and ABT-263 led to dramatic elevation of two pro-apoptotic sphingolipids, namely ceramide and sphingosine. Furthermore, treatment of cells with the sphingosine kinase inhibitor, SKi-II, also dramatically synergized with ABT-263 to kill leukemia cells and similarly increased ceramides and sphingosine. Data suggest that synergism with ABT-263 requires accumulation of ceramides and sphingosine, as AMP-deoxynojirimycin, (an inhibitor of the glycosphingolipid pathway) did not elevate ceramides or sphingosine and importantly did not sensitize cells to ABT-263 treatment. Taken together, our data suggest that combining inhibitors of anti-apoptotic BCL2-like proteins with drugs that alter the balance of bioactive sphingolipids will be a powerful combination for the treatment of human cancers.	[Casson, Lavona; Beverly, Levi J.] Univ Louisville, James Graham Brown Canc Ctr, Dept Med, Div Hematol & Oncol, Louisville, KY 40292 USA; [Howell, Lauren; Siskind, Leah J.] Med Sch S Carolina, S Carolina Coll Pharm, Dept Drug Discovery & Biomed Sci, Charleston, SC USA; [Mathews, Lesley A.; Ferrer, Marc; Southall, Noel; Guha, Rajarshi; Keller, Jonathan M.; Thomas, Craig] NIH, Div Preclin Innovat, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA; [Siskind, Leah J.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA; [Beverly, Levi J.] NHGRI, Canc Biol & Genet Sect, Canc Genet Branch, NIH, Bethesda, MD 20892 USA	University of Louisville; Medical University of South Carolina; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Siskind, LJ (corresponding author), Med Sch S Carolina, S Carolina Coll Pharm, Dept Drug Discovery & Biomed Sci, Charleston, SC USA.	Siskind@MUSC.edu; Levi.Beverly@Louisville.edu	Ferrer, Marta/C-4319-2016; Southall, Noel T/H-8991-2012	Ferrer, Marta/0000-0001-8495-1302; Southall, Noel T/0000-0003-4500-880X; Thomas, Craig/0000-0001-9386-9001; Siskind, Leah/0000-0001-5026-5187	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [R01DK093462]; Cancer Center Support Grant [P30 CA138313]; NIH/NCRR COBRE in Lipidomics and Pathobiology [P20 RR17677]; National Institutes of Health, Molecular Targets COBRE [8P20GM103482-10]; Wendy Will Case Cancer Fund [GB220413]; Kosair Pediatric Cancer Research Program award; NIH Common Fund Molecular Libraries and Imaging Program [U54 MH084681]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103482] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cancer Center Support Grant; NIH/NCRR COBRE in Lipidomics and Pathobiology; National Institutes of Health, Molecular Targets COBRE; Wendy Will Case Cancer Fund; Kosair Pediatric Cancer Research Program award; NIH Common Fund Molecular Libraries and Imaging Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by: National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health, R01DK093462 (to LJS), the Lipidomics Shared Resource of the Hollings Cancer Center at the Medical University of South Carolina supported by a Cancer Center Support Grant (P30 CA138313), pilot project (to LJS) from the NIH/NCRR P20 RR17677 COBRE in Lipidomics and Pathobiology, National Institutes of Health, Molecular Targets COBRE, 8P20GM103482-10 (to LJB), Wendy Will Case Cancer Fund, GB220413 (to LJB), Kosair Pediatric Cancer Research Program award (to LJB). This research was partly supported by the NIH Common Fund Molecular Libraries and Imaging Program, Grant U54 MH084681. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; Allouche M, 1997, ONCOGENE, V14, P1837, DOI 10.1038/sj.onc.1201023; Alphonse G, 2004, ONCOGENE, V23, P2703, DOI 10.1038/sj.onc.1207357; Baran Y, 2011, J CANCER RES CLIN, V137, P1535, DOI 10.1007/s00432-011-1016-y; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Camgoz A, 2011, LEUKEMIA LYMPHOMA, V52, P1574, DOI 10.3109/10428194.2011.568653; Chipuk JE, 2012, CELL, V148, P988, DOI 10.1016/j.cell.2012.01.038; Colombini M, 2010, BBA-BIOENERGETICS, V1797, P1239, DOI 10.1016/j.bbabio.2010.01.021; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; El-Assaad W, 1998, BIOCHEM J, V336, P735, DOI 10.1042/bj3360735; Ganesan V, 2010, FEBS LETT, V584, P2128, DOI 10.1016/j.febslet.2010.02.032; Ganesan V, 2010, APOPTOSIS, V15, P553, DOI 10.1007/s10495-009-0449-0; Geley S, 1997, FEBS LETT, V400, P15, DOI 10.1016/S0014-5793(96)01284-7; Giraldo P, 2009, HAEMATOL-HEMATOL J, V94, P1771, DOI 10.3324/haematol.2009.008078; Grazide S, 2004, J BIOL CHEM, V279, P18256, DOI 10.1074/jbc.M314105200; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Horvitz HR, 1999, CANCER RES, V59, p1701S; Issuree PDA, 2009, FASEB J, V23, P2412, DOI 10.1096/fj.09-130542; Itoh M, 2003, CLIN CANCER RES, V9, P415; Kartal M, 2011, NUTR CANCER, V63, P637, DOI 10.1080/01635581.2011.538485; Kawatani M, 2003, EXP CELL RES, V286, P57, DOI 10.1016/S0014-4827(03)00098-3; Kim HJ, 2001, FEBS LETT, V505, P264, DOI 10.1016/S0014-5793(01)02836-8; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Letai A, 2004, CANCER CELL, V6, P241, DOI 10.1016/j.ccr.2004.07.011; Lim KG, 2012, BRIT J PHARMACOL, V166, P1605, DOI 10.1111/j.1476-5381.2012.01862.x; Liu YY, 2004, J LIPID RES, V45, P933, DOI 10.1194/jlr.M300486-JLR200; Messner MC, 2010, ADV EXP MED BIOL, V688, P156; Moore VD, 2008, BLOOD, V111, P2300, DOI 10.1182/blood-2007-06-098012; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Perera MN, 2012, BIOCHEM J, V445, P81, DOI 10.1042/BJ20112103; RANI CSS, 1995, J BIOL CHEM, V270, P2859, DOI 10.1074/jbc.270.6.2859; Reed JC, 2006, CELL DEATH DIFFER, V13, P1378, DOI 10.1038/sj.cdd.4401975; Sawada M, 2000, ONCOGENE, V19, P3508, DOI 10.1038/sj.onc.1203699; Schnute ME, 2012, BIOCHEM J, V444, P79, DOI 10.1042/BJ20111929; Sinha UK, 2011, HEAD NECK-J SCI SPEC, V33, P178, DOI 10.1002/hed.21418; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Siskind LJ, 2010, J BIOL CHEM, V285, P11818, DOI 10.1074/jbc.M109.078121; Siskind LJ, 2008, J BIOL CHEM; Sobue S, 2008, INT J HEMATOL, V87, P266, DOI 10.1007/s12185-008-0052-0; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Taha TA, 2006, FEBS LETT, V580, P6047, DOI 10.1016/j.febslet.2006.09.070; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Tsujimoto Y, 1998, GENES CELLS, V3, P697, DOI 10.1046/j.1365-2443.1998.00223.x; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; von Haefen C, 2002, ONCOGENE, V21, P4009, DOI 10.1038/sj.onc.1205497; Wilson WH, 2010, LANCET ONCOL, V11, P1149, DOI 10.1016/S1470-2045(10)70261-8; Zhang JD, 1996, P NATL ACAD SCI USA, V93, P5325, DOI 10.1073/pnas.93.11.5325	50	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54525	10.1371/journal.pone.0054525	http://dx.doi.org/10.1371/journal.pone.0054525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342165	Green Published, Green Submitted, gold			2022-12-25	WOS:000313682700122
J	Young, WB; Park, JE; Tian, IX; Kempner, J				Young, William B.; Park, Jung E.; Tian, Iris X.; Kempner, Joanna			The Stigma of Migraine	PLOS ONE			English	Article							DISCRIMINATION; EPILEPSY; PEOPLE	Background: People who have a disease often experience stigma, a socially and culturally embedded process through which individuals experience stereotyping, devaluation, and discrimination. Stigma has great impact on quality of life, behavior, and life chances. We do not know whether or not migraine is stigmatizing. Methods: We studied 123 episodic migraine patients, 123 chronic migraine patients, and 62 epilepsy patients in a clinical setting to investigate the extent to which stigma attaches to migraine, using epilepsy as a comparison. We used the stigma scale for chronic illness, a 24-item questionnaire suitable for studying chronic neurologic diseases, and various disease impact measures. Results: Patients with chronic migraine had higher scores (54.0 +/- 20.2) on the stigma scale for chronic illness than either episodic migraine (41.7 +/- 14.8) or epilepsy patients (44.6 +/- 16.3) (p<0.001). Subjects with migraine reported greater inability to work than epilepsy subjects. Stigma correlated most strongly with the mental component score of the short form of the medical outcomes health survey (SF-12), then with ability to work and migraine disability score for chronic and episodic migraine and the Liverpool impact on epilepsy scale for epilepsy. Analysis of covariance showed adjusted scores for the stigma scale for chronic illness were similar for chronic migraine (49.3; 95% confidence interval, 46.2 to 52.4) and epilepsy (46.5; 95% confidence interval, 41.6 to 51.6), and lower for episodic migraine (43.7; 95% confidence interval, 40.9 to 46.6). Ability to work was the strongest predictor of stigma as measured by the stigma scale for chronic illness. Conclusion: In our model, adjusted stigma was similar for chronic migraine and epilepsy, which were greater than for episodic migraine. Stigma correlated most strongly with inability to work, and was greater for chronic migraine than epilepsy or episodic migraine because chronic migraine patients had less ability to work.	[Young, William B.; Park, Jung E.; Tian, Iris X.] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA; [Kempner, Joanna] Rutgers State Univ, Dept Sociol, New Brunswick, NJ 08903 USA	Jefferson University; Rutgers State University New Brunswick	Young, WB (corresponding author), Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA.	William.B.Young@jefferson.edu		Kempner, Joanna/0000-0002-0198-8781; Kempner, Joanna/0000-0002-9784-6381				Bandstra NF, 2008, CAN J NEUROL SCI, V35, P436, DOI 10.1017/S0317167100009082; Cella D, 2012, NEUROLOGY, V78, P1860, DOI 10.1212/WNL.0b013e318258f744; Finch BK, 2000, J HEALTH SOC BEHAV, V41, P295, DOI 10.2307/2676322; Genberg BL, 2009, SOC SCI MED, V68, P2279, DOI 10.1016/j.socscimed.2009.04.005; Goffman E., 1963, BEHAV PUBLIC PLACES; Heijnders Miriam, 2006, Psychol Health Med, V11, P353, DOI 10.1080/13548500600595327; JACOBY A, 1994, SOC SCI MED, V38, P269, DOI 10.1016/0277-9536(94)90396-4; Jacoby A, 2008, CURR NEUROL NEUROSCI, V8, P339, DOI 10.1007/s11910-008-0052-8; Koller M, 1996, CANCER, V77, P983, DOI 10.1002/(SICI)1097-0142(19960301)77:5<983::AID-CNCR27>3.0.CO;2-Z; Link BG, 2006, LANCET, V367, P528, DOI 10.1016/S0140-6736(06)68184-1; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Rao D, 2009, QUAL LIFE RES, V18, P585, DOI 10.1007/s11136-009-9475-1; Scambler G., 2004, SOC THEOR HEALTH, V2, P29, DOI [10.1057/palgrave.sth.8700012, DOI 10.1057/PALGRAVE.STH.8700012]; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Walton GM, 2011, SCIENCE, V331, P1447, DOI 10.1126/science.1198364	15	65	67	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54074	10.1371/journal.pone.0054074	http://dx.doi.org/10.1371/journal.pone.0054074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072OV	23342079	Green Submitted, Green Published, gold			2022-12-25	WOS:000313682700084
J	Das, S; Shetty, RK; Kumar, A; Shridharan, RN; Tatineni, R; Chi, G; Mukherjee, A; Das, S; Subbarao, SM; Karande, AA				Das, Soma; Shetty, Rohini K.; Kumar, Anuj; Shridharan, Radhika Nagamangalam; Tatineni, Ranjitha; Chi, Giriprakash; Mukherjee, Anirban; Das, Saumitra; Subbarao, Shaila Melkote; Karande, Anjali Anoop			Monoclonal Antibodies against Hepatitis C Genotype 3a Virus Like Particle Inhibit Virus Entry in Cell Culture System	PLOS ONE			English	Article							ENVELOPE GLYCOPROTEIN; HYPERVARIABLE REGION-1; VIRAL DYNAMICS; BINDING; CD81; PROTEINS; INFECTION; REQUIRES; HORMONE	The envelope protein (E1-E2) of Hepatitis C virus (HCV) is a major component of the viral structure. The glycosylated envelope protein is considered to be important for initiation of infection by binding to cellular receptor(s) and also known as one of the major antigenic targets to host immune response. The present study was aimed at identifying mouse monoclonal antibodies which inhibit binding of virus like particles of HCV to target cells. The first step in this direction was to generate recombinant HCV-like particles (HCV-LPs) specific for genotypes 3a of HCV (prevalent in India) using the genes encoding core, E1 and E2 envelop proteins in a baculovirus expression system. The purified HCV-LPs were characterized by ELISA and electron microscopy and were used to generate monoclonal antibodies (mAbs) in mice. Two monoclonal antibodies (E8G9 and H1H10) specific for the E2 region of envelope protein of HCV genotype 3a, were found to reduce the virus binding to Huh7 cells. However, the mAbs generated against HCV genotype 1b (D2H3, G2C7, E1B11) were not so effective. More importantly, mAb E8G9 showed significant inhibition of the virus entry in HCV JFH1 cell culture system. Finally, the epitopic regions on E2 protein which bind to the mAbs have also been identified. Results suggest a new therapeutic strategy and provide the proof of concept that mAb against HCV-LP could be effective in preventing virus entry into liver cells to block HCV replication.	[Das, Soma; Shridharan, Radhika Nagamangalam; Mukherjee, Anirban; Karande, Anjali Anoop] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Shetty, Rohini K.; Kumar, Anuj; Tatineni, Ranjitha; Chi, Giriprakash; Das, Saumitra; Subbarao, Shaila Melkote] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Karande, AA (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	anjali@biochem.iisc.ernet.in	KUMAR, ANUJ/AAB-5238-2019	KUMAR, ANUJ/0000-0002-8101-8012	Department of Biotechnology, Govt. of India; UGC, Govt. of India; CSIR, Govt. of India	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); UGC, Govt. of India(University Grants Commission, India); CSIR, Govt. of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Department of Biotechnology, Govt. of India. Dr. Soma Das was the recipient of S K Kothari postdoctoral Fellowship from UGC, Govt. of India. Anuj Kumar Dayal was a recipient of Junior Research Fellowship from CSIR, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTER MJ, 1992, NEW ENGL J MED, V327, P1899, DOI 10.1056/NEJM199212313272702; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Baumert TF, 1999, GASTROENTEROLOGY, V117, P1397, DOI 10.1016/S0016-5085(99)70290-8; Baumert TF, 1998, J VIROL, V72, P3827, DOI 10.1128/JVI.72.5.3827-3836.1998; Baumert TF, 2000, HEPATOLOGY, V32, P610, DOI 10.1053/jhep.2000.9876; Clayton RF, 2002, J VIROL, V76, P7672, DOI 10.1128/JVI.76.15.7672-7682.2002; Cormier EG, 2004, P NATL ACAD SCI USA, V101, P7270, DOI 10.1073/pnas.0402253101; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Dubuisson J, 1996, J VIROL, V70, P778, DOI 10.1128/JVI.70.2.778-786.1996; DUBUISSON J, 1994, J VIROL, V68, P6147, DOI 10.1128/JVI.68.10.6147-6160.1994; Fukumoto T, 1996, HEPATOLOGY, V24, P1351, DOI 10.1053/jhep.1996.v24.pm0008938160; Gangatirkar P, 2002, HYBRIDOMA HYBRIDOM, V21, P281, DOI 10.1089/153685902760213895; Gruener NH, 2001, J VIROL, V75, P5550, DOI 10.1128/JVI.75.12.5550-5558.2001; Haqshenas G, 2007, J GEN VIROL, V88, P895, DOI 10.1099/vir.0.82467-0; Helle F, 2010, J VIROL, V84, P11905, DOI 10.1128/JVI.01548-10; KARANDE AA, 1995, MOL CELL ENDOCRINOL, V114, P51, DOI 10.1016/0303-7207(95)03641-J; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; Keck ZY, 2004, J VIROL, V78, P9224, DOI 10.1128/JVI.78.17.9224-9232.2004; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Major ME, 1997, HEPATOLOGY, V25, P1527, DOI 10.1002/hep.510250637; Mukhopadhya A, 2008, J BIOSCIENCES, V33, P465, DOI 10.1007/s12038-008-0065-0; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Rice CM, 1996, FIELDS VIROLOGY, P931; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Steinmann D, 2004, J VIROL, V78, P9030, DOI 10.1128/JVI.78.17.9030-9040.2004; Triyatni M, 2002, J VIROL, V76, P9335, DOI 10.1128/JVI.76.18.9335-9344.2002; Triyatni M, 2002, VIROLOGY, V298, P124, DOI 10.1006/viro.2002.1463; Wellnitz S, 2002, J VIROL, V76, P1181, DOI 10.1128/JVI.76.3.1181-1193.2002; Xiang JH, 2002, J MED VIROL, V68, P537, DOI 10.1002/jmv.10237; Zhang J, 2004, J VIROL, V78, P1448, DOI 10.1128/JVI.78.3.1448-1455.2004; ZIBERT A, 1995, VIROLOGY, V208, P653, DOI 10.1006/viro.1995.1196	37	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53619	10.1371/journal.pone.0053619	http://dx.doi.org/10.1371/journal.pone.0053619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23341957	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000314707700021
J	Costa-da-Silva, AL; Navarrete, FR; Salvador, FS; Karina-Costa, M; Ioshino, RS; Azevedo, DS; Rocha, DR; Romano, CM; Capurro, ML				Costa-da-Silva, Andre Luis; Navarrete, Flavia Rosa; Salvador, Felipe Scassi; Karina-Costa, Maria; Ioshino, Rafaella Sayuri; Azevedo, Diego Soares; Rocha, Desiree Rafaela; Romano, Camila Malta; Capurro, Margareth Lara			Glytube: A Conical Tube and Parafilm M-Based Method as a Simplified Device to Artificially Blood-Feed the Dengue Vector Mosquito, Aedes aegypti	PLOS ONE			English	Article							RHODNIUS-PROLIXUS; SYSTEM; INSECT	Aedes aegypti, the main vector of dengue virus, requires a blood meal to produce eggs. Although live animals are still the main blood source for laboratory colonies, many artificial feeders are available. These feeders are also the best method for experimental oral infection of Ae. aegypti with Dengue viruses. However, most of them are expensive or laborious to construct. Based on principle of Rutledge-type feeder, a conventional conical tube, glycerol and Parafilm-M were used to develop a simple in-house feeder device. The blood feeding efficiency of this apparatus was compared to a live blood source, mice, and no significant differences (p = 0.1189) were observed between artificial-fed (51.3% of engorgement) and mice-fed groups (40.6%). Thus, an easy to assemble and cost-effective artificial feeder, designated "Glytube" was developed in this report. This simple and efficient feeding device can be built with common laboratory materials for research on Ae. aegypti.	[Costa-da-Silva, Andre Luis; Navarrete, Flavia Rosa; Karina-Costa, Maria; Ioshino, Rafaella Sayuri; Azevedo, Diego Soares; Rocha, Desiree Rafaela; Capurro, Margareth Lara] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, Brazil; [Salvador, Felipe Scassi; Romano, Camila Malta] Univ Sao Paulo, Virol Lab, Inst Trop Med, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Costa-da-Silva, AL (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, Brazil.	alcosta@icb.usp.br	Capurro, Margareth L/F-8679-2012; Romano, Camila M/C-8185-2013; Capurro, Margareth/M-5286-2019; Salvador, Felipe Scassi/AAU-8431-2021; Romano, Camila/ABC-2883-2020; Costa-da-Silva, Andre Luis/F-7874-2012; Silva, Andre/N-8654-2013; Costa-Da-Silva, André Luis/J-8913-2019; Ioshino, Rafaella Sayuri/P-9814-2016	Capurro, Margareth L/0000-0002-7480-2116; Romano, Camila/0000-0003-4550-1987; Costa-da-Silva, Andre Luis/0000-0002-7615-7376; Costa-Da-Silva, André Luis/0000-0002-7615-7376; Ioshino, Rafaella Sayuri/0000-0002-9225-0140	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2008/10254-1, 2009/53637-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq/Departamento de Ciencia e Tecnologia - DECIT [555648/2009-5]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES; Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular - INCT-EM	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq/Departamento de Ciencia e Tecnologia - DECIT; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular - INCT-EM	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (#2008/10254-1; #2009/53637-0) - www.fapesp.br, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq/Departamento de Ciencia e Tecnologia - DECIT (#555648/2009-5) - www.cnpq.br, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES - www.capes.gov.br, Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular - INCT-EM - www.inctem.bioqmed.ufrj.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedict M. Q., 2009, METHODS ANOPHELES RE, P288; BENZON GL, 1987, J AM MOSQUITO CONTR, V3, P322; Chiang RG, 2010, ARCH INSECT BIOCHEM, V74, P103, DOI 10.1002/arch.20365; Clements AN., 1992, BIOL MOSQUITOES DEV; COSGROVE JB, 1995, J AM MOSQUITO CONTR, V11, P339; COSGROVE JB, 1994, J AM MOSQUITO CONTR, V10, P434; Das Suchismita, 2007, J Vis Exp, P220, DOI 10.3791/220; Deng L, 2012, TROP BIOMED, V29, P169; Ferdowsian HR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024059; Filipecki Ana Tereza Pinto, 2011, ILAR J, V52, pE8; Gauthier C, 2008, I ANIMAL CARE COMMIT, V14, P157; Ghaninia M, 2008, J EXP BIOL, V211, P3020, DOI 10.1242/jeb.016360; HUEBNER E, 1994, CAN J ZOOL, V72, P2244, DOI 10.1139/z94-299; Jagjiwanram, 2004, INDIAN J ENG MATER S, V11, P125; Pothikasikorn J, 2010, J VECTOR ECOL, V35, P149, DOI 10.1111/j.1948-7134.2010.00041.x; Rampersad J, 2007, J AM MOSQUITO CONTR, V23, P149, DOI 10.2987/8756-971X(2007)23[149:VBBFLF]2.0.CO;2; RUTLEDGE L. C., 1964, MOSQUITO NEWS, V24, P407; Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9; Tseng M, 2003, J MED ENTOMOL, V40, P588, DOI 10.1603/0022-2585-40.4.588; Waladde SM, 1996, PARASITOL TODAY, V12, P272, DOI 10.1016/0169-4758(96)10027-2	20	36	36	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53816	10.1371/journal.pone.0053816	http://dx.doi.org/10.1371/journal.pone.0053816			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342010	gold, Green Published, Green Submitted			2022-12-25	WOS:000314759400088
J	Willis, KL; Christensen-Dalsgaard, J; Ketten, DR; Carr, CE				Willis, Katie L.; Christensen-Dalsgaard, Jakob; Ketten, Darlene R.; Carr, Catherine E.			Middle Ear Cavity Morphology Is Consistent with an Aquatic Origin for Testudines	PLOS ONE			English	Article							UNDERWATER HEARING; DIAPSID REPTILES; SISTER GROUP; TURTLES EAR; SEA-TURTLE; PHYLOGENY; EVOLUTION; POSITION; SENSITIVITY; POTENTIALS	The position of testudines in vertebrate phylogeny is being re-evaluated. At present, testudine morphological and molecular data conflict when reconstructing phylogenetic relationships. Complicating matters, the ecological niche of stem testudines is ambiguous. To understand how turtles have evolved to hear in different environments, we examined middle ear morphology and scaling in most extant families, as well as some extinct species, using 3-dimensional reconstructions from micro magnetic resonance (MR) and submillimeter computed tomography (CT) scans. All families of testudines exhibited a similar shape of the bony structure of the middle ear cavity, with the tympanic disk located on the rostrolateral edge of the cavity. Sea Turtles have additional soft tissue that fills the middle ear cavity to varying degrees. When the middle ear cavity is modeled as an air-filled sphere of the same volume resonating in an underwater sound field, the calculated resonances for the volumes of the middle ear cavities largely fell within testudine hearing ranges. Although there were some differences in morphology, there were no statistically significant differences in the scaling of the volume of the bony middle ear cavity with head size among groups when categorized by phylogeny and ecology. Because the cavity is predicted to resonate underwater within the testudine hearing range, the data support the hypothesis of an aquatic origin for testudines, and function of the middle ear cavity in underwater sound detection.	[Willis, Katie L.; Carr, Catherine E.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Christensen-Dalsgaard, Jakob] Univ So Denmark, Inst Biol, Odense M, Denmark; [Ketten, Darlene R.] Harvard Univ, Sch Med, Dept Biol, Dept Otol & Laryngol,Woods Hole Oceanog Inst, Woods Hole, MA USA	University System of Maryland; University of Maryland College Park; University of Southern Denmark; Harvard University; Woods Hole Oceanographic Institution	Willis, KL (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	kwillis@umd.edu	Christensen-Dalsgaard, Jakob/H-5299-2019; Christensen-Dalsgaard, Jakob/G-9947-2012	Christensen-Dalsgaard, Jakob/0000-0002-6075-3819	Danish National Science Foundation [09-065990]; Carlsberg Foundation [2009-01-0684]; Velux Foundation (Denmark); ONR [N000140811231]; NIH (National Institutes of Health) [DC00436, P30 DC0466]; NSF [IIS 9874781, 0208675]; Directorate For Geosciences [0948842] Funding Source: National Science Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000046, F32DC000466, R29DC000436, R01DC000436] Funding Source: NIH RePORTER	Danish National Science Foundation(Danmarks Grundforskningsfond); Carlsberg Foundation(Carlsberg Foundation); Velux Foundation (Denmark); ONR(Office of Naval Research); NIH (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by awards from the Danish National Science Foundation 09-065990 and Carlsberg Foundation 2009-01-0684 (JCD), the Velux Foundation (Denmark), ONR N000140811231(DRK) and NIH (National Institutes of Health) DC00436 (CEC), and by NIH P30 DC0466 to the University of Maryland Center for Comparative and Evolutionary Biology of Hearing, by NSF IIS 9874781 and 0208675 to T. Rowe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian ED, 1938, PROC R SOC SER B-BIO, V125, P435, DOI 10.1098/rspb.1938.0036; Bartol SM, 1999, COPEIA, P836, DOI 10.2307/1447625; Brinkman DB, 2005, DINOSAUR PROVINCIAL; CAMPBELL H W, 1972, Herpetologica, V28, P277; CAMPBELL HOWARD W., 1967, HERPETOLOGICA, V23, P204; Carr AF, 1969, HDB TURTLES TURTLES; Chiari Y, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-65; Christensen-Dalsgaard J, 1995, J COMP PHYSIOL A, V176, P1; Christensen-Dalsgaard J, 2008, JARO-J ASSOC RES OTO, V9, P407, DOI 10.1007/s10162-008-0130-2; Christensen-Dalsgaard J, 2008, BRAIN RES BULL, V75, P365, DOI 10.1016/j.brainresbull.2007.10.044; Christensen-Dalsgaard J, 2012, P ROY SOC B-BIOL SCI, V279, P2816, DOI 10.1098/rspb.2012.0290; Clack JA., 2012, GAINING GROUND ORIGI; Crawford N. G., 2012, BIOL LETT, V8, P1; Evans HM, 1925, P R SOC LOND B-CONTA, V97, P545, DOI 10.1098/rspb.1925.0018; Frazier J, 1981, AMPHIBIA-REPTILIA, V2, P1; Gaffney E.S., 1983, Journal of Vertebrate Paleontology, V3, P25, DOI 10.1080/02724634.1983.10011953; Gaffney E.S., 1972, ILLUSTRATED GLOSSARY, P1; Giles JC, 2009, J ACOUST SOC AM, V126, P434, DOI 10.1121/1.3148209; Guillon JM, 2012, CONTRIB ZOOL, V81, P147, DOI 10.1163/18759866-08103002; Hedges SB, 1999, SCIENCE, V283, P998, DOI 10.1126/science.283.5404.998; Iwabe N, 2005, MOL BIOL EVOL, V22, P810, DOI 10.1093/molbev/msi075; Ketten DR, 1999, ACOUST SOC AM ANN M; KONISHI M, 1970, Z VERGL PHYSIOL, V66, P257, DOI 10.1007/BF00297829; Lee MSY, 2001, CONTRIB ZOOL, V70, P1; Li C, 2008, NATURE, V456, P497, DOI 10.1038/nature07533; LOMBARD RE, 1981, J EXP BIOL, V91, P57; Lyson TR, 2010, BIOL LETTERS, V6, P830, DOI 10.1098/rsbl.2010.0371; Mannen H, 1999, MOL PHYLOGENET EVOL, V13, P144, DOI 10.1006/mpev.1999.0640; Mason Mj, 2009, Proc Inst Acoust, V31, P13; Pineiro G, 2012, CR PALEVOL, V11, P379, DOI 10.1016/j.crpv.2012.02.001; PLASSMANN W, 1991, BRAIN BEHAV EVOLUT, V38, P115, DOI 10.1159/000114382; Polgar G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021434; Ravicz ME, 1997, J ACOUST SOC AM, V101, P2135, DOI 10.1121/1.418275; RIDGWAY SH, 1969, P NATL ACAD SCI USA, V64, P884, DOI 10.1073/pnas.64.3.884; Rieppel O, 1999, ANNU REV ECOL SYST, V30, P1, DOI 10.1146/annurev.ecolsys.30.1.1; Rieppel O, 1996, NATURE, V384, P453, DOI 10.1038/384453a0; Shen XX, 2011, MOL BIOL EVOL, V28, P3237, DOI 10.1093/molbev/msr148; Tang YZ, 2012, J COMP NEUROL, V520, P1784, DOI 10.1002/cne.23013; Thewissen JGM, 2008, SENSORY EVOLUTION ON THE THRESHOLD: ADAPTATIONS IN SECONDARILY AQUATIC VERTEBRATES, P1; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3; van Dijk P. P., 2011, CONSERVATION BIOL FR; Webb JF, 2006, J MORPHOL, V267, P1338, DOI 10.1002/jmor.10480; WEBSTER DOUGLAS B., 1962, PHYSIOL ZOOL, V35, P248; Wever E.., 1978, REPTILE EAR ITS STRU; WEVER EG, 1956, P NATL ACAD SCI USA, V42, P292, DOI 10.1073/pnas.42.5.292; WEVER EG, 1956, P NATL ACAD SCI USA, V42, P213, DOI 10.1073/pnas.42.4.213; WEVER EG, 1956, P NATL ACAD SCI USA, V42, P962, DOI 10.1073/pnas.42.12.962; Willis KL, 2011, SOC NEUR ANN M; Witmer LM, 2008, ANATOMICAL IMAGING: TOWARDS A NEW MORPHOLOGY, P67, DOI 10.1007/978-4-431-76933-0_6; Zardoya R, 2001, NATURWISSENSCHAFTEN, V88, P193, DOI 10.1007/s001140100228; Zeddies DG, 2005, J EXP BIOL, V208, P1363, DOI 10.1242/jeb.01534	51	22	22	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54086	10.1371/journal.pone.0054086	http://dx.doi.org/10.1371/journal.pone.0054086			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342082	gold, Green Published			2022-12-25	WOS:000314759400120
J	Nath, AK; Roberts, LD; Liu, Y; Mahon, SB; Kim, S; Ryu, JH; Werdich, A; Januzzi, JL; Boss, GR; Rockwood, GA; MacRae, CA; Brenner, M; Gerszten, RE; Peterson, RT				Nath, Anjali K.; Roberts, Lee D.; Liu, Yan; Mahon, Sari B.; Kim, Sonia; Ryu, Justine H.; Werdich, Andreas; Januzzi, James L.; Boss, Gerry R.; Rockwood, Gary A.; MacRae, Calum A.; Brenner, Matthew; Gerszten, Robert E.; Peterson, Randall T.			Chemical and metabolomic screens identify novel biomarkers and antidotes for cyanide exposure	FASEB JOURNAL			English	Article						mitochondria; inosine; zebrafish; riboflavin	CYTOCHROME-C-OXIDASE; LIPID-PEROXIDATION; SMALL MOLECULES; DIFFERENT MODES; INHIBITION; INOSINE; IDENTIFICATION; PARKINSONISM; APOPTOSIS; TOXICITY	Exposure to cyanide causes a spectrum of cardiac, neurological, and metabolic dysfunctions that can be fatal. Improved cyanide antidotes are needed, but the ideal biological pathways to target are not known. To understand better the metabolic effects of cyanide and to discover novel cyanide antidotes, we developed a zebrafish model of cyanide exposure and scaled it for high-throughput chemical screening. In a screen of 3120 small molecules, we discovered 4 novel antidotes that block cyanide toxicity. The most potent antidote was riboflavin. Metabolomic profiling of cyanide-treated zebrafish revealed changes in bile acid and purine metabolism, most notably by an increase in inosine levels. Riboflavin normalizes many of the cyanide-induced neurological and metabolic perturbations in zebrafish. The metabolic effects of cyanide observed in zebrafish were conserved in a rabbit model of cyanide toxicity. Further, humans treated with nitroprusside, a drug that releases nitric oxide and cyanide ions, display increased circulating bile acids and inosine. In summary, riboflavin may be a novel treatment for cyanide toxicity and prophylactic measure during nitroprusside treatment, inosine may serve as a biomarker of cyanide exposure, and metabolites in the bile acid and purine metabolism pathways may shed light on the pathways critical to reversing cyanide toxicity.-Nath, A. K., Roberts, L. D., Liu, Y., Mahon, S. B., Kim, S., Ryu, J. H., Werdich, A., Januzzi, J. L., Boss, G. R., Rockwood, G. A., MacRae, C. A., Brenner, M., Gerszten, R. E., Peterson, R. T. Chemical and metabolomic screens identify novel biomarkers and antidotes for cyanide exposure. FASEB J. 27, 1928-1938 (2013). www.fasebj.org	[Nath, Anjali K.; Roberts, Lee D.; Liu, Yan; Kim, Sonia; Ryu, Justine H.; Januzzi, James L.; Gerszten, Robert E.; Peterson, Randall T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA USA; [Nath, Anjali K.; Roberts, Lee D.; Liu, Yan; Kim, Sonia; Ryu, Justine H.; Januzzi, James L.; Gerszten, Robert E.; Peterson, Randall T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Cardiol,Dept Med, Charlestown, MA USA; [Nath, Anjali K.; Roberts, Lee D.; Liu, Yan; Gerszten, Robert E.; Peterson, Randall T.] Broad Inst, Cambridge, MA USA; [Mahon, Sari B.; Brenner, Matthew] Univ Calif Irvine, Irvine Med Ctr, Orange, CA 92668 USA; [Werdich, Andreas; MacRae, Calum A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiol,Dept Med, Boston, MA 02115 USA; [Boss, Gerry R.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Rockwood, Gary A.] USA, Analyt Toxicol Div, Med Res Inst Chem Def, Aberdeen Proving Ground, MD USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California Irvine; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of California System; University of California San Diego; Research Institute of Chemical Defense - China	Nath, AK (corresponding author), Cardiovasc Res Ctr, 149 13th St, Charlestown, MA 02129 USA.	anath@cvrc.mgh.harvard.edu; peterson@cvrc.mgh.harvard.edu	Januzzi, James/Y-2436-2019	Peterson, Randall/0000-0003-0727-3469; Werdich, Andreas/0000-0002-1222-1180; Roberts, Lee/0000-0002-1455-5248; Boss, Gerry/0000-0002-9758-8714	U.S. National Institutes of Health (NIH) grant [T32 HL-007208]; NIH Countermeasures Against Chemical Threats (Counter ACT) [U54NS063718, U54NS079201]; CounterACT Program, NIH Office of the Director; National Institute of Allergy and Infectious Diseases, NIH/U.S. Army Medical Research and Materiel Command [Y1-OD-9611-01/A120-B.P2009-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007208, K99HL112724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS063718, U01NS058030, U54NS079201] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Countermeasures Against Chemical Threats (Counter ACT)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CounterACT Program, NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases, NIH/U.S. Army Medical Research and Materiel Command; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for this project has been provided by U.S. National Institutes of Health (NIH) grant T32 HL-007208 (A.K.N. and Y.L.) and NIH Countermeasures Against Chemical Threats (Counter ACT) grants U54NS063718 and U54NS079201 (S.B.M. and M.B.) and U54NS079201 (R.T.P). The zebrafish research was supported, in part, by the CounterACT Program, NIH Office of the Director, and the National Institute of Allergy and Infectious Diseases, NIH/U.S. Army Medical Research and Materiel Command interagency agreement no. Y1-OD-9611-01/A120-B.P2009-1 (G.A.R.).	Alcorta Richard, 2004, JEMS, V29, P6; ANTHONY ML, 1994, ARCH TOXICOL, V68, P43; ARDELT BK, 1989, TOXICOLOGY, V56, P147, DOI 10.1016/0300-483X(89)90129-7; Ascherio A, 2009, ARCH NEUROL-CHICAGO, V66, P1460, DOI 10.1001/archneurol.2009.247; Baskin SI, 1999, J APPL TOXICOL, V19, P173, DOI 10.1002/(SICI)1099-1263(199905/06)19:3<173::AID-JAT556>3.0.CO;2-2; Boehnke C, 2004, EUR J NEUROL, V11, P475, DOI 10.1111/j.1468-1331.2004.00813.x; BORGOHAIN R, 1995, CLIN NEUROL NEUROSUR, V97, P213, DOI 10.1016/0303-8467(95)00029-J; Brenner M, 2010, TOXICOL APPL PHARM, V248, P269, DOI 10.1016/j.taap.2010.08.002; Chen P, 2002, P NATL ACAD SCI USA, V99, P9031, DOI 10.1073/pnas.132076299; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Di Filippo M, 2008, MOVEMENT DISORD, V23, P468, DOI 10.1002/mds.21871; Farthing D, 2006, BIOMARKERS, V11, P449, DOI 10.1080/13547500600800074; GARTLAND KPR, 1989, MOL PHARMACOL, V35, P242; Gracia R, 2004, PHARMACOTHERAPY, V24, P1358, DOI 10.1592/phco.24.14.1358.43149; GRANDAS F, 1989, MOVEMENT DISORD, V4, P188, DOI 10.1002/mds.870040211; HALL A H, 1987, Journal of Emergency Medicine, V5, P115, DOI 10.1016/0736-4679(87)90074-6; HALL AH, 1989, J TOXICOL CLIN EXPER, V9, P3; Houten SM, 2006, EMBO J, V25, P1419, DOI 10.1038/sj.emboj.7601049; Isom GE, 1995, TOXICOL LETT, V82-3, P795, DOI 10.1016/0378-4274(95)03521-4; Jurkowitz MS, 1998, J NEUROCHEM, V71, P535; Katz A, 2003, J PHYSIOL-LONDON, V553, P523, DOI 10.1113/jphysiol.2003.051078; KIMMEL CB, 1974, DEV PSYCHOBIOL, V7, P47, DOI 10.1002/dev.420070109; Kohashi T, 2008, J NEUROSCI, V28, P10641, DOI 10.1523/JNEUROSCI.1435-08.2008; Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307; Leavesley HB, 2010, TOXICOL SCI, V115, P569, DOI 10.1093/toxsci/kfq084; Lee QP, 1996, TERATOLOGY, V53, P21, DOI 10.1002/(SICI)1096-9926(199601)53:1<21::AID-TERA3>3.0.CO;2-C; Markowitz CE, 2009, J ALTERN COMPLEM MED, V15, P619, DOI 10.1089/acm.2008.0513; MARRS TC, 1985, HUM TOXICOL, V4, P591, DOI 10.1177/096032718500400605; Mills EM, 1996, J NEUROCHEM, V67, P1039; MULLER U, 1995, BRAIN RES, V678, P265, DOI 10.1016/0006-8993(95)00196-W; Nagahara Noriyuki, 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P198, DOI 10.2174/1568008033340162; Nicholls AW, 2000, BIOMARKERS, V5, P410, DOI 10.1080/135475000750052420; Nicholls AW, 2001, CHEM RES TOXICOL, V14, P975, DOI 10.1021/tx000231j; Okolie N. P., 2002, GLOBAL J PURE APPL S, V8, P491; Peal DS, 2011, CIRCULATION, V123, P23, DOI 10.1161/CIRCULATIONAHA.110.003731; Pearce LL, 2003, J BIOL CHEM, V278, P52139, DOI 10.1074/jbc.M310359200; Peterson RT, 2004, METHOD CELL BIOL, V76, P569; Portugues R, 2009, CURR OPIN NEUROBIOL, V19, P644, DOI 10.1016/j.conb.2009.10.007; ROBIN ED, 1992, CHEST, V102, P1842, DOI 10.1378/chest.102.6.1842; ROSENBERG NL, 1989, NEUROLOGY, V39, P142, DOI 10.1212/WNL.39.1.142; ROSENOW F, 1995, ANN NEUROL, V38, P825, DOI 10.1002/ana.410380518; Sachidanandan C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001947; Sauer SW, 2001, ANN EMERG MED, V37, P635, DOI 10.1067/mem.2001.114315; Shaham O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.50; Shimizu S, 1996, ONCOGENE, V12, P2045; Top H, 2006, NUCL MED COMMUN, V27, P91, DOI 10.1097/00006231-200601000-00013; Unna K, 1942, J PHARMACOL EXP THER, V76, P75; Venglovecz V., 2012, PANCREAPEDIA, DOI [10.3998/panc.2012.8, DOI 10.3998/PANC.2012.8]; VESEY CJ, 1976, BRIT J ANAESTH, V48, P651, DOI 10.1093/bja/48.7.651; Voronina SG, 2004, J BIOL CHEM, V279, P27327, DOI 10.1074/jbc.M311698200; WOODS HG, 1970, BIOCHEM J, V119, P501, DOI 10.1042/bj1190501; Yamada M, 1996, J PHARMACOL TOXICOL, V35, P11, DOI 10.1016/1056-8719(95)00111-5; Zilinski JL, 2012, CRIT CARE, V16, DOI 10.1186/cc11440	53	29	30	1	35	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2013	27	5					1928	1938		10.1096/fj.12-225037	http://dx.doi.org/10.1096/fj.12-225037			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	134PU	23345455	Green Published			2022-12-25	WOS:000318226100013
J	Blum, AP; Van Arnam, EB; German, LA; Lester, HA; Dougherty, DA				Blum, Angela P.; Van Arnam, Ethan B.; German, Laurel A.; Lester, Henry A.; Dougherty, Dennis A.			Binding Interactions with the Complementary Subunit of Nicotinic Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLCHOLINE-RECEPTORS; DEPENDENT CONTRIBUTIONS; HYDROGEN-BOND; M2 DOMAIN; CHANNEL; AGONISTS; PROTEIN; ACHBP; SITE	The agonist-binding site of nicotinic acetylcholine receptors (nAChRs) spans an interface between two subunits of the pentameric receptor. The principal component of this binding site is contributed by an alpha subunit, and it binds the cationic moiety of the nicotinic pharmacophore. The other part of the pharmacophore, a hydrogen bond acceptor, has recently been shown to bind to the complementary non-alpha subunit via the backbone NH of a conserved Leu. This interaction was predicted by studies of ACh-binding proteins and confirmed by functional studies of the neuronal (CNS) nAChR, alpha 4 beta 2. The ACh-binding protein structures further suggested that the hydrogen bond to the backbone NH is mediated by a water molecule and that a second hydrogen bonding interaction occurs between the water molecule and the backbone CO of a conserved Asn, also on the non-alpha subunit. Here, we provide new insights into the nature of the interactions between the hydrogen bond acceptor of nicotinic agonists and the complementary subunit backbone. We studied both the nAChR of the neuromuscular junction (muscle-type) and a neuronal subtype, (alpha 4)(2)(beta 4)(3). In the muscle-type receptor, both ACh and nicotine showed a strong interaction with the Leu NH, but the potent nicotine analog epibatidine did not. This interaction was much attenuated in the alpha 4 beta 4 receptor. Surprisingly, we found no evidence for a functionally significant interaction with the backbone carbonyl of the relevant Asn in either receptor with an array of agonists.	[Blum, Angela P.; Van Arnam, Ethan B.; German, Laurel A.; Dougherty, Dennis A.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Lester, Henry A.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Dougherty, DA (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	dadougherty@caltech.edu			National Institutes of Health [NS34407, NS11756]; Tobacco-Related Disease Research Program Award from the University of California [19XT-0102]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034407, R37NS034407, R01NS011756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tobacco-Related Disease Research Program Award from the University of California; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS34407 and NS11756. This work was also supported by Tobacco-Related Disease Research Program Award 19XT-0102 from the University of California.	BEERS WH, 1970, NATURE, V228, P917, DOI 10.1038/228917a0; Blum A. P., 2012, THESIS CALTECH PASAD; Blum AP, 2010, P NATL ACAD SCI USA, V107, P13206, DOI 10.1073/pnas.1007140107; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Cashin AL, 2005, J AM CHEM SOC, V127, P350, DOI 10.1021/ja0461771; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Deechongkit S, 2004, J AM CHEM SOC, V126, P16762, DOI 10.1021/ja045934s; Deechongkit S, 2004, NATURE, V430, P101, DOI 10.1038/nature02611; Dougherty DA, 2008, CHEM REV, V108, P1642, DOI 10.1021/cr078207z; England PM, 1999, CELL, V96, P89, DOI 10.1016/S0092-8674(00)80962-9; FILATOV GN, 1995, MOL PHARMACOL, V48, P379; Gleitsman KR, 2009, BIOPHYS J, V96, P3168, DOI 10.1016/j.bpj.2008.12.3949; Gleitsman KR, 2008, J BIOL CHEM, V283, P35638, DOI 10.1074/jbc.M807226200; Grutter T, 2001, TRENDS BIOCHEM SCI, V26, P459, DOI 10.1016/S0968-0004(01)01921-1; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2006, J MOL NEUROSCI, V30, P101, DOI 10.1385/JMN:30:1:101; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Koh JT, 1997, BIOCHEMISTRY-US, V36, P11314, DOI 10.1021/bi9707685; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; LINNELL RH, 1960, J ORG CHEM, V25, P290, DOI 10.1021/jo01072a623; NOWAK MW, 1995, SCIENCE, V268, P439, DOI 10.1126/science.7716551; Nowak MW, 1998, METHOD ENZYMOL, V293, P504; Sixma TK, 2003, ANNU REV BIOPH BIOM, V32, P311, DOI 10.1146/annurev.biophys.32.110601.142536; Tavares XDS, 2012, J AM CHEM SOC, V134, P11474, DOI 10.1021/ja3011379; Xiu XA, 2009, NATURE, V458, P534, DOI 10.1038/nature07768; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088	30	20	20	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6991	6997		10.1074/jbc.M112.439968	http://dx.doi.org/10.1074/jbc.M112.439968			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23349463	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000316002400021
J	Tran, DN; Thi, MHP; Ha, MT; Thi, TLT; Thi, KHD; Yoshida, LM; Okitsu, S; Hayakawa, S; Mizuguchi, M; Ushijima, H				Dinh Nguyen Tran; Thi Minh Hong Pham; Manh Tuan Ha; Thi Thu Loan Tran; Thi Kim Huyen Dang; Yoshida, Lay-Myint; Okitsu, Shoko; Hayakawa, Satoshi; Mizuguchi, Masashi; Ushijima, Hiroshi			Molecular Epidemiology and Disease Severity of Human Respiratory Syncytial Virus in Vietnam	PLOS ONE			English	Article							GROUP-A; SUBGROUP-A; GROUP-B; GENETIC-VARIABILITY; G-PROTEIN; CLINICAL CHARACTERISTICS; VIRAL PATHOGENS; INFECTION; INFANTS; CHILDREN	Respiratory syncytial virus (RSV) is a major cause of acute respiratory infections (ARIs) in children worldwide and can cause high mortality, especially in developing countries. However, information on the clinical and molecular characteristics of RSV infection in developing countries is limited. From April 2010 to May 2011, 1,082 nasopharyngeal swabs were collected from children with ARI admitted to the Children's Hospital 2, Ho Chi Minh City, Vietnam. Samples were screened for RSV and genotyped by reverse transcription-PCR and sequencing. Demographic and clinical data was also recorded. RSV was found in 23.8% (257/1,082) of samples. RSV A was the dominant subgroup, accounting for 91.4% (235/257), followed by RSV B, 5.1% (13/257), and 9 cases (3.5%) were mixed infection of these subgroups. The phylogenetic analysis revealed that all group A strains belonged to the GA2 genotype. All group B strains belonged to the recently identified BA genotype, and further clustered into 2 recently described subgenotypes BA9 and BA10. One GA2 genotype strain had a premature stop codon which shortened the G protein length. RSV infection was significantly associated with younger age and higher severity score than those without. Co-infection with other viruses did not affect disease severity. RSV A caused more severe disease than RSV B. The results from this study will not only contribute to the growing database on the molecular diversity of RSV circulating worldwide but may be also useful in clinical management and vaccine development.	[Dinh Nguyen Tran; Okitsu, Shoko; Mizuguchi, Masashi; Ushijima, Hiroshi] Univ Tokyo, Grad Sch Med, Sch Int Hlth, Dept Dev Med Sci, Tokyo, Japan; [Dinh Nguyen Tran; Thi Minh Hong Pham] Univ Med & Pharm Ho Chi Minh City, Dept Pediat, Ho Chi Minh City, Vietnam; [Dinh Nguyen Tran; Manh Tuan Ha; Thi Thu Loan Tran; Thi Kim Huyen Dang] Childrens Hosp 2, Ho Chi Minh City, Vietnam; [Yoshida, Lay-Myint] Nagasaki Univ, Inst Trop Med, Nagasaki 852, Japan; [Okitsu, Shoko; Hayakawa, Satoshi; Ushijima, Hiroshi] Nihon Univ, Sch Med, Div Microbiol, Dept Pathol & Microbiol, Tokyo, Japan	University of Tokyo; Hochiminh City University of Medicine & Pharmacy; Nagasaki University; Nihon University	Ushijima, H (corresponding author), Univ Tokyo, Grad Sch Med, Sch Int Hlth, Dept Dev Med Sci, Tokyo, Japan.	ushijima-hiroshi@jcom.home.ne.jp		YOSHIDA, LAYMYINT/0000-0002-7567-3248; Ha Manh, Tuan/0000-0002-4998-2581	Ministry of Education and Sciences; Ministry of Health, Labor and Welfare, Japan; Honjo International Scholarship Foundation	Ministry of Education and Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Honjo International Scholarship Foundation(Honjo International Scholarship Foundation)	This study was supported by Grants-in-Aid from the Ministry of Education and Sciences and the Ministry of Health, Labor and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We deeply thank Dr. Nguyen Tran Quynh Nhu and Ms. Pham Thi Ngoc Hue, Cardiovascular Department, Children's Hospital 2, Ho Chi Minh City for their help in patient counseling and sample collection. DNT is a recipient of the scholarship from the Honjo International Scholarship Foundation.	Bedoya VI, 1996, PEDIATR INFECT DIS J, V15, P1123, DOI 10.1097/00006454-199612000-00014; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Boonyasuppayakorn S, 2010, INFLUENZA OTHER RESP, V4, P313, DOI 10.1111/j.1750-2659.2010.00152.x; Brandenburg AH, 1997, J MED VIROL, V52, P97, DOI 10.1002/(SICI)1096-9071(199705)52:1&lt;97::AID-JMV16&gt;3.0.CO;2-Y; Brandenburg AH, 2000, J CLIN MICROBIOL, V38, P3849, DOI 10.1128/JCM.38.10.3849-3852.2000; CANE PA, 1995, J VIROL, V69, P2918, DOI 10.1128/JVI.69.5.2918-2925.1995; Cane PA, 2001, REV MED VIROL, V11, P103, DOI 10.1002/rmv.305; Chan PKS, 1999, EPIDEMIOL INFECT, V123, P257, DOI 10.1017/S0950268899002824; CHERIAN T, 1990, AM J DIS CHILD, V144, P1026, DOI 10.1001/archpedi.1990.02150330086028; Choi EH, 2006, CLIN INFECT DIS, V43, P585, DOI 10.1086/506350; Collins PL, 2007, FIELDS VIROLOGY, P1601; Dapat IC, 2010, J CLIN MICROBIOL, V48, P3423, DOI 10.1128/JCM.00646-10; Do Anh Ha Lien, 2011, PLoS One, V6, pe18176, DOI 10.1371/journal.pone.0018176; Ekalaksananan Tipaya, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P513; Gern JE, 2002, PEDIAT ALLERG IMM-UK, V13, P386, DOI 10.1034/j.1399-3038.2002.01093.x; HALL CB, 1990, J INFECT DIS, V162, P1283, DOI 10.1093/infdis/162.6.1283; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HAZLETT DTG, 1988, AM J TROP MED HYG, V39, P632, DOI 10.4269/ajtmh.1988.39.632; HEIKKINEN T, 1995, ACTA PAEDIATR, V84, P419, DOI 10.1111/j.1651-2227.1995.tb13663.x; HENDRY RM, 1986, J INFECT DIS, V153, P291, DOI 10.1093/infdis/153.2.291; Hornsleth A, 1998, PEDIATR INFECT DIS J, V17, P1114, DOI 10.1097/00006454-199812000-00003; Houben ML, 2010, J MED VIROL, V82, P1266, DOI 10.1002/jmv.21771; JOHNSON PR, 1987, P NATL ACAD SCI USA, V84, P5625, DOI 10.1073/pnas.84.16.5625; Juven T, 2000, PEDIATR INFECT DIS J, V19, P293, DOI 10.1097/00006454-200004000-00006; Kneyber MCJ, 1996, ARCH DIS CHILD, V75, P137, DOI 10.1136/adc.75.2.137; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Marguet C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004596; MCCONNOCHIE KM, 1990, J PEDIATR-US, V117, P52, DOI 10.1016/S0022-3476(05)82443-6; MCINTOSH EDG, 1993, PEDIATR INFECT DIS J, V12, P815, DOI 10.1097/00006454-199310000-00004; MONTO AS, 1990, J INFECT DIS, V161, P781, DOI 10.1093/infdis/161.4.781; MUFSON MA, 1988, J INFECT DIS, V157, P143, DOI 10.1093/infdis/157.1.143; MUFSON MA, 1985, J GEN VIROL, V66, P2111, DOI 10.1099/0022-1317-66-10-2111; Palomo C, 2000, J MED VIROL, V60, P468, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;468::AID-JMV16&gt;3.0.CO;2-E; Parveen S, 2006, J CLIN MICROBIOL, V44, P3055, DOI 10.1128/JCM.00187-06; Reiche J, 2009, J CLIN MICROBIOL, V47, P1800, DOI 10.1128/JCM.02286-08; Richard N, 2008, PEDIATR INFECT DIS J, V27, P213, DOI 10.1097/INF.0b013e31815b4935; Roca A, 2001, J GEN VIROL, V82, P103, DOI 10.1099/0022-1317-82-1-103; RUSSI JC, 1989, LANCET, V2, P1039; SALOMON HE, 1991, J INFECT DIS, V163, P1167, DOI 10.1093/infdis/163.5.1167; Sato M, 2005, J CLIN MICROBIOL, V43, P36, DOI 10.1128/JCM.43.1.36-40.2005; Scott PD, 2007, J MED VIROL, V79, P1943, DOI 10.1002/jmv.20999; Scott PD, 2004, J MED VIROL, V74, P344, DOI 10.1002/jmv.20183; Semple MG, 2005, J INFECT DIS, V191, P382, DOI 10.1086/426457; Shobugawa Y, 2009, J CLIN MICROBIOL, V47, P2475, DOI 10.1128/JCM.00115-09; Straliotto S M, 1994, Rev Soc Bras Med Trop, V27, P1, DOI 10.1590/S0037-86821994000100001; Sullender WM, 2000, CLIN MICROBIOL REV, V13, P1, DOI 10.1128/CMR.13.1.1-15.2000; TAYLOR CE, 1989, LANCET, V1, P777; Trento A, 2010, J VIROL, V84, P7500, DOI 10.1128/JVI.00345-10; TSUTSUMI H, 1991, SCAND J INFECT DIS, V23, P671, DOI 10.3109/00365549109024291; Viegas M, 2004, J INFECTION, V49, P222, DOI 10.1016/j.jinf.2003.10.006; Walsh EE, 1997, J INFECT DIS, V175, P814, DOI 10.1086/513976; WANG EEL, 1995, J PEDIATR-US, V126, P212, DOI 10.1016/S0022-3476(95)70547-3; Wang W, 2010, J CLIN VIROL, V49, P211, DOI 10.1016/j.jcv.2010.08.005; Weber MW, 1998, TROP MED INT HEALTH, V3, P268, DOI 10.1046/j.1365-3156.1998.00213.x; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C; Yoshida LM, 2010, PEDIATR INFECT DIS J, V29, P75, DOI 10.1097/INF.0b013e3181af61e9; Zlateva KT, 2007, J CLIN MICROBIOL, V45, P3022, DOI 10.1128/JCM.00339-07; Zlateva KT, 2005, J VIROL, V79, P9157, DOI 10.1128/JVI.79.14.9157-9167.2005	58	42	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e45436	10.1371/journal.pone.0045436	http://dx.doi.org/10.1371/journal.pone.0045436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349659	Green Published, gold, Green Submitted			2022-12-25	WOS:000314019100002
J	Jones, MC; Dye, SR; Fernandes, JA; Frolicher, TL; Pinnegar, JK; Warren, R; Cheung, WWL				Jones, Miranda C.; Dye, Stephen R.; Fernandes, Jose A.; Froelicher, Thomas L.; Pinnegar, John K.; Warren, Rachel; Cheung, William W. L.			Predicting the Impact of Climate Change on Threatened Species in UK Waters	PLOS ONE			English	Article							POTENTIAL IMPACTS; FISH ASSEMBLAGE; MARINE FISHES; DISTRIBUTIONS; MODELS; AREAS; PROJECTIONS; FUTURE; SHIFTS; SCALE	Global climate change is affecting the distribution of marine species and is thought to represent a threat to biodiversity. Previous studies project expansion of species range for some species and local extinction elsewhere under climate change. Such range shifts raise concern for species whose long-term persistence is already threatened by other human disturbances such as fishing. However, few studies have attempted to assess the effects of future climate change on threatened vertebrate marine species using a multi-model approach. There has also been a recent surge of interest in climate change impacts on protected areas. This study applies three species distribution models and two sets of climate model projections to explore the potential impacts of climate change on marine species by 2050. A set of species in the North Sea, including seven threatened and ten major commercial species were used as a case study. Changes in habitat suitability in selected candidate protected areas around the UK under future climatic scenarios were assessed for these species. Moreover, change in the degree of overlap between commercial and threatened species ranges was calculated as a proxy of the potential threat posed by overfishing through bycatch. The ensemble projections suggest northward shifts in species at an average rate of 27 km per decade, resulting in small average changes in range overlap between threatened and commercially exploited species. Furthermore, the adverse consequences of climate change on the habitat suitability of protected areas were projected to be small. Although the models show large variation in the predicted consequences of climate change, the multi-model approach helps identify the potential risk of increased exposure to human stressors of critically endangered species such as common skate (Dipturus batis) and angelshark (Squatina squatina).	[Jones, Miranda C.; Fernandes, Jose A.; Warren, Rachel] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Jones, Miranda C.; Dye, Stephen R.; Pinnegar, John K.] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft, Suffolk, England; [Jones, Miranda C.; Warren, Rachel] Tyndall Ctr Climate Change Res, Norwich, Norfolk, England; [Froelicher, Thomas L.] Princeton Univ, Atmospher & Ocean Sci Program, Princeton, NJ 08544 USA; [Cheung, William W. L.] Univ British Columbia, Fisheries Ctr, Changing Ocean Res Unit, Vancouver, BC V5Z 1M9, Canada	University of East Anglia; Centre for Environment Fisheries & Aquaculture Science; University of East Anglia; National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University; University of British Columbia	Jones, MC (corresponding author), Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England.	miranda.jones@uea.ac.uk	Dye, Stephen R/C-9456-2011; Salvador, Jose Antonio Fernandes/AAH-7939-2019; Frölicher, Thomas L/E-5137-2015; Pinnegar, John K/C-4400-2012; Cheung, William/F-5104-2013; Froelicher, Thomas/AAG-9598-2019	Dye, Stephen R/0000-0002-4182-8475; Salvador, Jose Antonio Fernandes/0000-0003-4677-6077; Frölicher, Thomas L/0000-0003-2348-7854; Cheung, William/0000-0003-3626-1045; Froelicher, Thomas/0000-0003-2348-7854; Warren, Rachel/0000-0002-0122-1599; Pinnegar, John/0000-0001-5061-9520	UK Department for Environment, Food and Rural Affairs (DEFRA)/Centre for Environment, Fisheries and Aquaculture Science (CEFAS) [ME5102-ACME]; National Geographic Society; Natural Sciences and Engineering Research Council of Canada; NF-UBC Nereus Program; European project EURO-BASIN; EU; NERC [NE/F016107/1] Funding Source: UKRI; Natural Environment Research Council [NE/F016107/1] Funding Source: researchfish	UK Department for Environment, Food and Rural Affairs (DEFRA)/Centre for Environment, Fisheries and Aquaculture Science (CEFAS); National Geographic Society(National Geographic Society); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NF-UBC Nereus Program; European project EURO-BASIN; EU(European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the UK Department for Environment, Food and Rural Affairs (DEFRA)/Centre for Environment, Fisheries and Aquaculture Science (CEFAS) under project ME5102-ACME. WWLC acknowledges funding support from the National Geographic Society and Natural Sciences and Engineering Research Council of Canada. The authors also thank the EU Vectors project for supporting time for JKP. TLF is partly supported by NF-UBC Nereus Program. JAF is funded by the European project EURO-BASIN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albouy C, 2012, GLOBAL CHANGE BIOL, V18, P2995, DOI 10.1111/j.1365-2486.2012.02772.x; Almond S, 2011, UK SEA FISHERIES STA; [Anonymous], 1992, OFFICIAL J L, VL 206, P0007; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Barange M, 2010, CURR OPIN ENV SUST, V2, P326, DOI 10.1016/j.cosust.2010.10.002; Beaugrand G, 2004, PROG OCEANOGR, V60, P245, DOI 10.1016/j.pocean.2004.02.018; Blanchard JL, 2012, PHILOS T R SOC B, V367, P2979, DOI 10.1098/rstb.2012.0231; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; BRIG, 2007, REPORT ON THE SPECIE; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Cheung WWL, 2013, NAT CLIM CHANGE, V3, P254, DOI 10.1038/NCLIMATE1691; Cheung WWL, 2011, ICES J MAR SCI, V68, P1008, DOI 10.1093/icesjms/fsr012; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Cheung WWL, 2005, BIOL CONSERV, V124, P97, DOI 10.1016/j.biocon.2005.01.017; Cheung WWL, 2008, FISHERIES CENTRE RES, V16; Cianfrani C, 2011, BIOL CONSERV, V144, P2068, DOI 10.1016/j.biocon.2011.03.027; Close Chris, 2006, University of British Columbia Fisheries Centre Research Reports, V14, P27; Coetzee BWT, 2009, GLOBAL ECOL BIOGEOGR, V18, P701, DOI 10.1111/j.1466-8238.2009.00485.x; Conroy MJ, 2011, BIOL CONSERV, V144, P1204, DOI 10.1016/j.biocon.2010.10.019; Deutsch C, 2011, SCIENCE, V333, P336, DOI 10.1126/science.1202422; Dockerty T, 2003, GLOBAL ENVIRON CHANG, V13, P125, DOI 10.1016/S0959-3780(03)00010-4; Dulvy N, 2006, IUCN 2001 IUCN RED L; Dulvy NK, 2008, J APPL ECOL, V45, P1029, DOI 10.1111/j.1365-2664.2008.01488.x; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Ellis J, 2009, IUCN 2001 IUCN RED L; Ellis J, 2005, IUCN 2001 IUCN RED L; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Froese R., 2011, FISHBASE WORLD WIDE; Fuller T, 2008, BIOL CONSERV, V141, P1547, DOI 10.1016/j.biocon.2008.03.021; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hagerman S, 2010, GLOBAL ENVIRON CHANG, V20, P192, DOI 10.1016/j.gloenvcha.2009.10.005; Harborne AR, 2011, CURR BIOL, V21, pR822, DOI 10.1016/j.cub.2011.08.043; Henderson PA, 2007, J MAR BIOL ASSOC UK, V87, P589, DOI 10.1017/S0025315407052447; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Hu JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022873; IUCN, 2012, IUCN RED LIST CATEGO, VSecond; IUCN, 2011, IUCN RED LIST OF THR; JNCC, 2012, MARINE SACS; Jones MC, 2012, ECOL MODEL, V225, P133, DOI 10.1016/j.ecolmodel.2011.11.003; Kaschner K, 2006, MAR ECOL PROG SER, V316, P285, DOI 10.3354/meps316285; Kearney MR, 2010, CONSERV LETT, V3, P203, DOI 10.1111/j.1755-263X.2010.00097.x; LAWTON JH, 1994, PHILOS T ROY SOC B, V344, P61, DOI 10.1098/rstb.1994.0052; Lemieux CJ, 2011, LAND USE POLICY, V28, P928, DOI 10.1016/j.landusepol.2011.03.008; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Masson-Delmotte V, 2018, SPEC REP GLOB WARM 1; MCEACHRAN JD, 1990, ELASMOBRANCHS LIVING, V90, P305; Micheli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040832; Nenzen HK, 2011, ECOL MODEL, V222, P3346, DOI 10.1016/j.ecolmodel.2011.07.011; OSPAR, 2008, REFERENCE NUMBER 200; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Phillips S.J., 2004, P 21 INT C MACH LEAR, P655, DOI [DOI 10.1145/1015330.1015412, 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Renkonen Olavi, 1938, ANN ZOOL SOC ZOOL BOT FENNICAE VANAMO, V6, P1; Rodder D, 2011, GLOBAL ECOL BIOGEOGR, V20, P915, DOI 10.1111/j.1466-8238.2011.00659.x; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rose NA, 2009, FOREST ECOL MANAG, V258, pS64, DOI 10.1016/j.foreco.2009.07.053; Sarmiento JL, 2010, BIOGEOSCIENCES, V7, P3593, DOI 10.5194/bg-7-3593-2010; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Simpson SD, 2011, CURR BIOL, V21, P1565, DOI 10.1016/j.cub.2011.08.016; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stralberg D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006825; Sumaila UR, 2011, NAT CLIM CHANGE, V1, P449, DOI 10.1038/NCLIMATE1301; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2006, GLOBAL CHANGE BIOL, V12, P759, DOI 10.1111/j.1365-2486.2006.01140.x; Toropova C., 2010, GLOBAL OCEAN PROTECT; Wilson EO, 1967, THEORY ISLAND BIOGEO	78	93	94	2	244	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54216	10.1371/journal.pone.0054216	http://dx.doi.org/10.1371/journal.pone.0054216			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349829	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000314019100051
J	Liu, SQ; Li, WS; Wu, YM; Chen, CM; Lei, JJ				Liu, Shaoqun; Li, Wanshun; Wu, Yimin; Chen, Changming; Lei, Jianjun			De Novo Transcriptome Assembly in Chili Pepper (Capsicum frutescens) to Identify Genes Involved in the Biosynthesis of Capsaicinoids	PLOS ONE			English	Article							PUNGENT PRINCIPLE; GENOME SEQUENCE; METABOLISM; MARKERS; FRUITS; PLACENTA; VARIETY; ANALOGS; RFLP; KAS	The capsaicinoids are a group of compounds produced by chili pepper fruits and are used widely in many fields, especially in medical purposes. The capsaicinoid biosynthetic pathway has not yet been established clearly. To understand more knowledge in biosynthesis of capsaicinoids, we applied RNA-seq for the mixture of placenta and pericarp of pungent pepper (Capsicum frutescens L.). We have assessed the effect of various assembly parameters using different assembly software, and obtained one of the best strategies for de novo assembly of transcriptome data. We obtained a total 54,045 high-quality unigenes (transcripts) using Trinity software. About 92.65% of unigenes showed similarity to the public protein sequences, genome of potato and tomato and pepper (C. annuum) ESTs databases. Our results predicted 3 new structural genes (DHAD, TD, PAT), which filled gaps of the capsaicinoid biosynthetic pathway predicted by Mazourek, and revealed new candidate genes involved in capsaicinoid biosynthesis based on KEGG (Kyoto Encyclopedia of Genes and Genomes) analysis. A significant number of SSR (Simple Sequence Repeat) and SNP (Single Nucleotide Polymorphism) markers were predicted in C. frutescens and C. annuum sequences, which will be helpful in the identification of polymorphisms within chili pepper populations. These data will provide new insights to the pathway of capsaicinoid biosynthesis and subsequent research of chili peppers. In addition, our strategy of de novo transcriptome assembly is applicable to a wide range of similar studies.	[Liu, Shaoqun; Li, Wanshun; Wu, Yimin; Chen, Changming; Lei, Jianjun] S China Agr Univ, Coll Hort, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Lei, JJ (corresponding author), S China Agr Univ, Coll Hort, Guangzhou, Guangdong, Peoples R China.	jjlei@scau.edu.cn			Natural Science Foundation of Guangdong Province [10151064201000056]; Principal Foundation of South China Agricultural University	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Principal Foundation of South China Agricultural University	This work was supported by the Natural Science Foundation of Guangdong Province (NO. 10151064201000056) and the Principal Foundation of South China Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluru MR, 2003, J EXP BOT, V54, P1655, DOI 10.1093/jxb/erg176; Aza-Gonzalez C, 2011, PLANT CELL REP, V30, P695, DOI 10.1007/s00299-010-0968-8; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; BENNETT DJ, 1968, J CHEM SOC C, P442, DOI 10.1039/j39680000442; Blum E, 2003, THEOR APPL GENET, V108, P79, DOI 10.1007/s00122-003-1405-y; CARMICHAEL JK, 1991, AM FAM PHYSICIAN, V44, P203; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Curry J, 1999, PLANT SCI, V148, P47, DOI 10.1016/S0168-9452(99)00118-1; Daood HG, 2002, J SUPERCRIT FLUID, V23, P143, DOI 10.1016/S0896-8446(02)00022-0; Abraham-Juarez MD, 2008, PLANTA, V227, P681, DOI 10.1007/s00425-007-0651-7; Deng MH, 2009, GENET RESOUR CROP EV, V56, P605, DOI 10.1007/s10722-009-9445-z; FUJIWAKE H, 1982, AGR BIOL CHEM TOKYO, V46, P2685, DOI 10.1080/00021369.1982.10865495; FUJIWAKE H, 1982, AGR BIOL CHEM TOKYO, V46, P2591, DOI 10.1080/00021369.1982.10865477; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gongora-Castillo E, 2012, BIOINFORMATION, V8, P43; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hao DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021220; HENRY CJK, 1986, HUM NUTR-CLIN NUTR, V40C, P165; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kim HJ, 2008, THEOR APPL GENET, V118, P15, DOI 10.1007/s00122-008-0873-5; Kim M, 2001, MOL CELLS, V11, P213; Lang YQ, 2006, BREEDING SCI, V56, P55, DOI 10.1270/jsbbs.56.55; Lee CJ, 2005, MOL CELLS, V19, P262; Lee HR, 2009, MOL CELLS, V27, P21, DOI 10.1007/s10059-009-0002-6; Lee R J, 1996, J Am Optom Assoc, V67, P548; LEETE E, 1968, J AM CHEM SOC, V90, P6837, DOI 10.1021/ja01026a049; Lu FH, 2012, MOL BIOL REP, V39, P3327, DOI 10.1007/s11033-011-1102-x; Lu FH, 2011, SCI HORTIC-AMSTERDAM, V129, P38, DOI 10.1016/j.scienta.2011.03.003; Luo XJ, 2011, EUR J PHARMACOL, V650, P1, DOI 10.1016/j.ejphar.2010.09.074; Malmstrom RR, 2010, PLOS ONE, P5; Martin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-663; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Mazourek M, 2009, PLANT PHYSIOL, V150, P1806, DOI 10.1104/pp.109.136549; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ochoa-Alejo N, 2001, IN VITRO CELL DEV-PL, V37, P701; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; SALGADOGARCIGLIA R, 1990, PLANT CELL REP, V8, P617, DOI 10.1007/BF00270067; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schulzeck S, 1997, SCHMERZ, V11, P345, DOI 10.1007/s004820050109; Smeds L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026314; Stewart C, 2005, PLANT J, V42, P675, DOI 10.1111/j.1365-313X.2005.02410.x; Stewart C, 2007, J EXP BOT, V58, P979, DOI 10.1093/jxb/erl243; Su CL, 2011, PLANT CELL PHYSIOL, V52, P1501, DOI 10.1093/pcp/pcr097; SUKRASNO N, 1993, PHYTOCHEMISTRY, V32, P839, DOI 10.1016/0031-9422(93)85217-F; SUZUKI T, 1981, PLANT CELL PHYSIOL, V22, P23; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Xue J, 2010, PLOS ONE, DOI [10.1371/journal.-pone.0014233, DOI 10.1371/JOURNAL.-PONE.0014233]; Yi GB, 2006, THEOR APPL GENET, V114, P113, DOI 10.1007/s00122-006-0415-y; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	53	103	113	2	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e48156	10.1371/journal.pone.0048156	http://dx.doi.org/10.1371/journal.pone.0048156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349661	gold, Green Published, Green Submitted			2022-12-25	WOS:000314019100003
J	Rastrick, JMD; Stevenson, CS; Eltom, S; Grace, M; Davies, M; Kilty, I; Evans, SM; Pasparakis, M; Catley, MC; Lawrence, T; Adcock, IM; Belvisi, MG; Birrell, MA				Rastrick, Joseph M. D.; Stevenson, Christopher S.; Eltom, Suffwan; Grace, Megan; Davies, Meirion; Kilty, Iain; Evans, Steven M.; Pasparakis, Manolis; Catley, Matthew C.; Lawrence, Toby; Adcock, Ian M.; Belvisi, Maria G.; Birrell, Mark A.			Cigarette Smoke Induced Airway Inflammation Is Independent of NF-kappa B Signalling	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; INDUCED LUNG INFLAMMATION; BETA-DEPENDENT GENES; IKK-BETA; MOUSE LUNG; CHRONIC-BRONCHITIS; INDUCED EMPHYSEMA; OXIDATIVE STRESS; EPITHELIAL-CELLS; FLOW LIMITATION	Rationale: COPD is an inflammatory lung disease largely associated with exposure to cigarette smoke (CS). The mechanism by which CS leads to the pathogenesis of COPD is currently unclear; it is known however that many of the inflammatory mediators present in the COPD lung can be produced via the actions of the transcription factor Nuclear Factor-kappaB (NF-kappa B) and its upstream signalling kinase, Inhibitor of kappa B kinase-2 (IKK-2). Therefore the NF-kappa B/IKK-2 signalling pathway may represent a therapeutic target to attenuate the inflammation associated with COPD. Aim: To use a range of assays, genetically modified animals and pharmacological tools to determine the role of NF-kappa B in CS-induced airway inflammation. Methods: NF-kappa B pathway activation was measured in pre-clinical models of CS-induced airway inflammation and in human lung tissue from COPD patients. This data was complemented by employing mice missing a functional NF-kappa B pathway in specific cell types (epithelial and myeloid cells) and with systemic inhibitors of IKK-2. Results: We showed in an airway inflammation model known to be NF-kappa B-dependent that the NF-kappa B pathway activity assays and modulators were functional in the mouse lung. Then, using the same methods, we demonstrated that the NF-kappa B pathway appears not to play an important role in the inflammation observed after exposure to CS. Furthermore, assaying human lung tissue revealed that in the clinical samples there was also no increase in NF-kappa B pathway activation in the COPD lung, suggesting that our pre-clinical data is translational to human disease. Conclusions: In this study we present compelling evidence that the IKK-2/NF-kappa B signalling pathway does not play a prominent role in the inflammatory response to CS exposure and that this pathway may not be important in COPD pathogenesis.	[Rastrick, Joseph M. D.; Stevenson, Christopher S.; Eltom, Suffwan; Grace, Megan; Davies, Meirion; Belvisi, Maria G.; Birrell, Mark A.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, London, England; [Stevenson, Christopher S.] Roche, Nutley, NJ USA; [Kilty, Iain; Evans, Steven M.] Pfizer Inc, Pfizer, Cambridge, MA USA; [Pasparakis, Manolis] Univ Cologne, D-50931 Cologne, Germany; [Catley, Matthew C.] AstraZeneca, Molndal, Sweden; [Lawrence, Toby] Ctr Immunol Marseille Luminy, Marseille, France; [Adcock, Ian M.] Imperial Coll London, London, England	Imperial College London; Roche Holding; Pfizer; University of Cologne; AstraZeneca; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Imperial College London	Belvisi, MG (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, London, England.	m.belvisi@imperial.ac.uk	Lawrence, Toby/GLU-3895-2022; Adcock, Ian/L-3217-2019; Pasparakis, Manolis/N-4350-2019; Pasparakis, Manolis/H-9292-2017; Grace, Megan/AAA-7285-2019	Lawrence, Toby/0000-0003-0967-6122; Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis, Manolis/0000-0002-9870-0966; Adcock, Ian/0000-0003-2101-8843	Medical Research Council (MRC), United Kingdom [G0800196]; MRC [G0800196, G0800195] Funding Source: UKRI; Medical Research Council [G0800195, G0800196] Funding Source: researchfish	Medical Research Council (MRC), United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	JMDR was supported by a Medical Research Council (MRC), United Kingdom studentship and consumables support from UCB. CSS and MAB were funded by a project grant from the MRC, United Kingdom (G0800196). IKK-2 Delta Mye mice were obtained from Prof. Toby Lawrence and the IKK-2 Delta Epi mice were obtained from Pfizer. TPCA1 was a kind donation from GlaxoSmithKline. The human tissue experiments in this study were undertaken with the support of the National Institute for Health Research Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield National Health Service Foundation Trust and Imperial College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2007, PLOS MED, V4, P779, DOI 10.1371/journal.pmed.0040112; Barnes PJ, 2005, EUR RESPIR J, V25, P1084, DOI 10.1183/09031936.05.00139104; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Birrell MA, 2005, AM J RESP CRIT CARE, V172, P962, DOI 10.1164/rccm.200412-1647OC; Birrell MA, 2006, MOL PHARMACOL, V69, P1791, DOI 10.1124/mol.105.019521; Broide DH, 2005, P NATL ACAD SCI USA, V102, P17723, DOI 10.1073/pnas.0509235102; Caramori G, 2003, THORAX, V58, P348, DOI 10.1136/thorax.58.4.348; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Culpitt SV, 1999, AM J RESP CRIT CARE, V160, P1635, DOI 10.1164/ajrccm.160.5.9811058; Di Stefano A, 2002, EUR RESPIR J, V20, P556, DOI 10.1183/09031936.02.00272002; DiStefano A, 1996, AM J RESP CRIT CARE, V153, P629, DOI 10.1164/ajrccm.153.2.8564109; Drost EM, 2005, THORAX, V60, P293, DOI 10.1136/thx.2004.027946; Edwards MR, 2009, PHARMACOL THERAPEUT, V121, P1, DOI 10.1016/j.pharmthera.2008.09.003; Eltom S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024097; Fong CHY, 2008, J EXP MED, V205, P1269, DOI 10.1084/jem.20080124; Gottipati KR, 2008, EXP DERMATOL, V17, P780, DOI 10.1111/j.1600-0625.2007.00685.x; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Jacque E, 2005, P NATL ACAD SCI USA, V102, P14635, DOI 10.1073/pnas.0507342102; Keatings VM, 1997, AM J RESP CRIT CARE, V155, P542, DOI 10.1164/ajrccm.155.2.9032192; Lee SY, 2010, INT IMMUNOPHARMACOL, V10, P906, DOI 10.1016/j.intimp.2010.05.001; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li YT, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-79; Marwick JA, 2004, AM J RESP CELL MOL, V31, P633, DOI 10.1165/rcmb.2004-0006OC; Murata T, 2004, BIOORG MED CHEM LETT, V14, P4019, DOI 10.1016/j.bmcl.2004.05.041; Oliver KM, 2009, ANTIOXID REDOX SIGN, V11, P2057, DOI [10.1089/ars.2008.2400, 10.1089/ARS.2008.2400]; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Perl AKT, 2005, AM J RESP CELL MOL, V33, P455, DOI 10.1165/rcmb.2005-0180OC; Podolin PL, 2005, J PHARMACOL EXP THER, V312, P373, DOI 10.1124/jpet.104.074484; Rajendrasozhan S, 2010, PULM PHARMACOL THER, V23, P172, DOI 10.1016/j.pupt.2010.01.002; Rajendrasozhan S, 2010, AM J PHYSIOL-LUNG C, V298, pL197, DOI 10.1152/ajplung.00265.2009; Saetta M, 1997, AM J RESP CRIT CARE, V156, P1633, DOI 10.1164/ajrccm.156.5.9701081; Szulakowski P, 2006, AM J RESP CRIT CARE, V174, P41, DOI 10.1164/rccm.200505-725OC; Takahashi H, 2010, CANCER CELL, V17, P89, DOI 10.1016/j.ccr.2009.12.008; Tharappel JC, 2010, J TOXICOL ENV HEAL A, V73, P1288, DOI 10.1080/15287394.2010.484708; Thatcher TH, 2007, AM J PATHOL, V170, P855, DOI 10.2353/ajpath.2007.060391; Tudhope SJ, 2007, J IMMUNOL, V179, P6237, DOI 10.4049/jimmunol.179.9.6237; Valenca SS, 2006, INT J EXP PATHOL, V87, P373, DOI 10.1111/j.1365-2613.2006.00492.x; van der Strate BWA, 2006, AM J RESP CRIT CARE, V173, P751, DOI 10.1164/rccm.200504-594OC; Vlahos R, 2006, AM J PHYSIOL-LUNG C, V290, pL931, DOI 10.1152/ajplung.00201.2005; WHO, 2008, WORLD HLTH STAT; Yang SR, 2008, AM J RESP CELL MOL, V38, P689, DOI 10.1165/rcmb.2007-0379OC; Yao HW, 2008, AM J PHYSIOL-LUNG C, V294, pL1174, DOI 10.1152/ajplung.00439.2007; Zeng LX, 2010, PULM PHARMACOL THER, V23, P411, DOI 10.1016/j.pupt.2010.05.004; Zhong CY, 2008, TOXICOL APPL PHARM, V230, P150, DOI 10.1016/j.taap.2008.02.005; Zhong CY, 2006, AM J RESP CRIT CARE, V174, P428, DOI 10.1164/rccm.200503-509OC	49	32	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54128	10.1371/journal.pone.0054128	http://dx.doi.org/10.1371/journal.pone.0054128			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349803	Green Published, gold, Green Submitted			2022-12-25	WOS:000314019100047
J	Elnagdy, S; Messing, S; Majerus, MEN				Elnagdy, Sherif; Messing, Susan; Majerus, Michael E. N.			Two Strains of Male-Killing Wolbachia in a Ladybird, Coccinella undecimpunctata, from a Hot Climate	PLOS ONE			English	Article							BIPUNCTATA LINNAEUS COLEOPTERA; ADALIA-BIPUNCTATA; INHERITED MICROORGANISMS; COLEOMEGILLA-MACULATA; SEX-RATIO; BEETLE; EVOLUTION; BACTERIA; AGENT; IDENTIFICATION	Ladybirds are a hot-spot for the invasion of male-killing bacteria. These maternally inherited endosymbionts cause the death of male host embryos, to the benefit of female sibling hosts and the bacteria that they contain. Previous studies have shown that high temperatures can eradicate male-killers from ladybirds, leaving the host free from infection. Here we report the discovery of two maternally inherited sex ratio distorters in populations of a coccinellid, Coccinella undecimpunctata, from a hot lowland region of the Middle East. DNA sequence analysis indicates that the male killing is the result of infection by Wolbachia, that the trait is tetracycline sensitive, and that two distinct strains of Wolbachia co-occur within one beetle population. We discuss the implications of these findings for theories of male-killing and suggest avenues for future fieldwork on this system.	[Elnagdy, Sherif; Majerus, Michael E. N.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Elnagdy, Sherif] Cairo Univ, Fac Sci, Dept Bot, Giza, Egypt; [Messing, Susan] Univ Rochester, Div Psychiat Stat, Dept Biostat & Computat Biol, Rochester, NY USA	University of Cambridge; Egyptian Knowledge Bank (EKB); Cairo University; University of Rochester	Elnagdy, S (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.	sh.elnagdy@gmail.com		Elnagdy, Sherif/0000-0003-1331-8977	BP Egypt Trust; Cambridge Overseas Trust	BP Egypt Trust; Cambridge Overseas Trust	BP Egypt and Cambridge Overseas Trusts funded Sherif Elnagdy project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Dixon A.F.G., 2000, INSECT PREDATOR PREY; Dyson EA, 2002, HEREDITY, V88, P166, DOI 10.1038/sj.hdy.6800021; Elnagdy S, 2011, J EVOLUTION BIOL, V24, P2164, DOI 10.1111/j.1420-9101.2011.02346.x; Elnagdy S. E., 2008, THESIS U CAMBRIDGE C; Hurst CDD, 1997, INFLUENTIAL PASSENGERS, P125; Hurst GDD, 1997, GENET RES, V70, P1, DOI 10.1017/S0016672397002838; Hurst GDD, 1999, PARASITOLOGY, V118, P125, DOI 10.1017/S0031182098003655; HURST GDD, 1993, HEREDITY, V71, P81, DOI 10.1038/hdy.1993.110; HURST GDD, 1994, HEREDITY, V73, P309, DOI 10.1038/hdy.1994.138; Hurst GDD, 2000, EMERG INFECT DIS, V6, P329, DOI 10.3201/eid0604.000402; HURST GDD, 1993, BIOL J LINN SOC, V49, P195, DOI 10.1111/j.1095-8312.1993.tb00898.x; Hurst GDD, 2003, CONT T ENT, P177; Hurst GDD, 1996, HEREDITY, V77, P177, DOI 10.1038/hdy.1996.122; HURST GDD, 1992, HEREDITY, V69, P84, DOI 10.1038/hdy.1992.97; Hurst GDD, 1999, INSECT MOL BIOL, V8, P133, DOI 10.1046/j.1365-2583.1999.810133.x; Hurst GDD, 1999, P ROY SOC B-BIOL SCI, V266, P735, DOI 10.1098/rspb.1999.0698; Hurst GDD, 2000, GENETICS, V156, P699; HURST LD, 1991, P ROY SOC B-BIOL SCI, V244, P91, DOI 10.1098/rspb.1991.0056; Jiggins FM, 2000, PARASITOLOGY, V120, P439, DOI 10.1017/S0031182099005867; Jiggins FM, 2001, HEREDITY, V86, P161, DOI 10.1046/j.1365-2540.2001.00804.x; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Majerus M. E. N., 1989, NATURALISTS HDB, V10; Majerus M. E. N., 1999, EVOLUTION ECOLOGY AR, P777; Majerus M. E. N, 1994, NEW NATURALIST SERIE, V81; Majerus MEN, 2006, EUR J ENTOMOL, V103, P1, DOI 10.14411/eje.2006.001; MAJERUS MEN, 1989, J BIOL EDUC, V23, P85, DOI 10.1080/00219266.1989.9655039; Majerus MEN, 2000, ECOL ENTOMOL, V25, P234, DOI 10.1046/j.1365-2311.2000.00249.x; Majerus MEN, 1997, ENTOMOPHAGA, V42, P13, DOI 10.1007/BF02769875; Majerus MEN, 2000, HEREDITY, V84, P605, DOI 10.1046/j.1365-2540.2000.00710.x; Majerus Michael E.N., 1997, Bulletin of the Amateur Entomologists' Society, V56, P235; Majerus T. M. O., 2001, THESIS U CAMBRIDGE C; Majerus TMO, 2012, EVOL ECOL, V26, P207, DOI 10.1007/s10682-011-9490-x; Majerus TMO, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-37; Majerus TMO, 1998, HEREDITY, V81, P683, DOI 10.1046/j.1365-2540.1998.00438.x; Majerus TMO, 1999, INSECT MOL BIOL, V8, P551, DOI 10.1046/j.1365-2583.1999.00151.x; MALOGOLOWKIN C, 1958, GENETICS, V43, P274; Niijima K., 1981, B FAC AGR TAMAGAWA U, V21, P59; Randerson JP, 2000, HEREDITY, V84, P152, DOI 10.1046/j.1365-2540.2000.00645.x; SAKAGUCHI B, 1963, GENETICS, V48, P841; Schulenberg JHGvd, 2000, THESIS U CAMBRIDGE C; Schulenburg JHGV, 2001, APPL ENVIRON MICROB, V67, P270, DOI 10.1128/AEM.67.1.270-277.2001; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Tinsley MC, 2006, PARASITOLOGY, V132, P757, DOI 10.1017/S0031182005009789; Tinsley MC, 2003, THESIS U CAMBRIDGE C; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Weinert LA, 2007, BIOL LETTERS, V3, P678, DOI 10.1098/rsbl.2007.0373; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; WERREN JH, 1994, J BACTERIOL, V176, P388, DOI 10.1128/JB.176.2.388-394.1994; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	50	2	3	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54218	10.1371/journal.pone.0054218	http://dx.doi.org/10.1371/journal.pone.0054218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349831	gold, Green Submitted, Green Published			2022-12-25	WOS:000313943000031
J	Park, YM; Lee, WT; Bokara, KK; Seo, SK; Park, SH; Kim, JH; Yenari, MA; Park, KA; Eun, J				Park, Yu Mi; Lee, Won Taek; Bokara, Kiran Kumar; Seo, Su Kyoung; Park, Seung Hwa; Kim, Jae Hwan; Yenari, Midori A.; Park, Kyung Ah; Eun, Jong			The Multifaceted Effects of Agmatine on Functional Recovery after Spinal Cord Injury through Modulations of BMP-2/4/7 Expressions in Neurons and Glial Cells	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-7; CLONIDINE-DISPLACING SUBSTANCE; PROGENITOR CELLS; BMP; DIFFERENTIATION; REMYELINATION; LOCOMOTION; PATHWAY; OLIGODENDROCYTES; PROLIFERATION	Presently, few treatments for spinal cord injury (SCI) are available and none have facilitated neural regeneration and/or significant functional improvement. Agmatine (Agm), a guanidinium compound formed from decarboxylation of L-arginine by arginine decarboxylase, is a neurotransmitter/neuromodulator and been reported to exert neuroprotective effects in central nervous system injury models including SCI. The purpose of this study was to demonstrate the multifaceted effects of Agm on functional recovery and remyelinating events following SCI. Compression SCI in mice was produced by placing a 15 g/mm(2) weight for 1 min at thoracic vertebra (Th) 9 segment. Mice that received an intraperitoneal (i.p.) injection of Agm (100 mg/kg/day) within 1 hour after SCI until 35 days showed improvement in locomotor recovery and bladder function. Emphasis was made on the analysis of remyelination events, neuronal cell preservation and ablation of glial scar area following SCI. Agm treatment significantly inhibited the demyelination events, neuronal loss and glial scar around the lesion site. In light of recent findings that expressions of bone morphogenetic proteins (BMPs) are modulated in the neuronal and glial cell population after SCI, we hypothesized whether Agm could modulate BMP- 2/4/7 expressions in neurons, astrocytes, oligodendrocytes and play key role in promoting the neuronal and glial cell survival in the injured spinal cord. The results from computer assisted stereological toolbox analysis (CAST) demonstrate that Agm treatment dramatically increased BMP-2/7 expressions in neurons and oligodendrocytes. On the other hand, BMP-4 expressions were significantly decreased in astrocytes and oligodendrocytes around the lesion site. Together, our results reveal that Agm treatment improved neurological and histological outcomes, induced oligodendrogenesis, protected neurons, and decreased glial scar formation through modulating the BMP-2/4/7 expressions following SCI.	[Park, Yu Mi; Lee, Won Taek; Bokara, Kiran Kumar; Seo, Su Kyoung; Kim, Jae Hwan; Park, Kyung Ah; Eun, Jong] Yonsei Univ, Coll Med, Dept Anat, Seoul, South Korea; [Park, Yu Mi; Seo, Su Kyoung; Eun, Jong] Yonsei Univ, Coll Med, BK Project Med Sci 21, Seoul, South Korea; [Park, Seung Hwa] Konkuk Univ, Coll Med, Dept Anat, Seoul, South Korea; [Yenari, Midori A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Yenari, Midori A.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Konkuk University; Konkuk University Medical Center; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Eun, J (corresponding author), Yonsei Univ, Coll Med, Dept Anat, Seoul, South Korea.	jelee@yuhs.ac		Lee, Won Taek/0000-0001-7348-9562; Lee, Jong Eun/0000-0001-6203-7413	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology (MEST) [2012-0002340]; National Institutes of Health [NS40516]; Veteran's Merit Award; Veterans Affairs Medical Center, San Francisco, California; Brain Korea 21 Project for Medical Science, Yonsei University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040516] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran's Merit Award; Veterans Affairs Medical Center, San Francisco, California; Brain Korea 21 Project for Medical Science, Yonsei University(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) (2012-0002340) and National Institutes of Health (NS40516, to MY), the Veteran's Merit Award (to MY). Grants to MY were administered by the Northern California Institute for Research and Education, and supported by resources of the Veterans Affairs Medical Center, San Francisco, California. This work was also supported by the Brain Korea 21 Project for Medical Science, Yonsei University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar AP, 1999, NEUROSURGERY, V44, P1027, DOI 10.1097/00006123-199905000-00052; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; AUGUET M, 1995, JPN J PHARMACOL, V69, P285, DOI 10.1254/jjp.69.285; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Boido M, 2011, J NEUROSURG-SPINE, V15, P97, DOI 10.3171/2011.1.SPINE10607; Boulenguez P, 2009, CURR OPIN NEUROBIOL, V19, P587, DOI 10.1016/j.conb.2009.10.005; BREGMAN BS, 1993, EXP NEUROL, V123, P3, DOI 10.1006/exnr.1993.1136; Butt SJB, 2002, J NEUROSCI, V22, P9961; Chalazonitis A, 2011, DEV BIOL, V350, P64, DOI 10.1016/j.ydbio.2010.11.017; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Chang CF, 2003, STROKE, V34, P558, DOI 10.1161/01.STR.0000051507.64423.00; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; CHOI BH, 1986, J NEUROPATH EXP NEUR, V45, P513, DOI 10.1097/00005072-198609000-00003; Cigognini D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019782; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Cunha JD, 2007, WOUND REPAIR REGEN, V15, P134, DOI 10.1111/j.1524-475X.2006.00194.x; Davies Jeannette E, 2008, J Biol, V7, P24, DOI 10.1186/jbiol85; de Groat WC, 2006, PROG BRAIN RES, V152, P59, DOI 10.1016/S0079-6123(05)52005-3; Estores IM, 2003, J REHABIL RES DEV, V40, P93, DOI 10.1682/JRRD.2003.08.0093; Fairbanks CA, 2000, P NATL ACAD SCI USA, V97, P10584, DOI 10.1073/pnas.97.19.10584; Finley MFA, 1999, J NEUROBIOL, V40, P271, DOI 10.1002/(SICI)1097-4695(19990905)40:3<271::AID-NEU1>3.0.CO;2-C; Fouad K, 2010, J NEUROPHYSIOL, V104, P2975, DOI 10.1152/jn.00499.2010; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Fuller ML, 2007, ANN NEUROL, V62, P288, DOI 10.1002/ana.21179; Galea E, 1996, BIOCHEM J, V316, P247, DOI 10.1042/bj3160247; Gambaro K, 2006, CELL DEATH DIFFER, V13, P1075, DOI 10.1038/sj.cdd.4401799; Gomes WA, 2003, DEV BIOL, V255, P164, DOI 10.1016/S0012-1606(02)00037-4; GRILLNER S, 1979, EXP BRAIN RES, V34, P241; Guertin Pierre A, 2008, Neuropsychiatr Dis Treat, V4, P759; Halaris A, 2007, CNS DRUGS, V21, P885, DOI 10.2165/00023210-200721110-00002; Hampton DW, 2007, EUR J NEUROSCI, V26, P3024, DOI 10.1111/j.1460-9568.2007.05940.x; Harvey BK, 2005, PHARMACOL THERAPEUT, V105, P113, DOI 10.1016/j.pharmthera.2004.09.003; Hawryluk GWJ, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E14; Henriquez JP, 2011, INT J MOL SCI, V12, P8924, DOI 10.3390/ijms12128924; Hvid M, 2009, INT ARCH ALLERGY IMM, V149, P188, DOI 10.1159/000199714; Ille F, 2007, DEV BIOL, V304, P394, DOI 10.1016/j.ydbio.2006.12.045; Jacobs BL, 2002, BRAIN RES REV, V40, P45, DOI 10.1016/S0165-0173(02)00187-X; Jarjour AA, 2012, GLIA, V60, P1, DOI 10.1002/glia.21231; Jordan LM, 2008, BRAIN RES REV, V57, P183, DOI 10.1016/j.brainresrev.2007.07.019; Karimi-Abdolrezaee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037589; Keirstead HS, 1997, J NEUROPATH EXP NEUR, V56, P1191, DOI 10.1097/00005072-199711000-00003; Kim JH, 2011, SPINE, V36, P2130, DOI 10.1097/BRS.0b013e318205e3f7; Kotter MR, 2011, BRAIN, V134, P1882, DOI 10.1093/brain/awr014; Kulbatski I, 2007, J HISTOCHEM CYTOCHEM, V55, P209, DOI 10.1369/jhc.6A7020.2006; Lein PJ, 2002, J NEUROSCI, V22, P10377; LI G, 1994, SCIENCE, V263, P966, DOI 10.1126/science.7906055; Liu AM, 2005, NAT REV NEUROSCI, V6, P945, DOI 10.1038/nrn1805; Lytle JM, 2007, EUR J NEUROSCI, V25, P1711, DOI 10.1111/j.1460-9568.2007.05390.x; Matsuura I, 2008, J NEUROCHEM, V105, P1471, DOI 10.1111/j.1471-4159.2008.05251.x; McDonald JW, 2006, J NEUROTRAUM, V23, P345, DOI 10.1089/neu.2006.23.345; MURAYAMA T, 1993, BIOCHEMISTRY-US, V32, P561, DOI 10.1021/bi00053a022; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Nishiyama A, 2007, NEUROSCIENTIST, V13, P62, DOI 10.1177/1073858406295586; NYGREN LG, 1974, BRAIN RES, V78, P377, DOI 10.1016/0006-8993(74)90922-6; Obermair FJ, 2008, PHYSIOLOGY, V23, P296, DOI 10.1152/physiol.00017.2008; Pajoohesh-Ganji A, 2010, NEUROSCI RES, V67, P117, DOI 10.1016/j.neures.2010.02.009; Parikh P, 2011, P NATL ACAD SCI USA, V108, pE99, DOI 10.1073/pnas.1100426108; PILETZ JE, 1995, J PHARMACOL EXP THER, V272, P581; Pisano JM, 2000, DEV BIOL, V227, P1, DOI 10.1006/dbio.2000.9876; Qi XA, 2010, EXP NEUROL, V221, P353, DOI 10.1016/j.expneurol.2009.12.003; Rasouli A, 2009, J ORTHOP RES, V27, P931, DOI 10.1002/jor.20793; Redwine JM, 1998, J NEUROBIOL, V37, P413, DOI 10.1002/(SICI)1097-4695(19981115)37:3<413::AID-NEU7>3.0.CO;2-8; Reiriz J, 1999, J NEUROBIOL, V38, P161, DOI 10.1002/(SICI)1097-4695(19990205)38:2<161::AID-NEU1>3.3.CO;2-V; Reissmann E, 1996, DEVELOPMENT, V122, P2079; Saruhashi Y, 2009, ARCH ORTHOP TRAUM SU, V129, P1279, DOI 10.1007/s00402-008-0754-z; See J, 2007, MOL CELL NEUROSCI, V35, P171, DOI 10.1016/j.mcn.2007.02.012; Setoguchi T, 2004, EXP NEUROL, V189, P33, DOI 10.1016/j.expneurol.2003.12.007; Setoguchi T, 2001, BRAIN RES, V921, P219, DOI 10.1016/S0006-8993(01)03123-7; Sharp KG, 2012, EXP NEUROL, V235, P345, DOI 10.1016/j.expneurol.2012.02.016; Shoichet Molly S., 2008, P221; Shunmugavel A, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-17; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Tsujii M, 2009, CLIN ORTHOP RELAT R, V467, P3183, DOI 10.1007/s11999-009-1009-1; Vaccari JPD, 2009, NEUROSCI LETT, V465, P226, DOI 10.1016/j.neulet.2009.09.013; White RE, 2008, RESTOR NEUROL NEUROS, V26, P197; Widerstrom-Noga E, 2004, J NEUROTRAUM, V21, P195, DOI 10.1089/089771504322778659; Wu B, 2009, J NEUROTRAUM, V26, P1847, DOI 10.1089/neu.2008.0551; Wu JF, 2010, GLIA, V58, P410, DOI 10.1002/glia.20932; Yoshimura N, 1999, PROG NEUROBIOL, V57, P583, DOI 10.1016/S0301-0082(98)00070-7; Yu CG, 2000, NEUROREPORT, V11, P3203, DOI 10.1097/00001756-200009280-00031	83	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e53911	10.1371/journal.pone.0053911	http://dx.doi.org/10.1371/journal.pone.0053911			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349763	Green Published, gold			2022-12-25	WOS:000313943000020
J	Gallacher, J; Collins, R; Elliott, P; Palmer, S; Burton, P; Mitchell, C; John, G; Lyons, R				Gallacher, John; Collins, Rory; Elliott, Paul; Palmer, Stephen; Burton, Paul; Mitchell, Clive; John, Gareth; Lyons, Ronan			A Platform for the Remote Conduct of Gene-Environment Interaction Studies	PLOS ONE			English	Article							WEB-BASED QUESTIONNAIRES; EPIDEMIOLOGY	Background: Gene-environment interaction studies offer the prospect of robust causal inference through both gene identification and instrumental variable approaches. As such they are a major and much needed development. However, conducting these studies using traditional methods, which require direct participant contact, is resource intensive. The ability to conduct gene-environment interaction studies remotely would reduce costs and increase capacity. Aim: To develop a platform for the remote conduct of gene-environment interaction studies. Methods: A random sample of 15,000 men and women aged 50+ years and living in Cardiff, South Wales, of whom 6,012 were estimated to have internet connectivity, were mailed inviting them to visit a web-site to join a study of successful ageing. Online consent was obtained for questionnaire completion, cognitive testing, re-contact, record linkage and genotyping. Cognitive testing was conducted using the Cardiff Cognitive Battery. Bio-sampling was randomised to blood spot, buccal cell or no request. Results: A heterogeneous sample of 663 (4.5% of mailed sample and 11% of internet connected sample) men and women (47% female) aged 50-87 years (median = 61 yrs) from diverse backgrounds (representing the full range of deprivation scores) was recruited. Bio-samples were donated by 70% of those agreeing to do so. Self report questionnaires and cognitive tests showed comparable distributions to those collected using face-to-face methods. Record linkage was achieved for 99.9% of participants. Conclusion: This study has demonstrated that remote methods are suitable for the conduct of gene-environment interaction studies. Up-scaling these methods provides the opportunity to increase capacity for large-scale gene-environment interaction studies.	[Gallacher, John; Palmer, Stephen; Mitchell, Clive] Cardiff Univ, Inst Primary Care & Publ Hlth, Cardiff CF10 3AX, S Glam, Wales; [Collins, Rory] Univ Oxford, Clin Trials Serv Unit, Oxford, England; [Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Burton, Paul] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [John, Gareth] NHS Wales Informat Serv, Cardiff, S Glam, Wales; [Lyons, Ronan] Swansea Univ, Inst Life Sci, Swansea, W Glam, Wales	Cardiff University; University of Oxford; Imperial College London; University of Leicester; Swansea University	Gallacher, J (corresponding author), Cardiff Univ, Inst Primary Care & Publ Hlth, Cardiff CF10 3AX, S Glam, Wales.	Gallacher@cf.ac.uk		Elliott, Paul/0000-0002-7511-5684	Welsh Assembly Government; ESRC [ES/G007543/1] Funding Source: UKRI; MRC [MC_U137686860, G0801056, MR/K006525/1] Funding Source: UKRI; British Heart Foundation [SP/13/2/30111] Funding Source: researchfish; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish; Medical Research Council [G0801056, MC_U137686860, MR/K006525/1, G0801056B] Funding Source: researchfish	Welsh Assembly Government; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the Welsh Assembly Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almqvist C, 2011, EUR J EPIDEMIOL, V26, P67, DOI 10.1007/s10654-010-9521-x; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; Ekman A, 2006, EUR J EPIDEMIOL, V21, P103, DOI 10.1007/s10654-005-6030-4; Ekman A, 2007, EUROPEAN J EPIDEMIOL, V22, P281; Gallacher JEJ, 2007, EUR J PUBLIC HEALTH, V17, P548, DOI 10.1093/eurpub/ckm086; Hercberg S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-242; Huybrechts KF, 2010, EUR J EPIDEMIOL, V25, P297, DOI 10.1007/s10654-010-9431-y; Kivimaki M, 2011, INT J EPIDEMIOL, V40, P845, DOI 10.1093/ije/dyr114; Klovning A, 2009, J CLIN EPIDEMIOL, V62, P1068, DOI 10.1016/j.jclinepi.2008.10.015; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; Manolio TA, 2012, AM J EPIDEMIOL, V175, P859, DOI 10.1093/aje/kwr453; McCabe SE, 2006, ADDICT BEHAV, V31, P1619, DOI 10.1016/j.addbeh.2005.12.009; Mikkelsen EM, 2009, INT J EPIDEMIOL, V38, P938, DOI 10.1093/ije/dyn191; Reilly R, 2012, BJOG-INT J OBSTET GY, V119, P236, DOI 10.1111/j.1471-0528.2011.03052.x; Rothman KJ, 1997, EPIDEMIOLOGY, V8, P123; Smith B, 2007, AM J EPIDEMIOL, V166, P1345, DOI 10.1093/aje/kwm212; Smith GD, 2005, BMJ-BRIT MED J, V330, P1076, DOI 10.1136/bmj.330.7499.1076; Smith GD, 2011, EPIDEMIOLOGY, V22, P460, DOI 10.1097/EDE.0b013e31821d0426; Taverner N, 2010, INTERACTIVE J MED IN; Touvier M, 2010, EUR J EPIDEMIOL, V25, P287, DOI 10.1007/s10654-010-9433-9; van Gelder MMHJ, 2010, AM J EPIDEMIOL, V172, P1292, DOI 10.1093/aje/kwq291; Welsh Assembly Government, 2008, LIV WAL SURV 2007; Wood F, 2011, J MED ETHICS, V37, P487, DOI 10.1136/jme.2010.040352	24	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54331	10.1371/journal.pone.0054331	http://dx.doi.org/10.1371/journal.pone.0054331			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349852	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000313872800040
J	Koreishi, M; Yu, S; Oda, M; Honjo, Y; Satoh, A				Koreishi, Mayuko; Yu, Sidney; Oda, Mayumi; Honjo, Yasuko; Satoh, Ayano			CK2 Phosphorylates Sec31 and Regulates ER-To-Golgi Trafficking	PLOS ONE			English	Article							RETICULUM EXIT SITES; COPII VESICLE COAT; PROTEIN-KINASE CK2; ENDOPLASMIC-RETICULUM; IN-VIVO; MAMMALIAN-CELLS; BINDING; TRANSPORT; COMPONENT; MEMBRANE	Protein export from the endoplasmic reticulum (ER) is an initial and rate-limiting step of molecular trafficking and secretion. This is mediated by coat protein II (COPII)-coated vesicles, whose formation requires small GTPase Sar1 and 6 Sec proteins including Sec23 and Sec31. Sec31 is a component of the outer layer of COPII coat and has been identified as a phosphoprotein. The initiation and promotion of COPII vesicle formation is regulated by Sar1; however, the mechanism regulating the completion of COPII vesicle formation followed by vesicle release is largely unknown. Hypothesizing that the Sec31 phosphorylation may be such a mechanism, we identified phosphorylation sites in the middle linker region of Sec31. Sec31 phosphorylation appeared to decrease its association with ER membranes and Sec23. Non-phosphorylatable mutant of Sec31 stayed longer at ER exit sites and bound more strongly to Sec23. We also found that CK2 is one of the kinases responsible for Sec31 phosphorylation because CK2 knockdown decreased Sec31 phosphorylation, whereas CK2 overexpression increased Sec31 phosphorylation. Furthermore, CK2 knockdown increased affinity of Sec31 for Sec23 and inhibited ER-to-Golgi trafficking. These results suggest that Sec31 phosphorylation by CK2 controls the duration of COPII vesicle formation, which regulates ER-to-Golgi trafficking.	[Koreishi, Mayuko; Oda, Mayumi; Satoh, Ayano] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Yu, Sidney] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Yu, Sidney] Chinese Univ Hong Kong, Epithelial Cell Biol Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Honjo, Yasuko] Okayama Univ, Res Core Interdisciplinary Sci RCIS, Okayama 7008530, Japan	Okayama University; Chinese University of Hong Kong; Chinese University of Hong Kong; Okayama University	Satoh, A (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan.	ayano113@cc.okayama-u.ac.jp	Satoh, Ayano/B-2423-2011; Bin Sidney Yu, Siu/R-4936-2018; Oda, Mayumi/Z-2010-2019	Satoh, Ayano/0000-0003-3736-1283; Bin Sidney Yu, Siu/0000-0001-9643-2729; Oda, Mayumi/0000-0001-5102-7076	National Institute of Aging [R03 AG030101]; special Coordination Fund for Promoting Science and Technology of MEXT (Ministry of Education, Culture, Sports, Science and Technology, Japan); Hayashi Memorial Foundation for Female Natural Scientists; Ryobi Teien Memorial Foundation; Naito Foundation; Uehara Memorial Foundation; Kurata Memorial Hitachi Science and technology foundation; Kanae Foundation for the Promotion of Medical Science; NATIONAL INSTITUTE ON AGING [R03AG030101] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); special Coordination Fund for Promoting Science and Technology of MEXT (Ministry of Education, Culture, Sports, Science and Technology, Japan); Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists); Ryobi Teien Memorial Foundation(Ryobi Teien Memory Foundation); Naito Foundation(Naito Memorial Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); Kurata Memorial Hitachi Science and technology foundation; Kanae Foundation for the Promotion of Medical Science; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded to AS by the National Institute of Aging (R03 AG030101), the special Coordination Fund for Promoting Science and Technology of MEXT (Ministry of Education, Culture, Sports, Science and Technology, Japan), Hayashi Memorial Foundation for Female Natural Scientists, Ryobi Teien Memorial Foundation, Naito Foundation, Uehara Memorial Foundation, Kurata Memorial Hitachi Science and technology foundation, and Kanae Foundation for the Promotion of Medical Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonny B, 2003, EMBO REP, V4, P419, DOI 10.1038/sj.embor.embor812; Barlowe C, 2002, DEV CELL, V3, P467, DOI 10.1016/S1534-5807(02)00293-9; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bickford LC, 2004, CURR OPIN STRUC BIOL, V14, P147, DOI 10.1016/j.sbi.2004.02.002; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Brandon E, 2006, MOL BIOL CELL, V17, P2996, DOI 10.1091/mbc.e05-09-0862; Buchanan R, 2010, TRAFFIC, V11, P1034, DOI 10.1111/j.1600-0854.2010.01080.x; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dirac-Svejstrup AB, 2000, J CELL BIOL, V150, P475, DOI 10.1083/jcb.150.3.475; Farhan H, 2010, J CELL BIOL, V189, P997, DOI 10.1083/jcb.200912082; Forster R, 2006, CURR BIOL, V16, P173, DOI 10.1016/j.cub.2005.11.076; Franz-Wachtel M, 2012, MOL CELL PROTEOMICS, V11, P160, DOI 10.1074/mcp.M111.016014; Futai E, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600428; Gurkan C, 2006, NAT REV MOL CELL BIO, V7, P727, DOI 10.1038/nrm2025; Hanif IM, 2010, INT J BIOCHEM CELL B, V42, P1602, DOI 10.1016/j.biocel.2010.06.010; Ho HH, 2006, P NATL ACAD SCI USA, V103, P7676, DOI 10.1073/pnas.0602595103; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Kung LF, 2012, EMBO J, V31, P1014, DOI 10.1038/emboj.2011.444; Lambert IH, 2011, CELL PHYSIOL BIOCHEM, V28, P1099, DOI 10.1159/000335846; Lang MR, 2006, NAT GENET, V38, P1198, DOI 10.1038/ng1880; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Maday S, 2008, TRAFFIC, V9, P1915, DOI 10.1111/j.1600-0854.2008.00805.x; Montegna EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031156; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ong YS, 2010, J CELL BIOL, V190, P331, DOI 10.1083/jcb.201003005; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Pelletier L, 2000, NAT CELL BIOL, V2, P840, DOI 10.1038/35041089; Puthenveedu MA, 2004, P NATL ACAD SCI USA, V101, P1253, DOI 10.1073/pnas.0306373101; Rutz C, 2009, TRAFFIC, V10, P994, DOI 10.1111/j.1600-0854.2009.00934.x; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; Salama NR, 1997, MOL BIOL CELL, V8, P205, DOI 10.1091/mbc.8.2.205; Sato K, 2005, NAT STRUCT MOL BIOL, V12, P167, DOI 10.1038/nsmb893; Scott GK, 2006, EMBO J, V25, P4423, DOI 10.1038/sj.emboj.7601336; Shaywitz DA, 1997, J BIOL CHEM, V272, P25413, DOI 10.1074/jbc.272.41.25413; Shibata H, 2010, BIOSCI BIOTECH BIOCH, V74, P1819, DOI 10.1271/bbb.100215; Shimoi W, 2005, J BIOL CHEM, V280, P10141, DOI 10.1074/jbc.M409673200; Shugrue CA, 1999, J CELL SCI, V112, P4547; Sohda M, 1998, J BIOL CHEM, V273, P5385, DOI 10.1074/jbc.273.9.5385; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Stockli J, 2004, J BIOL CHEM, V279, P23542, DOI 10.1074/jbc.M313525200; Sucic S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230037; Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070; Trembley JH, 2010, BIOFACTORS, V36, P187, DOI 10.1002/biof.96; Watson P, 2006, TRAFFIC, V7, P1678, DOI 10.1111/j.1600-0854.2006.00493.x; Weissman JT, 2001, TRAFFIC, V2, P465, DOI 10.1034/j.1600-0854.2001.20704.x; Wendeler MW, 2007, EMBO REP, V8, P258, DOI 10.1038/sj.embor.7400893; Whittle JRR, 2010, J CELL BIOL, V190, P347, DOI 10.1083/jcb.201003092; Yamasaki A, 2006, MOL BIOL CELL, V17, P4876, DOI 10.1091/mbc.E06-05-0444; Yamasaki A, 2009, MOL BIOL CELL, V20, P4205, DOI 10.1091/mbc.E09-05-0387; Yorimitsu T, 2012, MOL BIOL CELL; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644	52	41	41	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54382	10.1371/journal.pone.0054382	http://dx.doi.org/10.1371/journal.pone.0054382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349870	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872800046
J	Myers, RP; Shaheen, AAM; Faris, P; Aspinall, AI; Burak, KW				Myers, Robert P.; Shaheen, Abdel Aziz M.; Faris, Peter; Aspinall, Alexander I.; Burak, Kelly W.			Revision of MELD to Include Serum Albumin Improves Prediction of Mortality on the Liver Transplant Waiting List	PLOS ONE			English	Article							DYE-BINDING METHODS; DISEASE SCORE; PROGNOSTIC INDICATORS; ORGAN ALLOCATION; MODEL; SURVIVAL; RISK; CIRRHOSIS; SODIUM; FUTURE	Background: Allocation of donor livers for transplantation in most regions is based on the Model for End-Stage Liver Disease (MELD) or MELD-sodium (MELDNa). Our objective was to assess revisions to MELD and MELDNa that include serum albumin for predicting waiting list mortality. Methods: Adults registered for liver transplantation in the United States (2002-2007) were identified from the United Network for Organ Sharing (UNOS) database. Cox regression was used to determine the association between serum albumin and 3-month mortality, and to derive revised MELD and MELDNa scores incorporating albumin ('MELD-albumin' and '5-variable MELD [5vMELD]'). Results: Among 40,393 patients, 9% died and 24% underwent transplantation within 3 months of listing. For serum albumin concentrations between 1.0 and 4.0 g/dL, a linear, inverse relationship was observed between albumin and 3-month mortality (adjusted hazard ratio per 1 g/dL reduction in albumin: 1.44; 95% CI 1.35-1.54). The c-statistics for 3-month mortality of MELD-albumin and MELD were 0.913 and 0.896, respectively (P < 0.001); 5vMELD was superior to MELDNa (c-statistics 0.922 vs. 0.912, P < 0.001). The potential benefit of 5vMELD was greatest in patients with low MELD (<15). Among low MELD patients who died, 27% would have gained >= 10 points with 5vMELD over MELD versus only 4-7% among low MELD survivors and high MELD (>= 15) candidates (P < 0.0005). Conclusion: Modification of MELD and MELDNa to include serum albumin is associated with improved prediction of waiting list mortality. If validated and shown to be associated with reduced mortality, adoption of 5vMELD as the basis for liver allograft allocation may improve outcomes on the liver transplant waiting list.	[Myers, Robert P.; Shaheen, Abdel Aziz M.; Faris, Peter; Aspinall, Alexander I.; Burak, Kelly W.] Univ Calgary, Div Gastroenterol & Hepatol, Dept Med, Liver Unit, Calgary, AB, Canada	University of Calgary	Myers, RP (corresponding author), Univ Calgary, Div Gastroenterol & Hepatol, Dept Med, Liver Unit, Calgary, AB, Canada.	rpmyers@ucalgary.ca	Shaheen, Abdel Aziz/AAX-3773-2021; Faris, Peter/AAJ-3436-2020	Shaheen, Abdel Aziz/0000-0002-2940-897X; Faris, Peter/0000-0001-5208-817X; Aspinall, Alexander/0000-0001-5534-6146	Alberta Innovates - Health Solutions (AIHS); Canadian Institutes for Health Research (CIHR); AIHS; CIHR; Health Resources and Services Administration [231-00-0115]	Alberta Innovates - Health Solutions (AIHS); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); AIHS; CIHR(Canadian Institutes of Health Research (CIHR)); Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA))	Dr. Myers is supported by awards from Alberta Innovates - Health Solutions (AIHS) and the Canadian Institutes for Health Research (CIHR). This work was supported in part by grants from AIHS and CIHR, and Health Resources and Services Administration contract 231-00-0115, which funds data collection and management of the UNOS STAR database. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is the responsibility of the authors alone and does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U. S. government.	Bambha KM, 2008, CURR OPIN ORGAN TRAN, V13, P227, DOI 10.1097/MOT.0b013e3282ff84c7; Brown RS, 2005, AM J TRANSPLANT, V5, P203, DOI 10.1111/j.1600-6143.2005.00769.x; BUSH V, 1987, CLIN CHEM, V33, P821; Cholongitas E, 2007, LIVER TRANSPLANT, V13, P523, DOI 10.1002/lt.20994; College of American Pathologists, 2010, SURV 2010 CLIN CHEM; Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; Cook NR, 2009, ANN INTERN MED, V150, P795, DOI 10.7326/0003-4819-150-11-200906020-00007; D'Agostino RB, 2004, HANDB STAT, V23, P1; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; Doumas BT, 2009, CLIN CHEM, V55, P583, DOI 10.1373/clinchem.2008.112854; DOUMAS BT, 1971, CLIN CHIM ACTA, V31, P87, DOI 10.1016/0009-8981(71)90365-2; Doumas BT, 1997, CLIN CHIM ACTA, V258, P3, DOI 10.1016/S0009-8981(96)06446-7; Fattovich G, 1997, GASTROENTEROLOGY, V112, P463, DOI 10.1053/gast.1997.v112.pm9024300; Freeman RB, 2002, LIVER TRANSPLANT, V8, P851, DOI 10.1053/jlts.2002.35927; Heagerty PJ, 2005, BIOMETRICS, V61, P92, DOI 10.1111/j.0006-341X.2005.030814.x; Huo SC, 2007, TRANSPLANTATION, V84, P1406, DOI 10.1097/01.tp.0000282867.92367.d0; Huo TI, 2007, LIVER INT, V27, P498, DOI 10.1111/j.1478-3231.2007.01445.x; Ingelsson E, 2007, JAMA-J AM MED ASSOC, V298, P776, DOI 10.1001/jama.298.7.776; Janes H, 2008, ANN INTERN MED, V149, P751, DOI 10.7326/0003-4819-149-10-200811180-00009; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Kremers WK, 2007, CONCORDANCE SURVIVAL, V80; Luca A, 2007, LIVER TRANSPLANT, V13, P1174, DOI 10.1002/lt.21197; MAGUIRE GA, 1986, CLIN CHIM ACTA, V155, P83, DOI 10.1016/0009-8981(86)90102-6; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; McDiarmid SV, 2002, TRANSPLANTATION, V74, P173, DOI 10.1097/00007890-200207270-00006; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; MERKEL C, 1989, AM J GASTROENTEROL, V84, P717; Myers RP, 2011, J HEPATOL, V54, P462, DOI 10.1016/j.jhep.2010.07.015; Paynter NP, 2009, ANN INTERN MED, V150, P65, DOI 10.7326/0003-4819-150-2-200901200-00003; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Ravaioli M, 2007, TRANSPLANTATION, V83, P919, DOI 10.1097/01.tp.0000259251.92398.2a; REALDI G, 1994, J HEPATOL, V21, P656, DOI 10.1016/S0168-8278(94)80115-0; Schaubel DE, 2009, AM J TRANSPLANT, V9, P970, DOI 10.1111/j.1600-6143.2009.02571.x; Sharma P, 2008, GASTROENTEROLOGY, V135, P1575, DOI 10.1053/j.gastro.2008.08.004; Therneau TM, 2000, MODELING SURVIVAL DA; Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004; Tripodi A, 2007, HEPATOLOGY, V46, P520, DOI 10.1002/hep.21732; Trotter JF, 2007, AM J TRANSPLANT, V7, P1624, DOI 10.1111/j.1600-6143.2007.01822.x; Vincent JL, 2003, ANN SURG, V237, P319, DOI 10.1097/00000658-200303000-00005; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; ZOLI M, 1991, AM J GASTROENTEROL, V86, P1508	44	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e51926	10.1371/journal.pone.0051926	http://dx.doi.org/10.1371/journal.pone.0051926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349678	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872800003
J	Ploenes, T; Scholtes, B; Krohn, A; Burger, M; Passlick, B; Muller-Quernheim, J; Zissel, G				Ploenes, Till; Scholtes, Ben; Krohn, Alexander; Burger, Meike; Passlick, Bernward; Mueller-Quernheim, Joachim; Zissel, Gernot			CC-Chemokine Ligand 18 Induces Epithelial to Mesenchymal Transition in Lung Cancer A549 Cells and Elevates the Invasive Potential	PLOS ONE			English	Article							COLLAGEN PRODUCTION; PULMONARY-FIBROSIS; TUMOR PROGRESSION; PROTEIN S100A4; BREAST-CANCER; METASTASIS; EXPRESSION; CCL18; FIBROBLASTS; MACROPHAGES	Lung cancer is one of the leading causes of cancer related death worldwide with more than a million deaths per year. The poor prognosis is due to its high aggressiveness and its early metastasis. Although the exact mechanisms are still unknown, the process of epithelial to mesenchymal transition (EMT) seems to be involved in these neoplastic processes. We already demonstrated that serum levels of CCL18, a primate specific chemokine, are highly elevated in patients with lung cancer and correlate with their survival time of patients with adenocarcinoma of the lung. Therefore, we hypothesized that CCL18 may be directly involved in pathological processes of lung cancer, e. g. EMT. We investigated the effect of CCL18 on A549, an adenocarcinoma cell line of the lung, on EMT and other cell functions like proliferation, chemotaxis, invasion, chemoresistance and proliferation. Exposure of A549 lung cancer cells to CCL18 in various concentrations decreases the epithelial marker E-cadherin, whereas FSP-1, a marker of the mesenchymal phenotype increases. Accordingly, CCL18 induced the transcriptional EMT regulator SNAIL1 in a dose dependent fashion. In contrast, an increasing CCL18 concentration was associated with a decline of cell proliferation rate. In addition, CCL18 induced chemotaxis of these cells and increased their chemoresistance. Therefore, CCL18 may be an interesting therapeutic target for NSCLC.	[Ploenes, Till; Passlick, Bernward] Univ Freiburg, Med Ctr Freiburg, Div Thorac Surg, D-79106 Freiburg, Germany; [Scholtes, Ben; Mueller-Quernheim, Joachim; Zissel, Gernot] Univ Med Ctr Freiburg, Div Internal Med, Dept Pneumol, Freiburg, Germany; [Krohn, Alexander; Burger, Meike] Univ Med Ctr Freiburg, Div Internal Med, Dept Hematol & Oncol, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Zissel, G (corresponding author), Univ Med Ctr Freiburg, Div Internal Med, Dept Pneumol, Freiburg, Germany.	gernot.zissel@uniklinik-freiburg.de	Zissel, Gernot/B-1208-2010; Plönes, Till/AAK-8208-2021	Zissel, Gernot/0000-0001-8021-9798; Plönes, Till/0000-0003-4839-2130	Albert-Ludwig University Freiburg (Stiftung Mattern)	Albert-Ludwig University Freiburg (Stiftung Mattern)	There are no current external funding sources for this study. T. P. is a recipient of a grant by the Albert-Ludwig University Freiburg (Stiftung Mattern). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atamas SP, 2003, AM J RESP CELL MOL, V29, P743, DOI 10.1165/rcmb.2003-0078OC; Catusse J, 2010, J CELL PHYSIOL, V225, P792, DOI 10.1002/jcp.22284; Chen JQ, 2011, CANCER CELL, V19, P541, DOI 10.1016/j.ccr.2011.02.006; Chen XF, 2012, MOL BIOL REP, V39, P3549, DOI 10.1007/s11033-011-1128-0; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Guo J, 2008, J ALLERGY CLIN IMMUN, V122, P195, DOI 10.1016/j.jaci.2008.03.012; Helfman DM, 2005, BRIT J CANCER, V92, P1955, DOI 10.1038/sj.bjc.6602613; Hsu DSS, 2010, CLIN CANCER RES, V16, P4561, DOI 10.1158/1078-0432.CCR-10-0593; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hung JJ, 2009, THORAX, V64, P1082, DOI 10.1136/thx.2009.115691; Janssen-Heijnen MLG, 2003, LUNG CANCER-J IASLC, V41, P245, DOI 10.1016/S0169-5002(03)00230-7; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Kim JH, 2007, J KOREAN MED SCI, V22, P898, DOI 10.3346/jkms.2007.22.5.898; Kim MA, 2009, HISTOPATHOLOGY, V54, P442, DOI 10.1111/j.1365-2559.2009.03247.x; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Leung SY, 2004, GASTROENTEROLOGY, V127, P457, DOI 10.1053/j.gastro.2004.05.031; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Luzina IG, 2006, J CELL PHYSIOL, V206, P221, DOI 10.1002/jcp.20452; Miyazaki N, 2006, INT J ONCOL, V28, P1369; Osanai K, 1997, AM J RESP CRIT CARE, V155, pA750; Plones T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041746; Prasse A, 2006, AM J RESP CRIT CARE, V173, P781, DOI 10.1164/rccm.200509-1518OC; Prasse A, 2007, ARTHRITIS RHEUM-US, V56, P1685, DOI 10.1002/art.22559; Prassel A, 2009, AM J RESP CRIT CARE, V179, P717, DOI 10.1164/rccm.200808-1201OC; Rudland PS, 2000, CANCER RES, V60, P1595; Saxena M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.61; Stemmler MP, 2008, MOL BIOSYST, V4, P835, DOI 10.1039/b719215k; Struyf S, 2003, AM J PATHOL, V163, P2065, DOI 10.1016/S0002-9440(10)63564-X; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Wakelee HA, 2006, CANCER-AM CANCER SOC, V106, P2208, DOI 10.1002/cncr.21869; Yang CC, 2005, AM J PHYSIOL-CELL PH, V288, pC321, DOI 10.1152/ajpcell.00171.2004; Zissel G, 2011, AM J RESP CRIT CARE, V183, pA5574; Zissel G, 2011, AM J RESP CRIT CARE	33	41	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e53068	10.1371/journal.pone.0053068	http://dx.doi.org/10.1371/journal.pone.0053068			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349697	gold, Green Submitted, Green Published			2022-12-25	WOS:000313872800006
J	Sabir, HJ; Nehlin, JO; Qanie, D; Harkness, L; Prokhorova, TA; Blagoev, B; Kassem, M; Isa, A; Barington, T				Sabir, Hardee J.; Nehlin, Jan O.; Qanie, Diyako; Harkness, Linda; Prokhorova, Tatyana A.; Blagoev, Blagoy; Kassem, Moustapha; Isa, Adiba; Barington, Torben			Separate Developmental Programs for HLA-A and -B Cell Surface Expression during Differentiation from Embryonic Stem Cells to Lymphocytes, Adipocytes and Osteoblasts	PLOS ONE			English	Article							MHC CLASS-I; COMPLEX CLASS-I; LANGERHANS CELLS; HEAVY-CHAINS; ANTIGENS; MOLECULES; TISSUE; GENES; LINES; KERATINOCYTES	A major problem of allogeneic stem cell therapy is immunologically mediated graft rejection. HLA class I A, B, and Cw antigens are crucial factors, but little is known of their respective expression on stem cells and their progenies. We have recently shown that locus-specific expression (HLA-A, but not -B) is seen on some multipotent stem cells, and this raises the question how this is in other stem cells and how it changes during differentiation. In this study, we have used flow cytometry to investigate the cell surface expression of HLA-A and -B on human embryonic stem cells (hESC), human hematopoietic stem cells (hHSC), human mesenchymal stem cells (hMSC) and their fully-differentiated progenies such as lymphocytes, adipocytes and osteoblasts. hESC showed extremely low levels of HLA-A and no -B. In contrast, multipotent hMSC and hHSC generally expressed higher levels of HLA-A and clearly HLA-B though at lower levels. IFN gamma induced HLA-A to very high levels on both hESC and hMSC and HLA-B on hMSC. Even on hESC, a low expression of HLA-B was achieved. Differentiation of hMSC to osteoblasts downregulated HLA-A expression (P = 0.017). Interestingly HLA class I on T lymphocytes differed between different compartments. Mature bone marrow CD4(+) and CD8(+) T cells expressed similar HLA-A and -B levels as hHSC, while in the peripheral blood they expressed significantly more HLA-B7 (P = 0.0007 and P = 0.004 for CD4(+) and CD8(+) T cells, respectively). Thus different HLA loci are differentially regulated during differentiation of stem cells.	[Sabir, Hardee J.; Nehlin, Jan O.; Isa, Adiba; Barington, Torben] Univ So Denmark, Dept Clin Immunol, Odense Univ Hosp, Odense, Denmark; [Sabir, Hardee J.; Nehlin, Jan O.; Isa, Adiba; Barington, Torben] Univ So Denmark, Inst Clin, Odense, Denmark; [Qanie, Diyako; Harkness, Linda; Kassem, Moustapha] Odense Univ Hosp, Mol Endocrinol Lab KMEB, Dept Endocrinol, DK-5000 Odense, Denmark; [Prokhorova, Tatyana A.; Blagoev, Blagoy] Univ So Denmark, Ctr Expt BioInformat, Dept Biochem & Mol Biol, Odense, Denmark; [Kassem, Moustapha] King Saud Univ, Coll Med, Dept Anat, Stem Cell Unit, Riyadh 11461, Saudi Arabia	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; King Saud University	Barington, T (corresponding author), Univ So Denmark, Dept Clin Immunol, Odense Univ Hosp, Odense, Denmark.	barington@dadlnet.dk	Nehlin, Jan O./AAR-8721-2020; Barington, Torben/R-6841-2019; Harkness, Linda/A-5654-2017; Kassem, Moustapha/O-3819-2019; Barington, Torben/C-3922-2009	Nehlin, Jan O./0000-0001-6038-5027; Harkness, Linda/0000-0002-1648-9301; Kassem, Moustapha/0000-0003-1557-0869; Barington, Torben/0000-0001-6968-148X; Prokhorova, Tatyana/0000-0001-8768-8298; Blagoev, Blagoy/0000-0002-3596-0066	Danish Regions; Odense University Hospital; University of Southern Denmark; Else Poulsens Mindelegat; Horslev's Fund; Lundbeck Fund; Kurdistan Regional Government; Nanakaly Fund, Kurdistan, Iraq	Danish Regions; Odense University Hospital; University of Southern Denmark; Else Poulsens Mindelegat; Horslev's Fund; Lundbeck Fund(Lundbeckfonden); Kurdistan Regional Government; Nanakaly Fund, Kurdistan, Iraq	The present work was supported by funds from Danish Regions, Odense University Hospital, the University of Southern Denmark, Else Poulsens Mindelegat, the Horslev's Fund, Lundbeck Fund (BB) and a PhD fellowship from the Kurdistan Regional Government and Nanakaly Fund, Kurdistan, Iraq (to HJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A.K., 2010, CELL MOL IMMUNOL, Vseventh, P109; AHMEDANSARI A, 1988, TRANSPLANTATION, V45, P972, DOI 10.1097/00007890-198805000-00027; Apps R, 2009, IMMUNOLOGY, V127, P26, DOI 10.1111/j.1365-2567.2008.03019.x; BAKKER M, 1985, CURR EYE RES, V4, P599, DOI 10.3109/02713688508999991; Basak GW, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-27; Benevolo M, 2007, AM J SURG PATHOL, V31, P76, DOI 10.1097/01.pas.0000213343.55605.b9; Cabrera CM, 2007, CELL BIOL INT, V31, P1072, DOI 10.1016/j.cellbi.2007.03.015; COCKFIELD SM, 1989, TRANSPLANT P, V21, P630; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; CUNNINGHAM AC, 1994, J CELL SCI, V107, P443; DAAR AS, 1984, TRANSPLANTATION, V38, P287, DOI 10.1097/00007890-198409000-00018; DAVID-WATINE B, 1990, IMMUNOL TODAY, V11, P286, DOI 10.1016/0167-5699(90)90114-O; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; Dutta N, 2005, HUM IMMUNOL, V66, P164, DOI 10.1016/j.humimm.2004.10.010; EBERLEINGONSKA M, 1989, VERH DEUT G, V73, P117; FLEMING KA, 1981, J CLIN PATHOL, V34, P779, DOI 10.1136/jcp.34.7.779; Foglieni C, 2008, AM J PHYSIOL-HEART C, V294, pH2831, DOI 10.1152/ajpheart.91428.2007; Friedrich D, 2011, JAIDS-J ACQ IMM DEF, V58, P248, DOI 10.1097/QAI.0b013e318228f992; Giacomini P, 1997, TISSUE ANTIGENS, V50, P555, DOI 10.1111/j.1399-0039.1997.tb02913.x; GIELEN V, 1988, ARCH DERMATOL RES, V280, P131, DOI 10.1007/BF00456841; Gono T, 2009, CLIN RHEUMATOL, V28, P873, DOI 10.1007/s10067-009-1172-5; Greene JM, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-39; Harkness L, 2011, BONE, V48, P231, DOI 10.1016/j.bone.2010.09.023; Harkness L, 2010, IN VITRO CELL DEV-AN, V46, P259, DOI 10.1007/s11626-010-9281-7; Hobbs CGL, 2006, CLIN EXP IMMUNOL, V145, P365, DOI 10.1111/j.1365-2249.2006.03125.x; Horwitz MS, 1999, LAB INVEST, V79, P235; Isa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010900; Johnson DR, 2000, HUM IMMUNOL, V61, P389, DOI 10.1016/S0198-8859(99)00186-X; JONES RA, 1988, LEUKEMIA RES, V12, P799, DOI 10.1016/0145-2126(88)90032-X; Kaslow RA, 2001, J VIROL, V75, P8681, DOI 10.1128/JVI.75.18.8681-8689.2001; Kim AY, 2011, GASTROENTEROLOGY, V140, P686, DOI 10.1053/j.gastro.2010.09.042; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Lee SJ, 2007, BLOOD, V110, P4576, DOI 10.1182/blood-2007-06-097386; Li L, 2004, STEM CELLS, V22, P448, DOI 10.1634/stemcells.22-4-448; Loyson SAJ, 1997, HISTOPATHOLOGY, V31, P412, DOI 10.1046/j.1365-2559.1997.2980886.x; Meunier L, 1996, CYTOMETRY, V26, P260, DOI 10.1002/(SICI)1097-0320(19961215)26:4<260::AID-CYTO4>3.3.CO;2-T; Parham P, 2009, IMMUNE SYSTEM, V3rd; Peh CA, 1998, IMMUNITY, V8, P531, DOI 10.1016/S1074-7613(00)80558-0; Prokhorova TA, 2009, MOL CELL PROTEOMICS, V8, P959, DOI 10.1074/mcp.M800287-MCP200; Roitt I., 2001, IMMUNOLOGY, V6th; Saenz-Lopez P, 2010, TISSUE ANTIGENS, V75, P110, DOI 10.1111/j.1399-0039.2009.01409.x; SINGER DS, 1990, CRIT REV IMMUNOL, V10, P235; STAM NJ, 1990, INT IMMUNOL, V2, P113, DOI 10.1093/intimm/2.2.113; SUTTON R, 1987, TRANSPLANT P, V19, P220; Taipaleenmaki H, 2011, EXP CELL RES, V317, P745, DOI 10.1016/j.yexcr.2010.12.015; THEOBALD VA, 1993, TRANSPLANTATION, V55, P128, DOI 10.1097/00007890-199301000-00024; Wang EC, 2006, OTOLARYNG HEAD NECK, V134, P280, DOI 10.1016/j.otohns.2005.10.015; Wognum AW, 2003, ARCH MED RES, V34, P461, DOI 10.1016/j.arcmed.2003.09.008	49	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54366	10.1371/journal.pone.0054366	http://dx.doi.org/10.1371/journal.pone.0054366			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349864	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872800044
J	Shi, G; Sohn, KC; Li, Z; Choi, DK; Park, YM; Kim, JH; Fan, YM; Nam, YH; Kim, S; Im, M; Lee, Y; Seo, YJ; Kim, CD; Lee, JH				Shi, Ge; Sohn, Kyung-Cheol; Li, Zhengjun; Choi, Dae-Kyoung; Park, Young Min; Kim, Jin-Hwa; Fan, Yi-Ming; Nam, Yong Hee; Kim, Sooyeon; Im, Myung; Lee, Young; Seo, Young-Joon; Kim, Chang Deok; Lee, Jeung-Hoon			Expression and Functional Role of Sox9 in Human Epidermal Keratinocytes	PLOS ONE			English	Article							BASAL-CELL CARCINOMA; TRANSCRIPTION FACTOR; DIFFERENTIATION; PATHWAY; NOTCH; INVOLVEMENT; INITIATION; PROTEIN; GROWTH; GENES	In this study, we investigated the expression and putative role of Sox9 in epidermal keratinocyte. Immunohistochemical staining showed that Sox9 is predominantly expressed in the basal layer of normal human skin epidermis, and highly expressed in several skin diseases including psoriasis, basal cell carcinoma, keratoacanthoma and squamous cell carcinoma. In calcium-induced keratinocyte differentiation model, the expression of Sox9 was decreased in a time dependent manner. When Sox9 was overexpressed using a recombinant adenovirus, cell growth was enhanced, while the expression of differentiation-related genes such as loricrin and involucrin was markedly decreased. Similarly, when rat skin was intradermally injected with the adenovirus expressing Sox9, the epidermis was thickened with increase of PCNA positive cells, while the epidermal differentiation was decreased. Finally, UVB irradiation induced Sox9 expression in cultured human epidermal keratinocytes, and keratinocytes are protected from UVB-induced apoptosis by Sox9 overexpression. Together, these results suggest that Sox9 is an important regulator of epidermal keratinocytes with putative pro-proliferation and/or pro-survival functions, and may be related to several cutaneous diseases that are characterized by abnormal differentiation and hyperproliferation.	[Shi, Ge; Fan, Yi-Ming] Guangdong Med Coll, Dept Dermatol, Affiliated Hosp 1, Zhanjiang, Peoples R China; [Shi, Ge; Sohn, Kyung-Cheol; Li, Zhengjun; Choi, Dae-Kyoung; Nam, Yong Hee; Kim, Sooyeon; Im, Myung; Lee, Young; Seo, Young-Joon; Kim, Chang Deok; Lee, Jeung-Hoon] Chungnam Natl Univ, Dept Dermatol, Sch Med, Taejon, South Korea; [Shi, Ge; Sohn, Kyung-Cheol; Li, Zhengjun; Choi, Dae-Kyoung; Nam, Yong Hee; Kim, Sooyeon; Im, Myung; Lee, Young; Seo, Young-Joon; Kim, Chang Deok; Lee, Jeung-Hoon] Chungnam Natl Univ, Res Inst Med Sci, Sch Med, Taejon, South Korea; [Park, Young Min] Catholic Univ Korea, Dept Dermatol, Coll Med, Seoul, South Korea; [Kim, Jin-Hwa] SkinMED Corp, Taejon, South Korea	Guangdong Medical University; Chungnam National University; Chungnam National University; Catholic University of Korea	Lee, JH (corresponding author), Chungnam Natl Univ, Dept Dermatol, Sch Med, Taejon, South Korea.	jhoon@cnu.ac.kr	Fan, Yi-Ming/K-7567-2019; Fan, Yi-Ming/U-9192-2017	Fan, Yi-Ming/0000-0002-6206-1306; Fan, Yi-Ming/0000-0002-6206-1306; Seo, Young-Joon/0000-0002-4955-590X; Lee, Young/0000-0001-9205-1785; Kim, Chang Deok/0000-0001-9341-6491	National Research Foundation of Korea [KRF-2008-314-E00152]; Korea Health 21 R&D Project from the Korea Ministry of Health, Welfare and Family Affairs [01-PJ3-PG6-01GN12-0001]	National Research Foundation of Korea(National Research Foundation of Korea); Korea Health 21 R&D Project from the Korea Ministry of Health, Welfare and Family Affairs	This study was supported by a grant of the National Research Foundation of Korea (KRF-2008-314-E00152), and a grant of the Korea Health 21 R&D Project from the Korea Ministry of Health, Welfare and Family Affairs (01-PJ3-PG6-01GN12-0001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Bikle DD, 2011, MOL CELL ENDOCRINOL, V347, P80, DOI 10.1016/j.mce.2011.05.017; Blache P, 2004, J CELL BIOL, V166, P37, DOI 10.1083/jcb.200311021; Chen W, 2006, J EUR ACAD DERMATOL, V20, P846, DOI 10.1111/j.1468-3083.2006.01663.x; Decker Patrice, 2002, Current Pharmaceutical Biotechnology, V3, P275, DOI 10.2174/1389201023378265; Dessinioti C, 2010, PHOTOCHEM PHOTOBIOL, V86, P481, DOI 10.1111/j.1751-1097.2010.00735.x; Eckert RL, 2004, J INVEST DERMATOL, V123, P13, DOI 10.1111/j.0022-202X.2004.22723.x; Feldman SR, 2011, CUTIS, V87, P201; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Garcia-Borron JC, 2008, PIGM CELL MELANOMA R, V21, P3, DOI 10.1111/j.1755-148X.2007.00431.x; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Iwai S, 2010, INT J ONCOL, V37, P1095, DOI 10.3892/ijo_00000761; Iwasaki JK, 2012, J AM ACAD DERMATOL, V66, pE167, DOI 10.1016/j.jaad.2010.06.054; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; MISSERO C, 1995, P NATL ACAD SCI USA, V92, P5451, DOI 10.1073/pnas.92.12.5451; Moriyama M, 2008, DEV CELL, V14, P594, DOI 10.1016/j.devcel.2008.01.017; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Nishi K, 2009, J CELL BIOCHEM, V106, P63, DOI 10.1002/jcb.21978; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Passeron T, 2007, P NATL ACAD SCI USA, V104, P13984, DOI 10.1073/pnas.0705117104; Piao MS, 2011, J DERMATOL SCI, V62, P147, DOI 10.1016/j.jdermsci.2011.02.003; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Seo EY, 2005, GENOMICS, V86, P528, DOI 10.1016/j.ygeno.2005.06.013; Shi G, 2011, ANN DERMATOL, V23, P138, DOI 10.5021/ad.2011.23.2.138; Shi G, 2010, EXP CELL RES, V316, P3263, DOI 10.1016/j.yexcr.2010.09.013; Shi G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013216; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Tollefson Ann E, 2007, Methods Mol Med, V130, P223; Vidal VPI, 2008, J CUTAN PATHOL, V35, P373, DOI 10.1111/j.1600-0560.2007.00815.x; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Yano F, 2005, BIOCHEM BIOPH RES CO, V333, P1300, DOI 10.1016/j.bbrc.2005.06.041; Yoon HK, 2008, BIOCHEM BIOPH RES CO, V377, P662, DOI 10.1016/j.bbrc.2008.10.051	35	44	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54355	10.1371/journal.pone.0054355	http://dx.doi.org/10.1371/journal.pone.0054355			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349860	Green Submitted, gold, Green Published			2022-12-25	WOS:000313872800041
J	Abbott, SA; Haberland, NA; Mulenga, DM; Hewett, PC				Abbott, Sharon A.; Haberland, Nicole A.; Mulenga, Drosin M.; Hewett, Paul C.			Female Sex Workers, Male Circumcision and HIV: A Qualitative Study of Their Understanding, Experience, and HIV Risk in Zambia	PLOS ONE			English	Article							PREVENTION; BEHAVIOR; CONTEXT; KENYA; MEN	Several sub-Saharan African countries, including Zambia, have initiated national voluntary medical male circumcision (MC) programs to reduce HIV incidence. In-depth interviews were conducted with twenty female sex workers (FSWs) in Lusaka to examine their understanding of MC and experiences with circumcised clients. Knowledge of MC was derived primarily through informal sources, with very few FSWs reporting exposure to MC educational campaigns. MC was not widely believed to be protective against HIV, however it was viewed by some as protective against STIs. Three FSWs reported having sex with recently circumcised clients, and most reported that men often used their MC status to try to convince FSWs to forego condoms. Findings suggest that FSWs, already at high risk for HIV infection, may face additional pressure toward higher risk behavior as a result of MC. As MC services are expanded, programs should support FSWs' efforts to protect themselves by providing information about what MC can - and cannot - offer for HIV/STI infection prevention.	[Abbott, Sharon A.; Haberland, Nicole A.] Populat Council, New York, NY 10021 USA; [Mulenga, Drosin M.; Hewett, Paul C.] Populat Council, Lusaka, Zambia	Population Council	Abbott, SA (corresponding author), Populat Council, 1230 York Ave, New York, NY 10021 USA.	sharonabbott@gmail.com			Population Services International (PSI) through the Male Circumcision Partnership; Bill & Melinda Gates Foundation	Population Services International (PSI) through the Male Circumcision Partnership; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was conducted under a subgrant from Population Services International (PSI) through the Male Circumcision Partnership, which is sponsored by PSI with support from the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDS Vaccine Advocacy Coalition, 2008, CIV SOC DIAL MAL CIR; [Anonymous], 2008, OPEN DEMOGRAPHY J, DOI [DOI 10.2174/1874918600801010001, 10.2174/1874918600801010001]; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Chipamaunga S, 2010, SAHARA J-J SOC ASP H, V7, P44, DOI 10.1080/17290376.2010.9724968; (CSO) CSO (MOH) MoH Zambia Uo Evaluation M, 2010, ZAMB SEX BEH SURV 20; Fitzgerald-Husek A, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-35; Gallo MF, 2011, J WOMENS HEALTH, V20, P733, DOI 10.1089/jwh.2010.2436; Gray RH, 2007, LANCET, V369; Gray R, 2012, AIDS, V26, P609, DOI 10.1097/QAD.0b013e3283504a3f; Grund JM, 2012, AIDS CARE, V24, P245, DOI 10.1080/09540121.2011.596516; Hallett TB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002212; Hankins C, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000109; Herman-Roloff A, 2011, AIDS BEHAV; Hewett PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036251; Hewett PC, 2012, AIDS, V26, P749, DOI 10.1097/QAD.0b013e32835097ff; Leclerc PM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005439; Londish GJ, 2008, INT J EPIDEMIOL, V37, P1246, DOI 10.1093/ije/dyn038; McClelland L, 2011, AIDS EDUC PREV, V23, P299, DOI 10.1521/aeap.2011.23.4.299; Ministry of Health (MOH), 2010, NAT MAL CIRC STRAT I; Ministry of Health (MOH) Zambia, 2012, COUNTR OP PLAN SCAL; Mulenga O, 2009, ZAMBIA HIV PREVENTIO; Munoz J, 2010, SAHARA J-J SOC ASP H, V7, P52, DOI 10.1080/17290376.2010.9724957; Ndubani P, 2005, BEHAV BIOL SURVEILLA; Ndubani P, 2009, FEMALE SEX WORKERS B; Scorgie F, 2012, AIDS BEHAV, V16, P920, DOI 10.1007/s10461-011-9985-z; UNAIDS/WHO, 2007, NEW DAT MAL CIRC HIV; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3	29	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53809	10.1371/journal.pone.0053809	http://dx.doi.org/10.1371/journal.pone.0053809			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	073JI	23349745	gold, Green Published, Green Submitted			2022-12-25	WOS:000313738900021
J	Lynch, T; Chong, P; Zhang, J; Hizon, R; Du, T; Graham, MR; Beniac, DR; Booth, TF; Kibsey, P; Miller, M; Gravel, D; Mulvey, MR				Lynch, Tarah; Chong, Patrick; Zhang, Jason; Hizon, Romeo; Du, Tim; Graham, Morag R.; Beniac, Daniel R.; Booth, Timothy F.; Kibsey, Pamela; Miller, Mark; Gravel, Denise; Mulvey, Michael R.		CNISP	Characterization of a Stable, Metronidazole-Resistant Clostridium difficile Clinical Isolate	PLOS ONE			English	Article							SMALL-COLONY VARIANTS; HELICOBACTER-PYLORI; MULTIINSTITUTIONAL OUTBREAK; DIARRHEA; TOXIN; STRAINS; GENES; SUSCEPTIBILITY; VANCOMYCIN; EPIDEMIOLOGY	Background: Clostridium difficile are Gram-positive, spore forming anaerobic bacteria that are the leading cause of healthcare-associated diarrhea, usually associated with antibiotic usage. Metronidazole is currently the first-line treatment for mild to moderate C. difficile diarrhea however recurrence occurs at rates of 15-35%. There are few reports of C. difficile metronidazole resistance in the literature, and when observed, the phenotype has been transient and lost after storage or exposure of the bacteria to freeze/thaw cycles. Owing to the unstable nature of the resistance phenotype in the laboratory, clinical significance and understanding of the resistance mechanisms is lacking. Methodology/Principal Findings: Genotypic and phenotypic characterization was performed on a metronidazole resistant clinical isolate of C. difficile. Whole-genome sequencing was used to identify potential genetic contributions to the phenotypic variation observed with molecular and bacteriological techniques. Phenotypic observations of the metronidazole resistant strain revealed aberrant growth in broth and elongated cell morphology relative to a metronidazole-susceptible, wild type NAP1 strain. Comparative genomic analysis revealed single nucleotide polymorphism (SNP) level variation within genes affecting core metabolic pathways such as electron transport, iron utilization and energy production. Conclusions/Significance: This is the first characterization of stable, metronidazole resistance in a C. difficile isolate. The study provides an in-depth genomic and phenotypic analysis of this strain and provides a foundation for future studies to elucidate mechanisms conferring metronidazole resistance in C. difficile that have not been previously described.	[Lynch, Tarah; Chong, Patrick; Zhang, Jason; Hizon, Romeo; Du, Tim; Graham, Morag R.; Beniac, Daniel R.; Booth, Timothy F.; Mulvey, Michael R.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Kibsey, Pamela] Victoria Gen Hosp, Victoria, BC, Canada; [Miller, Mark] McGill Univ, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada; [Gravel, Denise] Publ Hlth Agcy Canada, Ottawa, ON, Canada	Public Health Agency of Canada; University of Victoria; McGill University; Public Health Agency of Canada	Mulvey, MR (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.	Michael_mulvey@phac-aspc.gc.ca			Public Health Agency of Canada; National Science and Engineering Research Council of Canada	Public Health Agency of Canada; National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	No external funding sources were received for this study. This project was funded solely by the Public Health Agency of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the National Science and Engineering Research Council of Canada's Visiting Fellowship in Canadian Government Laboratories Program; the Genomics, Bioinformatics and Media Core Facilities at the National Microbiology Laboratory for their expertise, hard work and technical support. Members of the Canadian Nosocomial Infection Surveillance Program are: David Boyd, National Microbiology Laboratory, Public Health Agency of Canada; Natalie Bridger, Eastern Health-HSC, St. John's, Nfld.; Elizabeth Bryce, Vancouver General Hospital, Vancouver, BC; John Conly, Foothills Medical Centre, Calgary, Alta.; Andre Dascal, SMBD-Jewish General Hospital, Montreal, Que.; Janice de Heer, Interior Health Authority, Kelowna, BC; John Embil, Health Sciences Centre, Winnipeg, Man.; Joanne Embree, Health Sciences Centre, Winnipeg, Man.; Gerald Evans, Kingston General Hospital, Kingston, Ont; Sarah Forgie, Stollery Children's Hospital, Edmonton, AB; Charles Frenette, McGill University Health Centre, Montreal, Que; David Haldane, Queen Elizabeth II Health Sciences Centre, Halifax, Nova ScotiaGregory German, Queen Elizabeth Hospital, Charlottetown, PEI; George Golding, National Microbiology Laboratory, Public Health Agency of Canada; Denise Gravel, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada; Deanna Hembroff, University Hospital of Northern BC, Prince George, BC; Elizabeth Henderson, Alberta Health Services, Calgary, Alta.; Michael John, London Health Sciences Centre, London, Ont.; Lynn Johnston, Queen Elizabeth II Health Sciences Centre, Halifax, NS; Kevin Katz, North York General Hospital, Toronto, ON; Pamela Kibsey, Victoria General Hospital, Victoria, BC; Magdalena Kuhn, South East Regional Health Authority, Moncton, NB; Joanne Langley, IWK. Health Centre, Halifax, NS; Camille Lemieux, University Health Network, Toronto, Ont.; Nicole Le Saux, Children's Hospital of Eastern Ontario, Ottawa, ON; Mark Loeb, Hamilton Health Sciences Corporation, Hamilton, Ont.; Susan Richardson, Hospital for Sick Children, Toronto, Ont.; Allison McGeer, Mount Sinai Hospital, Toronto, Ont.; Dominik Mertz, Hamilton Health Sciences Corporation, Hamilton, Ont; Mark Miller, SMBD-Jewish General Hospital, Montreal, Que.; Robyn Mitchell, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada; Dorothy Moore, Montreal Children's Hospital, McGill University Health Centre, Montreal, Que.; Aboubakar Mounchili, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada; Michael Mulvey, National Microbiology Laboratory, Public Health Agency of Canada; Suzanne Pelletier, Health Sciences North, Sudbury, ON; Linda Pelude, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada; Caroline Quach, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec Virginia Roth, The Ottawa Hospital, Ottawa, Ont.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Albert TJ, 2005, NAT METHODS, V2, P951, DOI 10.1038/NMETH805; Alfa MJ, 2000, J CLIN MICROBIOL, V38, P2706, DOI 10.1128/JCM.38.7.2706-2714.2000; Baines SD, 2008, J ANTIMICROB CHEMOTH, V62, P1046, DOI 10.1093/jac/dkn313; Barbut F, 2000, J CLIN MICROBIOL, V38, P2386; BOLTON RP, 1986, GUT, V27, P1169, DOI 10.1136/gut.27.10.1169; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Bourgault AM, 2006, ANTIMICROB AGENTS CH, V50, P3473, DOI 10.1128/AAC.00479-06; Brouwer MSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023014; Burns DA, 2011, J MICROBIOL METH, V87, P133, DOI 10.1016/j.mimet.2011.07.017; Chang KC, 1997, BIOCHEM BIOPH RES CO, V236, P785, DOI 10.1006/bbrc.1997.7050; Chernak E., 2005, Morbidity and Mortality Weekly Report, V54, P1201; Choi SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018236; CLSI, 2007, M11A7 CLSI; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Diniz CG, 2004, J ANTIMICROB CHEMOTH, V54, P100, DOI 10.1093/jac/dkh256; EDWARDS DI, 1993, J ANTIMICROB CHEMOTH, V31, P9, DOI 10.1093/jac/31.1.9; Forgetta V, 2011, J CLIN MICROBIOL, V49, P2230, DOI 10.1128/JCM.00391-11; Gal M, 2004, J ANTIMICROB CHEMOTH, V54, P109, DOI 10.1093/jac/dkh296; Goodwin A, 1998, MOL MICROBIOL, V28, P383, DOI 10.1046/j.1365-2958.1998.00806.x; Gravel D, 2009, CLIN INFECT DIS, V48, P568, DOI 10.1086/596703; Grobner S, 2012, INT J MED MICROBIOL, V302, P40, DOI 10.1016/j.ijmm.2011.07.001; HAGGOUD A, 1994, ANTIMICROB AGENTS CH, V38, P1047, DOI 10.1128/AAC.38.5.1047; Helmann JD, 2003, J BACTERIOL, V185, P243, DOI 10.1128/JB.185.1.243-253.2003; Huang HH, 2009, INT J ANTIMICROB AG, V34, P516, DOI 10.1016/j.ijantimicag.2009.09.012; Indra A, 2008, J MED MICROBIOL, V57, P702, DOI 10.1099/jmm.0.47476-0; Jeong JY, 2000, J BACTERIOL, V182, P5082, DOI 10.1128/JB.182.18.5082-5090.2000; Johnson S, 1999, NEW ENGL J MED, V341, P1645, DOI 10.1056/NEJM199911253412203; Kaakoush NO, 2009, ANTIMICROB AGENTS CH, V53, P1884, DOI 10.1128/AAC.01449-08; Kahl BC, 2003, J CLIN MICROBIOL, V41, P410, DOI 10.1128/JCM.41.1.410-413.2003; Kyne L, 2002, CLIN INFECT DIS, V34, P346, DOI 10.1086/338260; Lemee L, 2004, J CLIN MICROBIOL, V42, P5710, DOI 10.1128/JCM.42.12.5710-5714.2004; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lin YC, 2011, ANTIMICROB AGENTS CH, V55, P1701, DOI 10.1128/AAC.01440-10; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; Martin H, 2008, J CLIN MICROBIOL, V46, P2999, DOI 10.1128/JCM.02437-07; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Miller M, 2010, CLIN INFECT DIS, V50, P194, DOI 10.1086/649213; Murray R., 2009, BMC Infectious Diseases, V9; Musher DM, 2005, CLIN INFECT DIS, V40, P1586, DOI 10.1086/430311; Oka K, 2012, J CLIN MICROBIOL, V50, P915, DOI 10.1128/JCM.05588-11; Pelaez T, 2008, J CLIN MICROBIOL, V46, P3028, DOI 10.1128/JCM.00524-08; Pelaez T, 2002, ANTIMICROB AGENTS CH, V46, P1647, DOI 10.1128/AAC.46.6.1647-1650.2002; Pelaez T, 1994, 34 INT C ANT AG CHEM; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; Petkau A, 2010, BIOINFORMATICS, V26, P3125, DOI 10.1093/bioinformatics/btq588; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; REYSSET G, 1993, CLIN INFECT DIS, V16, pS401, DOI 10.1093/clinids/16.Supplement_4.S401; Reysset G, 2012, MED MALADIES INFECT, V26, P213; Sakka V, 2008, CLIN MICROBIOL INFEC, V14, P14, DOI 10.1111/j.1469-0691.2007.01840.x; Sisson G, 2000, J BACTERIOL, V182, P5091, DOI 10.1128/JB.182.18.5091-5096.2000; Spigaglia P, 2004, J MED MICROBIOL, V53, P1129, DOI 10.1099/jmm.0.45682-0; Spigaglia P, 2002, J CLIN MICROBIOL, V40, P3470, DOI 10.1128/JCM.40.9.3470-3475.2002; Spigaglia P, 2011, J ANTIMICROB CHEMOTH, V66, P2227, DOI 10.1093/jac/dkr292; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Steffens LS, 2010, RES MICROBIOL, V161, P346, DOI 10.1016/j.resmic.2010.04.003; Tenover FC, 2012, ANTIMICROB AGENTS CH, V56, P2929, DOI 10.1128/AAC.00220-12; Tsugawa H, 2011, BIOCHEM BIOPH RES CO, V404, P656, DOI 10.1016/j.bbrc.2010.12.034; Tsugawa H, 2011, ANTIOXID REDOX SIGN, V14, P15, DOI 10.1089/ars.2010.3146; Underwood S, 2009, J BACTERIOL, V191, P7296, DOI 10.1128/JB.00882-09; Wellinghausen N, 2009, J CLIN MICROBIOL, V47, P2802, DOI 10.1128/JCM.00485-09; Yuan L, 2006, EVIDENCE REV COMMUNI; Zar FA, 2007, CLIN INFECT DIS, V45, P302, DOI 10.1086/519265	66	55	61	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53757	10.1371/journal.pone.0053757	http://dx.doi.org/10.1371/journal.pone.0053757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349739	Green Submitted, Green Published, gold			2022-12-25	WOS:000313738900020
J	Zhang, Q; Zhou, C; Zhang, Q; Qian, HF; Liu, WP; Zhao, MR				Zhang, Qiong; Zhou, Cong; Zhang, Quan; Qian, Haifeng; Liu, Weiping; Zhao, Meirong			Stereoselective Phytotoxicity of HCH Mediated by Photosynthetic and Antioxidant Defense Systems in Arabidopsis thaliana	PLOS ONE			English	Article							OXIDATIVE STRESS; DELTA-HEXACHLOROCYCLOHEXANE; BETA-HEXACHLOROCYCLOHEXANE; SUPEROXIDE-DISMUTASE; ELECTRON-TRANSPORT; PHOTOSYSTEM-I; OXYGEN; SOIL; DDT; INHIBITION	Background: Hexachlorocyclohexane (HCH) has been used for plant protection and sanitation world-widely, and its isomers have been detected in water, soil, and air as well as in vegetation. As a sink for lipophilic pollutants, vegetation is very important for the degradation and fate of organic contamination; however, little was known about their phytotoxicity and mechanisms of toxic effect. In this study, the stereoselective phototoxicity of four isomers (alpha, beta, gamma, and delta) of HCHs mediated by independent as well as interconnecting systems of photosynthesis and enzymatic antioxidant defense system in Arabidopsis thaliana were assessed. Principal Findings: Our results revealed that all the HCHs not only stimulated the activities of catalase (CAT) and peroxidase (POD), but also inhibited the activity of superoxide dismutase (SOD). In photosynthesis system, the photosynthetic efficiency of PSI and PSII were all down regulated. Meanwhile, results from both systems showed that delta-HCH was the most toxic one, while alpha-HCH the least in Arabidopsis thaliana. Conclusions: For the first time, stereoselective effects of different isomers of HCH in plant were demonstrated. And the results suggest that it requires further research to fully elucidate the environmental toxicity and their mechanisms.	[Zhang, Qiong; Zhou, Cong; Zhang, Quan; Qian, Haifeng; Zhao, Meirong] Zhejiang Univ Technol, Coll Biol & Environm Engn, Hangzhou, Zhejiang, Peoples R China; [Zhang, Quan; Liu, Weiping] Zhejiang Univ, Inst Environm Sci, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University of Technology; Zhejiang University	Liu, WP (corresponding author), Zhejiang Univ, Inst Environm Sci, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China.	wliu@zju.edu.cn; zhaomr@zjut.edu.cn	Liu, Weiping/E-9208-2010; Qian, Haifeng/A-7791-2012	Liu, Weiping/0000-0002-1173-892X; Qian, Haifeng/0000-0003-0807-9991	National Basic Research Program of China [2009CB421603]; Zhejiang Provincial Natural Science Foundation of China [LR12B07002]; National Natural Science Foundation of China [20837002]	National Basic Research Program of China(National Basic Research Program of China); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Basic Research Program of China (No. 2009CB421603), the Zhejiang Provincial Natural Science Foundation of China (LR12B07002) and the National Natural Science Foundation of China (No. 20837002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews J, 2000, PLANT CELL ENVIRON, V23, P415, DOI 10.1046/j.1365-3040.2000.00555.x; Anilakumar KR, 2006, PLANT FOOD HUM NUTR, V61, P169, DOI 10.1007/s11130-006-0027-3; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Babu GS, 2003, WATER AIR SOIL POLL, V144, P149, DOI 10.1023/A:1022929502510; BARRIE LA, 1992, SCI TOTAL ENVIRON, V122, P1, DOI 10.1016/0048-9697(92)90245-N; Bchanan BB, 2004, BIOCH MOL BIOL PLANT, P976; Bidlan R, 2004, CHEMOSPHERE, V56, P803, DOI 10.1016/j.chemosphere.2004.01.015; Bigsby RM, 1997, CANCER RES, V57, P865; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; Pereira RC, 2006, ENVIRON POLLUT, V144, P210, DOI 10.1016/j.envpol.2005.12.030; Pereira RC, 2010, CHEMOSPHERE, V79, P326, DOI 10.1016/j.chemosphere.2010.01.035; del Rio LA, 1998, PLANT PHYSIOL, V116, P1195, DOI 10.1104/pp.116.4.1195; DeLorenzo ME, 2001, ENVIRON TOXICOL CHEM, V20, P84, DOI [10.1002/etc.5620200108, 10.1897/1551-5028(2001)020&lt;0084:TOPTAM&gt;2.0.CO;2]; Erhard P., 2008, PAM APPL NOTES, V1, P21; Feng K, 2004, ENVIRON GEOCHEM HLTH, V26, P253, DOI 10.1023/B:EGAH.0000039588.10092.37; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Foyer CH, 2009, ANTIOXID REDOX SIGN, V11, P861, DOI 10.1089/ars.2008.2177; Gao S, 2011, PLANT CELL PHYSIOL, V52, P885, DOI 10.1093/pcp/pcr038; Golding AJ, 2003, PLANTA, V218, P107, DOI 10.1007/s00425-003-1077-5; GOTH L, 1991, CLIN CHIM ACTA, V196, P143, DOI 10.1016/0009-8981(91)90067-M; Huang W, 2010, PHOTOSYNTH RES, V103, P175, DOI 10.1007/s11120-010-9539-7; Kim SJ, 2001, PLANT CELL PHYSIOL, V42, P842, DOI 10.1093/pcp/pce109; KLUGHAMMER C, 1994, PLANTA, V192, P261, DOI 10.1007/BF01089043; Klughammer C., 2008, PAM APP NOTES, V1, P11, DOI DOI 10.1007/S00415-017-8571-3; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Kumar M, 2005, ENVIRON SCI TECHNOL, V39, P4005, DOI 10.1021/es048497q; Li YF, 1999, SCI TOTAL ENVIRON, V232, P121, DOI 10.1016/S0048-9697(99)00114-X; LINDENAU A, 1994, HUM REPROD, V9, P772, DOI 10.1093/oxfordjournals.humrep.a138595; Lu Y, 2010, BIOMED ENVIRON SCI, V23, P230, DOI 10.1016/S0895-3988(10)60057-8; Marco JAM, 2007, CHEMOSPHERE, V68, P832, DOI 10.1016/j.chemosphere.2007.02.026; Nagata K, 1996, BRAIN RES, V738, P131, DOI 10.1016/0006-8993(96)00775-5; Niewiadomska E, 2011, PLANTA, V233, P275, DOI 10.1007/s00425-010-1302-y; Ott T, 1999, PLANTA, V209, P250, DOI 10.1007/s004250050629; PATERSON S, 1994, ENVIRON SCI TECHNOL, V28, P2259, DOI 10.1021/es00062a009; PATTICHIS K, 1994, ANAL BIOCHEM, V221, P428, DOI 10.1006/abio.1994.1441; POMES A, 1993, DEV BRAIN RES, V73, P85, DOI 10.1016/0165-3806(93)90049-G; Ricking M, 2008, ENVIRON CHEM LETT, V6, P83, DOI 10.1007/s10311-007-0104-3; Romero-Puertas MC, 2004, PLANT CELL ENVIRON, V27, P1135, DOI 10.1111/j.1365-3040.2004.01219.x; Rugh CL, 2004, TRENDS BIOTECHNOL, V22, P496, DOI 10.1016/j.tibtech.2004.08.003; SAFE S, 1992, ENVIRON SCI TECHNOL, V26, P394, DOI 10.1021/es00026a023; Samanta L, 1999, ARCH TOXICOL, V73, P96, DOI 10.1007/s002040050593; SIMONICH SL, 1995, ENVIRON SCI TECHNOL, V29, P2905, DOI 10.1021/es00012a004; SMIRNOFF N, 1993, NEW PHYTOL, V125, P27, DOI 10.1111/j.1469-8137.1993.tb03863.x; Srivastava A, 2006, MOL CELL BIOCHEM, V286, P87, DOI 10.1007/s11010-005-9096-0; Srivastava A, 2010, CHEM-BIOL INTERACT, V183, P34, DOI 10.1016/j.cbi.2009.09.026; SUNDERMAN FW, 1985, ANN CLIN LAB SCI, V15, P229; Van Aken B, 2010, ENVIRON SCI TECHNOL, V44, P2767, DOI 10.1021/es902514d; Waliszewski SM, 2008, B ENVIRON CONTAM TOX, V81, P343, DOI 10.1007/s00128-008-9484-8; Wieczorek JK, 2007, ECOTOX ENVIRON SAFE, V66, P369, DOI 10.1016/j.ecoenv.2005.10.002; Willett KL, 1998, ENVIRON SCI TECHNOL, V32, P2197, DOI 10.1021/es9708530	51	9	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e51043	10.1371/journal.pone.0051043	http://dx.doi.org/10.1371/journal.pone.0051043			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349669	Green Submitted, Green Published, gold			2022-12-25	WOS:000313738900001
J	Grimm, JW; Weber, R; Barnes, J; Koerber, J; Dorsey, K; Glueck, E				Grimm, Jeffrey W.; Weber, Rachel; Barnes, Jesse; Koerber, Jon; Dorsey, Kylan; Glueck, Edwin			Brief Exposure to Novel or Enriched Environments Reduces Sucrose Cue-Reactivity and Consumption in Rats after 1 or 30 Days of Forced Abstinence from Self-Administration	PLOS ONE			English	Article							DRUG-ADDICTION; ORBITOFRONTAL CORTEX; COCAINE-SEEKING; FEMALE RATS; REINSTATEMENT; BEHAVIOR; OBESITY; AMPHETAMINE; INCUBATION; ALCOHOL	Environmental enrichment (EE) reduces drug and sucrose cue-reactivity in rats. In a previous study we reported that 1 month of EE (large cage, toys, and social cohorts) significantly reduced sucrose cue-reactivity. In the present study, we examined whether overnight (22 h) EE would be as effective. We also examined whether social enrichment (SE), enrichment alone (SoloEE), or exposure to an alternative environment (AEnv) might account for the EE effect. Rats self-administered 10% sucrose (.2 mL/delivery) in 10 daily 2-h sessions. Sucrose delivery was accompanied by a tone+light cue. Rats were then exposed to enrichment or alternative environment conditions overnight (acute) or for 29 days (chronic). Sucrose cue-reactivity was measured after this period of forced abstinence in a session identical to training, but no sucrose was delivered with the cue. All acute conditions markedly reduced sucrose cue-reactivity after 1 day of forced abstinence compared to single-housed rats in standard vivarium housing (CON). Sucrose consumption was also significantly reduced in all groups but SoloEE in a next-day test. All acute conditions but SE significantly reduced sucrose cue-reactivity when administered just prior to Day 30 of forced abstinence; all reduced sucrose consumption in a next-day test. All chronic conditions except for SE and AEnv significantly reduced sucrose cue-reactivity on the Day 30 test and sucrose consumption in a next day test. For both acute and chronic comparisons, EE manipulations were the most effective at reducing sucrose cue-reactivity and consumption. SoloEE and EE were equally effective at reducing sucrose cue-reactivity and similarly effective at reducing sucrose consumption. This indicates that social interaction is not a necessary condition for reducing sucrose-motivated behaviors. These results may be useful in the development of anti-relapse strategies for drug and food addictions.	[Grimm, Jeffrey W.] Western Washington Univ, Dept Psychol, Bellingham, WA 98225 USA; Western Washington Univ, Program Behav Neurosci, Bellingham, WA 98225 USA	Western Washington University; Western Washington University	Grimm, JW (corresponding author), Western Washington Univ, Dept Psychol, Bellingham, WA 98225 USA.	jeff.grimm@wwu.edu			NIH [R15 DA016285-03]; Western Washington University Biomedical Research Activities in Neuroscience Initiative; NATIONAL INSTITUTE ON DRUG ABUSE [R15DA016285] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Western Washington University Biomedical Research Activities in Neuroscience Initiative; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by NIH Grant R15 DA016285-03 and the Western Washington University Biomedical Research Activities in Neuroscience Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardo MT, 2001, PSYCHOPHARMACOLOGY, V155, P278; Brenes JC, 2008, NEUROSCI LETT, V436, P278, DOI 10.1016/j.neulet.2008.03.045; Burke KA, 2008, NATURE, V454, P340, DOI 10.1038/nature06993; Cain ME, 2006, BEHAV PROCESS, V73, P360, DOI 10.1016/j.beproc.2006.08.007; Chauvet C, 2012, NEUROPHARMACOLOGY, V63, P635, DOI 10.1016/j.neuropharm.2012.05.014; Chauvet C, 2009, NEUROPSYCHOPHARMACOL, V34, P2767, DOI 10.1038/npp.2009.127; De Alba I, 2004, AM J ADDICTION, V13, P33, DOI 10.1080/10550490490265307; Deehan GA, 2011, BEHAV NEUROSCI, V125, P184, DOI 10.1037/a0022627; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Gill MJ, 2011, BEHAV PHARMACOL, V22, P40, DOI 10.1097/FBP.0b013e3283425a86; Gipson CD, 2011, PSYCHOPHARMACOLOGY, V214, P557, DOI 10.1007/s00213-010-2060-z; Grimm J. W., 2012, FOOD ADDICTION, P214; Grimm JW, 2008, BEHAV PHARMACOL, V19, P777, DOI 10.1097/FBP.0b013e32831c3b18; Grimm JW, 2011, JOVE-J VIS EXP, DOI 10.3791/3335; Harkness JH, 2010, PSYCHOPHARMACOLOGY, V208, P521, DOI 10.1007/s00213-009-1755-5; Klebaur JE, 2001, EXP CLIN PSYCHOPHARM, V9, P372, DOI 10.1037/1064-1297.9.4.372; Konkle ATM, 2010, J AM ASSOC LAB ANIM, V49, P427; Mar AC, 2011, J NEUROSCI, V31, P6398, DOI 10.1523/JNEUROSCI.6620-10.2011; Murphy ER, 2012, PSYCHOPHARMACOLOGY, V219, P401, DOI 10.1007/s00213-011-2572-1; Nair SG, 2009, PROG NEUROBIOL, V89, P18, DOI 10.1016/j.pneurobio.2009.05.003; Pickens CL, 2011, TRENDS NEUROSCI, V34, P411, DOI 10.1016/j.tins.2011.06.001; Puhl MD, 2012, BEHAV PHARMACOL, V23, P43, DOI 10.1097/FBP.0b013e32834eb060; Rehm J, 2006, DRUG ALCOHOL REV, V25, P503, DOI 10.1080/09595230600944453; REYNOLDS GS, 1961, J EXP ANAL BEHAV, V4, P289, DOI 10.1901/jeab.1961.4-289; Shahan TA, 2011, J EXP ANAL BEHAV, V95, P91, DOI 10.1901/jeab.2011.95-91; Smith MA, 2009, BEHAV PHARMACOL, V20, P312, DOI 10.1097/FBP.0b013e32832ec568; Solinas M, 2010, PROG NEUROBIOL, V92, P572, DOI 10.1016/j.pneurobio.2010.08.002; Thiel KJ, 2010, NEUROSCIENCE, V171, P1187, DOI 10.1016/j.neuroscience.2010.10.001; Thiel KJ, 2012, ADDICT BIOL, V17, P365, DOI 10.1111/j.1369-1600.2011.00358.x; Thiel KJ, 2011, PHARMACOL BIOCHEM BE, V97, P595, DOI 10.1016/j.pbb.2010.09.014; Thiel KJ, 2009, INT J NEUROPSYCHOPH, V12, P1151, DOI 10.1017/S1461145709990472; Trezza V, 2011, J NEUROSCI, V31, P6362, DOI 10.1523/JNEUROSCI.5492-10.2011; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Wang GJ, 2004, J ADDICT DIS, V23, P39, DOI 10.1300/J069v23n03_04; Wood DA, 2006, PHYSIOL BEHAV, V88, P132, DOI 10.1016/j.physbeh.2006.03.024; Wood DA, 2009, BRAIN RES, V1259, P59, DOI 10.1016/j.brainres.2008.12.038; Zlebnik NE, 2010, PSYCHOPHARMACOLOGY, V209, P113, DOI 10.1007/s00213-010-1776-0	37	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54164	10.1371/journal.pone.0054164	http://dx.doi.org/10.1371/journal.pone.0054164			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342096	Green Published, Green Submitted, gold			2022-12-25	WOS:000313682700092
J	Moore, XL; Michell, D; Lee, S; Skilton, MR; Nair, R; Dixon, JB; Dart, AM; Chin-Dusting, J				Moore, Xiao L.; Michell, Danielle; Lee, Sabrina; Skilton, Michael R.; Nair, Rajesh; Dixon, John B.; Dart, Anthony M.; Chin-Dusting, Jaye			Increased Carotid Intima-Media Thickness and Reduced Distensibility in Human Class III Obesity: Independent and Differential Influences of Adiposity and Blood Pressure on the Vasculature	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; CARDIOVASCULAR-DISEASE; ARTERIAL STIFFNESS; ABDOMINAL OBESITY; RISK; MICROPARTICLES; HEALTHY; IMPACT; ATHEROSCLEROSIS; DYSFUNCTION	Carotid intima-media-thickness (cIMT) and carotid distensibility (distensibility), structural and functional properties of carotid arteries respectively, are early markers, as well as strong predictors of cardiovascular disease (CVD). The characteristic of these two parameters in individuals with BMI>40.0 kg/m(2) (Class III obesity), however, are largely unknown. The present study was designed to document cIMT and distensibility in this population and to relate these to other factors with established association with CVD in obesity. The study included 96 subjects (65 with BMI>40.0 kg/m(2) and 31, age- and gender-matched, with BMI of 18.5 to 30.0 kg/m(2)). cIMT and distensibility were measured by non-invasive high resolution ultrasonography, circulatory CD133(+)/KDR+ angiogenic cells and endothelial microparticles (EMP) by flow cytometry, and plasma levels of adipokines, growth factors and cytokines by Luminex immunoassay kits. The study results demonstrated increased cIMT (0.62 +/- 0.11 mm vs. 0.54 +/- 0.08 mm, P = 0.0002) and reduced distensibility (22.52 +/- 10.79 10(-3) kpa(-1) vs. 29.91 +/- 12.37 10(-3) kpa(-1), P<0.05) in individuals with BMI>40.0 kg/m(2). Both cIMT and distensibility were significantly associated with traditional CVD risk factors, adiposity/adipokines and inflammatory markers but had no association with circulating angiogenic cells. We also demonstrated, for the first time, elevated plasma EMP levels in individuals with BMI>40.0 kg/m(2). In conclusion, cIMT is increased and distensibility reduced in Class III obesity with the changes predominantly related to conventional CVD risk factors present in this condition, demonstrating that both cIMT and distensibility remain as CVD markers in Class III obesity.	[Moore, Xiao L.; Michell, Danielle; Lee, Sabrina; Nair, Rajesh; Dixon, John B.; Dart, Anthony M.; Chin-Dusting, Jaye] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Skilton, Michael R.] Univ Sydney, Boden Inst Obes Nutr Exercise & Eating Disorders, Camperdown, NSW, Australia; [Dixon, John B.] Monash Univ, Dept Gen Practise, Obes Res Unit, Clayton, Vic, Australia; [Nair, Rajesh; Dart, Anthony M.] Alfred Hosp, Alfred Heart Ctr, Prahran, Vic 3181, Australia	Baker Heart and Diabetes Institute; University of Sydney; Monash University; Florey Institute of Neuroscience & Mental Health	Dart, AM (corresponding author), Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia.	A.Dart@alfred.org.au	Michell, Danielle/D-9367-2013; Dixon, John B/A-5318-2011; Dart, Anthony/E-7461-2010	Dixon, John B/0000-0001-5391-4082; Dart, Anthony/0000-0003-1360-3778; Lee, Poay Sian Sabrina/0000-0002-4660-514X; Skilton, Michael/0000-0003-2793-2388	National Heart Foundation of Australia [APP1012003]; Victorian Government's Operational Infrastructure Support Program; National Health and Medical Research Council of Australia	National Heart Foundation of Australia(National Heart Foundation of Australia); Victorian Government's Operational Infrastructure Support Program; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by a National Heart Foundation of Australia Project Grant (APP1012003) and in part by the Victorian Government's Operational Infrastructure Support Program. MRS is a National Health and Medical Research Council of Australia (NHMRC) Career Development Fellow. AMD, JCD and JBD are NHMRC Fellows. Funding also provided by National Heart Foundation of Australia: http://www.heartfoundation.org.au/Pages/default.aspx, Victorian Government's Operational Infrastructure Support Program: http://www.business.vic.gov.au/industries/science-technology-and-innovation/programs/medical-research-operational-infrastructure-program and National Health and Medical Research Council of Australia: http://www.nhmrc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellows CF, 2011, OBESITY, V19, P1722, DOI 10.1038/oby.2010.347; Blaha MJ, 2009, HYPERTENSION, V54, P1408, DOI 10.1161/HYPERTENSIONAHA.109.138396; Burke GL, 2008, ARCH INTERN MED, V168, P928, DOI 10.1001/archinte.168.9.928; Cheriyath P, 2010, EUR J CARDIOV PREV R, V17, P309, DOI 10.1097/HJR.0b013e32833189b8; Chironi GN, 2009, CELL TISSUE RES, V335, P143, DOI 10.1007/s00441-008-0710-9; Clement K, 2007, J INTERN MED, V262, P422, DOI 10.1111/j.1365-2796.2007.01851.x; De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423; Elkiran O, 2011, INT J CARDIOL; Enjeti AK, 2007, SEMIN THROMB HEMOST, V33, P771, DOI 10.1055/s-2007-1000369; Esposito K, 2006, J CLIN ENDOCR METAB, V91, P3676, DOI 10.1210/jc.2006-0851; Feng B, 2010, ATHEROSCLEROSIS, V208, P264, DOI 10.1016/j.atherosclerosis.2009.06.037; Folsom AR, 2000, ARCH INTERN MED, V160, P2117, DOI 10.1001/archinte.160.14.2117; Fonseca Vivian A, 2005, Clin Cornerstone, V7, P61, DOI 10.1016/S1098-3597(05)80069-9; Grisar J, 2005, CIRCULATION, V111, P204, DOI 10.1161/01.CIR.0000151875.21836.AE; Harloff A, 2006, STROKE, V37, P2708, DOI 10.1161/01.STR.0000244763.19013.dc; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Juonala M, 2008, EUR HEART J, V29, P1198, DOI 10.1093/eurheartj/ehm556; Ketel IJ, 2010, J CLIN ENDOCR METAB, V95, P4566, DOI 10.1210/jc.2010-0868; Laakso M, 2010, DIABETES CARE, V33, P442, DOI 10.2337/dc09-0749; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Liang YL, 1998, CLIN SCI, V95, P669, DOI 10.1042/cs0950669; Loehr LR, 2009, CIRC-HEART FAIL, V2, P18, DOI 10.1161/CIRCHEARTFAILURE.108.813782; Martinez-Estrada OM, 2005, CARDIOVASC RES, V65, P328, DOI 10.1016/j.cardiores.2004.11.015; Montes M, 2006, J IMMUNOL METHODS, V317, P45, DOI 10.1016/j.jim.2006.09.013; Muller-Ehmsen J, 2008, EUR HEART J, V29, P1560, DOI 10.1093/eurheartj/ehn213; Noon JP, 2008, J CLIN NURS, V17, P2311, DOI 10.1111/j.1365-2702.2007.02155.x; Nozaki T, 2010, EUR J HEART FAIL, V12, P1223, DOI 10.1093/eurjhf/hfq145; Peralta CA, 2010, AM J EPIDEMIOL, V171, P63, DOI 10.1093/aje/kwp319; Polak JF, 2011, NEW ENGL J MED, V365, P213, DOI 10.1056/NEJMoa1012592; Potenza MV, 2009, NUTR CLIN PRACT, V24, P560, DOI 10.1177/0884533609342436; Recio-Rodriguez JI, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-3; Rosendorff Clive, 2007, J Clin Hypertens (Greenwich), V9, P790; Rustemeyer P, 2007, J IMMUNOASS IMMUNOCH, V28, P13, DOI 10.1080/15321810601025549; Sen S, 2011, CLIN SCI, V120, P263, DOI 10.1042/CS20100429; Skilton MR, 2008, DIABETES OBES METAB, V10, P874, DOI 10.1111/j.1463-1326.2007.00817.x; Sturm R, 2007, PUBLIC HEALTH, V121, P492, DOI 10.1016/j.puhe.2007.01.006; Sturm W, 2009, OBESITY, V17, P1783, DOI 10.1038/oby.2009.81; Tentolouris N, 2003, EUR J CLIN INVEST, V33, P1075, DOI 10.1111/j.1365-2362.2003.01279.x; Tounian P, 2001, LANCET, V358, P1400, DOI 10.1016/S0140-6736(01)06525-4; Zhao BC, 2010, HEPATO-GASTROENTEROL, V57, P1382	40	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53972	10.1371/journal.pone.0053972	http://dx.doi.org/10.1371/journal.pone.0053972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342053	Green Published, Green Submitted, gold			2022-12-25	WOS:000313682700070
J	Pando, MA; Coloccini, RS; Reynaga, E; Fermepin, MR; Vaulet, LG; Kochel, TJ; Montano, SM; Avila, MM				Pando, Maria A.; Coloccini, Romina S.; Reynaga, Elena; Rodriguez Fermepin, Marcelo; Gallo Vaulet, Lucia; Kochel, Tadeusz J.; Montano, Silvia M.; Avila, Maria M.			Violence as a Barrier for HIV Prevention among Female Sex Workers in Argentina	PLOS ONE			English	Article							PARTNER VIOLENCE; CONDOM NEGOTIATION; PREVALENCE; RISK; HEALTH; WOMEN; PROSTITUTION; INFECTION; INTIMATE; IMPACT	Background: Violence against female sex workers (FSWs) has been increasingly reported as an important determinant of HIV infection risk. This study explores the frequency of different violent experiences (sexual abuse, rejection, beating and imprisonment) among FSWs in Argentina and its association with condom use and HIV and T. pallidum prevalence. Methods: A convenience sample of 1255 FSWs was included in a cross-sectional study conducted between October 2006 and November 2009. Results: Sexual abuse was reported by 24.1% (219/907) of women. A total of 34.7% (42/1234) reported rejection experiences, 21.9% (267/1215) reported having been beaten and 45.4% (561/1236) stated having been arrested because of their sex work activity. There was a higher frequency of inconsistent condom use with clients among FSWs who had experienced sexual abuse, rejection, and police detention. A higher frequency of HIV and T. pallidum infection was detected among FSWs who reported having been arrested by the police. Conclusion: The study shows for the first time the frequency of different violent situations among FSWs in Argentina. The association between violence against sex workers, condom use and STI prevalence demonstrated here calls for measures to reduce stigma and violence against FSWs. Such violent experiences may increase vulnerability to STI through coerced unprotected sex.	[Pando, Maria A.; Coloccini, Romina S.; Avila, Maria M.] Univ Buenos Aires, Fac Med, Inst Invest Biomed Retrovirus & SIDA INBIRS, Buenos Aires, DF, Argentina; [Pando, Maria A.; Coloccini, Romina S.; Avila, Maria M.] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina; [Reynaga, Elena] Asociac Mujeres Meretrices Argentina, AMMAR, Buenos Aires, DF, Argentina; [Rodriguez Fermepin, Marcelo; Gallo Vaulet, Lucia] Univ Buenos Aires, Fac Farm & Bioquim, Dept Bioquim Clin, Inmunol Clin, RA-1113 Buenos Aires, DF, Argentina; [Kochel, Tadeusz J.; Montano, Silvia M.] USN, Med Res Unit 6, Lima, Peru	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Pando, MA (corresponding author), Univ Buenos Aires, Fac Med, Inst Invest Biomed Retrovirus & SIDA INBIRS, Buenos Aires, DF, Argentina.	mpando@fmed.uba.ar	RODRIGUEZ FERMEPIN, Marcelo/AAY-7762-2021	RODRIGUEZ FERMEPIN, Marcelo/0000-0003-2543-4262	Global Fund [112]; Work Unit [62787A S17 H B0002]	Global Fund; Work Unit	This work was supported by Global Fund (Sub-project No112) and Work Unit Number 62787A S17 H B0002. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad K, 2001, LANCET, V358, P643, DOI 10.1016/S0140-6736(01)05819-6; Beattie TSH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-476; Carlson CE, 2012, J INTERPERS VIOLENCE, V27, P1911, DOI 10.1177/0886260511431439; Chakrapani V, 2009, AIDS PATIENT CARE ST, V23, P973, DOI 10.1089/apc.2009.0035; Damacena GN, 2011, JAIDS-J ACQ IMM DEF, V57, pS144, DOI 10.1097/QAI.0b013e31821e9bf6; Pando MD, 2011, REV PANAM SALUD PUBL, V30, P303; Decker MR, 2012, SEX TRANSM INFECT, V88, P278, DOI 10.1136/sextrans-2011-050171; Decker MR, 2010, SEX TRANSM INFECT, V86, P236, DOI 10.1136/sti.2009.037846; Decker MR, 2009, INT J GYNECOL OBSTET, V107, P151, DOI 10.1016/j.ijgo.2009.06.002; Farley M, 1998, FEM PSYCHOL, V8, P405, DOI 10.1177/0959353598084002; Frye V, 2011, AIDS BEHAV, V15, P153, DOI 10.1007/s10461-009-9659-2; Ghimire L, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-42; Lang DL, 2012, AIDS BEHAV; Ministerio de Salud Presidencia de la Nacion, 2010, B HIV SID ARG; Pando MA, 2011, AIDS RES HUM RETROV, V27, P17, DOI 10.1089/aid.2010.0013; Pando MA, 2006, AM J TROP MED HYG, V74, P233, DOI 10.4269/ajtmh.2006.74.233; Pontecorvo C, 2004, MEDICINA-BUENOS AIRE, V64, P492; Rekart ML, 2005, LANCET, V366, P2123, DOI 10.1016/S0140-6736(05)67732-X; Rhodes T., 2008, BMJ-BRIT MED J, V337/7669, P560; Schacht RL, 2010, ARCH SEX BEHAV, V39, P898, DOI 10.1007/s10508-009-9544-0; Shannon K, 2010, JAMA-J AM MED ASSOC, V304, P573, DOI 10.1001/jama.2010.1090; Shannon K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2939; Simic M, 2009, SOCIOL HEALTH ILL, V31, P1, DOI 10.1111/j.1467-9566.2008.01112.x; Swain SN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-357; Swan H, 2012, J INTERPERS VIOLENCE, V27, P775, DOI 10.1177/0886260511423240; UNAIDS, 2002, SEX WORK HIV AIDS; Watts C, 2002, LANCET, V359, P1232, DOI 10.1016/S0140-6736(02)08221-1; World Health Organization, 2002, WORLD REPORT VIOLENC; World Health Organization, 2007, 3 MIL GLOB CAMP VIOL; World Health Organization, 2005, WHO INF B SER, V3; Zhang C, 2012, AIDS BEHAV, V16, P1020, DOI 10.1007/s10461-011-9968-0	31	55	55	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54147	10.1371/journal.pone.0054147	http://dx.doi.org/10.1371/journal.pone.0054147			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072OV	23342092	Green Submitted, Green Published, gold			2022-12-25	WOS:000313682700090
J	Guan, Y; Du, QA; Zhu, W; Zou, C; Wu, D; Chen, L; Zhang, YA				Guan, Yunqian; Du, Qing-An; Zhu, Wanwan; Zou, Chunlin; Wu, Di; Chen, Ling; Zhang, Yu Alex			Function of Mouse Embryonic Stem Cell-Derived Supporting Cells in Neural Progenitor Cell Maturation and Long Term Cxpansion	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; DOPAMINERGIC-NEURONS; PARKINSONS-DISEASE; ES CELLS; TERATOMA FORMATION; RAT MODEL; IN-VITRO; DIFFERENTIATION; TRANSPLANTATION; MIDBRAIN	Background: In the differentiation of mouse embryonic stem (ES) cells into neurons using the 5-stage method, cells in stage 4 are in general used as neural progenitors (NPs) because of their ability to give rise to neurons. The choice of stage 4 raises several questions about neural progenitors such as the type of cell types that are specifically considered to be neural progenitors, the exact time when these progenitors become capable of neurogenesis and whether neurogenesis is an independent and autonomous process or the result of an interaction between NP cells and the surrounding cells. Methodology/Principal Findings: In this study, we found that the confluent monolayer cells and neural sphere like cell clusters both appeared in the culture of the first 14 days and the subsequent 6 weeks. However, only the sphere cells are neural progenitors that give rise to neurons and astrocytes. The NP cells require 14 days to mature into neural lineages fully capable of differentiation. We also found that although the confluent monolayer cells do not undergo neurogenesis, they play a crucial role in the growth, differentiation, and apoptosis of the sphere cells, during the first 14 days and long term culture, by secreted factors and direct cell to cell contact. Conclusions/Significance: The sphere cells in stage 4 are more committed to developing into neural progenitors than monolayer cells. Interaction between the monolayer cells and sphere cells is important in the development of stage 4 cell characteristics.	[Guan, Yunqian; Du, Qing-An; Zhu, Wanwan; Zou, Chunlin; Wu, Di; Zhang, Yu Alex] Capital Med Univ, Xuanwu Hosp, Beijing Inst Geriatr, Cell Therapy Ctr, Beijing, Peoples R China; [Chen, Ling] Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Chen, L (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing, Peoples R China.	chlyz34@163.com; yaz@bjsap.org		ZOU, CHUNLIN/0000-0002-3308-5544	High Level Talent Fund of the Beijing Healthcare System [2009-2-14, 2011-3-093]; National Science Foundation of China [81272804, 30940039, 30970939]; National Science Foundation of Beijing [7102078]; Beijing Nova Program of Science and Technology [2009B22]; Youth Foundation of Capital Medical University; Science Foundation of the Ministry of Education in China [11120066]; Key Project of Chinese Ministry of Education [210003]	High Level Talent Fund of the Beijing Healthcare System; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of Beijing; Beijing Nova Program of Science and Technology; Youth Foundation of Capital Medical University; Science Foundation of the Ministry of Education in China(Ministry of Education, China); Key Project of Chinese Ministry of Education(Ministry of Education, China)	This work was supported by a research grant from the High Level Talent Fund of the Beijing Healthcare System (Grant No: 2009-2-14, 2011-3-093), National Science Foundation of China (Grant No. 81272804; 30940039; 30970939), National Science Foundation of Beijing (Grant No. 7102078), Beijing Nova Program of Science and Technology (Grant No. 2009B22), Youth Foundation of Capital Medical University and Science Foundation of the Ministry of Education in China (Grant No. 11120066) and Key Project of Chinese Ministry of Education (Grant No. 210003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Boonman Z, 1999, EXP NEUROL, V156, P1, DOI 10.1006/exnr.1999.7056; Brederlau A, 2006, STEM CELLS, V24, P1433, DOI 10.1634/stemcells.2005-0393; Brignier AC, 2010, J ALLERGY CLIN IMMUN, V125, pS336, DOI 10.1016/j.jaci.2009.09.032; Brustle O, 1996, CURR OPIN NEUROBIOL, V6, P688, DOI 10.1016/S0959-4388(96)80104-8; Buhnemann C, 2006, BRAIN, V129, P3238, DOI 10.1093/brain/awl261; Caldero J, 1998, J NEUROSCI, V18, P356; Chung S, 2006, STEM CELLS, V24, P1583, DOI 10.1634/stemcells.2005-0558; Chung S, 2011, P NATL ACAD SCI USA, V108, P9703, DOI 10.1073/pnas.1016443108; Dihne M, 2006, STEM CELLS, V24, P1458, DOI 10.1634/stemcells.2005-0413; Doi D, 2012, STEM CELLS, V30, P935, DOI 10.1002/stem.1060; Du QA, 2011, NEUROSCI LETT, V504, P285, DOI 10.1016/j.neulet.2011.09.048; Friling S, 2009, P NATL ACAD SCI USA, V106, P7613, DOI 10.1073/pnas.0902396106; Goldman S, 2005, NAT BIOTECHNOL, V23, P862, DOI 10.1038/nbt1119; Hayashi MAF, 2010, TISSUE ENG PART C-ME, V16, P1493, DOI [10.1089/ten.tec.2009.0788, 10.1089/ten.TEC.2009.0788]; Hong S, 2008, J NEUROCHEM, V104, P316, DOI 10.1111/j.1471-4159.2007.04952.x; Kawasaki H, 2002, P NATL ACAD SCI USA, V99, P1580, DOI 10.1073/pnas.032662199; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Keung AJ, 2010, ANNU REV CELL DEV BI, V26, P533, DOI 10.1146/annurev-cellbio-100109-104042; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Ringden O, 2003, TRANSPLANTATION, V76, P1011, DOI 10.1097/01.TP.0000090343.52309.CF; Schierle GS, 1999, NAT MED, V5, P97, DOI 10.1038/4785; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Solozobova V, 2012, STEM CELL REV REP, V8, P813, DOI 10.1007/s12015-012-9381-8; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Swistowska AM, 2010, STEM CELLS DEV, V19, P71, DOI 10.1089/scd.2009.0107; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vazin T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006606; Yandava BD, 1999, P NATL ACAD SCI USA, V96, P7029, DOI 10.1073/pnas.96.12.7029; Zeng XM, 2004, STEM CELLS, V22, P925, DOI 10.1634/stemcells.22-6-925	36	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54332	10.1371/journal.pone.0054332	http://dx.doi.org/10.1371/journal.pone.0054332			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342136	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400151
J	Marchetti, M; Onorati, F; Matteucci, M; Mainardi, L; Piccione, F; Silvoni, S; Priftis, K				Marchetti, Mauro; Onorati, Francesco; Matteucci, Matteo; Mainardi, Luca; Piccione, Francesco; Silvoni, Stefano; Priftis, Konstantinos			Improving the Efficacy of ERP-Based BCIs Using Different Modalities of Covert Visuospatial Attention and a Genetic Algorithm-Based Classifier	PLOS ONE			English	Article							BRAIN-COMPUTER-INTERFACE; MENTAL PROSTHESIS; COMMUNICATION; SYSTEM	We investigated whether the covert orienting of visuospatial attention can be effectively used in a brain-computer interface guided by event-related potentials. Three visual interfaces were tested: one interface that activated voluntary orienting of visuospatial attention and two interfaces that elicited automatic orienting of visuospatial attention. We used two epoch classification procedures. The online epoch classification was performed via Independent Component Analysis, and then it was followed by fixed features extraction and support vector machines classification. The offline epoch classification was performed by means of a genetic algorithm that permitted us to retrieve the relevant features of the signal, and then to categorise the features with a logistic classifier. The offline classification, but not the online one, allowed us to differentiate between the performances of the interface that required voluntary orienting of visuospatial attention and those that required automatic orienting of visuospatial attention. The offline classification revealed an advantage of the participants in using the "voluntary" interface. This advantage was further supported, for the first time, by neurophysiological data. Moreover, epoch analysis was performed better with the "genetic algorithm classifier" than with the "independent component analysis classifier". We suggest that the combined use of voluntary orienting of visuospatial attention and of a classifier that permits feature extraction ad personam (i.e., genetic algorithm classifier) can lead to a more efficient control of visual BCIs.	[Marchetti, Mauro; Priftis, Konstantinos] Univ Padua, Dept Gen Psychol, Padua, Italy; [Onorati, Francesco] Politecn Milan, Dept Bioengn, I-20133 Milan, Italy; [Matteucci, Matteo; Mainardi, Luca] Politecn Milan, Dept Elect & Informat, I-20133 Milan, Italy; [Piccione, Francesco; Silvoni, Stefano] IRCCS San Camillo Hosp, Dept Neurophysiol, Venice, Italy; [Priftis, Konstantinos] IRCCS San Camillo Hosp, Neuropsychol Lab, Venice, Italy	University of Padua; Polytechnic University of Milan; Polytechnic University of Milan; IRCCS Ospedale San Camillo; IRCCS Ospedale San Camillo	Priftis, K (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	konstantinos.priftis@unipd.it	MAINARDI, LUCA/CAG-8179-2022; Onorati, Francesco/U-8336-2019; Onorati, Francesco/J-4279-2018; Priftis, Konstantinos/B-7862-2008; Piccione, Francesco/K-7214-2016	Onorati, Francesco/0000-0002-0879-3557; Priftis, Konstantinos/0000-0002-5215-4621; Piccione, Francesco/0000-0002-0173-903X; Mainardi, Luca/0000-0002-6276-6314; Marchetti, Mauro/0000-0002-8474-2874				Allison BZ, 2003, IEEE T NEUR SYS REH, V11, P110, DOI 10.1109/TNSRE.2003.814448; Beverina F, 2004, PSYCHNOLOGY J, V1, P331; Bianchi L, 2007, IEEE T NEUR SYS REH, V15, P207, DOI 10.1109/TNSRE.2007.897024; Birbaumer N, 2006, CLIN NEUROPHYSIOL, V117, P479, DOI 10.1016/j.clinph.2005.11.002; Birbaumer N, 2006, PSYCHOPHYSIOLOGY, V43, P517, DOI 10.1111/j.1469-8986.2006.00456.x; Boostani R, 2007, MED BIOL ENG COMPUT, V45, P403, DOI 10.1007/s11517-007-0169-y; Brouwer AM, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00019; Brunner P, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056013; Cecotti H, 2010, IEEE T NEUR SYS REH, V18, P127, DOI 10.1109/TNSRE.2009.2039594; Citi L, 2004, LAT BREAK GEN EV COM; Cohen J, 1997, INT J PSYCHOPHYSIOL, V25, P249, DOI 10.1016/S0167-8760(96)00743-X; Cover TM, 1991, ELEMENTS INFORM THEO; Dal Seno Bernardo, 2010, Computational Intelligence & Neuroscience, DOI 10.1155/2010/307254; Dal Seno B, 2010, IEEE T NEUR SYS REH, V18, P20, DOI 10.1109/TNSRE.2009.2032642; Dal Seno B, 2008, IEEE IJCNN, P3145, DOI 10.1109/IJCNN.2008.4634243; Donchin E, 2000, IEEE T REHABIL ENG, V8, P174, DOI 10.1109/86.847808; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Furdea A, 2009, PSYCHOPHYSIOLOGY, V46, P617, DOI 10.1111/j.1469-8986.2008.00783.x; Goldberg D. E., 1989, GENETIC ALGORITHMS S; Goldberg D. E., 1989, COMPLEX SYST, V3, P493, DOI DOI 10.1007/978-1-4757-3643-4; Halder S, 2010, CLIN NEUROPHYSIOL, V121, P516, DOI 10.1016/j.clinph.2009.11.087; Hoffmann U, 2008, J NEUROSCI METH, V167, P115, DOI 10.1016/j.jneumeth.2007.03.005; Holland J.H., 1992, ADAPTATION NATURAL A; Jung JP, 1998, ADV NEURAL INFORM PR, V10, P894; Jung TP, 2001, HUM BRAIN MAPP, V14, P166, DOI 10.1002/hbm.1050; Karjalainen PA, 1999, IEEE T BIO-MED ENG, V46, P849, DOI 10.1109/10.771195; Kleih SC, 2011, PROG BRAIN RES, V194, P27, DOI 10.1016/B978-0-444-53815-4.00019-4; Klobassa DS, 2009, CLIN NEUROPHYSIOL, V120, P1252, DOI 10.1016/j.clinph.2009.04.019; Krusienski DJ, 2008, J NEUROSCI METH, V167, P15, DOI 10.1016/j.jneumeth.2007.07.017; KUBLER A, 2001, BRAIN COMPUTER COMMU, V127, P358, DOI DOI 10.1037//0033-2909.127.3.358; Kubler A, 2008, CLIN NEUROPHYSIOL, V119, P2658, DOI 10.1016/j.clinph.2008.06.019; LECESSIE S, 1992, APPL STAT-J ROY ST C, V41, P191; Li YQ, 2011, INT J HUM-COMPUT INT, V27, P52, DOI 10.1080/10447318.2011.535753; Liu Y, 2011, CLIN NEUROPHYSIOL, V122, P1127, DOI 10.1016/j.clinph.2010.10.049; Luck S.J., 2005, INTRO EVENT RELATED; Marchetti M, 2012, CLIN NEUROPHYSIOL, V123, P774, DOI 10.1016/j.clinph.2011.07.045; Miceli G, 1994, BATTERIA PER ANALISI; Murguialday AR, 2011, CLIN NEUROPHYSIOL, V122, P925, DOI 10.1016/j.clinph.2010.08.019; Murray LM, 2010, NEUROPATH APPL NEURO, V36, P133, DOI [10.1111/j.1365-2990.2009.01061.x, 10.1111/j.1365-2990.2010.01061.x]; Piccione F, 2006, CLIN NEUROPHYSIOL, V117, P531, DOI 10.1016/j.clinph.2005.07.024; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1017/S0048577200000305; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Rakotomarnonjy A, 2008, IEEE T BIO-MED ENG, V55, P1147, DOI 10.1109/TBME.2008.915728; Rastjoo A, 2009, STUD HEALTH TECHNOL, V142, P265, DOI 10.3233/978-1-58603-964-6-265; Sellers EW, 2006, BIOL PSYCHOL, V73, P242, DOI 10.1016/j.biopsycho.2006.04.007; Sellers EW, 2010, AMYOTROPH LATERAL SC, V11, P449, DOI 10.3109/17482961003777470; Sellers EW, 2006, CLIN NEUROPHYSIOL, V117, P538, DOI 10.1016/j.clinph.2005.06.027; Silvoni S, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.20.001.2009; Smith E, 2005, BMJ-BRIT MED J, V330, P406, DOI 10.1136/bmj.330.7488.406; STONE M, 1974, BIOMETRIKA, V61, P509, DOI 10.1093/biomet/61.3.509; Takano K, 2009, CLIN NEUROPHYSIOL, V120, P1562, DOI 10.1016/j.clinph.2009.06.002; Treder MS, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-28; van Gerven M, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/041001; Van Rijsbergen C, 1980, INFORM RETRIEVAL; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; Wang T, 2004, CLIN NEUROPHYSIOL, V115, P2744, DOI 10.1016/j.clinph.2004.06.022; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Wright R.D, 2008, ORIENTING ATTENTION	59	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53946	10.1371/journal.pone.0053946	http://dx.doi.org/10.1371/journal.pone.0053946			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	087KE	23342043	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400103
J	Oteng-Ntim, E; Kopeika, J; Seed, P; Wandiembe, S; Doyle, P				Oteng-Ntim, Eugene; Kopeika, Julia; Seed, Paul; Wandiembe, Symon; Doyle, Pat			Impact of Obesity on Pregnancy Outcome in Different Ethnic Groups: Calculating Population Attributable Fractions	PLOS ONE			English	Article							BODY-MASS INDEX; MATERNAL OBESITY; RISK-FACTORS; INEQUALITIES; WEIGHT; COHORT; BMI	Objectives: To quantify the proportion of adverse pregnancy outcome attributable to maternal obesity. Design: Cross sectional analysis of routine obstetric dataset. Setting: Guy's and St Thomas's NHS Foundation Trust (GSTFT). Population: 23,668 women who had singleton deliveries at GSTFT between 2004 and 2008. Methods: Logistic regression was used to estimate the association between BMI and outcome in different ethnic groups. Adjusted odds ratios, and the proportions of obese women, were used to calculate population attributable risk fractions (PAFs). Main Outcome Measures: (i) Maternal outcomes: diabetes, type of delivery, post-partum haemorrhage, and preterm delivery. (ii) Perinatal outcomes: macrosomia, low birth weight, admission to neonatal intensive care/special care baby unit, and perinatal death. Results: The prevalence of maternal obesity was 14%. Increasing BMI was independently associated with increasing risk of adverse obstetric and neonatal outcome. At the individual level, the effect of obesity on diabetes was highest in Asian women compared to white women (p for interaction = 0.03). Calculation of population attributable risk fractions demonstrated that one third of diabetes cases and one in six Caesarean sections could be avoided in this population if all obese women were of normal BMI. At the population level, the contribution of obesity to diabetes was highest for Black women (42%), and lowest for oriental women (8%). Seven percent of neonatal macrosomia in all the population, and 13% in Black mothers, were attributable to obesity. Conclusions: Preventing obesity prior to pregnancy will substantially reduce the burden of obstetric and neonatal morbidity in this population. This reduction will be higher in Black women.	[Oteng-Ntim, Eugene; Kopeika, Julia; Seed, Paul; Wandiembe, Symon] St Thomas Hosp, Dept Womens Hlth, Guys & St Thomas Natl Hlth Serv NHS Fdn Trust, Kings Hlth Partners, London, England; [Oteng-Ntim, Eugene; Doyle, Pat] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; London School of Hygiene & Tropical Medicine	Oteng-Ntim, E (corresponding author), St Thomas Hosp, Dept Womens Hlth, Guys & St Thomas Natl Hlth Serv NHS Fdn Trust, Kings Hlth Partners, London, England.	Eugene.Oteng-Ntim@gstt.nhs.uk	Seed, Paul T/C-4435-2008	Seed, Paul T/0000-0001-7904-7933; Kopeika, Julia/0000-0001-8363-388X	Guy's and St Thomas' Charity; National Institute for Health Research [ACF-2009-17-020] Funding Source: researchfish	Guy's and St Thomas' Charity; National Institute for Health Research(National Institute for Health Research (NIHR))	Support of this work was funded by Guy's and St Thomas' Charity. The funders have no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, DEF DIAGN CLASS DI 1; Carr DB, 2011, HYPERTENS PREGNANCY, V30, P153, DOI 10.3109/10641950903115012; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; Djelantik AAAMJ, 2012, BJOG-INT J OBSTET GY, V119, P283, DOI 10.1111/j.1471-0528.2011.03205.x; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Government Docal. IMD, 2007, ENGL IND DEPR; GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206; Heslehurst N, 2008, OBES REV, V9, P635, DOI 10.1111/j.1467-789X.2008.00511.x; Heslehurst N, 2010, INT J OBESITY, V34, P420, DOI 10.1038/ijo.2009.250; Hulsey TC, 2005, SOUTH MED J, V98, P411, DOI 10.1097/01.SMJ.0000145283.69631.FC; Knight M, 2008, BJOG-INT J OBSTET GY, V115, P453, DOI 10.1111/j.1471-0528.2007.01622.x; Knight M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b542; Lu GC, 2001, AM J OBSTET GYNECOL, V185, P845, DOI 10.1067/mob.2001.117351; Makgoba M, 2012, BJOG-INT J OBSTET GY, V119, P276, DOI 10.1111/j.1471-0528.2011.03156.x; Metzger BE, 2010, BJOG-INT J OBSTET GY, V117, P575, DOI 10.1111/j.1471-0528.2009.02486.x; Modder J., 2010, CMACE RCOG JOINT GUI, P1; National Institute for Health and Clinical Excellence, 2008, NICE DIAB PREGN GUID; National Institute for Health and Clinical Excellence, 2010, NICE PUBL HLTH GUID, P60; Nelson SM, 2010, HUM REPROD UPDATE, V16, P255, DOI 10.1093/humupd/dmp050; O'Brien TE, 2003, EPIDEMIOLOGY, V14, P368, DOI 10.1097/00001648-200305000-00020; Poobalan AS, 2009, OBES REV, V10, P28, DOI 10.1111/j.1467-789X.2008.00537.x; Poston L, 2011, PROG BIOPHYS MOL BIO, V106, P315, DOI 10.1016/j.pbiomolbio.2010.11.011; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Torloni MR, 2009, OBES REV, V10, P194, DOI 10.1111/j.1467-789X.2008.00541.x	26	52	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53749	10.1371/journal.pone.0053749	http://dx.doi.org/10.1371/journal.pone.0053749			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341993	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000314759400077
J	Pan, SC; Tien, KL; Hung, IC; Lin, YJ; Sheng, WH; Wang, MJ; Chang, SC; Kunin, CM; Chen, YC				Pan, Sung-Ching; Tien, Kuei-Lien; Hung, I-Chen; Lin, Yu-Jiun; Sheng, Wang-Huei; Wang, Ming-Jiuh; Chang, Shan-Chwen; Kunin, Calvin M.; Chen, Yee-Chun			Compliance of Health Care Workers with Hand Hygiene Practices: Independent Advantages of Overt and Covert Observers	PLOS ONE			English	Article							IMPROVE COMPLIANCE	Background: Evaluation and feedback of hand hygiene (HH) compliance are important elements of the WHO multimodal strategy for hospital infection control. Overt observation is recommended, but it may be confounded by Hawthorne effect. Covert observation offers the opportunity to decrease observer bias. In this study we conducted a one year hospital-wide HH promotion program that included medical students (MS) as covert observers. Methods: HH compliance for the five WHO indications was determined by trained and validated observers. The overt observers consisted of eleven infection control nurses (ICNs) and two unit HH ambassadors (UAs) in each of 83 wards. The covert observers consisted of nine MS during their rotating clinical clerkships. Feedback was provided to department heads and staff each quarter. Results: Of the 23,333 HH observations 76.0% were by MS, 5.3% by ICNs and 18.7% by UAs. The annual compliance rates were MS 44.1%, ICNs 74.4% and UAs 94.1%; P<0.001. The MS found significantly lower annual compliance rates for 4/5 HH indications compared to ICNs and UAs; P<0.05. The ICNs reported significantly improvement from the first to the fourth quarter; P<0.001. This was associated with feedback from the MS of very poor compliance by nurses during the first quarter. Conclusions: Based on these findings we recommend a two-pronged approach to HH programs. The role of ICNs and UAs is to educate, serve as role models, establish, sustain good HH practices and provide direct feedback. The role of the covert observers is to measure compliance and provide independent feedback.	[Pan, Sung-Ching; Tien, Kuei-Lien; Hung, I-Chen; Lin, Yu-Jiun; Sheng, Wang-Huei; Chang, Shan-Chwen; Chen, Yee-Chun] Natl Taiwan Univ Hosp, Ctr Infect Control, Taipei, Taiwan; [Pan, Sung-Ching; Sheng, Wang-Huei; Chen, Yee-Chun] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Wang, Ming-Jiuh] Natl Taiwan Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Wang, Ming-Jiuh] Natl Taiwan Univ Hosp, Dept Hosp Planning, Taipei, Taiwan; [Chang, Shan-Chwen; Chen, Yee-Chun] Natl Taiwan Univ, Dept Med, Coll Med, Taipei 10764, Taiwan; [Kunin, Calvin M.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Kunin, Calvin M.] Univ Arizona, Tucson, AZ USA	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; University System of Ohio; Ohio State University; University of Arizona	Chen, YC (corresponding author), Natl Taiwan Univ Hosp, Ctr Infect Control, Taipei, Taiwan.	yeechunchen@gmail.com	Chen, Yee-Chun/AGW-7535-2022	Chen, Yee-Chun/0000-0002-1816-9010; PAN, SUNG-CHING/0000-0003-3154-6690; CHANG, SHAN-CHWEN/0000-0001-6505-4139; SHENG, WANG-HUEI/0000-0002-5605-7853	Center for Diseases Control, Department of Health, Taiwan [EU098040]; Department of Health, Taiwan [DOH100-TD-B-111-001]	Center for Diseases Control, Department of Health, Taiwan; Department of Health, Taiwan	The authors are grateful to members of the NTUH Center for Infection Control and Center for Quality Control for their sustained support of the hand hygiene program and the hospital staff for their commitment to improve patient safety and reduce healthcare-associated infections. The authors are indebted to the Center for Diseases Control, Department of Health, Taiwan, for providing financial support for the Center for Excellence for Hand Hygiene (EU098040). Y. C. Chen also received a grant from Department of Health, Taiwan (DOH100-TD-B-111-001). The funding organizations were not involved in designing or conducting the study, the data collection, management, analysis, and interpretation, nor the preparation, and approval of the manuscript.	Boyce JM, 2002, INFECT CONT HOSP EP, V23, pS3, DOI 10.1086/503164; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Chuang YC, 2010, J HOSP INFECT, V76, P143, DOI 10.1016/j.jhin.2010.05.001; Daniels TL, 2012, J INFECT DIS, V206, P1488, DOI 10.1093/infdis/jis549; Eckmanns T, 2006, INFECT CONT HOSP EP, V27, P931, DOI 10.1086/507294; Haas JP, 2007, J HOSP INFECT, V66, P6, DOI 10.1016/j.jhin.2006.11.013; Hornbeck T, 2012, J INFECT DIS, V206, P1549, DOI 10.1093/infdis/jis542; Lin HC, 2010, INFECT CONTROL J, V20, P146; McAteer J, 2008, J HOSP INFECT, V68, P222, DOI 10.1016/j.jhin.2007.12.009; Miyachi H, 2007, AM J INFECT CONTROL, V35, P115, DOI 10.1016/j.ajic.2006.09.003; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Pittet D, 1999, ANN INTERN MED, V130, P126, DOI 10.7326/0003-4819-130-2-199901190-00006; Rosenthal T, 2009, ACAD MED, V84, P1705, DOI 10.1097/ACM.0b013e3181bf6988; SETO WH, 1991, AM J INFECT CONTROL, V19, P86, DOI 10.1016/0196-6553(91)90044-D; Son C, 2011, AM J INFECT CONTROL, V39, P716, DOI 10.1016/j.ajic.2010.12.008; van de Mortel T, 2006, AM J INFECT CONTROL, V34, P95, DOI 10.1016/j.ajic.2005.07.006; WHO Training Film, IMPL TOOLK; World Health Organization (WHO), 2009, WHO GUID HAND HYG HL	18	99	100	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53746	10.1371/journal.pone.0053746	http://dx.doi.org/10.1371/journal.pone.0053746			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341991	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400076
J	Rao, KH; Ghosh, S; Natarajan, K; Datta, A				Rao, Kongara Hanumantha; Ghosh, Swagata; Natarajan, Krishnamurthy; Datta, Asis			N-Acetylglucosamine Kinase, HXK1 Is Involved in Morphogenetic Transition and Metabolic Gene Expression in Candida albicans	PLOS ONE			English	Article							FILAMENTOUS GROWTH; CATABOLIC PATHWAY; GLUCOSE SENSOR; IDENTIFICATION; INDUCTION; HEXOKINASE; EPITHELIUM; VIRULENCE; PROTEINS; PROMOTER	Candida albicans, a common fungal pathogen which diverged from the baker's yeast Saccharomyces cerevisiae has the unique ability to utilise N-acetylglucosamine, an amino sugar and exhibits phenotypic differences. It has acquired intricate regulatory mechanisms at different levels in accordance with its life style. N-acetylglucosamine kinase, a component of the N-acetylglucosamine catabolic cascade is an understudied gene since Saccharomyces cerevisiae lacks it. We report HXK1 to act as both positive and negative regulator of transcription of genes involved in maintaining cellular homeostasis. It is involved in repression of hyphal specific genes in addition to metabolic genes. Its regulation of filamentation and GlcNAc metabolism is independent of the known classical regulators like EFG1, CPH1, RAS1, TPK2 or TUP1. Moreover, Hxk1-GFP is localised to cytoplasm, nucleus and mitochondria in a condition specific manner. By employing two-step affinity purification, we report the interaction of HXK1 with SIR2 under filamentation inducing conditions. Our work highlights a novel regulatory mechanism involved in filamentation repression and attempts to decipher the GlcNAc catabolic regulatory cascade in eukaryotes.	[Rao, Kongara Hanumantha; Ghosh, Swagata; Datta, Asis] Natl Inst Plant Genome Res, New Delhi, India; [Natarajan, Krishnamurthy] Jawaharlal Nehru Univ, Sch Life Sci, Lab Eukaryot Gene Express, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR); Jawaharlal Nehru University, New Delhi	Natarajan, K (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Lab Eukaryot Gene Express, New Delhi 110067, India.	nat0200@mail.jnu.ac.in; asis_datta@rediffmail.com		Hanumantha Rao, Kongara/0000-0002-2856-9704	Indian Council of Medical Research (ICMR), Government of India [5/3/3/16/2007-ECD-1]; Department of Biotechnology, Ministry of Science & Technology, Government of India; CSIR	Indian Council of Medical Research (ICMR), Government of India(Indian Council of Medical Research (ICMR)); Department of Biotechnology, Ministry of Science & Technology, Government of India(Department of Biotechnology (DBT) India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This study was funded by Indian Council of Medical Research (ICMR, project-file number 5/3/3/16/2007-ECD-1), Government of India and Professor of Eminence Scheme of NIPGR, Department of Biotechnology, Ministry of Science & Technology, Government of India. K. H. R and S. G. received financial assistance from CSIR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez FJ, 2007, MOL BIOL CELL, V18, P965, DOI 10.1091/mbc.E06-10-0931; Aususbel FM, 2000, CURRENT PROTOCOLS MO; Bertram G, 1996, YEAST, V12, P115, DOI 10.1002/(SICI)1097-0061(199602)12:2<115::AID-YEA889>3.0.CO;2-E; Bhushan D, 2006, J PROTEOME RES, V5, P1711, DOI 10.1021/pr060116f; BISWAS M, 1979, BIOCHIM BIOPHYS ACTA, V585, P535, DOI 10.1016/0304-4165(79)90186-7; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Boehmelt G, 2000, EMBO J, V19, P5092, DOI 10.1093/emboj/19.19.5092; Braun BR, 2000, GENETICS, V156, P31; Braun BR, 2000, GENETICS, V155, P57; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; Brown V, 2006, EUKARYOT CELL, V5, P1726, DOI 10.1128/EC.00186-06; Brown V, 2009, CURR BIOL, V19, P436, DOI 10.1016/j.cub.2009.01.056; Cho YH, 2006, CELL, V127, P579, DOI 10.1016/j.cell.2006.09.028; DELBRUCK S, 1993, MOL MICROBIOL, V10, P859, DOI 10.1111/j.1365-2958.1993.tb00956.x; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; FONZI WA, 1993, GENETICS, V134, P717; Frommer WB, 2003, SCIENCE, V300, P261, DOI 10.1126/science.1084120; Gancedo C, 2008, MICROBIOL MOL BIOL R, V72, P197, DOI 10.1128/MMBR.00036-07; Gerami-Nejad M, 2001, YEAST, V18, P859, DOI 10.1002/yea.738; Gietz D, 1998, METHOD MICROBIOL, V26, P53; Giusani AD, 2002, GENETICS, V160, P1749; Gunasekera A, 2010, EUKARYOT CELL, V9, P1476, DOI 10.1128/EC.00178-10; Guthrie C, 1991, GUIDE YEAST GENETICS; Hall DA, 2004, SCIENCE, V306, P482, DOI 10.1126/science.1096773; Kadosh D, 2005, MOL BIOL CELL, V16, P2903, DOI 10.1091/mbc.E05-01-0073; Kaneko A, 2004, YEAST, V21, P1025, DOI 10.1002/yea.1147; Kumar MJ, 2000, P NATL ACAD SCI USA, V97, P14218, DOI 10.1073/pnas.250452997; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Liu HP, 2001, CURR OPIN MICROBIOL, V4, P728, DOI 10.1016/S1369-5274(01)00275-2; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; MALATHI K, 1994, J BIOL CHEM, V269, P22945; Martchenko M, 2007, CURR BIOL, V17, P1007, DOI 10.1016/j.cub.2007.05.017; Mio T, 2000, MICROBIOL-SGM, V146, P1753, DOI 10.1099/00221287-146-7-1753; Mishra PK, 2011, P NATL ACAD SCI USA, V108, P11965, DOI 10.1073/pnas.1109631108; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Moreno F, 2005, BIOCHEM SOC T, V33, P265, DOI 10.1042/BST0330265; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Naseem S, 2011, J BIOL CHEM, V286, P28671, DOI 10.1074/jbc.M111.249854; Perez-Martin J, 1999, EMBO J, V18, P2580, DOI 10.1093/emboj/18.9.2580; Reutter, 1997, GLYCOSCIENCES STATUS, P245; Sambrook J., 2001, MOL CLONING LAB MANU; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sexton JA, 2007, YEAST, V24, P847, DOI 10.1002/yea.1514; SHEPHERD MG, 1980, CAN J MICROBIOL, V26, P21, DOI 10.1139/m80-004; Singh P, 2001, INFECT IMMUN, V69, P7898, DOI 10.1128/IAI.69.12.7898-7903.2001; Sonneborn A, 2000, MOL MICROBIOL, V35, P386, DOI 10.1046/j.1365-2958.2000.01705.x; Stevenson John S, 2011, Mol Microbiol, V81, P1078, DOI 10.1111/j.1365-2958.2011.07754.x; Stoldt VR, 1997, EMBO J, V16, P1982, DOI 10.1093/emboj/16.8.1982; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VIDOTTO V, 1986, MYCOPATHOLOGIA, V95, P73, DOI 10.1007/BF00437163; Wendland J, 2006, J BASIC MICROB, V46, P513, DOI 10.1002/jobm.200610167; Whiteway M, 2007, ANNU REV MICROBIOL, V61, P529, DOI 10.1146/annurev.micro.61.080706.093341; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Wolosker H, 1998, FASEB J, V12, P91, DOI 10.1096/fasebj.12.1.91; Yamada-Okabe T, 2001, EUR J BIOCHEM, V268, P2498, DOI 10.1046/j.1432-1327.2001.02135.x; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	57	29	33	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53638	10.1371/journal.pone.0053638	http://dx.doi.org/10.1371/journal.pone.0053638			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341961	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400055
J	Romanelli, P; Fardone, E; Battaglia, G; Brauer-Krisch, E; Prezado, Y; Requardt, H; Le Duc, G; Nemoz, C; Anschel, DJ; Spiga, J; Bravin, A				Romanelli, Pantaleo; Fardone, Erminia; Battaglia, Giuseppe; Braeuer-Krisch, Elke; Prezado, Yolanda; Requardt, Herwig; Le Duc, Geraldine; Nemoz, Christian; Anschel, David J.; Spiga, Jenny; Bravin, Alberto			Synchrotron-Generated Microbeam Sensorimotor Cortex Transections Induce Seizure Control without Disruption of Neurological Functions	PLOS ONE			English	Article							X-RAY MICROBEAMS; MULTIPLE SUBPIAL TRANSECTIONS; RADIATION-THERAPY; IN-VIVO; MICROPLANAR BEAMS; VISUAL-CORTEX; EPILEPTIFORM DISCHARGES; CLINICAL-TRIALS; MOUSE-BRAIN; NEOCORTEX	Synchrotron-generated X-ray microplanar beams (microbeams) are characterized by the ability to deliver extremely high doses of radiation to spatially restricted volumes of tissue. Minimal dose spreading outside the beam path provides an exceptional degree of protection from radio-induced damage to the neurons and glia adjacent to the microscopic slices of tissue irradiated. The preservation of cortical architecture following high-dose microbeam irradiation and the ability to induce non-invasively the equivalent of a surgical cut over the cortex is of great interest for the development of novel experimental models in neurobiology and new treatment avenues for a variety of brain disorders. Microbeams (size 100 mu m/600 mu m, center-to-center distance of 400 mu m/1200 mu m, peak entrance doses of 360-240 Gy/150-100 Gy) delivered to the sensorimotor cortex of six 2-month-old naive rats generated histologically evident cortical transections, without modifying motor behavior and weight gain up to 7 months. Microbeam transections of the sensorimotor cortex dramatically reduced convulsive seizure duration in a further group of 12 rats receiving local infusion of kainic acid. No subsequent neurological deficit was associated with the treatment. These data provide a novel tool to study the functions of the cortex and pave the way for the development of new therapeutic strategies for epilepsy and other neurological diseases.	[Romanelli, Pantaleo] Cyberknife Ctr, Ctr Diagnost Italiano, Milan, Italy; [Romanelli, Pantaleo] AB Med, Lainate, Italy; [Romanelli, Pantaleo; Fardone, Erminia; Braeuer-Krisch, Elke; Prezado, Yolanda; Requardt, Herwig; Le Duc, Geraldine; Nemoz, Christian; Bravin, Alberto] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Battaglia, Giuseppe] Ist Ricovero & Cura Carattere Sci Neuromed, Localita Camerelle, Pozzilli, Italy; [Anschel, David J.] St Charles Hosp, Comprehens Epilepsy Ctr Long Isl, Port Jefferson, NY USA; [Spiga, Jenny] Univ Cagliari, Dept Phys, Monserrato, Italy; [Spiga, Jenny] Ist Nazl Fis Nucl, Monserrato, Italy	European Synchrotron Radiation Facility (ESRF); IRCCS Neuromed; University of Cagliari; Istituto Nazionale di Fisica Nucleare (INFN)	Romanelli, P (corresponding author), Cyberknife Ctr, Ctr Diagnost Italiano, Milan, Italy.	radiosurgery2000@yahoo.com	Bravin, Alberto/AAN-6114-2020; prezado, yolanda/O-7376-2014; Bravin, Alberto/R-8633-2016; Battaglia, Giuseppe/A-7709-2010; Fardone, Erminia/ABA-1695-2021; Brauer-Krisch, Elke/O-6026-2017; prezado, yolanda/B-8455-2009	Bravin, Alberto/0000-0001-6868-2755; Bravin, Alberto/0000-0001-6868-2755; Battaglia, Giuseppe/0000-0001-7571-3417; Spiga, Jenny/0000-0002-6741-8028; Brauer-Krisch, Elke/0000-0003-4587-1160; prezado, yolanda/0000-0001-5957-2327	European Synchrotron Radiation Facility	European Synchrotron Radiation Facility	European Synchrotron Radiation Facility (internal research funds). http://www.esrf.fr/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blattmann H, 2005, NUCL INSTRUM METH A, V548, P17, DOI 10.1016/j.nima.2005.03.060; Brauer-Krisch E, 2010, MUTAT RES-REV MUTAT, V704, P160, DOI 10.1016/j.mrrev.2009.12.003; Brauer-Krisch E, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3170035; CHERVIN RD, 1988, J NEUROPHYSIOL, V60, P1695, DOI 10.1152/jn.1988.60.5.1695; Cullen DE, 1989, UCRL50400 EPDL LAW A, V6; Curtis H J, 1967, Radiat Res Suppl, V7, P250, DOI 10.2307/3583718; Curtis H J, 1967, Radiat Res Suppl, V7, P258, DOI 10.2307/3583719; Dilmanian FA, 2007, EXP HEMATOL, V35, P69, DOI 10.1016/j.exphem.2007.01.014; Dilmanian FA, 2006, P NATL ACAD SCI USA, V103, P9709, DOI 10.1073/pnas.0603567103; Dilmanian FA, 2005, NUCL INSTRUM METH A, V548, P30, DOI 10.1016/j.nima.2005.03.062; Dilmanian FA, 2003, RADIAT RES, V159, P632, DOI 10.1667/0033-7587(2003)159[0632:MECHTE]2.0.CO;2; Dilmanian FA, 2002, NEURO-ONCOLOGY, V4, P26, DOI 10.1093/neuonc/4.1.26; Dilmanian FA, 2001, CELL MOL BIOL, V47, P485; Eidelberg G, 1959, ELECTROENCEPHALOGR C, V11, P121; GABBIANI G, 1984, J CELL SCI, V66, P39; Hashizume K, 1998, EPILEPSY RES, V32, P389, DOI 10.1016/S0920-1211(98)00065-5; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Laissue JA, 2007, DEV MED CHILD NEUROL, V49, P577, DOI 10.1111/j.1469-8749.2007.00577.x; Laissue JA, 1998, INT J CANCER, V78, P654, DOI 10.1002/(SICI)1097-0215(19981123)78:5<654::AID-IJC21>3.0.CO;2-L; Martinez-Rovira I, 2010, PHYS MED BIOL, V55, P4375, DOI 10.1088/0031-9155/55/15/012; Miura M, 2006, BRIT J RADIOL, V79, P71, DOI 10.1259/bjr/50464795; MORRELL F, 1989, J NEUROSURG, V70, P231, DOI 10.3171/jns.1989.70.2.0231; Morrell F, 1995, BRAIN, V118, P1529, DOI 10.1093/brain/118.6.1529; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Mulligan LP, 2001, EPILEPSIA, V42, P226; Orbach D, 2001, EPILEPSIA, V42, P1316, DOI 10.1111/j.1528-1167.2001.45300.x; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Prezado Y, 2011, MED PHYS, V38, P5012, DOI 10.1118/1.3608908; Prezado Y, 2009, MED PHYS, V36, P725, DOI 10.1118/1.3070538; REICHENTHAL E, 1977, ELECTROEN CLIN NEURO, V42, P248, DOI 10.1016/0013-4694(77)90031-1; Romanelli P, 2011, NEUROL RES, V33, P825, DOI 10.1179/016164111X13123658647445; Salvat F, 2006, 6222 OECD NUCL EN AG, V6222; Sempau J, 2006, PHYS MED BIOL, V51, P3533, DOI 10.1088/0031-9155/51/14/017; Sempau J, 2001, PHYS MED BIOL, V46, P1163, DOI 10.1088/0031-9155/46/4/318; Serduc R, 2006, INT J RADIAT ONCOL, V64, P1519, DOI 10.1016/j.ijrobp.2005.11.047; Serduc R, 2008, PHYS MED BIOL, V53, P3609, DOI 10.1088/0031-9155/53/13/015; Serduc R, 2010, J SYNCHROTRON RADIAT, V17, P325, DOI 10.1107/S0909049510006667; Siegbahn EA, 2006, MED PHYS, V33, P3248, DOI 10.1118/1.2229422; SLATKIN DN, 1992, MED PHYS, V19, P1395, DOI 10.1118/1.596771; SLATKIN DN, 1995, P NATL ACAD SCI USA, V92, P8783, DOI 10.1073/pnas.92.19.8783; Smilowitz HM, 2006, J NEURO-ONCOL, V78, P135, DOI 10.1007/s11060-005-9094-9; SPERRY RW, 1955, J COMP PHYSIOL PSYCH, V48, P50, DOI 10.1037/h0043456; Telfeian AE, 1998, EPILEPSIA, V39, P700, DOI 10.1111/j.1528-1157.1998.tb01154.x; Torres J, 2004, MED PHYS, V31, P296, DOI 10.1118/1.1637970; Uyama A, 2011, J SYNCHROTRON RADIAT, V18, P671, DOI 10.1107/S090904951101185X; WADMAN WJ, 1993, NEUROSCIENCE, V52, P255, DOI 10.1016/0306-4522(93)90154-8; ZEMAN W, 1961, RADIAT RES, V15, P496, DOI 10.2307/3571293; Zhong N, 2003, RADIAT RES, V160, P133, DOI 10.1667/3033	49	19	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53549	10.1371/journal.pone.0053549	http://dx.doi.org/10.1371/journal.pone.0053549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341950	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400049
J	Sebban, S; Farago, M; Gashai, D; Ilan, L; Pikarsky, E; Ben-Porath, I; Katzav, S				Sebban, Shulamit; Farago, Marganit; Gashai, Dan; Ilan, Lena; Pikarsky, Eli; Ben-Porath, Ittai; Katzav, Shulamit			Vav1 Fine Tunes p53 Control of Apoptosis versus Proliferation in Breast Cancer	PLOS ONE			English	Article							SIGNAL TRANSDUCER VAV1; CELL-RECEPTOR SIGNALS; TYROSINE PHOSPHORYLATION; PROTOONCOGENE PRODUCT; NEGATIVE REGULATION; GROWTH-FACTOR; LUNG-CANCER; T-CELLS; CBL-B; ACTIVATION	Vav1 functions as a signal transducer protein in the hematopoietic system, where it is exclusively expressed. Vav1 was recently implicated in several human cancers, including lung, pancreatic and neuroblasoma. In this study, we analyzed the expression and function of Vav1 in human breast tumors and breast cancer cell lines. Immunohistochemical analysis of primary human breast carcinomas indicated that Vav1 is expressed in 62% of 65 tumors tested and is correlated positively with estrogen receptor expression. Based on published gene profiling of 50 breast cancer cell lines, several Vav1-expressing cell lines were identified. RT-PCR confirmed Vav1 mRNA expression in several of these cell lines, yet no detectable levels of Vav1 protein were observed due to cbl-c proteasomal degradation. We used two of these lines, MCF-7 (Vav1 mRNA negative) and AU565 (Vav1 mRNA positive), to explore the effect of Vav1 expression on breast cell phenotype and function. Vav1 expression had opposite effects on function in these two lines: it reduced proliferation and enhanced cell death in MCF-7 cells but enhanced proliferation in AU565 cells. Consistent with these findings, transcriptome analysis revealed an increase in expression of proliferation-related genes in Vav1-expressing AU565 cells compared to controls, and an increase in apoptosis-related genes in Vav1-expressing MCF-7 cells compared with controls. TUNEL and gamma-H2AX foci assays confirmed that expression of Vav1 increased apoptosis in MCF-7 cells but not AU565 cells and shRNA experiments revealed that p53 is required for this pro-apoptotic effect of Vav1 in these cells. These results highlight for the first time the potential role of Vav1 as an oncogenic stress activator in cancer and the p53 dependence of its pro-apoptotic effect in breast cells.	[Sebban, Shulamit; Farago, Marganit; Gashai, Dan; Ilan, Lena; Ben-Porath, Ittai; Katzav, Shulamit] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-91010 Jerusalem, Israel; [Pikarsky, Eli] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Immunol & Canc Res, IL-91010 Jerusalem, Israel; [Pikarsky, Eli] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Pathol, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Katzav, S (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-91010 Jerusalem, Israel.	shulamitk@ekmd.huji.ac.il	pikarsky, eli/GXV-7099-2022	Ilan, Lena/0000-0002-7300-4606; pikarsky, eli/0000-0003-4186-7105	Israel Academy of Sciences; Israel Cancer Research Foundation; Israeli Cancer Association; Hubert H. Humphrey Center for Experimental Medicine and Cancer Research	Israel Academy of Sciences; Israel Cancer Research Foundation; Israeli Cancer Association; Hubert H. Humphrey Center for Experimental Medicine and Cancer Research	This work was supported by grants from the Israel Academy of Sciences, and the Israel Cancer Research Foundation, The Israeli Cancer Association and the Hubert H. Humphrey Center for Experimental Medicine and Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrogio C, 2008, CANCER RES, V68, P8899, DOI 10.1158/0008-5472.CAN-08-2568; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Bartolome RA, 2006, CANCER RES, V66, P248, DOI 10.1158/0008-5472.CAN-05-2489; Bertagnolo V, 2008, J PROTEOME RES, V7, P3729, DOI 10.1021/pr7008719; Bertini E, 2009, CELL CYCLE, V8, P49, DOI 10.4161/cc.8.1.7259; BROWER M, 1986, CANCER RES, V46, P798; BUSTELO XR, 1992, NATURE, V356, P68, DOI 10.1038/356068a0; CAMERON DJ, 1979, J CLIN INVEST, V63, P977, DOI 10.1172/JCI109398; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chiang J, 2011, PLOS ONE, V6; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; CLARK GM, 1984, J CLIN ONCOL, V2, P1102, DOI 10.1200/JCO.1984.2.10.1102; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Costello PS, 1999, P NATL ACAD SCI USA, V96, P3035, DOI 10.1073/pnas.96.6.3035; Elyada E, 2011, NATURE, V470, P409, DOI 10.1038/nature09673; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Gjerstorff MF, 2006, INT J ONCOL, V28, P1327; Groysman M, 2002, J BIOL CHEM, V277, P50121, DOI 10.1074/jbc.M204299200; Gu Y, 2006, ONCOGENE, V25, P3963, DOI 10.1038/sj.onc.1209427; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Hornstein I, 2004, CELL SIGNAL, V16, P1, DOI 10.1016/S0898-6568(03)00110-4; Hornstein I, 2003, J PATHOL, V199, P526, DOI 10.1002/path.1314; Ilan L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029939; Ishida M, 2010, TOXICOLOGY, V275, P72, DOI 10.1016/j.tox.2010.06.005; KATZAV S, 1989, ONCOGENE, V4, P1129; Katzav S, 2007, CANCER LETT, V255, P241, DOI 10.1016/j.canlet.2007.04.015; Kim J, 2012, ONCOL LETT, V3, P607, DOI 10.3892/ol.2011.531; Kong YY, 1998, J EXP MED, V188, P2099, DOI 10.1084/jem.188.11.2099; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P1033, DOI 10.1677/ERC-06-0001; Lane J, 2008, INT J ONCOL, V33, P585, DOI 10.3892/ijo_00000044; LARRICK JW, 1980, J IMMUNOL, V125, P6; Lazer G, 2009, J PATHOL, V219, P25, DOI 10.1002/path.2579; Lopez-Lago M, 2000, MOL CELL BIOL, V20, P1678, DOI 10.1128/MCB.20.5.1678-1691.2000; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Marengere LEM, 1997, J IMMUNOL, V159, P70; MARGOLIS B, 1992, NATURE, V356, P71, DOI 10.1038/356071a0; MARTE BM, 1995, ONCOGENE, V10, P167; Melamed I, 1999, CELL IMMUNOL, V191, P83, DOI 10.1006/cimm.1998.1402; Miura-Shimura Y, 2003, J BIOL CHEM, V278, P38495, DOI 10.1074/jbc.M305656200; Mondal B, 2011, INDIAN J EXP BIOL, V49, P574; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Prieto-Sanchez RM, 2006, BRIT J HAEMATOL, V133, P642, DOI 10.1111/j.1365-2141.2006.06094.x; Ramaswamy M, 2007, J IMMUNOL, V179, P6384, DOI 10.4049/jimmunol.179.10.6384; Reynolds LF, 2004, J BIOL CHEM, V279, P18239, DOI 10.1074/jbc.M400257200; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vigorito E, 2005, BLOOD, V106, P2391, DOI 10.1182/blood-2004-12-4894; Villalba M, 2000, EUR J IMMUNOL, V30, P1587, DOI 10.1002/1521-4141(200006)30:6<1587::AID-IMMU1587>3.0.CO;2-T; WEISS A, 1984, J IMMUNOL, V133, P123; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; WESTLEY B, 1979, BIOCHEM BIOPH RES CO, V90, P410, DOI 10.1016/0006-291X(79)91250-6; Wilsbacher Julie L, 2006, Cell Commun Signal, V4, P5, DOI 10.1186/1478-811X-4-5; Yin J, 2011, ACTA PHARMACOL SIN, V32, P99, DOI 10.1038/aps.2010.185	58	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54321	10.1371/journal.pone.0054321	http://dx.doi.org/10.1371/journal.pone.0054321			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342133	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400148
J	Real, R; Romero, D; Olivero, J; Estrada, A; Marquez, AL				Real, Raimundo; Romero, David; Olivero, Jesus; Estrada, Alba; Marquez, Ana L.			Estimating How Inflated or Obscured Effects of Climate Affect Forecasted Species Distribution	PLOS ONE			English	Article							DISTRIBUTION MODELS; ENVELOPE MODELS; GLOBAL CHANGE; RICHNESS; UNCERTAINTY; IMPACTS; SHIFT; PREDICTIONS; SCENARIOS; ABUNDANCE	Climate is one of the main drivers of species distribution. However, as different environmental factors tend to co-vary, the effect of climate cannot be taken at face value, as it may be either inflated or obscured by other correlated factors. We used the favourability models of four species (Alytes dickhilleni, Vipera latasti, Aquila fasciata and Capra pyrenaica) inhabiting Spanish mountains as case studies to evaluate the relative contribution of climate in their forecasted favourability by using variation partitioning and weighting the effect of climate in relation to non-climatic factors. By calculating the pure effect of the climatic factor, the pure effects of non-climatic factors, the shared climatic effect and the proportion of the pure effect of the climatic factor in relation to its apparent effect (rho), we assessed the apparent effect and the pure independent effect of climate. We then projected both types of effects when modelling the future favourability for each species and combination of AOGCM-SRES (two Atmosphere-Ocean General Circulation Models: CGCM2 and ECHAM4, and two Special Reports on Emission Scenarios (SRES): A2 and B2). The results show that the apparent effect of climate can be either inflated (overrated) or obscured (underrated) by other correlated factors. These differences were species-specific; the sum of favourable areas forecasted according to the pure climatic effect differed from that forecasted according to the apparent climatic effect by about 61% on average for one of the species analyzed, and by about 20% on average for each of the other species. The pure effect of future climate on species distributions can only be estimated by combining climate with other factors. Transferring the pure climatic effect and the apparent climatic effect to the future delimits the maximum and minimum favourable areas forecasted for each species in each climate change scenario.	[Real, Raimundo; Romero, David; Olivero, Jesus; Marquez, Ana L.] Univ Malaga, Fac Sci, Dept Anim Biol, Biogeog Divers & Conservat Res Team, E-29071 Malaga, Spain; [Estrada, Alba] CSIC UCLM, Inst Invest Recursos Cineget IREC, Ciudad Real, Spain	Universidad de Malaga; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha	Marquez, AL (corresponding author), Univ Malaga, Fac Sci, Dept Anim Biol, Biogeog Divers & Conservat Res Team, E-29071 Malaga, Spain.	almarquez@uma.es	Real, Raimundo/E-6559-2010; Márquez, Ana Luz/K-8345-2014; Romero, David/H-7684-2015; Olivero, Jesús/K-8727-2014; ESTRADA, ALBA/A-9632-2018	Real, Raimundo/0000-0002-6642-1284; Márquez, Ana Luz/0000-0001-5586-9334; Romero, David/0000-0003-4540-6349; Olivero, Jesús/0000-0003-1714-0360; ESTRADA, ALBA/0000-0003-2727-1970	Ministerio de Ciencia e Innovacion of Spain; FEDER [CGL2009-11316/BOS]; Ministerio de Educacion y Ciencia [AP 2007-03633]	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER(European Commission); Ministerio de Educacion y Ciencia(Spanish Government)	The research was funded by the Ministerio de Ciencia e Innovacion of Spain and FEDER (project CGL2009-11316/BOS). D. Romero is a PhD student at the University of Malaga with a grant of the Ministerio de Educacion y Ciencia (AP 2007-03633). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2012, GLOBAL CHANGE BIOL, V18, P1509, DOI 10.1111/j.1365-2486.2012.02655.x; Acevedo P, 2011, ECOL MODEL, V222, P814, DOI 10.1016/j.ecolmodel.2010.10.006; Aragon P, 2010, GLOBAL ECOL BIOGEOGR, V19, P40, DOI 10.1111/j.1466-8238.2009.00488.x; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Baer P, 2009, CLIMATIC CHANGE, V92, P31, DOI 10.1007/s10584-008-9529-3; Barbosa AM, 2010, CONSERV BIOL, V24, P1378, DOI 10.1111/j.1523-1739.2010.01517.x; Barbosa Ana Marcia, 2001, Diversity and Distributions, V7, P137, DOI 10.1046/j.1472-4642.2001.00104.x; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; Beniston M, 2003, CLIMATIC CHANGE, V59, P5, DOI 10.1023/A:1024458411589; Borcard D, 1992, ECOLOGY, V87, P2614; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Dormann CF, 2008, ECOL LETT, V11, P235, DOI 10.1111/j.1461-0248.2007.01142.x; Dubey S, 2011, CLIMATIC CHANGE, V107, P531, DOI 10.1007/s10584-010-9963-x; Duncan RP, 2009, P ROY SOC B-BIOL SCI, V276, P1449, DOI 10.1098/rspb.2008.1801; Engler R, 2011, GLOBAL CHANGE BIOL, V17, P2330, DOI 10.1111/j.1365-2486.2010.02393.x; Galantinho A, 2009, ECOL RES, V24, P671, DOI 10.1007/s11284-008-0538-5; Garcia-Ortega E, 2007, ATMOS RES, V83, P225, DOI 10.1016/j.atmosres.2005.08.004; Gasner MR, 2010, BIOL CONSERV, V143, P1250, DOI 10.1016/j.biocon.2010.02.034; Godinho C, 2010, ECOL RES, V25, P283, DOI 10.1007/s11284-009-0655-9; Green RE, 2008, BIOL LETTERS, V4, P599, DOI 10.1098/rsbl.2008.0052; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hortal J, 2008, J BIOGEOGR, V35, P1202, DOI 10.1111/j.1365-2699.2007.01850.x; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; Jimenez-Valverde A, 2007, ECOL ENTOMOL, V32, P113, DOI 10.1111/j.1365-2311.2006.00848.x; Kharouba HM, 2009, ECOLOGY, V90, P2213, DOI 10.1890/08-1304.1; Klanderud K, 2003, HOLOCENE, V13, P1, DOI 10.1191/0959683603hl589ft; Lavergne S, 2005, J BIOGEOGR, V32, P799, DOI 10.1111/j.1365-2699.2005.01207.x; Lawler JJ, 2010, CONSERV BIOL, V24, P38, DOI 10.1111/j.1523-1739.2009.01403.x; Marquez AL, 2011, CLIMATIC CHANGE, V108, P135, DOI 10.1007/s10584-010-0010-8; Marquez AL, 2004, GLOBAL ECOL BIOGEOGR, V13, P295, DOI 10.1111/j.1466-822X.2004.00100.x; Munoz AR, 2005, DIVERS DISTRIB, V11, P477, DOI 10.1111/j.1366-9516.2005.00188.x; Munoz-Diaz D, 2004, ANN GEOPHYS-GERMANY, V22, P1435, DOI 10.5194/angeo-22-1435-2004; Nielsen C, 2008, DIVERS DISTRIB, V14, P307, DOI 10.1111/j.1472-4642.2007.00456.x; Pauli H, 2007, GLOBAL CHANGE BIOL, V13, P147, DOI 10.1111/j.1365-2486.2006.01282.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Penuelas J, 2003, GLOBAL CHANGE BIOL, V9, P131, DOI 10.1046/j.1365-2486.2003.00566.x; PEREIRA JMC, 1991, PHOTOGRAMM ENG REM S, V57, P1475; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Peres-Neto PR, 2010, GLOBAL ECOL BIOGEOGR, V19, P174, DOI 10.1111/j.1466-8238.2009.00506.x; Randin CF, 2009, J VEG SCI, V20, P996, DOI 10.1111/j.1654-1103.2009.01098.x; Real R, 2008, DIVERS DISTRIB, V14, P364, DOI 10.1111/j.1472-4642.2007.00419.x; Real R, 2006, ENVIRON ECOL STAT, V13, P237, DOI 10.1007/s10651-005-0003-3; Real R, 2010, ECOGRAPHY, V33, P304, DOI 10.1111/j.1600-0587.2010.06251.x; Ritchie EG, 2009, J ANIM ECOL, V78, P724, DOI 10.1111/j.1365-2656.2008.01520.x; Rubidge EM, 2011, GLOBAL CHANGE BIOL, V17, P696, DOI 10.1111/j.1365-2486.2010.02297.x; Santos X, 2006, BIOL CONSERV, V130, P416, DOI 10.1016/j.biocon.2006.01.003; Stanton JC, 2012, METHODS ECOL EVOL, V3, P349, DOI 10.1111/j.2041-210X.2011.00157.x; Stefanescu C, 2004, J BIOGEOGR, V31, P905, DOI 10.1111/j.1365-2699.2004.01088.x; Thuiller W, 2006, GLOBAL CHANGE BIOL, V12, P424, DOI 10.1111/j.1365-2486.2006.01115.x; Trivino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029373; WallisDeVries MF, 2011, OECOLOGIA, V167, P559, DOI 10.1007/s00442-011-2007-z; Willis SG, 2009, ECOGRAPHY, V32, P5, DOI 10.1111/j.1600-0587.2008.05711.x; Wilson RJ, 2005, ECOL LETT, V8, P1138, DOI 10.1111/j.1461-0248.2005.00824.x; Wilson RJ, 2007, GLOBAL CHANGE BIOL, V13, P1873, DOI 10.1111/j.1365-2486.2007.01418.x	55	24	25	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53646	10.1371/journal.pone.0053646	http://dx.doi.org/10.1371/journal.pone.0053646			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23349726	gold, Green Published			2022-12-25	WOS:000314705800066
J	Chen, RHC; Wislet-Gendebien, S; Samuel, F; Visanji, NP; Zhang, G; Marsilio, D; Langman, T; Fraser, PE; Tandon, A				Chen, Robert H. C.; Wislet-Gendebien, Sabine; Samuel, Filsy; Visanji, Naomi P.; Zhang, Gang; Marsilio, Diana; Langman, Tammy; Fraser, Paul E.; Tandon, Anurag			alpha-Synuclein Membrane Association Is Regulated by the Rab3a Recycling Machinery and Presynaptic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CSP-ALPHA; DIFFERENTIAL REGULATION; WILD-TYPE; IN-VIVO; DISEASE; BINDING; PROTEIN; DISSOCIATION; PROMOTES; RELEASE	alpha-Synuclein is an abundant presynaptic protein and a primary component of Lewy bodies in Parkinson disease. Although its pathogenic role remains unclear, in healthy nerve terminals alpha-synuclein undergoes a cycle of membrane binding and dissociation. An alpha-synuclein binding assay was used to screen for vesicle proteins involved in alpha-synuclein membrane interactions and showed that antibodies directed to the Ras-related GTPase Rab3a and its chaperone RabGDI abrogated alpha-synuclein membrane binding. Biochemical analyses, including density gradient sedimentation and co-immunoprecipitation, suggested that alpha-synuclein interacts with membrane-associated GTP-bound Rab3a but not to cytosolic GDP-Rab3a. Accumulation of membrane-bound alpha-synuclein was induced by the expression of a GTPase-deficient Rab3a mutant, by a dominant-negative GDP-dissociation inhibitor mutant unable to recycle Rab3a off membranes, and by Hsp90 inhibitors, radicicol and geldanamycin, which are known to inhibit Rab3a dissociation from membranes. Thus, all treatments that inhibited Rab3a recycling also increased alpha-synuclein sequestration on intracellular membranes. Our results suggest that membrane-bound GTP-Rab3a stabilizes alpha-synuclein on synaptic vesicles and that the GDP dissociation inhibitor.Hsp90 complex that controls Rab3 a membrane dissociation also regulates alpha-synuclein dissociation during synaptic activity.	[Chen, Robert H. C.; Wislet-Gendebien, Sabine; Samuel, Filsy; Visanji, Naomi P.; Zhang, Gang; Marsilio, Diana; Langman, Tammy; Fraser, Paul E.; Tandon, Anurag] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; [Fraser, Paul E.] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 3H2, Canada; [Tandon, Anurag] Univ Toronto, Dept Med, Toronto, ON M5S 3H2, Canada	University of Toronto; University of Toronto; University of Toronto	Tandon, A (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, 6 Queens Pk Crescent West, Toronto, ON M5S 3H2, Canada.	a.tandon@utoronto.ca	Visanji, Naomi P/AAW-4618-2021; Chen, Robert HC/K-9348-2019	Chen, Robert HC/0000-0003-3141-7637; Visanji, Naomi/0000-0001-5968-7845; wislet, sabine/0000-0003-4279-9669	Canadian Institutes of Health Research Operating Grants [MOP 84501, MOP 115056]; Parkinson Society of Canada operating grant; Canadian Institutes of Health Research; Edmond J. Safra Foundation; Parkinson's Society of Canada	Canadian Institutes of Health Research Operating Grants(Canadian Institutes of Health Research (CIHR)); Parkinson Society of Canada operating grant; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Edmond J. Safra Foundation; Parkinson's Society of Canada	This work was supported in part by Canadian Institutes of Health Research Operating Grants MOP 84501 (to A. T.) and MOP 115056 (to P. E. F.) and a Parkinson Society of Canada operating grant (to A. T.).; Supported by fellowships from the Canadian Institutes of Health Research.; Supported by a fellowship from the Edmond J. Safra Foundation.; Supported by a fellowship from the Parkinson's Society of Canada.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; An Y, 2003, STRUCTURE, V11, P347, DOI 10.1016/S0969-2126(03)00034-0; BRONDYK WH, 1993, J BIOL CHEM, V268, P9410; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; BURSTEIN ES, 1992, J BIOL CHEM, V267, P22715; Bussell R, 2004, BIOCHEMISTRY-US, V43, P4810, DOI 10.1021/bi036135+; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chen CY, 2005, METHOD ENZYMOL, V403, P339, DOI 10.1016/S0076-6879(05)03029-6; Chen FS, 2003, J BIOL CHEM, V278, P19974, DOI 10.1074/jbc.M210049200; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Dalfo E, 2004, NEUROBIOL DIS, V16, P92, DOI 10.1016/j.nbd.2004.01.001; Dalfo E, 2005, NEUROSCI LETT, V380, P170, DOI 10.1016/j.neulet.2005.01.034; Dalfo E, 2004, J NEUROPATH EXP NEUR, V63, P302, DOI 10.1093/jnen/63.4.302; Darios F, 2010, EMBO REP, V11, P528, DOI 10.1038/embor.2010.66; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; FARNSWORTH CC, 1991, P NATL ACAD SCI USA, V88, P6196, DOI 10.1073/pnas.88.14.6196; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Fortin DL, 2005, J NEUROSCI, V25, P10913, DOI 10.1523/JNEUROSCI.2922-05.2005; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Geng XH, 2011, AM J PHYSIOL-ENDOC M, V300, pE276, DOI 10.1152/ajpendo.00262.2010; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Goody RS, 2005, CELL MOL LIFE SCI, V62, P1657, DOI 10.1007/s00018-005-4486-8; Irizarry MC, 1996, J NEUROPATH EXP NEUR, V55, P889, DOI 10.1097/00005072-199608000-00004; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Jo E, 2004, EUR J BIOCHEM, V271, P3180, DOI 10.1111/j.1432-1033.2004.04250.x; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; KHOSRAVIFAR R, 1991, P NATL ACAD SCI USA, V88, P6264, DOI 10.1073/pnas.88.14.6264; Kim KS, 2010, J BIOL CHEM, V285, P21416, DOI 10.1074/jbc.M110.103499; Kubo S, 2005, J BIOL CHEM, V280, P31664, DOI 10.1074/jbc.M504894200; Lang Thorsten, 2008, V184, P107; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Liu J, 2009, J NEUROSCI, V29, P1480, DOI 10.1523/JNEUROSCI.6202-08.2009; Luan P, 2000, TRAFFIC, V1, P270, DOI 10.1034/j.1600-0854.2000.010309.x; Luan P, 1999, J BIOL CHEM, V274, P14806, DOI 10.1074/jbc.274.21.14806; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; MUSHA T, 1992, J BIOL CHEM, V267, P9821; Narayanan V, 2001, BIOCHEMISTRY-US, V40, P9927, DOI 10.1021/bi002952n; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Park SM, 2002, BLOOD, V100, P2506, DOI 10.1182/blood.V100.7.2506; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Sakisaka T, 2002, EMBO J, V21, P6125, DOI 10.1093/emboj/cdf603; Schalk I, 1996, NATURE, V381, P42, DOI 10.1038/381042a0; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; Schluter OM, 2002, J BIOL CHEM, V277, P40919, DOI 10.1074/jbc.M203704200; Scott D, 2012, J NEUROSCI, V32, P10129, DOI 10.1523/JNEUROSCI.0535-12.2012; Scott DA, 2010, J NEUROSCI, V30, P8083, DOI 10.1523/JNEUROSCI.1091-10.2010; Sharma M, 2012, EMBO J, V31, P829, DOI 10.1038/emboj.2011.467; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Tandon A, 1998, NEURON, V21, P147, DOI 10.1016/S0896-6273(00)80522-X; Thayanidhi N, 2010, MOL BIOL CELL, V21, P1850, DOI 10.1091/mbc.E09-09-0801; Visanji NP, 2011, J BIOL CHEM, V286, P35863, DOI 10.1074/jbc.M111.253450; VONMOLLARD GF, 1991, NATURE, V349, P79, DOI 10.1038/349079a0; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wislet-Gendebien S, 2006, J BIOL CHEM, V281, P32148, DOI 10.1074/jbc.M605965200; Wislet-Gendebien S, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-92; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200	63	71	72	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7438	7449		10.1074/jbc.M112.439497	http://dx.doi.org/10.1074/jbc.M112.439497			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23344955	hybrid, Green Published			2022-12-25	WOS:000316455300002
J	Kareva, I				Kareva, Irina			Biological Stoichiometry in Tumor Micro-environments	PLOS ONE			English	Article							HIPPEL-LINDAU-DISEASE; EVOLUTIONARY BIOLOGY; CANCER; DORMANCY; ECOLOGY; GROWTH; HEMANGIOBLASTOMAS; ANGIOGENESIS; METASTASIS; DIVERSITY	Tumors can be viewed as evolving ecological systems, in which heterogeneous populations of cancer cells compete with each other and somatic cells for space and nutrients within the ecosystem of the human body. According to the growth rate hypothesis (GRH), increased phosphorus availability in an ecosystem, such as the tumor micro-environment, may promote selection within the tumor for a more proliferative and thus potentially more malignant phenotype. The applicability of the GRH to tumor growth is evaluated using a mathematical model, which suggests that limiting phosphorus availability might promote intercellular competition within a tumor, and thereby delay disease progression. It is also shown that a tumor can respond differently to changes in its micro-environment depending on the initial distribution of clones within the tumor, regardless of its initial size. This suggests that composition of the tumor as a whole needs to be evaluated in order to maximize the efficacy of therapy.	Tufts Univ, Sch Med, Ctr Canc Syst Biol, Steward St Elizabeths Med Ctr, Boston, MA 02111 USA	St. Elizabeth's Medical Center; Tufts University	Kareva, I (corresponding author), Tufts Univ, Sch Med, Ctr Canc Syst Biol, Steward St Elizabeths Med Ctr, Boston, MA 02111 USA.	Irina.Kareva@tufts.edu			National Science Foundation (NSF) [DMPS-0838705]; National Security Agency (NSA) [H98230-09-1-0104]; Alfred P. Sloan Foundation; Office of the Provost of Arizona State University	National Science Foundation (NSF)(National Science Foundation (NSF)); National Security Agency (NSA)(National Security Agency); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Office of the Provost of Arizona State University	This project has been partially supported by grants from the National Science Foundation (NSF - Grant DMPS-0838705), the National Security Agency (NSA - Grant H98230-09-1-0104), the Alfred P. Sloan Foundation, and the Office of the Provost of Arizona State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almog N, 2010, CANCER LETT, V294, P139, DOI 10.1016/j.canlet.2010.03.004; Ammerman JM, 2006, J NEUROSURG, V105, P248, DOI 10.3171/jns.2006.105.2.248; Asthagiri AR, 2010, NEURO-ONCOLOGY, V12, P80, DOI 10.1093/neuonc/nop018; Boersma M, 2006, ECOLOGY, V87, P1325, DOI 10.1890/0012-9658(2006)87[1325:TMOAGT]2.0.CO;2; Camalier CE, 2010, CANCER PREV RES, V3, P359, DOI 10.1158/1940-6207.CAPR-09-0068; Crespi B, 2005, TRENDS ECOL EVOL, V20, P545, DOI 10.1016/j.tree.2005.07.007; Croker AK, 2009, CANCER DRUG DISCOV D, P141, DOI 10.1007/978-1-60327-933-8_11; CUKIER RI, 1973, J CHEM PHYS, V59, P3873, DOI 10.1063/1.1680571; Demicheli R, 2008, ANN ONCOL, V19, P1821, DOI 10.1093/annonc/mdn386; Elser J, 2006, AM NAT, V168, pS25, DOI 10.1086/509048; Elser JJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001028; Elser JJ, 2003, BIOSCIENCE, V53, P1112, DOI 10.1641/0006-3568(2003)053[1112:BSAEPO]2.0.CO;2; Gatenby RA, 2009, CANCER RES, V69, P4894, DOI 10.1158/0008-5472.CAN-08-3658; Jin H, 2009, AM J RESP CRIT CARE, V179, P59, DOI 10.1164/rccm.200802-306OC; Kareva I, 2011, TRANSL ONCOL, V4, P266, DOI 10.1593/tlo.11154; Krakauer DC, 2009, AM NAT, V173, P26, DOI 10.1086/593707; LANGE K, 1992, MATH BIOSCI, V111, P261, DOI 10.1016/0025-5564(92)90074-7; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Mulder C, 2009, GLOBAL CHANGE BIOL, V15, P2730, DOI 10.1111/j.1365-2486.2009.01899.x; Nagy JD, 2005, MATH BIOSCI ENG, V2, P381, DOI 10.3934/mbe.2005.2.381; Naumov GN, 2009, CLIN EXP METASTAS, V26, P51, DOI 10.1007/s10585-008-9176-0; Naumov GN, 2006, JNCI-J NATL CANCER I, V98, P316, DOI 10.1093/jnci/djj068; Robey IF, 2009, CANCER RES, V69, P2260, DOI 10.1158/0008-5472.CAN-07-5575; Rocken M, 2010, J CLIN INVEST, V120, P1800, DOI 10.1172/JCI43424; Song DK, 2008, J NEUROSURG-PEDIATR, V2, P397, DOI 10.3171/PED.2008.2.12.397; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Teng MWL, 2008, J LEUKOCYTE BIOL, V84, P988, DOI 10.1189/jlb.1107774; Uhra JW, 2011, P NATL ACAD SCI USA, V108, P12396, DOI 10.1073/pnas.1106613108; Weinberg F, 2009, ANN NY ACAD SCI, V1177, P66, DOI 10.1111/j.1749-6632.2009.05039.x; Wood PA, 2005, MOL CANCER THER, V4, P1065, DOI 10.1158/1535-7163.MCT-05-0028	30	16	16	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e51844	10.1371/journal.pone.0051844	http://dx.doi.org/10.1371/journal.pone.0051844			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349677	gold, Green Published			2022-12-25	WOS:000314019100010
J	Suman, SK; Ravindra, D; Sharma, Y; Mishra, A				Suman, Shashi Kumar; Ravindra, Daddali; Sharma, Yogendra; Mishra, Amita			Association Properties and Unfolding of a beta gamma-Crystallin Domain of a Vibrio-Specific Protein	PLOS ONE			English	Article							SPORE COAT PROTEIN; X-RAY-ANALYSIS; EYE LENS; MYXOCOCCUS-XANTHUS; STABILITY; BINDING; AGGREGATION; SINGLE; SUPERFAMILY; EVOLUTION	The beta gamma-crystallin superfamily possesses a large number of versatile members, of which only a few members other than lens beta gamma-crystallins have been studied. Understanding the non-crystallin functions as well as origin of crystallin-like properties of such proteins is possible by exploring novel members from diverse sources. We describe a novel beta gamma-crystallin domain with S-type (Spherulin 3a type) Greek key motifs in protein vibrillin from a pathogenic bacterium Vibrio cholerae. This domain is a part of a large Vibrio-specific protein prevalent in Vibrio species (found in at least fourteen different strains sequenced so far). The domain contains two canonical N/D-N/D-X-X-S/T-S Ca2+-binding motifs, and bind Ca2+. Unlike spherulin 3a and other microbial homologues studied so far, beta gamma-crystallin domain of vibrillin self-associates forming oligomers of various sizes including dimers. The fractionated dimers readily form octamers in concentration-dependent manner, suggesting an association between these two major forms. The domain associates/dissociates forming dimers at the cost of monomeric populations in the presence of Ca2+. No such effect of Ca2+ has been observed in oligomeric species. The equilibrium unfolding of both forms follows a similar pattern, with the formation of an unfolding intermediate at sub-molar concentrations of denaturant. These properties exhibited by this beta gamma-crystallin domain are not shown by any other domain studied so far, demonstrating the diversity in domain properties.	[Suman, Shashi Kumar; Ravindra, Daddali; Sharma, Yogendra; Mishra, Amita] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Sharma, Y (corresponding author), CSIR, Ctr Cellular & Mol Biol, Uppal Rd, Hyderabad, Andhra Pradesh, India.	yogendra@ccmb.res.in; amita@ccmb.res.in		SUMAN, Shashi Kumar/0000-0002-7668-5515	Department of Biotechnology (DBT-PDF); Council of Scientific and Industrial Research (CSIR), Government of India; Department of Science and Technology (SERC, DST); DBT, Government of India	Department of Biotechnology (DBT-PDF); Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (SERC, DST); DBT, Government of India(Department of Biotechnology (DBT) India)	AM is supported by a post-doctoral fellowship of the Department of Biotechnology (DBT-PDF), SKS is the recipient of senior research fellowship from the Council of Scientific and Industrial Research (CSIR), Government of India. This research was supported by a Department of Science and Technology (SERC, DST), and a DBT, Government of India, grants to YS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Sampson L, 2010, J MOL BIOL, V401, P134, DOI 10.1016/j.jmb.2010.05.067; Aravind P, 2009, BIOCHEMISTRY-US, V48, P12180, DOI 10.1021/bi9017076; Aravind P, 2009, J MOL BIOL, V385, P163, DOI 10.1016/j.jmb.2008.10.035; BAGBY S, 1994, P NATL ACAD SCI USA, V91, P4308, DOI 10.1073/pnas.91.10.4308; Baldwin RL, 1996, FOLD DES, V1, pR1, DOI 10.1016/S1359-0278(96)00003-X; Bilecen K, 2009, ENVIRON MICROBIOL, V11, P2015, DOI 10.1111/j.1462-2920.2009.01923.x; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; BLUNDELL T, 1981, NATURE, V289, P771, DOI 10.1038/289771a0; Clout NJ, 2001, STRUCTURE, V9, P115, DOI 10.1016/S0969-2126(01)00573-1; Clout NJ, 2000, J MOL BIOL, V304, P253, DOI 10.1006/jmbi.2000.4197; Das P, 2011, P NATL ACAD SCI USA, V108, P10514, DOI 10.1073/pnas.1019152108; Jaenicke R, 2001, CRIT REV BIOCHEM MOL, V36, P435, DOI 10.1080/20014091074237; Jobby MK, 2007, BIOCHEMISTRY-US, V46, P12298, DOI 10.1021/bi700843q; Jobby MK, 2005, J BIOL CHEM, V280, P1209, DOI 10.1074/jbc.M409253200; Kierek K, 2003, P NATL ACAD SCI USA, V100, P14357, DOI 10.1073/pnas.2334614100; Mayr EM, 1997, J MOL BIOL, V269, P260, DOI 10.1006/jmbi.1997.1033; Mishra A, 2012, J MOL BIOL, V415, P75, DOI 10.1016/j.jmb.2011.10.037; Moreau KL, 2009, J BIOL CHEM, V284, P33285, DOI 10.1074/jbc.M109.031344; Pace C N, 1986, Methods Enzymol, V131, P266; Rajini B, 2003, BIOCHEMISTRY-US, V42, P4552, DOI 10.1021/bi027384l; Shimeld SM, 2005, CURR BIOL, V15, P1684, DOI 10.1016/j.cub.2005.08.046; Srivastava AK, 2010, BIOCHEMISTRY-US, V49, P9746, DOI 10.1021/bi101000m; Suman SK, 2011, J BIOL CHEM, V286, P43891, DOI 10.1074/jbc.M111.247890; Talla V, 2006, INVEST OPHTH VIS SCI, V47, P5212, DOI 10.1167/iovs.06-0427; Vendra VPR, 2010, MOL VIS, V16, P2822; Wenk M, 1999, J MOL BIOL, V293, P117, DOI 10.1006/jmbi.1999.3146; WISTOW G, 1983, J MOL BIOL, V170, P175, DOI 10.1016/S0022-2836(83)80232-0; WISTOW G, 1990, J MOL EVOL, V30, P140, DOI 10.1007/BF02099940; WISTOW G, 1985, NATURE, V315, P771, DOI 10.1038/315771a0; Wistow G, 1995, MOL BIOL EVOLUTION C; Yildiz FH, 2009, TRENDS MICROBIOL, V17, P109, DOI 10.1016/j.tim.2008.12.004	31	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53610	10.1371/journal.pone.0053610	http://dx.doi.org/10.1371/journal.pone.0053610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349723	gold, Green Published, Green Submitted			2022-12-25	WOS:000314019100024
J	Chang, YS; Choi, SJ; Ahn, SY; Sung, DK; Sung, SI; Yoo, HS; Oh, WI; Park, WS				Chang, Yun Sil; Choi, Soo Jin; Ahn, So Yoon; Sung, Dong Kyung; Sung, Se In; Yoo, Hye Soo; Oh, Won Il; Park, Won Soon			Timing of Umbilical Cord Blood Derived Mesenchymal Stem Cells Transplantation Determines Therapeutic Efficacy in the Neonatal Hyperoxic Lung Injury	PLOS ONE			English	Article							NADPH OXIDASE COMPLEX; RETINOIC ACID; ALVEOLARIZATION; INFANTS; GROWTH	Intratracheal transplantation of human umbilical cord blood (UCB)-derived mesenchymal stem cells (MSCs) attenuates the hyperoxia-induced neonatal lung injury. The aim of this study was to optimize the timing of MSCs transplantation. Newborn Sprague-Dawley rats were randomly exposed to hyperoxia (90% for 2 weeks and 60% for 1 week) or normoxia after birth for 21 days. Human UCB-derived MSCs (5x10(5) cells) were delivered intratracheally early at postnatal day (P) 3 (HT3), late at P10 (HT10) or combined early+late at P3+10 (HT3+10). Hyperoxia-induced increase in mortality, TUNEL positive cells, ED1 positive alveolar macrophages, myeloperoxidase activity and collagen levels, retarded growth and reduced alveolarization as evidenced by increased mean linear intercept and mean alveolar volume were significantly better attenuated in both HT3 and HT3+10 than in HT10. Hyperoxia-induced up-regulation of both cytosolic and membrane p47(phox) indicative of oxidative stress, and increased inflammatory markers such as tumor necrosis factor-alpha, interleukin (IL)-1 alpha, IL-1 beta, IL-6, and transforming growth factor-beta measured by ELISA, and tissue inhibitor of metalloproteinase-1, CXCL7, RANTES, L-selectin and soluble intercellular adhesion molecule-1 measured by protein array were consistently more attenuated in both HT3 and HT3+10 than in HT10. Hyperoxia-induced decrease in hepatocyte growth factor and vascular endothelial growth factor was significantly up-regulated in both HT3 and HT3+10, but not in HT10. In summary, intratracheal transplantation of human UCB derived MSCs time-dependently attenuated hyperoxia-induced lung injury in neonatal rats, showing significant protection only in the early but not in the late phase of inflammation. There were no synergies with combined early+late MSCs transplantation.	[Chang, Yun Sil; Ahn, So Yoon; Sung, Se In; Yoo, Hye Soo; Park, Won Soon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul, South Korea; [Chang, Yun Sil; Sung, Dong Kyung; Park, Won Soon] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Seoul, South Korea; [Choi, Soo Jin; Oh, Won Il] MEDIPOST Co Ltd, Biomed Res Inst, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; MEDIPOST	Park, WS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul, South Korea.	wonspark@skku.edu			Ministry for Health, Welfare & Family Affairs, Republic of Korea [A102136]; National Research Foundation of Korea (NRF); Ministry of Education, Science, and Technology [S-2011-0317-000]; Samsung Biomedical Research Institute Grant [SBRI CB11271]	Ministry for Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Samsung Biomedical Research Institute Grant(Samsung)	This work was supported by a grant from the Korea Healthcare technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A102136), by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (S-2011-0317-000), and by a Samsung Biomedical Research Institute Grant (#SBRI CB11271). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslam M, 2009, AM J RESP CRIT CARE, V180, P1122, DOI 10.1164/rccm.200902-0242OC; AVERY ME, 1987, PEDIATRICS, V79, P26; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; BASTIAN NR, 1994, CURR OPIN IMMUNOL, V6, P131, DOI 10.1016/0952-7915(94)90044-2; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; BREGMAN J, 1992, CLIN PERINATOL, V19, P673, DOI 10.1016/S0095-5108(18)30451-2; Chang YS, 2011, CELL TRANSPLANT; Chang YS, 2009, CELL TRANSPLANT, V18, P869, DOI 10.3727/096368909X471189; Cho HJ, 2007, J EXP MED, V204, P3257, DOI 10.1084/jem.20070166; Cho SJ, 2005, AM J RESP CELL MOL, V33, P622, DOI 10.1165/rcmb.2005-0050OC; Choo-Wing R, 2007, AM J PHYSIOL-LUNG C, V293, pL142, DOI 10.1152/ajplung.00434.2006; Coalson Jacqueline J, 2003, Semin Neonatol, V8, P73, DOI 10.1016/S1084-2756(02)00193-8; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; Deuse T, 2009, CIRCULATION, V120, pS247, DOI 10.1161/CIRCULATIONAHA.108.843680; Fahy John V, 2009, Proc Am Thorac Soc, V6, P256, DOI 10.1513/pats.200808-087RM; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Gray KD, 2003, AM J SURG, V186, P526, DOI 10.1016/j.amjsurg.2003.07.010; Hohler B, 2000, HISTOCHEM CELL BIOL, V114, P29; Jang YK, 2006, ANN HEMATOL, V85, P212, DOI 10.1007/s00277-005-0047-3; Jobe AJ, 1999, PEDIATR RES, V46, P641, DOI 10.1203/00006450-199912000-00007; Kokaia Z, 2012, NAT NEUROSCI, V15, P1078, DOI 10.1038/nn.3163; Kunig AM, 2005, AM J PHYSIOL-LUNG C, V289, pL529, DOI 10.1152/ajplung.00336.2004; Lee JK, 2007, CELL TRANSPLANT, V16, P849, DOI 10.3727/000000007783465271; Li JM, 2002, J BIOL CHEM, V277, P19952, DOI 10.1074/jbc.M110073200; McGrath-Morrow SA, 2001, AM J RESP CELL MOL, V25, P150, DOI 10.1165/ajrcmb.25.2.4362; Moodley Y, 2009, AM J PATHOL, V175, P303, DOI 10.2353/ajpath.2009.080629; Reinecke H, 2002, J MOL CELL CARDIOL, V34, P251, DOI 10.1006/jmcc.2001.1494; ROBINSON JM, 1995, HISTOCHEM CELL BIOL, V103, P163, DOI 10.1007/BF01454021; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Saugstad Ola Didrik, 2003, Semin Neonatol, V8, P39, DOI 10.1016/S1084-2756(02)00194-X; Snyder JM, 2005, PEDIATR RES, V57, P384, DOI 10.1203/01.PDR.0000151315.81106.D3; THURLBECK WM, 1982, THORAX, V37, P564, DOI 10.1136/thx.37.8.564; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Warner BB, 1998, AM J PHYSIOL-LUNG C, V275, pL110, DOI 10.1152/ajplung.1998.275.1.L110; Yang SE, 2004, CYTOTHERAPY, V6, P476, DOI 10.1080/14653240410005041	36	155	160	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e52419	10.1371/journal.pone.0052419	http://dx.doi.org/10.1371/journal.pone.0052419			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349686	Green Published, Green Submitted, gold			2022-12-25	WOS:000313943000008
J	Sainath, R; Granato, M				Sainath, Rajiv; Granato, Michael			Plexin A3 and Turnout Regulate Motor Axonal Branch Morphogenesis in Zebrafish	PLOS ONE			English	Article							DEVELOPMENTAL REGULATION; DIFFERENTIAL REQUIREMENT; IDENTIFIED MOTONEURONS; GROWTH; GENE; EXPRESSION; NEURONS; MUSCLE; SYNAPTOGENESIS; SEMAPHORINS	During embryogenesis motor axons navigate to their target muscles, where individual motor axons develop complex branch morphologies. The mechanisms that control axonal branching morphogenesis have been studied intensively, yet it still remains unclear when branches begin to form or how branch locations are determined. Live cell imaging of individual zebrafish motor axons reveals that the first axonal branches are generated at the ventral extent of the myotome via bifurcation of the growth cone. Subsequent branches are generated by collateral branching restricted to their synaptic target field along the distal portion of the axon. This precisely timed and spatially restricted branching process is disrupted in turnout mutants we identified in a forward genetic screen. Molecular genetic mapping positioned the turnout mutation within a 300 kb region encompassing eight annotated genes, however sequence analysis of all eight open reading frames failed to unambiguously identify the turnout mutation. Chimeric analysis and single cell labeling reveal that turnout function is required cell non-autonomously for intraspinal motor axon guidance and peripheral branch formation. turnout mutant motor axons form the first branch on time via growth cone bifurcation, but unlike wild-type they form collateral branches precociously, when the growth cone is still navigating towards the ventral myotome. These precocious collateral branches emerge along the proximal region of the axon shaft typically devoid of branches, and they develop into stable, permanent branches. Furthermore, we find that null mutants of the guidance receptor plexin A3 display identical motor axon branching defects, and time lapse analysis reveals that precocious branch formation in turnout and plexin A3 mutants is due to increased stability of otherwise short-lived axonal protrusions. Thus, plexin A3 dependent intrinsic and turnout dependent extrinsic mechanisms suppress collateral branch morphogenesis by destabilizing membrane protrusions before the growth cone completes navigation into the synaptic target field.	[Sainath, Rajiv; Granato, Michael] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Granato, M (corresponding author), Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA.	granatom@mail.med.upenn.edu			NIH [HD37975, MH092257]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092257] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by NIH grants HD37975 and MH092257 to M. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andlauer Till F M, 2012, Cold Spring Harb Protoc, V2012, P481, DOI 10.1101/pdb.prot068593; Appel B, 1995, DEVELOPMENT, V121, P4117; Banerjee S, 2011, DEVELOPMENT, V138, P3287, DOI 10.1242/dev.067306; Barnes SH, 2010, DEVELOPMENT, V137, P805, DOI 10.1242/dev.042457; Birely J, 2005, DEV BIOL, V280, P162, DOI 10.1016/j.ydbio.2005.01.012; Bonanomi D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001735; Dent EW, 2004, J NEUROSCI, V24, P3002, DOI 10.1523/JNEUROSCI.4963-03.2004; Dent EW, 2001, J NEUROSCI, V21, P9757, DOI 10.1523/JNEUROSCI.21-24-09757.2001; Downes GB, 2004, DEV BIOL, V270, P232, DOI 10.1016/j.ydbio.2004.02.027; EISEN JS, 1986, NATURE, V320, P269, DOI 10.1038/320269a0; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Gallo G, 1998, J NEUROSCI, V18, P5403, DOI 10.1523/JNEUROSCI.18-14-05403.1998; Gallo G, 2011, DEV NEUROBIOL, V71, P201, DOI 10.1002/dneu.20852; Gibson DA, 2011, DEVELOPMENT, V138, P183, DOI 10.1242/dev.046441; Grider MH, 2009, J NEUROSCI RES, V87, P3033, DOI 10.1002/jnr.22140; Homma N, 2003, CELL, V114, P229, DOI 10.1016/S0092-8674(03)00522-1; Hung RJ, 2011, SCIENCE, V334, P1710, DOI 10.1126/science.1211956; Hung RJ, 2010, NATURE, V463, P823, DOI 10.1038/nature08724; INOUE A, 1994, DEV DYNAM, V199, P1, DOI 10.1002/aja.1001990102; Knapik EW, 1996, DEVELOPMENT, V123, P451; Lefebvre JL, 2007, P NATL ACAD SCI USA, V104, P2483, DOI 10.1073/pnas.0610822104; Lichtman JW, 2003, J NEUROCYTOL, V32, P767, DOI 10.1023/B:NEUR.0000020622.58471.37; Liu DYT, 2008, J MICROSC-OXFORD, V231, P349, DOI 10.1111/j.1365-2818.2008.02068.x; LIU DWC, 1990, J NEUROSCI, V10, P3947, DOI 10.1523/JNEUROSCI.10-12-03947.1990; Low LK, 2008, P NATL ACAD SCI USA, V105, P8136, DOI 10.1073/pnas.0803849105; Melancon E, 1997, J NEUROSCI, V17, P7796; Mould AP, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-24; MYERS PZ, 1986, J NEUROSCI, V6, P2278; Neufeld SQ, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-15; Noda Y, 2012, P NATL ACAD SCI USA, V109, P1725, DOI 10.1073/pnas.1107808109; Palaisa KA, 2007, DEVELOPMENT, V134, P3251, DOI 10.1242/dev.007112; Panagiotaki N, 2010, DEVELOPMENT, V137, P4005, DOI 10.1242/dev.053173; Panzer JA, 2005, DEV BIOL, V285, P340, DOI 10.1016/j.ydbio.2005.06.027; Puschel AW, 2007, ADV EXP MED BIOL, V600, P12; Sagasti A, 2005, CURR BIOL, V15, P804, DOI 10.1016/j.cub.2005.03.048; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sato-Maeda M, 2006, DEVELOPMENT, V133, P937, DOI 10.1242/dev.02268; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Schwander M, 2004, J NEUROSCI, V24, P8181, DOI 10.1523/JNEUROSCI.1345-04.2004; Suto F, 2005, J NEUROSCI, V25, P3628, DOI 10.1523/JNEUROSCI.4480-04.2005; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; TOMASELLI KJ, 1988, J NEUROSCI RES, V21, P275, DOI 10.1002/jnr.490210220; VARNUMFINNEY B, 1995, NEURON, V14, P1213, DOI 10.1016/0896-6273(95)90268-6; Waimey KE, 2006, NEUROSCIENTIST, V12, P398, DOI 10.1177/1073858406292631; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; WEAVER CD, 1995, J NEUROSCI, V15, P5275; Wyatt RM, 2003, J NEUROCYTOL, V32, P777, DOI 10.1023/B:NEUR.0000020623.62043.33; Yaron A, 2005, NEURON, V45, P513, DOI 10.1016/j.neuron.2005.01.013; YU WQ, 1994, J NEUROSCI, V14, P5872; Zeller J, 1999, DEVELOPMENT, V126, P3461; Zeller J, 2002, DEV BIOL, V252, P241, DOI 10.1006/dbio.2002.0852	51	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54071	10.1371/journal.pone.0054071	http://dx.doi.org/10.1371/journal.pone.0054071			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349787	Green Submitted, Green Published, gold			2022-12-25	WOS:000313943000025
J	Whang, YM; Jo, U; Sung, JS; Ju, HJ; Kim, HK; Park, KH; Lee, JW; Koh, IS; Kim, YH				Whang, Young Mi; Jo, Ukhyun; Sung, Jae Sook; Ju, Hyun Jung; Kim, Hyun Kyung; Park, Kyong Hwa; Lee, Jong Won; Koh, In Song; Kim, Yeul Hong			Wnt5a Is Associated with Cigarette Smoke-Related Lung Carcinogenesis via Protein Kinase C	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; TOBACCO-SMOKE; CANCER CELLS; EXPRESSION; TRANSFORMATION; PROLIFERATION; RELEASE; GROWTH; GENES; ALPHA	Wnt5a is overexpressed during the progression of human non-small cell lung cancer. However, the roles of Wnt5a during smoking-related lung carcinogenesis have not been clearly elucidated. We investigated the associations between Wnt5a and the early development of cigarette smoke related lung cancer using human bronchial epithelial (HBE) cells (NHBE, BEAS-2B, 1799, 1198 and 1170I) at different malignant stages established by exposure to cigarette smoke condensate (CSC). Abnormal up-regulation of Wnt5a mRNA and proteins was detected in CSC-exposed transformed 1198 and tumorigenic 1170I cells as compared with other non-CSC exposed HBE cells. Tumor tissues obtained from smokers showed higher Wnt5a expressions than matched normal tissues. In non-CSC exposed 1799 cells, treatment of recombinant Wnt5a caused the activations of PKC and Akt, and the blockage of Wnt5a and PKC significantly decreased the viabilities of CSC-transformed 1198 cells expressing high levels of Wnt5a. This reduced cell survival rate was associated with increased apoptosis via the down-regulation of Bcl2 and the induction of cleaved poly ADP-ribose polymerase. Moreover, CSC-treated 1799 cells showed induction of Wnt5a expression and enhanced colony-forming capacity. The CSC-induced colony forming efficiency was suppressed by the co-incubation with a PKC inhibitor. In conclusion, these results suggest that cigarette smoke induces Wnt5a-coupled PKC activity during lung carcinogenesis, which causes Akt activity and anti-apoptosis in lung cancer. Therefore, current study provides novel clues for the crucial role of Wnt5a in the smoking-related lung carcinogenesis.	[Whang, Young Mi; Jo, Ukhyun; Sung, Jae Sook; Ju, Hyun Jung; Kim, Hyun Kyung; Park, Kyong Hwa; Lee, Jong Won; Kim, Yeul Hong] Korea Univ, Coll Med, Anam Hosp, Dept Hematol Oncol, Seoul 136705, South Korea; [Whang, Young Mi; Jo, Ukhyun; Sung, Jae Sook; Ju, Hyun Jung; Kim, Hyun Kyung; Park, Kyong Hwa; Lee, Jong Won; Kim, Yeul Hong] Korea Univ, Coll Med, Anam Hosp, Brain Korea Project Biomed Sci 21, Seoul 136705, South Korea; [Koh, In Song] Hanyang Univ, Dept Physiol, Coll Med, Seoul 133791, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Hanyang University	Kim, YH (corresponding author), Korea Univ, Coll Med, Anam Hosp, Dept Hematol Oncol, Seoul 136705, South Korea.	yhk0215@korea.ac.kr	JO, Ukhyun/ABE-3019-2021	jo, ukhyun/0000-0002-2826-1355; PARK, KYONG HWA/0000-0002-2464-7920; Kim, Yeul Hong/0000-0002-2555-2333	National Project for Personalized Genomic Medicine, Ministry for Health & Welfare, Republic of Korea [A111218-11-GM04]; Seoul Research and Business Development Program [10574]	National Project for Personalized Genomic Medicine, Ministry for Health & Welfare, Republic of Korea; Seoul Research and Business Development Program(Seoul RBD program)	This study was supported by a grant from the National Project for Personalized Genomic Medicine, Ministry for Health & Welfare, Republic of Korea (A111218-11-GM04) and Seoul Research and Business Development Program (10574). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberg AJ, 2007, CHEST, V132, p29S, DOI 10.1378/chest.07-1347; Anto RJ, 2002, CARCINOGENESIS, V23, P1511, DOI 10.1093/carcin/23.9.1511; Gao Zhi-qiang, 2010, Zhonghua Jie He He Hu Xi Za Zhi, V33, P284; HECHT SS, 1988, CARCINOGENESIS, V9, P875, DOI 10.1093/carcin/9.6.875; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; Hoffmann D, 2001, CHEM RES TOXICOL, V14, P767, DOI 10.1021/tx000260u; Huang CL, 2005, J CLIN ONCOL, V23, P8765, DOI 10.1200/JCO.2005.02.2871; Huang RY, 2011, BBA-REV CANCER, V1815, P158, DOI 10.1016/j.bbcan.2010.11.005; Ikegami Y, 1996, JPN J PHARMACOL, V70, P65, DOI 10.1254/jjp.70.65; KLEINSZANTO AJP, 1992, P NATL ACAD SCI USA, V89, P6693, DOI 10.1073/pnas.89.15.6693; Lacroix L, 2006, CANCER BIOL THER, V5, P665, DOI 10.4161/cbt.5.6.2870; LEJEUNE S, 1995, CLIN CANCER RES, V1, P215; Lemjabbar H, 2003, J BIOL CHEM, V278, P26202, DOI 10.1074/jbc.M207018200; Lemjabbar-Alaoui H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000093; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; MacLeod RJ, 2007, AM J PHYSIOL-GASTR L, V293, pG403, DOI 10.1152/ajpgi.00119.2007; REDDEL RR, 1988, CANCER RES, V48, P1904; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; Roman-Gomez J, 2007, EUR J CANCER, V43, P2736, DOI 10.1016/j.ejca.2007.10.004; Schuller HM, 1999, CANCER RES, V59, P4510; Van Scoyk M, 2008, TRANSL RES, V151, P175, DOI 10.1016/j.trsl.2007.12.011; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Wen Jing, 2011, Chin J Cancer, V30, P551, DOI 10.5732/cjc.011.10059; Wyatt TA, 1999, AM J RESP CELL MOL, V21, P283, DOI 10.1165/ajrcmb.21.2.3636; Ying JM, 2008, CLIN CANCER RES, V14, P55, DOI 10.1158/1078-0432.CCR-07-1644; Zheng Y, 2007, AM J RESP CELL MOL, V37, P681, DOI 10.1165/rcmb.2007-0051OC	26	25	27	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e53012	10.1371/journal.pone.0053012	http://dx.doi.org/10.1371/journal.pone.0053012			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349696	gold, Green Published, Green Submitted			2022-12-25	WOS:000313943000010
J	Godugu, C; Patel, AR; Desai, U; Andey, T; Sams, A; Singh, M				Godugu, Chandraiah; Patel, Apurva R.; Desai, Utkarsh; Andey, Terrick; Sams, Alexandria; Singh, Mandip			AlgiMatrix (TM) Based 3D Cell Culture System as an In-Vitro Tumor Model for Anticancer Studies	PLOS ONE			English	Article							CANCER STEM-CELL; EXTRACELLULAR-MATRIX; DRUG-RESISTANCE; SOLID TUMORS; TISSUE; SCAFFOLDS; THERAPY; 3RD-DIMENSION; PENETRATION; SPHEROIDS	Background: Three-dimensional (3D) in-vitro cultures are recognized for recapitulating the physiological microenvironment and exhibiting high concordance with in-vivo conditions. Taking the advantages of 3D culture, we have developed the in-vitro tumor model for anticancer drug screening. Methods: Cancer cells grown in 6 and 96 well AlgiMatrix (TM) scaffolds resulted in the formation of multicellular spheroids in the size range of 100-300 mu m. Spheroids were grown in two weeks in cultures without compromising the growth characteristics. Different marketed anticancer drugs were screened by incubating them for 24 h at 7, 9 and 11 days in 3D cultures and cytotoxicity was measured by AlamarBlue (R) assay. Effectiveness of anticancer drug treatments were measured based on spheroid number and size distribution. Evaluation of apoptotic and anti-apoptotic markers was done by immunohistochemistry and RT-PCR. The 3D results were compared with the conventional 2D monolayer cultures. Cellular uptake studies for drug (Doxorubicin) and nanoparticle (NLC) were done using spheroids. Results: IC50 values for anticancer drugs were significantly higher in AlgiMatrix (TM) systems compared to 2D culture models. The cleaved caspase-3 expression was significantly decreased (2.09 and 2.47 folds respectively for 5-Fluorouracil and Camptothecin) in H460 spheroid cultures compared to 2D culture system. The cytotoxicity, spheroid size distribution, immunohistochemistry, RT-PCR and nanoparticle penetration data suggested that in vitro tumor models show higher resistance to anticancer drugs and supporting the fact that 3D culture is a better model for the cytotoxic evaluation of anticancer drugs in vitro. Conclusion: The results from our studies are useful to develop a high throughput in vitro tumor model to study the effect of various anticancer agents and various molecular pathways affected by the anticancer drugs and formulations.	[Godugu, Chandraiah; Patel, Apurva R.; Desai, Utkarsh; Andey, Terrick; Singh, Mandip] Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA; [Sams, Alexandria] Life Technol Corp, Cell Syst Div, Primary & Stem Cell Syst, Frederick, MA USA	State University System of Florida; Florida A&M University; Thermo Fisher Scientific	Singh, M (corresponding author), Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA.	mandip.sachdeva@famu.edu	Godugu, Chandraiah/F-4741-2018	Godugu, Chandraiah/0000-0001-5904-3134; HYDERABAD, NIPER/0000-0001-7521-1150	NCMHD [P 20MD 006738-01]; SC-1 grant [1SC1CA161676-01A1]; National Institutes of Health (NIH) [SC1CA161676-01A1]; NATIONAL CANCER INSTITUTE [SC1CA161676] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003020] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007582, P20MD006738] Funding Source: NIH RePORTER	NCMHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); SC-1 grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by NCMHD grant P 20MD 006738-01 and SC-1 grant 1SC1CA161676-01A1. This work was also supported by National Institutes of Health (NIH) funding grant number SC1CA161676-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbone D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.58; Bokhari M, 2007, J ANAT, V211, P567, DOI 10.1111/j.1469-7580.2007.00778.x; Chen L, 2012, BIOMATERIALS, V33, P1437, DOI 10.1016/j.biomaterials.2011.10.056; Chitcholtan K, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-38; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Dhiman HK, 2005, BIOMATERIALS, V26, P979, DOI 10.1016/j.biomaterials.2004.04.012; Diop-Frimpong B, 2011, P NATL ACAD SCI USA, V108, P2909, DOI 10.1073/pnas.1018892108; Dubrovska A, 2010, CLIN CANCER RES, V16, P5692, DOI 10.1158/1078-0432.CCR-10-1601; Duong HS, 2005, INT J EXP PATHOL, V86, P365, DOI 10.1111/j.0959-9673.2005.00441.x; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; Fischbach C, 2009, P NATL ACAD SCI USA, V106, P399, DOI 10.1073/pnas.0808932106; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Horning JL, 2008, MOL PHARMACEUT, V5, P849, DOI 10.1021/mp800047v; Howe GA, 2012, CELL ADHES MIGR, V6, P71, DOI 10.4161/cam.20077; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; Kim JB, 2005, SEMIN CANCER BIOL, V15, P365, DOI 10.1016/j.semcancer.2005.05.002; Kim JW, 2011, ANTICANCER RES, V31, P3237; Kyle AH, 2004, CANCER RES, V64, P6304, DOI 10.1158/0008-5472.CAN-04-1099; Kyle AH, 2007, CLIN CANCER RES, V13, P2804, DOI 10.1158/1078-0432.CCR-06-1941; Labarbera DV, 2012, EXPERT OPIN DRUG DIS; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064; Mitra M, 2012, MOL VIS, V18, P1361; Ong SM, 2010, BIOMATERIALS, V31, P1180, DOI 10.1016/j.biomaterials.2009.10.049; Oshikata A, 2011, J BIOSCI BIOENG, V111, P590, DOI 10.1016/j.jbiosc.2011.01.006; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Patlolla RR, 2010, J CONTROL RELEASE, V144, P233, DOI 10.1016/j.jconrel.2010.02.006; Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542; Prestwich GD, 2008, ACCOUNTS CHEM RES, V41, P139, DOI 10.1021/ar7000827; Prestwich GD, 2007, J CELL BIOCHEM, V101, P1370, DOI 10.1002/jcb.21386; Sarkar B, 2009, CHEM REV, V109, P3200, DOI 10.1021/cr9000397; Sethi T, 1999, NAT MED, V5, P662, DOI 10.1038/9511; Szot CS, 2011, BIOMATERIALS, V32, P7905, DOI 10.1016/j.biomaterials.2011.07.001; Tang C, 2007, FASEB J, V21, P3777, DOI 10.1096/fj.07-8560rev; Xiang XR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014640; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yang TM, 2009, AM J RESP CELL MOL, V41, P14, DOI 10.1165/rcmb.2008-0320OC; Zschenker O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034279	39	163	165	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e53708	10.1371/journal.pone.0053708	http://dx.doi.org/10.1371/journal.pone.0053708			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349734	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872800012
J	Johansson, J; Manneras-Holm, L; Shao, RJ; Olsson, A; Lonn, M; Billig, H; Stener-Victorin, E				Johansson, Julia; Manneras-Holm, Louise; Shao, Ruijin; Olsson, AnneLiese; Lonn, Malin; Billig, Hakan; Stener-Victorin, Elisabet			Electrical vs Manual Acupuncture Stimulation in a Rat Model of Polycystic Ovary Syndrome: Different Effects on Muscle and Fat Tissue Insulin Signaling	PLOS ONE			English	Article							LOW-FREQUENCY ELECTROACUPUNCTURE; MESSENGER-RNA EXPRESSION; BLOOD-FLOW RESPONSES; PHYSICAL-EXERCISE; ADIPOSE-TISSUE; GLUCOSE-TRANSPORT; SKELETAL-MUSCLE; GENE-EXPRESSION; GROUP-III; WOMEN	In rats with dihydrotestosterone (DHT)-induced polycystic ovary syndrome (PCOS), repeated low-frequency electrical stimulation of acupuncture needles restores whole-body insulin sensitivity measured by euglycemic hyperinsulinemic clamp. We hypothesized that electrical stimulation causing muscle contractions and manual stimulation causing needle sensation have different effects on insulin sensitivity and related signaling pathways in skeletal muscle and adipose tissue, with electrical stimulation being more effective in DHT-induced PCOS rats. From age 70 days, rats received manual or low-frequency electrical stimulation of needles in abdominal and hind limb muscle five times/wk for 4-5 wks; controls were handled but untreated rats. Low-frequency electrical stimulation modified gene expression (decreased Tbc1d1 in soleus, increased Nr4a3 in mesenteric fat) and protein expression (increased pAS160/AS160, Nr4a3 and decreased GLUT4) by western blot and increased GLUT4 expression by immunohistochemistry in soleus muscle; glucose clearance during oral glucose tolerance tests was unaffected. Manual stimulation led to faster glucose clearance and modified mainly gene expression in mesenteric adipose tissue (increased Nr4a3, Mapk3/Erk, Adcy3, Gsk3b), but not protein expression to the same extent; however, Nr4a3 was reduced in soleus muscle. The novel finding is that electrical and manual muscle stimulation affect glucose homeostasis in DHT-induced PCOS rats through different mechanisms. Repeated electrical stimulation regulated key functional molecular pathways important for insulin sensitivity in soleus muscle and mesenteric adipose tissue to a larger extent than manual stimulation. Manual stimulation improved whole-body glucose tolerance, an effect not observed after electrical stimulation, but did not affect molecular signaling pathways to the same extent as electrical stimulation. Although more functional signaling pathways related to insulin sensitivity were affected by electrical stimulation, our findings suggest that manual stimulation of acupuncture needles has a greater effect on glucose tolerance. The underlying mechanism of the differential effects of the intermittent manual and the continuous electrical stimulation remains to be elucidated.	[Johansson, Julia; Manneras-Holm, Louise; Shao, Ruijin; Olsson, AnneLiese; Billig, Hakan; Stener-Victorin, Elisabet] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol, Gothenburg, Sweden; [Lonn, Malin] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Clin Chem & Transfus Med, Gothenburg, Sweden; [Stener-Victorin, Elisabet] Heilongjiang Univ Chinese Med, Dept Obstet & Gynecol, Affiliated Hosp 1, Harbin, Peoples R China	University of Gothenburg; University of Gothenburg; Heilongjiang University of Chinese Medicine	Stener-Victorin, E (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol, Gothenburg, Sweden.	elisabet.stener-victorin@neuro.gu.se	Billig, Hakan/E-8891-2011; Shao, Linus R/M-3134-2019; Stener-Victorin, Elisabet/W-6322-2018; Shao, Linus R/M-3059-2019	Billig, Hakan/0000-0001-6140-9182; Shao, Linus R/0000-0002-1339-9570; Stener-Victorin, Elisabet/0000-0002-3424-1502; Shao, Linus R/0000-0002-1339-9570	Genomics Core Facility at the Sahlgrenska Academy, University of Gothenburg; Knut and Alice Wallenberg Foundation	Genomics Core Facility at the Sahlgrenska Academy, University of Gothenburg; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	For the use of technical equipment and support we thank the Genomics Core Facility at the Sahlgrenska Academy, University of Gothenburg, which was funded by a grant from the Knut and Alice Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MI, 2008, HUM REPROD, V23, P2564, DOI 10.1093/humrep/den273; Atherton PJ, 2005, FASEB J, V19, P786, DOI 10.1096/fj.04-2179fje; Bruss MD, 2005, DIABETES, V54, P41, DOI 10.2337/diabetes.54.1.41; CEDERHOLM J, 1990, DIABETES RES CLIN PR, V10, P167, DOI 10.1016/0168-8227(90)90040-Z; Chadt A, 2008, NAT GENET, V40, P1354, DOI 10.1038/ng.244; Chang SL, 2006, LIFE SCI, V79, P967, DOI 10.1016/j.lfs.2006.05.005; Ciaraldi TP, 2009, J CLIN ENDOCR METAB, V94, P157, DOI 10.1210/jc.2008-1492; CIARALDI TP, 1992, J CLIN ENDOCR METAB, V75, P577, DOI 10.1210/jc.75.2.577; Deshmukh AS, 2008, INT J OBESITY, V32, pS18, DOI 10.1038/ijo.2008.118; DUNAIF A, 1992, DIABETES, V41, P1257, DOI 10.2337/diabetes.41.10.1257; Dunaif A, 2001, AM J PHYSIOL-ENDOC M, V281, pE392, DOI 10.1152/ajpendo.2001.281.2.E392; Feng Y, 2012, EXP PHYSL; Feng Y, 2012, EXP PHYSIOL, V97, P651, DOI 10.1113/expphysiol.2011.063131; Feng Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006638; Frosig C, 2009, OBESITY, V17, pS15, DOI 10.1038/oby.2009.383; Fu YC, 2007, J BIOL CHEM, V282, P31525, DOI 10.1074/jbc.M701132200; Goodyear LJ, 1998, ANNU REV MED, V49, P235, DOI 10.1146/annurev.med.49.1.235; Han J. S., 1997, J ALTERN COMPLEME S1, V3, P101; Han JS, 2003, TRENDS NEUROSCI, V26, P17, DOI 10.1016/S0166-2236(02)00006-1; Higashimura Y, 2009, AUTON NEUROSCI-BASIC, V150, P100, DOI 10.1016/j.autneu.2009.06.003; Ishizaki N, 2009, METABOLISM, V58, P1372, DOI 10.1016/j.metabol.2009.05.001; Jedel E, 2011, AM J PHYSIOL-ENDOC M, V300, pE37, DOI 10.1152/ajpendo.00495.2010; Jensterle M, 2008, EUR J ENDOCRINOL, V158, P793, DOI 10.1530/EJE-07-0857; Johansson J, 2010, AM J PHYSIOL-ENDOC M, pE; Kagitani F, 2005, JPN J PHYSIOL, V55, P149, DOI 10.2170/jjphysiol.R2120; KAUFMAN MP, 1984, CARDIOVASC RES, V18, P663, DOI 10.1093/cvr/18.11.663; Kawasaki E, 2009, J APPL PHYSIOL, V106, P1826, DOI 10.1152/japplphysiol.90923.2008; Krook A, 2004, MED SCI SPORT EXER, V36, P1212, DOI 10.1249/01.MSS.0000132387.25853.3B; Lai Mao-Hua, 2010, Zhen Ci Yan Jiu, V35, P298; Liang FX, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/735297; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; Manneras L, 2008, ENDOCRINOLOGY, V149, P3559, DOI 10.1210/en.2008-0053; Manneras L, 2007, ENDOCRINOLOGY, V148, P3781, DOI 10.1210/en.2007-0168; Manneras L, 2009, AM J PHYSIOL-REG I, V296, pR1124, DOI 10.1152/ajpregu.90947.2008; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Ohkura N, 1996, BBA-GENE STRUCT EXPR, V1308, P205, DOI 10.1016/0167-4781(96)00101-7; Padmanabhan V, 2011, SEMIN REPROD MED, V29, P173, DOI 10.1055/s-0031-1275519; Pastore LM, 2011, J CLIN ENDOCR METAB, V96, P3143, DOI 10.1210/jc.2011-1126; Rizza RA, 2010, DIABETES, V59, P2697, DOI 10.2337/db10-1032; ROSENBAUM D, 1993, AM J PHYSIOL, V264, pE197, DOI 10.1152/ajpendo.1993.264.2.E197; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; Sato A, 2002, INT CONGR SER, V1238, P111, DOI 10.1016/S0531-5131(02)00418-1; Seow KM, 2007, HUM REPROD, V22, P1003, DOI 10.1093/humrep/del466; Shao RJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE147, DOI 10.1152/ajpendo.00101.2007; Stener-Victorin E, 2003, AUTON NEUROSCI-BASIC, V108, P50, DOI 10.1016/j.autneu.2003.08.006; Stener-Victorin E, 2006, J APPL PHYSIOL, V101, P84, DOI 10.1152/japplphysiol.01593.2005; Stener-Victorin E, 2012, FERTIL STERIL, V97, P501, DOI 10.1016/j.fertnstert.2011.11.010; Stener-Victorin E, 2009, AM J PHYSIOL-REG I, V297, pR387, DOI 10.1152/ajpregu.00197.2009; Suwa M, 2008, METABOLISM, V57, P986, DOI 10.1016/j.metabol.2008.02.017; Taylor EB, 2008, J BIOL CHEM, V283, P9787, DOI 10.1074/jbc.M708839200; Teede HJ, 2006, ENDOCRINE, V30, P45, DOI 10.1385/ENDO:30:1:45; Zierath JR, 2000, DIABETOLOGIA, V43, P821, DOI 10.1007/s001250051457	54	25	26	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54357	10.1371/journal.pone.0054357	http://dx.doi.org/10.1371/journal.pone.0054357			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349861	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872800042
J	Wang, XD; Inzunza, H; Chang, H; Qi, ZH; Hu, BH; Malone, D; Cogswell, J				Wang, Xi-De; Inzunza, Hector; Chang, Han; Qi, Zhenhao; Hu, Beihong; Malone, Daniel; Cogswell, John			Mutations in the Hedgehog Pathway Genes SMO and PTCH1 in Human Gastric Tumors	PLOS ONE			English	Article							BASAL-CELL CARCINOMA; HUMAN HOMOLOG; PATCHED GENE; CANCER; MEDULLOBLASTOMA; POLYMORPHISM; ACTIVATION; INHIBITOR; MEDICINE; DIFFUSE	The causal role of the hedgehog pathway in cancer has been best documented in basal cell carcinoma of the skin. To assess potential DNA alterations of the hedgehog pathway in gastric cancer, we sequenced SMO and PTCH1 genes in a set of 39 gastric tumors. Tumors were classified by histology based on the Lauren classification and Sanger sequencing was performed to obtain full length coding sequences. Genomic instability was evident in these tumors as a number of silent or missense mutations were found. In addition to those that are potential germline polymorphisms, we found three SMO missense mutations, and one PTCH1 frameshift mutation that are novel and have not been documented in basal cell carcinoma. Mutations were found in both intestinal and diffuse type gastric tumors as well as in tumors that exhibit both intestinal and diffuse features. mRNA expression of hedgehog pathway genes was also examined and their levels do not indicate unequivocal higher pathway activity in tumors with mutations than those without. In summary, SMO and/or PTCH1 mutations are present at low frequency in different histologic subtypes of gastric tumors and these do not appear to be driver mutations.	[Wang, Xi-De; Inzunza, Hector; Chang, Han; Qi, Zhenhao; Hu, Beihong; Malone, Daniel; Cogswell, John] Bristol Myers Squibb Co, Princeton, NJ USA	Bristol-Myers Squibb	Wang, XD (corresponding author), Bristol Myers Squibb Co, Princeton, NJ USA.	xi-de.wang@bms.com						Asplund A, 2005, BRIT J DERMATOL, V152, P868, DOI 10.1111/j.1365-2133.2005.06464.x; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Chang-Claude J, 2003, INT J CANCER, V103, P779, DOI 10.1002/ijc.10889; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fukaya M, 2006, GASTROENTEROLOGY, V131, P14, DOI 10.1053/j.gastro.2006.05.008; GAILANI MR, 1992, CELL, V69, P111, DOI 10.1016/0092-8674(92)90122-S; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; Hafner C, 2007, HUM PATHOL, V38, P1496, DOI 10.1016/j.humpath.2007.02.015; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Holbrook JD, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-119; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; La Thangue NB, 2011, NAT REV CLIN ONCOL, V8, P587, DOI 10.1038/nrclinonc.2011.121; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Ma XL, 2005, CARCINOGENESIS, V26, P1698, DOI 10.1093/carcin/bgi130; Maesawa C, 1998, GENE CHROMOSOME CANC, V21, P276, DOI 10.1002/(SICI)1098-2264(199803)21:3<276::AID-GCC15>3.3.CO;2-H; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Santos FPS, 2011, CANCER J, V17, P465, DOI 10.1097/PPO.0b013e31823dec8d; Vestergaard J, 2006, LUNG CANCER, V52, P281, DOI 10.1016/j.lungcan.2005.12.014; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Xie JW, 1997, CANCER RES, V57, P2369; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yan TQ, 2008, CLIN ORTHOP RELAT R, V466, P2184, DOI 10.1007/s11999-008-0332-2; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Zhang JX, 2007, J UROLOGY, V177, P1179, DOI 10.1016/j.juro.2006.10.032	26	28	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54415	10.1371/journal.pone.0054415	http://dx.doi.org/10.1371/journal.pone.0054415			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349881	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872800051
J	Capps, KA; Flecker, AS				Capps, Krista A.; Flecker, Alexander S.			Invasive Fishes Generate Biogeochemical Hotspots in a Nutrient-Limited System	PLOS ONE			English	Article							CATFISH LORICARIIDAE PTERYGOPLICHTHYS; SUCKERMOUTH ARMORED CATFISH; FOOD WEBS; STOICHIOMETRY; STREAMS; PISCES; LIMITATION; PERIPHYTON; BIOMASS; RECORD	Fishes can play important functional roles in the nutrient dynamics of freshwater systems. Aggregating fishes have the potential to generate areas of increased biogeochemical activity, or hotspots, in streams and rivers. Many of the studies documenting the functional role of fishes in nutrient dynamics have focused on native fish species; however, introduced fishes may restructure nutrient storage and cycling freshwater systems as they can attain high population densities in novel environments. The purpose of this study was to examine the impact of a non-native catfish (Loricariidae: Pterygoplichthys) on nitrogen and phosphorus remineralization and estimate whether large aggregations of these fish generate measurable biogeochemical hotspots within nutrient-limited ecosystems. Loricariids formed large aggregations during daylight hours and dispersed throughout the stream during evening hours to graze benthic habitats. Excretion rates of phosphorus were twice as great during nighttime hours when fishes were actively feeding; however, there was no diel pattern in nitrogen excretion rates. Our results indicate that spatially heterogeneous aggregations of loricariids can significantly elevate dissolved nutrient concentrations via excretion relative to ambient nitrogen and phosphorus concentrations during daylight hours, creating biogeochemical hotspots and potentially altering nutrient dynamics in invaded systems.	[Capps, Krista A.; Flecker, Alexander S.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [Capps, Krista A.] Univ Maine, Sustainabil Solut Initiat, Orono, ME USA	Cornell University; University of Maine System; University of Maine Orono	Capps, KA (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA.	krista.capps@maine.edu			National Science Foundation (Doctoral Dissertation Enhancement Program Grant) [183-8371]; Integrated Graduate Education and Research in Biogeochemistry and Environmental Biocomplexity [0221658]; Fulbright-Hays Doctoral Dissertation Research Abroad Program, Sigma Xi; Tinker Field Research Grant; Andrew and Margaret Paul Graduate Fellowship in the Life Sciences; American Cichlid Association Paul V. Loiselle Conservation Fund	National Science Foundation (Doctoral Dissertation Enhancement Program Grant); Integrated Graduate Education and Research in Biogeochemistry and Environmental Biocomplexity; Fulbright-Hays Doctoral Dissertation Research Abroad Program, Sigma Xi; Tinker Field Research Grant; Andrew and Margaret Paul Graduate Fellowship in the Life Sciences; American Cichlid Association Paul V. Loiselle Conservation Fund	This work was funded by the National Science Foundation (Doctoral Dissertation Enhancement Program Grant (183-8371); Integrated Graduate Education and Research in Biogeochemistry and Environmental Biocomplexity (0221658) Small Grant Program), the Fulbright-Hays Doctoral Dissertation Research Abroad Program, Sigma Xi, the Tinker Field Research Grant, the Andrew and Margaret Paul Graduate Fellowship in the Life Sciences, and the American Cichlid Association Paul V. Loiselle Conservation Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benstead JP, 2010, FRESHWATER BIOL, V55, P2047, DOI 10.1111/j.1365-2427.2010.02461.x; Bomford M., 2004, RISK ASSESSMENT MODE; Bouletreau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025732; Bunkley-Williams Lucy, 1994, Caribbean Journal of Science, V30, P90; Bunnell DB, 2005, CAN J FISH AQUAT SCI, V62, P15, DOI 10.1139/F04-172; Capps KA, 2012, CHANGES COMMUNITY ST; Capps KA, 2011, AQUAT CONSERV, V21, P528, DOI 10.1002/aqc.1210; Capps KA, 2011, J N AM BENTHOL SOC, V30, P522, DOI 10.1899/10-146.1; Casatti L, 2006, NEOTROP ICHTHYOL, V4, P203, DOI 10.1590/S1679-62252006000200006; Chavez JM, 2006, ZOOTAXA, P57, DOI 10.11646/zootaxa.1109.1.6; Courtenay W.R. Jr, 1986, P675; Davis M, 2011, NATURE, V474, P153, DOI 10.1038/474153a; DEVICK WS, 1989, DISTURBANCES FLUCTUA; Evans-White MA, 2006, ECOL LETT, V9, P1186, DOI 10.1111/j.1461-0248.2006.00971.x; Froese R., 2012, FISHBASE; Gonzalez AL, 2010, OIKOS, V119, P779, DOI 10.1111/j.1600-0706.2009.18549.x; Hood JM, 2005, OECOLOGIA, V146, P247, DOI 10.1007/s00442-005-0202-5; Hoover J. J., 2004, SUCKERMOUTH CATFISHE; Johnson LT, 2009, J N AM BENTHOL SOC, V28, P694, DOI 10.1899/08-107.1; Kitchell J.F., 1975, Verhandlungen Int Verein Theor Angew Limnol, V19, P2478; Knoll LB, 2009, OIKOS, V118, P1732, DOI 10.1111/j.1600-0706.2009.17367.x; KRAFT CE, 1993, T AM FISH SOC, V122, P749, DOI 10.1577/1548-8659(1993)122<0749:PRBLMA>2.3.CO;2; Liang SH, 2005, ZOOL STUD, V44, P252; Lienart GDH, 2012, SW NATURALI IN PRESS; Liess A, 2006, J N AM BENTHOL SOC, V25, P632, DOI 10.1899/0887-3593(2006)25[632:RONSIG]2.0.CO;2; McClain ME, 2003, ECOSYSTEMS, V6, P301, DOI 10.1007/s10021-003-0161-9; McIntyre PB, 2008, ECOLOGY, V89, P2335, DOI 10.1890/07-1552.1; McIntyre PB, 2007, P NATL ACAD SCI USA, V104, P4461, DOI 10.1073/pnas.0608148104; McIntyre PB, 2006, LIMNOL OCEANOGR, V51, P1514, DOI 10.4319/lo.2006.51.3.1514; Mendoza R, 2009, TRINATIONAL RISK ASS; Mendoza-Carranza M, 2010, NEOTROP ICHTHYOL, V8, P171, DOI 10.1590/S1679-62252010000100020; MEYER JL, 1983, SCIENCE, V220, P1047, DOI 10.1126/science.220.4601.1047; Nico LG, 2010, NEOTROP ICHTHYOL, V8, P893, DOI 10.1590/S1679-62252010005000014; Nico LG, 2001, SOUTHWEST NAT, V46, P98, DOI 10.2307/3672381; Nico LG, 2009, ANSRP B, V9, P1; Ozdilek SY, 2007, SU URUN DERG, V24, P303; Pound KL, 2011, ENVIRON BIOL FISH, V90, P277, DOI 10.1007/s10641-010-9741-7; REDFIELD AC, 1958, AM SCI, V46, P205; Reisinger AJ, 2011, J N AM BENTHOL SOC, V30, P840, DOI 10.1899/10-169.1; Sinha RK, 2010, J APPL ICHTHYOL, V26, P606, DOI 10.1111/j.1439-0426.2010.01474.x; Small GE, 2011, ECOLOGY, V92, P386, DOI 10.1890/10-0081.1; Taylor BW, 2007, J N AM BENTHOL SOC, V26, P167, DOI 10.1899/0887-3593(2007)26[167:ITFAMM]2.0.CO;2; Vander Zanden MJ, 2002, ECOLOGY, V83, P2152, DOI 10.1890/0012-9658(2002)083[2152:FAIOBA]2.0.CO;2; Vanni MJ, 2002, ECOL LETT, V5, P285, DOI 10.1046/j.1461-0248.2002.00314.x; WEBER C, 1991, REV SUISSE ZOOL, V98, P637; Zalucki J.M., 1999, BASELINE ENV DATA RE	46	63	67	3	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54093	10.1371/journal.pone.0054093	http://dx.doi.org/10.1371/journal.pone.0054093			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342083	gold, Green Submitted, Green Published			2022-12-25	WOS:000313682700086
J	Chang, KH; Chen, CM; Chen, YC; Hsiao, YC; Huang, CC; Kuo, HC; Hsu, HC; Lee-Chen, GJ; Wu, YR				Chang, Kuo-Hsuan; Chen, Chiung-Mei; Chen, Yi-Chun; Hsiao, Ya-Chin; Huang, Chin-Chang; Kuo, Hung-Chou; Hsu, Hsuan-Chu; Lee-Chen, Guey-Jen; Wu, Yih-Ru			Association between GRN rs5848 Polymorphism and Parkinson's Disease in Taiwanese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FRONTOTEMPORAL LOBAR DEGENERATION; RISK-FACTOR; GENE-EXPRESSION; COMMON VARIANTS; PROGRANULIN; LRRK2; LOCI; DEMENTIA; GENDER	A single nucleotide polymorphism GRN rs5848 (3'UTR+78 C > T) was reported to alter the risk for frontotemporal lobar degeneration. Herein, we investigated the effect of GRN rs5848 on the risk of Parkinson's disease (PD) by genotyping 573 Taiwanese patients with PD and 490 age-matched control subjects. Compared to subjects with CC genotype, those with TT genotype had a 1.58-fold increased risk of PD (95% CI: 1.77 similar to 2.34, P = 0.021). PD patients demonstrate a higher frequency of T allele (37.2%) than controls (32.2%; odds ratio [OR] = 1.24, 95% CI: 1.04 similar to 1.49, P = 0.017). This susceptibility was particularly observed in female subjects, in which TT genotype had a 2.16-fold increased risk of PD as compared with controls(95% CI: 1.24 similar to 3.78, P = 0.006). The frequency of T allele (39.3%) in female PD patients was higher than in female control subjects (31.1%; OR = 1.43, CI: 1.11 similar to 1.87, P = 0.007). No association was observed between GRN rs5848 and susceptibility in male subjects. These findings show that the GRN rs5848 TT genotype and T allele are risk factors for female Taiwanese patients with PD.	[Chang, Kuo-Hsuan; Chen, Chiung-Mei; Chen, Yi-Chun; Huang, Chin-Chang; Kuo, Hung-Chou; Wu, Yih-Ru] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Neurol, Taipei, Taiwan; [Hsiao, Ya-Chin; Hsu, Hsuan-Chu; Lee-Chen, Guey-Jen] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Taiwan Normal University	Lee-Chen, GJ (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.	t43019@ntnu.edu.tw; yihruwu@adm.cgmh.org.tw	Chen, Chiung-Mei/AAL-6260-2020		Chang Gung Memorial Hospital, Taipei, Taiwan [CMRPG3A0131]; National Science Council, Executive Yuan, Taiwan [NSC98-2628-B-182A-001-MY3]	Chang Gung Memorial Hospital, Taipei, Taiwan(Chang Gung Memorial Hospital); National Science Council, Executive Yuan, Taiwan(Ministry of Science and Technology, Taiwan)	This study was sponsored by Chang Gung Memorial Hospital, Taipei, Taiwan (CMRPG3A0131), and National Science Council, Executive Yuan, Taiwan (NSC98-2628-B-182A-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-7; Baldereschi M, 2000, NEUROLOGY, V55, P1358, DOI 10.1212/WNL.55.9.1358; BHANDARI V, 1992, BIOCHEM BIOPH RES CO, V188, P57, DOI 10.1016/0006-291X(92)92349-3; Biskup S, 2005, ANN NEUROL, V58, P905, DOI 10.1002/ana.20664; Cantuti-Castelvetri I, 2007, NEUROBIOL DIS, V26, P606, DOI 10.1016/j.nbd.2007.02.009; Chen CC, 2009, NEUROEPIDEMIOLOGY, V33, P350, DOI 10.1159/000254572; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Farrer MJ, 2007, PARKINSONISM RELAT D, V13, P89, DOI 10.1016/j.parkreldis.2006.12.001; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; Fung HC, 2006, LANCET NEUROL, V5, P911, DOI 10.1016/S1474-4422(06)70578-6; Ghidoni R, 2008, NEUROLOGY, V71, P1235, DOI 10.1212/01.wnl.0000325058.10218.fc; Gillies GE, 2010, HORM BEHAV, V57, P23, DOI 10.1016/j.yhbeh.2009.06.002; Hamza TH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002237; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; He ZH, 1999, CANCER RES, V59, P3222; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; Hsiung GYR, 2011, J NEUROL SCI, V300, P28, DOI 10.1016/j.jns.2010.10.009; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jasinska-Myga B, 2009, EUR J NEUROL, V16, P909, DOI 10.1111/j.1468-1331.2009.02621.x; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Liu XM, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-104; Paisan-Ruiz C, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.036889; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Rademakers R, 2008, HUM MOL GENET, V17, P3631, DOI 10.1093/hmg/ddn257; Rocca WA, 2008, NEUROLOGY, V70, P200, DOI 10.1212/01.wnl.0000280573.30975.6a; Ross OA, 2008, ANN NEUROL, V64, P88, DOI 10.1002/ana.21405; Saad M, 2011, HUM MOL GENET, V20, P615, DOI 10.1093/hmg/ddq497; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Saunders-Pullman R, 2003, ENDOCRINE, V21, P81, DOI 10.1385/ENDO:21:1:81; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Simunovic F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008856; Sleegers K, 2009, ANN NEUROL, V65, P603, DOI 10.1002/ana.21621; Spencer CCA, 2011, HUM MOL GENET, V20, P345, DOI 10.1093/hmg/ddq469; Suzuki M, 2009, J REPROD DEVELOP, V55, P351, DOI 10.1262/jrd.20249; Tan EK, 2010, NEUROLOGY, V75, P508, DOI 10.1212/WNL.0b013e3181eccfcd; Tan EK, 2010, HUM MUTAT, V31, P561, DOI 10.1002/humu.21225; Van Damme P, 2008, J CELL BIOL, V181, P37, DOI 10.1083/jcb.200712039	38	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54448	10.1371/journal.pone.0054448	http://dx.doi.org/10.1371/journal.pone.0054448			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342160	gold, Green Published, Green Submitted			2022-12-25	WOS:000313682700118
J	Karsten, M; van Vuuren, BJ; Barnaud, A; Terblanche, JS				Karsten, Minette; van Vuuren, Bettine Jansen; Barnaud, Adeline; Terblanche, John S.			Population Genetics of Ceratitis capitata in South Africa: Implications for Dispersal and Pest Management	PLOS ONE			English	Article							MEDITERRANEAN FRUIT-FLY; COMPUTER-PROGRAM; MICROSATELLITE ANALYSIS; DIPTERA; INVASION; FLOW; TEPHRITIDAE; EXPANSION; DIFFERENTIATION; FASCIVENTRIS	The invasive Mediterranean fruit fly (medfly), Ceratitis capitata, is one of the major agricultural and economical pests globally. Understanding invasion risk and mitigation of medfly in agricultural landscapes requires knowledge of its population structure and dispersal patterns. Here, estimates of dispersal ability are provided in medfly from South Africa at three spatial scales using molecular approaches. Individuals were genotyped at 11 polymorphic microsatellite loci and a subset of individuals were also sequenced for the mitochondrial cytochrome oxidase subunit I gene. Our results show that South African medfly populations are generally characterized by high levels of genetic diversity and limited population differentiation at all spatial scales. This suggests high levels of gene flow among sampling locations. However, natural dispersal in C. capitata has been shown to rarely exceed 10 km. Therefore, documented levels of high gene flow in the present study, even between distant populations (> 1600 km), are likely the result of human-mediated dispersal or at least some form of long-distance jump dispersal. These findings may have broad applicability to other global fruit production areas and have significant implications for ongoing pest management practices, such as the sterile insect technique.	[Karsten, Minette] Univ Stellenbosch, Dept Bot & Zool, Evolutionary Genom Grp, Matieland, South Africa; [van Vuuren, Bettine Jansen] Univ Johannesburg, Dept Zool, Ctr Invas Biol, Auckland Pk, South Africa; [Barnaud, Adeline] IRD, Montpellier, France; [Karsten, Minette; Terblanche, John S.] Univ Stellenbosch, Ctr Invas Biol, Dept Conservat Ecol & Entomol, Matieland, South Africa	Stellenbosch University; University of Johannesburg; Institut de Recherche pour le Developpement (IRD); Stellenbosch University	Terblanche, JS (corresponding author), Univ Stellenbosch, Ctr Invas Biol, Dept Conservat Ecol & Entomol, Matieland, South Africa.	jst@sun.ac.za	Jansen van Vuuren, Bettine/E-6227-2013; Terblanche, John/AAB-4457-2020	Jansen van Vuuren, Bettine/0000-0002-5334-5358; barnaud, adeline/0000-0001-9896-1210; Terblanche, John/0000-0001-9665-9405	Fruitgro Science; NRF-THRIP; NRF Scarce Skills	Fruitgro Science; NRF-THRIP; NRF Scarce Skills	This study was funded by Fruitgro Science (JST), NRF-THRIP (P. Addison) and NRF Scarce Skills. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaoui A, 2010, INT J AGRIC BIOL, V12, P291; ANNECKE DP, 1982, INSECTS MITES CULTIV; ARITA L H, 1985, Proceedings of the Hawaiian Entomological Society, V25, P39; Baliraine FN, 2004, MOL ECOL, V13, P683, DOI 10.1046/j.1365-294X.2004.02105.x; Barclay HJ, 2011, INT J AGRON, V2011, DOI 10.1155/2011/409328; Barnes B, 2007, FLA ENTOMOL, V90, P41, DOI 10.1653/0015-4040(2007)90[41:PAQAIT]2.0.CO;2; Barr NB, 2006, MOL PHYLOGENET EVOL, V38, P216, DOI 10.1016/j.ympev.2005.10.013; Bedford E.C.G., 1998, CITRUS PESTS REPUBLI; Belkhir K, 1996, 5000 CNRS UMR U MONT; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Bonizzoni M, 2002, MOL ECOL, V11, P1915, DOI 10.1046/j.1365-294X.2002.01602.x; Bonizzoni M, 2004, MOL ECOL, V13, P3845, DOI 10.1111/j.1365-294X.2004.02371.x; Bonizzoni M, 2001, MOL ECOL, V10, P2515, DOI 10.1046/j.0962-1083.2001.01376.x; Bonizzoni M, 2000, INSECT MOL BIOL, V9, P251, DOI 10.1046/j.1365-2583.2000.00184.x; Broquet T, 2009, ANNU REV ECOL EVOL S, V40, P193, DOI 10.1146/annurev.ecolsys.110308.120324; Casey DG, 2001, MOL ECOL NOTES, V1, P120, DOI 10.1046/j.1471-8278.2001.00038.x; Chapuis MP, 2011, P ROY SOC B-BIOL SCI, V278, P3152, DOI 10.1098/rspb.2010.2605; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; COYNE JA, 1987, AM NAT, V130, P70, DOI 10.1086/284698; De Meyer M, 2008, J BIOGEOGR, V35, P270, DOI 10.1111/j.1365-2699.2007.01769.x; De Meyer M, 2000, ZOOL J LINN SOC-LOND, V128, P439, DOI 10.1111/j.1096-3642.2000.tb01523.x; De Meyer M., 2002, P 6 INT FRUIT FLY S; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; Duyck PF, 2006, J ANIM ECOL, V75, P518, DOI 10.1111/j.1365-2656.2006.01072.x; Ekesi S, 2007, FIELD GUIDE MANAGEME; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Facon B, 2008, CURR BIOL, V18, P363, DOI 10.1016/j.cub.2008.01.063; Falush D, 2003, GENETICS, V164, P1567; Fu YX, 1997, GENETICS, V147, P915; Gasperi G, 2002, GENETICA, V116, P125, DOI 10.1023/A:1020971911612; GASPERI G, 1991, HEREDITY, V67, P347, DOI 10.1038/hdy.1991.98; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hendrichs J, 2002, FLA ENTOMOL, V85, P1, DOI 10.1653/0015-4040(2002)085[0001:MASITP]2.0.CO;2; Hendrichs J, 2007, AREA WIDE CONTROL IN; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Katzner TE, 2011, ANIM CONSERV, V14, P328, DOI 10.1111/j.1469-1795.2011.00444.x; Kourti A, 2004, B ENTOMOL RES, V94, P449, DOI 10.1079/BER2004324; Lance D, 2005, STERILE INSECT TECHN; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Malacrida AR, 2007, GENETICA, V131, P1, DOI 10.1007/s10709-006-9117-2; Malacrida AR, 1998, J HERED, V89, P501, DOI 10.1093/jhered/89.6.501; MALACRIDA AR, 1992, HEREDITY, V69, P101, DOI 10.1038/hdy.1992.102; Manrakhan A, 2007, S AFRICAN FRUIT J, V6, P16; MANTEL N, 1967, CANCER RES, V27, P209; Meats A, 2007, J APPL ENTOMOL, V131, P518, DOI 10.1111/j.1439-0418.2007.01168.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Novak SJ, 2007, P NATL ACAD SCI USA, V104, P3671, DOI 10.1073/pnas.0700224104; Nyamukondiwa C, 2009, J THERM BIOL, V34, P406, DOI 10.1016/j.jtherbio.2009.09.002; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Roderick GK, 1996, ANNU REV ENTOMOL, V41, P325, DOI 10.1146/annurev.en.41.010196.001545; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SHARP JL, 1976, P HAWAII ENTOMOL SOC, V22, P335; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Stratikopoulos EE, 2008, GENETICA, V133, P147, DOI 10.1007/s10709-007-9195-9; Tolley KA, 2008, DIVERS DISTRIB, V14, P400, DOI 10.1111/j.1472-4642.2007.00428.x; Villablanca FX, 1998, MOL ECOL, V7, P547, DOI 10.1046/j.1365-294x.1998.00351.x; Virgilio M, 2008, MOL PHYLOGENET EVOL, V48, P270, DOI 10.1016/j.ympev.2008.04.018; Wang IJ, 2010, MOL ECOL, V19, P2605, DOI 10.1111/j.1365-294X.2010.04715.x; White I, 1994, FRUIT FLIES EC SIGNI, V82, P433, DOI 10.1017/S0007485300041237; Wilson JRU, 2009, TRENDS ECOL EVOL, V24, P136, DOI 10.1016/j.tree.2008.10.007; Yuval B, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P429	73	48	48	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54281	10.1371/journal.pone.0054281	http://dx.doi.org/10.1371/journal.pone.0054281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342117	Green Submitted, Green Published, gold			2022-12-25	WOS:000313682700101
J	Cho, IH; Kim, DH; Lee, MJ; Bae, J; Lee, KH; Song, WK				Cho, In Ha; Kim, Dae Hwan; Lee, Min-Jung; Bae, Jeomil; Lee, Kun Ho; Song, Woo Keun			SPIN90 Phosphorylation Modulates Spine Structure and Synaptic Function	PLOS ONE			English	Article							DENDRITIC SPINES; MORPHOGENESIS; COMPLEX; PROTEIN; ACTIN; ACTIVATION; PLASTICITY; PSD-95; MECHANISMS; MORPHOLOGY	The correct rearrangement of postsynaptic components in dendritic spines is important for driving changes of spine structure and synaptic function. SPIN90 plays an essential role in many cellular processes including actin polymerization, endocytosis, growth cone formation and dendritic spine morphogenesis. Here, we demonstrate that SPIN90, which is a binding partner of PSD95 and Shank in spines, is targeted to synapses and leads to enhanced synaptic activity in neurons. We show, using in vitro and in vivo kinase assays, that SPIN90 is tyrosine phosphorylated by Src kinase. SPIN90 that was tyrosine-phosphorylated by Src was targeted to dendritic spines in cultured hippocampal neurons. Moreover, a SPIN90 phospho-deficient mutant was unable to accumulate at dendritic spines whereas SPIN90 WT and a phospho-mimicking mutant were localized at spines and bound PSD95 and Shank with increased efficiency. Consistent with these findings, hippocampal neurons that overexpressed SPIN90 WT or a phospho-mimicking mutant had enlarged spine heads, leading to enhanced postsynaptic function in terms of both amplitude and frequency. Together, our findings show that SPIN90 modulates synaptic activity in neurons as a result of its phosphorylation.	[Cho, In Ha; Kim, Dae Hwan; Lee, Min-Jung; Bae, Jeomil; Song, Woo Keun] Gwangju Inst Sci & Technol, Sch Life Sci, Bio Imaging & Cell Dynam Ctr, Kwangju, South Korea; [Lee, Kun Ho] Chosun Univ, Dept Marine Life Sci, Kwangju, South Korea	Gwangju Institute of Science & Technology (GIST); Chosun University	Song, WK (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Bio Imaging & Cell Dynam Ctr, Kwangju, South Korea.	wksong@gist.ac.kr		Bae, Jeomil/0000-0001-9374-6802	Bio Imaging and Cell Dynamics Research Center [2012-0000761]; Converging Research Center Program [2011K000690]; National Research Foundation [2011-0017009]	Bio Imaging and Cell Dynamics Research Center; Converging Research Center Program; National Research Foundation	This work was supported in part by the Bio Imaging and Cell Dynamics Research Center (2012-0000761) and the Converging Research Center Program (2011K000690) and National Research Foundation (Kun Ho Lee, 2011-0017009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asrar S, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-39; Bhatt DH, 2009, ANNU REV PHYSIOL, V71, P261, DOI 10.1146/annurev.physiol.010908.163140; Bingol B, 2010, CELL, V140, P567, DOI 10.1016/j.cell.2010.01.024; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; Bosch M, 2012, CURR OPIN NEUROBIOL, V22, P383, DOI 10.1016/j.conb.2011.09.002; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen YJ, 2011, J CELL BIOL, V194, P905, DOI 10.1083/jcb.201104114; Choi J, 2005, J NEUROSCI, V25, P869, DOI 10.1523/JNEUROSCI.3212-04.2005; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Frost NA, 2010, CURR OPIN NEUROBIOL, V20, P578, DOI 10.1016/j.conb.2010.06.009; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Han K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000187; He KW, 2011, J NEUROPHYSIOL, V105, P1897, DOI 10.1152/jn.00913.2010; Hering H, 2003, J NEUROSCI, V23, P11759; Ho GPH, 2011, NEURON, V71, P131, DOI 10.1016/j.neuron.2011.05.033; Hoe HS, 2009, BIOCHEM BIOPH RES CO, V384, P55, DOI 10.1016/j.bbrc.2009.04.069; Hori K, 2005, J NEUROSCI, V25, P2670, DOI 10.1523/JNEUROSCI.3638-04.2005; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Kim DJ, 2006, J BIOL CHEM, V281, P617, DOI 10.1074/jbc.M504450200; Kim SM, 2011, EXP CELL RES, V317, P2276, DOI 10.1016/j.yexcr.2011.06.018; Kim SM, 2009, J NEUROCHEM, V109, P1106, DOI 10.1111/j.1471-4159.2009.06039.x; Kim SH, 2006, GENES CELLS, V11, P1197, DOI 10.1111/j.1365-2443.2006.01008.x; Kim Y, 2005, J NEUROSCI, V25, P9515, DOI 10.1523/JNEUROSCI.1643-05.2005; Ko JW, 2006, NEURON, V50, P233, DOI 10.1016/j.neuron.2006.04.005; Kodama Y, 2010, BIOTECHNIQUES, V49, P793, DOI 10.2144/000113519; Lee S, 2006, EMBO J, V25, P4983, DOI 10.1038/sj.emboj.7601349; Li D, 2011, J PHYSIOL-LONDON, V589, P4491, DOI 10.1113/jphysiol.2011.215566; Lim CS, 2001, J BIOL CHEM, V276, P12871, DOI 10.1074/jbc.M009411200; Lin YC, 2010, ANNU REV NEUROSCI, V33, P349, DOI 10.1146/annurev-neuro-060909-153204; Murata T, 2006, J NEUROSCI, V26, P12397, DOI 10.1523/JNEUROSCI.3981-06.2006; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Nakamura Y, 2011, EMBO J, V30, P719, DOI 10.1038/emboj.2010.357; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Raemaekers T, 2012, EMBO J, V31, P3252, DOI 10.1038/emboj.2012.182; Saneyoshi T, 2010, CURR OPIN NEUROBIOL, V20, P108, DOI 10.1016/j.conb.2009.09.013; Satoh S, 2001, J BIOL CHEM, V276, P39290, DOI 10.1074/jbc.M107026200; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Sokolova IV, 2006, J NEUROPHYSIOL, V95, P2570, DOI 10.1152/jn.00617.2005; Takahashi H, 2003, J NEUROSCI, V23, P6586; Teodorof C, 2009, EXP CELL RES, V315, P2410, DOI 10.1016/j.yexcr.2009.05.010; Terry-Lorenzo RT, 2005, MOL BIOL CELL, V16, P2349, DOI 10.1091/mbc.E04-12-1054; Unoki T, 2012, NEURON, V73, P135, DOI 10.1016/j.neuron.2011.09.034; Wu Q, 2012, J BIOL CHEM, V287, P30781, DOI 10.1074/jbc.M112.351452; Zhao LX, 2006, NAT NEUROSCI, V9, P234, DOI 10.1038/nn1630	47	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54276	10.1371/journal.pone.0054276	http://dx.doi.org/10.1371/journal.pone.0054276			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342115	gold, Green Submitted, Green Published			2022-12-25	WOS:000314759400139
J	Guo, QH; Yang, Y; Mu, YM; Lu, JM; Pan, CY; Dou, JT; Lv, ZH; Ba, JM; Wang, BA; Zou, XM; Yang, LJ; Ouyang, JZ; Yang, GQ; Wang, XL; Du, J; Gu, WJ; Jin, N; Chen, K; Zang, L; Erickson, BJ				Guo, Qinghua; Yang, Yan; Mu, Yiming; Lu, Jvming; Pan, Changyu; Dou, Jingtao; Lv, Zhaohui; Ba, Jianming; Wang, Baoan; Zou, Xiaoman; Yang, Lijuan; Ouyang, Jinzhi; Yang, Guoqing; Wang, Xianling; Du, Jin; Gu, Weijun; Jin, Nan; Chen, Kang; Zang, Li; Erickson, Bradley J.			Pituitary Stalk Interruption Syndrome in Chinese People: Clinical Characteristic Analysis of 55 Cases	PLOS ONE			English	Article							GROWTH-HORMONE DEFICIENCY; IDIOPATHIC HYPOPITUITARISM; ECTOPIC NEUROHYPOPHYSIS; CHILDREN; TRANSECTION; DISORDERS; ADULTHOOD; STATURE	Objective: Pituitary stalk interruption syndrome (PSIS) is characterized by the absence of pituitary stalk, pituitary hypoplasia, and ectopic posterior pituitary. Due to the rarity of PSIS, clinical data are limited, especially in Chinese people. Herein, we analyzed the clinical characteristics of patients diagnosed with PSIS from our center over 10 years. Patients and Methods: We retrospectively analyzed the clinical manifestations and laboratory and MRI findings in 55 patients with PSIS. Results: Of the 55 patients with PSIS, 48 (87.3%) were male. The average age was 19.7 +/- 6.7 years and there was no familial case. A history of breech delivery was documented in 40 of 45 patients (88.9%) and 19 of 55 patients (34.5%) had a history of dystocia. Short stature was found in 47 of 55 patients (85.5%) and bone age delayed 7.26 +/- 5.37 years. Secondary sex characteristics were poor or undeveloped in most patients. The prevalence of deficiencies in growth hormone, gonadotropins, corticotropin, and thyrotropin were 100%, 95.8%, 81.8%, 76.3%, respectively. Hyperprolactinemia was found in 36.4% of patients. Three or more pituitary hormone deficiencies were found in 92.7% of the patients. All patients had normal posterior pituitary function and absent pituitary stalk on imaging. The average height of anterior pituitary was 28 mm, documented anterior pituitary hypoplasia. Midline abnormalities were presented in 9.1% of patients. Conclusions: The clinical features of our Chinese PSIS patients seem to be different from other reported patients in regarding to the higher degree of hypopituitarism and lower prevalence of midline defects. In addition, our patients were older at the time of case detection and the bone age was markedly delayed. We also had no cases of familial PSIS.	[Guo, Qinghua; Yang, Yan; Mu, Yiming; Lu, Jvming; Pan, Changyu; Dou, Jingtao; Lv, Zhaohui; Ba, Jianming; Wang, Baoan; Zou, Xiaoman; Yang, Lijuan; Ouyang, Jinzhi; Yang, Guoqing; Wang, Xianling; Du, Jin; Gu, Weijun; Jin, Nan; Chen, Kang; Zang, Li] Chinese Peoples Liberat Army Gen Hosp, Div Endocrinol, Beijing, Peoples R China; [Erickson, Bradley J.] Mayo Clin, Mayo Med Sch, Rochester, MN USA	Chinese People's Liberation Army General Hospital; Mayo Clinic	Mu, YM (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Div Endocrinol, Beijing, Peoples R China.	muyiming@301hospital.com.cn			National Natural Science Foundation of China [81270866]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work has been partially supported by the National Natural Science Foundation of China (Project Grant No: 81270866). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abernethy LJ, 1998, EUR J RADIOL, V26, P102, DOI 10.1016/S0720-048X(97)00086-7; Albertsson-Wikland K, 1990, Acta Paediatr Scand Suppl, V370, P115; Arrigo T, 1998, EUR J ENDOCRINOL, V139, P84, DOI 10.1530/eje.0.1390084; Barbeau C, 1998, ARCH PEDIATRIE, V5, P274, DOI 10.1016/S0929-693X(97)89368-2; Chen S, 1999, J CLIN ENDOCR METAB, V84, P2408, DOI 10.1210/jc.84.7.2408; Coutant R, 2001, J CLIN ENDOCR METAB, V86, P4649, DOI 10.1210/jc.86.10.4649; CRAFT WH, 1980, J PEDIATR-US, V96, P397, DOI 10.1016/S0022-3476(80)80680-9; den Ouden DT, 2002, J CLIN ENDOCR METAB, V87, P5430, DOI 10.1210/jc.2002-020672; El Chehadeh-Djebbar S, 2011, EUR J MED GENET, V54, P369, DOI 10.1016/j.ejmg.2011.03.001; Fang XJ, 2007, MED WORLD, V02, P16; Fernandez-Rodriguez E, 2011, NEUROENDOCRINOLOGY, V93, P181, DOI 10.1159/000324087; FUJISAWA I, 1987, RADIOLOGY, V165, P487, DOI 10.1148/radiology.165.2.3659371; Gascoin-Lachambre G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016367; Gudat D., 2008, SCI SYNTHESIS, P155; [郭清华 GUO Qinghua], 2008, [中华内分泌代谢杂志, Chinese Journal of Endocrinology and Metabolism], V24, P480; Hamilton J, 1998, AM J NEURORADIOL, V19, P1609; Ioachimescu AG, 2012, PITUITARY, V15, P405, DOI 10.1007/s11102-011-0337-9; Kageyama K, 1998, INTERNAL MED, V37, P472, DOI 10.2169/internalmedicine.37.472; Kornreich L, 1998, AM J NEURORADIOL, V19, P1495; Leger J, 2005, J CLIN ENDOCR METAB, V90, P650, DOI 10.1210/jc.2004-1274; Liu Y, 2004, CHINESE J CLIN NEURO, V17, P456; Marcu M, 2008, BMC ENDOCR DISORD, V11, P7; Pinto G, 1997, J CLIN ENDOCR METAB, V82, P3450, DOI 10.1210/jc.82.10.3450; Reynaud R, 2011, EUR J ENDOCRINOL, V164, P457, DOI 10.1530/EJE-10-0892; Rottembourg D, 2008, CLIN ENDOCRINOL, V69, P105, DOI 10.1111/j.1365-2265.2007.03155.x; Shalet SM, 1998, ENDOCR REV, V19, P203, DOI 10.1210/er.19.2.203; Tauber M, 2005, HORM RES, V64, P266, DOI 10.1159/000089425; Vijayanand P, 2007, INDIAN J PEDIATR, V74, P874, DOI 10.1007/s12098-007-0161-4; [王高良 WANG Gao-liang], 2010, [中华儿科杂志, Chinese Journal of Pediatrics], V48, P305; [赵明 Zhao Ming], 2005, [中华内分泌代谢杂志, Chinese Journal of Endocrinology and Metabolism], V21, P280; 刘影, 2006, [中华放射学杂志, Chinese Journal of Radiology], V40, P324	31	25	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53579	10.1371/journal.pone.0053579	http://dx.doi.org/10.1371/journal.pone.0053579			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341953	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400051
J	Jiang, GC; Plo, I; Wang, T; Rahman, M; Cho, JH; Yang, E; Lopez, BS; Xia, F				Jiang, Guochun; Plo, Isabelle; Wang, Tong; Rahman, Mohammad; Cho, Ju Hwan; Yang, Eddy; Lopez, Bernard S.; Xia, Fen			BRCA1-Ku80 Protein Interaction Enhances End-joining Fidelity of Chromosomal Double-strand Breaks in the G(1) Phase of the Cell Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; DNA-DAMAGE CHECKPOINT; MAMMALIAN-CELLS; NUCLEAR PHOSPHOPROTEIN; COMPLEX-FORMATION; REPAIR PATHWAY; MUTATIONS; CANCER; PHOSPHORYLATION; KU80	Quality control of DNA double-strand break (DSB) repair is vital in preventing mutagenesis. Non-homologous end-joining (NHEJ), a repair process predominant in the G(1) phase of the cell cycle, rejoins DSBs either accurately or with errors, but the mechanisms controlling its fidelity are poorly understood. Here we show that BRCA1, a tumor suppressor, enhances the fidelity of NHEJ-mediated DSB repair and prevents mutagenic deletional end-joining through interaction with canonical NHEJ machinery during G(1). BRCA1 binds and stabilizes Ku80 at DSBs through its N-terminal region, promotes precise DSB rejoining, and increases cellular resistance to radiation-induced DNA damage in a G(1) phase-specific manner. These results suggest that BRCA1, as a central player in genome integrity maintenance, ensures high fidelity repair of DSBs by not only promoting homologous recombination repair in G(2)/M phase but also facilitating fidelity of Ku80-dependent NHEJ repair, thus preventing deletional end-joining of chromosomal DSBs during G(1).	[Jiang, Guochun; Rahman, Mohammad; Cho, Ju Hwan; Xia, Fen] Ohio State Univ, Med Ctr, Arthur G James Comprehens Canc Ctr, Dept Radiat Oncol, Columbus, OH 43210 USA; [Plo, Isabelle; Lopez, Bernard S.] CNRS, UMR217, F-92265 Fontenay Aux Roses, France; [Plo, Isabelle; Lopez, Bernard S.] Inst Radiobiol Cellulaire & Mol, F-92265 Fontenay Aux Roses, France; [Wang, Tong] Vanderbilt Univ, Sch Med, Div Cardiol, Nashville, TN 37232 USA; [Yang, Eddy] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL 35249 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Universite Paris Saclay; Vanderbilt University; University of Alabama System; University of Alabama Birmingham	Xia, F (corresponding author), Ohio State Univ, Sch Med, Arthur G James Comprehens Canc Ctr, Richard L Solove Res Inst,Dept Radiat Oncol, 300 W 10th Ave, Columbus, OH 43210 USA.	fen.xia@osumc.edu	Plo, Isabelle/C-9056-2017; Xia, Fen/G-3708-2013; Jiang, Guochun/H-8809-2019; Plo, Isabelle/AAT-6742-2021; Lopez, Bernard S/O-7308-2017	Plo, Isabelle/0000-0002-5915-6910; Jiang, Guochun/0000-0003-1911-5089; Lopez, Bernard S/0000-0001-5088-0155	National Institutes of Health [R01 CA118158, UL1 RR024975]; NATIONAL CANCER INSTITUTE [R01CA118158] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA118158 (to F. X.) and UL1 RR024975 (Vanderbilt Clinical and Translational Science Award; to G. J.).	Anderson SE, 1998, NAT GENET, V19, P254, DOI 10.1038/930; Baldeyron C, 2002, ONCOGENE, V21, P1401, DOI 10.1038/sj.onc.1205200; Bennardo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000683; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bennett CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001448; Beucher A, 2009, EMBO J, V28, P3413, DOI 10.1038/emboj.2009.276; Bregeon D, 2011, NAT REV CANCER, V11, P218, DOI 10.1038/nrc3006; Charbonnel C, 2010, PLANT J, V64, P280, DOI 10.1111/j.1365-313X.2010.04331.x; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Chen YM, 1996, CANCER RES, V56, P3168; Choudhary SK, 2002, J CELL BIOCHEM, V84, P666, DOI 10.1002/jcb.10081; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; Couch FJ, 1996, HUM MUTAT, V8, P8, DOI 10.1002/humu.1380080102; Dinkelmann M, 2009, NAT STRUCT MOL BIOL, V16, P808, DOI 10.1038/nsmb.1639; Dohrn L, 2012, BIOCHEM J, V441, P919, DOI 10.1042/BJ20110314; Durant ST, 2005, CELL CYCLE, V4, P1216, DOI 10.4161/cc.4.9.2027; Fnu S, 2011, P NATL ACAD SCI USA, V108, P540, DOI 10.1073/pnas.1013571108; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Guirouilh-Barbat J, 2004, MOL CELL, V14, P611, DOI 10.1016/j.molcel.2004.05.008; Guirouilh-Barbat J, 2007, P NATL ACAD SCI USA, V104, P20902, DOI 10.1073/pnas.0708541104; Hsu LC, 2001, CANCER RES, V61, P7713; Iliakis G, 2004, CYTOGENET GENOME RES, V104, P14, DOI 10.1159/000077461; Jiang GC, 2006, MOL CELL BIOL, V26, P39, DOI 10.1128/MCB.26.1.39-49.2006; Jin Y, 1997, P NATL ACAD SCI USA, V94, P12075, DOI 10.1073/pnas.94.22.12075; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; Kao GD, 2001, ONCOGENE, V20, P3486, DOI 10.1038/sj.onc.1204445; Keimling M, 2008, INT J CANCER, V123, P730, DOI 10.1002/ijc.23551; Keimling M, 2011, FASEB J, V25, P3849, DOI 10.1096/fj.11-185546; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kleiman FE, 2005, GENE DEV, V19, P1227, DOI 10.1101/gad.1309505; Langerak P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002271; Lee MS, 2010, CANCER RES, V70, P4880, DOI 10.1158/0008-5472.CAN-09-4563; Liang F, 1996, P NATL ACAD SCI USA, V93, P8929, DOI 10.1073/pnas.93.17.8929; Lim DS, 2000, MOL CELL BIOL, V20, P3772, DOI 10.1128/MCB.20.11.3772-3780.2000; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Mak TW, 2000, NAT IMMUNOL, V1, P77, DOI 10.1038/76950; Malone KE, 1998, JAMA-J AM MED ASSOC, V279, P922, DOI 10.1001/jama.279.12.922; Moisan A, 2006, J BIOL CHEM, V281, P21119, DOI 10.1074/jbc.M600712200; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Pankotai T, 2012, NAT STRUCT MOL BIOL, V19, P276, DOI 10.1038/nsmb.2224; Quennet V, 2011, NUCLEIC ACIDS RES, V39, P2144, DOI 10.1093/nar/gkq1175; Ransburgh DJR, 2010, CANCER RES, V70, P988, DOI 10.1158/0008-5472.CAN-09-2850; Rass E, 2009, NAT STRUCT MOL BIOL, V16, P819, DOI 10.1038/nsmb.1641; Rich T, 2000, NATURE, V407, P777, DOI 10.1038/35037717; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Ruffner H, 1997, P NATL ACAD SCI USA, V94, P7138, DOI 10.1073/pnas.94.14.7138; Schulte-Uentrop L, 2008, NUCLEIC ACIDS RES, V36, P2561, DOI 10.1093/nar/gkn094; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; Simsek D, 2010, NAT STRUCT MOL BIOL, V17, P410, DOI 10.1038/nsmb.1773; Soulas-Sprauel P, 2007, ONCOGENE, V26, P7780, DOI 10.1038/sj.onc.1210875; Summers K C, 2011, Int J Proteomics, V2011, P373816, DOI 10.1155/2011/373816; Sun J, 2012, J BIOL CHEM, V287, P4936, DOI 10.1074/jbc.M111.306167; Thomas JE, 1997, CELL GROWTH DIFFER, V8, P801; Thompson EG, 2012, ENVIRON MOL MUTAGEN, V53, P32, DOI 10.1002/em.21674; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Veras L, 2009, J MOL BIOL, V387, P523, DOI 10.1016/j.jmb.2009.02.008; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Wang HC, 2006, CANCER RES, V66, P1391, DOI 10.1158/0008-5472.CAN-05-3270; Wei LZ, 2008, MOL CELL BIOL, V28, P7380, DOI 10.1128/MCB.01075-08; Willers H, 2006, RADIAT RES, V166, P567, DOI 10.1667/RR0524.1; Xie AY, 2009, NAT STRUCT MOL BIOL, V16, P814, DOI 10.1038/nsmb.1640; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Yang ES, 2009, J CLIN INVEST, V119, P1124, DOI 10.1172/JCI34051; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zhu Q, 2011, NATURE, V477, P179, DOI 10.1038/nature10371; Zhuang J, 2006, CANCER RES, V66, P1401, DOI 10.1158/0008-5472.CAN-05-3278; Zhuang J, 2009, J BIOL CHEM, V284, P30565, DOI 10.1074/jbc.M109.059444	72	38	41	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8966	8976		10.1074/jbc.M112.412650	http://dx.doi.org/10.1074/jbc.M112.412650			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23344954	Green Published, hybrid			2022-12-25	WOS:000316862200016
J	Brauer, L; Schicht, M; Worlitzsch, D; Bensel, T; Sawers, RG; Paulsen, F				Braeuer, Lars; Schicht, Martin; Worlitzsch, Dieter; Bensel, Tobias; Sawers, R. Gary; Paulsen, Friedrich			Staphylococcus aureus and Pseudomonas aeruginosa Express and Secrete Human Surfactant Proteins	PLOS ONE			English	Article							HUMAN TEAR FLUID; PULMONARY SURFACTANT; LUNG SURFACTANT; SP-B; BIOPHYSICAL ACTIVITY; CYSTIC-FIBROSIS; ACTIVE MATERIAL; SP-A; LOCALIZATION; INFLAMMATION	Surfactant proteins (SP), originally known from human lung surfactant, are essential to proper respiratory function in that they lower the surface tension of the alveoli. They are also important components of the innate immune system. The functional significance of these proteins is currently reflected by a very large and growing number of publications. The objective goal of this study was to elucidate whether Staphylococcus aureus and Pseudomonas aeruginosa is able to express surfactant proteins. 10 different strains of S. aureus and P. aeruginosa were analyzed by means of RT-PCR, Western blot analysis, ELISA, immunofluorescence microscopy and immunoelectron microscopy. The unexpected and surprising finding revealed in this study is that different strains of S. aureus and P. aeruginosa express and secrete proteins that react with currently commercially available antibodies to known human surfactant proteins. Our results strongly suggest that the bacteria are either able to express 'human-like' surfactant proteins on their own or that commercially available primers and antibodies to human surfactant proteins detect identical bacterial proteins and genes. The results may reflect the existence of a new group of bacterial surfactant proteins and DNA currently lacking in the relevant sequence and structure databases. At any rate, our knowledge of human surfactant proteins obtained from immunological and molecular biological studies may have been falsified by the presence of bacterial proteins and DNA and therefore requires critical reassessment.	[Braeuer, Lars; Schicht, Martin; Paulsen, Friedrich] Univ Erlangen Nurnberg, Dept Anat 2, D-91054 Erlangen, Germany; [Worlitzsch, Dieter; Bensel, Tobias] Univ Halle Wittenberg, Dept Hyg, Fac Med, D-06108 Halle, Germany; [Sawers, R. Gary] Univ Halle Wittenberg, Inst Biol Microbiol, D-06108 Halle, Germany	University of Erlangen Nuremberg; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Brauer, L (corresponding author), Univ Erlangen Nurnberg, Dept Anat 2, D-91054 Erlangen, Germany.	lars.braeuer@anatomie2.med.uni-erlangen.de		Schicht, Martin/0000-0001-5155-5477; Paulsen, Friedrich/0000-0002-0527-0953	German Research Foundation (DFG) [1329/12-1 BR, BR 3681/2-1]; Wilhelm Roux Program, Halle, Germany [FKZ 17/20]	German Research Foundation (DFG)(German Research Foundation (DFG)); Wilhelm Roux Program, Halle, Germany	The study was supported by the German Research Foundation (DFG, Program Grants 1329/12-1 BR and BR 3681/2-1) and the Wilhelm Roux Program, Halle, Germany (Program Grants FKZ 17/20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2004, J BIOL CHEM, V279, P30871, DOI 10.1074/jbc.M400796200; Alcorn JL, 2005, AM J PHYSIOL-LUNG C, V289, pL1113, DOI 10.1152/ajplung.00436.2004; Anderson Mark T, 2011, Mob Genet Elements, V1, P85; Beck DC, 2000, J BIOL CHEM, V275, P3365, DOI 10.1074/jbc.275.5.3365; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; Brauer L, 2007, CURR EYE RES, V32, P931, DOI 10.1080/02713680701694369; Braeuer L, 2007, INVEST OPHTH VIS SCI, V48, P3945, DOI 10.1167/iovs.07-0201; Brauer L, 2009, HISTOCHEM CELL BIOL, V132, P331, DOI 10.1007/s00418-009-0609-x; Engel P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001296; FORSGREN A, 1966, J IMMUNOL, V97, P822; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Glasser JR, 2012, MICROBES INFECT, V14, P17, DOI 10.1016/j.micinf.2011.08.019; GLASSER SW, 1988, J BIOL CHEM, V263, P9; Haczku A, 2001, AM J RESP CELL MOL, V25, P45, DOI 10.1165/ajrcmb.25.1.4391; Handford JI, 2009, J BACTERIOL, V191, P4732, DOI 10.1128/JB.00136-09; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Hull J, 1997, AM J RESP CRIT CARE, V156, P161, DOI 10.1164/ajrccm.156.1.9609090; Kankavi O, 2003, ACTA BIOCHIM POL, V50, P1057; Kim JK, 2007, AM J PHYSIOL-LUNG C, V292, pL879, DOI 10.1152/ajplung.00156.2006; KING RJ, 1973, AM J PHYSIOL, V224, P788, DOI 10.1152/ajplegacy.1973.224.4.788; KLAUS MH, 1961, P NATL ACAD SCI USA, V47, P1858, DOI 10.1073/pnas.47.11.1858; KOBAYASHI T, 1991, J APPL PHYSIOL, V71, P530, DOI 10.1152/jappl.1991.71.2.530; Kuroki Y, 2007, CELL MICROBIOL, V9, P1871, DOI 10.1111/j.1462-5822.2007.00953.x; Lemos MP, 2011, INFECT IMMUN, V79, P1077, DOI 10.1128/IAI.00286-10; Leth-Larsen R, 2003, CLIN IMMUNOL, V108, P29, DOI 10.1016/S1521-6616(03)00042-1; LONGO ML, 1993, SCIENCE, V261, P453, DOI 10.1126/science.8332910; Mason RJ, 1998, AM J PHYSIOL-LUNG C, V275, pL1, DOI 10.1152/ajplung.1998.275.1.L1; Mirani ZA, 2012, JCPSP-J COLL PHYSICI, V22, P10, DOI 01.2012/JCPSP.1014; Moyes RB, 2009, CURRENT PROTOCOLS IN; Ni M, 2005, INFECT IMMUN, V73, P2147, DOI 10.1128/IAI.73.4.2147-2156.2005; NOTTER RH, 1987, CHEM PHYS LIPIDS, V44, P1, DOI 10.1016/0009-3084(87)90002-8; Ohnishi H, 2002, AM J RESP CRIT CARE, V165, P378, DOI 10.1164/ajrccm.165.3.2107134; OOSTERLAKENDIJKSTERHUIS MA, 1991, BIOCHEMISTRY-US, V30, P10965, DOI 10.1021/bi00109a022; Orgeig S, 2010, RESP PHYSIOL NEUROBI, V173, pS43, DOI 10.1016/j.resp.2010.04.023; Pandit Hrishikesh, 2012, Front Biosci (Elite Ed), V4, P651; PHIZACKERLEY PJR, 1979, BIOCHEM J, V183, P731, DOI 10.1042/bj1830731; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; Sever-Chroneos Z, 2011, J BIOL CHEM, V286, P4854, DOI 10.1074/jbc.M110.125567; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; SPRAGG RG, 1994, CHEST, V105, P195, DOI 10.1378/chest.105.1.195; Stahlman MT, 2002, J HISTOCHEM CYTOCHEM, V50, P651, DOI 10.1177/002215540205000506; Stevens P, 2004, SURFACTANTTHERAPIE G, P11; Tagaram HRS, 2007, AM J PHYSIOL-LUNG C, V292, pL1052, DOI 10.1152/ajplung.00249.2006; ten Brinke A, 2002, BBA-MOL CELL BIOL L, V1583, P253, DOI 10.1016/S1388-1981(02)00248-2; VANIWAARDEN F, 1990, AM J RESP CELL MOL, V2, P91, DOI 10.1165/ajrcmb/2.1.91; VANIWAARDEN JF, 1994, BIOCHEM J, V303, P407, DOI 10.1042/bj3030407; Von Neergaard K., 1929, Z GES EXP MED, V66, P373; VOORHOUT WF, 1992, AM J PHYSIOL, V263, pL479, DOI 10.1152/ajplung.1992.263.4.L479; Vorbroker DK, 1995, AM J PHYSIOL-LUNG C, V269, pL727, DOI 10.1152/ajplung.1995.269.6.L727; WHITSETT JA, 1986, PEDIATR RES, V20, P460, DOI 10.1203/00006450-198605000-00016; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387; Woodworth BA, 2007, LARYNGOSCOPE, V117, P1296, DOI 10.1097/MLG.0b013e31805c9a28; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Wu HX, 2003, J CLIN INVEST, V111, P1589, DOI 10.1172/JCI200316889; Xue HP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020332; Yang L, 2010, J IMMUNOL, V184, P975, DOI 10.4049/jimmunol.0900650; YU SH, 1990, BIOCHIM BIOPHYS ACTA, V1046, P233, DOI 10.1016/0005-2760(90)90236-Q; Zhang SP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000564	59	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53705	10.1371/journal.pone.0053705	http://dx.doi.org/10.1371/journal.pone.0053705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349731	Green Published, gold, Green Submitted			2022-12-25	WOS:000314019100026
J	Gally, F; Chu, HW; Bowler, RP				Gally, Fabienne; Chu, Hong Wei; Bowler, Russell P.			Cigarette Smoke Decreases Airway Epithelial FABP5 Expression and Promotes Pseudomonas aeruginosa Infection	PLOS ONE			English	Article							ACID-BINDING PROTEIN; ACTIVATED RECEPTOR-GAMMA; HUMAN BETA-DEFENSIN-2; ACUTE EXACERBATIONS; METABOLIC SYNDROME; INNATE IMMUNITY; INFLAMMATION; CELLS; MAL1; LUNG	Cigarette smoking is the primary cause of Chronic Obstructive Pulmonary Disease (COPD), which is characterized by chronic inflammation of the airways and destruction of lung parenchyma. Repeated and sustained bacterial infections are clearly linked to disease pathogenesis (e.g., exacerbations) and a huge burden on health care costs. The airway epithelium constitutes the first line of host defense against infection and our previous study indicated that Fatty Acid Binding Protein 5 (FABP5) is down regulated in airway epithelial cells of smokers with COPD as compared to smokers without COPD. We hypothesized that cigarette smoke (CS) exposure down regulates FABP5, thus, contributing to a more sustained inflammation in response to bacterial infection. In this report, we show that FABP5 is increased following bacterial infection but decreased following CS exposure of primary normal human bronchial epithelial (NHBE) cells. The goal of this study was to address FABP5 function by knocking down or overexpressing FABP5 in primary NHBE cells exposed to CS. Our data indicate that FABP5 down regulation results in increased P. aeruginosa bacterial load and inflammatory cytokine levels (e.g., IL-8) and decreased expression of the anti-bacterial peptide, beta defensin-2. On the contrary, FABP5 overexpression exerts a protective function in airway epithelial cells against P. aeruginosa infection by limiting the production of IL-8 and increasing the expression of beta defensin-2. Our study indicates that FABP5 exerts immunomodulatory functions in the airway epithelium against CS exposure and subsequent bacterial infection through its modulation of the nuclear receptor peroxisome proliferator-activated receptor (PPAR)-gamma activity. These findings support the development of FABP5/PPAR-gamma targeted therapeutic approach to prevent airway inflammation by restoring antimicrobial immunity during COPD exacerbations.	[Gally, Fabienne; Chu, Hong Wei; Bowler, Russell P.] Natl Jewish Hlth, Dept Med, Div Pulm, Denver, CO USA	National Jewish Health	Bowler, RP (corresponding author), Natl Jewish Hlth, Dept Med, Div Pulm, Denver, CO USA.	bowlerr@njhealth.org		Gally, Fabienne/0000-0003-0503-7411	Flight Attendant Medical Research Institute	Flight Attendant Medical Research Institute	This work was supported by the Young Clinical Scientist Award (F.G.) and Clinical Innovator Awards (H.W.C. and R.P.B.) from the Flight Attendant Medical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Babaev VR, 2011, ARTERIOSCL THROM VAS, V31, P1283, DOI 10.1161/ATVBAHA.111.225839; Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Baqir M, 2008, RESP MED, V102, P1604, DOI 10.1016/j.rmed.2008.05.002; Birchler T, 2001, EUR J IMMUNOL, V31, P3131, DOI 10.1002/1521-4141(200111)31:11<3131::AID-IMMU3131>3.0.CO;2-G; Boord JB, 2004, CIRCULATION, V110, P1492, DOI 10.1161/01.CIR.0000141735.13202.B6; Boughan PK, 2006, J BIOL CHEM, V281, P11637, DOI 10.1074/jbc.M510275200; Chu HW, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-155; Chung KF, 2008, EUR RESPIR J, V31, P1334, DOI 10.1183/09031936.00018908; Eller J, 1998, CHEST, V113, P1542, DOI 10.1378/chest.113.6.1542; Fabbri LM, 2003, EUR RESPIR J, V22, P1, DOI 10.1183/09031936.03.00063703; Feingold KR, 2010, ATHEROSCLEROSIS, V209, P81, DOI 10.1016/j.atherosclerosis.2009.08.042; Green RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006860; Greene CM, 2005, J IMMUNOL, V174, P1638, DOI 10.4049/jimmunol.174.3.1638; HOLT PG, 1977, BACTERIOL REV, V41, P205, DOI 10.1128/MMBR.41.1.205-216.1977; Hong J, 2011, ATHEROSCLEROSIS, V217, P194, DOI 10.1016/j.atherosclerosis.2011.03.002; Janssens W, 2010, AM J RESP CRIT CARE, V182, P163, DOI 10.1164/rccm.200905-0767OC; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Lode H, 2007, INFECTION, V35, P143, DOI 10.1007/s15010-007-6078-z; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Maeda K, 2003, DIABETES, V52, P300, DOI 10.2337/diabetes.52.2.300; Mahanonda R, 2009, J PERIODONTAL RES, V44, P557, DOI 10.1111/j.1600-0765.2008.01153.x; Makowski L, 2005, CURR OPIN LIPIDOL, V16, P543, DOI 10.1097/01.mol.0000180166.08196.07; Martin Richard J, 2006, COPD, V3, P3, DOI 10.1080/15412550500493162; Martinez-Solano L, 2008, CLIN INFECT DIS, V47, P1526, DOI 10.1086/593186; Miravitlles M, 1999, CHEST, V116, P40, DOI 10.1378/chest.116.1.40; Murphy TF, 2008, AM J RESP CRIT CARE, V177, P853, DOI 10.1164/rccm.200709-1413OC; Naveed B, 2012, AM J RESP CRIT CARE, V185, P392, DOI 10.1164/rccm.201109-1672OC; Parameswaran GI, 2009, DRUG AGING, V26, P985, DOI 10.2165/11315700-000000000-00000; Peyrin-Biroulet L, 2010, P NATL ACAD SCI USA, V107, P8772, DOI 10.1073/pnas.0905745107; Phillips J, 2005, ATLA-ALTERN LAB ANIM, V33, P239, DOI 10.1177/026119290503300310; Polosukhin VV, 2011, AM J RESP CRIT CARE, V184, P317, DOI 10.1164/rccm.201010-1629OC; Puchelle Edith, 2006, Proc Am Thorac Soc, V3, P726, DOI 10.1513/pats.200605-126SF; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Rosell A, 2005, ARCH INTERN MED, V165, P891, DOI 10.1001/archinte.165.8.891; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; SIEGENTHALER G, 1994, BIOCHEM J, V302, P363, DOI 10.1042/bj3020363; Soler N, 1999, EUR RESPIR J, V14, P1015, DOI 10.1183/09031936.99.14510159; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Travassos LH, 2005, J BIOL CHEM, V280, P36714, DOI 10.1074/jbc.M501649200; Vora P, 2004, J IMMUNOL, V173, P5398, DOI 10.4049/jimmunol.173.9.5398; Wu Q, 2007, AM J PHYSIOL-LUNG C, V292, pL1064, DOI 10.1152/ajplung.00301.2006; Yeung DCY, 2008, EUR HEART J, V29, P2156, DOI 10.1093/eurheartj/ehn295; Zimmerman AW, 2001, BIOCHEM J, V360, P159, DOI 10.1042/0264-6021:3600159	45	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e51784	10.1371/journal.pone.0051784	http://dx.doi.org/10.1371/journal.pone.0051784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349676	Green Published, Green Submitted, gold			2022-12-25	WOS:000314019100009
J	Gao, F; Shi, LL; Russin, J; Zeng, LY; Chang, X; He, SH; Chen, TC; Giannotta, SL; Weisenberger, DJ; Zada, G; Mack, WJ; Wang, K				Gao, Fan; Shi, Lingling; Russin, Jonathan; Zeng, Liyun; Chang, Xiao; He, Shuhan; Chen, Thomas C.; Giannotta, Steven L.; Weisenberger, Daniel J.; Zada, Gabriel; Mack, William J.; Wang, Kai			DNA Methylation in the Malignant Transformation of Meningiomas	PLOS ONE			English	Article							5-METHYLCYTOSINE CONTENT; GENE-EXPRESSION; HUMAN NEOPLASIA; CPG ISLANDS; CANCER; HYPERMETHYLATION; METHYLTRANSFERASES; PROGRESSION; GENOME; TUMORS	Meningiomas are central nervous system tumors that originate from the meningeal coverings of the brain and spinal cord. Most meningiomas are pathologically benign or atypical, but 3-5% display malignant features. Despite previous studies on benign and atypical meningiomas, the key molecular pathways involved in malignant transformation remain to be determined, as does the extent of epigenetic alteration in malignant meningiomas. In this study, we explored the landscape of DNA methylation in ten benign, five atypical and four malignant meningiomas. Compared to the benign tumors, the atypical and malignant meningiomas demonstrate increased global DNA hypomethylation. Clustering analysis readily separates malignant from atypical and benign tumors, implicating that DNA methylation patterns may serve as diagnostic biomarkers for malignancy. Genes with hypermethylated CpG islands in malignant meningiomas (such as HOXA6 and HOXA9) tend to coincide with the binding sites of polycomb repressive complexes (PRC) in early developmental stages. Most genes with hypermethylated CpG islands at promoters are suppressed in malignant and benign meningiomas, suggesting the switching of gene silencing machinery from PRC binding to DNA methylation in malignant meningiomas. One exception is the MAL2 gene that is highly expressed in benign group and silenced in malignant group, representing de novo gene silencing induced by DNA methylation. In summary, our results suggest that malignant meningiomas have distinct DNA methylation patterns compared to their benign and atypical counterparts, and that the differentially methylated genes may serve as diagnostic biomarkers or candidate causal genes for malignant transformation.	[Gao, Fan; Shi, Lingling; Zeng, Liyun; Chang, Xiao; Mack, William J.; Wang, Kai] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Russin, Jonathan; He, Shuhan; Chen, Thomas C.; Giannotta, Steven L.; Zada, Gabriel; Mack, William J.] Univ So Calif, Keck Sch Med, Dept Neurosurg, Los Angeles, CA 90033 USA; [Weisenberger, Daniel J.] Univ So Calif, Keck Sch Med, USC Epigenome Ctr, Los Angeles, CA 90033 USA; [Wang, Kai] Univ So Calif, Keck Sch Med, Dept Psychiat, Los Angeles, CA 90033 USA; [Wang, Kai] Univ So Calif, Keck Sch Med, Dept Prevent Med, Div Bioinformat, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Mack, WJ (corresponding author), Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA.	mackw@usc.edu; kaiwang@usc.edu	He, Shuhan/AAF-1764-2020; Xiao, Chang/AAO-9713-2020; Weisenberger, Daniel/AAA-8314-2020	He, Shuhan/0000-0002-9902-5077; Weisenberger, Daniel/0000-0001-8303-2603; Zeng, Liyun/0000-0001-5959-8295	American Cancer Society [IRG-58-007-51]; SC CTSI (NIH/NCRR/NCATS) [KL2RR031991]; National Institutes of Health through Southern California CTSI [KL2]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR031991] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); SC CTSI (NIH/NCRR/NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health through Southern California CTSI; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	WJM is supported by an National Institutes of Health KL2 grant through the Southern California CTSI. This project was supported in part by IRG-58-007-51 from the American Cancer Society, and in part by SC CTSI (NIH/NCRR/NCATS) through grant KL2RR031991. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RLP, 1993, FEBS LETT, V320, P243, DOI 10.1016/0014-5793(93)80595-L; ADAMS RLP, 1982, CRC CR REV BIOCH MOL, V13, P349, DOI 10.3109/10409238209108714; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; BAYLIN SB, 1991, CANCER CELL-MON REV, V3, P383; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; BEDFORD MT, 1987, CANCER RES, V47, P5274; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Brigati C, 2012, TRANSL RES; DEBUSTROS A, 1988, P NATL ACAD SCI USA, V85, P5693; DIALA ES, 1983, J NATL CANCER I, V71, P755; Dobbins SE, 2011, NAT GENET, V43, P825, DOI 10.1038/ng.879; FEINBERG AP, 1988, CANCER RES, V48, P1159; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P6883, DOI 10.1093/nar/11.19.6883; Jair KW, 2006, CANCER RES, V66, P682, DOI 10.1158/0008-5472.CAN-05-1980; Jones P A, 1990, Adv Cancer Res, V54, P1, DOI 10.1016/S0065-230X(08)60806-4; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kishida Y, 2012, CARCINOGENESIS, V33, P436, DOI 10.1093/carcin/bgr260; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Lee Y, 2010, BRAIN PATHOL, V20, P751, DOI 10.1111/j.1750-3639.2009.00356.x; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; MAKOS M, 1993, CANCER RES, V53, P2715; MAKOS M, 1993, CANCER RES, V53, P2719; Mawrin C, 2010, J NEURO-ONCOL, V99, P379, DOI 10.1007/s11060-010-0342-2; Mimori K, 2003, ONCOGENE, V22, P3463, DOI 10.1038/sj.onc.1206378; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Perry A, 2004, J NEURO-ONCOL, V70, P183, DOI 10.1007/s11060-004-2749-0; Perry A, 1999, CANCER, V85, P2046, DOI 10.1002/(SICI)1097-0142(19990501)85:9<2046::AID-CNCR23>3.0.CO;2-M; Riemenschneider MJ, 2006, LANCET NEUROL, V5, P1045, DOI 10.1016/S1474-4422(06)70625-1; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thorvaldsdottir H, 2012, BRIEF BIOINFORM; Ting AH, 2006, CANCER RES, V66, P729, DOI 10.1158/0008-5472.CAN-05-1537; Tsai HC, 2011, CELL RES, V21, P502, DOI 10.1038/cr.2011.24; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wrobel G, 2005, INT J CANCER, V114, P249, DOI 10.1002/ijc.20733; Wu XW, 2010, CANCER RES, V70, P2718, DOI 10.1158/0008-5472.CAN-09-3631	42	77	78	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54114	10.1371/journal.pone.0054114	http://dx.doi.org/10.1371/journal.pone.0054114			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349797	Green Submitted, Green Published, gold			2022-12-25	WOS:000314019100043
J	Grin'kina, NM; Abdel-Baki, SG; Bergold, PJ				Grin'kina, Natalia M.; Abdel-Baki, Samah G.; Bergold, Peter J.			Reversible Behavioral Deficits in Rats during a Cycle of Demyelination-Remyelination of the Fimbria	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; MORRIS WATER MAZE; COGNITIVE FUNCTION; HIPPOCAMPUS; MEMORY; NAVIGATION; PLACE; SEGREGATION; AVOIDANCE	Traumatic brain injury (TBI) selectively damages white matter. White matter damage does not produce deficits in many behavioral tests used to analyze experimental TBI. Rats were impaired on an active place avoidance task following inactivation of one hippocampal injection of tetrodotoxin. The need for both hippocampi suggests that acquisition of the active place avoidance task may require interhippocampal communication. The controlled cortical impact model of TBI demyelinates midline white matter and impairs rats on the active place avoidance task. One white matter region that is demyelinated is the fimbria that contains hippocampal commissural fibers. We therefore tested whether demyelination of the fimbria produces deficits in active place avoidance. Lysophosphatidylcholine (LPC) was injected stereotaxically to produce a cycle of demyelination-remyelination of the fimbria. At 4 days, myelin loss was observed in the fimbria of LPC-, but not saline-injected rats. Fourteen days after injection, myelin content increased in LPC-, but not saline-injected rats. Three days after injection, both saline- and LPC-injected rats had similar performance on an open field and passive place avoidance task in which the rat avoided a stationary shock zone on a stationary arena. The following day, on the active place avoidance task, LPC-injected rats had a significantly higher number of shock zone entrances suggesting learning was impaired. At 14 days after injection, saline- and LPC-injected rats had similar performance on open field and passive place avoidance. On active place avoidance, however, saline-and LPC-injected rats had a similar number of total entrances suggesting that the impairment seen at 4 days was no longer present at 14 days. These data suggest that active place avoidance is highly sensitive to white matter injury.	[Grin'kina, Natalia M.; Abdel-Baki, Samah G.; Bergold, Peter J.] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural Sci, Brooklyn, NY 11203 USA; [Grin'kina, Natalia M.; Abdel-Baki, Samah G.; Bergold, Peter J.] Suny Downstate Med Ctr, Dept Physiol Pharmacol & Neurol, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Bergold, PJ (corresponding author), Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural Sci, Brooklyn, NY 11203 USA.	pbergold@downstate.edu		Bergold, Peter/0000-0002-6335-1380	United States Army Medical Research and Materiel Command [W81XWH-10-2-0171]	United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This work was supported by contract W81XWH-10-2-0171 from the United States Army Medical Research and Materiel Command. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P., 2007, HIPPOCAMPUS BOOK; Baki SGA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012490; Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Blakemore WF, 2008, CURR TOP MICROBIOL, V318, P193; Cimadevilla JM, 2001, P NATL ACAD SCI USA, V98, P3531, DOI 10.1073/pnas.051628398; Duarte FS, 2010, PSYCHOPHARMACOLOGY, V212, P653, DOI 10.1007/s00213-010-1985-6; Easton A, 2010, BEHAV BRAIN RES, V215, P310, DOI 10.1016/j.bbr.2009.10.019; FENTON AA, 1993, BEHAV NEUROSCI, V107, P552, DOI 10.1037/0735-7044.107.4.552; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Jean I, 2003, BRAIN RES, V972, P110, DOI 10.1016/S0006-8993(03)02510-1; Klur S, 2009, HIPPOCAMPUS, V19, P800, DOI 10.1002/hipo.20562; Kubik S, 2005, J NEUROSCI, V25, P9205, DOI 10.1523/JNEUROSCI.1707-05.2005; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Markgraf CG, 2001, J NEUROTRAUM, V18, P175, DOI 10.1089/08977150150502604; OLTON DS, 1982, BRAIN RES, V233, P241, DOI 10.1016/0006-8993(82)91200-8; Olypher AV, 2006, J NEUROSCI, V26, P158, DOI 10.1523/JNEUROSCI.2064-05.2006; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shinohara Y, 2012, HIPPOCAMPUS, V22, P117, DOI 10.1002/hipo.20886; Skelton RW, 1998, BEHAV BRAIN RES, V96, P13, DOI 10.1016/S0166-4328(97)00199-X; Wesierska M, 2005, J NEUROSCI, V25, P2413, DOI 10.1523/JNEUROSCI.3962-04.2005; Wesierska M, 2009, NEUROBIOL LEARN MEM, V91, P41, DOI 10.1016/j.nlm.2008.09.005; Woodruff RH, 1999, GLIA, V25, P216, DOI 10.1002/(SICI)1098-1136(19990201)25:3<216::AID-GLIA2>3.0.CO;2-L	27	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53775	10.1371/journal.pone.0053775	http://dx.doi.org/10.1371/journal.pone.0053775			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349742	Green Submitted, Green Published, gold			2022-12-25	WOS:000314019100031
J	Lin, A; Bik, EM; Costello, EK; Dethlefsen, L; Haque, R; Relman, DA; Singh, U				Lin, Audrie; Bik, Elisabeth M.; Costello, Elizabeth K.; Dethlefsen, Les; Haque, Rashidul; Relman, David A.; Singh, Upinder			Distinct Distal Gut Microbiome Diversity and Composition in Healthy Children from Bangladesh and the United States	PLOS ONE			English	Article							RIBOSOMAL-RNA SEQUENCES; ACUTE DIARRHEA; INSIGHTS; BIODIVERSITY; ENVIRONMENT; ASSOCIATION; COMMUNITIES; ENTEROPATHY; EVOLUTION; ECOSYSTEM	Background: Our current understanding of the composition and stability of the human distal gut microbiota is based largely on studies of infants and adults living in developed countries. In contrast, little is known about the gut microbiota and its variation over time in older children and adolescents, especially in developing countries. Methodology/Principal Findings: We compared the diversity, composition, and temporal stability of the fecal microbiota of healthy children, ages 9 to 14 years, living in an urban slum in Bangladesh with that of children of the same age range in an upper-middle class suburban community in the United States. We analyzed >8,000 near full-length 16S rRNA gene sequences and over 845,000 pyrosequencing reads of the 16S rRNA V1-V3 region. The distal gut of Bangladeshi children harbored significantly greater bacterial diversity than that of U. S. children, including novel lineages from several bacterial phyla. Bangladeshi and U. S. children had distinct fecal bacterial community membership and structure; the microbiota of Bangladeshi children was enriched in Prevotella, Butyrivibrio, and Oscillospira and depleted in Bacteroides relative to U. S. children (although similar to Bangladeshi adults). Furthermore, community membership and structure in Bangladeshi children was significantly less stable month-to-month than U. S. children. Conclusions/Significance: Together, these results suggest that differing environmental or genetic factors may shape the microbiota of healthy children in the two countries. Further investigation is necessary to understand the mechanisms and factors that underlie these differences, and to incorporate these findings into new strategies for the prevention and treatment of childhood and adolescent diseases.	[Lin, Audrie; Bik, Elisabeth M.; Costello, Elizabeth K.; Dethlefsen, Les; Relman, David A.; Singh, Upinder] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Haque, Rashidul] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Relman, David A.; Singh, Upinder] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Relman, David A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; International Centre for Diarrhoeal Disease Research (ICDDR); Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Relman, DA (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.	relman@stanford.edu; usingh@stanford.edu	Bik, Elisabeth M/A-1204-2007; Dethlefsen, Les/R-2220-2018	Bik, Elisabeth M/0000-0001-5477-0324; Dethlefsen, Les/0000-0001-9622-1630; Relman, David A./0000-0001-8331-1354; Singh, Upinder/0000-0003-0630-0306; Lin, Audrie/0000-0002-3877-3469	Doris Duke Charitable Trust (DAR); National Institutes of Health Director's Pioneer Award [DP1OD000964]; NIH Clinical and Translational Science Award for the Stanford Center for Clinical and Translational Education and Research (Spectrum) (US) [1UL1 RR025744]; Lucile Packard Foundation for Children's Health; National Science Foundation Graduate Research Fellowship; Stanford Graduate Fellowship; Thomas C. and Joan M. Merigan Endowment at Stanford University; National Institutes of Health [AI 53724, AI 069382, 5R01AI043596]; Walter V. and Idun Berry Postdoctoral Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043596, R21AI069382, R01AI053724] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000964] Funding Source: NIH RePORTER	Doris Duke Charitable Trust (DAR); National Institutes of Health Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Clinical and Translational Science Award for the Stanford Center for Clinical and Translational Education and Research (Spectrum) (US); Lucile Packard Foundation for Children's Health; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Stanford Graduate Fellowship(Stanford University); Thomas C. and Joan M. Merigan Endowment at Stanford University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Walter V. and Idun Berry Postdoctoral Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Distinguished Clinical Scientist Award from the Doris Duke Charitable Trust (DAR), the National Institutes of Health Director's Pioneer Award DP1OD000964 (DAR), the NIH Clinical and Translational Science Award 1UL1 RR025744 for the Stanford Center for Clinical and Translational Education and Research (Spectrum) (US), and the Lucile Packard Foundation for Children's Health. AL was supported by a National Science Foundation Graduate Research Fellowship and a Stanford Graduate Fellowship. DAR is supported by the Thomas C. and Joan M. Merigan Endowment at Stanford University. US is supported by grants from the National Institutes of Health (AI 53724 and AI 069382). EKC is supported by a Walter V. and Idun Berry Postdoctoral Fellowship. R. H. and the longitudinal ICDDR,B child cohort study are supported by National Institutes of Health grant 5R01AI043596 to William A. Petri, Jr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; BERNET MF, 1994, GUT, V35, P483, DOI 10.1136/gut.35.4.483; Borruel N, 2002, GUT, V51, P659, DOI 10.1136/gut.51.5.659; Campbell DI, 2002, BRIT J NUTR, V88, P499, DOI 10.1079/BJN2002697; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chatterjee B, 2012, NATURE, V487, P39, DOI 10.1038/487039d; Clark KR., 2006, PRIMER V6 USER MANUA; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Grice EA, 2010, P NATL ACAD SCI USA, V107, P14799, DOI 10.1073/pnas.1004204107; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Haque R, 2003, AM J TROP MED HYG, V69, P398, DOI 10.4269/ajtmh.2003.69.398; Haque R, 2009, CLIN INFECT DIS, V48, P1191, DOI 10.1086/597580; Hayashi H, 2007, INT J SYST EVOL MICR, V57, P941, DOI 10.1099/ijs.0.64778-0; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; Humphrey JH, 2009, LANCET, V374, P1032, DOI 10.1016/S0140-6736(09)60950-8; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lievin V, 2000, GUT, V47, P646, DOI 10.1136/gut.47.5.646; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Mai V, 2006, J CLIN MICROBIOL, V44, P4550, DOI 10.1128/JCM.01542-06; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McMurdie PJ, 2012, BIOCOMPUT-PAC SYM, P235; Monira S, 2012, J HEALTH POPUL NUTR, V30, P250; Monira S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00228; Monteils V, 2008, FEMS MICROBIOL ECOL, V66, P620, DOI 10.1111/j.1574-6941.2008.00611.x; Murphy Stephen F, 2012, Curr Gastroenterol Rep, V14, P146, DOI 10.1007/s11894-012-0250-z; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Purushe J, 2010, MICROB ECOL, V60, P721, DOI 10.1007/s00248-010-9692-8; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Servin AL, 2004, FEMS MICROBIOL REV, V28, P405, DOI 10.1016/j.femsre.2004.01.003; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Thompson JR, 2005, SCIENCE, V307, P1311, DOI 10.1126/science.1106028; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; UNICEF, 2011, AD AG OPP; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	60	162	166	4	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53838	10.1371/journal.pone.0053838	http://dx.doi.org/10.1371/journal.pone.0053838			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349750	Green Published, Green Submitted, gold			2022-12-25	WOS:000314019100034
J	Yang, HY; Tan, YF; Zhang, TT; Tang, LJ; Wang, J; Ke, YH; Guo, ZB; Yang, XM; Yang, RF; Du, ZM				Yang, Huiying; Tan, Yafang; Zhang, Tingting; Tang, Liujun; Wang, Jian; Ke, Yuehua; Guo, Zhaobiao; Yang, Xiaoming; Yang, Ruifu; Du, Zongmin			Identification of Novel Protein-Protein Interactions of Yersinia pestis Type III Secretion System by Yeast Two Hybrid System	PLOS ONE			English	Article							YOP SECRETION; SUBSTRATE-SPECIFICITY; YSCC SECRETIN; ENTEROCOLITICA; TRANSLOCATION; EXPRESSION; CHAPERONE; 2-HYBRID; NEEDLE; REGULATOR	Type III secretion system (T3SS) of the plague bacterium Y. pestis encodes a syringe-like structure consisting of more than 20 proteins, which can inject virulence effectors into host cells to modulate the cellular functions. Here in this report, interactions among the possible components in T3SS of Yersinia pestis were identified using yeast mating technique. A total of 57 genes, including all the pCD1-encoded genes except those involved in plasmid replication and partition, pseudogenes, and the putative transposase genes, were subjected to yeast mating analysis. 21 pairs of interaction proteins were identified, among which 9 pairs had been previously reported and 12 novel pairs were identified in this study. Six of them were tested by GST pull down assay, and interaction pairs of YscG-SycD, YscG-TyeA, YscI-YscF, and YopN-YpCD1.09c were successfully validated, suggesting that these interactions might play potential roles in function of Yersinia T3SS. Several potential new interactions among T3SS components could help to understand the assembly and regulation of Yersinia T3SS.	[Yang, Huiying; Tan, Yafang; Ke, Yuehua; Guo, Zhaobiao; Yang, Ruifu; Du, Zongmin] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Zhang, Tingting] Sichuan Agr Univ, Coll Vet Med, Dept Clin Med, Yaan, Sichuan, Peoples R China; [Tang, Liujun; Wang, Jian; Yang, Xiaoming] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Sichuan Agricultural University; Academy of Military Medical Sciences - China	Yang, XM (corresponding author), Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China.	xmyang2@nic.bmi.ac.cn; ruifuyang@gmail.com; zongmindu@gmail.com	Yang, Ruifu/A-2273-2011	Yang, Ruifu/0000-0003-3219-7269	National Basic Research Program of China (973 Program) [2012CB518700]; National Natural Science Foundation of China [30970121, 31170122]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (973 Program, 2012CB518700) and National Natural Science Foundation of China (No. 30970121, 31170122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrain C, 2005, MOL MICROBIOL, V57, P1415, DOI 10.1111/j.1365-2958.2005.04758.x; Agrain C, 2005, MOL MICROBIOL, V56, P54, DOI 10.1111/j.1365-2958.2005.04534.x; ALLAOUI A, 1995, MOL MICROBIOL, V18, P343, DOI 10.1111/j.1365-2958.1995.mmi_18020343.x; Blaylock B, 2006, J BACTERIOL, V188, P3525, DOI 10.1128/JB.188.10.3525-3534.2006; Broz P, 2007, MOL MICROBIOL, V65, P1311, DOI 10.1111/j.1365-2958.2007.05871.x; Bruckner A, 2009, INT J MOL SCI, V10, P2763, DOI 10.3390/ijms10062763; Burghout P, 2004, J BACTERIOL, V186, P4645, DOI 10.1128/JB.186.14.4645-4654.2004; Burghout P, 2004, J BACTERIOL, V186, P5366, DOI 10.1128/JB.186.16.5366-5375.2004; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Cambronne ED, 2004, J BACTERIOL, V186, P829, DOI 10.1128/JB.186.3.829-841.2004; Cattin Cedric, 2009, STOICHIOMETRY ANAL T; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Cornelis GR, 2002, J CELL BIOL, V158, P401, DOI 10.1083/jcb.200205077; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Day JB, 1998, MOL MICROBIOL, V30, P777, DOI 10.1046/j.1365-2958.1998.01110.x; Day JB, 2003, MOL MICROBIOL, V47, P807, DOI 10.1046/j.1365-2958.2003.03343.x; Du ZM, 2009, INT J MED MICROBIOL, V299, P355, DOI 10.1016/j.ijmm.2008.10.003; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798; Iriarte M, 1998, EMBO J, V17, P1907, DOI 10.1093/emboj/17.7.1907; Jackson MW, 2000, FEMS MICROBIOL LETT, V186, P85, DOI 10.1111/j.1574-6968.2000.tb09086.x; Koster M, 1997, MOL MICROBIOL, V26, P789, DOI 10.1046/j.1365-2958.1997.6141981.x; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822; Matson JS, 2001, J BACTERIOL, V183, P5082, DOI 10.1128/JB.183.17.5082-5091.2001; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Neyt C, 1999, MOL MICROBIOL, V31, P143, DOI 10.1046/j.1365-2958.1999.01154.x; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; PLANO GV, 1991, J BACTERIOL, V173, P7293, DOI 10.1128/jb.173.22.7293-7303.1991; PLANO GV, 1993, J BACTERIOL, V175, P3536, DOI 10.1128/jb.175.11.3536-3545.1993; Prentice MB, 2007, LANCET, V369, P1196, DOI 10.1016/S0140-6736(07)60566-2; ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x; Schubot FD, 2005, J MOL BIOL, V346, P1147, DOI 10.1016/j.jmb.2004.12.036; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Silva-Herzog E, 2008, MICROBIOL-SGM, V154, P593, DOI 10.1099/mic.0.2007/013045-0; SKRZYPEK E, 1993, J BACTERIOL, V175, P3520, DOI 10.1128/jb.175.11.3520-3528.1993; Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603; Swietnicki W, 2004, J BIOL CHEM, V279, P38693, DOI 10.1074/jbc.M405217200; Tampakaki AP, 2004, CELL MICROBIOL, V6, P805, DOI 10.1111/j.1462-5822.2004.00432.x; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; WOESTYN S, 1994, J BACTERIOL, V176, P1561, DOI 10.1128/jb.176.6.1561-1569.1994; Woestyn S, 1996, MOL MICROBIOL, V20, P1261, DOI 10.1111/j.1365-2958.1996.tb02645.x; Wood SE, 2008, J BACTERIOL, V190, P4252, DOI 10.1128/JB.00328-08; Wulff-Strobel CR, 2002, MOL MICROBIOL, V43, P411, DOI 10.1046/j.1365-2958.2002.02752.x; Yang F, 2010, PLOS ONE, P5	47	15	17	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54121	10.1371/journal.pone.0054121	http://dx.doi.org/10.1371/journal.pone.0054121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349800	Green Published, Green Submitted, gold			2022-12-25	WOS:000314019100045
J	Maddox, SA; Watts, CS; Doyere, V; Schafe, GE				Maddox, Stephanie A.; Watts, Casey S.; Doyere, Valerie; Schafe, Glenn E.			A Naturally-Occurring Histone Acetyltransferase Inhibitor Derived from Garcinia indica Impairs Newly Acquired and Reactivated Fear Memories	PLOS ONE			English	Article							LONG-TERM-MEMORY; POSTTRAUMATIC-STRESS-DISORDER; ESTRADIOL-INDUCED ENHANCEMENT; RUBINSTEIN-TAYBI-SYNDROME; PROTEIN-KINASE-A; LATERAL AMYGDALA; SYNAPTIC PLASTICITY; EPIGENETIC ALTERATIONS; MOLECULAR-MECHANISMS; OBJECT RECOGNITION	The study of the cellular and molecular mechanisms underlying the consolidation and reconsolidation of traumatic fear memories has progressed rapidly in recent years, yet few compounds have emerged that are readily useful in a clinical setting for the treatment of anxiety disorders such as post-traumatic stress disorder (PTSD). Here, we use a combination of biochemical, behavioral, and neurophysiological methods to systematically investigate the ability of garcinol, a naturally-occurring histone acetyltransferase (HAT) inhibitor derived from the rind of the fruit of the Kokum tree (Garcina indica), to disrupt the consolidation and reconsolidation of Pavlovian fear conditioning, a widely studied rodent model of PTSD. We show that local infusion of garcinol into the rat lateral amygdala (LA) impairs the training and retrieval-related acetylation of histone H3 in the LA. Further, we show that either intra-LA or systemic administration of garcinol within a narrow window after either fear conditioning or fear memory retrieval significantly impairs the consolidation and reconsolidation of a Pavlovian fear memory and associated neural plasticity in the LA. Our findings suggest that a naturally-occurring compound derived from the diet that regulates chromatin function may be useful in the treatment of newly acquired or recently reactivated traumatic memories.	[Maddox, Stephanie A.; Watts, Casey S.; Schafe, Glenn E.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Schafe, Glenn E.] Yale Univ, Interdept Neurosci Program, New Haven, CT USA; [Doyere, Valerie] Univ Paris 11, Ctr Neurosci Paris Sud, UMR 8195, Orsay, France; [Doyere, Valerie] CNRS, F-91405 Orsay, France	Yale University; Yale University; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet; Centre National de la Recherche Scientifique (CNRS)	Schafe, GE (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	glenn.schafe@yale.edu	Maddox, Stephanie/AAD-6943-2022	Doyere, Valerie/0000-0002-3851-669X	National Institutes of Health [MH 073949]; Yale University; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale University; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by National Institutes of Health Grant MH 073949 (to G. E. S.) and by Yale University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; Arif M, 2009, J MED CHEM, V52, P267, DOI 10.1021/jm800657z; BAILEY CH, 1992, NEURON, V9, P749, DOI 10.1016/0896-6273(92)90037-E; Bailey DJ, 1999, BEHAV NEUROSCI, V113, P276, DOI 10.1037/0735-7044.113.2.276; Balasubramanyam K, 2004, J BIOL CHEM, V279, P33716, DOI 10.1074/jbc.M402839200; Baliga MS, 2011, FOOD RES INT, V44, P1790, DOI 10.1016/j.foodres.2011.01.064; Barrett RM, 2008, LEARN MEMORY, V15, P460, DOI 10.1101/lm.917508; Barrett RM, 2011, NEUROPSYCHOPHARMACOL, V36, P1545, DOI 10.1038/npp.2011.61; Ben Mamou C, 2006, NAT NEUROSCI, V9, P1237, DOI 10.1038/nn1778; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; BOUTON ME, 1979, LEARN MOTIV, V10, P445, DOI 10.1016/0023-9690(79)90057-2; BOUTON ME, 1994, ANIM LEARN BEHAV, V22, P317, DOI 10.3758/BF03209840; Brunet A, 2008, J PSYCHIATR RES, V42, P503, DOI 10.1016/j.jpsychires.2007.05.006; Bush DEA, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00154; Chhatwal JP, 2006, NAT NEUROSCI, V9, P870, DOI 10.1038/nn1718; Dal Piaz F, 2011, MOL DIVERS, V15, P401, DOI 10.1007/s11030-010-9299-5; Debiec J, 2006, P NATL ACAD SCI USA, V103, P3428, DOI 10.1073/pnas.0507168103; Debiec J, 2004, NEUROSCIENCE, V129, P267, DOI 10.1016/j.neuroscience.2004.08.018; Doyere V, 2007, NAT NEUROSCI, V10, P414, DOI 10.1038/nn1871; Duclot F, 2010, NEUROSCI LETT, V475, P179, DOI 10.1016/j.neulet.2010.03.077; Dudai Y, 2004, NEURON, V44, P93, DOI 10.1016/j.neuron.2004.09.003; Duvarci S, 2004, J NEUROSCI, V24, P9269, DOI 10.1523/JNEUROSCI.2971-04.2004; Duvarci S, 2005, EUR J NEUROSCI, V21, P283, DOI 10.1111/j.1460-9568.2004.03824.x; Duvarci S, 2008, LEARN MEMORY, V15, P747, DOI 10.1101/lm.1027208; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Fischer A, 2010, TRENDS PHARMACOL SCI, V31, P605, DOI 10.1016/j.tips.2010.09.003; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hawk JD, 2011, LEARN MEMORY, V18, P367, DOI 10.1101/lm.2097411; Hoge EA, 2012, CNS NEUROSCI THER, V18, P21, DOI 10.1111/j.1755-5949.2010.00227.x; Hsu CL, 2012, FOOD FUNCT, V3, P49, DOI 10.1039/c1fo10209e; Jiang Y, 2008, J NEUROSCI, V28, P11753, DOI 10.1523/JNEUROSCI.3797-08.2008; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; Kilgore M, 2010, NEUROPSYCHOPHARMACOL, V35, P870, DOI 10.1038/npp.2009.197; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; Koeberle A, 2009, BIOCHEM PHARMACOL, V77, P1513, DOI 10.1016/j.bcp.2009.02.005; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Lee JLC, 2005, NEURON, V47, P795, DOI 10.1016/j.neuron.2005.08.007; Levenson JM, 2006, CELL MOL LIFE SCI, V63, P1009, DOI 10.1007/s00018-006-6026-6; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Lopez-Atalaya JP, 2012, J MED GENET, V49, P66, DOI 10.1136/jmedgenet-2011-100354; Maddox SA, 2011, LEARN MEMORY, V18, P579, DOI 10.1101/lm.2243411; Maddox SA, 2011, J NEUROSCI, V31, P7073, DOI 10.1523/JNEUROSCI.1120-11.2011; Maddox SA, 2011, LEARN MEMORY, V18, P24, DOI 10.1101/lm.1980211; Manzo F, 2009, EXPERT OPIN THER PAT, V19, P761, DOI 10.1517/13543770902895727; Marek R, 2011, J NEUROSCI, V31, P7486, DOI 10.1523/JNEUROSCI.0133-11.2011; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Maurice T, 2008, NEUROPSYCHOPHARMACOL, V33, P1584, DOI 10.1038/sj.npp.1301551; McGhee LL, 2009, J BURN CARE RES, V30, P92, DOI 10.1097/BCR.0b013e3181921f51; Miller CA, 2008, NEUROBIOL LEARN MEM, V89, P599, DOI 10.1016/j.nlm.2007.07.016; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Milton AL, 2008, J NEUROSCI, V28, P8230, DOI 10.1523/JNEUROSCI.1723-08.2008; Monsey MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019958; Muravieva EV, 2010, LEARN MEMORY, V17, P306, DOI 10.1101/lm.1794710; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nugent NR, 2010, J TRAUMA STRESS, V23, P282, DOI 10.1002/jts.20517; Oike Y, 1999, HUM MOL GENET, V8, P387, DOI 10.1093/hmg/8.3.387; Oliveira AMM, 2007, LEARN MEMORY, V14, P564, DOI 10.1101/lm.656907; Oliveira AMM, 2011, LEARN MEMORY, V18, P161, DOI 10.1101/lm.1939811; Pavlov I.P., 1927, CONDITIONED REFLEXES; Penner MR, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00009; Pitman R. K., 2000, NEW COGNITIVE NEUROS; Pitman RK, 2002, BIOL PSYCHIAT, V51, P189, DOI 10.1016/S0006-3223(01)01279-3; Ploski JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023760; Ploski JE, 2008, J NEUROSCI, V28, P12383, DOI 10.1523/JNEUROSCI.1662-08.2008; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Rodrigues SM, 2004, NEURON, V44, P75, DOI 10.1016/j.neuron.2004.09.014; Rodrigues SM, 2001, J NEUROSCI, V21, P6889, DOI 10.1523/JNEUROSCI.21-17-06889.2001; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Schafe GE, 2005, J NEUROSCI, V25, P10010, DOI 10.1523/JNEUROSCI.3307-05.2005; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Schafe GE, 2000, J NEUROSCI, V20, P8177; Schafe GE, 2001, TRENDS NEUROSCI, V24, P540, DOI 10.1016/S0166-2236(00)01969-X; Stefanko DP, 2009, P NATL ACAD SCI USA, V106, P9447, DOI 10.1073/pnas.0903964106; Stilling RM, 2011, NEUROBIOL LEARN MEM, V96, P19, DOI 10.1016/j.nlm.2011.04.002; Tronson NC, 2007, NAT REV NEUROSCI, V8, P262, DOI 10.1038/nrn2090; Tronson NC, 2006, NAT NEUROSCI, V9, P167, DOI 10.1038/nn1628; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Valor LM, 2011, J NEUROSCI, V31, P1652, DOI 10.1523/JNEUROSCI.4737-10.2011; Varga-Weisz PD, 1998, CURR OPIN CELL BIOL, V10, P346, DOI 10.1016/S0955-0674(98)80010-0; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Wood MA, 2005, LEARN MEMORY, V12, P111, DOI 10.1101/lm.86605; Wood MA, 2006, LEARN MEMORY, V13, P609, DOI 10.1101/lm.213906; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yoshida K, 2005, CANCER LETT, V221, P29, DOI 10.1016/j.canlet.2004.08.016; Zhao ZR, 2012, J NEUROSCI, V32, P2344, DOI 10.1523/JNEUROSCI.5819-11.2012; Zhao ZR, 2010, P NATL ACAD SCI USA, V107, P5605, DOI 10.1073/pnas.0910578107	94	44	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54463	10.1371/journal.pone.0054463	http://dx.doi.org/10.1371/journal.pone.0054463			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349897	Green Published, gold			2022-12-25	WOS:000313943000039
J	Schiessl, IM; Bardehle, S; Castrop, H				Schiessl, Ina Maria; Bardehle, Sophia; Castrop, Hayo			Superficial Nephrons in BALB/c and C57BL/6 Mice Facilitate In Vivo Multiphoton Microscopy of the Kidney	PLOS ONE			English	Article							GLOMERULI; ALBUMIN; RAT; PROTEINURIA; FILTRATION; NUMBER; ANGIOTENSIN; MATURATION; INJURY	Multiphoton microscopy (MPM) offers a unique approach for addressing both the function and structure of an organ in near-real time in the live animal. The method however is limited by the tissue-specific penetration depth of the excitation laser. In the kidney, structures in the range of 100 mm from the surface are accessible for MPM. This limitation of MPM aggravates the investigation of the function of structures located deeper in the renal cortex, like the glomerulus and the juxtaglomerular apparatus. In view of the relevance of gene-targeted mice for investigating the function of these structures, we aimed to identify a mouse strain with a high percentage of superficially located glomeruli. The mean distance of the 30 most superficial glomeruli from the kidney surface was determined in 10 commonly used mouse strains. The mean depth of glomeruli was 118.4 +/- 3.4, 123.0 +/- 2.7, 133.7 +/- 3.0, 132.3 +/- 2.6, 141.0 +/- 4.0, 145.3 +/- 4.3, 148.9 +/- 4.2, 151.6 +/- 2.7, 167.7 +/- 3.9, and 207.8 +/- 3.2 mm in kidney sections from 4-week-old C3H/HeN, BALB/cAnN, SJL/J, C57BL/6N, DBA/2N, CD1 (CRI), 129S2/SvPas, CB6F1, FVB/N and NMRI (Han) mice, respectively (n = 5 animals from each strain). The mean distance from the kidney surface of the most superficial glomeruli was significantly lower in the strains C3H/HeN Crl, BALB/cAnN, DBA/2NCrl, and C57BL/6N when compared to a peer group consisting of all the other strains (p<.0001). In 10-week-old mice, the most superficial glomeruli were located deeper in the cortex when compared to 4-week-old animals, with BALB/cAnN and C57BL/6N being the strains with the highest percentage of superficial glomeruli (25% percentile 116.7 and 121.9 mm, respectively). In summary, due to significantly more superficial glomeruli compared to other commonly used strains, BALB/cAnN and C57BL/6N mice appear to be particularly suitable for the investigation of glomerular function using MPM.	[Schiessl, Ina Maria; Castrop, Hayo] Univ Regensburg, Inst Physiol, D-93053 Regensburg, Germany; [Bardehle, Sophia] Univ Munich, Inst Physiol, Dept Physiol Genom, D-80539 Munich, Germany; [Bardehle, Sophia] Helmholtz Zentrum, Inst Stem Cell Res, Munich, Germany	University of Regensburg; University of Munich; Helmholtz Association	Castrop, H (corresponding author), Univ Regensburg, Inst Physiol, D-93053 Regensburg, Germany.	hayo@castrop.com		Schiessl, Ina Maria/0000-0003-1613-2000	Uwe deVries; Institute of Anatomy; University of Regensburg; Deutsche Forschungsgemeinschaft [SFB699]	Uwe deVries; Institute of Anatomy; University of Regensburg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The expert support provided by Uwe deVries, Institute of Anatomy, University of Regensburg, is gratefully acknowledged. The microscope used in this study was financed in part by funding from the Deutsche Forschungsgemeinschaft (SFB699). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONVALET JP, 1977, J PHYSIOL-LONDON, V269, P627, DOI 10.1113/jphysiol.1977.sp011919; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; EISENBACH GM, 1975, KIDNEY INT, V8, P80, DOI 10.1038/ki.1975.83; FETTERMAN GH, 1965, PEDIATRICS, V35, P601; Forbes MS, 2011, AM J PHYSIOL-RENAL, V301, pF110, DOI 10.1152/ajprenal.00022.2011; HACKBARTH H, 1983, RENAL PHYSIOL BIOCH, V6, P63; HACKBARTH H, 1991, RENAL PHYSIOL BIOCH, V14, P246; HORSTER M, 1971, J CLIN INVEST, V50, P796, DOI 10.1172/JCI106550; Kobat D, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3646209; Kuligowski MP, 2006, J IMMUNOL, V176, P6991, DOI 10.4049/jimmunol.176.11.6991; Peti-Peterdi J, 2012, AM J PHYSIOL-RENAL, V302, pF227, DOI 10.1152/ajprenal.00561.2011; Peti-Peterdi J, 2010, J AM SOC NEPHROL, V21, P1835, DOI 10.1681/ASN.2010040378; REMUZZI A, 1988, KIDNEY INT, V34, P481, DOI 10.1038/ki.1988.206; REMUZZI A, 1990, J CLIN INVEST, V85, P541, DOI 10.1172/JCI114470; Rochefort NL, 2008, TRENDS MOL MED, V14, P389, DOI 10.1016/j.molmed.2008.07.005; ROVIRAHALBACH G, 1986, RENAL PHYSIOL BIOCH, V9, P317; Russo LM, 2007, KIDNEY INT, V71, P504, DOI 10.1038/sj.ki.5002041; Sandoval RM, 2012, J AM SOC NEPHROL, V23, P447, DOI 10.1681/ASN.2011070666; Schulz A, 2002, J AM SOC NEPHROL, V13, P2706, DOI 10.1097/01.ASN.0000031803.55613.86; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Tanner GA, 2009, AM J PHYSIOL-RENAL, V296, pF1258, DOI 10.1152/ajprenal.90638.2008; THURAU K, 1965, KLIN WOCHENSCHR, V43, P410, DOI 10.1007/BF01483845	22	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e52499	10.1371/journal.pone.0052499	http://dx.doi.org/10.1371/journal.pone.0052499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349687	Green Published, Green Submitted, gold			2022-12-25	WOS:000313943000009
J	Barr, MP; Gray, SG; Hoffmann, AC; Hilger, RA; Thomale, J; O'Flaherty, JD; Fennell, DA; Richard, D; O'Leary, JJ; O'Byrne, KJ				Barr, Martin P.; Gray, Steven G.; Hoffmann, Andreas C.; Hilger, Ralf A.; Thomale, Juergen; O'Flaherty, John D.; Fennell, Dean A.; Richard, Derek; O'Leary, John J.; O'Byrne, Kenneth J.			Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature	PLOS ONE			English	Article							OVARIAN-CANCER; IN-VITRO; DNA; SENSITIVITY; OVEREXPRESSION; IDENTIFICATION; PHARMACOLOGY; ARREST; AGENTS; COPPER	Introduction: Inherent and acquired cisplatin resistance reduces the effectiveness of this agent in the management of non-small cell lung cancer (NSCLC). Understanding the molecular mechanisms underlying this process may result in the development of novel agents to enhance the sensitivity of cisplatin. Methods: An isogenic model of cisplatin resistance was generated in a panel of NSCLC cell lines (A549, SKMES-1, MOR, H460). Over a period of twelve months, cisplatin resistant (CisR) cell lines were derived from original, age-matched parent cells (PT) and subsequently characterized. Proliferation (MTT) and clonogenic survival assays (crystal violet) were carried out between PT and CisR cells. Cellular response to cisplatin-induced apoptosis and cell cycle distribution were examined by FACS analysis. A panel of cancer stem cell and pluripotent markers was examined in addition to the EMT proteins, c-Met and beta-catenin. Cisplatin-DNA adduct formation, DNA damage (gamma H2AX) and cellular platinum uptake (ICP-MS) was also assessed. Results: Characterisation studies demonstrated a decreased proliferative capacity of lung tumour cells in response to cisplatin, increased resistance to cisplatin-induced cell death, accumulation of resistant cells in the G0/G1 phase of the cell cycle and enhanced clonogenic survival ability. Moreover, resistant cells displayed a putative stem-like signature with increased expression of CD133+/CD44+cells and increased ALDH activity relative to their corresponding parental cells. The stem cell markers, Nanog, Oct-4 and SOX-2, were significantly upregulated as were the EMT markers, c-Met and beta-catenin. While resistant sublines demonstrated decreased uptake of cisplatin in response to treatment, reduced cisplatin-GpG DNA adduct formation and significantly decreased gamma H2AX foci were observed compared to parental cell lines. Conclusion: Our results identified cisplatin resistant subpopulations of NSCLC cells with a putative stem-like signature, providing a further understanding of the cellular events associated with the cisplatin resistance phenotype in lung cancer.	[Barr, Martin P.; Gray, Steven G.; O'Flaherty, John D.; O'Byrne, Kenneth J.] St James Hosp, Trinity Ctr Hlth Sci, Inst Mol Med, Dublin, Ireland; [Barr, Martin P.; Gray, Steven G.; O'Flaherty, John D.; O'Leary, John J.; O'Byrne, Kenneth J.] Trinity Coll Dublin, Dublin, Ireland; [Hoffmann, Andreas C.; Hilger, Ralf A.] Univ Hosp Essen, W German Canc Ctr, Dept Med Oncol, Essen, Germany; [Thomale, Juergen] Univ Duisburg Essen, Dept Cell Biol Canc Res, Essen, Germany; [Fennell, Dean A.] Univ Leicester, Leicester, Leics, England; [Fennell, Dean A.] Leicester Univ Hosp, Leicester, Leics, England; [Richard, Derek] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [O'Leary, John J.] St James Hosp, Dept Histopathol, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin; University of Duisburg Essen; University of Duisburg Essen; University of Leicester; University Hospitals of Leicester NHS Trust; Queensland University of Technology (QUT); Trinity College Dublin	Barr, MP (corresponding author), St James Hosp, Trinity Ctr Hlth Sci, Inst Mol Med, Dublin, Ireland.	mbarr@stjames.ie	Richard, Derek/J-1338-2012; Gray, Steven G./I-3081-2019	Richard, Derek/0000-0002-4839-8471; Gray, Steven G./0000-0002-5850-6392; Hoffmann, Andreas-Claudius/0000-0001-6609-4503; O'Leary, John/0000-0001-7311-9326; O'Byrne, Kenneth/0000-0002-6754-5633; Barr, Martin/0000-0001-5202-9655				AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Alexander CM, 2009, CELL STEM CELL, V5, P579, DOI 10.1016/j.stem.2009.11.008; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Boulikas T, 2003, ONCOL REP, V10, P1663; Bunn PA, 1998, CLIN CANCER RES, V4, P1087; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Crawford N, 2011, APOPTOSIS, V16, P311, DOI 10.1007/s10495-010-0561-1; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; EISENHAUER E, 1990, CARBOPLATIN CURRENT, P133; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Furuta T, 2002, CANCER RES, V62, P4899; Giaccone G, 2000, DRUGS, V59, P9, DOI 10.2165/00003495-200059004-00002; Giaccone G, 1998, J CLIN ONCOL, V16, P2133, DOI 10.1200/JCO.1998.16.6.2133; GORE ME, 1989, BRIT J CANCER, V60, P767, DOI 10.1038/bjc.1989.356; Gutova M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000243; HARPER JW, 1993, CELL, V75, P805; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Katano K, 2002, CANCER RES, V62, P6559; Kelland LR, 2000, DRUGS, V59, P37; Leung ELH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014062; Liedert B, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl051; Liedert B, 2003, J INVEST DERMATOL, V121, P172, DOI 10.1046/j.1523-1747.2003.12313.x; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; McDonald ES, 2005, NEUROBIOL DIS, V18, P305, DOI 10.1016/j.nbd.2004.09.013; Meijer C, 2000, INT J CANCER, V85, P777, DOI 10.1002/(SICI)1097-0215(20000315)85:6<777::AID-IJC6>3.0.CO;2-D; Moreb J, 1996, CANCER GENE THER, V3, P24; OZOLS RF, 1991, CANCER TREAT REV, V18, P77, DOI 10.1016/0305-7372(91)90027-W; OZOLS RF, 1992, HEMATOL ONCOL CLIN N, V6, P879; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Patnaik SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022379; PRESTAYKO AW, 1979, CANCER TREAT REV, V6, P17, DOI 10.1016/S0305-7372(79)80057-2; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Samimi G, 2004, MOL PHARMACOL, V66, P25, DOI 10.1124/mol.66.1.25; Sekiguchi I, 1996, ONCOLOGY, V53, P19; SORENSON CM, 1990, JNCI-J NATL CANCER I, V82, P749, DOI 10.1093/jnci/82.9.749; Sreerama L, 1997, ADV EXP MED BIOL, V414, P81; Stuelten CH, 2010, STEM CELLS, V28, P649, DOI 10.1002/stem.324; Sullivan JP, 2010, CANCER METAST REV, V29, P61, DOI 10.1007/s10555-010-9216-5; Tirino V, 2009, EUR J CARDIO-THORAC, V36, P446, DOI 10.1016/j.ejcts.2009.03.063; TWENTYMAN PR, 1992, CANCER RES, V52, P5674; Vasey PA, 1996, MOL PHARMACOL, V50, P1536; Wang JR, 2010, ANTICANCER RES, V30, P3593; Wu YJ, 2009, STEM CELLS DEV, V18, P1127, DOI 10.1089/scd.2008.0338	46	179	186	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54193	10.1371/journal.pone.0054193	http://dx.doi.org/10.1371/journal.pone.0054193			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349823	Green Published, Green Submitted, gold			2022-12-25	WOS:000313738900051
J	Binkley, PF; Cooke, GE; Lesinski, A; Taylor, M; Chen, M; Laskowski, B; Waldman, WJ; Ariza, ME; Williams, MV; Knight, DA; Glaser, R				Binkley, Philip F.; Cooke, Glen E.; Lesinski, Amanda; Taylor, Mackenzie; Chen, Min; Laskowski, Bryon; Waldman, W. James; Ariza, Maria E.; Williams, Marshall V., Jr.; Knight, Deborah A.; Glaser, Ronald			Evidence for the Role of Epstein Barr Virus Infections in the Pathogenesis of Acute Coronary Events	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; ACUTE MYOCARDIAL-INFARCTION; DEOXYURIDINE TRIPHOSPHATE NUCLEOTIDOHYDROLASE; CHRONIC-FATIGUE-SYNDROME; APPARENTLY HEALTHY-MEN; HERPES-SIMPLEX-VIRUS; CARDIOVASCULAR-DISEASE; HEART-DISEASE; ENDOTHELIAL-CELLS; ARTERY DISEASE	Background: The role of viral infections in the pathogenesis of atherosclerosis remains controversial largely due to inconsistent detection of the virus in atherosclerotic lesions. However, viral infections elicit a pro-inflammatory cascade known to be atherogenic and to precipitate acute ischemic events. We have published in vitro data that provide the foundation for a mechanism that reconciles these conflicting observations. To determine the relation between an early viral protein, deoxyuridine triphosphate nucleotidohydrolase (dUTPase), produced following reactivation of Epstein Barr Virus (EBV) to circulating pro-inflammatory cytokines, intercellular adhesion molecule-1 (ICAM-1) and acute coronary events. Methodology/Principal Findings: Blood samples were obtained from 299 patients undergoing percutaneous coronary intervention for stable angina (SA), unstable angina (UA), or acute myocardial infarction (AMI). Plasma concentrations of pro-inflammatory cytokines and neutralizing antibody against EBV-encoded dUTPase were compared in the three patient groups. AMI was associated with the highest measures of interleukin-6 (ANOVA p < 0.05; 4.6 +/- 2.6 pg/mL in patients with AMI vs. 3.2 +/- 2.3 pg/mL in SA). ICAM-1 was significantly higher in patients with AMI (ANOVA p < 0.05; 304 +/- 116 pg/mL in AMI vs. 265 +/- 86 pg/mL SA). The highest values of ICAM-1 were found in patients having an AMI and who were antibody positive for dUTPase (ANOVA p = 0.008; 369 +/- 183 pg/mL in AMI and positive for dUTPase vs. 249 +/- 70 pg/mL in SA negative for dUTPase antibody). Conclusions/Significance: These clinical data support a model, based on in vitro studies, by which EBV may precipitate AMI even under conditions of low viral load through the pro-inflammatory action of the early protein dUTPase that is produced even during incomplete viral replication. They further support the putative role of viral infections in the pathogenesis of atherosclerosis and coronary artery events.	[Binkley, Philip F.; Cooke, Glen E.; Lesinski, Amanda] Ohio State Univ, Coll Med, Div Cardiovasc Med, Columbus, OH 43210 USA; [Binkley, Philip F.; Cooke, Glen E.; Taylor, Mackenzie] Ohio State Univ, Coll Med, Dept Internal Med, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Ariza, Maria E.; Williams, Marshall V., Jr.; Knight, Deborah A.; Glaser, Ronald] Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Chen, Min; Laskowski, Bryon; Glaser, Ronald] Ohio State Univ, Coll Med, Inst Behav Med Res, Columbus, OH 43210 USA; [Waldman, W. James] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Binkley, PF (corresponding author), Ohio State Univ, Coll Med, Div Cardiovasc Med, Columbus, OH 43210 USA.	Philip.Binkley@osumc.edu	Glaser, Ronald/E-3124-2011		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084898] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI084898] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ariza ME, 2009, J IMMUNOL, V182, P851, DOI 10.4049/jimmunol.182.2.851; Bhattacharyya MR, 2007, PROG CARDIOVASC DIS, V49, P353, DOI 10.1016/j.pcad.2006.11.002; Blankenberg S, 2001, CIRCULATION, V104, P1336, DOI 10.1161/hc3701.095949; Danesh J, 1998, Expert Opin Investig Drugs, V7, P691, DOI 10.1517/13543784.7.5.691; Danesh J, 2008, PLOS MED, V5, P600, DOI 10.1371/journal.pmed.0050078; Dimsdale JE, 2008, J AM COLL CARDIOL, V51, P1237, DOI 10.1016/j.jacc.2007.12.024; Dvorakova A, 2004, ATHEROSCLEROSIS, V172, P391, DOI 10.1016/j.atherosclerosis.2003.09.005; Emani S, 2010, CIRC-HEART FAIL, V3, P715, DOI 10.1161/CIRCHEARTFAILURE.110.951509; Empana JP, 2008, EUR HEART J, V29, P1966, DOI 10.1093/eurheartj/ehn331; Fisman EZ, 2006, AM J CARDIOL, V98, P14, DOI 10.1016/j.amjcard.2006.01.045; FUSTER V, 1992, NEW ENGL J MED, V326, P310; Gattone M, 2001, AM HEART J, V142, P633, DOI 10.1067/mhj.2001.118118; GLASER R, 1991, BRAIN BEHAV IMMUN, V5, P219, DOI 10.1016/0889-1591(91)90018-6; Glaser R, 2006, VIROLOGY, V346, P205, DOI 10.1016/j.virol.2005.10.034; Glaser R, 2005, BRAIN BEHAV IMMUN, V19, P91, DOI 10.1016/j.bbi.2004.09.001; Guan XR, 2008, INFLAMMATION, V31, P266, DOI 10.1007/s10753-008-9074-2; Haim M, 2002, J AM COLL CARDIOL, V39, P1133, DOI 10.1016/S0735-1097(02)01728-X; Horvath R, 2000, J CLIN VIROL, V16, P17, DOI 10.1016/S1386-6532(99)00064-5; Hwang SJ, 1997, CIRCULATION, V96, P4219; Ibrahim AI, 2005, J CLIN VIROL, V32, P29, DOI 10.1016/j.jcv.2004.06.010; JONES JF, 1988, ARCH INTERN MED, V148, P1957, DOI 10.1001/archinte.148.9.1957; KIECOLTGLASER JK, 1991, PSYCHOSOM MED, V53, P345, DOI 10.1097/00006842-199107000-00001; Lee KW, 2005, THROMB HAEMOSTASIS, V94, P1077, DOI 10.1160/TH05-03-0179; Lee KW, 2005, BLOOD, V105, P526, DOI 10.1182/blood-2004-03-1106; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lindmark E, 2001, JAMA-J AM MED ASSOC, V286, P2107, DOI 10.1001/jama.286.17.2107; Lippi G, 2010, SEMIN THROMB HEMOST, V36, P49, DOI 10.1055/s-0030-1248724; Morre SA, 2000, J CLIN PATHOL, V53, P647, DOI 10.1136/jcp.53.9.647; Padgett DA, 2004, J MED VIROL, V74, P442, DOI 10.1002/jmv.20196; Phrommintikul A, 2011, EUR HEART J, V32, P1730, DOI 10.1093/eurheartj/ehr004; Postadzhiyan AS, 2008, CLIN BIOCHEM, V41, P126, DOI 10.1016/j.clinbiochem.2007.09.001; Pretet JL, 2012, J AM COLL CARDIOL, V60, P81, DOI 10.1016/j.jacc.2012.02.049; PRINTSEVA OY, 1992, AM J PATHOL, V140, P889; Ridker PM, 1998, LANCET, V351, P88, DOI 10.1016/S0140-6736(97)09032-6; Rohde LEP, 1999, ARTERIOSCL THROM VAS, V19, P1595, DOI 10.1161/01.ATV.19.7.1595; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rozanski A, 2005, J AM COLL CARDIOL, V45, P637, DOI 10.1016/j.jacc.2004.12.005; Stassen FR, 2006, J CLIN VIROL, V35, P349, DOI 10.1016/j.jcv.2005.11.007; Stassen FR, 2008, PHARMACOL REP, V60, P85; Vliegen I, 2005, ATHEROSCLEROSIS, V181, P39, DOI 10.1016/j.atherosclerosis.2004.12.035; Waldman WJ, 2008, BRAIN BEHAV IMMUN, V22, P215, DOI 10.1016/j.bbi.2007.07.007; Warren-Gash C, 2009, LANCET INFECT DIS, V9, P601, DOI 10.1016/S1473-3099(09)70233-6; WILLIAMS MV, 1987, VIROLOGY, V156, P282, DOI 10.1016/0042-6822(87)90408-9; WILLIAMS MV, 1985, VIROLOGY, V142, P326, DOI 10.1016/0042-6822(85)90341-1	44	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54008	10.1371/journal.pone.0054008	http://dx.doi.org/10.1371/journal.pone.0054008			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349778	gold, Green Published, Green Submitted			2022-12-25	WOS:000313738900031
J	Li, XL; Wu, ZQ; Wang, Y; Mei, Q; Fu, XB; Han, WD				Li, Xiaolei; Wu, Zhiqiang; Wang, Yao; Mei, Qian; Fu, Xiaobing; Han, Weidong			Characterization of Adult alpha- and beta-Globin Elevated by Hydrogen Peroxide in Cervical Cancer Cells That Play A Cytoprotective Role Against Oxidative Insults	PLOS ONE			English	Article							DIFFERENTIAL GENE-EXPRESSION; OXIDANT-ANTIOXIDANT STATUS; ALVEOLAR EPITHELIAL-CELLS; HEMOGLOBIN EXPRESSION; TUMOR PROGRESSION; STRESS; OXYGEN; IDENTIFICATION; NEURONS; FLAVOHEMOGLOBIN	Objectives: Hemoglobin (Hgb) is the main oxygen and carbon dioxide carrier in cells of erythroid lineage and is responsible for oxygen delivery to the respiring tissues of the body. However, Hgb is also expressed in nonerythroid cells. In the present study, the expression of Hgb in human uterine cervix carcinoma cells and its role in cervical cancer were investigated. Methodology: The expression level of Hgb in cervical cancer tissues was assessed by quantitative reverse transcriptase-PCR (qRT-PCR). We applied multiple methods, such as RT-PCR, immunoblotting, and immunohistochemical analysis, to confirm Hgb expression in cervical cancer cells. The effects of ectopic expression of Hgb and Hgb mutants on oxidative stress and cell viability were investigated by cellular reactive oxygen species (ROS) analysis and lactate dehydrogenase (LDH) array, respectively. Both Annexin V staining assay by flow cytometry and caspase-3 activity assay were used, respectively, to evaluate cell apoptosis. Results: qRT-PCR analysis showed that Hgb-alpha- (HBA1) and Hgb-beta-globin (HBB) gene expression was significantly higher in cervical carcinoma than in normal cervical tissues, whereas the expression of hematopoietic transcription factors and erythrocyte specific marker genes was not increased. Immunostaining experiments confirmed the expression of Hgb in cancer cells of the uterine cervix. Hgb mRNA and protein were also detected in the human cervical carcinoma cell lines SiHa and CaSki, and Hgb expression was up-regulated by hydrogen peroxide-induced oxidative stress. Importantly, ectopic expression of wild type HBA1/HBB or HBA1, rather than mutants HBA1(H88R)/HBBH93R unable to bind hemo, suppressed oxidative stress and improved cell viability. Conclusions: The present findings show for the first time that Hgb is expressed in cervical carcinoma cells and may act as an antioxidant, attenuating oxidative stress-induced damage in cervical cancer cells. These data provide a significant impact not only in globin biology but also in understanding of cervical cancer pathogenesis associated with oxidative stress.	[Li, Xiaolei; Wu, Zhiqiang; Mei, Qian; Fu, Xiaobing; Han, Weidong] Chinese Peoples Liberat Army Gen Hosp, Sch Life Sci, Inst Basic Med, Dept Mol Biol, Beijing, Peoples R China; [Wang, Yao; Fu, Xiaobing; Han, Weidong] Chinese Peoples Liberat Army Gen Hosp, Sch Life Sci, Inst Basic Med, Dept Immunol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Han, WD (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Sch Life Sci, Inst Basic Med, Dept Mol Biol, Beijing, Peoples R China.	hanwdrsw69@yahoo.com	Wang, Yao/GXV-3833-2022; May, Mere/HIK-1050-2022; li, Xiaolei/V-1383-2019	li, Xiaolei/0000-0002-2697-6496; Yao, Wang/0000-0002-9352-422X	National Natural Science Foundation of China [31201033, 31270820, 81230061, 81001184]; National Basic Science and Development Programme of China [2012CB518103, 2012CB518105]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Science and Development Programme of China	This research was supported by the grants from the National Natural Science Foundation of China (website is http://www.nsfc.gov.cn/ Portal0/default124.htm) (No. 31201033, 31270820, 81230061 and 81001184) and was partially supported by the grants from National Basic Science and Development Programme of China (website is http://www.973.gov.cn/Default_3.aspx) (No. 2012CB518103 and 2012CB518105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn WS, 2005, CANCER SCI, V96, P197, DOI 10.1111/j.1349-7006.2005.00029.x; Bauer M, 2002, ANTIOXID REDOX SIGN, V4, P749, DOI 10.1089/152308602760598891; Bhaskaran M, 2005, BIOCHEM BIOPH RES CO, V333, P1348, DOI 10.1016/j.bbrc.2005.06.042; Bignotti E, 2006, GYNECOL ONCOL, V103, P405, DOI 10.1016/j.ygyno.2006.03.056; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dassen H, 2008, HUM REPROD, V23, P635, DOI 10.1093/humrep/dem430; Franco R, 2008, CANCER LETT, V266, P6, DOI 10.1016/j.canlet.2008.02.026; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Gerber M, 1996, J NUTR, V126, pS1201, DOI 10.1093/jn/126.suppl_4.1201S; Gerber M, 1997, CANCER LETT, V114, P211, DOI 10.1016/S0304-3835(97)04665-X; Goldstein S, 2005, FREE RADICAL BIO MED, V39, P511, DOI 10.1016/j.freeradbiomed.2005.04.003; Grek CL, 2011, AM J RESP CELL MOL, V44, P439, DOI 10.1165/rcmb.2009-0307OC; Gupta SC, 2012, ANTIOXID REDOX SIGN, V16, P1295, DOI 10.1089/ars.2011.4414; Han WD, 2009, NUCLEIC ACIDS RES, V37, P3996, DOI 10.1093/nar/gkp332; Hardison RC, 1996, P NATL ACAD SCI USA, V93, P5675, DOI 10.1073/pnas.93.12.5675; Hausladen A, 1998, P NATL ACAD SCI USA, V95, P14100, DOI 10.1073/pnas.95.24.14100; Higuchi M, 1998, ONCOGENE, V17, P2753, DOI 10.1038/sj.onc.1202211; Karbownik M, 2003, NEUROENDOCRINOL LETT, V24, P293; Klaes R, 2001, INT J CANCER, V92, P276, DOI 10.1002/ijc.1174; Kluck RM, 1997, EMBO J, V16, P4639, DOI 10.1093/emboj/16.15.4639; Lee RA, 2006, WORLD J GASTROENTERO, V12, P5644, DOI 10.3748/wjg.v12.i35.5644; Liu LM, 1999, P NATL ACAD SCI USA, V96, P6643, DOI 10.1073/pnas.96.12.6643; Liu W.S., 2011, PLOS ONE, V6; Lu G, 2012, ANTIOXID REDOX SIGN, V16, P217, DOI 10.1089/ars.2011.4112; Marcos-Almaraz MT, 2012, BIOCHEM J, V441, P843, DOI 10.1042/BJ20111640; Masuoka N, 2003, BBA-MOL BASIS DIS, V1637, P46, DOI 10.1016/S0925-4439(02)00213-2; MAYER M, 1994, P NATL ACAD SCI USA, V91, P7496, DOI 10.1073/pnas.91.16.7496; McLaughlin-Drubin ME, 2011, P NATL ACAD SCI USA, V108, P2130, DOI 10.1073/pnas.1009933108; Newton DA, 2006, J BIOL CHEM, V281, P5668, DOI 10.1074/jbc.M509314200; Nishi H, 2008, J AM SOC NEPHROL, V19, P1500, DOI 10.1681/ASN.2007101085; Richter F, 2009, J COMP NEUROL, V515, P538, DOI 10.1002/cne.22062; Saintot M, 1996, CARCINOGENESIS, V17, P1267, DOI 10.1093/carcin/17.6.1267; Schechter AN, 2008, BLOOD, V112, P3927, DOI 10.1182/blood-2008-04-078188; Schelshorn DW, 2009, J CEREBR BLOOD F MET, V29, P585, DOI 10.1038/jcbfm.2008.152; Schmidt M, 2004, J BIOL CHEM, V279, P8063, DOI 10.1074/jbc.M310540200; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Smith MJ, 2009, BRIT J CANCER, V100, P1452, DOI 10.1038/sj.bjc.6604931; Smith MJ, 2008, ANN SURG ONCOL, V15, P2954, DOI 10.1245/s10434-008-0037-5; Stamatoyannopoulos G, 2005, EXP HEMATOL, V33, P259, DOI 10.1016/j.exphem.2004.11.007; Tezel G, 2010, INVEST OPHTH VIS SCI, V51, P907, DOI 10.1167/iovs.09-4014; Tezel TH, 2009, INVEST OPHTH VIS SCI, V50, P1911, DOI 10.1167/iovs.07-1372; Tsiftsoglou AS, 2009, IUBMB LIFE, V61, P800, DOI 10.1002/iub.226; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Vinogradov SN, 2008, J BIOL CHEM, V283, P8773, DOI 10.1074/jbc.R700029200; Wang D, 2011, ENDOCR-RELAT CANCER, V18, P773, DOI 10.1530/ERC-11-0230; Widmer CC, 2010, ANTIOXID REDOX SIGN, V12, P185, DOI 10.1089/ars.2009.2826; WITTENBERG BA, 1989, ANNU REV PHYSIOL, V51, P857, DOI 10.1146/annurev.physiol.51.1.857; Wu Z. Y., 2011, PLOS ONE, V6	49	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54342	10.1371/journal.pone.0054342	http://dx.doi.org/10.1371/journal.pone.0054342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349856	gold, Green Submitted, Green Published			2022-12-25	WOS:000313738900061
J	Masschelein, J; Mattheus, W; Gao, LJ; Moons, P; Van Houdt, R; Uytterhoeven, B; Lamberigts, C; Lescrinier, E; Rozenski, J; Herdewijn, P; Aertsen, A; Michiels, C; Lavigne, R				Masschelein, Joleen; Mattheus, Wesley; Gao, Ling-Jie; Moons, Pieter; Van Houdt, Rob; Uytterhoeven, Birgit; Lamberigts, Chris; Lescrinier, Eveline; Rozenski, Jef; Herdewijn, Piet; Aertsen, Abram; Michiels, Chris; Lavigne, Rob			A PKS/NRPS/FAS Hybrid Gene Cluster from Serratia plymuthica RVH1 Encoding the Biosynthesis of Three Broad Spectrum, Zeamine-Related Antibiotics	PLOS ONE			English	Article							PHOSPHOPANTETHEINYL TRANSFERASE GENE; POLYUNSATURATED FATTY-ACIDS; COMPLETE GENOME SEQUENCE; GRAM-NEGATIVE BACTERIA; EICOSAPENTAENOIC ACID; POLYKETIDE SYNTHASES; SUBSTRATE-SPECIFICITY; COMPONENT PRODUCTION; PEPTIDE SYNTHETASE; DOMAINS	Serratia plymuthica strain RVH1, initially isolated from an industrial food processing environment, displays potent antimicrobial activity towards a broad spectrum of Gram-positive and Gram-negative bacterial pathogens. Isolation and subsequent structure determination of bioactive molecules led to the identification of two polyamino antibiotics with the same molecular structure as zeamine and zeamine II as well as a third, closely related analogue, designated zeamine I. The gene cluster encoding the biosynthesis of the zeamine antibiotics was cloned and sequenced and shown to encode FAS, PKS as well as NRPS related enzymes in addition to putative tailoring and export enzymes. Interestingly, several genes show strong homology to the pfa cluster of genes involved in the biosynthesis of long chain polyunsaturated fatty acids in marine bacteria. We postulate that a mixed FAS/PKS and a hybrid NRPS/PKS assembly line each synthesize parts of the backbone that are linked together post-assembly in the case of zeamine and zeamine I. This interaction reflects a unique interplay between secondary lipid and secondary metabolite biosynthesis. Most likely, the zeamine antibiotics are produced as prodrugs that undergo activation in which a nonribosomal peptide sequence is cleaved off.	[Masschelein, Joleen; Mattheus, Wesley; Uytterhoeven, Birgit; Lamberigts, Chris; Lavigne, Rob] Katholieke Univ Leuven, Div Gene Technol, Heverlee, Belgium; [Masschelein, Joleen; Moons, Pieter; Van Houdt, Rob; Aertsen, Abram; Michiels, Chris] Katholieke Univ Leuven, Food Microbiol Lab, Heverlee, Belgium; [Gao, Ling-Jie; Herdewijn, Piet] Katholieke Univ Leuven, Louvain, Belgium; [Lescrinier, Eveline; Rozenski, Jef; Herdewijn, Piet] Catholic Univ Louvain, Rega Inst Med Res, Med Chem Lab, B-3000 Louvain, Belgium	KU Leuven; KU Leuven; KU Leuven; KU Leuven; Universite Catholique Louvain	Lavigne, R (corresponding author), Katholieke Univ Leuven, Div Gene Technol, Heverlee, Belgium.	rob.lavigne@biw.kuleuven.be	Lescrinier, Eveline/G-9339-2016; Michiels, Chris/I-6847-2013; Van Houdt, Rob/B-8599-2011	Lescrinier, Eveline/0000-0001-7066-4329; Michiels, Chris/0000-0002-7710-6802; Van Houdt, Rob/0000-0002-7459-496X; Aertsen, Abram/0000-0002-1897-2305; Lavigne, Rob/0000-0001-7377-1314; moons, pieter/0000-0002-9830-0444; Lamberigts, Chris/0000-0002-7484-0059; Rozenski, Jef/0000-0001-9624-5536; Masschelein, Joleen/0000-0003-4366-3675; Herdewijn, Piet/0000-0003-3589-8503				Allen EE, 2002, MICROBIOL-SGM, V148, P1903, DOI 10.1099/00221287-148-6-1903; Aparicio JF, 1996, GENE, V169, P9, DOI 10.1016/0378-1119(95)00800-4; Aron ZD, 2005, J AM CHEM SOC, V127, P14986, DOI 10.1021/ja055247g; BARRETT AJ, 1992, BIOL CHEM H-S, V373, P353, DOI 10.1515/bchm3.1992.373.2.353; Blight Mark A., 1994, Current Opinion in Biotechnology, V5, P468, DOI 10.1016/0958-1669(94)90059-0; Borodovsky Mark, 2003, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0405s01; Brenner C, 2002, CURR OPIN STRUC BIOL, V12, P775, DOI 10.1016/S0959-440X(02)00387-1; Caffrey P, 2003, CHEMBIOCHEM, V4, P654, DOI 10.1002/cbic.200300581; DAVIS AL, 1992, J MAGN RESON, V98, P207, DOI 10.1016/0022-2364(92)90126-R; DAVIS AL, 1991, J MAGN RESON, V94, P637, DOI 10.1016/0022-2364(91)90154-L; DECRECYLAGARD V, 1995, CR ACAD SCI III-VIE, V318, P927; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Duitman EH, 1999, P NATL ACAD SCI USA, V96, P13294, DOI 10.1073/pnas.96.23.13294; Fujii I, 2004, J BIOL CHEM, V279, P44613, DOI 10.1074/jbc.M406758200; Gaitatzis N, 2001, P NATL ACAD SCI USA, V98, P11136, DOI 10.1073/pnas.201167098; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; HAYDOCK SF, 1995, FEBS LETT, V374, P246, DOI 10.1016/0014-5793(95)01119-Y; Hertweck C, 2007, NAT PROD REP, V24, P162, DOI 10.1039/b507395m; Hirota K, 2005, INT J SYST EVOL MICR, V55, P2355, DOI 10.1099/ijs.0.63804-0; Keating TA, 2000, BIOCHEMISTRY-US, V39, P15513, DOI 10.1021/bi001651a; Keating TA, 2000, BIOCHEMISTRY-US, V39, P15522, DOI 10.1021/bi0016523; Liu F, 2004, CHEM BIOL, V11, P1533, DOI 10.1016/j.chembiol.2004.08.017; Mahlen SD, 2011, CLIN MICROBIOL REV, V24, P755, DOI 10.1128/CMR.00017-11; Marahiel MA, 2009, J PEPT SCI, V15, P799, DOI 10.1002/psc.1183; Mattheus W, 2010, CHEM BIOL, V17, P149, DOI 10.1016/j.chembiol.2010.01.014; Metz JG, 2001, SCIENCE, V293, P290, DOI 10.1126/science.1059593; Miller DA, 2002, CHEM BIOL, V9, P333, DOI 10.1016/S1074-5521(02)00115-1; Moons P, 2008, THESIS KATHOLIEKE U; Moons P, 2006, APPL ENVIRON MICROB, V72, P7294, DOI 10.1128/AEM.01708-06; Moons P, 2011, APPL ENVIRON MICROB, V77, P3422, DOI 10.1128/AEM.02763-10; Moss SJ, 2004, NAT PROD REP, V21, P575, DOI 10.1039/b315020h; Neupane S, 2012, STAND GENOMIC SCI, V6, P165, DOI 10.4056/sigs.2705996; Neupane S, 2012, STAND GENOMIC SCI, V6, P54, DOI 10.4056/sigs.2595762; Okuyama H, 2007, APPL ENVIRON MICROB, V73, P665, DOI 10.1128/AEM.02270-06; Orikasa Y, 2006, FEBS LETT, V580, P4423, DOI 10.1016/j.febslet.2006.07.008; Osoegawa K, 1998, GENOMICS, V52, P1, DOI 10.1006/geno.1998.5423; Pace HC, 2001, GENOME BIOL, V2; Park SR, 2010, J ANTIBIOT, V63, P434, DOI 10.1038/ja.2010.71; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Reid R, 2003, BIOCHEMISTRY-US, V42, P72, DOI 10.1021/bi0268706; Reimer D, 2011, NAT CHEM BIOL, V7, P888, DOI [10.1038/NCHEMBIO.688, 10.1038/nchembio.688]; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; SATTLER M, 1995, J BIOMOL NMR, V6, P11, DOI 10.1007/BF00417487; SCHLUMBOHM W, 1991, J BIOL CHEM, V266, P23135; SHAKA AJ, 1985, J MAGN RESON, V64, P547, DOI 10.1016/0022-2364(85)90122-2; Shulse CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020146; Silakowski B, 2000, EUR J BIOCHEM, V267, P6476, DOI 10.1046/j.1432-1327.2000.01740.x; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Sugihara S, 2008, BIOTECHNOL LETT, V30, P411, DOI 10.1007/s10529-007-9579-z; Sugihara S, 2010, FEMS MICROBIOL LETT, V307, P207, DOI 10.1111/j.1574-6968.2010.01987.x; Tanaka M, 1999, BIOTECHNOL LETT, V21, P939, DOI 10.1023/A:1005601606929; Van Houdt R, 2006, FEMS MICROBIOL LETT, V256, P83, DOI 10.1111/j.1574-6968.2006.00103.x; Van Houdt R, 2005, FEMS MICROBIOL LETT, V246, P265, DOI 10.1016/j.femsle.2005.04.016; Van Houdt R, 2004, J APPL MICROBIOL, V96, P177, DOI 10.1046/j.1365-2672.2003.02131.x; Van Houdt R, 2007, RES MICROBIOL, V158, P150, DOI 10.1016/j.resmic.2006.11.008; Van Houdt R, 2006, J BACTERIOL, V188, P4570, DOI 10.1128/JB.00144-06; Wilkinson B, 2000, CHEM BIOL, V7, P111, DOI 10.1016/S1074-5521(00)00076-4; Wu J, 2010, CHEM COMMUN, V46, P333, DOI 10.1039/b916307g; Yadav G, 2003, J MOL BIOL, V328, P335, DOI 10.1016/S0022-2836(03)00232-8; Yazawa K, 1996, LIPIDS, V31, pS297, DOI 10.1007/BF02637095; Zhou JU, 2011, MOL PLANT MICROBE IN, V24, P1156, DOI 10.1094/MPMI-04-11-0087	62	52	52	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54143	10.1371/journal.pone.0054143	http://dx.doi.org/10.1371/journal.pone.0054143			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349809	Green Published, Green Submitted, gold			2022-12-25	WOS:000313738900045
J	De Araujo, ME; Erhart, G; Buck, K; Muller-Holzner, E; Hubalek, M; Fiegl, H; Campa, D; Canzian, F; Eilber, U; Chang-Claude, J; Coassin, S; Haun, M; Kedenko, L; Paulweber, B; Reitsamer, R; Himmel, I; Flesch-Janys, D; Lamina, C; Kronenberg, F; Huber, LA; Kloss-Brandstatter, A				De Araujo, Mariana E.; Erhart, Gertraud; Buck, Katharina; Mueller-Holzner, Elisabeth; Hubalek, Michael; Fiegl, Heidelinde; Campa, Daniele; Canzian, Federico; Eilber, Ursula; Chang-Claude, Jenny; Coassin, Stefan; Haun, Margot; Kedenko, Lyudmyla; Paulweber, Bernhard; Reitsamer, Roland; Himmel, Irmgard; Flesch-Janys, Dieter; Lamina, Claudia; Kronenberg, Florian; Huber, Lukas A.; Kloss-Brandstaetter, Anita			Polymorphisms in the Gene Regions of the Adaptor Complex LAMTOR2/LAMTOR3 and Their Association with Breast Cancer Risk	PLOS ONE			English	Article							SIGNALING PATHWAY; CROSS-TALK; EXPRESSION; KINASE; PROTEIN; ACTIVATION; RECEPTOR; TARGETS; SURVIVAL; MIR-126	Background: The late endosomal LAMTOR complex serves as a convergence point for both the RAF/MEK/ERK and the PI3K/AKT/mTOR pathways. Interestingly, both of these signalling cascades play a significant role in the aetiology of breast cancer. Our aim was to address the possible role of genetic polymorphisms in LAMTOR2 and LAMTOR3 as genetic risk factors for breast cancer. Methodology/Results: We sequenced the exons and exon-intron boundaries of LAMTOR2 (p14) and LAMTOR3 (MP1) in 50 prospectively collected pairs of cancerous tissue and blood samples from breast cancer patients and compared their genetic variability. We found one single nucleotide polymorphism (SNP) in LAMTOR2 (rs7541) and two SNPs in LAMTOR3 (rs2298735 and rs148972953) in both tumour and blood samples, but no somatic mutations in cancerous tissues. In addition, we genotyped all three SNPs in 296 samples from the Risk Prediction of Breast Cancer Metastasis Study and found evidence of a genetic association between rs148972953 and oestrogen (ER) and progesterone receptor negative status (PR) (ER: OR = 3.60 (1.15-11.28); PR: OR = 4.27 (1.43-12.72)). However, when we additionally genotyped rs148972953 in the MARIE study including 2,715 breast cancer cases and 5,216 controls, we observed neither a difference in genotype frequencies between patients and controls nor was the SNP associated with ER or PR. Finally, all three SNPs were equally frequent in breast cancer samples and female participants (n = 640) of the population-based SAPHIR Study. Conclusions: The identified polymorphisms in LAMTOR2 and LAMTOR3 do not seem to play a relevant role in breast cancer. Our work does not exclude a role of other not yet identified SNPs or that the here annotated polymorphism may in fact play a relevant role in other diseases. Our results underscore the importance of replication in association studies.	[De Araujo, Mariana E.; Huber, Lukas A.] Med Univ Innsbruck, Div Cell Biol, A-6020 Innsbruck, Austria; [Erhart, Gertraud; Coassin, Stefan; Haun, Margot; Lamina, Claudia; Kronenberg, Florian; Kloss-Brandstaetter, Anita] Med Univ Innsbruck, Div Genet Epidemiol, A-6020 Innsbruck, Austria; [Buck, Katharina; Eilber, Ursula; Chang-Claude, Jenny] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Mueller-Holzner, Elisabeth; Hubalek, Michael; Fiegl, Heidelinde] Med Univ Innsbruck, Dept Obstet & Gynaecol, A-6020 Innsbruck, Austria; [Campa, Daniele; Canzian, Federico] German Canc Res Ctr, Genom Epidemiol Grp, Heidelberg, Germany; [Kedenko, Lyudmyla; Paulweber, Bernhard] Paracelsus Med Univ, Dept Internal Med 1, Salzburg, Austria; [Reitsamer, Roland] Paracelsus Med Univ, Breast Ctr Salzburg, Salzburg, Austria; [Himmel, Irmgard] Hosp Meran, Dept Gynecol & Obstet, Meran, Italy; [Flesch-Janys, Dieter] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometr & Epidemiol, Hamburg, Germany	Medical University of Innsbruck; Medical University of Innsbruck; Helmholtz Association; German Cancer Research Center (DKFZ); Medical University of Innsbruck; Helmholtz Association; German Cancer Research Center (DKFZ); Paracelsus Private Medical University; Paracelsus Private Medical University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Kloss-Brandstatter, A (corresponding author), Med Univ Innsbruck, Div Genet Epidemiol, A-6020 Innsbruck, Austria.	anita.kloss@i-med.ac.at	Campa, Daniele/K-1617-2016; Lamina, Claudia/F-7608-2010; Hubalek, Michael/ABD-8041-2021; Coassin, Stefan/J-2611-2018; Huber, Lukas Alfons/AAM-3499-2021; Canzian, Federico/I-2804-2014; Kronenberg, Florian/B-1736-2008; Fiegl, Heidi/K-4445-2017	Campa, Daniele/0000-0003-3220-9944; Lamina, Claudia/0000-0002-5398-5806; Coassin, Stefan/0000-0001-5677-8979; Kronenberg, Florian/0000-0003-2229-1120; Kloss-Brandstatter, Anita/0000-0002-0873-6704; Canzian, Federico/0000-0002-4261-4583; Huber, Lukas Alfons/0000-0003-1116-2120; Fiegl, Heidi/0000-0002-1236-6806; Eca Guimaraes de Araujo, Mariana/0000-0003-0576-2680	COMET Centre ONCOTYROL; BMVIT; BMWFJ; Tiroler-Zukunftsstiftung; Styrian Business Promotion Agency; Innsbruck Medical University; Verein Sanitatsbetrieb Autonome Provinz-Bozen; Tiroler-Landeskrankenanstalten-GmbH (TILAK); Sequencing & Genotyping Unit of the Innsbruck Medical University; FWF (Austria) [SFB021]	COMET Centre ONCOTYROL; BMVIT; BMWFJ; Tiroler-Zukunftsstiftung; Styrian Business Promotion Agency; Innsbruck Medical University; Verein Sanitatsbetrieb Autonome Provinz-Bozen; Tiroler-Landeskrankenanstalten-GmbH (TILAK); Sequencing & Genotyping Unit of the Innsbruck Medical University; FWF (Austria)(Austrian Science Fund (FWF))	The project was supported by the COMET Centre ONCOTYROL (which is funded by BMVIT, BMWFJ, the Tiroler-Zukunftsstiftung and the Styrian Business Promotion Agency), by the Innsbruck Medical University, by the Verein Sanitatsbetrieb Autonome Provinz-Bozen, by the Tiroler-Landeskrankenanstalten-GmbH (TILAK), and by the Sequencing & Genotyping Unit of the Innsbruck Medical University. Work in the Huber laboratory was supported by the FWF (Austria) funded special research program "cell proliferation and cell death in tumors"-SFB021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyinka A, 2002, CLIN CANCER RES, V8, P1747; Atanaskova N, 2002, ONCOGENE, V21, P4000, DOI 10.1038/sj.onc.1205506; Biscardi JS, 2000, BREAST CANCER RES, V2, P203, DOI 10.1186/bcr55; Bland JM, 2000, BRIT MED J, V320, P1468, DOI 10.1136/bmj.320.7247.1468; Brandstatter A, 2010, ATHEROSCLEROSIS, V210, P474, DOI 10.1016/j.atherosclerosis.2009.12.013; Brandstatter A, 2007, FORENSIC SCI INT, V166, P164, DOI 10.1016/j.forsciint.2006.05.006; Coassin S, 2010, ATHEROSCLEROSIS, V209, P321, DOI 10.1016/j.atherosclerosis.2009.10.026; Cui R, 2009, GASTROENTEROLOGY, V137, P1768, DOI 10.1053/j.gastro.2009.07.070; Dan HC, 2004, ONCOGENE, V23, P706, DOI 10.1038/sj.onc.1207171; delPeso L, 1997, SCIENCE, V278, P687; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Fiesch-Janys D, 2008, INT J CANCER, V123, P933, DOI 10.1002/ijc.23655; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Georges M, 2006, COLD SPRING HARB SYM, V71, P343, DOI 10.1101/sqb.2006.71.056; Gilles C, 1997, CLIN EXP METASTAS, V15, P519, DOI 10.1023/A:1018427027270; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; Harari D, 2000, ONCOGENE, V19, P6102, DOI 10.1038/sj.onc.1203973; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hollestelle A, 2007, MOL CANCER RES, V5, P195, DOI 10.1158/1541-7786.MCR-06-0263; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Kang S, 2005, CELL CYCLE, V4, P578, DOI 10.4161/cc.4.4.1593; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kurzbauer R, 2004, P NATL ACAD SCI USA, V101, P10984, DOI 10.1073/pnas.0403435101; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Li ZJ, 2008, P NATL ACAD SCI USA, V105, P15535, DOI 10.1073/pnas.0808266105; Li ZJ, 2011, METHODS MOL BIOL, V676, P185, DOI 10.1007/978-1-60761-863-8_13; Malaney S, 2001, J MAMMARY GLAND BIOL, V6, P101, DOI 10.1023/A:1009572700317; Marina M, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-18; McKay JD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001333; Meister J, 2010, THESCIENTIFICWORLDJO, V10, P2090, DOI 10.1100/tsw.2010.198; Murphy LC, 2006, J STEROID BIOCHEM, V102, P139, DOI 10.1016/j.jsbmb.2006.09.021; Musiyenko A, 2008, J MOL MED, V86, P313, DOI 10.1007/s00109-007-0296-9; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; Prescott JD, 2004, MOL CELL BIOL, V24, P5548, DOI 10.1128/MCB.24.12.5548-5564.2004; Reumers J, 2008, NUCLEIC ACIDS RES, V36, pD825, DOI 10.1093/nar/gkm979; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Santarelli L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018232; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; Steelman LS, 2008, MOL MED REP, V1, P139; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; Troppmair J, 2003, BIOCHEM PHARMACOL, V66, P1341, DOI 10.1016/S0006-2952(03)00483-0; Watahiki A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024950; Wunderlich W, 2001, J CELL BIOL, V152, P765, DOI 10.1083/jcb.152.4.765; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zhang J, 2008, BIOCHEM BIOPH RES CO, V377, P136, DOI 10.1016/j.bbrc.2008.09.089; Zhao HJ, 2004, MOL BIOL CELL, V15, P2523, DOI 10.1091/mbc.E03-11-0786	53	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53768	10.1371/journal.pone.0053768	http://dx.doi.org/10.1371/journal.pone.0053768			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341997	Green Published, gold, Green Submitted			2022-12-25	WOS:000313682700044
J	Polverino, G; Liao, JC; Porfiri, M				Polverino, Giovanni; Liao, Jian Cong; Porfiri, Maurizio			Mosquitofish (Gambusia affinis) Preference and Behavioral Response to Animated Images of Conspecifics Altered in Their Color, Aspect Ratio, and Swimming Depth	PLOS ONE			English	Article							ZEBRAFISH DANIO-RERIO; INVASIVE MOSQUITOFISH; SEXUAL-HARASSMENT; INTRODUCED MOSQUITOFISH; WESTERN MOSQUITOFISH; EASTERN MOSQUITOFISH; FEMALE PREFERENCE; MALE COMPETITION; VIDEO PLAYBACK; PLAGUE MINNOW	Mosquitofish (Gambusia affinis) is an example of a freshwater fish species whose remarkable diffusion outside its native range has led to it being placed on the list of the world's hundred worst invasive alien species (International Union for Conservation of Nature). Here, we investigate mosquitofish shoaling tendency using a dichotomous choice test in which computer-animated images of their conspecifics are altered in color, aspect ratio, and swimming level in the water column. Pairs of virtual stimuli are systematically presented to focal subjects to evaluate their attractiveness and the effect on fish behavior. Mosquitofish respond differentially to some of these stimuli showing preference for conspecifics with enhanced yellow pigmentation while exhibiting highly varying locomotory patterns. Our results suggest that computer-animated images can be used to understand the factors that regulate the social dynamics of shoals of Gambusia affinis. Such knowledge may inform the design of control plans and open new avenues in conservation and protection of endangered animal species.	[Polverino, Giovanni; Liao, Jian Cong; Porfiri, Maurizio] NYU, Polytech Inst, Dept Mech & Aerosp Engn, Brooklyn, NY USA	New York University; New York University Tandon School of Engineering	Porfiri, M (corresponding author), NYU, Polytech Inst, Dept Mech & Aerosp Engn, Brooklyn, NY USA.	mporfiri@poly.edu	Polverino, Giovanni/AAC-2556-2020; Porfiri, Maurizio/A-1712-2009	Polverino, Giovanni/0000-0001-9737-7995; Porfiri, Maurizio/0000-0002-1480-3539	National Science Foundation [CMMI-0745753, CMMI-1129820]	National Science Foundation(National Science Foundation (NSF))	Funding provided by National Science Foundation grants #CMMI-0745753 and #CMMI-1129820. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaid N, 2012, BEHAV BRAIN RES, V233, P545, DOI 10.1016/j.bbr.2012.05.047; Abaid N, 2012, BEHAV BRAIN RES, V232, P406, DOI 10.1016/j.bbr.2012.03.028; Agrillo C, 2008, ANIM COGN, V11, P495, DOI 10.1007/s10071-008-0140-9; Alcaraz C, 2008, OECOLOGIA, V155, P205, DOI 10.1007/s00442-007-0899-4; Baldauf SA, 2009, J FISH BIOL, V75, P738, DOI 10.1111/j.1095-8649.2009.02347.x; Baldauf SA, 2008, ETHOLOGY, V114, P737, DOI 10.1111/j.1439-0310.2008.01520.x; Barrier R. F. G., 1994, Ecology of Freshwater Fish, V3, P93, DOI 10.1111/j.1600-0633.1994.tb00110.x; BELK MC, 1994, COPEIA, P296; Bisazza A, 2000, BEHAV GENET, V30, P207, DOI 10.1023/A:1001914208075; Brookhouse Nicola, 2010, Ecological Management & Restoration, V11, P226, DOI 10.1111/j.1442-8903.2010.00556.x; Butail S, 2012, J R SOC INTERFACE, V9, P77, DOI 10.1098/rsif.2011.0113; Butkowski T, 2011, JOVE-J VIS EXP, DOI 10.3791/2374; Cahill GM, 2002, CELL TISSUE RES, V309, P27, DOI 10.1007/s00441-002-0570-7; Clark DL, 1999, ENVIRON BIOL FISH, V56, P317, DOI 10.1023/A:1007549721631; Cote J, 2010, P ROY SOC B-BIOL SCI, V277, P1571, DOI 10.1098/rspb.2009.2128; Courtenay Walter R., 1997, P109; COURTENAY WR, 1993, BIOLOGICAL POLLUTION: THE CONTROL AND IMPACT OF INVASIVE EXOTIC SPECIES, P35; D'eath RB, 1998, BIOL REV, V73, P267, DOI 10.1017/S0006323198005179; Dadda M, 2005, ANIM BEHAV, V70, P463, DOI 10.1016/j.anbehav.2004.12.010; Engeszer RE, 2008, P NATL ACAD SCI USA, V105, P929, DOI 10.1073/pnas.0708778105; Fleisch VC, 2006, ZEBRAFISH, V3, P191, DOI 10.1089/zeb.2006.3.191; Gerlai R, 2010, MOLECULES, V15, P2609, DOI 10.3390/molecules15042609; Gerlai R, 2009, BEHAV BRAIN RES, V201, P318, DOI 10.1016/j.bbr.2009.03.003; Green J, 2012, J NEUROSCI METH, V210, P266, DOI 10.1016/j.jneumeth.2012.07.017; Harcourt JL, 2009, ANIM BEHAV, V77, P1501, DOI 10.1016/j.anbehav.2009.03.004; Herbert-Read JE, 2011, P NATL ACAD SCI USA, V108, P18726, DOI 10.1073/pnas.1109355108; Kats LB, 2003, DIVERS DISTRIB, V9, P99, DOI 10.1046/j.1472-4642.2003.00013.x; Keller K, 2008, J FISH BIOL, V73, P1714, DOI 10.1111/j.1095-8649.2008.02045.x; Komak S, 2000, WILDLIFE RES, V27, P185, DOI 10.1071/WR99028; KRUMHOLZ LA, 1948, ECOL MONOGR, V18, P1, DOI 10.2307/1948627; Kunzler R, 2001, BEHAV ECOL, V12, P681, DOI 10.1093/beheco/12.6.681; Laha M, 2007, ENVIRON BIOL FISH, V78, P1, DOI 10.1007/s10641-006-9040-5; Lambertini M, 2011, SCIENCE, V333, P404, DOI 10.1126/science.333.6041.404-b; LANZING WJR, 1982, CELL TISSUE RES, V223, P431, DOI 10.1007/BF01258500; Lawler SP, 1999, CONSERV BIOL, V13, P613, DOI 10.1046/j.1523-1739.1999.98075.x; Leprieur F, 2008, PLOS BIOL, V6, P404, DOI 10.1371/journal.pbio.0060028; Lloyd L., 1986, ARBOVIRUSES RES AUST, P156; Lowe S., 2000, 100 WORLDS WORST INV, DOI DOI 10.1525/9780520948433-159; Luca RM, 2012, BEHAV BRAIN RES, V226, P66, DOI 10.1016/j.bbr.2011.09.001; Mazzi D, 2003, BEHAV ECOL SOCIOBIOL, V54, P156, DOI 10.1007/s00265-003-0609-0; MCALISTER WH, 1958, ECOLOGY, V39, P477, DOI 10.2307/1931756; McRobert SP, 1998, ANIM BEHAV, V56, P611, DOI 10.1006/anbe.1998.0846; Meffe G.K., 1989, P13; Meffe G.K., 1983, North American Journal of Fisheries Management, V3, P315, DOI 10.1577/1548-8659(1983)3<315:ACROAA>2.0.CO;2; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Pather S, 2009, BEHAV BRAIN RES, V196, P323, DOI 10.1016/j.bbr.2008.09.013; Pilastro A, 2003, ANIM BEHAV, V65, P1161, DOI 10.1006/anbe.2003.2118; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Polverino G, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/3/036019; Pritchard VL, 2001, ANIM BEHAV, V62, P1085, DOI 10.1006/anbe.2001.1858; Pyke GH, 2005, REV FISH BIOL FISHER, V15, P339, DOI 10.1007/s11160-006-6394-x; Pyke GH, 2008, ANNU REV ECOL EVOL S, V39, P171, DOI 10.1146/annurev.ecolsys.39.110707.173451; Raven P.H., 1992, BIOLOGY; Rehage JS, 2005, BEHAV ECOL SOCIOBIOL, V57, P256, DOI 10.1007/s00265-004-0850-1; Robinson-Wolrath SI, 2006, ENVIRON BIOL FISH, V75, P409, DOI 10.1007/s10641-006-0024-2; Rosenthal GG, 2005, ANIM BEHAV, V70, P1063, DOI 10.1016/j.anbehav.2005.02.005; Rosenthal GG, 2002, ANIM BEHAV, V63, P37, DOI 10.1006/anbe.2001.1887; Rosenthal GG, 1999, ENVIRON BIOL FISH, V56, P307, DOI 10.1023/A:1007597604793; Rosenthal Gil G., 2000, Acta Ethologica, V3, P49, DOI 10.1007/s102110000024; Saverino C, 2008, BEHAV BRAIN RES, V191, P77, DOI 10.1016/j.bbr.2008.03.013; Simberloff D, 2011, NATURE, V475, P36, DOI 10.1038/475036a; Smith CC, 2006, ANIM BEHAV, V71, P401, DOI 10.1016/j.anbehav.2005.06.003; Smith CC, 2007, BEHAV ECOL SOCIOBIOL, V61, P1349, DOI 10.1007/s00265-007-0365-7; Stein B., 2000, PRECIOUS HERITAGE ST; Turnell ER, 2003, BIOL BULL-US, V205, P225, DOI 10.2307/1543265; Ward AJW, 2011, P NATL ACAD SCI USA, V108, P2312, DOI 10.1073/pnas.1007102108; Ward AJW, 2010, BEHAV ECOL, V21, P1315, DOI 10.1093/beheco/arq152; Wittenberg R, 2011, INVASIVE ALIEN SPECI; Woo KL, 2011, BEHAV ECOL SOCIOBIOL, V65, P1671, DOI 10.1007/s00265-011-1226-y; Wright D, 2006, NAT PROTOC, V1, P1828, DOI 10.1038/nprot.2006.287	70	21	21	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54315	10.1371/journal.pone.0054315	http://dx.doi.org/10.1371/journal.pone.0054315			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342131	gold, Green Published, Green Submitted			2022-12-25	WOS:000313682700107
J	Bomash, I; Roudi, Y; Nirenberg, S				Bomash, Illya; Roudi, Yasser; Nirenberg, Sheila			A Virtual Retina for Studying Population Coding	PLOS ONE			English	Article							ACCESSORY OPTIC-SYSTEM; GANGLION-CELLS; RECEPTIVE-FIELDS; MAMMALIAN RETINA; PRIMATE RETINA; VISION; MECHANISM; PATHWAYS; SIGNALS; BRAIN	At every level of the visual system - from retina to cortex - information is encoded in the activity of large populations of cells. The populations are not uniform, but contain many different types of cells, each with its own sensitivities to visual stimuli. Understanding the roles of the cell types and how they work together to form collective representations has been a long-standing goal. This goal, though, has been difficult to advance, and, to a large extent, the reason is data limitation. Large numbers of stimulus/response relationships need to be explored, and obtaining enough data to examine even a fraction of them requires a great deal of experiments and animals. Here we describe a tool for addressing this, specifically, at the level of the retina. The tool is a data-driven model of retinal input/output relationships that is effective on a broad range of stimuli - essentially, a virtual retina. The results show that it is highly reliable: (1) the model cells carry the same amount of information as their real cell counterparts, (2) the quality of the information is the same - that is, the posterior stimulus distributions produced by the model cells closely match those of their real cell counterparts, and (3) the model cells are able to make very reliable predictions about the functions of the different retinal output cell types, as measured using Bayesian decoding (electrophysiology) and optomotor performance (behavior). In sum, we present a new tool for studying population coding and test it experimentally. It provides a way to rapidly probe the actions of different cell classes and develop testable predictions. The overall aim is to build constrained theories about population coding and keep the number of experiments and animals to a minimum.	[Bomash, Illya; Roudi, Yasser; Nirenberg, Sheila] Cornell Univ, Dept Physiol & Biophys, Weill Med Coll, New York, NY 10021 USA	Cornell University	Nirenberg, S (corresponding author), Cornell Univ, Dept Physiol & Biophys, Weill Med Coll, New York, NY 10021 USA.	shn2010@med.cornell.edu		Roudi, Yasser/0000-0002-6989-3420	NIH [R01 EY12978]; Tri-Institutional Training Program in Computational Biology and Medicine, NIH [T32GM083937]; NATIONAL EYE INSTITUTE [R01EY012978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM083937] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tri-Institutional Training Program in Computational Biology and Medicine, NIH; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH R01 EY12978, the Tri-Institutional Training Program in Computational Biology and Medicine, NIH T32GM083937. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar E, 2008, BIOL CYBERN, V98, P449, DOI 10.1007/s00422-008-0214-4; Balasubramanian V, 2009, J PHYSIOL-LONDON, V587, P2753, DOI 10.1113/jphysiol.2009.170704; BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P69, DOI 10.1113/jphysiol.1953.sp004829; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Carcieri SM, 2003, J NEUROPHYSIOL, V90, P1704, DOI 10.1152/jn.00127.2003; Chichilnisky EJ, 2002, J NEUROSCI, V22, P2737, DOI 10.1523/JNEUROSCI.22-07-02737.2002; CLELAND BG, 1971, J PHYSIOL-LONDON, V217, P473, DOI 10.1113/jphysiol.1971.sp009581; DANN JF, 1987, J COMP NEUROL, V262, P141, DOI 10.1002/cne.902620111; Dedek K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001714; Demb JB, 2001, J NEUROSCI, V21, P7447, DOI 10.1523/JNEUROSCI.21-19-07447.2001; DeVries SH, 1997, J NEUROPHYSIOL, V78, P2048, DOI 10.1152/jn.1997.78.4.2048; Di Lorenzo PM, 2000, PHYSIOL BEHAV, V69, P87, DOI 10.1016/S0031-9384(00)00191-8; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; Field GD, 2007, ANNU REV NEUROSCI, V30, P1, DOI 10.1146/annurev.neuro.30.051606.094252; FOLEY JM, 1981, VISION RES, V21, P1041, DOI 10.1016/0042-6989(81)90009-2; Giolli RA, 2006, PROG BRAIN RES, V151, P407, DOI 10.1016/S0079-6123(05)51013-6; Grinstead C. M., 1997, INTRO PROBABILITY; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P237, DOI 10.1113/jphysiol.1976.sp011594; Jacobs AL, 2009, P NATL ACAD SCI USA, V106, P5936, DOI 10.1073/pnas.0900573106; Jeffreys H., 1961, THEORY PROBABILITY, V3rd ed.; Konishi M, 2003, ANNU REV NEUROSCI, V26, P31, DOI 10.1146/annurev.neuro.26.041002.131123; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Marsat G, 2010, J NEUROPHYSIOL, V104, P2543, DOI 10.1152/jn.00256.2010; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Nirenberg S., 2011, International Patent, Patent No. [W02011106783, 2011106783]; Nirenberg S, 2012, P NATL ACAD SCI USA, V109, P15012, DOI 10.1073/pnas.1207035109; Oizumi M, 2010, J NEUROSCI, V30, P4815, DOI 10.1523/JNEUROSCI.4360-09.2010; Pandarinath C, 2010, J NEUROSCI, V30, P10006, DOI 10.1523/JNEUROSCI.5616-09.2010; Pandarinath C, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00002; Paninski L, 2007, PROG BRAIN RES, V165, P493, DOI 10.1016/S0079-6123(06)65031-0; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; RODIECK RW, 1983, BRAIN BEHAV EVOLUT, V23, P121, DOI 10.1159/000121492; Sagdullaev BT, 2005, VISUAL NEUROSCI, V22, P649, DOI 10.1017/S0952523805225142; Simoncelli EP, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P327; Sinclair JR, 2004, J NEUROSCI, V24, P1459, DOI 10.1523/JNEUROSCI.3959-03.2004; Smith DV, 2000, PHYSIOL BEHAV, V69, P77, DOI 10.1016/S0031-9384(00)00190-6; Thomas MC, 2006, ELEMENTS INFORM THEO; TREVES A, 1995, NEURAL COMPUT, V7, P399, DOI 10.1162/neco.1995.7.2.399; Umino Y, 2008, J NEUROSCI, V28, P189, DOI 10.1523/JNEUROSCI.3551-07.2008; VICTOR JD, 1979, J GEN PHYSIOL, V74, P671, DOI 10.1085/jgp.74.6.671; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497	42	8	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53363	10.1371/journal.pone.0053363	http://dx.doi.org/10.1371/journal.pone.0053363			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341940	Green Submitted, gold, Green Published			2022-12-25	WOS:000314759400042
J	Busch, C; Krochmann, J; Drews, U				Busch, Christian; Krochmann, Jelena; Drews, Ulrich			The Chick Embryo as an Experimental System for Melanoma Cell Invasion	PLOS ONE			English	Article							NEURAL CREST; IN-VIVO; MIGRATION; GROWTH; MODEL; METASTASIS; PROGRESSION; PATHWAYS; NOGGIN; CUP	Background: A primary cutaneous melanoma will not kill the patient, but its metastases. Since in vitro studies on melanoma cells in 2-D cultures do often not reflect reality, 3-D models might come closer to the physiological situation in the patient during cancer initiation and progression. Methodology/Principal Findings: Here, we describe the chick embryo model for in vivo studies of melanoma cell migration and invasion. After transplantation of neural crest-derived melanoma cells into the neural tube, the melanoma cells resume neural crest cell migration along the medial and lateral pathways and finally undergo apoptosis in the target areas. Upon transplantation into ectopic areas such as the hindbrain or the optic cup malignant invasion and local tissue destruction occurs. In contrast, melanocytes are not able to spontaneously resume neural crest cell migration. However, malignant invasion can be induced in melanocytes by pre-treatment with the TGF-beta family members bone morphegenetic protein-2 or nodal. Transplantation of MCF7 breast cancer cells yields a different growth pattern in the rhombencephalon than melanoma cells. Conclusions/Significance: The chick embryo model is a feasible, cost-effective in vivo system to study invasion by cancer cells in an embryonic environment. It may be useful to study invasive behavior induced by embryonic oncogenes and for targeted manipulation of melanoma or breast cancer cells aiming at ablation of invasive properties.	[Busch, Christian; Krochmann, Jelena; Drews, Ulrich] Univ Tubingen, Dept Dermatol, Sect Dermatooncol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Busch, C (corresponding author), Univ Tubingen, Dept Dermatol, Sect Dermatooncol, Tubingen, Germany.	Christian.Busch@med.uni-tuebingen.de			Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich (SFB) 773]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This project was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) Sonderforschungsbereich (SFB) 773 "Understanding and overcoming drug resistance of solid tumors" to CB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartl K, 1998, ANN ANAT, V180, P43; Busch C, 2008, INT J CANCER, V122, P526, DOI 10.1002/ijc.23139; Busch C, 2007, INT J ONCOL, V31, P1367; CHAMBERS AF, 1982, CANCER RES, V42, P4018; DREWS U, 1988, ANAT EMBRYOL, V178, P529, DOI 10.1007/BF00305040; Eigentler TK, 2011, CANCER-AM CANCER SOC, V117, P1697, DOI 10.1002/cncr.25631; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Garbe C, 2010, EUR J CANCER, V46, P270, DOI 10.1016/j.ejca.2009.10.032; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Just L, 2003, J NEUROSCI METH, V126, P69, DOI 10.1016/S0165-0270(03)00065-7; Krochmann J, 2012, PIGM CELL MELANOMA R, V25, P113, DOI 10.1111/j.1755-148X.2011.00914.x; Landsberg J, 2010, PIGM CELL MELANOMA R, V23, P649, DOI 10.1111/j.1755-148X.2010.00744.x; Le Douarin NM, 1999, NEURAL CREAST, P469; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; LUYTEN GPM, 1993, BIOCHEM BIOPH RES CO, V192, P22, DOI 10.1006/bbrc.1993.1376; NEWGREEN DF, 1995, DEV BIOL, V170, P91, DOI 10.1006/dbio.1995.1198; NISHIKAWA K, 1987, JPN J CLIN ONCOL, V17, P319; Oppitz M, 2007, MELANOMA RES, V17, P17, DOI 10.1097/CMR.0b013e3280114f49; Rothhammer T, 2005, CANCER RES, V65, P448; Rottner K, 1999, NAT CELL BIOL, V1, P321, DOI 10.1038/13040; Satyamoorthy K, 1997, MELANOMA RES, V7, pS35; Schriek G, 2005, MELANOMA RES, V15, P225, DOI 10.1097/00008390-200508000-00001; Sinnberg T, 2010, CANCER RES, V70, P6999, DOI 10.1158/0008-5472.CAN-10-0645; Topczewska JM, 2006, NAT MED, V12, P925, DOI 10.1038/nm1448	26	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53970	10.1371/journal.pone.0053970	http://dx.doi.org/10.1371/journal.pone.0053970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342051	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400107
J	Denisov, BP; Sakevich, VI; Jasilioniene, A				Denisov, Boris P.; Sakevich, Victoria I.; Jasilioniene, Aiva			Divergent Trends in Abortion and Birth Control Practices in Belarus, Russia and Ukraine	PLOS ONE			English	Article							CONTRACEPTIVE USE; WORLDWIDE; WOMEN; USSR	Context: The last decade witnessed growing differences in abortion dynamics in Belarus, Russia, and Ukraine despite demographic, social, and historical similarities of these nations. This paper investigates changes in birth control practices in the three countries and searches for an explanation of the diverging trends in abortion. Methods: Official abortion and contraceptive use statistics, provided by national statistical agencies, were analysed. Respective laws and other legal documents were examined and compared between the three countries. To disclose intercountry differences in prevalence of the modern methods of contraception and its association with major demographic and social factors, an analysis of data from national sample surveys was performed, including binary logistic regression. Results: The growing gap in abortion rate in Belarus, Russia, and Ukraine is a genuine phenomenon, not a statistical artefact. The examination of abortion and prevalence of contraception based on official statistics and three national sample surveys did not reveal any unambiguous factors that could explain differences in abortion dynamics in Belarus, Russia, and Ukraine. However, it is very likely that the cause of the inter-country discrepancies lies in contraceptive behavior itself, in adequacies of contraceptive knowledge and practices. Additionally, large differences in government policies, which are very important in shaping contraceptive practices of the population, were detected. Conclusion: Since the end of the 1990s, the Russian government switched to archaic ideology in the area of reproductive health and family planning and neglects evidence-based arguments. Such an extreme turn in the governmental position is not observed in Belarus or Ukraine. This is an important factor contributing to the slowdown in the decrease of abortion rates in Russia.	[Denisov, Boris P.] Moscow MV Lomonosov State Univ, Lab Populat Econ & Demog, Moscow, Russia; [Sakevich, Victoria I.] Natl Res Univ, Higher Sch Econ, Inst Demog, Moscow, Russia; [Jasilioniene, Aiva] Max Planck Inst Demog Res, Lab Demog Data, Rostock, Germany	Lomonosov Moscow State University; HSE University (National Research University Higher School of Economics); Max Planck Society	Denisov, BP (corresponding author), Moscow MV Lomonosov State Univ, Lab Populat Econ & Demog, Moscow, Russia.	denisov@demography.ru	Sakevich, Victoria/H-2315-2015	Sakevich, Victoria/0000-0002-4569-1760	National Research University Higher School of Economics [10-01-0076 2010/2011]	National Research University Higher School of Economics	This research was supported by the National Research University Higher School of Economics (grant No. 10-01-0076 2010/2011, awarded to Victoria Sakevich). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agadjanian V, 2002, STUD FAMILY PLANN, V33, P237, DOI 10.1111/j.1728-4465.2002.00237.x; [Anonymous], EUROPEAN HEALTH FOR; [Anonymous], YEARBOOKS; Avdeev A., 1995, POPULATION ENGLISH S, V7, P39, DOI 10.2307/2949057; Bongaarts J, 2000, STUD FAMILY PLANN, V31, P193, DOI 10.1111/j.1728-4465.2000.00193.x; Centers for Disease Control and Prevention and ORC Macro, 2003, REPRODUCTIVE MATERNA; David HP, 1999, FROM ABORTION TO CON; Denisov BP, 2009, EVIDENCE BASED MEDIC, V1, P34; Denisov BP, 2011, DEMSOSCOPE WEEKLY, P465; Frost JJ, 2007, PERSPECT SEX REPRO H, V39, P48, DOI 10.1363/3904807; Goldberg HI, 2001, 24 GEN C INT UN SCI; Goldstein JR, 2009, POPUL DEV REV, V35, P663, DOI 10.1111/j.1728-4457.2009.00304.x; HENSHAW SK, 1986, FAM PLANN PERSPECT, V18, P250, DOI 10.2307/2134947; Kiev International Institute of Sociology (KIIS) Centers for Disease Control and Prevention (CDC) and United States Agency for International Development (USAID), 2001, 1999 UKRAINE REPRODU; Levchuk Nataliia, 2009, MPIDR WORKING PAPER; Ministry of Health of Ukraine WHO, 2008, REPORT AND RECOMMEND; Mogilevkina, 1996, ACTA OBSTETRICIA ET, V75, P908; Mogilevkina I, 2003, EUR J CONTRACEP REPR, V8, P185, DOI 10.1080/713604469; Perlman F, 2009, PERSPECT SEX REPRO H, V41, P40, DOI [10.1363/4104009, 10.1111/j.1931-2393.2009.4114009.x]; Philipov D, 2004, EUR J POPUL, V20, P95, DOI 10.1023/B:EUJP.0000034499.24658.7a; Pirozhkov Sergii, 2010, DEMOSCOPE WEEKLY, P405; POPOV AA, 1991, STUD FAMILY PLANN, V22, P368, DOI 10.2307/1966450; Population of Russia, 2009, ANNUAL DEMOGRAPHIC R, P136; Regushevskaya E, 2009, PERSPECT SEX REPRO H, V41, P51, DOI [10.1111/j.1931-2393.2009.04115109.x, 10.1363/4105109]; REMENNICK LI, 1991, SOC SCI MED, V33, P841, DOI 10.1016/0277-9536(91)90389-T; Sedgh G, 2011, INT PERSPECT SEX R H, V37, P84, DOI 10.1363/3708411; Shakhotko LP, 2009, THE MODEL OF DEMOGRA; Shakhotko LP, COMMUNICATION; Trussell J, 2004, CONTRACEPTIVE TECHNO; Ukrainian Center for Social Reforms (UCSR) State Statistical Committee (SSC) [Ukraine] Ministry of Health (MoH) [Ukraine] and Macro International Inc., 2008, UKRAINE DEMOGRAPHIC; UNFPA, 2004, NATIONAL POPULATION; UNFPA Ukrainian center of social reforms Institute of demography and social studies of the National Academy of Science of Ukraine State statistical committee of Ukraine, 2009, UKRAINE ON THE PATH; United Nations, 2009, WORLD CONTRACEPTIVE; Vishnevsky A.G., 2006, DEMOGRAPHIC MODERNIZ; Zakharov SV, 2011, DEMOSCOPE WEEKLY, P453; Zhilka H, 2001, REPRODUCTIVE HEALTH	36	16	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e49986	10.1371/journal.pone.0049986	http://dx.doi.org/10.1371/journal.pone.0049986			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	054WM	23349656	gold, Green Published, Green Submitted			2022-12-25	WOS:000312376100042
J	Shimamoto, S; Kubota, Y; Yamaguchi, F; Tokumitsu, H; Kobayashi, R				Shimamoto, Seiko; Kubota, Yasuo; Yamaguchi, Fuminori; Tokumitsu, Hiroshi; Kobayashi, Ryoji			Ca2+/S100 Proteins Act as Upstream Regulators of the Chaperone-associated Ubiquitin Ligase CHIP (C Terminus of Hsc70-interacting Protein)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; U-BOX PROTEINS; TETRATRICOPEPTIDE REPEAT; PROTEASOMAL DEGRADATION; CARBOXYL-TERMINUS; S100 PROTEINS; MEDIATED DEGRADATION; MOLECULAR CHAPERONES; SIGNAL-TRANSDUCTION; ESCHERICHIA-COLI	The U-box E3 ubiquitin ligase CHIP (C terminus of Hsc70-interacting protein) binds Hsp90 and/or Hsp70 via its tetratricopeptide repeat (TPR), facilitating ubiquitination of the chaperone-bound client proteins. Mechanisms that regulate the activity of CHIP are, at present, poorly understood. We previously reported that Ca2+/S100 proteins directly associate with the TPR proteins, such as Hsp70/Hsp90-organizing protein (Hop), kinesin light chain, Tom70, FKBP52, CyP40, and protein phosphatase 5 (PP5), leading to the dissociation of the interactions of the TPR proteins with their target proteins. Therefore, we have hypothesized that Ca2+/S100 proteins can interact with CHIP and regulate its function. GST pulldown assays indicated that Ca2+/S100A2 and S100P bind to the TPR domain and lead to interference with the interactions of CHIP with Hsp70, Hsp90, HSF1, and Smad1. In vitro ubiquitination assays indicated that Ca2+/S100A2 and S100P are efficient and specific inhibitors of CHIP-mediated ubiquitination of Hsp70, Hsp90, HSF1, and Smad1. Overexpression of S100A2 and S100P suppressed CHIP-chaperone complex-dependent mutant p53 ubiquitination and degradation in Hep3B cells. The association of the S100 proteins with CHIP provides a Ca2+-dependent regulatory mechanism for the ubiquitination and degradation of intracellular proteins by the CHIP-proteasome pathway.	[Shimamoto, Seiko; Tokumitsu, Hiroshi; Kobayashi, Ryoji] Kagawa Univ, Fac Med, Dept Signal Transduct Sci, Miki, Kagawa 7610793, Japan; [Kubota, Yasuo] Kagawa Univ, Fac Med, Dept Dermatol, Miki, Kagawa 7610793, Japan; [Yamaguchi, Fuminori] Kagawa Univ, Fac Med, Dept Cell Physiol, Miki, Kagawa 7610793, Japan; [Shimamoto, Seiko] Kagawa Univ, Nanomicro Struct Device Integrated Res Ctr, Takamatsu, Kagawa 7610396, Japan	Kagawa University; Kagawa University; Kagawa University; Kagawa University	Kobayashi, R (corresponding author), Kagawa Univ, Fac Med, Dept Signal Transduct Sci, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	ryoji@med.kagawa-u.ac.jp	Tokumitsu, Hiroshi/M-3978-2015	Tokumitsu, Hiroshi/0000-0002-2193-6794	Kagawa University Characteristic Prior Research Fund	Kagawa University Characteristic Prior Research Fund	This research was supported by the Kagawa University Characteristic Prior Research Fund 2011.	Alberti S, 2002, J BIOL CHEM, V277, P45920, DOI 10.1074/jbc.M204196200; Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Allan RK, 2011, CELL STRESS CHAPERON, V16, P353, DOI 10.1007/s12192-010-0248-0; Arndt V, 2005, MOL BIOL CELL, V16, P5891, DOI 10.1091/mbc.E05-07-0660; Arumugam T, 2011, AMINO ACIDS, V41, P893, DOI 10.1007/s00726-010-0496-4; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bennett MK, 1997, CURR OPIN NEUROBIOL, V7, P316, DOI 10.1016/S0959-4388(97)80058-X; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Dai Q, 2005, J BIOL CHEM, V280, P38673, DOI 10.1074/jbc.M507986200; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Fan MY, 2005, MOL ENDOCRINOL, V19, P2901, DOI 10.1210/me.2005-0111; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Hatakeyama S, 2003, BIOCHEM BIOPH RES CO, V302, P635, DOI 10.1016/S0006-291X(03)00245-6; Hayashi N, 1998, PROTEIN EXPRES PURIF, V12, P25, DOI 10.1006/prep.1997.0807; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Jana NR, 2005, J BIOL CHEM, V280, P11635, DOI 10.1074/jbc.M412042200; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kajiro M, 2009, NAT CELL BIOL, V11, P312, DOI 10.1038/ncb1839; Kamynina E, 2007, MOL CELL BIOL, V27, P1809, DOI 10.1128/MCB.01051-06; Kim SA, 2005, FEBS LETT, V579, P6559, DOI 10.1016/j.febslet.2005.10.043; Lesniak W, 2009, BIOCHEM BIOPH RES CO, V390, P1087, DOI 10.1016/j.bbrc.2009.10.150; Li RF, 2005, COLLOID SURFACE B, V40, P133, DOI 10.1016/j.colsurfb.2004.10.013; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Morano KA, 1999, GENE EXPRESSION, V7, P271; Morishima Y, 2005, BIOCHEMISTRY-US, V44, P16333, DOI 10.1021/bi0515570; Muller P, 2008, ONCOGENE, V27, P3371, DOI 10.1038/sj.onc.1211010; Murata S, 2005, METHOD ENZYMOL, V398, P271, DOI 10.1016/S0076-6879(05)98022-1; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Okada M, 2004, J BIOL CHEM, V279, P4221, DOI 10.1074/jbc.M309014200; Pabarcus MK, 2009, ARCH BIOCHEM BIOPHYS, V483, P66, DOI 10.1016/j.abb.2008.12.001; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; RADANYI C, 1994, P NATL ACAD SCI USA, V91, P11197, DOI 10.1073/pnas.91.23.11197; Ratajczak T, 1996, J BIOL CHEM, V271, P2961, DOI 10.1074/jbc.271.6.2961; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Schaub MC, 2008, BIOCHEM BIOPH RES CO, V369, P247, DOI 10.1016/j.bbrc.2007.10.082; Shimamoto S, 2008, J BIOL CHEM, V283, P28246, DOI 10.1074/jbc.M801473200; Shimamoto S, 2010, FEBS LETT, V584, P1119, DOI 10.1016/j.febslet.2010.02.055; Smith DF, 2004, CELL STRESS CHAPERON, V9, P109, DOI 10.1379/CSC-31.1; SMITH DF, 1993, MOL CELL BIOL, V13, P869, DOI 10.1128/MCB.13.2.869; Tateishi Y, 2006, MOL CELL BIOL, V26, P7966, DOI 10.1128/MCB.00713-06; Tetzlaff JE, 2008, J BIOL CHEM, V283, P17962, DOI 10.1074/jbc.M802283200; Urushitani M, 2004, J NEUROCHEM, V90, P231, DOI 10.1111/j.1471-4159.2004.02486.x; Wang L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201814; Wolf S, 2011, AMINO ACIDS, V41, P849, DOI 10.1007/s00726-010-0623-2; Xin H, 2005, J BIOL CHEM, V280, P20842, DOI 10.1074/jbc.M412275200; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Xu Z, 2006, BIOCHEMISTRY-US, V45, P4749, DOI 10.1021/bi0601508; Xu Z, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-26; Yamaguchi F, 2012, J BIOL CHEM, V287, P13787, DOI 10.1074/jbc.M111.329771; Yamashita K, 1999, PROTEIN EXPRES PURIF, V16, P47, DOI 10.1006/prep.1998.1026; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023	62	30	32	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7158	7168		10.1074/jbc.M112.436758	http://dx.doi.org/10.1074/jbc.M112.436758			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23344957	Green Published, hybrid			2022-12-25	WOS:000316002400037
J	Aizawa, S; Senda, M; Harada, A; Maruyama, N; Ishida, T; Aigaki, T; Ishigami, A; Senda, T				Aizawa, Shingo; Senda, Miki; Harada, Ayaka; Maruyama, Naoki; Ishida, Tetsuo; Aigaki, Toshiro; Ishigami, Akihito; Senda, Toshiya			Structural Basis of the gamma-Lactone-Ring Formation in Ascorbic Acid Biosynthesis by the Senescence Marker Protein-30/Gluconolactonase	PLOS ONE			English	Article							PROTEIN-30 SMP30; DIISOPROPYL PHOSPHOROFLUORIDATE; MOUSE-LIVER; RAT-LIVER; BINDING; PURIFICATION; FLUOROPHOSPHATASE; REGUCALCIN; MECHANISM; EVOLUTION	The senescence marker protein-30 (SMP30), which is also called regucalcin, exhibits gluconolactonase (GNL) activity. Biochemical and biological analyses revealed that SMP30/GNL catalyzes formation of the gamma-lactone-ring of L-gulonate in the ascorbic acid biosynthesis pathway. The molecular basis of the gamma-lactone formation, however, remains elusive due to the lack of structural information on SMP30/GNL in complex with its substrate. Here, we report the crystal structures of mouse SMP30/GNL and its complex with xylitol, a substrate analogue, and those with 1,5-anhydro-D-glucitol and D-glucose, product analogues. Comparison of the crystal structure of mouse SMP30/GNL with other related enzymes has revealed unique characteristics of mouse SMP30/GNL. First, the substrate-binding pocket of mouse SMP30/GNL is designed to specifically recognize monosaccharide molecules. The divalent metal ion in the active site and polar residues lining the substrate-binding cavity interact with hydroxyl groups of substrate/product analogues. Second, in mouse SMP30/GNL, a lid loop covering the substrate-binding cavity seems to hamper the binding of L-gulonate in an extended (or all-trans) conformation; L-gulonate seems to bind to the active site in a folded conformation. In contrast, the substrate-binding cavities of the other related enzymes are open to the solvent and do not have a cover. This structural feature of mouse SMP30/GNL seems to facilitate the gamma-lactone-ring formation.	[Aizawa, Shingo; Aigaki, Toshiro] Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Hachioji, Tokyo, Japan; [Aizawa, Shingo; Maruyama, Naoki; Ishigami, Akihito] Tokyo Metropolitan Inst Gerontol, Itabashi Ku, Tokyo, Japan; [Aizawa, Shingo; Harada, Ayaka; Senda, Toshiya] Natl Inst Adv Ind Sci & Technol, BIRC, Koto Ku, Tokyo, Japan; [Senda, Miki] JBIC, Dept Res & Dev, Koto Ku, Tokyo, Japan; [Harada, Ayaka] Tokyo Denki Univ, Adachi Ku, Tokyo 101, Japan; [Ishida, Tetsuo] Shiga Univ Med Sci, Dept Biochem & Mol Biol, Otsu, Shiga, Japan	Tokyo Metropolitan University; Tokyo Metropolitan Institute of Gerontology; National Institute of Advanced Industrial Science & Technology (AIST); Tokyo Denki University; Shiga University of Medical Science	Senda, T (corresponding author), Natl Inst Adv Ind Sci & Technol, BIRC, Koto Ku, Tokyo, Japan.	toshiya-senda@aist.go.jp		Harada, Ayaka/0000-0001-7976-8984; Senda, Toshiya/0000-0002-5153-928X; Ishigami, Akihito/0000-0001-7875-7482	Japan Society for the Promotion of Science [24380073, 23590441]; Ministry of Education, Science, and Culture, Japan [22121005]; New Energy and Industrial Technology Development Organization (NEDO) [P08005]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by Grant-in-Aid for Scientific Research (B) (24380073 AI), Grant-in-Aid for Scientific Research (C) (23590441 NM) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-grants/index.html), and Grant-in-Aid for Scientific Research on Innovative Areas (22121005 TS) from the Ministry of Education, Science, and Culture, Japan (http://www.mext.go.jp/english/). This work was also supported by the New Energy and Industrial Technology Development Organization (NEDO) (http://www.nedo.go.jp/english/index.html) (P08005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Belinskaya T, 2012, BBA-PROTEINS PROTEOM, V1824, P701, DOI 10.1016/j.bbapap.2012.02.007; Billecke SS, 1999, CHEM-BIOL INTERACT, V119, P251, DOI 10.1016/S0009-2797(99)00034-4; Blum MM, 2006, J AM CHEM SOC, V128, P12750, DOI 10.1021/ja061887n; Blum MM, 2010, ACTA CRYSTALLOGR F, V66, P379, DOI 10.1107/S1744309110004318; Chakraborti S, 2010, BIOCHEMISTRY-US, V49, P3436, DOI 10.1021/bi9022297; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7; Fujita T, 1996, BBA-GENE STRUCT EXPR, V1308, P49, DOI 10.1016/0167-4781(96)00064-4; FUJITA T, 1995, BBA-GENE STRUCT EXPR, V1263, P249, DOI 10.1016/0167-4781(95)00120-6; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; HUCHO F, 1972, BIOCHIM BIOPHYS ACTA, V276, P176, DOI 10.1016/0005-2744(72)90018-6; Inai Y, 2003, J NUTR SCI VITAMINOL, V49, P315, DOI 10.3177/jnsv.49.315; Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5; Ishigarni A, 2007, GERIATR GERONTOL INT, V7, P316, DOI 10.1111/j.1447-0594.2007.00420.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103; Kondo Y, 2004, FEBS LETT, V570, P57, DOI 10.1016/j.febslet.2004.06.028; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laurentino SS, 2012, MOL HUM REPROD, V18, P161, DOI 10.1093/molehr/gar075; Maruyama N, 2010, GERIATR GERONTOL INT, V10, pS88, DOI 10.1111/j.1447-0594.2010.00586.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Tanaka Y, 2007, J BIOL CHEM, V282, P5770, DOI 10.1074/jbc.M607340200; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; YAMAGUCHI M, 1978, CHEM PHARM BULL, V26, P1915; Yamaguchi M, 2011, MOL CELL BIOCHEM, V353, P101, DOI 10.1007/s11010-011-0779-4; Yu L, 2001, J BIOCHEM, V129, P411, DOI 10.1093/oxfordjournals.jbchem.a002872	32	13	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53706	10.1371/journal.pone.0053706	http://dx.doi.org/10.1371/journal.pone.0053706			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349732	Green Submitted, gold, Green Published			2022-12-25	WOS:000314019100027
J	Rivera, C; Simonson, SJS; Yamben, IF; Shatadal, S; Nguyen, MM; Beurg, M; Lambert, PF; Griep, AE				Rivera, Charlene; Simonson, Sara J. S.; Yamben, Idella F.; Shatadal, Shalini; Nguyen, Minh M.; Beurg, Maryline; Lambert, Paul F.; Griep, Anne E.			Requirement for Dlgh-1 in Planar Cell Polarity and Skeletogenesis during Vertebrate Development	PLOS ONE			English	Article							LARGE TUMOR-SUPPRESSOR; NEURAL-TUBE DEFECTS; DISCS-LARGE; HUMAN HOMOLOG; CAENORHABDITIS-ELEGANS; LOOP-TAIL; CRANIOFACIAL DEVELOPMENT; COOPERATIVE REGULATION; CONVERGENT EXTENSION; CONTAINING PROTEINS	The development of specialized organs is tightly linked to the regulation of cell growth, orientation, migration and adhesion during embryogenesis. In addition, the directed movements of cells and their orientation within the plane of a tissue, termed planar cell polarity (PCP), appear to be crucial for the proper formation of the body plan. In Drosophila embryogenesis, Discs large (dlg) plays a critical role in apical-basal cell polarity, cell adhesion and cell proliferation. Craniofacial defects in mice carrying an insertional mutation in Dlgh-1 suggest that Dlgh-1 is required for vertebrate development. To determine what roles Dlgh-1 plays in vertebrate development, we generated mice carrying a null mutation in Dlgh-1. We found that deletion of Dlgh-1 caused open eyelids, open neural tube, and misorientation of cochlear hair cell stereociliary bundles, indicative of defects in planar cell polarity (PCP). Deletion of Dlgh-1 also caused skeletal defects throughout the embryo. These findings identify novel roles for Dlgh-1 in vertebrates that differ from its well-characterized roles in invertebrates and suggest that the Dlgh-1 null mouse may be a useful animal model to study certain human congenital birth defects.	[Rivera, Charlene; Yamben, Idella F.; Shatadal, Shalini; Nguyen, Minh M.; Griep, Anne E.] Univ Wisconsin, Dept Cell & Regenerat Biol, Madison, WI 53706 USA; [Simonson, Sara J. S.; Lambert, Paul F.] Univ Wisconsin, Dept Oncol, Madison, WI USA; [Beurg, Maryline] Hop Pellegrin, INSERM, F-33076 Bordeaux, France	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm)	Griep, AE (corresponding author), Univ Wisconsin, Dept Cell & Regenerat Biol, Madison, WI 53706 USA.	aegriep@wisc.edu	Griep, Anne/ABA-9636-2020	Beurg, Maryline/0000-0003-3069-267X	NIH [EY09091, CA908428]; University of Wisconsin Carbone Cancer Center [P30 CA14520]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY009091] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin Carbone Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grants EY09091 (AEG), CA908428 (PFL/AEG). The University of Wisconsin Carbone Cancer Center (P30 CA14520) provided shared service support for the project. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barrow JR, 2011, ORGANOGENESIS, V7, P260, DOI 10.4161/org.7.4.19049; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Bekman E, 2002, MECH DEVELOP, V119, pS77, DOI 10.1016/S0925-4773(03)00095-9; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Bilder D, 2001, TRENDS GENET, V17, P511, DOI 10.1016/S0168-9525(01)02407-6; Bossinger O, 2001, DEV BIOL, V230, P29, DOI 10.1006/dbio.2000.0113; Brault V, 2001, DEVELOPMENT, V128, P1253; Caruana G, 2002, INT J DEV BIOL, V46, P511; Caruana G, 2001, MOL CELL BIOL, V21, P1475, DOI 10.1128/MCB.21.5.1475-1483.2001; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Dabdoub A, 2003, DEVELOPMENT, V130, P2375, DOI 10.1242/dev.00448; Darken RS, 2002, EMBO J, V21, P976, DOI 10.1093/emboj/21.5.976; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; De Calisto J, 2005, DEVELOPMENT, V132, P2587, DOI 10.1242/dev.01857; Dow LE, 2003, ONCOGENE, V22, P9225, DOI 10.1038/sj.onc.1207154; Dudas M, 2004, MECH DEVELOP, V121, P173, DOI 10.1016/j.mod.2003.12.003; Feng W, 2004, NAT STRUCT MOL BIOL, V11, P475, DOI 10.1038/nsmb751; Firestein BL, 2001, MOL BIOL CELL, V12, P3465, DOI 10.1091/mbc.12.11.3465; Frese KK, 2006, EMBO J, V25, P1406, DOI 10.1038/sj.emboj.7601030; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Gros J, 2010, CURR BIOL, V20, P1993, DOI 10.1016/j.cub.2010.09.063; Hartmann C, 2006, TRENDS CELL BIOL, V16, P151, DOI 10.1016/j.tcb.2006.01.001; He FL, 2008, DEVELOPMENT, V135, P3871, DOI 10.1242/dev.025767; Hering H, 2002, FEBS LETT, V521, P185, DOI 10.1016/S0014-5793(02)02831-4; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hirata A, 2004, VIROLOGY, V318, P327, DOI 10.1016/j.virol.2003.10.006; Iizuka-Kogo A, 2007, DEVELOPMENT, V134, P1799, DOI 10.1242/dev.02830; Ishidate T, 2000, ONCOGENE, V19, P365, DOI 10.1038/sj.onc.1203309; Ito Y, 2003, DEVELOPMENT, V130, P5269, DOI 10.1242/dev.00708; Joeng KS, 2011, DEV BIOL, V359, P222, DOI 10.1016/j.ydbio.2011.08.020; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kiyono T, 1997, P NATL ACAD SCI USA, V94, P11612, DOI 10.1073/pnas.94.21.11612; Koppen M, 2001, NAT CELL BIOL, V3, P983, DOI 10.1038/ncb1101-983; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Laprise P, 2004, J BIOL CHEM, V279, P10157, DOI 10.1074/jbc.M309843200; Le SS, 1997, P NATL ACAD SCI USA, V94, P6670, DOI 10.1073/pnas.94.13.6670; Lee S, 2002, MOL CELL BIOL, V22, P1778, DOI 10.1128/MCB.22.6.1778-1791.2002; Lin LH, 1997, BBA-MOL BASIS DIS, V1362, P1, DOI 10.1016/S0925-4439(97)00059-8; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; Mahoney ZX, 2006, P NATL ACAD SCI USA, V103, P19872, DOI 10.1073/pnas.0609326103; McLaughlin M, 2002, J BIOL CHEM, V277, P6406, DOI 10.1074/jbc.M108724200; McMahon L, 2001, J CELL SCI, V114, P2265; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Montcouquiol M, 2006, J NEUROSCI, V26, P5265, DOI 10.1523/JNEUROSCI.4680-05.2006; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Murdoch JN, 2003, HUM MOL GENET, V12, P87, DOI 10.1093/hmg/ddg014; Murdoch JN, 2001, HUM MOL GENET, V10, P2593, DOI 10.1093/hmg/10.22.2593; Murdoch JN, 2001, GENOMICS, V78, P55, DOI 10.1006/geno.2001.6638; Naim E, 2005, KIDNEY INT, V68, P955, DOI 10.1111/j.1523-1755.2005.00489.x; Nguyen MM, 2005, MOL VIS, V11, P1183; Nguyen MM, 2003, MOL CELL BIOL, V23, P8970, DOI 10.1128/MCB.23.24.8970-8981.2003; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Rachel RA, 2000, GENESIS, V27, P32, DOI 10.1002/1526-968X(200005)27:1<32::AID-GENE50>3.0.CO;2-T; Rafael JA, 1998, NEUROREPORT, V9, P2121, DOI 10.1097/00001756-199806220-00039; Rivera C, 2009, DEV DYNAM, V238, P2292, DOI 10.1002/dvdy.22036; Romereim SM, 2011, ORGANOGENESIS, V7, P217, DOI 10.4161/org.7.3.18583; Sasaki T, 2006, DEVELOPMENT, V133, P371, DOI 10.1242/dev.02200; Segbert C, 2004, DEV BIOL, V266, P17, DOI 10.1016/j.ydbio.2003.10.019; Shai A, 2007, CANCER RES, V67, P1626, DOI 10.1158/0008-5472.CAN-06-3344; Simonson SJS, 2005, CANCER RES, V65, P8266, DOI 10.1158/0008-5472.CAN-05-1651; Suzuki T, 1999, ONCOGENE, V18, P5967, DOI 10.1038/sj.onc.1203008; Thomas U, 1997, MECH DEVELOP, V62, P161, DOI 10.1016/S0925-4773(97)00658-8; Topczewski J, 2011, ORGANOGENESIS, V7, P255, DOI 10.4161/org.7.4.18797; Torban E, 2007, GENE EXPR PATTERNS, V7, P346, DOI 10.1016/j.modgep.2006.07.007; Trokovic N, 2003, GENE DEV, V17, P141, DOI 10.1101/gad.250703; Valiente M, 2005, J BIOL CHEM, V280, P28936, DOI 10.1074/jbc.M504761200; Van Campenhout CA, 2011, DEV CELL, V21, P479, DOI 10.1016/j.devcel.2011.08.003; Wang B, 2011, HUM MOL GENET, V20, P271, DOI 10.1093/hmg/ddq462; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Wawrzak D, 2009, ADV ENZYME REGUL, V49, P98, DOI 10.1016/j.advenzreg.2009.01.002; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; Wyngaarden LA, 2010, DEVELOPMENT, V137, P2551, DOI 10.1242/dev.046987; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yamamoto Y, 2004, ONCOGENE, V23, P3889, DOI 10.1038/sj.onc.1207495; Yao R, 2004, ONCOGENE, V23, P6023, DOI 10.1038/sj.onc.1207817	82	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54410	10.1371/journal.pone.0054410	http://dx.doi.org/10.1371/journal.pone.0054410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349879	gold, Green Submitted, Green Published			2022-12-25	WOS:000314019100065
J	Srivastava, G; Mehrotra, RC				Srivastava, Gaurav; Mehrotra, Rakesh C.			First Fossil Record of Alphonsea Hk. f. & T. (Annonaceae) from the Late Oligocene Sediments of Assam, India and Comments on Its Phytogeography	PLOS ONE			English	Article							MAKUM COALFIELD; TERTIARY; DIVERSIFICATION; CRYPTERONIACEAE; DISPERSAL; PETROLOGY; ORIGIN; FLORA; LEAF	A new fossil leaf impression of Alphonsea Hk. f. & T. of the family Annonaceae is described from the Late Oligocene sediments of Makum Coalfield, Assam, India. This is the first authentic record of the fossil of Alphonsea from the Tertiary rocks of South Asia. The Late Oligocene was the time of the last significant globally warm climate and the fossil locality was at 10 degrees-15 degrees N palaeolatitude. The known palaeoflora and sedimentological studies indicate a fluvio-marine deltaic environment with a mosaic of mangrove, fluvial, mire and lacustrine depositional environments. During the depositional period the suturing between the Indian and Eurasian plates was not complete to facilitate the plant migration. The suturing was over by the end of the Late Oligocene/beginning of Early Miocene resulting in the migration of the genus to Southeast Asia where it is growing profusely at present. The present study is in congruence with the earlier published palaeofloral and molecular phylogenetic data. The study also suggests that the Indian plate was not only a biotic ferry during its northward voyage from Gondwana to Asia but also a place for the origin of several plant taxa.	[Srivastava, Gaurav; Mehrotra, Rakesh C.] Birbal Sahni Inst Paleobot, Lucknow 226007, Uttar Pradesh, India	Department of Science & Technology (India); Birbal Sahni Institute of Palaeobotany (BSIP)	Srivastava, G (corresponding author), Birbal Sahni Inst Paleobot, Lucknow 226007, Uttar Pradesh, India.	gaurav_jan10@yahoo.co.in	Srivastava, Gaurav/A-1384-2019	Srivastava, Gaurav/0000-0001-7498-4338				Ahmed M, 1996, INT J COAL GEOL, V30, P319, DOI 10.1016/0166-5162(95)00051-8; BANDE M B, 1973, Botanique (Nagpur), V4, P41; BANDE MB, 1986, REV PALAEOBOT PALYNO, V49, P203, DOI 10.1016/0034-6667(86)90028-X; Bonde S. D., 1993, J INDIAN BOT SOC, V72, P251; Bossuyt F, 2001, SCIENCE, V292, P93, DOI 10.1126/science.1058875; Burnham RJ, 2004, PHILOS T R SOC B, V359, P1595, DOI 10.1098/rstb.2004.1531; Carter HJ, 1852, J BOMBAY BRCH R ASIA, V5, P179; Chatterjee S, 1999, P INDIAN NATL SCI A, V65, P397; Chester K. I. M., 1955, ANN MAGAZINE NATURAL, V8, P498, DOI DOI 10.1080/00222935508655660; Conti E, 2002, EVOLUTION, V56, P1931; Couvreur TLP, 2011, J BIOGEOGR, V38, P664, DOI 10.1111/j.1365-2699.2010.02434.x; DEPORTA NS, 1971, STUD GEOL SALAMANCA, V2, P133; DILCHER DL, 1974, BOT REV, V40, P1, DOI 10.1007/BF02860067; DOYLE JA, 1994, ACTA BOT GALLICA, V141, P149, DOI 10.1080/12538078.1994.10515148; Gamble J., 1990, MANUAL INDIAN TIMBER, P143; GENTRY AH, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P500; GULERIA J.S., 1999, PALEOBOTANIST, V47, P68; Hably L., 2006, Studia Botanica Hungarica, V37, P41; HICKEY LJ, 1973, AM J BOT, V60, P17, DOI 10.2307/2441319; Kress JW, 2006, ALISO, V22, P619; Kumar M, 2012, PALAEOGEOGR PALAEOCL, V342, P143, DOI 10.1016/j.palaeo.2012.05.001; LAKHANPAL R N, 1983, Geophytology, V13, P46; Lakhanpal RN, 1976, CATALOGUE INDIAN FOS, P1; Mabberley D. J., 1997, PLANT BOOK PORTABLE; MEHROTRA R C, 1990, Phytomorphology, V40, P169; Mehrotra R. C., 1998, Phytomorphology, V48, P91; Mehrotra R.C., 2000, PALAEOBOTANIST, V49, P255; Mehrotra RC, 2003, GEOBIOS-LYON, V36, P83, DOI 10.1016/S0016-6995(02)00107-9; Mishra HK, 1996, INT J COAL GEOL, V30, P65, DOI 10.1016/0166-5162(95)00038-0; Misra BK, 1992, PALEOBOTANIST, V39, P309; Molnar P, 2009, TECTONICS, V28; Morley RJ, 2003, AM J BOT, V90, P1638, DOI 10.3732/ajb.90.11.1638; Punyasena SW, 2008, J BIOGEOGR, V35, P117, DOI 10.1111/j.1365-2699.2007.01773.x; QIU YL, 1993, ANN MO BOT GARD, V80, P587, DOI 10.2307/2399848; Qiu YL, 1999, NATURE, V402, P404, DOI 10.1038/46536; Richardson JE, 2004, PHILOS T R SOC B, V359, P1495, DOI 10.1098/rstb.2004.1537; Rutschmann F, 2004, INT J PLANT SCI, V165, pS69, DOI 10.1086/383335; Srivastava G.A., 2010, MEMOIR GEOLOGICAL SO, V75, P123; Srivastava G, 2012, PALAEOGEOGR PALAEOCL, V342, P130, DOI 10.1016/j.palaeo.2012.05.002; Srivastava G, 2012, CURR SCI INDIA, V102, P398; Srivastava G, 2010, J GEOL SOC INDIA, V75, P820, DOI 10.1007/s12594-010-0069-x; Srivastava R, 1991, CATALOGUE FOSSIL PLA, P1; Srivastava R, 2005, CATALOGUE CENOZOIC T, P1; STEENIS C. G. G. J. VAN., 1962, Blumea, V11, P235; Su YCF, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-153; Takahashi M, 2008, INT J PLANT SCI, V169, P908, DOI 10.1086/589693; Tchouto MGP, 2006, BIODIVERS CONSERV, V15, P1353, DOI 10.1007/s10531-005-5394-9; Tomlinson PB, 1990, STRUCTURAL BIOL PLAN; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x	50	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53177	10.1371/journal.pone.0053177	http://dx.doi.org/10.1371/journal.pone.0053177			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349701	Green Published, gold, Green Submitted			2022-12-25	WOS:000314019100017
J	Wei, XL; Zou, GY; Yin, J; Walley, J; Zhou, BA; Yu, YX; Tian, LW; Chen, K				Wei, Xiaolin; Zou, Guanyang; Yin, Jia; Walley, John; Zhou, Biao; Yu, Yunxian; Tian, Linwei; Chen, Kun			Characteristics of High Risk People with Cardiovascular Disease in Chinese Rural Areas: Clinical Indictors, Disease Patterns and Drug Treatment	PLOS ONE			English	Article							PRIMARY PREVENTION; BLOOD-PRESSURE; HEART-DISEASE; MIDDLE-INCOME; DOUBLE-BLIND; STROKE; HYPERTENSION; INDIVIDUALS; CHOLESTEROL; POLYPILL	Background and Aims: Current cardiovascular disease (CVD) prevention is based on diagnosis and treatment of specific disease. Little is known for high risk people with CVD at the community level. In rural China, health records of all residents were established after the recent health reforms. This study aims to describe the characters of the rural population with high CVD risk regarding their clinical indicators, disease patterns, drug treatment and adherence. Methods and Results: 17042 (87%) of all the 19500 rural residents in the two townships had valid health records in 2009. We employed a validated tool, the Asian Equation, to screen 8182 (48%) resident health records of those aged between 40-75 years in 2010. Those who were identified with a CVD risk of 20% or higher were selected for a face-to-face questionnaire survey regarding their diagnosed disease and drug treatment. 453 individuals were identified as high risk of CVD, with an average age of 53 years, 62% males, 50% smoking rate and average systolic blood pressure of 161 mmHg. 386 (85%) participated in the survey, while 294 (76%) were diagnosed with and 88 (23%) were suspects of CVD, hypertension, diabetes or hyperlipidaemia. 75 (19%) took drug regularly and 125 (32%) either stopped treatment or missed drugs. The most often used drugs were calcium channel blockers (20%). Only 2% used aspirins and 0.8% used statins. The median costs of drugs were 17 RMB (USD2.66) per month. Conclusion: The majority of the high risk population in our setting of rural China had already been diagnosed with a CVD related disease, but very few took any drugs, and less still took highly effective drugs to prevent CVD. A holistic strategy focused on population with high risk CVD and based on the current China public health reform is suggested in the context of primary care.	[Wei, Xiaolin; Tian, Linwei] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Zou, Guanyang; Yin, Jia; Walley, John] Univ Leeds, Nuffield Ctr Int Hlth & Dev, Leeds, W Yorkshire, England; [Zhou, Biao; Yu, Yunxian; Chen, Kun] Zhejiang Univ, Sch Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China	Chinese University of Hong Kong; University of Leeds; Zhejiang University	Chen, K (corresponding author), Zhejiang Univ, Sch Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China.	ck@zju.edu.cn	Walley, John D/AAY-1375-2021; Tian, Linwei/A-9736-2009; Wei, Xiaolin/H-5364-2013	Walley, John D/0000-0001-7290-0989; Tian, Linwei/0000-0002-4739-1534; Tian, Linwei/0000-0003-2240-8886	World Universities Network Fund for international research collaborations [dvnuid374700]	World Universities Network Fund for international research collaborations	This work was supported by the World Universities Network Fund for international research collaborations, grant number: dvnuid374700. However, the sponsor of this study has no role in research design, data collection and result interpretation. The authors take full responsibility of views expressed in this manuscript.	Baker S, 2000, BMJ-BRIT MED J, V320, P680, DOI 10.1136/bmj.320.7236.680; Barzi F, 2007, J EPIDEMIOL COMMUN H, V61, P115, DOI 10.1136/jech.2005.044842; Brindle P, 2006, HEART, V92, P1752, DOI 10.1136/hrt.2006.087932; Chen Z, 2009, LANCET, V373, P1322, DOI 10.1016/S0140-6736(09)60753-4; Fan FF, 2010, J ZHEJIANG UNIV-SC B, V11, P583, DOI 10.1631/jzus.B1001003; Hu Da-yi, 2008, Zhonghua Nei Ke Za Zhi, V47, P976; Jackson R, 2005, LANCET, V365, P434, DOI 10.1016/S0140-6736(05)17833-7; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Liu LS, 2010, CHINESE J HYPERTENS, V18, P11; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Malekzadeh F, 2010, INT J CLIN PRACT, V64, P1220, DOI 10.1111/j.1742-1241.2010.02412.x; Mendis S, 2005, B WORLD HEALTH ORGAN, V83, P820; Moran A, 2010, CIRC-CARDIOVASC QUAL, V3, P243, DOI 10.1161/CIRCOUTCOMES.109.910711; National Center for Cardiovascular Dseases C, 2011, ENCY CHIN PUBL HOUS; National Centre for Cardiovascular Disease, 2007, REP CARD DIS CHIN 20; NICE, 2008, CLIN GUID EV REV LIP; NICE, 2010, NICE IND GUID QOF CA; Tang JL, 2010, INT J EPIDEMIOL, V39, P244, DOI 10.1093/ije/dyp213; The World Bank, 2011, HLTH HARM LIF CHIN S; Volmink J, 2006, COCHRANE DATABASE SY, P2; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Walley J, 2012, B WORLD HEALTH ORGAN, V90, P402, DOI 10.2471/BLT.12.106674; Wang XB, 2007, LANCET, V369, P1876, DOI 10.1016/S0140-6736(07)60854-X; Wei XL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-260; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Wu YF, 2006, CIRCULATION, V114, P2217, DOI 10.1161/CIRCULATIONAHA.105.607499; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Xiao JZ, 2010, NEW ENGL J MED, V362, P2426; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4; Zhang LF, 2003, STROKE, V34, P2091, DOI 10.1161/01.STR.0000087149.42294.8C	33	25	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54169	10.1371/journal.pone.0054169	http://dx.doi.org/10.1371/journal.pone.0054169			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349814	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872800029
J	Jovicic, A; Jolissaint, JFZ; Moser, R; Santos, MDS; Luthi-Carter, R				Jovicic, Ana; Jolissaint, Julien Francisco Zaldivar; Moser, Roger; Santos, Mariana de Fatima Silva; Luthi-Carter, Ruth			MicroRNA-22 (miR-22) Overexpression Is Neuroprotective via General Anti-Apoptotic Effects and May also Target Specific Huntington's Disease-Related Mechanisms	PLOS ONE			English	Article							3-NITROPROPIONIC ACID; EXPRESSION; BRAIN; MODELS; NEURODEGENERATION; NEURONS; CULTURE; DEATH	Background: Whereas many causes and mechanisms of neurodegenerative diseases have been identified, very few therapeutic strategies have emerged in parallel. One possible explanation is that successful treatment strategy may require simultaneous targeting of more than one molecule of pathway. A new therapeutic approach to have emerged recently is the engagement of microRNAs (miRNAs), which affords the opportunity to target multiple cellular pathways simultaneously using a single sequence. Methodology/Principal Findings: We identified miR-22 as a potentially neuroprotective miRNA based on its predicted regulation of several targets implicated in Huntington's disease (histone deacetylase 4 (HDAC4), REST corepresor 1 (Rcor1) and regulator of G-protein signaling 2 (Rgs2)) and its diminished expression in Huntington's and Alzheimer's disease brains. We then tested the hypothesis that increasing cellular levels of miRNA-22 would achieve neuroprotection in in vitro models of neurodegeneration. As predicted, overexpression of miR-22 inhibited neurodegeneration in primary striatal and cortical cultures exposed to a mutated human huntingtin fragment (Htt171-82Q). Overexpression of miR-22 also decreased neurodegeneration in primary neuronal cultures exposed to 3-nitropropionic acid (3-NP), a mitochondrial complex II/III inhibitor. In addition, miR-22 improved neuronal viability in an in vitro model of brain aging. The mechanisms underlying the effects of miR-22 included a reduction in caspase activation, consistent with miR-22's targeting the pro-apoptotic activities of mitogen-activated protein kinase 14/p38 (MAPK14/p38) and tumor protein p53-inducible nuclear protein 1 (Tp53inp1). Moreover, HD-specific effects comprised not only targeting HDAC4, Rcor1 and Rgs2 mRNAs, but also decreasing focal accumulation of mutant Htt-positive foci, which occurred via an unknown mechanism. Conclusions: These data show that miR-22 has multipartite anti-neurodegenerative activities including the inhibition of apoptosis and the targeting of mRNAs implicated in the etiology of HD. These results motivate additional studies to evaluate the feasibility and therapeutic efficacy of manipulating miR-22 in vivo.	[Jovicic, Ana; Jolissaint, Julien Francisco Zaldivar; Moser, Roger; Luthi-Carter, Ruth] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lausanne, Vaud, Switzerland; [Santos, Mariana de Fatima Silva; Luthi-Carter, Ruth] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Leicester	Luthi-Carter, R (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Lausanne, Vaud, Switzerland.	relc3@leicester.ac.uk			Swiss National Science Foundation; Roche Foundation; Ecole Polytechnique Federale de Lausanne	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Roche Foundation; Ecole Polytechnique Federale de Lausanne	This work was supported by the Swiss National Science Foundation, the Roche Foundation and the Ecole Polytechnique Federale de Lausanne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ALSTON TA, 1977, P NATL ACAD SCI USA, V74, P3767, DOI 10.1073/pnas.74.9.3767; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; BEAL MF, 1993, J NEUROSCI, V13, P4181; Cao J, 2004, J BIOL CHEM, V279, P35903, DOI 10.1074/jbc.M402353200; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Fink SL, 1996, EXP NEUROL, V138, P298, DOI 10.1006/exnr.1996.0068; Gambazzi L, 2010, J PHARMACOL EXP THER, V335, P13, DOI 10.1124/jpet.110.167551; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Lee ST, 2011, EXP NEUROL, V227, P172, DOI 10.1016/j.expneurol.2010.10.012; Lesuisse C, 2002, J NEUROBIOL, V51, P9, DOI 10.1002/neu.10037; LUDOLPH AC, 1991, CAN J NEUROL SCI, V18, P492, DOI 10.1017/S0317167100032212; LUTHICARTER R, 2007, DRUG DISCOV TODAY DI, V4, P111; Marti E, 2010, NUCLEIC ACIDS RES, V38, P7219, DOI 10.1093/nar/gkq575; Mielcarek M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027746; Okamura S, 2001, MOL CELL, V8, P85, DOI 10.1016/S1097-2765(01)00284-2; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Rudinskiy N, 2009, J NEUROCHEM, V111, P460, DOI 10.1111/j.1471-4159.2009.06344.x; Runne H, 2008, J NEUROSCI, V28, P9723, DOI 10.1523/JNEUROSCI.3044-08.2008; Sadri-Vakili G, 2007, HUM MOL GENET, V16, P1293, DOI 10.1093/hmg/ddm078; Savas JN, 2008, P NATL ACAD SCI USA, V105, P10820, DOI 10.1073/pnas.0800658105; Seredenina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022231; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Zala D, 2005, NEUROBIOL DIS, V20, P785, DOI 10.1016/j.nbd.2005.05.017; Zuccato C, 2007, J NEUROSCI, V27, P6972, DOI 10.1523/JNEUROSCI.4278-06.2007	30	124	129	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54222	10.1371/journal.pone.0054222	http://dx.doi.org/10.1371/journal.pone.0054222			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349832	gold, Green Published, Green Submitted			2022-12-25	WOS:000313738900054
J	Morley, CG; Winder, L				Morley, Craig G.; Winder, Linton			The Effect of the Small Indian Mongoose (Urva auropunctatus), Island Quality and Habitat on the Distribution of Native and Endemic Birds on Small Islands within Fiji	PLOS ONE			English	Article							HERPESTES-AUROPUNCTATUS; JAVANICUS; CARNIVORA; MAMMALS; IMPACT; GENUS; DIET; AVES	This study investigated the effect of the presence of introduced mongoose, environmental quality and habitat on the distribution of native and endemic birds on 16 small islands within Fiji. In total, 9055 birds representing 45 species were observed within four key habitats (forest, villages, crop land and coastal vegetation) on the 16 islands, half of which had mongoose present. Previous studies attribute bird declines and extirpation anecdotally to the mongoose. The presence of mongoose, environmental quality and habitat type had a measurable influence on observed extant native and endemic bird communities. We conclude that three ground birds; Gallirallus phillipensis, Anas supericiliosa and Porphyrio porhyrio were negatively influenced by the presence of mongoose and that Ptilinopus perousii, Phigys solitarius, Chrysoenas victor, Ducula latrans, Clytorhyrchus vitiensis, Pachycephala pectoralis, Prospeia tabunesis, and Foulehaio carunculata were particularly dependent on good quality forest habitat. Conservation priorities in relation to protecting Fiji's endemic birds from the effect of mongoose are discussed and preventative measures suggested.	[Morley, Craig G.] Waiariki Inst Technol, Sch Forestry & Primary Ind, Rotorua, New Zealand; [Winder, Linton] Unitec Inst Technol, Fac Social & Hlth Sci, Dept Nat Sci, Auckland, New Zealand	Waiariki Institute of Technology; Unitec NZ	Morley, CG (corresponding author), Waiariki Inst Technol, Sch Forestry & Primary Ind, Rotorua, New Zealand.	craig.morley@waiariki.ac.nz	Morley, CRaig/R-9163-2019	Morley, Craig/0000-0001-7149-4915	University of the South Pacific	University of the South Pacific	This work was funded by a research grant from the University of the South Pacific. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen Glover M., 1911, Bulletin of the Museum of Comparative Zoology at Harvard College, V54; Allison N.A., 1980, Sea Swallow, V29, P10; Atkinson IAE, 2006, ECOL STU AN, V186, P49; Bahr PH, 1912, IBIS, V6, P282; Baker J.K., 1979, Elepaio, V40, P51; BALDWIN PH, 1952, J MAMMAL, V33, P335, DOI 10.2307/1375771; Barun A, 2010, ANIM CONSERV, V13, P549, DOI 10.1111/j.1469-1795.2010.00374.x; Barun A., 2011, ISLAND INVASIVES ERA; Beckon W, 1988, DISTRIBUTION L UNPUB; BirdLife International, 2008, STAT WORLDS BIRDS IN; BLACKBURN A, 1971, Notornis, V18, P147; Blackburn TM, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P85; CAVALLINI P, 1995, J MAMMAL, V76, P569, DOI 10.2307/1382365; Cheke A.S., 1987, P5, DOI 10.1017/CBO9780511735769.003; Clunie F, 1984, BIRDS FIJI BUSH; Clunie F, 1972, FIJI MUSEUM ED SERIE; COLLINGS DF, 1984, NEW ZEAL VET J, V32, P21, DOI 10.1080/00480169.1984.35050; Finch O, 1877, P ZOOL SOC LOND, P723; Franklin J, 2010, PLOS ONE, V5, P1; GORMAN ML, 1975, J ZOOL, V175, P273, DOI 10.1111/j.1469-7998.1975.tb01401.x; GORMAN ML, 1975, IBIS, V117, P152, DOI 10.1111/j.1474-919X.1975.tb04202.x; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Griffiths R, 2011, TURNING TIDE ERADICA; Hartlaub G., 1864, Ibis, P232; Hays WST, 2003, PAC SCI, V61, P3; Hedges SB, 2012, ZOOTAXA, P1; Holdaway Richard N., 1999, P189; HOLYOAK DT, 1979, EMU, V79, P7, DOI 10.1071/MU9790007; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Innes J, 2011, TURNING TIDE ERADICA; KAMI HARRY T., 1964, ZOONOSES RES, V3, P165; KING WARREN B., 1967, LIVING BIRD, V6, P163; Layard E. L., 1876, P137; Leps J, 2003, MULTIVARIATE ANAL EC; Lorvelec O, 2004, REV ECOL-TERRE VIE, V59, P293; MAC ARTHUR ROBERT H., 1967; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Martin AH, 1938, T FIJI SOC SCI IND, P4; Martin P.S., 1999, EXTINCTIONS NEAR TIM, P17, DOI DOI 10.1007/978-1-4757-5202-1_2; Mercer R, 1970, FIJI MUSEUM SPECIAL; Moors P. J., 1985, INT COUNCIL BIRD PRE, VPublication No. 3, P35; Morley CG, 2004, ORYX, V38, P457, DOI 10.1017/S0030605304000857; Morley Craig G., 2004, Proceedings of the Vertebrate Pest Conference, V21, P37; Nellis DW, 1983, BIOL MONGOOSE CARIBB; NELLIS DW, 1983, STUD FAUNA CURACAO, V64, P1; Patou ML, 2009, MOL PHYLOGENET EVOL, V53, P69, DOI 10.1016/j.ympev.2009.05.038; PERNETTA JC, 1978, PAC SCI, V32, P223; Peters D, 2011, ISLAND INVASIVES ERA; PIMENTEL DAVID, 1955, JOUR MAMMAL, V36, P62, DOI 10.2307/1375723; Quinn JH, 2005, J ZOOL, V267, P339, DOI 10.1017/S0952836905007491; Rimmer A., 2009, TIRITIRI MATANGI MOD; Roy S.S., 2002, Occasional Papers of the IUCN Species Survival Commission, V27, P266; Ryan P.A., 2000, FIJIS NATURAL HERITA; Seaman G. A., 1962, Journal of Mammalogy, V43, P544, DOI 10.2307/1376922; Seaman G. A., 1952, T N AM WILDL C, V17, P188; Simberloff D, 2003, CONSERV BIOL, V17, P83, DOI 10.1046/j.1523-1739.2003.02028.x; Simberloff D, 2011, ENCY BIOL INVASIONS; SPREP, 2003, ACT STRAT NAT CONS P; Steadman David W., 1999, Ecotropica, V5, P13; Steadman DW, 2006, EXTINCTION BIOGEOGRA; Stone C. P., 1994, ELEPAIO, V54, P73; Stratford JMC, 2000, PALAEOGEOGR PALAEOCL, V162, P137, DOI 10.1016/S0031-0182(00)00109-7; Swinnerton K, 2006, PRELIMINARY RE UNPUB; TARBURTON M K, 1992, Bulletin of the British Ornithologists' Club, V112, P34; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Thaman R. R., 2005, Pacific Science, V59, P193, DOI 10.1353/psc.2005.0027; Trevino HS, 2007, CONSERV BIOL, V21, P125, DOI 10.1111/j.1523-1739.2006.00581.x; Urich J. W., 1931, TROPICAL AGR, V8, P95; Veitch C. R., 2011, ISLAND INVASIVES ERA; Veron G, 2007, ZOOL SCR, V36, P1, DOI 10.1111/j.1463-6409.2006.00261.x; Vilella Francisco J., 1993, Caribbean Journal of Science, V29, P24; Watling D., 1985, Bulletin of the British Ornithologists' Club, V105, P96; Watling D, 2001, GUIDE BIRDS FIJI W P; WILLIAMS C. B., 1918, Bull. Dep. Agric. Trinidad and Tobago, V17, P167; Wood C. A., 1925, Ibis, V1925, P814; Worthy T, 2001, B BRIT ORNITHOLOGIST, V123, P90; Worthy TH, 2004, J ROY SOC NEW ZEAL, V34, P295, DOI 10.1080/03014223.2004.9517768; Worthy TH, 2000, J ROY SOC NEW ZEAL, V30, P337, DOI 10.1080/03014223.2000.9517627; Yamada F, 2002, TURNING TIDE ERADICA, P389	79	6	8	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53842	10.1371/journal.pone.0053842	http://dx.doi.org/10.1371/journal.pone.0053842			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349751	Green Published, gold			2022-12-25	WOS:000313738900023
J	Ding, YM; Zhang, RY; Zhang, KN; Lv, XY; Chen, YA; Li, AQ; Wang, LL; Zhang, X; Xia, Q				Ding, Yuemin; Zhang, Ruyi; Zhang, Kena; Lv, Xinyou; Chen, Yanan; Li, Aiqing; Wang, Linlin; Zhang, Xiong; Xia, Qiang			Nischarin Is Differentially Expressed in Rat Brain and Regulates Neuronal Migration	PLOS ONE			English	Article							RHO-GTPASES; CELL-MIGRATION; MENTAL-RETARDATION; AXONAL GROWTH; CDNA-CLONE; INVASION; PHOSPHORYLATION; ANTISERA; SUBUNIT; PROTEIN	Nischarin is a protein known to inhibit breast cancer cell motility by regulating the signaling of the Rho GTPase family. However, little is known about its location and function in the nervous system. The aim of the present study was to investigate the regional and cellular expression and functions of Nischarin in the adult rodent brain. As assessed by real-time PCR, Western blot analysis and immunostaining, we found that Nischarin was widely distributed throughout the brain, with a higher expression in the cerebral cortex and hippocampus. Double-labeling showed that Nischarin was expressed in neurons and was mainly located in the perinuclear region and F-actin-rich protrusions. The expression pattern of Nischarin in the brain was thought to be closely associated with its function. This was verified by our findings from cell migration assays that Nischarin regulated neuronal migration. These results provide a preliminary survey of the distribution of Nischarin in different regions and cell types in the rat brain. This might help to elucidate its physiological roles, and to evaluate its potential clinical implications.	[Ding, Yuemin; Zhang, Ruyi; Zhang, Kena; Wang, Linlin; Zhang, Xiong; Xia, Qiang] Zhejiang Univ, Sch Med, Dept Physiol, Hangzhou 310003, Zhejiang, Peoples R China; [Ding, Yuemin; Zhang, Ruyi] Zhejiang Univ City Coll, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [Lv, Xinyou] Zhejiang Univ, Sch Med, Dept Neurobiol, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Yanan] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Li, Aiqing] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Gastroenterol Lab, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University City College; Zhejiang University; Hangzhou Normal University; Zhejiang University	Xia, Q (corresponding author), Zhejiang Univ, Sch Med, Dept Physiol, Hangzhou 310003, Zhejiang, Peoples R China.	xiaqiang@zju.edu.cn			National Natural Science Foundation of China [81000535]; Natural Science Foundation of Zhejiang Province [Y2100508]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Natural Science Foundation of China (No. 81000535) and the Natural Science Foundation of Zhejiang Province (No. Y2100508). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahari SK, 2004, EMBO J, V23, P2777, DOI 10.1038/sj.emboj.7600291; Alahari SK, 2004, BIOCHEM J, V377, P449, DOI 10.1042/BJ20030411; Alahari SK, 2003, EXP CELL RES, V288, P415, DOI 10.1016/S0014-4827(03)00233-7; Alahari SK, 2000, J CELL BIOL, V151, P1141, DOI 10.1083/jcb.151.6.1141; Antoine-Bertrand J, 2011, CURR DRUG TARGETS, V12, P1202, DOI 10.2174/138945011795906543; Auer M, 2011, ANN ANAT, V193, P259, DOI 10.1016/j.aanat.2011.02.015; Baranwal S, 2011, J NATL CANCER I, V103, P1513, DOI 10.1093/jnci/djr350; Benarroch EE, 2007, NEUROLOGY, V68, P1315, DOI 10.1212/01.wnl.0000259588.97409.8f; Cayre M, 2009, PROG NEUROBIOL, V88, P41, DOI 10.1016/j.pneurobio.2009.02.001; Chen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042413; Cooper JA, 2008, TRENDS NEUROSCI, V31, P113, DOI 10.1016/j.tins.2007.12.003; Ding YM, 2008, MOL CELL BIOL, V28, P3742, DOI 10.1128/MCB.01832-07; Fournier AE, 2000, METHOD ENZYMOL, V325, P473; Ghashghaei HT, 2007, NAT REV NEUROSCI, V8, P141, DOI 10.1038/nrn2074; Guerrini R, 2010, NEUROBIOL DIS, V38, P154, DOI 10.1016/j.nbd.2009.02.008; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Ivanov TR, 1998, J AUTONOM NERV SYST, V72, P98, DOI 10.1016/S0165-1838(98)00094-0; Khalil BD, 2012, J NEURO-ONCOL, V108, P333, DOI 10.1007/s11060-012-0866-8; Li AQ, 2010, ONCOL REP, V23, P1247, DOI 10.3892/or_00000757; Newey SE, 2005, J NEUROBIOL, V64, P58, DOI 10.1002/neu.20153; Piletz JE, 1999, ANN NY ACAD SCI, V881, P1, DOI 10.1111/j.1749-6632.1999.tb09335.x; Rathinam R, 2011, FRONT BIOSCI-LANDMRK, V16, P2561, DOI 10.2741/3872; Reddig PJ, 2005, J BIOL CHEM, V280, P30994, DOI 10.1074/jbc.M502546200; Tashiro A, 2008, METHOD ENZYMOL, V439, P285, DOI 10.1016/S0076-6879(07)00421-1; Thies E, 2003, J NEUROBIOL, V54, P358, DOI 10.1002/neu.10135; Valiente M, 2010, CURR OPIN NEUROBIOL, V20, P68, DOI 10.1016/j.conb.2009.12.003; Verrotti A, 2010, EUR J PAEDIATR NEURO, V14, P1, DOI 10.1016/j.ejpn.2009.01.005; Wang XY, 2012, J ZHEJIANG UNIV-SC B, V13, P356, DOI 10.1631/jzus.B1100386	28	21	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54563	10.1371/journal.pone.0054563	http://dx.doi.org/10.1371/journal.pone.0054563			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342172	Green Submitted, gold, Green Published			2022-12-25	WOS:000313682700127
J	Liu, CM; Hsieh, CL; He, YC; Lo, SJ; Liang, JA; Hsieh, TF; Josson, S; Chung, LWK; Hung, MC; Sung, SY				Liu, Che-Ming; Hsieh, Chia-Ling; He, Yun-Chi; Lo, Sen-Jei; Liang, Ji-An; Hsieh, Teng-Fu; Josson, Sajni; Chung, Leland W. K.; Hung, Mien-Chie; Sung, Shian-Ying			In Vivo Targeting of ADAM9 Gene Expression Using Lentivirus-Delivered shRNA Suppresses Prostate Cancer Growth by Regulating REG4 Dependent Cell Cycle Progression	PLOS ONE			English	Article							MITOXANTRONE PLUS PREDNISONE; IV; DOCETAXEL; SURVIVAL; IMMUNOTHERAPY; RESISTANCE; MARKER; SERUM; DISINTEGRIN; METASTASIS	Cancer cells respond to stress by activating a variety of survival signaling pathways. A disintegrin and metalloproteinase (ADAM) 9 is upregulated during cancer progression and hormone therapy, functioning in part through an increase in reactive oxygen species. Here, we present in vitro and in vivo evidence that therapeutic targeting of ADAM9 gene expression by lentivirus-delivered small hairpin RNA (shRNA) significantly inhibited proliferation of human prostate cancer cell lines and blocked tumor growth in a murine model of prostate cancer bone metastasis. Cell cycle studies confirmed an increase in the G1-phase and decrease in the S-phase population of cancer cells under starvation stress conditions, which correlated with elevated intracellular superoxide levels. Microarray data showed significantly decreased levels of regenerating islet-derived family member 4 (REG4) expression in prostate cancer cells with knockdown of ADAM9 gene expression. This REG4 downregulation also resulted in induction of expression of p21(Cip1/WAF1), which negatively regulates cyclin D1 and blocks the G1/S transition. Our data reveal a novel molecular mechanism of ADAM9 in the regulation of prostate cancer cell proliferation, and suggests a combined modality of ADAM9 shRNA gene therapy and cytotoxic agents for hormone refractory and bone metastatic prostate cancer.	[Liu, Che-Ming; Sung, Shian-Ying] China Med Univ, PhD Program Canc Biol & Drug Discovery, Taichung, Taiwan; [Liu, Che-Ming; Sung, Shian-Ying] Acad Sinica, Taichung, Taiwan; [Hsieh, Chia-Ling; He, Yun-Chi; Lo, Sen-Jei; Hung, Mien-Chie; Sung, Shian-Ying] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Hsieh, Teng-Fu] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Hsieh, Chia-Ling; Hung, Mien-Chie; Sung, Shian-Ying] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan; [Liang, Ji-An] China Med Univ Hosp, Div Radiat Oncol, Taichung, Taiwan; [Hsieh, Teng-Fu] Buddhist Tzu Chi Gen Hosp, Div Urol, Taichung Branch, Taichung, Taiwan; [Hsieh, Teng-Fu] Buddhist Tzu Chi Univ, Sch Med, Dept Urol, Hualien, Taiwan; [Josson, Sajni; Chung, Leland W. K.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Hsieh, Chia-Ling; Hung, Mien-Chie] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA	China Medical University Taiwan; Academia Sinica - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Tzu Chi University; Cedars Sinai Medical Center; Asia University Taiwan; University of Texas System; UTMD Anderson Cancer Center	Sung, SY (corresponding author), China Med Univ, PhD Program Canc Biol & Drug Discovery, Taichung, Taiwan.	ssung@mail.cmu.edu.tw	Hung, Mien-Chie/ABD-5911-2021	Hung, Mien-Chie/0000-0003-4317-4740	National Science Council, Taiwan [NSC99-2320-B-039-029-MY3]; National Health Research Institute, Taiwan [NHRI-EX99-9902BI, NHRI-EX100- 9902BI, NHRI-EX101-9902BI]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan)	This study was supported by NSC99-2320-B-039-029-MY3 of National Science Council, Taiwan (http://web1.nsc.gov.tw); NHRI-EX99-9902BI, NHRI-EX100- 9902BI and NHRI-EX101-9902BI of National Health Research Institute, Taiwan (http://www.nhri.org.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthold DR, 2008, J CLIN ONCOL, V26, P242, DOI 10.1200/JCO.2007.12.4008; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; Cao DX, 2004, CANCER LETT, V214, P103, DOI 10.1016/j.canlet.2004.03.047; COLEMAN WB, 1995, CLIN CHEM, V41, P644; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Fischer OM, 2004, MOL CELL BIOL, V24, P5172, DOI 10.1128/MCB.24.12.5172-5183.2004; Fizazi K, 2011, LANCET, V377, P813, DOI 10.1016/S0140-6736(10)62344-6; Franzke CW, 2009, J BIOL CHEM, V284, P23386, DOI 10.1074/jbc.M109.034090; Fritzsche FR, 2008, EUR UROL, V54, P1097, DOI 10.1016/j.eururo.2007.11.034; Fry JL, 2010, CANCER RES, V70, P8187, DOI 10.1158/0008-5472.CAN-09-4231; Gu ZN, 2005, CLIN CANCER RES, V11, P2237, DOI 10.1158/1078-0432.CCR-04-0356; Hayashi T, 2009, ONCOL REP, V21, P95, DOI 10.3892/or_00000194; Hotoda N, 2002, BIOCHEM BIOPH RES CO, V293, P800, DOI 10.1016/S0006-291X(02)00302-9; Ip SW, 2008, IN VIVO, V22, P237; Izumi Y, 1998, EMBO J, V17, P7260, DOI 10.1093/emboj/17.24.7260; Josson S, 2011, PROSTATE, V71, P232, DOI 10.1002/pros.21237; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kantoff PW, 2010, J CLIN ONCOL, V28, P1099, DOI 10.1200/JCO.2009.25.0597; Kuniyasu H, 2009, CELL PROLIFERAT, V42, P110, DOI 10.1111/j.1365-2184.2008.00577.x; Kuo PL, 2012, J BIOL CHEM, V287, P9753, DOI 10.1074/jbc.M111.321190; Mahimkar RM, 2005, BIOCHEM J, V385, P461, DOI 10.1042/BJ20041133; McMurtry CT, 2003, J AM GERIATR SOC, V51, P1136, DOI 10.1046/j.1532-5415.2003.51367.x; Mizumachi T, 2008, ONCOGENE, V27, P831, DOI 10.1038/sj.onc.1210681; Moon JH, 2012, J SURG ONCOL, V105, P189, DOI 10.1002/jso.22021; NAKAZAKI M, 1983, J CHEM SOC CHEM COMM, P787, DOI 10.1039/c39830000787; Nanakin A, 2007, LAB INVEST, V87, P304, DOI 10.1038/labinvest.3700507; Ohara S, 2008, CANCER SCI, V99, P1570, DOI 10.1111/j.1349-7006.2008.00846.x; Pen CC, 2012, CHINESE J PHYSIOL, V55, P390, DOI 10.4077/CJP.2012.BAA075; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Rafa L, 2010, INT J ONCOL, V36, P689, DOI 10.3892/ijo_00000544; Ramanathan B, 2005, CANCER RES, V65, P8455, DOI 10.1158/0008-5472.CAN-05-1162; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; Shigemura K, 2007, PROSTATE, V67, P722, DOI 10.1002/pros.20565; Singh B, 2009, INT J CANCER, V124, P531, DOI 10.1002/ijc.23974; Small EJ, 2007, CLIN CANCER RES, V13, P3883, DOI 10.1158/1078-0432.CCR-06-2937; Smith Matthew R, 2004, Oncology (Williston Park), V18, P21; Smith MR, 2012, LANCET, V379, P39, DOI 10.1016/S0140-6736(11)61226-9; Sternberg CN, 2009, J CLIN ONCOL, V27, P5431, DOI 10.1200/JCO.2008.20.1228; Sung SY, 2008, CANCER RES, V68, P9996, DOI 10.1158/0008-5472.CAN-08-2492; Sung SY, 2006, CANCER RES, V66, P9519, DOI 10.1158/0008-5472.CAN-05-4375; Takehara A, 2006, CANCER SCI, V97, P1191, DOI 10.1111/j.1349-7006.2006.00297.x; Tamura H, 2009, HUM PATHOL, V40, P1686, DOI 10.1016/j.humpath.2009.06.001; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Vanderlaag K, 2012, INT J CANCER, V130, P1251, DOI 10.1002/ijc.26089; VILLAVICENCIO H, 1993, EUR UROL, V24, P118; Violette S, 2003, INT J CANCER, V103, P185, DOI 10.1002/ijc.10788; Zhang YW, 2003, CHINESE MED J-PEKING, V116, P918	48	21	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53795	10.1371/journal.pone.0053795	http://dx.doi.org/10.1371/journal.pone.0053795			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342005	Green Published, Green Submitted, gold			2022-12-25	WOS:000313682700047
J	Sunyakumthorn, P; Paris, DH; Chan, TC; Jones, M; Luce-Fedrow, A; Chattopadhyay, S; Jiang, J; Anantatat, T; Turner, GDH; Day, NPJ; Richards, AL				Sunyakumthorn, Piyanate; Paris, Daniel H.; Chan, Teik-Chye; Jones, Margaret; Luce-Fedrow, Alison; Chattopadhyay, Suchismita; Jiang, Ju; Anantatat, Tippawan; Turner, Gareth D. H.; Day, Nicholas P. J.; Richards, Allen L.			An Intradermal Inoculation Model of Scrub Typhus in Swiss CD-1 Mice Demonstrates More Rapid Dissemination of Virulent Strains of Orientia tsutsugamushi	PLOS ONE			English	Article							HOST DEFENSES; RICKETTSIAL INFECTIONS; CYNOMOLGUS MONKEYS; VACCINE CANDIDATE; IMMUNE-RESPONSES; DENDRITIC CELLS; MACROPHAGES; RESISTANCE; JAPAN; EPIDEMIOLOGY	Scrub typhus is an important endemic disease of the Asia-Pacific region caused by Orientia tsutsugamushi. To develop an effective vaccine to prevent scrub typhus infection, a better understanding of the initial host-pathogen interaction is needed. The objective of this study was to investigate early bacterial dissemination in a CD-1 Swiss outbred mouse model after intradermal injection of O. tsutsugamushi. Three human pathogenic strains of O. tsutsugamushi (Karp, Gilliam, and Woods) were chosen to investigate the early infection characteristics associated with bacterial virulence. Tissue biopsies of the intradermal injection site and draining lymph nodes were examined using histology and immunohistochemistry to characterize bacterial dissemination, and correlated with quantitative real-time PCR for O. tsutsugamushi in blood and tissue from major organs. Soluble adhesion molecules were measured to examine cellular activation in response to infection. No eschar formation was seen at the inoculation site and no clinical disease developed within the 7 day period of observation. However, O. tsutsugamushi was localized at the injection site and in the draining lymph nodes by day 7 post inoculation. Evidence of leukocyte and endothelial activation was present by day 7 with significantly raised levels of sL-selectin, sICAM-1 and sVCAM-1. Infection with the Karp strain was associated with earlier and higher bacterial loads and more extensive dissemination in various tissues than the less pathogenic Gilliam and Woods strains. The bacterial loads of O. tsutsugamushi were highest in the lungs and spleens of mice inoculated with Karp and Gilliam, but not Woods strains. Strains of higher virulence resulted in more rapid systemic infection and dissemination in this model. The CD-1 mouse intradermal inoculation model demonstrates features relevant to early scrub typhus infection in humans, including the development of regional lymphadenopathy, leukocyte activation and distant organ dissemination after low-dose intradermal injection with O. tsutsugamushi.	[Sunyakumthorn, Piyanate; Chan, Teik-Chye; Luce-Fedrow, Alison; Chattopadhyay, Suchismita; Jiang, Ju; Richards, Allen L.] USN, Viral & Rickettsial Dis Dept, Med Res Ctr, Silver Spring, MD USA; [Sunyakumthorn, Piyanate; Paris, Daniel H.; Anantatat, Tippawan; Turner, Gareth D. H.; Day, Nicholas P. J.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [Jones, Margaret; Turner, Gareth D. H.] Univ Oxford, Nuffield Dept Clin Lab Sci, Oxford, England; [Richards, Allen L.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	United States Department of Defense; United States Navy; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; Uniformed Services University of the Health Sciences - USA	Richards, AL (corresponding author), USN, Viral & Rickettsial Dis Dept, Med Res Ctr, Silver Spring, MD USA.	Allen.Richards@med.navy.mil	Paris, Daniel/GLN-7566-2022; Paris, Daniel/AFV-4762-2022	PARIS, Daniel/0000-0003-4743-5987	U.S. Military Infectious Diseases Research Program [A0310]; Wellcome Trust of Great Britain [089275/Z/09/Z]	U.S. Military Infectious Diseases Research Program; Wellcome Trust of Great Britain(Wellcome Trust)	This work was funded by the U.S. Military Infectious Diseases Research Program, work unit number A0310, and by the Wellcome Trust of Great Britain, grant 089275/Z/09/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen ACC, 1945, AM J PATHOL, P603; CATANZARO PJ, 1976, INFECT IMMUN, V13, P861, DOI 10.1128/IAI.13.3.861-875.1976; Chan TC, 2003, VACCINE, V21, P4550, DOI 10.1016/S0264-410X(03)00505-X; Chattopadhyay S, 2005, INFECT IMMUN, V73, P5039, DOI 10.1128/IAI.73.8.5039-5047.2005; Chattopadhyay S, 2007, HUM VACCINES, V3, P73, DOI 10.4161/hv.3.3.4009; Fukuhara M, 2005, MICROB PATHOGENESIS, V39, P177, DOI 10.1016/j.micpath.2005.08.004; GROVES MG, 1978, INFECT IMMUN, V19, P583, DOI 10.1128/IAI.19.2.583-588.1978; Guinet F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001688; JERRELLS TR, 1983, INFECT IMMUN, V41, P666, DOI 10.1128/IAI.41.2.666-674.1983; JERRELLS TR, 1982, INFECT IMMUN, V37, P1066, DOI 10.1128/IAI.37.3.1066-1073.1982; Jiang J, 2004, AM J TROP MED HYG, V70, P351, DOI 10.4269/ajtmh.2004.70.351; KAWAMURA A, 1988, JPN J EXP MED, V58, P169; Kawamura A., 1995, TSUTSUGAMUSHI DIS; Kelly DJ, 2009, CLIN INFECT DIS, V48, pS203, DOI 10.1086/596576; Lee YS, 2006, JPN J INFECT DIS, V59, P235; Lerdthusnee K, 2006, ANN NY ACAD SCI, V1078, P607, DOI 10.1196/annals.1374.121; Lurchachaiwong W, 2012, EXP APPL ACAROL, V58, P23, DOI 10.1007/s10493-012-9563-8; Murdoch DR, 2004, AM J TROP MED HYG, V70, P670, DOI 10.4269/ajtmh.2004.70.670; Mwangi W, 2005, J LEUKOCYTE BIOL, V78, P401, DOI 10.1189/jlb.1204722; Mwangi W, 2002, J IMMUNOL, V169, P3837, DOI 10.4049/jimmunol.169.7.3837; NACY CA, 1981, INFECT IMMUN, V31, P1239, DOI 10.1128/IAI.31.3.1239-1250.1981; Nagano I, 1996, MICROBIOL IMMUNOL, V40, P743, DOI 10.1111/j.1348-0421.1996.tb01135.x; Ogawa M, 2002, AM J TROP MED HYG, V67, P162, DOI 10.4269/ajtmh.2002.67.162; Paris DH, 2008, CLIN EXP IMMUNOL, V153, P63, DOI 10.1111/j.1365-2249.2008.03673.x; Paris DH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001466; Phongmany S, 2006, EMERG INFECT DIS, V12, P256; RIDGWAY RL, 1986, LAB ANIM SCI, V36, P481; SHIRAI A, 1976, INFECT IMMUN, V14, P39, DOI 10.1128/IAI.14.1.39-46.1976; Tay ST, 2000, T ROY SOC TROP MED H, V94, P280, DOI 10.1016/S0035-9203(00)90322-5; Walsh DS, 2007, VECTOR-BORNE ZOONOT, V7, P547, DOI 10.1089/vbz.2006.0642; Xu GA, 2005, ANN NY ACAD SCI, V1063, P266, DOI 10.1196/annals.1355.043	31	29	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54570	10.1371/journal.pone.0054570	http://dx.doi.org/10.1371/journal.pone.0054570			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342173	Green Submitted, Green Published, gold			2022-12-25	WOS:000313682700128
J	Szpak, P; White, CD; Longstaffe, FJ; Millaire, JF; Sanchez, VFV				Szpak, Paul; White, Christine D.; Longstaffe, Fred J.; Millaire, Jean-Francois; Vasquez Sanchez, Victor F.			Carbon and Nitrogen Isotopic Survey of Northern Peruvian Plants: Baselines for Paleodietary and Paleoecological Studies	PLOS ONE			English	Article							N-15 NATURAL-ABUNDANCE; WATER-USE EFFICIENCY; SYMBIOTIC N-2 FIXATION; VERTEBRATE FOOD-WEB; STABLE-ISOTOPE; BONE-COLLAGEN; MYCORRHIZAL FUNGI; DELTA-C-13 VALUES; DELTA-N-15 VALUES; C-13/C-12 RATIOS	The development of isotopic baselines for comparison with paleodietary data is crucial, but often overlooked. We review the factors affecting the carbon (delta C-13) and nitrogen (delta N-15) isotopic compositions of plants, with a special focus on the carbon and nitrogen isotopic compositions of twelve different species of cultivated plants (n = 91) and 139 wild plant species collected in northern Peru. The cultivated plants were collected from nineteen local markets. The mean delta C-13 value for maize (grain) was -11.8 +/- 60.4%(n = 27). Leguminous cultigens (beans, Andean lupin) were characterized by significantly lower delta N-15 values and significantly higher %N than non-leguminous cultigens. Wild plants from thirteen sites were collected in the Moche River Valley area between sea level and similar to 4,000 meters above sea level (masl). These sites were associated with mean annual precipitation ranging from 0 to 710 mm. Plants growing at low altitude sites receiving low amounts of precipitation were characterized by higher delta N-15 values than plants growing at higher altitudes and receiving higher amounts of precipitation, although this trend dissipated when altitude was >2,000 masl and MAP was >400 mm. For C-3 plants, foliar delta C-13 was positively correlated with altitude and precipitation. This suggests that the influence of altitude may overshadow the influence of water availability on foliar delta C-13 values at this scale.	[Szpak, Paul; White, Christine D.; Millaire, Jean-Francois] Univ Western Ontario, Dept Anthropol, London, ON, Canada; [Longstaffe, Fred J.] Univ Western Ontario, Dept Earth Sci, London, ON, Canada; [Vasquez Sanchez, Victor F.] Ctr Invest Arqueobiol & Paleoecol Andinas ARQUEOB, Trujillo, Peru	Western University (University of Western Ontario); Western University (University of Western Ontario)	Szpak, P (corresponding author), Univ Western Ontario, Dept Anthropol, London, ON, Canada.	pszpak@uwo.ca	Longstaffe, Fred J/A-6843-2008	Millaire, Jean-Francois/0000-0002-8074-5912	Wenner-Gren Foundation [8333]; Social Sciences and Humanities Research Council of Canada; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs Program; Canada Foundation for Innovation; Ontario Research Infrastructure Program	Wenner-Gren Foundation; Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Research Infrastructure Program	This research was supported by the Wenner-Gren Foundation (PS, Dissertation Fieldwork Grant #8333), the Social Sciences and Humanities Research Council of Canada, the Natural Sciences and Engineering Research Council of Canada, the Canada Research Chairs Program, the Canada Foundation for Innovation and the Ontario Research Infrastructure Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera M, 2008, RAPID COMMUN MASS SP, V22, P1653, DOI 10.1002/rcm.3501; Ambrose S.H., 2000, BIOGEOCHEMICAL APPRO, P243; AMBROSE SH, 1986, OECOLOGIA, V69, P395, DOI 10.1007/BF00377062; Ambrose SH, 1997, AM J PHYS ANTHROPOL, V104, P343; AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; Amundson R, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001903; Aranibar JN, 2004, GLOBAL CHANGE BIOL, V10, P359, DOI 10.1111/j.1365-2486.2003.00698.x; Austin AT, 1998, OECOLOGIA, V113, P519, DOI 10.1007/s004420050405; BADA JL, 1989, GEOCHIM COSMOCHIM AC, V53, P3337, DOI 10.1016/0016-7037(89)90114-2; Badeck FW, 2005, RAPID COMMUN MASS SP, V19, P1381, DOI 10.1002/rcm.1912; Bateman AS, 2007, ISOT ENVIRON HEALT S, V43, P237, DOI 10.1080/10256010701550732; Belane AK, 2010, BIOL FERT SOILS, V46, P191, DOI 10.1007/s00374-009-0415-6; Ben-David M, 1998, OIKOS, V83, P47, DOI 10.2307/3546545; BENNER R, 1987, NATURE, V329, P708, DOI 10.1038/329708a0; Beresford-Jones DG, 2009, LAT AM ANTIQ, V20, P303, DOI 10.1017/S1045663500002650; Beron MA, 2009, INT J OSTEOARCHAEOL, V19, P250, DOI 10.1002/oa.1049; Bode A, 2006, MAR ECOL PROG SER, V318, P89, DOI 10.3354/meps318089; Bosl C, 2006, INT J OSTEOARCHAEOL, V16, P296, DOI 10.1002/oa.834; Broadmeadow M. S. J., 1993, Stable isotopes and plant carbon-water relations., P109; Brush S., 1982, MOUNTAIN RES DEV, V2, DOI [DOI 10.2307/3672931, 10.2307/3672931]; Buchmann N, 1997, OECOLOGIA, V110, P120, DOI 10.1007/s004420050140; Burkhardt S, 1999, GEOCHIM COSMOCHIM AC, V63, P3729, DOI 10.1016/S0016-7037(99)00217-3; Bush MB, 2005, J QUATERNARY SCI, V20, P703, DOI 10.1002/jqs.983; Casey MM, 2011, EARTH-SCI REV, V106, P131, DOI 10.1016/j.earscirev.2011.02.001; Catenazzi A, 2007, J ARID ENVIRON, V71, P330, DOI 10.1016/j.jaridenv.2007.05.003; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Cernusak LA, 2009, FUNCT PLANT BIOL, V36, P199, DOI 10.1071/FP08216; Choi WJ, 2005, COMMUN SOIL SCI PLAN, V36, P2719, DOI 10.1080/00103620500303913; Choi WJ, 2002, PLANT SOIL, V245, P223, DOI 10.1023/A:1020475017254; Codron J, 2005, J ARCHAEOL SCI, V32, P1757, DOI 10.1016/j.jas.2005.06.006; Coetsee C, 2011, AFR J ECOL, V49, P62, DOI 10.1111/j.1365-2028.2010.01236.x; Corbisier TN, 2004, POLAR BIOL, V27, P75, DOI 10.1007/s00300-003-0567-z; Cornelisen CD, 2007, LIMNOL OCEANOGR, V52, P820, DOI 10.4319/lo.2007.52.2.0820; Craine JM, 2009, NEW PHYTOL, V183, P980, DOI 10.1111/j.1469-8137.2009.02917.x; CRAWFORD TW, 1982, PLANT PHYSIOL, V70, P1654, DOI 10.1104/pp.70.6.1654; Damesin C, 1997, OECOLOGIA, V111, P26, DOI 10.1007/s004420050204; Damesin C, 2003, PLANT CELL ENVIRON, V26, P207, DOI 10.1046/j.1365-3040.2003.00951.x; DELWICHE CC, 1970, ENVIRON SCI TECHNOL, V4, P929, DOI 10.1021/es60046a004; DELWICHE CC, 1979, BOT GAZ, V140, pS65, DOI 10.1086/337037; DeMera AG, 1997, GLOBAL ECOL BIOGEOGR, V6, P349, DOI 10.2307/2997336; DeNiro M.J., 1988, BAR International Series, P119; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1977, SCIENCE, V197, P261, DOI 10.1126/science.327543; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; DENIRO MJ, 1985, GEOCHIM COSMOCHIM AC, V49, P97, DOI 10.1016/0016-7037(85)90194-2; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; Drucker DG, 2008, PALAEOGEOGR PALAEOCL, V266, P69, DOI 10.1016/j.palaeo.2008.03.020; Ehleringer JR, 1999, FORENSIC SCI INT, V106, P27, DOI 10.1016/S0379-0738(99)00139-5; Ehleringer JR, 1998, REV CHIL HIST NAT, V71, P79; EHLERINGER JR, 1986, OECOLOGIA, V70, P520, DOI 10.1007/BF00379898; Ericson J.E., 1989, CHEM PREHISTORIC HUM, P68; Evans RD, 1996, PLANT CELL ENVIRON, V19, P1317, DOI 10.1111/j.1365-3040.1996.tb00010.x; Evans RD, 2001, TRENDS PLANT SCI, V6, P121, DOI 10.1016/S1360-1385(01)01889-1; Falabella F, 2007, CHUNGARA, V39, P5, DOI 10.4067/S0717-73562007000100002; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; FARQUHAR GD, 1984, AUST J PLANT PHYSIOL, V11, P539, DOI 10.1071/PP9840539; FARQUHAR GD, 1982, OECOLOGIA, V52, P121, DOI 10.1007/BF00349020; Filgueira R, 2011, CONT SHELF RES, V31, P476, DOI 10.1016/j.csr.2010.10.010; Finucane B, 2006, J ARCHAEOL SCI, V33, P1766, DOI 10.1016/j.jas.2006.03.012; Finucane BC, 2008, AM J PHYS ANTHROPOL, V135, P75, DOI 10.1002/ajpa.20710; Finucane BC, 2007, J ARCHAEOL SCI, V34, P2115, DOI 10.1016/j.jas.2007.02.006; Finucane BC, 2009, CURR ANTHROPOL, V50, P534, DOI 10.1086/599860; Fiorentino G, 2012, RAPID COMMUN MASS SP, V26, P327, DOI 10.1002/rcm.5323; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; Frank DA, 2004, BIOGEOCHEMISTRY, V68, P169, DOI 10.1023/B:BIOG.0000025736.19381.91; Frank DA, 1997, ECOLOGY, V78, P2238, DOI 10.1890/0012-9658(1997)078[2238:EONGOG]2.0.CO;2; Fredriksen S, 2003, MAR ECOL PROG SER, V260, P71, DOI 10.3354/meps260071; FRIEND AD, 1989, FUNCT ECOL, V3, P117, DOI 10.2307/2389682; Gathumbi SM, 2002, SOIL BIOL BIOCHEM, V34, P1059, DOI 10.1016/S0038-0717(02)00038-X; Gil AF, 2009, INT J OSTEOARCHAEOL, V19, P215, DOI 10.1002/oa.1041; Gil A.F., 2006, HIST MAIZE MULTIDISC, P199; Gil AF, 2011, J ARCHAEOL SCI, V38, P1395, DOI 10.1016/j.jas.2011.01.010; Gillies CL, 2012, POLAR BIOL, V35, P813, DOI 10.1007/s00300-011-1126-7; GLEIXNER G, 1993, PLANT PHYSIOL, V102, P1287, DOI 10.1104/pp.102.4.1287; Gollety C, 2010, J SEA RES, V64, P304, DOI 10.1016/j.seares.2010.04.003; Golluscio RA, 2009, ECOSYSTEMS, V12, P686, DOI 10.1007/s10021-009-9252-6; Grall J, 2006, J EXP MAR BIOL ECOL, V338, P1, DOI 10.1016/j.jembe.2006.06.013; Grocke DR, 1997, EARTH PLANET SC LETT, V153, P279, DOI 10.1016/S0012-821X(97)00189-1; Grupe G, 2009, J ARCHAEOL SCI, V36, P2125, DOI 10.1016/j.jas.2009.05.011; GUY RD, 1980, OECOLOGIA, V44, P241, DOI 10.1007/BF00572686; Handley LL, 1999, AUST J PLANT PHYSIOL, V26, P185, DOI 10.1071/PP98146; Hartman G, 2011, FUNCT ECOL, V25, P122, DOI 10.1111/j.1365-2435.2010.01782.x; Hartman G, 2010, OECOLOGIA, V162, P837, DOI 10.1007/s00442-009-1514-7; Heaton THE, 1999, J ARCHAEOL SCI, V26, P637, DOI 10.1006/jasc.1998.0381; Hilderbrand GV, 1999, OECOLOGIA, V121, P546, DOI 10.1007/s004420050961; Hobbie EA, 1999, OECOLOGIA, V118, P353, DOI 10.1007/s004420050736; Hobbie EA, 2005, OECOLOGIA, V146, P258, DOI 10.1007/s00442-005-0208-z; Hobbie EA, 2004, NEW PHYTOL, V161, P371, DOI 10.1111/j.1469-8137.2004.00970.x; Hobbie EA, 2003, NEW PHYTOL, V157, P115, DOI 10.1046/j.1469-8137.2003.00657.x; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; HOGBERG P, 1990, NEW PHYTOL, V115, P483, DOI 10.1111/j.1469-8137.1990.tb00474.x; Hogberg P, 1997, NEW PHYTOL, V137, P179, DOI 10.1046/j.1469-8137.1997.00808.x; Hogberg P, 1996, OECOLOGIA, V108, P207, DOI 10.1007/BF00334643; Huiskes AHL, 2006, PLANT ECOL, V182, P79, DOI 10.1007/s11258-005-9032-0; Hultine KR, 2000, OECOLOGIA, V123, P32, DOI 10.1007/s004420050986; Isla R, 1998, FIELD CROP RES, V58, P97, DOI 10.1016/S0378-4290(98)00088-4; Izeta AD, 2009, INT J OSTEOARCHAEOL, V19, P204, DOI 10.1002/oa.1066; Jones DL, 2005, SOIL BIOL BIOCHEM, V37, P413, DOI 10.1016/j.soilbio.2004.08.008; Kang CK, 2008, MAR BIOL, V153, P1181, DOI 10.1007/s00227-007-0890-y; Katzenberg MA, 1999, J ARCHAEOL SCI, V26, P651, DOI 10.1006/jasc.1998.0382; Keeling CD, 1979, ENVIRON INT, V2, P229, DOI [10.1016/0160-4120(79)90005-9, DOI 10.1016/0160-4120(79)90005-9]; Kellner CM, 2008, J ANTHROPOL ARCHAEOL, V27, P226, DOI 10.1016/j.jaa.2007.12.003; Knudson KJ, 2007, J ARCHAEOL SCI, V34, P451, DOI 10.1016/j.jas.2006.07.003; Koepcke H.W., 1961, SYNOKOLOGISCHE STUDI; Koepcke M, 1954, MEMORIAS, V3; Korner C, 1987, FUNCT ECOL, V1, P179, DOI 10.2307/2389420; KOHL DH, 1980, PLANT PHYSIOL, V66, P51, DOI 10.1104/pp.66.1.51; Kohn MJ, 2010, P NATL ACAD SCI USA, V107, P19691, DOI 10.1073/pnas.1004933107; Kolb KJ, 2002, NEW PHYTOL, V156, P57, DOI 10.1046/j.1469-8137.2002.00490.x; KOPCZYNSKA EE, 1995, J PLANKTON RES, V17, P685, DOI 10.1093/plankt/17.4.685; KORNER C, 1991, OECOLOGIA, V88, P30, DOI 10.1007/BF00328400; KROOPNICK PM, 1985, DEEP-SEA RES, V32, P57, DOI 10.1016/0198-0149(85)90017-2; LAJTHA K, 1993, OECOLOGIA, V94, P95, DOI 10.1007/BF00317308; LANGE OL, 1988, OECOLOGIA, V75, P494, DOI 10.1007/BF00776410; Latorre C, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001521; LAWS EA, 1995, GEOCHIM COSMOCHIM AC, V59, P1131, DOI 10.1016/0016-7037(95)00030-4; LEAVITT SW, 1982, NATURE, V298, P742, DOI 10.1038/298742a0; LEDGARD SF, 1985, AUST J PLANT PHYSIOL, V12, P631, DOI 10.1071/PP9850631; Lee YI, 2009, POLAR BIOL, V32, P1607, DOI 10.1007/s00300-009-0659-5; Li CL, 2010, J PLANT NUTR SOIL SC, V173, P946, DOI 10.1002/jpln.200900243; Lightfoot E, 2012, J ARCHAEOL SCI, V39, P656, DOI 10.1016/j.jas.2011.10.026; MARIOTTI A, 1980, PHYSIOL VEG, V18, P163; MARIOTTI A, 1983, NATURE, V303, P685, DOI 10.1038/303685a0; Martinelli LA, 1999, BIOGEOCHEMISTRY, V46, P45, DOI 10.1023/A:1006100128782; Martinez G, 2009, INT J OSTEOARCHAEOL, V19, P281, DOI 10.1002/oa.1057; Masuda S., 1985, ANDEAN ECOLOGY CIVIL, P233; Mayr CC, 2011, MAR ECOL PROG SER, V428, P89, DOI 10.3354/meps09015; MEDINA E, 1991, OECOLOGIA, V87, P369, DOI 10.1007/BF00634593; Michelsen A, 1998, OECOLOGIA, V115, P406, DOI 10.1007/s004420050535; Michelsen A, 1996, OECOLOGIA, V105, P53, DOI 10.1007/BF00328791; Miller MJ, 2010, J ARCHAEOL SCI, V37, P317, DOI 10.1016/j.jas.2009.09.043; Miller RJ, 2012, MAR BIOL, V159, P1391, DOI 10.1007/s00227-012-1929-2; Murphy BP, 2006, FUNCT ECOL, V20, P1062, DOI 10.1111/j.1365-2435.2006.01186.x; Murphy BP, 2009, FUNCT ECOL, V23, P1040, DOI 10.1111/j.1365-2435.2009.01576.x; Nadon MO, 2010, AQUAT LIVING RESOUR, V23, P167, DOI 10.1051/alr/2010010; NASHOLM T, 1994, OECOLOGIA, V99, P290, DOI 10.1007/BF00627741; Nasholm T, 2009, NEW PHYTOL, V182, P31, DOI 10.1111/j.1469-8137.2008.02751.x; Nehlich O, 2009, ARCHAEOL ANTHROP SCI, V1, P59, DOI 10.1007/s12520-009-0003-6; O'Connell TC, 2001, J ARCHAEOL SCI, V28, P1247, DOI 10.1006/jasc.2001.0698; Oka S., 1984, GEOGR REPORTS TOKYO, V19, P113; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; OLEARY MH, 1981, PHYTOCHEMISTRY, V20, P553, DOI 10.1016/0031-9422(81)85134-5; Olsen YS, 2011, MAR ECOL PROG SER, V421, P83, DOI 10.3354/meps08900; ONO M., 1986, TAXONOMIC ECOLOGICAL; OSMOND CB, 1981, OECOLOGIA, V50, P117, DOI 10.1007/BF00378804; Ostrom NE, 1997, GEOCHIM COSMOCHIM AC, V61, P2929, DOI 10.1016/S0016-7037(97)00131-2; Panarello H, 2002, RADIOCARBON, V44, P709, DOI 10.1017/S0033822200032161; PEFAUR JE, 1982, VEGETATIO, V49, P163, DOI 10.1007/BF00123840; Persson J, 2001, ECOL LETT, V4, P434, DOI 10.1046/j.1461-0248.2001.00260.x; Peterson TC, 1997, B AM METEOROL SOC, V78, P2837, DOI 10.1175/1520-0477(1997)078<2837:AOOTGH>2.0.CO;2; Pilbeam DJ, 2010, ANN PLANT REV, V42, P305; Politis GG, 2009, INT J OSTEOARCHAEOL, V19, P266, DOI 10.1002/oa.1053; Raven JA, 2002, FUNCT PLANT BIOL, V29, P355, DOI 10.1071/PP01201; Rice SK, 2000, OECOLOGIA, V123, P1, DOI 10.1007/s004420050983; Riera P, 2009, ESTUAR COAST SHELF S, V81, P143, DOI 10.1016/j.ecss.2008.10.018; Robinson D, 2001, TRENDS ECOL EVOL, V16, P153, DOI 10.1016/S0169-5347(00)02098-X; RUNDEL P W, 1991, Aliso, V13, P1; RUNDEL PW, 1979, OECOLOGIA, V44, P91, DOI 10.1007/BF00346404; Rundel PW, 2003, PLANT ECOL, V169, P179, DOI 10.1023/A:1026075721045; Sage R., 2004, PHOTOSYNTHESIS PHYSL, V9, P497; Sandweiss DH, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P93, DOI 10.1007/978-0-387-74907-5_6; Scartazza A, 1998, AUST J PLANT PHYSIOL, V25, P489, DOI 10.1071/PP98017; Schaal G, 2012, MAR ECOL-EVOL PERSP, V33, P370, DOI 10.1111/j.1439-0485.2011.00487.x; Schaal G, 2010, J SEA RES, V63, P24, DOI 10.1016/j.seares.2009.09.002; Schaal G, 2009, ESTUAR COAST SHELF S, V85, P565, DOI 10.1016/j.ecss.2009.09.027; Schoeninger MJ, 1997, AM J PHYS ANTHROPOL, V103, P69, DOI 10.1002/(SICI)1096-8644(199705)103:1<69::AID-AJPA5>3.0.CO;2-8; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; SCHULZE ED, 1994, OECOLOGIA, V100, P406, DOI 10.1007/BF00317862; Schulze ED, 1996, OECOLOGIA, V106, P352, DOI 10.1007/BF00334563; Schwarcz H, 2006, HIST MAIZE MULTIDISC, P315; Schwarcz HP, 1999, J ARCHAEOL SCI, V26, P629, DOI 10.1006/jasc.1998.0380; SEALY JC, 1987, GEOCHIM COSMOCHIM AC, V51, P2707, DOI 10.1016/0016-7037(87)90151-7; SHEARER G, 1983, OECOLOGIA, V56, P365, DOI 10.1007/BF00379714; SHEARER G, 1986, AUST J PLANT PHYSIOL, V13, P699, DOI 10.1071/PP9860699; SHEARER G, 1978, SOIL SCI SOC AM J, V42, P899, DOI 10.2136/sssaj1978.03615995004200060013x; SHIMADA M, 1985, AM ANTIQUITY, V50, P3, DOI 10.2307/280631; SILFER JA, 1992, CHEM GEOL, V101, P211, DOI 10.1016/0009-2541(92)90003-N; Slovak NM, 2011, INT J OSTEOARCHAEOL, V21, P253, DOI 10.1002/oa.1128; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; SONESSON M, 1992, OECOLOGIA, V92, P23, DOI 10.1007/BF00317258; Sprent JI, 1996, OECOLOGIA, V105, P440, DOI 10.1007/BF00330006; Spriggs AC, 2003, PLANT SOIL, V255, P495, DOI 10.1023/A:1026044831178; STEELE KW, 1983, PLANT PHYSIOL, V72, P1001, DOI 10.1104/pp.72.4.1001; Swap RJ, 2004, GLOBAL CHANGE BIOL, V10, P350, DOI 10.1111/j.1365-2486.2003.00702.x; Syvertsen JP, 1997, J AM SOC HORTIC SCI, V122, P226, DOI 10.21273/JASHS.122.2.226; Szpak P, 2012, J ARCHAEOL SCI, V39, P3721, DOI 10.1016/j.jas.2012.06.035; Szpak P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033741; Szpak P, 2012, J ARCHAEOL SCI, V39, P1553, DOI 10.1016/j.jas.2011.12.006; Szpak P, 2011, J ARCHAEOL SCI, V38, P3358, DOI 10.1016/j.jas.2011.07.022; Szpak P, 2010, PALAEOGEOGR PALAEOCL, V286, P88, DOI 10.1016/j.palaeo.2009.12.009; Szpak P, 2009, J ARCHAEOL SCI, V36, P2734, DOI 10.1016/j.jas.2009.08.013; Terwilliger VJ, 1996, PHYTOCHEMISTRY, V43, P1183, DOI 10.1016/S0031-9422(96)00538-9; Tessone A, 2009, INT J OSTEOARCHAEOL, V19, P297, DOI 10.1002/oa.1039; Thornton EK, 2011, INT J OSTEOARCHAEOL, V21, P544, DOI 10.1002/oa.1157; Tieszen Larry, 1992, P 1 WORLD C MUMMY ST, P409; TIESZEN LL, 1993, J ARCHAEOL SCI, V20, P25, DOI 10.1006/jasc.1993.1002; Tomczak PD, 2003, J ANTHROPOL ARCHAEOL, V22, P262, DOI 10.1016/S0278-4165(03)00039-4; TOSI J, 1960, ZONAS VIDA NATURAL P; Towle M.A., 1961, ETHNOBOTANY PRECOLUM; Townsend-Small A, 2005, LIMNOL OCEANOGR, V50, P672, DOI 10.4319/lo.2005.50.2.0672; Troll C, 1968, C GEOGRAPHICUM, P15; Turner BL, 2010, CHUNGARA, V42, P515, DOI 10.4067/S0717-73562010000200012; Tykot RH, 2006, HIST MAIZE MULTIDISC, P187; van Groenigen JW, 2002, SOIL SCI SOC AM J, V66, P489, DOI 10.2136/sssaj2002.0489; Van Klinken GJ, 1999, J ARCHAEOL SCI, V26, P687, DOI 10.1006/jasc.1998.0385; VANDERMERWE NJ, 1989, GEOCHIM COSMOCHIM AC, V53, P1091, DOI 10.1016/0016-7037(89)90213-5; VANDERMERWE NJ, 1991, J ARCHAEOL SCI, V18, P249, DOI 10.1016/0305-4403(91)90064-V; VERANO JW, 1993, INVESTIGATIONS ANCIE, P361; VIRGINIA RA, 1982, OECOLOGIA, V54, P317, DOI 10.1007/BF00380000; Vitousek PM, 2002, BIOGEOCHEMISTRY, V57, P1, DOI 10.1023/A:1015798428743; VITOUSEK PM, 1990, OECOLOGIA, V84, P362, DOI 10.1007/BF00329760; Vizzini S, 2003, MAR BIOL, V142, P1009, DOI 10.1007/s00227-003-1027-6; VOGEL JC, 1978, OECOLOG PLANTAR, V13, P89; Voigt CC, 2010, BIOTROPICA, V42, P634, DOI 10.1111/j.1744-7429.2010.00703.x; Wainright SC, 1998, MAR BIOL, V131, P63, DOI 10.1007/s002270050297; Wang WL, 2003, BOT BULL ACAD SINICA, V44, P107; Warinner C, 2013, J ARCHAEOL SCI, V40, P868, DOI 10.1016/j.jas.2012.07.003; Waser NAD, 1998, LIMNOL OCEANOGR, V43, P215, DOI 10.4319/lo.1998.43.2.0215; West M, 1971, CALIFORNIA ANTHR, V1, P47; White CD, 2009, J ARCHAEOL SCI, V36, P1527, DOI 10.1016/j.jas.2009.03.008; WIENCKE C, 1990, MAR ECOL PROG SER, V65, P283, DOI 10.3354/meps065283; Williams JS, 2012, J ARCHAEOL SCI, V39, P41, DOI 10.1016/j.jas.2011.07.013; Winterhalder BP, 1978, GEOEC S HIGHL PER; Wittmer MHOM, 2011, PLANT SOIL, V340, P25, DOI 10.1007/s11104-010-0411-5; Wu JP, 1997, DEEP-SEA RES PT I, V44, P287, DOI 10.1016/S0967-0637(96)00099-4; Xu JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037438; Xu YQ, 2010, J PLANT ECOL-UK, V3, P201, DOI 10.1093/jpe/rtq023; Yacobaccio HD, 2009, INT J OSTEOARCHAEOL, V19, P144, DOI 10.1002/oa.1050; Yakir D, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034007; YONEYAMA T, 1993, PLANT SOIL, V153, P295, DOI 10.1007/BF00013003; YONEYAMA T, 1986, PLANT CELL PHYSIOL, V27, P791, DOI 10.1093/oxfordjournals.pcp.a077165; Yoneyama Tadakatsu, 2003, Phytochemistry Reviews, V2, P121, DOI 10.1023/B:PHYT.0000004198.95836.ad; Yun SI, 2006, SOIL BIOL BIOCHEM, V38, P1682, DOI 10.1016/j.soilbio.2005.11.022; ZIMMERMAN JK, 1990, OECOLOGIA, V83, P247, DOI 10.1007/BF00317759	235	99	100	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53763	10.1371/journal.pone.0053763	http://dx.doi.org/10.1371/journal.pone.0053763			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341996	gold, Green Published, Green Submitted			2022-12-25	WOS:000313682700043
J	Fu, SL; Sun, CF; Yang, MY; Fei, YY; Tan, FQ; Yan, BJ; Ren, ZL; Tang, ZX				Fu, Shulan; Sun, Chuanfei; Yang, Manyu; Fei, Yunyan; Tan, Feiqun; Yan, Benju; Ren, Zhenglong; Tang, Zongxiang			Genetic and Epigenetic Variations Induced by Wheat-Rye 2R and 5R Monosomic Addition Lines	PLOS ONE			English	Article							NEWLY SYNTHESIZED AMPHIPLOIDS; RAPID GENOMIC CHANGES; CHROMOSOMES; DNA; TRITICUM; POLYPLOIDIZATION; HETEROCHROMATIN; INTROGRESSION; METHYLATION; CHROMATIN	Background: Monosomic alien addition lines (MAALs) can easily induce structural variation of chromosomes and have been used in crop breeding; however, it is unclear whether MAALs will induce drastic genetic and epigenetic alterations. Methodology/Principal Findings: In the present study, wheat-rye 2R and 5R MAALs together with their selfed progeny and parental common wheat were investigated through amplified fragment length polymorphism (AFLP) and methylation-sensitive amplification polymorphism (MSAP) analyses. The MAALs in different generations displayed different genetic variations. Some progeny that only contained 42 wheat chromosomes showed great genetic/epigenetic alterations. Cryptic rye chromatin has introgressed into the wheat genome. However, one of the progeny that contained cryptic rye chromatin did not display outstanding genetic/epigenetic variation. 78 and 49 sequences were cloned from changed AFLP and MSAP bands, respectively. Blastn search indicated that almost half of them showed no significant similarity to known sequences. Retrotransposons were mainly involved in genetic and epigenetic variations. Genetic variations basically affected Gypsy-like retrotransposons, whereas epigenetic alterations affected Copia-like and Gypsy-like retrotransposons equally. Genetic and epigenetic variations seldom affected low-copy coding DNA sequences. Conclusions/Significance: The results in the present study provided direct evidence to illustrate that monosomic wheat-rye addition lines could induce different and drastic genetic/epigenetic variations and these variations might not be caused by introgression of rye chromatins into wheat. Therefore, MAALs may be directly used as an effective means to broaden the genetic diversity of common wheat.	[Fu, Shulan; Sun, Chuanfei; Yang, Manyu; Fei, Yunyan; Tan, Feiqun; Yan, Benju; Ren, Zhenglong; Tang, Zongxiang] Sichuan Agr Univ, State Key Lab Plant Breeding & Genet, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University	Fu, SL (corresponding author), Sichuan Agr Univ, State Key Lab Plant Breeding & Genet, Chengdu, Sichuan, Peoples R China.	fusl@sicau.edu.cn; zhlren@sohu.com			National Natural Science Foundation of China [31000713]; National High Technology Research and Development Program ("863" Program) of China [2011AA100101, 2011AA100103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program ("863" Program) of China(National High Technology Research and Development Program of China)	This study was supported by National Natural Science Foundation of China (No. 31000713) and by the National High Technology Research and Development Program ("863" Program) of China (No. 2011AA100101; 2011AA100103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhimova AG, 1999, CHROMOSOME RES, V7, P205, DOI 10.1023/A:1009299300018; APPELS R, 1982, THEOR APPL GENET, V63, P235, DOI 10.1007/BF00304002; Bento M, 2010, THEOR APPL GENET, V121, P489, DOI 10.1007/s00122-010-1325-6; Bento M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001402; Brar DS, 1997, PLANT MOL BIOL, V35, P35, DOI 10.1023/A:1005825519998; Chen JF, 2004, THEOR APPL GENET, V108, P1343, DOI 10.1007/s00122-003-1546-z; Chevre AM, 1996, PLANT BREEDING, V115, P113, DOI 10.1111/j.1439-0523.1996.tb00884.x; GUSTAFSON JP, 1983, CHROMOSOMA, V88, P293, DOI 10.1007/BF00292906; Han FP, 2006, P NATL ACAD SCI USA, V103, P3238, DOI 10.1073/pnas.0509650103; Katto MC, 2004, GENES GENET SYST, V79, P245, DOI 10.1266/ggs.79.245; LAPITAN NLV, 1984, THEOR APPL GENET, V68, P547, DOI 10.1007/BF00285012; Liu B, 1998, GENOME, V41, P272, DOI 10.1139/gen-41-2-272; Ma XF, 2004, GENOME, V47, P839, DOI [10.1139/g04-051, 10.1139/G04-051]; Ma XF, 2006, GENOME, V49, P950, DOI 10.1139/G06-078; Multani DS, 2003, THEOR APPL GENET, V107, P395, DOI 10.1007/s00122-003-1214-3; REAMONRAMOS SM, 1992, THEOR APPL GENET, V84, P411, DOI 10.1007/BF00229501; Ren ZL, 1997, SCI CHINA SER C, V40, P323, DOI 10.1007/BF02879094; REN ZL, 1990, PLANT BREEDING, V105, P257, DOI 10.1111/j.1439-0523.1990.tb01283.x; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Singh RJ, 1998, CROP SCI, V38, P1483, DOI 10.2135/cropsci1998.0011183X003800060013x; Szakacs E, 2010, J APPL GENET, V51, P149, DOI 10.1007/BF03195723; Tang ZX, 2008, GENOME, V51, P399, DOI 10.1139/G08-027; Tang ZX, 2012, INT J PLANT SCI, V173, P1, DOI 10.1086/662655; van Heusden AW, 2000, THEOR APPL GENET, V100, P480, DOI 10.1007/s001220050062; ZHANG HB, 1995, PLANT J, V7, P175, DOI 10.1046/j.1365-313X.1995.07010175.x; Zhang Y, 2008, CHINESE SCI BULL, V53, P58, DOI 10.1007/s11434-008-0049-3	26	14	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54057	10.1371/journal.pone.0054057	http://dx.doi.org/10.1371/journal.pone.0054057			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342073	Green Submitted, Green Published, gold			2022-12-25	WOS:000314759400116
J	Oliveira, AF; Yasuda, R				Oliveira, Ana F.; Yasuda, Ryohei			An Improved Ras Sensor for Highly Sensitive and Quantitative FRET-FLIM Imaging	PLOS ONE			English	Article							GROWTH-FACTOR; RHO GTPASES; ACTIVATION; PROTEINS; TRAFFICKING; PLASTICITY; TARGETS; BINDING	Ras is a signaling protein involved in a variety of cellular processes. Hence, studying Ras signaling with high spatiotemporal resolution is crucial to understanding the roles of Ras in many important cellular functions. Previously, fluorescence lifetime imaging (FLIM) of fluorescent resonance energy transfer (FRET)-based Ras activity sensors, FRas and FRas-F, have been demonstrated to be useful for measuring the spatiotemporal dynamics of Ras signaling in subcellular micro-compartments. However the predominantly nuclear localization of the sensors' acceptor has limited its sensitivity. Here, we have overcome this limitation and developed two variants of the existing FRas sensor with different affinities: FRas2-F (K-d similar to 1.7 mu M) and FRas2-M (K-d similar to 0.5 mu M). We demonstrate that, under 2-photon fluorescence lifetime imaging microscopy, FRas2 sensors provide higher sensitivity compared to previous sensors in 293T cells and neurons.	[Oliveira, Ana F.; Yasuda, Ryohei] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Oliveira, Ana F.] Univ Coimbra, Ctr Neurosci & Cell Biol, Doctoral Program Biomed & Expt Biol, Coimbra, Portugal; [Yasuda, Ryohei] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Yasuda, Ryohei] Max Planck Florida Inst, Jupiter, FL USA	Duke University; Universidade de Coimbra; Duke University; Howard Hughes Medical Institute; Max Planck Society	Yasuda, R (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	Ryohei.Yasuda@mpfi.org		Yasuda, Ryohei/0000-0001-6263-9297; Oliveira, Ana/0000-0002-0330-3643	National Institute of Health [R01MH080047, R01NS068410]; Portuguese Foundation for Science and Technology [SFRH/BD/15226/2004]; Children's Tumor Foundation [2009-01-014]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS068410] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Children's Tumor Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study is funded by National Institute of Health (R01MH080047, R01NS068410), the Pre-Doctoral Fellowship from the Portuguese Foundation for Science and Technology (SFRH/BD/15226/2004) and Young Investigator Award, Children's Tumor Foundation (YIA # 2009-01-014). and the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Habas A, 2006, J NEUROCHEM, V96, P335, DOI 10.1111/j.1471-4159.2005.03543.x; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Hetman M, 2002, J BIOL CHEM, V277, P49577, DOI 10.1074/jbc.M111227200; Jaitner BK, 1997, J BIOL CHEM, V272, P29927, DOI 10.1074/jbc.272.47.29927; LACOWICZ JR, 2006, PRINCIPLES FLUORESCE; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; MEDEMA RH, 1993, MOL CELL BIOL, V13, P155, DOI 10.1128/MCB.13.1.155; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Murakoshi H, 2011, NATURE, V472, P100, DOI 10.1038/nature09823; Murakoshi H, 2008, BRAIN CELL BIOL, V36, P31, DOI 10.1007/s11068-008-9024-9; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Raaijmakers JH, 2009, J BIOL CHEM, V284, P10995, DOI 10.1074/jbc.R800061200; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Stornetta RL, 2011, NEUROSCIENTIST, V17, P54, DOI 10.1177/1073858410365562; Szatmari E, 2007, J NEUROSCI, V27, P11389, DOI 10.1523/JNEUROSCI.3473-07.2007; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Wimmer R, 2010, TRENDS BIOCHEM SCI, V35, P660, DOI 10.1016/j.tibs.2010.06.001; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Ye XJ, 2010, NEURON, V68, P340, DOI 10.1016/j.neuron.2010.09.013; Zhao J, 2002, BIOCHEM BIOPH RES CO, V297, P653, DOI 10.1016/S0006-291X(02)02257-X; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	28	21	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52874	10.1371/journal.pone.0052874	http://dx.doi.org/10.1371/journal.pone.0052874			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23349692	Green Submitted, gold, Green Published			2022-12-25	WOS:000314759400025
J	Young, MH; U'Ren, L; Huang, SX; Mallevaey, T; Scott-Browne, J; Crawford, F; Lantz, O; Hansen, TH; Kappler, J; Marrack, P; Gapin, L				Young, Mary H.; U'Ren, Lance; Huang, Shouxiong; Mallevaey, Thierry; Scott-Browne, James; Crawford, Frances; Lantz, Olivier; Hansen, Ted H.; Kappler, John; Marrack, Philippa; Gapin, Laurent			MAIT Cell Recognition of MR1 on Bacterially Infected and Uninfected Cells	PLOS ONE			English	Article							INVARIANT T-CELLS; MHC-RELATED PROTEIN-1; ANTIGEN PRESENTATION	Mucosal-associated invariant T cells are a unique population of T cells that express a semi-invariant ab TCR and are restricted by the MHC class I-related molecule MR1. MAIT cells recognize uncharacterized ligand(s) presented by MR1 through the cognate interaction between their TCR and MR1. To understand how the MAIT TCR recognizes MR1 at the surface of APCs cultured both with and without bacteria, we undertook extensive mutational analysis of both the MAIT TCR and MR1 molecule. We found differential contribution of particular amino acids to the MAIT TCR-MR1 interaction based upon the presence of bacteria, supporting the hypothesis that the structure of the MR1 molecules with the microbial-derived ligand(s) differs from the one with the endogenous ligand(s). Furthermore, we demonstrate that microbial-derived ligand(s) is resistant to proteinase K digestion and does not extract with common lipids, suggesting an unexpected class of antigen(s) might be recognized by this unique lymphocyte population.	[Young, Mary H.; U'Ren, Lance; Mallevaey, Thierry; Scott-Browne, James; Crawford, Frances; Kappler, John; Marrack, Philippa; Gapin, Laurent] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO USA; [Young, Mary H.; U'Ren, Lance; Mallevaey, Thierry; Scott-Browne, James; Crawford, Frances; Kappler, John; Marrack, Philippa; Gapin, Laurent] Univ Colorado, Sch Med, Denver, CO USA; [Kappler, John; Marrack, Philippa] Univ Colorado, Howard Hughes Med Inst, Sch Med, Aurora, CO USA; [Kappler, John; Marrack, Philippa] Univ Colorado, Dept Med, Sch Med, Aurora, CO USA; [Kappler, John] Univ Colorado, Dept Pharmacol, Sch Med, Aurora, CO USA; [Kappler, John] Univ Colorado, Program Biomol Struct, Sch Med, Aurora, CO USA; [Marrack, Philippa] Univ Colorado, Dept Biochem & Mol Genet, Sch Med, Aurora, CO USA; [Lantz, Olivier] Inst Curie, INSERM, U732, Paris, France; [Huang, Shouxiong; Hansen, Ted H.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Washington University (WUSTL)	Marrack, P (corresponding author), Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO USA.	marrackp@njhealth.org; gapinl@njhealth.org	Mallevaey, Thierry/AAH-4499-2020; Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687; Huang, Shouxiong/0000-0001-7797-3626; Lantz, olivier/0000-0003-3161-7719	National Institutes of Health (NIH) [AI18785, AI22295, AI046553, AI078246, AI076463, AI092108]; ANR; NIH [T32 AI07405]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI022295, R56AI078246, R01AI018785, R37AI018785, R01AI046553, T32AI007405, R21AI076463, R01AI092108, R56AI018785] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ANR(French National Research Agency (ANR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (NIH) (AI18785 and AI22295 to PM and JWK, AI046553 to TH and AI078246, AI076463 and AI092108 to LG) and an ANR grant to OL. JPS-B and MHY were supported by an NIH training grant (T32 AI07405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chua WJ, 2011, J IMMUNOL, V186, P4744, DOI 10.4049/jimmunol.1003254; Chua WJ, 2012, INFECT IMMUN; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gapin L, 2010, NAT REV IMMUNOL, V10, P272, DOI 10.1038/nri2743; Georgel P, 2011, MOL IMMUNOL, V48, P769, DOI 10.1016/j.molimm.2010.12.002; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Huang SX, 2008, J EXP MED, V205, P1201, DOI 10.1084/jem.20072579; Huang SX, 2009, P NATL ACAD SCI USA, V106, P8290, DOI 10.1073/pnas.0903196106; Huang SX, 2005, J BIOL CHEM, V280, P21183, DOI 10.1074/jbc.M501087200; Kawachi I, 2006, J IMMUNOL, V176, P1618, DOI 10.4049/jimmunol.176.3.1618; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; Miley MJ, 2003, J IMMUNOL, V170, P6090, DOI 10.4049/jimmunol.170.12.6090; Reantragoon R, 2012, J EXP MED, V209, P761, DOI 10.1084/jem.20112095; Scott-Browne JP, 2009, NATURE, V458, P1043, DOI 10.1038/nature07812; Shimamura M, 2008, MINI-REV MED CHEM, V8, P285, DOI 10.2174/138955708783744119; Tilloy F, 1999, J EXP MED, V189, P1907, DOI 10.1084/jem.189.12.1907; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Yamaguchi H, 1997, BIOCHEM BIOPH RES CO, V238, P697, DOI 10.1006/bbrc.1997.7379	21	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53789	10.1371/journal.pone.0053789	http://dx.doi.org/10.1371/journal.pone.0053789			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342002	Green Submitted, gold, Green Published			2022-12-25	WOS:000314759400083
J	Zhang, JP; Fei, T; Li, ZW; Zhu, GY; Wang, L; Chen, YG				Zhang, Jianping; Fei, Teng; Li, Zhongwei; Zhu, Gaoyang; Wang, Lu; Chen, Ye-Guang			BMP Induces Cochlin Expression to Facilitate Self- renewal and Suppress Neural Differentiation of Mouse Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA INHIBITORY FACTOR; FUNCTIONAL-CHARACTERIZATION; DEVELOPMENTAL REGULATORS; BETA; SPECIFICITY; ACTIVATION; BINDING; IDENTIFICATION; POLYCOMB; PROMOTER	BMP4 maintains self-renewal of mouse embryonic stem cells (ESCs) in collaboration with LIF. Here, we report the identification of a novel key BMP target gene, cochlin (Coch) in mouse ESCs. Coch can be significantly up-regulated by BMP4 specifically in ESCs but not in somatic differentiated cells, and this up-regulation is dependent on the BMP signaling mediators Smad1/5 and Smad4. Overexpression of Coch can partially substitute BMP4 to promote self-renewal of mouse ESCs together with LIF, whereas knockdown of Coch impairs self-renewal marker gene expression even in the presence of both BMP4 and LIF. Further studies showed that COCH could mimic BMP4 in repressing neural differentiation of mouse ESCs upon LIF withdrawal and the inhibitory effect of BMP4 on neural differentiation is compromised by Coch knockdown. Taken together, our data suggest that COCH is a part of the downstream target network of BMP signaling and serves as another important effector to fine-tune mouse ESC fates.	[Zhang, Jianping; Fei, Teng; Li, Zhongwei; Zhu, Gaoyang; Wang, Lu; Chen, Ye-Guang] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China	Tsinghua University	Chen, YG (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China.	ygchen@tsinghua.edu.cn	Chen, Ye-Guang/L-6998-2019; Fei, Teng/G-5324-2015	Fei, Teng/0000-0001-5707-0673; FEI, TENG/0000-0001-9620-0450	National Key Basic Research Program of China (973 Program) [2011CB943803]; National Natural Science Foundation of China [30930050, 30921004]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Key Basic Research Program of China (973 Program) (2011CB943803) and the National Natural Science Foundation of China (30930050, 30921004) (to Y.G.C.).	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Bhattacharya SK, 2009, INVEST OPHTH VIS SCI, V50, P551, DOI 10.1167/iovs.08-2632; Bibikova M, 2008, CELL STEM CELL, V2, P123, DOI 10.1016/j.stem.2008.01.005; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Christophersen NS, 2010, J EXP MED, V207, P2287, DOI 10.1084/jem.20101438; Cole MF, 2008, COLD SH Q B, V73, P183, DOI 10.1101/sqb.2008.73.027; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fei T, 2010, SCI CHINA LIFE SCI, V53, P497, DOI 10.1007/s11427-010-0096-2; Fei T, 2010, GENOME RES, V20, P36, DOI 10.1101/gr.092114.109; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Ishida W, 2000, J BIOL CHEM, V275, P6075, DOI 10.1074/jbc.275.9.6075; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kusanagi K, 2000, MOL BIOL CELL, V11, P555, DOI 10.1091/mbc.11.2.555; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li ZW, 2012, PROTEIN CELL, V3, P401, DOI 10.1007/s13238-012-2925-5; Li ZW, 2012, CELL STEM CELL, V10, P171, DOI 10.1016/j.stem.2011.12.016; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, GENE DEV, V14, P627; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Rodriguez CI, 2004, ENDOCRINOLOGY, V145, P1410, DOI 10.1210/en.2003-1361; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032	35	22	24	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8053	8060		10.1074/jbc.M112.433995	http://dx.doi.org/10.1074/jbc.M112.433995			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23344953	hybrid, Green Published			2022-12-25	WOS:000316564500006
J	Jiang, ZY; Applegate, TJ; Lossie, AC				Jiang, Zhengyu; Applegate, Todd J.; Lossie, Amy C.			Cloning, Annotation and Developmental Expression of the Chicken Intestinal MUC2 Gene	PLOS ONE			English	Article							MOLECULAR-CLONING; C-TERMINUS; SEQUENCE; LAYERS; DOMAIN; DATABASE; COLITIS; CELLS; GLYCOSYLATION; COLLECTION	Intestinal mucin 2 (MUC2) encodes a heavily glycosylated, gel-forming mucin, which creates an important protective mucosal layer along the gastrointestinal tract in humans and other species. This first line of defense guards against attacks from microorganisms and is integral to the innate immune system. As a first step towards characterizing the innate immune response of MUC2 in different species, we report the cloning of a full-length, 11,359 bp chicken MUC2 cDNA, and describe the genomic organization and functional annotation of this complex, 74.5 kb locus. MUC2 contains 64 exons and demonstrates distinct spatiotemporal expression profiles throughout development in the gastrointestinal tract; expression increases with gestational age and from anterior to posterior along the gut. The chicken protein has a similar domain organization as the human orthologue, with a signal peptide and several von Willebrand domains in the N-terminus and the characteristic cystine knot at the C-terminus. The PTS domain of the chicken MUC2 protein spans similar to 1600 amino acids and is interspersed with four CysD motifs. However, the PTS domain in the chicken diverges significantly from the human orthologue; although the chicken domain is shorter, the repetitive unit is 69 amino acids in length, which is three times longer than the human. The amino acid composition shows very little similarity to the human motif, which potentially contributes to differences in the innate immune response between species, as glycosylation across this rapidly evolving domain provides much of the musical barrier. Future studies of the function of MUC2 in the innate immune response system in chicken could provide an important model organism to increase our understanding of the biological significance of MUC2 in host defense and highlight the potential of the chicken for creating new immune-based therapies.	[Jiang, Zhengyu; Applegate, Todd J.; Lossie, Amy C.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Lossie, Amy C.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University Bloomington	Lossie, AC (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.	alossie@purdue.edu	Lossie, Amy/D-2480-2009	Lossie, Amy/0000-0001-5078-7743; Applegate, Todd/0000-0002-2406-5058	Biomin Research Center, (Tulln, Austria); BBSRC [BBS/E/D/20310000] Funding Source: UKRI; MRC [MR/K001744/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20310000] Funding Source: researchfish; Medical Research Council [MR/K001744/1] Funding Source: researchfish	Biomin Research Center, (Tulln, Austria); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded through state and federal funds appropriated to Purdue University, as well as through gift funds from Biomin Research Center, (Tulln, Austria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambort D, 2012, P NATL ACAD SCI USA, V109, P5645, DOI 10.1073/pnas.1120269109; Ambort D, 2011, BIOCHEM J, V436, P61, DOI 10.1042/BJ20102066; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Asker N, 1998, J BIOL CHEM, V273, P18857, DOI 10.1074/jbc.273.30.18857; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Boardman PE, 2002, CURR BIOL, V12, P1965, DOI 10.1016/S0960-9822(02)01296-4; Buisine MP, 1998, GUT, V43, P519, DOI 10.1136/gut.43.4.519; Burger-van Paassen N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038798; Burger-van Paassen N, 2011, AM J PHYSIOL-GASTR L, V301, pG667, DOI 10.1152/ajpgi.00199.2010; Byrne CM, 2007, MICROBIOL-SGM, V153, P561, DOI 10.1099/mic.0.2006/000711-0; CHAMBERS JA, 1994, J CELL SCI, V107, P413; Collier CT, 2008, VET IMMUNOL IMMUNOP, V122, P104, DOI 10.1016/j.vetimm.2007.10.014; Desseyn JL, 2008, GENE, V410, P215, DOI 10.1016/j.gene.2007.12.014; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Escande F, 2004, BBA-GENE STRUCT EXPR, V1676, P240, DOI 10.1016/j.bbaexp.2004.01.001; Galperin MY, 2009, NUCLEIC ACIDS RES, V37, pD1, DOI 10.1093/nar/gkn942; Godl K, 2002, J BIOL CHEM, V277, P47248, DOI 10.1074/jbc.M208483200; GUM JR, 1989, J BIOL CHEM, V264, P6480; GUM JR, 1994, J BIOL CHEM, V269, P2440; Hansson GC, 2012, CURR OPIN MICROBIOL, V15, P57, DOI 10.1016/j.mib.2011.11.002; Hasnain SZ, 2010, GASTROENTEROLOGY, V138, P1763, DOI 10.1053/j.gastro.2010.01.045; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Heger A, 2000, PROTEINS, V41, P224, DOI 10.1002/1097-0134(20001101)41:2<224::AID-PROT70>3.0.CO;2-Z; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Hoorens PR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-140; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Jeong YH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001163; Jiang ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022691; Johansson MEV, 2011, CELL MOL LIFE SCI, V68, P3635, DOI 10.1007/s00018-011-0822-3; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Karcher DM, 2009, GROWTH HORM IGF RES, V19, P31, DOI 10.1016/j.ghir.2008.05.003; Karlsson NG, 1996, GLYCOCONJUGATE J, V13, P823, DOI 10.1007/BF00702346; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Lang TA, 2007, P NATL ACAD SCI USA, V104, P16209, DOI 10.1073/pnas.0705984104; Lang TG, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-197; Larsson JMH, 2009, GLYCOBIOLOGY, V19, P756, DOI 10.1093/glycob/cwp048; Lidell ME, 2003, BIOCHEM J, V372, P335, DOI 10.1042/BJ20030003; Lu P, 2011, INFLAMM BOWEL DIS, V17, P2047, DOI 10.1002/ibd.21592; Matsuoka Y, 1999, BBA-GENE STRUCT EXPR, V1489, P336, DOI 10.1016/S0167-4781(99)00186-4; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Sternberg LR, 2004, ARCH BIOCHEM BIOPHYS, V421, P21, DOI 10.1016/j.abb.2003.10.002; TAM PY, 1981, NATURE, V292, P340, DOI 10.1038/292340a0; Uni Z, 2003, POULTRY SCI, V82, P320, DOI 10.1093/ps/82.2.320; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Wang P, 1997, J BIOL CHEM, V272, P16663, DOI 10.1074/jbc.272.26.16663; Watanabe K, 2004, DNA SEQUENCE, V15, P251, DOI 10.1080/10425170410001723921; Xu GQ, 2000, EUR J BIOCHEM, V267, P2998, DOI 10.1046/j.1432-1327.2000.01319.x	51	30	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e53781	10.1371/journal.pone.0053781	http://dx.doi.org/10.1371/journal.pone.0053781			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349743	Green Published, Green Submitted, gold			2022-12-25	WOS:000313943000017
J	Munang'andu, HM; Sandtro, A; Mutoloki, S; Brudeseth, BE; Santi, N; Evensen, O				Munang'andu, Hetron M.; Sandtro, Ane; Mutoloki, Stephen; Brudeseth, Bjorn E.; Santi, Nina; Evensen, Oystein			Immunogenicity and Cross Protective Ability of the Central VP2 Amino Acids of Infectious Pancreatic Necrosis Virus in Atlantic Salmon (Salmo salar L.)	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; BROOK TROUT; AQUATIC BIRNAVIRUSES; CARRIER STATE; PROTEIN VP2; VIRULENCE; VACCINE; CHALLENGE; STRAIN; IPNV	Infectious pancreatic necrosis virus (IPNV) is a member of the family Birnaviridae that has been linked to high mortalities in juvenile salmonids and postsmolt stages of Atlantic salmon (Salmo salar L.) after transfer to seawater. IPN vaccines have been available for a long time but their efficacy has been variable. The reason for the varying immune response to these vaccines has not well defined and studies on the importance of using vaccine trains homologous to the virulent field strain has not been conclusive. In this study we prepared one vaccine identical to the virulent Norwegian Sp strain NVI-015 (NCBI: 379740) (T(217)A(221)T(247) of VP2) and three other vaccine strains developed using the same genomic backbone altered by reverse genetics at three residues yielding variants, T217T221T247, P(217)A(221)A(24)7, P(217)T(221)A(247). These 4 strains, differing in these three positions only, were used as inactivated, oil-adjuvanted vaccines while two strains, T(217)A(221)T(247) and P(217)T(221)A(247), were used as live vaccines. The results show that these three residues of the VP2 capsid play a key role for immunogenicity of IPNV vaccines. The virulent strain for inactivated vaccines elicited the highest level of virus neutralization (VN) titers and ELISA antibodies. Interestingly, differences in immunogenicity were not reflected in differences in post challenge survival percentages (PCSP) for oil-adjuvanted, inactivated vaccines but clearly so for live vaccines (TAT and PTA). Further post challenge viral carrier state correlated inversely with VN titers at challenge for inactivated vaccines and prevalence of pathology in target organs inversely correlated with protection for live vaccines. Overall, our findings show that a few residues localized on the VP2-capsid are important for immunogenicity of IPNV vaccines.	[Munang'andu, Hetron M.; Sandtro, Ane; Mutoloki, Stephen; Evensen, Oystein] Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, Oslo, Norway; [Brudeseth, Bjorn E.] PHARMAQ AS, Oslo, Norway; [Santi, Nina] AquaGen, Trondheim, Norway	Norwegian University of Life Sciences	Evensen, O (corresponding author), Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, Oslo, Norway.	oystein.evensen@nvh.no	Munang'andu, Hetron Mweemba/C-5926-2014; Evensen, Øystein/O-3011-2015	Munang'andu, Hetron Mweemba/0000-0002-1021-6396; Evensen, Øystein/0000-0002-4856-3043	Research Council of Norway [183204]	Research Council of Norway(Research Council of Norway)	This work was performed with financial support from the Research Council of Norway, project no. 183204. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audibert F, 2003, INT IMMUNOPHARMACOL, V3, P1187, DOI 10.1016/S1567-5769(03)00011-0; Bain N, 2008, J FISH DIS, V31, P37, DOI 10.1111/j.1365-2761.2007.00864.x; Belshe RB, 2000, J INFECT DIS, V181, P1133, DOI 10.1086/315323; Biering E, 2005, DEV BIOLOGICALS, V121, P97; BOOTLAND LM, 1991, DIS AQUAT ORGAN, V10, P13, DOI 10.3354/dao010013; BOOTLAND LM, 1986, VET IMMUNOL IMMUNOP, V12, P365, DOI 10.1016/0165-2427(86)90142-X; BROOME C V, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P219; Bruslind LD, 2000, J AQUAT ANIM HEALTH, V12, P301, DOI 10.1577/1548-8667(2000)012&lt;0301:VCOTBS&gt;2.0.CO;2; Calhoun K, 2011, ARCH PATHOL LAB MED, V135, P207, DOI 10.1043/1543-2165-135.2.207; CASWELLRENO P, 1989, J CLIN MICROBIOL, V27, P1924, DOI 10.1128/JCM.27.9.1924-1929.1989; Coulibaly F, 2010, J VIROL, V84, P1792, DOI 10.1128/JVI.01536-09; DAVIES JR, 1989, EPIDEMIOL INFECT, V102, P325, DOI 10.1017/S0950268800030004; DOBOS P, 1977, J VIROL, V24, P805, DOI 10.1128/JVI.24.3.805-820.1977; DOBOS P, 1976, NUCLEIC ACIDS RES, V3, P1903, DOI 10.1093/nar/3.8.1903; DOBOS P, 1983, CAN J MICROBIOL, V29, P377, DOI 10.1139/m83-062; DOMINGUEZ J, 1990, DIS AQUAT ORGAN, V8, P157, DOI 10.3354/dao008157; Evensen O, 1990, J Vet Diagn Invest, V2, P288; Evensen O., 2008, ENCY VIROLOGY, P83, DOI DOI 10.1016/B978-012374410-4.00772-X; FROST P, 1995, J GEN VIROL, V76, P1165, DOI 10.1099/0022-1317-76-5-1165; Gomez-Casado E, 2011, VACCINE, V29, P2657, DOI 10.1016/j.vaccine.2011.01.097; GOODEVE A, 1983, J HYG-CAMBRIDGE, V90, P107, DOI 10.1017/S0022172400063907; Gudding R, 1999, VET IMMUNOL IMMUNOP, V72, P203, DOI 10.1016/S0165-2427(99)00133-6; HAHN CS, 1987, P NATL ACAD SCI USA, V84, P2019, DOI 10.1073/pnas.84.7.2019; HEPPELL J, 1995, VIROLOGY, V214, P40, DOI 10.1006/viro.1995.9956; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Levitz SM, 2012, CELL, V148, P1284, DOI 10.1016/j.cell.2012.02.012; LIAO L, 1995, VIROLOGY, V209, P684, DOI 10.1006/viro.1995.1304; MASUREL N, 1984, J HYG-CAMBRIDGE, V92, P263, DOI 10.1017/S0022172400064500; MEIKLEJOHN G, 1952, AM J HYG, V55, P12, DOI 10.1093/oxfordjournals.aje.a119500; MELBY HP, 1994, J FISH DIS, V17, P409, DOI 10.1111/j.1365-2761.1994.tb00236.x; Melby HP, 1995, J FISH DIS, V18, P579, DOI 10.1111/j.1365-2761.1995.tb00362.x; Munang'andu HM, 2012, VACCINE, V30, P4007, DOI 10.1016/j.vaccine.2012.04.039; Mutoloki S, 2011, J GEN VIROL, V92, P1721, DOI 10.1099/vir.0.030270-0; Santi N, 2005, VIROLOGY, V342, P13, DOI 10.1016/j.virol.2005.07.028; Santi N, 2005, J VIROL, V79, P9206, DOI 10.1128/JVI.79.14.9206-9216.2005; Santi N, 2004, VIROLOGY, V322, P31, DOI 10.1016/j.virol.2003.12.016; Skjesol A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-396; Song HC, 2005, J VIROL, V79, P10289, DOI 10.1128/JVI.79.16.10289-10299.2005; TARRAB E, 1993, J GEN VIROL, V74, P2025, DOI 10.1099/0022-1317-74-9-2025; TARRAB E, 1995, J GEN VIROL, V76, P551, DOI 10.1099/0022-1317-76-3-551; WOLSKI SC, 1986, VET IMMUNOL IMMUNOP, V12, P373, DOI 10.1016/0165-2427(86)90143-1; Yao K, 1998, J VIROL, V72, P8913, DOI 10.1128/JVI.72.11.8913-8920.1998	42	27	29	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54263	10.1371/journal.pone.0054263	http://dx.doi.org/10.1371/journal.pone.0054263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349841	gold, Green Published, Green Submitted			2022-12-25	WOS:000313943000033
J	Rish, I; Cecchi, G; Thyreau, B; Thirion, B; Plaze, M; Paillere-Martinot, ML; Martelli, C; Martinot, JL; Poline, JB				Rish, Irina; Cecchi, Guillermo; Thyreau, Benjamin; Thirion, Bertrand; Plaze, Marion; Paillere-Martinot, Marie Laure; Martelli, Catherine; Martinot, Jean-Luc; Poline, Jean-Baptiste			Schizophrenia as a Network Disease: Disruption of Emergent Brain Function in Patients with Auditory Hallucinations	PLOS ONE			English	Article							SMALL-WORLD NETWORKS; CONNECTIVITY	Schizophrenia is a psychiatric disorder that has eluded characterization in terms of local abnormalities of brain activity, and is hypothesized to affect the collective, "emergent" working of the brain. Indeed, several recent publications have demonstrated that functional networks in the schizophrenic brain display disrupted topological properties. However, is it possible to explain such abnormalities just by alteration of local activation patterns? This work suggests a negative answer to this question, demonstrating that significant disruption of the topological and spatial structure of functional MRI networks in schizophrenia (a) cannot be explained by a disruption to area-based task-dependent responses, i.e. indeed relates to the emergent properties, (b) is global in nature, affecting most dramatically long-distance correlations, and (c) can be leveraged to achieve high classification accuracy (93%) when discriminating between schizophrenic vs control subjects based just on a single fMRI experiment using a simple auditory task. While the prior work on schizophrenia networks has been primarily focused on discovering statistically significant differences in network properties, this work extends the prior art by exploring the generalization (prediction) ability of network models for schizophrenia, which is not necessarily captured by such significance tests.	[Rish, Irina; Cecchi, Guillermo] IBM Corp, TJ Watson Res Ctr, Computat Biol Ctr, Yorktown Hts, NY USA; [Thyreau, Benjamin; Thirion, Bertrand; Poline, Jean-Baptiste] CEA Saclay, Neurospin, Saclay, France; [Thirion, Bertrand] INRIA Saclay Ile de France, EPI Parietal, Saclay, France; [Plaze, Marion; Martinot, Jean-Luc] Univ Paris Sud, INSERM, CEA, U797 Neuroimaging & Psychiat SHFJ, Orsay, France; [Plaze, Marion; Martinot, Jean-Luc] Neurospin, Orsay, France; [Paillere-Martinot, Marie Laure] Univ Paris 05, Cochin Hosp, AP HP, Adolescent Psychopathol & Med Dept Maison de Sole, Paris, France; [Martelli, Catherine] Ctr Hosp Paul Brousse, Dept Psychiat & Addictol, Villejuif, France	International Business Machines (IBM); CEA; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP	Rish, I (corresponding author), IBM Corp, TJ Watson Res Ctr, Computat Biol Ctr, Yorktown Hts, NY USA.	rish@us.ibm.com	Martinot, Jean-Luc/N-3704-2018	Plaze, Marion/0000-0001-9022-4945	INSERM [RBM 01-26]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	We would like to thank Rahul Garg for his help with the data preprocessing and many stimulating discussions that contributed to the ideas of this paper, and Drs. Andre Galinowski, Thierry Gallarda, and Frank Bellivier who recruited and clinically rated the patients. We also would like to thank INSERM as promotor of the MR data acquired (project RBM 01-26).	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Banerjee O, 2008, J MACH LEARN RES, V9, P485; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Benedetti F, 2010, GENES BRAIN BEHAV, V9, P365, DOI 10.1111/j.1601-183X.2010.00566.x; Bleuler E., 1911, DEMENTIA PRAECOX GRO; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Braun P, 2008, P NATL ACAD SCI USA, V105, P9849, DOI 10.1073/pnas.0805644105; Burkard TR, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-17; Cecchi G, 2009, P NIPS 09; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; FRISTON KJ, 1995, CLIN NEUROSCI, V3, P89; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Garg R, 2011, NEUROIMAGE, V58, P416, DOI 10.1016/j.neuroimage.2011.02.074; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Haken H., 2002, BRAIN DYNAMICS; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Kircher TTJ, 2005, BRIT J PSYCHIAT, V186, P209, DOI 10.1192/bjp.186.3.209; Lauritzen S.L, 1996, GRAPHICAL MODELS; Lawrie SM, 2002, BIOL PSYCHIAT, V51, P1008, DOI 10.1016/S0006-3223(02)01316-1; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Mandl RCW, 2010, SCHIZOPHRENIA BULL, V36, P778, DOI 10.1093/schbul/sbn161; Meyer-Lindenberg A, 2001, AM J PSYCHIAT, V158, P1809, DOI 10.1176/appi.ajp.158.11.1809; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Monk CS, 2009, NEUROIMAGE, V47, P764, DOI 10.1016/j.neuroimage.2009.04.069; Plaze M, 2006, SCHIZOPHR RES, V87, P109, DOI 10.1016/j.schres.2006.05.005; Rish I, 2012, P SPIE MED IM 2012; Stephan KE, 2009, SCHIZOPHRENIA BULL, V35, P509, DOI 10.1093/schbul/sbn176; Storkey A. J., 2007, ADV NEURAL INFORM PR, V19, P1329; Thirion B, 2006, HUM BRAIN MAPP, V27, P678, DOI 10.1002/hbm.20210; Valdes-Sosa PA, 2005, PHILOS T R SOC B, V360, P969, DOI 10.1098/rstb.2005.1654; WERNICKE C, 1906, GRUNDRISSE PSYCHIAT; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; Yu QB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025423; Zhang L., 2006, ADV NEURAL INF PROCE, V18, P1593; Zhou Y, 2007, SCHIZOPHR RES, V97, P194, DOI 10.1016/j.schres.2007.05.029	37	23	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e50625	10.1371/journal.pone.0050625	http://dx.doi.org/10.1371/journal.pone.0050625			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349665	Green Submitted, Green Published, gold			2022-12-25	WOS:000313943000002
J	Dong, B; Wang, AX; Yuan, LH; Chen, LS; Pu, KF; Duan, W; Yan, XY; Zhu, YM				Dong, Bing; Wang, Anxin; Yuan, Lihua; Chen, Lisha; Pu, Kefeng; Duan, Wei; Yan, Xiyun; Zhu, Yimin			Peptide-Fluorescent Bacteria Complex as Luminescent Reagents for Cancer Diagnosis	PLOS ONE			English	Article							FROZEN-SECTION; THERAPY; EXPRESSION; DELIVERY; CELLS	Currently in clinic, people use hematoxylin and eosin stain (H&E stain) and immunohistochemistry methods to identify the generation and genre of cancers for human pathological samples. Since these methods are inaccurate and time consuming, developing a rapid and accurate method to detect cancer is urgently demanded. In our study, binding peptides for lung cancer cell line A549 were identified using bacteria surface display method. With those binding peptides for A549 cells on the surface, the fluorescent bacteria (Escherichia coli with stably expressed green fluorescent protein) were served as specific detecting reagents for the diagnosis of cancers. The binding activity of peptide-fluorescent bacteria complex was confirmed by detached cancer cells, attached cancer cells and mice tumor xenograft samples. A unique fixation method was developed for peptide-bacteria complex in order to make this complex more feasible for the clinic use. This peptide-fluorescent bacteria complex has great potential to become a new diagnostic tool for clinical application.	[Dong, Bing; Wang, Anxin; Yuan, Lihua; Chen, Lisha; Pu, Kefeng; Zhu, Yimin] Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, Div Nanobiomed, Suzhou Key Lab Nanobiomed, Suzhou, Jiangsu, Peoples R China; [Dong, Bing; Wang, Anxin; Chen, Lisha; Pu, Kefeng; Yan, Xiyun] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Duan, Wei] Deakin Univ, Sch Med, Geelong, Vic 3217, Australia	Chinese Academy of Sciences; Suzhou Institute of Nano-Tech & Nano-Bionics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Deakin University	Zhu, YM (corresponding author), Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, Div Nanobiomed, Suzhou Key Lab Nanobiomed, Suzhou, Jiangsu, Peoples R China.	ymzhu2008@sinano.ac.cn	Duan, Wei/A-5181-2015; Wang, Anxin/AAF-6657-2019; Chen, Lisha/HGC-6247-2022	Duan, Wei/0000-0001-5782-9184; 	National Natural Science Foundation of China [30870683, 81171451]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China( No.30870683 and 81171451). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardeshirpour Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031881; Bessette PH, 2004, PROTEIN ENG DES SEL, V17, P731, DOI 10.1093/protein/gzh084; Bidwell GL, 2012, THER DELIV, V3, P609, DOI 10.4155/TDE.12.37; Bonaccorsi Silvia, 2011, Cold Spring Harb Protoc, V2011, P1270, DOI 10.1101/pdb.prot065763; Boulware KT, 2006, P NATL ACAD SCI USA, V103, P7583, DOI 10.1073/pnas.0511108103; Brown MV, 2012, GENOME MED, V4, DOI 10.1186/gm332; Cronin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030940; Dane KY, 2006, J IMMUNOL METHODS, V309, P120, DOI 10.1016/j.jim.2005.11.021; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Esposito CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024071; Feng SP, 2011, NUCLEIC ACIDS RES, V39, P6669, DOI 10.1093/nar/gkr232; FRANCISCO JA, 1993, P NATL ACAD SCI USA, V90, P10444, DOI 10.1073/pnas.90.22.10444; Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994; Gao YZ, 2009, CARCINOGENESIS, V30, P2064, DOI 10.1093/carcin/bgp283; Graham MM, 2011, J NUCL MED, V52, p56S, DOI 10.2967/jnumed.110.085746; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Heatley MK, 2012, INT J GYNECOL PATHOL, V31, P111, DOI 10.1097/PGP.0b013e318226043b; Liu GJ, 2010, BIOMATERIALS, V31, P7575, DOI 10.1016/j.biomaterials.2010.06.021; Mace E, 2011, NAT METHODS, V8, P662, DOI [10.1038/NMETH.1641, 10.1038/nmeth.1641]; Pichler BJ, 2010, J NUCL MED, V51, P333, DOI 10.2967/jnumed.109.061853; PUCHTLER H, 1986, HISTOCHEMISTRY, V85, P353, DOI 10.1007/BF00982665; Qu DZ, 2011, ANAL BIOCHEM, V417, P112, DOI 10.1016/j.ab.2011.05.037; Ramos-Vara JA, 2005, VET PATHOL, V42, P405, DOI 10.1354/vp.42-4-405; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Shi H, 2011, P NATL ACAD SCI USA, V108, P3900, DOI 10.1073/pnas.1016197108; Singh B, 2011, ORAL ONCOL, V47, pS70, DOI 10.1016/j.oraloncology.2011.06.235; Stahl S, 1997, TRENDS BIOTECHNOL, V15, P185, DOI 10.1016/S0167-7799(97)01034-2; Suzuki Y, 2008, MAGN RESON MED, V60, P1269, DOI 10.1002/mrm.21816; van Essen HF, 2010, J CLIN PATHOL, V63, P1090, DOI 10.1136/jcp.2010.079905; Wang F, 2010, ANALYST, V135, P1839, DOI 10.1039/c0an00144a; Wernerus H, 2004, BIOTECHNOL APPL BIOC, V40, P209; Xu RX, 2010, EXPERT REV MED DEVIC, V7, P303, DOI [10.1586/erd.10.9, 10.1586/ERD.10.9]; Yaghoubi SS, 2009, NAT CLIN PRACT ONCOL, V6, P53, DOI 10.1038/ncponc1278; Yildiz-Aktas IZ, 2012, AM J CLIN PATHOL, V137, P691, DOI 10.1309/AJCPQRAG67GJRPMT	34	11	11	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54467	10.1371/journal.pone.0054467	http://dx.doi.org/10.1371/journal.pone.0054467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349898	gold, Green Submitted, Green Published			2022-12-25	WOS:000313872800056
J	Kits, JH; Marshall, SA; Skevington, JH				Kits, Joel H.; Marshall, Stephen A.; Skevington, Jeffrey H.			Phylogeny of the Archiborborinae (Diptera: Sphaeroceridae) Based on Combined Morphological and Molecular Analysis	PLOS ONE			English	Article							NORTH-AMERICA; INFERENCE; MRBAYES; GENUS; AMPLIFICATION; EVOLUTION; APTILOTUS; PRIMERS; INSECTA; UTILITY	The Archiborborinae is a diverse Neotropical subfamily of Sphaeroceridae, with many undescribed species. The existing generic classification includes three genera consisting of brachypterous species, with all other species placed in the genus Archiborborus. We present the first phylogenetic hypothesis for the subfamily based on morphological, molecular, and combined datasets. Morphological data include 53 characters and cover all valid described taxa (33 species in 4 genera) in the subfamily, as well as 83 undescribed species. Molecular data for five genes (mitochondrial 12S rDNA, cytochrome c oxidase subunit I, and cytochrome B, and nuclear alanyl-tRNA synthetase and 28S rDNA) were obtained for 21 ingroup taxa. Data support the separation of the Archiborborinae from the Copromyzinae, with which they were formerly combined. Analyses support consistent groups within the subfamily, but relationships between groups are poorly resolved. The validity of the brachypterous genera Penola Richards and Frutillaria Richards is supported. The former genus Archiborborus Duda is paraphyletic, and will be divided into monophyletic genera on the basis of this work. Aptery and brachyptery have evolved multiple times in the subfamily. Antrops Enderlein, previously including a single brachypterous species, is a senior synonym of Archiborborus.	[Kits, Joel H.; Marshall, Stephen A.] Univ Guelph, Sch Environm Sci, Insect Collect & Insect Systemat Lab, Guelph, ON N1G 2W1, Canada; [Skevington, Jeffrey H.] Agr & Agri Food Canada, Canadian Natl Collect Insects Arachnids & Nematod, Ottawa, ON, Canada; [Skevington, Jeffrey H.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	University of Guelph; Agriculture & Agri Food Canada; Carleton University	Kits, JH (corresponding author), Univ Guelph, Sch Environm Sci, Insect Collect & Insect Systemat Lab, Guelph, ON N1G 2W1, Canada.	joel.kits@gmail.com			NSERC; Dipterology Fund; Agriculture and Agri-Food Canada	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Dipterology Fund; Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada)	Funding was provided by NSERC (http://www.nserc-crsng.gc.ca/) discovery grants to S. A. M., O. G. S. (http://www.tcu.gov.on.ca/) and NSERC postgraduate scholarships to J. H. K., and a grant from the Dipterology Fund (http://www.nadsdiptera.org/DipFund/Fundhome.htm) to J. H. K. Sequencing was supported by funding to J. H. S. by Agriculture and Agri-Food Canada (http://www.agr.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberer AJ, 2012, SYSTEMATIC IN PRESS; Bertone MA, 2008, SYST ENTOMOL, V33, P668, DOI 10.1111/j.1365-3113.2008.00437.x; Brown JM, 2007, SYSTEMATIC BIOL, V56, P643, DOI 10.1080/10635150701546249; Drummond A.J., 2007, TRACER VERSION 15; Fan Y, 2011, MOL BIOL EVOL, V28, P523, DOI 10.1093/molbev/msq224; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gibson JF, 2011, ANN ENTOMOL SOC AM, V104, P976, DOI 10.1603/AN10153; Gibson JF, 2010, MOL PHYLOGENET EVOL, V56, P1126, DOI 10.1016/j.ympev.2010.05.005; Gibson JF, 2010, MOL PHYLOGENET EVOL, V56, P91, DOI 10.1016/j.ympev.2010.03.026; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; HACKMAN W, 1969, Notulae Entomologicae, V49, P193; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Han HY, 2005, MOL PHYLOGENET EVOL, V34, P416, DOI 10.1016/j.ympev.2004.10.017; HANCOCK JM, 1988, MOL BIOL EVOL, V5, P393; Huelsenbeck JP, 2004, MOL BIOL EVOL, V21, P1123, DOI 10.1093/molbev/msh123; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kits JH, 2011, ZOOTAXA, P1; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Lewis PO, 2010, PHYCAS SOFTWARE PHYL; MARSHALL SA, 1990, CAN J ZOOL, V68, P2338, DOI 10.1139/z90-325; MARSHALL SA, 1983, CAN J ZOOL, V61, P1910, DOI 10.1139/z83-248; Marshall SA, 1997, P ENTOMOL SOC WASH, V99, P279; Marshall Steve A., 1996, Studia Dipterologica, V3, P283; McAlpine DK, 2007, RECORDS AUSTR MUSEUM, V59, P1; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; NORRBOM AL, 1985, SYST ENTOMOL, V10, P167, DOI 10.1111/j.1365-3113.1985.tb00527.x; NORRBOM AL, 1984, P ENTOMOL SOC WASH, V86, P305; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Richards O. W., 1961, Proceedings of the Royal Entomological Society of London (B), V30, P57; Richards O. W., 1941, BRIT MUS [NAT HIST] BRIT GRAHAM LAND EXPED 1934 37 SCI REPTS, V1, P323; ROHACEK J, 2001, WORLD CATALOGUE SPHA; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; Will S, 2007, PLOS COMPUT BIOL, V3, P680, DOI 10.1371/journal.pcbi.0030065; Winkler IS, 2010, MOL PHYLOGENET EVOL, V54, P746, DOI 10.1016/j.ympev.2009.12.016	40	9	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e51190	10.1371/journal.pone.0051190	http://dx.doi.org/10.1371/journal.pone.0051190			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349671	gold, Green Published			2022-12-25	WOS:000313872800002
J	Miles, DC; Wakeling, SI; Stringer, JM; van den Bergen, JA; Wilhelm, D; Sinclair, AH; Western, PS				Miles, Denise C.; Wakeling, Stephanie I.; Stringer, Jessica M.; van den Bergen, Jocelyn A.; Wilhelm, Dagmar; Sinclair, Andrew H.; Western, Patrick S.			Signaling through the TGF Beta-Activin Receptors ALK4/5/7 Regulates Testis Formation and Male Germ Cell Development	PLOS ONE			English	Article							FEMALE SEX-REVERSAL; MEIOTIC INITIATION; RETINOIC ACID; OVARIAN DEVELOPMENT; NANOG EXPRESSION; MAMMALIAN OVARY; GENE-EXPRESSION; MOUSE EMBRYOS; FETAL TESTIS; STEM-CELLS	The developing testis provides an environment that nurtures germ cell development, ultimately ensuring spermatogenesis and fertility. Impacts on this environment are considered to underlie aberrant germ cell development and formation of germ cell tumour precursors. The signaling events involved in testis formation and male fetal germ cell development remain largely unknown. Analysis of knockout mice lacking single Tgf beta family members has indicated that Tgf beta's are not required for sex determination. However, due to functional redundancy, it is possible that additional functions for these ligands in gonad development remain to be discovered. Using FACS purified gonadal cells, in this study we show that the genes encoding Activin's, TGF beta's, Nodal and their respective receptors, are expressed in sex and cell type specific patterns suggesting particular roles in testis and germ cell development. Inhibition of signaling through the receptors ALK4, ALK5 and ALK7, and ALK5 alone, demonstrated that TGF beta signaling is required for testis cord formation during the critical testis-determining period. We also show that signaling through the Activin/NODAL receptors, ALK4 and ALK7 is required for promoting differentiation of male germ cells and their entry into mitotic arrest. Finally, our data demonstrate that Nodal is specifically expressed in male germ cells and expression of the key pluripotency gene, Nanog was significantly reduced when signaling through ALK4/5/7 was blocked. Our strategy of inhibiting multiple Activin/NODAL/TGF beta receptors reduces the functional redundancy between these signaling pathways, thereby revealing new and essential roles for TGF beta and Activin signaling during testis formation and male germ cell development.	[Miles, Denise C.; Wakeling, Stephanie I.; Stringer, Jessica M.; Western, Patrick S.] Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Clayton, Vic, Australia; [van den Bergen, Jocelyn A.; Sinclair, Andrew H.] Univ Melbourne, Dept Paediat, Murdoch Childrens Res Inst, Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Wilhelm, Dagmar] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia	Monash University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Monash University	Western, PS (corresponding author), Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Clayton, Vic, Australia.	patrick.western@monash.edu	Sinclair, Andrew H/A-3598-2010; Stringer, Jessica/I-5525-2013; Wilhelm, Dagmar/B-6915-2009	Sinclair, Andrew H/0000-0003-2741-7992; Stringer, Jessica/0000-0003-4729-3026; Wilhelm, Dagmar/0000-0002-7757-4075; Western, Patrick/0000-0002-7587-8227	Monash University Faculty of Medicine, Nursing and Health Sciences; Victorian Government's Operational Infrastructure Support Program; ARC Centre of Excellence for Biotechnology and Development; Sydney Parker Smith Postdoctoral Research Fellowship from the Cancer Council Victoria; ARC Future Fellowship	Monash University Faculty of Medicine, Nursing and Health Sciences(Monash University); Victorian Government's Operational Infrastructure Support Program; ARC Centre of Excellence for Biotechnology and Development(Australian Research Council); Sydney Parker Smith Postdoctoral Research Fellowship from the Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); ARC Future Fellowship(Australian Research Council)	This work was supported by funding from the Monash University Faculty of Medicine, Nursing and Health Sciences funding granted to PW, and the Victorian Government's Operational Infrastructure Support Program and ARC Centre of Excellence for Biotechnology and Development awarded to AHS. DM was supported by a Sydney Parker Smith Postdoctoral Research Fellowship from the Cancer Council Victoria. DW is supported by an ARC Future Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams IR, 2002, DEVELOPMENT, V129, P1155; Archambeault DR, 2010, P NATL ACAD SCI USA, V107, P10526, DOI 10.1073/pnas.1000318107; Bagheri-Fam S, 2008, DEV BIOL, V314, P71, DOI 10.1016/j.ydbio.2007.11.010; Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Barrios F, 2010, J CELL SCI, V123, P871, DOI 10.1242/jcs.057968; BEHRINGER RR, 1994, CELL, V79, P415, DOI 10.1016/0092-8674(94)90251-8; Best D, 2008, DEVELOPMENT, V135, P1415, DOI 10.1242/dev.019497; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Bowles J, 2010, DEV CELL, V19, P440, DOI 10.1016/j.devcel.2010.08.010; Brennan J, 2004, NAT REV GENET, V5, P509, DOI 10.1038/nrg1381; Brown CW, 2000, NAT GENET, V25, P453, DOI 10.1038/78140; Byfield SD, 2004, MOL PHARMACOL, V65, P744, DOI 10.1124/mol.65.3.744; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; Combes AN, 2009, DEV BIOL, V326, P112, DOI 10.1016/j.ydbio.2008.10.040; Cook MS, 2009, DEV BIOL, V328, P377, DOI 10.1016/j.ydbio.2009.01.041; Daggag H, 2008, BIOL REPROD, V79, P468, DOI 10.1095/biolreprod.107.067348; DiNapoli L, 2006, DEVELOPMENT, V133, P1519, DOI 10.1242/dev.02303; Garcia-Ortiz JE, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-36; Ewen KA, 2010, MOL CELL ENDOCRINOL, V323, P76, DOI 10.1016/j.mce.2009.12.013; Guerquin MJ, 2010, DEV BIOL, V346, P320, DOI 10.1016/j.ydbio.2010.08.002; Hueng DY, 2011, J NEURO-ONCOL, V104, P21, DOI 10.1007/s11060-010-0467-3; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Itman C, 2006, REPRODUCTION, V132, P233, DOI 10.1530/rep.1.01075; Kim Y, 2007, P NATL ACAD SCI USA, V104, P16558, DOI 10.1073/pnas.0702581104; Kim Y, 2006, PLOS BIOL, V4, P1000, DOI 10.1371/journal.pbio.0040187; Kocer A, 2009, MOL HUM REPROD, V15, P205, DOI 10.1093/molehr/gap008; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Krentz AD, 2009, P NATL ACAD SCI USA, V106, P22323, DOI 10.1073/pnas.0905431106; Kumar S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1136; La Salle S, 2004, DEV BIOL, V268, P403, DOI 10.1016/j.ydbio.2003.12.031; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Lin YF, 2008, SCIENCE, V322, P1685, DOI 10.1126/science.1166340; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; McClive PJ, 2001, MOL REPROD DEV, V60, P225, DOI 10.1002/mrd.1081; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; Memon MA, 2008, MOL CELL ENDOCRINOL, V294, P70, DOI 10.1016/j.mce.2008.08.017; Mendis SHS, 2011, BIOL REPROD, V84, P379, DOI 10.1095/biolreprod.110.086231; Mesnard D, 2006, DEVELOPMENT, V133, P2497, DOI 10.1242/dev.02413; Miles DC, 2012, DEV BIOL, V365, P101, DOI 10.1016/j.ydbio.2012.02.014; Miles DC, 2012, HISTOL HISTOPATHOL, V27, P445, DOI 10.14670/HH-27.445; Miles DC, 2010, CELL CYCLE, V9, P408, DOI 10.4161/cc.9.2.10691; Mithraprabhu S, 2010, BIOL REPROD, V82, P980, DOI 10.1095/biolreprod.109.079855; Moreno SG, 2010, DEV BIOL, V342, P74, DOI 10.1016/j.ydbio.2010.03.007; Morizane A, 2011, J NEUROSCI RES, V89, P117, DOI 10.1002/jnr.22547; Nef S, 2005, DEV BIOL, V287, P361, DOI 10.1016/j.ydbio.2005.09.008; Ottolenghi C, 2007, HUM MOL GENET, V16, P2795, DOI 10.1093/hmg/ddm235; Sarraj MA, 2010, BIOL REPROD, V82, P153, DOI 10.1095/biolreprod.109.078766; Sawyer JS, 2003, J MED CHEM, V46, P3953, DOI 10.1021/jm0205705; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Singh J, 2003, BIOORG MED CHEM LETT, V13, P4355, DOI 10.1016/j.bmcl.2003.09.028; Souquet B, 2012, ENDOCRINOLOGY, V153, P2466, DOI 10.1210/en.2011-2056; Spiller CM, 2010, BIOL REPROD, V82, P433, DOI 10.1095/biolreprod.109.078691; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; van den Bergen JA, 2009, BIOL REPROD, V81, P362, DOI 10.1095/biolreprod.109.076224; Western P, 2009, INT J DEV BIOL, V53, P393, DOI 10.1387/ijdb.082671pw; Western PS, 2008, STEM CELLS, V26, P339, DOI 10.1634/stemcells.2007-0622; Western PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020736; Western PS, 2010, FASEB J, V24, P3026, DOI 10.1096/fj.09-151555; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Yao HHC, 2004, DEV DYNAM, V230, P210, DOI 10.1002/dvdy.20042; Yao HHC, 2006, BIOL REPROD, V74, P978, DOI 10.1095/biolreprod.105.050286	66	65	69	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54606	10.1371/journal.pone.0054606	http://dx.doi.org/10.1371/journal.pone.0054606			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342175	Green Published, gold			2022-12-25	WOS:000313682700130
J	Goncalves, LCP; Tonelli, RR; Bagnaresi, P; Mortara, RA; Ferreira, AG; Bastos, EL				Pires Goncalves, Leticia Christina; Tonelli, Renata Rosito; Bagnaresi, Piero; Mortara, Renato Arruda; Ferreira, Antonio Gilberto; Bastos, Erick Leite			A Nature-Inspired Betalainic Probe for Live-Cell Imaging of Plasmodium-Infected Erythrocytes	PLOS ONE			English	Article							FALCIPARUM; PURIFICATION; PH; PERFORMANCE; PIGMENTS; PK(A)	A model betalainic dye was semisynthesized from betanin, the magenta pigment of the red beet, and was effective for live-cell imaging of Plasmodium-infected red blood cells. This water-soluble fluorescent probe is photostable, excitable in the visible region and cell membrane-permeable, and its photophysical properties are not notably pH-sensitive. Fluorescence imaging microscopy of erythrocytes infected with Plasmodium falciparum, a causative agent of malaria in humans, showed that only the parasite was stained. Z-stacking analysis suggested that the probe accumulates proximal to the nucleus of the parasite. Indicaxanthin, one of the natural fluorescent betalains found in the petals of certain flowers, did not stain the parasite or the red blood cell.	[Pires Goncalves, Leticia Christina] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Sao Paulo, Brazil; [Tonelli, Renata Rosito] Univ Sao Paulo, Dept Ciencias Biol, Sao Paulo, Brazil; [Bagnaresi, Piero] Univ Fed Sao Paulo, Dept Biofis, Sao Paulo, Brazil; [Mortara, Renato Arruda] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunobiol & Parasitol, Sao Paulo, Brazil; [Ferreira, Antonio Gilberto] Univ Fed Sao Carlos, Dept Quim, Sao Paulo, Brazil; [Bastos, Erick Leite] Univ Sao Paulo, Inst Quim, Dept Quim Fundamental, Sao Paulo, Brazil	Universidade Federal do ABC (UFABC); Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Carlos; Universidade de Sao Paulo	Bastos, EL (corresponding author), Univ Sao Paulo, Inst Quim, Dept Quim Fundamental, Sao Paulo, Brazil.	elbastos@iq.usp.br	Tonelli, Renata R/H-1334-2012; Ferreira, Antonio Gilberto/D-8254-2013; Mortara, Renato A./C-1864-2012; Ferreira, Antonio/GXH-7620-2022; Gonçalves, Letícia/AAB-9283-2021; Bastos, Erick L/F-8746-2012; Goncalves, Letícia C. P./N-1439-2015	Tonelli, Renata R/0000-0002-1685-9042; Ferreira, Antonio Gilberto/0000-0003-2314-216X; Mortara, Renato A./0000-0002-2311-8349; Ferreira, Antonio/0000-0001-5239-8020; Gonçalves, Letícia/0000-0002-1195-9810; Bastos, Erick L/0000-0002-0592-9455; Goncalves, Letícia C. P./0000-0002-1195-9810	Sao Paulo Research Foundation (FAPESP) [07/00684-6, 10/15042-2, 11/23036-5, 07/59407-1]; Coordination for the Improvement of Higher Education Personnel [PNPD 427-10/2009]; CNPq	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Education Personnel(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding was provided by the Sao Paulo Research Foundation (FAPESP) (07/00684-6, 10/15042-2, 11/23036-5). LCPG was supported by a FAPESP fellowship (07/59407-1) and the Coordination for the Improvement of Higher Education Personnel (PNPD 427-10/2009) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A.G.F., E L.B and R.A.M. thank CNPq for productivity fellowships. We also thank B.M. Di Genova and F. Dorr for technical assistance, E. Pinto for granting access to the HPLC/MS facility and M.L.G. Dutra, R.L.O.R. Cunha and F. Quina for their advice.	ALONSO A, 1993, HYPERTENSION, V22, P348, DOI 10.1161/01.HYP.22.3.348; Bartoloni FH, 2013, MONATSH CHEM, V144, P567, DOI 10.1007/s00706-012-0883-5; CHENG SY, 1980, P NATL ACAD SCI-BIOL, V77, P3425, DOI 10.1073/pnas.77.6.3425; Cho S, 2012, TRENDS BIOTECHNOL, V30, P71, DOI 10.1016/j.tibtech.2011.08.004; DIXON SL, 1993, J COMPUT CHEM, V14, P1460, DOI 10.1002/jcc.540141208; Foglieni C, 2001, HISTOCHEM CELL BIOL, V115, P223; Freitas AA, 2007, J BRAZIL CHEM SOC, V18, P1537, DOI 10.1590/S0103-50532007000800014; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Gandia-Herrero F, 2005, NATURE, V437, P334, DOI 10.1038/437334a; Gandia-Herrero F, 2006, PHYTOCHEM ANALYSIS, V17, P262, DOI 10.1002/pca.909; Gandia-Herrero F, 2010, PLANTA, V232, P449, DOI 10.1007/s00425-010-1191-0; GIROD PA, 1991, PHYTOCHEMISTRY, V30, P169, DOI 10.1016/0031-9422(91)84119-D; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Hanssen E, 2010, INT J PARASITOL, V40, P1127, DOI 10.1016/j.ijpara.2010.04.012; Hatlestad GJ, 2012, NAT GENET, V44, P816, DOI 10.1038/ng.2297; Hilou A, 2006, J ETHNOPHARMACOL, V103, P236, DOI 10.1016/j.jep.2005.08.006; KAWAMOTO F, 1991, LANCET, V337, P200, DOI 10.1016/0140-6736(91)92159-Y; Keiser J, 2002, ANN TROP MED PARASIT, V96, P643, DOI 10.1179/000349802125001834; Kelly JX, 2007, EXP PARASITOL, V116, P103, DOI 10.1016/j.exppara.2006.12.001; Kirk K, 2001, PHYSIOL REV, V81, P495, DOI 10.1152/physrev.2001.81.2.495; Klonis N, 2007, BIOCHEM J, V407, P343, DOI 10.1042/BJ20070934; Klonis N, 2010, BIOCHEMISTRY-US, V49, P6804, DOI 10.1021/bi100567j; Kobayashi N, 2002, THESIS HALLE WITTENB; Kowalski LA, 2000, ENVIRON MOL MUTAGEN, V35, P300, DOI 10.1002/1098-2280(2000)35:4<300::AID-EM4>3.0.CO;2-Z; Kuhn Y, 2007, CELL MICROBIOL, V9, P1004, DOI 10.1111/j.1462-5822.2006.00847.x; Maxmen A, 2012, NATURE, V485, P293, DOI 10.1038/485293a; Pal H, 2003, J CHEM PHYS, V119, P443, DOI 10.1063/1.1578057; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Goncalves LCP, 2012, FOOD CHEM, V131, P231, DOI 10.1016/j.foodchem.2011.08.067; Rohrbach P, 2005, J BIOL CHEM, V280, P27960, DOI 10.1074/jbc.M500777200; Sabnis R.W., 2010, HDB BIOL DYES STAINS, P1; Schliemann W, 1999, PLANT PHYSIOL, V119, P1217, DOI 10.1104/pp.119.4.1217; SCHWARTZ SJ, 1980, J AGR FOOD CHEM, V28, P540, DOI 10.1021/jf60229a032; Stintzing FC, 2005, J AGR FOOD CHEM, V53, P442, DOI 10.1021/jf048751y; Stintzing FC, 2006, HELV CHIM ACTA, V89, P1008, DOI 10.1002/hlca.200690077; Tesoriere L, 2005, J AGR FOOD CHEM, V53, P1266, DOI 10.1021/jf048134+; Tesoriere L, 2013, EUR J NUTR, V52, P1077, DOI 10.1007/s00394-012-0414-5; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; VISWANADHAN VN, 1989, J CHEM INF COMP SCI, V29, P163, DOI 10.1021/ci00063a006	39	22	22	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53874	10.1371/journal.pone.0053874	http://dx.doi.org/10.1371/journal.pone.0053874			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342028	Green Published, gold, Green Submitted			2022-12-25	WOS:000313682700060
J	Mielnik-Sikorska, M; Daca, P; Malyarchuk, B; Derenko, M; Skonieczna, K; Perkova, M; Dobosz, T; Grzybowski, T				Mielnik-Sikorska, Marta; Daca, Patrycja; Malyarchuk, Boris; Derenko, Miroslava; Skonieczna, Katarzyna; Perkova, Maria; Dobosz, Tadeusz; Grzybowski, Tomasz			The History of Slavs Inferred from Complete Mitochondrial Genome Sequences	PLOS ONE			English	Article							MTDNA HAPLOGROUP-H; DNA VARIABILITY; CZECH POPULATION; PHYLOGENY; EASTERN; DIVERSITY; REGION; DISSECTION; SELECTION; EUROPE	To shed more light on the processes leading to crystallization of a Slavic identity, we investigated variability of complete mitochondrial genomes belonging to haplogroups H5 and H6 (63 mtDNA genomes) from the populations of Eastern and Western Slavs, including new samples of Poles, Ukrainians and Czechs presented here. Molecular dating implies formation of H5 approximately 11.5-16 thousand years ago (kya) in the areas of southern Europe. Within ancient haplogroup H6, dated at around 15-28 kya, there is a subhaplogroup H6c, which probably survived the last glaciation in Europe and has undergone expansion only 3-4 kya, together with the ancestors of some European groups, including the Slavs, because H6c has been detected in Czechs, Poles and Slovaks. Detailed analysis of complete mtDNAs allowed us to identify a number of lineages that seem specific for Central and Eastern Europe (H5a1f, H5a2, H5a1r, H5a1s, H5b4, H5e1a, H5u1, some subbranches of H5a1a and H6a1a9). Some of them could possibly be traced back to at least,4 kya, which indicates that some of the ancestors of today's Slavs (Poles, Czechs, Slovaks, Ukrainians and Russians) inhabited areas of Central and Eastern Europe much earlier than it was estimated on the basis of archaeological and historical data. We also sequenced entire mitochondrial genomes of several non-European lineages (A, C, D, G, L) found in contemporary populations of Poland and Ukraine. The analysis of these haplogroups confirms the presence of Siberian (C5c1, A8a1) and Ashkenazi-specific (L2a1l2a) mtDNA lineages in Slavic populations. Moreover, we were able to pinpoint some lineages which could possibly reflect the relatively recent contacts of Slavs with nomadic Altaic peoples (C4a1a, G2a, D5a2a1a1).	[Mielnik-Sikorska, Marta; Daca, Patrycja; Skonieczna, Katarzyna; Grzybowski, Tomasz] Nicolaus Copernicus Univ, Ludwik Rydygier Coll Med, Inst Forens Med, Dept Mol & Forens Genet, Bydgoszcz, Poland; [Malyarchuk, Boris; Derenko, Miroslava; Perkova, Maria] Russian Acad Sci, Inst Biol Problems N, Far E Branch, Magadan, Russia; [Dobosz, Tadeusz] Wroclaw Med Univ, Dept Forens Med, Wroclaw, Poland	Nicolaus Copernicus University; Institute of Biological Problems of the North; Russian Academy of Sciences; Wroclaw Medical University	Grzybowski, T (corresponding author), Nicolaus Copernicus Univ, Ludwik Rydygier Coll Med, Inst Forens Med, Dept Mol & Forens Genet, Bydgoszcz, Poland.	tgrzyb@cm.umk.pl	Skonieczna, Katarzyna/AAT-7176-2021; Dobosz, Tadeusz/ABE-9988-2021; Skonieczna, Katarzyna/E-1178-2014; Malyarchuk, Boris/D-5783-2018; Derenko, Miroslava/J-1495-2018; Grzybowski, Tomasz/A-1676-2015; Dobosz, Tadeusz/T-8250-2018	Malyarchuk, Boris/0000-0002-0304-0652; Derenko, Miroslava/0000-0002-1849-784X; Grzybowski, Tomasz/0000-0001-6228-6460; Skonieczna, Katarzyna/0000-0001-5788-9398; Dobosz, Tadeusz/0000-0003-0413-9109; Daca-Roszak, Patrycja/0000-0003-1094-1333	Polish Ministry of Science and Higher Education [N N301 075839, N N303 307737]; Program of Presidium of Russian Academy of Sciences "Biodiversity" [12-I-P30-12]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Program of Presidium of Russian Academy of Sciences "Biodiversity"	This study was partially supported by the Polish Ministry of Science and Higher Education grants (nos. N N301 075839 and N N303 307737) and the Program of Presidium of Russian Academy of Sciences "Biodiversity" (grant no. 12-I-P30-12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Alekseeva TI, 2002, ESTERN SLAVS ANTHR E; Alvarez-Iglesias V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005112; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Barbujani G, 2004, ANNU REV GENOM HUM G, V5, P119, DOI 10.1146/annurev.genom.5.061903.180021; Barford P. M., 2001, EARLY SLAVS CULTURE; Behar DM, 2006, AM J HUM GENET, V78, P487, DOI 10.1086/500307; Behar DM, 2004, EUR J HUM GENET, V12, P355, DOI 10.1038/sj.ejhg.5201156; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Belyaeva O, 2003, HUM BIOL, V75, P647, DOI 10.1353/hub.2003.0069; Brandstatter A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-191; Brandstatter A, 2006, ELECTROPHORESIS, V27, P2541, DOI 10.1002/elps.200500772; Branicki W, 2005, J FORENSIC SCI, V50, P732; Buko A, 2006, POLISH ARCHEOLOGY EA; Cerezo M, 2012, GENOME RES, V22, P821, DOI 10.1101/gr.134452.111; Chandrasekar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007447; Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6; Curta F, 2001, CAMBRIDGE STUDIES ME, V52, pxxv; Derenko M, 2007, AM J HUM GENET, V81, P1025, DOI 10.1086/522933; Derenko M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032179; Derenko M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015214; Godlowski K, 2000, 1 SETTLEMENTS SLAVS; Golab Z., 1992, ORIGINS SLAVS LINGUI; Greenspan, 2008, FAMILY TREE DNA PROJ; Grzybowski T, 2007, FORENSIC SCI INT-GEN, V1, P141, DOI 10.1016/j.fsigen.2007.01.010; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Howell N, 2003, AM J HUM GENET, V72, P659, DOI 10.1086/368264; Kaczanowski P, 2005, ARCH OR SLAVS P C CR; Karachanak S, 2012, INT J LEGAL MED, V126, P497, DOI 10.1007/s00414-011-0589-y; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Kostrzewski J, 1965, PREHISTORY POLAND; Lappalainen T, 2008, ANN HUM GENET, V72, P337, DOI 10.1111/j.1469-1809.2007.00429.x; Loogvali EL, 2004, MOL BIOL EVOL, V21, P2012, DOI 10.1093/molbev/msh209; Mallory J. P., 1989, SEARCH INDOEUROPEANS; Malyarchuk B, 2008, MOL BIOL EVOL, V25, P1651, DOI 10.1093/molbev/msn114; Malyarchuk B, 2004, HUM BIOL, V76, P877, DOI 10.1353/hub.2005.0021; Malyarchuk BA, 2003, ANN HUM GENET, V67, P412, DOI 10.1046/j.1469-1809.2003.00042.x; Malyarchuk BA, 2002, ANN HUM GENET, V66, P261, DOI 10.1017/S0003480002001161; Malyarchuk BA, 2001, ANN HUM GENET, V65, P63, DOI 10.1046/j.1469-1809.2001.6510063.x; Malyarchuk B, 2010, MOL BIOL EVOL, V27, P2220, DOI 10.1093/molbev/msq065; Malyarchuk B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010285; Malyarchuk BA, 2008, EUR J HUM GENET, V16, P1091, DOI 10.1038/ejhg.2008.70; Malyarchuk BA, 2008, ANN HUM GENET, V72, P228, DOI 10.1111/j.1469-1809.2007.00410.x; Malyarchuk BA, 2006, HUM BIOL, V78, P681, DOI 10.1353/hub.2007.0014; Metspalu M, 2006, NUCL ACID M, V18, P181; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Orekhov V, 1999, FEBS LETT, V445, P197, DOI 10.1016/S0014-5793(99)00115-5; Pajnic IZ, 2004, INT J LEGAL MED, V118, P1, DOI 10.1007/s00414-003-0394-3; Pala M, 2009, AM J HUM GENET, V84, P814, DOI 10.1016/j.ajhg.2009.05.004; Pereira L, 2005, GENOME RES, V15, P19, DOI 10.1101/gr.3182305; Pereira L, 2006, FORENSIC SCI INT, V159, P43, DOI 10.1016/j.forsciint.2005.06.008; Piechota J, 2004, ACTA BIOCHIM POL, V51, P883; Piontek J, 2006, SLAVIA ANTIQUA, V47, P161; Piontek J, 2008, CENTURY JAGIELLONIAN, P175; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; Salas A, 2004, AM J HUM GENET, V74, P454, DOI 10.1086/382194; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; SEDOV VV, 1979, ORIGIN EARLY HIST SL; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; Underhill PA, 2010, EUR J HUM GENET, V18, P479, DOI 10.1038/ejhg.2009.194; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Vanecek T, 2004, INT J LEGAL MED, V118, P14, DOI 10.1007/s00414-003-0407-2	66	48	49	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54360	10.1371/journal.pone.0054360	http://dx.doi.org/10.1371/journal.pone.0054360			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342138	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400153
J	Xia, Y; Ju, F; Fang, HHP; Zhang, T				Xia, Yu; Ju, Feng; Fang, Herbert H. P.; Zhang, Tong			Mining of Novel Thermo-Stable Cellulolytic Genes from a Thermophilic Cellulose-Degrading Consortium by Metagenomics	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; HYDROLASES; ALIGNMENT; REVEALS; RUMEN	In this study, metagenomics was applied to characterize the microbial community and to discover carbohydrate-active genes of an enriched thermophilic cellulose-degrading sludge. The 16S analysis showed that the sludge microbiome was dominated by genus of cellulolytic Clostridium and methanogenesis Methanothermobacter. In order to retrieve genes from the metagenome, de novo assembly of the 11,930,760 Illumina 100 bp paired-end reads (totally 1.2 Gb) was carried out. 75% of all reads was utilized in the de novo assembly. 31,499 ORFs (Open Reading Frame) with an average length of 852 bp were predicted from the assembly; and 64% of these ORFs were predicted to present full-length genes. Based on the Hidden Markol Model, 253 of the predicted thermo-stable genes were identified as putatively carbohydrate-active. Among them the relative dominance of GH9 (Glycoside Hydrolase) and corresponding CBM3 (Carbohydrate Binding Module) revealed a cellulosome-based attached metabolism of polysaccharide in the thermophilic sludge. The putative carbohydrate-active genes ranged from 20% to 100% amino acid sequence identity to known proteins in NCBI nr database, with half of them showed less than 50% similarity. In addition, the coverage of the genes (in terms of ORFs) identified in the sludge were developed into three clear trends (112x, 29x and 8x) in which 85% of the high coverage trend (112x) mainly consisted of phylum of Firmicutes while 49.3% of the 29x trend was affiliated to the phylum of Chloroflexi.	[Xia, Yu; Ju, Feng; Fang, Herbert H. P.; Zhang, Tong] Univ Hong Kong, Environm Biotechnol Lab, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Zhang, T (corresponding author), Univ Hong Kong, Environm Biotechnol Lab, Hong Kong, Hong Kong, Peoples R China.	zhangt@hkucc.hku.hk	Zhang, Tong/HGC-1090-2022; Ju, Feng/I-8437-2016; 張彤, Tong Zhang/C-6786-2008; XIA, Yu/I-4037-2018; Xia, Yu/AAM-7471-2020	Ju, Feng/0000-0003-4137-5928; XIA, Yu/0000-0003-2842-6639; Xia, Yu/0000-0003-2842-6639; Zhang, Tong/0000-0003-1148-4322	Hong Kong General Research Fund [HKU7125/09E]; University of Hong Kong	Hong Kong General Research Fund; University of Hong Kong(University of Hong Kong)	This work was supported by a grant from the Hong Kong General Research Fund (HKU7125/09E) (http://www.ugc.edu.hk/eng/rgc/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Dr. Lin Cai for his technical assistance on primer design. Yu Xia and Feng Ju, wish to thank The University of Hong Kong for the postgraduate studentship.	Albertsen M, 2012, ISME J, V6, P1094, DOI 10.1038/ismej.2011.176; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Dai X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040430; Delmont TO, 2012, ISME J, V6, P1677, DOI 10.1038/ismej.2011.197; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Geng AL, 2012, APPL MICROBIOL BIOT, V96, P951, DOI 10.1007/s00253-012-3873-y; HEALY FG, 1995, APPL MICROBIOL BIOT, V43, P667, DOI [10.1007/s002530050468, 10.1007/BF00164771]; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hugenholtz P, 2008, NATURE, V455, P481, DOI 10.1038/455481a; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Ilmberger N, 2012, APPL MICROBIOL BIOT, V95, P135, DOI 10.1007/s00253-011-3732-2; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Mackelprang R, 2011, NATURE, V480, P368, DOI 10.1038/nature10576; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Nealson KH, 2007, ISME J, V1, P185, DOI 10.1038/ismej.2007.43; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Rees HC, 2003, EXTREMOPHILES, V7, P415, DOI 10.1007/s00792-003-0339-2; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; Voget S, 2006, J BIOTECHNOL, V126, P26, DOI 10.1016/j.jbiotec.2006.02.011; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Xia Y, 2012, INT J HYDROGEN ENERG, V37, P13652, DOI 10.1016/j.ijhydene.2012.02.079; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	30	42	43	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53779	10.1371/journal.pone.0053779	http://dx.doi.org/10.1371/journal.pone.0053779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341999	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400081
J	Theisen, JWM; Gucwa, JS; Yusufzai, T; Khuong, MT; Kadonaga, JT				Theisen, Joshua W. M.; Gucwa, James S.; Yusufzai, Timur; Khuong, Mai T.; Kadonaga, James T.			Biochemical Analysis of Histone Deacetylase-independent Transcriptional Repression by MeCP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETT-SYNDROME MUTATIONS; CPG-BINDING PROTEIN-2; METHYL-CPG; CHROMOSOMAL PROTEIN; RNA-POLYMERASE; IN-VITRO; DNA; CHROMATIN; SELECTIVITY; PROMOTER	MeCP2 is an abundant methyl-cytosine-guanine (CG)-binding protein and transcriptional repressor. We developed a biochemical system that exhibits CG methylation-specific transcriptional repression by purified human MeCP2. MeCP2 represses transcription by histone deacetylase (HDAC)-dependent and HDAC-independent mechanisms. Our system appears to recreate the HDAC-independent component of MeCP2-mediated repression and occurs via inhibition of the assembly of transcription preinitiation complexes. At a ratio of approximately one molecule of MeCP2 per two methyl-CG dinucleotides, as found in mammalian neurons, the magnitude of methylation-specific repression was greater than 10-fold. Notably, the HDAC inhibitor trichostatin A had no effect on MeCP2-mediated repression with either naked DNA or chromatin templates. We designed a CG-deficient core promoter that is resistant to MeCP2-mediated repression when placed in a plasmid lacking CG dinucleotides. By using this CG-deficient reporter as a reference, we found that eight CG dinucleotides in the core promoter region are sufficient for strong methylation-specific repression by MeCP2. In contrast, MeCP2 does not repress a construct with 13 CG dinucleotides located similar to 1.7 kbp upstream of the promoter. Furthermore, by analysis of C-terminally truncated MeCP2 proteins, we found that binding of MeCP2 to methyl-CG dinucleotides is not sufficient for transcriptional repression. Hence, MeCP2-mediated repression is not due to the simple steric blockage of the transcriptional machinery. These experiments suggest that MeCP2 can function as a global methyl-CG-specific, HDAC-independent repressor. This HDAC-independent mechanism of MeCP2-mediated repression may be important in cells, such as mammalian neurons, that have high levels of CG methylation and MeCP2.	[Theisen, Joshua W. M.; Gucwa, James S.; Yusufzai, Timur; Khuong, Mai T.; Kadonaga, James T.] Univ Calif San Diego, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kadonaga, JT (corresponding author), Univ Calif San Diego, Mol Biol Sect, 0347,Pacific Hall,Room 2212B,9500 Gilman Dr, La Jolla, CA 92093 USA.	jkadonaga@ucsd.edu		Theisen, Joshua/0000-0002-6267-5391	National Institutes of Health [GM041249]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041249, T32GM007198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health grant GM041249 (to J. T. K.). This project was initiated by an International Rett Syndrome Foundation (Rett Syndrome Research Foundation) grant.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ballestar E, 2000, BIOCHEMISTRY-US, V39, P7100, DOI 10.1021/bi0001271; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Fraga MF, 2003, NUCLEIC ACIDS RES, V31, P1765, DOI 10.1093/nar/gkg249; Fyodorov DV, 2003, METHOD ENZYMOL, V371, P499; Gleghorn ML, 2008, MOL CELL, V32, P707, DOI 10.1016/j.molcel.2008.11.010; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; HAWLEY DK, 1987, J BIOL CHEM, V262, P3452; Huang XJ, 2001, J BIOL CHEM, V276, P12497, DOI 10.1074/jbc.C100034200; Ishibashi T, 2008, FEBS LETT, V582, P1157, DOI 10.1016/j.febslet.2008.03.005; Jiang W, 2000, J BIOL CHEM, V275, P39819, DOI 10.1074/jbc.C000713200; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Juven-Gershon T, 2006, NAT METHODS, V3, P917, DOI 10.1038/NMETH937; KADONAGA JT, 1990, J BIOL CHEM, V265, P2624; Kaludov NK, 2000, NUCLEIC ACIDS RES, V28, P1921, DOI 10.1093/nar/28.9.1921; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Yu F, 2000, NUCLEIC ACIDS RES, V28, P2201, DOI 10.1093/nar/28.10.2201; Yusufzai TM, 2000, NUCLEIC ACIDS RES, V28, P4172, DOI 10.1093/nar/28.21.4172	25	9	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7096	7104		10.1074/jbc.M112.438697	http://dx.doi.org/10.1074/jbc.M112.438697			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23349465	Green Published, hybrid			2022-12-25	WOS:000316002400031
J	Loken-Amsrud, KI; Myhr, KM; Bakke, SJ; Beiske, AG; Bjerve, KS; Bjornara, BT; Hovdal, H; Lilleas, F; Midgard, R; Pedersen, T; Benth, JS; Torkildsen, O; Wergeland, S; Holmoy, T				Loken-Amsrud, Kristin I.; Myhr, Kjell-Morten; Bakke, Soren J.; Beiske, Antonie G.; Bjerve, Kristian S.; Bjornara, Bard T.; Hovdal, Harald; Lilleas, Finn; Midgard, Rune; Pedersen, Tom; Benth, Jurate Saltyte; Torkildsen, Oivind; Wergeland, Stig; Holmoy, Trygve			Alpha-tocopherol and MRI Outcomes in Multiple Sclerosis - Association and Prediction	PLOS ONE			English	Article							VITAMIN-E; CAROTENOIDS; LIPIDS; BLOOD; RISK; DNA	Objective: Alpha-tocopherol is the main vitamin E compound in humans, and has important antioxidative and immunomodulatory properties. The aim of this study was to study alpha-tocopherol concentrations and their relationship to disease activity in Norwegian multiple sclerosis (MS) patients. Methods: Prospective cohort study in 88 relapsing-remitting MS (RRMS) patients, originally included in a randomised placebo-controlled trial of omega-3 fatty acids (the OFAMS study), before and during treatment with interferon beta. The patients were followed for two years with repeated 12 magnetic resonance imaging (MRI) scans and nine serum measurements of alpha-tocopherol. Results: During interferon beta (IFNB) treatment, each 10 mu mol/L increase in alpha-tocopherol reduced the odds (CI 95%) for simultaneous new T2 lesions by 36.8 (0.5-59.8) %, p = 0.048, and for combined unique activity by 35.4 (1.6-57.7) %, p = 0.042, in a hierarchical regression model. These associations were not significant prior to IFNB treatment, and were not noticeably changed by gender, age, body mass index, HLA-DRB1*15, treatment group, compliance, or the concentrations of 25-hydroxyvitamin D, retinol, neutralising antibodies against IFNB, or the omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid. The corresponding odds for having new T1 gadolinium enhancing lesions two months later was reduced by 65.4 (16.5-85.7) %, p = 0.019, and for new T2 lesions by 61.0 (12.4-82.6) %, p = 0.023. Conclusion: During treatment with IFNB, increasing serum concentrations of alpha-tocopherol were associated with reduced odds for simultaneous and subsequent MRI disease activity in RRMS patients.	[Loken-Amsrud, Kristin I.] Innlandet Hosp Trust, Dept Neurol, Lillehammer, Norway; [Loken-Amsrud, Kristin I.; Benth, Jurate Saltyte; Holmoy, Trygve] Univ Oslo, Inst Clin Med, Oslo, Norway; [Myhr, Kjell-Morten; Torkildsen, Oivind; Wergeland, Stig] Haukeland Hosp, Dept Neurol, Norwegian Multiple Sclerosis Competence Ctr, N-5021 Bergen, Norway; [Myhr, Kjell-Morten] Univ Bergen, Dept Clin Med, Bergen, Norway; [Myhr, Kjell-Morten] Univ Bergen, Kristian Gerhard Jebsen Multiple Sclerosis Res Ct, Bergen, Norway; [Bakke, Soren J.] Oslo Univ Hosp, Dept Neuroradiol, Oslo, Norway; [Beiske, Antonie G.] Multiple Sclerosis Ctr Hakadal, Hakadal, Norway; [Bjerve, Kristian S.] Univ Trondheim Hosp, St Olavs Hosp, Dept Med Biochem, Trondheim, Norway; [Bjerve, Kristian S.] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, N-7034 Trondheim, Norway; [Bjornara, Bard T.] Helsehuset Kongsberg, Kongsberg, Norway; [Hovdal, Harald] Univ Trondheim Hosp, St Olavs Hosp, Dept Neurol, Trondheim, Norway; [Lilleas, Finn] Curato Oslo, Oslo, Norway; [Midgard, Rune] Molde Hosp, Dept Neurol, Molde, Norway; [Midgard, Rune] Norwegian Univ Sci & Technol, Unit Appl Clin Res, N-7034 Trondheim, Norway; [Pedersen, Tom] Unilabs Drammen, Drammen, Norway; [Benth, Jurate Saltyte] Akershus Univ Hosp, Helse Sor Ost Hlth Serv Res Ctr, Lorenskog, Norway; [Holmoy, Trygve] Akershus Univ Hosp, Dept Neurol, Lorenskog, Norway	Innlandet Hospital Trust; University of Oslo; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; University of Oslo; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Oslo; University of Oslo	Holmoy, T (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.	trygve.holmoy@medisin.uio.no	Torkildsen, Øivind/A-1606-2008; Myhr, Kjell-Morten/H-1528-2018	Torkildsen, Øivind/0000-0001-5294-2866; Myhr, Kjell-Morten/0000-0002-0980-510X; Midgard, Rune/0000-0002-6096-726X	Merck-Serono; Pronova Biocare; Bayer Schering; Innlandet Hospital Trust [150164]; Western Norway Regional Health Authority; Odd Fellow Research Foundation for multiple sclerosis; Kare Waerner's Legacy; Norwegian MS Society; Biogen Idec; Novartis; Sanofi Aventis; Merck Serono	Merck-Serono(Merck & Company); Pronova Biocare; Bayer Schering(Bayer AG); Innlandet Hospital Trust; Western Norway Regional Health Authority; Odd Fellow Research Foundation for multiple sclerosis; Kare Waerner's Legacy; Norwegian MS Society; Biogen Idec(Biogen); Novartis(Novartis); Sanofi Aventis(Sanofi-Aventis); Merck Serono(Merck & Company)	The study was supported by Merck-Serono, Pronova Biocare, Bayer Schering, Innlandet Hospital Trust (Grant number 150164), The Western Norway Regional Health Authority, Odd Fellow Research Foundation for multiple sclerosis, Kare Waerner's Legacy and The Norwegian MS Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was partly supported by Merck-Serono, Pronova Biocare and Bayer Schering. Bard T. Bjornara is employed by Helsehuset Kongsberg, Finn Lilleas by Curato Oslo and Tom Pedersen by Unilabs. Kristin I. Loken-Amsrud has received travel support and an unrestricted research grant from Biogen Idec and travel support from Merck Serono. Kjell-Morten Myhr has received honoraria for lecturing, participation in pharmaceutical company sponsored clinical trials, and travel support from Bayer Schering, Biogen Idec, Novartis, Merck-Serono and Sanofi Aventis. Harald Hovdal has participated in pharmaceutical company sponsored clinical trials and received travel support from Merck Serono, Biogen Idec and Bayer Schering. Rune Midgard has received honoraria for lecturing, participation in pharmaceutical company sponsored clinical trials, and travel support from Bayer Schering, Biogen Idec, Novartis, Merck-Serono and Sanofi Aventis. Stig Wergeland has received speaker honoraria and travel support from Sanofi Aventis, Biogen Idec, Bayer Schering and Novartis. Trygve Holmoy has received speaker honoraria and travel support from Sanofi Aventis, Biogen Idec, Bayer Schering, Novartis and Merck Serono. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Al-Azemi MK, 2009, REPROD BIOMED ONLINE, V19, P583, DOI 10.1016/j.rbmo.2009.05.005; Becker W., 2004, Scandinavian Journal of Nutrition, V48, P178, DOI 10.1080/1102680410003794; Besler HT, 2002, NUTR NEUROSCI, V5, P215, DOI 10.1080/10284150290029205; BJORNSON LK, 1976, J LIPID RES, V17, P343; BO L, 1994, ANN NEUROL, V36, P778, DOI 10.1002/ana.410360515; Garcia-Closas R, 2004, BRIT J NUTR, V91, P1005, DOI 10.1079/BJN20041130; Goudarzvand M, 2010, CELL MOL NEUROBIOL, V30, P289, DOI 10.1007/s10571-009-9451-x; Hedstrom AK, 2011, BRAIN, V134, P653, DOI 10.1093/brain/awq371; Heppner FL, 1998, GLIA, V22, P180, DOI 10.1002/(SICI)1098-1136(199802)22:2<180::AID-GLIA9>3.0.CO;2-B; Hsieh CC, 2005, NUTRITION, V21, P940, DOI 10.1016/j.nut.2004.11.021; JARVINEN R, 1995, INT J VITAM NUTR RES, V65, P24; Jimenez-Jimenez FJ, 1998, NEUROSCI LETT, V249, P65, DOI 10.1016/S0304-3940(98)00370-X; Karg E, 2003, EUR NEUROL, V50, P215, DOI 10.1159/000073862; Karg E, 1999, J NEUROL, V246, P533, DOI 10.1007/s004150050399; Lassmann H, 2011, FEBS LETT, V585, P3715, DOI 10.1016/j.febslet.2011.08.004; Loken-Amsrud KI, 2013, MULT SCLER J, V19, P451, DOI 10.1177/1352458512457843; Loken-Amsrud KI, 2012, NEUROLOGY, V79, P267, DOI 10.1212/WNL.0b013e31825fdf01; Lucas M, 2003, NEUROCHEM INT, V42, P67, DOI 10.1016/S0197-0186(02)00057-8; Mehta LR, 2009, NAT CLIN PRACT NEURO, V5, P82, DOI 10.1038/ncpneuro1009; Pekmezci D, 2011, VITAM HORM, V86, P179, DOI 10.1016/B978-0-12-386960-9.00008-3; RUULS SR, 1995, J NEUROIMMUNOL, V56, P207, DOI 10.1016/0165-5728(94)00154-G; Saarela J, 2006, PLOS GENET, V2, P364, DOI 10.1371/journal.pgen.0020042; Salemi G, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-19; Sheridan PA, 2009, FREE RADICAL BIO MED, V46, P1581, DOI 10.1016/j.freeradbiomed.2009.03.010; Simpson JL, 2011, J MATERN-FETAL NEO M, V24, P1, DOI 10.3109/14767051003678226; Torkildsen O, 2012, ARCH NEUROL-CHICAGO, V69, P1044, DOI 10.1001/archneurol.2012.283; Venkatraman JT, 1999, J AM COLL NUTR, V18, P602, DOI 10.1080/07315724.1999.10718895; Vladimirova O, 1998, MULT SCLER, V4, P413, DOI 10.1191/135245898678919456; Vladimirova O, 1999, INFLAMM RES, V48, P412, DOI 10.1007/s000110050480; Weinstock-Guttman B, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-127; Zhang SM, 2001, NEUROLOGY, V57, P75, DOI 10.1212/WNL.57.1.75; Zingg JM, 2004, CURR MED CHEM, V11, P1113, DOI 10.2174/0929867043365332	32	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54417	10.1371/journal.pone.0054417	http://dx.doi.org/10.1371/journal.pone.0054417			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349882	Green Published, gold, Green Submitted			2022-12-25	WOS:000314019100066
J	Brioude, F; Bouligand, J; Francou, B; Fagart, J; Roussel, R; Viengchareun, S; Combettes, L; Brailly-Tabard, S; Lombes, M; Young, J; Guiochon-Mantel, A				Brioude, Frederic; Bouligand, Jerome; Francou, Bruno; Fagart, Jerome; Roussel, Ronan; Viengchareun, Say; Combettes, Laurent; Brailly-Tabard, Sylvie; Lombes, Marc; Young, Jacques; Guiochon-Mantel, Anne			Two Families with Normosmic Congenital Hypogonadotropic Hypogonadism and Biallelic Mutations in KISS1R (KISS1 Receptor): Clinical Evaluation and Molecular Characterization of a Novel Mutation	PLOS ONE			English	Article							GNRH RECEPTOR; NEUROKININ B; GENE; PATIENT; NEUROENDOCRINE; KISSPEPTIN; EXPRESSION; ROLES; LOOP	Context: KISS1R mutations have been reported in few patients with normosmic congenital hypogonadotropic hypogonadism (nCHH) (OMIM # 146110). Objective: To describe in detail nCHH patients with biallelic KISS1R mutations belonging to 2 unrelated families, and to functionally characterize a novel KISS1R mutation. Results: An original mutant, p.Tyr313His, was found in the homozygous state in 3 affected kindred (2 females and 1 male) from a consanguineous Portuguese family. This mutation, located in the seventh transmembrane domain, affects a highly conserved amino acid, perturbs the conformation of the transmembrane segment, and impairs MAP kinase signaling and intracellular calcium release. In the second family, a French Caucasian male patient with nCHH was found to carry two recurrent mutations in the compound heterozygous state (p.Leu102Pro/Stop399Arg). In this man, pulsatile GnRH (Gonadotropin Releasing Hormone) administration restored pulsatile LH (Luteinizing Hormone) secretion and testicular hormone secretion. Later, long-term combined gonadotropin therapy induced spermatogenesis, enabling 3 successive pregnancies that resulted in 2 miscarriages and the birth of a healthy boy. Conclusion: We show that a novel loss-of-function mutation (p.Tyr313His) in the KISS1R gene can cause familial nCHH, revealing the crucial role of this amino acid in KISS1R function. The observed restoration of gonadotropin secretion by exogenous GnRH administration further supports, in humans, the hypothalamic origin of the gonadotropin deficiency in this genetic form of nCHH.	[Brioude, Frederic; Bouligand, Jerome; Francou, Bruno; Fagart, Jerome; Viengchareun, Say; Brailly-Tabard, Sylvie; Lombes, Marc; Young, Jacques; Guiochon-Mantel, Anne] Univ Paris Sud, Fac Med Paris Sud, UMR S693, F-94275 Le Kremlin Bicetre, France; [Brioude, Frederic; Bouligand, Jerome; Francou, Bruno; Fagart, Jerome; Viengchareun, Say; Brailly-Tabard, Sylvie; Lombes, Marc; Young, Jacques; Guiochon-Mantel, Anne] INSERM, IFR93, U693, F-94275 Le Kremlin Bicetre, France; [Bouligand, Jerome; Francou, Bruno; Brailly-Tabard, Sylvie; Guiochon-Mantel, Anne] Hop Bicetre, Assistance Publ Hop Paris, Serv Genet Mol Pharmacogenet & Hormonol, Le Kremlin Bicetre, France; [Roussel, Ronan] Univ Paris 07, Paris, France; [Roussel, Ronan] Hop Bichat Claude Bernard, Assistance Publ Hop Paris, Dept Endocrinol Diabetol & Nutr, F-75877 Paris, France; [Combettes, Laurent] Univ Paris Sud, Fac Sci, INSERM, UMR S757, Orsay, France; [Lombes, Marc; Young, Jacques] Hop Bicetre, Assistance Publ Hop Paris, Serv Endocrinol & Malad Reprod, Paris, France; [Lombes, Marc; Young, Jacques] Hop Bicetre, Assistance Publ Hop Paris, Ctr Reference Malad Endocriniennes Rares Croissan, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay	Young, J (corresponding author), Univ Paris Sud, Fac Med Paris Sud, UMR S693, F-94275 Le Kremlin Bicetre, France.	jacques.young@bct.aphp.fr; anne.mantel@bct.aphp.fr	Combettes, Laurent/L-1842-2013; Young, Jacques/N-5251-2019; Viengchareun, Say/M-6612-2017; Brioude, Frédéric/H-7898-2014; Lombes, Marc/L-5933-2018; Francou, Bruno/B-8156-2015; Viengchareun, Say/GOV-6812-2022; Young, Jacques/T-2976-2018; Francou, Bruno/AAX-7301-2020; Guiochon-Mantel, Anne S/S-8408-2018; Fagart, Jerome/S-4581-2018; BOULIGAND, Jérôme/S-5716-2018	Combettes, Laurent/0000-0002-1376-4574; Young, Jacques/0000-0001-9286-5631; Brioude, Frédéric/0000-0001-8122-760X; Lombes, Marc/0000-0003-3189-023X; Young, Jacques/0000-0001-9286-5631; Francou, Bruno/0000-0002-3903-2320; Guiochon-Mantel, Anne S/0000-0003-1737-1409; Fagart, Jerome/0000-0002-7965-0553; viengchareun, say/0000-0003-4280-3250	Paris-Sud University (Bonus Qualite Recherche); INSERM [KalGenopath 09-GENO-017]; PHRC HYPOPROTEO [P081212]; Agence Francaise de lutte contre le Dopage (AFLD); BMBS intergovernmental framework for European Cooperation in Science and Technology (COST) Action [BM1105]	Paris-Sud University (Bonus Qualite Recherche); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); PHRC HYPOPROTEO; Agence Francaise de lutte contre le Dopage (AFLD); BMBS intergovernmental framework for European Cooperation in Science and Technology (COST) Action	Paris-Sud University (Bonus Qualite Recherche 2009), INSERM KalGenopath 09-GENO-017, PHRC HYPOPROTEO P081212, Agence Francaise de lutte contre le Dopage (AFLD) and BMBS intergovernmental framework for European Cooperation in Science and Technology (COST) Action BM1105: GnRH deficiency: Elucidation of the neuroendocrine control of human reproduction. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouligand J, 2009, NEW ENGL J MED, V360, P2742, DOI 10.1056/NEJMoa0900136; Breuer O, 2012, EUR J ENDOCRINOL, V167, P209, DOI 10.1530/EJE-12-0127; Brioude F, 2010, EUR J ENDOCRINOL, V162, P835, DOI 10.1530/EJE-10-0083; Bry-Gauillard H, 2010, ANN ENDOCRINOL-PARIS, V71, P158, DOI 10.1016/j.ando.2010.02.024; Chan YM, 2009, P NATL ACAD SCI USA, V106, P11703, DOI 10.1073/pnas.0903449106; Chevrier L, 2011, MOL CELL ENDOCRINOL, V346, P21, DOI 10.1016/j.mce.2011.04.018; Clair C, 2001, J CELL SCI, V114, P1999; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; De Roux N, 1999, J CLIN ENDOCR METAB, V84, P567, DOI 10.1210/jc.84.2.567; deRoux N, 1997, NEW ENGL J MED, V337, P1597, DOI 10.1056/NEJM199711273372205; Dode C, 2003, NAT GENET, V33, P463, DOI 10.1038/ng1122; Dode C, 2006, PLOS GENET, V2, P1648, DOI 10.1371/journal.pgen.0020175; Eloit Corinne, 1994, Rhinology (Utrecht), V32, P57; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Francou B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025614; Gianetti E, 2010, J CLIN ENDOCR METAB, V95, P2857, DOI 10.1210/jc.2009-2320; Goze C, 2010, EUR J PHARMACOL, V643, P153, DOI 10.1016/j.ejphar.2010.06.018; Guran T, 2009, J CLIN ENDOCR METAB, V94, P3633, DOI 10.1210/jc.2009-0551; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lanfranco F, 2005, EUR J ENDOCRINOL, V153, P845, DOI 10.1530/eje.1.02031; Layman LC, 1998, NAT GENET, V18, P14, DOI 10.1038/ng0198-14; Lovell S.C., 2003, PROTEINS STRUCT FUNC, V50, P437, DOI [10.1002/prot.10286, DOI 10.1002/PROT.10286]; Mitchell AL, 2011, TRENDS ENDOCRIN MET, V22, P249, DOI 10.1016/j.tem.2011.03.002; Nimri R, 2011, J CLIN ENDOCR METAB, V96, pE536, DOI 10.1210/jc.2010-1676; Noel SD, 2011, MOL CELL ENDOCRINOL, V346, P91, DOI 10.1016/j.mce.2011.06.022; Pallais JC, 2006, MOL CELL ENDOCRINOL, V254, P70, DOI 10.1016/j.mce.2006.04.019; Pinilla L, 2012, PHYSIOL REV, V92, P1235, DOI 10.1152/physrev.00037.2010; Ramaswamy S, 2009, J NEUROENDOCRINOL, V21, P795, DOI 10.1111/j.1365-2826.2009.01905.x; Sarfati J, 2010, J CLIN ENDOCR METAB, V95, P659, DOI 10.1210/jc.2009-0843; Schmidlin F, 2003, AM J PHYSIOL-CELL PH, V285, pC945, DOI 10.1152/ajpcell.00541.2002; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Semple RK, 2005, J CLIN ENDOCR METAB, V90, P1849, DOI 10.1210/jc.2004-1418; Shaw ND, 2011, J CLIN ENDOCR METAB, V96, pE566, DOI 10.1210/jc.2010-2292; SIMONIN F, 1995, P NATL ACAD SCI USA, V92, P7006, DOI 10.1073/pnas.92.15.7006; Szereszewski JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012964; Teles MG, 2010, EUR J ENDOCRINOL, V163, P29, DOI 10.1530/EJE-10-0012; Teles MG, 2008, NEW ENGL J MED, V358, P709, DOI 10.1056/NEJMoa073443; Tello JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038456; Tenenbaum-Rakover Y, 2007, J CLIN ENDOCR METAB, V92, P1137, DOI 10.1210/jc.2006-2147; Topaloglu AK, 2012, NEW ENGL J MED, V366, P629, DOI 10.1056/NEJMoa1111184; Topaloglu AK, 2009, NAT GENET, V41, P354, DOI 10.1038/ng.306; Trabado S, 2011, FERTIL STERIL, V95, P2324, DOI 10.1016/j.fertnstert.2011.03.091; Wahab F, 2011, MOL CELL ENDOCRINOL, V346, P29, DOI 10.1016/j.mce.2011.05.043; Young J, 2012, J CLIN ENDOCR METAB, V97, P707, DOI 10.1210/jc.2011-1664; Young J, 2010, J CLIN ENDOCR METAB, V95, P2287, DOI 10.1210/jc.2009-2600	45	34	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e53896	10.1371/journal.pone.0053896	http://dx.doi.org/10.1371/journal.pone.0053896			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349759	gold, Green Published, Green Submitted			2022-12-25	WOS:000313872800018
J	Granja, C; Povoa, P; Lobo, C; Teixeira-Pinto, A; Carneiro, A; Costa-Pereira, A				Granja, Cristina; Povoa, Pedro; Lobo, Cristina; Teixeira-Pinto, Armando; Carneiro, Antonio; Costa-Pereira, Altamiro			The Predisposition, Infection, Response and Organ Failure (Piro) Sepsis Classification System: Results of Hospital Mortality Using a Novel Concept and Methodological Approach	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; INTENSIVE-CARE-UNIT; PRACTICE GUIDELINES; EPIDEMIOLOGY; MANAGEMENT; SCORE; DYSFUNCTION; ENGLAND; STATES; WALES	Introduction: PIRO is a conceptual classification system in which a number of demographic, clinical, biological and laboratory variables are used to stratify patients with sepsis in categories with different outcomes, including mortality rates. Objectives: To identify variables to be included in each component of PIRO aiming to improve the hospital mortality prediction. Methods: Patients were selected from the Portuguese ICU-admitted community-acquired sepsis study (SACiUCI). Variables concerning the R and O component included repeated measurements along the first five days in ICU stay. The trends of these variables were summarized as the initial value at day 1 (D1) and the slope of the tendency during the five days, using a linear mixed model. Logistic regression models were built to assess the best set of covariates that predicted hospital mortality. Results: A total of 891 patients (age 60 +/- 17 years, 64% men, 38% hospital mortality) were studied. Factors significantly associated with mortality for P component were gender, age, chronic liver failure, chronic renal failure and metastatic cancer; for I component were positive blood cultures, guideline concordant antibiotic therapy and health-care associated sepsis; for R component were C-reactive protein slope, D1 heart rate, heart rate slope, D1 neutrophils and neutrophils slope; for O component were D1 serum lactate, serum lactate slope, D1 SOFA and SOFA slope. The relative weight of each component of PIRO was calculated. The combination of these four results into a single-value predictor of hospital mortality presented an AUC-ROC 0.84 (IC95%: 0.81-0.87) and a test of goodness-of-fit (Hosmer and Lemeshow) of p = 0.368. Conclusions: We identified specific variables associated with each of the four components of PIRO, including biomarkers and a dynamic view of the patient daily clinical course. This novel approach to PIRO concept and overall score can be a better predictor of mortality for patients with community-acquired sepsis admitted to ICUs.	[Granja, Cristina; Teixeira-Pinto, Armando; Costa-Pereira, Altamiro] Fac Med Porto, Dept Hlth Informat & Decis Sci, Oporto, Portugal; [Granja, Cristina; Lobo, Cristina; Teixeira-Pinto, Armando; Costa-Pereira, Altamiro] Fac Med Porto, CINTESIS Ctr Res Hlth Technol & Hlth Syst, Oporto, Portugal; [Povoa, Pedro] Sao Francisco Xavier Hosp CHLO, Polyvalent Intens Care Unit, Lisbon, Portugal; [Povoa, Pedro] Univ Nova Lisboa, Fac Med Sci, CEDOC, Lisbon, Portugal; [Teixeira-Pinto, Armando] Univ Sydney, Sch Publ Hlth, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia; [Carneiro, Antonio] Hosp Arrabida, Intens Care Unit, Vila Nova De Gaia, Portugal	Universidade do Porto; Universidade do Porto; Centro Hospitalar de Lisboa Ocidental, EPE; Universidade Nova de Lisboa; University of Sydney	Granja, C (corresponding author), Fac Med Porto, Dept Hlth Informat & Decis Sci, Oporto, Portugal.	cristinagranja@hotmail.com	Povoa, Pedro/I-1669-2013; Costa-Pereira, Altamiro/I-5987-2012; Granja, Cristina/ABG-6861-2020; Granja, Cristina/H-8146-2013; Teixeira-Pinto, Armando/H-7947-2013; , CINTESIS/C-6631-2014	Costa-Pereira, Altamiro/0000-0001-8467-6398; Granja, Cristina/0000-0002-5503-051X; Teixeira-Pinto, Armando/0000-0002-9389-2516; Povoa, Pedro/0000-0002-7069-7304; , CINTESIS/0000-0001-7248-2086	Fundacao para a Ciencia e Tecnologia [PIC/IC/83312/2007]; Fundação para a Ciência e a Tecnologia [PIC/IC/83312/2007, 2021.06067.BD] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	Cristina Lobo was financially supported by the Grant from Fundacao para a Ciencia e Tecnologia (PIC/IC/83312/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Beale R, 2009, INFECTION, V37, P222, DOI 10.1007/s15010-008-8203-z; Brun-Buisson C, 2004, INTENS CARE MED, V30, P580, DOI 10.1007/s00134-003-2121-4; Cardoso T, 2010, CRIT CARE, V14, DOI 10.1186/cc9008; Chalupka AN, 2012, CRIT CARE CLIN, V28, P57, DOI 10.1016/j.ccc.2011.09.003; Finfer S, 2004, INTENS CARE MED, V30, P589, DOI 10.1007/s00134-004-2157-0; Harrison DA, 2006, CRIT CARE, V10, DOI 10.1186/cc4854; Howell MD, 2011, CRIT CARE MED, V39, P322, DOI 10.1097/CCM.0b013e3182037a8e; Hutt E, 2002, J FAM PRACTICE, V51, P709; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Levy MM, 2005, CRIT CARE MED, V33, P2194, DOI 10.1097/01.CCM.0000182798.39709.84; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lisboa T, 2008, CHEST, V134, P1208, DOI 10.1378/chest.08-1106; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Menendez R, 2005, AM J RESP CRIT CARE, V172, P757, DOI 10.1164/rccm.200411-1444OC; Mermel LA, 2001, CLIN INFECT DIS, V32, P1249, DOI 10.1086/320001; Metnitz PGH, 2005, INTENS CARE MED, V31, P1336, DOI 10.1007/s00134-005-2762-6; Moreno RP, 2008, INTENS CARE MED, V34, P496, DOI 10.1007/s00134-007-0943-1; Mylotte JM, 2002, CLIN INFECT DIS, V35, P1205, DOI 10.1086/344281; Padkin A, 2003, CRIT CARE MED, V31, P2332, DOI 10.1097/01.CCM.0000085141.75513.2B; Ferreira AMP, 2011, SEMIN RESP CRIT CARE, V32, P543, DOI 10.1055/s-0031-1287862; Povoa P, 2008, CURR OPIN INFECT DIS, V21, P157, DOI 10.1097/QCO.0b013e3282f47c32; Povoa P, 2011, CRIT CARE, V15, DOI 10.1186/cc10313; Povoa PR, 2009, CRIT CARE MED, V37, P410, DOI 10.1097/CCM.0b013e3181958b1c; Rello J, 2009, CRIT CARE MED, V37, P456, DOI 10.1097/CCM.0b013e318194b021; Rivers EP, 2007, CRIT CARE MED, V35, P2016, DOI 10.1097/01.CCM.0000281637.08984.6E; Rubulotta F, 2009, CRIT CARE MED, V37, P1329, DOI 10.1097/CCM.0b013e31819d5db1; Schuetz P, 2009, JAMA-J AM MED ASSOC, V302, P1059, DOI 10.1001/jama.2009.1297; Soares M, 2011, CRIT CARE MED, V39, P408, DOI 10.1097/CCM.0b013e3181f17a04; Solomkin JS, 2003, CLIN INFECT DIS, V37, P997, DOI 10.1086/378702; Stevens DL, 2005, CLIN INFECT DIS, V41, P1373, DOI 10.1086/497143; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Vincent JL, 2003, CRIT CARE MED, V31, P834, DOI 10.1097/01.CCM.0000051515.56179.E1; Warren JW, 1999, CLIN INFECT DIS, V29, P745, DOI 10.1086/520427	38	26	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e53885	10.1371/journal.pone.0053885	http://dx.doi.org/10.1371/journal.pone.0053885			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349756	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872800017
J	Pongor, LS; Pinter, F; Petak, I				Pongor, Lorinc S.; Pinter, Ferenc; Petak, Istvan			HeurAA: Accurate and Fast Detection of Genetic Variations with a Novel Heuristic Amplicon Aligner Program for Next Generation Sequencing	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG CANCERS; MOLECULAR DIAGNOSTICS; SOMATIC MUTATIONS; READ ALIGNMENT; COPY NUMBER; GEFITINIB; PROTEIN; CATALOG; SEARCH	Next generation sequencing (NGS) of PCR amplicons is a standard approach to detect genetic variations in personalized medicine such as cancer diagnostics. Computer programs used in the NGS community often miss insertions and deletions (indels) that constitute a large part of known human mutations. We have developed HeurAA, an open source, heuristic amplicon aligner program. We tested the program on simulated datasets as well as experimental data from multiplex sequencing of 40 amplicons in 12 oncogenes collected on a 454 Genome Sequencer from lung cancer cell lines. We found that HeurAA can accurately detect all indels, and is more than an order of magnitude faster than previous programs. HeurAA can compare reads and reference sequences up to several thousand base pairs in length, and it can evaluate data from complex mixtures containing reads of different gene-segments from different samples. HeurAA is written in C and Perl for Linux operating systems, the code and the documentation are available for research applications at http://sourceforge.net/projects/heuraa/	[Pongor, Lorinc S.; Pinter, Ferenc; Petak, Istvan] KPS Med Biotechnol & Healthcare Serv Ltd, Budapest, Hungary		Pongor, LS (corresponding author), KPS Med Biotechnol & Healthcare Serv Ltd, Budapest, Hungary.	pongorlorinc@gmail.com; petak@kps.hu	Pongor, Lorinc/AAA-9835-2021; Petak, Istvan/X-3656-2019	Pongor, Lorinc/0000-0001-5917-4628; 	Hungarian National Development Agency [TECH_08_A2 STEMKILL OM-107/2008]	Hungarian National Development Agency	This work was supported by a research grant from the Hungarian National Development Agency (TECH_08_A2 STEMKILL OM-107/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Croes EA, 2004, J NEUROL NEUROSUR PS, V75, P1166, DOI 10.1136/jnnp.2003.020198; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Ferragina P, 2000, EXPT STUDY OPPORTUNI, P390; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; GOLDFARB LG, 1993, NEUROLOGY, V43, P2392, DOI 10.1212/WNL.43.11.2392; Hach F, 2010, NAT METHODS, V7, P576, DOI 10.1038/nmeth0810-576; Jackman DM, 2006, CLIN CANCER RES, V12, P3908, DOI 10.1158/1078-0432.CCR-06-0462; Kobayashi S, 2005, CANCER RES, V65, P7096, DOI 10.1158/0008-5472.CAN-05-1346; KRETZSCHMAR HA, 1986, DNA-J MOLEC CELL BIO, V5, P315, DOI 10.1089/dna.1986.5.315; Kris NG, 2011, ASCOS BLUEPRINT TRAN; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mertes F, 2011, BRIEF FUNCT GENOMICS, V10, P374, DOI 10.1093/bfgp/elr033; Mukohara T, 2005, JNCI-J NATL CANCER I, V97, P1185, DOI 10.1093/jnci/dji238; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Oliver GR, 2012, F1000 RES, V1, P1; Petak I, 2010, NAT REV DRUG DISCOV, V9, P523, DOI 10.1038/nrd3135; Pinter F, 2008, J MOL DIAGN, V10, P160, DOI 10.2353/jmoldx.2008.070125; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schwab R, 2005, J CLIN ONCOL, V23, P7736, DOI 10.1200/JCO.2005.02.4760; Sequist LV, 2011, ANN ONCOL, V22, P2616, DOI 10.1093/annonc/mdr489; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stenson Peter D, 2009, Hum Genomics, V4, P69	27	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54294	10.1371/journal.pone.0054294	http://dx.doi.org/10.1371/journal.pone.0054294			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349847	gold, Green Published, Green Submitted			2022-12-25	WOS:000313872800037
J	Joseph, HSSL; Liversedge, SP				Joseph, Holly S. S. L.; Liversedge, Simon P.			Children's and Adults' On-Line Processing of Syntactically Ambiguous Sentences during Reading	PLOS ONE			English	Article							Z-READER MODEL; EYE-MOVEMENTS; SACCADE GENERATION; EXECUTIVE FUNCTIONS; COGNITIVE CONTROL; SPOKEN LANGUAGE; DYNAMICAL MODEL; WORKING-MEMORY; LEXICAL-BIASES; INFORMATION	While there has been a fair amount of research investigating children's syntactic processing during spoken language comprehension, and a wealth of research examining adults' syntactic processing during reading, as yet very little research has focused on syntactic processing during text reading in children. In two experiments, children and adults read sentences containing a temporary syntactic ambiguity while their eye movements were monitored. In Experiment 1, participants read sentences such as, 'The boy poked the elephant with the long stick/trunk from outside the cage' in which the attachment of a prepositional phrase was manipulated. In Experiment 2, participants read sentences such as, 'I think I'll wear the new skirt I bought tomorrow/yesterday. It's really nice' in which the attachment of an adverbial phrase was manipulated. Results showed that adults and children exhibited similar processing preferences, but that children were delayed relative to adults in their detection of initial syntactic misanalysis. It is concluded that children and adults have the same sentence-parsing mechanism in place, but that it operates with a slightly different time course. In addition, the data support the hypothesis that the visual processing system develops at a different rate than the linguistic processing system in children.	[Joseph, Holly S. S. L.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Liversedge, Simon P.] Univ Southampton, Sch Psychol, Southampton, Hants, England	University of Oxford; University of Southampton	Joseph, HSSL (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	holly.joseph@psy.ox.ac.uk		Joseph, Holly/0000-0003-4325-4628	ESRC studentship [PTA-026-27-1912]; Leverhulme Trust [F/00128/AB F/00 180/AN]; ESRC [ES/I032398/1]; Economic and Social Research Council [ES/F040725/1, ES/I032398/1] Funding Source: researchfish; ESRC [ES/F040725/1] Funding Source: UKRI	ESRC studentship(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Leverhulme Trust(Leverhulme Trust); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was supported by an ESRC studentship (PTA-026-27-1912) to the first author. The second author acknowledges support from the Leverhulme Trust (Grants F/00128/AB & F/00 180/AN) and the ESRC (ES/I032398/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN G, 1988, COGNITION, V30, P191, DOI 10.1016/0010-0277(88)90020-0; Altmann GTM, 1998, J MEM LANG, V38, P459, DOI 10.1006/jmla.1997.2562; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; [Anonymous], 1992, EYE MOVEMENTS VISUAL; Arnold JE, 2007, LANG COGNITIVE PROC, V22, P527, DOI 10.1080/01690960600845950; Bates E, 1989, CROSS LINGUISTIC STU; Blythe H. I., 2011, OXFORD HDB EYE MOVEM, P643, DOI [10.1093/oxfordhb/9780199539789.013.0036, DOI 10.1093/OXFORDHB/9780199539789.013.0036]; Blythe HI, 2006, VISION RES, V46, P3898, DOI 10.1016/j.visres.2006.06.006; Blythe HI, 2011, VISION RES, V51, P84, DOI 10.1016/j.visres.2010.10.003; Blythe HI, 2009, VISION RES, V49, P1583, DOI 10.1016/j.visres.2009.03.015; BOWEY JA, 1986, J PSYCHOLINGUIST RES, V15, P285, DOI 10.1007/BF01067676; Choi Y, 2011, ARCH MECH LANG PROC; COOPER RM, 1974, COGNITIVE PSYCHOL, V6, P84, DOI 10.1016/0010-0285(74)90005-X; CRAIN S, 1985, NATURAL LANGUAGE PAR, P320, DOI DOI 10.1017/CBO9780511597855.011; Crocker MW, 2000, J PSYCHOLINGUIST RES, V29, P647, DOI 10.1023/A:1026560822390; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; Engbert R, 2005, PSYCHOL REV, V112, P777, DOI 10.1037/0033-295X.112.4.777; Engbert R, 2002, VISION RES, V42, P621, DOI 10.1016/S0042-6989(01)00301-7; FRAZIER L, 1982, COGNITIVE PSYCHOL, V14, P178, DOI 10.1016/0010-0285(82)90008-1; Frazier Lyn, 1978, THESIS U CONNECTICUT; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Gibson E, 1998, COGNITION, V68, P1, DOI 10.1016/S0010-0277(98)00034-1; Haikio T, 2009, J EXP CHILD PSYCHOL, V102, P167, DOI 10.1016/j.jecp.2008.04.002; Hale J, 2001, 2ND MEETING OF THE NORTH AMERICAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P159; Huestegge L, 2009, VISION RES, V49, P2948, DOI 10.1016/j.visres.2009.09.012; Hurewitz F, 2000, J PSYCHOLINGUIST RES, V29, P597, DOI 10.1023/A:1026468209238; Hyona J, 2002, J EDUC PSYCHOL, V94, P44, DOI 10.1037//0022-0663.94.1.44; HYONA J, 1995, J EXP PSYCHOL LEARN, V21, P1430, DOI 10.1037/0278-7393.21.6.1430; Inhoff AW, 2005, MEM COGNITION, V33, P447, DOI 10.3758/BF03193062; Joseph HSSL, 2008, Q J EXP PSYCHOL, V61, P708, DOI 10.1080/17470210701400657; Joseph HSSL, 2009, VISION RES, V49, P2078, DOI 10.1016/j.visres.2009.05.015; Jurafsky D, 1996, COGNITIVE SCI, V20, P137, DOI 10.1207/s15516709cog2002_1; KENNEDY A, 1987, Q J EXP PSYCHOL-A, V39, P649, DOI 10.1080/14640748708401807; KIDD E, 2007, 1 LANGUAGE, V0027; Kidd E, 2012, DEV PSYCHOL, V48, P171, DOI 10.1037/a0025405; Kidd E, 2011, J CHILD LANG, V38, P222, DOI 10.1017/S0305000909990316; Levy R, 2008, COGNITION, V106, P1126, DOI 10.1016/j.cognition.2007.05.006; Liu YP, 2010, COGNITION IN FLUX, P1136; Liversedge SP, 2000, TRENDS COGN SCI, V4, P6, DOI 10.1016/S1364-6613(99)01418-7; MACDONALD MC, 1994, PSYCHOL REV, V101, P676, DOI 10.1037/0033-295X.101.4.676; MACDONALD MC, 1994, LANG COGNITIVE PROC, V9, P157, DOI 10.1080/01690969408402115; McConkie G.W., 1991, VISION VISUAL DYSLEX; McRae K, 1998, J MEM LANG, V38, P283, DOI 10.1006/jmla.1997.2543; Mitchell DC, 2008, J MEM LANG, V59, P266, DOI 10.1016/j.jml.2008.06.002; MORGAN JL, 1987, COGNITIVE PSYCHOL, V19, P498, DOI 10.1016/0010-0285(87)90017-X; Novick JM, 2005, COGN AFFECT BEHAV NE, V5, P263, DOI 10.3758/CABN.5.3.263; O'Regan J K, 1990, Rev Oculomot Res, V4, P395; OREGAN JK, 1987, ATTENTION PERFORM, P363; Palladino P, 2001, MEM COGNITION, V29, P344, DOI 10.3758/BF03194929; Parviainen T, 2006, J NEUROSCI, V26, P6052, DOI 10.1523/JNEUROSCI.0673-06.2006; Pickering M.J., 2006, HDB PSYCHOLINGUISTIC, V2nd ed., P455; Pollatsek A, 2006, COGNITIVE PSYCHOL, V52, P1, DOI 10.1016/j.cogpsych.2005.06.001; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1983, J VERB LEARN VERB BE, V22, P358, DOI 10.1016/S0022-5371(83)90236-0; RAYNER K, 1986, J EXP CHILD PSYCHOL, V41, P211, DOI 10.1016/0022-0965(86)90037-8; Reichle ED, 2006, PSYCHOL REV, V113, P390, DOI 10.1037/0033-295X.113.2.390; Reichle ED, 2003, BEHAV BRAIN SCI, V26, P445, DOI 10.1017/S0140525X03000104; Reichle ED, 2012, DEV REV IN PRESS; Rust J, 1993, WECHSLER OBJECTIVE R; Saffran JR, 2001, P NATL ACAD SCI USA, V98, P12874, DOI 10.1073/pnas.231498898; Sekerina IA, 2004, J CHILD LANG, V31, P123, DOI 10.1017/S0305000903005890; Snedeker J, 2004, COGNITIVE PSYCHOL, V49, P238, DOI 10.1016/j.cogpsych.2004.03.001; Snedeker J, 2001, P 23 ANN C COGN SCI, P964; SPIVEYKNOWLTON M, 1995, COGNITION, V55, P227, DOI 10.1016/0010-0277(94)00647-4; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; TARABAN R, 1988, J MEM LANG, V27, P597, DOI 10.1016/0749-596X(88)90011-3; TAYLOR SE, 1965, AM EDUC RES J, V2, P187, DOI 10.2307/1161646; Tomasello M, 2000, TRENDS COGN SCI, V4, P156, DOI 10.1016/S1364-6613(00)01462-5; Traxler MJ, 1998, J MEM LANG, V39, P558, DOI 10.1006/jmla.1998.2600; Trueswell J, 1999, COGNITION, P73; TRUESWELL JC, 1994, PERSPECTIVES ON SENTENCE PROCESSING, P155; TRUESWELL JC, 1994, J MEM LANG, V33, P285, DOI 10.1006/jmla.1994.1014; van Gompel RPG, 2005, J MEM LANG, V52, P284, DOI 10.1016/j.jml.2004.11.003; van Gompel RPG, 2001, J MEM LANG, V45, P225, DOI 10.1006/jmla.2001.2773; Weger UW, 2007, MEM COGNITION, V35, P1293, DOI 10.3758/BF03193602; Weighall AR, 2008, J EXP CHILD PSYCHOL, V99, P75, DOI 10.1016/j.jecp.2007.10.004; WILLOWS DM, 1986, READ RES QUART, V21, P253, DOI 10.2307/747708; WILLOWS DM, 1981, J EDUC PSYCHOL, V73, P607, DOI 10.1037/0022-0663.73.5.607; Yang SN, 2004, EUR J COGN PSYCHOL, V16, P226, DOI 10.1080/09541440340000231; Yang SN, 2001, VISION RES, V41, P3567, DOI 10.1016/S0042-6989(01)00025-6; Zang G, 2012, J EXP PSYCH IN PRESS	81	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54141	10.1371/journal.pone.0054141	http://dx.doi.org/10.1371/journal.pone.0054141			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	073JI	23349807	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000313738900043
J	Namjoshi, DR; Martin, G; Donkin, J; Wilkinson, A; Stukas, S; Fan, JJ; Carr, M; Tabarestani, S; Wuerth, K; Hancock, REW; Wellington, CL				Namjoshi, Dhananjay R.; Martin, Georgina; Donkin, James; Wilkinson, Anna; Stukas, Sophie; Fan, Jianjia; Carr, Michael; Tabarestani, Sepideh; Wuerth, Kelli; Hancock, Robert E. W.; Wellington, Cheryl L.			The Liver X Receptor Agonist GW3965 Improves Recovery from Mild Repetitive Traumatic Brain Injury in Mice Partly through Apolipoprotein E	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; E-DEFICIENT MICE; ALZHEIMERS-DISEASE; AXONAL INJURY; HEAD-INJURY; AMYLOID DEPOSITION; E POLYMORPHISM; MOUSE MODEL; LIPOPROTEIN PARTICLES; APP23 MICE	Traumatic brain injury (TBI) increases Alzheimer's disease (AD) risk and leads to the deposition of neurofibrillary tangles and amyloid deposits similar to those found in AD. Agonists of Liver X receptors (LXRs), which regulate the expression of many genes involved in lipid homeostasis and inflammation, improve cognition and reduce neuropathology in AD mice. One pathway by which LXR agonists exert their beneficial effects is through ATP-binding cassette transporter A1 (ABCA1)-mediated lipid transport onto apolipoprotein E (apoE). To test the therapeutic utility of this pathway for TBI, we subjected male wild-type (WT) and apoE(-/-) mice to mild repetitive traumatic brain injury (mrTBI) followed by treatment with vehicle or the LXR agonist GW3965 at 15 mg/kg/day. GW3965 treatment restored impaired novel object recognition memory in WT but not apoE(-/-) mice. GW3965 did not significantly enhance the spontaneous recovery of motor deficits observed in all groups. Total soluble A beta(40) and A beta(42) levels were significantly elevated in WT and apoE(-/-) mice after injury, a response that was suppressed by GW3965 in both genotypes. WT mice showed mild but significant axonal damage at 2 d post-mrTBI, which was suppressed by GW3965. In contrast, apoE(-/-) mice showed severe axonal damage from 2 to 14 d after mrTBI that was unresponsive to GW3965. Because our mrTBI model does not produce significant inflammation, the beneficial effects of GW3965 we observed are unlikely to be related to reduced inflammation. Rather, our results suggest that both apoE-dependent and apoE-independent pathways contribute to the ability of GW3965 to promote recovery from mrTBI.	[Namjoshi, Dhananjay R.; Martin, Georgina; Donkin, James; Wilkinson, Anna; Stukas, Sophie; Fan, Jianjia; Carr, Michael; Tabarestani, Sepideh; Wellington, Cheryl L.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Wuerth, Kelli; Hancock, Robert E. W.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Wellington, CL (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada.	cheryl@cmmt.ubc.ca	Stukas, Sophie/GQO-7639-2022; Hancock, Robert E. W./E-1145-2013	Hancock, Robert E. W./0000-0001-5989-8503; Stukas, Sophie/0000-0001-8819-8821; Wuerth, Kelli/0000-0001-5260-9166; Namjoshi, Dhananjay/0000-0003-1753-5581	operating grant from the Canadian Institutes of Health Research (CIHR) [MOP 67088]; Alzheimer Society Research Program (ASRP, Alzheimer Society of Canada) doctoral award; ASRP post-doctoral award; CIHR Vanier studentship; Child & Family Research Institute studentship	operating grant from the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alzheimer Society Research Program (ASRP, Alzheimer Society of Canada) doctoral award; ASRP post-doctoral award; CIHR Vanier studentship(Canadian Institutes of Health Research (CIHR)); Child & Family Research Institute studentship	This work was supported by an operating grant (MOP 67088) to C.L.W. from the Canadian Institutes of Health Research (CIHR). D.R.N. was supported by Alzheimer Society Research Program (ASRP, Alzheimer Society of Canada) doctoral award. J.D. was supported by an ASRP post-doctoral award. S.S. was supported by a CIHR Vanier studentship. J.F. was supported by a Child & Family Research Institute studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; DeCuypere M, 2012, SURG CLIN N AM, V92, P939, DOI 10.1016/j.suc.2012.04.005; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Donkin JJ, 2010, J BIOL CHEM, V285, P34144, DOI 10.1074/jbc.M110.108100; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Fitz NF, 2010, J NEUROSCI, V30, P6862, DOI 10.1523/JNEUROSCI.1051-10.2010; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Goldstein LE, 2012, SCI TRANSL MED, V4; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Groot PHE, 2005, J LIPID RES, V46, P2182, DOI 10.1194/jlr.M500116-JLR200; Han SH, 2000, ANN NY ACAD SCI, V903, P357, DOI 10.1111/j.1749-6632.2000.tb06387.x; Hirsch-Reinshagen V, 2005, J BIOL CHEM, V280, P43243, DOI 10.1074/jbc.M508781200; Hirsch-Reinshagen V, 2004, J BIOL CHEM, V279, P41197, DOI 10.1074/jbc.M407962200; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Iwata A, 2005, J NEUROSCI RES, V82, P103, DOI 10.1002/jnr.20607; Jamroz-Wisniewska Anna, 2007, Postepy Hig Med Dosw (Online), V61, P760; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Jiang Y, 2008, ACTA NEUROCHIR SUPPL, V105, P233; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kay AD, 2003, J NEUROTRAUM, V20, P717, DOI 10.1089/089771503767869953; Koldamova R, 2005, J BIOL CHEM, V280, P43224, DOI 10.1074/jbc.M504513200; LaDu MJ, 2000, ANN NY ACAD SCI, V903, P167, DOI 10.1111/j.1749-6632.2000.tb06365.x; Laskowitz DT, 1998, J CEREBR BLOOD F MET, V18, P465, DOI 10.1097/00004647-199805000-00001; Li Y, 2011, J NEUROTRAUM, V28, P1767, DOI 10.1089/neu.2010.1687; Lichtman SW, 2000, NEUROLOGY, V55, P1536, DOI 10.1212/WNL.55.10.1536; Loane DJ, 2011, J NEUROTRAUM, V28, P225, DOI 10.1089/neu.2010.1595; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Magnoni S, 2010, ARCH NEUROL-CHICAGO, V67, P1068, DOI 10.1001/archneurol.2010.214; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; May S, 2011, J NEUROLOGY NEUROSCI, V2, P1; Miao B, 2004, J LIPID RES, V45, P1410, DOI 10.1194/jlr.M300450-JLR200; Pan WH, 2003, EXP BRAIN RES, V149, P195, DOI 10.1007/s00221-002-1355-7; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Petit-Turcotte C, 2007, NEUROSCIENCE, V150, P58, DOI 10.1016/j.neuroscience.2007.05.021; POIRIER J, 1994, TRENDS NEUROSCI, V17, P525, DOI 10.1016/0166-2236(94)90156-2; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; Pruthi N, 2010, NEUROL INDIA, V58, P264, DOI 10.4103/0028-3886.63810; Riddell DR, 2007, MOL CELL NEUROSCI, V34, P621, DOI 10.1016/j.mcn.2007.01.011; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Schwetye KE, 2010, NEUROBIOL DIS, V40, P555, DOI 10.1016/j.nbd.2010.06.018; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Smith C, 2006, J NEUROL NEUROSUR PS, V77, P363, DOI 10.1136/jnnp.2005.074617; Tang YP, 1997, J NEUROTRAUM, V14, P851, DOI 10.1089/neu.1997.14.851; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Wahrle SE, 2005, J BIOL CHEM, V280, P43236, DOI 10.1074/jbc.M508780200; Wahrle SE, 2004, J BIOL CHEM, V279, P40987, DOI 10.1074/jbc.M407963200; Wahrle SE, 2008, J CLIN INVEST, V118, P671, DOI 10.1172/JCI33622; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wojcicka Grazyna, 2007, Postepy Hig Med Dosw (Online), V61, P736; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	68	43	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53529	10.1371/journal.pone.0053529	http://dx.doi.org/10.1371/journal.pone.0053529			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349715	Green Published, gold, Green Submitted			2022-12-25	WOS:000313738900009
J	Zheng, WL; Xu, HY; Lam, SH; Luo, HE; Karuturi, RKM; Gong, ZY				Zheng, Weiling; Xu, Hongyan; Lam, Siew Hong; Luo, Huaien; Karuturi, R. Krishna Murthy; Gong, Zhiyuan			Transcriptomic Analyses of Sexual Dimorphism of the Zebrafish Liver and the Effect of Sex Hormones	PLOS ONE			English	Article							HEPATIC GENE-EXPRESSION; DANIO-RERIO; TRANSGENIC ZEBRAFISH; HEPATOCELLULAR-CARCINOMA; ESTROGENIC COMPOUNDS; VITELLOGENIN GENES; ENRICHED GENES; METABOLISM; RECEPTOR; EXPOSURE	The liver is one of the most sex-dimorphic organs in both oviparous and viviparous animals. In order to understand the molecular basis of the difference between male and female livers, high-throughput RNA-SAGE (serial analysis of gene expression) sequencing was performed for zebrafish livers of both sexes and their transcriptomes were compared. Both sexes had abundantly expressed genes involved in translation, coagulation and lipid metabolism, consistent with the general function of the liver. For sex-biased transcripts, from in addition to the high enrichment of vitellogenin transcripts in spawning female livers, which constituted nearly 80% of total mRNA, it is apparent that the female-biased genes were mostly involved in ribosome/translation, estrogen pathway, lipid transport, etc, while the male-biased genes were enriched for oxidation reduction, carbohydrate metabolism, coagulation, protein transport and localization, etc. Sexual dimorphism on xenobiotic metabolism and anti-oxidation was also noted and it is likely that retinol x receptor (RXR) and liver x receptor (LXR) play central roles in regulating the sexual differences of lipid and cholesterol metabolisms. Consistent with high ribosomal/translational activities in the female liver, female-biased genes were significantly regulated by two important transcription factors, Myc and Mycn. In contrast, Male livers showed activation of transcription factors Ppargc1b, Hnf4a, and Stat4, which regulate lipid and glucose metabolisms and various cellular activities. The transcriptomic responses to sex hormones, 17 beta-estradiol (E2) or 11-keto testosterone (KT11), were also investigated in both male and female livers and we found that female livers were relatively insensitive to sex hormone disturbance, while the male livers were readily affected. E2 feminized male liver by up-regulating female-biased transcripts and down-regulating male-biased transcripts. The information obtained in this study provides comprehensive insights into the sexual dimorphism of zebrafish liver transcriptome and will facilitate further development of the zebrafish as a human liver disease model.	[Zheng, Weiling; Xu, Hongyan; Lam, Siew Hong; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Luo, Huaien; Karuturi, R. Krishna Murthy] Genome Inst Singapore, Singapore, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Gong, ZY (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsgzy@nus.edu.sg	Lam, Siew Hong/H-8483-2012; Gong, Zhiyuan/H-8794-2012	Gong, Zhiyuan/0000-0002-9660-5260	Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme [R-154-000-328-272]	Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme	This work was supported by the Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme and administered by the Environment & Water Industry Programme Office (EWI) of the PUB, grant number R-154-000-328-272. The funders had no role in study design, data collection and analysis, decision to publish, or reparation of the manuscript.	Nguyen AT, 2012, DIS MODEL MECH, V5, P63, DOI 10.1242/dmm.008367; Nguyen AT, 2011, DIS MODEL MECH, V4, P801, DOI 10.1242/dmm.007831; BAKER ME, 1988, BIOCHEM J, V255, P1057, DOI 10.1042/bj2551057; Cheng W, 2006, DEV BIOL, V294, P482, DOI 10.1016/j.ydbio.2006.03.018; Pham CH, 2011, AQUAT TOXICOL, V105, P569, DOI 10.1016/j.aquatox.2011.08.019; Cinaroglu A, 2011, HEPATOLOGY; Correale J, 2011, MULT SCLER J, V17, P521, DOI 10.1177/1352458510392619; Curado S, 2010, SEMIN LIVER DIS, V30, P288, DOI 10.1055/s-0030-1255357; Curado S, 2010, DIS MODEL MECH, V3, P486, DOI 10.1242/dmm.004390; Davis LK, 2008, GEN COMP ENDOCR, V156, P544, DOI 10.1016/j.ygcen.2008.03.002; Deaciuc IV, 2004, J HEPATOL, V40, P219, DOI 10.1016/j.jhep.2003.10.021; Dell H, 1999, J BIOL CHEM, V274, P9013, DOI 10.1074/jbc.274.13.9013; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Gao B, 2005, CELL MOL IMMUNOL, V2, P92; Gao HY, 2010, HUM MOL GENET, V19, P16, DOI 10.1093/hmg/ddp463; Gao MH, 2011, BBA-MOL CELL RES, V1813, P1239, DOI 10.1016/j.bbamcr.2011.03.017; Goetz FW, 2009, PHYSIOL GENOMICS, V38, P261, DOI 10.1152/physiolgenomics.00069.2009; Groh KJ, 2011, FISH PHYSIOL BIOCHEM, V37, P619, DOI 10.1007/s10695-010-9464-x; Hallare A, 2006, ECOTOX ENVIRON SAFE, V63, P378, DOI 10.1016/j.ecoenv.2005.07.006; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hashimoto S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004108; Hoffmann JL, 2008, AQUAT TOXICOL, V87, P69, DOI 10.1016/j.aquatox.2008.01.012; Holth TF, 2008, AQUAT TOXICOL, V90, P277, DOI 10.1016/j.aquatox.2008.08.020; Hook SE, 2006, AQUAT TOXICOL, V77, P372, DOI 10.1016/j.aquatox.2006.01.007; Howarth DL, 2011, ALCOHOL CLIN EXP RES, V35, P826, DOI 10.1111/j.1530-0277.2010.01407.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kausch U, 2008, ENVIRON TOXICOL, V23, P15, DOI 10.1002/tox.20306; Kling P, 2008, ECOTOX ENVIRON SAFE, V71, P319, DOI 10.1016/j.ecoenv.2007.12.010; Knoll-Gellida A, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-46; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Lam SH, 2006, CELL CYCLE, V5, P573, DOI 10.4161/cc.5.6.2550; Lam SH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-41; Lam SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000121; Levi L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-141; Li Y, 2004, COMP FUNCT GENOM, V5, P403, DOI 10.1002/cfg.418; Li Z, 2012, DIS MODELS MECH; Li ZJ, 2009, MOL IMMUNOL, V46, P3232, DOI 10.1016/j.molimm.2009.08.006; Li Z, 2012, J HEPATOL, V56, P419, DOI 10.1016/j.jhep.2011.07.025; Liu XJ, 2006, BIOL REPROD, V74, P1016, DOI 10.1095/biolreprod.105.049403; Liu YF, 2011, J BREAST CANCER, V14, P20, DOI 10.4048/jbc.2011.14.1.20; Mode A, 2006, DRUG METAB REV, V38, P197, DOI 10.1080/03602530600570057; Moens LN, 2007, J BIOCHEM MOL TOXIC, V21, P299, DOI 10.1002/jbt.20190; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robison BD, 2008, COMP BIOCHEM PHYS D, V3, P141, DOI 10.1016/j.cbd.2008.01.001; Rogers AB, 2004, TOXICOL PATHOL, V32, P668, DOI 10.1080/01926230490524247; Rogers AB, 2007, CANCER RES, V67, P11536, DOI 10.1158/0008-5472.CAN-07-1479; ROY AK, 1983, ANNU REV PHYSIOL, V45, P37, DOI 10.1146/annurev.ph.45.030183.000345; Ruggeri B, 2008, GEN COMP ENDOCR, V158, P138, DOI 10.1016/j.ygcen.2008.05.012; Santos EM, 2008, COMP BIOCHEM PHYS A, V149, P314, DOI 10.1016/j.cbpa.2008.01.010; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Small CM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-579; Sreenivasan R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001791; STERNBERG EM, 1992, ANN INTERN MED, V117, P854, DOI 10.7326/0003-4819-117-10-854; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; Taboada X, 2012, GENE, V492, P250, DOI 10.1016/j.gene.2011.10.020; Tan XP, 2006, GASTROENTEROLOGY, V131, P1561, DOI 10.1053/j.gastro.2006.08.042; Tong Y, 2004, GENE, V328, P25, DOI 10.1016/j.gene.2003.12.001; Troxel CM, 1997, TOXICOL APPL PHARM, V143, P213, DOI 10.1006/taap.1996.8058; Ung CY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-212; Ung CY, 2009, ZEBRAFISH, V6, P425, DOI 10.1089/zeb.2009.0608; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Wang CY, 2011, MOL ENDOCRINOL, V25, P1527, DOI 10.1210/me.2011-1037; Wang H, 2005, GENE, V356, P91, DOI 10.1016/j.gene.2005.03.041; Wang-Buhler JL, 2005, COMP BIOCHEM PHYS C, V140, P207, DOI 10.1016/j.cca.2005.02.002; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; Wen CM, 2005, DEV DYNAM, V232, P171, DOI 10.1002/dvdy.20210; Weng Y, 2005, J BIOL CHEM, V280, P31686, DOI 10.1074/jbc.M504447200; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wiwi CA, 2004, MOL ENDOCRINOL, V18, P1975, DOI 10.1210/me.2004-0129; Wolfrum C, 2006, CELL METAB, V3, P99, DOI 10.1016/j.cmet.2006.01.001; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Zeng S, 2002, GENE, V294, P45, DOI 10.1016/S0378-1119(02)00791-6; Zhang W, 2012, ENVIRON SCI TECHNOL, V46, P5175, DOI 10.1021/es300147w; Zhao CY, 2010, J ENDOCRINOL, V204, P233, DOI 10.1677/JOE-09-0271; Zhao S, 2012, BIOCHEM CELL BIOL, V90, P142, DOI [10.1139/O11-079, 10.1139/o11-079]	78	52	53	4	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53562	10.1371/journal.pone.0053562	http://dx.doi.org/10.1371/journal.pone.0053562			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349717	Green Published, Green Submitted, gold			2022-12-25	WOS:000313738900011
J	Kurashige, M; Imamura, M; Araki, SI; Suzuki, D; Babazono, T; Uzu, T; Umezono, T; Toyoda, M; Kawai, K; Imanishi, M; Hanaoka, K; Maegawa, H; Uchigata, Y; Hosoya, T; Maeda, S				Kurashige, Mahiro; Imamura, Minako; Araki, Shin-ichi; Suzuki, Daisuke; Babazono, Tetsuya; Uzu, Takashi; Umezono, Tomoya; Toyoda, Masao; Kawai, Koichi; Imanishi, Masahito; Hanaoka, Kazushige; Maegawa, Hiroshi; Uchigata, Yasuko; Hosoya, Tatsuo; Maeda, Shiro			The Influence of a Single Nucleotide Polymorphism within CNDP1 on Susceptibility to Diabetic Nephropathy in Japanese Women with Type 2 Diabetes	PLOS ONE			English	Article							CARNOSINASE GENE CNDP1; STAGE RENAL-DISEASE; LEUCINE REPEAT; AFRICAN-AMERICANS; SKELETAL-MUSCLE; ASSOCIATION; CELLS; SCAN; RISK; SEX	Background: Several linkage analyses have mapped a susceptibility locus for diabetic nephropathy to chromosome 18q22-23, and polymorphisms within the carnosine dipeptidase 1 gene (CNDP1), located on 18q22.3, have been shown to be associated with diabetic nephropathy in European subjects with type 2 diabetes. However, the association of this locus with diabetic nephropathy has not been evaluated in the Japanese population. In this study, we examined the association of polymorphisms within the CNDP1/CNDP 2 locus with diabetic nephropathy in Japanese subjects with type 2 diabetes. Methodology/Principal Findings: We genotyped a leucine repeat polymorphism (D18S880) that is within CNDP1 along with 29 single nucleotide polymorphisms (SNPs) in the CNDP1/CNDP2 locus for 2,740 Japanese subjects with type 2 diabetes (1,205 nephropathy cases with overt nephropathy or with end-stage renal disease [ ESRD], and 1,535 controls with normoalbuminuria). The association of each polymorphism with diabetic nephropathy was analysed by performing logistic regression analysis. We did not observe any association between D18S880 and diabetic nephropathy in Japanese subjects with type 2 diabetes. None of the 29 SNPs within the CNDP1/CNDP2 locus were associated with diabetic nephropathy, but a subsequent sex-stratified analysis revealed that 1 SNP in CNDP1 was nominally associated with diabetic nephropathy in women (rs12604675-A; p = 0.005, odds ratio [OR] = 1.76, 95% confidence interval [CI], 1.19-2.61). Rs12604675 was associated with overt proteinuria (p = 0.002, OR = 2.18, 95% CI, 1.32-3.60), but not with ESRD in Japanese women with type 2 diabetes. Conclusions/Significance: Rs12604675-A in CNDP1 may confer susceptibility to overt proteinuria in Japanese women with type 2 diabetes.	[Kurashige, Mahiro; Imamura, Minako; Maeda, Shiro] RIKEN Ctr Genom Med, Lab Endocrinol & Metab, Yokohama, Kanagawa, Japan; [Kurashige, Mahiro; Hanaoka, Kazushige; Hosoya, Tatsuo] Jikei Univ, Sch Med, Dept Internal Med, Div Kidney & Hypertens, Tokyo, Japan; [Araki, Shin-ichi; Uzu, Takashi; Maegawa, Hiroshi] Shiga Univ Med Sci, Dept Med, Otsu, Shiga 52021, Japan; [Suzuki, Daisuke; Umezono, Tomoya; Toyoda, Masao] Tokai Univ, Sch Med, Dept Internal Med, Div Nephrol & Metab, Isehara, Kanagawa 25911, Japan; [Babazono, Tetsuya; Uchigata, Yasuko] Tokyo Womens Med Univ, Ctr Diabet, Tokyo, Japan; [Kawai, Koichi] Kawai Clin, Tsukuba, Ibaraki, Japan; [Imanishi, Masahito] Osaka City Gen Hosp, Dept Internal Med, Osaka, Japan	RIKEN; Jikei University; Shiga University of Medical Science; Tokai University; Tokyo Women's Medical University; Osaka City General Hospital	Maeda, S (corresponding author), RIKEN Ctr Genom Med, Lab Endocrinol & Metab, Yokohama, Kanagawa, Japan.	smaeda@src.riken.jp	Koya, Daisuke/J-3257-2014	Toyoda, Masao/0000-0003-4142-1218; Maegawa, Hiroshi/0000-0002-4611-8149	Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to S.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia TS, 2011, DIABETOLOGIA, V54, P2295, DOI 10.1007/s00125-011-2178-5; Alkhalaf A, 2010, DIABETOLOGIA, V53, P2562, DOI 10.1007/s00125-010-1863-0; Baguet A, 2012, AMINO ACIDS, V43, P13, DOI 10.1007/s00726-011-1197-3; Bowden DW, 2004, KIDNEY INT, V66, P1517, DOI 10.1111/j.1523-1755.2004.00915.x; Chakkera HA, 2011, MOL GENET METAB, V103, P185, DOI 10.1016/j.ymgme.2011.02.010; ERA-EDTA Registry committee, 2012, ERA EDTA REG ANN REP; Freedman BI, 2007, NEPHROL DIAL TRANSPL, V22, P1131, DOI 10.1093/ndt/gfl717; Hobart LJ, 2004, LIFE SCI, V75, P1379, DOI 10.1016/j.lfs.2004.05.002; Hou WC, 2003, J AGR FOOD CHEM, V51, P1706, DOI 10.1021/jf0260242; Iyengar SK, 2007, DIABETES, V56, P1577, DOI 10.2337/db06-1154; Janssen B, 2005, DIABETES, V54, P2320, DOI 10.2337/diabetes.54.8.2320; Krolewski AS, 2006, KIDNEY INT, V69, P129, DOI 10.1038/sj.ki.5000023; Maeda Shiro, 2008, Ther Adv Cardiovasc Dis, V2, P363, DOI 10.1177/1753944708094768; McDonough CW, 2009, HUM GENET, V126, P265, DOI 10.1007/s00439-009-0667-0; Mooyaart AL, 2009, DIABETES RES CLIN PR, V85, P272, DOI 10.1016/j.diabres.2009.06.001; Mooyaart AL, 2010, DIABETES, V59, P1555, DOI 10.2337/db09-1377; Mozdzan M, 2005, BASIC CLIN PHARMACOL, V96, P352, DOI 10.1111/j.1742-7843.2005.pto_03.x; Nakai S, 2012, THER APHER DIAL, V16, P11, DOI 10.1111/j.1744-9987.2011.01050.x; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Penafiel R, 2004, AMINO ACIDS, V26, P53, DOI 10.1007/s00726-003-0034-8; Poon PYK, 2010, CLIN NEPHROL, V74, P343; Riedl E, 2007, DIABETES, V56, P2410, DOI 10.2337/db07-0128; Riedl E, 2011, CELL PHYSIOL BIOCHEM, V28, P279, DOI 10.1159/000331740; Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200; Vardarli I, 2002, KIDNEY INT, V62, P2176, DOI 10.1046/j.1523-1755.2002.00663.x; Wanic K, 2008, DIABETES, V57, P2547, DOI 10.2337/db07-1303	26	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54064	10.1371/journal.pone.0054064	http://dx.doi.org/10.1371/journal.pone.0054064			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342076	Green Submitted, Green Published, gold			2022-12-25	WOS:000313682700082
J	Lyng, MB; Laenkholm, AV; Tan, QH; Vach, W; Gravgaard, KH; Knoop, A; Ditzel, HJ				Lyng, Maria B.; Laenkholm, Anne-Vibeke; Tan, Qihua; Vach, Werner; Gravgaard, Karina H.; Knoop, Ann; Ditzel, Henrik J.			Gene Expression Signatures That Predict Outcome of Tamoxifen-Treated Estrogen Receptor-Positive, High-Risk, Primary Breast Cancer Patients: A DBCG Study	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; CLINICAL-PRACTICE; RECURRENCE; WOMEN; ASSAY; CARCINOMAS; EXPERIENCE; SELECTION; EFFICACY; SUBTYPES	Background: Tamoxifen significantly improves outcome for estrogen receptor-positive (ER+) breast cancer, but the 15-year recurrence rate remains 30%. The aim of this study was to identify gene profiles that accurately predicted the outcome of ER+ breast cancer patients who received adjuvant Tamoxifen mono-therapy. Methodology/Principal Findings: Post-menopausal breast cancer patients diagnosed no later than 2002, being ER+ as defined by >1% IHC staining and having a frozen tumor sample with >50% tumor content were included. Tumor samples from 108 patients treated with adjuvant Tamoxifen were analyzed for the expression of 59 genes using quantitative-PCR. End-point was clinically verified recurrence to distant organs or ipsilateral breast. Gene profiles were identified using a model building procedure based on conditional logistic regression and leave-one-out cross-validation, followed by a non-parametric bootstrap (1000x re-sampling). The optimal profiles were further examined in 5 previously-reported datasets containing similar patient populations that were either treated with Tamoxifen or left untreated (n = 623). Three gene signatures were identified, the strongest being a 2-gene combination of BCL2-CDKN1A, exhibiting an accuracy of 75% for prediction of outcome. Independent examination using 4 previously-reported microarray datasets of Tamoxifen-treated patient samples (n = 503) confirmed the potential of BCL2-CDKN1A. The predictive value was further determined by comparing the ability of the genes to predict recurrence in an additional, previously-published, cohort consisting of Tamoxifen-treated (n = 58, p = 0.015) and untreated patients (n = 62, p = 0.25). Conclusions/Significance: A novel gene expression signature predictive of outcome of Tamoxifen-treated patients was identified. The validation suggests that BCL2-CDKN1A exhibit promising predictive potential.	[Lyng, Maria B.; Gravgaard, Karina H.; Ditzel, Henrik J.] Univ So Denmark, Inst Mol Med, Odense, Denmark; [Laenkholm, Anne-Vibeke] Odense Univ Hosp, Dept Pathol, DK-5000 Odense, Denmark; [Laenkholm, Anne-Vibeke] Slagelse Hosp, Dept Pathol, Slagelse, Denmark; [Tan, Qihua] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Tan, Qihua] Univ So Denmark, Inst Publ Hlth, Odense, Denmark; [Vach, Werner] Univ Med Ctr Freiburg, Inst Med Biometry & Med Informat, Freiburg, Germany; [Knoop, Ann; Ditzel, Henrik J.] Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark; [Knoop, Ann] Rigshosp, Dept Oncol, DK-2100 Copenhagen, Denmark	University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Freiburg; University of Southern Denmark; Odense University Hospital; Rigshospitalet; University of Copenhagen	Lyng, MB (corresponding author), Univ So Denmark, Inst Mol Med, Odense, Denmark.	mlyng@health.sdu.dk; hdtizel@health.sdu.dk	Knoop, Ann Soeegaard/GLR-2775-2022; Tan, Qihua/F-1349-2015; Tan, Qihua/AAG-2582-2019; Vach, Werner/F-2512-2011	Knoop, Ann Soeegaard/0000-0003-2898-1093; Tan, Qihua/0000-0003-3194-0030; Tan, Qihua/0000-0003-3194-0030; Vach, Werner/0000-0003-1865-8399; Ditzel, Henrik J./0000-0003-3927-5135; Gravgaard Thomsen, Karina/0000-0002-9593-7239; Laenkholm, Anne-Vibeke/0000-0003-2166-8686	Danish Cancer Society; Danish Cancer Research Foundation; A Race Against Breast Cancer; Sino-Danish Breast Cancer Research Centre; Danish Strategic Research Council; Danish Center for Translational Breast Cancer research	Danish Cancer Society(Danish Cancer Society); Danish Cancer Research Foundation; A Race Against Breast Cancer; Sino-Danish Breast Cancer Research Centre; Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Danish Center for Translational Breast Cancer research	This work was supported by grants from the Danish Cancer Society, the Danish Cancer Research Foundation, A Race Against Breast Cancer, Sino-Danish Breast Cancer Research Centre, The Danish Strategic Research Council and Danish Center for Translational Breast Cancer research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abukhdeir AM, 2008, P NATL ACAD SCI USA, V105, P288, DOI 10.1073/pnas.0710887105; Barton S, 2012, BRIT J CANCER, V106, P1760, DOI 10.1038/bjc.2012.166; Baum M, 2002, LANCET, V359, P2131; Bertoldo F, 2010, EXPERT OPIN EMERG DR, V15, P323, DOI 10.1517/14728211003631385; Bilal E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038575; BLAND JM, 1994, BRIT MED J, V309, P1128, DOI 10.1136/bmj.309.6962.1128; Cardoso F, 2008, J CLIN ONCOL, V26, P729, DOI 10.1200/JCO.2007.14.3222; Chanrion M, 2008, CLIN CANCER RES, V14, P1744, DOI 10.1158/1078-0432.CCR-07-1833; Ciocca DR, 2000, ENDOCRINE, V13, P1, DOI 10.1385/ENDO:13:1:1; Coates AS, 2007, J CLIN ONCOL, V25, P486, DOI 10.1200/JCO.2006.08.8617; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Daidone MG, 2000, BRIT J CANCER, V82, P270; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Ditzel HJ, 2008, NAT CLIN PRACT ONCOL, V5, P376, DOI 10.1038/ncponc1139; ELSTON CW, 1984, AUST NZ J SURG, V54, P11, DOI 10.1111/j.1445-2197.1984.tb06677.x; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Eroles P, 2012, CANCER TREAT REV, V38, P698, DOI 10.1016/j.ctrv.2011.11.005; Goetz MP, 2006, CLIN CANCER RES, V12, P2080, DOI 10.1158/1078-0432.CCR-05-1263; Hajage D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027446; Jankowitz RC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3038; Knoop AS, 2001, J CLIN ONCOL, V19, P3376, DOI 10.1200/JCO.2001.19.14.3376; Larsen MS, 2012, ACTA ONCOL; Linke SP, 2006, CLIN CANCER RES, V12, P1175, DOI 10.1158/1078-0432.CCR-05-1562; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Loi S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-239; Lonning PE, 2007, J STEROID BIOCHEM, V106, P55, DOI 10.1016/j.jsbmb.2007.05.002; Lyng MB, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-20; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Moller S, 2008, ACTA ONCOL, V47, P506, DOI 10.1080/02841860802059259; Mouridsen HT, 2008, SABCS; Nielsen TO, 2010, CLIN CANCER RES, V16, P5222, DOI 10.1158/1078-0432.CCR-10-1282; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2004, BREAST CANCER RES TR, V88, pS15; Paik S, 2011, BREAST, V20, pS87, DOI 10.1016/S0960-9776(11)70301-0; Pellikainen MJ, 2003, J CLIN PATHOL, V56, P214, DOI 10.1136/jcp.56.3.214; Perillo B, 2000, MOL CELL BIOL, V20, P2890, DOI 10.1128/MCB.20.8.2890-2901.2000; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rakha EA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2607; Ravdin PM, 2001, J CLIN ONCOL, V19, P980, DOI 10.1200/JCO.2001.19.4.980; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sparano JA, 2008, J CLIN ONCOL, V26, P721, DOI 10.1200/JCO.2008.16.7528; Sturmer T, 2000, J Epidemiol Biostat, V5, P125; Tan Q, 2007, CANCER INFORM, V3, P213; Thomassen M, 2007, CLIN CANCER RES, V13, P5355, DOI 10.1158/1078-0432.CCR-07-0249; van de Velde CJH, 2010, CANCER TREAT REV, V36, P54, DOI 10.1016/j.ctrv.2009.10.003; Vendrell JA, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2158; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1042, DOI 10.1093/oxfordjournals.aje.a116398; Wong ZW, 2004, BRIT J CANCER, V90, P20, DOI 10.1038/sj.bjc.6601508; YANAGAWA T, 1979, ENVIRON HEALTH PERSP, V32, P143, DOI 10.2307/3429012; Zhang Y, 2009, BREAST CANCER RES TR, V116, P303, DOI 10.1007/s10549-008-0183-2	50	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54078	10.1371/journal.pone.0054078	http://dx.doi.org/10.1371/journal.pone.0054078			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342080	Green Published, gold, Green Submitted			2022-12-25	WOS:000313682700085
J	Sen, A; Damm, VT; Cox, RT				Sen, Aditya; Damm, Vanessa T.; Cox, Rachel T.			Drosophila Clueless Is Highly Expressed in Larval Neuroblasts, Affects Mitochondrial Localization and Suppresses Mitochondrial Oxidative Damage	PLOS ONE			English	Article							SELF-RENEWAL; MORPHOLOGY; DYNAMICS; PATTERNS; MUTATION; FISSION; FUSION; GENES; ROLES; BRAIN	Mitochondria are critical for neuronal function due to the high demand of ATP in these cell types. During Drosophila development, neuroblasts in the larval brain divide asymmetrically to populate the adult central nervous system. While many of the proteins responsible for maintaining neuroblast cell fate and asymmetric cell divisions are known, little is know about the role of metabolism and mitochondria in neuroblast division and maintenance. The gene clueless (clu) has been previously shown to be important for mitochondrial function. clu mutant adults have severely shortened lifespans and are highly uncoordinated. Part of their lack of coordination is due to defects in muscle, however, in this study we have identified high levels of Clu expression in larval neuroblasts and other regions of the dividing larval brain. We show while mitochondria in clu mutant neuroblasts are mislocalized during the cell cycle, surprisingly, overall brain morphology appears to be normal. This is explained by our observation that clu mutant larvae have normal levels of ATP and do not suffer oxidative damage, in sharp contrast to clu mutant adults. Mutations in two other genes encoding mitochondrial proteins, technical knockout and stress sensitive B, do not cause neuroblast mitochondrial mislocalization, even though technical knockout mutant larvae suffer oxidative damage. These results suggest Clu functions upstream of electron transport and oxidative phosphorylation, has a role in suppressing oxidative damage in the cell, and that lack of Clu's specific function causes mitochondria to mislocalize. These results also support the previous observation that larval development relies on aerobic glycolysis, rather than oxidative phosphorylation. Thus Clu's role in mitochondrial function is not critical during larval development, but is important for pupae and adults.	[Sen, Aditya; Damm, Vanessa T.; Cox, Rachel T.] Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD USA; [Damm, Vanessa T.; Cox, Rachel T.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD USA	Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA	Cox, RT (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD USA.	rachel.cox@usuhs.edu			USUHS [CO71IQ]; Center for Neuroscience and Regeneration [G171JA]; NICHD	USUHS; Center for Neuroscience and Regeneration; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by USUHS start-up grant CO71IQ and the Center for Neuroscience and Regeneration grant G171JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Cheng-Yu Lee for the aur<SUP>14641</SUP> stock, Dr. Chris Doe for the anti-Mir antibody, Dr. Michael Pallandino for the ATP6<SUP>1</SUP>; sesB<SUP>1</SUP> stock, and Dr. Chun-Fang Wu for the tko<SUP>25t</SUP> stock. We would also like to thank Xin Xiang for helpful discussions and Allan Spradling, in whose lab we first observed Clu labeling in neuroblasts. The anti-tubulin antibodies AA4.3, AA12.1, and E7, developed by Drs. Charles Walsh and Michael Klymkowsky, respectfully, were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242. We also thank the members of the USUHS Biomedical Instrumentation Core for imaging support.	Akong K, 2002, DEV BIOL, V250, P71, DOI 10.1006/dbio.2002.0777; BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303; Celotto AM, 2006, J NEUROSCI, V26, P810, DOI 10.1523/JNEUROSCI.4162-05.2006; Chai PC, 2012, WIRES DEV BIOL, V1, P307, DOI 10.1002/wdev.27; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Chia W, 2008, J CELL BIOL, V180, P267, DOI 10.1083/jcb.200708159; Cox RT, 2006, DEVELOPMENT, V133, P3371, DOI 10.1242/dev.02514; Cox RT, 2009, DIS MODEL MECH, V2, P490, DOI 10.1242/dmm.002378; Cox RT, 2003, DEVELOPMENT, V130, P1579, DOI 10.1242/dev.00365; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; Duttaroy A, 2003, GENETICS, V165, P2295; Fergestad Tim, 2006, Genetics, V173, P1357, DOI 10.1534/genetics.106.057463; Fields SD, 1998, J CELL SCI, V111, P1717; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Hayden MA, 2007, DEV BIOL, V305, P358, DOI 10.1016/j.ydbio.2007.02.018; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; JUDD BH, 1972, GENETICS, V71, P139; Kirby K, 2002, P NATL ACAD SCI USA, V99, P16162, DOI 10.1073/pnas.252342899; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kumar S, 2011, BIOINFORMATICS, V27, P3319, DOI 10.1093/bioinformatics/btr567; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406; Logan DC, 2003, PLANT J, V36, P500, DOI 10.1046/j.1365-313X.2003.01894.x; Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142; Rebollo E, 2007, DEV CELL, V12, P467, DOI 10.1016/j.devcel.2007.01.021; ROYDEN CS, 1987, CELL, V51, P165, DOI 10.1016/0092-8674(87)90144-9; Rusan NM, 2007, J CELL BIOL, V177, P13, DOI 10.1083/jcb.200612140; Tennessen JM, 2011, CELL METAB, V13, P139, DOI 10.1016/j.cmet.2011.01.005; Terhzaz S, 2010, PHYSIOL GENOMICS, V41, P33, DOI 10.1152/physiolgenomics.00147.2009; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; Wang H, 2006, GENE DEV, V20, P3453, DOI 10.1101/gad.1487506; WANG T, 1976, NATURE, V261, P702, DOI 10.1038/261702a0; Zhang YQ, 1999, GENETICS, V153, P891; Zhu QL, 1997, P NATL ACAD SCI USA, V94, P7308, DOI 10.1073/pnas.94.14.7308	37	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54283	10.1371/journal.pone.0054283	http://dx.doi.org/10.1371/journal.pone.0054283			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342118	Green Submitted, gold, Green Published			2022-12-25	WOS:000313682700102
J	Wakimoto, S; Nakayama-Imaohji, H; Ichimura, M; Morita, H; Hirakawa, H; Hayashi, T; Yasutomo, K; Kuwahara, T				Wakimoto, Shin; Nakayama-Imaohji, Haruyuki; Ichimura, Minoru; Morita, Hidetoshi; Hirakawa, Hideki; Hayashi, Tetsuya; Yasutomo, Koji; Kuwahara, Tomomi			PhoB Regulates the Survival of Bacteroides fragilis in Peritoneal Abscesses	PLOS ONE			English	Article							EXPRESSION PROFILE; GUT MICROBIOME; VIRULENCE; GENES; IDENTIFICATION; DIVERSITY; PHOSPHATE; PATHOGEN; REVEALS; REGULON	In response to phosphate limitation, bacteria employ the Pho regulon, a specific regulatory network for phosphate acquisition. The two-component signal transduction system of PhoRB plays a crucial role in the induction of Pho regulon genes, leading to the adaptation to phosphate starvation. Herein, we identified the PhoRB system in Bacteroides fragilis, a commensal gut bacterium, and evaluated its role in gut colonization and survival in peritoneal abscesses. BF1575 and BF1576 encoded PhoR (sensor histidine kinase) and PhoB (response regulator) in the sequenced B. fragilis strain YCH46, respectively. Transcriptome analysis revealed that deletion of phoB affected the expression of 585 genes (more than 4-fold change) in B. fragilis, which included genes for stress response (chaperons and heat shock proteins), virulence (capsular polysaccharide biosynthesis) and phosphate metabolism. Deletion of phoB reduced the ability of the bacterium to persist in peritoneal abscesses induced by an intra-abdominal challenge of B. fragilis. Furthermore, PhoB was necessary for survival of this anaerobe in peritoneal abscesses but not for in vitro growth in rich media or in intestinal colonization. These results indicate that PhoB plays an important role in the survival of B. fragilis under stressful extraintestinal conditions.	[Wakimoto, Shin; Ichimura, Minoru; Yasutomo, Koji] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Immunol & Parasitol, Tokushima 770, Japan; [Nakayama-Imaohji, Haruyuki; Ichimura, Minoru; Kuwahara, Tomomi] Kagawa Univ, Fac Med, Dept Microbiol, Kagawa, Japan; [Morita, Hidetoshi] Azabu Univ, Sch Vet Med, Kanagawa, Japan; [Hirakawa, Hideki] Kazusa DNA Res Inst, Chiba, Japan; [Hayashi, Tetsuya] Miyazaki Univ, Frontier Sci Res Ctr, Miyazaki, Japan	Tokushima University; Kagawa University; Azabu University; Kazusa DNA Research Institute; University of Miyazaki	Kuwahara, T (corresponding author), Kagawa Univ, Fac Med, Dept Microbiol, Kagawa, Japan.	tomomi@med.kagawa-u.ac.jp	Hayashi, Tetsuya/ABA-1074-2020		Ministry of Education, Science and Culture of Japan [22790409]; Japan Society for the Promotion of Science [20510187]	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported partly by a Grant-in-Aid for Scientific Research for Young Scientists B (no. 22790409) from the Ministry of Education, Science and Culture of Japan and a Grant for Scientific Research C (no. 20510187) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alverdy J, 2000, ANN SURG, V232, P480, DOI 10.1097/00000658-200010000-00003; Bayley DP, 2000, FEMS MICROBIOL LETT, V193, P149, DOI 10.1111/j.1574-6968.2000.tb09417.x; Bertrand N, 2010, INFECT IMMUN, V78, P5324, DOI 10.1128/IAI.00452-10; Chatterjee SS, 2006, INFECT IMMUN, V74, P1323, DOI 10.1128/IAI.74.2.1323-1338.2006; Chatzidaki-Livanis M, 2010, P NATL ACAD SCI USA, V101, P14919; Chu FF, 2004, CANCER RES, V64, P962, DOI 10.1158/0008-5472.CAN-03-2272; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Coyne MJ, 2000, INFECT IMMUN, V68, P6176, DOI 10.1128/IAI.68.11.6176-6181.2000; Coyne MJ, 2001, INFECT IMMUN, V69, P4342, DOI 10.1128/IAI.69.7.4342-4350.2001; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dubail I, 2000, INFECT IMMUN, V68, P3242, DOI 10.1128/IAI.68.6.3242-3250.2000; Elson CO, 2005, IMMUNOL REV, V206, P260, DOI 10.1111/j.0105-2896.2005.00291.x; Grabenstein JP, 2006, INFECT IMMUN, V74, P3727, DOI 10.1128/IAI.00255-06; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Ichimura M, 2010, APPL ENVIRON MICROB, V76, P3325, DOI 10.1128/AEM.02420-09; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Krinos CM, 2001, NATURE, V414, P555, DOI 10.1038/35107092; Kuwahara T, 2004, P NATL ACAD SCI USA, V101, P14919, DOI 10.1073/pnas.0404172101; Kuwahara T, 2002, FEMS MICROBIOL LETT, V207, P193, DOI 10.1016/S0378-1097(01)00584-5; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long J, 2008, SURGERY, V144, P189, DOI 10.1016/j.surg.2008.03.045; Marijuan PC, 2010, BIOSYSTEMS, V99, P94, DOI 10.1016/j.biosystems.2009.09.004; Nakayama-Imaohji H, 2009, J BACTERIOL, V191, P6003, DOI 10.1128/JB.00687-09; Patrick S, 2010, MICROBIOL-SGM, V156, P3255, DOI 10.1099/mic.0.042978-0; Pratt JT, 2010, MOL MICROBIOL, V77, P1595, DOI 10.1111/j.1365-2958.2010.07310.x; Rocha ER, 1997, J BACTERIOL, V179, P7033, DOI 10.1128/jb.179.22.7033-7039.1997; Salyers AA, 1999, METHOD MICROBIOL, V29, P229; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; VAREL VH, 1974, APPL MICROBIOL, V28, P251, DOI 10.1128/AEM.28.2.251-257.1974; Wanner BL, 1996, ESCHERICHIA COLI SAL, P1357, DOI DOI 10.1007/978-3-642-75969-7_16; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Wu Licheng R, 2005, Surg Infect (Larchmt), V6, P185, DOI 10.1089/sur.2005.6.185; Yang SH, 2004, MOL PLANT MICROBE IN, V17, P999, DOI 10.1094/MPMI.2004.17.9.999	39	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53829	10.1371/journal.pone.0053829	http://dx.doi.org/10.1371/journal.pone.0053829			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23342014	Green Published, Green Submitted, gold			2022-12-25	WOS:000314707700034
J	Crooke, AK; Fuller, JR; Obrist, MW; Tomkovich, SE; Vitko, NP; Richardson, AR				Crooke, Adrianne K.; Fuller, James R.; Obrist, Markus W.; Tomkovich, Sarah E.; Vitko, Nicholas P.; Richardson, Anthony R.			CcpA-Independent Glucose Regulation of Lactate Dehydrogenase 1 in Staphylococcus aureus	PLOS ONE			English	Article							NITRIC-OXIDE; BACILLUS-SUBTILIS; INNATE IMMUNITY; METABOLISM; RESISTANCE; GENE; INFECTIONS; EXPRESSION; REPRESSOR; REGULON	Lactate Dehydrogenase 1 (Ldh1) is a key enzyme involved in Staphylococcus aureus NO-resistance. Full ldh1-induction requires the presence of glucose, and mutants lacking the Carbon-Catabolite Protein (CcpA) exhibit decreased ldh1 transcription and diminished Ldh1 activity. The redox-regulator Rex represses ldh1 directly by binding to Rex-sites within the ldh1 promoter (P-ldh1). In the absence of Rex, neither glucose nor CcpA affect ldh1 expression implying that glucose/CcpA-mediated activation requires Rex activity. Rex-mediated repression of ldh1 depends on cellular redox status and is maximal when NADH levels are low. However, compared to WT cells, the Delta ccpA mutant exhibited impaired redox balance with relatively high NADH levels, yet ldh1 was still poorly expressed. Furthermore, CcpA did not drastically alter Rex transcript levels, nor did glucose or CcpA affect the expression of other Rex-regulated genes indicating that the glucose/CcpA effect is specific for P-ldh1. A putative catabolite response element (CRE) is located similar to 30 bp upstream of the promoter-distal Rex-binding site in P-ldh1. However, CcpA had no affinity for P-ldh1 in vitro and a genomic mutation of CRE upstream of P-ldh1 in S. aureus had no affect on Ldh1 expression in vivo. In contrast to WT, Delta ccpA S. aureus preferentially consumes non-glycolytic carbon sources. However when grown in defined medium with glucose as the primary carbon source, Delta ccpA mutants express high levels of Ldh1 compared to growth in media devoid of glucose. Thus, the actual consumption of glucose stimulates Ldh1 expression rather than direct CcpA interaction at P-ldh1.	[Crooke, Adrianne K.; Fuller, James R.; Obrist, Markus W.; Tomkovich, Sarah E.; Vitko, Nicholas P.; Richardson, Anthony R.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Richardson, AR (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.	anthony_richardson@med.unc.edu	Tomkovich, Sarah/ABF-7952-2020	Tomkovich, Sarah/0000-0003-1638-5307	National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) [AI093613]; Pew Charitable Trusts (Pew Scholars Program in the Biomedical Sciences); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093613] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Pew Charitable Trusts (Pew Scholars Program in the Biomedical Sciences); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funding from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) (AI093613 to ARR) and the Pew Charitable Trusts (Pew Scholars Program in the Biomedical Sciences). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai K, 2011, J BIOCHEM, V150, P579, DOI 10.1093/jb/mvr100; Brown GC, 1997, BIOCHEM SOC T, V25, P901, DOI 10.1042/bst0250901; Bruckner R, 1997, FEMS MICROBIOL LETT, V151, P1; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; DYKE KGH, 1969, J MED MICROBIOL, V2, P261, DOI 10.1099/00222615-2-3-261; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Fuller JR, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00019; GARVIE EI, 1980, MICROBIOL REV, V44, P106, DOI 10.1128/MMBR.44.1.106-139.1980; Hochgrafe F, 2008, J BACTERIOL, V190, P4997, DOI 10.1128/JB.01846-07; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Lambert M, 2011, AM FAM PHYSICIAN, V84, P455; Li CL, 2010, J BACTERIOL, V192, P3883, DOI 10.1128/JB.00237-10; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Makhlin J, 2007, J BACTERIOL, V189, P5976, DOI 10.1128/JB.00592-07; Marciniak BC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-401; Pagels M, 2010, MOL MICROBIOL, V76, P1142, DOI 10.1111/j.1365-2958.2010.07105.x; Richardson AR, 2008, SCIENCE, V319, P1672, DOI 10.1126/science.1155207; Richardson AR, 2006, MOL MICROBIOL, V61, P927, DOI 10.1111/j.1365-2958.2006.05290.x; Richardson AR, 2011, CELL HOST MICROBE, V10, P33, DOI 10.1016/j.chom.2011.06.004; SABATH LD, 1972, ANTIMICROB AGENTS CH, V22, P350, DOI 10.1128/AAC.2.5.350; Seidl K, 2006, ANTIMICROB AGENTS CH, V50, P1183, DOI 10.1128/AAC.50.4.1183-1194.2006; Seidl K, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-95; Titgemeyer F, 2002, ANTON LEEUW INT J G, V82, P59, DOI 10.1023/A:1020628909429; Toledo JC, 2012, CHEM RES TOXICOL, V25, P975, DOI 10.1021/tx300042g; Wang E, 2008, MOL MICROBIOL, V69, P466, DOI 10.1111/j.1365-2958.2008.06295.x; Yang SJ, 2006, MOL MICROBIOL, V60, P458, DOI 10.1111/j.1365-2958.2006.05105.x	26	24	25	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54293	10.1371/journal.pone.0054293	http://dx.doi.org/10.1371/journal.pone.0054293			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342123	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400143
J	Ma, GF; Miao, Q; Zeng, XQ; Luo, TC; Ma, LL; Liu, YM; Lian, JJ; Gao, H; Chen, SY				Ma, Gui-Fen; Miao, Qing; Zeng, Xiao-Qing; Luo, Tian-Cheng; Ma, Li-Li; Liu, Yi-Mei; Lian, Jing-Jing; Gao, Hong; Chen, Shi-Yao			Transforming Growth Factor-beta 1 and -beta 2 in Gastric Precancer and Cancer and Roles in Tumor-Cell Interactions with Peripheral Blood Mononuclear Cells In Vitro	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; PANCREATIC DUCTAL ADENOCARCINOMA; TGF-BETA-3 PROTEIN EXPRESSION; REGULATORY T-CELLS; TGF-BETA; SUPPRESSION; ACTIVATION; CARCINOMA; SMAD2; SERUM	Transforming growth factor-beta 1 (TGF-beta 1) and -beta 2 are correlated with poorer prognosis in gastric cancer (GC), which act in both tumor and immune cells. However, their expressions in precancer and tumor-cell interactions with peripheral blood mononuclear cells (PBMCs) remain unclear. Protein levels of TGF-beta 1 and -beta 2 were analyzed by immunohistochemistry and corresponding mRNA levels were determined by quantitative real-time polymerase chain reaction in 93 surgical and biopsy specimens. Serum TGF-beta concentration was detected by enzyme-linked immunosorbent assays. AGS and MKN45 cell lines were directly or indirectly cocultured with PBMCs in vitro. TGF-beta and Smad molecules were detected after cocultures and the growths of GC cells and PBMCs were assessed by cell proliferation assay. The results showed positive staining for TGF-beta 1 was detected in 20% of control samples, 52.3% of precancer, 59.1% of early GC and 66.7% of advanced GC samples, correlated with lesion progression (chi(2) = 9.487, P = 0.002). All tissues were positive for TGF-beta 2. TGF-beta 1 mRNA levels were increased in advanced cancers, while TGF-beta 2 increased earlier. TGF-beta 1 mRNA levels were higher in tumor than in peritumor, which positively correlated with Smad2 and Smad7. Serum TGF-beta levels were significantly higher in patients with early and advanced cancers compared to controls (TGF-beta 1:50.08 +/- 4.38 and 45.76 +/- 5.00 vs. 27.78 +/- 6.11 ng/mL; TGF-beta 2:133.61 +/- 21.90 and 111.34 +/- 15.76 vs. 59.41 +/- 15.42 ng/mL, both P<0.05). The levels of TGF-beta 1 mRNA and cytokine secretion were higher in GC cells after direct coculture compared to indirect culture. TGF-beta 1 was decreased and TGF-beta 2 was increased in PBMCs after cocultures. Moreover, TGF-beta 1 inhibited the viability of PBMCs but not cancer cells. Collectively, neoplastic transformation may be an early event involving the increase of TGF-beta 1 in the general and local environment. TGF-beta 1 production is promoted by the direct interaction between GC cells and PBMCs, which might facilitate cancer development.	[Ma, Gui-Fen; Miao, Qing; Zeng, Xiao-Qing; Luo, Tian-Cheng; Liu, Yi-Mei; Gao, Hong; Chen, Shi-Yao] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China; [Ma, Li-Li; Lian, Jing-Jing; Chen, Shi-Yao] Fudan Univ, Zhongshan Hosp, Endoscopy Ctr, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Chen, SY (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China.	shiyao_chen@163.com			Xinjiang Uygur Autonomous Region Science and Technology Support Project [200991127]	Xinjiang Uygur Autonomous Region Science and Technology Support Project	This work was supported by Xinjiang Uygur Autonomous Region Science and Technology Support Project (No.200991127) (http://www.kjzj.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achyut BR, 2011, GASTROENTEROLOGY, V141, P1167, DOI 10.1053/j.gastro.2011.07.048; Ananiev J, 2011, WIEN KLIN WOCHENSCHR, V123, P668, DOI 10.1007/s00508-011-0078-9; Bachman KE, 2005, CURR OPIN ONCOL, V17, P49, DOI 10.1097/01.cco.0000143682.45316.ae; Beck C, 2001, MICROSC RES TECHNIQ, V52, P387, DOI 10.1002/1097-0029(20010215)52:4<387::AID-JEMT1023>3.0.CO;2-W; Bellone G, 2010, INT J ONCOL, V37, P1153, DOI 10.3892/ijo_00000767; Bessler H, 2010, BIOMED PHARMACOTHER, V64, P706, DOI 10.1016/j.biopha.2010.08.006; Coban S, 2007, HEPATO-GASTROENTEROL, V54, P1472; Comerci JT, 1996, CANCER, V77, P1107, DOI 10.1002/(SICI)1097-0142(19960315)77:6<1107::AID-CNCR16>3.3.CO;2-A; de Caestecker MP, 2000, JNCI-J NATL CANCER I, V92, P1388, DOI 10.1093/jnci/92.17.1388; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Do TV, 2008, MOL CANCER RES, V6, P695, DOI 10.1158/1541-7786.MCR-07-0294; Fu H, 2009, ACTA BIOCH BIOPH SIN, V41, P648, DOI 10.1093/abbs/gmp053; Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; Hamilton SR, 2000, WHO CLASSIFICATION T; Hawinkels LJAC, 2007, BRIT J CANCER, V97, P398, DOI 10.1038/sj.bjc.6603877; Javelaud D, 2011, CANCER RES, V71, P5606, DOI 10.1158/0008-5472.CAN-11-1194; Konrad L, 2009, REGUL PEPTIDES, V155, P28, DOI 10.1016/j.regpep.2009.04.012; Laverty HG, 2009, CYTOKINE GROWTH F R, V20, P305, DOI 10.1016/j.cytogfr.2009.07.002; Lee MS, 2004, INT J ONCOL, V24, P1229; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li X, 2007, CANCER LETT, V253, P144, DOI 10.1016/j.canlet.2007.01.024; Li X, 2008, J CLIN LAB ANAL, V22, P164, DOI 10.1002/jcla.20236; Li ZW, 2006, SCAND J GASTROENTERO, V41, P1007, DOI 10.1080/00365520600554477; Liu VC, 2007, J IMMUNOL, V178, P2883, DOI 10.4049/jimmunol.178.5.2883; Lu XM, 2011, J SURG ONCOL, V104, P571, DOI 10.1002/jso.22005; MABOGUNJE OA, 1978, GUT, V19, P425, DOI 10.1136/gut.19.5.425; Martignoni ME, 2005, CLIN CANCER RES, V11, P5802, DOI 10.1158/1078-0432.CCR-05-0185; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Monteleone G, 2004, GASTROENTEROLOGY, V126, P674, DOI 10.1053/j.gastro.2003.11.048; Naef M, 1997, INT J CANCER, V71, P131; Nowak M, 2010, SCAND J IMMUNOL, V71, P91, DOI 10.1111/j.1365-3083.2009.02350.x; Ono Y, 2012, CANCER SCI, V103, P317, DOI 10.1111/j.1349-7006.2011.02133.x; Ottaviano AJ, 2006, CANCER RES, V66, P7032, DOI 10.1158/0008-5472.CAN-05-4421; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Poggi A, 2006, ARCH IMMUNOL THER EX, V54, P323, DOI 10.1007/s00005-006-0038-7; REINHOLD D, 1994, CYTOKINE, V6, P382, DOI 10.1016/1043-4666(94)90062-0; Schniewind B, 2007, ONCOGENE, V26, P4850, DOI 10.1038/sj.onc.1210272; Sekimoto G, 2007, CANCER RES, V67, P5090, DOI 10.1158/0008-5472.CAN-06-4629; Shen ZB, 2010, J CANCER RES CLIN, V136, P1585, DOI 10.1007/s00432-010-0816-9; Suda A, 2009, INT SURG, V94, P182; Taylor A, 2006, IMMUNOLOGY, V117, P433, DOI 10.1111/j.1365-2567.2006.02321.x; Ten Dijke PT, 2002, J CELL PHYSIOL, V191, P1, DOI 10.1002/jcp.10066; Tsamandas AC, 2004, STRAHLENTHER ONKOL, V180, P201, DOI 10.1007/s00066-004-1149-x; Ungefroren H, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-67; Vagenas K, 2007, J SURG RES, V139, P182, DOI 10.1016/j.jss.2006.10.005; Yang L, 2010, TRENDS IMMUNOL, V31, P220, DOI 10.1016/j.it.2010.04.002; Yannelli JR, 2009, ONCOL REP, V22, P1459, DOI 10.3892/or_00000588; Zhang Y, 2012, J CELL PHYSIOL, V227, P35, DOI 10.1002/jcp.22722	48	46	52	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54249	10.1371/journal.pone.0054249	http://dx.doi.org/10.1371/journal.pone.0054249			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342108	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400136
J	Matsuzaki, Y; Hosokai, H; Mizuguchi, Y; Fukamachi, S; Shimizu, A; Saya, H				Matsuzaki, Yuriko; Hosokai, Haru; Mizuguchi, Yukiyo; Fukamachi, Shoji; Shimizu, Atsushi; Saya, Hideyuki			Establishment of HRAS(G12V) Transgenic Medaka as a Stable Tumor Model for In Vivo Screening of Anticancer Drugs	PLOS ONE			English	Article							ZEBRAFISH MODEL; ORYZIAS-LATIPES; MELANOMA; PROGRESSION; EXPRESSION; RATIONALE; PATHWAYS; CELLS; GENE	Most targeted anticancer drugs have been identified by screening at the molecular or cellular level in vitro. However, many compounds selected by such costly and time-consuming screening do not prove effective against tumors in vivo. The development of anticancer drugs would thus be facilitated by the availability of an in vivo screening system based on a multicellular organism. We have now established a transgenic line of the freshwater fish medaka in which melanophores (melanocytes) proliferate in a manner dependent on heat shock-induced signaling by a human RAS oncoprotein. The human HRAS(G12V) oncogene was expressed under the control of a melanophore-specific gene promoter in order to allow visualization of tumor growth in live fish maintained in a water tank. The expression of HRAS(G12V) was induced as a result of Cre-mediated recombination by exposure of the fish to a temperature of 37 degrees C for 30 min, given that the Cre gene was placed under the control of a medaka heat shock promoter. One of the stable transgenic lines developed abnormal pigment cell proliferation in the eyes and epidermis with 100% penetrance by 6 months postfertilization. Sorafenib, an inhibitor of RAS signaling, was administered to the transgenic fish and was found both to reduce the extent of melanophore proliferation and to improve survival. The transgenic medaka established here thus represents a promising in vivo system with which to screen potential anticancer drugs that target RAS signaling, and this system can readily be adapted for the screening of agents that target other oncogenes.	[Matsuzaki, Yuriko; Mizuguchi, Yukiyo; Saya, Hideyuki] Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat, Tokyo, Japan; [Hosokai, Haru] Japan Womens Univ, Div Mat & Biol Sci, Tokyo 112, Japan; [Fukamachi, Shoji] Japan Womens Univ, Dept Chem & Biol Sci, Lab Evolutionary Genet, Tokyo 112, Japan; [Shimizu, Atsushi] Keio Univ, Sch Med, Dept Mol Biol, Tokyo, Japan; [Saya, Hideyuki] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo, Japan	Keio University; Japan Womens University; Japan Womens University; Keio University; Japan Science & Technology Agency (JST)	Saya, H (corresponding author), Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat, Tokyo, Japan.	hsaya@a5.keio.jp	Matsuzaki, Yuriko/L-5309-2013; Saya, Hideyuki/J-4325-2013	Fukamachi, Shoji/0000-0001-7967-1883; Saya, Hideyuki/0000-0001-6610-1902	Japan Science and Technology Agency, Core Research for Evolutional Science and Technology; Grants-in-Aid for Scientific Research [24591633] Funding Source: KAKEN	Japan Science and Technology Agency, Core Research for Evolutional Science and Technology(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study was supported by Japan Science and Technology Agency, Core Research for Evolutional Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Alfa GK, 2006, J CLIN ONCOL, V24, P4293, DOI 10.1200/JCO.2005.01.3441; Nguyen AT, 2012, DIS MODEL MECH, V5, P63, DOI 10.1242/dmm.008367; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Dovey M, 2009, ZEBRAFISH, V6, P397, DOI 10.1089/zeb.2009.0606; Flaherty KT, 2012, NAT REV CANCER, V12, P349, DOI 10.1038/nrc3218; Hawkins William E., 2003, Toxicologic Pathology, V31, P88; INAGAKI H, 1994, GENE, V150, P319, DOI 10.1016/0378-1119(94)90445-6; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kaufman CK, 2009, NAT PROTOC, V4, P1422, DOI 10.1038/nprot.2009.144; Klaunig J E, 1984, Natl Cancer Inst Monogr, V65, P155; Kobayashi Y, 2011, AM J PATHOL, V179, P1471, DOI 10.1016/j.ajpath.2011.05.019; Larue L, 2007, PIGM CELL RES, V20, P485, DOI 10.1111/j.1600-0749.2007.00411.x; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Maruyama K, 2002, J BIOCHEM, V132, P581, DOI 10.1093/oxfordjournals.jbchem.a003260; Michailidou C, 2009, DIS MODEL MECH, V2, P399, DOI 10.1242/dmm.001149; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Santoriello C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015170; Schartl M, 2010, J INVEST DERMATOL, V130, P249, DOI 10.1038/jid.2009.213; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; White RM, 2011, NATURE, V471, P518, DOI 10.1038/nature09882; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443	22	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54424	10.1371/journal.pone.0054424	http://dx.doi.org/10.1371/journal.pone.0054424			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342156	gold, Green Submitted, Green Published			2022-12-25	WOS:000314759400165
J	Salinas, RY; Baker, SA; Gospe, SM; Arshavsky, VY				Salinas, Raquel Y.; Baker, Sheila A.; Gospe, Sidney M., III; Arshavsky, Vadim Y.			A Single Valine Residue Plays an Essential Role in Peripherin/rds Targeting to Photoreceptor Outer Segments	PLOS ONE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; TRANSGENIC XENOPUS-LAEVIS; PROTEIN-COUPLED-RECEPTORS; DEGENERATION SLOW RDS; RETINAL DEGENERATION; ROD PHOTORECEPTORS; C-TERMINUS; DISK MEMBRANES; MUTANT MICE; LOCALIZATION	Peripherin/retinal degeneration slow (rds) is an integral membrane protein specifically localized to the light-sensing organelle of the photoreceptor cell, the outer segment. Within the outer segment, peripherin is found at the edges of photoreceptor discs, where it plays a critical role in disc morphogenesis and maintenance. Peripherin loss or mutations are often associated with severe forms of visual impairments. Like all other resident outer segment proteins, peripherin is synthesized in the photoreceptor cell body and subsequently transported to the outer segment. In an effort to further examine peripherin's delivery to outer segments, we undertook a careful examination of its targeting sequence. Using a fluorescently labeled reporter expressed in the rods of transgenic tadpoles, we narrowed peripherin's targeting sequence to ten amino acids within its C-terminal tail. This small stretch of amino acid residues is both necessary and sufficient for outer segment targeting. We also conducted alanine scanning of all residues within this sequence and found that only a single residue, valine at position 332, is essential for outer segment targeting. This valine is conserved in all species and its mutation is sufficient to completely abrogate the targeting of full-length peripherin in mouse rods.	[Salinas, Raquel Y.; Gospe, Sidney M., III; Arshavsky, Vadim Y.] Duke Univ Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA; [Baker, Sheila A.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Gospe, Sidney M., III; Arshavsky, Vadim Y.] Duke Univ Med Ctr, Dept Ophthalmol, Durham, NC USA	Duke University; University of Iowa; Duke University	Arshavsky, VY (corresponding author), Duke Univ Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA.	vadim.arshavsky@duke.edu		Gospe III, Sidney/0000-0003-2838-7983; Salinas, Raquel/0000-0002-3119-7737; Baker, Sheila/0000-0002-0259-0652	National Institutes of Health (NIH) grant [EY12859]; IH Core Grant for Vision Research [EY05722]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [F31EY022862, P30EY005722, R01EY012859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007184] Funding Source: NIH RePORTER	National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IH Core Grant for Vision Research; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) grant EY12859 (VYA), the NIH Core Grant for Vision Research EY05722, and an unrestricted grant from Research to Prevent Blindness to Duke University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali RR, 2000, NAT GENET, V25, P306, DOI 10.1038/77068; Amaya E, 1999, METH MOL B, V97, P393, DOI 10.1385/1-59259-270-8:393; ARIKAWA K, 1992, J CELL BIOL, V116, P659, DOI 10.1083/jcb.116.3.659; Baker SA, 2008, J CELL BIOL, V183, P485, DOI 10.1083/jcb.200806009; Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Berger W, 2010, PROG RETIN EYE RES, V29, P335, DOI 10.1016/j.preteyeres.2010.03.004; Berson EL, 2002, INVEST OPHTH VIS SCI, V43, P3027; Bessant D A, 1999, Hum Mutat, V13, P83, DOI 10.1002/(SICI)1098-1004(1999)13:1<83::AID-HUMU12>3.0.CO;2-5; Boesze-Battaglia K, 2003, EXP EYE RES, V77, P505, DOI 10.1016/S0014-4835(03)00151-9; Boesze-Battaglia K, 1998, BIOCHEMISTRY-US, V37, P9477, DOI 10.1021/bi980173p; Boesze-Battaglia K, 2002, INT REV CYTOL, V217, P183; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Deretic D, 2005, P NATL ACAD SCI USA, V102, P3301, DOI 10.1073/pnas.0500095102; Deretic D, 1998, P NATL ACAD SCI USA, V95, P10620, DOI 10.1073/pnas.95.18.10620; Deretic D, 2012, VISION RES; Edrington TC, 2007, BIOCHEMISTRY-US, V46, P3605, DOI 10.1021/bi061820c; FARISS RN, 1992, MOL BIOL CELL, V3, pA56; Geng L, 2006, J CELL SCI, V119, P1383, DOI 10.1242/jcs.02818; Goldberg AFX, 1996, BIOCHEMISTRY-US, V35, P6144, DOI 10.1021/bi960259n; GOLDBERG AFX, 1995, BIOCHEMISTRY-US, V34, P14213, DOI 10.1021/bi00043a028; Gospe SM, 2010, J CELL SCI, V123, P3639, DOI 10.1242/jcs.072389; Grover S, 2002, OPHTHALMOLOGY, V109, P1110, DOI 10.1016/S0161-6420(02)01029-1; Hagstrom SA, 1999, INVEST OPHTH VIS SCI, V40, P2795; Jenkins PM, 2006, CURR BIOL, V16, P1211, DOI 10.1016/j.cub.2006.04.034; Knox BE, 1998, FEBS LETT, V423, P117, DOI 10.1016/S0014-5793(98)00018-0; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Lee ES, 2006, INVEST OPHTH VIS SCI, V47, P2150, DOI 10.1167/iovs.05-0919; Loewen CJR, 2000, J BIOL CHEM, V275, P5370, DOI 10.1074/jbc.275.8.5370; Luo WQ, 2004, J NEUROSCI, V24, P2623, DOI 10.1523/JNEUROSCI.5302-03.2004; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; MOLDAY LL, 1992, INVEST OPHTH VIS SCI, V33, P740; Nour M, 2004, MOL THER, V9, pS89; Nour M, 2008, ADV EXP MED BIOL, V613, P129, DOI 10.1007/978-0-387-74904-4_14; Pandey KN, 2010, CURR OPIN BIOTECH, V21, P611, DOI 10.1016/j.copbio.2010.08.007; PETERS KR, 1983, J CELL BIOL, V96, P265, DOI 10.1083/jcb.96.1.265; Ritter LM, 2004, J BIOL CHEM, V279, P39958, DOI 10.1074/jbc.M403943200; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; SANYAL S, 1980, J COMP NEUROL, V194, P193, DOI 10.1002/cne.901940110; SANYAL S, 1981, NEUROSCI LETT, V21, P23, DOI 10.1016/0304-3940(81)90051-3; SUNG CH, 1994, J NEUROSCI, V14, P5818; Tam BM, 2004, MOL BIOL CELL, V15, P2027, DOI 10.1091/mbc.e03-09-0650; Tam BM, 2000, J CELL BIOL, V151, P1369, DOI 10.1083/jcb.151.7.1369; TRAVIS GH, 1992, NEURON, V9, P113, DOI 10.1016/0896-6273(92)90226-4; TRAVIS GH, 1989, NATURE, V338, P70, DOI 10.1038/338070a0; Ward HH, 2011, MOL BIOL CELL, V22, P3289, DOI 10.1091/mbc.E11-01-0082; Zhang L, 2005, BIOCHEMISTRY-US, V44, P14509, DOI 10.1021/bi051386z	47	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54292	10.1371/journal.pone.0054292	http://dx.doi.org/10.1371/journal.pone.0054292			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342122	Green Submitted, gold, Green Published			2022-12-25	WOS:000314759400142
J	Socquet-Juglard, D; Kamber, T; Pothier, JF; Christen, D; Gessler, C; Duffy, B; Patocchi, A				Socquet-Juglard, Didier; Kamber, Tim; Pothier, Joel F.; Christen, Danilo; Gessler, Cesare; Duffy, Brion; Patocchi, Andrea			Comparative RNA-Seq Analysis of Early-Infected Peach Leaves by the Invasive Phytopathogen Xanthomonas arboricola pv. pruni	PLOS ONE			English	Article							DISEASE RESISTANCE; EXPRESSION ANALYSIS; LINKAGE MAP; GENE; IDENTIFICATION; PEROXIDASE; METABOLISM; RESPONSES; PROTEINS; SEQUENCE	Xanthomonas arboricola pv. pruni is a quarantine bacterial pathogen that threatens peach production by causing necrotic spots on leaves and fruits, thus with the potential of severely reducing yields. The current understanding of the host plant defense responses to the pathogen is very limited. Using whole transcriptome sequencing, differential gene expression was analyzed at two time points, 2 h and 12 h post inoculation (hpi), by comparing the inoculated samples to their respective controls. On the total of 19,781 known peach genes that were expressed in all time points and conditions, 34 and 263 were differentially expressed at 2 and 12 hpi, respectively. Of those, 82% and 40% were up-regulated, respectively; and 18% and 60% were down-regulated, respectively. The functional annotation based on gene ontology (GO) analysis highlighted that genes involved in metabolic process and response to stress were particularly represented at 2 hpi whereas at 12 hpi cellular and metabolic processes were the categories with the highest number of genes differentially expressed. Of particular interest among the differentially expressed genes identified were several pathogen-associated molecular pattern (PAMP) receptors, disease resistance genes including several RPM1-like and pathogenesis related thaumatin encoding genes. Other genes involved in photosynthesis, in cell wall reorganization, in hormone signaling pathways or encoding cytochrome were also differentially expressed. In addition, novel transcripts were identified, providing another basis for further characterization of plant defense-related genes. Overall, this study gives a first insight of the peach defense mechanisms during the very early stages of infection with a bacterial disease in the case of a compatible interaction.	[Socquet-Juglard, Didier; Kamber, Tim; Pothier, Joel F.; Duffy, Brion; Patocchi, Andrea] Res Stn Agroscope Changins Wadenswil ACW, Wadenswil, Switzerland; [Socquet-Juglard, Didier; Gessler, Cesare] Swiss Fed Inst Technol, IBZ, Zurich, Switzerland; [Christen, Danilo] Conthey Res Ctr, Res Stn Agroscope Changins Wadenswil, Berries Med Plants Greenhouse Crops & Apricots Gr, Conthey, Switzerland	Swiss Federal Research Station Agroscope; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Research Station Agroscope	Patocchi, A (corresponding author), Res Stn Agroscope Changins Wadenswil ACW, Wadenswil, Switzerland.	andrea.patocchi@acw.admin.ch	Pothier, Joël F./H-9344-2013	Pothier, Joël F./0000-0002-9604-7780; CHRISTEN, Danilo/0000-0002-6113-549X; Patocchi, Andrea/0000-0002-0919-2702	Swiss Secretariat for Education and Research [SBF COST C08.0124]; European Science Foundation [873]	Swiss Secretariat for Education and Research; European Science Foundation(European Science Foundation (ESF)European Commission)	This project was partially funded by the Swiss Secretariat for Education and Research (SBF COST C08.0124) and was conducted within the European Science Foundation funded research network COST Action 873. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aarrouf J, 2008, J PHYTOPATHOL, V156, P338, DOI 10.1111/j.1439-0434.2007.01364.x; Abbott AG, 2002, ACTA HORTIC, P199, DOI 10.17660/ActaHortic.2002.592.28; Adhikari BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034954; Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Allison SD, 2004, J CHEM ECOL, V30, P1363, DOI 10.1023/B:JOEC.0000037745.66972.3e; An SH, 2008, PLANTA, V228, P61, DOI 10.1007/s00425-008-0719-z; [Anonymous], 2006, B OEPP, V36, P129, DOI DOI 10.1111/j.1365-2338.2006.00925.x; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Arus P, 2006, PL BRED RE, V27, P175; Arus P, 2012, TREE GENET GENOMES, V8, P531, DOI 10.1007/s11295-012-0493-8; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bazzi C., 1990, INFORM AGRARIO, V46, P71; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Bolwell GP, 2002, J EXP BOT, V53, P1367, DOI 10.1093/jexbot/53.372.1367; Bonfig KB, 2006, PLANTA, V225, P1, DOI 10.1007/s00425-006-0303-3; Bonghi C, 2010, ACTA HORTIC, V877, P69, DOI 10.17660/ActaHortic.2010.877.3; Bourquin V, 2002, PLANT CELL, V14, P3073, DOI 10.1105/tpc.007773; Byrne DH, 2012, HANDB PLANT BREED, V8, P505, DOI 10.1007/978-1-4419-0763-9_14; CAMERON RK, 1994, PLANT J, V5, P715, DOI 10.1111/j.1365-313X.1994.00715.x; Coker JS, 2003, BIOTECHNIQUES, V35, P740, DOI 10.2144/03354st04; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; Dondini L, 2007, TREE GENET GENOMES, V3, P239, DOI 10.1007/s11295-006-0059-8; Eduardo I, 2013, TREE GENET GENOMES, V9, P189, DOI 10.1007/s11295-012-0546-z; Escamilla-Trevino LL, 2006, PHYTOCHEMISTRY, V67, P1651, DOI 10.1016/j.phytochem.2006.05.022; Garcin A., 2011, ARBORICULTURE FRUITI, V653, P30; Garcin A, 2005, XANTHOMONAS ARBRES F; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Greenberg JT, 2003, CURR OPIN MICROBIOL, V6, P20, DOI 10.1016/S1369-5274(02)00004-8; Hajri A, 2012, APPL ENVIRON MICROB, V78, P371, DOI 10.1128/AEM.06119-11; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Howad W, 2005, GENETICS, V171, P1305, DOI 10.1534/genetics.105.043661; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Joobeur T, 1998, THEOR APPL GENET, V97, P1034, DOI 10.1007/s001220050988; Jung S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-76; Khalaf AA, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-159; Kim KH, 2011, DNA RES, P1; Kogovsek P, 2010, PLANT PATHOL, V59, P1121, DOI 10.1111/j.1365-3059.2010.02340.x; Kristoffersen P, 2000, PLANTA, V210, P407, DOI 10.1007/PL00008149; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Mahmood T, 2009, BIOL PLANTARUM, V53, P285, DOI 10.1007/s10535-009-0052-9; Manganaris GA, 2011, TREE GENET GENOMES, V7, P609, DOI 10.1007/s11295-010-0360-4; Manosalva PM, 2009, PLANT PHYSIOL, V149, P286, DOI 10.1104/pp.108.128348; McCarthy FM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-229; Morant A, 2006, PHYTOCHEMISTRY, V69, P1795; Niyogi KK, 2000, CURR OPIN PLANT BIOL, V3, P455, DOI 10.1016/S1369-5266(00)00113-8; Ogundiwin EA, 2008, PLANT MOL BIOL, V68, P379, DOI 10.1007/s11103-008-9378-5; Orshinsky AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041150; Park CJ, 2010, CELL MICROBIOL, V12, P1017, DOI 10.1111/j.1462-5822.2010.01489.x; Pasquer F, 2008, PLANT BREEDING, V127, P413, DOI 10.1111/j.1439-0523.2007.01476.x; Pothier JF, 2011, PHYTOPATHOLOGY, V101, pS144; RAJAPAKSE S, 1995, THEOR APPL GENET, V90, P503, DOI 10.1007/BF00221996; Schenk A, 2008, MOL PLANT PATHOL, V9, P227, DOI 10.1111/J.1364-3703.2007.00452.X; Sherif S, 2012, J PLANT PHYSIOL, V169, P731, DOI 10.1016/j.jplph.2012.02.003; Sherif S, 2012, PLANT CELL REP, V31, P697, DOI 10.1007/s00299-011-1188-6; Smith E., 1903, SCIENCE, V17, P456, DOI DOI 10.1126/SCIENCE.17.420.114-A; Socquet-Juglard D, 2013, TREE GENET GENOMES, V9, P409, DOI 10.1007/s11295-012-0562-z; Socquet-Juglard D, 2012, J PLANT PATHOL, V94, pS191; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Sosinski B., 2010, 5 INT ROS GEN C NOV, pO46; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Trainotti L, 2006, PLANT SCI, V170, P606, DOI 10.1016/j.plantsci.2005.10.015; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; Wichmann F, 2011, THEOR APPL GENET, V122, P567, DOI 10.1007/s00122-010-1470-y; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Yang N, 2012, THESIS CLEMSON U; YE XS, 1990, PHYSIOL MOL PLANT P, V36, P523, DOI 10.1016/0885-5765(90)90024-R	74	47	47	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54196	10.1371/journal.pone.0054196	http://dx.doi.org/10.1371/journal.pone.0054196			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342103	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400132
J	Wang, GB; Zhou, Y; Xu, X; Ruan, HH; Wang, JS				Wang, Guobing; Zhou, Yan; Xu, Xia; Ruan, Honghua; Wang, Jiashe			Temperature Sensitivity of Soil Organic Carbon Mineralization along an Elevation Gradient in the Wuyi Mountains, China	PLOS ONE			English	Article							CONIFEROUS FOREST SOILS; RESPIRATION RATE; NITROGEN MINERALIZATION; MATTER DECOMPOSITION; CLIMATE-CHANGE; DEPENDENCE; DYNAMICS; CO2; RESPONSES; POOLS	Soil organic carbon (SOC) actively participates in the global carbon (C) cycle. Despite much research, however, our understanding of the temperature sensitivity of soil organic carbon (SOC) mineralization is still very limited. To investigate the responses of SOC mineralization to temperature, we sampled surface soils (0-10 cm) from evergreen broad-leaf forest (EBF), coniferous forest (CF), sub-alpine dwarf forest (SDF), and alpine meadow (AM) along an elevational gradient in the Wuyi Mountains, China. The soil samples were incubated at 5, 15, 25, and 35 degrees C with constant soil moisture for 360 days. The temperature sensitivity of SOC mineralization (Q(10)) was calculated by comparing the time needed to mineralize the same amount of C at any two adjacent incubation temperatures. Results showed that the rates of SOC mineralization and the cumulative SOC mineralized during the entire incubation significantly increased with increasing incubation temperatures across the four sites. With the increasing extent of SOC being mineralized (increasing incubation time), the Q(10) values increased. Moreover, we found that both the elevational gradient and incubation temperature intervals significantly impacted Q(10) values. Q(10) values of the labile and recalcitrant organic C linearly increased with elevation. For the 5-15, 15-25, and 25-35 degrees C intervals, surprisingly, the overall Q(10) values for the labile C did not decrease as the recalcitrant C did. Generally, our results suggest that subtropical forest soils may release more carbon than expected in a warmer climate.	[Wang, Guobing; Ruan, Honghua] Nanjing Forestry Univ, Fac Forest Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China; [Wang, Guobing; Ruan, Honghua] Nanjing Forestry Univ, Key Lab Forestry & Ecol Engn Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Zhou, Yan] Nanning Landscape Adm Bur, Nanning, Guangxi, Peoples R China; [Xu, Xia] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA; [Wang, Jiashe] Adm Bur Wuyishan Natl Nat Reserve, Wuyishan, Fujian, Peoples R China	Nanjing Forestry University; Nanjing Forestry University; University of Oklahoma System; University of Oklahoma - Norman	Ruan, HH (corresponding author), Nanjing Forestry Univ, Fac Forest Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China.	hhruan@njfu.edu.cn			Chinese National Public-warfare Programs [200804006, 201104006]; National Science Foundation of China [31170417]	Chinese National Public-warfare Programs; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Chinese National Public-warfare Programs (No. 200804006 & No. 201104006) and National Science Foundation of China (31170417). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison I, 2009, COPENHAGEN DIAGNOSIS; Bekku YS, 2004, ARCT ANTARCT ALP RES, V36, P395, DOI 10.1657/1523-0430(2004)036[0395:SMBRRA]2.0.CO;2; Bekku YS, 2003, APPL SOIL ECOL, V22, P205, DOI 10.1016/S0929-1393(02)00158-0; Bottner P, 2000, SOIL BIOL BIOCHEM, V32, P527, DOI 10.1016/S0038-0717(99)00182-0; Conant RT, 2008, ECOLOGY, V89, P2384, DOI 10.1890/08-0137.1; Conen F, 2006, BIOGEOSCIENCES, V3, P515, DOI 10.5194/bg-3-515-2006; Cote L, 2000, SOIL BIOL BIOCHEM, V32, P1079, DOI 10.1016/S0038-0717(00)00017-1; Craine JM, 2011, SOIL BIOL BIOCHEM, V43, P455, DOI 10.1016/j.soilbio.2010.10.011; Craine JM, 2010, NAT GEOSCI, V3, P854, DOI [10.1038/ngeo1009, 10.1038/NGEO1009]; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2000, NATURE, V408, P789, DOI 10.1038/35048672; De Neve S, 2000, BIOL FERT SOILS, V30, P544, DOI 10.1007/s003740050034; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Fierer N, 2005, ECOLOGY, V86, P320, DOI 10.1890/04-1254; Garten CT, 1999, BIOGEOCHEMISTRY, V45, P115, DOI 10.1007/BF01106778; Giardina CP, 2000, NATURE, V404, P858, DOI 10.1038/35009076; He J. Y., 1994, WUYISHAN RES SERIES; HOWARD DM, 1993, SOIL BIOL BIOCHEM, V25, P1537, DOI 10.1016/0038-0717(93)90008-Y; Hunter MD, 2003, PEDOBIOLOGIA, V47, P231, DOI 10.1078/0031-4056-00187; Hyvonen R, 2002, PLANT SOIL, V242, P33, DOI 10.1023/A:1019677521133; JENKINSON DS, 1991, NATURE, V351, P304, DOI 10.1038/351304a0; Katterer T, 1998, BIOL FERT SOILS, V27, P258, DOI 10.1007/s003740050430; Kirschbaum MUF, 2006, SOIL BIOL BIOCHEM, V38, P2510, DOI 10.1016/j.soilbio.2006.01.030; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Kirschbaum MUF, 2000, BIOGEOCHEMISTRY, V48, P21, DOI 10.1023/A:1006238902976; Lange OL, 2005, OECOLOGIA, V142, P11, DOI 10.1007/s00442-004-1697-x; Li JW, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001769; Mikan CJ, 2002, SOIL BIOL BIOCHEM, V34, P1785, DOI 10.1016/S0038-0717(02)00168-2; Niklinska M, 1999, BIOGEOCHEMISTRY, V44, P239, DOI 10.1023/A:1006049204600; Niklinska M, 2007, BIOL FERT SOILS, V43, P511, DOI 10.1007/s00374-006-0129-y; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1754, DOI 10.1111/j.1365-2486.2005.001010.x; Rey A, 2005, EUR J SOIL SCI, V56, P589, DOI 10.1111/j.1365-2389.2004.00699.x; Reynolds BC, 2001, SOIL BIOL BIOCHEM, V33, P1641, DOI 10.1016/S0038-0717(01)00085-2; Rodeghiero M, 2005, GLOBAL CHANGE BIOL, V11, P1024, DOI 10.1111/j.1365-2486.2005.00963.x; SCHIMEL DS, 1994, GLOBAL BIOGEOCHEM CY, V8, P279, DOI 10.1029/94GB00993; Silver WL, 1998, CLIMATIC CHANGE, V39, P337, DOI 10.1023/A:1005396714941; Simmons JA, 1996, FOREST ECOL MANAG, V84, P81, DOI 10.1016/0378-1127(96)03739-5; Six J, 2002, AGRONOMIE, V22, P755, DOI 10.1051/agro:2002043; Smith JL, 2002, SOIL BIOL BIOCHEM, V34, P1749, DOI 10.1016/S0038-0717(02)00162-1; Townsend AR, 1997, BIOGEOCHEMISTRY, V38, P1, DOI 10.1023/A:1017942918708; Trumbore SE, 1997, P NATL ACAD SCI USA, V94, P8284, DOI 10.1073/pnas.94.16.8284; TRUMBORE SE, 1995, GLOBAL BIOGEOCHEM CY, V9, P515, DOI 10.1029/95GB02148; Wardle DA, 2003, SOIL BIOL BIOCHEM, V35, P827, DOI 10.1016/S0038-0717(03)00118-4; Wetterstedt JAM, 2010, GLOBAL CHANGE BIOL, V16, P1806, DOI 10.1111/j.1365-2486.2009.02112.x; Wu, 2005, ECOL SCI, V25, P243; Xu X, 2012, GLOBAL CHANGE BIOL, V18, P1648, DOI 10.1111/j.1365-2486.2012.02651.x; Xu X, 2010, SOIL BIOL BIOCHEM, V42, P1811, DOI 10.1016/j.soilbio.2010.06.021; Yuste JC, 2007, GLOBAL CHANGE BIOL, V13, P2018, DOI 10.1111/j.1365-2486.2007.01415.x; [郑成洋 Zheng Chengyang], 2004, [气象学报, Acta Meteorologica Sinica], V62, P251; Zhu BA, 2011, SOIL BIOL BIOCHEM, V43, P866, DOI 10.1016/j.soilbio.2010.12.021	51	60	66	4	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53914	10.1371/journal.pone.0053914	http://dx.doi.org/10.1371/journal.pone.0053914			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342038	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400099
J	Xie, Q; Yang, Y; Huang, J; Ninkovic, J; Walcher, T; Wolf, L; Vitenzon, A; Zheng, DY; Gotz, M; Beebe, DC; Zavadil, J; Cvekl, A				Xie, Qing; Yang, Ying; Huang, Jie; Ninkovic, Jovica; Walcher, Tessa; Wolf, Louise; Vitenzon, Ariel; Zheng, Deyou; Goetz, Magdalena; Beebe, David C.; Zavadil, Jiri; Cvekl, Ales			Pax6 Interactions with Chromatin and Identification of Its Novel Direct Target Genes in Lens and Forebrain	PLOS ONE			English	Article							ALPHA-A-CRYSTALLIN; TRANSCRIPTION FACTOR PAX6; EMBRYONIC STEM-CELLS; REGULATORY NETWORKS; EYE DEVELOPMENT; HIGH-RESOLUTION; PAIRED DOMAIN; MOUSE MODEL; DNA-BINDING; C-MAF	Pax6 encodes a specific DNA-binding transcription factor that regulates the development of multiple organs, including the eye, brain and pancreas. Previous studies have shown that Pax6 regulates the entire process of ocular lens development. In the developing forebrain, Pax6 is expressed in ventricular zone precursor cells and in specific populations of neurons; absence of Pax6 results in disrupted cell proliferation and cell fate specification in telencephalon. In the pancreas, Pax6 is essential for the differentiation of alpha-, beta- and delta-islet cells. To elucidate molecular roles of Pax6, chromatin immunoprecipitation experiments combined with high-density oligonucleotide array hybridizations (ChIP-chip) were performed using three distinct sources of chromatin (lens, forebrain and beta-cells). ChIP-chip studies, performed as biological triplicates, identified a total of 5,260 promoters occupied by Pax6. 1,001 (133) of these promoter regions were shared between at least two (three) distinct chromatin sources, respectively. In lens chromatin, 2,335 promoters were bound by Pax6. RNA expression profiling from Pax6(+/-) lenses combined with in vivo Pax6-binding data yielded 76 putative Pax6-direct targets, including the Gaa, Isl1, Kif1b, Mtmr2, Pcsk1n, and Snca genes. RNA and ChIP data were validated for all these genes. In lens cells, reporter assays established Kib1b and Snca as Pax6 activated and repressed genes, respectively. In situ hybridization revealed reduced expression of these genes in E14 cerebral cortex. Moreover, we examined differentially expressed transcripts between E9.5 wild type and Pax6(-/-) lens placodes that suggested Efnb2, Fat4, Has2, Nav1, and Trpm3 as novel Pax6-direct targets. Collectively, the present studies, through the identification of Pax6-direct target genes, provide novel insights into the molecular mechanisms of Pax6 gene control during mouse embryonic development. In addition, the present data demonstrate that Pax6 interacts preferentially with promoter regions in a tissue-specific fashion. Nevertheless, nearly 20% of the regions identified are accessible to Pax6 in multiple tissues.	[Xie, Qing; Yang, Ying; Zheng, Deyou; Cvekl, Ales] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Wolf, Louise; Vitenzon, Ariel; Cvekl, Ales] Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10467 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Huang, Jie; Beebe, David C.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Ninkovic, Jovica; Walcher, Tessa; Goetz, Magdalena] Helmholtz Zentrum Munchen, Inst Stem Cell Res, Neuherberg, Germany; [Ninkovic, Jovica; Walcher, Tessa; Goetz, Magdalena] Univ Munich, Inst Physiol, Dept Physiol Genom, Munich Ctr Integrated Prot Sci CiPS, D-80539 Munich, Germany; [Zavadil, Jiri] NYU, Dept Pathol, Langone Med Ctr, New York, NY 10016 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Washington University (WUSTL); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; New York University; NYU Langone Medical Center	Cvekl, A (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA.	ales.cvekl@einstein.yu.edu	Ninkovic, Jovica/AAH-5220-2019; Huang, Jie/D-7728-2014; Zavadil, Jiri/ABG-1780-2020	Ninkovic, Jovica/0000-0002-4381-0041; Zavadil, Jiri/0000-0003-0640-5562; Zheng, Deyou/0000-0003-4354-5337	National Institutes of Health [R01 EY012200, R21 EY017296, EY04853]; Research to Prevent Blindness; Washington University; NATIONAL EYE INSTITUTE [R01EY004853, R21EY017296, R01EY012200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Washington University; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health grants R01 EY012200 and R21 EY017296 to AC and EY04853 to DCB, and unrestricted grants from Research to Prevent Blindness to the Departments of Ophthalmology and Visual Sciences at Albert Einstein and Washington University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aota S, 2003, DEV BIOL, V257, P1, DOI 10.1016/S0012-1606(03)00058-7; Ashery-Padan R, 2004, DEV BIOL, V269, P479, DOI 10.1016/j.ydbio.2004.01.040; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Aulchenko YS, 2008, NAT GENET, V40, P1402, DOI 10.1038/ng.251; Barolo S, 2002, GENE DEV, V16, P1167, DOI 10.1101/gad.976502; Baulmann DC, 2002, MECH DEVELOP, V118, P3, DOI 10.1016/S0925-4773(02)00260-5; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Biggin MD, 2011, DEV CELL, V21, P611, DOI 10.1016/j.devcel.2011.09.008; Bijvoet AGA, 1998, HUM MOL GENET, V7, P53, DOI 10.1093/hmg/7.1.53; Bolino A, 2004, J CELL BIOL, V167, P711, DOI 10.1083/jcb.200407010; Callaerts P, 1997, ANNU REV NEUROSCI, V20, P483, DOI 10.1146/annurev.neuro.20.1.483; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Chauhan BK, 2011, P NATL ACAD SCI USA, V108, P18289, DOI 10.1073/pnas.1108993108; Chauhan BK, 2004, NUCLEIC ACIDS RES, V32, P1696, DOI 10.1093/nar/gkh334; Chauhan BK, 2004, INVEST OPHTH VIS SCI, V45, P385, DOI 10.1167/iovs.03-0968; Cheng C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028147; Collinson JM, 2001, P NATL ACAD SCI USA, V98, P9688, DOI 10.1073/pnas.161144098; Coutinho P, 2011, GENOME RES, V21, P1349, DOI 10.1101/gr.124115.111; Cvekl A, 2004, INT J DEV BIOL, V48, P829, DOI 10.1387/ijdb.041866ac; Cvekl A, 2010, HEREDITY, V105, P135, DOI 10.1038/hdy.2010.16; CVEKL A, 1995, MOL CELL BIOL, V15, P653; Cvekl A, 1996, BIOESSAYS, V18, P621, DOI 10.1002/bies.950180805; CZERNY T, 1995, MOL CELL BIOL, V15, P2858; D'Elia AV, 2006, EUR J HUM GENET, V14, P744, DOI 10.1038/sj.ejhg.5201579; Dames P, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-39; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; DAVIS A, 1993, HUM MOL GENET, V2, P2093, DOI 10.1093/hmg/2.12.2093; Davis LK, 2008, HUM GENET, V123, P371, DOI 10.1007/s00439-008-0484-x; Delacroix L, 2010, MOL CELL BIOL, V30, P231, DOI 10.1128/MCB.00756-09; DeRuisseau LR, 2009, P NATL ACAD SCI USA, V106, P9419, DOI 10.1073/pnas.0902534106; Dohrmann C, 2000, MECH DEVELOP, V92, P47, DOI 10.1016/S0925-4773(99)00324-X; Duparc RH, 2006, DEV BIOL, V300, P647, DOI 10.1016/j.ydbio.2006.07.045; EFRAT S, 1991, J BIOL CHEM, V266, P11141; Erclik T, 2009, DEV BIOL, V332, P70, DOI 10.1016/j.ydbio.2009.05.565; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Fricker LD, 2000, J NEUROSCI, V20, P639, DOI 10.1523/JNEUROSCI.20-02-00639.2000; Gordan R, 2009, GENOME RES, V19, P2090, DOI 10.1101/gr.094144.109; Gosmain Y, 2010, J BIOL CHEM, V285, P33381, DOI 10.1074/jbc.M110.147215; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Graw J, 2010, CURR TOP DEV BIOL, V90, P343, DOI 10.1016/S0070-2153(10)90010-0; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; He SY, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-21; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Holm PC, 2007, MOL CELL NEUROSCI, V34, P99, DOI 10.1016/j.mcn.2006.10.008; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang J, 2011, DEV BIOL, V355, P32, DOI 10.1016/j.ydbio.2011.04.008; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Jonasova K, 2008, SEMIN CELL DEV BIOL, V19, P71, DOI 10.1016/j.semcdb.2007.10.005; Kiselev Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031915; Kohwi M, 2005, J NEUROSCI, V25, P6997, DOI 10.1523/JNEUROSCI.1435-05.2005; Kokhan VS, 2012, BEHAV BRAIN RES; Kuracha MR, 2011, INVEST OPHTH VIS SCI, V52, P6887, DOI 10.1167/iovs.11-7531; Laakso M, 2009, DIABETOLOGIA, V52, P381, DOI 10.1007/s00125-008-1251-1; LaVaute TM, 2009, STEM CELLS, V27, P1741, DOI 10.1002/stem.99; Leonard M, 2008, DEV BIOL, V319, P298, DOI 10.1016/j.ydbio.2008.04.036; Liu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046934; Lyons DA, 2009, NAT GENET, V41, P854, DOI 10.1038/ng.376; Machon O, 2010, GENESIS, V48, P86, DOI 10.1002/dvg.20583; Madhavan M, 2006, P NATL ACAD SCI USA, V103, P14848, DOI 10.1073/pnas.0601949103; Maekawa M, 2009, NEUROSCI LETT, V462, P267, DOI 10.1016/j.neulet.2009.07.021; Marquardt T, 2002, TRENDS NEUROSCI, V25, P32, DOI 10.1016/S0166-2236(00)02028-2; Martinez-Lopez MJ, 2005, MOL CELL NEUROSCI, V28, P599, DOI 10.1016/j.mcn.2004.09.016; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; Michaut L, 2003, P NATL ACAD SCI USA, V100, P4024, DOI 10.1073/pnas.0630561100; Molotkov A, 2006, DEVELOPMENT, V133, P1901, DOI 10.1242/dev.02328; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Nasonkin IO, 2011, J COMP NEUROL, V519, P1914, DOI 10.1002/cne.22613; Nfonsam LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044583; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Ninkovic J, 2010, NEURON, V68, P682, DOI 10.1016/j.neuron.2010.09.030; Nomura T, 2007, DEV GROWTH DIFFER, V49, P683, DOI 10.1111/j.1440-169x.2007.00965.x; Numayama-Tsuruta K, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-6; Oron-Karni V, 2008, DEVELOPMENT, V135, P4037, DOI 10.1242/dev.028308; Ostrin EJ, 2006, GENOME RES, V16, P466, DOI 10.1101/gr.4673006; Osumi N, 2008, STEM CELLS, V26, P1663, DOI 10.1634/stemcells.2007-0884; Pan L, 2008, DEVELOPMENT, V135, P1981, DOI 10.1242/dev.010751; Peter IS, 2011, CELL, V144, P970, DOI 10.1016/j.cell.2011.02.017; Pinto LW, 2008, VIRCHOWS ARCH, V452, P481, DOI 10.1007/s00428-007-0562-9; POKORNY KS, 1982, INVEST OPHTH VIS SCI, V22, P25; Rodgers LS, 2006, CIRC RES, V99, P583, DOI 10.1161/01.RES.0000242561.95978.43; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; Sander T, 1999, EPILEPSY RES, V36, P61, DOI 10.1016/S0920-1211(99)00024-8; Sansom SN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000511; Secker GA, 2008, STEM CELL REV, V4, P159, DOI 10.1007/s12015-008-9029-x; Senturk A, 2011, NATURE, V472, P356, DOI 10.1038/nature09874; Shaham O, 2009, DEVELOPMENT, V136, P2567, DOI 10.1242/dev.032888; Shankaranarayanan P, 2011, NAT METHODS, V8, P565, DOI [10.1038/NMETH.1626, 10.1038/nmeth.1626]; Shinawi M, 2011, AM J MED GENET A, V155A, P1272, DOI 10.1002/ajmg.a.33878; Simpson TI, 2002, BIOESSAYS, V24, P1041, DOI 10.1002/bies.10174; Smith AN, 2010, DEV BIOL, V337, P195, DOI 10.1016/j.ydbio.2009.11.009; Soleimani VD, 2012, DEV CELL, V22, P1208, DOI 10.1016/j.devcel.2012.03.014; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Straub BK, 2003, J CELL SCI, V116, P4985, DOI 10.1242/jcs.00815; Suga H, 2010, P NATL ACAD SCI USA, V107, P14263, DOI 10.1073/pnas.1008389107; Sugiyama Y, 2011, ORGANOGENESIS, V7, P191, DOI 10.4161/org.7.3.18421; Thaung C, 2002, HUM MOL GENET, V11, P755, DOI 10.1093/hmg/11.7.755; Thompson PJ, 2004, NEUROLOGY, V62, P1216, DOI 10.1212/01.WNL.0000118298.81140.62; Tien JYL, 2005, DEV DYNAM, V233, P130, DOI 10.1002/dvdy.20328; Tong YR, 2009, NEURON, V64, P771, DOI 10.1016/j.neuron.2009.12.017; Urness LD, 2010, DEV BIOL, V340, P595, DOI 10.1016/j.ydbio.2010.02.016; van Heyningen V, 2002, HUM MOL GENET, V11, P1161, DOI 10.1093/hmg/11.10.1161; van Raamsdonk CD, 2000, DEVELOPMENT, V127, P5439; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; WILSON DS, 1995, CELL, V82, P709, DOI 10.1016/0092-8674(95)90468-9; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Wolf LV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004159; Xie Q, 2011, J BIOL CHEM, V286, P43259, DOI 10.1074/jbc.M111.264580; Xu HE, 1999, GENE DEV, V13, P1263, DOI 10.1101/gad.13.10.1263; Yamaguchi Y, 1997, GENES CELLS, V2, P255, DOI 10.1046/j.1365-2443.1997.1170315.x; Yang Y, 2005, J MOL BIOL, V351, P453, DOI 10.1016/j.jmb.2005.05.072; Yang Y, 2004, J MOL BIOL, V344, P351, DOI 10.1016/j.jmb.2004.07.102; Yang Y, 2006, EMBO J, V25, P2107, DOI 10.1038/sj.emboj.7601114; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	125	51	52	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54507	10.1371/journal.pone.0054507	http://dx.doi.org/10.1371/journal.pone.0054507			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342162	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400166
J	Jensen, TH; Bech, M; Binderup, T; Bottiger, A; David, C; Weitkamp, T; Zanette, I; Reznikova, E; Mohr, J; Rank, F; Feidenhans'l, R; Kjaer, A; Hojgaard, L; Pfeiffer, F				Jensen, Torben Haugaard; Bech, Martin; Binderup, Tina; Boettiger, Arvid; David, Christian; Weitkamp, Timm; Zanette, Irene; Reznikova, Elena; Mohr, Juergen; Rank, Fritz; Feidenhans'l, Robert; Kjaer, Andreas; Hojgaard, Liselotte; Pfeiffer, Franz			Imaging of Metastatic Lymph Nodes by X-ray Phase-Contrast Micro-Tomography	PLOS ONE			English	Article							BREAST-CANCER PATIENTS; GRATING INTERFEROMETER; TALBOT INTERFEROMETRY; BIOPSY; CT; DISSECTION	Invasive cancer causes a change in density in the affected tissue, which can be visualized by x-ray phase-contrast tomography. However, the diagnostic value of this method has so far not been investigated in detail. Therefore, the purpose of this study was, in a blinded manner, to investigate whether malignancy could be revealed by non-invasive x-ray phase-contrast tomography in lymph nodes from breast cancer patients. Seventeen formalin-fixed paraffin-embedded lymph nodes from 10 female patients (age range 37-83 years) diagnosed with invasive ductal carcinomas were analyzed by X-ray phase-contrast tomography. Ten lymph nodes had metastatic deposits and 7 were benign. The phase-contrast images were analyzed according to standards for conventional CT images looking for characteristics usually only visible by pathological examinations. Histopathology was used as reference. The result of this study was that the diagnostic sensitivity of the image analysis for detecting malignancy was 100% and the specificity was 87%. The positive predictive value was 91% for detecting malignancy and the negative predictive value was 100%. We conclude that x-ray phase-contrast imaging can accurately detect density variations to obtain information regarding lymph node involvement previously inaccessible with standard absorption x-ray imaging.	[Jensen, Torben Haugaard; Boettiger, Arvid; Feidenhans'l, Robert] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Bech, Martin; Zanette, Irene; Pfeiffer, Franz] Tech Univ Munich, Dept Phys, D-80290 Munich, Germany; [Bech, Martin] Lund Univ, Lund, Sweden; [Binderup, Tina; Rank, Fritz; Kjaer, Andreas; Hojgaard, Liselotte] Rigshosp, Dept Clin Physiol, DK-2100 Copenhagen, Denmark; [Binderup, Tina; Kjaer, Andreas; Hojgaard, Liselotte] Univ Copenhagen, Copenhagen, Denmark; [David, Christian] Paul Scherrer Inst, Villigen, Switzerland; [Weitkamp, Timm] Synchrotron Soleil, Gif Sur Yvette, France; [Weitkamp, Timm; Zanette, Irene] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Reznikova, Elena; Mohr, Juergen] Karlsruhe Inst Technol, Inst Microstruct Technol, D-76021 Karlsruhe, Germany	University of Copenhagen; Niels Bohr Institute; Technical University of Munich; University of Munich; Lund University; Rigshospitalet; University of Copenhagen; University of Copenhagen; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; SOLEIL Synchrotron; European Synchrotron Radiation Facility (ESRF); Helmholtz Association; Karlsruhe Institute of Technology	Bech, M (corresponding author), Tech Univ Munich, Dept Phys, D-80290 Munich, Germany.	martin.bech@tum.de	Weitkamp, Timm/A-8975-2012; Bech, Martin/K-4331-2012; Højgaard, Liselotte/AAK-8329-2020; Kjaer, Andreas/E-8932-2015	Weitkamp, Timm/0000-0002-0374-0472; Bech, Martin/0000-0001-9109-7175; Zanette, Irene/0000-0001-6096-6059; Kjaer, Andreas/0000-0002-2706-5547; Feidenhansl, Robert/0000-0002-7963-3649; Reznikova, Elena/0000-0002-7277-6858	Faculty of Science and Health at the University of Copenhagen, through the European Synchrotron Radiation Facility (ESRF); Faculties of Science and Health through the DFG Cluster of Excellence Munich-Center for Advanced Photonics [DFG EXC-158]; European Research Council [24012]	Faculty of Science and Health at the University of Copenhagen, through the European Synchrotron Radiation Facility (ESRF); Faculties of Science and Health through the DFG Cluster of Excellence Munich-Center for Advanced Photonics; European Research Council(European Research Council (ERC)European Commission)	Financial support is given through Faculties of Science and Health at the University of Copenhagen, through the European Synchrotron Radiation Facility (ESRF), and through the DFG Cluster of Excellence Munich-Center for Advanced Photonics (DFG EXC-158) and the European Research Council (FP7, Starting Grant No. 24012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Benjamin O, 2003, J Natl Compr Canc Netw, V1 Suppl 1, pS64; David C, 2007, SPECTROCHIM ACTA B, V62, P626, DOI 10.1016/j.sab.2007.03.001; David C, 2002, APPL PHYS LETT, V81, P3287, DOI 10.1063/1.1516611; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Fuster D, 2008, J CLIN ONCOL, V26, P4746, DOI 10.1200/JCO.2008.17.1496; Heusner TA, 2009, EUR J NUCL MED MOL I, V36, P1543, DOI 10.1007/s00259-009-1145-6; Hsiang DJ, 2007, ARCH SURG-CHICAGO, V142, P855, DOI 10.1001/archsurg.142.9.855; Lang S, 2012, MICROVASC RES, V84, P314, DOI 10.1016/j.mvr.2012.07.002; McDonald SA, 2009, J PHYS CONF SER, V186, DOI 10.1088/1742-6596/186/1/012043; Momose A, 2003, JPN J APPL PHYS 2, V42, pL866, DOI 10.1143/JJAP.42.L866; Momose A, 2006, JPN J APPL PHYS 1, V45, P5254, DOI 10.1143/JJAP.45.5254; Momose A, 2009, J PHYS CONF SER, V186, DOI 10.1088/1742-6596/186/1/012044; Muller B, 2010, PROC SPIE, V7804, DOI 10.1117/12.859052; Peintinger F, 2003, BRIT J CANCER, V89, P648, DOI 10.1038/sj.bjc.6601150; Pfeiffer F, 2007, PHYS MED BIOL, V52, P6923, DOI 10.1088/0031-9155/52/23/010; Pfeiffer F, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108105; Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265; Qi ZH, 2010, PHYS MED BIOL, V55, P2669, DOI 10.1088/0031-9155/55/9/016; Reintgen D, 2002, CANCER J, V8, pS15; Reznikova E, 2008, MICROSYST TECHNOL, V14, P1683, DOI 10.1007/s00542-007-0507-x; Samphao S, 2008, ANN SURG ONCOL, V15, P1282, DOI 10.1245/s10434-008-9863-8; Schulz G, 2010, J R SOC INTERFACE, V7, P1665, DOI 10.1098/rsif.2010.0281; Schulze T, 2006, J SURG ONCOL, V93, P109, DOI 10.1002/jso.20406; Shien T, 2008, INT J CLIN ONCOL, V13, P314, DOI 10.1007/s10147-007-0753-z; Stampanoni M, 2011, INVEST RADIOL, V46, P801, DOI 10.1097/RLI.0b013e31822a585f; Stutman D, 2011, PHYS MED BIOL, V56, P5697, DOI 10.1088/0031-9155/56/17/015; Takei H, 2010, BREAST CANCER-TOKYO, V17, P9, DOI 10.1007/s12282-009-0154-4; Tapfer A, 2012, P NATL ACAD SCI USA, V109, P15691, DOI 10.1073/pnas.1207503109; Tapfer A, 2011, MED PHYS, V38, P5910, DOI 10.1118/1.3644844; Taras AR, 2010, AM J SURG, V199, P625, DOI 10.1016/j.amjsurg.2010.01.009; Veronesi U, 2006, LANCET ONCOL, V7, P983, DOI 10.1016/S1470-2045(06)70947-0; Wang ZL, 2011, J ELECTRON SPECTROSC, V184, P342, DOI 10.1016/j.elspec.2010.12.009; Weitkamp T, 2005, OPT EXPRESS, V13, P6296, DOI 10.1364/OPEX.13.006296; Weitkamp T, 2010, PROC SPIE, V7804, DOI 10.1117/12.860203; Weitkamp T, 2010, AIP CONF PROC, V1221, P33, DOI 10.1063/1.3399253; Zanette I, 2012, P NATL ACAD SCI USA, V109, P10199, DOI 10.1073/pnas.1117861109	36	10	10	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54047	10.1371/journal.pone.0054047	http://dx.doi.org/10.1371/journal.pone.0054047			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349784	Green Published, gold			2022-12-25	WOS:000313872800023
J	Clark, EL; Hadjimichael, C; Temperley, R; Barnard, A; Fuller-Pace, FV; Robson, CN				Clark, Emma L.; Hadjimichael, Christiana; Temperley, Richard; Barnard, Amy; Fuller-Pace, Frances V.; Robson, Craig N.			p68/DdX5 Supports beta-Catenin & RNAP II during Androgen Receptor Mediated Transcription in Prostate Cancer	PLOS ONE			English	Article							WNT SIGNALING PATHWAYS; HISTONE DEACETYLASE-1; HELICASE P68; MULTIFUNCTIONAL PROTEINS; NUCLEAR TRANSLOCATION; WNT/BETA-CATENIN; COLON-CANCER; COACTIVATOR; EXPRESSION; GROWTH	The DEAD box RNA helicase p68 (Ddx5) is an important androgen receptor (AR) transcriptional co-activator in prostate cancer (PCa) and is over-expressed in late stage disease. beta-Catenin is a multifunctional protein with important structural and signalling functions which is up-regulated in PCa and similar to p68, interacts with the AR to co-activate expression of AR target genes. Importantly, p68 forms complexes with nuclear beta-Catenin and promotes gene transcription in colon cancer indicating a functional interplay between these two proteins in cancer progression. In this study, we explore the relationship of p68 and beta-Catenin in PCa to assess their potential co-operation in AR-dependent gene expression, which may be of importance in the development of castrate resistant prostate cancer (CRPCa). We use immunoprecipitation to demonstrate a novel interaction between p68 and beta-Catenin in the nucleus of PCa cells, which is androgen dependent in LNCaP cells but androgen independent in a hormone refractory derivative of the same cell line (representative of the CRPCa disease type). Enhanced AR activity is seen in androgen-dependent luciferase reporter assays upon transient co-transfection of p68 and beta-Catenin as an additive effect, and p68-depleted Chromatin-Immunoprecipitation (ChIP) showed a decrease in the recruitment of the AR and beta-Catenin to androgen responsive promoter regions. In addition, we found p68 immunoprecipitated with the processive and non-processive form of RNA polymerase II (RNAP II) and show p68 recruited to elongating regions of the AR mediated PSA gene, suggesting a role for p68 in facilitating RNAP II transcription of AR mediated genes. These results suggest p68 is important in facilitating beta-Catenin and AR transcriptional activity in PCa cells.	[Clark, Emma L.; Temperley, Richard; Barnard, Amy; Robson, Craig N.] Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Hadjimichael, Christiana] Inst Mol Biol & Biotechnol, Iraklion, Crete, Greece; [Fuller-Pace, Frances V.] Univ Dundee, Ninewells Hosp & Med Sch, Div Canc Res, Dundee DD1 9SY, Scotland	Newcastle University - UK; University of Dundee	Robson, CN (corresponding author), Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	c.n.robson@ncl.ac.uk			Prostate Action Charity [PCRF9/07]; Medical Research Council, Cancer Research UK; Department of Health Prostate cancer Mechanisms of Progression and Treatment (ProMPT) collaboration [G0100100/64424]; MRC [G0900871] Funding Source: UKRI; Medical Research Council [G0900871] Funding Source: researchfish	Prostate Action Charity; Medical Research Council, Cancer Research UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Cancer Research UK); Department of Health Prostate cancer Mechanisms of Progression and Treatment (ProMPT) collaboration; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Prostate Action Charity [PCRF9/07 to CNR & ELC]; and the Medical Research Council, Cancer Research UK, and Department of Health Prostate cancer Mechanisms of Progression and Treatment (ProMPT) collaboration [G0100100/64424 to CNR]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Brady ME, 1999, J BIOL CHEM, V274, P17599, DOI 10.1074/jbc.274.25.17599; Brookes E, 2009, EMBO REP, V10, P1213, DOI 10.1038/embor.2009.221; Buszczak M, 2006, GENE DEV, V20, P977, DOI 10.1101/gad.1396306; Caretti G, 2007, CELL CYCLE, V6, P1172, DOI 10.4161/cc.6.10.4228; Causevic M, 2001, ONCOGENE, V20, P7734, DOI 10.1038/sj.onc.1204976; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chesire DR, 2002, ONCOGENE, V21, P2679, DOI 10.1038/sj.onc.1205352; Clark EL, 2008, CANCER RES, V68, P7938, DOI 10.1158/0008-5472.CAN-08-0932; Clark EL, 2008, BIOCHEM SOC T, V36, P546, DOI 10.1042/BST0360546; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Edwards J, 2005, BJU INT, V95, P1320, DOI 10.1111/j.1464-410X.2005.05526.x; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; Fuller-Pace FV, 2011, FUTURE ONCOL, V7, P239, DOI 10.2217/FON.11.1; Gaughan L, 2005, NUCLEIC ACIDS RES, V33, P13, DOI 10.1093/nar/gki141; Gaughan L, 2002, J BIOL CHEM, V277, P25904, DOI 10.1074/jbc.M203423200; Germann S, 2012, ONCOGENE, P1; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Halkidou K, 2003, ONCOGENE, V22, P2466, DOI 10.1038/sj.onc.1206342; Honig A, 2002, MOL CELL BIOL, V22, P5698, DOI 10.1128/MCB.22.16.5698-5707.2002; Jacobs AMF, 2007, ONCOGENE, V26, P5866, DOI 10.1038/sj.onc.1210387; Janknecht R, 2010, AM J TRANSL RES, V2, P223; Lee DY, 2006, J BIOL CHEM, V281, P8476, DOI 10.1074/jbc.M511093200; Li HW, 2004, J BIOL CHEM, V279, P4212, DOI 10.1074/jbc.M311374200; Liu S, 2008, ONCOGENE, V27, P499, DOI 10.1038/sj.onc.1210671; Liu XH, 2007, CANCER RES, V67, P5747, DOI 10.1158/0008-5472.CAN-07-0478; Logan IR, 2006, MOL CELL BIOL, V26, P6502, DOI 10.1128/MCB.00147-06; Mulholland DJ, 2002, J BIOL CHEM, V277, P17933, DOI 10.1074/jbc.M200135200; Nieto M, 2007, INT J BIOCHEM CELL B, V39, P1562, DOI 10.1016/j.biocel.2007.01.005; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Saporita AJ, 2011, CANCER RES, V71, P6708, DOI 10.1158/0008-5472.CAN-11-1472; Schweizer L, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-4; Shin S, 2007, CANCER RES, V67, P7572, DOI 10.1158/0008-5472.CAN-06-4652; Stucke VM, 2008, CELL CYCLE, V7, P830, DOI 10.4161/cc.7.6.5614; Terry S, 2006, J CELL BIOCHEM, V99, P402, DOI 10.1002/jcb.20983; Truica CI, 2000, CANCER RES, V60, P4709; Verras M, 2006, CANCER LETT, V237, P22, DOI 10.1016/j.canlet.2005.06.004; Wang G, 2008, CANCER RES, V68, P9918, DOI 10.1158/0008-5472.CAN-08-1718; Wang HZ, 2009, CELL RES, V19, P1388, DOI 10.1038/cr.2009.113; Whitaker HC, 2008, PROSTATE, V68, P1196, DOI 10.1002/pros.20780; Wortham NC, 2009, ONCOGENE, V28, P4053, DOI 10.1038/onc.2009.261; Yang LQ, 2007, J BIOL CHEM, V282, P16811, DOI 10.1074/jbc.M610488200; Yang LQ, 2006, CELL, V127, P139, DOI 10.1016/j.cell.2006.08.036; Yardy GW, 2005, PROSTATE CANCER P D, V8, P119, DOI 10.1038/sj.pcan.4500794	45	30	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54150	10.1371/journal.pone.0054150	http://dx.doi.org/10.1371/journal.pone.0054150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349811	Green Published, Green Submitted, gold			2022-12-25	WOS:000313738900046
J	Connor, TMF; Oygar, DD; Gale, DP; Steenkamp, R; Nitsch, D; Neild, GH; Maxwell, PH				Connor, Thomas M. F.; Oygar, D. Deren; Gale, Daniel P.; Steenkamp, Retha; Nitsch, Dorothea; Neild, Guy H.; Maxwell, Patrick H.			Incidence of End-Stage Renal Disease in the Turkish-Cypriot Population of Northern Cyprus: A Population Based Study	PLOS ONE			English	Article							REPLACEMENT THERAPY; KIDNEY-DISEASE; FAILURE; MUTATIONS; PREVALENCE; IDENTIFICATION; THALASSEMIA; OVERWEIGHT; DIAGNOSIS; DIALYSIS	Background: This is the first report of the incidence and causes of end-stage renal disease (ESRD) of the Turkish-Cypriot population in Northern Cyprus. Methods: Data were collected over eight consecutive years (2004-2011) from all those starting renal replacement therapy (RRT) in this population. Crude and age-standardised incidence at 90 days was calculated and comparisons made with other national registries. We collected DNA from the entire prevalent population. As an initial experiment we looked for two genetic causes of ESRD that have been reported in Greek Cypriots. Results: Crude and age-standardised incidence at 90 days was 234 and 327 per million population (pmp) per year, respectively. The mean age was 63, and 62% were male. The age-adjusted prevalence of RRT in Turkish-Cypriots was 1543 pmp on 01/01/2011. The incidence of RRT is higher than other countries reporting to the European Renal Association European Dialysis and Transplant Association, with the exception of Turkey. Diabetes is a major cause of ESRD in those under 65, accounting for 36% of incident cases followed by 30% with uncertain aetiology. 18% of the incident population had a family history of ESRD. We identified two families with thin basement membrane nephropathy caused by a mutation in COL4A3, but no new cases of CFHR5 nephropathy. Conclusions: This study provides the first estimate of RRT incidence in the Turkish-Cypriot population, describes the contribution of different underlying diagnoses to ESRD, and provides a basis for healthcare policy planning.	[Connor, Thomas M. F.; Gale, Daniel P.; Neild, Guy H.; Maxwell, Patrick H.] UCL, UCL Div Med, London, England; [Connor, Thomas M. F.; Gale, Daniel P.; Neild, Guy H.; Maxwell, Patrick H.] UCL, Ctr Nephrol, London, England; [Oygar, D. Deren] Burhan Nalbantoglu Gen Hosp, Nicosia State Hosp, Nicosia, Cyprus; [Steenkamp, Retha] Southmead Hosp, UK Renal Registry, Bristol, Avon, England; [Nitsch, Dorothea] London Sch Hyg & Trop Med, London WC1, England	University of London; University College London; University of London; University College London; Southmead Hospital; University of London; London School of Hygiene & Tropical Medicine	Connor, TMF (corresponding author), UCL, UCL Div Med, London, England.	t.connor@ucl.ac.uk	Neild, Guy/K-2513-2013; Maxwell, Patrick H/C-5557-2008; Gale, Daniel/D-5594-2013	Maxwell, Patrick H/0000-0002-0338-2679; Gale, Daniel/0000-0002-9170-1579; Connor, Thomas/0000-0002-5896-7084; Nitsch, Dorothea/0000-0001-5767-248X	Clinical Research Training Fellowship from the Medical Research Council; St Peter's Trust for Kidney, Bladder and Prostate Research; Medical Research Council [G0802266] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10315] Funding Source: researchfish; MRC [G0802266] Funding Source: UKRI	Clinical Research Training Fellowship from the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); St Peter's Trust for Kidney, Bladder and Prostate Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Clinical Research Training Fellowship to TMFC from the Medical Research Council (http://www.mrc.ac.uk/index.htm) and a grant from the St Peter's Trust for Kidney, Bladder and Prostate Research (http://www.stpeterstrust.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agodoa L, 2007, SEMIN DIALYSIS, V20, P577, DOI 10.1111/j.1525-139X.2007.00350.x; Alves TP, 2010, CLIN NEPHROL, V74, pS72; BAYSAL E, 1995, BRIT J HAEMATOL, V89, P496, DOI 10.1111/j.1365-2141.1995.tb08354.x; BAYSAL E, 1992, BRIT J HAEMATOL, V81, P607, DOI 10.1111/j.1365-2141.1992.tb03000.x; Boddana Preetham, 2009, Nephron Clin Pract, V111 Suppl 1, pc269, DOI 10.1159/000210003; Byrne C, 2010, NEPHRON CLIN PRACT, V115, pC9, DOI 10.1159/000299800; Caskey FJ, 2011, NEPHROL DIAL TRANSPL, V26, P2604, DOI 10.1093/ndt/gfq781; Census, 2006, FIN RES TRNC GEN POP; Deltas CC, 2002, GENET TEST, V6, P15, DOI 10.1089/109065702760093861; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; ERA, 2008, ERA EDTA REG ANN REP; Eurostat, 2010, EUR COMM POP STAT; Freedman BI, 2005, AM J NEPHROL, V25, P529, DOI 10.1159/000088491; Gale DP, 2011, J ROY SOC MED, V104, P186, DOI 10.1258/jrsm.2011.11k013; Gale DP, 2010, LANCET, V376, P794, DOI 10.1016/S0140-6736(10)60670-8; HANLEY JA, 1983, JAMA-J AM MED ASSOC, V249, P1743, DOI 10.1001/jama.249.13.1743; Institute TS, 2008, MID POP PROJ AG GROU; Irwin J, 2008, INT J LEGAL MED, V122, P87, DOI 10.1007/s00414-007-0173-7; Lemley KV, 2008, PEDIATR NEPHROL, V23, P1933, DOI 10.1007/s00467-008-0763-8; Loizou T, 2006, DIABETES CARE, V29, P1714, DOI 10.2337/dc06-0696; Lubensky IA, 1999, AM J PATHOL, V155, P517, DOI 10.1016/S0002-9440(10)65147-4; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Neild GH, 2011, SAUDI J KIDNEY DIS T, V22, P651; Neild GH, 2009, PEDIATR NEPHROL, V24, P1913, DOI 10.1007/s00467-008-1108-3; Nephrology TSo, 2008, REG NEPHR DIAL TRANS; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Olds T, 2011, INT J PEDIATR OBES, V6, P342, DOI 10.3109/17477166.2011.605895; [ONS Statistics Ofn], 2011, MID YEAR POP EST 200; PERNEGER TV, 1995, AM J EPIDEMIOL, V141, P10, DOI 10.1093/oxfordjournals.aje.a117338; Rosansky SJ, 2009, KIDNEY INT, V76, P257, DOI 10.1038/ki.2009.161; Savva SC, 2008, INT J PEDIATR OBES, V3, P186, DOI 10.1080/17477160701705451; Shaheen FAM, 2005, KIDNEY INT, V68, pS37, DOI 10.1111/j.1523-1755.2005.09807.x; Stavrou C, 2002, KIDNEY INT, V62, P1385, DOI 10.1111/j.1523-1755.2002.kid581.x; Stewart JH, 2007, NEPHROLOGY, V12, P520, DOI 10.1111/j.1440-1797.2007.00830.x; Suleymanlar G, 2011, NEPHROL DIAL TRANSPL, V26, P1862, DOI 10.1093/ndt/gfq656; Suleymanlar G, 2011, AM J KIDNEY DIS, V57, P456, DOI 10.1053/j.ajkd.2010.12.007; USRDS. U.S. Renal Data System, 2011, US REN DAT SYST USRD; van Dijk PCW, 2007, KIDNEY INT, V71, P53, DOI 10.1038/sj.ki.5002008; Voskarides K, 2007, J AM SOC NEPHROL, V18, P3004, DOI 10.1681/ASN.2007040444; White SL, 2008, B WORLD HEALTH ORGAN, V86, P229, DOI 10.2471/BLT.07.041715; Wikipedia editor, 2011, NO CYPRUS; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88	42	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54394	10.1371/journal.pone.0054394	http://dx.doi.org/10.1371/journal.pone.0054394			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349874	Green Published, gold, Green Submitted			2022-12-25	WOS:000313738900063
J	Bjorkenstam, E; Hjern, A; Mittendorfer-Rutz, E; Vinnerljung, B; Hallqvist, J; Ljung, R				Bjorkenstam, Emma; Hjern, Anders; Mittendorfer-Rutz, Ellenor; Vinnerljung, Bo; Hallqvist, Johan; Ljung, Rickard			Multi-Exposure and Clustering of Adverse Childhood Experiences, Socioeconomic Differences and Psychotropic Medication in Young Adults	PLOS ONE			English	Article							RISK-FACTORS; NATIONAL COHORT; MAJOR DEPRESSION; MENTAL-DISORDERS; SOCIAL-CLASS; CHILDREN; HEALTH; MORBIDITY; REGISTER; EPIDEMIOLOGY	Purpose: Stressful childhood experiences have negative long-term health consequences. The present study examines the association between adverse childhood experiences, socioeconomic position, and risk of psychotropic medication in young adulthood. Methods: This register-based cohort study comprises the birth cohorts between 1985 and 1988 in Sweden. We followed 362 663 individuals for use of psychotropic medication from January 2006 until December 2008. Adverse childhood experiences were severe criminality among parents, parental alcohol or drug abuse, social assistance recipiency, parental separation or single household, child welfare intervention before the age of 12, mentally ill or suicidal parents, familial death, and number of changes in place of residency. Estimates of risk of psychotropic medication were calculated as odds ratio (OR) with 95% confidence intervals (CIs) using logistic regression analysis. Results: Adverse childhood experiences were associated with increased risks of psychotropic medication. The OR for more than three adverse childhood experiences and risk of psychotropic medication was for women 2.4 (95% CI 2.3-2.5) and for men 3.1 (95% CI 2.9-3.2). The risk of psychotropic medication increased with a higher rate of adverse childhood experiences, a relationship similar in all socioeconomic groups. Conclusions: Accumulation of adverse childhood experiences increases the risk of psychotropic medication in young adults. Parental educational level is of less importance when adjusting for adverse childhood experiences. The higher risk for future mental health problems among children from lower socioeconomic groups, compared to peers from more advantaged backgrounds, seems to be linked to a higher rate of exposure to adverse childhood experiences.	[Bjorkenstam, Emma; Ljung, Rickard] Karolinska Inst, Div Social Med, Dept Publ Hlth Sci, Stockholm, Sweden; [Bjorkenstam, Emma; Ljung, Rickard] Natl Board Hlth & Welf, Dept Stat Monitoring & Evaluat, Stockholm, Sweden; [Hjern, Anders] Stockholm Univ, Karolinska Inst, Ctr Hlth Equ Studies CHESS, S-10691 Stockholm, Sweden; [Mittendorfer-Rutz, Ellenor] Karolinska Inst, Div Insurance Med, Dept Clin Neurosci, Stockholm, Sweden; [Vinnerljung, Bo] Stockholm Univ, Dept Social Work, S-10691 Stockholm, Sweden; [Hallqvist, Johan] Karolinska Inst, Div Publ Hlth Epidemiol, Dept Publ Hlth Sci, Stockholm, Sweden; [Hallqvist, Johan] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Ljung, Rickard] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden	Karolinska Institutet; National Board of Health & Welfare; Karolinska Institutet; Stockholm University; Karolinska Institutet; Stockholm University; Karolinska Institutet; Uppsala University; Karolinska Institutet	Bjorkenstam, E (corresponding author), Karolinska Inst, Div Social Med, Dept Publ Hlth Sci, Stockholm, Sweden.	emma.bjorkenstam@ki.se	Ljung, Rickard/E-6752-2011	Ljung, Rickard/0000-0002-0654-4530; Hjern, Anders/0000-0002-1645-2058	Gadelius Foundation; Swedish Research Council	Gadelius Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Gadelius Foundation. Dr. Mittendorfer-Rutz is the recipient of the Assistant Professorship grant from the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P55; Anda R.F., HLTH SOCIAL IMPACT G; Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; Anda RF, 2007, AM J PREV MED, V32, P389, DOI 10.1016/j.amepre.2007.01.005; Chapman DP, 2004, J AFFECT DISORDERS, V82, P217, DOI 10.1016/j.jad.2003.12.013; Christ GH, 2002, JAMA-J AM MED ASSOC, V288, P1269, DOI 10.1001/jama.288.10.1269; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Dong MX, 2004, CHILD ABUSE NEGLECT, V28, P771, DOI 10.1016/j.chiabu.2004.01.008; Dube SR, 2003, PREV MED, V37, P268, DOI 10.1016/S0091-7435(03)00123-3; DUBE SR, 2006, J ADOLESCENT HEALTH, V38, P1; Ebrahim S, 2004, BMJ-BRIT MED J, V328, P861, DOI 10.1136/bmj.38034.702836.55; Evans GW, 2003, DEV PSYCHOL, V39, P924, DOI 10.1037/0012-1649.39.5.924; Farrington D., 2007, SAVING CHILDREN LIFE; Gilbert R, 2012, LANCET, V379, P758, DOI 10.1016/S0140-6736(11)61087-8; Gilman SE, 2002, INT J EPIDEMIOL, V31, P359, DOI 10.1093/ije/31.2.359; Hjern A, 2004, J EPIDEMIOL COMMUN H, V58, P412, DOI 10.1136/jech.2003.014282; Kivimaki M, 2007, AM J PUBLIC HEALTH, V97, P874, DOI 10.2105/AJPH.2005.078691; LewisHall F, 1996, MT SINAI J MED, V63, P326; Ljung R, 2007, AM J PUBLIC HEALTH, V97, P1927, DOI 10.2105/AJPH.2007.119248; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Mark TL, 2010, CNS DRUGS, V24, P319, DOI 10.2165/11533120-000000000-00000; Marks NF, 2007, J FAM ISSUES, V28, P1611, DOI 10.1177/0192513X07302728; Marmot M, 2001, J EPIDEMIOL COMMUN H, V55, P301, DOI 10.1136/jech.55.5.301; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; McLaughlin KA, 2011, SOC SCI MED, V73, P1088, DOI 10.1016/j.socscimed.2011.06.011; National Board of Health and Welfare, 2012, PHARM STAT 2011; National Records of Scotland, 2011, CHANG COD CAUS DEATH; Power C, 2008, J EPIDEMIOL COMMUN H, V62, P1030, DOI 10.1136/jech.2007.068817; Reinherz HZ, 2003, AM J PSYCHIAT, V160, P2141, DOI 10.1176/appi.ajp.160.12.2141; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Tracy M, 2008, J PSYCHIATR RES, V42, P1163, DOI 10.1016/j.jpsychires.2008.01.011; Turner HA, 2006, SOC SCI MED, V62, P13, DOI 10.1016/j.socscimed.2005.05.030; Vinnerljung B, 2006, J CHILD PSYCHOL PSYC, V47, P723, DOI 10.1111/j.1469-7610.2005.01530.x; Vinnerljung B, 2007, INT J SOC WELF, V16, P163; Weitoft GR, 2008, PHARMACOEPIDEM DR S, V17, P1020, DOI 10.1002/pds.1635; Weitoft GR, 2003, LANCET, V361, P289, DOI 10.1016/S0140-6736(03)12324-0; Weitoft GR, 2008, SOC SCI MED, V66, P14, DOI 10.1016/j.socscimed.2007.07.031; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Whitfield CL, 2005, CHILD ABUSE NEGLECT, V29, P797, DOI 10.1016/j.chiabu.2005.01.004; WOOD D, 1993, JAMA-J AM MED ASSOC, V270, P1334, DOI 10.1001/jama.270.11.1334	41	56	56	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53551	10.1371/journal.pone.0053551	http://dx.doi.org/10.1371/journal.pone.0053551			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072OV	23341951	Green Published, gold, Green Submitted			2022-12-25	WOS:000313682700029
J	Yudowski, GA; Olsen, O; Adesnik, H; Marek, KW; Bredt, DS				Yudowski, Guillermo A.; Olsen, Olav; Adesnik, Hillel; Marek, Kurt W.; Bredt, David S.			Acute Inactivation of PSD-95 Destabilizes AMPA Receptors at Hippocampal Synapses	PLOS ONE			English	Article							STARGAZIN; TRAFFICKING; DOMAIN	Postsynatptic density protein (PSD-95) is a 95 kDa scaffolding protein that assembles signaling complexes at synapses. Over-expression of PSD-95 in primary hippocampal neurons selectively increases synaptic localization of AMPA receptors; however, mice lacking PSD-95 display grossly normal glutamatergic transmission in hippocampus. To further study the scaffolding role of PSD-95 at excitatory synapses, we generated a recombinant PSD-95-4c containing a tetracysteine motif, which specifically binds a fluorescein derivative and allows for acute and permanent inactivation of PSD-95. Interestingly, acute inactivation of PSD-95 in rat hippocampal cultures rapidly reduced surface AMPA receptor immunostaining, but did not affected NMDA or transferrin receptor localization. Acute photoinactivation of PSD-95 in dissociated neurons causes similar to 80% decrease in GluR2 surface staining observed by live-cell microscopy within 15 minutes of PSD-95-4c ablation. These results confirm that PSD-95 stabilizes AMPA receptors at postsynaptic sites and provides insight into the dynamic interplay between PSD-95 and AMPA receptors in live neurons.	[Yudowski, Guillermo A.] Univ Puerto Rico, Sch Med, Dept Anat & Neurobiol, San Juan, PR 00936 USA; [Yudowski, Guillermo A.] Univ Puerto Rico, Inst Neurobiol, San Juan, PR 00936 USA; [Olsen, Olav] Rockefeller Univ, Lab Brain Dev & Repair, New York, NY 10021 USA; [Adesnik, Hillel] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Marek, Kurt W.] NHLBI, NIH, Bethesda, MD 20892 USA; [Bredt, David S.] Johnson & Johnson, Neurosci, San Diego, CA USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; Rockefeller University; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johnson & Johnson; Johnson & Johnson USA	Yudowski, GA (corresponding author), Univ Puerto Rico, Sch Med, Dept Anat & Neurobiol, San Juan, PR 00936 USA.	Guillermo.yudowski@upr.edu		Yudowski, Guillermo/0000-0001-5989-4131	National Institute of Health (NIH) from National Institute on Drug Abuse (NIDA) [K99/R00, DA023444]; American Recovery & Reinvestment Act (ARRA) [1P30NS069258]; Puerto Rico Science, Technology and Research Trust Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA023444, K99DA023444] Funding Source: NIH RePORTER	National Institute of Health (NIH) from National Institute on Drug Abuse (NIDA); American Recovery & Reinvestment Act (ARRA); Puerto Rico Science, Technology and Research Trust Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by research grants from the National Institute of Health (NIH) K99/R00 from National Institute on Drug Abuse (NIDA) DA023444, American Recovery & Reinvestment Act (ARRA) 1P30NS069258 and the Puerto Rico Science, Technology and Research Trust Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Beck S, 2002, PROTEOMICS, V2, P247, DOI 10.1002/1615-9861(200203)2:3<247::AID-PROT247>3.0.CO;2-K; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; DiCiommo DP, 1998, J BIOL CHEM, V273, P18060, DOI 10.1074/jbc.273.29.18060; El-Hussein AE, 2000, SCIENCE, V290, P1364; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Habets RLP, 2011, COLD SPRING HARBOR P; Habets RLP, 2011, COLD SPRING HARBOR P; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Marek KW, 2002, NEURON, V36, P805, DOI 10.1016/S0896-6273(02)01068-1; Olsen O, 2003, J BIOL CHEM, V278, P6873, DOI 10.1074/jbc.M210165200; Opazo P, 2012, CURR OPIN NEUROBIOL, V22, P453, DOI 10.1016/j.conb.2011.10.010; Sainlos M, 2011, NAT CHEM BIOL, V7, P81, DOI 10.1038/NCHEMBIO.498; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Stein V, 2003, J NEUROSCI, V23, P5503; Tochio H, 2000, J MOL BIOL, V303, P359, DOI 10.1006/jmbi.2000.4148; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624	25	24	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53965	10.1371/journal.pone.0053965	http://dx.doi.org/10.1371/journal.pone.0053965			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342049	Green Published, gold, Green Submitted			2022-12-25	WOS:000313682700068
J	Altenhoff, AM; Gil, M; Gonnet, GH; Dessimoz, C				Altenhoff, Adrian M.; Gil, Manuel; Gonnet, Gaston H.; Dessimoz, Christophe			Inferring Hierarchical Orthologous Groups from Orthologous Gene Pairs	PLOS ONE			English	Article							DATABASE; DUPLICATION; PREDICTION; ALGORITHM; ORTHOMCL; CLUSTERS	Hierarchical orthologous groups are defined as sets of genes that have descended from a single common ancestor within a taxonomic range of interest. Identifying such groups is useful in a wide range of contexts, including inference of gene function, study of gene evolution dynamics and comparative genomics. Hierarchical orthologous groups can be derived from reconciled gene/species trees but, this being a computationally costly procedure, many phylogenomic databases work on the basis of pairwise gene comparisons instead ("graph-based" approach). To our knowledge, there is only one published algorithm for graph-based hierarchical group inference, but both its theoretical justification and performance in practice are as of yet largely uncharacterised. We establish a formal correspondence between the orthology graph and hierarchical orthologous groups. Based on that, we devise GETHOGs ("Graph-based Efficient Technique for Hierarchical Orthologous Groups"), a novel algorithm to infer hierarchical groups directly from the orthology graph, thus without needing gene tree inference nor gene/species tree reconciliation. GETHOGs is shown to correctly reconstruct hierarchical orthologous groups when applied to perfect input, and several extensions with stringency parameters are provided to deal with imperfect input data. We demonstrate its competitiveness using both simulated and empirical data. GETHOGs is implemented as a part of the freely-available OMA standalone package (http://omabrowser.org/standalone). Furthermore, hierarchical groups inferred by GETHOGs ("OMA HOGs") on >1,000 genomes can be interactively queried via the OMA browser (http://omabrowser.org).	[Altenhoff, Adrian M.; Gil, Manuel; Gonnet, Gaston H.; Dessimoz, Christophe] ETH, Dept Comp Sci, Zurich, Switzerland; [Altenhoff, Adrian M.; Gil, Manuel; Gonnet, Gaston H.; Dessimoz, Christophe] Swiss Inst Bioinformat, Zurich, Switzerland; [Dessimoz, Christophe] EMBL European Bioinformat Inst, Cambridge, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics; European Molecular Biology Laboratory (EMBL)	Dessimoz, C (corresponding author), ETH, Dept Comp Sci, Zurich, Switzerland.	cdessimoz@ebi.ac.uk	Dessimoz, Christophe/D-3678-2011; Altenhoff, Adrian Michael/P-5024-2019	Dessimoz, Christophe/0000-0002-2170-853X; Altenhoff, Adrian Michael/0000-0001-7492-1273	ETH Independent Investigators' Research Award; SNSF advanced researcher fellowship [136461]	ETH Independent Investigators' Research Award; SNSF advanced researcher fellowship	This work was supported by an ETH Independent Investigators' Research Award to CD and GHG, and an SNSF advanced researcher fellowship to CD (#136461). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoff AM, 2012, METHODS MOL BIOL, V855, P259, DOI 10.1007/978-1-61779-582-4_9; Altenhoff AM, 2011, NUCLEIC ACIDS RES, V39, pD289, DOI 10.1093/nar/gkq1238; Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Boeckmann B, 2011, BRIEF BIOINFORM, V12, P423, DOI 10.1093/bib/bbr034; Chen CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018910; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Dalquen DA, 2012, MOL BIOL EVOL, V29, P1115, DOI 10.1093/molbev/msr268; DeLuca TF, 2006, BIOINFORMATICS, V22, P2044, DOI 10.1093/bioinformatics/btl286; Dessimoz C, 2006, NUCLEIC ACIDS RES, V34, P3309, DOI 10.1093/nar/gkl433; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Ford LR, 1956, CAN J MATH, V8, P399, DOI [10.4153/CJM-1956-045-5, 10.4153/CJM-1956-045-5., DOI 10.4153/CJM-1956-045-5]; Gonnet GH, 2000, BIOINFORMATICS, V16, P101, DOI 10.1093/bioinformatics/16.2.101; Huerta-Cepas J, 2008, NUCLEIC ACIDS RES, V36, pD491, DOI 10.1093/nar/gkm899; Jothi R, 2006, BIOINFORMATICS, V22, P779, DOI 10.1093/bioinformatics/btl009; Karger DR, 1996, J ACM, V43, P601, DOI 10.1145/234533.234534; Kristensen DM, 2011, BRIEF BIOINFORM, V12, P379, DOI 10.1093/bib/bbr030; Kristensen DM, 2010, BIOINFORMATICS, V26, P1481, DOI 10.1093/bioinformatics/btq229; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Linard B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-11; Miele V, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-116; NEYMAN J, 1971, STAT DECISION THEORY, P1; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Roth ACJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-518; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; TARJAN RE, 1984, J ACM, V31, P245, DOI 10.1145/62.2160; Trachana K, 2011, BIOESSAYS, V33, P769, DOI 10.1002/bies.201100062; van der Heijden RTJM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-83; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wall DP, 2003, BIOINFORMATICS, V19, P1710, DOI 10.1093/bioinformatics/btg213; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Waterhouse RM, 2011, NUCLEIC ACIDS RES, V39, pD283, DOI 10.1093/nar/gkq930; Yang ZH, 2000, GENETICS, V155, P431	35	94	94	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53786	10.1371/journal.pone.0053786	http://dx.doi.org/10.1371/journal.pone.0053786			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342000	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400082
J	Cai, L; Ye, L; Tong, AHY; Lok, S; Zhang, T				Cai, Lin; Ye, Lin; Tong, Amy Hin Yan; Lok, Si; Zhang, Tong			Biased Diversity Metrics Revealed by Bacterial 16S Pyrotags Derived from Different Primer Sets	PLOS ONE			English	Article							MICROBIAL COMMUNITY STRUCTURES; RARE BIOSPHERE; GUT MICROBIOTA; GENERATION; GENES; AMPLICONS; WRINKLES; DESIGN	In recent years, PCR-based pyrosequencing of 16S rRNA genes has continuously increased our understanding of complex microbial communities in various environments of the Earth. However, there is always concern on the potential biases of diversity determination using different 16S rRNA gene primer sets and covered regions. Here, we first report how bacterial 16S rRNA gene pyrotags derived from a series of different primer sets resulted in the biased diversity metrics. In total, 14 types of pyrotags were obtained from two-end pyrosequencing of 7 amplicon pools generated by 7 primer sets paired by 1 of 4 forward primers (V1F, V3F, V5F, and V7F) and 1 of 4 reverse primers (V2R, V4R, V6R, and V9R), respectively. The results revealed that: i) the activated sludge exhibited a large bacterial diversity that represented a broad range of bacterial populations and served as a good sample in this methodology research; ii) diversity metrics highly depended on the selected primer sets and covered regions; iii) paired pyrotags obtained from two-end pyrosequencing of each short amplicon displayed different diversity metrics; iv) relative abundance analysis indicated the sequencing depth affected the determination of rare bacteria but not abundant bacteria; v) the primer set of V1F and V2R significantly underestimated the diversity of activated sludge; and vi) the primer set of V3F and V4R was highly recommended for future studies due to its advantages over other primer sets. All of these findings highlight the significance of this methodology research and offer a valuable reference for peer researchers working on microbial diversity determination.	[Cai, Lin; Ye, Lin; Zhang, Tong] Univ Hong Kong, Environm Biotechnol Lab, Dept Civil Engn, Hong Kong, Hong Kong, Peoples R China; [Tong, Amy Hin Yan; Lok, Si] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Chinese University of Hong Kong	Zhang, T (corresponding author), Univ Hong Kong, Environm Biotechnol Lab, Dept Civil Engn, Hong Kong, Hong Kong, Peoples R China.	zhangt@hku.hk	Cai, Lin/AAN-8018-2020; Cai, Lin/K-2105-2013; 張彤, Tong Zhang/C-6786-2008; Ye, Lin/F-9709-2013; Zhang, Tong/HGC-1090-2022	Cai, Lin/0000-0001-5993-2011; Ye, Lin/0000-0002-4682-8917; Zhang, Tong/0000-0003-1148-4322	Hong Kong General Research Fund [7198/10E]; HKU Small Project Fund [201109176001]; HKU	Hong Kong General Research Fund; HKU Small Project Fund(University of Hong Kong); HKU(University of Hong Kong)	This study is supported by Hong Kong General Research Fund (7198/10E)and HKU Small Project Fund (201109176001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Lin Cai thanks HKU for the Postdoctoral Fellowship. We thank Ms. Kyana Young from University of Wisconsin-Madison and Mr. Derrick Anderson from HKU for language editing.	Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Flores GE, 2011, ENVIRON MICROBIOL, V13, P2158, DOI 10.1111/j.1462-2920.2011.02463.x; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; He ZL, 2012, CURR OPIN BIOTECH, V23, P460, DOI 10.1016/j.copbio.2011.12.021; Hu M, 2012, BIORESOURCE TECHNOL, V117, P72, DOI 10.1016/j.biortech.2012.04.061; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Humblot C, 2009, APPL ENVIRON MICROB, V75, P4354, DOI 10.1128/AEM.00451-09; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Kumar PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020956; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Price LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008422; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Roh SW, 2010, TRENDS BIOTECHNOL, V28, P291, DOI 10.1016/j.tibtech.2010.03.001; Sanapareddy N, 2009, APPL ENVIRON MICROB, V75, P1688, DOI 10.1128/AEM.01210-08; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Soergel DAW, 2012, ISME J, V6, P1440, DOI 10.1038/ismej.2011.208; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wagner M, 1998, WATER SCI TECHNOL, V37, P441, DOI 10.1016/S0273-1223(98)00143-7; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188	43	115	118	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53649	10.1371/journal.pone.0053649	http://dx.doi.org/10.1371/journal.pone.0053649			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341963	gold, Green Published, Green Submitted			2022-12-25	WOS:000314759400057
J	Nair, S; Aldrich, AJ; McDonnell, E; Cheng, Q; Aggarwal, A; Patel, P; Williams, MM; Boczkowski, D; Lyerly, HK; Morse, MA; Devi, GR				Nair, Smita; Aldrich, Amy J.; McDonnell, Eoin; Cheng, Qing; Aggarwal, Anshu; Patel, Pujan; Williams, Monique M.; Boczkowski, David; Lyerly, H. Kim; Morse, Michael A.; Devi, Gayathri R.			Immunologic Targeting of FOXP3 in Inflammatory Breast Cancer Cells	PLOS ONE			English	Article							REGULATORY T-CELLS; X-LINKED INHIBITOR; TRANSCRIPTION FACTOR FOXP3; NF-KAPPA-B; PERIPHERAL-BLOOD; DENDRITIC CELLS; TUMOR-IMMUNITY; LUNG-CANCER; EXPRESSION; APOPTOSIS	The forkhead transcription factor FOXP3 is necessary for induction of regulatory T lymphocytes (Tregs) and their immunosuppressive function. We have previously demonstrated that targeting Tregs by vaccination of mice with murine FOXP3 mRNA-transfected dendritic cells (DCs) elicits FOXP3-specific T cell responses and enhances tumor immunity. It is clear that FOXP3 expression is not restricted to T-cell lineage and herein, using RT-PCR, flow cytometry, and western immunoblot we demonstrate for the first time that FOXP3 is expressed in inflammatory breast cancer (IBC) cells, SUM149 (triple negative, ErbB1-activated) and SUM190 (ErbB2-overexpressing). Importantly, FOXP3-specific T cells generated in vitro using human FOXP3 RNA-transfected DCs as stimulators efficiently lyse SUM149 cells. Interestingly, an isogenic model (rSUM149) derived from SUM149 with an enhanced anti-apoptotic phenotype was resistant to FOXP3-specific T cell mediated lysis. The MHC class I cellular processing mechanism was intact in both cell lines at the protein and transcription levels suggesting that the resistance to cytolysis by rSUM149 cells was not related to MHC class I expression or to the MHC class I antigen processing machinery in these cells. Our data suggest that FOXP3 may be an effective tumor target in IBC cells however increased anti-apoptotic signaling can lead to immune evasion.	[Nair, Smita; Aldrich, Amy J.; McDonnell, Eoin; Cheng, Qing; Aggarwal, Anshu; Patel, Pujan; Williams, Monique M.; Boczkowski, David; Lyerly, H. Kim; Devi, Gayathri R.] Duke Univ Med Ctr, Dept Surg, Durham, NC USA; [Nair, Smita; Lyerly, H. Kim; Morse, Michael A.; Devi, Gayathri R.] Duke Univ Med Ctr, Duke Canc Inst, Durham, NC USA; [Morse, Michael A.] Duke Univ Med Ctr, Dept Med, Durham, NC USA	Duke University; Duke University; Duke University	Devi, GR (corresponding author), Duke Univ Med Ctr, Dept Surg, Durham, NC USA.	gayathri.devi@duke.edu	Lyerly, Herbert K/B-6528-2014; Lyerly, Herbert Kim/AAX-4925-2020; Nair, Smita/GYR-2993-2022; Nair Jain, Smita/M-2765-2018	Lyerly, Herbert K/0000-0002-0063-4770; Lyerly, Herbert Kim/0000-0002-0063-4770; Nair, Smita/0000-0001-5615-7056; Nair Jain, Smita/0000-0002-1542-9913	Department of Defense [W81XWH-07-1-0392, W81XWH-10-1-0339]; Duke SROP training program; Duke Graduate fellowship	Department of Defense(United States Department of Defense); Duke SROP training program; Duke Graduate fellowship	This work was entirely supported by Department of Defense W81XWH-07-1-0392 (GRD) and in part by Department of Defense W81XWH-10-1-0339 (SN), Duke SROP training program (MMW) and Duke Graduate fellowship (EM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird KM, 2008, MOL CANCER THER, V7, P38, DOI 10.1158/1535-7163.MCT-07-0370; Aird KM, 2012, BREAST CANCER RES TR, V132, P109, DOI 10.1007/s10549-011-1568-1; Aird KM, 2010, MOL CANCER THER, V9, P1432, DOI 10.1158/1535-7163.MCT-10-0160; Allensworth JL, 2012, MOL CANC THER; Anderson William F, 2005, Breast Dis, V22, P9; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Cheng Q, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3168; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; deLeeuw RJ, 2012, CLIN CANCER RES, V18, P3022, DOI 10.1158/1078-0432.CCR-11-3216; Dougan M, 2010, J EXP MED, V207, P2195, DOI 10.1084/jem.20101123; Douglass S, 2012, CANCER METAST REV, V31, P843, DOI 10.1007/s10555-012-9395-3; Drake CG, 2006, ADV IMMUNOL, V90, P51, DOI 10.1016/S0065-2776(06)90002-9; Ebert LM, 2008, CANCER RES, V68, P3001, DOI 10.1158/0008-5472.CAN-07-5664; Fassnacht M, 2005, CLIN CANCER RES, V11, P5566, DOI 10.1158/1078-0432.CCR-05-0699; Fecci PE, 2006, CANCER RES, V66, P3294, DOI 10.1158/0008-5472.CAN-05-3773; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gobert M, 2009, CANCER RES, V69, P2000, DOI 10.1158/0008-5472.CAN-08-2360; Grant C, 2006, PLOS PATHOG, V2, P303, DOI 10.1371/journal.ppat.0020033; Hinz S, 2007, CANCER RES, V67, P8344, DOI 10.1158/0008-5472.CAN-06-3304; Hu DQ, 2010, J BIOL CHEM, V285, P18326, DOI 10.1074/jbc.M109.083170; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Jaberipour M, 2010, PATHOL ONCOL RES, V16, P547, DOI 10.1007/s12253-010-9256-8; Jazirehi AR, 2010, ANTI-CANCER DRUG, V21, P805, DOI 10.1097/CAD.0b013e32833dad91; Karanikas V, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-19; Ladoire S, 2008, CLIN CANCER RES, V14, P2413, DOI 10.1158/1078-0432.CCR-07-4491; Ladoire S, 2011, BREAST CANCER RES TR, V125, P65, DOI 10.1007/s10549-010-0831-1; Liu RH, 2009, CANCER RES, V69, P2252, DOI 10.1158/0008-5472.CAN-08-3717; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Mansfield AS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-231; Mapara MY, 2004, J CLIN ONCOL, V22, P1136, DOI 10.1200/JCO.2004.10.041; Martin F, 2010, ONCOGENE, V29, P4121, DOI 10.1038/onc.2010.174; Merkenschlager M, 2010, J EXP MED, V207, P1347, DOI 10.1084/jem.20101156; Merlo A, 2009, J CLIN ONCOL, V27, P1746, DOI 10.1200/JCO.2008.17.9036; Morse MA, 2012, CANCER GENE THER, V19, P30, DOI 10.1038/cgt.2011.63; Morse MA, 2008, BLOOD, V112, P610, DOI 10.1182/blood-2008-01-135319; Morse MA, 2011, CLIN CANCER RES, V17, P3408, DOI 10.1158/1078-0432.CCR-10-2614; Mosca PJ, 2000, BLOOD, V96, P3499; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nair S, 2003, BLOOD, V102, P964, DOI 10.1182/blood-2002-12-3738; Nair S., 2012, CURR PROTOC IMMUNOL, P32; Nair SK, 2000, NAT MED, V6, P1011, DOI 10.1038/79519; Nair S, 2007, CANCER RES, V67, P371, DOI 10.1158/0008-5472.CAN-06-2903; Niu JZ, 2011, CANCER IMMUNOL IMMUN, V60, P1109, DOI 10.1007/s00262-011-1025-3; Ormandy LA, 2005, CANCER RES, V65, P2457, DOI 10.1158/0008-5472.CAN-04-3232; Perez SA, 2007, CLIN CANCER RES, V13, P2714, DOI 10.1158/1078-0432.CCR-06-2347; Pruitt SK, 2011, EUR J IMMUNOL, V41, P3553, DOI 10.1002/eji.201141383; Robertson FM, 2010, CA-CANCER J CLIN, V60, P351, DOI 10.3322/caac.20082; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Seeger JM, 2010, BRIT J CANCER, V102, P1717, DOI 10.1038/sj.bjc.6605704; Varfolomeev E, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001878; Viguier M, 2004, J IMMUNOL, V173, P1444, DOI 10.4049/jimmunol.173.2.1444; Wang R, 2009, P NATL ACAD SCI USA, V106, P13439, DOI 10.1073/pnas.0901965106; Wolf AM, 2003, CLIN CANCER RES, V9, P606; Woo EY, 2002, J IMMUNOL, V168, P4272, DOI 10.4049/jimmunol.168.9.4272; Woo EY, 2001, CANCER RES, V61, P4766; Zhang M, 2009, CLIN EXP PHARMACOL P, V36, P304, DOI 10.1111/j.1440-1681.2008.05066.x; Zuo T, 2007, J CLIN INVEST, V117, P3765, DOI 10.1172/JCI32538; Zuo T, 2007, CELL, V129, P1275, DOI 10.1016/j.cell.2007.04.034	58	12	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53150	10.1371/journal.pone.0053150	http://dx.doi.org/10.1371/journal.pone.0053150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341929	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400034
J	Pio, R; Jia, ZY; Baron, VT; Mercola, D				Pio, Rebecca; Jia, Zhenyu; Baron, Veronique T.; Mercola, Dan		UCI NCI SPECS Consortium Strategic	Early Growth Response 3 (Egr3) Is Highly Over-Expressed in Non-Relapsing Prostate Cancer but Not in Relapsing Prostate Cancer	PLOS ONE			English	Article							TRANSCRIPTION FACTOR EGR3; LARGE GENE LISTS; UP-REGULATION; CYTOPLASMIC SEQUESTRATION; IONIZING-RADIATION; BREAST-CANCER; CELL-GROWTH; KAPPA-B; NGFI-A; P53	Members of the early growth response (EGR) family of transcription factors play diverse functions in response to many cellular stimuli, including growth, stress, and inflammation. Egr3 has gone relatively unstudied, but here through use of the SPECS (Strategic Partners for the Evaluation of Predictive Signatures of Prostate Cancer) Affymetrix whole genome gene expression database we report that Egr3 mRNA is significantly over-expressed in prostate cancer compared to normal prostate tissue (5-fold). The Human Protein Atlas (http://www.proteinatlas.org), a database of tissue microarrays labeled with antibodies against over 11,000 human proteins, was utilized to quantify Egr3 protein expression in normal prostate and prostate cancer patients. In agreement with the SPECS data, we found that Egr3 protein is significantly increased in prostate cancer. The SPECS database has the benefit of extensive clinical follow up for the prostate cancer patients. Analysis of Egr3 mRNA expression in relation to the relapse status reveals that Egr3 mRNA expression is increased in tumor cells of non-relapsed samples (n = 63) compared to normal prostate cells, but is significantly lower in relapsed samples (n = 38) compared to non-relapse. The observations were confirmed using an independent data set. A list of genes correlating with this unique expression pattern was determined. These Egr3-correlated genes were enriched with Egr binding sites in their promoters. The gene list contains inflammatory genes such as IL-6, IL-8, IL1 beta and COX-2, which have extensive connections to prostate cancer.	[Pio, Rebecca; Jia, Zhenyu; Mercola, Dan] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA 92717 USA; [Baron, Veronique T.] San Diego Sci Ctr, Vaccine Res Inst San Diego, San Diego, CA USA	University of California System; University of California Irvine	Mercola, D (corresponding author), Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA 92717 USA.	dmercola@uci.edu	mercola, dan/L-4182-2013	mercola, dan/0000-0002-0281-9840; McClelland, Michael/0000-0003-1788-9347	USPHS [U01 CA1148102, U01 CA152738]; University of California of Irvine Faculty Career Development Award; NATIONAL CANCER INSTITUTE [R01CA076173, U01CA152738] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); University of California of Irvine Faculty Career Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the USPHS grants U01 CA1148102 (NIH/NCI SPECS consortium) and U01 CA152738 (NIH/NCI EDRN), and by the University of California of Irvine Faculty Career Development Award (to Dr. Z. Jia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkadir SA, 2001, NAT MED, V7, P101, DOI 10.1038/83231; Ahmed MM, 1997, J BIOL CHEM, V272, P33056, DOI 10.1074/jbc.272.52.33056; Beckmann AM, 1997, J NEUROCHEM, V69, P2227; Calogero A, 2001, CLIN CANCER RES, V7, P2788; Castellanos MD, 2002, EUR J IMMUNOL, V32, P3108; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chandran UR, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-45; Cullen EM, 2010, MOL IMMUNOL, V47, P1701, DOI 10.1016/j.molimm.2010.03.003; Dalgaard P, 2008, STAT COMPUT SER, P1, DOI 10.1007/978-0-387-79054-1_1; DATTA R, 1993, P NATL ACAD SCI USA, V90, P2419, DOI 10.1073/pnas.90.6.2419; Diaz-Munoz MD, 2010, CELL SIGNAL, V22, P1427, DOI 10.1016/j.cellsig.2010.05.011; Eickelberg O, 1999, J BIOL CHEM, V274, P12933, DOI 10.1074/jbc.274.18.12933; Eid MA, 1998, CANCER RES, V58, P2461; Eldredge LC, 2008, DEVELOPMENT, V135, P2949, DOI 10.1242/dev.023960; Ferrer FA, 1998, UROLOGY, V51, P161, DOI 10.1016/S0090-4295(97)00491-3; Gallitano-Mendel A, 2007, NEUROSCIENCE, V148, P633, DOI 10.1016/j.neuroscience.2007.05.050; Giri D, 2001, AM J PATHOL, V159, P2159, DOI 10.1016/S0002-9440(10)63067-2; Hoffmann E, 2008, J BIOL CHEM, V283, P12120, DOI 10.1074/jbc.M800583200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; HUANG RP, 1995, CANCER RES, V55, P5054; Inoue A, 2004, J MOL ENDOCRINOL, V32, P649, DOI 10.1677/jme.0.0320649; Jia ZY, 2011, CANCER RES, V71, P2476, DOI 10.1158/0008-5472.CAN-10-2585; LEE SL, 1995, J BIOL CHEM, V270, P9971, DOI 10.1074/jbc.270.17.9971; LEVIN WJ, 1994, CHEST, V106, pS372, DOI 10.1378/chest.106.6.372S; Li S, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-73; Liu D, 2008, ONCOGENE, V27, P2989, DOI 10.1038/sj.onc.1210959; LIU JW, 1991, J BIOL CHEM, V266, P5929; Ma JJ, 2009, J BIOL CHEM, V284, P34600, DOI 10.1074/jbc.M109.016246; Maltzman JS, 1996, MOL CELL BIOL, V16, P2283; MOLL UM, 1995, P NATL ACAD SCI USA, V92, P4407, DOI 10.1073/pnas.92.10.4407; Moll UM, 1996, MOL CELL BIOL, V16, P1126; MOLL UM, 1992, P NATL ACAD SCI USA, V89, P7262, DOI 10.1073/pnas.89.15.7262; Plymate SR, 1996, J CLIN ENDOCR METAB, V81, P3709, DOI 10.1210/jc.81.10.3709; Ramana CV, 2009, MOL IMMUNOL, V47, P623, DOI 10.1016/j.molimm.2009.09.001; Recio JA, 2003, CANCER RES, V63, P1576; Rojas A, 2011, ONCOGENE, V30, P2345, DOI 10.1038/onc.2010.605; Sauer L, 2010, ONCOGENE, V29, P2628, DOI 10.1038/onc.2010.24; Singh RK, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-57; Stuart RO, 2004, P NATL ACAD SCI USA, V101, P615, DOI 10.1073/pnas.2536479100; Suehiro J, 2010, BLOOD, V115, P2520, DOI 10.1182/blood-2009-07-233478; SUKHATME VP, 1990, J AM SOC NEPHROL, V1, P859; SUKHATME VP, 1987, ONCOGENE RES, V1, P343; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; Suzuki T, 2007, ENDOCR-RELAT CANCER, V14, P279, DOI 10.1677/ERC-06-0005; SWIRNOFF AH, 1995, MOL CELL BIOL, V15, P2275; Thigpen AE, 1996, J UROLOGY, V155, P975, DOI 10.1016/S0022-5347(01)66361-4; Tourtellotte WG, 1998, NAT GENET, V20, P87, DOI 10.1038/1757; Tourtellotte WG, 2001, DEV BIOL, V232, P388, DOI 10.1006/dbio.2001.0202; TWILLIE DA, 1995, UROLOGY, V45, P542, DOI 10.1016/S0090-4295(99)80034-X; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Wieland GD, 2005, J CELL SCI, V118, P3203, DOI 10.1242/jcs.02445; Yan SF, 2000, NAT MED, V6, P1355, DOI 10.1038/82168; Yu J, 2007, CELL DEATH DIFFER, V14, P436, DOI 10.1038/sj.cdd.4402029; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	55	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54096	10.1371/journal.pone.0054096	http://dx.doi.org/10.1371/journal.pone.0054096			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342084	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400121
J	Rondelli, T; Berardi, M; Peruzzi, B; Boni, L; Caporale, R; Dolara, P; Notaro, R; Luzzatto, L				Rondelli, Tommaso; Berardi, Margherita; Peruzzi, Benedetta; Boni, Luca; Caporale, Roberto; Dolara, Piero; Notaro, Rosario; Luzzatto, Lucio			The Frequency of Granulocytes with Spontaneous Somatic Mutations: A Wide Distribution in a Normal Human Population	PLOS ONE			English	Article							PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; RED-BLOOD-CELLS; PIG-A; MAMMALIAN-CELLS; CANCER; ASSAY; INDIVIDUALS; PHENOTYPE; PATHWAYS; DISEASE	Germ-line mutation rate has been regarded classically as a fundamental biological parameter, as it affects the prevalence of genetic disorders and the rate of evolution. Somatic mutation rate is also an important biological parameter, as it may influence the development and/or the course of acquired diseases, particularly of cancer. Estimates of this parameter have been previously obtained in few instances from dermal fibroblasts and lymphoblastoid cells. However, the methodology required has been laborious and did not lend itself to the analysis of large numbers of samples. We have previously shown that the X-linked gene PIG-A, since its product is required for glycosyl-phosphatidylinositol-anchored proteins to become surface bound, is a good sentinel gene for studying somatic mutations. We now show that by this approach we can accurately measure the proportion of PIG-A mutant peripheral blood granulocytes, which we call mutant frequency, e. We found that the results are reproducible, with a variation coefficient (CV) of 45%. Repeat samples from 32 subjects also had a CV of 44%, indicating that e is a relatively stable individual characteristic. From a study of 142 normal subjects we found that log e is a normally distributed variable; e variability spans a 80-fold range, from less than 1 x 10(-6) to 37.5 x 10(-6), with a median of 4.9 x 10(-6). Unlike other techniques commonly employed in population studies, such as comet assay, this method can detect any kind of mutation, including point mutation, as long as it causes functional inactivation of PIG-A gene. Since the test is rapid and requires only a small sample of peripheral blood, this methodology will lend itself to investigating genetic factors that underlie the variation in the somatic mutation rate, as well as environmental factors that may affect it. It will be also possible to test whether e is a determinant of the risk of cancer.	[Rondelli, Tommaso; Berardi, Margherita; Peruzzi, Benedetta; Notaro, Rosario] ITT, CRL, Lab Canc Genet & Gene Transfer, Florence, Italy; [Boni, Luca] ITT, CRL, Clin Trials Coordinating Ctr, Florence, Italy; [Caporale, Roberto] Careggi Hosp, Flow Cytometry Unit, Florence, Italy; [Dolara, Piero] Univ Florence, Dept Pharmacol, Florence, Italy; [Luzzatto, Lucio] Ist Toscano Tumori, Florence, Italy	University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica	Notaro, R (corresponding author), ITT, CRL, Lab Canc Genet & Gene Transfer, Florence, Italy.	rosario.notaro@ittumori.it	Notaro, Rosario/J-7293-2016; Peruzzi, Benedetta/AAC-5178-2022; Boni, Luca/ABI-6243-2020	Notaro, Rosario/0000-0002-9087-9404; Boni, Luca/0000-0003-2217-4047	"Regione Toscana", Bando Salute; Associazione Italiana per la Ricerca sul Cancro - AIRC	"Regione Toscana", Bando Salute(Regione Toscana); Associazione Italiana per la Ricerca sul Cancro - AIRC(Fondazione AIRC per la ricerca sul cancro)	The work reported in this manuscript has been funded in part by: 1) "Regione Toscana", Bando Salute 2009 (RN): http://www.regione.toscana.it; 2) ''Associazione Italiana per la Ricerca sul Cancro - AIRC" (LL): http://www.airc.it. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTINI RJ, 1990, ANNU REV GENET, V24, P305; AMES BN, 1975, MUTAT RES, V31, P347, DOI 10.1016/0165-1161(75)90046-1; Araten DJ, 2005, CANCER RES, V65, P8111, DOI 10.1158/0008-5472.CAN-04-1198; Araten DJ, 1999, P NATL ACAD SCI USA, V96, P5209, DOI 10.1073/pnas.96.9.5209; BESSLER M, 1994, HUM MOL GENET, V3, P751, DOI 10.1093/hmg/3.5.751; Bigbee WL, 1998, MUTAT RES-FUND MOL M, V397, P119, DOI 10.1016/S0027-5107(97)00186-3; Bonassi S, 2009, MUTAGENESIS, V24, P295, DOI 10.1093/mutage/gep019; Bryce SM, 2008, ENVIRON MOL MUTAGEN, V49, P256, DOI 10.1002/em.20379; D'Andrea AD, 2010, NEW ENGL J MED, V362, P1909, DOI 10.1056/NEJMra0809889; Dacie JV., 1999, HAEMOLYTIC ANAEMIAS, P139; Dobrovolsky VN, 2011, ENVIRON MOL MUTAGEN, V52, P784, DOI 10.1002/em.20667; Dobrovolsky VN, 2009, MUTAT RES-GEN TOX EN, V673, P21, DOI 10.1016/j.mrgentox.2008.11.006; ENGLISH D, 1974, J IMMUNOL METHODS, V5, P249, DOI 10.1016/0022-1759(74)90109-4; Evans HJ, 1996, MUTAT RES-FUND MOL M, V351, P89, DOI 10.1016/0027-5107(95)00201-4; GLUER CC, 1995, OSTEOPOROSIS INT, V5, P262, DOI 10.1007/BF01774016; HALD A, 1952, STATISTICAL THEORY E, P144; HILLMEN P, 1993, SOMAT CELL MOLEC GEN, V19, P123, DOI 10.1007/BF01233528; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Janeway CA, 2005, IMMUNOBIOLOGY; Kennedy RD, 2006, J CLIN ONCOL, V24, P3799, DOI 10.1200/JCO.2005.05.4171; Kinoshita T, 2008, J BIOCHEM, V144, P287, DOI 10.1093/jb/mvn090; Luzzatto L, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-S1-S12; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; NAFA K, 1995, BLOOD, V86, P4650, DOI 10.1182/blood.V86.12.4650.bloodjournal86124650; Notaro R, 2003, BLOOD PRINCIPLES PRA, P319; Peruzzi B, 2010, MUTAT RES-REV MUTAT, V705, P3, DOI 10.1016/j.mrrev.2009.12.004; Pitozzi V, 2006, FREE RADICAL RES, V40, P1149, DOI 10.1080/10715760600863116; ROSSE WF, 1991, BRIT J HAEMATOL, V79, P99, DOI 10.1111/j.1365-2141.1991.tb08014.x; ROSSMAN TG, 1995, MUTAT RES-FUND MOL M, V328, P21, DOI 10.1016/0027-5107(94)00190-G; Strachan T, 1999, HUMAN MOL GENETICS; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943	31	33	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54046	10.1371/journal.pone.0054046	http://dx.doi.org/10.1371/journal.pone.0054046			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342069	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400114
J	Rosvall, KA				Rosvall, Kimberly A.			Life History Trade-Offs and Behavioral Sensitivity to Testosterone: An Experimental Test When Female Aggression and Maternal Care Co-Occur	PLOS ONE			English	Article							EXPERIMENTALLY-ELEVATED TESTOSTERONE; SEX-ROLE REVERSAL; TREE SWALLOWS; EXOGENOUS TESTOSTERONE; PARENTAL BEHAVIOR; REPRODUCTIVE-PERFORMANCE; TERRITORIAL AGGRESSION; MONOGAMOUS SONGBIRD; PLASMA TESTOSTERONE; SOCIAL MODULATION	Research on male animals suggests that the hormone testosterone plays a central role in mediating the trade-off between mating effort and parental effort. However, the direct links between testosterone, intrasexual aggression and parental care are remarkably mixed across species. Previous attempts to reconcile these patterns suggest that selection favors behavioral insensitivity to testosterone when paternal care is essential to reproductive success and when breeding seasons are especially short. Females also secrete testosterone, though the degree to which similar testosterone-mediated trade-offs occur in females is much less clear. Here, I ask whether testosterone mediates trade-offs between aggression and incubation in females, and whether patterns of female sensitivity to testosterone relate to female life history, as is often the case in males. I experimentally elevated testosterone in free-living, incubating female tree swallows (Tachycineta bicolor), a songbird with a short breeding season during which female incubation and intrasexual aggression are both essential to female reproductive success. Testosterone-treated females showed significantly elevated aggression, reduced incubation temperatures, and reduced hatching success, relative to controls. Thus, prolonged testosterone elevation during incubation was detrimental to reproductive success, but females nonetheless showed behavioral sensitivity to testosterone. These findings suggest that the relative importance of both mating effort and parental effort may be central to understanding patterns of behavioral sensitivity in both sexes.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Rosvall, KA (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	krosvall@indiana.edu	Rosvall, Kimberly/GQB-1395-2022		National Science Foundation [IBN-0710118]; United States National Institutes of Health NRSA [T32HD049336, F32HD068222]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD049336] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD068222] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); United States National Institutes of Health NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	KAR supported by an National Science Foundation doctoral dissertation improvement grant at the time of field components of this study (IBN-0710118) and a United States National Institutes of Health NRSA postdoctoral fellowship during analysis/preparation of the manuscript (T32HD049336 and F32HD068222). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins-Regan E., 2005, HORMONES ANIMAL SOCI; [Anonymous], 2020, BIRDS N AM CORNELL L, DOI DOI 10.2173/BOW.ROSGOO.01; Ardia DR, 2007, BEHAV ECOL, V18, P259, DOI 10.1093/beheco/arl078; Ardia DR, 2010, P ROY SOC B-BIOL SCI, V277, P1881, DOI 10.1098/rspb.2009.2138; Ball GF, 2008, PHILOS T R SOC B, V363, P1699, DOI 10.1098/rstb.2007.0010; Beletsky LD, 1995, CURRENT ORNITHOLOGY; Bishop CA, 1998, J TOXICOL ENV HEAL A, V55, P561, DOI 10.1080/009841098158250; Buntin John D., 1996, Advances in the Study of Behavior, V25, P161; Cain KE, 2012, BEHAV ECOL SOCIOBIOL, V66, P241, DOI 10.1007/s00265-011-1272-5; Canoine V, 2007, DEV NEUROBIOL, V67, P57, DOI 10.1002/dneu.20296; Clark MM, 1999, J COMP PSYCHOL, V113, P388, DOI 10.1037/0735-7036.113.4.388; Clotfelter ED, 2004, HORM BEHAV, V46, P171, DOI 10.1016/j.yhbeh.2004.03.003; Clutton-Brock T, 2007, SCIENCE, V318, P1882, DOI 10.1126/science.1133311; Clutton-Brock T, 2009, ANIM BEHAV, V77, P3, DOI 10.1016/j.anbehav.2008.08.026; Cresswell W, 2004, BEHAV ECOL, V15, P498, DOI 10.1093/beheco/arh042; De Ridder E, 2002, AUK, V119, P487, DOI 10.1642/0004-8038(2002)119[0487:SALTEO]2.0.CO;2; De Ridder E, 2000, BEHAV ECOL SOCIOBIOL, V49, P24, DOI 10.1007/s002650000266; DESTEVEN D, 1978, IBIS, V120, P516; DUNN PO, 1994, BEHAV ECOL SOCIOBIOL, V35, P273, DOI 10.1007/s002650050098; Eens M, 2000, BEHAV PROCESS, V51, P135, DOI 10.1016/S0376-6357(00)00124-8; Elekonich MM, 2000, ETHOLOGY, V106, P493, DOI 10.1046/j.1439-0310.2000.00555.x; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Fusani L, 2008, GEN COMP ENDOCR, V157, P249, DOI 10.1016/j.ygcen.2008.04.016; Gahr M, 1997, BRAIN RES BULL, V44, P509, DOI 10.1016/S0361-9230(97)00233-5; Gebhardt-Henrich Sabine, 1998, Oxford Ornithology Series, V8, P324; Goodson JL, 2005, HORM BEHAV, V48, P11, DOI 10.1016/j.yhbeh.2005.02.003; Goymann W, 2008, P ROY SOC B-BIOL SCI, V275, P1053, DOI 10.1098/rspb.2007.1707; Goymann W, 2009, GEN COMP ENDOCR, V163, P149, DOI 10.1016/j.ygcen.2008.11.027; Hau M, 2007, BIOESSAYS, V29, P133, DOI 10.1002/bies.20524; HEGNER RE, 1987, AUK, V104, P462, DOI 10.2307/4087545; Hepp GR, 2006, FUNCT ECOL, V20, P307, DOI 10.1111/j.1365-2435.2006.01108.x; Hirschenhauser K, 2006, ANIM BEHAV, V71, P265, DOI 10.1016/j.anbehav.2005.04.014; HUNT K, 1995, AM ZOOL, V35, P274; Hunt KE, 1999, BEHAV ECOL SOCIOBIOL, V45, P360, DOI 10.1007/s002650050572; Hunt KE, 1997, ANIM BEHAV, V54, P1177, DOI 10.1006/anbe.1997.0558; HUSSELL DJT, 1983, J FIELD ORNITHOL, V54, P312; Jawor JM, 2006, HORM BEHAV, V49, P362, DOI 10.1016/j.yhbeh.2005.08.009; Ketterson ED, 2005, AM NAT, V166, pS85, DOI 10.1086/444602; Ketterson ED, 1999, AM NAT, V154, pS4, DOI 10.1086/303280; KETTERSON ED, 1992, AM NAT, V140, P980, DOI 10.1086/285451; Ketterson ED, 2009, INTEGR COMP BIOL, V49, P365, DOI 10.1093/icb/icp057; Knapp R, 1999, HORM BEHAV, V35, P81, DOI 10.1006/hbeh.1998.1499; KRINER E, 1991, ETHOLOGY, V87, P37; LANDE R, 1983, EVOLUTION, V37, P1210, DOI [10.1111/j.1558-5646.1983.tb00236.x, 10.2307/2408842]; Langmore NE, 1997, ANIM BEHAV, V53, P881, DOI 10.1006/anbe.1996.0306; LEFFELAAR D, 1985, WILSON BULL, V97, P221; Lombardo MP, 1995, AUK, V112, P973, DOI 10.2307/4089028; Lynn SE, 2005, HORM BEHAV, V47, P170, DOI 10.1016/j.yhbeh.2004.10.004; Lynn SE, 2002, ANIM BEHAV, V63, P795, DOI 10.1006/anbe.2001.1980; Lynn SE, 2008, GEN COMP ENDOCR, V157, P233, DOI 10.1016/j.ygcen.2008.05.009; Lynn SE, 2008, GEN COMP ENDOCR, V156, P181, DOI 10.1016/j.ygcen.2008.01.004; Lynn SE, 2009, PHYSIOL BIOCHEM ZOOL, V82, P699, DOI 10.1086/605915; Magrath MJL, 2003, TRENDS ECOL EVOL, V18, P424, DOI 10.1016/S0169-5347(03)00124-1; Mank JE, 2007, AM NAT, V169, P142, DOI 10.1086/510103; McCarty JP, 2001, AUK, V118, P176, DOI 10.1642/0004-8038(2001)118[0176:VIGONT]2.0.CO;2; McDonald PG, 2001, HORM BEHAV, V39, P185, DOI 10.1006/hbeh.2001.1644; McGlothlin JW, 2007, AM NAT, V170, P864, DOI 10.1086/522838; Moller AP, 2005, BEHAV ECOL SOCIOBIOL, V58, P534, DOI 10.1007/s00265-005-0962-2; O'Neal DM, 2008, HORM BEHAV, V54, P571, DOI 10.1016/j.yhbeh.2008.05.017; Oliveira RF, 2009, INTEGR COMP BIOL, V49, P423, DOI 10.1093/icb/icp055; Perez JH, 2008, BIOL LETTERS, V4, P468, DOI 10.1098/rsbl.2008.0266; Raouf SA, 1997, P ROY SOC B-BIOL SCI, V264, P1599, DOI 10.1098/rspb.1997.0223; Reed WL, 2006, AM NAT, V167, P667, DOI 10.1086/503054; Robertson R.J., 1992, Birds of North America, V11, P1; Roff DA, 2002, EVOLUTION, V56, P84, DOI 10.1111/j.0014-3820.2002.tb00851.x; Rosvall KA, 2012, P ROY SOC B-BIOL SCI, V279, P3547, DOI 10.1098/rspb.2012.0442; Rosvall KA, 2008, ANIM BEHAV, V75, P1603, DOI 10.1016/j.anbehav.2007.09.038; Rosvall KA, 2011, BEHAV ECOL, V22, P1131, DOI 10.1093/beheco/arr106; Rosvall KA, 2011, ETHOLOGY, V117, P332, DOI 10.1111/j.1439-0310.2011.01881.x; Rosvall KA, 2010, BEHAV ECOL, V21, P161, DOI 10.1093/beheco/arp167; Sandell MI, 2007, BEHAV ECOL SOCIOBIOL, V62, P255, DOI 10.1007/s00265-007-0460-9; Sandell MI, 1998, P ROY SOC B-BIOL SCI, V265, P1307, DOI 10.1098/rspb.1998.0434; Schoech SJ, 1998, HORM BEHAV, V34, P1, DOI 10.1006/hbeh.1998.1455; Schwagmeyer PL, 2005, ANIM BEHAV, V69, P481, DOI 10.1016/j.anbehav.2004.04.017; SHUSTER SM, 2003, MG BEH ECOL, pR7; SILVERIN B, 1980, ANIM BEHAV, V28, P906, DOI 10.1016/S0003-3472(80)80152-7; Soma KK, 2008, FRONT NEUROENDOCRIN, V29, P476, DOI 10.1016/j.yfrne.2007.12.003; Staub NL, 1997, GEN COMP ENDOCR, V108, P1, DOI 10.1006/gcen.1997.6962; Stearns S.C., 1992, pi; Stockley P, 2011, BIOL REV, V86, P341, DOI 10.1111/j.1469-185X.2010.00149.x; STUTCHBURY BJ, 1987, AUK, V104, P717, DOI 10.1093/auk/104.4.717; STUTCHBURY BJ, 1987, BEHAV ECOL SOCIOBIOL, V20, P413, DOI 10.1007/BF00302984; STUTCHBURY BJ, 1988, CAN J ZOOL, V66, P827, DOI 10.1139/z88-122; STUTCHBURY BJ, 1985, AUK, V102, P651, DOI 10.1093/auk/102.3.651; Swett MB, 2008, COMP BIOCHEM PHYS A, V151, P226, DOI 10.1016/j.cbpa.2008.06.031; Trainor BC, 2001, HORM BEHAV, V40, P32, DOI 10.1006/hbeh.2001.1652; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Van Roo BL, 2004, HORM BEHAV, V46, P678, DOI 10.1016/j.yhbeh.2004.06.011; Veiga JP, 2008, AM NAT, V172, P42, DOI 10.1086/587850; Voigt C, 2007, DEV NEUROBIOL, V67, P1560, DOI 10.1002/dneu.20528; Wang JM, 2011, AUK, V128, P454, DOI 10.1525/auk.2011.10208; Wang JM, 2009, ANIM BEHAV, V78, P601, DOI 10.1016/j.anbehav.2009.05.022; While GM, 2010, HORM BEHAV, V58, P208, DOI 10.1016/j.yhbeh.2010.03.016; WINGFIELD JC, 1984, GEN COMP ENDOCR, V56, P417, DOI 10.1016/0016-6480(84)90084-4; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; Wingfield JC, 2002, COMP BIOCHEM PHYS B, V132, P275, DOI 10.1016/S1096-4959(01)00540-1; Wingfield JC, 2001, BRAIN BEHAV EVOLUT, V57, P239, DOI 10.1159/000047243; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006; Zysling DA, 2006, HORM BEHAV, V50, P200, DOI 10.1016/j.yhbeh.2006.03.004	99	53	55	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54120	10.1371/journal.pone.0054120	http://dx.doi.org/10.1371/journal.pone.0054120			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342089	gold, Green Published			2022-12-25	WOS:000314759400124
J	Shehadah, A; Chen, JL; Kramer, B; Zacharek, A; Cui, YS; Roberts, C; Lu, M; Chopp, M				Shehadah, Amjad; Chen, Jieli; Kramer, Brian; Zacharek, Alex; Cui, Yisheng; Roberts, Cynthia; Lu, Mei; Chopp, Michael			Efficacy of Single and Multiple Injections of Human Umbilical Tissue-Derived Cells following Experimental Stroke in Rats	PLOS ONE			English	Article							MARROW STROMAL CELLS; TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; CEREBRAL-ISCHEMIA; STEM-CELLS; SYNAPTIC PLASTICITY; GENE-EXPRESSION; RECOVERY; SYNAPTOGENESIS; SYNAPTOPHYSIN	Introduction: Human umbilical tissue-derived cells (hUTC) are a promising source of cells for regenerative treatment of stroke. In this study, we tested the efficacy of hUTC in experimental stroke and whether multiple injections of hUTC provide additional therapeutic benefits as compared to a single injection. Methods: Adult male Wistar rats were subjected to 2 hours of middle cerebral artery occlusion (MCAo), and randomly selected animals were injected (i.v) with 3 x 10(6) hUTC or with vehicle control (at day: 1, 1&3 or 1&7 after MCAo, n = 8-9/group). A battery of functional outcome tests was performed at days 1, 7, 14, 21, 28, 35, 42, 49, 56 and 63 after MCAo. Rats were sacrificed at 63 days after MCAo and lesion volumes were measured. To investigate the underlying mechanism of hUTC treatment of stroke, Von Willebrand Factor (vWF), and Synaptophysin immunostaining were performed. Results: All hUTC treated groups, single or multiple injections, had better functional recovery compared to control (p<0.01). There was no statistically significant difference between a single and multiple injections of hUTC (p = 0.23) or between different multiple injections groups (p>0.07) in functional outcome. All hUTC treatment groups showed significant increases in Synaptophysin, vascular density and perimeter compared to the control group (p<0.05). There was no statistically significant difference between a single and multiple injections of hUTC or between the two groups of multiple injections in all immunohistochemical measurements (p>0.1). Conclusion: hUTC treatment significantly improves long term functional outcome after stroke and promotes vascular density and synaptic plasticity. At the proscribed doses, multiple injections of hUTC were not superior to single injection therapy in both functional outcome and histological assessments.	[Shehadah, Amjad; Chen, Jieli; Zacharek, Alex; Cui, Yisheng; Roberts, Cynthia; Chopp, Michael] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Kramer, Brian] Adv Technol & Regenerat Med LLC, Somerville, NJ USA; [Lu, Mei] Henry Ford Hosp, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Oakland University	Chen, JL (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	jieli@neuro.hfh.edu		Shehadah, Amjad/0000-0001-8679-3774	Advanced Technologies and Regenerative Medicine, LLC, Somerville, NJ, USA; Advanced Technologies and Regenerative Medicine	Advanced Technologies and Regenerative Medicine, LLC, Somerville, NJ, USA; Advanced Technologies and Regenerative Medicine	This work was funded by Advanced Technologies and Regenerative Medicine, LLC, Somerville, NJ 08876, USA. The funders had no role in study design, data collection, analysis or preparation of the manuscript. Study design and decision to publish were approved by the funders.; The authors declare that one of our co-authors, Brian Kramer PhD, is an employee of Advanced Technologies and Regenerative Medicine, the commercial funder of the study. This affiliation does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The authors do not have any other declarations related to patents, products in development or marketed products.	Alder J, 2012, DEV NEUROBIOL, V72, P755, DOI 10.1002/dneu.20980; BARTH TM, 1990, STROKE, V21, P153; Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62; Bohotin Catalina Roxana, 2004, Rom J Physiol, V41, P99; CABALKA LM, 1990, J COMP NEUROL, V295, P83, DOI 10.1002/cne.902950108; Chen J, 2006, NEUROSCIENCE, V141, P737, DOI 10.1016/j.neuroscience.2006.04.042; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen JL, 2002, J NEUROL SCI, V199, P17, DOI 10.1016/S0022-510X(02)00075-8; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chopp M, 2009, STROKE, V40, pS143, DOI 10.1161/STROKEAHA.108.533141; Cramer SC, 2000, TRENDS NEUROSCI, V23, P265, DOI 10.1016/S0166-2236(00)01562-9; Cramer SC, 1997, STROKE, V28, P2518, DOI 10.1161/01.STR.28.12.2518; Cui X, 2010, STROKE, V41, P2044, DOI 10.1161/STROKEAHA.110.589333; GARCIA JH, 1971, ACTA NEUROPATHOL, V18, P273, DOI 10.1007/BF00688441; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kolb B, 1999, CAN J EXP PSYCHOL, V53, P62, DOI 10.1037/h0087300; KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; MASLIAH E, 1991, EXP NEUROL, V113, P131, DOI 10.1016/0014-4886(91)90169-D; MASLIAH E, 1989, NEUROSCI LETT, V103, P234, DOI 10.1016/0304-3940(89)90582-X; MASLIAH E, 1990, J HISTOCHEM CYTOCHEM, V38, P837, DOI 10.1177/38.6.2110586; Mochizuki N, 2008, EXP NEUROL, V211, P194, DOI 10.1016/j.expneurol.2008.01.027; Nudo RJ, 2001, MUSCLE NERVE, V24, P1000, DOI 10.1002/mus.1104; Omori Y, 2008, BRAIN RES, V1236, P30, DOI 10.1016/j.brainres.2008.07.116; Pratt Phillip F, 2004, Curr Opin Investig Drugs, V5, P952; Rempe DA, 2002, NEUROLOGY, V59, P486, DOI 10.1212/WNL.59.4.486; SCHALLERT T, 1984, BEHAV NEUROSCI, V98, P518; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Stroemer RP, 1998, STROKE, V29, P2381, DOI 10.1161/01.STR.29.11.2381; Sun JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024529; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Takahashi K, 2008, BRAIN RES, V1234, P172, DOI 10.1016/j.brainres.2008.07.086; Ujike H, 2002, ANN NY ACAD SCI, V965, P55; Yoon YS, 2005, BIOL CELL, V97, P253, DOI 10.1042/BC20040099; Zacharek A, 2010, STROKE, V41, P524, DOI 10.1161/STROKEAHA.109.568881; Zacharek A, 2009, STROKE, V40, P254, DOI 10.1161/STROKEAHA.108.524116; Zhang L, 2011, STROKE, V42, P1437, DOI 10.1161/STROKEAHA.110.593129; Zhang Y, 2011, CARDIOVASC PATHOL, V20, P204, DOI [10.1016/j.carpath.2010.06.007, 10.1088/1674-1056/20/11/110204]; Zhang ZG, 2002, J CEREBR BLOOD F MET, V22, P379, DOI 10.1097/00004647-200204000-00002; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4; Zhao LR, 2002, EXP NEUROL, V174, P11, DOI 10.1006/exnr.2001.7853	47	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54083	10.1371/journal.pone.0054083	http://dx.doi.org/10.1371/journal.pone.0054083			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342081	gold, Green Published, Green Submitted			2022-12-25	WOS:000314759400119
J	Wall, JD; Kim, SK; Luca, F; Carbone, L; Mootnick, AR; de Jong, PJ; Di Rienzo, A				Wall, Jeffrey D.; Kim, Sung K.; Luca, Francesca; Carbone, Lucia; Mootnick, Alan R.; de Jong, Pieter J.; Di Rienzo, Anna			Incomplete Lineage Sorting Is Common in Extant Gibbon Genera	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; DIVERGENCE; HOMINOIDS; EVOLUTION	We sequenced reduced representation libraries by means of Illumina technology to generate over 1.5 Mb of orthologous sequence from a representative of each of the four extant gibbon genera (Nomascus, Hylobates, Symphalangus, and Hoolock). We used these data to assess the evolutionary relationships between the genera by evaluating the likelihoods of all possible bifurcating trees involving the four taxa. Our analyses provide weak support for a tree with Nomascus and Hylobates as sister taxa and with Hoolock and Symphalangus as sister taxa, though bootstrap resampling suggests that other phylogenetic scenarios are also possible. This uncertainty is due to short internal branch lengths and extensive incomplete lineage sorting across taxa. The true phylogenetic relationships among gibbon genera will likely require a more extensive whole-genome sequence analysis.	[Wall, Jeffrey D.; Kim, Sung K.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Wall, Jeffrey D.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Luca, Francesca; Di Rienzo, Anna] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Carbone, Lucia] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Mootnick, Alan R.] Gibbon Conservat Ctr, Santa Clarita, CA USA; [de Jong, Pieter J.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Chicago; Oregon Health & Science University; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Wall, JD (corresponding author), Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA.	wallj@humgen.ucsf.edu	Luca, Francesca/B-4850-2019	Luca, Francesca/0000-0001-8252-9052; Di Rienzo, Anna/0000-0002-8982-9098	National Institutes of Health (NIH) [R01 HG005226, R01 GM079558]; NIH [OD011092]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079558] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (NIH) grants R01 HG005226 to JDW and R01 GM079558 to ADR. LC was supported in part by NIH grant OD011092. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; Chatterjee HJ, 2006, INT J PRIMATOL, V27, P699, DOI 10.1007/s10764-006-9044-1; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; Fischer A, 2006, CURR BIOL, V16, P1133, DOI 10.1016/j.cub.2006.04.033; Geissmann T, 2002, EVOL ANTHROPOL, V11, P28, DOI 10.1002/evan.10047; Groves C.P., 1972, P1; HAIMOFF EH, 1982, FOLIA PRIMATOL, V39, P213, DOI 10.1159/000156079; Hobolth A, 2011, GENOME RES, V21, P349, DOI 10.1101/gr.114751.110; Israfil H, 2011, MOL PHYLOGENET EVOL, V58, P447, DOI 10.1016/j.ympev.2010.11.005; Kim SK, 2011, MOL BIOL EVOL, V28, P2211, DOI 10.1093/molbev/msr033; Locke DP, 2011, NATURE, V469, P529, DOI 10.1038/nature09687; Luca F, 2011, GENOME RES, V21, P1087, DOI 10.1101/gr.119792.110; Matsudaira K, 2010, MOL PHYLOGENET EVOL, V55, P454, DOI 10.1016/j.ympev.2010.01.032; Meyer TJ, 2012, MOL BIOL EVOL, V29, P3441, DOI 10.1093/molbev/mss149; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Muller S, 2003, HUM GENET, V113, P493, DOI 10.1007/s00439-003-0997-2; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Roos C, 2001, MOL PHYLOGENET EVOL, V19, P486, DOI 10.1006/mpev.2001.0939; Ruvolo M, 1997, MOL BIOL EVOL, V14, P248, DOI 10.1093/oxfordjournals.molbev.a025761; Satta Y, 2000, MOL PHYLOGENET EVOL, V14, P259, DOI 10.1006/mpev.2000.0704; Takacs Z, 2005, MOL PHYLOGENET EVOL, V36, P456, DOI 10.1016/j.ympev.2005.03.032; Thinh VN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-74; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; ZEHR SM, 1999, THESIS HARVARD U	28	12	13	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53682	10.1371/journal.pone.0053682	http://dx.doi.org/10.1371/journal.pone.0053682			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341974	gold, Green Published, Green Submitted			2022-12-25	WOS:000314759400065
J	Walsh, AM; Sweeney, T; Bahar, B; O'Doherty, JV				Walsh, Ann M.; Sweeney, Torres; Bahar, Bojlul; O'Doherty, John V.			Multi-Functional Roles of Chitosan as a Potential Protective Agent against Obesity	PLOS ONE			English	Article							HIGH-FAT DIET; ADIPOSE-TISSUE; GASTROINTESTINAL-TRACT; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; PROTEOME ANALYSIS; CHITIN-CHITOSAN; WEIGHT-LOSS; OB/OB MICE; INFLAMMATION	Chitosan, a natural polysaccharide comprising copolymers of glucosamine and N-acetylglucosamine, has been shown to have anti-obesity properties. Two experiments (Exp. 1 and Exp. 2) were performed to determine the role of chitosan on dietary intake, body weight gain, and fat deposition in a pig model, as well as identifying potential mechanisms underlying the anti-obesity effect of chitosan. In Exp. 1, the nutrient digestibility experiment, 16 pigs (n = 4/treatment) were randomly allocated to one of four dietary treatments as follows: 1) basal diet; 2) basal diet plus 300 ppm chitosan; 3) basal diet plus 600 ppm chitosan; 4) basal diet plus 1200 ppm chitosan. The main observation was that crude fat digestibility was lower in the 1200 ppm chitosan group when compared with the control group (P<0.05). In Exp. 2, a total of 80 pigs (n = 20/treatment) were offered identical dietary treatments to that offered to animals in Exp. 1. Blood samples were collected on day 0, day 35 and at the end of the experiment (day 57). Animals offered diets containing 1200 ppm chitosan had a lower daily dietary intake (P<0.001) and body weight gain (P<0.001) from day 35 to 57 when compared with all the other treatment groups. Animals offered diets containing 1200 ppm chitosan had a significantly lower final body weight (P<0.01) when compared with all the other treatment groups. The decreased dietary intake observed in the 1200 ppm chitosan group was associated with increased serum leptin concentrations (P<0.001) and a decrease in serum C-reactive protein (CRP) concentrations (P<0.05). In conclusion, the results of this study highlight novel endocrine mechanisms involving the modulation of serum leptin and CRP concentrations by which chitosan exhibits anti-obesity properties in vivo.	[Walsh, Ann M.; Bahar, Bojlul; O'Doherty, John V.] Univ Coll Dublin, Sch Agr & Food Sci, Lyons Res Farm, Newcastle, Co Dublin, Ireland; [Sweeney, Torres; Bahar, Bojlul] Univ Coll Dublin, Sch Vet Med, Belfield, Co Dublin, Ireland	University College Dublin; University College Dublin	O'Doherty, JV (corresponding author), Univ Coll Dublin, Sch Agr & Food Sci, Lyons Res Farm, Newcastle, Co Dublin, Ireland.	john.vodoherty@ucd.ie	O'Doherty, John/AAS-7261-2021	O'Doherty, John/0000-0002-0906-4065; Sweeney, Torres/0000-0003-2639-395X	Marine Functional Food Research Consortium (NutraMara); Marine Institute; Department of Agriculture, Fisheries and Food, Agriculture House, Co. Dublin, Ireland	Marine Functional Food Research Consortium (NutraMara); Marine Institute; Department of Agriculture, Fisheries and Food, Agriculture House, Co. Dublin, Ireland	Funding for this research was provided under the Marine Functional Food Research Consortium (NutraMara) by the Marine Institute and the Department of Agriculture, Fisheries and Food, Agriculture House, Co. Dublin, Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, OFFICIAL J EUROPEA L, VL257/23; Antuna-Puente B, 2008, DIABETES METAB, V34, P2, DOI 10.1016/j.diabet.2007.09.004; Bahar B, 2011, BRIT J NUTR, V106, P1142, DOI 10.1017/S0007114511001486; Baldrick P, 2010, REGUL TOXICOL PHARM, V56, P290, DOI 10.1016/j.yrtph.2009.09.015; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bray GA, 2000, NUTRITION, V16, P953, DOI 10.1016/S0899-9007(00)00424-X; Candek-Potokar M, 1998, MEAT SCI, V48, P287, DOI 10.1016/S0309-1740(97)00109-5; CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286; CLOSE WH, 1994, PRINCIPLES OF PIG SCIENCE, P123; Coleman RA, 1999, DIABETOLOGIA, V42, P639, DOI 10.1007/s001250051210; Considine RV, 2000, J CLIN ENDOCR METAB, V85, P3551, DOI 10.1210/jc.85.10.3551; DEUCHI K, 1995, BIOSCI BIOTECH BIOCH, V59, P781, DOI 10.1271/bbb.59.781; Egras AM, 2011, J OBES, V2011, P297; Gades MD, 2003, OBES RES, V11, P683, DOI 10.1038/oby.2003.97; Han LK, 1999, INT J OBESITY, V23, P174, DOI 10.1038/sj.ijo.0800806; Heilbronn LK, 2001, ARTERIOSCL THROM VAS, V21, P968, DOI 10.1161/01.ATV.21.6.968; HIRANO S, 1995, J SCI FOOD AGR, V69, P91, DOI 10.1002/jsfa.2740690114; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Koide SS, 1998, NUTR RES, V18, P1091, DOI 10.1016/S0271-5317(98)00091-8; Kumar SG, 2009, PROTEOMICS, V9, P2149, DOI 10.1002/pmic.200800571; Latorre MA, 2004, J ANIM SCI, V82, P526; Lau DCW, 2005, AM J PHYSIOL-HEART C, V288, pH2031, DOI 10.1152/ajpheart.01058.2004; Lee KY, 2004, FOOD CHEM TOXICOL, V42, P687, DOI 10.1016/j.fct.2003.12.005; Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Maachi M, 2004, INT J OBESITY, V28, P993, DOI 10.1038/sj.ijo.0802718; MARSHALL S, 1991, FASEB J, V5, P3031, DOI 10.1096/fasebj.5.15.1743436; Mozes S, 2008, FOLIA MICROBIOL, V53, P225, DOI 10.1007/s12223-008-0031-0; NRC, 1998, NUTR REQ SWIN, DOI [10.17226/6016, DOI 10.17226/6016]; O'Shea CJ, 2011, J ANIM SCI, V89, P1366, DOI 10.2527/jas.2010-2922; Papanicolaou DA, 1998, ANN INTERN MED, V128, P127, DOI 10.7326/0003-4819-128-2-199801150-00009; Pedron T, 2008, CELL HOST MICROBE, V3, P344, DOI 10.1016/j.chom.2008.05.010; Rahman MA, 2010, BIOTECHNOL BIOPROC E, V15, P559, DOI 10.1007/s12257-009-3135-8; Santacruz A, 2009, OBESITY, V17, P1906, DOI 10.1038/oby.2009.112; SAS, 2004, SAS US GUID 9 1 2; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Sumiyoshi M, 2006, J PHARM PHARMACOL, V58, P201, DOI 10.1211/jpp.58.2.0007; Tan B, 2009, AMINO ACIDS, V37, P169, DOI 10.1007/s00726-008-0148-0; Thanou M, 2001, ADV DRUG DELIVER REV, V52, P117, DOI 10.1016/S0169-409X(01)00231-9; Tran G., 2004, TABLE COMPOSITION NU, V1st ed.; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Varley PF, 2011, LIVEST SCI, V135, P282, DOI 10.1016/j.livsci.2010.07.025; Yun JW, 2010, PHYTOCHEMISTRY, V71, P1625, DOI 10.1016/j.phytochem.2010.07.011; Zeng LT, 2008, CARBOHYD POLYM, V71, P435, DOI 10.1016/j.carbpol.2007.06.016; Zhang JL, 2008, NUTR RES, V28, P383, DOI 10.1016/j.nutres.2007.12.013	47	46	46	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53828	10.1371/journal.pone.0053828	http://dx.doi.org/10.1371/journal.pone.0053828			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342013	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400090
J	Dai, J; Shen, DF; Bian, ZY; Zhou, H; Gan, HW; Zong, J; Deng, W; Yuan, Y; Li, FF; Wu, QQ; Gao, L; Zhang, R; Ma, ZG; Li, HL; Tang, QZ				Dai, Jia; Shen, Di-Fei; Bian, Zhou-Yan; Zhou, Heng; Gan, Hua-Wen; Zong, Jing; Deng, Wei; Yuan, Yuan; Li, FangFang; Wu, Qing-Qing; Gao, Lu; Zhang, Rui; Ma, Zhen-Guo; Li, Hong-Liang; Tang, Qi-Zhu			IKKi Deficiency Promotes Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis	PLOS ONE			English	Article							NF-KAPPA-B; INDUCED CARDIOMYOCYTE HYPERTROPHY; HEART-FAILURE; SIGNALING PATHWAY; PULMONARY INFLAMMATION; TASK-FORCE; TNF-ALPHA; EPSILON; GENE; INVOLVEMENT	The inducible I kappa B kinase (IKKi/IKK epsilon) is a recently described serine-threonine IKK-related kinase. Previous studies have reported the role of IKKi in infectious diseases and cancer. However, its role in the cardiac response to pressure overload remains elusive. In this study, we investigated the effects of IKKi deficiency on the development of pathological cardiac hypertrophy using in vitro and in vivo models. First, we developed mouse models of pressure overload cardiac hypertrophy induced by pressure overload using aortic banding (AB). Four weeks after AB, cardiac function was then assessed through echocardiographic and hemodynamic measurements. Western blotting, real-time PCR and histological analyses were used to assess the pathological and molecular mechanisms. We observed that IKKi-deficient mice showed significantly enhanced cardiac hypertrophy, cardiac dysfunction, apoptosis and fibrosis compared with WT mice. Furthermore, we recently revealed that the IKKi-deficient mice spontaneously develop cardiac hypertrophy. Moreover, in vivo experiments showed that IKKi deficiency-induced cardiac hypertrophy was associated with the activation of the AKT and NF-kappa B signaling pathway in response to AB. In cultured cells, IKKi overexpression suppressed the activation of this pathway. In conclusion, we demonstrate that IKKi deficiency exacerbates cardiac hypertrophy by regulating the AKT and NF-kappa B signaling pathway.	[Dai, Jia; Shen, Di-Fei; Bian, Zhou-Yan; Zhou, Heng; Gan, Hua-Wen; Zong, Jing; Deng, Wei; Yuan, Yuan; Li, FangFang; Wu, Qing-Qing; Zhang, Rui; Ma, Zhen-Guo; Li, Hong-Liang; Tang, Qi-Zhu] Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430072, Peoples R China; [Dai, Jia; Shen, Di-Fei; Bian, Zhou-Yan; Zhou, Heng; Gan, Hua-Wen; Zong, Jing; Deng, Wei; Yuan, Yuan; Li, FangFang; Wu, Qing-Qing; Zhang, Rui; Ma, Zhen-Guo; Li, Hong-Liang; Tang, Qi-Zhu] Wuhan Univ, Cardiovasc Res Inst, Wuhan 430072, Peoples R China; [Gao, Lu] Huazhong Univ Sci & Technol, Dept Cardiol, Inst Cardiovasc Dis, Union Hosp,Tongji Med Coll, Wuhan 430074, Peoples R China	Wuhan University; Wuhan University; Huazhong University of Science & Technology	Tang, QZ (corresponding author), Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430072, Peoples R China.	qztang@whu.edu.cn			National Natural Science Foundation of China [30901628, 81000036]; Fundamental Research Funds for the Central Universities of China [201130202020007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This research was supported by the National Natural Science Foundation of China (30901628 and 81000036) (http://www.nsfc.gov.cn/Portal0/default106.htm) and the Fundamental Research Funds for the Central Universities of China (No. 201130202020007) (http://www.gs.whu.edu.cn/newscenter/Readews.asp?NewsID=728). The funders had the role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anilkumar N, 2009, FRONT BIOSCI-LANDMRK, V14, P3168, DOI 10.2741/3443; Bian ZY, 2012, J MOL MED BERL; Bulek K, 2011, NAT IMMUNOL, V12, P844, DOI 10.1038/ni.2080; Chau TL, 2008, TRENDS BIOCHEM SCI, V33, P171, DOI 10.1016/j.tibs.2008.01.002; De Boer RA, 2003, MICROCIRCULATION, V10, P113, DOI 10.1038/sj.mn.7800188; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gaspar-Pereira S, 2012, AM J PATHOL, V180, P929, DOI 10.1016/j.ajpath.2011.11.007; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Higuchi Y, 2006, AM J PHYSIOL-HEART C, V290, pH590, DOI 10.1152/ajpheart.00379.2005; Higuchi Y, 2002, J MOL CELL CARDIOL, V34, P233, DOI 10.1006/jmcc.2001.1505; Hikoso S, 2009, CIRC RES, V105, P70, DOI 10.1161/CIRCRESAHA.108.193318; Hirotani S, 2002, CIRCULATION, V105, P509, DOI 10.1161/hc0402.102863; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Iemitsu M, 2001, AM J PHYSIOL-REG I, V281, pR2029, DOI 10.1152/ajpregu.2001.281.6.R2029; Joung SM, 2011, J IMMUNOL, V186, P499, DOI 10.4049/jimmunol.0903534; Koop A, 2011, EUR J IMMUNOL, V41, P224, DOI 10.1002/eji.201040814; Kravchenko VV, 2003, J BIOL CHEM, V278, P26612, DOI 10.1074/jbc.M303001200; Li HL, 2010, P NATL ACAD SCI USA, V107, P13818, DOI 10.1073/pnas.1008397107; Liu QH, 2012, CIRC RES, V110, P1077, DOI 10.1161/CIRCRESAHA.111.260729; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Pazos-Lopez P, 2011, VASC HEALTH RISK MAN, V7, P237, DOI 10.2147/VHRM.S10669; Peant B, 2011, PROSTATE, V71, P1131, DOI 10.1002/pros.21329; Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1; Sambandam N, 2004, EUR J BIOCHEM, V271, P2831, DOI 10.1111/j.1432-1033.2004.04218.x; Shembade N, 2011, CELL MOL IMMUNOL, V8, P447, DOI 10.1038/cmi.2011.44; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; Sun HZ, 2010, J ENDOCRINOL, V204, P311, DOI 10.1677/JOE-09-0270; Tamargo J, 2011, NAT REV DRUG DISCOV, V10, P536, DOI 10.1038/nrd3431; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Wang NZ, 2005, GENE, V353, P118, DOI 10.1016/j.gene.2005.04.013; Yamazaki T, 2012, HYPERTENS RES, V35, P34, DOI 10.1038/hr.2011.139; Yan L, 2011, CARDIOVASC RES, V92, P85, DOI 10.1093/cvr/cvr159; Zelarayan L, 2009, CARDIOVASC RES, V84, P416, DOI 10.1093/cvr/cvp237; Zhou H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026744	38	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53412	10.1371/journal.pone.0053412	http://dx.doi.org/10.1371/journal.pone.0053412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349709	gold, Green Published, Green Submitted			2022-12-25	WOS:000314019100020
J	Wang, NK; Lai, CC; Chou, CL; Chen, YP; Chuang, LH; Chao, AN; Tseng, HJ; Chang, CJ; Wu, WC; Chen, KJ; Tsang, SH				Wang, Nan-Kai; Lai, Chi-Chun; Chou, Chai Lin; Chen, Yen-Po; Chuang, Lan-Hsin; Chao, An-Ning; Tseng, Hsiao-Jung; Chang, Chee-Jen; Wu, Wei-Chi; Chen, Kuan-Jen; Tsang, Stephen H.			Choroidal Thickness and Biometric Markers for the Screening of Lacquer Cracks in Patients with High Myopia	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGICAL MYOPIA; VISUAL IMPAIRMENT; PREVALENCE; NEOVASCULARIZATION; EYE; POPULATION; BLINDNESS; REPRODUCIBILITY; PROGRESSION	Objective: Validation of choroidal thickness and other biometrics measured by spectral domain optical coherence tomography (SD-OCT) in predicting lacquer cracks formation in highly myopic eyes. Methods: Patients with a refractive error worse than -8 diopters and moderate myopic maculopathy were recruited into two groups based on the presence or absence of lacquer cracks (36 eyes without and 33 eyes with lacquer cracks). Choroidal thickness, refractive error, and axial length were measured and subjected to receiver operating characteristic curve analysis to identify the optimal cutoff values at predicting lacquer crack formation. The width of the retinal pigment epithelium (RPE), RPE to the inner segment/outer segment line, RPE to the external limiting membrane were also measured and compared to the subfoveal choroidal thickness to assess their relationships as potential markers of lacquer crack formation. Results: Lacquer crack is associated with decreased choroidal thickness, lower best-corrected visual acuity, longer axial length and higher refractive errors. Choroidal thickness has the strongest association with lacquer crack formation versus axial length and refractive error. In eyes with lacquer cracks, stellate lacquer cracks are associated with thinner choroidal thickness compared to eyes with linear lacquer cracks. Subfoveal choroidal thickness less than the width of the retinal pigment epithelium to the inner segment/outer segment line is also associated with lacquer crack formation (sensitivity 78.8%, specificity 88.3%, and accuracy 81.2%). Conclusions: This study suggests that choroidal thickness and other SD-OCT measurements could be employed clinically to predict the development and severity of lacquer cracks in patients with high myopia.	[Wang, Nan-Kai; Lai, Chi-Chun; Chen, Yen-Po; Chuang, Lan-Hsin; Chao, An-Ning; Wu, Wei-Chi; Chen, Kuan-Jen] Chang Gung Univ, Coll Med, Dept Med, Tao Yuan, Taiwan; [Wang, Nan-Kai; Lai, Chi-Chun; Chen, Yen-Po; Chao, An-Ning; Wu, Wei-Chi; Chen, Kuan-Jen] Chang Gung Mem Hosp, Dept Ophthalmol, Linkuo Med Ctr, Tao Yuan, Taiwan; [Chou, Chai Lin] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Chuang, Lan-Hsin] Chang Gung Mem Hosp, Dept Ophthalmol, Keelung, Taiwan; [Tseng, Hsiao-Jung; Chang, Chee-Jen] Chang Gung Mem Hosp, Biostat Ctr Clin Res, Tao Yuan, Taiwan; Chang Gung Univ, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Chang, Chee-Jen] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Tao Yuan, Taiwan; [Tsang, Stephen H.] Columbia Univ, Bernard & Shirlee Brown Glaucoma Lab, Dept Pathol & Cell Biol, New York, NY USA; [Tsang, Stephen H.] Columbia Univ, Edward S Harkness Eye Inst, New York, NY USA	Chang Gung University; Chang Gung Memorial Hospital; University of British Columbia; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Columbia University; Columbia University	Wang, NK (corresponding author), Chang Gung Univ, Coll Med, Dept Med, Tao Yuan, Taiwan.	wang.nankai@gmail.com	Wang, Nan-Kai/AAO-6559-2020; Wang, Nan-Kai/D-6608-2011; Chou, Chai Lin/C-2331-2008	Wang, Nan-Kai/0000-0002-6277-9879; Wang, Nan-Kai/0000-0002-6277-9879; Chou, Chai Lin/0000-0003-4754-0488; Lai, Chi-Chun/0000-0001-9547-7212; Chao, An-Ning/0000-0002-4761-9244; Chang, Chee Jen/0000-0002-7725-7555; Chen, Kuan-Jen/0000-0002-4994-8391	Taiwan National Science Council, Taiwan [NSC-99-2314-B-182A-029-MY3]; Chang Gung Memorial Hospital, Linkou, Taiwan [381561similar to381563, 391801similar to391802]; National Eye Institute/National Institutes of Health (Bethesda, Maryland) [EY018213, P30EY019007]; Research to Prevent Blindness (New York, New York); NATIONAL EYE INSTITUTE [P30EY019007, R01EY018213] Funding Source: NIH RePORTER	Taiwan National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Linkou, Taiwan(Chang Gung Memorial Hospital); National Eye Institute/National Institutes of Health (Bethesda, Maryland)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness (New York, New York)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported in part by research grant NSC-99-2314-B-182A-029-MY3 from the Taiwan National Science Council, Taiwan, and CMRPG 381561 similar to 381563 and 391801 similar to 391802 from Chang Gung Memorial Hospital, Linkou, Taiwan, National Eye Institute/National Institutes of Health (Bethesda, Maryland) EY018213 (SHT), P30EY019007 (Core Support for Vision Research; Columbia University), Foundation Fighting Blindness (Owings Mills, Maryland), and unrestricted funds from Research to Prevent Blindness (New York, New York). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVILA MP, 1984, OPHTHALMOLOGY, V91, P1573; Axer-Siegez R, 2004, OPHTHAL SURG LAS IM, V35, P139, DOI 10.3928/1542-8877-20040301-09; Branchini L, 2012, OPHTHALMOLOGY, V119, P119, DOI 10.1016/j.ophtha.2011.07.002; Curtin BJ, 1971, AM J OPHTHALMOL, V1, P42; Fujiwara T, 2009, AM J OPHTHALMOL, V148, P445, DOI 10.1016/j.ajo.2009.04.029; Hayashi K, 2010, OPHTHALMOLOGY, V117, P1595, DOI 10.1016/j.ophtha.2009.11.003; Hsu WM, 2004, OPHTHALMOLOGY, V111, P62, DOI 10.1016/j.ophtha.2003.05.011; Ikuno Y, 2008, RETINA-J RET VIT DIS, V28, P1124, DOI 10.1097/IAE.0b013e318174417a; Ikuno Y, 2010, INVEST OPHTH VIS SCI, V51, P2173, DOI 10.1167/iovs.09-4383; Ikuno Y, 2009, INVEST OPHTH VIS SCI, V50, P3876, DOI 10.1167/iovs.08-3325; Iwase A, 2006, OPHTHALMOLOGY, V113, P1354, DOI 10.1016/j.ophtha.2006.04.022; Johnson DA, 1998, RETINA-J RET VIT DIS, V18, P118, DOI 10.1097/00006982-199818020-00004; KLEIN RM, 1975, AM J OPHTHALMOL, V79, P386, DOI 10.1016/0002-9394(75)90611-X; Leske MC, 2002, OPHTHALMOLOGY, V109, P1303, DOI 10.1016/S0161-6420(02)01094-1; Lim R, 1999, INVEST OPHTH VIS SCI, V40, P3021; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Lin LLK, 2004, ANN ACAD MED SINGAP, V33, P27; Liu J H, 2001, Ophthalmic Epidemiol, V8, P339; Michon JJ, 2002, BRIT J OPHTHALMOL, V86, P133, DOI 10.1136/bjo.86.2.133; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Ohno-Matsui K, 2003, BRIT J OPHTHALMOL, V87, P570, DOI 10.1136/bjo.87.5.570; Ohno-Matsui K, 1998, JPN J OPHTHALMOL, V42, P293, DOI 10.1016/S0021-5155(98)00008-2; OhnoMatsui K, 1996, RETINA-J RET VIT DIS, V16, P29, DOI 10.1097/00006982-199616010-00006; Quaranta M, 1996, AM J OPHTHALMOL, V122, P663, DOI 10.1016/S0002-9394(14)70484-2; RABB M F, 1981, International Ophthalmology Clinics, V21, P51, DOI 10.1097/00004397-198102130-00006; Salzmann M, 1902, ARCH OPHTHALMOL-CHIC, V31, P41; Sato A, 2010, BRIT J OPHTHALMOL, V94, P1624, DOI 10.1136/bjo.2009.165472; Soubrane G CG, 2005, RETINA, P1136; Tokoro T., 1998, ATLAS POSTERIOR FUND; Vongphanit J, 2002, OPHTHALMOLOGY, V109, P704, DOI 10.1016/S0161-6420(01)01024-7; Wang NK, 2012, AM J OPHTHALMOL, V153, P669, DOI 10.1016/j.ajo.2011.08.039; Wong TY, 2001, INVEST OPHTH VIS SCI, V42, P1449; Xu L, 2006, OPHTHALMOLOGY, V113, P1134, DOI 10.1016/j.ophtha.2006.01.035	33	46	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53660	10.1371/journal.pone.0053660	http://dx.doi.org/10.1371/journal.pone.0053660			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349728	Green Published, gold, Green Submitted			2022-12-25	WOS:000314019100025
J	Chan, YS; Ng, TB				Chan, Yau Sang; Ng, Tzi Bun			A Lectin with Highly Potent Inhibitory Activity toward Breast Cancer Cells from Edible Tubers of Dioscorea opposita cv. Nagaimo	PLOS ONE			English	Article							MANNOSE-BINDING LECTIN; FRENCH BEAN LEGUMES; ANTIFUNGAL ACTIVITY; PLANT-LECTINS; ANTITUMOR; PURIFICATION; PROTEINS; HEMAGGLUTININ; APOPTOSIS; GALECTINS	A 70-kDa galactose-specific lectin was purified from the tubers of Dioscorea opposita cv. nagaimo. The purification involved three chromatographic steps: anion exchange chromatography on a Q-Sepharose column, FPLC-anion exchange chromatography on a Mono Q column, and FPLC-gel filtration on a Superdex 75 column. The purified nagaimo lectin presented as a single 35-kDa band in reducing SDS-PAGE while it exhibited a 70-kDa single band in non-reducing SDS-PAGE suggesting its dimeric nature. Nagaimo lectin displayed moderate thermostability, retaining full hemagglutinating activity after heating up to 62 degrees C for 30 minutes. It also manifested stability over a wide pH range from pH 2 to 13. Nagaimo lectin was a galactose-specific lectin, as evidenced by binding with galactose and galactose-containing sugars such as lactose and raffinose. The minimum concentration of galactose, lactose and raffinose required to exert an inhibitory effect on hemagglutinating activity of nagaimo lectin was 20 mM, 5 mM and 40 mM, respectively. Nagaimo lectin inhibited the growth of some cancer cell lines including breast cancer MCF7 cells, hepatoma HepG2 cells and nasopharyngeal carcinoma CNE2 cells, with IC50 values of 3.71 mu M, 7.12 mu M and 19.79 mu M, respectively, after 24 hour treatment with nagaimo lectin. The induction of phosphatidylserine externalization and mitochondrial depolarization indicated that nagaimo lectin evoked apoptosis in MCF7 cells. However, the anti-proliferative activity of nagaimo lectin was not blocked by application of galactose, signifying that the activity was not related to the carbohydrate binding specificity of the lectin.	[Chan, Yau Sang; Ng, Tzi Bun] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong	Ng, TB (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.	b021770@mailserv.cuhk.edu.hk						Amano K, 2012, BIOSCI BIOTECH BIOCH, V76, P967, DOI 10.1271/bbb.110982; Angata T, 2002, BBA-GEN SUBJECTS, V1572, P294, DOI 10.1016/S0304-4165(02)00316-1; Ashraf GM, 2011, PROTEIN J, V30, P39, DOI 10.1007/s10930-010-9300-2; Bhandari MR, 2005, PLANT FOOD HUM NUTR, V60, P129, DOI 10.1007/s11130-005-6841-1; Cardoso MRD, 2011, VACCINE, V29, P9183, DOI 10.1016/j.vaccine.2011.09.136; Carvalho FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027892; EDMAN P, 1950, ACTA CHEM SCAND, V4, P283, DOI 10.3891/acta.chem.scand.04-0283; Ellgaard L, 2003, CELL BIOCHEM BIOPHYS, V39, P223, DOI 10.1385/CBB:39:3:223; Fang EF, 2011, CURR MED CHEM, V18, P4410; Fang EF, 2010, J AGR FOOD CHEM, V58, P2221, DOI 10.1021/jf903964u; Feng L, 2010, FASEB J, V24, P3861, DOI 10.1096/fj.10-159111; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Fu LL, 2011, INT J BIOCHEM CELL B, V43, P1442, DOI 10.1016/j.biocel.2011.07.004; Gaidamashvili M, 2004, J BIOL CHEM, V279, P26028, DOI 10.1074/jbc.M402139200; Guo SC, 2011, BBA-REV CANCER, V1815, P197, DOI 10.1016/j.bbcan.2010.12.002; He XC, 2011, FISH SHELLFISH IMMUN, V31, P1247, DOI 10.1016/j.fsi.2011.08.021; Hsu HC, 1999, BIOCHEM J, V323, P557; Kaur M, 2006, ARCH BIOCHEM BIOPHYS, V445, P156, DOI 10.1016/j.abb.2005.10.021; Kheeree N, 2010, APPL BIOCHEM BIOTECH, V162, P912, DOI 10.1007/s12010-009-8804-8; Kobayashi T, 2010, LEUKEMIA, V24, P843, DOI 10.1038/leu.2010.25; KOIKE T, 1995, J BIOCHEM-TOKYO, V118, P1205, DOI 10.1093/oxfordjournals.jbchem.a125008; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; Lam SK, 2010, BIOSCIENCE REP, V30, P307, DOI 10.1042/BSR20090059; Lannoo N, 2010, BBA-GEN SUBJECTS, V1800, P190, DOI 10.1016/j.bbagen.2009.07.021; Lee CH, 2009, INT IMMUNOPHARMACOL, V9, P1555, DOI 10.1016/j.intimp.2009.09.011; Li T, 2010, ACTA BIOCH BIOPH SIN, V44, P606; McAnuff MA, 2005, PLANT FOOD HUM NUTR, V60, P93, DOI 10.1007/s11130-005-5105-0; Naeem A, 2007, BIOCHEMISTRY-MOSCOW+, V72, P44, DOI 10.1134/S0006297907010051; Nakagawa R, 1996, BIOSCI BIOTECH BIOCH, V60, P259, DOI 10.1271/bbb.60.259; Nawrot R, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-78; Ohizumi Y, 2009, J AGR FOOD CHEM, V57, P2896, DOI 10.1021/jf8040269; Ola MS, 2007, CELL BIOL INT, V31, P578, DOI 10.1016/j.cellbi.2006.11.032; Omokawa Y, 2010, INT J PHARMACEUT, V389, P157, DOI 10.1016/j.ijpharm.2010.01.033; Peumans WJ, 1998, CRIT REV BIOCHEM MOL, V33, P209; Poon TYC, 2011, J DIABETES, V3, P184, DOI 10.1111/j.1753-0407.2011.00130.x; Saekoo J, 2010, J MED ASS THAI S7, V93, P277; Salatino M, 2011, METHODS MOL BIOL, V677, P355, DOI 10.1007/978-1-60761-869-0_23; Sharma A, 2010, PROTEIN PEPTIDE LETT, V17, P221, DOI 10.2174/092986610790226067; She QB, 1998, BIOCHEM BIOPH RES CO, V247, P106, DOI 10.1006/bbrc.1998.8744; Shewry PR, 2003, ANN BOT-LONDON, V91, P755, DOI 10.1093/aob/mcg084; Subramanyam S, 2008, PLANT PHYSIOL, V147, P1412, DOI 10.1104/pp.108.116145; Toledo RG, 2010, MOL IMMUNOL, V48, P26, DOI 10.1016/j.molimm.2010.09.015; Tsivileva OM, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1154, DOI 10.1134/S0006297908100131; Van Damme EJM, 2008, ADV BOT RES, V48, P107, DOI 10.1016/S0065-2296(08)00403-5; Vasta GR, 2012, ADV EXP MED BIOL, V946, P21, DOI 10.1007/978-1-4614-0106-3_2; Wojcikowsi K, 2008, FOOD CHEM TOXICOL, V46, P3122, DOI 10.1016/j.fct.2008.06.090; Wong JH, 2005, ARCH BIOCHEM BIOPHYS, V439, P91, DOI 10.1016/j.abb.2005.05.004; Xia LX, 2006, J CHROMATOGR B, V844, P213, DOI 10.1016/j.jchromb.2006.07.042; Xia LX, 2005, PEPTIDES, V26, P2397, DOI 10.1016/j.peptides.2005.06.003; Xu ZT, 2011, AM J CHINESE MED, V39, P579, DOI 10.1142/S0192415X11009044; Yagi F, 2002, EUR J BIOCHEM, V269, P4335, DOI 10.1046/j.1432-1033.2002.03127.x; Yan QJ, 2009, PHYTOMEDICINE, V16, P586, DOI 10.1016/j.phymed.2008.12.024; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Yang Y, 2011, PHYTOMEDICINE, V18, P748, DOI 10.1016/j.phymed.2010.11.001; Ye XY, 2002, LIFE SCI, V71, P1667, DOI 10.1016/S0024-3205(02)01925-2; Ye XY, 1999, BIOCHEM BIOPH RES CO, V263, P130, DOI 10.1006/bbrc.1999.1166; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	57	29	31	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54212	10.1371/journal.pone.0054212	http://dx.doi.org/10.1371/journal.pone.0054212			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349827	gold, Green Published			2022-12-25	WOS:000313943000030
J	Lim, S; Kawamura, E; Fielding, AB; Maydan, M; Dedhar, S				Lim, Simin; Kawamura, Eiko; Fielding, Andrew B.; Maydan, Mykola; Dedhar, Shoukat			Integrin-Linked Kinase Regulates Interphase and Mitotic Microtubule Dynamics	PLOS ONE			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; PROTEIN-KINASE; CELL-PROLIFERATION; BETA-CATENIN; CANCER-CELLS; INDIVIDUAL MICROTUBULES; SUPPRESSES DYNAMICS; THERAPEUTIC TARGET; VINCA ALKALOIDS; INHIBITION	Integrin-linked kinase (ILK) localizes to both focal adhesions and centrosomes in distinct multiprotein complexes. Its dual function as a kinase and scaffolding protein has been well characterized at focal adhesions, where it regulates integrin-mediated cell adhesion, spreading, migration and signaling. At the centrosomes, ILK regulates mitotic spindle organization and centrosome clustering. Our previous study showed various spindle defects after ILK knockdown or inhibition that suggested alteration in microtubule dynamics. Since ILK expression is frequently elevated in many cancer types, we investigated the effects of ILK overexpression on microtubule dynamics. We show here that overexpressing ILK in HeLa cells was associated with a shorter duration of mitosis and decreased sensitivity to paclitaxel, a chemotherapeutic agent that suppresses microtubule dynamics. Measurement of interphase microtubule dynamics revealed that ILK overexpression favored microtubule depolymerization, suggesting that microtubule destabilization could be the mechanism behind the decreased sensitivity to paclitaxel, which is known to stabilize microtubules. Conversely, the use of a small molecule inhibitor selective against ILK, QLT-0267, resulted in suppressed microtubule dynamics, demonstrating a new mechanism of action for this compound. We further show that treatment of HeLa cells with QLT-0267 resulted in higher inter-centromere tension in aligned chromosomes during mitosis, slower microtubule regrowth after cold depolymerization and the presence of a more stable population of spindle microtubules. These results demonstrate that ILK regulates microtubule dynamics in both interphase and mitotic cells.	[Lim, Simin; Kawamura, Eiko; Fielding, Andrew B.; Maydan, Mykola; Dedhar, Shoukat] British Columbia Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC V5Z 1L3, Canada; [Lim, Simin] Univ British Columbia, Fac Grad Studies, Vancouver, BC V5Z 1M9, Canada; [Fielding, Andrew B.] Univ Liverpool, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England; [Dedhar, Shoukat] Univ British Columbia, Inst Life Sci, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada	British Columbia Cancer Agency; University of British Columbia; University of Liverpool; University of British Columbia	Dedhar, S (corresponding author), British Columbia Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC V5Z 1L3, Canada.	sdedhar@bccrc.ca		Dedhar, Shoukat/0000-0003-4355-1657; Fielding, Andrew/0000-0002-3170-9966	Canadian Institutes of Health Research [199901]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html), grant number: 199901. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Andreassen Paul R, 2004, Methods Mol Biol, V281, P213; Barr AR, 2008, MOL CELL BIOL, V28, P7199, DOI 10.1128/MCB.01040-08; Cassimeris L, 2009, CELL MOTIL CYTOSKEL, V66, P535, DOI 10.1002/cm.20359; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; DHAMODHARAN R, 1995, MOL BIOL CELL, V6, P1215, DOI 10.1091/mbc.6.9.1215; Dobreva I, 2008, J PROTEOME RES, V7, P1740, DOI 10.1021/pr700852r; Fielding AB, 2011, ONCOGENE, V30, P521, DOI 10.1038/onc.2010.431; Fielding AB, 2008, J CELL BIOL, V180, P681, DOI 10.1083/jcb.200710074; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Goncalves A, 2001, P NATL ACAD SCI USA, V98, P11737, DOI 10.1073/pnas.191388598; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Hu LM, 2002, CANCER RES, V62, P1087; Huang P, 2007, ONCOGENE, V26, P4357, DOI 10.1038/sj.onc.1210217; JORDAN MA, 1991, CANCER RES, V51, P2212; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Kalra J, 2011, CANCER BIOL THER, V11, P826, DOI 10.4161/cbt.11.9.15183; Kalra J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2252; Kamath K, 2010, METHOD CELL BIOL, V97, P1, DOI 10.1016/S0091-679X(10)97001-5; Kaplan DD, 2004, J BIOL CHEM, V279, P10829, DOI 10.1074/jbc.C400035200; Kelling J, 2003, CANCER RES, V63, P2794; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Li FG, 1999, J CELL SCI, V112, P4589; Maresca TJ, 2009, J CELL BIOL, V184, P373, DOI 10.1083/jcb.200808130; Maydan M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012356; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; Muranyi AL, 2009, EXP HEMATOL, V37, P450, DOI 10.1016/j.exphem.2009.01.002; Ngan VK, 2001, MOL PHARMACOL, V60, P225, DOI 10.1124/mol.60.1.225; Novak A, 1998, P NATL ACAD SCI USA, V95, P4374, DOI 10.1073/pnas.95.8.4374; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Rowinsky EK, 1997, ANNU REV MED, V48, P353; Troussard AA, 2006, CANCER RES, V66, P393, DOI 10.1158/0008-5472.CAN-05-2304; Waters JC, 1996, J CELL SCI, V109, P2823; WEBSTER DR, 1989, J CELL SCI, V92, P57; Wickstrom SA, 2010, DEV CELL, V19, P574, DOI 10.1016/j.devcel.2010.09.007; WILSON PJ, 1994, J CELL SCI, V107, P3015; Wu CY, 1998, J BIOL CHEM, V273, P528, DOI 10.1074/jbc.273.1.528; Younes MN, 2005, MOL CANCER THER, V4, P1146, DOI 10.1158/1535-7163.MCT-05-0078; Yvon AMC, 1999, MOL BIOL CELL, V10, P947, DOI 10.1091/mbc.10.4.947	41	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e53702	10.1371/journal.pone.0053702	http://dx.doi.org/10.1371/journal.pone.0053702			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349730	Green Submitted, Green Published, gold			2022-12-25	WOS:000313943000016
J	Risse, B; Thomas, S; Otto, N; Lopmeier, T; Valkov, D; Jiang, XY; Klambt, C				Risse, Benjamin; Thomas, Silke; Otto, Nils; Loepmeier, Tim; Valkov, Dimitar; Jiang, Xiaoyi; Klaembt, Christian			FIM, a Novel FTIR-Based Imaging Method for High Throughput Locomotion Analysis	PLOS ONE			English	Article							DROSOPHILA LARVAL; DECISION-MAKING; FRUIT-FLY; TRACKING; SYSTEM; BEHAVIOR; LEVEL; CELLS; MICE	We designed a novel imaging technique based on frustrated total internal reflection (FTIR) to obtain high resolution and high contrast movies. This FTIR-based Imaging Method (FIM) is suitable for a wide range of biological applications and a wide range of organisms. It operates at all wavelengths permitting the in vivo detection of fluorescent proteins. To demonstrate the benefits of FIM, we analyzed large groups of crawling Drosophila larvae. The number of analyzable locomotion tracks was increased by implementing a new software module capable of preserving larval identity during most collision events. This module is integrated in our new tracking program named FIMTrack which subsequently extracts a number of features required for the analysis of complex locomotion phenotypes. FIM enables high throughput screening for even subtle behavioral phenotypes. We tested this newly developed setup by analyzing locomotion deficits caused by the glial knockdown of several genes. Suppression of kinesin heavy chain (khc) or rab30 function led to contraction pattern or head sweeping defects, which escaped in previous analysis. Thus, FIM permits forward genetic screens aimed to unravel the neural basis of behavior.	[Risse, Benjamin; Thomas, Silke; Otto, Nils; Klaembt, Christian] Univ Munster, Inst Neurobiol, D-48149 Munster, Germany; [Risse, Benjamin; Loepmeier, Tim; Valkov, Dimitar; Jiang, Xiaoyi] Univ Munster, Inst Comp Sci, D-48149 Munster, Germany	University of Munster; University of Munster	Klambt, C (corresponding author), Univ Munster, Inst Neurobiol, D-48149 Munster, Germany.	klaembt@uni-muenster.de	Jiang, Xiaoyi/AAA-3532-2022	Jiang, Xiaoyi/0000-0001-7678-9528; Rodrigues, Silke/0000-0003-0407-0615; Otto, Nils/0000-0001-9713-4088	Boehringer Ingelheim Fonds	Boehringer Ingelheim Fonds(Boehringer Ingelheim)	ST acknowledges a predoctoral fellowship of the Boehringer Ingelheim Fonds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERRIGAN D, 1995, J INSECT PHYSIOL, V41, P329, DOI 10.1016/0022-1910(94)00113-U; Cheng LE, 2010, NEURON, V67, P373, DOI 10.1016/j.neuron.2010.07.004; Duda RO, 2001, PATTERN CLASSICATION; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; Fry SN, 2003, SCIENCE, V300, P495, DOI 10.1126/science.1081944; Frye MA, 2004, CURR OPIN NEUROBIOL, V14, P729, DOI 10.1016/j.conb.2004.10.004; Gershow M, 2012, NAT METHODS, V9, P290, DOI [10.1038/NMETH.1853, 10.1038/nmeth.1853]; Glassner A. S., 1993, GRAPHICS GEMS; Gohl DM, 2011, NAT METHODS, V8, P231, DOI 10.1038/NMETH.1561; Gomez-Marin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041642; Gomez-Marin A, 2012, CURR OPIN NEUROBIOL, V22, P208, DOI 10.1016/j.conb.2011.11.008; Gomez-Marin A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1455; Heckscher ES, 2012, J NEUROSCI, V32, P12460, DOI 10.1523/JNEUROSCI.0222-12.2012; Inada K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029019; Keene AC, 2012, TRENDS NEUROSCI, V35, P104, DOI 10.1016/j.tins.2011.11.003; Khurana S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015259; Lahiri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023180; Luo LJ, 2010, J NEUROSCI, V30, P4261, DOI 10.1523/JNEUROSCI.4090-09.2010; Maimon G, 2008, CURR BIOL, V18, P464, DOI 10.1016/j.cub.2008.02.054; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pistori H, 2010, PATTERN RECOGN LETT, V31, P337, DOI 10.1016/j.patrec.2009.05.015; Scantlebury N, 2007, BEHAV GENET, V37, P513, DOI 10.1007/s10519-007-9146-3; Schmidt I, 2012, J NEUROSCI, V32, P7466, DOI 10.1523/JNEUROSCI.0349-12.2012; Sinadinos C, 2012, J NEUROSCI METH, V203, P325, DOI 10.1016/j.jneumeth.2011.08.037; Spink AJ, 2001, PHYSIOL BEHAV, V73, P731, DOI 10.1016/S0031-9384(01)00530-3; Straw AD, 2011, J R SOC INTERFACE, V8, P395, DOI 10.1098/rsif.2010.0230; Suzuki S, 1985, COMPUTER VISION; Swierczek NA, 2011, NAT METHODS, V8, P592, DOI [10.1038/NMETH.1625, 10.1038/nmeth.1625]; Venken KJT, 2011, NEURON, V72, P202, DOI 10.1016/j.neuron.2011.09.021; Yemini E, 2011, COLD SPRING HARBOR P, V2011	30	70	70	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e53963	10.1371/journal.pone.0053963	http://dx.doi.org/10.1371/journal.pone.0053963			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349775	Green Published, Green Submitted, gold			2022-12-25	WOS:000313943000022
J	Schwenke, M; Knofler, M; Velicky, P; Weimar, CHE; Kruse, M; Samalecos, A; Wolf, A; Macklon, NS; Bamberger, AM; Gellersen, B				Schwenke, Maren; Knoefler, Martin; Velicky, Philipp; Weimar, Charlotte H. E.; Kruse, Michelle; Samalecos, Annemarie; Wolf, Anja; Macklon, Nick S.; Bamberger, Ana-Maria; Gellersen, Birgit			Control of Human Endometrial Stromal Cell Motility by PDGF-BB, HB-EGF and Trophoblast-Secreted Factors	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; SIGNALING PATHWAYS; FACTOR RECEPTOR; EMBRYO IMPLANTATION; EXPRESSION; PREGNANCY; INVASION; ROLES; DECIDUALIZATION; MIGRATION	Human implantation involves extensive tissue remodeling at the fetal-maternal interface. It is becoming increasingly evident that not only trophoblast, but also decidualizing endometrial stromal cells are inherently motile and invasive, and likely contribute to the highly dynamic processes at the implantation site. The present study was undertaken to further characterize the mechanisms involved in the regulation of endometrial stromal cell motility and to identify trophoblast-derived factors that modulate migration. Among local growth factors known to be present at the time of implantation, heparin-binding epidermal growth factor-like growth factor (HB-EGF) triggered chemotaxis (directed locomotion), whereas platelet-derived growth factor (PDGF)-BB elicited both chemotaxis and chemokinesis (non-directed locomotion) of endometrial stromal cells. Supernatants of the trophoblast cell line AC-1M88 and of first trimester villous explant cultures stimulated chemotaxis but not chemokinesis. Proteome profiling for cytokines and angiogenesis factors revealed neither PDGF-BB nor HB-EGF in conditioned media from trophoblast cells or villous explants, while placental growth factor, vascular endothelial growth factor and PDGF-AA were identified as prominent secretory products. Among these, only PDGF-AA triggered endometrial stromal cell chemotaxis. Neutralization of PDGF-AA in trophoblast conditioned media, however, did not diminish chemoattractant activity, suggesting the presence of additional trophoblast-derived chemotactic factors. Pathway inhibitor studies revealed ERK1/2, PI3 kinase/Akt and p38 signaling as relevant for chemotactic motility, whereas chemokinesis depended primarily on PI3 kinase/Akt activation. Both chemotaxis and chemokinesis were stimulated upon inhibition of Rho-associated, coiled-coil containing protein kinase. The chemotactic response to trophoblast secretions was not blunted by inhibition of isolated signaling cascades, indicating activation of overlapping pathways in trophoblast-endometrial communication. In conclusion, trophoblast signals attract endometrial stromal cells, while PDGF-BB and HB-EGF, although not identified as trophoblast-derived, are local growth factors that may serve to fine-tune directed and non-directed migration at the implantation site.	[Schwenke, Maren; Kruse, Michelle; Samalecos, Annemarie; Wolf, Anja; Gellersen, Birgit] Endokrinologikum Hamburg, Hamburg, Germany; [Knoefler, Martin; Velicky, Philipp] Med Univ Vienna, Dept Obstet & Fetal Maternal Med, Reprod Biol Unit, Vienna, Austria; [Weimar, Charlotte H. E.; Macklon, Nick S.] Univ Med Ctr Utrecht, Lab Neuroimmunol & Dev Origins Dis NIDOD, Utrecht, Netherlands; [Macklon, Nick S.] Univ Southampton, Princess Anne Hosp, Fac Med, Southampton, Hants, England; [Bamberger, Ana-Maria] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany	Medical University of Vienna; Utrecht University; Utrecht University Medical Center; University of Southampton; University of Hamburg; University Medical Center Hamburg-Eppendorf	Gellersen, B (corresponding author), Endokrinologikum Hamburg, Hamburg, Germany.	gellersen@endokrinologikum.com		Velicky, Philipp/0000-0002-2340-7431	Deutsche Forschungsgemeinschaft [DFG-GE 748/11-2]; Austrian Science Funds, Vienna, Austria [P-22687-B13]; Foundation "De Drie Lichten" in the Netherlands; Alexandre-Suermann scholarship from the University Medical Center Utrecht, The Netherlands; Austrian Science Fund (FWF) [P 22687] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Science Funds, Vienna, Austria(Austrian Science Fund (FWF)); Foundation "De Drie Lichten" in the Netherlands; Alexandre-Suermann scholarship from the University Medical Center Utrecht, The Netherlands; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Deutsche Forschungsgemeinschaft grant DFG-GE 748/11-2 (to B. G. and A. M. B). P. V. was supported by grant P-22687-B13 of the Austrian Science Funds, Vienna, Austria. This project was further supported by Foundation "De Drie Lichten" in the Netherlands and the Alexandre-Suermann scholarship from the University Medical Center Utrecht, The Netherlands (to C. H. E. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anacker J, 2011, MOL HUM REPROD, V17, P637, DOI 10.1093/molehr/gar033; Apps R, 2011, PLACENTA, V32, P33, DOI 10.1016/j.placenta.2010.10.010; Baulida J, 1996, J BIOL CHEM, V271, P5251; Bilban M, 2010, PLACENTA, V31, P989, DOI 10.1016/j.placenta.2010.08.011; Bilban M, 2009, ENDOCRINOLOGY, V150, P1000, DOI 10.1210/en.2008-0456; Boomsma CM, 2010, FERTIL STERIL, V94, P1764, DOI 10.1016/j.fertnstert.2009.10.044; Brahmbhatt AA, 2003, J BIOL CHEM, V278, P13016, DOI 10.1074/jbc.M211873200; Brar AK, 2001, PHYSIOL GENOMICS, V7, P135, DOI 10.1152/physiolgenomics.00061.2001; Brosens JJ, 2006, J MOL ENDOCRINOL, V36, P389, DOI 10.1677/jme.1.02060; Brosens JJ, 2010, ULTRASOUND OBST GYN, V36, P1, DOI 10.1002/uog.7714; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; Burton GJ, 2004, J SOC GYNECOL INVEST, V11, P342, DOI 10.1016/j.jsgi.2004.03.003; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Chobotova K, 2005, J CLIN ENDOCR METAB, V90, P913, DOI 10.1210/jc.2004-0476; Clark DE, 1998, J ENDOCRINOL, V159, P459, DOI 10.1677/joe.0.1590459; Cloke B, 2008, ENDOCRINOLOGY, V149, P4462, DOI 10.1210/en.2008-0356; Cohen M, 2006, PLACENTA, V27, P783, DOI 10.1016/j.placenta.2005.08.006; Fazleabas AT, 2004, PLACENTA, V25, pS26, DOI 10.1016/j.placenta.2004.01.014; Ferretti C, 2007, HUM REPROD UPDATE, V13, P121, DOI 10.1093/humupd/dml048; Fiedler J, 2005, BIOCHEM BIOPH RES CO, V334, P561, DOI 10.1016/j.bbrc.2005.06.116; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; Funayama H., 1997, PLACENTA, V18, P191; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Gaus G, 1997, PLACENTA S2, V18, P181, DOI DOI 10.1016/S0143-4004(97)80088-4; Gellersen B, 2010, HUM REPROD, V25, P862, DOI 10.1093/humrep/dep468; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Gentilini D, 2007, MOL HUM REPROD, V13, P317, DOI 10.1093/molehr/gam001; Gentilini D, 2010, FERTIL STERIL, V93, P2588, DOI 10.1016/j.fertnstert.2010.02.006; Gonzalez M, 2011, MOL HUM REPROD, V17, P421, DOI 10.1093/molehr/gar015; Grewal S, 2008, P NATL ACAD SCI USA, V105, P16189, DOI 10.1073/pnas.0806219105; Grewal S, 2010, BIOL REPROD, V83, P75, DOI 10.1095/biolreprod.109.080630; Hannan NJ, 2011, ENDOCRINOLOGY, V152, P4948, DOI 10.1210/en.2011-1248; Hannan NJ, 2010, BIOL REPROD, V82, P235, DOI 10.1095/biolreprod.109.077800; Haouzi D, 2011, HUM REPROD, V26, P1440, DOI 10.1093/humrep/der075; Ihnatovych I, 2007, ENDOCRINOLOGY, V148, P3176, DOI 10.1210/en.2006-1673; Jessmon P, 2010, BIOL REPROD, V82, P921, DOI 10.1095/biolreprod.109.082305; Jessmon P, 2009, MOL REPROD DEV, V76, P1116, DOI 10.1002/mrd.21066; Jiang Y, 2011, BIOCHEM BIOPH RES CO, V404, P628, DOI 10.1016/j.bbrc.2010.12.027; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; Kawada K, 2009, MOL CELL BIOL, V29, P4508, DOI 10.1128/MCB.00015-09; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Knofler M, 2012, PLACENTA, V33, pS55, DOI 10.1016/j.placenta.2011.09.019; Knofler M, 2010, INT J DEV BIOL, V54, P269, DOI 10.1387/ijdb.082769mk; Lash GE, 2003, PLACENTA, V24, P549, DOI 10.1053/plac.2002.0923; Lash GE, 2012, HUM REPROD, V27, P183, DOI 10.1093/humrep/der376; Leach RE, 1999, J CLIN ENDOCR METAB, V84, P3355, DOI 10.1210/jc.84.9.3355; Leach RE, 2004, DEV BIOL, V266, P223, DOI 10.1016/j.ydbio.2003.09.026; Leach RE, 2012, HUM REPROD, V27, P814, DOI 10.1093/humrep/der436; Lessey BA, 2002, MOL REPROD DEV, V62, P446, DOI 10.1002/mrd.10129; Lim HJ, 2009, EXP CELL RES, V315, P619, DOI 10.1016/j.yexcr.2008.07.025; Llorens F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-326; Lyall F, 2005, PLACENTA, V26, pS31, DOI 10.1016/j.placenta.2005.02.010; Maijenburg MW, 2012, STEM CELLS DEV, V21, P228, DOI 10.1089/scd.2011.0076; Matsumoto H, 2005, J CLIN ENDOCR METAB, V90, P3560, DOI 10.1210/jc.2004-1918; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Popovici RM, 2000, ENDOCRINOLOGY, V141, P3510, DOI 10.1210/en.141.9.3510; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Salamonsen LA, 2007, SEMIN REPROD MED, V25, P437, DOI 10.1055/s-2007-991041; Salker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010287; Samalecos A, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-76; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Stavreus-Evers A, 2002, MOL HUM REPROD, V8, P765, DOI 10.1093/molehr/8.8.765; Teklenburg G, 2010, MOL HUM REPROD, V16, P886, DOI 10.1093/molehr/gaq079; Teklenburg G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010258; Thomas CP, 2009, J CLIN ENDOCR METAB, V94, P2524, DOI 10.1210/jc.2009-0017; Tullai JW, 2007, J BIOL CHEM, V282, P23981, DOI 10.1074/jbc.M702044200; Weimar CHE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041424; Xie H, 2007, P NATL ACAD SCI USA, V104, P18315, DOI 10.1073/pnas.0707909104; Yamazaki Y, 2006, MOL DIVERS, V10, P515, DOI 10.1007/s11030-006-9027-3; Yoo HJ, 1997, DEV GENET, V21, P102, DOI 10.1002/(SICI)1520-6408(1997)21:1<102::AID-DVG12>3.0.CO;2-C; Yotova IY, 2011, HUM REPROD, V26, P885, DOI 10.1093/humrep/der010; Zhu JX, 2005, J BIOL CHEM, V280, P32468, DOI 10.1074/jbc.M503833200	76	43	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54336	10.1371/journal.pone.0054336	http://dx.doi.org/10.1371/journal.pone.0054336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349855	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000313943000034
J	Fang, ZD; Du, RF; Edwards, A; Flemington, EK; Zhang, K				Fang, Zhide; Du, Ruofei; Edwards, Andrea; Flemington, Erik K.; Zhang, Kun			The Sequence Structures of Human MicroRNA Molecules and Their Implications	PLOS ONE			English	Article							BREAST-CANCER; EVOLUTION; TARGETS; GENES; RNA; ANNOTATION; EXPRESSION; PREDICTION; MIRBASE; ELEGANS	The count of the nucleotides in a cloned, short genomic sequence has become an important criterion to annotate such a sequence as a miRNA molecule. While the majority of human mature miRNA sequences consist of 22 nucleotides, there exists discrepancy in the characteristic lengths of the miRNA sequences. There is also a lack of systematic studies on such length distribution and on the biological factors that are related to or may affect this length. In this paper, we intend to fill this gap by investigating the sequence structure of human miRNA molecules using statistics tools. We demonstrate that the traditional discrete probability distributions do not model the length distribution of the human mature miRNAs well, and we obtain the statistical distribution model with a decent fit. We observe that the four nucleotide bases in a miRNA sequence are not randomly distributed, implying that possible structural patterns such as dinucleotide (trinucleotide or higher order) may exist. Furthermore, we study the relationships of this length distribution to multiple important factors such as evolutionary conservation, tumorigenesis, the length of precursor loop structures, and the number of predicted targets. The association between the miRNA sequence length and the distributions of target site counts in corresponding predicted genes is also presented. This study results in several novel findings worthy of further investigation that include: (1) rapid evolution introduces variation to the miRNA sequence length distribution; (2) miRNAs with extreme sequence lengths are unlikely to be cancer-related; and (3) the miRNA sequence length is positively correlated to the precursor length and the number of predicted target genes.	[Fang, Zhide; Du, Ruofei] Louisiana State Univ, Hlth Sci Ctr, Sch Publ Hlth, Biostat Program, New Orleans, LA USA; [Edwards, Andrea; Zhang, Kun] Xavier Univ Louisiana, Dept Comp Sci, New Orleans, LA USA; [Flemington, Erik K.] Tulane Univ, Sch Med, Dept Pathol, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Xavier University of Louisiana; Tulane University	Flemington, EK (corresponding author), Tulane Univ, Sch Med, Dept Pathol, New Orleans, LA 70112 USA.	eflemin@tulane.edu; kzhang@xula.edu	Du, Ruofei/Q-6245-2017	Du, Ruofei/0000-0002-4006-7416	National Institutes of Health [NIGMS P20GM103424, NCRR-RCMI 5G12RR026260-04]; US Department of Army [W911NF-12-1-0066]; NSF [EPS-1006891]; NATIONAL CANCER INSTITUTE [R01CA138268] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR026260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103424] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Army; NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Research reported in this publication was supported by National Institutes of Health grants (NIGMS P20GM103424, NCRR-RCMI 5G12RR026260-04), an US Department of Army grant (W911NF-12-1-0066) and an NSF grant (EPS-1006891). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Caldas C, 2005, NAT MED, V11, P712, DOI 10.1038/nm0705-712; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2007, CANCER CELL, V12, P215, DOI 10.1016/j.ccr.2007.07.027; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Ellwanger DC, 2011, BIOINFORMATICS, V27, P1346, DOI 10.1093/bioinformatics/btr149; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; HOAGLIN DC, 1980, AM STAT, V34, P146, DOI 10.2307/2683871; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Kotz S, 2002, ANN I STAT MATH, V54, P816, DOI 10.1023/A:1022467519537; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; Park SY, 2009, J ECONOMETRICS, V150, P219, DOI 10.1016/j.jeconom.2008.12.014; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; QUESENBERRY CP, 1964, TECHNOMETRICS, V6, P191, DOI 10.2307/1266151; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Vaucheret H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006442; Wang D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013067; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zhang Q, 2008, NATURE P; Zhang R, 2007, GENOME RES, V17, P612, DOI 10.1101/gr.6146507	47	41	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54215	10.1371/journal.pone.0054215	http://dx.doi.org/10.1371/journal.pone.0054215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349828	gold, Green Published, Green Submitted			2022-12-25	WOS:000313872800032
J	Ramaseshadri, P; Segers, G; Flannagan, R; Wiggins, E; Clinton, W; Ilagan, O; McNulty, B; Clark, T; Bolognesi, R				Ramaseshadri, Parthasarathy; Segers, Gerrit; Flannagan, Ronald; Wiggins, Elizabeth; Clinton, William; Ilagan, Oliver; McNulty, Brian; Clark, Thomas; Bolognesi, Renata			Physiological and Cellular Responses Caused by RNAi-Mediated Suppression of Snf7 Orthologue in Western Corn Rootworm (Diabrotica virgifera virgifera) Larvae	PLOS ONE			English	Article							ESCRT MACHINERY; MULTIVESICULAR BODIES; AUTOPHAGIC CLEARANCE; FAT-BODY; DROSOPHILA; PROTEIN; TRAFFICKING; ENDOCYTOSIS; COMPLEXES; ENDOSOME	Ingestion of double stranded RNA (dsRNA) has been previously demonstrated to be effective in triggering RNA interference (RNAi) in western corn rootworm (WCR, Diabrotica virgifera virgifera LeConte), providing potential novel opportunities for insect pest control. The putative Snf7 homolog of WCR (DvSnf7) has previously been shown to be an effective RNAi target for insect control, as DvSnf7 RNAi leads to lethality of WCR larvae. Snf7 functions as a part of the ESCRT (Endosomal Sorting Complex Required for Transport) pathway which plays a crucial role in cellular housekeeping by internalization, transport, sorting and lysosomal degradation of transmembrane proteins. To understand the effects that lead to death of WCR larvae by DvSnf7 RNAi, we examined some of the distinct cellular processes associated with ESCRT functions such as de-ubiquitination of proteins and autophagy. Our data indicate that ubiquitinated proteins accumulate in DvSnf7 dsRNA-fed larval tissues and that the autophagy process seems to be impaired. These findings suggest that the malfunctioning of these cellular processes in both midgut and fat body tissues triggered by DvSnf7 RNAi were the main effects leading to the death of WCR. This study also illustrates that Snf7 is an essential gene in WCR and its functions are consistent with biological functions described for other eukaryotes.	[Ramaseshadri, Parthasarathy; Segers, Gerrit; Flannagan, Ronald; Wiggins, Elizabeth; Clinton, William; Ilagan, Oliver; McNulty, Brian; Clark, Thomas; Bolognesi, Renata] Monsanto Co, Dept Biotechnol, Chesterfield, MO USA	Monsanto	Bolognesi, R (corresponding author), Monsanto Co, Dept Biotechnol, Chesterfield, MO USA.	renata.bolognesi@monsanto.com			Monsanto Creative Services (St. Louis); In silico Analytics Team (Monsanto Research Center, Bangalore)	Monsanto Creative Services (St. Louis); In silico Analytics Team (Monsanto Research Center, Bangalore)	We thank Monsanto Creative Services (St. Louis) and In silico Analytics Team (Monsanto Research Center, Bangalore) for their support.	Alves AP, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14122; Babst M, 2011, CURR OPIN CELL BIOL, V23, P452, DOI 10.1016/j.ceb.2011.04.008; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Belles X, 2010, ANNU REV ENTOMOL, V55, P111, DOI 10.1146/annurev-ento-112408-085301; Bolognesi R, 2012, PLOS ONE; Bowers K, 2004, TRAFFIC, V5, P194, DOI 10.1111/j.1600-0854.2004.00169.x; Caballe A, 2011, TRAFFIC, V12, P1318, DOI 10.1111/j.1600-0854.2011.01244.x; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Doyotte A, 2005, J CELL SCI, V118, P3003, DOI 10.1242/jcs.02421; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; GORDON PB, 1988, BIOCHEM BIOPH RES CO, V151, P40, DOI 10.1016/0006-291X(88)90556-6; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hennig KM, 2006, J CELL BIOL, V173, P963, DOI 10.1083/jcb.200511140; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kim DW, 2011, MOL CELLS, V31, P585, DOI 10.1007/s10059-011-1045-z; Lee JA, 2008, AUTOPHAGY, V4, P230, DOI 10.4161/auto.5384; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Lone M, 2010, J CELL SCI, V123, P2369, DOI 10.1242/jcs.060582; Luhtala N, 2004, J CELL BIOL, V166, P717, DOI 10.1083/jcb.200403139; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Michelet X, 2010, BIOL CELL, V102, P191, DOI 10.1042/BC20090145; Neufeld TP, 2003, CURR TOP MICROBIOL, V279, P139; Odorizzi G, 2003, J CELL SCI, V116, P1893, DOI 10.1242/jcs.00395; Peck JW, 2004, BIOCHEM J, V377, P693, DOI 10.1042/bj20031347; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Ren XF, 2011, TRAFFIC, V12, P1282, DOI 10.1111/j.1600-0854.2011.01208.x; Roxrud I, 2010, BIOL CELL, V102, P293, DOI 10.1042/BC20090161; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Rusten TE, 2008, CELL CYCLE, V7, P1166, DOI 10.4161/cc.7.9.5784; Rusten TE, 2008, AUTOPHAGY, V4, P233, DOI 10.4161/auto.5396; Rusten TE, 2007, CURR BIOL, V17, P1817, DOI 10.1016/j.cub.2007.09.032; Sambrook J, 2001, MOL CLONING LAB MANU, V1, P33; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Shields SB, 2011, TRAFFIC, V12, P1306, DOI 10.1111/j.1600-0854.2011.01242.x; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Sweeney NT, 2006, CURR BIOL, V16, P1006, DOI 10.1016/j.cub.2006.03.067; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; TU JL, 1993, GENETICS, V135, P17; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Vaccari T, 2009, J CELL SCI, V122, P2413, DOI 10.1242/jcs.046391; Wegner CS, 2011, TRAFFIC, V12, P1291, DOI 10.1111/j.1600-0854.2011.01210.x; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Winter V, 2006, TRENDS PLANT SCI, V11, P115, DOI 10.1016/j.tplants.2006.01.008; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504	50	72	74	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54270	10.1371/journal.pone.0054270	http://dx.doi.org/10.1371/journal.pone.0054270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349844	gold, Green Published, Green Submitted			2022-12-25	WOS:000313872800035
J	Baharnoori, M; Bhardwaj, SK; Srivastava, LK				Baharnoori, Moogeh; Bhardwaj, Sanjeev K.; Srivastava, Lalit K.			Effect of Maternal Lipopolysaccharide Administration on the Development of Dopaminergic Receptors and Transporter in the Rat Offspring	PLOS ONE			English	Article							PRENATAL IMMUNE ACTIVATION; MEDIAL PREFRONTAL CORTEX; GAMMA-AMINOBUTYRIC-ACID; WORKING-MEMORY; HIPPOCAMPAL NEUROGENESIS; CORTICAL INTERNEURONS; COGNITIVE IMPAIRMENT; BACTERIAL-ENDOTOXIN; ANIMAL-MODELS; SCHIZOPHRENIA	Epidemiological evidence supports that maternal infection during gestation are notable risk factors for developmental mental illnesses including schizophrenia and autism. In prenatal lipopolysaccharide (LPS) model of immune activation in rats, the offspring exhibit significant impairments in behaviors mediated by central dopamine (DA) system. This study aimed to examine the temporal and regional pattern of postnatal DA development in the male offspring of pregnant Sprague-Dawley rats administered with 100 mu g/kg LPS or saline at gestational days 15/16. Using ligand autoradiography, D1 and D2 dopamine receptors (D1R, D2R) and dopamine transporter (DAT) binding levels were measured in the prefrontal cortex (PFC) and sub cortical regions (dorsal striatum and nucleus accumbens core and shell) at pre pubertal (P35) and post pubertal ages (P60). We found a significant decrease in D2R ligand [H-3] YM-90151-2 binding in the medial PFC (mPFC) in prenatal LPS-treated animals at P35 and P60 compared to respective saline groups. The decrease in D2R levels was not observed in the striatum or accumbens of maternal LPS-treated animals. No significant changes were observed in [H-3] SCH23390 binding to D1R. However, the level of [I-125] RTI-121 binding to DAT was selectively reduced in the nucleus accumbens core and shell at P35 in the prenatal LPS group. Immunohistochemical analysis showed that number of D2R immunopositive cells in infralimbic/prelimbic (IL/PL) part of mPFC was significantly reduced in the LPS group at P60. Prenatal LPS treatment did not significantly affect either the total number of mature neurons or parvalbumin (PV)- immunopositive interneurons in this region. However the number of PV and D2R co-labeled neurons was significantly reduced in the IL/PL subregion of PFC of LPS treated animals. Our data suggests D2R deficit in the PFC and PV interneurons may be relevant to understanding mechanisms of cortical dysfunctions described in prenatal infection animal models as well as schizophrenia.	[Srivastava, Lalit K.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada	McGill University; McGill University	Srivastava, LK (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.	lalit.srivastava@mcgill.ca		Srivastava, Lalit/0000-0002-1222-3223	Canadian Institute of Health Research [ELA 80228]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by team grant from Canadian Institute of Health Research # ELA 80228. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto S, 2005, J NEUROSCI, V25, P2471, DOI 10.1523/JNEUROSCI.2097-04.2005; Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y; Baharnoori M, 2009, SCHIZOPHR RES, V107, P99, DOI 10.1016/j.schres.2008.10.003; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Bitanihirwe BKY, 2010, INT J NEUROPSYCHOPH, V13, P981, DOI 10.1017/S1461145710000192; Boksa P, 2008, J PSYCHIATR NEUROSCI, V33, P183; Boksa P, 2010, BRAIN BEHAV IMMUN, V24, P881, DOI 10.1016/j.bbi.2010.03.005; Borrell J, 2002, NEUROPSYCHOPHARMACOL, V26, P204, DOI 10.1016/S0893-133X(01)00360-8; BOUNDY VA, 1993, MOL PHARMACOL, V43, P666; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Cui K, 2009, SCHIZOPHR RES, V113, P288, DOI 10.1016/j.schres.2009.05.003; Dick Danielle M, 2010, Dialogues Clin Neurosci, V12, P7; Druzin MY, 2000, BEHAV BRAIN RES, V109, P99, DOI 10.1016/S0166-4328(99)00166-7; Ducharme G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029754; Ernst M, 1997, LANCET, V350, P638, DOI 10.1016/S0140-6736(05)63326-0; Fatemi SH, 2008, SCHIZOPHR RES, V99, P56, DOI 10.1016/j.schres.2007.11.018; Flores G, 1998, BRAIN RES, V814, P34, DOI 10.1016/S0006-8993(98)01011-7; Flores G, 1996, J NEUROSCI, V16, P7366; Fortier ME, 2007, BEHAV BRAIN RES, V181, P270, DOI 10.1016/j.bbr.2007.04.016; Fortier ME, 2004, J PSYCHIATR RES, V38, P335, DOI 10.1016/j.jpsychires.2003.10.001; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Guillin O, 2007, INT REV NEUROBIOL, V78, P1, DOI 10.1016/S0074-7742(06)78001-1; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Hashimoto T, 2003, J NEUROSCI, V23, P6315; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Leviel V, 2011, J NEUROCHEM, V118, P475, DOI 10.1111/j.1471-4159.2011.07335.x; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lewis DA, 2006, ARCH NEUROL-CHICAGO, V63, P1372, DOI 10.1001/archneur.63.10.1372; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Mendez P, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/976856; Mengual E, 2002, SYNAPSE, V43, P151, DOI 10.1002/syn.10033; Meyer U, 2008, NEUROSCIENCE, V154, P701, DOI 10.1016/j.neuroscience.2008.04.031; Meyer U, 2008, BRAIN BEHAV IMMUN, V22, P469, DOI 10.1016/j.bbi.2007.09.012; Meyer U, 2008, NEUROPSYCHOPHARMACOL, V33, P441, DOI 10.1038/sj.npp.1301413; Meyer U, 2009, NEUROSCI BIOBEHAV R, V33, P1061, DOI 10.1016/j.neubiorev.2009.05.001; Muly EC, 1998, J NEUROSCI, V18, P10553; Nakamura K, 2010, ARCH GEN PSYCHIAT, V67, P59, DOI 10.1001/archgenpsychiatry.2009.137; Nouel D, 2012, EUR NEUROPSYCHOPHARM, V22, P300, DOI 10.1016/j.euroneuro.2011.08.001; O'Donnell P, 2010, NEUROTOX RES, V18, P306, DOI 10.1007/s12640-010-9157-3; Ozawa K, 2006, BIOL PSYCHIAT, V59, P546, DOI 10.1016/j.biopsych.2005.07.031; Patterson PH, 2009, BEHAV BRAIN RES, V204, P313, DOI 10.1016/j.bbr.2008.12.016; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Piontkewitz Y, 2012, BRAIN BEHAV IMMUN, V26, P353, DOI 10.1016/j.bbi.2011.11.004; Riley B, 2011, SCHIZOPHRENIA, P245; Romero E, 2010, MOL PSYCHIATR, V15, P372, DOI 10.1038/mp.2008.44; Santana N, 2009, CEREB CORTEX, V19, P849, DOI 10.1093/cercor/bhn134; SEEMAN P, 1987, SYNAPSE, V1, P133, DOI 10.1002/syn.890010203; Sesack SR, 1998, J NEUROSCI, V18, P2697; Sorensen HJ, 2009, SCHIZOPHRENIA BULL, V35, P631, DOI 10.1093/schbul/sbn121; Tseng KY, 2008, J NEUROSCI, V28, P12691, DOI 10.1523/JNEUROSCI.4166-08.2008; Tseng KY, 2007, CEREB CORTEX, V17, P1235, DOI 10.1093/cercor/bhl034; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; VINCENT SL, 1993, J NEUROSCI, V13, P2551, DOI 10.1523/JNEUROSCI.13-06-02551.1993; Volk DW, 2000, ARCH GEN PSYCHIAT, V57, P237, DOI 10.1001/archpsyc.57.3.237; Vuillermot S, 2010, J NEUROSCI, V30, P1270, DOI 10.1523/JNEUROSCI.5408-09.2010; Zuckerman L, 2005, J PSYCHIATR RES, V39, P311, DOI 10.1016/j.jpsychires.2004.08.008	56	29	29	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54439	10.1371/journal.pone.0054439	http://dx.doi.org/10.1371/journal.pone.0054439			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349891	Green Submitted, Green Published, gold			2022-12-25	WOS:000313738900068
J	Elizaga, ML; Vasan, S; Marovich, MA; Sato, AH; Lawrence, DN; Chaitman, BR; Frey, SE; Keefer, MC				Elizaga, Marnie L.; Vasan, Sandhya; Marovich, Mary A.; Sato, Alicia H.; Lawrence, Dale N.; Chaitman, Bernard R.; Frey, Sharon E.; Keefer, Michael C.		MVA Cardiac Safety Working Grp	Prospective Surveillance for Cardiac Adverse Events in Healthy Adults Receiving Modified Vaccinia Ankara Vaccines: A Systematic Review	PLOS ONE			English	Article							T-CELL RESPONSES; PHASE-I TRIAL; SMALLPOX VACCINATION; UNITED-STATES; VIRUS; SAFETY; IMMUNOGENICITY; MVA; HIV-1; DNA	Background: Vaccinia-associated myo/pericarditis was observed during the US smallpox vaccination (DryVax) campaign initiated in 2002. A highly-attenuated vaccinia strain, modified vaccinia Ankara (MVA) has been evaluated in clinical trials as a safer alternative to DryVax and as a vector for recombinant vaccines. Due to the lack of prospectively collected cardiac safety data, the US Food and Drug Administration required cardiac screening and surveillance in all clinical trials of MVA since 2004. Here, we report cardiac safety surveillance from 6 phase I trials of MVA vaccines. Methods: Four clinical research organizations contributed cardiac safety data using common surveillance methods in trials administering MVA or recombinant MVA vaccines to healthy participants. 'Routine cardiac investigations' (ECGs and cardiac enzymes obtained 2 weeks after injections of MVA or MVA-HIV recombinants, or placebo-controls), and 'Symptom-driven cardiac investigations' are reported. The outcome measure is the number of participants who met the CDC-case definition for vaccinia-related myo/pericarditis or who experienced cardiac adverse events from an MVA vaccine. Results: Four hundred twenty-five study participants had post-vaccination safety data analyzed, 382 received at least one MVA-containing vaccine and 43 received placebo; 717 routine ECGs and 930 cardiac troponin assays were performed. Forty-five MVA recipients (12%) had additional cardiac testing performed; 22 for cardiac symptoms, 19 for ECG/laboratory changes, and 4 for cardiac symptoms with an ECG/laboratory change. No participant had evidence of symptomatic or asymptomatic myo/pericarditis meeting the CDC-case definition and judged to be related to an MVA vaccine. Conclusions: Prospective surveillance of MVA recipients for myo/pericarditis did not detect cardiac adverse reactions in 382 study participants.	[Elizaga, Marnie L.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Vasan, Sandhya] Aaron Diamond AIDS Res Ctr, New York, NY USA; [Marovich, Mary A.] Walter Reed Army Inst Res, US Mil HIV Res Program, Rockville, MD USA; [Sato, Alicia H.] Fred Hutchinson Canc Res Ctr, SCHARP, Seattle, WA 98104 USA; [Lawrence, Dale N.] NIAID, Div Aids, NIH, Bethesda, MD 20892 USA; [Chaitman, Bernard R.] St Louis Univ, Sch Med, Div Cardiol, St Louis, MO USA; [Frey, Sharon E.] St Louis Univ, Sch Med, Clin Res Div Infect Dis Allergy & Immunol, St Louis, MO USA; [Keefer, Michael C.] Univ Rochester, Sch Med & Dent, Rochester, NY 14627 USA	Fred Hutchinson Cancer Center; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Saint Louis University; Saint Louis University; University of Rochester	Keefer, MC (corresponding author), Univ Rochester, Sch Med & Dent, Rochester, NY 14627 USA.	Michael_Keefer@URMC.Rochester.edu			National Institutes of Health [N01 AI25464, UM1 AI069511, UM1 AI068614, UM1 AI046747, UM1 AIO68614, UM1 AI068635]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI046747, UM1AI069511, UM1AI068614, N01AI025464, UM1AI068635] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health grant numbers N01 AI25464, UM1 AI069511, UM1 AI068614, UM1 AI046747, UM1 AIO68614, UM1 AI068635. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bart PA, 2008, VACCINE, V26, P3153, DOI 10.1016/j.vaccine.2008.03.083; Carroll MW, 1997, VIROLOGY, V238, P198, DOI 10.1006/viro.1997.8845; Casey CG, 2005, JAMA-J AM MED ASSOC, V294, P2734, DOI 10.1001/jama.294.21.2734; Cassimatis DC, 2004, J AM COLL CARDIOL, V43, P1503, DOI 10.1016/j.jacc.2003.11.053; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P492; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P248; Currier JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013983; Eckart RE, 2004, J AM COLL CARDIOL, V44, P201, DOI 10.1016/j.jacc.2004.05.004; Fenner F., 1988, SMALLPOX ITS ERADICA; Fortescue EB, 2007, ANN EMERG MED, V49, P137, DOI 10.1016/j.annemergmed.2006.09.024; Frey SE, 2007, VACCINE, V25, P8562, DOI 10.1016/j.vaccine.2007.10.017; Goepfert PA, 2011, J INFECT DIS, V203, P610, DOI 10.1093/infdis/jiq105; Gorse GJ, 2012, CLIN VACCINE IMMUNOL; Guimaraes-Walker A, 2008, VACCINE, V26, P6671, DOI 10.1016/j.vaccine.2008.09.016; Halsell JS, 2003, JAMA-J AM MED ASSOC, V289, P3283, DOI 10.1001/jama.289.24.3283; Jaoko W, 2008, VACCINE, V26, P2788, DOI 10.1016/j.vaccine.2008.02.071; Keefer MC, 2011, VACCINE, V29, P1948, DOI 10.1016/j.vaccine.2010.12.104; MACKETT M, 1982, P NATL ACAD SCI-BIOL, V79, P7415, DOI 10.1073/pnas.79.23.7415; Mayr A, 1978, Dev Biol Stand, V41, P225; Mayr A., 1975, INFECTION, V3, P6, DOI [10.1007/BF01641272, DOI 10.1007/BF01641272]; McCormack S, 2008, VACCINE, V26, P3162, DOI 10.1016/j.vaccine.2008.02.072; McCurdy LH, 2004, CLIN INFECT DIS, V38, P1749, DOI 10.1086/421266; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Moorthy VS, 2004, J INFECT DIS, V189, P2213, DOI 10.1086/421118; Morgan J, 2008, CLIN INFECT DIS, V46, pS242, DOI 10.1086/524747; Mwau M, 2004, J GEN VIROL, V85, P911, DOI 10.1099/vir.0.19701-0; NEFF JM, 1967, NEW ENGL J MED, V276, P125, DOI 10.1056/NEJM196701192760301; Parrino J, 2007, VACCINE, V25, P1513, DOI 10.1016/j.vaccine.2006.10.047; Peters BS, 2007, VACCINE, V25, P2120, DOI 10.1016/j.vaccine.2006.11.016; PIALOUX G, 1995, AIDS RES HUM RETROV, V11, P373, DOI 10.1089/aid.1995.11.373; Poland GA, 2005, VACCINE, V23, P2078, DOI 10.1016/j.vaccine.2005.01.012; Ramanathan VD, 2009, AIDS RES HUM RETROV, V25, P1107, DOI 10.1089/aid.2009.0096; Sano J, 2009, AM J MED, V122, P79, DOI 10.1016/j.amjmed.2008.07.025; STICKL H, 1974, DEUT MED WOCHENSCHR, V99, P2386, DOI 10.1055/s-0028-1108143; Stittelaar KJ, 2001, VACCINE, V19, P3700, DOI 10.1016/S0264-410X(01)00075-5; US FDA, 2007, FOOD DRUG ADM ACAMBI; Vasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008816; WALLACK MK, 1986, AM SURGEON, V52, P148; ZAGURY D, 1988, NATURE, V332, P728, DOI 10.1038/332728a0	39	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54407	10.1371/journal.pone.0054407	http://dx.doi.org/10.1371/journal.pone.0054407			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349878	Green Published, Green Submitted, gold			2022-12-25	WOS:000313738900066
J	Fabricius, KE; Cseke, S; Humphrey, C; De'ath, G				Fabricius, Katharina E.; Cseke, Szilvia; Humphrey, Craig; De'ath, Glenn			Does Trophic Status Enhance or Reduce the Thermal Tolerance of Scleractinian Corals? A Review, Experiment and Conceptual Framework	PLOS ONE			English	Review							GREAT-BARRIER-REEF; WATER-QUALITY; STYLOPHORA-PISTILLATA; MORTALITY RISK; CLIMATE-CHANGE; GROWTH; TEMPERATURE; HETEROTROPHY; ENERGETICS; SEDIMENTS	Global warming, and nutrient and sediment runoff from coastal development, both exert increasing pressures on coastal coral reefs. The objective of this study was to resolve the question of whether coastal eutrophication may protect corals from thermal stress by improving their nutritional status, or rather diminish their thermal tolerance through the synergy of dual stressors. A review of previous studies on the topic of combined trophic status and heat exposure on the thermal tolerance of corals reveals a broad range of outcomes, including synergistic, additive and antagonistic effects. We conducted a 90-day long experiment exposing corals to realistic levels of elevated nutrients and sediments, and heat stress. Colonies of two common scleractinian corals (Acropora millepora and Montipora tuberculosa) were kept in coastal seawater, or coastal seawater that was further organically and nutrient enriched (OE), and/or enriched with nitrate. Batches of OE were created daily, facilitating nutrient uptake, plankton succession and organic enrichment as observed in coastal waters. After 10 days of acclimation, 67% of the colonies had their temperature gradually increased from 27 degrees to 31.2 degrees C. After 3-7 weeks of heat stress, colonies of both species had significantly greater reductions in fluorescence yields and lower survival in OE than without addition of OE. Furthermore, photophysiological recovery was incomplete 31-38 days after ending the heat stress only in the OE treatments. Nitrate alone had no measurable effect on survival, bleaching and recovery in either species. Skeletal growth rates were reduced by 45% in heat-stressed A. millepora and by 24% in OE-exposed M. tuberculosa. We propose a conceptual trophic framework that resolves some of the apparently contradictory outcomes revealed by the review. Our study shows that management actions to reduce coastal eutrophication can improve the resistance and resilience of vulnerable coastal coral reefs to warming temperatures.	[Fabricius, Katharina E.; Cseke, Szilvia; Humphrey, Craig; De'ath, Glenn] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Cseke, Szilvia] Leibniz Ctr Trop Marine Ecol, Bremen, Germany	Australian Institute of Marine Science; Leibniz Zentrum fur Marine Tropenforschung (ZMT)	Fabricius, KE (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	k.fabricius@aims.gov.au	Fabricius, Katharina E/F-1759-2010	Fabricius, Katharina E/0000-0001-7671-4358; Humphrey, Craig/0000-0002-1303-036X	Australian Institute of Marine Science; Australian Government's Marine and Tropical Sciences Research Facility; Australian Government's National Environmental Research Program	Australian Institute of Marine Science; Australian Government's Marine and Tropical Sciences Research Facility(Australian Government); Australian Government's National Environmental Research Program(Australian Government)	This study was jointly funded by the Australian Institute of Marine Science, the Australian Government's Marine and Tropical Sciences Research Facility, and the Australian Government's National Environmental Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2007, LIMNOL OCEANOGR, V52, P716, DOI 10.4319/lo.2007.52.2.0716; Anthony KRN, 2009, FUNCT ECOL, V23, P539, DOI 10.1111/j.1365-2435.2008.01531.x; Anthony KRN, 2004, OECOLOGIA, V141, P373, DOI 10.1007/s00442-004-1647-7; Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Borell EM, 2008, J EXP MAR BIOL ECOL, V364, P116, DOI 10.1016/j.jembe.2008.07.033; Borell EM, 2008, OECOLOGIA, V157, P593, DOI 10.1007/s00442-008-1102-2; Brodie J, 2010, MAR FRESHWATER RES, V61, P651, DOI 10.1071/MF08030; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; Carilli JE, 2010, GLOBAL CHANGE BIOL, V16, P1247, DOI 10.1111/j.1365-2486.2009.02043.x; Carilli JE, 2009, MAR POLLUT BULL, V58, P1835, DOI 10.1016/j.marpolbul.2009.07.024; Connolly SR, 2012, CORAL REEFS IN PRESS; Cooper TF, 2012, SCIENCE, V335, P593, DOI 10.1126/science.1214570; Cunning R, 2013, NAT CLIM CHANGE, V3, P259, DOI [10.1038/NCLIMATE1711, 10.1038/nclimate1711]; DAVIES PS, 1989, MAR BIOL, V101, P389; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; DUBINSKY Z, 1990, PROC R SOC SER B-BIO, V239, P231, DOI 10.1098/rspb.1990.0015; Fabricius K, 2012, ESTUARINE COASTAL SH; Fabricius KE, 2010, CORAL REEFS, V29, P593, DOI 10.1007/s00338-010-0628-z; Fabricius KE, 2012, MAR POLLUT BULL, V65, P320, DOI 10.1016/j.marpolbul.2011.09.004; Fabricius KE, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P493, DOI 10.1007/978-94-007-0114-4_28; Fabricius KE, 2006, LIMNOL OCEANOGR, V51, P30, DOI 10.4319/lo.2006.51.1.0030; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fabricius KE, 2004, ECOL APPL, V14, P1448, DOI 10.1890/03-5320; Fabricius KE, 2003, ESTUAR COAST SHELF S, V57, P613, DOI 10.1016/S0272-7714(02)00400-6; Fabricius KE, 2004, MOL ECOL, V13, P2445, DOI 10.1111/j.1365-294X.2004.02230.x; Ferrier-Pages C, 2001, J EXP MAR BIOL ECOL, V259, P249, DOI 10.1016/S0022-0981(01)00241-6; Ferrier-Pages C, 2010, J EXP MAR BIOL ECOL, V390, P118, DOI 10.1016/j.jembe.2010.05.007; Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677, DOI 10.4319/lo.2000.45.3.0677; Fussel HM, 2009, CLIMATIC CHANGE, V97, P469, DOI 10.1007/s10584-009-9648-5; Goreau T, 2000, CONSERV BIOL, V14, P5, DOI 10.1046/j.1523-1739.2000.00011.x; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Grottoli AG, 2004, MAR BIOL, V145, P621, DOI 10.1007/s00227-004-1337-3; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoogenboom MO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030167; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; Jimenez IM, 2008, LIMNOL OCEANOGR, V53, P1548, DOI 10.4319/lo.2008.53.4.1548; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Kroon FJ, 2012, MAR POLLUT BULL, V65, P167, DOI 10.1016/j.marpolbul.2011.10.018; Lough JM, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002050; Manzello DP, 2010, CORAL REEFS, V29, P749, DOI 10.1007/s00338-010-0623-4; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; McCullagh P, 1989, GEN LINEAR MODELS; McCulloch M, 2003, NATURE, V421, P727, DOI 10.1038/nature01361; Nordemar I, 2003, MAR BIOL, V142, P669, DOI 10.1007/s00227-002-0989-0; R Development Core Team, 2012, R LANG ENV STAT COMP; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Robertson AI, 1998, ESTUAR COAST SHELF S, V46, P319, DOI 10.1006/ecss.1997.0270; Sampayo EM, 2009, MOL ECOL, V18, P500, DOI 10.1111/j.1365-294X.2008.04037.x; Schaffelke B, 2012, MAR POLLUT BULL, V65, P249, DOI 10.1016/j.marpolbul.2011.10.031; Secretariat of the Convention on Biological Diversity, 2010, COP 10 DEC X 2 STRAT; Shick JM, 2011, LIMNOL OCEANOGR, V56, P813, DOI 10.4319/lo.2011.56.3.0813; State of Queensland, 2009, REEF WAT QUAL PROT P; van Oppen Madeleine J. H., 2009, V205, P83; Wagner DE, 2010, MAR ECOL PROG SER, V408, P65, DOI 10.3354/meps08584; Warner ME, 2002, MAR BIOL, V141, P31, DOI 10.1007/s00227-002-0807-8; Weber M, 2006, J EXP MAR BIOL ECOL, V336, P18, DOI 10.1016/j.jembe.2006.04.007; Weber M, 2012, P NATL ACAD SCI USA, V109, pE1558, DOI 10.1073/pnas.1100715109; West J, 2003, COMMENTARY, V115, P17; Wiedenmann J, 2013, NAT CLIM CHANGE, V3, P160, DOI 10.1038/NCLIMATE1661; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wooldridge S, 2006, MAR POLLUT BULL, V52, P1467, DOI 10.1016/j.marpolbul.2006.05.009; Wooldridge SA, 2009, ECOL APPL, V19, P1492, DOI 10.1890/08-0963.1; Wooldridge SA, 2009, MAR POLLUT BULL, V58, P745, DOI 10.1016/j.marpolbul.2008.12.013	65	37	37	3	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54399	10.1371/journal.pone.0054399	http://dx.doi.org/10.1371/journal.pone.0054399			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349876	Green Published, Green Submitted, gold			2022-12-25	WOS:000313738900064
J	Ilinsky, Y				Ilinsky, Yury			Coevolution of Drosophila melanogaster mtDNA and Wolbachia Genotypes	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; CYTOPLASMIC INCOMPATIBILITY; NATURAL-POPULATIONS; GENETIC-VARIATION; GENIC VARIATION; INFECTION; SELECTION; HISTORY; VIRULENT; SEQUENCE	Maternally inherited microorganisms can influence the mtDNA pattern of variation in hosts. This influence is driven by selection among symbionts and can cause the frequency of mitochondrial variants in the population to eventually increase or decrease. Wolbachia infection is common and widespread in Drosophila melanogaster populations. We compared genetic variability of D. melanogaster mitotypes with Wolbachia genotypes among isofemale lines associated with different geographic locations and time intervals to study coevolution of the mtDNA and Wolbachia. Phylogenetic analysis of D. melanogaster mtDNA revealed two clades diverged in Africa, each associated with one of the two Wolbachia genotype groups. No evidence of horizontal transmission of Wolbachia between maternal lineages has been found. All the mtDNA variants that occur in infected isofemale lines are found in uninfected isofemale lines and vice versa, which is indicative of a recent loss of infection from some maternal fly lineages and confirms a significant role of Wolbachia in the D. melanogaster mtDNA pattern of variation. Finally, we present a comparative analysis of biogeographic distribution of D. melanogaster mitotypes all over the world.	[Ilinsky, Yury] Russian Acad Sci, Siberian Branch, Inst Cytol & Genet, Lab Populat Genet, Novosibirsk, Russia; [Ilinsky, Yury] Novosibirsk State Univ, Dept Cytol & Genet, Novosibirsk 630090, Russia	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Novosibirsk State University; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Ilinsky, Y (corresponding author), Russian Acad Sci, Siberian Branch, Inst Cytol & Genet, Lab Populat Genet, Novosibirsk, Russia.	paulee@bionet.nsc.ru	Ilinsky, Yury Y/A-1326-2017	Ilinsky, Yury/0000-0002-2691-3241	Russian Foundation for Basic Research [12-04-01319-a]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by grant number 12-04-01319-a from the Russian Foundation for Basic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azou Y, 2001, HEREDITY, V86, P110, DOI 10.1046/j.1365-2540.2001.00814.x; Baldo L, 2008, MOL ECOL, V17, P557, DOI 10.1111/j.1365-294X.2007.03608.x; Ballard JWO, 2000, J MOL EVOL, V51, P48, DOI 10.1007/s002390010066; Bourtzis K., 1994, Insect Molecular Biology, V3, P131, DOI 10.1111/j.1365-2583.1994.tb00160.x; Charlat S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-64; Clancy DJ, 2008, AGING CELL, V7, P795, DOI 10.1111/j.1474-9726.2008.00428.x; DAVID JR, 1988, TRENDS GENET, V4, P106, DOI 10.1016/0168-9525(88)90098-4; DEBRUIJN MHL, 1983, NATURE, V304, P234, DOI 10.1038/304234a0; Fry AJ, 2004, HEREDITY, V93, P379, DOI 10.1038/sj.hdy.6800514; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; GARESSE R, 1988, GENETICS, V118, P649; Gleason JM, 1997, EVOLUTION, V51, P433, DOI 10.1111/j.1558-5646.1997.tb02430.x; Glinka S, 2003, GENETICS, V165, P1269; Glinka S, 2006, MOL BIOL EVOL, V23, P1869, DOI 10.1093/molbev/msl069; Haag-Liautard C, 2008, PLOS BIOL, V6, P1706, DOI 10.1371/journal.pbio.0060204; Haddrill PR, 2005, GENOME RES, V15, P790, DOI 10.1101/gr.3541005; HALE LR, 1991, GENETICS, V129, P103; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hoffmann AA, 1998, GENETICS, V148, P221; HOLDEN PR, 1993, GENET RES, V62, P23, DOI 10.1017/S0016672300031529; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Hutter S, 2009, GENETICS, V181, P1699; Ilinsky YY, 2007, RUSS J GENET+, V43, P748, DOI 10.1134/S102279540707006X; Ilinsky Yu.Yu., 2007, DOKL BIOL SCI, V413, P166, DOI [10.1134/S0012496607020238, DOI 10.1134/S0012496607020238]; Ilinsky YY, 2006, DROS INF SERV, V89, P89; Jensen JD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000198; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lewis DL, 1995, INSECT MOL BIOL, V4, P263, DOI 10.1111/j.1365-2583.1995.tb00032.x; Li HP, 2006, PLOS GENET, V2, P1580, DOI 10.1371/journal.pgen.0020166; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Nunes MDS, 2008, MOL BIOL EVOL, V25, P2493, DOI 10.1093/molbev/msn199; Ometto L, 2005, MOL BIOL EVOL, V22, P2119, DOI 10.1093/molbev/msi207; ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699; Palumbi Stephen R., 1996, P205; Parsch J, 2009, MOL BIOL EVOL, V26, P691, DOI 10.1093/molbev/msn297; Pool JE, 2012, POPULATION GENOMICS; Pool JE, 2006, GENETICS, V174, P915, DOI 10.1534/genetics.106.058693; RAND DM, 1994, GENETICS, V138, P741; Reynolds KT, 2003, GENETICS, V164, P1027; Richardson MF, 2012, POPULATION GENOMICS; Riegler M, 2005, CURR BIOL, V15, P1428, DOI 10.1016/j.cub.2005.06.069; Rodriguero MS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-340; Schofl G, 2005, GENETICS, V170, P1701, DOI 10.1534/genetics.104.037507; SINGH RS, 1987, GENETICS, V115, P313; SOLIGNAC M, 1994, CR ACAD SCI III-VIE, V317, P461; Stephan W, 2007, HEREDITY, V98, P65, DOI 10.1038/sj.hdy.6800901; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Verspoor RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026318; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324; Zhukova MV, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S15	55	40	47	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54373	10.1371/journal.pone.0054373	http://dx.doi.org/10.1371/journal.pone.0054373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349865	Green Published, gold, Green Submitted			2022-12-25	WOS:000313738900062
J	Li, XL; Tai, HH				Li, Xiuling; Tai, Hsin-Hsiung			Activation of Thromboxane A(2) Receptor (TP) Increases the Expression of Monocyte Chemoattractant Protein-1 (MCP-1)/Chemokine (C-C motif) Ligand 2 (CCL2) and Recruits Macrophages to Promote Invasion of Lung Cancer Cells	PLOS ONE			English	Article							MULTIPLE SIGNALING PATHWAYS; NF-KAPPA-B; PROSTATE-CANCER; GENE-EXPRESSION; BLADDER-CANCER; IN-VIVO; ENDOTHELIAL-CELLS; ASTROCYTOMA-CELLS; TUMOR-METASTASIS; CARCINOMA CELLS	Thromboxane synthase (TXAS) and thromboxane A(2) receptor (TP), two critical components for thromboxane A(2) (TXA(2)) signaling, have been suggested to be involved in cancer invasion and metastasis. However, the mechanisms by which TXA(2) promotes these processes are still unclear. Here we show that TXA(2) mimetic, I-BOP, induced monocyte chemoattractant protein -1(MCP-1)/chemokine (C-C motif) ligand 2 (CCL2) expression at both mRNA and protein levels in human lung adenocarcinoma A549 cells stably over-expressing TP receptor alpha isoform (A549-TP alpha). The induction of MCP-1 was also found in other lung cancer cells H157 and H460 that express relatively high levels of endogenous TP. Using specific inhibitors of several signaling molecules and promoter/luciferase assay, we identified that transcription factor SP1 mediates I-BOP-induced MCP-1 expression. Furthermore, supernatants from I-BOP-treated A549-TP alpha cells enhanced MCP-1-dependent migration of RAW 264.7 macrophages. Moreover, co-culture of A549 cells with RAW 264.7 macrophages induced expression of MMPs, VEGF and MCP-1 genes, and increased the invasive potential in A549 cells. These findings suggest that TXA(2) may stimulate invasion of cancer cells through MCP-1-mediated macrophage recruitment.	[Li, Xiuling; Tai, Hsin-Hsiung] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY USA	University of Kentucky	Tai, HH (corresponding author), Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY USA.	htai1@email.uky.edu	li, xiu/GXV-1745-2022		University of Kentucky	University of Kentucky	University of Kentucky supported the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenberg DA, 2000, CANCER IMMUNOL IMMUN, V49, P63, DOI 10.1007/s002620050603; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Cai Z, 2009, NEOPLASIA, V11, P228, DOI 10.1593/neo.81282; Chen JJW, 2003, CLIN CANCER RES, V9, P729; Chiu HY, 2012, CYTOKINE, V59, P423, DOI 10.1016/j.cyto.2012.04.017; Coursey TG, 2011, CANCER RES, V71, P2445, DOI 10.1158/0008-5472.CAN-10-2628; Ekambaram P, 2011, CANC METASTASIS REV; Ferrero E, 1998, EUR J IMMUNOL, V28, P2530, DOI 10.1002/(SICI)1521-4141(199808)28:08<2530::AID-IMMU2530>3.0.CO;2-6; Fujimoto H, 2009, INT J CANCER, V125, P1276, DOI 10.1002/ijc.24378; Giese A, 1999, Neuro Oncol, V1, P3, DOI 10.1093/neuonc/1.1.3; Gu LY, 2006, NEPHROL DIAL TRANSPL, V21, P299, DOI 10.1093/ndt/gfi210; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Hanada T, 2000, INT J UROL, V7, P263, DOI 10.1046/j.1442-2042.2000.00190.x; HEPPNER GH, 1984, CANCER RES, V44, P2259; HU ED, 1994, EMBO J, V13, P3094, DOI 10.1002/j.1460-2075.1994.tb06608.x; Hung JJ, 2005, J BIOL CHEM, V280, P36283, DOI 10.1074/jbc.M504904200; Ishitsuka Y, 2009, J PHARMACOL SCI, V111, P211, DOI 10.1254/jphs.09128SC; Ishizuka T, 2000, CLIN EXP IMMUNOL, V120, P71, DOI 10.1046/j.1365-2249.2000.01169.x; Joshi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004208; Keelan JA, 2000, J SOC GYNECOL INVEST, V7, P37, DOI 10.1016/S1071-5576(99)00065-9; Koide N, 2004, AM J GASTROENTEROL, V99, P1667, DOI 10.1111/j.1572-0241.2004.30733.x; Leek RD, 1999, BRIT J CANCER, V79, P991, DOI 10.1038/sj.bjc.6690158; Li XL, 2012, CURR CANCER DRUG TAR, V12, P703, DOI 10.2174/156800912801784884; Li XL, 2009, CARCINOGENESIS, V30, P1606, DOI 10.1093/carcin/bgp161; Lim JH, 2009, EXP MOL MED, V41, P757, DOI 10.3858/emm.2009.41.10.082; Lin CW, 2010, CARCINOGENESIS, V31, P2039, DOI 10.1093/carcin/bgq172; Lissbrant IF, 2000, INT J ONCOL, V17, P445; Loberg RD, 2007, NEOPLASIA, V9, P556, DOI 10.1593/neo.07307; Loberg RD, 2006, NEOPLASIA, V8, P578, DOI 10.1593/neo.06280; Lu X, 2009, J BIOL CHEM, V284, P29087, DOI 10.1074/jbc.M109.035899; Lu Y, 2006, PROSTATE, V66, P1311, DOI 10.1002/pros.20464; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Martin T, 1997, EUR J IMMUNOL, V27, P1091, DOI 10.1002/eji.1830270508; McDonough W, 1998, J NEUROPATH EXP NEUR, V57, P449, DOI 10.1097/00005072-199805000-00008; Melgarejo E, 2009, INT J BIOCHEM CELL B, V41, P998, DOI 10.1016/j.biocel.2008.07.018; MILLER DM, 1987, AM J MED SCI, V294, P388, DOI 10.1097/00000441-198711000-00015; Moussa O, 2008, CANCER RES, V68, P4097, DOI 10.1158/0008-5472.CAN-07-6560; Nakayama T, 2006, J LEUKOCYTE BIOL, V79, P95, DOI 10.1189/jlb.0405226; NEEDLEMAN P, 1976, NATURE, V261, P558, DOI 10.1038/261558a0; Nie DT, 2000, BIOCHEM BIOPH RES CO, V267, P245, DOI 10.1006/bbrc.1999.1840; Ohri CM, 2009, EUR RESPIR J, V33, P118, DOI 10.1183/09031936.00065708; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ping DS, 1996, IMMUNITY, V4, P455, DOI 10.1016/S1074-7613(00)80412-4; Ping DS, 1999, J BIOL CHEM, V274, P31909, DOI 10.1074/jbc.274.45.31909; Potula HSK, 2009, J BIOL CHEM, V284, P31142, DOI 10.1074/jbc.M109.012526; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Thompson WL, 2009, BRAIN RES, V1287, P47, DOI 10.1016/j.brainres.2009.06.081; Toomey D, 2003, INT J CANCER, V103, P408, DOI 10.1002/ijc.10836; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Wei J, 2007, BIOCHEM PHARMACOL, V74, P787, DOI 10.1016/j.bcp.2007.06.008; Wei JY, 2010, LUNG CANCER, V69, P26, DOI 10.1016/j.lungcan.2009.09.009; Wolf MJ, 2012, CANCER CELL, V22, P91, DOI 10.1016/j.ccr.2012.05.023; Yan WL, 2006, J PHARMACOL EXP THER, V317, P267, DOI 10.1124/jpet.105.096826; Yao Y, 2010, J BIOL CHEM, V285, P31509, DOI 10.1074/jbc.M110.124891; Yoshimoto A, 2005, ONCOL REP, V13, P1049; Zeni E, 2007, EUR RESPIR J, V30, P627, DOI 10.1183/09031936.00129306; Zhang JH, 2011, AM J PATHOL, V178, P382, DOI 10.1016/j.ajpath.2010.11.017; Zhou ZHL, 1998, J IMMUNOL, V160, P3908	58	25	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54073	10.1371/journal.pone.0054073	http://dx.doi.org/10.1371/journal.pone.0054073			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349788	Green Published, gold			2022-12-25	WOS:000313738900036
J	Ondrusova, L; Vachtenheim, J; Reda, J; Zakova, P; Benkova, K				Ondrusova, Lubica; Vachtenheim, Jiri; Reda, Jiri; Zakova, Petra; Benkova, Kamila			MITF-Independent Pro-Survival Role of BRG1-Containing SWI/SNF Complex in Melanoma Cells	PLOS ONE			English	Article							CHROMATIN REMODELING COMPLEXES; TRANSCRIPTION FACTOR MITF; LUNG-CANCER; INCREASED EXPRESSION; CUTANEOUS MELANOMA; MASTER REGULATOR; XIII COLLAGEN; TARGET GENES; BRG1; BRM	Metastasized malignant melanoma has a poor prognosis because of its intrinsic resistance to chemotherapy and radiotherapy. The central role in the melanoma transcriptional network has the transcription factor MITF (microphthalmia-associated transcription factor). It has been shown recently that the expression of MITF and some of its target genes require the SWI/SNF chromatin remodeling complex. Here we demonstrate that survival of melanoma cells requires functional SWI/SNF complex not only by supporting expression of MITF and its targets and but also by activating expression of prosurvival proteins not directly regulated by MITF. Microarray analysis revealed that besides the MITF-driven genes, expression of proteins like osteopontin, IGF1, TGF beta 2 and survivin, the factors known to be generally associated with progression of tumors and the antiapoptotic properties, were reduced in acute BRG1-depleted 501mel cells. Western blots and RT-PCR confirmed the microarray findings. These proteins have been verified to be expressed independently of MITF, because MITF depletion did not impair their expression. Because these genes are not regulated by MITF, the data suggests that loss of BRG1-based SWI/SNF complexes negatively affects survival pathways beyond the MITF cascade. Immunohistochemistry showed high expression of both BRM and BRG1 in primary melanomas. Exogenous CDK2, osteopontin, or IGF1 each alone partly relieved the block of proliferation imposed by BRG1 depletion, implicating that more factors, besides the MITF target genes, are involved in melanoma cell survival. Together these results demonstrate an essential role of SWI/SNF for the expression of MITF-dependent and MITF-independent prosurvival factors in melanoma cells and suggest that SWI/SNF may be a potential and effective target in melanoma therapy.	[Ondrusova, Lubica; Vachtenheim, Jiri; Reda, Jiri; Zakova, Petra] Charles Univ Prague, Fac Med 1, Inst Med Biochem, Lab Transcript & Cell Signaling, Prague, Czech Republic; [Ondrusova, Lubica; Vachtenheim, Jiri; Reda, Jiri; Zakova, Petra] Charles Univ Prague, Fac Med 1, Diagnost Lab, Prague, Czech Republic; [Benkova, Kamila] Hosp Bulovka, Dept Pathol, Prague, Czech Republic	Charles University Prague; Charles University Prague; Bulovka University Hospital	Vachtenheim, J (corresponding author), Charles Univ Prague, Fac Med 1, Inst Med Biochem, Lab Transcript & Cell Signaling, Prague, Czech Republic.	jiri.vachtenheim@lf1.cuni.cz	Žáková, Petra/J-3270-2017; Réda, Jiří/I-7023-2017; Vachtenheim, Jiri/I-6232-2017; Ondrušová, Lubica/HII-2979-2022	Žáková, Petra/0000-0002-8172-6115; Réda, Jiří/0000-0002-4455-4756; Vachtenheim, Jiri/0000-0002-4923-9296; 	Internal Granting Agency, Ministry of Health, Czech Rep [NT/11229-3]	Internal Granting Agency, Ministry of Health, Czech Rep	This work was supported by a grant no. NT/11229-3 (to JV) from the Internal Granting Agency, Ministry of Health (www.mzcr.cz), Czech Rep. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay D, 2007, AGING CELL, V6, P577, DOI 10.1111/j.1474-9726.2007.00308.x; Bartlett C, 2011, J CELL PHYSIOL, V226, P1989, DOI 10.1002/jcp.22533; Becker TM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-4; Bourgo RJ, 2009, MOL BIOL CELL, V20, P3192, DOI 10.1091/mbc.E08-12-1224; Busca R, 2005, J CELL BIOL, V170, P49, DOI 10.1083/jcb.200501067; Carreira S, 2005, NATURE, V433, P764, DOI 10.1038/nature03269; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Das S, 2009, J BIOL CHEM; de la Serna IL, 2006, J BIOL CHEM, V281, P20233, DOI 10.1074/jbc.M512052200; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Dynek JN, 2008, CANCER RES, V68, P3124, DOI 10.1158/0008-5472.CAN-07-6622; Flowers S, 2009, J BIOL CHEM, V284, P10067, DOI 10.1074/jbc.M808782200; Fukuoka J, 2004, CLIN CANCER RES, V10, P4314, DOI 10.1158/1078-0432.CCR-03-0489; Giuliano S, 2010, CANCER RES, V70, P3813, DOI 10.1158/0008-5472.CAN-09-2913; Glaros S, 2007, ONCOGENE, V26, P7058, DOI 10.1038/sj.onc.1210514; Goding CR, 2000, GENE DEV, V14, P1712; Goodall J, 2008, CANCER RES, V68, P7788, DOI 10.1158/0008-5472.CAN-08-1053; Halliday GM, 2009, INT J BIOCHEM CELL B, V41, P725, DOI 10.1016/j.biocel.2008.04.026; Hilmi C, 2008, J INVEST DERMATOL, V128, P1499, DOI 10.1038/sj.jid.5701185; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Javelaud D, 2008, PIGM CELL MELANOMA R, V21, P123, DOI 10.1111/j.1755-148X.2008.00450.x; Keenen B, 2010, ONCOGENE, V29, P81, DOI 10.1038/onc.2009.304; Kido K, 2009, CANCER SCI, V100, P1863, DOI 10.1111/j.1349-7006.2009.01266.x; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Lin H, 2010, BRIT J DERMATOL, V163, P502, DOI 10.1111/j.1365-2133.2010.09851.x; Liu T, 2004, ONCOGENE, V23, P39, DOI 10.1038/sj.onc.1206978; McGill GG, 2006, J BIOL CHEM, V281, P10365, DOI 10.1074/jbc.M513094200; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Medina PP, 2008, HUM MUTAT, V29, P617, DOI 10.1002/humu.20730; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Ohanna M, 2011, GENE DEV, V25, P1245, DOI 10.1101/gad.625811; Peltonen S, 1999, J INVEST DERMATOL, V113, P635, DOI 10.1046/j.1523-1747.1999.00736.x; Pierrat M.J., 2012, J BIOL CHEM; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Reisman DN, 2003, CANCER RES, V63, P560; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Saladi SV, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-280; Sentani K, 2001, PATHOBIOLOGY, V69, P315, DOI 10.1159/000064638; Shen H, 2008, CANCER RES, V68, P10154, DOI 10.1158/0008-5472.CAN-08-1794; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Strobeck MW, 2002, J BIOL CHEM, V277, P4782, DOI 10.1074/jbc.M109532200; Sun A, 2007, PROSTATE, V67, P203, DOI 10.1002/pros.20521; Vachtenheim J, 2004, PIGM CELL RES, V17, P43, DOI 10.1046/j.1600-0749.2003.00108.x; Vachtenheim J, 2001, J INVEST DERMATOL, V117, P1505, DOI 10.1046/j.0022-202x.2001.01563.x; Vachtenheim J, 2010, EXP DERMATOL, V19, P617, DOI 10.1111/j.1600-0625.2009.01053.x; Vachtenheim J, 2010, BIOCHEM BIOPH RES CO, V392, P454, DOI 10.1016/j.bbrc.2010.01.048; Vaisanen T, 2005, J PATHOL, V207, P324, DOI 10.1002/path.1836; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Vinod Saladi Srinivas, 2010, Epigenetics, V5, P469; Watanabe H, 2006, ONCOGENE, V25, P470, DOI 10.1038/sj.onc.1209068; Xu Y, 2007, J BIOL CHEM, V282, P37429, DOI 10.1074/jbc.M706039200; Yarnamichi N, 2007, CANCER RES, V67, P10727, DOI 10.1158/0008-5472.CAN-07-2601; Zhang CY, 2009, CANCER RES, V69, P828, DOI 10.1158/0008-5472.CAN-08-2588; Zhou YW, 2005, J INVEST DERMATOL, V124, P1044, DOI 10.1111/j.0022-202X.2005.23680.x	56	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54110	10.1371/journal.pone.0054110	http://dx.doi.org/10.1371/journal.pone.0054110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349796	gold, Green Published, Green Submitted			2022-12-25	WOS:000313738900040
J	Borie, R; Quesnel, C; Phin, S; Debray, MP; Marchal-Somme, J; Tiev, K; Bonay, M; Fabre, A; Soler, P; Dehoux, M; Crestani, B				Borie, Raphael; Quesnel, Christophe; Phin, Sophie; Debray, Marie-Pierre; Marchal-Somme, Joelle; Tiev, Kiet; Bonay, Marcel; Fabre, Aurelie; Soler, Paul; Dehoux, Monique; Crestani, Bruno			Detection of Alveolar Fibrocytes in Idiopathic Pulmonary Fibrosis and Systemic Sclerosis	PLOS ONE			English	Article							CIRCULATING FIBROCYTES; LUNG-DISEASE; FIBROBLASTS; CELLS; PROGENITOR	Background: Fibrocytes are circulating precursors for fibroblasts. Blood fibrocytes are increased in patients with idiopathic pulmonary fibrosis (IPF). The aim of this study was to determine whether alveolar fibrocytes are detected in broncho-alveolar lavage (BAL), to identify their prognostic value, and their potential association with culture of fibroblasts from BAL. Methods: We quantified fibrocytes in BAL from 26 patients with IPF, 9 patients with Systemic Sclerosis(SSc)-interstitial lung disease (ILD), and 11 controls. BAL cells were cultured to isolate alveolar fibroblasts. Results: Fibrocytes were detected in BAL in 14/26 IPF (54%) and 5/9 SSc patients (55%), and never in controls. Fibrocytes were in median 2.5% [0.4-19.7] and 3.0% [2.7-3.7] of BAL cells in IPF and SSc-ILD patients respectively. In IPF patients, the number of alveolar fibrocytes was correlated with the number of alveolar macrophages and was associated with a less severe disease but not with a better outcome. Fibroblasts were cultured from BAL in 12/26 IPF (46%), 5/9 SSc-ILD (65%) and never in controls. The detection of BAL fibrocytes did not predict a positive culture of fibroblasts. Conclusion: Fibrocytes were detected in BAL fluid in about half of the patients with IPF and SSc-ILD. Their number was associated with less severe disease in IPF patients and did not associate with the capacity to grow fibroblasts from BAL fluid.	[Borie, Raphael; Crestani, Bruno] Hop Bichat Claude Bernard, AP HP, Serv Pneumol A, Ctr Competences Malad Rares Pulm, F-75877 Paris, France; [Borie, Raphael; Quesnel, Christophe; Phin, Sophie; Marchal-Somme, Joelle; Bonay, Marcel; Fabre, Aurelie; Soler, Paul; Dehoux, Monique; Crestani, Bruno] Univ Paris 07, INSERM, U700, Fac Bichat, Paris, France; [Quesnel, Christophe] Hop Tenon, AP HP, Serv Anesthesie & Reanimat Chirurg, F-75970 Paris, France; [Debray, Marie-Pierre] Hop Bichat Claude Bernard, AP HP, Serv Radiol, F-75877 Paris, France; [Tiev, Kiet] Hop St Antoine, AP HP, Serv Med Interne, F-75571 Paris, France; [Bonay, Marcel] Hop St Antoine, AP HP, Serv Explorat Fonct, F-75571 Paris, France; [Bonay, Marcel; Fabre, Aurelie; Crestani, Bruno] Univ Paris 07, PRES Sorbonne Paris Cite, Paris, France; [Fabre, Aurelie] Hop Bichat Claude Bernard, AP HP, Serv Anatomopathol, F-75877 Paris, France; [Dehoux, Monique] Hop Bichat Claude Bernard, AP HP, Serv Biochim, F-75877 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Crestani, B (corresponding author), Hop Bichat Claude Bernard, AP HP, Serv Pneumol A, Ctr Competences Malad Rares Pulm, F-75877 Paris, France.	bruno.crestani@bch.aphp.fr	Bonay, Marcel/ABG-2039-2020	Bonay, Marcel/0000-0003-1446-7456; Borie, Raphael/0000-0002-9906-0024; fabre, aurelie/0000-0001-8176-1386	Association des Sclerodermiques de France (ASF); Groupe Francais de Recherche sur la Sclerodermie; Chancellerie des Universites de Paris (legs Poix); Fondation pour la Recherche Medicale; l'association Pierre Enjalran; European Commission [202224]	Association des Sclerodermiques de France (ASF); Groupe Francais de Recherche sur la Sclerodermie; Chancellerie des Universites de Paris (legs Poix); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); l'association Pierre Enjalran; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by a grant from the Association des Sclerodermiques de France (ASF), the Groupe Francais de Recherche sur la Sclerodermie, the Chancellerie des Universites de Paris (legs Poix), the Fondation pour la Recherche Medicale, l'association Pierre Enjalran and the European Commission (FP7 grant agreement #202224, European IPF Network). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Andersson-Sjoland A, 2008, INT J BIOCHEM CELL B, V40, P2129, DOI 10.1016/j.biocel.2008.02.012; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; Fireman E, 2001, LUNG, V179, P105, DOI 10.1007/s004080000051; Fujiwara A, 2012, RESPIROLOGY, V17, P693, DOI 10.1111/j.1440-1843.2012.02167.x; Gan Y, 2011, ARTHRITIS RHEUM-US, V63, P2484, DOI 10.1002/art.30386; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Kazerooni EA, 1997, AM J ROENTGENOL, V169, P977, DOI 10.2214/ajr.169.4.9308447; Lama VN, 2007, J CLIN INVEST, V117, P989, DOI 10.1172/JCI29713; Lama Vibha N, 2006, Proc Am Thorac Soc, V3, P373, DOI 10.1513/pats.200512-133TK; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Maharaj SS, 2012, PULM PHARMACOL THER, V25, P263, DOI 10.1016/j.pupt.2011.09.002; Mattoli S, 2009, CURR STEM CELL RES T, V4, P266, DOI 10.2174/157488809789649232; Medina A, 2010, MOL CELL BIOCHEM, V344, P11, DOI 10.1007/s11010-010-0524-4; Metz CN, 2003, CELL MOL LIFE SCI, V60, P1342, DOI 10.1007/s00018-003-2328-0; Moeller A, 2009, AM J RESP CRIT CARE, V179, P588, DOI 10.1164/rccm.200810-1534OC; Moore BB, 2005, AM J PATHOL, V166, P675, DOI 10.1016/S0002-9440(10)62289-4; Pilling D, 2007, J IMMUNOL, V179, P4035, DOI 10.4049/jimmunol.179.6.4035; Quesnel C, 2010, EUR RESPIR J, V35, P1312, DOI 10.1183/09031936.00074709; Quesnel C, 2008, AM J PHYSIOL-LUNG C, V294, pL334, DOI 10.1152/ajplung.00096.2007; Quesnel C, 2012, CRIT CARE MED, V40, P21, DOI 10.1097/CCM.0b013e31822d718b; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rao RM, 2004, J EXP MED, V200, P713, DOI 10.1084/jem.20040499; Reilkoff RA, 2011, NAT REV IMMUNOL, V11, P427, DOI 10.1038/nri2990; Tourkina E, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-15; Valenzuela-Fernandez A, 2002, J BIOL CHEM, V277, P15677, DOI 10.1074/jbc.M111388200	29	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53736	10.1371/journal.pone.0053736	http://dx.doi.org/10.1371/journal.pone.0053736			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341987	Green Published, Green Submitted, gold			2022-12-25	WOS:000313682700041
J	Cheng, H; Wang, J; Chu, SS; Yan, HL; Yu, DY				Cheng, Hao; Wang, Jiao; Chu, Shanshan; Yan, Hong-Lang; Yu, Deyue			Diversifying Selection on Flavanone 3-Hydroxylase and Isoflavone Synthase Genes in Cultivated Soybean and Its Wild Progenitors	PLOS ONE			English	Article							BIOSYNTHESIS; RECOMBINATION; ACCUMULATION; EXPRESSION; NUMBER	Soybean isoflavone synthase (IFS) and flavanone 3-hydroxylase (F3H) are two key enzymes catalyzing the biosynthesis of isoflavonoids and flavonoids, both of which play diverse roles in stress responses. However, little is known about the evolutionary pattern of these genes in cultivated soybean and its wild progenitors. Herein, we investigated the nucleotide polymorphisms in Isoflavone synthase (IFS1, IFS2) and Flavanone 3-hydroxylase (F3H2) genes from 33 soybean accessions, including 17 cultivars (Glycine max) and 16 their wild progenitors (Glycine soja). Our data showed that the target genes shared the levels of nucleotide polymorphism with three reference genes involved in plant-microbe interactions, but possessed a much higher nucleotide polymorphism than other reference genes. Moreover, no significant genetic differentiation was found between cultivated soybean and its wild relatives in three target genes, despite of considering bottleneck and founder effect during domestication. These results indicate that IFS and F3H genes could have experienced gene introgressions or diversifying selection events during domestication process. Especially, F3H2 gene appears to evolve under positive selection and enjoy a faster evolutionary rate than IFS1 and IFS2 genes.	[Cheng, Hao; Wang, Jiao; Chu, Shanshan; Yan, Hong-Lang; Yu, Deyue] Nanjing Agr Univ, Natl Ctr Soybean Improvement, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Yu, DY (corresponding author), Nanjing Agr Univ, Natl Ctr Soybean Improvement, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	dyyu@njau.edu.cn			National Basic Research Program of China (973 Program) [2010CB125906, 2009CB118400]; National Natural Science Foundation of China [31000718, 31171573, 31201230]; Jiangsu Provincial Support Program [BE2012328, BK2012768]; Ph.D. Programs Foundation of Ministry of Education of China [20090097120016]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Support Program; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China)	This work was supported in part by National Basic Research Program of China (973 Program) (2010CB125906, 2009CB118400), National Natural Science Foundation of China (31000718, 31171573, 31201230), Jiangsu Provincial Support Program(BE2012328, BK2012768) and Ph.D. Programs Foundation of Ministry of Education of China (No. 20090097120016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguade M, 2001, MOL BIOL EVOL, V18, P1, DOI 10.1093/oxfordjournals.molbev.a003714; Akashi T, 1999, PLANT PHYSIOL, V121, P821, DOI 10.1104/pp.121.3.821; Bergelson J, 2001, SCIENCE, V292, P2281, DOI 10.1126/science.1061337; Cheng H, 2008, PLANT SCI, V175, P505, DOI 10.1016/j.plantsci.2008.05.020; Cheng H, 2010, MOL BREEDING, V25, P13, DOI 10.1007/s11032-009-9305-8; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gutierrez-Gonzalez JJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-105; Hudson RR, 2000, GENETICS, V155, P2011; HUDSON RR, 1985, GENETICS, V111, P147; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; Jung W, 2000, NAT BIOTECHNOL, V18, P208, DOI 10.1038/72671; Keim P., 1988, Soybean Genetics Newsletter, V15, P150; Kim HK, 2005, MOL CELLS, V19, P67; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Lee GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026720; LYNCH M, 1990, MOL BIOL EVOL, V7, P377; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nei M, 1987, MOL EVOLUTIONARY GEN; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SHEN P, 1986, GENETICS, V112, P441; Springob K, 2003, NAT PROD REP, V20, P288, DOI 10.1039/b109542k; Steele CL, 1999, ARCH BIOCHEM BIOPHYS, V367, P146, DOI 10.1006/abbi.1999.1238; TAJIMA F, 1989, GENETICS, V123, P597; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang Yusheng, 2002, Yingyong Shengtai Xuebao, V13, P71; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weir BS., 1996, GENETIC DATA ANAL; Xu DH, 2002, THEOR APPL GENET, V105, P645, DOI 10.1007/s00122-002-0972-7; Yu O, 2005, ADV AGRON, V86, P147, DOI 10.1016/S0065-2113(05)86003-1; Zabala G, 2005, PLANT CELL, V17, P2619, DOI 10.1105/tpc.105.033506; [智海剑 Zhi Haijian], 2005, [大豆科学, Soybean Science], V24, P5	32	8	8	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54154	10.1371/journal.pone.0054154	http://dx.doi.org/10.1371/journal.pone.0054154			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342093	gold, Green Published, Green Submitted			2022-12-25	WOS:000313682700091
J	Huh, JE; Ko, R; Jung, HJ; Lee, SY				Huh, Jeong-Eun; Ko, Ryeojin; Jung, Hyun Ju; Lee, Soo Young			Glycogen Synthase Kinase 3 beta Promotes Osteogenic Differentiation of Murine Adipose-Derived Stromal Cells	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; OSTEOBLAST DIFFERENTIATION; BETA-CATENIN; BONE-MARROW; CHONDROGENIC DIFFERENTIATION; WNT; PROLIFERATION; TISSUE; EXPANSION; INACTIVATION	Although the role of glycogen synthase kinase 3 beta (GSK3 beta) in osteogenic differentiation of bone marrow-derived mesenchymal stromal cells (BMSCs) is well-characterized as a negative regulator of beta-catenin, its effect on osteogenesis of adipose-derived stromal cells (ADSCs) is poorly understood. Here, we show that GSK3 beta positively regulates osteogenic differentiation of murine ADSCs. Gain-of-function studies showed that GSK3 beta promotes in vitro osteogenesis of ADSCs. Regulation of GSK3 beta activity in ADSCs, either by small interfering RNA (siRNA)-mediated GSK3 beta silencing or by pharmacological inhibitors, blunted osteogenesis and the expression of osteogenic markers. Importantly, we demonstrated that transgenic mice, engineered to overexpress the constitutively active GSK3 beta (GSK3 beta-S9A) mutant, exhibited a marked increase in osteogenesis, whereas expression of the catalytically inactive GSK3 beta (GSK3 beta-K85A) in mice inhibits osteogenic differentiation. Molecular analyses showed that the enhanced osteoblast differentiation induced by GSK3 beta was mediated by downregulation of beta-catenin. Remarkably, beta-catenin silencing enhances osteogenesis and osteoblast marker gene expression such as alkaline phosphatase (ALP) and osterix. Taken together, these findings demonstrate a novel role for GSK3 beta in the regulation of osteogenic differentiation in ADSCs.	[Huh, Jeong-Eun; Ko, Ryeojin; Jung, Hyun Ju; Lee, Soo Young] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea; [Lee, Soo Young] Ewha Womans Univ, Dept Life Sci, Dept Bioinspired Sci, Seoul, South Korea	Ewha Womans University; Ewha Womans University	Lee, SY (corresponding author), Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea.	leesy@ewha.ac.kr			National Research Foundation of Korea (NRF) grant; Korea Government (MEST) [R0A-2008-000-20001-0, R31-2008-000-10010-0, 2012-0000952, 2010-0020577]; Brain Korea 21 Project; LG Yonam Foundation	National Research Foundation of Korea (NRF) grant(National Research Foundation of Korea); Korea Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Brain Korea 21 Project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); LG Yonam Foundation	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea Government (MEST; R0A-2008-000-20001-0; R31-2008-000-10010-0; No. 2012-0000952; No. 2010-0020577). JEH and RK were supported by the second stage of the Brain Korea 21 Project. SYL is grateful for LG Yonam Foundation for the visiting scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad HA, 2003, TISSUE ENG, V9, P1301, DOI 10.1089/10763270360728215; Bain G, 2003, BIOCHEM BIOPH RES CO, V301, P84, DOI 10.1016/S0006-291X(02)02951-0; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Cho HH, 2006, TISSUE ENG, V12, P111, DOI 10.1089/ten.2006.12.111; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Davis LA, 2008, CELL MOL LIFE SCI, V65, P2658, DOI 10.1007/s00018-008-8042-1; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; De Boer J, 2004, TISSUE ENG, V10, P393, DOI 10.1089/107632704323061753; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712; Gregory CA, 2006, DRUG NEWS PERSPECT, V19, P445, DOI 10.1358/dnp.2006.19.8.1043960; Gregory CA, 2003, J BIOL CHEM, V278, P28067, DOI 10.1074/jbc.M300373200; Hamidouche Z, 2009, P NATL ACAD SCI USA, V106, P18587, DOI 10.1073/pnas.0812334106; Hartmann C, 2006, TRENDS CELL BIOL, V16, P151, DOI 10.1016/j.tcb.2006.01.001; Ito T, 2008, CYTOTECHNOLOGY, V56, P1, DOI 10.1007/s10616-007-9092-1; Jang HD, 2011, J BIOL CHEM, V286, P39043, DOI 10.1074/jbc.M111.256768; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; Mak KK, 2006, DEVELOPMENT, V133, P3695, DOI 10.1242/dev.02546; Krause U, 2010, P NATL ACAD SCI USA, V107, P4147, DOI 10.1073/pnas.0914360107; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Levi B, 2011, STEM CELLS, V29, P576, DOI 10.1002/stem.612; Li XF, 2005, NAT GENET, V37, P945, DOI 10.1038/ng1614; Lin GL, 2011, J CELL BIOCHEM, V112, P3491, DOI 10.1002/jcb.23287; Liu GZ, 2009, J CELL BIOL, V185, P67, DOI 10.1083/jcb.200810137; Liu N, 2011, J BONE MINER RES, V26, P2082, DOI 10.1002/jbmr.440; Majumdar MK, 2000, J HEMATOTH STEM CELL, V9, P841, DOI 10.1089/152581600750062264; Ogawa R, 2004, BIOCHEM BIOPH RES CO, V319, P511, DOI 10.1016/j.bbrc.2004.05.021; PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857; Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 2003, P NATL ACAD SCI USA, V100, P11917, DOI 10.1073/pnas.1834138100; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Rebelatto CK, 2008, EXP BIOL MED, V233, P901, DOI 10.3181/0712-RM-356; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; Rich JT, 2008, BIOCHEM BIOPH RES CO, V372, P230, DOI 10.1016/j.bbrc.2008.05.022; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Tsutsumi S, 2001, BIOCHEM BIOPH RES CO, V288, P413, DOI 10.1006/bbrc.2001.5777; van der Horst G, 2005, J BONE MINER RES, V20, P1867, DOI 10.1359/JBMR.050614; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Zaragosi LE, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-11; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	45	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54551	10.1371/journal.pone.0054551	http://dx.doi.org/10.1371/journal.pone.0054551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342170	Green Submitted, gold, Green Published			2022-12-25	WOS:000313682700125
J	Parente, V; Balasso, S; Pompilio, G; Verduci, L; Colombo, GI; Milano, G; Guerrini, U; Squadroni, L; Cotelli, F; Pozzoli, O; Capogrossi, MC				Parente, Valeria; Balasso, Serena; Pompilio, Giulio; Verduci, Lorena; Colombo, Gualtiero I.; Milano, Giuseppina; Guerrini, Uliano; Squadroni, Lidia; Cotelli, Franco; Pozzoli, Ombretta; Capogrossi, Maurizio C.			Hypoxia/Reoxygenation Cardiac Injury and Regeneration in Zebrafish Adult Heart	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; CELL-DEATH; RAT-HEART; IN-VIVO; EXPRESSION; HYPOXIA; GENE; ERYTHROPOIETIN; MYOCYTES; RELEASE	Aims: the adult zebrafish heart regenerates spontaneously after injury and has been used to study the mechanisms of cardiac repair. However, no zebrafish model is available that mimics ischemic injury in mammalian heart. We developed and characterized zebrafish cardiac injury induced by hypoxia/reoxygenation (H/R) and the regeneration that followed it. Methods and Results: adult zebrafish were kept either in hypoxic (H) or normoxic control (C) water for 15 min; thereafter fishes were returned to C water. Within 2-6 hours (h) after reoxygenation there was evidence of cardiac oxidative stress by dihydroethidium fluorescence and protein nitrosylation, as well as of inflammation. We used Tg(cmlc2:nucDsRed) transgenic zebrafish to identify myocardial cell nuclei. Cardiomyocyte apoptosis and necrosis were evidenced by TUNEL and Acridine Orange (AO) staining, respectively; 18 h after H/R, 9.9 +/- 2.6% of myocardial cell nuclei were TUNEL+ and 15.0 +/- 2.5% were AO(+). At the 30-day (d) time point myocardial cell death was back to baseline (n = 3 at each time point). We evaluated cardiomyocyte proliferation by Phospho Histone H3 (pHH3) or Proliferating Cell Nuclear Antigen (PCNA) expression. Cardiomyocyte proliferation was apparent 18-24 h after H/R, it achieved its peak 3-7d later, and was back to baseline at 30d. 7d after H/R 17.4 +/- 2.3% of all cardiomyocytes were pHH3(+) and 7.4 +/- 0.6% were PCNA(+) (n = 3 at each time point). Cardiac function was assessed by 2D-echocardiography and Ventricular Diastolic and Systolic Areas were used to compute Fractional Area Change (FAC). FAC decreased from 29.3 +/- 2.0% in normoxia to 16.4 +/- 1.8% at 18 h after H/R; one month later ventricular function was back to baseline (n = 12 at each time point). Conclusions: zebrafish exposed to H/R exhibit evidence of cardiac oxidative stress and inflammation, myocardial cell death and proliferation. The initial decrease in ventricular function is followed by full recovery. This model more closely mimics reperfusion injury in mammals than other cardiac injury models.	[Parente, Valeria; Balasso, Serena; Pompilio, Giulio; Verduci, Lorena; Milano, Giuseppina; Pozzoli, Ombretta] Ist Ricovero & Cura Carattere Sci, Ctr Cardiol Monzino, Lab Biol Vasc & Med Rigenerat, Rome, Italy; [Parente, Valeria] Ist Nazl Genet Mol, Milan, Italy; [Colombo, Gualtiero I.] Ist Ricovero & Cura Carattere Sci, Ctr Cardiol Monzino, Lab Immunol & Genom Funz, Rome, Italy; [Guerrini, Uliano] Univ Milan, Dipartimento Sci Farmacol & Biomol, Lab Farmacol Trombosi & Aterosclero, Milan, Italy; [Squadroni, Lidia] Osped S Carlo Borromeo, Div Cardiol, Milan, Italy; [Cotelli, Franco] Univ Milan, Dipartimento Biol, Milan, Italy; [Cotelli, Franco] Univ Milan, Dipartimento Biosci, Lab Biol Sviluppo, Milan, Italy; [Capogrossi, Maurizio C.] Ist Ricovero & Cura Carattere Sci, Lab Patol Vascolare, Ist Dermopat Immacolata, Rome, Italy	IRCCS Centro Cardiologico Monzino; IRCCS Centro Cardiologico Monzino; University of Milan; University of Milan; University of Milan; IRCCS Istituto Dermopatico dell'Immacolata (IDI)	Capogrossi, MC (corresponding author), Ist Ricovero & Cura Carattere Sci, Lab Patol Vascolare, Ist Dermopat Immacolata, Rome, Italy.	capogrossi@idi.it	Pompilio, Giulio/J-6701-2014; Parente, Valeria/H-7817-2016; Colombo, Gualtiero I./B-4737-2010	Pompilio, Giulio/0000-0003-2581-5735; Parente, Valeria/0000-0001-6559-9817; Colombo, Gualtiero I./0000-0002-7348-1939; Milano, Giuseppina/0000-0002-5560-4667	Centro Cardiologico Monzino Istituto di Ricovero e Cura a Carattere Scientifico [RC2008-2011]; Italian Ministero della Salute [RF2007-2009]	Centro Cardiologico Monzino Istituto di Ricovero e Cura a Carattere Scientifico; Italian Ministero della Salute(Ministry of Health, Italy)	This work was supported by Centro Cardiologico Monzino Istituto di Ricovero e Cura a Carattere Scientifico [RC2008-2011]; and Italian Ministero della Salute [grant RF2007-2009]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Qare AW, 2001, J TOXICOL ENV HEAL B, V4, P313, DOI 10.1080/109374001301419737; Bohuslavova R, 2010, J APPL PHYSIOL, V109, P1195, DOI 10.1152/japplphysiol.00366.2010; Bolli R, 1999, PHYSIOL REV, V79, P609, DOI 10.1152/physrev.1999.79.2.609; Bouma W, 2010, AM J PHYSIOL-HEART C, V298, pH1510, DOI 10.1152/ajpheart.01021.2009; Cai ZQ, 2003, CIRCULATION, V108, P79, DOI 10.1161/01.CIR.0000078635.89229.8A; Calvillo L, 2003, P NATL ACAD SCI USA, V100, P4802, DOI 10.1073/pnas.0630444100; Chablais F, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-21; Czibik G, 2009, CARDIOVASC RES, V82, P107, DOI 10.1093/cvr/cvp035; HEARSE DJ, 1973, J MOL CELL CARDIOL, V5, P395, DOI 10.1016/0022-2828(73)90030-8; Hu N, 2001, ANAT REC, V264, P1, DOI 10.1002/ar.1111; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Jordan JE, 1999, CARDIOVASC RES, V43, P860, DOI 10.1016/S0008-6363(99)00187-X; Kawata H, 2001, CIRC RES, V88, P696, DOI 10.1161/hh0701.088842; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Kim J, 2010, P NATL ACAD SCI USA, V107, P17206, DOI 10.1073/pnas.0915016107; Laird AS, 2011, METHODS MOL BIOL, V793, P167, DOI 10.1007/978-1-61779-328-8_11; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Lien CL, 2006, PLOS BIOL, V4, P1386, DOI 10.1371/journal.pbio.0040260; Loor G, 2008, CELL DEATH DIFFER, V15, P686, DOI 10.1038/cdd.2008.13; Gonzalez-Rosa JM, 2011, DEVELOPMENT, V138, P1663, DOI 10.1242/dev.060897; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Paquet D, 2009, J CLIN INVEST, V119, P1382, DOI 10.1172/JCI37537; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Raya A, 2003, P NATL ACAD SCI USA, V100, P11889, DOI 10.1073/pnas.1834204100; Schnabel K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018503; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; SILVERMAN HS, 1991, CIRC RES, V69, P196, DOI 10.1161/01.RES.69.1.196; STERN MD, 1985, CIRC RES, V56, P899, DOI 10.1161/01.RES.56.6.899; STERN MD, 1988, P NATL ACAD SCI USA, V85, P6954, DOI 10.1073/pnas.85.18.6954; Tada H, 2006, CARDIOVASC RES, V71, P466, DOI 10.1016/j.cardiores.2006.05.010; Tang YL, 2005, J CARDIOVASC PHARM T, V10, P251, DOI 10.1177/107424840501000405; Wang JH, 2011, DEVELOPMENT, V138, P3421, DOI 10.1242/dev.068601; Yet SF, 2001, CIRC RES, V89, P168, DOI 10.1161/hh1401.093314; Zweier JL, 2006, CARDIOVASC RES, V70, P181, DOI 10.1016/j.cardiores.2006.02.025	35	50	56	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53748	10.1371/journal.pone.0053748	http://dx.doi.org/10.1371/journal.pone.0053748			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341992	Green Published, gold, Green Submitted			2022-12-25	WOS:000313682700042
J	Walmsley, CW; Smits, PD; Quayle, MR; McCurry, MR; Richards, HS; Oldfield, CC; Wroe, S; Clausen, PD; McHenry, CR				Walmsley, Christopher W.; Smits, Peter D.; Quayle, Michelle R.; McCurry, Matthew R.; Richards, Heather S.; Oldfield, Christopher C.; Wroe, Stephen; Clausen, Phillip D.; McHenry, Colin R.			Why the Long Face? The Mechanics of Mandibular Symphysis Proportions in Crocodiles	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; FUNCTIONAL-MORPHOLOGY; FEEDING-BEHAVIOR; MORPHOSPACE OCCUPATION; PREDATORY BEHAVIOR; CRANIAL STRENGTH; BITE FORCE; IN-VIVO; BIOMECHANICS; PERFORMANCE	Background: Crocodilians exhibit a spectrum of rostral shape from long snouted (longirostrine), through to short snouted (brevirostrine) morphologies. The proportional length of the mandibular symphysis correlates consistently with rostral shape, forming as much as 50% of the mandible's length in longirostrine forms, but 10% in brevirostrine crocodilians. Here we analyse the structural consequences of an elongate mandibular symphysis in relation to feeding behaviours. Methods/Principal Findings: Simple beam and high resolution Finite Element (FE) models of seven species of crocodile were analysed under loads simulating biting, shaking and twisting. Using beam theory, we statistically compared multiple hypotheses of which morphological variables should control the biomechanical response. Brevi- and mesorostrine morphologies were found to consistently outperform longirostrine types when subject to equivalent biting, shaking and twisting loads. The best predictors of performance for biting and twisting loads in FE models were overall length and symphyseal length respectively; for shaking loads symphyseal length and a multivariate measurement of shape (PC1 - which is strongly but not exclusively correlated with symphyseal length) were equally good predictors. Linear measurements were better predictors than multivariate measurements of shape in biting and twisting loads. For both biting and shaking loads but not for twisting, simple beam models agree with best performance predictors in FE models. Conclusions/Significance: Combining beam and FE modelling allows a priori hypotheses about the importance of morphological traits on biomechanics to be statistically tested. Short mandibular symphyses perform well under loads used for feeding upon large prey, but elongate symphyses incur high strains under equivalent loads, underlining the structural constraints to prey size in the longirostrine morphotype. The biomechanics of the crocodilian mandible are largely consistent with beam theory and can be predicted from simple morphological measurements, suggesting that crocodilians are a useful model for investigating the palaeobiomechanics of other aquatic tetrapods.	[Walmsley, Christopher W.; Quayle, Michelle R.; McCurry, Matthew R.; McHenry, Colin R.] Monash Univ, Sch Biomed Sci, Dept Anat & Dev Biol, Melbourne, Vic 3004, Australia; [Walmsley, Christopher W.; Richards, Heather S.; Oldfield, Christopher C.; Wroe, Stephen; Clausen, Phillip D.; McHenry, Colin R.] Univ Newcastle, Sch Engn, Newcastle, NSW 2300, Australia; [Smits, Peter D.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia; [Smits, Peter D.] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Wroe, Stephen] Univ New S Wales, Sch Biol Environm & Earth Sci, Sydney, NSW, Australia	Monash University; University of Newcastle; Monash University; University of Chicago; University of New South Wales Sydney	Walmsley, CW (corresponding author), Monash Univ, Sch Biomed Sci, Dept Anat & Dev Biol, Melbourne, Vic 3004, Australia.	c.w.walmsley@gmail.com	Wroe, Stephen/A-4462-2010; Clausen, Philip/G-7337-2013	Wroe, Stephen/0000-0002-5813-9182; Wroe, Stephen/0000-0002-6365-5915; Clausen, Philip/0000-0003-1186-6419; Smits, Peter D/0000-0003-4074-1447; McCurry, Matthew/0000-0002-2452-1404	Australian Research Council Discovery Project grants [DP0986471, DP0987985]; Monash University; Newcastle University summer vacation scholarship; Directorate For Geosciences [0948842] Funding Source: National Science Foundation	Australian Research Council Discovery Project grants(Australian Research Council); Monash University(Monash University); Newcastle University summer vacation scholarship; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Work was funded by Australian Research Council Discovery Project grants DP0986471 (to CRM) and DP0987985 (to SW), Monash University internal funding (to CRM), and a Newcastle University summer vacation scholarship (to CWW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andrews C. W., 1913, DESCRIPTIVE CATALOGU; Barton K., 2012, MUMIN MULTIMODEL INF; Bell PR, 2009, ANAT REC, V292, P1338, DOI 10.1002/ar.20978; Bloodworth B, 2005, J EXP BIOL, V208, P3721, DOI 10.1242/jeb.01807; Bourke J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002200; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; BUSBEY AB, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P173; Clausen P, 2008, J BIOMECH, V41, P3184, DOI 10.1016/j.jbiomech.2008.08.019; CLEUREN J, 1995, BELG J ZOOL, V125, P79; Cruickshank Arthur R. I., 1997, Annals of the South African Museum, V105, P207; Curtis N, 2010, J BIOMECH, V43, P2804, DOI 10.1016/j.jbiomech.2010.05.037; Dryden I., 1998, STAT ANAL SHAPE; Dryden I., 2009, SHAPES STAT SHAPE AN; Dumont ER, 2009, J THEOR BIOL, V256, P96, DOI 10.1016/j.jtbi.2008.08.017; Ellis R., 2003, SEA DRAGONS PREDATOR; Erickson GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031781; Fish FE, 2007, J EXP BIOL, V210, P2811, DOI 10.1242/jeb.004267; Fitzgerald EMG, 2006, P ROY SOC B-BIOL SCI, V273, P2955, DOI 10.1098/rspb.2006.3664; Holliday CM, 2009, J VERTEBR PALEONTOL, V29, P715, DOI 10.1671/039.029.0330; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.1093/biomet/76.2.297; IORDANSKY N. N., 1964, ANAT ANZ, V115, P256; Iordansky N.N., 1973, P201; KENDALL DG, 1977, ADV APPL PROBAB, V9, P428, DOI 10.2307/1426091; Langston W. Jr., 1973, P263; Massare J.A., 1987, Journal of Vertebrate Paleontology, V7, P121; McGowan, 1992, DINOSAURS SPITFIRES; McHenry C.R., 2009, THESIS U NEWCASTLE; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Mchenry CR, 2006, ANAT REC PART A, V288A, P827, DOI 10.1002/ar.a.20360; Metzger KA, 2005, ANAT REC PART A, V283A, P331, DOI 10.1002/ar.a.20167; Moreno K, 2008, J ANAT, V212, P736, DOI 10.1111/j.1469-7580.2008.00899.x; Motani R, 2005, ANNU REV EARTH PL SC, V33, P395, DOI 10.1146/annurev.earth.33.092203.122707; Motani R, 1999, J VERTEBR PALEONTOL, V19, P473, DOI 10.1080/02724634.1999.10011160; Mueller-Towe IJ, 2006, THESIS U MAINZ GERMA; O'Keefe ER, 2004, J VERTEBR PALEONTOL, V24, P326; OHiggins P., 2006, TOOLS STAT SHAPE ANA; Owen R., 1881, MONOGRAPH FOSSIL R 3, P83; Panagiotopoulou O, 2009, ANN HUM BIOL, V36, P609, DOI 10.1080/03014460903019879; Parr WCH, 2012, J THEOR BIOL, V301, P1, DOI 10.1016/j.jtbi.2012.01.030; Pierce SE, 2008, J MORPHOL, V269, P840, DOI 10.1002/jmor.10627; Pierce SE, 2009, PALAEONTOLOGY, V52, P1057, DOI 10.1111/j.1475-4983.2009.00904.x; Porro LB, 2011, J MORPHOL, V272, P910, DOI 10.1002/jmor.10957; Porro LB, 2009, THESIS U CAMBRIDGE; R Development C, 2010, R LANG ENV STAT COMP; Rayfield EJ, 2007, J VERTEBR PALEONTOL, V27, P892, DOI 10.1671/0272-4634(2007)27[892:FMOSCD]2.0.CO;2; Rayfield EJ, 2007, ANNU REV EARTH PL SC, V35, P541, DOI 10.1146/annurev.earth.35.031306.140104; Ross C. A., 1989, CROCODILES ALLIGATOR; Ross CF, 2004, ANN ANAT, V186, P387, DOI 10.1016/S0940-9602(04)80070-0; Snively E, 2006, ACTA PALAEONTOL POL, V51, P435; Snively Eric, 2010, Kirtlandia, V57, P53; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; TAYLOR MA, 1993, PHILOS T ROY SOC B, V341, P399, DOI 10.1098/rstb.1993.0124; TAYLOR MA, 1987, ZOOL J LINN SOC-LOND, V91, P171, DOI 10.1111/j.1096-3642.1987.tb01727.x; THOMASON JJ, 1991, CAN J ZOOL, V69, P2326, DOI 10.1139/z91-327; THORBJARNARSON JB, 1990, J HERPETOL, V24, P99, DOI 10.2307/1564301; Tseng ZJ, 2009, BIOL J LINN SOC, V96, P51, DOI 10.1111/j.1095-8312.2008.01095.x; TURNBULL WD, 1970, FIELDIANA GEOLOGY, V18, P149; Wiley D.F, 2006, LANDMARK EDITOR 3 0; Wroe S, 2005, P ROY SOC B-BIOL SCI, V272, P619, DOI 10.1098/rspb.2004.2986; Wroe S, 2007, P ROY SOC B-BIOL SCI, V274, P2819, DOI 10.1098/rspb.2007.0906; Wroe S, 2010, P ROY SOC B-BIOL SCI, V277, P3579, DOI 10.1098/rspb.2010.0509; Young MT, 2012, NATURWISSENSCHAFTEN, V99, P637, DOI 10.1007/s00114-012-0944-y; Zelditch M.L., 2004, GEOMETRIC MORPHOMETR, DOI DOI 10.1016/B978-0-12-778460-1.X5000-5	64	75	76	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53873	10.1371/journal.pone.0053873	http://dx.doi.org/10.1371/journal.pone.0053873			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342027	gold, Green Published, Green Submitted			2022-12-25	WOS:000313682700059
J	Albersen, M; Bosma, M; Knoers, NVVAM; de Ruiter, BHB; Diekman, EF; de Ruijter, J; Visser, WF; de Koning, TJ; Verhoeven-Duif, NM				Albersen, Monique; Bosma, Marjolein; Knoers, Nine V. V. A. M.; de Ruiter, Berna H. B.; Diekman, Eugene F.; de Ruijter, Jessica; Visser, Wouter F.; de Koning, Tom J.; Verhoeven-Duif, Nanda M.			The Intestine Plays a Substantial Role in Human Vitamin B6 Metabolism: A Caco-2 Cell Model	PLOS ONE			English	Article							PYRIDOXINE HYDROCHLORIDE; TISSUE DISTRIBUTION; MASS-SPECTROMETRY; TRANSPORT; RAT; PLASMA; MICE; 5'-PHOSPHATE; PYRIDOXAMINE; ABSORPTION	Background: Vitamin B6 is present in various forms (vitamers) in the diet that need to be metabolized to pyridoxal phosphate (PLP), the active cofactor form of vitamin B6. In literature, the liver has been reported to be the major site for this conversion, whereas the exact role of the intestine remains to be elucidated. Objective: To gain insight into the role of the intestine in human vitamin B6 metabolism. Materials and Methods: Expression of the enzymes pyridoxal kinase (PK), pyridox(am)ine phosphate oxidase (PNPO) and PLP-phosphatase was determined in Caco-2 cells and in lysates of human intestine. Vitamin B6 uptake, conversion and excretion were studied in polarized Caco-2 cell monolayers. B6 vitamer concentrations (pyridoxine (PN), pyridoxal (PL), PLP, pyridoxamine (PM), pyridoxamine phosphate (PMP)) and pyridoxic acid (PA) were quantified by ultra performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) using stable isotope-labeled internal standards. Results: The enzymatic system involved in vitamin B6 metabolism (PK, PNPO and PLP-phosphatase) is fully expressed in Caco-2 cells as well as in human intestine. We show uptake of PN, PM and PL by Caco-2 cells, conversion of PN and PM into PL and excretion of all three unphosphorylated B6 vitamers. Conclusion: We demonstrate, in a Caco-2 cell model, that the intestine plays a substantial role in human vitamin B6 metabolism.	[Albersen, Monique; Bosma, Marjolein; Knoers, Nine V. V. A. M.; de Ruiter, Berna H. B.; Diekman, Eugene F.; de Ruijter, Jessica; Visser, Wouter F.; de Koning, Tom J.; Verhoeven-Duif, Nanda M.] Univ Med Ctr, Dept Med Genet, Utrecht, Netherlands; [de Koning, Tom J.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands	Utrecht University; Utrecht University Medical Center; University of Groningen	Verhoeven-Duif, NM (corresponding author), Univ Med Ctr, Dept Med Genet, Utrecht, Netherlands.	N.Verhoeven@umcutrecht.nl	De Koning, Tom J/AAE-1323-2020	De Koning, Tom J/0000-0001-5609-1309	Wilhelmina Research Fund, Wilhelmina Children's Hospital, University Medical Center (UMC) Utrecht	Wilhelmina Research Fund, Wilhelmina Children's Hospital, University Medical Center (UMC) Utrecht	This research was supported by the Wilhelmina Research Fund, Wilhelmina Children's Hospital, University Medical Center (UMC) Utrecht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender D., 2005, HUMAN NUTR, P194; BOOTH CC, 1962, J PHYSIOL-LONDON, V164, P282, DOI 10.1113/jphysiol.1962.sp007021; CHERN CJ, 1975, CLIN CHIM ACTA, V61, P353, DOI 10.1016/0009-8981(75)90425-8; COLOMBINI CE, 1970, BIOCHEMISTRY-US, V9, P533, DOI 10.1021/bi00805a012; CONTRACTOR SF, 1971, BIOCHIM BIOPHYS ACTA, V230, P127, DOI 10.1016/0304-4165(71)90060-2; Footitt E.J., 2012, J INHERIT METAB DIS; Halbleib JM, 2007, MOL BIOL CELL, V18, P4261, DOI 10.1091/mbc.E07-04-0308; HAMM MW, 1979, J NUTR, V109, P1552, DOI 10.1093/jn/109.9.1552; Jang YM, 2003, J BIOL CHEM, V278, P50040, DOI 10.1074/jbc.M309619200; JOHANSSON S, 1968, BIOCHEMISTRY-US, V7, P2327, DOI 10.1021/bi00846a039; JOHANSSON S, 1974, J BIOL CHEM, V249, P6040; Kang JH, 2004, EUR J BIOCHEM, V271, P2452, DOI 10.1111/j.1432-1033.2004.04175.x; LUMENG L, 1980, J CLIN INVEST, V66, P688, DOI 10.1172/JCI109906; LUMENG L, 1974, J LAB CLIN MED, V84, P334; MEHANSHO H, 1979, J NUTR, V109, P1542, DOI 10.1093/jn/109.9.1542; MEHANSHO H, 1980, BIOCHIM BIOPHYS ACTA, V631, P112, DOI 10.1016/0304-4165(80)90059-8; MERRILL AH, 1984, J NUTR, V114, P1664, DOI 10.1093/jn/114.9.1664; MIDDLETON HM, 1977, J NUTR, V107, P126, DOI 10.1093/jn/107.1.126; Midttun O, 2009, RAPID COMMUN MASS SP, V23, P1371, DOI 10.1002/rcm.4013; Said HM, 2003, AM J PHYSIOL-CELL PH, V285, pC1219, DOI 10.1152/ajpcell.00204.2003; Said ZM, 2008, AM J PHYSIOL-CELL PH, V294, pC1192, DOI 10.1152/ajpcell.00015.2008; SAKURAI T, 1991, J NUTR SCI VITAMINOL, V37, P341, DOI 10.3177/jnsv.37.341; SAKURAI T, 1987, J NUTR SCI VITAMINOL, V33, P11, DOI 10.3177/jnsv.33.11; SAKURAI T, 1988, J NUTR SCI VITAMINOL, V34, P179, DOI 10.3177/jnsv.34.179; SNELL EE, 1945, J AM CHEM SOC, V67, P194, DOI 10.1021/ja01218a013; Taipalensuu J, 2001, J PHARMACOL EXP THER, V299, P164; van der Ham M, 2012, ANAL CHIM ACTA, V712, P108, DOI 10.1016/j.aca.2011.11.018	27	29	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54113	10.1371/journal.pone.0054113	http://dx.doi.org/10.1371/journal.pone.0054113			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342087	gold, Green Published, Green Submitted			2022-12-25	WOS:000314759400122
J	Yan, P; Sun, B; Shi, HM; Zhu, W; Zhou, Q; Jiang, YW; Zhu, H; Huang, GQ				Yan, Ping; Sun, Bin; Shi, Haiming; Zhu, Wen; Zhou, Qing; Jiang, Yuwen; Zhu, Hui; Huang, Guoqian			Left Atrial and Right Atrial Deformation in Patients with Coronary Artery Disease: A Velocity Vector Imaging-Based Study	PLOS ONE			English	Article							SPECKLE-TRACKING ECHOCARDIOGRAPHY; VENTRICULAR DIASTOLIC FUNCTION; STRAIN-RATE ECHOCARDIOGRAPHY; 2-DIMENSIONAL STRAIN; DOPPLER-ECHOCARDIOGRAPHY; MYOCARDIAL-FUNCTION; FILLING PRESSURES; SYSTOLIC FUNCTION; CLINICAL UTILITY; ISCHEMIA	Background: Impaired left ventricular (LV) function has been shown by strain rate (SR) imaging in patients with coronary artery disease (CAD). Our aim was to investigate global and regional, systolic and diastolic left atrial (LA) and right atrial (RA) longitudinal deformation in CAD using velocity vector imaging. Methods: Echocardiographic and velocity vector imaging studies were performed in 20 patients with mild CAD, 40 patients with severe CAD and 25 controls. Maximal atrial volume, peak atrial longitudinal strain (epsilon(s)) and SR during LV systole (SRs), SR during early LV filling (SRe) and late LV filling (SRa) were measured. Longitudinal strain during atrial contraction (epsilon(a)) was obtained at the onset of P-wave on electrocardiography, and epsilon(a)/epsilon(s) was calculated. Results: Longitudinal peak epsilon(s) and SRs of LA showed decreased trend among CAD patients. The global and lateral LA SRe were prominently lower, while RA epsilon(a), SRa and epsilon(a)/epsilon(s) were prominently higher in 2 CAD groups than control group (P value<0.05). As compared with controls and patients with other single-vessel disease, LA SRa and epsilon(a)/epsilon(s) ratio were significantly increased among patients with exclusively left anterior descending coronary artery (LAD) stenosis (SRa 1.14 +/- 0.38 s(-1), 1.10 +/- 0.41 s(-1), 1.45 +/- 0.46 s(-1), P value<0.05; epsilon(a)/epsilon(s) 0.44 +/- 0.11, 0.44 +/- 0.20, 0.57 +/- 0.12, P value<0.01). Conclusions: Apparently decreased SRe of LA and increased epsilon(a), SRa and epsilon(a)/epsilon(s) of RA were found in CAD patients with preserved LVEF and E/E' in gray zone. SRa and epsilon(a)/epsilon(s) of LA were found to significantly increase in those with LAD stenosis.	[Yan, Ping; Sun, Bin; Shi, Haiming; Zhu, Wen; Zhou, Qing; Jiang, Yuwen; Zhu, Hui; Huang, Guoqian] Fudan Univ, Dept Cardiol, Huashan Hosp, Shanghai 200433, Peoples R China	Fudan University	Huang, GQ (corresponding author), Fudan Univ, Dept Cardiol, Huashan Hosp, Shanghai 200433, Peoples R China.	guoqian_huang@yahoo.com.cn	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454				Amundsen BH, 2006, J AM COLL CARDIOL, V47, P789, DOI 10.1016/j.jacc.2005.10.040; BONOW RO, 1981, CIRCULATION, V64, P315, DOI 10.1161/01.CIR.64.2.315; Dattilo G, 2010, INT J CARDIOL, V145, pE6, DOI 10.1016/j.ijcard.2008.12.100; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Dokainish H, 2010, J AM SOC ECHOCARDIOG, V23, P156, DOI 10.1016/j.echo.2009.11.015; Guan ZQ, 2010, CLIN CARDIOL, V33, P643, DOI 10.1002/clc.20784; Gurbel PA, 2008, AM HEART J, V155, P56, DOI 10.1016/j.ahj.2007.08.021; Her AY, 2012, CAN J CARDIOL; Hoit BD, 2011, CIRC-CARDIOVASC IMAG, V4, P179, DOI 10.1161/CIRCIMAGING.110.959817; Kalay N, 2011, ECHOCARDIOGR-J CARD, V28, P203, DOI 10.1111/j.1540-8175.2010.01298.x; KEYS A, 1972, J CHRON DIS, V25, P329, DOI 10.1016/0021-9681(72)90027-6; Kim DG, 2009, ECHOCARDIOGR-J CARD, V26, P1179, DOI 10.1111/j.1540-8175.2009.00955.x; Kimura K, 2011, J CARDIOL; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lee KW, 2005, AM HEART J, V150, P756, DOI 10.1016/j.ahj.2004.11.019; Leung DY, 2010, HEART LUNG CIRC, V19, P161, DOI 10.1016/j.hlc.2009.11.006; Leung DY, 2008, AM HEART J, V156, P1056, DOI 10.1016/j.ahj.2008.07.021; Liu YY, 2011, ECHOCARDIOGR-J CARD, V28, P1095, DOI 10.1111/j.1540-8175.2011.01513.x; Min PK, 2007, AM J CARDIOL, V100, P326, DOI 10.1016/j.amjcard.2007.02.102; MITCHELL JH, 1962, AM J CARDIOL, V9, P237, DOI 10.1016/0002-9149(62)90043-7; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; Motoki H, 2012, J AM SOC ECHOCARDIOG, V25, P428, DOI 10.1016/j.echo.2011.12.020; Nesbitt GC, 2009, INT J CARDIOVAS IMAG, V25, P9, DOI 10.1007/s10554-008-9414-1; NISHIMURA RA, 1985, MAYO CLIN PROC, V60, P321, DOI 10.1016/S0025-6196(12)60540-0; Ommen SR, 2000, CIRCULATION, V102, P1788; Paulus WJ, 2010, HEART, V96, P1147, DOI 10.1136/hrt.2009.169052; Perk G, 2009, ECHOCARDIOGR-J CARD, V26, P299, DOI 10.1111/j.1540-8175.2008.00863.x; Pirat B, 2008, J AM COLL CARDIOL, V51, P651, DOI 10.1016/j.jacc.2007.10.029; Psaty BM, 1997, CIRCULATION, V96, P2455; Russo C, 2012, HEART, V98, P813, DOI 10.1136/heartjnl-2011-301388; SIGWART U, 1990, AM J CARDIOL, V65, P282, DOI 10.1016/0002-9149(90)90288-C; Stefanadis C, 1999, J AM COLL CARDIOL, V33, P687, DOI 10.1016/S0735-1097(98)00623-8; STEWART JT, 1992, BRIT HEART J, V68, P377; Stolker JM, 2010, J INVASIVE CARDIOL, V22, P107; Sun Tao, 2010, Clin Cardiol, V33, pE1, DOI 10.1002/clc.20698; Tanaka H, 2007, CIRC J, V71, P517, DOI 10.1253/circj.71.517; Tsai WC, 2010, J AM SOC ECHOCARDIOG, V23, P1183, DOI 10.1016/j.echo.2010.08.011; Vianna-Pinton R, 2009, J AM SOC ECHOCARDIOG, V22, P299, DOI 10.1016/j.echo.2008.12.017; Yan P, 2011, NEPHRON CLIN PRACT, V118, pC232, DOI 10.1159/000321383	39	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e51204	10.1371/journal.pone.0051204	http://dx.doi.org/10.1371/journal.pone.0051204			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23349657	Green Published, Green Submitted, gold			2022-12-25	WOS:000312108500050
J	Tikkanen, O; Haakana, P; Pesola, AJ; Hakkinen, K; Rantalainen, T; Havu, M; Pullinen, T; Finni, T				Tikkanen, Olli; Haakana, Piia; Pesola, Arto J.; Hakkinen, Keijo; Rantalainen, Timo; Havu, Marko; Pullinen, Teemu; Finni, Taija			Muscle Activity and Inactivity Periods during Normal Daily Life	PLOS ONE			English	Article							TIME PHYSICAL-ACTIVITY; TYPE-2 DIABETES-MELLITUS; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; SEDENTARY BEHAVIORS; ENERGY-EXPENDITURE; SEASONAL-VARIATION; ADULTS; RISK; OBESITY	Recent findings suggest that not only the lack of physical activity, but also prolonged times of sedentary behaviour where major locomotor muscles are inactive, significantly increase the risk of chronic diseases. The purpose of this study was to provide details of quadriceps and hamstring muscle inactivity and activity during normal daily life of ordinary people. Eighty-four volunteers (44 females, 40 males, 44.1 +/- 17.3 years, 172.3 +/- 6.1 cm, 70.1 +/- 10.2 kg) were measured during normal daily life using shorts measuring muscle electromyographic (EMG) activity (recording time 11.3 +/- 2.0 hours). EMG was normalized to isometric MVC (EMG(MVC)) during knee flexion and extension, and inactivity threshold of each muscle group was defined as 90% of EMG activity during standing (2.5 +/- 1.7% of EMG(MVC)). During normal daily life the average EMG amplitude was 4.0 +/- 2.6% and average activity burst amplitude was 5.8 +/- 3.4% of EMG(MVC) (mean duration of 1.4 +/- 1.4 s) which is below the EMG level required for walking (5 km/h corresponding to EMG level of about 10% of EMG(MVC)). Using the proposed individual inactivity threshold, thigh muscles were inactive 67.5 +/- 11.9% of the total recording time and the longest inactivity periods lasted for 13.9 +/- 7.3 min (2.5-38.3 min). Women had more activity bursts and spent more time at intensities above 40% EMG(MVC) than men (p < 0.05). In conclusion, during normal daily life the locomotor muscles are inactive about 7.5 hours, and only a small fraction of muscle's maximal voluntary activation capacity is used averaging only 4% of the maximal recruitment of the thigh muscles. Some daily non-exercise activities such as stair climbing produce much higher muscle activity levels than brisk walking, and replacing sitting by standing can considerably increase cumulative daily muscle activity.	[Tikkanen, Olli; Haakana, Piia; Pesola, Arto J.; Hakkinen, Keijo; Havu, Marko; Pullinen, Teemu; Finni, Taija] Univ Jyvaskyla, Dept Biol Phys Act, Neuromuscular Res Ctr, SF-40100 Jyvaskyla, Finland; [Rantalainen, Timo] Univ Jyvaskyla, Dept Hlth Sci, SF-40100 Jyvaskyla, Finland	University of Jyvaskyla; University of Jyvaskyla	Tikkanen, O (corresponding author), Univ Jyvaskyla, Dept Biol Phys Act, Neuromuscular Res Ctr, SF-40100 Jyvaskyla, Finland.	olli.tikkanen@megaemg.com	Finni, Taija/F-6544-2014; Havu, Marko/AAJ-9720-2020; Pesola, Arto/AAF-2800-2020; Finni, Taija/AAV-9073-2020; Havu, Marko/Q-6259-2016	Finni, Taija/0000-0002-7697-2813; Havu, Marko/0000-0002-4109-6593; Pesola, Arto/0000-0002-2984-9847; Havu, Marko/0000-0002-4109-6593; Haakana, Piia/0000-0003-0005-3834; Rantalainen, Timo/0000-0001-6977-4782	Academy of Finland [128643]; Ministry of Education [42/627/2010]; Urheiluopistosaatio	Academy of Finland(Academy of Finland); Ministry of Education; Urheiluopistosaatio	This study was funded by Academy of Finland (# 128643/Finni), Ministry of Education (42/627/2010/Finni) and Urheiluopistosaatio (Tikkanen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertrais S, 2005, OBES RES, V13, P936, DOI 10.1038/oby.2005.108; Buchowski MS, 2009, J PHYS ACT HEALTH, V6, P252, DOI 10.1123/jpah.6.2.252; Byrne NM, 2005, J APPL PHYSIOL, V99, P1112, DOI 10.1152/japplphysiol.00023.2004; Crouter SE, 2006, EUR J APPL PHYSIOL, V98, P601, DOI 10.1007/s00421-006-0307-5; De Luca CJ, 2010, J NEUROPHYSIOL, V104, P1034, DOI 10.1152/jn.01018.2009; Desmedt J, 1977, J PHYSL, V234, P723; Dunstan DW, 2007, DIABETES CARE, V30, P516, DOI 10.2337/dc06-1996; Dunstan DW, 2005, DIABETOLOGIA, V48, P2254, DOI 10.1007/s00125-005-1963-4; Dunstan DW, 2004, DIABETES CARE, V27, P2603, DOI 10.2337/diacare.27.11.2603; Edgerton VR, 2001, J EXP BIOL, V204, P3217; Finni T, 2007, PHYSIOL MEAS, V28, P1405, DOI 10.1088/0967-3334/28/11/007; Finni T, 2014, SCAND J MED SCI SPOR, V24, P211, DOI 10.1111/j.1600-0838.2012.01456.x; Ford ES, 2005, OBES RES, V13, P608, DOI 10.1038/oby.2005.65; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Hirvensalo M, 2011, SCAND J PUBLIC HEALT, V39, P669, DOI 10.1177/1403494811420324; Howe TE, 2009, J ELECTROMYOGR KINES, V19, pE78, DOI 10.1016/j.jelekin.2007.10.005; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Jakes RW, 2003, EUR J CLIN NUTR, V57, P1089, DOI 10.1038/sj.ejcn.1601648; Kern DS, 2001, J APPL PHYSIOL, V91, P2224, DOI 10.1152/jappl.2001.91.5.2224; Klein CS, 2010, J APPL PHYSIOL, V108, P655, DOI 10.1152/japplphysiol.00757.2009; Kraemer WJ HK, 2002, STRENGTH TRAINING SP; Kronenberg F, 2000, ATHEROSCLEROSIS, V153, P433, DOI 10.1016/S0021-9150(00)00426-3; Masakado Yoshihisa, 1994, Keio Journal of Medicine, V43, P137; Matthews CE, 2001, AM J EPIDEMIOL, V153, P172, DOI 10.1093/aje/153.2.172; MONSTER AW, 1978, SCIENCE, V200, P314, DOI 10.1126/science.635587; Ochia RS, 2007, J ELECTROMYOGR KINES, V17, P365, DOI 10.1016/j.jelekin.2006.01.003; Pivarnik JM, 2003, MED SCI SPORT EXER, V35, P1004, DOI 10.1249/01.MSS.0000069747.55950.B1; Powell KE, 2011, ANNU REV PUBL HEALTH, V32, P349, DOI 10.1146/annurev-publhealth-031210-101151; Rassier DE, 1999, J APPL PHYSIOL, V86, P1445, DOI 10.1152/jappl.1999.86.5.1445; Scilingo EP, 2005, IEEE T INF TECHNOL B, V9, P345, DOI 10.1109/TITB.2005.854506; Stephens BR, 2011, METABOLISM, V60, P941, DOI 10.1016/j.metabol.2010.08.014; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; Westerterp KR, 2009, EUR J APPL PHYSIOL, V105, P823, DOI 10.1007/s00421-009-1000-2	34	85	85	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e52228	10.1371/journal.pone.0052228	http://dx.doi.org/10.1371/journal.pone.0052228			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349681	gold, Green Published, Green Submitted			2022-12-25	WOS:000313872800004
J	Su, D; Cheng, Y; Liu, M; Liu, DZ; Cui, H; Zhang, BL; Zhou, SY; Yang, TH; Mei, QB				Su, Dan; Cheng, Ying; Liu, Miao; Liu, Daozhou; Cui, Han; Zhang, Bangle; Zhou, Siyuan; Yang, Tiehong; Mei, Qibing			Comparision of Piceid and Resveratrol in Antioxidation and Antiproliferation Activities In Vitro	PLOS ONE			English	Article							BREAST-CANCER CELLS; TRANS-RESVERATROL; OXIDATIVE STRESS; GROWTH-INHIBITION; WINE POLYPHENOLS; S-PHASE; BIOAVAILABILITY; METABOLISM; APOPTOSIS; ABSORPTION	Background: The clinic therapeutic effect of resveratrol is limited due to its low oral bioavailability. Piceid, a precursor of resveratrol, is the most abundant form of resveratrol in nature. A number of studies have hypothesized that piceid may have the same bioactivities like those of resveratrol. The aim of this work is to compare piceid with resveratrol in antioxidation and antiproliferation activities in vitro. Methods: The antioxidative effects of resveratrol and piceid were evaluated by phenanthroline-Fe2+ method and H2O2-induced oxidative injury cell model. The antiproliferation effects were determined by MTT method in human liver tumor HepG2 cells, human breast cancer MDA-MB-231 cells and MCF-7 cells. The effects of resveratrol and piceid on the cell cycle and the apoptosis were evaluated by flow cytometry. Additionally, the uptake profiles of resveratrol and piceid in cancer cells were observed using fluorescence microscopy and clarified by LC-MS/MS. Conclusion: Piceid exhibited higher scavenging activity against hydroxyl radicals than resveratrol in vitro. Resveratrol showed a significant protective effect against H2O2-induced cell damage. What is more, resveratrol had biphasic effects on tumor cells. Resveratrol and piceid only showed significant cytotoxicity on tumor cells at high concentration (>= 50 mu mol/L), while low concentration of resveratrol (<30 mu mol/L) increased the cell viability. The principal effect of resveratrol and piceid on the viability of tumor cells was caused by the cell cycle arrest, while the effect on apoptosis was relatively minor. The reason that piceid showed lower biological activity than resveratrol at the same concentration was probably because piceid was more difficult in being uptaken by cells.	[Su, Dan; Cheng, Ying; Liu, Miao; Liu, Daozhou; Cui, Han; Zhang, Bangle; Zhou, Siyuan] Fourth Mil Med Univ, Sch Pharm, Dept Pharmaceut, Xian 710032, Peoples R China; [Yang, Tiehong; Mei, Qibing] Fourth Mil Med Univ, Sch Pharm, Natl Key Lab Gastrointestinal Pharmacol Chinese M, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Zhou, SY (corresponding author), Fourth Mil Med Univ, Sch Pharm, Dept Pharmaceut, Xian 710032, Peoples R China.	zhousy@fmmu.edu.cn; yangziyi@fmmu.edu.cn; qbmei@fmmu.edu.cn	su, dan/GYJ-1940-2022	Zhang, Bang-Le/0000-0001-9008-5391; Liu, Miao/0000-0002-7975-6702	Collaborative Innovation Center for Chinese Medicine in Qinba Mountains; National Nature Science Foundation [81072671]	Collaborative Innovation Center for Chinese Medicine in Qinba Mountains; National Nature Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported in part by Collaborative Innovation Center for Chinese Medicine in Qinba Mountains and National Nature Science Foundation (NO.81072671). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Alfaras I, 2010, J AGR FOOD CHEM, V58, P4523, DOI 10.1021/jf9042858; Alkhalaf M, 2007, EUR J CANCER PREV, V16, P334, DOI 10.1097/01.cej.0000228413.06471.4c; Appeldoorn MM, 2009, J AGR FOOD CHEM, V57, P7693, DOI 10.1021/jf901381x; Bai Y, 2010, CANCER SCI, V101, P488, DOI 10.1111/j.1349-7006.2009.01415.x; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Boocock DJ, 2007, CANCER EPIDEM BIOMAR, V16, P1246, DOI 10.1158/1055-9965.EPI-07-0022; Brohan M, 2011, J AGR FOOD CHEM, V59, P4088, DOI 10.1021/jf1047755; Chen Liang-Wei, 2007, CNS & Neurological Disorders-Drug Targets, V6, P273; CHUNG MI, 1992, PLANTA MED, V58, P274, DOI 10.1055/s-2006-961453; Das Samarjit, 2007, Recent Pat Cardiovasc Drug Discov, V2, P133; de la Monte SM, 2000, LAB INVEST, V80, P1323, DOI 10.1038/labinvest.3780140; Delmas D, 2005, MOL NUTR FOOD RES, V49, P377, DOI 10.1002/mnfr.200400098; Delmas D, 2006, CURR DRUG TARGETS, V7, P423, DOI 10.2174/138945006776359331; Delmas D, 2011, MOL NUTR FOOD RES, V55, P1142, DOI 10.1002/mnfr.201100065; Elbling L, 2005, FASEB J, V19, P807, DOI 10.1096/fj.04-2915fje; Esterbauer H, 1996, REV PHYSIOL BIOCH P, V127, P31, DOI 10.1007/BFb0048264; Goldberg DA, 2003, CLIN BIOCHEM, V36, P79, DOI 10.1016/S0009-9120(02)00397-1; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Joe AK, 2002, CLIN CANCER RES, V8, P893; Kaldas MI, 2003, J PHARM PHARMACOL, V55, P307, DOI 10.1211/002235702612; Kuwajerwala N, 2002, CANCER RES, V62, P2488; Lambert JD, 2010, ARCH BIOCHEM BIOPHYS, V501, P65, DOI 10.1016/j.abb.2010.06.013; Lancon A, 2004, BIOCHEM BIOPH RES CO, V316, P1132, DOI 10.1016/j.bbrc.2004.02.164; Lancon A, 2007, DRUG METAB DISPOS, V35, P699, DOI 10.1124/dmd.106.013664; Lanzilli G, 2012, INFLAMMATION, V35, P240, DOI 10.1007/s10753-011-9310-z; Lee KW, 2006, MECH AGEING DEV, V127, P424, DOI 10.1016/j.mad.2006.01.021; Maeda R, 2008, HYPERTENS RES, V31, P141, DOI 10.1291/hypres.31.141; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; Martowicz A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-501; Ming J, 1996, PROG BIOCHEM BIOPHYS, V23, P553; Mukherjee S, 2010, DOSE-RESPONSE, V8, P478, DOI 10.2203/dose-response.09-015.Mukherjee; Nakata R, 2012, BIOL PHARM BULL, V35, P273, DOI 10.1248/bpb.35.273; Opipari AW, 2004, CANCER RES, V64, P696, DOI 10.1158/0008-5472.CAN-03-2404; Orsini F, 1997, J NAT PROD, V60, P1082, DOI 10.1021/np970069t; Osmond GW, 2012, J SURG RES, V172, P109, DOI 10.1016/j.jss.2010.07.033; Osmond GW, 2012, J SURG RES; Paulo M, 2009, MENOPAUSE, V16, P539, DOI 10.1097/gme.0b013e31818d6349; Pintea A, 2011, J OCUL PHARMACOL TH, V27, P315, DOI 10.1089/jop.2010.0144; Pozo-Guisado E, 2005, INT J CANCER, V115, P74, DOI 10.1002/ijc.20856; Rathel TR, 2007, J HYPERTENS, V25, P541, DOI 10.1097/HJH.0b013e328013e805; Regev-Shoshani G, 2003, BIOCHEM J, V374, P157, DOI 10.1042/BJ20030141; Russo GL, 2007, BIOCHEM PHARMACOL, V74, P533, DOI 10.1016/j.bcp.2007.02.014; Shakibaei M, 2009, MOL NUTR FOOD RES, V53, P115, DOI 10.1002/mnfr.200800148; Signorelli P, 2005, J NUTR BIOCHEM, V16, P449, DOI 10.1016/j.jnutbio.2005.01.017; Soleas GJ, 2001, CLIN BIOCHEM, V34, P415, DOI 10.1016/S0009-9120(01)00246-6; Stocco B, 2012, MATURITAS, V72, P72, DOI 10.1016/j.maturitas.2012.02.004; SX L, 2009, CHINESE TRADITIONAL, V3, P469; Szende B, 2000, EXP MOL MED, V32, P88, DOI 10.1038/emm.2000.16; van de Wetering K, 2009, MOL PHARMACOL, V75, P876, DOI 10.1124/mol.108.052019; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Walle T, 2011, ANN NY ACAD SCI, V1215, P9, DOI 10.1111/j.1749-6632.2010.05842.x; Wang YC, 2011, J NEUROL SCI, V304, P29, DOI 10.1016/j.jns.2011.02.025; Wenzel E, 2005, MOL NUTR FOOD RES, V49, P472, DOI 10.1002/mnfr.200500010; Wenzel E, 2005, MOL NUTR FOOD RES, V49, P482, DOI 10.1002/mnfr.200500003; Zhai L, 2011, PHARMACOL REP, V63, P1469, DOI 10.1016/S1734-1140(11)70711-3; Zhou SY, 2009, J AGR FOOD CHEM, V57, P4572, DOI 10.1021/jf803948g	57	109	110	4	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54505	10.1371/journal.pone.0054505	http://dx.doi.org/10.1371/journal.pone.0054505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342161	Green Published, gold, Green Submitted			2022-12-25	WOS:000313682700119
J	Sung, KC; Choi, JH; Gwon, HC; Choi, SH; Kim, BS; Kwag, HJ; Kim, SH				Sung, Ki-Chul; Choi, Jin-Ho; Gwon, Hyeon-Cheol; Choi, Seung-Hyuk; Kim, Bum-Soo; Kwag, Hyon Joo; Kim, Sun H.			Relationship between Insulin Resistance and Coronary Artery Calcium in Young Men and Women	PLOS ONE			English	Article							RISK-FACTOR LEVELS; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; CALCIFICATION; QUANTIFICATION; METAANALYSIS; ASSOCIATION; PROGRESSION; PREVALENCE	Background: The gender disparity in cardiovascular disease (CVD) risk is greatest between young men and women. However, the causes of that are not fully understood. The objective of this study was to evaluate the relationship between insulin resistance and the presence of coronary artery calcium (CAC) to identify risk factors that may predispose young men and women to CVD. Methodology/Principal Findings: Insulin resistance and CVD risk factors were examined in 8682 Korean men and 1829 women aged 30-45 years old. Insulin resistance was estimated using the homeostasis model assessment of insulin resistance (HOMA-IR), and CAC was measured using computed tomography. Women were less likely to be insulin resistant (upper quartile of HOMA-IR, 18% vs. 27%, p<0.001) and had a lower prevalence of CAC (1.6% vs. 6.4%, p<0.001). Even when equally insulin resistant men and women were compared, women continued to have lower prevalence of CAC (3.1% vs. 7.2%, p = 0.004) and a more favorable CVD risk profile. Finally, after adjustment for traditional CVD risk factors, insulin resistance remained an independent predictor of CAC only in men (p = 0.03). Conclusions/Significance: Young women have a lower risk for CVD and a lower CAC prevalence compared with men. This favorable CVD risk profile in women appears to occur regardless of insulin sensitivity. Unlike men, insulin resistance was not a predictor of CAC in women in this cohort. Therefore, insulin resistance has less impact on CVD risk and CAC in young women compared with men, and insulin resistance alone does not explain the gender disparity in CVD risk that is observed at an early age.	[Sung, Ki-Chul; Kim, Bum-Soo] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Div Cardiol,Dept Med, Seoul, South Korea; [Choi, Jin-Ho; Gwon, Hyeon-Cheol; Choi, Seung-Hyuk] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Cardiol,Cardiac & Vasc Ctr, Seoul, South Korea; [Kwag, Hyon Joo] Univ Sch Med, Kangbuk Samsung Hosp Sungkyunkwan, Dept Radiol, Seoul, South Korea; [Kim, Sun H.] Stanford Univ, Dept Med, Sch Med, Div Endocrinol, Stanford, CA 94305 USA	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Stanford University	Sung, KC (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Div Cardiol,Dept Med, Seoul, South Korea.	kcmd.sung@samsung.com		Choi, Seung-Hyuk/0000-0002-0304-6317; Kim, Sun/0000-0003-0895-7491	Samsung Biomedical Research Institute grant [SBRI C-B1-114-1]; NIH Career Development Award [K23 MH079114]; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH079114] Funding Source: NIH RePORTER	Samsung Biomedical Research Institute grant(Samsung); NIH Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was partially supported by a Samsung Biomedical Research Institute grant [SBRI C-B1-114-1]. S.H.K. is funded by a NIH Career Development Award [K23 MH079114]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc12-s064, 10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc11-S062]; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Arad Y, 2005, J AM COLL CARDIOL, V46, P158, DOI 10.1016/j.jacc.2005.02.088; Arad Y, 2001, ARTERIOSCL THROM VAS, V21, P2051, DOI 10.1161/hq1201.100257; Cavanaugh-Hussey MW, 2008, PREV MED, V47, P619, DOI 10.1016/j.ypmed.2008.07.012; Chen K, 2008, DIABETES VASC DIS RE, V5, P96, DOI 10.3132/dvdr.2008.016; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Colhoun HM, 2000, J AM COLL CARDIOL, V36, P2160, DOI 10.1016/S0735-1097(00)00986-4; Ervin R Bethene, 2009, Natl Health Stat Report, P1; Ho JE, 2005, J WOMENS HEALTH, V14, P117, DOI 10.1089/jwh.2005.14.117; Hoffmann U, 2008, AM J CARDIOL, V102, P1136, DOI 10.1016/j.amjcard.2008.06.038; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Jeppesen J, 2007, J AM COLL CARDIOL, V49, P2112, DOI 10.1016/j.jacc.2007.01.088; KALIN MF, 1990, STEROIDS, V55, P330, DOI 10.1016/0039-128X(90)90058-J; Larsson CA, 2005, DIABETES CARE, V28, P2246, DOI 10.2337/diacare.28.9.2246; Lee KK, 2009, AM HEART J, V157, P939, DOI 10.1016/j.ahj.2009.02.006; Lee WL, 2000, DIABETES CARE, V23, P962, DOI 10.2337/diacare.23.7.962; Loria CM, 2007, J AM COLL CARDIOL, V49, P2013, DOI 10.1016/j.jacc.2007.03.009; Mahoney LT, 1996, J AM COLL CARDIOL, V27, P277, DOI 10.1016/0735-1097(95)00461-0; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moran A, 2008, CIRCULATION, V117, P2361, DOI 10.1161/CIRCULATIONAHA.107.704569; Newman AB, 2002, ARTERIOSCL THROM VAS, V22, P424, DOI 10.1161/hq0302.105357; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Regitz-Zagrosek V, 2006, CLIN RES CARDIOL, V95, P136, DOI 10.1007/s00392-006-0351-5; Reilly MP, 2004, CIRCULATION, V110, P803, DOI 10.1161/01.CIR.0000138740.84883.9C; Rodriguez A, 2007, J CLIN ENDOCR METAB, V92, P3568, DOI 10.1210/jc.2006-2764; Sekikawa A, 2005, INT J EPIDEMIOL, V34, P173, DOI 10.1093/ije/dyh285; Taylor AJ, 2001, AM HEART J, V141, P463, DOI 10.1067/mhj.2001.113069; Wannamethee SG, 2011, DIABETOLOGIA; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wong ND, 2003, J AM COLL CARDIOL, V41, P1547, DOI 10.1016/S0735-1097(03)00193-1; Yeni-Komshian H, 2000, DIABETES CARE, V23, P171, DOI 10.2337/diacare.23.2.171; Yoon HC, 2002, RADIOLOGY, V224, P236, DOI 10.1148/radiol.2241011191	34	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53316	10.1371/journal.pone.0053316	http://dx.doi.org/10.1371/journal.pone.0053316			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341938	Green Submitted, Green Published, gold			2022-12-25	WOS:000313682700025
J	Tang, J; Pecka, JL; Fritzsch, B; Beisel, KW; He, DZZ				Tang, Jie; Pecka, Jason L.; Fritzsch, Bernd; Beisel, Kirk W.; He, David Z. Z.			Lizard and Frog Prestin: Evolutionary Insight into Functional Changes	PLOS ONE			English	Article							OUTER HAIR CELL; SPONTANEOUS OTOACOUSTIC EMISSIONS; MOTOR PROTEIN; ANION TRANSPORTER; ECHOLOCATING BATS; CHARGE MOVEMENT; BOBTAIL LIZARD; ELECTROMOTILITY; SENSITIVITY; ZEBRAFISH	The plasma membrane of mammalian cochlear outer hair cells contains prestin, a unique motor protein. Prestin is the fifth member of the solute carrier protein 26A family. Orthologs of prestin are also found in the ear of non-mammalian vertebrates such as zebrafish and chicken. However, these orthologs are electrogenic anion exchangers/transporters with no motor function. Amphibian and reptilian lineages represent phylogenic branches in the evolution of tetrapods and subsequent amniotes. Comparison of the peptide sequences and functional properties of these prestin orthologs offer new insights into prestin evolution. With the recent availability of the lizard and frog genome sequences, we examined amino acid sequence and function of lizard and frog prestins to determine how they are functionally and structurally different from prestins of mammals and other non-mammals. Somatic motility, voltage-dependent nonlinear capacitance (NLC), the two hallmarks of prestin function, and transport capability were measured in transfected human embryonic kidney cells using voltage-clamp and radioisotope techniques. We demonstrated that while the transport capability of lizard and frog prestin was compatible to that of chicken prestin, the NLC of lizard prestin was more robust than that of chicken's and was close to that of platypus. However, unlike platypus prestin which has acquired motor capability, lizard or frog prestin did not demonstrate motor capability. Lizard and frog prestins do not possess the same 11-amino-acid motif that is likely the structural adaptation for motor function in mammals. Thus, lizard and frog prestins appear to be functionally more advanced than that of chicken prestin, although motor capability is not yet acquired.	[Tang, Jie; Pecka, Jason L.; Beisel, Kirk W.; He, David Z. Z.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA; [Tang, Jie] So Med Univ, Sch Basic Med Sci, Dept Physiol, Guangzhou, Guangdong, Peoples R China; [Fritzsch, Bernd] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	Creighton University; Southern Medical University - China; University of Iowa	Beisel, KW (corresponding author), Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA.	beisel@creighton.edu; hed@creighton.edu	Tang, Jie/GNW-2318-2022	He (he zhi zhou), Zhi-Zhou/0000-0001-8383-9634; Tang, Jie/0000-0001-7882-4462; Fritzsch, Bernd/0000-0002-4882-8398	National Institutes of Health [R01 DC008649, R01 DC004696]; NIH from the NCRR [2P20 RR 18788]; NCRR, NIH [C06 RR17417-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017417, P20RR018788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008649, R01DC004696] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH from the NCRR; NCRR, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work has been supported by the National Institutes of Health grants R01 DC008649 to KB and R01 DC004696 to DH. JT was supported by the NIH grant 2P20 RR 18788 from the NCRR. The Integrated Biological Imaging Facility, supported by the Creighton University School of Medicine, was constructed with support from C06 Grant RR17417-01 from the NCRR, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert JT, 2007, J PHYSIOL-LONDON, V580, P451, DOI 10.1113/jphysiol.2007.127993; Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; Ashmore J. F., 1989, COCHLEAR MECH, P107; Ashmore J, 2008, PHYSIOL REV, V88, P173, DOI 10.1152/physrev.00044.2006; Bai JP, 2009, BIOPHYS J, V96, P3179, DOI 10.1016/j.bpj.2008.12.3948; Beisel KW, 2005, J NEUROSCI, V25, P9285, DOI 10.1523/JNEUROSCI.2110-05.2005; Elgoyhen AB, 2011, HEARING RES, V273, P100, DOI 10.1016/j.heares.2009.12.028; Bergevin C, 2008, J COMP PHYSIOL A, V194, P665, DOI 10.1007/s00359-008-0338-y; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Dallos P, 2002, NAT REV MOL CELL BIO, V3, P104, DOI 10.1038/nrm730; Dossena S, 2009, J MOL ENDOCRINOL, V43, P93, DOI 10.1677/JME-08-0175; EVANS BN, 1991, HEARING RES, V52, P288, DOI 10.1016/0378-5955(91)90019-6; Franchini LF, 2006, MOL PHYLOGENET EVOL, V41, P622, DOI 10.1016/j.ympev.2006.05.042; He DZZ, 2006, J MEMBRANE BIOL, V209, P119, DOI 10.1007/s00232-005-0833-9; He DZZ, 2003, J PHYSIOL-LONDON, V546, P511, DOI 10.1113/jphysiol.2002.026070; He DZZ, 1997, J NEUROSCI, V17, P3634; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; HILGEMANN DW, 1991, NATURE, V352, P715, DOI 10.1038/352715a0; Homma K, 2011, J BIOL CHEM, V286, P2297, DOI 10.1074/jbc.M110.185694; Jia SP, 2005, NAT NEUROSCI, V8, P1028, DOI 10.1038/nn1509; KOPPL C, 1994, HEARING RES, V72, P159, DOI 10.1016/0378-5955(94)90215-1; KOPPL C, 1993, HEARING RES, V71, P157, DOI 10.1016/0378-5955(93)90031-U; Li G, 2008, P NATL ACAD SCI USA, V105, P13959, DOI 10.1073/pnas.0802097105; Li Y, 2010, CURR BIOL, V20, pR55, DOI 10.1016/j.cub.2009.11.042; Liu Y, 2010, CURR BIOL, V20, pR53, DOI 10.1016/j.cub.2009.11.058; Liu Z, 2012, MOL BIOL EVOL, V29, P2187, DOI 10.1093/molbev/mss087; Manley GA, 2001, P NATL ACAD SCI USA, V98, P2826, DOI 10.1073/pnas.041604998; Manley GA, 2000, P NATL ACAD SCI USA, V97, P11736, DOI 10.1073/pnas.97.22.11736; Manley GA, 2011, HEARING RES, V273, P1, DOI 10.1016/j.heares.2011.01.005; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; Muallem D, 2006, BIOPHYS J, V90, P4035, DOI 10.1529/biophysj.105.073254; Okoruwa OE, 2008, EVOL DEV, V10, P300, DOI 10.1111/j.1525-142X.2008.00239.x; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; SANTOS-SACCHI J, 1989, J NEUROSCI, V9, P2954; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Santos-Sacchi J, 2001, J PHYSIOL-LONDON, V531, P661, DOI 10.1111/j.1469-7793.2001.0661h.x; Schaechinger TJ, 2007, P NATL ACAD SCI USA, V104, P7693, DOI 10.1073/pnas.0608583104; SCHNEIDER MF, 1973, NATURE, V242, P244, DOI 10.1038/242244a0; Song L, 2010, BIOPHYS J, V98, P371, DOI 10.1016/j.bpj.2009.10.027; Tan XD, 2012, J CELL SCI, V125, P1039, DOI 10.1242/jcs.097337; Tan XD, 2011, J NEUROPHYSIOL, V105, P36, DOI 10.1152/jn.00234.2010; Tang J, 2011, J BIOL CHEM, V286, P31014, DOI 10.1074/jbc.M111.259564; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANDIJK P, 1987, J ACOUST SOC AM, V82, P2147, DOI 10.1121/1.395660; vanDijk P, 1996, HEARING RES, V101, P102, DOI 10.1016/S0378-5955(96)00140-2; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Wang X, 2010, BRAIN RES, V1333, P28, DOI 10.1016/j.brainres.2010.03.070; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zheng J, 2005, J CELL SCI, V118, P2987, DOI 10.1242/jcs.02431; Zheng J, 2002, AUDIOL NEURO-OTOL, V7, P9, DOI 10.1159/000046855	51	15	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54388	10.1371/journal.pone.0054388	http://dx.doi.org/10.1371/journal.pone.0054388			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342145	gold, Green Published, Green Submitted			2022-12-25	WOS:000313682700110
J	Wang, Y; Yang, J; Li, HS; Wang, X; Zhu, LL; Fan, M; Wang, XM				Wang, Yue; Yang, Jian; Li, Haisheng; Wang, Xuan; Zhu, Lingling; Fan, Ming; Wang, Xiaomin			Hypoxia Promotes Dopaminergic Differentiation of Mesenchymal Stem Cells and Shows Benefits for Transplantation in a Rat Model of Parkinson's Disease	PLOS ONE			English	Article							NEURAL PRECURSOR CELLS; P38 MAP KINASE; ACTIVATED PROTEIN-KINASE; INDUCIBLE FACTOR 1-ALPHA; MARROW STROMAL CELLS; BONE-MARROW; NEURONAL DIFFERENTIATION; EFFICIENT GENERATION; SIGNALING PATHWAYS; PROGENITOR CELLS	Mesenchymal stem cells (MSCs) are multipotent cells capable of differentiating into dopaminergic (DAergic) neurons, which is one of the major cell types damaged in Parkinson's disease (PD). For this reason, MSCs are considered a potential cell source for PD therapy. It has been proved that hypoxia is involved in the proliferation and differentiation of stem cells. In this study, we investigated the effect of hypoxia on MSC proliferation and DAergic neuronal differentiation. Our results demonstrate that 3% O-2 treatment can enhance rat MSC proliferation by upregulation of phosphorylated p38 MAPK and subsequent nuclear translocation of hypoxia inducible factor (HIF)-1 alpha. During neural differentiation, 3% O-2 treatment increases the expression of HIF-1 alpha, phosphorylated ERK and p38 MAPK. These changes are followed by promotion of neurosphere formation and further DAergic neuronal differentiation. Furthermore, we explored the physiological function of hypoxia-induced DAergic neurons from human fetal MSCs by transplanting them into parkinsonian rats. Grafts induced with hypoxia display more survival of DAergic neurons and greater amelioration of behavioral impairments. Altogether, these results suggest that hypoxia can promote MSC proliferation and DAergic neuronal differentiation, and benefit for intrastriatal transplantation. Therefore, this study may provide new perspectives in application of MSCs to clinical PD therapy.	[Yang, Jian; Wang, Xuan; Wang, Xiaomin] Capital Med Univ, Educ Minist, Key Lab Neurodegenerat Dis, Dept Physiol & Neurobiol, Beijing, Peoples R China; [Wang, Yue] Peking Univ, Key Lab Neurosci PKU, Hlth Sci Ctr, Neurosci Res Inst,Minist Educ, Beijing 100871, Peoples R China; [Yang, Jian] Beijing An Ding Hosp, Beijing, Peoples R China; [Li, Haisheng; Zhu, Lingling; Fan, Ming] Beijing Inst Basic Med Sci, Dept Brain Protect, Beijing, Peoples R China	Capital Medical University; Peking University; Academy of Military Medical Sciences - China	Fan, M (corresponding author), Beijing Inst Basic Med Sci, Dept Brain Protect, Beijing, Peoples R China.	fanmingchina@126.com; xmwang@ccmu.edu.cn	Yang, Kevin/GRE-7923-2022		Chinese National Basic Research 973 Program [2011CB504100, 2010CB944801, 2011CB910800, 2012CB518200]; National Science Foundation of Beijing [5102010, 90919025]	Chinese National Basic Research 973 Program(National Basic Research Program of China); National Science Foundation of Beijing	This work was supported by grants from the Chinese National Basic Research 973 Program (2011CB504100, 2010CB944801, 2011CB910800, 2012CB518200) and National Science Foundation of Beijing (5102010, 90919025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barzilay R, 2008, STEM CELLS DEV, V17, P547, DOI 10.1089/scd.2007.0172; Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158; Cho MS, 2008, NAT PROTOC, V3, P1888, DOI 10.1038/nprot.2008.188; Comerford KM, 2004, CANCER RES, V64, P9057, DOI 10.1158/0008-5472.CAN-04-1919; Cox BD, 2006, J CELL BIOCHEM, V99, P36, DOI 10.1002/jcb.20956; Csete M, 2005, ANN NY ACAD SCI, V1049, P1, DOI 10.1196/annals.1334.001; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; Grayson WL, 2007, BIOCHEM BIOPH RES CO, V358, P948, DOI 10.1016/j.bbrc.2007.05.054; Hu XY, 2008, J THORAC CARDIOV SUR, V135, P799, DOI 10.1016/j.jtcvs.2007.07.071; Hur E, 2001, MOL PHARMACOL, V59, P1216, DOI 10.1124/mol.59.5.1216; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Kanichai M, 2008, J CELL PHYSIOL, V216, P708, DOI 10.1002/jcp.21446; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kim TS, 2008, J NEUROSCI RES, V86, P2353, DOI 10.1002/jnr.21687; Kubo M, 2009, J CELL PHYSIOL, V220, P508, DOI 10.1002/jcp.21803; Kulisz A, 2002, AM J PHYSIOL-LUNG C, V282, pL1324, DOI 10.1152/ajplung.00326.2001; Le Belle JE, 2002, BIODRUGS, V16, P389, DOI 10.2165/00063030-200216060-00001; Lee SH, 2008, J CELL BIOCHEM, V104, P1598, DOI 10.1002/jcb.21657; Lee SH, 2010, AM J PHYSIOL-CELL PH, V298, pC847, DOI 10.1152/ajpcell.00418.2009; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Lennon DP, 2001, J CELL PHYSIOL, V187, P345, DOI 10.1002/jcp.1081; Leroux L, 2010, MOL THER, V18, P1545, DOI 10.1038/mt.2010.108; Milosevic J, 2007, J NEUROSCI, V27, P412, DOI 10.1523/JNEUROSCI.2482-06.2007; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Mortimer HJ, 2007, PULM PHARMACOL THER, V20, P718, DOI 10.1016/j.pupt.2006.08.007; Neumeister B, 2009, STEM CELLS, V27, P714, DOI 10.1634/stemcells.2008-0985; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; Pacary E, 2007, MOL CELL NEUROSCI, V35, P409, DOI 10.1016/j.mcn.2007.04.002; Pacary E, 2006, J CELL SCI, V119, P2667, DOI 10.1242/jcs.03004; Paxinos G., 1996, RAT BRAIN STEREOTAXI; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ren HX, 2010, P NATL ACAD SCI USA, V107, P5857, DOI 10.1073/pnas.0909570107; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Sanchez-Ramos JR, 2002, J NEUROSCI RES, V69, P880, DOI 10.1002/jnr.10337; Schnell PO, 2003, J NEUROCHEM, V85, P483, DOI 10.1046/j.1471-4159.2003.01696.x; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Sharp FR, 2004, NAT REV NEUROSCI, V5, P437, DOI 10.1038/nrn1408; Stacpoole SRL, 2011, NAT PROTOC, V6, P1229, DOI 10.1038/nprot.2011.380; Storch A, 2001, EXP NEUROL, V170, P317, DOI 10.1006/exnr.2001.7706; Studer L, 2000, J NEUROSCI, V20, P7377; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Swistowski A, 2010, STEM CELLS, V28, P1893, DOI 10.1002/stem.499; Trzaska KA, 2011, METHODS MOL BIOL, V698, P295, DOI 10.1007/978-1-60761-999-4_22; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang X, 2004, INT J DEV NEUROSCI, V22, P175, DOI 10.1016/j.ijdevneu.2004.05.008; Wang X, 2004, NEUROSCI LETT, V362, P117, DOI 10.1016/j.neulet.2004.03.007; Wei L, 2012, NEUROBIOL DIS, V46, P635, DOI 10.1016/j.nbd.2012.03.002; Welsh DJ, 2006, PULM PHARMACOL THER, V19, P128, DOI 10.1016/j.pupt.2005.04.008; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Xu L, 2004, CLIN CANCER RES, V10, P701, DOI 10.1158/1078-0432.CCR-0953-03; Zhang CL, 2010, BIOCHEM BIOPH RES CO, V394, P976, DOI 10.1016/j.bbrc.2010.03.102	53	31	35	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54296	10.1371/journal.pone.0054296	http://dx.doi.org/10.1371/journal.pone.0054296			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342124	Green Published, gold, Green Submitted			2022-12-25	WOS:000313682700104
J	Soderberg, CAG; Rajan, S; Shkumatov, AV; Gakh, O; Schaefer, S; Ahlgren, EC; Svergun, DI; Isaya, G; Al-Karadaghi, S				Soderberg, Christopher A. G.; Rajan, Sreekanth; Shkumatov, Alexander V.; Gakh, Oleksandr; Schaefer, Susanne; Ahlgren, Eva-Christina; Svergun, Dmitri I.; Isaya, Grazia; Al-Karadaghi, Salam			The Molecular Basis of Iron-induced Oligomerization of Frataxin and the Role of the Ferroxidation Reaction in Oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFUR CLUSTER BIOSYNTHESIS; ESCHERICHIA-COLI CYAY; YEAST FRATAXIN; FRIEDREICHS-ATAXIA; SOLUTION SCATTERING; BINDING-PROPERTIES; MISSENSE MUTATION; CRYSTAL-STRUCTURE; POINT MUTATIONS; 2FE-2S CLUSTERS	The role of the mitochondrial protein frataxin in iron storage and detoxification, iron delivery to iron-sulfur cluster biosynthesis, heme biosynthesis, and aconitase repair has been extensively studied during the last decade. However, still no general consensus exists on the details of the mechanism of frataxin function and oligomerization. Here, using small-angle x-ray scattering and x-ray crystallography, we describe the solution structure of the oligomers formed during the iron-dependent assembly of yeast (Yfh1) and Escherichia coli (CyaY) frataxin. At an iron-to-protein ratio of 2, the initially monomeric Yfh1 is converted to a trimeric form in solution. The trimer in turn serves as the assembly unit for higher order oligomers induced at higher iron-to-protein ratios. The x-ray crystallographic structure obtained from iron-soaked crystals demonstrates that iron binds at the trimer-trimer interaction sites, presumably contributing to oligomer stabilization. For the ferroxidation-deficient D79A/D82A variant of Yfh1, iron-dependent oligomerization may still take place, although > 50% of the protein is found in the monomeric state at the highest iron-to-protein ratio used. This demonstrates that the ferroxidation reaction controls frataxin assembly and presumably the iron chaperone function of frataxin and its interactions with target proteins. For E. coli CyaY, the assembly unit of higher order oligomers is a tetramer, which could be an effect of the much shorter N-terminal region of this protein. The results show that understanding of the mechanistic features of frataxin function requires detailed knowledge of the interplay between the ferroxidation reaction, iron-induced oligomerization, and the structure of oligomers formed during assembly.	[Soderberg, Christopher A. G.; Rajan, Sreekanth; Schaefer, Susanne; Ahlgren, Eva-Christina; Al-Karadaghi, Salam] Lund Univ, Inst Chem & Chem Engn, Ctr Mol Prot Sci, SE-22100 Lund, Sweden; [Shkumatov, Alexander V.; Svergun, Dmitri I.] DESY, Hamburg Unit, EMBL, D-22603 Hamburg, Germany; [Gakh, Oleksandr; Isaya, Grazia] Mayo Clin, Coll Med, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; [Gakh, Oleksandr; Isaya, Grazia] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Lund University; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Mayo Clinic; Mayo Clinic	Isaya, G (corresponding author), Mayo Clin, Coll Med, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA.	isaya@mayo.edu; salam.al-karadaghi@biochemistry.lu.se	Al-karadaghi, Salam/F-1492-2011; Söderberg, Christopher/E-1819-2013	Al-karadaghi, Salam/0000-0001-8608-0635; RAJAN, SREEKANTH/0000-0003-4453-3936; Svergun, Dmitri/0000-0003-0830-5696	National Institutes of Health (NIA) [AG15709]; Swedish Research Council (Vetenskapsradet); Natural Science Faculty of Lund University; Crafoord Foundation; Carl Trygger Foundation; Bundesministerium fur Bildung und Forschung [05K10YEA]; EU [261572]; NATIONAL INSTITUTE ON AGING [R01AG015709] Funding Source: NIH RePORTER	National Institutes of Health (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Natural Science Faculty of Lund University; Crafoord Foundation; Carl Trygger Foundation; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); EU(European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG15709 (NIA; to G.I.). This work was also supported by the Swedish Research Council (Vetenskapsradet), a MAX IV/ESS grant from the Natural Science Faculty of Lund University, the Crafoord Foundation, and the Carl Trygger Foundation (to S.A.K.).; Supported by Bundesministerium fur Bildung und Forschung Research Grant SYNC-LIFE (contract 05K10YEA) and the EU FP7 e-Infrastructure Grant WeNMR (contract 261572).	Adamec J, 2000, AM J HUM GENET, V67, P549, DOI 10.1086/303056; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andre I, 2007, P NATL ACAD SCI USA, V104, P17656, DOI 10.1073/pnas.0702626104; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bartolo C, 1998, AM J MED GENET, V79, P396, DOI 10.1002/(SICI)1096-8628(19981012)79:5<396::AID-AJMG13>3.3.CO;2-B; Bedekovics T, 2007, FEMS YEAST RES, V7, P1276, DOI 10.1111/j.1567-1364.2007.00296.x; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bidichandani SI, 1997, AM J HUM GENET, V60, P1251; Blanchet CE, 2012, J APPL CRYSTALLOGR, V45, P489, DOI 10.1107/S0021889812013490; Bou-Abdallah F, 2004, J MOL BIOL, V341, P605, DOI 10.1016/j.jmb.2004.05.072; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Cavadini P, 2002, HUM MOL GENET, V11, P217, DOI 10.1093/hmg/11.3.217; Chasteen ND, 1999, J STRUCT BIOL, V126, P182, DOI 10.1006/jsbi.1999.4118; Cho SJ, 2000, P NATL ACAD SCI USA, V97, P8932, DOI 10.1073/pnas.160270897; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Condo I, 2007, HUM MOL GENET, V16, P1534, DOI 10.1093/hmg/ddm102; Cook JD, 2006, BIOCHEMISTRY-US, V45, P7767, DOI 10.1021/bi060424r; Cossee M, 1999, ANN NEUROL, V45, P200, DOI 10.1002/1531-8249(199902)45:2<200::AID-ANA10>3.0.CO;2-U; De Castro M, 2000, HUM GENET, V106, P86, DOI 10.1007/s004399900201; Dey S, 2010, J MOL BIOL, V398, P146, DOI 10.1016/j.jmb.2010.02.020; Dhe-Paganon S, 2000, J BIOL CHEM, V275, P30753, DOI 10.1074/jbc.C000407200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fornasari MS, 2004, MOL BIOL EVOL, V21, P97, DOI 10.1093/molbev/msg244; Forrest SM, 1998, NEUROGENETICS, V1, P253, DOI 10.1007/s100480050037; Franke D, 2012, NUCL INSTRUM METH A, V689, P52, DOI 10.1016/j.nima.2012.06.008; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461; Gakh O, 2002, BIOCHEMISTRY-US, V41, P6798, DOI 10.1021/bi025566+; Gakh O, 2008, J BIOL CHEM, V283, P31500, DOI 10.1074/jbc.M805415200; Gakh O, 2010, J BIOL CHEM, V285, P38486, DOI 10.1074/jbc.M110.145144; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; He YN, 2004, BIOCHEMISTRY-US, V43, P16254, DOI 10.1021/bi0488193; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karlberg T, 2006, STRUCTURE, V14, P1535, DOI 10.1016/j.str.2006.08.010; Kell DB, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-2; Knaapila M, 2009, J SYNCHROTRON RADIAT, V16, P498, DOI 10.1107/S0909049509018986; Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koutnikova H, 1998, HUM MOL GENET, V7, P1485, DOI 10.1093/hmg/7.9.1485; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Lewin A, 2005, DALTON T, P3597, DOI 10.1039/b506071k; Li HQ, 2009, J BIOL CHEM, V284, P21971, DOI 10.1074/jbc.M109.011197; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nair M, 2004, STRUCTURE, V12, P2037, DOI 10.1016/j.str.2004.08.012; Nichol H, 2003, BIOCHEMISTRY-US, V42, P5971, DOI 10.1021/bi027021l; O'Neill HA, 2005, BIOCHEMISTRY-US, V44, P537, DOI 10.1021/bi048459j; O'Neill HA, 2005, J MOL BIOL, V345, P433, DOI 10.1016/j.jmb.2004.10.074; Park S, 2003, J BIOL CHEM, V278, P31340, DOI 10.1074/jbc.M303158200; Park S, 2002, J BIOL CHEM, V277, P38589, DOI 10.1074/jbc.M206711200; Pastore C, 2007, FEBS J, V274, P4199, DOI 10.1111/j.1742-4658.2007.05946.x; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Porod G., 1982, SMALL ANGLE XRAY SCA, P17, DOI DOI 10.1002/ACTP.1985.010360520; Ptitsyn OB, 1998, J MOL BIOL, V278, P655, DOI 10.1006/jmbi.1997.1620; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Schagerlof U, 2008, BIOCHEMISTRY-US, V47, P4948, DOI 10.1021/bi800052m; Schmucker S, 2008, HUM MOL GENET, V17, P3521, DOI 10.1093/hmg/ddn244; Seguin A, 2009, MITOCHONDRION, V9, P130, DOI 10.1016/j.mito.2009.01.007; Soderberg CAG, 2011, J MOL BIOL, V414, P783, DOI 10.1016/j.jmb.2011.10.034; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Vaubel R. A., 2012, MOL CELL NEUROSCI; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang T, 2008, J BIOL CHEM, V283, P12674, DOI 10.1074/jbc.M800399200; Yoon T, 2004, J BIOL CHEM, V279, P25943, DOI 10.1074/jbc.C400107200; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i	75	21	20	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8156	8167		10.1074/jbc.M112.442285	http://dx.doi.org/10.1074/jbc.M112.442285			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23344952	Green Published, hybrid			2022-12-25	WOS:000316564500016
J	Kim, HR; Choi, HJ; Kim, YK; Kim, HJ; Shin, JH; Suh, SP; Ryang, DW; Shin, MG				Kim, Hye-Ran; Choi, Hyun-Jung; Kim, Yeo-Kyeoung; Kim, Hyeoung-Joon; Shin, Jong-Hee; Suh, Soon-Pal; Ryang, Dong-Wook; Shin, Myung-Geun			Allelic Expression Imbalance of JAK2 V617F Mutation in BCR-ABL Negative Myeloproliferative Neoplasms	PLOS ONE			English	Article							DISORDERS; PREVALENCE; DIAGNOSIS; CRITERIA; GENE; PCR	The discovery of a single point mutation in the JAK2 gene in patients with BCR/ABL-negative myeloproliferative neoplasms (MPNs) has not only brought new insights and pathogenesis, but also has made the diagnosis of MPNs much easier. Although, to date, several mechanisms for the contribution of single JAK2V617F point mutation to phenotypic diversity of MPNs have been suggested in multiple studies, but it is not clear how a unique mutation can cause the phenotypic diversity of MPNs. In this study, our results show that allelic expression imbalance of JAK2 V617F mutant frequently occurs and contributes to phenotypic diversity of BCR-ABL-negative MPNs. The proportion of JAK2 V617F mutant allele was significantly augmented in RNA levels as compared with genomic DNA differently by distinct MPNs subtypes. In detail, preferential expression of JAK2 mutant allele showed threefold increase from the cDNA compared with the genomic DNA from patients with essential thrombocythemia and twofold increase in polycythemia vera. In conclusion, allelic expression imbalance of JAK2 V617F mutant proposes another plausible mechanism for the contribution of single JAK2 point mutation to phenotypic diversity of MPNs.	[Kim, Hye-Ran] Chonnam Natl Univ, Ctr Biomed Human Resources, Brain Korea Project 21, Kwangju, South Korea; [Choi, Hyun-Jung; Shin, Jong-Hee; Suh, Soon-Pal; Ryang, Dong-Wook; Shin, Myung-Geun] Chonnam Natl Univ, Sch Med, Dept Lab Med, Hwasun, South Korea; [Choi, Hyun-Jung; Shin, Jong-Hee; Suh, Soon-Pal; Ryang, Dong-Wook; Shin, Myung-Geun] Chonnam Natl Univ, Hwasun Hosp, Dept Lab Med, Hwasun, South Korea; [Kim, Yeo-Kyeoung; Kim, Hyeoung-Joon] Chonnam Natl Univ, Sch Med, Dept Hematol, Hwasun, South Korea; [Kim, Yeo-Kyeoung; Kim, Hyeoung-Joon] Chonnam Natl Univ, Sch Med, Genome Res Ctr Hematopoiet Dis, Hwasun, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University	Shin, MG (corresponding author), Chonnam Natl Univ, Sch Med, Dept Lab Med, Hwasun, South Korea.	mgshin@chonnam.ac.kr			Leading Foreign Research Institute Recruitment Program through National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology (MEST) [2011-0030034, 2010-0024326]; NRF; Korean Health Technology R&D Project, Ministry of Health & Welfare, and Republic of Korea [A110367]	Leading Foreign Research Institute Recruitment Program through National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); NRF; Korean Health Technology R&D Project, Ministry of Health & Welfare, and Republic of Korea	This work was supported by Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) (2011-0030034), Basic Science Research Program through NRF funded by the MEST (No. 2010-0024326) and a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, and Republic of Korea (A110367). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Campbell PJ, 2005, LANCET, V366, P1945, DOI 10.1016/S0140-6736(05)67785-9; Chae H, 2009, KOREAN J LAB MED, V29, P243, DOI 10.3343/kjlm.2009.29.3.243; Chun JY, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm051; Haferlach T, 2008, ANN HEMATOL, V87, P1, DOI 10.1007/s00277-007-0403-6; James Chloe, 2008, Hematology Am Soc Hematol Educ Program, P69, DOI 10.1182/asheducation-2008.1.69; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Kondo T, 2008, LEUKEMIA LYMPHOMA, V49, P1784, DOI 10.1080/10428190802258972; Kralovics R, 2008, LEUKEMIA, V22, P1841, DOI 10.1038/leu.2008.233; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Larsen TS, 2007, BRIT J HAEMATOL, V136, P745, DOI 10.1111/j.1365-2141.2007.06497.x; Lippert E, 2009, HAEMATOL-HEMATOL J, V94, P38, DOI 10.3324/haematol.13486; Pastinen T, 2010, NAT REV GENET, V11, P533, DOI 10.1038/nrg2815; Poodt J, 2006, HEMATOL ONCOL, V24, P227, DOI 10.1002/hon.800; Sazawal S, 2010, INDIAN J MED RES, V132, P423; Tefferi A, 2008, LEUKEMIA, V22, P14, DOI 10.1038/sj.leu.2404955; Thoennissen NH, 2010, BLOOD, V115, P2882, DOI 10.1182/blood-2009-07-235119; Vannucchi AM, 2008, LEUKEMIA, V22, pCP5, DOI 10.1038/leu.2008.113; Vilaine M, 2011, BLOOD, V118, P6468, DOI 10.1182/blood-2011-08-372813; Wang DX, 2006, AAPS J, V8, pE515, DOI 10.1208/aapsj080361	20	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e52518	10.1371/journal.pone.0052518	http://dx.doi.org/10.1371/journal.pone.0052518			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349688	Green Submitted, gold, Green Published			2022-12-25	WOS:000314019100012
J	Mita-Mendoza, NK; van de Hoef, DL; Lopera-Mesa, TM; Doumbia, S; Konate, D; Doumbouya, M; Gu, WJ; Anderson, JM; Santos-Argumedo, L; Rodriguez, A; Fay, MP; Diakite, M; Long, CA; Fairhurst, RM				Mita-Mendoza, Neida K.; van de Hoef, Diana L.; Lopera-Mesa, Tatiana M.; Doumbia, Saibou; Konate, Drissa; Doumbouya, Mory; Gu, Wenjuan; Anderson, Jennifer M.; Santos-Argumedo, Leopoldo; Rodriguez, Ana; Fay, Michael P.; Diakite, Mahamadou; Long, Carole A.; Fairhurst, Rick M.			A Potential Role for Plasma Uric Acid in the Endothelial Pathology of Plasmodium falciparum malaria	PLOS ONE			English	Article							NITRIC-OXIDE; OXIDATIVE STRESS; CEREBRAL MALARIA; HYPERURICEMIA; INFLAMMATION; ASSOCIATION; COAGULATION; ACTIVATION; EXPRESSION; PLATELETS	Background: Inflammatory cytokinemia and systemic activation of the microvascular endothelium are central to the pathogenesis of Plasmodium falciparum malaria. Recently, 'parasite-derived' uric acid (UA) was shown to activate human immune cells in vitro, and plasma UA levels were associated with inflammatory cytokine levels and disease severity in Malian children with malaria. Since UA is associated with endothelial inflammation in non-malaria diseases, we hypothesized that elevated UA levels contribute to the endothelial pathology of P. falciparum malaria. Methodology/Principal Findings: We measured levels of UA and soluble forms of intercellular adhesion molecule-1 (sICAM-1), vascular cell adhesion molecule-1 (sVCAM-1), E-selectin (sE-Selectin), thrombomodulin (sTM), tissue factor (sTF) and vascular endothelial growth factor (VEGF) in the plasma of Malian children aged 0.5-17 years with uncomplicated malaria (UM, n = 487) and non-cerebral severe malaria (NCSM, n = 68). In 69 of these children, we measured these same factors once when they experienced a malaria episode and twice when they were healthy (i.e., before and after the malaria transmission season). We found that levels of UA, sICAM-1, sVCAM-1, sE-Selectin and sTM increase during a malaria episode and return to basal levels at the end of the transmission season (p < 0.0001). Plasma levels of UA and these four endothelial biomarkers correlate with parasite density and disease severity. In children with UM, UA levels correlate with parasite density (r = 0.092, p = 0.043), sICAM-1 (r = 0.255, p < 0.0001) and sTM (r = 0.175, p = 0.0001) levels. After adjusting for parasite density, UA levels predict sTM levels. Conclusions/Significance: Elevated UA levels may contribute to malaria pathogenesis by damaging endothelium and promoting a procoagulant state. The correlation between UA levels and parasite densities suggests that parasitized erythrocytes are one possible source of excess UA. UA-induced shedding of endothelial TM may represent a novel mechanism of malaria pathogenesis, in which activated thrombin induces fibrin deposition and platelet aggregation in microvessels. This protocol is registered at clinicaltrials.gov (NCT00669084).	[Mita-Mendoza, Neida K.; Lopera-Mesa, Tatiana M.; Anderson, Jennifer M.; Long, Carole A.; Fairhurst, Rick M.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Mita-Mendoza, Neida K.; Santos-Argumedo, Leopoldo] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Biomed Mol, Mexico City, DF, Mexico; [van de Hoef, Diana L.; Rodriguez, Ana] NYU, Sch Med, Dept Microbiol, Div Parasitol, New York, NY 10016 USA; [Doumbia, Saibou; Konate, Drissa; Doumbouya, Mory; Diakite, Mahamadou] Univ Bamako, Fac Med Pharm & Odontostomatol, Malaria Res & Training Ctr, Bamako, Mali; [Gu, Wenjuan; Fay, Michael P.] NIAID, Biostat Res Branch, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; New York University; University of Bamako; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fairhurst, RM (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA.	rfairhurst@niaid.nih.gov	Rodríguez, Ana/GQR-0554-2022; Fay, Michael P/A-2974-2008	Fay, Michael P/0000-0002-8643-9625; Santos-Argumedo, Leopoldo/0000-0002-4772-0713; Rodriguez, Ana/0000-0002-0060-3405	NIAID, National Institute of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001020, ZIAAI001000, ZIAAI001062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	NIAID, National Institute of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Intramural Research Program of the NIAID, National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Anstey NM, 1996, J EXP MED, V184, P557, DOI 10.1084/jem.184.2.557; Atoh Y, 2011, VIOPOINTS 1 D SCATTE; Barbier M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019651; Combes V, 2006, INT J PARASITOL, V36, P541, DOI 10.1016/j.ijpara.2006.02.005; Conroy AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015291; Corry DB, 2008, J HYPERTENS, V26, P269, DOI 10.1097/HJH.0b013e3282f240bf; Feig DI, 2006, CURR HYPERTENS REP, V8, P111, DOI 10.1007/s11906-006-0005-z; Filiopoulos V, 2012, RENAL FAILURE, V34, P510, DOI 10.3109/0886022X.2011.653753; Fiore E, 2002, ONCOGENE, V21, P5213, DOI 10.1038/sj.onc.1205684; Francischetti IMB, 2007, J THROMB HAEMOST, V5, P155, DOI 10.1111/j.1538-7836.2006.02232.x; Francischetti IMB, 2008, MICROCIRCULATION, V15, P81, DOI 10.1080/10739680701451516; Furuta T, 2010, AM J TROP MED HYG, V82, P136, DOI 10.4269/ajtmh.2010.09-0203; Gersch C, 2008, NUCLEOS NUCLEOT NUCL, V27, P967, DOI 10.1080/15257770802257952; Gillrie MR, 2012, AM J PATHOL, V180, P1028, DOI 10.1016/j.ajpath.2011.11.037; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; Hong Q, 2012, CELL CALCIUM, V51, P402, DOI 10.1016/j.ceca.2012.01.003; Hsieh MS, 2003, J CELL BIOCHEM, V89, P791, DOI 10.1002/jcb.10530; Jain V, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-83; JAKOBSEN PH, 1994, IMMUNOLOGY, V83, P665; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Kanellis J, 2005, SEMIN NEPHROL, V25, P39, DOI 10.1016/j.semnephrol.2004.09.007; Kawai T, 2012, HYPERTENS RES; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Kim H, 2011, CURR OPIN HEMATOL, V18, P177, DOI 10.1097/MOH.0b013e328345a4cf; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Lopera-Mesa TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046424; Nakagawa T, 2006, KIDNEY INT, V69, P1722, DOI 10.1038/sj.ki.5000391; Orengo JM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000013; Orengo JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005194; Panoulas VF, 2007, RHEUMATOLOGY, V46, P1466, DOI 10.1093/rheumatology/kem159; Pasalic D, 2012, BIOCHEM MEDICA, V22, P63; Prato M, 2011, CELL MICROBIOL, V13, P1275, DOI 10.1111/j.1462-5822.2011.01620.x; Price KL, 2006, J AM SOC NEPHROL, V17, P1791, DOI 10.1681/ASN.2006030264; Puddu P, 2012, J CARDIOL, V59, P235, DOI 10.1016/j.jjcc.2012.01.013; Shyu, 1992, STAT MODELS; So A, 2010, J CLIN INVEST, V120, P1791, DOI 10.1172/JCI42344; Sobolewski P, 2005, TRENDS PARASITOL, V21, P415, DOI 10.1016/j.pt.2005.07.002; Strazzullo P, 2007, NUTR METAB CARDIOVAS, V17, P409, DOI 10.1016/j.numecd.2007.02.011; Tchinda VHM, 2007, ACTA TROP, V102, P20, DOI 10.1016/j.actatropica.2007.02.011; Tomiyama H, 2011, AM J HYPERTENS, V24, P770, DOI 10.1038/ajh.2011.55; Turner GDH, 1998, AM J PATHOL, V152, P1477; Wassmer SC, 2006, J IMMUNOL, V176, P1180, DOI 10.4049/jimmunol.176.2.1180; WRIGHT SP, 1992, BIOMETRICS, V48, P1005, DOI 10.2307/2532694; Wu HL, 2008, BIOCHEM BIOPH RES CO, V367, P162, DOI 10.1016/j.bbrc.2007.12.135; Yeo TW, 2008, P NATL ACAD SCI USA, V105, P17097, DOI 10.1073/pnas.0805782105; Yeo TW, 2009, J INFECT DIS, V200, P1522, DOI 10.1086/644641	47	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54481	10.1371/journal.pone.0054481	http://dx.doi.org/10.1371/journal.pone.0054481			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349902	Green Published, gold, Green Submitted			2022-12-25	WOS:000314019100073
J	Wang, BY; Doan, D; Petersen, YR; Alvarado, E; Alvarado, G; Bhandari, A; Mohanty, A; Mohanty, S; Nissen, RM				Wang, Bingyan; Doan, Diana; Petersen, Yanett Roman; Alvarado, Estibaliz; Alvarado, Gregory; Bhandari, Ajay; Mohanty, Aditya; Mohanty, Sudipta; Nissen, Robert M.			Wdr68 Requires Nuclear Access for Craniofacial Development	PLOS ONE			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; MEDIATES CELL-SURVIVAL; MIRK PROTEIN-KINASE; HISTONE DEACETYLASES; PANCREATIC-CANCER; MIRK/DYRK1B; ZEBRAFISH; ACTIVATION; REPRESSION; GENES	Wdr68 is a highly conserved scaffolding protein required for craniofacial development and left-right asymmetry. A Ras-Map3k-Wdr68-Dyrk1 signaling relay may mediate these and other diverse signaling events important in development and disease. While the sub-cellular localization of Wdr68 has been shown to be dependent on that of its interaction partners, it is not clear where Wdr68 activity is required during development. Here we show that while a GFP-Wdr68 fusion functionally substituted for craniofacial development in the zebrafish, that a Nuclear Export Signal (NES) fusion protein (GFPNESWdr68) failed to support craniofacial development. As control for NES activity, we show that while GFP-Wdr68 exhibited a pan-cellular distribution in C2C12 cells, the GFPNESWdr68 fusion predominantly localized to the cell cytoplasm, as expected. Interestingly, while GFP-Wdr68 and RFP-Dyrk1a co-localized to the cell nucleus as expected based on the known sub-cellular localization for Dyrk1a, we found that the GFPNESWdr68 fusion redistributed RFP-Dyrk1a to the cell cytoplasm potentially disconnecting the Ras/Dyrk1 signal relay from further downstream targets. Consistent with a nuclear role in gene regulation, we also found that while a transcriptional activation domain fusion, CebpFlagWdr68, functionally substituted for endogenous Wdr68 for craniofacial development, that a transcriptional repression domain fusion, MadFlagWdr68, failed to support craniofacial development. Dyrk1b is required for myogenin (myog) expression in differentiating mouse C2C12 cells and here we report that wdr68 is also important for myog expression in differentiating C2C12 cells. Using a C2C12 cell myog promoter-reporter system, we found that Wdr68 overexpression increased reporter activity while moderate expression levels of MadFlagWdr68 interfered with reporter activity. Taken together, these findings support a nuclear role for Wdr68-containing complexes.	[Wang, Bingyan; Doan, Diana; Petersen, Yanett Roman; Alvarado, Estibaliz; Alvarado, Gregory; Bhandari, Ajay; Mohanty, Aditya; Mohanty, Sudipta; Nissen, Robert M.] Calif State Univ Los Angeles, Dept Biol Sci, Los Angeles, CA 90032 USA	California State University System; California State University Los Angeles	Nissen, RM (corresponding author), Calif State Univ Los Angeles, Dept Biol Sci, Los Angeles, CA 90032 USA.	rnissen@calstatela.edu	Wang, Bingyan/AAB-3883-2019	Wang, Bingyan/0000-0002-3522-2848; Nissen, Robert/0000-0002-0591-1167	United States National Science Foundation [IOS-0744454]; California State University Program for Education and Research in Biotechnology (CSUPERB); Division Of Graduate Education [0742426] Funding Source: National Science Foundation	United States National Science Foundation(National Science Foundation (NSF)); California State University Program for Education and Research in Biotechnology (CSUPERB); Division Of Graduate Education(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))	This study was funded by the United States National Science Foundation (IOS-0744454) and the California State University Program for Education and Research in Biotechnology (CSUPERB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Ayer DE, 1996, MOL CELL BIOL, V16, P5772; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Clouthier David E, 2004, Birth Defects Res C Embryo Today, V72, P190, DOI 10.1002/bdrc.20007; Deng XB, 2006, CANCER RES, V66, P4149, DOI 10.1158/0008-5472.CAN-05-3089; Deng XB, 2005, J BIOL CHEM, V280, P4894, DOI 10.1074/jbc.M411894200; Deng XB, 2003, J BIOL CHEM, V278, P41347, DOI 10.1074/jbc.M306780200; Deng XB, 2009, CANCER RES, V69, P3317, DOI 10.1158/0008-5472.CAN-08-2903; deVetten N, 1997, GENE DEV, V11, P1422, DOI 10.1101/gad.11.11.1422; Friedman E, 2007, J CELL BIOCHEM, V102, P274, DOI 10.1002/jcb.21451; Fukuda M, 1996, J BIOL CHEM, V271, P20024, DOI 10.1074/jbc.271.33.20024; Jin K, 2007, CANCER RES, V67, P7247, DOI 10.1158/0008-5472.can-06-4099; Kimmel CB, 1998, DEV BIOL, V203, P245, DOI 10.1006/dbio.1998.9016; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Lauth M, 2010, NAT STRUCT MOL BIOL, V17, P718, DOI 10.1038/nsmb.1833; Lee K, 2000, CANCER RES, V60, P3631; Lim S, 2002, J BIOL CHEM, V277, P25040, DOI 10.1074/jbc.M203257200; Lyons SE, 2001, GENE, V281, P43, DOI 10.1016/S0378-1119(01)00774-0; Mazmanian G, 2010, GENESIS, V48, P20, DOI 10.1002/dvg.20578; Mercer SE, 2005, J BIOL CHEM, V280, P25788, DOI 10.1074/jbc.M413594200; Mercer SE, 2006, CANCER RES, V66, P5143, DOI 10.1158/0008-5472.CAN-05-1539; Mercer SE, 2006, CELL BIOCHEM BIOPHYS, V45, P303, DOI 10.1385/CBB:45:3:303; Miller CT, 2007, DEV BIOL, V308, P144, DOI 10.1016/j.ydbio.2007.05.018; Miyata Y, 2011, BBA-MOL CELL RES, V1813, P1728, DOI 10.1016/j.bbamcr.2011.06.023; Nissen RM, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-28; Ritterhoff S, 2010, EMBO J, V29, P3750, DOI 10.1038/emboj.2010.251; RUSSELL M, 1995, J BIOL CHEM, V270, P11757, DOI 10.1074/jbc.270.20.11757; Skurat AV, 2004, J BIOL CHEM, V279, P2490, DOI 10.1074/jbc.M301769200; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Wang Y, 2011, PLANT CELL, V23, P486, DOI 10.1105/tpc.110.081661; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; Williamson EA, 1998, J BIOL CHEM, V273, P14796, DOI 10.1074/jbc.273.24.14796; Yujiri T, 2000, P NATL ACAD SCI USA, V97, P7272, DOI 10.1073/pnas.130176697	35	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54363	10.1371/journal.pone.0054363	http://dx.doi.org/10.1371/journal.pone.0054363			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349862	Green Published, gold, Green Submitted			2022-12-25	WOS:000314019100060
J	Wang, H; Chan, YL; Li, TL; Bauer, BA; Hsia, SM; Wang, CH; Huang, JS; Wang, HM; Yeh, KY; Huang, TH; Wu, GJ; Wu, CJ				Wang, Hang; Chan, Yi-Lin; Li, Tsung-Lin; Bauer, Brent A.; Hsia, Simon; Wang, Cheng-Hsu; Huang, Jen-Seng; Wang, Hung-Ming; Yeh, Kun-Yun; Huang, Tse-Hung; Wu, Gwo-Jang; Wu, Chang-Jer			Reduction of Splenic Immunosuppressive Cells and Enhancement of Anti-Tumor Immunity by Synergy of Fish Oil and Selenium Yeast	PLOS ONE			English	Article							IMMATURE MYELOID CELLS; REGULATORY T-CELLS; TUMOR-BEARING MICE; NUTRITIONAL-STATUS; SUPPRESSOR-CELLS; CANCER-PATIENTS; LUNG-CANCER; FATTY-ACIDS; CACHEXIA; INHIBITION	Growing evidence has shown that regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs) abnormally increase in cancer cachectic patients. Suppressions of Tregs and MDSCs may enhance anti-tumor immunity for cancer patients. Fish oil and selenium have been known to have many biological activities such as anti-inflammation and anti-oxidation. Whether fish oil and/or selenium have an additional effect on population of immunosuppressive cells in tumor-bearing hosts remained elusive and controversial. To gain insights into their roles on anti-tumor immunity, we studied the fish oil- and/or selenium-mediated tumor suppression and immunity on lung carcinoma, whereof cachexia develops. Advancement of cachexia in a murine lung cancer model manifested with such indicative symptoms as weight loss, chronic inflammation and disturbed immune functionality. The elevation of Tregs and MDSCs in spleens of tumor-bearing mice was positively correlated with tumor burdens. Consumption of either fish oil or selenium had little or no effect on the levels of Tregs and MDSCs. However, consumption of both fish oil and selenium together presented a synergistic effect-The population of Tregs and MDSCs decreased as opposed to increase of anti-tumor immunity when both fish oil and selenium were supplemented simultaneously, whereby losses of body weight and muscle/fat mass were alleviated significantly.	[Wang, Hang; Wu, Chang-Jer] Natl Taiwan Ocean Univ, Dept Food Sci, Keelung, Taiwan; [Wang, Hang; Wu, Chang-Jer] Natl Taiwan Ocean Univ, Ctr Excellence Marine Bioenvironm & Biotechnol, Keelung, Taiwan; [Chan, Yi-Lin; Wu, Gwo-Jang] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Li, Tsung-Lin] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Bauer, Brent A.] Mayo Clin, Div Gen Internal Med, Rochester, MN USA; [Hsia, Simon] Hung Kuang Univ, Inst Biomed Nutr, Taichung, Taiwan; [Wang, Cheng-Hsu; Huang, Jen-Seng; Yeh, Kun-Yun] Chang Gung Mem Hosp, Dept Internal Med, Div Hematooncol, Keelung, Taiwan; [Wang, Hung-Ming] Chang Gung Mem Hosp, Dept Internal Med, Div Hematooncol, Kweishan, Taiwan; [Huang, Tse-Hung] Chang Gung Mem Hosp, Dept Tradit Chinese Med, Kweishan, Taiwan; [Huang, Tse-Hung] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Kaohsiung, Taiwan	National Taiwan Ocean University; National Taiwan Ocean University; National Defense Medical Center; Academia Sinica - Taiwan; Mayo Clinic; Hungkuang University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Wu, CJ (corresponding author), Natl Taiwan Ocean Univ, Dept Food Sci, Keelung, Taiwan.	wuchangjer@yahoo.com.tw	Huang, Tse-Hung/N-5989-2019	Huang, Tse-Hung/0000-0002-5231-9932; Wu, Tsung-Han/0000-0001-8455-8009				Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; BALDIE G, 1993, BIOCHIM BIOPHYS ACTA, V1179, P125, DOI 10.1016/0167-4889(93)90133-A; Baniyash M, 2004, NAT REV IMMUNOL, V4, P675, DOI 10.1038/nri1434; BECK SA, 1987, CANCER RES, V47, P5919; Beyer M, 2006, BLOOD, V108, P804, DOI 10.1182/blood-2006-02-002774; Burns CP, 2004, CANCER, V101, P370, DOI 10.1002/cncr.20362; Cohen AC, 2006, J IMMUNOL, V177, P2770, DOI 10.4049/jimmunol.177.5.2770; DeLong P, 2003, CANCER RES, V63, P7845; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; duPre' SA, 2007, EXP MOL PATHOL, V82, P12, DOI 10.1016/j.yexmp.2006.06.007; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; Elkabets M, 2010, EUR J IMMUNOL, V40, P3347, DOI 10.1002/eji.201041037; ENDRES S, 1989, NEW ENGL J MED, V320, P265, DOI 10.1056/NEJM198902023200501; Evans C, 2006, ALIMENT PHARM THER, V24, P1163, DOI 10.1111/j.1365-2036.2006.03075.x; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Faber J, 2009, ONCOL REP, V22, P1403, DOI 10.3892/or_00000581; Furukawa K, 1999, ANN SURG, V229, P255, DOI 10.1097/00000658-199902000-00014; Herber DL, 2007, CANCER RES, V67, P5067, DOI 10.1158/0008-5472.CAN-07-0897; Hoffmann PR, 2007, ARCH IMMUNOL THER EX, V55, P289, DOI 10.1007/s00005-007-0036-4; Ip C, 1998, J NUTR, V128, P1845, DOI 10.1093/jn/128.11.1845; Kiremidjian-Schumacher L, 2001, BIOFACTORS, V14, P161, DOI 10.1002/biof.5520140121; Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989; Li HQ, 2009, J IMMUNOL, V182, P240, DOI 10.4049/jimmunol.182.1.240; Markowska J., 1995, European Journal of Gynaecological Oncology, V16, P54; Martin F, 1999, CYTOKINE, V11, P80, DOI 10.1006/cyto.1998.0398; McCarthy Donna O, 2003, Biol Res Nurs, V5, P3, DOI 10.1177/1099800403005001001; Moon PD, 2011, AMINO ACIDS; Ren J, 2007, J AGR FOOD CHEM, V55, P5073, DOI 10.1021/jf0702693; Ross PJ, 2004, BRIT J CANCER, V90, P1905, DOI 10.1038/sj.bjc.6601781; Roth MJ, 2006, EUR J CANCER PREV, V15, P548, DOI 10.1097/01.cej.0000220632.93104.2d; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SEVCIKOVA L, 1992, NEOPLASMA, V39, P219; Shchors K, 2006, GENE DEV, V20, P2527, DOI 10.1101/gad.1455706; Song XP, 2005, J IMMUNOL, V175, P8200, DOI 10.4049/jimmunol.175.12.8200; Takagi K, 2001, NUTRITION, V17, P478, DOI 10.1016/S0899-9007(01)00557-3; Takekoshi K, 2004, LIFE SCI, V74, P863, DOI 10.1016/J.lfs.2003.07.036; Tatsuta T, 1996, J IMMUNOL, V157, P3949; Ueha S, 2011, INT IMMUNOPHARMACOL, V11, P783, DOI 10.1016/j.intimp.2011.03.003; Van Cutsem Eric, 2005, Eur J Oncol Nurs, V9 Suppl 2, pS51, DOI 10.1016/j.ejon.2005.09.007; van der Meij BS, 2010, J NUTR, V140, P1774, DOI 10.3945/jn.110.121202; Xia S, 2011, J BIOL CHEM; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; YUHAS JM, 1974, CANCER RES, V34, P722; Zeng JH, 2009, J NUTR BIOCHEM, V20, P530, DOI 10.1016/j.jnutbio.2008.05.012	44	18	18	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e52912	10.1371/journal.pone.0052912	http://dx.doi.org/10.1371/journal.pone.0052912			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349693	Green Published, gold, Green Submitted			2022-12-25	WOS:000314019100014
J	Tseng, TS; Cheng, CS; Hsu, STD; Shih, MF; He, PL; Lyu, PC				Tseng, Tien-Sheng; Cheng, Chao-Sheng; Hsu, Shang-Te Danny; Shih, Min-Fang; He, Pei-Lin; Lyu, Ping-Chiang			Residue-Specific Annotation of Disorder-to-Order Transition and Cathepsin Inhibition of a Propeptide-Like Crammer from D. melanogaster	PLOS ONE			English	Article							BOMBYX CYSTEINE PROTEINASE; STRUCTURE-BASED DESIGN; LONG-TERM-MEMORY; CRYSTAL-STRUCTURE; SELECTIVE INHIBITOR; ALZHEIMERS-DISEASE; STRUCTURAL BASIS; PROTEASES; REVEALS; REGIONS	Drosophila melanogaster crammer is a novel cathepsin inhibitor involved in long-term memory formation. A molten globule-to-ordered structure transition is required for cathepsin inhibition. This study reports the use of alanine scanning to probe the critical residues in the two hydrophobic cores and the salt bridges of crammer in the context of disorder-to-order transition and cathepsin inhibition. Alanine substitution of the aromatic residues W9, Y12, F16, Y20, Y32, and W53 within the hydrophobic cores, and charged residues E8, R28, R29, and E67 in the salt bridges considerably decrease the ability of crammer to inhibit Drosophila cathepsin B (CTSB). Far-UV circular dichroism (CD), intrinsic fluorescence, and nuclear magnetic resonance (NMR) spectroscopies show that removing most of the aromatic and charged side-chains substantially reduces thermostability, alters pH-dependent helix formation, and disrupts the molten globule-to-ordered structure transition. Molecular modeling indicates that W53 in the hydrophobic Core 2 is essential for the interaction between crammer and the prosegment binding loop (PBL) of CTSB; the salt bridge between R28 and E67 is critical for the appropriate alignment of the alpha-helix 4 toward the CTSB active cleft. The results of this study show detailed residue-specific dissection of folding transition and functional contributions of the hydrophobic cores and salt bridges in crammer, which have hitherto not been characterized for cathepsin inhibition by propeptide-like cysteine protease inhibitors. Because of the involvements of cathepsin inhibitors in neurodegenerative diseases, these structural insights can serve as a template for further development of therapeutic inhibitors against human cathepsins.	[Tseng, Tien-Sheng; Cheng, Chao-Sheng; Shih, Min-Fang; He, Pei-Lin; Lyu, Ping-Chiang] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Hsu, Shang-Te Danny] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Lyu, Ping-Chiang] China Med Univ, Grad Inst Mol Syst Biomed, Taichung, Taiwan	National Tsing Hua University; Academia Sinica - Taiwan; China Medical University Taiwan	Lyu, PC (corresponding author), Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan.	lslpc@life.nthu.edu.tw	Hsu, Shang-Te Danny/L-2826-2014; Hsu, Shang-Te Danny/B-2324-2009; Tseng, Tien-Sheng Emerson/ABB-1352-2021; Tseng, Tien-Sheng Emerson/ABB-1365-2021	Hsu, Shang-Te Danny/0000-0002-7231-0185; Tseng, Tien-Sheng Emerson/0000-0002-2344-0485; Tseng, Tien-Sheng Emerson/0000-0003-0515-1855	National Science Council, Taiwan [NSC 99-2811-M-007-073, 99-3112-B-007-003, 99-2627-B-007-010, NSC 101-2321- B-007-005-MY2, 100-2113-M-001-031-MY2]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	National Science Council, Taiwan (Grant numbers: NSC 99-2811-M-007-073, 99-3112-B-007-003, 99-2627-B-007-010, NSC 101-2321- B-007-005-MY2, and 100-2113-M-001-031-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn NG, 2005, SCIENCE, V308, P1266, DOI 10.1126/science.1113707; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; BARRETT AJ, 1980, BIOCHEM J, V187, P909, DOI 10.1042/bj1870909; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; BERTI PJ, 1995, J MOL BIOL, V246, P273, DOI 10.1006/jmbi.1994.0083; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Bosshard HR, 2004, J MOL RECOGNIT, V17, P1, DOI 10.1002/jmr.657; Buhling F, 2000, ADV EXP MED BIOL, V477, P241; Chan CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021624; Chen YM, 1996, FEBS LETT, V393, P24, DOI 10.1016/0014-5793(96)00847-2; Cheng CS, 2008, PROTEINS, V70, P695, DOI 10.1002/prot.21520; Comas D, 2004, NATURE, V430, P460, DOI 10.1038/nature02726; Coulombe R, 1996, EMBO J, V15, P5492, DOI 10.1002/j.1460-2075.1996.tb00934.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DELARIA K, 1994, J BIOL CHEM, V269, P25172; DENIZOT F, 1989, EUR J IMMUNOL, V19, P631, DOI 10.1002/eji.1830190409; Deshapriya RMC, 2010, J BIOCHEM, V147, P393, DOI 10.1093/jb/mvp188; Deshapriya RMC, 2007, ZOOL SCI, V24, P21, DOI 10.2108/zsj.24.21; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Gelb BD, 1996, SCIENCE, V273, P1236, DOI 10.1126/science.273.5279.1236; Groves MR, 1998, PROTEINS, V32, P504, DOI 10.1002/(SICI)1097-0134(19980901)32:4<504::AID-PROT8>3.0.CO;2-F; Gutierrez-Gonzalez LH, 2006, ARCH BIOCHEM BIOPHYS, V446, P151, DOI 10.1016/j.abb.2005.12.005; Horovitz A, 1996, FOLD DES, V1, pR121, DOI 10.1016/S1359-0278(96)00056-9; Huo SH, 2002, J MED CHEM, V45, P1412, DOI 10.1021/jm010338j; II K, 1993, VIRCHOWS ARCH A, V423, P185, DOI 10.1007/BF01614769; Inui T, 1997, J BIOL CHEM, V272, P8109, DOI 10.1074/jbc.272.13.8109; Jerala R, 1998, J BIOL CHEM, V273, P11498, DOI 10.1074/jbc.273.19.11498; Jilkova A, 2011, J BIOL CHEM, V286, P35770, DOI 10.1074/jbc.M111.271304; Katunuma N, 2002, ARCH BIOCHEM BIOPHYS, V397, P305, DOI 10.1006/abbi.2001.2709; Kaulmann G, 2003, ACTA CRYSTALLOGR D, V59, P1243, DOI 10.1107/S0907444903008801; Kaulmann G, 2006, PROTEIN SCI, V15, P2619, DOI 10.1110/ps.062401806; Krashes MJ, 2008, J NEUROSCI, V28, P3103, DOI 10.1523/JNEUROSCI.5333-07.2008; Kurata M, 2003, PROTEIN EXPRES PURIF, V32, P119, DOI 10.1016/S1046-5928(03)00222-5; Kurata M, 2001, J BIOCHEM, V130, P857, DOI 10.1093/oxfordjournals.jbchem.a003058; LaLonde JM, 1999, BIOCHEMISTRY-US, V38, P862, DOI 10.1021/bi9822271; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Liu YN, 2007, BIOCHEM J, V403, P21, DOI 10.1042/BJ20061312; MANTLE D, 1995, J NEUROL SCI, V131, P65, DOI 10.1016/0022-510X(95)00035-Z; Markt P, 2008, J CHEM INF MODEL, V48, P1693, DOI 10.1021/ci800101j; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MASON RW, 1987, BIOCHEM J, V248, P449, DOI 10.1042/bj2480449; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; MORT JS, 1984, ARTHRITIS RHEUM, V27, P509, DOI 10.1002/art.1780270505; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Podobnik M, 1997, J MOL BIOL, V271, P774, DOI 10.1006/jmbi.1997.1218; Ravikumar M, 2008, CHEM BIOL DRUG DES, V72, P79, DOI 10.1111/j.1747-0285.2008.00667.x; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P461; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Roche L, 1999, MOL BIOCHEM PARASIT, V98, P271, DOI 10.1016/S0166-6851(98)00164-9; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sivaraman J, 1999, PROTEIN SCI, V8, P283; Teles RCL, 2005, BIOPHYS J, V88, P3509, DOI 10.1529/biophysj.104.045682; Thompson SK, 1999, BIOORGAN MED CHEM, V7, P599, DOI 10.1016/S0968-0896(99)00010-3; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Tseng TS, 2012, BIOCHEM J, V442, P563, DOI 10.1042/BJ20111360; Tseng TS, 2011, BIOCH J; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Turk D, 2003, ACTA CRYSTALLOGR D, V59, P203, DOI 10.1107/S0907444902021479; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wiederanders B, 2000, ADV EXP MED BIOL, V477, P261; WL D, 2002, PYMOL MOL GRAPHICS S; Yamamoto Y, 1999, FEBS LETT, V448, P257, DOI 10.1016/S0014-5793(99)00382-8; Zhang LS, 2009, ACTA BIOCH BIOPH SIN, V41, P437, DOI 10.1093/abbs/gmp031	66	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54187	10.1371/journal.pone.0054187	http://dx.doi.org/10.1371/journal.pone.0054187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349821	gold, Green Published, Green Submitted			2022-12-25	WOS:000313943000028
J	Zhou, HQ; Chen, ZN; Shi, HB; Wu, YQ; Yin, SK				Zhou, Huiqun; Chen, Zhengnong; Shi, Haibo; Wu, Yaqin; Yin, Shankai			Categories of Auditory Performance and Speech Intelligibility Ratings of Early-Implanted Children without Speech Training	PLOS ONE			English	Article							PEDIATRIC COCHLEAR IMPLANTATION; LANGUAGE-DEVELOPMENT; DEAFENED PATIENTS; PERCEPTION; AGE	Objective: To assess whether speech therapy can lead to better results for early cochlear implantation (CI) children. Patients: A cohort of thirty-four congenitally profoundly deaf children who underwent CI before the age of 18 months at the Sixth Hospital affiliated with Shanghai Jiaotong University from January 2005 to July 2008 were included. Nineteen children received speech therapy in rehabilitation centers (ST), whereas the remaining fifteen cases did not (NST), but were exposed to the real world, as are normal hearing children. Methods: All children were assessed before surgery and at 6, 12, and 24 months after surgery with the Categories of Auditory Performance test (CAP) and the Speech Intelligibility Rating (SIR). Each assessment was given by the same therapist who was blind to the situation of the child at each observation interval. CAP and SIR scores of the groups were compared at each time point. Results: Our study showed that the auditory performance and speech intelligibility of trained children were almost the same as to those of untrained children with early implantation. The CAP and SIR scores of both groups increased with increased time of implant use during the follow-up period, and at each time point, the median scores of the two groups were about equal. Conclusions: These results indicate that great communication benefits are achieved by early implantation (, 18 months) without routine speech therapy. The results exemplify the importance of enhanced social environments provided by everyday life experience for human brain development and reassure parents considering cochlear implants where speech training is unavailable.	[Zhou, Huiqun; Chen, Zhengnong; Shi, Haibo; Wu, Yaqin; Yin, Shankai] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Otolaryngol, Shanghai 200030, Peoples R China; [Zhou, Huiqun; Chen, Zhengnong; Shi, Haibo; Wu, Yaqin; Yin, Shankai] Shanghai Jiao Tong Univ, Otolaryngol Inst, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chen, ZN (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Otolaryngol, Shanghai 200030, Peoples R China.	jassey@126.com; yinshankai@china.com		Shi, Haibo/0000-0002-2920-0183	Ministry of Health Sector Fund [201202001]; joint research projects of Shanghai municipal hospitals [SHDC12010119]	Ministry of Health Sector Fund; joint research projects of Shanghai municipal hospitals	This work was supported by the Ministry of Health Sector Fund (grant no. 201202001) and the joint research projects of Shanghai municipal hospitals (grant no. SHDC12010119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2001, OTOL NEUROTOL, V22, P631, DOI 10.1097/00129492-200109000-00012; Allen MC, 1998, AM J OTOL, V19, P742; Archbold S, 1995, Ann Otol Rhinol Laryngol Suppl, V166, P312; BUSBY P A, 1991, British Journal of Audiology, V25, P291, DOI 10.3109/03005369109076601; Dawson PW, 1997, EAR HEARING, V18, P488, DOI 10.1097/00003446-199712000-00007; Dettman SJ, 2007, EAR HEARING, V28, p11S, DOI 10.1097/AUD.0b013e31803153f8; FryaufBertschy H, 1997, J SPEECH LANG HEAR R, V40, P183, DOI 10.1044/jslhr.4001.183; Fu QJ, 2008, HEARING RES, V242, P198, DOI 10.1016/j.heares.2007.11.010; Fu QJ, 2005, JARO-J ASSOC RES OTO, V6, P180, DOI 10.1007/s10162-005-5061-6; Geers AE, 2004, ARCH OTOLARYNGOL, V130, P634, DOI 10.1001/archotol.130.5.634; Geers Ann E, 2007, Audiol Med, V5, P262, DOI 10.1080/16513860701659404; Gilley PM, 2008, BRAIN RES, V1239, P56, DOI 10.1016/j.brainres.2008.08.026; Govaerts PJ, 2002, OTOL NEUROTOL, V23, P885, DOI 10.1097/00129492-200211000-00013; Hiraumi H, 2007, ACTA OTO-LARYNGOL, V127, P17, DOI 10.1080/03655230601065225; Houston DM, 2010, OTOL NEUROTOL, V31, P1248, DOI 10.1097/MAO.0b013e3181f1cc6a; Moore DR, 2009, NAT NEUROSCI, V12, P686, DOI 10.1038/nn.2326; O'Neill C, 2002, OTOL NEUROTOL, V23, P44, DOI 10.1097/00129492-200201000-00011; Pyman B, 2000, AM J OTOL, V21, P57, DOI 10.1016/S0196-0709(00)80076-9; Sharma A, 2005, HEARING RES, V203, P134, DOI 10.1016/j.heares.2004.12.010; Snik AFM, 1997, INT J PEDIATR OTORHI, V41, P121, DOI 10.1016/S0165-5876(97)00058-X; Svirsky MA, 2000, PSYCHOL SCI, V11, P153, DOI 10.1111/1467-9280.00231; Wu JL, 2007, AUDIOL NEURO-OTOL, V12, P307, DOI 10.1159/000103211; Yucel E, 2009, INT J PEDIATR OTORHI, V73, P1043, DOI 10.1016/j.ijporl.2009.04.009	23	15	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e53852	10.1371/journal.pone.0053852	http://dx.doi.org/10.1371/journal.pone.0053852			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349752	gold, Green Published, Green Submitted			2022-12-25	WOS:000313943000018
J	Dietz, MW; Rogers, KG; Piersma, T				Dietz, Maurine W.; Rogers, Ken G.; Piersma, Theunis			When the Seasons Don't Fit: Speedy Molt as a Routine Carry-Over Cost of Reproduction	PLOS ONE			English	Article							KNOTS CALIDRIS-CANUTUS; PLOVERS PLUVIALIS-SQUATAROLA; AVIAN PRIMARY MOLT; RED KNOTS; MIGRATION STRATEGIES; SOUTHWARD MIGRATION; FEATHER QUALITY; ANNUAL CYCLE; HABITAT USE; LIFE-CYCLE	The failure of animals to fit all life-cycle stages into an annual cycle could reduce the chances of successful breeding. In some cases, non-optimal strategies will be adopted in order to maintain the life-cycle within the scope of one year. We studied trade-offs made by a High Arctic migrant shorebird, the red knot Calidris canutus islandica, between reproduction and wing feather molt carried out in the non-breeding period in the Dutch Wadden Sea. We compared primary molt duration between birds undertaking the full migratory and breeding schedule with birds that forego breeding because they are young or are maintained in captivity. Molt duration was ca. 71 days in breeding adults, which was achieved by an accelerated feather replacement strategy. Second-year birds and captive adults took ca. 22% and 27% longer, respectively. Second-year birds start molt in late June, more than four weeks before captive adults, and almost seven weeks before adults that return from breeding in late July-August. Adults finish molt in October when steeply increasing thermostatic costs and reductions in food availability occur. Primary molt duration was longer in female than in male knots (all ages), which was accordance with the somewhat larger body size of females. Since fast growth leads to lower quality feathers, the speedy wing molt shown by Arctic-breeding birds may represent a time constraint that is an unavoidable and routine cost of reproduction. So far it was hypothesized that only birds over 1 kg would have difficulty fitting molt within a year. Here we show that in birds an order of magnitude smaller, temporal imperatives may impose the adoption of non-optimal life-cycle routines in the entire actively breeding population.	[Dietz, Maurine W.; Piersma, Theunis] Univ Groningen, Ctr Ecol & Evolutionary Studies, Anim Ecol Grp, Groningen, Netherlands; [Piersma, Theunis] Royal Netherlands Inst Sea Res, Dept Marine Ecol, Den Burg, Texel, Netherlands	University of Groningen; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Dietz, MW (corresponding author), Univ Groningen, Ctr Ecol & Evolutionary Studies, Anim Ecol Grp, Groningen, Netherlands.	M.W.Dietz@rug.nl	Dietz, Maurine W./F-2614-2013; Piersma, Theunis/D-1871-2012	Dietz, Maurine W./0000-0001-9022-3790; Piersma, Theunis/0000-0001-9668-466X	NIOZ Royal Netherlands Institute for Sea Research; NWO-PIONIER grant; Waddenfonds (programme Metawad)	NIOZ Royal Netherlands Institute for Sea Research; NWO-PIONIER grant; Waddenfonds (programme Metawad)	This research was funded by operational grants from the NIOZ Royal Netherlands Institute for Sea Research. NWO-PIONIER grant to Theunis Piersma and funding from the Waddenfonds (programme Metawad). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 1990, BIRD MIGRATION; Alerstam T, 2011, J ORNITHOL, V152, P5, DOI 10.1007/s10336-011-0694-1; Baker AJ, 1999, CONDOR, V101, P887, DOI 10.2307/1370083; Battley PF, 2006, BIOL LETTERS, V2, P517, DOI 10.1098/rsbl.2006.0535; Blomqvist S, 2002, OECOLOGIA, V133, P146, DOI 10.1007/s00442-002-1017-2; BOERE GC, 1976, ARDEA, V64, P210; Bridge ES, 2011, CONDOR, V113, P1, DOI 10.1525/cond.2011.100228; Broggi J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024942; Buehler DM, 2008, PHILOS T R SOC B, V363, P247, DOI 10.1098/rstb.2007.2138; DAVIDSON NC, 1992, WADER STUDY GROUP S, V64, P39; Dawson A, 2000, P ROY SOC B-BIOL SCI, V267, P2093, DOI 10.1098/rspb.2000.1254; Dawson A, 2004, IBIS, V146, P493, DOI 10.1111/j.1474-919x.2004.00290.x; de la Hera I, 2010, J AVIAN BIOL, V41, P342, DOI 10.1111/j.1600-048X.2009.04835.x; de la Hera I, 2009, BIOL J LINN SOC, V97, P98, DOI 10.1111/j.1095-8312.2008.01189.x; Dietz MW, 2010, CONDOR, V112, P48, DOI 10.1525/cond.2010.090139; Dietz MW, 1999, J EXP BIOL, V202, P2831; Erni B, 2012, J STAT SOFT IN PRESS; Forrest J, 2010, PHILOS T R SOC B, V365, P3101, DOI 10.1098/rstb.2010.0145; Ginn HB, 2007, BTO GUIDE; Hall KSS, 2000, J AVIAN BIOL, V31, P583, DOI 10.1034/j.1600-048X.2000.310419.x; Hedenstrom A, 2003, J AVIAN BIOL, V34, P324, DOI 10.1111/j.0908-8857.2003.03324.x; Hedenstrom A, 2006, ARDEA, V94, P399; Helseth A, 2005, ARDEA, V93, P213; Hout P.J. van den, 2009, LIMOSA, V82, P122; Jacobs JD, 2000, CONDOR, V102, P35, DOI 10.1650/0010-5422(2000)102[0035:ECOLCS]2.0.CO;2; Jenni L., 1994, BIOL MOULT BIRDS; Kjellen Nils, 1994, Ornis Svecica, V4, P1; Lank DB, 2003, OIKOS, V103, P303, DOI 10.1034/j.1600-0706.2003.12314.x; McNamara JM, 2008, PHILOS T R SOC B, V363, P301, DOI 10.1098/rstb.2007.2141; Mitchell GW, 2012, IBIS, V154, P325, DOI 10.1111/j.1474-919X.2012.01212.x; Nebel S, 2000, ARDEA, V88, P165; Nilsson JA, 1996, P ROY SOC B-BIOL SCI, V263, P711, DOI 10.1098/rspb.1996.0106; PIERSMA T, 1993, NETH J SEA RES, V31, P331, DOI 10.1016/0077-7579(93)90052-T; Piersma T, 1998, J AVIAN BIOL, V29, P97, DOI 10.2307/3677186; Piersma T, 2000, GEN COMP ENDOCR, V120, P118, DOI 10.1006/gcen.2000.7543; PIERSMA T, 1995, J COMP PHYSIOL B, V165, P37, DOI 10.1007/BF00264684; Piersma T, 2007, J ORNITHOL, V148, pS45, DOI 10.1007/s10336-007-0240-3; Piersma Theunis, 2005, P262; Prater A.J., 1979, GUIDE IDENTIFICATION; Quaintenne G, 2011, P ROY SOC B-BIOL SCI, V278, P2728, DOI 10.1098/rspb.2011.0026; Quinn JL, 2006, P R SOC B, V273, P2521, DOI 10.1098/rspb.2006.3612; Remisiewicz Magdalena, 2011, Wader Study Group Bulletin, V118, P163; Rohwer S, 2011, CONDOR, V113, P61, DOI 10.1525/cond.2011.100092; Rohwer S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000132; Serra L, 2006, IBIS, V148, P292, DOI 10.1111/j.1474-919X.2006.00532.x; Serra L, 2001, J AVIAN BIOL, V32, P377, DOI 10.1111/j.0908-8857.2001.320415.x; SIIKAMAKI P, 1994, FUNCT ECOL, V8, P587, DOI 10.2307/2389919; Summers RW, 2010, IBIS, V152, P127, DOI 10.1111/j.1474-919X.2009.00972.x; Tomkovich P.S., 1992, WADER STUDY GROUP S, V64, P17; Tomkovich PS, 1996, ARDEA, V84, P85; Underhill L.G., 1993, Wader Study Group Bulletin, V71, P29; UNDERHILL LG, 1990, IBIS, V132, P118, DOI 10.1111/j.1474-919X.1990.tb01024.x; UNDERHILL LG, 1988, IBIS, V130, P358, DOI 10.1111/j.1474-919X.1988.tb00993.x; Vagasi CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040651; Vagasi CI, 2011, ARDEA, V99, P53, DOI 10.5253/078.099.0107; Vagasi CI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014215; Van Den Hout PJ, 2008, IBIS, V150, P219, DOI 10.1111/j.1474-919X.2008.00785.x; van den Hout PJ, 2010, BEHAV ECOL, V21, P16, DOI 10.1093/beheco/arp146; van Gils JA, 2003, J EXP BIOL, V206, P3369, DOI 10.1242/jeb.00546; Vezina F, 2009, PHYSIOL BIOCHEM ZOOL, V82, P129, DOI 10.1086/596512; WHITFIELD DP, 1991, IBIS, V133, P246, DOI 10.1111/j.1474-919X.1991.tb04566.x; WIERSMA P, 1994, CONDOR, V96, P257, DOI 10.2307/1369313; Wingfield JC, 2008, PHILOS T R SOC B, V363, P425, DOI 10.1098/rstb.2007.2149	63	26	28	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53890	10.1371/journal.pone.0053890	http://dx.doi.org/10.1371/journal.pone.0053890			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349758	Green Published, Green Submitted, gold			2022-12-25	WOS:000313738900024
J	Donald, DB; Bogard, MJ; Finlay, K; Bunting, L; Leavitt, PR				Donald, Derek B.; Bogard, Matthew J.; Finlay, Kerri; Bunting, Lynda; Leavitt, Peter R.			Phytoplankton-Specific Response to Enrichment of Phosphorus-Rich Surface Waters with Ammonium, Nitrate, and Urea	PLOS ONE			English	Article							EXPERIMENTAL LAKES AREA; FRESH-WATER; COMMUNITY COMPOSITION; MICROCYSTIS-AERUGINOSA; OSCILLATORIA-AGARDHII; NITROGEN ASSIMILATION; TEMPORAL VARIABILITY; SUPPLY RATIOS; CHLOROPHYLL-A; ALGAL GROWTH	Supply of anthropogenic nitrogen (N) to the biosphere has tripled since 1960; however, little is known of how in situ response to N fertilisation differs among phytoplankton, whether species response varies with the chemical form of N, or how interpretation of N effects is influenced by the method of analysis (microscopy, pigment biomarkers). To address these issues, we conducted two 21-day in situ mesocosm (3140 L) experiments to quantify the species- and genus-specific responses of phytoplankton to fertilisation of P-rich lake waters with ammonium (NH4+), nitrate (NO3-), and urea ([NH2](2)CO). Phytoplankton abundance was estimated using both microscopic enumeration of cell densities and high performance liquid chromatographic (HPLC) analysis of algal pigments. We found that total algal biomass increased 200% and 350% following fertilisation with NO3- and chemically-reduced N (NH4+, urea), respectively, although 144 individual taxa exhibited distinctive responses to N, including compound-specific stimulation (Planktothrix agardhii and NH4+), increased biomass with chemically-reduced N alone (Scenedesmus spp., Coelastrum astroideum) and no response (Aphanizomenon flos-aquae, Ceratium hirundinella). Principle components analyses (PCA) captured 53.2-69.9% of variation in experimental assemblages irrespective of the degree of taxonomic resolution of analysis. PCA of species-level data revealed that congeneric taxa exhibited common responses to fertilisation regimes (e.g., Microcystis aeruginosa, M. flos-aquae, M. botrys), whereas genera within the same division had widely divergent responses to added N (e.g., Anabaena, Planktothrix, Microcystis). Least-squares regression analysis demonstrated that changes in phytoplankton biomass determined by microscopy were correlated significantly (p<0.005) with variations in HPLC-derived concentrations of biomarker pigments (r(2) = 0.13-0.64) from all major algal groups, although HPLC tended to underestimate the relative abundance of cyanobacteria. Together, these findings show that while fertilisation of P-rich lakes with N can increase algal biomass, there is substantial variation in responses of genera and divisions to specific chemical forms of added N.	[Donald, Derek B.; Bogard, Matthew J.; Bunting, Lynda; Leavitt, Peter R.] Univ Regina, Dept Biol, Limnol Lab, Regina, SK S4S 0A2, Canada	University of Regina	Leavitt, PR (corresponding author), Univ Regina, Dept Biol, Limnol Lab, Regina, SK S4S 0A2, Canada.	Peter.Leavitt@uregina.ca	Bunting, Lynda/K-2039-2013; Leavitt, Peter R/A-1048-2013	Leavitt, Peter R/0000-0001-9805-9307	Natural Sciences and Engineering Research Council (NSERC) of Canada; Canada Research Chairs, Canada Foundation for Innovation; Province of Saskatchewan; University of Regina	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs, Canada Foundation for Innovation(Canada Foundation for InnovationCanada Research Chairs); Province of Saskatchewan; University of Regina	This work was supported by the Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grant (PRL) and Graduate Scholarships (DBD), Canada Research Chairs, Canada Foundation for Innovation, the Province of Saskatchewan, and the University of Regina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN RJ, 1980, ENVIRON POLLUT B, V1, P217, DOI 10.1016/0143-148X(80)90012-9; [Anonymous], 2002, TRACKING ENV CHANGE, DOI DOI 10.1007/0-306-47668-1_15; Badger MR, 2006, J EXP BOT, V57, P249, DOI 10.1093/jxb/eri286; BARICA J, 1980, CAN J FISH AQUAT SCI, V37, P1175, DOI 10.1139/f80-150; Berg GM, 2003, AQUAT MICROB ECOL, V30, P263, DOI 10.3354/ame030263; Berman T, 1999, J PLANKTON RES, V21, P1423, DOI 10.1093/plankt/21.8.1423; BLOMQVIST P, 1994, ARCH HYDROBIOL, V132, P141; Bruggeman J, 2011, J PHYCOL, V47, P52, DOI 10.1111/j.1529-8817.2010.00946.x; Bunting L, 2007, LIMNOL OCEANOGR, V52, P354, DOI 10.4319/lo.2007.52.1.0354; Burger DF, 2007, FUND APPL LIMNOL, V169, P57, DOI 10.1127/1863-9135/2007/0169-0057; Carneiro FM, 2010, ECOL INDIC, V10, P249, DOI 10.1016/j.ecolind.2009.05.004; Carpenter SR, 2005, P NATL ACAD SCI USA, V102, P10002, DOI 10.1073/pnas.0503959102; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Carpenter SR, 1996, ECOLOGY, V77, P677, DOI 10.2307/2265490; Collier JL, 2012, J PHYCOL, V48, P106, DOI 10.1111/j.1529-8817.2011.01100.x; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; Dokulil MT, 2000, HYDROBIOLOGIA, V438, P1, DOI 10.1023/A:1004155810302; Dolman AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038757; Donald DB, 2011, LIMNOL OCEANOGR, V56, P2161, DOI 10.4319/lo.2011.56.6.2161; Droscher I, 2009, LIMNOL OCEANOGR, V54, P2469, DOI 10.4319/lo.2009.54.6_part_2.2469; Edwards KF, 2012, LIMNOL OCEANOGR, V57, P554, DOI 10.4319/lo.2012.57.2.0554; Edwards KF, 2011, ECOLOGY, V92, P2085, DOI 10.1890/11-0395.1; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Fastner J, 1999, ARCH HYDROBIOL, V145, P147; Fernandez E, 2007, J EXP BOT, V58, P2279, DOI 10.1093/jxb/erm106; Finlay K, 2009, LIMNOL OCEANOGR, V54, P2553, DOI 10.4319/lo.2009.54.6_part_2.2553; Finlay K, 2010, LIMNOL OCEANOGR, V55, P1213, DOI 10.4319/lo.2010.55.3.1213; Flores E, 2005, BIOCHEM SOC T, V33, P164, DOI 10.1042/BST0330164; FOY RH, 1995, WATER RES, V29, P1051, DOI 10.1016/0043-1354(94)00259-A; FOY RH, 1987, FRESHWATER BIOL, V17, P237, DOI 10.1111/j.1365-2427.1987.tb01045.x; Fujimoto N, 1997, LIMNOL OCEANOGR, V42, P250, DOI 10.4319/lo.1997.42.2.0250; Giani A, 2005, CAN J FISH AQUAT SCI, V62, P2100, DOI 10.1139/F05-124; Ginn HP, 2010, APPL ENVIRON MICROB, V76, P4362, DOI 10.1128/AEM.01862-09; Grover JP, 1999, ARCH HYDROBIOL, V145, P1; Herrero A, 2001, J BACTERIOL, V183, P411, DOI 10.1128/JB.183.2.411-425.2001; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; HOLMGREN SK, 1984, INT REV GES HYDROBIO, V69, P781, DOI 10.1002/iroh.19840690603; Hyenstrand P, 2000, HYDROBIOLOGIA, V435, P91, DOI 10.1023/A:1004008721373; James C, 2003, ARCH HYDROBIOL, V158, P249, DOI 10.1127/0003-9136/2003/0158-0249; Jeffrey S.W., 2003, PHYTOPLANKTON PIGMEN; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; JENSEN JP, 1994, CAN J FISH AQUAT SCI, V51, P1692, DOI 10.1139/f94-170; John D., 2002, FRESHWATER ALGAE FLO; Johnk KD, 2008, GLOBAL CHANGE BIOL, V14, P495, DOI 10.1111/j.1365-2486.2007.01510.x; KLEMER AR, 1976, ARCH HYDROBIOL, V78, P343; Kruk C, 2011, LIMNOL OCEANOGR, V56, P110, DOI 10.4319/lo.2011.56.1.0110; LATHROP RC, 1988, CAN J FISH AQUAT SCI, V45, P2061, DOI 10.1139/f88-240; Leavitt PR, 2006, LIMNOL OCEANOGR, V51, P2262, DOI 10.4319/lo.2006.51.5.2262; LEAVITT PR, 1994, CAN J FISH AQUAT SCI, V51, P2286, DOI 10.1139/f94-232; LEHMAN JT, 1985, LIMNOL OCEANOGR, V30, P34, DOI 10.4319/lo.1985.30.1.0034; Levine SN, 1999, CAN J FISH AQUAT SCI, V56, P451, DOI 10.1139/cjfas-56-3-451; Lewis WM, 2008, INT REV HYDROBIOL, V93, P446, DOI 10.1002/iroh.200811065; Lewis WM, 2011, ENVIRON SCI TECHNOL, V45, P10300, DOI 10.1021/es202401p; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; Lomas MW, 1999, LIMNOL OCEANOGR, V44, P556, DOI 10.4319/lo.1999.44.3.0556; MacDonald GK, 2011, P NATL ACAD SCI USA, V108, P3086, DOI 10.1073/pnas.1010808108; McCarthy MJ, 2009, LIMNOLOGY, V10, P215, DOI 10.1007/s10201-009-0277-5; McGowan S, 2005, ECOSYSTEMS, V8, P694, DOI 10.1007/s10021-003-0152-x; Millennium Ecosystem Assessment, 2005, MILL ASS SER, V1; MILLIE DF, 1993, CAN J FISH AQUAT SCI, V50, P2513, DOI 10.1139/f93-275; Paerl HW, 2010, ENVIRON SCI TECHNOL, V44, P7756, DOI 10.1021/es102665e; Patoine A, 2008, INT VER THEOR ANGEW, V30, P366; Patoine A, 2006, LIMNOL OCEANOGR, V51, P1665, DOI 10.4319/lo.2006.51.4.1665; PEREZMARTINEZ C, 1995, FRESHWATER BIOL, V33, P193, DOI 10.1111/j.1365-2427.1995.tb01160.x; Pham SV, 2009, LIMNOL OCEANOGR, V54, P101, DOI 10.4319/lo.2009.54.1.0101; PRESCOTT GW, 1982, ALGAE W GREAT LAKES; Revilla M, 2005, LIMNOL OCEANOGR-METH, V3, P290, DOI 10.4319/lom.2005.3.290; Reynolds C. S., 1984, ECOLOGY FRESHWATER P; Reynolds CS, 2002, J PLANKTON RES, V24, P417, DOI 10.1093/plankt/24.5.417; ROBARTS RD, 1987, NEW ZEAL J MAR FRESH, V21, P391, DOI 10.1080/00288330.1987.9516235; Sanderson MP, 2008, AQUAT MICROB ECOL, V51, P153, DOI 10.3354/ame01178; Sandgren C.D., 1988, GROWTH REPROD STRATE; Scheffer M, 1997, ECOLOGY, V78, P272; Schindler DW, 2006, LIMNOL OCEANOGR, V51, P356, DOI 10.4319/lo.2006.51.1_part_2.0356; Schindler DW, 2009, SCIENCE, V324, P721, DOI 10.1126/science.324_721b; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; Schwaderer AS, 2011, LIMNOL OCEANOGR, V56, P589, DOI 10.4319/lo.2011.56.2.0589; Smith VH, 2009, TRENDS ECOL EVOL, V24, P201, DOI 10.1016/j.tree.2008.11.009; Smith Val H., 1995, Archiv fuer Hydrobiologie Supplementband, V107, P71; Solomon CM, 2010, AQUAT MICROB ECOL, V59, P67, DOI 10.3354/ame01390; SOMMER U, 1989, LIMNOL OCEANOGR, V34, P1162, DOI 10.4319/lo.1989.34.7.1162; Staehr PA, 2002, MAR ECOL PROG SER, V238, P47, DOI 10.3354/meps238047; Stainton MP, 1977, CANADIAN FISHERIES M, V25; Sterner RW, 2008, INT REV HYDROBIOL, V93, P433, DOI 10.1002/iroh.200811068; TAKAMURA N, 1987, J PLANKTON RES, V9, P151, DOI 10.1093/plankt/9.1.151; TILMAN D, 1986, ARCH HYDROBIOL, V106, P473; TURPIN DH, 1985, PLANT PHYSIOL, V78, P746, DOI 10.1104/pp.78.4.746; United States Environmental Protection Agency, 2007, EPA823R07002 OFF WAT; Uthermol H., 1958, MITTEILINGEN INTERNA, V9, P1, DOI [10.1080/0 5384680.1958.11904091, DOI 10.1080/05384680.1958.11904091]; Valladares A, 2002, MOL MICROBIOL, V43, P703, DOI 10.1046/j.1365-2958.2002.02778.x; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Waiser MJ, 2011, ENVIRON TOXICOL CHEM, V30, P496, DOI 10.1002/etc.399; Wehr J. D., 2003, FRESHWATER ALGAE N A; ZEVENBOOM W, 1982, LIMNOL OCEANOGR, V27, P39, DOI 10.4319/lo.1982.27.1.0039	94	102	105	2	152	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53277	10.1371/journal.pone.0053277	http://dx.doi.org/10.1371/journal.pone.0053277			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349705	Green Published, gold, Green Submitted			2022-12-25	WOS:000313738900008
J	Ball, HC; Holmes, RK; Londraville, RL; Thewissen, JGM; Duff, RJ				Ball, Hope C.; Holmes, Robert K.; Londraville, Richard L.; Thewissen, Johannes G. M.; Duff, Robert Joel			Leptin in Whales: Validation and Measurement of mRNA Expression by Absolute Quantitative Real-Time PCR	PLOS ONE			English	Article							REFERENCE GENES; SERUM LEPTIN; HOUSEKEEPING GENES; RT-PCR; QUANTIFICATION; RESISTANCE; MAMMALS; OBESITY; WEIGHT; MASS	Leptin is the primary hormone in mammals that regulates adipose stores. Arctic adapted cetaceans maintain enormous adipose depots, suggesting possible modifications of leptin or receptor function. Determining expression of these genes is the first step to understanding the extreme physiology of these animals, and the uniqueness of these animals presents special challenges in estimating and comparing expression levels of mRNA transcripts. Here, we compare expression of two model genes, leptin and leptin-receptor gene-related product (OB-RGRP), using two quantitative real-time PCR (qPCR) methods: "relative'' and "absolute''. To assess the expression of leptin and OB-RGRP in cetacean tissues, we first examined how relative expression of those genes might differ when normalized to four common endogenous control genes. We performed relative expression qPCR assays measuring the amplification of these two model target genes relative to amplification of 18S ribosomal RNA (18S), ubiquitously expressed transcript (Uxt), ribosomal protein 9 (Rs9) and ribosomal protein 15 (Rs15) endogenous controls. Results demonstrated significant differences in the expression of both genes when different control genes were employed; emphasizing a limitation of relative qPCR assays, especially in studies where differences in physiology and/or a lack of knowledge regarding levels and patterns of expression of common control genes may possibly affect data interpretation. To validate the absolute quantitative qPCR methods, we evaluated the effects of plasmid structure, the purity of the plasmid standard preparation and the influence of type of qPCR "background'' material on qPCR amplification efficiencies and copy number determination of both model genes, in multiple tissues from one male bowhead whale. Results indicate that linear plasmids are more reliable than circular plasmid standards, no significant differences in copy number estimation based upon background material used, and that the use of ethanol precipitated, linearized plasmid preparation produce the most reliable results.	[Ball, Hope C.; Holmes, Robert K.; Londraville, Richard L.; Duff, Robert Joel] Univ Akron, Dept Biol, Akron, OH 44325 USA; [Thewissen, Johannes G. M.] NE Ohio Med Univ, Dept Anat & Neurobiol, Rootstown, OH USA	University of Akron; Northeast Ohio Medical University (NEOMED)	Duff, RJ (corresponding author), Univ Akron, Dept Biol, Akron, OH 44325 USA.	rjduff@uakron.edu		Londraville, Richard/0000-0002-9438-7976; Thewissen, J. G. M./0000-0002-0973-4137	Sigma Xi GIAR and two consecutive Choose Ohio First Scholarships; National Science Foundation [34284]; NIH [DK079282-01A1]; Division Of Earth Sciences [0745543] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK079282] Funding Source: NIH RePORTER	Sigma Xi GIAR and two consecutive Choose Ohio First Scholarships; National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	HCB was supported by a Sigma Xi GIAR and two consecutive Choose Ohio First Scholarships; JGMT was supported by a grant from the National Science Foundation (34284; RLL supported by NIH DK079282-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Bailleul B, 1997, NUCLEIC ACIDS RES, V25, P2752, DOI 10.1093/nar/25.14.2752; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Chavey C, 2009, CELL METAB, V9, P339, DOI 10.1016/j.cmet.2009.03.002; Chen J, 2007, NUCLEIC ACIDS RES, V35, P1377, DOI 10.1093/nar/gkm010; Concannon P, 2001, AM J PHYSIOL-REG I, V281, pR951, DOI 10.1152/ajpregu.2001.281.3.R951; COSEWIC, 2005, COSEWIC ASS UPD STAT; COSEWIC (Committee on the Status of Endangered Wildlife in Canada), 2015, COSEWIC ASS STAT REP; Couturier C, 2007, P NATL ACAD SCI USA, V104, P19476, DOI 10.1073/pnas.0706671104; Duverger O, 2012, J BIOL CHEM, V287, P12230, DOI 10.1074/jbc.M111.326900; Fernandes JMO, 2008, COMP BIOCHEM PHYS B, V150, P23, DOI 10.1016/j.cbpb.2008.01.003; Florant GL, 2004, J COMP PHYSIOL B, V174, P633, DOI 10.1007/s00360-004-0454-0; Freeman WM, 1999, BIOTECHNIQUES, V26, P112, DOI 10.2144/99261rv01; Gubern C, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-57; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hou YB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009545; Iverson S., 2002, ENCY MARINE MAMMALS, P107; Izraely S, 2012, INT J CANCER, V131, P1071, DOI 10.1002/ijc.27324; Jorgensen SM, 2006, MAR BIOTECHNOL, V8, P398, DOI 10.1007/s10126-005-5164-4; Kakuschke A, 2006, MAR MAMMAL SCI, V22, P985, DOI 10.1111/j.1748-7692.2006.00059.x; Kronfeld-Schor N, 2000, AM J PHYSIOL-REG I, V279, pR1277, DOI 10.1152/ajpregu.2000.279.4.R1277; Lubetkin SC, 2008, CAN J ZOOL, V86, P525, DOI 10.1139/Z08-028; Mollenhauer MAM, 2009, AQUAT TOXICOL, V91, P10, DOI 10.1016/j.aquatox.2008.09.013; Morin PA, 2006, MAR MAMMAL SCI, V22, P897, DOI 10.1111/j.1748-7692.2006.00070.x; Munzberg H, 2005, NAT NEUROSCI, V8, P566, DOI 10.1038/nn1454; Rosic NN, 2011, MAR BIOTECHNOL, V13, P355, DOI 10.1007/s10126-010-9308-9; Rousseau K, 2003, J NEUROENDOCRINOL, V15, P409, DOI 10.1046/j.1365-2826.2003.01007.x; Rugh DJ, 2002, ENCY MARINE MAMMALS, P129; Satoh T, 2009, BIOCHEM BIOPH RES CO, V389, P673, DOI 10.1016/j.bbrc.2009.09.056; Sitt T, 2008, DEV COMP IMMUNOL, V32, P1253, DOI 10.1016/j.dci.2008.05.001; Small BC, 2008, COMP BIOCHEM PHYS B, V151, P296, DOI 10.1016/j.cbpb.2008.07.010; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Townsend KL, 2008, J COMP PHYSIOL B, V178, P217, DOI 10.1007/s00360-007-0215-y; Yadav P, 2012, LIVEST SCI, V147, P72, DOI 10.1016/j.livsci.2012.04.004; Yuan JS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S6; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	37	8	9	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54277	10.1371/journal.pone.0054277	http://dx.doi.org/10.1371/journal.pone.0054277			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342116	gold, Green Published, Green Submitted			2022-12-25	WOS:000313682700100
J	Cibert-Goton, V; Yuan, GL; Battaglia, A; Fredriksson, S; Henkemeyer, M; Sears, T; Gavazzi, I				Cibert-Goton, Vincent; Yuan, Guanglu; Battaglia, Anna; Fredriksson, Sarah; Henkemeyer, Mark; Sears, Thomas; Gavazzi, Isabella			Involvement of EphB1 Receptors Signalling in Models of Inflammatory and Neuropathic Pain	PLOS ONE			English	Article							DORSAL-HORN NEURONS; PERIPHERAL-NERVE INJURY; LONG-TERM POTENTIATION; BONE CANCER PAIN; RAT SPINAL-CORD; NMDA RECEPTOR; SYNAPTIC PLASTICITY; NR2B SUBUNIT; CENTRAL SENSITIZATION; TYROSINE PHOSPHORYLATION	EphB receptors tyrosine kinases and ephrinB ligands were first identified as guidance molecules involved in the establishment of topographical mapping and connectivity in the nervous system during development. Later in development and into adulthood their primary role would switch from guidance to activity-dependent modulation of synaptic efficacy. In sensory systems, they play a role in both the onset of inflammatory and neuropathic pain, and in the establishment of central sensitisation, an NMDA-mediated form of synaptic plasticity thought to underlie most forms of chronic pain. We studied wild type and EphB1 knockout mice in a range of inflammatory and neuropathic pain models to determine 1), whether EphB1 expression is necessary for the onset and/or maintenance of persistent pain, regardless of origin; 2), whether in these models cellular and molecular changes, e.g. phosphorylation of the NR2B subunit of the NMDA receptor, increased c-fos expression or microglial activation, associated with the onset of pain, are affected by the lack of functional EphB1 receptors. Differences in phenotype were examined behaviourally, anatomically, biochemically and electrophysiologically. Our results establish firstly, that functional EphB1 receptors are not essential for the development of normal nociception, thermal or mechanical sensitivity. Secondly, they demonstrate a widespread involvement of EphB1 receptors in chronic pain. NR2B phosphorylation, c-fos expression and microglial activation are all reduced in EphB1 knockout mice. This last finding is intriguing, since microglial activation is supposedly triggered directly by primary afferents, therefore it was not expected to be affected. Interestingly, in some models of long-term pain (days), mechanical and thermal hyperalgesia develop both in wild type and EphB1 knockout mice, but recovery is faster in the latter, indicating that in particular models these receptors are required for the maintenance, rather than the onset of, thermal and mechanical hypersensitivity. This potentially makes them an attractive target for analgesic strategies.	[Cibert-Goton, Vincent; Yuan, Guanglu; Battaglia, Anna; Fredriksson, Sarah; Sears, Thomas; Gavazzi, Isabella] Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England; [Henkemeyer, Mark] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Kent Waldrep Ctr Basic Res Nerve Growth & Regener, Dallas, TX 75390 USA	University of London; King's College London; University of Texas System; University of Texas Southwestern Medical Center Dallas	Gavazzi, I (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, Wolfson Wing,Guys Campus, London WC2R 2LS, England.	isabella.gavazzi@kcl.ac.uk		CIBERT-GOTON, Vincent/0000-0002-8483-0284; Henkemeyer, Mark/0000-0002-7525-1061; Gavazzi, Isabella/0000-0002-7728-7682	Wellcome Trust Project [GR071663MA]; Biotechnology and Biological Sciences Research Council Project [C505816]; National Institutes of Health [2R01 MH66332]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066332] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/C505816/1] Funding Source: researchfish	Wellcome Trust Project(Wellcome Trust); Biotechnology and Biological Sciences Research Council Project(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Wellcome Trust Project Grant GR071663MA and Biotechnology and Biological Sciences Research Council Project Grant C505816 to IG and by National Institutes of Health grant 2R01 MH66332 to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2005, EUR J NEUROSCI, V22, P1445, DOI 10.1111/j.1460-9568.2005.04340.x; Battaglia AA, 2003, NAT NEUROSCI, V6, P339, DOI 10.1038/nn1034; Beggs S, 2002, EUR J NEUROSCI, V16, P1249, DOI 10.1046/j.1460-9568.2002.02185.x; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Calo L, 2006, J NEUROCHEM, V98, P1, DOI 10.1111/j.1471-4159.2006.03844.x; Cao JL, 2008, PAIN, V139, P617, DOI 10.1016/j.pain.2008.06.023; Caudle RM, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-25; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Cheng HT, 2008, NEUROSCIENCE, V155, P948, DOI 10.1016/j.neuroscience.2008.06.024; Clark AK, 2007, P NATL ACAD SCI USA, V104, P10655, DOI 10.1073/pnas.0610811104; Coggeshall RE, 2005, PROG NEUROBIOL, V77, P299, DOI 10.1016/j.pneurobio.2005.11.002; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Daulhac L, 2006, MOL PHARMACOL, V70, P1246, DOI 10.1124/mol.106.025478; Dong Y, 2011, NEUROSCI LETT, V496, P163, DOI 10.1016/j.neulet.2011.04.008; Dowdall T, 2005, PHARMACOL BIOCHEM BE, V80, P93, DOI 10.1016/j.pbb.2004.10.016; Drescher U, 1997, CURR BIOL, V7, pR799, DOI 10.1016/S0960-9822(06)00409-X; FITZGERALD M, 1994, J COMP NEUROL, V348, P225, DOI 10.1002/cne.903480205; Gao YJ, 2010, PHARMACOL THERAPEUT, V126, P56, DOI 10.1016/j.pharmthera.2010.01.002; Graeber MB, 2012, EXP NEUROL, V234, P255, DOI 10.1016/j.expneurol.2012.01.007; Graham BA, 2007, J PHYSIOL-LONDON, V578, P787, DOI 10.1113/jphysiol.2006.123349; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Guo W, 2002, J NEUROSCI, V22, P6208; Han Y, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-60; Harris JA, 1998, BRAIN RES BULL, V45, P1, DOI 10.1016/S0361-9230(97)00277-3; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Hruska M, 2012, MOL CELL NEUROSCI, V50, P35, DOI 10.1016/j.mcn.2012.03.004; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Inturrisi C E, 2005, Minerva Anestesiol, V71, P401; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Kobayashi H, 2007, SPINE, V32, P1592, DOI 10.1097/BRS.0b013e318074d46a; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lee BH, 1998, EXP BRAIN RES, V120, P432, DOI 10.1007/s002210050416; Liu S, 2011, CANCER RES, V71, P4392, DOI 10.1158/0008-5472.CAN-10-3870; Liu WT, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-29; Liu WT, 2009, FASEB J, V23, P90, DOI 10.1096/fj.08-114462; Liu XJ, 2008, NAT MED, V14, P1325, DOI 10.1038/nm.1883; MacDonald John F., 2006, Critical Reviews in Neurobiology, V18, P71; Matsumura S, 2010, EUR J NEUROSCI, V32, P798, DOI 10.1111/j.1460-9568.2010.07348.x; Orikawa Y, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-72; Otsubo Y, 2012, PAIN, V153, P2241, DOI 10.1016/j.pain.2012.07.020; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Qu XX, 2009, EXP NEUROL, V215, P298, DOI 10.1016/j.expneurol.2008.10.018; Richards AB, 2007, EUR J NEUROSCI, V25, P2619, DOI 10.1111/j.1460-9568.2007.05523.x; Rigaud M, 2008, PAIN, V136, P188, DOI 10.1016/j.pain.2008.01.016; Sammons MJ, 2000, BRAIN RES, V876, P48, DOI 10.1016/S0006-8993(00)02596-8; Sandkuhler J, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-9; Sandkuhler J, 2010, J PAIN, V11, P798, DOI 10.1016/j.jpain.2010.05.002; Seal RP, 2009, NATURE, V462, P651, DOI 10.1038/nature08505; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Slack S, 2008, NEUROSCIENCE, V156, P175, DOI 10.1016/j.neuroscience.2008.07.023; Song XJ, 2008, PAIN, V139, P168, DOI 10.1016/j.pain.2008.03.019; Song XJ, 2008, EUR J PAIN, V12, P1031, DOI 10.1016/j.ejpain.2008.01.011; South SM, 2003, J NEUROSCI, V23, P5031; Steffens H, 2001, NEUROSCI RES, V39, P413, DOI 10.1016/S0168-0102(01)00198-5; Suter MR, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-53; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Tan PH, 2005, GENE THER, V12, P59, DOI 10.1038/sj.gt.3302376; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Vikman KS, 2008, J PHYSIOL-LONDON, V586, P515, DOI 10.1113/jphysiol.2007.145581; Weyerbacher Amanda R, 2010, Pain, V148, P237, DOI 10.1016/j.pain.2009.11.003; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; Wu Q, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-37; Xu QH, 2011, CURR OPIN ANESTHESIO, V24, P400, DOI 10.1097/ACO.0b013e32834871df; Zhao J, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-77; Zhu YF, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-15; Zhuo M, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-31	70	26	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53673	10.1371/journal.pone.0053673	http://dx.doi.org/10.1371/journal.pone.0053673			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341972	Green Published, Green Submitted, gold			2022-12-25	WOS:000313682700034
J	Di Donato, V; Auer, TO; Duroure, K; Del Bene, F				Di Donato, Vincenzo; Auer, Thomas O.; Duroure, Karine; Del Bene, Filippo			Characterization of the Calcium Binding Protein Family in Zebrafish	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CHANNEL; GENE; MUTATIONS; EVOLUTION; NUCLEUS; VERSION; MODEL	Calcium Binding Proteins (CaBPs), part of the vast family of EF-Hand- domain containing proteins, modulate intracellular calcium levels. They thereby contribute to a broad spectrum of biological processes - amongst others cell migration, gene expression and neural activity. In this study we identified twelve members of this protein family in zebrafish including one gene (cabp4b) currently not present in the zebrafish genome assembly. To gain insight into their biological functions, we carried out a detailed analysis of the expression patterns of these genes during zebrafish late embryonic and early larval development. We detected specific transcription for most of them in different neuronal cell populations including the neuroretina, the inner ear and the notochord. Our data supports potential roles for CaBPs during neuronal development and function and provides a starting point for genetic studies to examine CaBPs' function in these tissues and organs.	[Di Donato, Vincenzo; Auer, Thomas O.; Duroure, Karine; Del Bene, Filippo] Inst Curie, Ctr Rech, Paris, France; [Di Donato, Vincenzo; Auer, Thomas O.; Duroure, Karine; Del Bene, Filippo] CNRS UMR 3215, Paris, France; [Di Donato, Vincenzo; Auer, Thomas O.; Duroure, Karine; Del Bene, Filippo] INSERM U934, Paris, France; [Auer, Thomas O.] Heidelberg Univ, Ctr Organismal Studies Heidelberg, Heidelberg, Germany	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Ruprecht Karls University Heidelberg	Del Bene, F (corresponding author), Inst Curie, Ctr Rech, Paris, France.	Filippo.Del-Bene@curie.fr	del bene, filippo/D-1245-2010	del bene, filippo/0000-0001-8551-2846; DUROURE, Karine/0000-0002-5959-569X; Auer, Thomas Oliver/0000-0003-3442-0567; Di Donato, Vincenzo/0000-0002-4080-9301	ATIP/AVENIR program from CNRS/INSERM; EC-IRG reintegration grant; Leonardo a scholarship of the Leonardo da Vinci project Unipharma-Graduates; Boeringer-Ingelheim Fonds Ph.D. fellowship	ATIP/AVENIR program from CNRS/INSERM; EC-IRG reintegration grant; Leonardo a scholarship of the Leonardo da Vinci project Unipharma-Graduates; Boeringer-Ingelheim Fonds Ph.D. fellowship	This work was supported by the ATIP/AVENIR program from CNRS/INSERM and an EC-IRG reintegration grant to FDB. VDD was supported by a Leonardo a scholarship of the Leonardo da Vinci project Unipharma-Graduates. TOA was supported by a Boeringer-Ingelheim Fonds Ph.D. fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Force A, 1999, GENETICS, V151, P1531; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Haynes LP, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00009; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jusuf PR, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-34; Kawasaki H, 1998, BIOMETALS, V11, P277, DOI 10.1023/A:1009282307967; McCue HV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004085; McCue Hannah V, 2010, BMC Res Notes, V3, P118, DOI 10.1186/1756-0500-3-118; Mikhaylova M, 2006, BBA-MOL CELL RES, V1763, P1229, DOI 10.1016/j.bbamcr.2006.08.047; Mochida S, 2008, NEURON, V57, P210, DOI 10.1016/j.neuron.2007.11.036; Rieke F, 2008, INVEST OPHTH VIS SCI, V49, P5126, DOI 10.1167/iovs.08-2236; Sprague J, 2006, NUCLEIC ACIDS RES, V34, pD581, DOI 10.1093/nar/gkj086; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Vihtelic TS, 2005, MOL VIS, V11, P1083; Vitorino M, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-14; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Westerfield M., ZEBRAFISH BOOK GUIDE; Wittbrodt J, 1998, BIOESSAYS, V20, P511, DOI 10.1002/(SICI)1521-1878(199806)20:6&lt;511::AID-BIES10&gt;3.0.CO;2-3; Wu YQ, 2001, MOL GENET METAB, V72, P343, DOI 10.1006/mgme.2001.3160; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861; Zeitz C, 2006, AM J HUM GENET, V79, P657, DOI 10.1086/508067	29	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53299	10.1371/journal.pone.0053299	http://dx.doi.org/10.1371/journal.pone.0053299			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341937	gold, Green Published, Green Submitted			2022-12-25	WOS:000313682700024
J	Donkor, ES; Adegbola, RA; Wren, BW; Antonio, M				Donkor, Eric S.; Adegbola, Richard A.; Wren, Brendan W.; Antonio, Martin			Population Biology of Streptococcus pneumoniae in West Africa: Multilocus Sequence Typing of Serotypes That Exhibit Different Predisposition to Invasive Disease and Carriage	PLOS ONE			English	Article							DAY-CARE-CENTERS; PNEUMOCOCCAL DISEASE; GENETIC RELATEDNESS; RESISTANCE PATTERNS; CHILDREN; MENINGITIS; CLONES; IDENTIFICATION; EPIDEMIOLOGY; OUTBREAK	Background: Little is known about the population biology of Streptococcus pneumoniae in developing countries, although the majority of pneumococcal infections occur in this setting. The aim of the study was to apply MLST to investigate the population biology of S. pneumoniae in West Africa. Methods: Seventy three invasive and carriage S. pneumoniae isolates from three West African countries including The Gambia, Nigeria and Ghana were investigated. The isolates covered seven serotypes (1, 3, 5, 6A, 11, 14, 23F) and were subjected to multilocus sequence typing and antibiotic susceptibility testing. Results: Overall, 50 different sequence types (STs) were identified, of which 38% (29) were novel. The most common ST was a novel clone-ST 4012 (6.5%), and some clones including STs 913, 925, 1737, 2160 and 3310 appeared to be specific to the study region. Two STs including ST 63 and ST 4012 were associated with multiple serotypes indicating a history of serotype switching. ST 63 was associated with serotypes 3 and 23F, while ST 4012 was associated with serotypes 6A and 23. eBURST analyses using the stringent 6/7 identical loci definition grouped the 50 STs into 5 clonal complexes and 65 singletons, expressing a high level of genetic diversity among the isolates. Compared to the other serotypes, serotypes 1 and 5 isolates appeared to be more clonal. Internationally recognized antibiotic resistant clones of S. pneumoniae were generally absent in the population investigated and the only multidrug resistant isolate identified (1/66) belong to the Pneumocococcal Epidemiology Network clone ST 63. Conclusions: The pneumococcal population in West Africa is quite divergent, and serotypes that are common in invasive disease (such as serotypes 1 and 5) are more likely to be clonal than serotypes that are common in carriage.	[Donkor, Eric S.; Wren, Brendan W.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1, England; [Antonio, Martin] MRC, Fajara, Gambia; [Adegbola, Richard A.] GlaxoSmithKline Vaccines, Wavre, Belgium; [Donkor, Eric S.] Univ Ghana, Sch Med, Dept Microbiol, Accra, Ghana	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; GlaxoSmithKline; University of Ghana	Antonio, M (corresponding author), MRC, Fajara, Gambia.	mantonio@mrc.gm		Donkor, Eric S./0000-0002-9368-0636	Medical Research Council; MRC [MR/K012053/1] Funding Source: UKRI; Medical Research Council [MR/K012053/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola RA, 2006, TROP MED INT HEALTH, V11, P1128, DOI 10.1111/j.1365-3156.2006.01652.x; Adetifa IMO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030548; Antonio M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-81; Antonio M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-198; Blossom DB, 2007, MICROB DRUG RESIST, V13, P21, DOI 10.1089/mdr.2006.9993; BOWERS EF, 1955, J CLIN PATHOL, V8, P58, DOI 10.1136/jcp.8.1.58; Brueggemann AB, 2003, J CLIN MICROBIOL, V41, P4966, DOI 10.1128/JCM.41.11.4966-4970.2003; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; CADOZ M, 1981, B WORLD HEALTH ORGAN, V59, P575; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Donkor ES, 2011, MBIO, V2, DOI 10.1128/mBio.00040-11; Donkor ES, 2010, SCAND J INFECT DIS, V42, P254, DOI 10.3109/00365540903490000; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Falade AG, 2009, CLIN INFECT DIS, V48, pS190, DOI 10.1086/596500; Feil EJ, 2000, GENETICS, V154, P1439; Fraser D, 2001, CLIN INFECT DIS, V33, P421, DOI 10.1086/321874; Hall LMC, 1996, J CLIN MICROBIOL, V34, P853, DOI 10.1128/JCM.34.4.853-859.1996; Hausdorff WP, 2007, VACCINE, V25, P2406, DOI 10.1016/j.vaccine.2006.09.009; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P122, DOI 10.1086/313609; Hill PC, 2008, CLIN INFECT DIS, V46, P807, DOI 10.1086/528688; Holliman RE, 2007, T ROY SOC TROP MED H, V101, P405, DOI 10.1016/j.trstmh.2006.08.014; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Leimkugel J, 2005, J INFECT DIS, V192, P192, DOI 10.1086/431151; Louie M, 1999, J INFECT DIS, V179, P892, DOI 10.1086/314664; Maiden MC, 1988, P NATL ACAD SCI USA, V95, P3140; Marsh R, 2010, J CLIN MICROBIOL, V48, P831, DOI 10.1128/JCM.01701-09; Marsh RL, 2007, VACCINE, V25, P2434, DOI 10.1016/j.vaccine.2006.09.016; Martin DR, 1996, NEW ZEAL MED J, V109, P288; MUFSON MA, 1974, ARCH INTERN MED, V134, P505, DOI 10.1001/archinte.134.3.505; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Obaro S, 2001, LANCET, V357, P1800, DOI 10.1016/S0140-6736(00)04915-1; Overweg K, 2000, J CLIN MICROBIOL, V38, P4548, DOI 10.1128/JCM.38.12.4548-4553.2000; Porat N, 2001, J CLIN MICROBIOL, V39, P1827, DOI 10.1128/JCM.39.5.1827-1832.2001; Rivera-Olivero IA, 2007, CLIN INFECT DIS, V45, P1427, DOI 10.1086/522984; Sa-Leao R, 2000, J INFECT DIS, V182, P1153, DOI 10.1086/315813; Slotved HC, 2004, J CLIN MICROBIOL, V42, P2518, DOI 10.1128/JCM.42.6.2518-2522.2004; Smith-Vaughan H, 2009, CLIN VACCINE IMMUNOL, V16, P218, DOI 10.1128/CVI.00283-08; Spratt BG, 2004, PNEUMOCCOCUS, P119; Spratt BG, 1999, CURR OPIN MICROBIOL, V2, P312, DOI 10.1016/S1369-5274(99)80054-X; Syrogiannopoulos GA, 1997, CLIN INFECT DIS, V25, P188, DOI 10.1086/514526; Vialle-Valentin CE, 2012, TROP MED INT HEALTH, V17, P211, DOI 10.1111/j.1365-3156.2011.02895.x; Yaro S, 2006, CLIN INFECT DIS, V43, P693, DOI 10.1086/506940	42	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53925	10.1371/journal.pone.0053925	http://dx.doi.org/10.1371/journal.pone.0053925			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342041	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000313682700065
J	Law, SP; Fung, R; Kung, C				Law, Sam-Po; Fung, Roxana; Kung, Carmen			An ERP Study of Good Production vis-a-vis Poor Perception of Tones in Cantonese: Implications for Top-Down Speech Processing	PLOS ONE			English	Article							PURE WORD DEAFNESS; MISMATCH NEGATIVITY; MEMORY TRACES; MOTOR THEORY; P300; ORGANIZATION; LATENCY; SOUNDS; SPOKEN; INTERFACE	This study investigated a theoretically challenging dissociation between good production and poor perception of tones among neurologically unimpaired native speakers of Cantonese. The dissociation is referred to as the near-merger phenomenon in sociolinguistic studies of sound change. In a passive oddball paradigm, lexical and nonlexical syllables of the T1/T6 and T4/T6 contrasts were presented to elicit the mismatch negativity (MMN) and P3a from two groups of participants, those who could produce and distinguish all tones in the language (Control) and those who could produce all tones but specifically failed to distinguish between T4 and T6 in perception (Dissociation). The presence of MMN to T1/T6 and null response to T4/T6 of lexical syllables in the dissociation group confirmed the near-merger phenomenon. The observation that the control participants exhibited a statistically reliable MMN to lexical syllables of T1/T6, weaker responses to nonlexical syllables of T1/T6 and lexical syllables of T4/T6, and finally null response to nonlexical syllables of T4/T6, suggests the involvement of top-down processing in speech perception. Furthermore, the stronger P3a response of the control group, compared with the dissociation group in the same experimental conditions, may be taken to indicate higher cognitive capability in attention switching, auditory attention or memory in the control participants. This cognitive difference, together with our speculation that constant top-down predictions without complete bottom-up analysis of acoustic signals in speech recognition may reduce one's sensitivity to small acoustic contrasts, account for the occurrence of dissociation in some individuals but not others.	[Law, Sam-Po] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Fung, Roxana] Hong Kong Polytech Univ, Hong Kong, Hong Kong, Peoples R China; [Kung, Carmen] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	University of Hong Kong; Hong Kong Polytechnic University; Radboud University Nijmegen	Law, SP (corresponding author), Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China.	splaw@hku.hk		Kung, Carmen/0000-0003-3981-6990	Hong Kong Polytechnic University [Z448F]; University of Hong Kong [10401150.14304.10010.323.01]	Hong Kong Polytechnic University(Hong Kong Polytechnic University); University of Hong Kong(University of Hong Kong)	This research was supported by the Hong Kong Polytechnic University (Project no. Z448F, http://www.polyu.edu.hk/cpa/polyu/index.php) and the University of Hong Kong (Project no. 10401150.14304.10010.323.01, http://www.hku.hk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov A, 2011, PLOS ONE, V6, P1; Atienza M, 2012, LEARN MEMORY, V9, P138; Auberbach SH, 1982, BRAIN, V105, P271; Bidelman GM, 2011, BRAIN COGNITION, V77, P1, DOI 10.1016/j.bandc.2011.07.006; Bishop DVM, 2011, DEVELOPMENTAL SCI, V14, P402, DOI 10.1111/j.1467-7687.2010.00990.x; Bishop DVM, 2010, J NEUROSCI, V30, P15578, DOI 10.1523/JNEUROSCI.2217-10.2010; BLUMSTEIN SE, 1977, NEUROPSYCHOLOGIA, V15, P19, DOI 10.1016/0028-3932(77)90111-7; Buchsbaum BR, 2001, COGNITIVE SCI, V25, P663, DOI 10.1207/s15516709cog2505_2; Chandrasekaran B, 2007, BRAIN RES, V1128, P148, DOI 10.1016/j.brainres.2006.10.064; Chen Y., 2011, P PSYCHOLINGUISTICS, P38; Davis MH, 2007, HEARING RES, V229, P132, DOI 10.1016/j.heares.2007.01.014; Dell GS, 1997, PSYCHOL REV, V104, P801, DOI 10.1037/0033-295X.104.4.801; Escera C, 2007, J PSYCHOPHYSIOL, V21, P251, DOI 10.1027/0269-8803.21.34.251; Fodor J. A, 1983, MODULARITY MIND; Fung RSY, 2010, TON INT 4 STOCKH SWE, V4; Fung RSY, 2010, 15 INT C YUE DIAL MA; Galantucci B, 2006, PSYCHON B REV, V13, P361, DOI 10.3758/BF03193857; GANONG WF, 1980, J EXP PSYCHOL HUMAN, V6, P110, DOI 10.1037/0096-1523.6.1.110; GARCIALARREA L, 1992, NEUROPSYCHOLOGIA, V30, P723, DOI 10.1016/0028-3932(92)90042-K; Gaskell MG, 1997, LANG COGNITIVE PROC, V12, P613, DOI 10.1080/016909697386646; GOODGLASS H, 1976, BRAIN LANG, V3, P359, DOI 10.1016/0093-934X(76)90032-8; GROSJEAN F, 1980, PERCEPT PSYCHOPHYS, V28, P267, DOI 10.3758/BF03204386; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Hickok G, 2001, J PSYCHOLINGUIST RES, V30, P225, DOI 10.1023/A:1010486816667; Hickok G., 2009, COGNITIVE NEUROSCIEN, P767; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hickok G, 2010, LANG COGNITIVE PROC, V25, P749, DOI 10.1080/01690961003595572; Hillis AE, 1999, NEUROLOGY, V53, P1813, DOI 10.1212/WNL.53.8.1813; Horvath J, 2008, BIOL PSYCHOL, V39, P179; Houlihan M, 1998, INTELLIGENCE, V26, P9, DOI 10.1016/S0160-2896(99)80049-X; JOHNSON R, 1985, PSYCHOPHYSIOLOGY, V22, P497, DOI 10.1111/j.1469-8986.1985.tb01639.x; Karen M., 1991, LANG VAR CHANGE, V3, P33, DOI 10.1017/S0954394500000442; Labov W., 1994, PRINCIPLES LINGUISTI, V1; Law SP, 2009, LANG COGNITIVE PROC, V24, P983, DOI 10.1080/01690960802193696; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; LIBERMAN AM, 1985, COGNITION, V21, P1, DOI 10.1016/0010-0277(85)90021-6; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; MCCLELLAND JL, 1986, COGNITIVE PSYCHOL, V18, P1, DOI 10.1016/0010-0285(86)90015-0; MICELI G, 1982, NEUROPSYCHOLOGIA, V20, P5, DOI 10.1016/0028-3932(82)90083-5; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Naatanen R, 1999, PSYCHOL BULL, V125, P826, DOI 10.1037/0033-2909.125.6.826; NOVAK G, 1992, PSYCHOPHYSIOLOGY, V29, P398, DOI 10.1111/j.1469-8986.1992.tb01713.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Peelle JE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00051; Poeppel D, 2001, COGNITIVE SCI, V25, P679, DOI 10.1207/s15516709cog2505_3; Poeppel D., 2011, LEXICAL REPRESENTATI, P171; Poeppel D, 2008, PHILOS T R SOC B, V363, P1071, DOI 10.1098/rstb.2007.2160; POLICH J, 1983, PSYCHOPHYSIOLOGY, V20, P665, DOI 10.1111/j.1469-8986.1983.tb00936.x; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; PORT RF, 1985, J PHONETICS, V13, P455, DOI 10.1016/S0095-4470(19)30797-1; Pulvermuller F, 2001, NEUROIMAGE, V14, P607, DOI 10.1006/nimg.2001.0864; Pulvermuller F, 2004, PSYCHOPHYSIOLOGY, V41, P106, DOI 10.1111/j.1469-8986.2003.00135.x; Rapp B, 1997, BRAIN LANG, V56, P248, DOI 10.1006/brln.1997.1735; Rapp B, 2000, PSYCHOL REV, V107, P460, DOI 10.1037/0033-295X.107.3.460; Reinvang I, 1999, NEUROPSYCHOL REV, V9, P231, DOI 10.1023/A:1021638723486; Rinne T, 2006, BRAIN RES, V1077, P135, DOI 10.1016/j.brainres.2006.01.043; Scott SK, 2003, TRENDS NEUROSCI, V26, P100, DOI 10.1016/S0166-2236(02)00037-1; Shtyrov Y, 2002, NEUROREPORT, V13, P521, DOI 10.1097/00001756-200203250-00033; Sohoglu E, 2012, J NEUROSCI, V32, P8443, DOI 10.1523/JNEUROSCI.5069-11.2012; Stefanatos GA, 2005, J INT NEUROPSYCH SOC, V11, P456, DOI 10.1017/S1355617705050538; Sussman E, 2003, PSYCHON B REV, V10, P630, DOI 10.3758/BF03196525; Sussman ES, 2007, J PSYCHOPHYSIOL, V21, P164, DOI 10.1027/0269-8803.21.34.164; Tsang YK, 2011, NEUROSCI LETT, V487, P268, DOI 10.1016/j.neulet.2010.10.035; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; WARREN RM, 1970, SCI AM, V223, P30, DOI 10.1038/scientificamerican1270-30; Yaeger Malcah, 1972, QUANTITATIVE STUDY S; Yu Alan C. L., 2007, PHONOLOGY, V24, P187, DOI DOI 10.1017/S0952675707001157; Yuan JH, J CHINESE L IN PRESS, V41	70	23	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54396	10.1371/journal.pone.0054396	http://dx.doi.org/10.1371/journal.pone.0054396			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072OV	23342146	Green Published, Green Submitted, gold			2022-12-25	WOS:000313682700111
J	Costantino, VV; Mansilla, SF; Speroni, J; Amaya, C; Cuello-Carrion, D; Ciocca, DR; Priestap, HA; Barbieri, MA; Gottifredi, V; Lopez, LA				Costantino, Valeria V.; Mansilla, Sabrina F.; Speroni, Juliana; Amaya, Celina; Cuello-Carrion, Dario; Ciocca, Daniel R.; Priestap, Horacio A.; Barbieri, Manuel A.; Gottifredi, Vanesa; Lopez, Luis A.			The Sesquiterpene Lactone Dehydroleucodine Triggers Senescence and Apoptosis in Association with Accumulation of DNA Damage Markers	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; NF-KAPPA-B; CELLULAR SENESCENCE; STEM-CELLS; HELA-CELLS; P53; PARTHENOLIDE; PROTEIN; TARGET; PHASE	Sesquiterpene lactones (SLs) are plant-derived compounds that display anti-cancer effects. Some SLs derivatives have a marked killing effect on cancer cells and have therefore reached clinical trials. Little is known regarding the mechanism of action of SLs. We studied the responses of human cancer cells exposed to various concentrations of dehydroleucodine (DhL), a SL of the guaianolide group isolated and purified from Artemisia douglasiana (Besser), a medicinal herb that is commonly used in Argentina. We demonstrate for the first time that treatment of cancer cells with DhL, promotes the accumulation of DNA damage markers such as phosphorylation of ATM and focal organization of gamma H2AX and 53BP1. This accumulation triggers cell senescence or apoptosis depending on the concentration of the DhL delivered to cells. Transient DhL treatment also induces marked accumulation of senescent cells. Our findings help elucidate the mechanism whereby DhL triggers cell cycle arrest and cell death and provide a basis for further exploration of the effects of DhL in in vivo cancer treatment models.	[Costantino, Valeria V.; Amaya, Celina; Lopez, Luis A.] Univ Nacl Cuyo, Fac Ciencias Med, Inst Histol & Embriol Dr MH Burgos IHEM, Lab Cell Cycle & Cytoskeleton, RA-5500 Mendoza, Argentina; [Cuello-Carrion, Dario; Ciocca, Daniel R.] Inst Med & Biol Expt Cuyo IMBECU CONICET, Mendoza, Argentina; [Mansilla, Sabrina F.; Speroni, Juliana; Gottifredi, Vanesa] Fdn Inst Leloir CONICET, Cell Cycle & Genom Stabil Lab, Buenos Aires, DF, Argentina; [Priestap, Horacio A.; Barbieri, Manuel A.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Barbieri, Manuel A.] Fairchild Trop Bot Garden, Coral Gables, FL USA	University Nacional Cuyo Mendoza; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; State University System of Florida; Florida International University	Gottifredi, V (corresponding author), Fdn Inst Leloir CONICET, Cell Cycle & Genom Stabil Lab, Buenos Aires, DF, Argentina.	vgottifredi@leloir.org.ar; llopez@fcm.uncu.edu.ar	Costantino, Valeria/AAN-1960-2020; Gottifredi, Vanesa/AAI-1788-2019; Barbieri, Marco/J-2597-2014	Costantino, Valeria/0000-0001-8723-9505; Gottifredi, Vanesa/0000-0001-9656-5951	Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina (ANPCyT); Secretaria de Ciencia, Tecnologia y Posgrado, Universidad Nacional de Cuyo of Argentina; United States National Institutes of Health [RO3 TW008924, SC1DK084343]; CONICET; ANPCyT; FOGARTY INTERNATIONAL CENTER [R03TW008924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [SC1DK084343] Funding Source: NIH RePORTER	Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina (ANPCyT)(ANPCyT); Secretaria de Ciencia, Tecnologia y Posgrado, Universidad Nacional de Cuyo of Argentina; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCyT(ANPCyT); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by funding from the Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina (ANPCyT) and the Secretaria de Ciencia, Tecnologia y Posgrado, Universidad Nacional de Cuyo of Argentina to LAL and by United States National Institutes of Health grants RO3 TW008924 and SC1DK084343 to V.G. and MAB, respectively. VC and SFM were supported by fellowships from CONICET and ANPCyT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly A, 2011, J MOL CELL BIOL, V3, P66, DOI 10.1093/jmcb/mjq055; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Christensen SB, 2009, ANTI-CANCER AGENT ME, V9, P276, DOI 10.2174/1871520610909030276; Cleaver JE, 2011, CELL CYCLE, V10, P3223, DOI 10.4161/cc.10.19.17448; Crespo-Ortiz MP, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/247597; Cruzado M, 2005, CELL MOL BIOL, V51, P525, DOI 10.1170/T659; Cuello-Carrion FD, 1999, J HISTOCHEM CYTOCHEM, V47, P837, DOI 10.1177/002215549904700614; Denmeade SR, 2005, CANCER BIOL THER, V4, P14; Dey A, 2008, NAT REV DRUG DISCOV, V7, P1031, DOI 10.1038/nrd2759; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Efferth T, 2006, CURR DRUG TARGETS, V7, P407, DOI 10.2174/138945006776359412; Ghantous A, 2010, DRUG DISCOV TODAY, V15, P668, DOI 10.1016/j.drudis.2010.06.002; GIORDANO OS, 1990, J NAT PROD, V53, P803, DOI 10.1021/np50070a004; Gopal YNV, 2009, MOL CANCER THER, V8, P552, DOI 10.1158/1535-7163.MCT-08-0661; Gopal YV, 2007, CHEM BIOL, V14, P813, DOI 10.1016/j.chembiol.2007.06.007; Gottifredi V, 2005, SEMIN CELL DEV BIOL, V16, P355, DOI 10.1016/j.semcdb.2005.02.011; Green DR, 2000, METHOD ENZYMOL, V322, P15; Hehner SP, 1998, J BIOL CHEM, V273, P1288, DOI 10.1074/jbc.273.3.1288; Heinrich M, 1998, ANNU REV PHARMACOL, V38, P539, DOI 10.1146/annurev.pharmtox.38.1.539; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Johnson TM, 2008, P NATL ACAD SCI USA, V105, P1215, DOI 10.1073/pnas.0706764105; Jones RM, 2012, BIOCHEM J, V443, P13, DOI 10.1042/BJ20112100; Jordan CT, 2007, BEST PRACT RES CL HA, V20, P13, DOI 10.1016/j.beha.2006.10.005; Jordan CT, 2006, CANCER CELL, V10, P253, DOI 10.1016/j.ccr.2006.09.010; Kawasaki BT, 2009, PROSTATE, V69, P827, DOI 10.1002/pros.20931; KNEHR M, 1995, EXP CELL RES, V217, P546, DOI 10.1006/excr.1995.1121; Lee YJ, 2006, CARBOHYD RES, V341, P1708, DOI 10.1016/j.carres.2006.03.014; Liao WL, 2009, INVEST OPHTH VIS SCI, V50, P4992, DOI 10.1167/iovs.09-3671; Liu YB, 1997, J NEUROCHEM, V69, P581, DOI 10.1046/j.1471-4159.1997.69020581.x; Liu ZF, 2009, J PHARMACOL EXP THER, V329, P505, DOI 10.1124/jpet.108.147934; Lopez ME, 2002, PROTOPLASMA, V219, P82, DOI 10.1007/s007090200008; Losinno AD, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095158; Nakase I, 2009, CANCER LETT, V274, P290, DOI 10.1016/j.canlet.2008.09.023; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Polo LM, 2007, EUR J PHARMACOL, V556, P19, DOI 10.1016/j.ejphar.2006.10.049; Priestap HA, 2011, ACTA CRYSTALLOGR E, V67, pO3470, DOI 10.1107/S1600536811048938; ROBLES M, 1995, PLANTA MED, V61, P199, DOI 10.1055/s-2006-958055; Toranzo GS, 2007, ZYGOTE, V15, P183, DOI 10.1017/S0967199407004212; Toranzo GS, 2010, ZYGOTE, V18, P41, DOI 10.1017/S0967199409990086; Sarkar FH, 2008, FRONT BIOSCI-LANDMRK, V13, P2950, DOI 10.2741/2900; Vicencio JM, 2008, GERONTOLOGY, V54, P92, DOI 10.1159/000129697; WOYNAROWSKI JM, 1981, MOL PHARMACOL, V19, P97; Xu Y, 2007, J BIOL CHEM, V282, P37429, DOI 10.1074/jbc.M706039200; Zhang Siyuan, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P239, DOI 10.2174/1568011053765976; Zhou JB, 2008, CELL CYCLE, V7, P1360, DOI 10.4161/cc.7.10.5953	49	23	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53168	10.1371/journal.pone.0053168	http://dx.doi.org/10.1371/journal.pone.0053168			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341930	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400035
J	Gibson, MP; Zhu, QL; Wang, SZ; Liu, QL; Liu, Y; Wang, XF; Yuan, BZ; Ruest, LB; Feng, JQ; D'Souza, RN; Qin, CL; Lu, YB				Gibson, Monica Prasad; Zhu, Qinglin; Wang, Suzhen; Liu, Qilin; Liu, Ying; Wang, Xiaofang; Yuan, Baozhi; Ruest, L. Bruno; Feng, Jian Q.; D'Souza, Rena N.; Qin, Chunlin; Lu, Yongbo			The Rescue of Dentin Matrix Protein 1 (DMP1)-deficient Tooth Defects by the Transgenic Expression of Dentin Sialophosphoprotein (DSPP) Indicates That DSPP Is a Downstream Effector Molecule of DMP1 in Dentinogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIBLING PROTEINS; ENDOPLASMIC-RETICULUM; DMP1-DEFICIENT MICE; GENE-TRANSCRIPTION; IN-VIVO; SIALOPROTEIN; MUTATION; IDENTIFICATION; PHOSPHOPROTEIN; ODONTOGENESIS	Dentin matrix protein 1 (DMP1) and dentin sialophosphoprotein (DSPP) are essential for the formation of dentin. Previous in vitro studies have indicated that DMP1 might regulate the expression of DSPP during dentinogenesis. To examine whether DMP1 controls dentinogenesis through the regulation of DSPP in vivo, we cross-bred transgenic mice expressing normal DSPP driven by a 3.6-kb rat Col1a1 promoter with Dmp1 KO mice to generate mice expressing the DSPP transgene in the Dmp1 KO genetic background (referred to as "Dmp1 KO/DSPP Tg mice"). We used morphological, histological, and biochemical techniques to characterize the dentin and alveolar bone of Dmp1 KO/DSPP Tg mice compared with Dmp1 KO and wild-type mice. Our analyses showed that the expression of endogenous DSPP was remarkably reduced in the Dmp1 KO mice. Furthermore, the transgenic expression of DSPP rescued the tooth and alveolar bone defects of the Dmp1 KO mice. In addition, our in vitro analyses showed that DMP1 and its 57-kDa C-terminal fragment significantly up-regulated the Dspp promoter activities in a mesenchymal cell line. In contrast, the expression of DMP1 was not altered in the Dspp KO mice. These results provide strong evidence that DSPP is a downstream effector molecule that mediates the roles of DMP1 in dentinogenesis.	[Gibson, Monica Prasad; Zhu, Qinglin; Wang, Suzhen; Liu, Qilin; Liu, Ying; Wang, Xiaofang; Ruest, L. Bruno; Feng, Jian Q.; D'Souza, Rena N.; Qin, Chunlin; Lu, Yongbo] Baylor Coll Dent, Texas A&M Hlth Sci Ctr, Dept Biomed Sci, Dallas, TX 75246 USA; [Yuan, Baozhi] Univ Wisconsin, Dept Med, Madison, WI 53705 USA; [Yuan, Baozhi] Geriatr Res Educ & Clin Ctr, Madison, WI 53705 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center	Qin, CL (corresponding author), Baylor Coll Dent, Texas A&M Hlth Sci Ctr, Dept Biomed Sci, 3302 Gaston Ave, Dallas, TX 75246 USA.	cqin@bcd.tamhsc.edu; ylu@bcd.tamhsc.edu		Ruest, L. Bruno/0000-0002-5446-9985; Lu, Yongbo/0000-0003-3692-1736; Wang, Xiaofang/0000-0002-7370-7192; D'Souza, Rena/0000-0002-1505-5173	National Institutes of Health [DE005092, DE021773, DE015209]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE021773, R01DE005092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE005092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE005092 (to C. Q.), DE021773 (to Y. L.), and DE015209 (to J. F.).	Avery J. K., 2001, ORAL DEV HISTOLOGY, P235; Baba O, 2004, EUR J ORAL SCI, V112, P163, DOI 10.1111/j.0909-8836.2004.00110.x; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; Duverger O, 2012, J BIOL CHEM, V287, P12230, DOI 10.1074/jbc.M111.326900; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Feng JQ, 2003, J DENT RES, V82, P776, DOI 10.1177/154405910308201003; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; GEORGE A, 1994, J HISTOCHEM CYTOCHEM, V42, P1527, DOI 10.1177/42.12.7983353; GEORGE A, 1993, J BIOL CHEM, V268, P12624; Gibson MP, 2013, J PERIODONTAL RES, V48, P221, DOI 10.1111/j.1600-0765.2012.01523.x; Holappa H, 2006, EUR J ORAL SCI, V114, P381, DOI 10.1111/j.1600-0722.2006.00391.x; Huang BZ, 2008, CALCIFIED TISSUE INT, V82, P401, DOI 10.1007/s00223-008-9140-7; Huang BZ, 2008, EUR J ORAL SCI, V116, P104, DOI 10.1111/j.1600-0722.2008.00522.x; Jiang BC, 2010, J BONE MINER RES, V25, P2155, DOI 10.1002/jbmr.117; Kim JW, 2007, J DENT RES, V86, P392, DOI 10.1177/154405910708600502; Kim JW, 2004, HUM GENET, V115, P248, DOI 10.1007/s00439-004-1143-5; Li Y, 2011, Adv Dent Res, V23, P280, DOI 10.1177/0022034511405387; Lu YB, 2007, DEV BIOL, V303, P191, DOI 10.1016/j.ydbio.2006.11.001; Lu YB, 2011, J BONE MINER RES, V26, P331, DOI 10.1002/jbmr.226; Lu YB, 2009, CELLS TISSUES ORGANS, V189, P175, DOI 10.1159/000151727; MacDougall M, 1997, J BIOL CHEM, V272, P835, DOI 10.1074/jbc.272.2.835; Maciejewska I, 2009, CELLS TISSUES ORGANS, V189, P186, DOI 10.1159/000151372; MARTIN DM, 1978, J MICROSC-OXFORD, V112, P345, DOI 10.1111/j.1365-2818.1978.tb00085.x; Narayanan K, 2003, J BIOL CHEM, V278, P17500, DOI 10.1074/jbc.M212700200; Narayanan K, 2001, P NATL ACAD SCI USA, V98, P4516, DOI 10.1073/pnas.081075198; Narayanan K, 2006, J BIOL CHEM, V281, P19064, DOI 10.1074/jbc.M600714200; Nikdin H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031525; Orsini G, 2007, CALCIFIED TISSUE INT, V81, P39, DOI 10.1007/s00223-007-9027-z; Prasad M, 2011, J HISTOCHEM CYTOCHEM, V59, P1009, DOI 10.1369/0022155411423406; Prasad M, 2010, CONNECT TISSUE RES, V51, P404, DOI 10.3109/03008200903329789; Qin C, 2002, J DENT RES, V81, P392, DOI 10.1177/154405910208100607; QIN C, 2005, P 8 ICCBMT, P174; Rajpar MH, 2002, HUM MOL GENET, V11, P2559, DOI 10.1093/hmg/11.21.2559; Ravindran S, 2008, J BIOL CHEM, V283, P29658, DOI 10.1074/jbc.M800786200; Siyam A, 2012, BIOCHEM BIOPH RES CO, V424, P641, DOI 10.1016/j.bbrc.2012.07.037; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Sreenath TL, 1999, INT J DEV BIOL, V43, P509; Sun Y, 2011, J DENT RES, V90, P619, DOI 10.1177/0022034510397839; Sun Y, 2010, INT J ORAL MAX SURG, V39, P272, DOI 10.1016/j.ijom.2009.12.017; Verdelis K, 2008, BONE, V43, P983, DOI 10.1016/j.bone.2008.08.110; WANG XF, 2010, HEALTH TECHNOL ASSES, V14, P957, DOI DOI 10.1369/JHC.2010.9565651; Wu H, 2011, J BIOL CHEM, V286, P29462, DOI 10.1074/jbc.M110.194746; Xiao SX, 2001, NAT GENET, V27, P201, DOI 10.1038/84848; Ye L, 2005, J BIOL CHEM, V280, P6197, DOI 10.1074/jbc.M412911200; Ye L, 2004, J BIOL CHEM, V279, P19141, DOI 10.1074/jbc.M400490200; Zhang B, 2010, ORAL DIS, V16, P453, DOI 10.1111/j.1601-0825.2010.01656.x; Zhang R, 2011, J BONE MINER RES, V26, P1047, DOI 10.1002/jbmr.294; Zhang XH, 2001, NAT GENET, V27, P151, DOI 10.1038/84765; Zhu QL, 2012, J BIOL CHEM, V287, P30426, DOI 10.1074/jbc.M112.388587; Zhu QL, 2012, CONNECT TISSUE RES, V53, P307, DOI 10.3109/03008207.2011.650301	50	58	59	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7204	7214		10.1074/jbc.M112.445775	http://dx.doi.org/10.1074/jbc.M112.445775			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23349460	Green Published, hybrid			2022-12-25	WOS:000316002400041
J	Lu, F; Taghbalout, A				Lu, Feng; Taghbalout, Aziz			Membrane Association via an Amino-terminal Amphipathic Helix Is Required for the Cellular Organization and Function of RNase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MESSENGER-RNA; TARGETING SEQUENCE; CHROMOSOMAL GENES; RIBONUCLEASE-II; MIND; BINDING; LOCALIZATION; DEGRADATION; REDISTRIBUTION	The subcellular localization of the exoribonuclease RNase II is not known despite the advanced biochemical characterization of the enzyme. Here we report that RNase II is organized into cellular structures that appear to coil around the Escherichia coli cell periphery and that RNase II is associated with the cytoplasmic membrane by its amino-terminal amphipathic helix. The helix also acts as an autonomous transplantable membrane binding domain capable of directing normally cytoplasmic proteins to the membrane. Assembly of the organized cellular structures of RNase II required the RNase II amphipathic membrane binding domain. Co-immunoprecipitation of the protein from cell extracts indicated that RNase II interacts with itself. The RNase II self-interaction and the ability of the protein to assemble into organized cellular structures required the membrane binding domain. The ability of RNase II to maintain cell viability in the absence of the exoribonuclease polynucleotide phosphorylase was markedly diminished when the RNase II cellular structures were lost due to changes in the amphipathicity of the amino-terminal helix, suggesting that membrane association and assembly of RNase II into organized cellular structures play an important role in the normal function of the protein within the bacterial cell.	[Lu, Feng; Taghbalout, Aziz] Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT 06032 USA	University of Connecticut	Taghbalout, A (corresponding author), Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, 263 Farmington Ave, Farmington, CT 06032 USA.	taghbalout@neuron.uchc.edu			National Institutes of Health Grant [R37 GM060632]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM060632] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R37 GM060632.	Amblar M, 2006, J MOL BIOL, V360, P921, DOI 10.1016/j.jmb.2006.05.043; Carabetta VJ, 2009, J BACTERIOL, V191, P6812, DOI 10.1128/JB.00870-09; Carpousis AJ, 2008, METHOD ENZYMOL, V447, P65, DOI 10.1016/S0076-6879(08)02204-0; CARPOUSIS AJ, 1994, CELL, V76, P889, DOI 10.1016/0092-8674(94)90363-8; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; COVARRUBIAS L, 1981, GENE, V13, P25, DOI 10.1016/0378-1119(81)90040-8; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; DeLano W.L., 2005, PYMOL MOL GRAPHICS S; DEUTSCHER MP, 1991, P NATL ACAD SCI USA, V88, P3277, DOI 10.1073/pnas.88.8.3277; Diestra E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008301; DONOVAN WP, 1986, P NATL ACAD SCI USA, V83, P120, DOI 10.1073/pnas.83.1.120; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Hu ZL, 2003, MOL MICROBIOL, V47, P345, DOI 10.1046/j.1365-2958.2003.03321.x; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; ISHIDATE K, 1986, J BIOL CHEM, V261, P428; JACKSON ME, 1988, MOL MICROBIOL, V2, P563, DOI 10.1111/j.1365-2958.1988.tb00064.x; Jasiecki J, 2005, BIOCHEM BIOPH RES CO, V329, P598, DOI 10.1016/j.bbrc.2005.02.025; Khemici V, 2008, MOL MICROBIOL, V70, P799, DOI 10.1111/j.1365-2958.2008.06454.x; Li ZW, 1998, P NATL ACAD SCI USA, V95, P2856, DOI 10.1073/pnas.95.6.2856; Li ZW, 1996, CELL, V86, P503, DOI 10.1016/S0092-8674(00)80123-3; Maniatis T., 1982, MOL CLONING LAB MANU; MICZAK A, 1991, MOL MICROBIOL, V5, P1801, DOI 10.1111/j.1365-2958.1991.tb01929.x; MILLER JH, 1992, SHORT COURSE BACTERI, P268; Morita T, 2004, MOL MICROBIOL, V54, P1063, DOI 10.1111/j.1365-2958.2004.04329.x; Murashko ON, 2012, P NATL ACAD SCI USA, V109, P7019, DOI 10.1073/pnas.1120181109; NOSSAL NG, 1968, J BIOL CHEM, V243, P913; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Rothfield L, 2005, NAT REV MICROBIOL, V3, P959, DOI 10.1038/nrmicro1290; Rowland SL, 2000, J BACTERIOL, V182, P613, DOI 10.1128/JB.182.3.613-619.2000; Salje J, 2011, MOL CELL, V43, P478, DOI 10.1016/j.molcel.2011.07.008; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; Shih YL, 2002, EMBO J, V21, P3347, DOI 10.1093/emboj/cdf323; Shih YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021425; Swulius MT, 2012, J BACTERIOL, V194, P6382, DOI 10.1128/JB.00505-12; Szeto TH, 2003, J BIOL CHEM, V278, P40050, DOI 10.1074/jbc.M306876200; Szeto TH, 2002, P NATL ACAD SCI USA, V99, P15693, DOI 10.1073/pnas.232590599; Taghbalout A, 2006, J BACTERIOL, V188, P2993, DOI 10.1128/JB.188.8.2993-3001.2006; Taghbalout A, 2007, P NATL ACAD SCI USA, V104, P1667, DOI 10.1073/pnas.0610491104; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Zuo YH, 2006, MOL CELL, V24, P149, DOI 10.1016/j.molcel.2006.09.004	44	21	25	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7241	7251		10.1074/jbc.M112.408674	http://dx.doi.org/10.1074/jbc.M112.408674			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23344958	hybrid, Green Published			2022-12-25	WOS:000316002400044
J	Lemes, P; Loyola, RD				Lemes, Priscila; Loyola, Rafael Dias			Accommodating Species Climate-Forced Dispersal and Uncertainties in Spatial Conservation Planning	PLOS ONE			English	Article							HABITAT SUITABILITY MODELS; BRAZILIAN ATLANTIC FOREST; RESERVE NETWORKS; PROTECTED AREAS; BIODIVERSITY; FACE; DISTRIBUTIONS; EXTINCTIONS; PREDICTION; MANAGEMENT	Spatial conservation prioritization should seek to anticipate climate change impacts on biodiversity and to mitigate these impacts through the development of dynamic conservation plans. Here, we defined spatial priorities for the conservation of amphibians inhabiting the Atlantic Forest Biodiversity Hotspot that overcome the likely impacts of climate change on the distribution of this imperiled fauna. First, we built ecological niche models (ENMs) for 431 amphibian species both for current time and for the mid-point of a 30-year period spanning 2071-2099 (i.e. 2080). For modeling species' niches, we combined six modeling methods and three different climate models. We also quantified and mapped model uncertainties. Our consensus models forecasted range shifts that culminate with high species richness in central and eastern Atlantic Forest, both for current time and for 2080. Most species had a significant range contraction (up to 72%) and 12% of species were projected to be regionally extinct. Most species would need to disperse because suitable climatic sites will change. Therefore, we identified a network of priority sites for conservation that minimizes the distance a given species would need to disperse because of changes in future habitat suitability (i.e. climate-forced dispersal) as well as uncertainties associated to ENMs. This network also maximized complementary species representation across currently established protected areas. Priority sites already include possible dispersal corridors linking current and future suitable habitats for amphibians. Although we used the a top-ranked Biodiversity Hotspot and amphibians as a case study for illustrating our approach, our study may help developing more effective conservation strategies under climate change, especially when applied at different spatial scales, geographic regions, and taxonomic groups.	[Lemes, Priscila] Univ Fed Goias, Programa Posgrad Ecol & Evolucao, Goiania, Go, Brazil; [Loyola, Rafael Dias] Univ Fed Goias, Dept Ecol, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias	Loyola, RD (corresponding author), Univ Fed Goias, Dept Ecol, Goiania, Go, Brazil.	rdiasloyola@gmail.com	Lemes, Priscila/I-5877-2013; Loyola, Rafael/S-3978-2019; Loyola, Rafael/A-4425-2008	Lemes, Priscila/0000-0002-0918-5158; Loyola, Rafael/0000-0001-5323-2735; Loyola, Rafael/0000-0001-5323-2735	CNPq [147345/2010-3]; CAPES-FCT Program (Brazil-Portugal); Brazilian Research Network on Global Climate Change (Rede CLIMA)	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES-FCT Program (Brazil-Portugal); Brazilian Research Network on Global Climate Change (Rede CLIMA)	P.L. received a CNPq doctoral scholarship (project # 147345/2010-3). R.D.L. research is funded by CAPES-FCT Program (Brazil-Portugal) and by the Brazilian Research Network on Global Climate Change (Rede CLIMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; ARAUJO MB, 2009, SPATIAL CONSERVATION, P172; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Arponen A, 2005, CONSERV BIOL, V21, P527; Becker CG, 2010, DIVERS DISTRIB, V16, P10, DOI 10.1111/j.1472-4642.2009.00625.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Bush Mark B., 2005, P125; Cabeza M, 2006, BIOL CONSERV, V132, P336, DOI 10.1016/j.biocon.2006.04.025; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Carroll C, 2010, GLOBAL CHANGE BIOL, V16, P891, DOI 10.1111/j.1365-2486.2009.01965.x; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Franklin J, 2009, MAPPING SPECIES DIST; Game ET, 2011, GLOBAL CHANGE BIOL, V17, P3150, DOI 10.1111/j.1365-2486.2011.02457.x; Gaston KJ, 2006, BIOL CONSERV, V132, P76, DOI 10.1016/j.biocon.2006.03.013; Gittleman JL, 2001, CONSERV BIOL SER, V5, P1; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hole DG, 2011, CONSERV BIOL, V25, P305, DOI 10.1111/j.1523-1739.2010.01633.x; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Kamino Luciana H Y, 2012, Biol Lett, V8, P324, DOI 10.1098/rsbl.2011.0942; Ladle R. J., 2011, CONSERVATION BIOGEOG, DOI 10.1002/9781444390001; Lawler JJ, 2011, PREDICTIVE SPECIES AND HABITAT MODELING IN LANDSCAPE ECOLOOGY: CONCEPTS AND APPLICATIONS, P271, DOI 10.1007/978-1-4419-7390-0_14; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; Lemes P, 2011, NAT CONSERVACAO, V9, P240, DOI 10.4322/natcon.2011.032; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Loyola RD, 2008, DIVERS DISTRIB, V14, P949, DOI 10.1111/j.1472-4642.2008.00508.x; Loyola RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002120; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; McCarthy MA, 2011, ECOL LETT, V14, P470, DOI 10.1111/j.1461-0248.2011.01608.x; Meir E, 2004, ECOL LETT, V7, P615, DOI 10.1111/j.1461-0248.2004.00624.x; Mittermeier R, 2010, NAT CONSERVACAO, V8, P197, DOI 10.4322/natcon.00802017; Mittermeier Russell A., 2004, P1; Moilanen A, 2005, P ROY SOC B-BIOL SCI, V272, P1885, DOI 10.1098/rspb.2005.3164; Moilanen A, 2009, SPATIAL CONSERVATION; Moilanen A, 2008, ZONATION SOFTWARE SP; Moilanen A, 2006, ECOL MODEL, V199, P115, DOI 10.1016/j.ecolmodel.2006.07.004; Munoz J, 2004, J VEG SCI, V15, P285, DOI 10.1111/j.1654-1103.2004.tb02263.x; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Nicholson E, 2007, ECOL APPL, V17, P251, DOI 10.1890/1051-0761(2007)017[0251:MCDUUF]2.0.CO;2; Nori J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025718; Parry ML, 2007, CLIMATE CHANGE 2007; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 2011, MONOGRAPHS POPULATIO, P328, DOI [DOI 10.5860/CHOICE.49-6266, 10.1515/9781400840670, DOI 10.1515/9781400840670]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Rayfield B, 2009, ECOL MODEL, V220, P725, DOI 10.1016/j.ecolmodel.2008.11.016; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rondinini C, 2005, CONSERV BIOL, V19, P1488, DOI 10.1111/j.1523-1739.2005.00204.x; Rondinini C, 2011, PHILOS T R SOC B, V366, P2633, DOI 10.1098/rstb.2011.0113; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Salazar LF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029695; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Sokal R.R., 1995, BIOMETRY PRINCIPLES, Vthird; SOS Mata Atlantica Instituto Nacional de Pesquisas Espaciais, 2008, ATL REM FLOR MAT ATL; STOCKWELL DRB, 1992, MATH COMPUT SIMULAT, V33, P385, DOI 10.1016/0378-4754(92)90126-2; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; UNEP-WCMC, 2010, DAT STAND WORLD DAT; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Willis KJ, 2009, SCIENCE, V326, P806, DOI 10.1126/science.1178838; Wilson KA, 2010, NAT CONSERVACAO, V8, P145, DOI 10.4322/natcon.00802007; YEE TW, 1991, J VEG SCI, V2, P587, DOI 10.2307/3236170	71	68	68	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54323	10.1371/journal.pone.0054323	http://dx.doi.org/10.1371/journal.pone.0054323			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349850	gold, Green Submitted, Green Published			2022-12-25	WOS:000314019100055
J	Qian, W; Deng, L; Lu, DS; Xu, SH				Qian, Wei; Deng, Lian; Lu, Dongsheng; Xu, Shuhua			Genome-Wide Landscapes of Human Local Adaptation in Asia	PLOS ONE			English	Article							RECENT POSITIVE SELECTION; NATURAL-SELECTION; LINKAGE DISEQUILIBRIUM; GENETIC DIVERSITY; SIGNATURES; SIGNALS; AFRICA; PIGMENTATION; EVOLUTION; VARIANTS	Genetic studies of human local adaptation have been facilitated greatly by recent advances in high-throughput genotyping and sequencing technologies. However, few studies have investigated local adaptation in Asian populations on a genome-wide scale and with a high geographic resolution. In this study, taking advantage of the dense population coverage in Southeast Asia, which is the part of the world least studied in term of natural selection, we depicted genome-wide landscapes of local adaptations in 63 Asian populations representing the majority of linguistic and ethnic groups in Asia. Using genome-wide data analysis, we discovered many genes showing signs of local adaptation or natural selection. Notable examples, such as FOXQ1, MAST2, and CDH4, were found to play a role in hair follicle development and human cancer, signal transduction, and tumor repression, respectively. These showed strong indications of natural selection in Philippine Negritos, a group of aboriginal hunter-gatherers living in the Philippines. MTTP, which has associations with metabolic syndrome, body mass index, and insulin regulation, showed a strong signature of selection in Southeast Asians, including Indonesians. Functional annotation analysis revealed that genes and genetic variants underlying natural selections were generally enriched in the functional category of alternative splicing. Specifically, many genes showing significant difference with respect to allele frequency between northern and southern Asian populations were found to be associated with human height and growth and various immune pathways. In summary, this study contributes to the overall understanding of human local adaptation in Asia and has identified both known and novel signatures of natural selection in the human genome.	[Xu, Shuhua] Chinese Acad Sci, Max Planck Independent Res Grp Populat Genom, Shanghai, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Max Planck Soc CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Max Planck Society; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Xu, SH (corresponding author), Chinese Acad Sci, Max Planck Independent Res Grp Populat Genom, Shanghai, Peoples R China.	xushua@picb.ac.cn	Xu, Shuhua/AAH-7620-2020; XU, SHUHUA/D-5345-2009	Xu, Shuhua/0000-0002-1975-1002; XU, SHUHUA/0000-0002-1975-1002	National Science Foundation of China [30971577, 31171218]; Shanghai Rising-Star Program [11QA1407600]; Science Foundation of the Chinese Academy of Sciences [KSCX2-EW-Q-1-11, KSCX2-EW-R-01-05, KSCX2-EW-J-15-05]; Ministry of Science and Technology (MoST) International Cooperation Base of China	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program; Science Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology (MoST) International Cooperation Base of China	SX was supported by the National Science Foundation of China (30971577; 31171218), Shanghai Rising-Star Program (11QA1407600), and Science Foundation of the Chinese Academy of Sciences (KSCX2-EW-Q-1-11; KSCX2-EW-R-01-05; KSCX2-EW-J-15-05). This research was supported in part by the Ministry of Science and Technology (MoST) International Cooperation Base of China. SX is Max-Planck Independent Junior Research Group Leader and member of CAS Youth Innovation Promotion Association. SX also gratefully acknowledges the support of the K.C. Wong Education Foundation, Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Carlson CS, 2005, GENOME RES, V15, P1553, DOI 10.1101/gr.4326505; Chen H, 2010, GENOME RES, V20, P393, DOI 10.1101/gr.100545.109; Diaz-Perales A, 2005, J BIOL CHEM, V280, P30367, DOI 10.1074/jbc.M504533200; Evseeva I, 2010, EUR J HUM GENET, V18, P924, DOI 10.1038/ejhg.2010.32; Fujimoto A, 2008, HUM MOL GENET, V17, P835, DOI 10.1093/hmg/ddm355; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Hill C, 2007, AM J HUM GENET, V80, P29, DOI 10.1086/510412; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hulpiau P, 2009, INT J BIOCHEM CELL B, V41, P349, DOI 10.1016/j.biocel.2008.09.027; Hurles ME, 2005, AM J HUM GENET, V76, P894, DOI 10.1086/430051; Jarvis JP, 2012, PLOS GENET, V8, P299, DOI 10.1371/journal.pgen.1002641; Jin WF, 2012, GENOME RES, V22, P519, DOI 10.1101/gr.124784.111; Kelley JL, 2006, GENOME RES, V16, P980, DOI 10.1101/gr.5157306; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lao O, 2007, ANN HUM GENET, V71, P354, DOI 10.1111/j.1469-1809.2006.00341.x; Ledmyr H, 2002, J LIPID RES, V43, P51; Li JJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002578; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Magalon H, 2008, EUR J HUM GENET, V16, P243, DOI 10.1038/sj.ejhg.5201963; Mothe I, 1997, MOL ENDOCRINOL, V11, P1911, DOI 10.1210/me.11.13.1911; Ngamphiw C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021451; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Niiro H, 2004, J IMMUNOL, V173, P5601, DOI 10.4049/jimmunol.173.9.5601; O'Reilly PF, 2007, GENET EPIDEMIOL, V31, P611; Ohashi J, 2004, AM J HUM GENET, V74, P1198, DOI 10.1086/421330; Ohashi J, 2011, MOL BIOL EVOL, V28, P849, DOI 10.1093/molbev/msq264; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Qiao YY, 2011, CANCER RES, V71, P3076, DOI 10.1158/0008-5472.CAN-10-2787; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Soares P, 2008, MOL BIOL EVOL, V25, P1209, DOI 10.1093/molbev/msn068; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; Tennessen JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002127; Teo YY, 2009, GENOME RES, V19, P2154, DOI 10.1101/gr.095000.109; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; Wilder JA, 2009, J HUM GENET, V54, P182, DOI 10.1038/jhg.2009.12; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Xu SH, 2011, MOL BIOL EVOL, V28, P1003, DOI 10.1093/molbev/msq277; Zhang HJ, 2011, CANCER RES, V71, P1292, DOI 10.1158/0008-5472.CAN-10-2825	54	17	17	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54224	10.1371/journal.pone.0054224	http://dx.doi.org/10.1371/journal.pone.0054224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349834	Green Published, Green Submitted, gold			2022-12-25	WOS:000314019100052
J	Salzman, J; Klass, DM; Brown, PO				Salzman, Julia; Klass, Daniel M.; Brown, Patrick O.			Improved Discovery of Molecular Interactions in Genome-Scale Data with Adaptive Model-Based Normalization	PLOS ONE			English	Article							MICROARRAY DATA; WIDE ANALYSIS; SPECIFICITY; EXPRESSION; BINDING	Background: High throughput molecular-interaction studies using immunoprecipitations (IP) or affinity purifications are powerful and widely used in biology research. One of many important applications of this method is to identify the set of RNAs that interact with a particular RNA-binding protein (RBP). Here, the unique statistical challenge presented is to delineate a specific set of RNAs that are enriched in one sample relative to another, typically a specific IP compared to a nonspecific control to model background. The choice of normalization procedure critically impacts the number of RNAs that will be identified as interacting with an RBP at a given significance threshold - yet existing normalization methods make assumptions that are often fundamentally inaccurate when applied to IP enrichment data. Methods: In this paper, we present a new normalization methodology that is specifically designed for identifying enriched RNA or DNA sequences in an IP. The normalization (called adaptive or AD normalization) uses a basic model of the IP experiment and is not a variant of mean, quantile, or other methodology previously proposed. The approach is evaluated statistically and tested with simulated and empirical data. Results and Conclusions: The adaptive (AD) normalization method results in a greatly increased range in the number of enriched RNAs identified, fewer false positives, and overall better concordance with independent biological evidence, for the RBPs we analyzed, compared to median normalization. The approach is also applicable to the study of pairwise RNA, DNA and protein interactions such as the analysis of transcription factors via chromatin immunoprecipitation (ChIP) or any other experiments where samples from two conditions, one of which contains an enriched subset of the other, are studied.	[Salzman, Julia; Klass, Daniel M.; Brown, Patrick O.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Salzman, Julia; Klass, Daniel M.; Brown, Patrick O.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Salzman, Julia] Stanford Univ, Dept Stat, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Salzman, J (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	julia.salzman@stanford.edu; pbrown@stanford.edu			Howard Hughes Medical Institute; National Institutes of Health [NIH RO1 CA77097]; National Science Foundation [NSF-DMS 0940077]; NATIONAL CANCER INSTITUTE [R01CA077097] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported mainly by the Howard Hughes Medical Institute and by a grant from the National Institutes of Health to POB (NIH RO1 CA77097). POB is an investigator for the Howard Hughes Medical Institute. DMK was also partially supported by a National Science Foundation pre-doctoral fellowship. JS was supported by National Science Foundation Mathematical Sciences Grant (NSF-DMS 0940077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Duttagupta R, 2005, MOL CELL BIOL, V25, P5499, DOI 10.1128/MCB.25.13.5499-5513.2005; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Gerber AP, 2006, P NATL ACAD SCI USA, V103, P4487, DOI 10.1073/pnas.0509260103; Guisbert KK, 2005, RNA, V11, P383, DOI 10.1261/rna.7234205; Hieronymus H, 2003, NAT GENET, V33, P155, DOI 10.1038/ng1080; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Mann HB, 1943, ANN MATH STAT, V14, P217, DOI 10.1214/aoms/1177731415; Mar JC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-110; Ni TT, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-505; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Tsvetanova NG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012671; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	19	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53930	10.1371/journal.pone.0053930	http://dx.doi.org/10.1371/journal.pone.0053930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349766	Green Published, gold, Green Submitted			2022-12-25	WOS:000314019100038
J	Brandt, KM; Mellmann, A; Ballhausen, B; Jenke, C; van der Wolf, PJ; Broens, EM; Becker, K; Kock, R				Brandt, Karin M.; Mellmann, Alexander; Ballhausen, Britta; Jenke, Christian; van der Wolf, Peter J.; Broens, Els M.; Becker, Karsten; Koeck, Robin			Evaluation of Multiple-Locus Variable Number of Tandem Repeats Analysis for Typing Livestock-Associated Methicillin-Resistant Staphylococcus aureus	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; MRSA CC398; NASAL COLONIZATION; PREVALENCE; STRAINS; PIGS; ST398; BURP; FOOD	Background: The increasing occurrence of livestock-associated (LA) methicillin-resistant Staphylococcus aureus (MRSA) associated with the clonal complex (CC) 398 within the past years shows the importance of standardized and comparable typing methods for the purposes of molecular surveillance and outbreak detection. Multiple-locus variable number of tandem repeats analysis (MLVA) has recently been described as an alternative and highly discriminative tool for S. aureus. However, until now the applicability of MLVA for the typing of LA-MRSA isolates from different geographic origin has not been investigated in detail. We therefore compared MLVA and S. aureus protein A (spa) typing for characterizing porcine MRSA from distinct Dutch and German farms. Methodology/Principal Findings: Overall, 134 MRSA isolates originating from 21 different pig-farms in the Netherlands and 36 farms in Germany comprising 21 different spa types were subjected to MLVA-typing. Amplification and subsequent automated fragment sizing of the tandem repeat loci on a capillary sequencer differentiated these 134 isolates into 20 distinct MLVA types. Whereas overall MLVA and spa typing showed the same discriminatory power to type LA-MRSA (p = 0.102), MLVA was more discriminatory than spa typing for isolates associated with the prevalent spa types t011 and t034 (Simpson's Index of Diversity 0.564 vs. 0.429, respectively; p<0.001). Conclusion: Although the applied MLVA scheme was not more discriminatory than spa typing in general, it added valuable information to spa typing results for specific spa types (t011, t034) which are highly prevalent in the study area, i.e. Dutch-German border area. Thus, both methods may complement each other to increase the discriminatory power to resolute highly conserved clones such as CC398 (spa types t011, t034) for the detection of outbreaks and molecular surveillance of zoonotic MRSA.	[Brandt, Karin M.; Mellmann, Alexander; Jenke, Christian; Koeck, Robin] Univ Hosp Munster, Inst Hyg, Munster, Germany; [Ballhausen, Britta; Becker, Karsten] Univ Hosp Munster, Inst Med Microbiol, Munster, Germany; [van der Wolf, Peter J.] Anim Hlth Serv, Pig Hlth Dept, Deventer, Netherlands; [Broens, Els M.] Univ Utrecht, Fac Vet Med, Vet Microbiol Diagnost Ctr, Dept Infect Dis & Immunol, Utrecht, Netherlands	University of Munster; University of Munster; Utrecht University	Kock, R (corresponding author), Univ Hosp Munster, Inst Hyg, Munster, Germany.	robin.koeck@ukmuenster.de	Köck, Robin/AAC-1552-2019; Becker, Karsten/O-2302-2018	Becker, Karsten/0000-0002-6391-1341; Mellmann, Alexander/0000-0002-0649-5185; van der Wolf, Peter/0000-0001-7893-5971	Bundesministerium fur Bildung und Forschung (BMBF), Germany [01KI1014A]; INTERREG IVa project SafeGuard (MRSA vet-net) [III-2-03 = 025]; BMBF [01KI1020]; Medical Faculty Munster [BD9817044]	Bundesministerium fur Bildung und Forschung (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); INTERREG IVa project SafeGuard (MRSA vet-net); BMBF(Federal Ministry of Education & Research (BMBF)); Medical Faculty Munster	This work was supported in part by grants from the Bundesministerium fur Bildung und Forschung (BMBF, http://www.bmbf.de/), Germany "Interdisciplinary Research Network MedVet-Staph" to R. K. and K. B. (01KI1014A), by the INTERREG IVa project SafeGuard (MRSA vet-net) to R. K., P.v.d.W. and K. B. (III-2-03 = 025) and by the BMBF (01KI1020) and the Medical Faculty Munster (BD9817044) to A. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2012, PHILOS T R SOC B, V367, P860, DOI 10.1098/rstb.2011.0303; [Anonymous], 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1376; Argudin MA, 2010, LETT APPL MICROBIOL, V50, P127, DOI 10.1111/j.1472-765X.2009.02742.x; Bens CCPM, 2006, J CLIN MICROBIOL, V44, P1875, DOI 10.1128/JCM.44.5.1875-1876.2006; Bosch T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-40; Broens EM, 2011, PREV VET MED, V98, P182, DOI 10.1016/j.prevetmed.2010.10.010; Cuny C, 2008, MICROB DRUG RESIST, V14, P307, DOI 10.1089/mdr.2008.0845; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; Espinosa-Gongora C, 2012, VET REC, V170, DOI 10.1136/vr.100704; Fanoy E, 2009, EUROSURVEILLANCE, V14; Fessler AT, 2011, APPL ENVIRON MICROB, V77, P7151, DOI 10.1128/AEM.00561-11; FRENAY HME, 1994, J CLIN MICROBIOL, V32, P846; Furuya D, 2010, JPN J INFECT DIS, V63, P364; Graveland H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010990; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Hasman H, 2010, VET MICROBIOL, V141, P326, DOI 10.1016/j.vetmic.2009.09.025; Holmes A, 2010, J CLIN MICROBIOL, V48, P3600, DOI 10.1128/JCM.01039-10; Holmes MA, 2011, J MAMMARY GLAND BIOL, V16, P373, DOI 10.1007/s10911-011-9237-x; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; HUIJSDENS XW, 2009, EURO SURVEILL, V14; Kock R, 2011, J HOSP INFECT, V79, P292, DOI 10.1016/j.jhin.2011.08.011; Kock R, 2010, EUROSURVEILLANCE, V15, P12, DOI 10.2807/ese.15.41.19688-en; Kock R, 2009, EUR J CLIN MICROBIOL, V28, P1375, DOI 10.1007/s10096-009-0795-4; Kock R, 2012, APPL ENVIRON MICROB, V78, P4046, DOI 10.1128/AEM.00212-12; Malachowa N, 2005, J CLIN MICROBIOL, V43, P3095, DOI 10.1128/JCM.43.7.3095-3100.2005; Meemken D, 2010, ZOONOSES PUBLIC HLTH, V57, pE143, DOI 10.1111/j.1863-2378.2009.01313.x; Mellmann A, 2006, PLOS MED, V3, P348, DOI 10.1371/journal.pmed.0030033; Mellmann A, 2008, J CLIN MICROBIOL, V46, P2805, DOI 10.1128/JCM.00071-08; Mellmann A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-98; Pourcel C, 2009, J CLIN MICROBIOL, V47, P3121, DOI 10.1128/JCM.00267-09; Sabat A, 2003, J CLIN MICROBIOL, V41, P1801, DOI 10.1128/JCM.41.4.1801-1804.2003; Schouls LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005082; Sobral D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033967; Strommenger B, 2006, J CLIN MICROBIOL, V44, P2533, DOI 10.1128/JCM.00420-06; Tenover FC, 2007, J CLIN MICROBIOL, V45, P2215, DOI 10.1128/JCM.02451-06; Van Den Broek IVF, 2009, EPIDEMIOL INFECT, V137, P700, DOI 10.1017/S0950268808001507; van der Wolf PJ, 2012, VET MICROBIOL, V158, P136, DOI 10.1016/j.vetmic.2012.01.025; van Rijen MML, 2009, J HOSP INFECT, V72, P299, DOI 10.1016/j.jhin.2009.05.006; Vanderhaeghen W, 2010, EPIDEMIOL INFECT, V138, P606, DOI 10.1017/S0950268809991567; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Wulf M. W., 2008, EURO SURVEILL, V13; Wulf MWH, 2008, CLIN MICROBIOL INFEC, V14, P29, DOI 10.1111/j.1469-0691.2007.01873.x; Wulf MWH, 2012, EUR J CLIN MICROBIOL, V31, P61, DOI 10.1007/s10096-011-1269-z; Wulf M, 2006, EMERG INFECT DIS, V12, P1939	45	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54425	10.1371/journal.pone.0054425	http://dx.doi.org/10.1371/journal.pone.0054425			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349886	gold, Green Published, Green Submitted			2022-12-25	WOS:000313943000037
J	Listl, S; Jansen, L; Stenzinger, A; Freier, K; Emrich, K; Holleczek, B; Katalinic, A; Gondos, A; Brenner, H				Listl, Stefan; Jansen, Lina; Stenzinger, Albrecht; Freier, Kolja; Emrich, Katharina; Holleczek, Bernd; Katalinic, Alexander; Gondos, Adam; Brenner, Hermann		GEKID Canc Survival Working Grp	Survival of Patients with Oral Cavity Cancer in Germany	PLOS ONE			English	Article							UP-TO-DATE; PERIOD ANALYSIS; QUALITY-CONTROL; UNITED-STATES; POPULATION; EUROPE; TRENDS; 21ST-CENTURY; EXPERIENCE; CARCINOMA	The purpose of the present study was to describe the survival of patients diagnosed with oral cavity cancer in Germany. The analyses relied on data from eleven population-based cancer registries in Germany covering a population of 33 million inhabitants. Patients with a diagnosis of oral cavity cancer (ICD-10: C00-06) between 1997 and 2006 are included. Period analysis for 2002-2006 was applied to estimate five-year age-standardized relative survival, taking into account patients' sex as well as grade and tumor stage. Overall five-year relative survival for oral cavity cancer patients was 54.6%. According to tumor localization, five-year survival was 86.5% for lip cancer, 48.1% for tongue cancer and 51.7% for other regions of the oral cavity. Differences in survival were identified with respect to age, sex, tumor grade and stage. The present study is the first to provide a comprehensive overview on survival of oral cavity cancer patients in Germany.	[Listl, Stefan] Univ Heidelberg Hosp, Dept Conservat Dent, Heidelberg, Germany; [Listl, Stefan] Max Planck Inst Social Law & Social Policy, Munich Ctr Econ Aging, Munich, Germany; [Jansen, Lina; Gondos, Adam; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Stenzinger, Albrecht] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany; [Freier, Kolja] Univ Heidelberg Hosp, Dept Oral & Maxillofacial Surg, Heidelberg, Germany; [Emrich, Katharina] Johannes Gutenberg Univ Mainz, Canc Registry Rhineland Palatine, Inst Med Biostat Epidemiol & Informat, Univ Med Ctr, D-55122 Mainz, Germany; [Holleczek, Bernd] Saarland Canc Registry, Saarbrucken, Germany; [Katalinic, Alexander] Inst Clin Epidemiol, Lubeck, Germany	Ruprecht Karls University Heidelberg; Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Johannes Gutenberg University of Mainz	Listl, S (corresponding author), Univ Heidelberg Hosp, Dept Conservat Dent, Heidelberg, Germany.	stefan.listl@med.uni-heidelberg.de	Brenner, Hermann/B-4627-2017; Brenner, Hermann/ABE-6383-2020; Listl, Stefan/S-7600-2017; Katalinic, Alexander/D-2512-2010; Jansen, Lina/D-7255-2016	Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572; Listl, Stefan/0000-0002-8176-3397; Katalinic, Alexander/0000-0003-0490-1554; Jansen, Lina/0000-0001-8004-4940	Medical Faculty of the University of Heidelberg; German Cancer Aid (Deutsche Krebshilfe) [108257]	Medical Faculty of the University of Heidelberg; German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe)	SL and AS are fully funded through a Postdoctoral Fellowship by the Medical Faculty of the University of Heidelberg. LJ, KF, KE, BH, AK, AG and HB were funded through their institutions. The study itself was funded by the German Cancer Aid (Deutsche Krebshilfe), grant number 108257. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berrino F, 1998, EUR J CANCER, V34, P2154, DOI 10.1016/S0959-8049(98)00328-1; BLOT WJ, 1988, CANCER RES, V48, P3282; Boyle P, 2005, ANN ONCOL, V16, P481, DOI 10.1093/annonc/mdi098; Brenner H, 2004, EUR J CANCER, V40, P326, DOI 10.1016/j.ejca.2003.10.013; Brenner H, 2002, EUR J CANCER, V38, P690, DOI 10.1016/S0959-8049(02)00003-5; Brenner H, 2002, AM J EPIDEMIOL, V156, P566, DOI 10.1093/aje/kwf071; Brenner H, 2006, AM J EPIDEMIOL, V164, P689, DOI 10.1093/aje/kwj243; Brenner H, 2011, CANCER EPIDEM BIOMAR, V20, P2480, DOI 10.1158/1055-9965.EPI-11-0697; Brenner H, 2009, EUR J CANCER, V45, P1028, DOI 10.1016/j.ejca.2008.11.005; Cancela MD, 2010, CANCER EPIDEMIOL, V34, P501, DOI 10.1016/j.canep.2010.04.012; Capocaccia R, 2003, ANN ONCOL, V14, pV14, DOI 10.1093/annonc/mdg751; CEREZO L, 1993, RADIOTHER ONCOL, V28, P142, DOI 10.1016/0167-8140(93)90006-T; Corazziari I, 2004, EUR J CANCER, V40, P2307, DOI 10.1016/j.ejca.2004.07.002; da Silva SD, 2011, ORAL ONCOL, V47, P783, DOI 10.1016/j.oraloncology.2011.07.004; De Angelis R, 2009, EUR J CANCER, V45, P909, DOI 10.1016/j.ejca.2008.11.003; Deng H, 2011, AUST DENT J, V56, P244, DOI 10.1111/j.1834-7819.2011.01349.x; Ederer F., 1959, INSTRUCTIONS IBM 650; Engholm G, 2010, ACTA ONCOL, V49, P725, DOI 10.3109/02841861003782017; Ferlay J, 2005, 42 IARC; Ferlito A, 2006, ORAL ONCOL, V42, P14, DOI 10.1016/j.oraloncology.2005.03.009; Gondos A, 2009, ANN ONCOL, V20, P564, DOI 10.1093/annonc/mdn639; Gondos A, 2007, INT J CANCER, V121, P395, DOI 10.1002/ijc.22683; HENSON DE, 1995, CANCER-AM CANCER SOC, V76, P1687, DOI 10.1002/1097-0142(19951115)76:10<1687::AID-CNCR2820761002>3.0.CO;2-I; Hiripi E, 2012, ANN ONCOL, V23, P472, DOI 10.1093/annonc/mdr131; Howlader N, 2011, SEER CANC STAT REV 1; Mehrotra R, 2011, HEAD NECK ONCOL, V3, DOI 10.1186/1758-3284-3-33; MOLNAR L, 1974, ONCOLOGY-BASEL, V29, P101, DOI 10.1159/000224893; Petersen PE, 2005, COMMUNITY DENT ORAL, V33, P397, DOI 10.1111/j.1600-0528.2005.00251.x; *R KOCH I, 2010, CANC GERM 2005 2006; Shiboski CH, 2000, COMMUNITY DENT ORAL, V28, P249, DOI 10.1034/j.1600-0528.2000.280402.x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Zigon G, 2011, ANN ONCOL, V22, P165, DOI 10.1093/annonc/mdq306	33	59	63	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e53415	10.1371/journal.pone.0053415	http://dx.doi.org/10.1371/journal.pone.0053415			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349710	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872800009
J	Prates, RA; Fuchs, BB; Mizuno, K; Naqvi, Q; Kato, IT; Ribeiro, MS; Mylonakis, E; Tegos, GP; Hamblin, MR				Prates, Renato A.; Fuchs, Beth Burgwyn; Mizuno, Kazue; Naqvi, Qurat; Kato, Ilka T.; Ribeiro, Martha S.; Mylonakis, Eleftherios; Tegos, George P.; Hamblin, Michael R.			Effect of Virulence Factors on the Photodynamic Inactivation of Cryptococcus neoformans	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; ANTIFUNGAL AGENTS; IN-VITRO; OXIDATIVE STRESS; THERAPY; SUSCEPTIBILITY; PHOTOSENSITIZERS; MELANIZATION; MECHANISMS; POLYSACCHARIDE	Opportunistic fungal pathogens may cause an array of superficial infections or serious invasive infections, especially in immunocompromised patients. Cryptococcus neoformans is a pathogen causing cryptococcosis in HIV/AIDS patients, but treatment is limited due to the relative lack of potent antifungal agents. Photodynamic inactivation (PDI) uses the combination of non-toxic dyes called photosensitizers and harmless visible light, which produces singlet oxygen and other reactive oxygen species that produce cell inactivation and death. We report the use of five structurally unrelated photosensitizers (methylene blue, Rose Bengal, selenium derivative of a Nile blue dye, a cationic fullerene and a conjugate between poly-L-lysine and chlorin(e6)) combined with appropriate wavelengths of light to inactivate C. neoformans. Mutants lacking capsule and laccase, and culture conditions that favoured melanin production were used to probe the mechanisms of PDI and the effect of virulence factors. The presence of cell wall, laccase and melanin tended to protect against PDI, but the choice of the appropriate photosensitizers and dosimetry was able to overcome this resistance.	[Prates, Renato A.; Kato, Ilka T.; Ribeiro, Martha S.] Nucl & Energy Res Inst, Ctr Lasers & Applicat, Sao Paulo, Brazil; [Prates, Renato A.] Univ Nove Julho, Sch Dent, Dept Hlth, Sao Paulo, Brazil; [Fuchs, Beth Burgwyn; Mylonakis, Eleftherios] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Prates, Renato A.; Mizuno, Kazue; Naqvi, Qurat; Tegos, George P.; Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Prates, Renato A.; Mizuno, Kazue; Tegos, George P.; Hamblin, Michael R.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Tegos, George P.] Univ New Mexico, Dept Pathol, Sch Med, Albuquerque, NM 87131 USA; [Hamblin, Michael R.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Comissao Nacional de Energia Nuclear (CNEN); Instituto de Pesquisas Energeticas e Nucleares (IPEN); Universidade Nove de Julho; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of New Mexico; Harvard University; Massachusetts Institute of Technology (MIT)	Tegos, GP (corresponding author), Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA.	GTegos@salud.unm.edu; Hamblin@helix.mgh.harvard.edu	Ribeiro, Martha Simões/G-3517-2012; Prates, Renato A/F-8235-2014; Hamblin, Michael R/H-2758-2019; Kato, Ilka Tiemy/X-5821-2019; Hamblin, Mike/AAB-2511-2022; Kato, Ilka/G-7644-2012	Ribeiro, Martha Simões/0000-0002-4203-1134; Prates, Renato A/0000-0002-8115-9237; Hamblin, Michael R/0000-0001-6431-4605; 	FAPESP [2010/13313 9]; Brazilian National Commission on Research (CNPq) [501499/2011 3]; United States National Institutes of Health (NIH) [R01A1050875, R01CA137108]; US Air Force MFEL Program [FA9550-04-1-0079]; NIH [5U54MH084690-02]; DTRA [HDTRA1-13-C-0005]; NATIONAL CANCER INSTITUTE [R01CA137108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084690] Funding Source: NIH RePORTER	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Commission on Research (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Air Force MFEL Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DTRA(United States Department of DefenseDefense Threat Reduction Agency); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was partially supported by FAPESP (2010/13313 9) and Brazilian National Commission on Research (CNPq grant 501499/2011 3). Research in the Hamblin laboratory was supported by United States National Institutes of Health (NIH) grants (R01A1050875 to MRH and R01CA137108 to Long Y. Chiang) and US Air Force MFEL Program (FA9550-04-1-0079). George P. Tegos was supported by the NIH (grant 5U54MH084690-02) and DTRA (contract HDTRA1-13-C-0005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanio A, 2011, MBIO, V2, DOI 10.1128/mBio.00158-11; Casadevall A, 1998, ANTIMICROB AGENTS CH, V42, P1437, DOI 10.1128/AAC.42.6.1437; CASADEVALL A, 1994, CLIN INFECT DIS, V19, P951, DOI 10.1093/clinids/19.5.951; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Castano AP, 2004, PHOTODIAGN PHOTODYN, V1, P279, DOI 10.1016/S1572-1000(05)00007-4; Chang YC, 1999, J BACTERIOL, V181, P5636, DOI 10.1128/JB.181.18.5636-5643.1999; Cowen LE, 2002, ANNU REV MICROBIOL, V56, P139, DOI 10.1146/annurev.micro.56.012302.160907; Cruess AF, 2009, ACTA OPHTHALMOL, V87, P118, DOI 10.1111/j.1755-3768.2008.01218.x; da Silva EG, 2006, J MED MICROBIOL, V55, P139, DOI 10.1099/jmm.0.46206-0; Dai TH, 2012, FRONT MICROBIOL, V3, DOI [10.3389/fmicb.2012.00120, 10.3389/fmicb.2012.00417]; Dai TH, 2010, LASER SURG MED, V42, P38, DOI 10.1002/lsm.20887; Dai T, 2009, PHOTODIAGN PHOTODYN, V6, P170, DOI 10.1016/j.pdpdt.2009.10.008; Demidova TN, 2005, ANTIMICROB AGENTS CH, V49, P2329, DOI 10.1128/AAC.49.6.2329-2335.2005; Demidova TN, 2004, INT J IMMUNOPATH PH, V17, P245, DOI 10.1177/039463200401700304; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Drakulic T, 2005, FEMS YEAST RES, V5, P1215, DOI 10.1016/j.femsyr.2005.06.001; Espinel-Ingroff A, 2009, REV IBEROAM MICOL, V26, P15, DOI 10.1016/S1130-1406(09)70004-X; Foley JW, 2006, J MED CHEM, V49, P5291, DOI 10.1021/JM060153i; Fuchs BB, 2007, ANTIMICROB AGENTS CH, V51, P2929, DOI 10.1128/AAC.00121-07; Fuchs BB, 2010, VIRULENCE, V1, P475, DOI 10.4161/viru.1.6.12985; Garber G, 2001, DRUGS, V61, P1, DOI 10.2165/00003495-200161001-00001; Garcia-Rivera J, 2001, MED MYCOL, V39, P353, DOI 10.1080/mmy.39.4.353.357; Hamblin MR, 2004, PHOTOCH PHOTOBIO SCI, V3, P436, DOI 10.1039/b311900a; Hamblin MR, 2002, J ANTIMICROB CHEMOTH, V49, P941, DOI 10.1093/jac/dkf053; Harris F, 2005, CURR DRUG TARGETS, V6, P615, DOI 10.2174/1389450054545962; HAY RJ, 1991, J ANTIMICROB CHEMOTH, V28, P17, DOI 10.1093/jac/28.suppl_B.17; Huang LY, 2012, LASER SURG MED, V44, P490, DOI 10.1002/lsm.22045; Huang L, 2010, ANTIMICROB AGENTS CH, V54, P3834, DOI 10.1128/AAC.00125-10; Huang LY, 2010, NANOMED-NANOTECHNOL, V6, P442, DOI 10.1016/j.nano.2009.10.005; Jett BD, 1997, BIOTECHNIQUES, V23, P648, DOI 10.2144/97234bm22; Jori G, 2006, LASER SURG MED, V38, P468, DOI 10.1002/lsm.20361; Khajo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025092; Konan YN, 2002, J PHOTOCH PHOTOBIO B, V66, P89, DOI 10.1016/S1011-1344(01)00267-6; Lam M, 2011, PHOTOCHEM PHOTOBIOL, V87, P904, DOI 10.1111/j.1751-1097.2011.00938.x; Li Q, 2008, FREE RADICAL BIO MED, V44, P394, DOI 10.1016/j.freeradbiomed.2007.09.019; McNeil MM, 2001, CLIN INFECT DIS, V33, P641, DOI 10.1086/322606; Mizuno Kazue, 2011, J Nanomed Nanotechnol, V2, P1; Moan J, 2003, ANTICANCER RES, V23, P3591; Monfrecola G, 2004, PHOTOCH PHOTOBIO SCI, V3, P419, DOI 10.1039/b315629j; Mylonakis E, 2004, MOL MICROBIOL, V54, P407, DOI 10.1111/j.1365-2958.2004.04310.x; Nelson RT, 2001, GENETICS, V157, P935; Ostrosky-Zeichner L, 2010, NAT REV DRUG DISCOV, V9, P719, DOI 10.1038/nrd3074; Ozaki K, 1996, EMBO J, V15, P2196, DOI 10.1002/j.1460-2075.1996.tb00573.x; PFALLER MA, 1988, J CLIN MICROBIOL, V26, P1437, DOI 10.1128/JCM.26.8.1437-1441.1988; Philip B, 2001, MOL CELL BIOL, V21, P271, DOI 10.1128/MCB.21.1.271-280.2001; Prates RA, 2011, J ANTIMICROB CHEMOTH, V66, P1525, DOI 10.1093/jac/dkr160; Prates RA, 2009, LASER PHYS, V19, P1038, DOI 10.1134/S1054660X09050284; Prates RA, 2007, J PHOTOCH PHOTOBIO B, V86, P70, DOI 10.1016/j.jphotobiol.2006.07.010; Rodrigues GB, 2012, PHOTOCHEM PHOTOBIOL, V88, P440, DOI 10.1111/j.1751-1097.2011.01055.x; Rosas AL, 1997, FEMS MICROBIOL LETT, V153, P265, DOI 10.1016/S0378-1097(97)00239-5; Salas SD, 1996, J EXP MED, V184, P377, DOI 10.1084/jem.184.2.377; Sanglard D, 2002, LANCET INFECT DIS, V2, P73, DOI 10.1016/S1473-3099(02)00181-0; Schafer M, 2000, PHOTOCHEM PHOTOBIOL, V71, P514, DOI 10.1562/0031-8655(2000)071<0514:SSOPIT>2.0.CO;2; Seaton RA, 1997, J MED VET MYCOL, V35, P7; Soares BM, 2011, PHOTOCHEM PHOTOBIOL, V87, P357, DOI 10.1111/j.1751-1097.2010.00868.x; Sorrell TC, 2001, MED MYCOL, V39, P155, DOI 10.1080/mmy.39.2.155.168; Steinbach WJ, 2005, CURR OPIN INFECT DIS, V18, P484, DOI 10.1097/01.qco.0000185986.64759.9a; Tegos GP, 2005, CHEM BIOL, V12, P1127, DOI 10.1016/j.chembiol.2005.08.014; van Duin D, 2002, ANTIMICROB AGENTS CH, V46, P3394, DOI 10.1128/AAC.46.11.3394-3400.2002; Vecchiarelli A, 2000, MED MYCOL, V38, P407, DOI 10.1080/mmy.38.6.407.417; Wainwright M, 1998, J ANTIMICROB CHEMOTH, V42, P13, DOI 10.1093/jac/42.1.13; Wainwright M, 2006, J PHOTOCH PHOTOBIO B, V84, P227, DOI 10.1016/j.jphotobiol.2006.03.002; WANG YL, 1994, INFECT IMMUN, V62, P3004, DOI 10.1128/IAI.62.7.3004-3007.1994; Williamson PR, 1998, J BACTERIOL, V180, P1570, DOI 10.1128/JB.180.6.1570-1572.1998; Wilson M, 2004, PHOTOCH PHOTOBIO SCI, V3, P412, DOI 10.1039/b211266c; WILSON M, 1995, J MED MICROBIOL, V42, P62, DOI 10.1099/00222615-42-1-62; Zaragoza O, 2006, FEMS YEAST RES, V6, P662, DOI 10.1111/j.1567-1364.2006.00070.x; Zhu XD, 2001, INFECT IMMUN, V69, P5589, DOI 10.1128/IAI.69.9.5589-5596.2001	68	22	22	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54387	10.1371/journal.pone.0054387	http://dx.doi.org/10.1371/journal.pone.0054387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349872	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872800047
J	Bonthoux, S; Baselga, A; Balent, G				Bonthoux, Sebastien; Baselga, Andres; Balent, Gerard			Assessing Community-Level and Single-Species Models Predictions of Species Distributions and Assemblage Composition after 25 Years of Land Cover Change	PLOS ONE			English	Article							BIRD DISTRIBUTIONS; BIOCLIMATIC MODELS; HABITAT USE; CLIMATE; BIODIVERSITY; LANDSCAPE; PATTERNS; DIVERSITY; CHALLENGES; ACCURACY	To predict the impact of environmental change on species distributions, it has been hypothesized that community-level models could give some benefits compared to species-level models. In this study we have assessed the performance of these two approaches. We surveyed 256 bird communities in an agricultural landscape in southwest France at the same locations in 1982 and 2007. We compared the ability of CQO (canonical quadratic ordination; a method of community-level GLM) and GLMs (generalized linear models) to i) explain species distributions in 1982 and ii) predict species distributions, community composition and species richness in 2007, after land cover change. Our results show that models accounting for shared patterns between species (CQO) slightly better explain the distribution of rare species than models that ignore them (GLMs). Conversely, the predictive performances were better for GLMs than for CQO. At the assemblage level, both CQO and GLMs overestimated species richness, compared with that actually observed in 2007, and projected community composition was only moderately similar to that observed in 2007. Species richness projections tended to be more accurate in sites where land cover change was more marked. In contrast, the composition projections tended to be less accurate in those sites. Both modelling approaches showed a similar but limited ability to predict species distribution and assemblage composition under conditions of land cover change. Our study supports the idea that our community-level model can improve understanding of rare species patterns but that species-level models can provide slightly more accurate predictions of species distributions. At the community level, the similar performance of both approaches for predicting patterns of assemblage variation suggests that species tend to respond individualistically or, alternatively, that our community model was unable to effectively account for the emergent community patterns.	[Bonthoux, Sebastien; Balent, Gerard] INRA, UMR1201, DYNAFOR, F-31326 Castanet Tolosan, France; [Bonthoux, Sebastien] ENSNP, UMR CITERES 7324, Blois, France; [Baselga, Andres] Univ Santiago de Compostela, Dept Zool, Fac Biol, Santiago De Compostela, Spain	INRAE; Universidade de Santiago de Compostela	Bonthoux, S (corresponding author), INRA, UMR1201, DYNAFOR, F-31326 Castanet Tolosan, France.	bonthoux.sebastien@gmail.com	Baselga, Andres/A-6740-2008	Baselga, Andres/0000-0001-7914-7109	INRA-SAD Research Department; INRA-Midi-Pyrenees Region PSDR project CHAPAY; National Research Agency grant BIODIVAGRIM [ANR-07-BDIV-002]; Spanish Ministry of Science and Innovation [CGL2009-10111]	INRA-SAD Research Department; INRA-Midi-Pyrenees Region PSDR project CHAPAY(Region Occitanie); National Research Agency grant BIODIVAGRIM; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was supported by INRA-SAD Research Department, and INRA-Midi-Pyrenees Region PSDR project CHAPAY. Sebastien Bonthoux was funded through the National Research Agency grant BIODIVAGRIM (ANR-07-BDIV-002)_Conserving biodiversity in agro-ecosystems: a spatially explicit landscape modeling approach. Andres Baselga is funded by the Spanish Ministry of Science and Innovation (grant CGL2009-10111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; BALENT G, 1992, LANDSCAPE ECOL, V6, P195; Baselga A, 2007, ECOGRAPHY, V30, P838, DOI 10.1111/j.2007.0906-7590.05191.x; Baselga A, 2012, J BIOGEOGR, V39, P760, DOI 10.1111/j.1365-2699.2011.02612.x; Baselga A, 2010, J BIOGEOGR, V37, P1842, DOI 10.1111/j.1365-2699.2010.02341.x; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Baselga A, 2009, ECOGRAPHY, V32, P55, DOI 10.1111/j.1600-0587.2009.05856.x; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Berg A, 2002, BIRD STUDY, V49, P153, DOI 10.1080/00063650209461260; Bonthoux S, 2012, J ORNITHOL, V153, P491, DOI 10.1007/s10336-011-0766-2; Campbell SP, 2010, ECOL MONOGR, V80, P287, DOI 10.1890/08-2366.1; Chapman DS, 2011, J BIOGEOGR, V38, P1524, DOI 10.1111/j.1365-2699.2011.02517.x; Choisis JP, 2010, CAH AGRIC, V19, P97, DOI 10.1684/agr.2010.0375; Cody M.L, 1974, COMPETITION STRUCTUR; Concepcion ED, 2011, AGR ECOSYST ENVIRON, V142, P303, DOI 10.1016/j.agee.2011.05.028; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Dubuis A, 2011, DIVERS DISTRIB, V17, P1122, DOI 10.1111/j.1472-4642.2011.00792.x; Elith J, 2007, DIVERS DISTRIB, V13, P265, DOI 10.1111/j.1472-4642.2007.00340.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Ferrier S, 2006, J APPL ECOL, V43, P393, DOI 10.1111/j.1365-2664.2006.01149.x; Ficetola GF, 2010, GLOBAL CHANGE BIOL, V16, P528, DOI 10.1111/j.1365-2486.2009.01957.x; Gotelli NJ, 2010, P NATL ACAD SCI USA, V107, P5030, DOI 10.1073/pnas.0914089107; Guisan A, 1999, PLANT ECOL, V143, P107, DOI 10.1023/A:1009841519580; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2011, J BIOGEOGR, V38, P1433, DOI 10.1111/j.1365-2699.2011.02550.x; Heikkinen RK, 2007, GLOBAL ECOL BIOGEOGR, V16, P754, DOI 10.1111/j.1466-8238.2007.00345.x; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Kissling W.D., 2012, Journal of Biogeography, V39, P2163; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; Leathwick JR, 2006, ECOL MODEL, V199, P188, DOI 10.1016/j.ecolmodel.2006.05.022; Lennon JJ, 2001, J ANIM ECOL, V70, P966, DOI 10.1046/j.0021-8790.2001.00563.x; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Luoto M, 2007, GLOBAL ECOL BIOGEOGR, V16, P34, DOI 10.1111/j.1466-8238.2006.00262.x; Merckx T, 2010, AGR ECOSYST ENVIRON, V138, P147, DOI 10.1016/j.agee.2010.04.010; Morales MB, 2012, ECOL RES, V27, P691, DOI 10.1007/s11284-012-0946-4; Newbold T, 2010, OIKOS, V119, P1326, DOI 10.1111/j.1600-0706.2009.18295.x; ORIANS GH, 1964, ECOLOGY, V45, P736, DOI 10.2307/1934921; Ovaskainen O, 2010, ECOLOGY, V91, P2514, DOI 10.1890/10-0173.1; Rodriguez JP, 2007, DIVERS DISTRIB, V13, P243, DOI 10.1111/j.1472-4642.2007.00356.x; Pelosi C, 2010, AGR ECOSYST ENVIRON, V139, P455, DOI 10.1016/j.agee.2010.09.004; Perkins AJ, 2000, BIOL CONSERV, V95, P279, DOI 10.1016/S0006-3207(00)00042-2; ROBINSON SK, 1995, J ANIM ECOL, V64, P1, DOI 10.2307/5822; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Siriwardena GM, 2000, ECOGRAPHY, V23, P702, DOI 10.1034/j.1600-0587.2000.230608.x; Soderstrom B, 2000, CONSERV BIOL, V14, P522, DOI 10.1046/j.1523-1739.2000.98564.x; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Tingley R, 2009, J BIOGEOGR, V36, P1656, DOI 10.1111/j.1365-2699.2009.02117.x; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Vallecillo S, 2009, ECOL APPL, V19, P538, DOI 10.1890/08-0348.1; Vaughan IP, 2005, J APPL ECOL, V42, P720, DOI 10.1111/j.1365-2664.2005.01052.x; Yee TW, 2004, ECOL MONOGR, V74, P685, DOI 10.1890/03-0078	58	13	13	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54179	10.1371/journal.pone.0054179	http://dx.doi.org/10.1371/journal.pone.0054179			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349818	Green Published, gold, Green Submitted			2022-12-25	WOS:000313738900050
J	Delaspre, F; Massumi, M; Salido, M; Soria, B; Ravassard, P; Savatier, P; Skoudy, A				Delaspre, Fabien; Massumi, Mohammad; Salido, Marta; Soria, Bernat; Ravassard, Philippe; Savatier, Pierre; Skoudy, Anouchka			Directed Pancreatic Acinar Differentiation of Mouse Embryonic Stem Cells via Embryonic Signalling Molecules and Exocrine Transcription Factors	PLOS ONE			English	Article							LOOP-HELIX COMPLEX; GENE-EXPRESSION; IN-VITRO; DEFINITIVE ENDODERM; ENDOCRINE PANCREAS; VISCERAL ENDODERM; DNA-BINDING; ES CELLS; PROGENITORS; INDUCTION	Pluripotent embryonic stem cells (ESC) are a promising cellular system for generating an unlimited source of tissue for the treatment of chronic diseases and valuable in vitro differentiation models for drug testing. Our aim was to direct differentiation of mouse ESC into pancreatic acinar cells, which play key roles in pancreatitis and pancreatic cancer. To that end, ESC were first differentiated as embryoid bodies and sequentially incubated with activin A, inhibitors of Sonic hedgehog (Shh) and bone morphogenetic protein (BMP) pathways, fibroblast growth factors (FGF) and retinoic acid (RA) in order to achieve a stepwise increase in the expression of mRNA transcripts encoding for endodermal and pancreatic progenitor markers. Subsequent plating in Matrigel (R) and concomitant modulation of FGF, glucocorticoid, and folllistatin signalling pathways involved in exocrine differentiation resulted in a significant increase of mRNAs encoding secretory enzymes and in the number of cells co-expressing their protein products. Also, pancreatic endocrine marker expression was down-regulated and accompanied by a significant reduction in the number of hormone-expressing cells with a limited presence of hepatic marker expressing-cells. These findings suggest a selective activation of the acinar differentiation program. The newly differentiated cells were able to release alpha-amylase and this feature was greatly improved by lentiviral-mediated expression of Rbpjl and Ptf1a, two transcription factors involved in the maximal production of digestive enzymes. This study provides a novel method to produce functional pancreatic exocrine cells from ESC.	[Delaspre, Fabien; Massumi, Mohammad; Salido, Marta; Skoudy, Anouchka] Inst Hosp Mar Invest Med IMIM, Canc Res Program, Barcelona, Spain; [Soria, Bernat] CABIMER, Seville, Spain; [Soria, Bernat] Inst Salud Carlos III, CIBERDEM, Madrid, Spain; [Ravassard, Philippe] ICM, Paris, France; [Savatier, Pierre] Stem Cells & Brain Res Inst, Bron, France; [Savatier, Pierre] Univ Lyon, Lyon, France	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III	Skoudy, A (corresponding author), Inst Hosp Mar Invest Med IMIM, Canc Res Program, Biomed Res Pk, Barcelona, Spain.	askoudy@imim.es	SAVATIER, Pierre/J-4663-2014; DELASPRE, FABIEN/M-3654-2015; , Bernat/AAL-6470-2021	DELASPRE, FABIEN/0000-0001-7815-5537; Massumi, Mohammad/0000-0001-8291-9798; ravassard, philippe/0000-0002-0393-9262; Soria, Bernat/0000-0002-2356-0380	Instituto de Salud Carlos III (ISCIII)-FEDER [PI052738, PI080511, PI100094]; Tercel [RD06/0010/0025]; ISCIII; Health Department of the Generalitat de Catalunya; Generalitat de Catalunya	Instituto de Salud Carlos III (ISCIII)-FEDER(Instituto de Salud Carlos IIIEuropean Commission); Tercel; ISCIII(Instituto de Salud Carlos III); Health Department of the Generalitat de Catalunya(Generalitat de Catalunya); Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by grants from the Instituto de Salud Carlos III (ISCIII)-FEDER (PI052738 and PI080511 to A.S.; PI100094 and Tercel RD06/0010/0025 to B.S.). A.S. was supported by ISCIII and the Health Department of the Generalitat de Catalunya; F.D. was the recipient of a Graduate Fellowship from ISCIII and was also supported by Tercel; M.M. was the recipient of a Graduate Fellowship from the Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beres TM, 2006, MOL CELL BIOL, V26, P117, DOI 10.1128/MCB.26.1.117-130.2006; Bernardo AS, 2009, STEM CELLS, V27, P341, DOI 10.1634/stemcells.2008-0310; Bhushan A, 2001, DEVELOPMENT, V128, P5109; CHRISTOPHE J, 1994, AM J PHYSIOL, V266, pG963, DOI 10.1152/ajpgi.1994.266.6.G963; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Decker K, 2006, DEV BIOL, V298, P415, DOI 10.1016/j.ydbio.2006.06.046; Fukuda A, 2008, DIABETES, V57, P2421, DOI 10.2337/db07-1558; Gesina E, 2004, DIABETES, V53, P2322, DOI 10.2337/diabetes.53.9.2322; Gittes GK, 2009, DEV BIOL, V326, P4, DOI 10.1016/j.ydbio.2008.10.024; Hale MA, 2005, DEV BIOL, V286, P225, DOI 10.1016/j.ydbio.2005.07.026; Hao JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002904; Hebrok M, 1998, GENE DEV, V12, P1705, DOI 10.1101/gad.12.11.1705; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Krapp A, 1996, EMBO J, V15, P4317, DOI 10.1002/j.1460-2075.1996.tb00806.x; Krapp A, 1998, GENE DEV, V12, P3752, DOI 10.1101/gad.12.23.3752; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Ledda-Columbano GM, 2005, J ENDOCRINOL, V185, P393, DOI 10.1677/joe.1.06110; LEE JT, 1991, PANCREAS, V6, P96, DOI 10.1097/00006676-199101000-00013; Liu Y, 2001, J BIOL CHEM, V276, P17985, DOI 10.1074/jbc.M100678200; LOGSDON CD, 1985, J CELL BIOL, V100, P1200, DOI 10.1083/jcb.100.4.1200; Martin M, 2005, DEV BIOL, V284, P399, DOI 10.1016/j.ydbio.2005.05.035; Masui T, 2007, GENE DEV, V21, P2629, DOI 10.1101/gad.1575207; Masui T, 2010, GASTROENTEROLOGY, V139, P270, DOI 10.1053/j.gastro.2010.04.003; Mfopou JK, 2010, GASTROENTEROLOGY, V138, P2233, DOI 10.1053/j.gastro.2010.02.056; Miralles F, 1998, DEVELOPMENT, V125, P1017; Miralles F, 1999, P NATL ACAD SCI USA, V96, P6267, DOI 10.1073/pnas.96.11.6267; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nakanishi M, 2007, DIFFERENTIATION, V75, P1, DOI 10.1111/j.1432-0436.2006.00109.x; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Pin CL, 2000, ANAT REC, V259, P157, DOI 10.1002/(SICI)1097-0185(20000601)259:2<157::AID-AR6>3.0.CO;2-0; Pin CL, 2001, J CELL BIOL, V155, P519, DOI 10.1083/jcb.200105060; Ravassard P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004731; Ren M, 2009, ACTA PHARMACOL SIN, V30, P1289, DOI 10.1038/aps.2009.115; Rooman I, 2012, GUT, V61, P449, DOI 10.1136/gut.2010.235804; Rose SD, 2001, J BIOL CHEM, V276, P44018, DOI 10.1074/jbc.M106264200; Rossi JM, 2001, GENE DEV, V15, P1998, DOI 10.1101/gad.904601; Rovira M, 2008, GASTROENTEROLOGY, V135, P1301, DOI 10.1053/j.gastro.2008.06.049; Rovira M, 2007, CLONING STEM CELLS, V9, P327, DOI 10.1089/clo.2006.0064; Schaffer AE, 2010, DEV CELL, V18, P1022, DOI 10.1016/j.devcel.2010.05.015; Serafimidis I, 2008, STEM CELLS, V26, P3, DOI 10.1634/stemcells.2007-0194; Sherwood RI, 2007, DEV BIOL, V304, P541, DOI 10.1016/j.ydbio.2007.01.011; Shirasawa S, 2011, BIOCHEM BIOPH RES CO, V410, P608, DOI 10.1016/j.bbrc.2011.06.036; Shirasawa S, 2011, STEM CELLS DEV, V20, P1071, DOI 10.1089/scd.2010.0185; Skoudy A, 2004, BIOCHEM J, V379, P749, DOI 10.1042/BJ20031784; Sphyris N, 2005, PANCREAS, V30, P148, DOI 10.1097/01.mpa.0000147086.15867.ab; Stafford D, 2002, CURR BIOL, V12, P1215, DOI 10.1016/S0960-9822(02)00929-6; Sulzbacher S, 2009, STEM CELL REV REP, V5, P159, DOI 10.1007/s12015-009-9061-5; Tosh D, 2002, BIOCHEM SOC T, V30, P51, DOI 10.1042/BST0300051; VILA MR, 1994, LAB INVEST, V71, P423; Vincent RK, 2009, DIFFERENTIATION, V78, P24, DOI 10.1016/j.diff.2009.03.006; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167	53	8	10	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54243	10.1371/journal.pone.0054243	http://dx.doi.org/10.1371/journal.pone.0054243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349836	Green Published, gold			2022-12-25	WOS:000313738900056
J	Kamran, N; Takai, Y; Miyoshi, J; Biswas, SK; Wong, JSB; Gasser, S				Kamran, Neha; Takai, Yoshimi; Miyoshi, Jun; Biswas, Subhra K.; Wong, Justin S. B.; Gasser, Stephan			Toll-Like Receptor Ligands Induce Expression of the Costimulatory Molecule CD155 on Antigen-Presenting Cells	PLOS ONE			English	Article							NF-KAPPA-B; NECTIN-2 CD112; TRANSCRIPTIONAL ACTIVATION; IMMUNE-RESPONSE; DENDRITIC CELLS; DISTINCT ROLES; CUTTING EDGE; PVR CD155; DNAM-1; GENE	Genotoxic stress and RAS induce the expression of CD155, a ligand for the immune receptors DNAM-1, CD96 and TIGIT. Here we show that antigen-presenting cells upregulate CD155 expression in response to Toll-like receptor activation. Induction of CD155 by Toll-like receptors depended on MYD88, TRIF and NF-kappa B. In addition, IRF3, but not IRF7, modulated CD155 upregulation in response to TLR3 signals. Immunization of CD155-deficient mice with OVA and the TLR9 agonist CpG resulted in increased OVA-specific IgG2a/c titers when compared to wild type mice. Splenocytes of immunized CD155-deficient mice secreted lower levels of IL-4 and fewer IL-4 and GATA-3 expressing CD4(+) T cells were present in the spleen of Cd155(-/-) mice. Our data suggest that CD155 regulates T(h)2 differentiation. Targeting of CD155 in immunization protocols using peptides may represent a promising new approach to boost protective humoral immunity in viral vaccines.	[Kamran, Neha; Wong, Justin S. B.; Gasser, Stephan] Natl Univ Singapore, Dept Microbiol, Immunol Programme, Singapore 117548, Singapore; [Kamran, Neha; Gasser, Stephan] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Takai, Yoshimi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Biol, Kobe, Hyogo 657, Japan; [Miyoshi, Jun] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Mol Biol, Osaka, Japan; [Biswas, Subhra K.] Singapore Immunol Network, Singapore, Singapore	National University of Singapore; National University of Singapore; Kobe University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Gasser, S (corresponding author), Natl Univ Singapore, Dept Microbiol, Immunol Programme, Singapore 117548, Singapore.	micsg@nus.edu.sg		Gasser, Stephan/0000-0002-5616-0914	NRF grant HUJ-CREATE - Cellular and Molecular Mechanisms of Inflammation; NMRC grant [NMRC/1158/2008]	NRF grant HUJ-CREATE - Cellular and Molecular Mechanisms of Inflammation; NMRC grant(National Medical Research Council, Singapore)	This work was supported by the NRF grant HUJ-CREATE - Cellular and Molecular Mechanisms of Inflammation (http://www.nrf.gov.sg/nrf/default.aspx) and the NMRC grant NMRC/1158/2008 (http://www.nmrc.gov.sg/content/nmrc_internet/home.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2009, J PATHOL, V217, P42, DOI 10.1002/path.2431; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Andersen J, 2008, GENES IMMUN, V9, P168, DOI 10.1038/sj.gene.6364449; Barr TA, 2009, J IMMUNOL, V183, P1005, DOI 10.4049/jimmunol.0803706; Barton GM, 2002, CURR OPIN IMMUNOL, V14, P380, DOI 10.1016/S0952-7915(02)00343-6; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; CHADENEAU C, 1994, J BIOL CHEM, V269, P15601; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Dardalhon V, 2005, J IMMUNOL, V175, P1558, DOI 10.4049/jimmunol.175.3.1558; De Becker G, 1998, EUR J IMMUNOL, V28, P3161, DOI 10.1002/(SICI)1521-4141(199810)28:10<3161::AID-IMMU3161>3.3.CO;2-H; Fuchs A, 2004, J IMMUNOL, V172, P3994, DOI 10.4049/jimmunol.172.7.3994; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gilfillan S, 2008, J EXP MED, V205, P2965, DOI 10.1084/jem.20081752; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hirota T, 2005, ONCOGENE, V24, P2229, DOI 10.1038/sj.onc.1208409; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; JOUVINMARCHE E, 1989, IMMUNOGENETICS, V29, P92, DOI 10.1007/BF00395856; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Klinman DM, 2006, INT REV IMMUNOL, V25, P135, DOI 10.1080/08830180600743057; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Krieg AM, 2000, CURR OPIN IMMUNOL, V12, P35, DOI 10.1016/S0952-7915(99)00048-5; Levin SD, 2011, EUR J IMMUNOL, V41, P902, DOI 10.1002/eji.201041136; Liew FY, 2002, NAT REV IMMUNOL, V2, P55, DOI 10.1038/nri705; Lin L, 2004, EUR J IMMUNOL, V34, P1483, DOI 10.1002/eji.200324736; Martin RM, 1998, J IMMUNOL METHODS, V212, P187, DOI 10.1016/S0022-1759(98)00015-5; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; Mizel SB, 2003, J IMMUNOL, V170, P6217, DOI 10.4049/jimmunol.170.12.6217; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Pende D, 2005, MOL IMMUNOL, V42, P463, DOI 10.1016/j.molimm.2004.07.028; Pende D, 2006, BLOOD, V107, P2030, DOI 10.1182/blood-2005-07-2696; Redecke V, 2004, J IMMUNOL, V172, P2739, DOI 10.4049/jimmunol.172.5.2739; Sasaki T, 2007, GENE DEV, V21, P848, DOI 10.1101/gad.1534107; Schmitz F, 2004, EUR J IMMUNOL, V34, P2863, DOI 10.1002/eji.200425228; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Seth S, 2007, BIOCH BIOPHYS RES CO; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Shibuya K, 2003, J EXP MED, V198, P1829, DOI 10.1084/jem.20030958; Soriani A, 2009, BLOOD, V113, P3503, DOI 10.1182/blood-2008-08-173914; Takai Y, 2003, CANCER SCI, V94, P655, DOI 10.1111/j.1349-7006.2003.tb01499.x; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; THOMPSON CB, 1995, CELL, V81, P979, DOI 10.1016/S0092-8674(05)80001-7; WANG PL, 1992, J IMMUNOL, V148, P2600; Xu H, 1997, J IMMUNOL, V159, P4217; Xu ZW, 2010, CELL MOL IMMUNOL, V7, P11, DOI 10.1038/cmi.2009.108; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yu X, 2009, NAT IMMUNOL, V10, P48, DOI 10.1038/ni.1674; Zamboni DS, 2003, INFECT IMMUN, V71, P1225, DOI 10.1128/IAI.71.3.1225-1233.2003	61	52	56	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54406	10.1371/journal.pone.0054406	http://dx.doi.org/10.1371/journal.pone.0054406			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349877	gold, Green Published, Green Submitted			2022-12-25	WOS:000313738900065
J	Thakur, K; Chawla, V; Bhatti, S; Swarnkar, MK; Kaur, J; Shankar, R; Jha, G				Thakur, Karnika; Chawla, Vandna; Bhatti, Shammi; Swarnkar, Mohit Kumar; Kaur, Jagdeep; Shankar, Ravi; Jha, Gopaljee			De Novo Transcriptome Sequencing and Analysis for Venturia inaequalis, the Devastating Apple Scab Pathogen	PLOS ONE			English	Article							MAGNAPORTHE-GRISEA; GENOME SEQUENCE; GENE; RESISTANCE; PROTEIN; DATABASE; IDENTIFICATION; EFFECTORS; BIOLOGY; ENZYME	Venturia inaequalis is the causal agent of apple scab, one of the most devastating diseases of apple. Due to several distinct features, it has emerged as a model fungal pathogen to study various aspects of hemibiotrophic plant pathogen interactions. The present study reports de novo assembling, annotation and characterization of the transcriptome of V. inaequalis. Venturia transcripts expressed during its growth on laboratory medium and that expressed during its biotrophic stage of infection on apple were sequenced using Illumina RNAseq technology. A total of 94,350,055 reads (50 bp read length) specific to Venturia were obtained after filtering. The reads were assembled into 62,061 contigs representing 24,571 unique genes. GO analysis suggested prevalence of genes associated with biological process categories like metabolism, transport and response to stimulus. Genes associated with molecular function like binding, catalytic activities and transferase activities were found in majority. EC and KEGG pathway analyses suggested prevalence of genes encoding kinases, proteases, glycoside hydrolases, cutinases, cytochrome P450 and transcription factors. The study has identified several putative pathogenicity determinants and candidate effectors in V. inaequalis. A large number of transcripts encoding membrane transporters were identified and comparative analysis revealed that the number of transporters encoded by Venturia is significantly more as compared to that encoded by several other important plant fungal pathogens. Phylogenomics analysis indicated that V. inaequalis is closely related to Pyrenophora tritici-repentis (the causal organism of tan spot of wheat). In conclusion, the findings from this study provide a better understanding of the biology of the apple scab pathogen and have identified candidate genes/functions required for its pathogenesis. This work lays the foundation for facilitating further research towards understanding this host-pathogen interaction.	[Thakur, Karnika; Bhatti, Shammi; Swarnkar, Mohit Kumar; Shankar, Ravi; Jha, Gopaljee] CSIR, Inst Himalayan Bioresource Technol, Div Biotechnol, Palampur, Himachal Prades, India; [Thakur, Karnika; Kaur, Jagdeep] Panjab Univ, Dept Biotechnol, Chandigarh 160014, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT); Panjab University	Shankar, R (corresponding author), CSIR, Inst Himalayan Bioresource Technol, Div Biotechnol, Palampur, Himachal Prades, India.	ravish@ihbt.res.in; jmsgopal@ihbt.res.in	Jha, Gopaljee/Y-8411-2018; thakur, karnika/ABD-6440-2021	Jha, Gopaljee/0000-0002-3965-3135; thakur, karnika/0000-0003-3859-4783; Kaur, Jagdeep/0000-0002-2252-2489; SWARNKAR, MOHIT KUMAR/0000-0002-7033-2364	Department of Biotechnology (Government of India); Council of Scientific and Industrial Research, (CSIR) Government of India [MLP0031, MLP0062];  [MLP0037]	Department of Biotechnology (Government of India)(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, (CSIR) Government of India(Council of Scientific & Industrial Research (CSIR) - India); 	The authors acknowledge the financial support provided by Department of Biotechnology (Government of India) under sub-program I (Enhancing productivity of apple through understanding the molecular basis of host-pathogen interactions) of network project entitled "Improvement of Apple through Biotechnological Interventions'' and in-house projects (MLP0031 and MLP0062) of Council of Scientific and Industrial Research, (CSIR) Government of India, that support the GJ lab research initiatives to unravel the molecular basis of fungal pathogenesis on apple. The computational part of this study was supported by MLP0037. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Benaouf G, 2000, PHYTOPATHOLOGY, V90, P236, DOI 10.1094/PHYTO.2000.90.3.236; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Bouwmeester K, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00075; Bowen JK, 2011, MOL PLANT PATHOL, V12, P105, DOI 10.1111/j.1364-3703.2010.00656.x; Bowen JK, 2009, MOL PLANT PATHOL, V10, P431, DOI [10.1111/j.1364-3703.2009.00543.x, 10.1111/J.1364-3703.2009.00543.X]; Broggini GAL, 2007, FUNGAL GENET BIOL, V44, P44, DOI 10.1016/j.fgb.2006.07.001; Brown NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033731; Bus VGM, 2011, ANNU REV PHYTOPATHOL, V49, P391, DOI 10.1146/annurev-phyto-072910-095339; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Celton JM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-155; Cresnar B, 2011, BBA-PROTEINS PROTEOM, V1814, P29, DOI 10.1016/j.bbapap.2010.06.020; DAY PR, 1956, AM J BOT, V43, P835, DOI 10.2307/2438999; de Jonge R, 2011, CURR OPIN PLANT BIOL, V14, P400, DOI 10.1016/j.pbi.2011.03.005; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; De Leeuw Jan, 1973, P 2 INT S INF THEOR, P267; Doehlemann G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000290; Elliot MA, 2004, CURR OPIN MICROBIOL, V7, P594, DOI 10.1016/j.mib.2004.10.013; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Gahlan P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-126; Gao QA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001264; Gehring AM, 1997, BIOCHEMISTRY-US, V36, P8495, DOI 10.1021/bi970453p; Gessler C, 2006, CRIT REV PLANT SCI, V25, P473, DOI 10.1080/07352680601015975; Ghawana Sanjay, 2011, BMC Res Notes, V4, P85, DOI 10.1186/1756-0500-4-85; Gladieux P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001455; Guerin F, 2004, PHYTOPATHOLOGY, V94, P364, DOI 10.1094/PHYTO.2004.94.4.364; GUPTA G K, 1985, Pesticides (Bombay), V19, P19; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jha G, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/680160; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Joshi SG, 2011, PLANT MOL BIOL, V75, P579, DOI 10.1007/s11103-011-9749-1; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim S, 2005, MOL MICROBIOL, V57, P1224, DOI 10.1111/j.1365-2958.2005.04750.x; Kim Y, 2007, TRENDS BIOTECHNOL, V25, P395, DOI 10.1016/j.tibtech.2007.07.008; King BC, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-4; Koller W, 2004, PLANT DIS, V88, P537, DOI 10.1094/PDIS.2004.88.5.537; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leuthner B, 2005, MOL GENET GENOMICS, V272, P639, DOI 10.1007/s00438-004-1085-6; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; MacHardy W.E, 1996, APPLE SCAB BIOL EPID; Malnoy M, 2007, MOL PLANT MICROBE IN, V20, P1568, DOI 10.1094/MPMI-20-12-1568; Mane SP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-264; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Marine SC, 2007, PLANT HLTH PROGR, DOI [10.1094/PHP-2007-1113-01-RS, DOI 10.1094/PHP-2007-1113-01-RS]; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Mueller O, 2008, FUNGAL GENET BIOL, V45, pS63, DOI 10.1016/j.fgb.2008.03.012; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oliva R, 2010, CELL MICROBIOL, V12, P705, DOI 10.1111/j.1462-5822.2010.01471.x; Palani PV, 1999, MYCOL RES, V103, P1157, DOI 10.1017/S0953756299008321; PARISI L, 1993, PHYTOPATHOLOGY, V83, P533, DOI 10.1094/Phyto-83-533; Park J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-402; Parsons JF, 2003, BIOCHEMISTRY-US, V42, P5684, DOI 10.1021/bi027385d; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Raffaele S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-637; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; Rees DJG, 2009, PLANT AN GEN 17 C; Reimann S, 2005, APPL ENVIRON MICROB, V71, P3269, DOI 10.1128/AEM.71.6.3269-3275.2005; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robbertse B, 2011, PLOS CURR-TREE LIFE, DOI 10.1371/currents.RRN1213; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Schomburg D, 2010, METHODS MOL BIOL, V609, P113, DOI 10.1007/978-1-60327-241-4_7; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Soanes DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002300; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stassen JHM, 2011, CURR OPIN PLANT BIOL, V14, P407, DOI 10.1016/j.pbi.2011.05.002; Talbot NJ, 1996, PLANT CELL, V8, P985, DOI 10.1105/tpc.8.6.985; van den Burg HA, 2006, MOL PLANT MICROBE IN, V19, P1420, DOI 10.1094/MPMI-19-1420; Van Dongen S, 2000, THESIS U UTRECHT NET; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Win J, 2003, PHYSIOL MOL PLANT P, V62, P193, DOI 10.1016/S0885-5765(03)00061-4; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Win J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002400; Winnenburg R, 2006, NUCLEIC ACIDS RES, V34, pD459, DOI 10.1093/nar/gkj047; Wu SC, 2006, APPL ENVIRON MICROB, V72, P986, DOI 10.1128/AEM.72.2.986-993.2006; Xu Xiangming, 2009, BMC Res Notes, V2, P163, DOI 10.1186/1756-0500-2-163; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zheng P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r116	92	25	26	1	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53937	10.1371/journal.pone.0053937	http://dx.doi.org/10.1371/journal.pone.0053937			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349770	Green Submitted, Green Published, gold			2022-12-25	WOS:000313738900028
J	Zhang, XB; Shen, YF; Ding, GT; Tian, Y; Liu, ZP; Li, B; Wang, Y; Jiang, CZ				Zhang, Xiaobai; Shen, Yuefeng; Ding, Guitao; Tian, Yi; Liu, Zhenping; Li, Bing; Wang, Yun; Jiang, Cizhong			TFPP: An SVM-Based Tool for Recognizing Flagellar Proteins in Trypanosoma brucei	PLOS ONE			English	Article							PREDICTING SUBCELLULAR-LOCALIZATION; WEB SERVER; CELL-DIVISION; SEQUENCE; CYTOKINESIS; MOTILITY; DATABASE	Trypanosoma brucei is a unicellular flagellated eukaryotic parasite that causes African trypanosomiasis in human and domestic animals with devastating health and economic consequences. Recent studies have revealed the important roles of the single flagellum of T. brucei in many aspects, especially that the flagellar motility is required for the viability of the bloodstream form T. brucei, suggesting that impairment of the flagellar function may provide a promising cure for African sleeping sickness. Knowing the flagellum proteome is crucial to study the molecular mechanism of the flagellar functions. Here we present a novel computational method for identifying flagellar proteins in T. brucei, called trypanosome flagellar protein predictor (TFPP). TFPP was developed based on a list of selected discriminating features derived from protein sequences, and could predict flagellar proteins with similar to 92% specificity at a similar to 84% sensitivity rate. Applied to the whole T. brucei proteome, TFPP reveals 811 more flagellar proteins with high confidence, suggesting that the flagellar proteome covers similar to 10% of the whole proteome. Comparison of the expression profiles of the whole T. brucei proteome at three typical life cycle stages found that similar to 45% of the flagellar proteins were significantly changed in expression levels between the three life cycle stages, indicating life cycle stage-specific regulation of flagellar functions in T. brucei. Overall, our study demonstrated that TFPP is highly effective in identifying flagellar proteins and could provide opportunities to study the trypanosome flagellar proteome systematically. Furthermore, the web server for TFPP can be freely accessed at http:/wukong.tongji.edu.cn/tfpp.	[Zhang, Xiaobai; Shen, Yuefeng; Ding, Guitao; Tian, Yi; Liu, Zhenping; Li, Bing; Wang, Yun; Jiang, Cizhong] Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Shanghai 200092, Peoples R China	Tongji University	Zhang, XB (corresponding author), Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Shanghai 200092, Peoples R China.	zhangxb@tongji.edu.cn; czjiang@tongji.edu.cn			National Natural Science Foundation of China [31200952]; New Century Talent Project of Ministry of Education of China [NCET-10-0600]; Aurora Talent Project of Shanghai [10SG24]; Pujiang Talent Project of Shanghai [10PJ1409500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Talent Project of Ministry of Education of China; Aurora Talent Project of Shanghai; Pujiang Talent Project of Shanghai	This work was supported by the National Natural Science Foundation of China [31200952 to X.Z.]; New Century Talent Project of Ministry of Education of China to [NCET-10-0600 to C.J.]; Aurora Talent Project of Shanghai [10SG24 to C.J.]; and Pujiang Talent Project of Shanghai [10PJ1409500 to C.J.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Baron DM, 2007, J CELL SCI, V120, P478, DOI 10.1242/jcs.03352; Benz C, 2007, MOL BIOCHEM PARASIT, V156, P217, DOI 10.1016/j.molbiopara.2007.08.005; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bloodgood RA, 2000, CELL BIOL INT, V24, P857, DOI 10.1006/cbir.2000.0598; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Chauhan JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040155; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Frearson JA, 2010, NATURE, V464, P728, DOI 10.1038/nature08893; Garrow AG, 2005, NUCLEIC ACIDS RES, V33, pW188, DOI 10.1093/nar/gki384; Guda C, 2004, NUCLEIC ACIDS RES, V32, pW372, DOI 10.1093/nar/gkh374; Hart SR, 2009, J AM SOC MASS SPECTR, V20, P167, DOI 10.1016/j.jasms.2008.08.014; Hill KL, 2010, CURR OPIN MICROBIOL, V13, P459, DOI 10.1016/j.mib.2010.05.015; Hong CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016875; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hua SJ, 2001, BIOINFORMATICS, V17, P721, DOI 10.1093/bioinformatics/17.8.721; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Kiemer L, 2005, BIOINFORMATICS, V21, P1269, DOI 10.1093/bioinformatics/bti130; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Li ZY, 2008, EUKARYOT CELL, V7, P1941, DOI 10.1128/EC.00249-08; Logan-Klumpler FJ, 2012, NUCLEIC ACIDS RES, V40, pD98, DOI 10.1093/nar/gkr1032; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Nilsson D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001037; Oberholzer M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010538; Park KJ, 2003, BIOINFORMATICS, V19, P1656, DOI 10.1093/bioinformatics/btg222; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Ralston KS, 2006, PLOS PATHOG, V2, P873, DOI 10.1371/journal.ppat.0020101; Ralston KS, 2009, ANNU REV MICROBIOL, V63, P335, DOI 10.1146/annurev.micro.091208.073353; Ralston KS, 2006, EUKARYOT CELL, V5, P696, DOI 10.1128/EC.5.4.696-711.2006; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Ruiz-Postigo JA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001541; Schneider A, 1997, J CELL SCI, V110, P431; Sharma R, 2008, PROTIST, V159, P137, DOI 10.1016/j.protis.2007.07.004; Shen HB, 2010, J THEOR BIOL, V264, P326, DOI 10.1016/j.jtbi.2010.01.018; Vaughan S, 2010, CURR OPIN MICROBIOL, V13, P453, DOI 10.1016/j.mib.2010.05.006; Xie D, 2005, NUCLEIC ACIDS RES, V33, pW105, DOI 10.1093/nar/gki359; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zhang XB, 2010, NUCLEIC ACIDS RES, V38, P7378, DOI 10.1093/nar/gkq618; Zhao N, 2011, PROTEOMICS, V11, P4321, DOI 10.1002/pmic.201100217	42	1	1	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54032	10.1371/journal.pone.0054032	http://dx.doi.org/10.1371/journal.pone.0054032			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349782	Green Published, gold, Green Submitted			2022-12-25	WOS:000313738900033
J	Cope, J; Rank, KC; Gilbert, SP; Rayment, I; Hoenger, A				Cope, Julia; Rank, Katherine C.; Gilbert, Susan P.; Rayment, Ivan; Hoenger, Andreas			Kar3Vik1 Uses a Minus-End Directed Powerstroke for Movement along Microtubules	PLOS ONE			English	Article							SINGLE KINESIN MOLECULES; MOTOR-PROTEIN COMPLEX; CRYSTAL-STRUCTURE; DIMERIC KINESIN; SACCHAROMYCES-CEREVISIAE; 3-DIMENSIONAL STRUCTURE; DRIVES MOTILITY; NCD; DOMAIN; BINDING	We have used cryo-electron microscopy (cryo-EM) and helical averaging to examine the 3-D structure of the heterodimeric kinesin-14 Kar3Vik1 complexed to microtubules at a resolution of 2.5 nm. 3-D maps were obtained at key points in Kar3Vik1's nucleotide hydrolysis cycle to gain insight into the mechanism that this motor uses for retrograde motility. In all states where Kar3Vik1 maintained a strong interaction with the microtubule, we found, as observed by cryo-EM, that the motor bound with one head domain while the second head extended outwards. 3-D reconstructions of Kar3Vik1-microtubule complexes revealed that in the nucleotide-free state, the motor's coiled-coil stalk points toward the plus-end of the microtubule. In the ATP-state, the outer head is shown to undergo a large rotation that reorients the stalk similar to 75 degrees to point toward the microtubule minus-end. To determine which of the two heads binds to tubulin in each nucleotide state, we employed specific Nanogold (R)-labeling of Vik1. The resulting maps confirmed that in the nucleotide-free, ATP and ADP+Pi states, Kar3 maintains contact with the microtubule surface, while Vik1 extends away from the microtubule and tracks with the coiled-coil as it rotates towards the microtubule minus-end. While many previous investigations have focused on the mechanisms of homodimeric kinesins, this work presents the first comprehensive study of the powerstroke of a heterodimeric kinesin. The stalk rotation shown here for Kar3Vik1 is highly reminiscent of that reported for the homodimeric kinesin-14 Ncd, emphasizing the conservation of a mechanism for minus-end directed motility.	[Cope, Julia; Hoenger, Andreas] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder Lab Microscopy Cells 3D, Boulder, CO 80309 USA; [Rank, Katherine C.; Rayment, Ivan] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; [Gilbert, Susan P.] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; [Gilbert, Susan P.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	University of Colorado System; University of Colorado Boulder; University of Wisconsin System; University of Wisconsin Madison; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Hoenger, A (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder Lab Microscopy Cells 3D, Boulder, CO 80309 USA.	hoenger@colorado.edu	rayment, ivan/A-2720-2008	rayment, ivan/0000-0001-9279-7835; Hoenger, Andreas/0000-0001-9176-6658	NIH/NCRR [P41-RR000592]; NIH [GM086351, GM54141, T32-GM065103, T32-GM07215]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054141, T32GM065103, T32GM007215, R01GM054141, R01GM086351] Funding Source: NIH RePORTER	NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH/NCRR grant P41-RR000592 to A.H., NIH GM086351 to I.R., NIH GM54141 to S.P.G., NIH Molecular Biophysics Training Grant T32-GM065103 to J.C., and NIH training grant T32-GM07215 to K.C.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allingham JS, 2007, CELL, V128, P1161, DOI 10.1016/j.cell.2006.12.046; Asenjo AB, 2003, NAT STRUCT BIOL, V10, P836, DOI 10.1038/nsb984; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Bodey AJ, 2009, J MOL BIOL, V388, P218, DOI 10.1016/j.jmb.2009.03.008; Cope J, 2010, J STRUCT BIOL, V170, P257, DOI 10.1016/j.jsb.2009.12.004; deCastro MJ, 1999, BIOCHEMISTRY-US, V38, P5076, DOI 10.1021/bi9829175; Endow SA, 2000, NATURE, V406, P913, DOI 10.1038/35022617; Endres NF, 2006, NATURE, V439, P875, DOI 10.1038/nature04320; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Gulick AM, 1998, BIOCHEMISTRY-US, V37, P1769, DOI 10.1021/bi972504o; Heuston E, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-19; Hirose K, 2006, MOL CELL, V23, P913, DOI 10.1016/j.molcel.2006.07.020; Hizlan D, 2006, J STRUCT BIOL, V153, P73, DOI 10.1016/j.jsb.2005.10.007; Hoenger A, 2000, J MOL BIOL, V297, P1087, DOI 10.1006/jmbi.2000.3627; Hoenger A, 2000, BIOL CHEM, V381, P1001, DOI 10.1515/BC.2000.123; HOENGER A, 1995, NATURE, V376, P271, DOI 10.1038/376271a0; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; HOYT MA, 1993, GENETICS, V135, P35; KIKKAWA M, 1995, NATURE, V376, P274, DOI 10.1038/376274a0; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Krzysiak TC, 2006, EMBO J, V25, P2263, DOI 10.1038/sj.emboj.7601108; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Manning BD, 1999, J CELL BIOL, V144, P1219, DOI 10.1083/jcb.144.6.1219; MCDONALD HB, 1990, CELL, V63, P1159, DOI 10.1016/0092-8674(90)90412-8; MELUH PB, 1990, CELL, V60, P1029, DOI 10.1016/0092-8674(90)90351-E; Mishima M, 2002, DEV CELL, V2, P41, DOI 10.1016/S1534-5807(01)00110-1; Muto E, 2005, J CELL BIOL, V168, P691, DOI 10.1083/jcb.200409035; PAGE BD, 1992, GENE DEV, V6, P1414, DOI 10.1101/gad.6.8.1414; PAGE BD, 1994, J CELL BIOL, V124, P507, DOI 10.1083/jcb.124.4.507; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rank KC, 2012, J CELL BIOL, V197, P957, DOI 10.1083/jcb.201201132; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Sablin EP, 1996, NATURE, V380, P555, DOI 10.1038/380555a0; Sablin EP, 1998, NATURE, V395, P813, DOI 10.1038/27463; Skiniotis G, 2003, EMBO J, V22, P1518, DOI 10.1093/emboj/cdg164; Song HB, 1998, NATURE, V396, P587, DOI 10.1038/25153; Sosa H, 1997, CELL, V90, P217, DOI 10.1016/S0092-8674(00)80330-X; Sproul LR, 2005, CURR BIOL, V15, P1420, DOI 10.1016/j.cub.2005.06.066; Wendt TG, 2002, EMBO J, V21, P5969, DOI 10.1093/emboj/cdf622; WHITTAKER M, 1995, ULTRAMICROSCOPY, V58, P245, DOI 10.1016/0304-3991(95)00057-8; Wittinghofer A, 1997, CURR BIOL, V7, pR682, DOI 10.1016/S0960-9822(06)00355-1; Yun M, 2003, EMBO J, V22, P5382, DOI 10.1093/emboj/cdg531	42	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53792	10.1371/journal.pone.0053792	http://dx.doi.org/10.1371/journal.pone.0053792			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342004	gold, Green Published			2022-12-25	WOS:000314759400084
J	Corominas, J; Ramayo-Caldas, Y; Puig-Oliveras, A; Perez-Montarelo, D; Noguera, JL; Folch, JM; Ballester, M				Corominas, Jordi; Ramayo-Caldas, Yuliaxis; Puig-Oliveras, Anna; Perez-Montarelo, Dafne; Noguera, Jose L.; Folch, Josep M.; Ballester, Maria			Polymorphism in the ELOVL6 Gene Is Associated with a Major QTL Effect on Fatty Acid Composition in Pigs	PLOS ONE			English	Article							TIME RT-PCR; ADIPOSE-TISSUE; TRANSCRIPTION FACTOR; EXPRESSION; ELONGASE; MUSCLE; MEAT; IDENTIFICATION; CARBOHYDRATE; PREDICTION	Background: The ELOVL fatty acid elongase 6 (ELOVL6), the only elongase related to de novo lipogenesis, catalyzes the rate-limiting step in the elongation cycle by controlling the fatty acid balance in mammals. It is located on pig chromosome 8 (SSC8) in a region where a QTL affecting palmitic, and palmitoleic acid composition was previously detected, using an Iberian x Landrace intercross. The main goal of this work was to fine-map the QTL and to evaluate the ELOVL6 gene as a positional candidate gene affecting the percentages of palmitic and palmitoleic fatty acids in pigs. Methodology and Principal Findings: The combination of a haplotype-based approach and single-marker analysis allowed us to identify the main, associated interval for the QTL, in which the ELOVL6 gene was identified and selected as a positional candidate gene. A polymorphism in the promoter region of ELOVL6, ELOVL6: c.-533C > T, was highly associated with the percentage of palmitic and palmitoleic acids in muscle and backfat. Significant differences in ELOVL6 gene expression were observed in backfat when animals were classified by the ELOVL6: c.-533C > T genotype. Accordingly, animals carrying the allele associated with a decrease in ELOVL6 gene expression presented an increase in C16:0 and C16: 1(n-7) fatty acid content and a decrease of elongation activity ratios in muscle and backfat. Furthermore, a SNP genome-wide association study with ELOVL6 relative expression levels in backfat showed the strongest effect on the SSC8 region in which the ELOVL6 gene is located. Finally, different potential genomic regions associated with ELOVL6 gene expression were also identified by GWAS in liver and muscle, suggesting a differential tissue regulation of the ELOVL6 gene. Conclusions and Significance: Our results suggest ELOVL6 as a potential causal gene for the QTL analyzed and, subsequently, for controlling the overall balance of fatty acid composition in pigs.	[Corominas, Jordi; Ramayo-Caldas, Yuliaxis; Puig-Oliveras, Anna; Folch, Josep M.; Ballester, Maria] Ctr Recerca Agrigenom CRAG, Dept Genet Anim, Bellaterra, Spain; [Perez-Montarelo, Dafne] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Mejora Genet Anim, Madrid, Spain; [Noguera, Jose L.] IRTA, Lleida, Spain; [Folch, Josep M.] Univ Autonoma Barcelona, Dept Ciencia Anim & Aliments, Bellaterra, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); University of Barcelona; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); IRTA; Autonomous University of Barcelona	Corominas, J (corresponding author), Ctr Recerca Agrigenom CRAG, Dept Genet Anim, Bellaterra, Spain.	jordi.corominas@uab.cat	Puig Oliveras, Anna/M-5551-2015; Folch, Josep M/I-4738-2015; Corominas Galbany, Jordi/B-6356-2018; Devis, Maria Ballester/AAV-2467-2020; Ballester, Maria/E-7201-2016; Ballester, Maria/H-7277-2013; Caldas, Yuliaxis Ramayo/B-6337-2014	Puig Oliveras, Anna/0000-0003-2551-9012; Folch, Josep M/0000-0003-3689-1303; Corominas Galbany, Jordi/0000-0003-1736-1278; Devis, Maria Ballester/0000-0002-5413-4640; Ballester, Maria/0000-0002-5413-4640; Caldas, Yuliaxis Ramayo/0000-0002-8142-0159	MICINN [AGL2008-04818-C03, AGL2011-29821-CO2]; Innovation Consolider-Ingenio Program (Center for Research in Agrigenomics) [CSD2007-00036]; Spanish Ministerio de Educacion [BES-2009-018223]; Formacion del Profesorado Universitario (FPU) [AP2008-01450]; Universitat Autonoma de Barcelona [458-01-1/2011]	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Innovation Consolider-Ingenio Program (Center for Research in Agrigenomics); Spanish Ministerio de Educacion(Spanish Government); Formacion del Profesorado Universitario (FPU)(Spanish Government); Universitat Autonoma de Barcelona	This study has been funded by MICINN projects (AGL2008-04818-C03 and AGL2011-29821-CO2) and the Innovation Consolider-Ingenio 2012 Program (CSD2007-00036, Center for Research in Agrigenomics). J. Corominas was funded by a Formacion de Personal Investigador (FPI) PhD grant from Spanish Ministerio de Educacion (BES-2009-018223), Y. Ramayo by a Formacion del Profesorado Universitario (FPU) PhD grant (AP2008-01450) and A. Puig was funded by a Personal Investigador en Formacion (PIF) PhD grant from the Universitat Autonoma de Barcelona (458-01-1/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland A, 1997, AM J CLIN NUTR, V65, P1774, DOI 10.1093/ajcn/65.6.1774; BALLARD FJ, 1969, FED PROC, V28, P218; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Clop A, 2003, MAMM GENOME, V14, P650, DOI 10.1007/s00335-002-2210-7; Damcott CM, 2004, METABOLISM, V53, P303, DOI 10.1016/j.metabol.2003.10.010; Drewes T, 1996, MOL CELL BIOL, V16, P925; Druet T, 2010, GENETICS, V184, P789, DOI 10.1534/genetics.109.108431; Erkens T, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-41; Estelle J, 2009, J ANIM BREED GENET, V126, P52, DOI 10.1111/j.1439-0388.2008.00754.x; Estelle J, 2009, ANIM GENET, V40, P813, DOI 10.1111/j.1365-2052.2009.01922.x; Green CD, 2010, J LIPID RES, V51, P1871, DOI 10.1194/jlr.M004747; Guillaumond F, 2010, MOL CELL BIOL, V30, P3059, DOI 10.1128/MCB.01141-09; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Henderson C. R, 1984, APPL LINEAR MODELS A; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Jansen GR, 1966, BIOCHEM J, V99, P10; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; KIM JB, 1995, MOL CELL BIOL, V15, P2582; Kumadaki S, 2008, BIOCHEM BIOPH RES CO, V368, P261, DOI 10.1016/j.bbrc.2008.01.075; Leonard AE, 2000, BIOCHEM J, V350, P765, DOI 10.1042/0264-6021:3500765; Lichtenstein AH, 2006, J LIPID RES, V47, P1661, DOI 10.1194/jlr.R600019-JLR200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mach N, 2006, J ANIM SCI, V84, P3039, DOI 10.2527/jas.2005-632; Matsuzaka T, 2002, J LIPID RES, V43, P911; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Moon YA, 2001, J BIOL CHEM, V276, P45358, DOI 10.1074/jbc.M108413200; Morcillo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021198; Munoz M, 2012, ANIM GENET, V43, P620, DOI 10.1111/j.1365-2052.2011.02301.x; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; OHEA EK, 1969, J NUTR, V99, P338, DOI 10.1093/jn/99.3.338; Overgard AC, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-36; Perez-Enciso M, 2000, J ANIM SCI, V78, P2525; Perez-Enciso M, 2002, GENETICS, V161, P1625; Perez-Enciso M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-202; Ramayo-Caldas Y, 2012, J ANIM SCI, V90, P2883, DOI 10.2527/jas.2011-4900; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruiz J, 1998, MEAT SCI, V49, P155, DOI 10.1016/S0309-1740(97)00136-8; Shin JH, 2006, J STAT SOFTWARE, P16; Sladek R, 1997, MOL CELL BIOL, V17, P5400, DOI 10.1128/MCB.17.9.5400; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Swierczynski J, 2000, METABOLISM, V49, P594, DOI 10.1016/S0026-0495(00)80033-5; Turyn J, 2010, MOL CELL BIOCHEM, V345, P181, DOI 10.1007/s11010-010-0571-x; Valsta LM, 2005, MEAT SCI, V70, P525, DOI 10.1016/j.meatsci.2004.12.016; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Wood JD, 2004, MEAT SCI, V66, P21, DOI 10.1016/S0309-1740(03)00022-6; Yang B, 2011, J ANIM BREED GENET, V128, P329, DOI 10.1111/j.1439-0388.2011.00928.x; Yang KX, 2010, J ANIM SCI, V88, P3538, DOI 10.2527/jas.2009-2602	53	41	45	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53687	10.1371/journal.pone.0053687	http://dx.doi.org/10.1371/journal.pone.0053687			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341976	Green Published, gold			2022-12-25	WOS:000314759400067
J	Liu, CR; Liu, Z; Li, M; Li, XL; Wong, YS; Ngai, SM; Zheng, WJ; Zhang, YB; Chen, TF				Liu, Chaoran; Liu, Zhong; Li, Meng; Li, Xiaoling; Wong, Yum-Shing; Ngai, Sai-Ming; Zheng, Wenjie; Zhang, Yibo; Chen, Tianfeng			Enhancement of Auranofin-Induced Apoptosis in MCF-7 Human Breast Cells by Selenocystine, a Synergistic Inhibitor of Thioredoxin Reductase	PLOS ONE			English	Article							PROTEIN-KINASE PATHWAYS; MAMMALIAN THIOREDOXIN; METHYLSELENINIC ACID; CANCER-CELLS; MEDIATED APOPTOSIS; CYCLE ARREST; SELENIUM; MITOCHONDRIA; SUBSTRATE; ERK	Thioredoxin system plays an important role in regulation of intracellular redox balance and various signaling pathways. Thioredoxin reductase (TrxR) is overexpressed in many cancer cells and has been identified as a potential target of anticancer drugs. Auranofin (AF) is potent TrxR inhibitor with novel in vitro and in vivo anticancer activities. Selenocystine (SeC) is a nutritionally available selenoamino acid with selective anticancer effects through induction of apoptosis. In the present study, we demonstrated the synergistic effects and the underlying molecular mechanisms of SeC in combination with AF on MCF-7 human breast cancer cells. The results showed that SeC and AF synergistically inhibited the cancer cell growth through induction of ROS-dependent apoptosis with the involvement of mitochondrial dysfunction. DNA damage-mediated p53 phosphorylation and down-regulation of phosphorylated AKT and ERK also contributed to cell apoptosis. Moreover, we demonstrated the important role of TrxR activity in the synergistic action of SeC and AF. Taken together, our results suggest the strategy to use SeC and AF in combination could be a highly efficient way to achieve anticancer synergism by targeting TrxR.	[Liu, Chaoran; Li, Meng; Li, Xiaoling; Zheng, Wenjie; Zhang, Yibo; Chen, Tianfeng] Jinan Univ, Dept Chem, Guangzhou, Guangdong, Peoples R China; [Liu, Zhong] Jinan Univ, Guangzhou Jinan Biomed Res & Dev Ctr, Guangdong Prov Key Lab Bioengn Med, Natl Engn Res Ctr Genet Med, Guangzhou, Guangdong, Peoples R China; [Wong, Yum-Shing; Ngai, Sai-Ming] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China	Jinan University; Jinan University; Chinese University of Hong Kong	Zheng, WJ (corresponding author), Jinan Univ, Dept Chem, Guangzhou, Guangdong, Peoples R China.	tzhwj@jnu.edu.cn; tchentf@jnu.edu.cn	Chen, Tianfeng/AAG-6123-2019; Ngai, Sai Ming/S-4898-2018; meng, li/GVT-2063-2022; Liu, Zhong/B-6323-2016	Ngai, Sai Ming/0000-0002-4484-2483; Liu, Zhong/0000-0002-5132-7463	Natural Science Foundation of China; Guangdong Province; Program for New Century Excellent Talents in University; Key Project of Science and Technology Department of Guangdong Province; Fundamental Research Funds for the Central Universities; China Postdoctoral Science Foundation	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Key Project of Science and Technology Department of Guangdong Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by Natural Science Foundation of China and Guangdong Province, Program for New Century Excellent Talents in University, Key Project of Science and Technology Department of Guangdong Province, the Fundamental Research Funds for the Central Universities and China Postdoctoral Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulah R, 2005, J TRACE ELEM MED BIO, V19, P141, DOI 10.1016/j.jtemb.2005.09.003; Anestal K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001846; Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arner ESJ, 1999, METHOD ENZYMOL, V300, P226; Boldt S, 2002, CARCINOGENESIS, V23, P1831, DOI 10.1093/carcin/23.11.1831; Cai WQ, 2012, FREE RADICAL BIO MED, V52, P257, DOI 10.1016/j.freeradbiomed.2011.10.447; Carvalho H, 2004, J CELL BIOCHEM, V92, P502, DOI 10.1002/jcb.20070; Cassidy PB, 2006, CARCINOGENESIS, V27, P2538, DOI 10.1093/carcin/bgl111; Chen T, 2008, CELL MOL LIFE SCI, V65, P2763, DOI 10.1007/s00018-008-8329-2; Chen TF, 2008, BIOMED PHARMACOTHER, V62, P77, DOI 10.1016/j.biopha.2007.12.002; Chen TF, 2009, INT J BIOCHEM CELL B, V41, P666, DOI 10.1016/j.biocel.2008.07.014; Didier C, 2001, FREE RADICAL BIO MED, V31, P585, DOI 10.1016/S0891-5849(01)00617-7; Du H, 2011, J BIOL CHEM, V286, P491, DOI 10.1074/jbc.M110.167148; Dvorakova K, 2002, MOL CANCER THER, V1, P185; El-Sayed WM, 2006, TOXICOLOGY, V220, P179, DOI 10.1016/j.tox.2005.12.016; Eriksson SE, 2009, FREE RADICAL BIO MED, V47, P1661, DOI 10.1016/j.freeradbiomed.2009.09.016; Fulda S, 2002, ONCOGENE, V21, P2295, DOI 10.1038/sj.onc.1205255; Green DR, 2008, NATURE, V455, P1047, DOI 10.1038/4551047a; Gromer S, 2002, J BIOL CHEM, V277, P9701, DOI 10.1074/jbc.M109234200; Hoffmann FW, 2011, ARCH BIOCHEM BIOPHYS, V512, P38, DOI 10.1016/j.abb.2011.05.007; Hu HB, 2005, CARCINOGENESIS, V26, P1374, DOI 10.1093/carcin/bgi094; Ip C, 2000, CANCER RES, V60, P2882; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Jiang C, 2002, MOL CANCER THER, V1, P1059; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kondo N, 2006, ANTIOXID REDOX SIGN, V8, P1881, DOI 10.1089/ars.2006.8.1881; Li S, 2007, MOL CANCER THER, V6, P1031, DOI 10.1158/1535-7163.MCT-06-0643; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Lu J, 2007, P NATL ACAD SCI USA, V104, P12288, DOI 10.1073/pnas.0701549104; Madeja Z, 2005, BIOCHEM PHARMACOL, V69, P1765, DOI 10.1016/j.bcp.2005.02.023; Marzano C, 2007, FREE RADICAL BIO MED, V42, P872, DOI 10.1016/j.freeradbiomed.2006.12.021; Myers JM, 2009, FREE RADICAL BIO MED, V47, P1477, DOI 10.1016/j.freeradbiomed.2009.08.015; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Rackham O, 2011, FREE RADICAL BIO MED, V50, P689, DOI 10.1016/j.freeradbiomed.2010.12.015; Rigobello MP, 2009, FREE RADICAL BIO MED, V47, P710, DOI 10.1016/j.freeradbiomed.2009.05.027; Sasada T, 1999, FREE RADICAL BIO MED, V27, P504, DOI 10.1016/S0891-5849(99)00101-X; Selenius M, 2008, BIOCHEM PHARMACOL, V75, P2092, DOI 10.1016/j.bcp.2008.02.028; Shaw CF, 1999, CHEM REV, V99, P2589, DOI 10.1021/cr980431o; Shiah HS, 2007, BIOCHEM PHARMACOL, V73, P610, DOI 10.1016/j.bcp.2006.10.019; Simstein R, 2003, EXP BIOL MED, V228, P995, DOI 10.1177/153537020322800903; Sinha R, 2004, CURR CANCER DRUG TAR, V4, P13, DOI 10.2174/1568009043481614; Snider G, 2010, BIOCHEMISTRY-US, V49, P10329, DOI 10.1021/bi101130t; Tallarida RJ, 2001, J PHARMACOL EXP THER, V298, P865; Tanel A, 2007, CELL SIGNAL, V19, P968, DOI 10.1016/j.cellsig.2006.10.014; Tichy A, 2007, ACTA BIOCHIM POL, V54, P281; Unni E, 2005, BREAST CANCER RES, V7, pR699, DOI 10.1186/bcr1276; van Gurp M, 2003, BIOCHEM BIOPH RES CO, V304, P487, DOI 10.1016/S0006-291X(03)00621-1; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Zhao F, 2006, CANCER LETT, V236, P46, DOI 10.1016/j.canlet.2005.05.010; Zhao R, 2002, P NATL ACAD SCI USA, V99, P8579, DOI 10.1073/pnas.122061399; Zhao R, 2009, NUTR CANCER, V61, P397, DOI 10.1080/01635580802582751	53	68	69	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53945	10.1371/journal.pone.0053945	http://dx.doi.org/10.1371/journal.pone.0053945			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342042	Green Submitted, Green Published, gold			2022-12-25	WOS:000314759400102
J	Marchive, C; Leon, C; Kappel, C; Coutos-Thevenot, P; Corio-Costet, MF; Delrot, S; Lauvergeat, V				Marchive, Chloe; Leon, Celine; Kappel, Christian; Coutos-Thevenot, Pierre; Corio-Costet, Marie-France; Delrot, Serge; Lauvergeat, Virginie			Over-Expression of VvWRKY1 in Grapevines Induces Expression of Jasmonic Acid Pathway-Related Genes and Confers Higher Tolerance to the Downy Mildew	PLOS ONE			English	Article							NECROTROPHIC FUNGAL PATHOGENS; THAUMATIN-LIKE PROTEIN; TRANSCRIPTION FACTOR; VITIS-VINIFERA; BOTRYTIS-CINEREA; PLASMOPARA-VITICOLA; ARABIDOPSIS WRKY33; DEFENSE RESPONSES; EUTYPA-LATA; RESISTANCE	Most WRKY transcription factors activate expression of defence genes in a salicylic acid- and/or jasmonic acid-dependent signalling pathway. We previously identified a WRKY gene, VvWRKY1, which is able to enhance tolerance to fungal pathogens when it is overexpressed in tobacco. The present work analyzes the effects of VvWRKY1 overexpression in grapevine. Microarray analysis showed that genes encoding defence-related proteins were up-regulated in the leaves of transgenic 35S::VvWRKY1 grapevines. Quantitative RT-PCR analysis confirmed that three genes putatively involved in jasmonic acid signalling pathway were overexpressed in the transgenic grapes. The ability of VvWRKY1 to trans-activate the promoters of these genes was demonstrated by transient expression in grape protoplasts. The resistance to the causal agent of downy mildew, Plasmopara viticola, was enhanced in the transgenic plants. These results show that VvWRKY1 can increase resistance of grapevine against the downy mildew through transcriptional reprogramming leading to activation of the jasmonic acid signalling pathway.	[Marchive, Chloe; Leon, Celine; Kappel, Christian; Delrot, Serge; Lauvergeat, Virginie] Univ Bordeaux, ISVV, EGFV, UMR 1287, F-33140 Villenave Dornon, France; [Marchive, Chloe; Leon, Celine; Kappel, Christian; Delrot, Serge; Lauvergeat, Virginie] INRA, ISVV, EGFV, UMR 1287, Villenave Dornon, France; [Coutos-Thevenot, Pierre] Univ Poitiers, CNRS, UMR Ecol & Biol Interact 7267, Equipe Physiol Mol Transport Sucres, Poitiers, France; [Corio-Costet, Marie-France] INRA, UMR SAVE 1065, ISVV, Villenave Dornon, France	UDICE-French Research Universities; Universite de Bordeaux; INRAE; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; INRAE	Lauvergeat, V (corresponding author), Univ Bordeaux, ISVV, EGFV, UMR 1287, F-33140 Villenave Dornon, France.	virginie.lauvergeat@bordeaux.inra.fr	corio-costet, marie-france/AAA-7705-2021	Delrot, Serge/0000-0001-9602-0441; Kappel, Christian/0000-0002-1450-1864; Lauvergeat, Virginie/0000-0002-5950-2051	Conseil Interprofessionnel du Vin de Bordeaux	Conseil Interprofessionnel du Vin de Bordeaux	This work was supported by grants from the "Conseil Interprofessionnel du Vin de Bordeaux" (http://www.bordeaux.com/fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2011, MOL BIOL REP, V38, P3883, DOI 10.1007/s11033-010-0504-5; Avanci NC, 2010, GENET MOL RES, V9, P484, DOI 10.4238/vol9-1gmr754; Bellin D, 2009, THEOR APPL GENET, V120, P163, DOI 10.1007/s00122-009-1167-2; Birkenbihl RP, 2012, PLANT PHYSIOL, V159, P266, DOI 10.1104/pp.111.192641; Blasi P, 2011, THEOR APPL GENET, V123, P43, DOI 10.1007/s00122-011-1565-0; Buhot N, 2004, MOL BIOL CELL, V15, P5047, DOI 10.1091/mbc.E04-07-0575; Camps C, 2010, J EXP BOT, V61, P1719, DOI 10.1093/jxb/erq040; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Chung HS, 2009, PHYTOCHEMISTRY, V70, P1547, DOI 10.1016/j.phytochem.2009.08.022; Corio-Costet MF, 2011, EUR J PLANT PATHOL, V129, P315, DOI 10.1007/s10658-010-9711-0; Coutos-Thevenot P, 2001, J EXP BOT, V52, P901, DOI 10.1093/jexbot/52.358.901; Decendit A, 1996, BIOTECHNOL LETT, V18, P659, DOI 10.1007/BF00130761; Encinas-Villarejo S, 2009, J EXP BOT, V60, P3043, DOI 10.1093/jxb/erp152; Eulgem T, 2005, TRENDS PLANT SCI, V10, P71, DOI 10.1016/j.tplants.2004.12.006; Figueiredo A, 2012, FUNCT INTEGR GENOMIC, V12, P379, DOI 10.1007/s10142-012-0261-8; Hamiduzzaman MM, 2005, MOL PLANT MICROBE IN, V18, P819, DOI 10.1094/MPMI-18-0819; Hazarika BN, 2006, SCI HORTIC-AMSTERDAM, V108, P105, DOI 10.1016/j.scienta.2006.01.038; Hichri I, 2010, MOL PLANT, V3, P509, DOI 10.1093/mp/ssp118; Hiroyuki K, 2008, PLANT CELL REP, V27, P1521, DOI 10.1007/s00299-008-0536-7; Horstmann V, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-13; Ishihama N, 2011, PLANT CELL, V23, P1153, DOI 10.1105/tpc.110.081794; Ismail A, 2012, J EXP BOT, V63, P2127, DOI 10.1093/jxb/err426; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kazan K, 2012, TRENDS PLANT SCI, V17, P22, DOI 10.1016/j.tplants.2011.10.006; Koo SC, 2009, BIOCHEM BIOPH RES CO, V387, P365, DOI 10.1016/j.bbrc.2009.07.026; Laquitaine L, 2006, MOL PLANT MICROBE IN, V19, P1103, DOI 10.1094/MPMI-19-1103; Malacarne G, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-114; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; Marchive C, 2007, J EXP BOT, V58, P1999, DOI 10.1093/jxb/erm062; Marguerit E, 2009, THEOR APPL GENET, V118, P1261, DOI 10.1007/s00122-009-0979-4; Mzid R, 2007, PHYSIOL PLANTARUM, V131, P434, DOI 10.1111/j.1399-3054.2007.00975.x; Pandey SP, 2010, PLANT J, V64, P912, DOI 10.1111/j.1365-313X.2010.04387.x; Podolyan A, 2010, FUNCT PLANT BIOL, V37, P767, DOI 10.1071/FP09271; Polesani M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-117; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Rotter A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-104; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Samuelian SK, 2009, PLANT SCI, V177, P211, DOI 10.1016/j.plantsci.2009.05.013; Tao Z, 2009, PLANT PHYSIOL, V151, P936, DOI 10.1104/pp.109.145623; Tattersall DB, 1997, PLANT PHYSIOL, V114, P759, DOI 10.1104/pp.114.3.759; Trouvelot S, 2008, MOL PLANT MICROBE IN, V21, P232, DOI 10.1094/MPMI-21-2-0232; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wu JA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-234; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x	45	72	76	2	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54185	10.1371/journal.pone.0054185	http://dx.doi.org/10.1371/journal.pone.0054185			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342101	gold, Green Published, Green Submitted			2022-12-25	WOS:000314759400131
J	Diaz-Villasenor, A; Cruz, L; Cebrian, A; Hernandez-Ramirez, RU; Hiriart, M; Garcia-Vargas, G; Bassol, S; Sordo, M; Gandolfi, AJ; Klimecki, WT; Lopez-Carillo, L; Cebrian, ME; Ostrosky-Wegman, P				Diaz-Villasenor, Andrea; Cruz, Laura; Cebrian, Arturo; Hernandez-Ramirez, Raul U.; Hiriart, Marcia; Garcia-Vargas, Gonzalo; Bassol, Susana; Sordo, Monserrat; Gandolfi, A. Jay; Klimecki, Walter T.; Lopez-Carillo, Lizbeth; Cebrian, Mariano E.; Ostrosky-Wegman, Patricia			Arsenic Exposure and Calpain-10 Polymorphisms Impair the Function of Pancreatic Beta-Cells in Humans: A Pilot Study of Risk Factors for T2DM	PLOS ONE			English	Article							DEPENDENT DIABETES-MELLITUS; STIMULATED GLUCOSE-UPTAKE; INSULIN-RESISTANCE; DRINKING-WATER; GENE; ASSOCIATION; PREVALENCE; SECRETION; INVOLVEMENT; HOMEOSTASIS	The incidence of type 2 diabetes mellitus (T2DM) is increasing worldwide and diverse environmental and genetic risk factors are well recognized. Single nucleotide polymorphisms (SNPs) in the calpain-10 gene (CAPN-10), which encodes a protein involved in the secretion and action of insulin, and chronic exposure to inorganic arsenic (iAs) through drinking water have been independently associated with an increase in the risk for T2DM. In the present work we evaluated if CAPN-10 SNPs and iAs exposure jointly contribute to the outcome of T2DM. Insulin secretion (beta-cell function) and insulin sensitivity were evaluated indirectly through validated indexes (HOMA2) in subjects with and without T2DM who have been exposed to a gradient of iAs in their drinking water in northern Mexico. The results were analyzed taking into account the presence of the risk factor SNPs SNP-43 and -44 in CAPN-10. Subjects with T2DM had significantly lower beta-cell function and insulin sensitivity. An inverse association was found between beta-cell function and iAs exposure, the association being more pronounced in subjects with T2DM. Subjects without T2DM who were carriers of the at-risk genotype SNP-43 or -44, also had significantly lower beta-cell function. The association of SNP-43 with beta-cell function was dependent on iAs exposure, age, gender and BMI, whereas the association with SNP-44 was independent of all of these factors. Chronic exposure to iAs seems to be a risk factor for T2DM in humans through the reduction of beta-cell function, with an enhanced effect seen in the presence of the at-risk genotype of SNP-43 in CAPN-10. Carriers of CAPN-10 SNP-44 have also shown reduced beta-cell function.	[Diaz-Villasenor, Andrea; Sordo, Monserrat; Ostrosky-Wegman, Patricia] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Med Genom & Toxicol Ambiental, Mexico City 04510, DF, Mexico; [Cruz, Laura; Bassol, Susana] Univ Autonoma Coahuila, Fac Med, Torreon, Coahuila, Mexico; [Cebrian, Arturo; Garcia-Vargas, Gonzalo] Univ Juarez Estado Durango, Fac Med, Gomez Palacio, Durango, Mexico; [Hernandez-Ramirez, Raul U.; Lopez-Carillo, Lizbeth] Inst Nacl Salud Publ, Ctr Invest Salud Poblac, Cuernavaca, Morelos, Mexico; [Hiriart, Marcia] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Div Neurociencias, Dept Neurodesarrollo & Fisiol, Mexico City 04510, DF, Mexico; [Gandolfi, A. Jay; Klimecki, Walter T.] Univ Arizona, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Cebrian, Mariano E.] IPN CINVESTAV, Ctr Invest & Estudios Avanzados, Secc Externa Toxicol, Mexico City, DF, Mexico; [Diaz-Villasenor, Andrea] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Fisiol Nutr, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Autonoma de Coahuila; Universidad Juarez del Estado de Durango; Instituto Nacional de Salud Publica; Universidad Nacional Autonoma de Mexico; University of Arizona; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Ostrosky-Wegman, P (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Med Genom & Toxicol Ambiental, Mexico City 04510, DF, Mexico.	ostrosky@biomedicas.unam.mx	Hiriart, Marcia/A-3988-2008	Hiriart, Marcia/0000-0001-5711-8868; Garcia Vargas, Gonzalo/0000-0003-1680-5236; Diaz-Villasenor, Andrea/0000-0003-1222-2615; ostrosky-wegman, patricia/0000-0002-8564-3472	CONACYT; DGAPA-PAPIIT (UNAM); Dean Carter Binational Center for Environmental Health Sciences; NIEHS [NIH ES-04940]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004940, P30ES006694] Funding Source: NIH RePORTER	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA-PAPIIT (UNAM)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); Dean Carter Binational Center for Environmental Health Sciences; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The work was partially supported by CONACYT, DGAPA-PAPIIT (UNAM) and by the Dean Carter Binational Center for Environmental Health Sciences. The analyses for arsenic determination in water and urine samples were performed by the Analytical Section of the Hazard Identification Core from the NIEHS-supported Superfund Basic Research Program Grant (NIH ES-04940). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aganna E, 2006, J ENDOCRINOL, V190, pR1, DOI 10.1677/joe.1.06737; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Baier LJ, 2000, J CLIN INVEST, V106, pR69, DOI 10.1172/JCI10665; Brown AE, 2007, MOL GENET METAB, V91, P318, DOI 10.1016/j.ymgme.2007.05.001; Coronado-Gonzalez JA, 2007, ENVIRON RES, V104, P383, DOI 10.1016/j.envres.2007.03.004; Day C., 2011, BR J DIABETES VASC D, V11, P55; del Bosque-Plata L, 2004, MOL GENET METAB, V81, P122, DOI 10.1016/j.ymgme.2003.10.005; Del Razo LM, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-73; DelRazo LM, 1997, ARCH TOXICOL, V71, P211; Diaz-Villasenor A, 2008, TOXICOL APPL PHARM; Diaz-Villasenor A, 2006, TOXICOL APPL PHARM, V214, P30, DOI 10.1016/j.taap.2005.11.015; Emoto M, 1999, DIABETES CARE, V22, P818, DOI 10.2337/diacare.22.5.818; Ettinger AS, 2009, ENVIRON HEALTH PERSP, V117, P1059, DOI 10.1289/ehp0800533; Fu JQ, 2010, ENVIRON HEALTH PERSP, V118, P864, DOI 10.1289/ehp.0901608; Hoffstedt J, 2002, DIABETOLOGIA, V45, P276, DOI 10.1007/s00125-001-0732-2; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Imamura M, 2011, ENDOCR J, V58, P723, DOI 10.1507/endocrj.EJ11-0113; Izquierdo-Vega JA, 2006, TOXICOL LETT, V160, P135, DOI 10.1016/j.toxlet.2005.06.018; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; LAI MS, 1994, AM J EPIDEMIOL, V139, P484, DOI 10.1093/oxfordjournals.aje.a117031; Lee DH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015977, 10.1371/journal.pone.0026172]; Logie LJ, 2005, MOL GENET METAB, V85, P54, DOI 10.1016/j.ymgme.2005.01.003; Lu TH, 2011, TOXICOL LETT, V201, P15, DOI 10.1016/j.toxlet.2010.11.019; Lyssenko V, 2009, CURR OPIN LIPIDOL, V20, P87, DOI 10.1097/MOL.0b013e32832923af; Makaji E, 2011, INT J TOXICOL, V30, P410, DOI 10.1177/1091581811405544; Marshall C, 2005, MOL ENDOCRINOL, V19, P213, DOI 10.1210/me.2004-0064; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meza MM, 2005, ENVIRON HEALTH PERSP, V113, P775, DOI 10.1289/ehp.7780; Meza MM, 2004, ENVIRON RES, V96, P119, DOI 10.1016/j.envres.2003.08.010; Navas-Acien A, 2008, JAMA-J AM MED ASSOC, V300, P814, DOI 10.1001/jama.300.7.814; Neel BA, 2011, DIABETES, V60, P1838, DOI 10.2337/db11-0153; Orho-Melander M, 2002, DIABETES, V51, P2658, DOI 10.2337/diabetes.51.8.2658; Paul DS, 2008, METAL IONS BIOL MED, V10, P1; Paul DS, 2007, TOXICOL APPL PHARM, V222, P305, DOI 10.1016/j.taap.2007.01.010; Paul DS, 2007, ENVIRON HEALTH PERSP, V115, P734, DOI 10.1289/ehp.9867; Paul DS, 2011, ENVIRON HEALTH PERSP, V119, P1104, DOI 10.1289/ehp.1003324; Paul DS, 2003, BIOCHEM J, V376, P625, DOI 10.1042/BJ20030681; Rahman M, 1999, OCCUP ENVIRON MED, V56, P277, DOI 10.1136/oem.56.4.277; Rahman M, 1998, AM J EPIDEMIOL, V148, P198, DOI 10.1093/oxfordjournals.aje.a009624; Shore AC, 2002, DIABETOLOGIA, V45, P899, DOI 10.1007/s00125-002-0847-0; Smeester L, 2011, CHEM RES TOXICOL, V24, P165, DOI 10.1021/tx1004419; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stumvoll M, 2001, DIABETES, V50, P2161, DOI 10.2337/diabetes.50.9.2161; Thayer KA, 2012, ENVIRON HEALTH PERSP, V120, P779, DOI 10.1289/ehp.1104597; Tschritter O, 2003, DIABETES CARE, V26, P1026, DOI 10.2337/diacare.26.4.1026; Tseng CH, 2000, ENVIRON HEALTH PERSP, V108, P847, DOI 10.2307/3434992; Turner MD, 2007, BIOCHEM BIOPH RES CO, V352, P650, DOI 10.1016/j.bbrc.2006.11.077; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wang SL, 2003, ENVIRON HEALTH PERSP, V111, P155, DOI 10.1289/ehp.5457; Weedon MN, 2003, AM J HUM GENET, V73, P1208, DOI 10.1086/379285; Xue P, 2011, BIOCHEM BIOPH RES CO, V407, P360, DOI 10.1016/j.bbrc.2011.03.024	52	26	27	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e51642	10.1371/journal.pone.0051642	http://dx.doi.org/10.1371/journal.pone.0051642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349674	Green Published, gold, Green Submitted			2022-12-25	WOS:000314019100007
J	Lennen, RM; Pfleger, BF				Lennen, Rebecca M.; Pfleger, Brian F.			Modulating Membrane Composition Alters Free Fatty Acid Tolerance in Escherichia coli	PLOS ONE			English	Article							CARRIER PROTEIN THIOESTERASE; P-BAD PROMOTER; ACP THIOESTERASE; EXPRESSION; OVERPRODUCTION; BIOSYNTHESIS; SPECIFICITY; CHEMICALS; VECTORS; BINDING	Microbial synthesis of free fatty acids (FFA) is a promising strategy for converting renewable sugars to advanced biofuels and oleochemicals. Unfortunately, FFA production negatively impacts membrane integrity and cell viability in Escherichia coli, the dominant host in which FFA production has been studied. These negative effects provide a selective pressure against FFA production that could lead to genetic instability at industrial scale. In prior work, an engineered E. coli strain harboring an expression plasmid for the Umbellularia californica acyl-acyl carrier protein (ACP) thioesterase was shown to have highly elevated levels of unsaturated fatty acids in the cell membrane. The change in membrane content was hypothesized to be one underlying cause of the negative physiological effects associated with FFA production. In this work, a connection between the regulator of unsaturated fatty acid biosynthesis in E. coli, FabR, thioesterase expression, and unsaturated membrane content was established. A strategy for restoring normal membrane saturation levels and increasing tolerance towards endogenous production of FFAs was implemented by modulating acyl-ACP pools with a second thioesterase (from Geobacillus sp. Y412MC10) that primarily targets medium chain length, unsaturated acyl-ACPs. The strategy succeeded in restoring membrane content and improving viability in FFA producing E. coli while maintaining FFA titers. However, the restored fitness did not increase FFA productivity, indicating the existence of additional metabolic or regulatory barriers.	[Lennen, Rebecca M.; Pfleger, Brian F.] Univ Wisconsin Madison, Dept Chem & Biol Engn, Madison, WI 53706 USA; [Lennen, Rebecca M.; Pfleger, Brian F.] Univ Wisconsin Madison, US DOE, Great Lakes Bioenergy Res Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison	Pfleger, BF (corresponding author), Univ Wisconsin Madison, Dept Chem & Biol Engn, Madison, WI 53706 USA.	pfleger@engr.wisc.edu	Pfleger, Brian Frederick/AAA-2559-2022	Pfleger, Brian Frederick/0000-0002-9232-9959	DOE Great Lakes Bioenergy Research Center (DOE BER Office of Sciences) [DE-FC02-07ER64494]; Department of Chemical and Biological Engineering Dahlke-Hougen Fellowship	DOE Great Lakes Bioenergy Research Center (DOE BER Office of Sciences)(United States Department of Energy (DOE)); Department of Chemical and Biological Engineering Dahlke-Hougen Fellowship	This work was funded by the DOE Great Lakes Bioenergy Research Center (DOE BER Office of Sciences DE-FC02-07ER64494). R. M. L. was supported as a trainee in the Chemistry-Biology Interface Training Program (NIH) and by the Department of Chemical and Biological Engineering Dahlke-Hougen Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew DE, 2012, METAB ENG, V14, P705, DOI 10.1016/j.ymben.2012.08.003; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; [Anonymous], 2003, LIPID ANAL; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; CHO HS, 1995, J BIOL CHEM, V270, P4216, DOI 10.1074/jbc.270.9.4216; Davis MS, 2000, J BIOL CHEM, V275, P28593, DOI 10.1074/jbc.M004756200; Dellomonaco C, 2011, NATURE, V476, P355, DOI 10.1038/nature10333; Feng YJ, 2011, MOL MICROBIOL, V80, P195, DOI 10.1111/j.1365-2958.2011.07564.x; Feng YJ, 2009, J BIOL CHEM, V284, P29526, DOI 10.1074/jbc.M109.023440; Goh EB, 2012, APPL ENVIRON MICROB, V78, P70, DOI 10.1128/AEM.06785-11; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Huffer S, 2012, TRENDS BIOTECHNOL; Jing FY, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-44; JONES A, 1995, PLANT CELL, V7, P359, DOI 10.1105/tpc.7.3.359; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; Lee SK, 2007, APPL ENVIRON MICROB, V73, P5711, DOI 10.1128/AEM.00791-07; Lennen RM, 2010, BIOTECHNOL BIOENG, V106, P193, DOI 10.1002/bit.22660; Lennen RM, 2012, TRENDS BIOTECHNOLOGY; Lennen RM, 2012, J BACTERIOLOGY; Lennen RM, 2011, APPL ENV MICROBIOL; Lu XF, 2008, METAB ENG, V10, P333, DOI 10.1016/j.ymben.2008.08.006; Maki-Arvela P, 2007, ENERG FUEL, V21, P30, DOI 10.1021/ef060455v; Roth BL, 1997, APPL ENVIRON MICROB, V63, P2421, DOI 10.1128/AEM.63.6.2421-2431.1997; Rude MA, 2011, APPL ENVIRON MICROB, V77, P1718, DOI 10.1128/AEM.02580-10; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Serrano-Vega MJ, 2005, PLANTA, V221, P868, DOI 10.1007/s00425-005-1502-z; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; VOELKER TA, 1994, J BACTERIOL, V176, P7320, DOI 10.1128/JB.176.23.7320-7327.1994; YUAN L, 1995, P NATL ACAD SCI USA, V92, P10639, DOI 10.1073/pnas.92.23.10639; Yuan L, 1996, J BIOL CHEM, V271, P3417; Zhang YM, 2002, J BIOL CHEM, V277, P15558, DOI 10.1074/jbc.M201399200; Zhu K, 2009, J BIOL CHEM, V284, P34880, DOI 10.1074/jbc.M109.068239	33	54	58	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54031	10.1371/journal.pone.0054031	http://dx.doi.org/10.1371/journal.pone.0054031			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349781	Green Published, Green Submitted, gold			2022-12-25	WOS:000313943000024
J	Bellucci, L; Dalvai, M; Kocanova, S; Moutahir, F; Bystricky, K				Bellucci, Luca; Dalvai, Mathieu; Kocanova, Silvia; Moutahir, Fatima; Bystricky, Kerstin			Activation of p21 by HDAC Inhibitors Requires Acetylation of H2A.Z	PLOS ONE			English	Article							BREAST-CANCER CELLS; HISTONE DEACETYLASE; ESTROGEN; RECEPTOR; GENE; TRANSCRIPTION; TRICHOSTATIN; SP1; P53; EXPRESSION	Differential positioning of the histone variant H2A.Z in a p53 dependent manner was shown to regulate p21 transcription. Whether H2A.Z is involved in p21 activity in the absence of p53 is not known. The p21 gene is repressed in estrogen receptor (ER) negative cell lines that are p53-/- and hormone independent for their growth. Here we demonstrate that class I and II pan Histone deacetylase inhibitors (HDACi) induce p21 transcription and reduce cell proliferation of MDA-MB231, an ER alpha-negative mammary tumor cell line, in a H2A.Z dependent manner. H2A.Z is associated with the transcription start site (TSS) of the repressed p21 gene. Depleting H2A.Z did not lead to transcription of p21 but annihilated the stimulating effect of HDACi on this gene. Acetylation of H2A.Z but not of H3K9 at the p21 promoter correlated with p21 activation. We further show that HDACi treatment reduced the presence of the p400 chromatin remodeler at the p21 TSS. We propose a model in which association of p400 negatively affects p21 transcription by interfering with acetylation of H2A.Z.	[Bellucci, Luca; Dalvai, Mathieu; Kocanova, Silvia; Moutahir, Fatima; Bystricky, Kerstin] Univ Toulouse, Lab Biol Mol Eucaryote, Toulouse, France; [Bellucci, Luca; Dalvai, Mathieu; Kocanova, Silvia; Moutahir, Fatima; Bystricky, Kerstin] CNRS, LBME, UMR5099, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Bystricky, K (corresponding author), Univ Toulouse, Lab Biol Mol Eucaryote, Toulouse, France.	kerstin@biotoul.fr	BYSTRICKY, Kerstin/B-8670-2009; Bystricky, Kerstin/AAA-3003-2020	BYSTRICKY, Kerstin/0000-0001-6717-3721; Bystricky, Kerstin/0000-0001-6717-3721	Ligue Nationale Contre le Cancer; Institut National du Cancer (INCa) [34696]; Fondation pour la Recherche Medicale (FRM)	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was supported by the Ligue Nationale Contre le Cancer (fellowship to LB), the Institut National du Cancer (INCa grant #34696) and the Fondation pour la Recherche Medicale (FRM, fellowship to MD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Bowman TA, 2011, INT J CELL BIOL, V2011; Chan HM, 2005, GENE DEV, V19, P196, DOI 10.1101/gad.1280205; Dalvai M, 2010, J MAMMARY GLAND BIOL, V15, P19, DOI 10.1007/s10911-010-9167-z; Fleury L, 2008, ONCOGENE, V27, P4075, DOI 10.1038/onc.2008.41; Fortunati N, 2010, BREAST CANCER RES TR, V124, P667, DOI 10.1007/s10549-010-0789-z; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Gevry N, 2009, GENE DEV, V23, P1522, DOI 10.1101/gad.1787109; Giamarchi C, 1999, ONCOGENE, V18, P533, DOI 10.1038/sj.onc.1202317; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Henikoff S, 2005, ANNU REV CELL DEV BI, V21, P133, DOI 10.1146/annurev.cellbio.21.012704.133518; Hua S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.25; Huang LL, 2000, ONCOGENE, V19, P5712, DOI 10.1038/sj.onc.1203963; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Lavigne A.C., 2012, ONCOGENE IN PRESS; Legube G, 2004, J BIOL CHEM, V279, P44825, DOI 10.1074/jbc.M407478200; Love IM, 2012, CELL CYCLE, V11, P2458, DOI 10.4161/cc.20864; Mattera L, 2009, ONCOGENE, V28, P1506, DOI 10.1038/onc.2008.499; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Ocker M, 2007, INT J BIOCHEM CELL B, V39, P1367, DOI 10.1016/j.biocel.2007.03.001; Owen GI, 1998, J BIOL CHEM, V273, P10696, DOI 10.1074/jbc.273.17.10696; Park JH, 2010, MOL CELL BIOL, V30, P2750, DOI 10.1128/MCB.00804-09; Sowa Y, 1999, ANN NY ACAD SCI, V886, P195, DOI 10.1111/j.1749-6632.1999.tb09415.x; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suganuma T, 2008, CELL, V135, P604, DOI 10.1016/j.cell.2008.10.036; Suzuki T, 2000, INT J CANCER, V88, P992, DOI 10.1002/1097-0215(20001215)88:6<992::AID-IJC24>3.0.CO;2-9; TOUITOU I, 1991, J STEROID BIOCHEM, V40, P231, DOI 10.1016/0960-0760(91)90187-A; Tyteca S, 2006, EMBO J, V25, P1680, DOI 10.1038/sj.emboj.7601066; Valdes-Mora F, 2012, GENOME RES, V22, P307, DOI 10.1101/gr.118919.110; Wharton W, 2000, J BIOL CHEM, V275, P33981, DOI 10.1074/jbc.M005600200; Yang XW, 2000, CANCER RES, V60, P6890; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174	35	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54102	10.1371/journal.pone.0054102	http://dx.doi.org/10.1371/journal.pone.0054102			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349794	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872800025
J	Chan, YS; Huen, DS; Glauert, R; Whiteway, E; Russell, S				Chan, Yuk-Sang; Huen, David S.; Glauert, Ruth; Whiteway, Eleanor; Russell, Steven			Optimising Homing Endonuclease Gene Drive Performance in a Semi-Refractory Species: The Drosophila melanogaster Experience	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; SITE; EXPRESSION; VECTOR; SYSTEM	Homing endonuclease gene (HEG) drive is a promising insect population control technique that employs meganucleases to impair the fitness of pest populations. Our previous studies showed that HEG drive was more difficult to achieve in Drosophila melanogaster than Anopheles gambiae and we therefore investigated ways of improving homing performance in Drosophila. We show that homing in Drosophila responds to increased expression of HEGs specifically during the spermatogonia stage and this could be achieved through improved construct design. We found that 39-UTR choice was important to maximise expression levels, with HEG activity increasing as we employed Hsp70, SV40, vasa and beta Tub56D derived UTRs. We also searched for spermatogonium-specific promoters and found that the Rcd-1r promoter was able to drive specific expression at this stage. Since Rcd-1 is a regulator of differentiation in other species, it suggests that Rcd-1r may serve a similar role during spermatogonial differentiation in Drosophila. Contrary to expectations, a fragment containing the entire region between the TBPH gene and the bgcn translational start drove strong HEG expression only during late spermatogenesis rather than in the germline stem cells and spermatogonia as expected. We also observed that the fraction of targets undergoing homing was temperature-sensitive, falling nearly four-fold when the temperature was lowered to 18 degrees C. Taken together, this study demonstrates how a few simple measures can lead to substantial improvements in the HEG-based gene drive strategy and reinforce the idea that the HEG approach may be widely applicable to a variety of insect control programs.	[Chan, Yuk-Sang; Huen, David S.; Glauert, Ruth; Whiteway, Eleanor; Russell, Steven] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Russell, Steven] Cambridge Syst Biol Ctr, Cambridge, England	University of Cambridge; University of Cambridge	Huen, DS (corresponding author), Wolverhampton Univ, Sch Appl Sci, Wolverhampton WV1 1DJ, W Midlands, England.	david.s.huen@googlemail.com	Huen, David/F-3676-2014; Russell, Steve/A-4072-2011	Huen, David/0000-0002-9900-2297; Russell, Steve/0000-0003-0546-3031	FNIH grant; Bill & Melinda Gates Foundation	FNIH grant; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was funded via a FNIH grant to Austin Burt (Imperial College). The FNIH funding originated from the generous support of the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birnbaum RY, 2012, GENOME RES, V22, P1059, DOI 10.1101/gr.133546.111; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319; BUTTGEREIT D, 1993, MOL GEN GENET, V241, P263, DOI 10.1007/BF00284677; Chan YS, 2011, GENETICS, V188, P33, DOI 10.1534/genetics.111.127506; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Deredec A, 2008, GENETICS, V179, P2013, DOI 10.1534/genetics.108.089037; Deredec A, 2011, P NATL ACAD SCI USA, V108, pE874, DOI 10.1073/pnas.1110717108; Duncker BP, 1997, MOL GEN GENET, V254, P291, DOI 10.1007/s004380050418; Gonczy P, 1997, DEVELOPMENT, V124, P4361; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Jeongsil KH, 1999, MOL CELL BIOL, V19, P2505; John B., 2005, MEIOSIS; Kim E, 2012, GENOME RES, V22, P1327, DOI 10.1101/gr.138792.112; Lee JC, 2011, PEST MANAG SCI, V67, P1358, DOI 10.1002/ps.2225; Li Y, 2009, P NATL ACAD SCI USA, V106, P9304, DOI 10.1073/pnas.0901452106; Malacrida AR, 2007, GENETICA, V131, P1, DOI 10.1007/s10709-006-9117-2; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; McQuilton P, 2011, NUCLEIC ACIDS RES, V40, P1; Metzger MJ, 2011, NUCLEIC ACIDS RES, V39, P926, DOI 10.1093/nar/gkq826; Morris CA, 2009, NAT PROTOC, V4, P1807, DOI 10.1038/nprot.2009.192; Niu Y, 2008, J MOL BIOL, V382, P188, DOI 10.1016/j.jmb.2008.07.010; PETERSEN R, 1988, GENE, V72, P161, DOI 10.1016/0378-1119(88)90138-2; Quezada-Diaz JE, 2010, GENETICA, V138, P925, DOI 10.1007/s10709-010-9474-8; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Rong YS, 2003, GENETICS, V165, P1831; Rorth P, 1998, DEVELOPMENT, V125, P1049; Smith AM, 2009, P NATL ACAD SCI USA, V106, P5099, DOI 10.1073/pnas.0810588106; Takeuchi R, 2011, P NATL ACAD SCI USA, V108, P13077, DOI 10.1073/pnas.1107719108; Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474; Ulge UY, 2011, NUCLEIC ACIDS RES, V39, P4330, DOI 10.1093/nar/gkr022; Vibranovski MD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000731; Wang JB, 2012, GENOME RES, V22, P1316, DOI 10.1101/gr.122879.111; Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937	35	44	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54130	10.1371/journal.pone.0054130	http://dx.doi.org/10.1371/journal.pone.0054130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349805	Green Submitted, Green Published, gold			2022-12-25	WOS:000313872800026
J	Raynes, R; Pombier, KM; Nguyen, K; Brunquell, J; Mendez, JE; Westerheide, SD				Raynes, Rachel; Pombier, Kathleen M.; Nguyen, Kevin; Brunquell, Jessica; Mendez, Jamie E.; Westerheide, Sandy D.			The SIRT1 Modulators AROS and DBC1 Regulate HSF1 Activity and the Heat Shock Response	PLOS ONE			English	Article							YEAST LIFE-SPAN; CALORIE RESTRICTION; DEACETYLASE SIRT1; TRANSCRIPTION FACTORS; CELL-SURVIVAL; STRESS; P53; FACTOR-1; PHOSPHORYLATION; PGC-1-ALPHA	The heat shock response, the cellular response to protein damaging stress, is critical in maintaining proteostasis. The heat shock response is regulated by the transcription factor HSF1, which is activated upon heat shock and other stresses to induce the expression of molecular chaperones. SIRT1 has previously been shown to activate HSF1 by deacetylating it, leading to increased DNA binding ability. We have investigated how the heat shock response may be controlled by factors influencing SIRT1 activity. We found that heat shock results in an increase in the cellular NAD(+)/NADH ratio and an increase in recruitment of SIRT1 to the hsp70 promoter. Furthermore, we found that the SIRT1 modulators AROS and DBC1 have an impact on hsp70 transcription, HSF1 acetylation status, and HSF1 recruitment to the hsp70 promoter. Therefore, AROS and DBC1 are now two new targets available for therapeutic regulation of the heat shock response.	[Raynes, Rachel; Pombier, Kathleen M.; Nguyen, Kevin; Brunquell, Jessica; Mendez, Jamie E.; Westerheide, Sandy D.] Univ S Florida, Coll Arts & Sci, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Westerheide, SD (corresponding author), Univ S Florida, Coll Arts & Sci, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA.	swesterheide@usf.edu			Cell Biology, Microbiology and Molecular Biology Department at the University of South Florida	Cell Biology, Microbiology and Molecular Biology Department at the University of South Florida	This work was supported by a departmental start-up grant from the Cell Biology, Microbiology and Molecular Biology Department at the University of South Florida to S.D.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Anderson RM, 2003, SCIENCE, V302, P2124, DOI 10.1126/science.1088697; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beresford GW, 2001, NAT IMMUNOL, V2, P652, DOI 10.1038/89810; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Cotto JJ, 1997, J CELL SCI, V110, P2925; Donmez G, 2012, J NEUROSCI, V32, P124, DOI 10.1523/JNEUROSCI.3442-11.2012; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Ethridge RT, 1998, GASTROENTEROLOGY, V115, P1454, DOI 10.1016/S0016-5085(98)70024-1; Holmberg CI, 2001, EMBO J, V20, P3800, DOI 10.1093/emboj/20.14.3800; Jung KJ, 2009, INFLAMM RES, V58, P143, DOI 10.1007/s00011-008-7227-2; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lavu S, 2008, NAT REV DRUG DISCOV, V7, P841, DOI 10.1038/nrd2665; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Menssen A, 2012, P NATL ACAD SCI USA, V109, pE187, DOI 10.1073/pnas.1105304109; Morimoto RI, 2009, HDB CELL SIGNALING, P2231; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Pagans S, 2005, PLOS BIOL, V3, P210, DOI 10.1371/journal.pbio.0030041; Rahat O, 2011, J GERONTOL A-BIOL, V66, P163, DOI 10.1093/gerona/glq165; Raynes R, 2012, J BIOL CHEM; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Salminen A, 2008, AGEING RES REV, V7, P83, DOI 10.1016/j.arr.2007.09.002; Santagata S, 2011, P NATL ACAD SCI USA, V108, P18378, DOI 10.1073/pnas.1115031108; Senawong T, 2005, ARCH BIOCHEM BIOPHYS, V434, P316, DOI 10.1016/j.abb.2004.10.028; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Westerheide SD, 2006, J BIOL CHEM, V281, P9616, DOI 10.1074/jbc.M512044200; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; Zschoernig B, 2008, BIOCHEM BIOPH RES CO, V376, P251, DOI 10.1016/j.bbrc.2008.08.137	42	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54364	10.1371/journal.pone.0054364	http://dx.doi.org/10.1371/journal.pone.0054364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349863	Green Submitted, Green Published, gold			2022-12-25	WOS:000313872800043
J	Mkrtchyan, HV; Russell, CA; Wang, N; Cutler, RR				Mkrtchyan, Hermine V.; Russell, Charlotte A.; Wang, Nan; Cutler, Ronald R.			Could Public Restrooms Be an Environment for Bacterial Resistomes?	PLOS ONE			English	Article							LASER-DESORPTION IONIZATION; FLIGHT MASS-SPECTROMETRY; STAPHYLOCOCCUS-HAEMOLYTICUS; RAPID IDENTIFICATION; RESISTANCE; COMMUNITY; TOILETS; CHALLENGES; PATHOGENS; CARRIAGE	Antibiotic resistance in bacteria remains a major problem and environments that help to maintain such resistance, represent a significant problem to infection control in the community. Restrooms have always been regarded as potential sources of infectious diseases and we suggest they have the potential to sustain bacterial "resistomes". Recent studies have demonstrated the wide range of different bacterial phyla that can be found in non-healthcare restrooms. In our study we focused on the Staphylococci. These species are often skin contaminants on man and have been reported as common restroom isolates in recent molecular studies. We collected samples from 18 toilets sited in 4 different public buildings. Using MALDI-TOF-MS and other techniques, we identified a wide range of antibiotic resistant Staphylococci and other bacteria from our samples. We identified 19 different Staphylococcal species within our isolates and 37.8% of the isolates were drug resistant. We also identified different Staphylococcal species with the same antibiograms inhabiting the same restrooms. Bacterial "resistomes" are communities of bacteria often localised in specific areas and within these environments drug resistance determinants may be freely transferred. Our study shows that non-healthcare restrooms are a source of antibiotic resistant bacteria where a collection of antibiotic resistance genes in pathogenic and non-pathogenic bacteria could form a resistome containing a "nexus of genetic diversity"	[Mkrtchyan, Hermine V.; Wang, Nan; Cutler, Ronald R.] Queen Mary Univ London, Sch Biol & Chem Sci, Preclin Drug Discovery Grp, London, England; [Russell, Charlotte A.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Wang, Nan] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Peoples R China	University of London; Queen Mary University London; University of London; Queen Mary University London; University of Electronic Science & Technology of China	Cutler, RR (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Preclin Drug Discovery Grp, London, England.	r.cutler@qmul.ac.uk		Mkrtchyan, Hermine/0000-0001-7339-7297				Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Barker J, 2000, J APPL MICROBIOL, V89, P137, DOI 10.1046/j.1365-2672.2000.01091.x; Benagli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016424; Bizzini A, 2010, CLIN MICROBIOL INFEC, V16, P1614, DOI 10.1111/j.1469-0691.2010.03311.x; Bocher S, 2010, CLIN MICROBIOL INFEC, V16, P1427, DOI [10.1111/j.1469-0691.2010.03137.x, 10.1111/j.1469-0691.2009.03137.x]; Carbonnelle E, 2007, J CLIN MICROBIOL, V45, P2156, DOI 10.1128/JCM.02405-06; Cizman M, 2003, INT J ANTIMICROB AG, V21, P297, DOI 10.1016/S0924-8579(02)00394-1; Edern A, 2012, NEPHROL THER; Fajardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001619; Flores GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028132; Fox K, 2011, J MICROBIOL METH, V84, P243, DOI 10.1016/j.mimet.2010.12.007; Fredheim EGA, 2009, J CLIN MICROBIOL, V47, P1172, DOI 10.1128/JCM.01891-08; Gardner A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000752; GERBA CP, 1975, APPL MICROBIOL, V30, P229, DOI 10.1128/AEM.30.2.229-237.1975; Goto H, 2009, J INFECT CHEMOTHER, V15, P347, DOI 10.1007/s10156-009-0719-3; Karakulska J, 2012, J MICROBIOL, V50, P444, DOI 10.1007/s12275-012-1550-6; Katayama Y, 2001, ANTIMICROB AGENTS CH, V45, P1955, DOI 10.1128/AAC.45.7.1955-1963.2001; Kliem M, 2012, CURR OPIN MICROBIOL, V15, P397, DOI 10.1016/j.mib.2012.02.006; Koksal F, 2009, MICROBIOL RES, V164, P404, DOI 10.1016/j.micres.2007.03.004; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Kummerer K, 2004, J ANTIMICROB CHEMOTH, V54, P311, DOI 10.1093/jac/dkh325; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Marshall B., 2009, MICROBE WASH 600, V4, P231, DOI [DOI 10.1128/MICROBE.4.231.1, 10.1128/microbe.4.231.1]; MENDES MF, 1976, J HYG-CAMBRIDGE, V76, P183, DOI 10.1017/S002217240005508X; Miller YW, 1996, J ANTIMICROB CHEMOTH, V38, P829; Miyakis S, 2011, CLIN INFECT DIS, V53, P177, DOI 10.1093/cid/cir323; Nakib Al M, 2012, DIAGN MICROBIOL INFE, V72, P193, DOI [10.1016/j.diagmicrobio.2011.10.004, DOI 10.1016/J.DIAGMICROBIO.2011.10.004]; Nathwani D, 2008, J ANTIMICROB CHEMOTH, V61, P976, DOI 10.1093/jac/dkn096; Nelson L, 2006, EMERG INFECT DIS, V12, P172, DOI 10.3201/eid1201.050279; OVERMAN TL, 1985, J CLIN MICROBIOL, V21, P542, DOI 10.1128/JCM.21.4.542-545.1985; Park JY, 2011, VET MICROBIOL, V147, P142, DOI 10.1016/j.vetmic.2010.06.020; Rahman A, 2012, Mymensingh Med J, V21, P195; SCOTT E, 1982, J HYG-CAMBRIDGE, V89, P279, DOI 10.1017/S0022172400070819; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Vickers AA, 2007, ANTIMICROB AGENTS CH, V51, P4484, DOI 10.1128/AAC.00708-07; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614; Wright GD, 2010, CURR OPIN MICROBIOL, V13, P589, DOI 10.1016/j.mib.2010.08.005	37	37	40	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54223	10.1371/journal.pone.0054223	http://dx.doi.org/10.1371/journal.pone.0054223			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349833	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000313738900055
J	Mushaben, EM; Brandt, EB; Hershey, GKK; Le Cras, TD				Mushaben, Elizabeth M.; Brandt, Eric B.; Hershey, Gurjit K. Khurana; Le Cras, Timothy D.			Differential Effects of Rapamycin and Dexamethasone in Mouse Models of Established Allergic Asthma	PLOS ONE			English	Article							REGULATORY T-CELLS; AIRWAY INFLAMMATION; GOBLET CELLS; HOUSE-DUST; B-CELLS; MTOR; HYPERREACTIVITY; DISEASE; PROTEIN; INNATE	The mammalian target of rapamycin (mTOR) plays an important role in cell growth/differentiation, integrating environmental cues, and regulating immune responses. Our lab previously demonstrated that inhibition of mTOR with rapamycin prevented house dust mite (HDM)-induced allergic asthma in mice. Here, we utilized two treatment protocols to investigate whether rapamycin, compared to the steroid, dexamethasone, could inhibit allergic responses during the later stages of the disease process, namely allergen re-exposure and/or during progression of chronic allergic disease. In protocol 1, BALB/c mice were sensitized to HDM (three i.p. injections) and administered two intranasal HDM exposures. After 6 weeks of rest/recovery, mice were re-exposed to HDM while being treated with rapamycin or dexamethasone. In protocol 2, mice were exposed to HDM for 3 or 6 weeks and treated with rapamycin or dexamethasone during weeks 4-6. Characteristic features of allergic asthma, including IgE, goblet cells, airway hyperreactivity (AHR), inflammatory cells, cytokines/chemokines, and T cell responses were assessed. In protocol 1, both rapamycin and dexamethasone suppressed goblet cells and total CD4(+) T cells including activated, effector, and regulatory T cells in the lung tissue, with no effect on AHR or total inflammatory cell numbers in the bronchoalveolar lavage fluid. Rapamycin also suppressed IgE, although IL-4 and eotaxin 1 levels were augmented. In protocol 2, both drugs suppressed total CD4+ T cells, including activated, effector, and regulatory T cells and IgE levels. IL-4, eotaxin, and inflammatory cell numbers were increased after rapamycin and no effect on AHR was observed. Dexamethasone suppressed inflammatory cell numbers, especially eosinophils, but had limited effects on AHR. We conclude that while mTOR signaling is critical during the early phases of allergic asthma, its role is much more limited once disease is established.	[Mushaben, Elizabeth M.; Le Cras, Timothy D.] Univ Cincinnati, Sch Med, Cincinnati Childrens Hosp, Div Pulm Biol,Dept Pediat, Cincinnati, OH 45221 USA; [Brandt, Eric B.; Hershey, Gurjit K. Khurana] Univ Cincinnati, Sch Med, Cincinnati Childrens Hosp, Div Asthma Res,Dept Pediat, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Le Cras, TD (corresponding author), Univ Cincinnati, Sch Med, Cincinnati Childrens Hosp, Div Pulm Biol,Dept Pediat, Cincinnati, OH 45221 USA.	tim.lecras@cchmc.org		Brandt, Eric/0000-0003-0617-4100; Le Cras, Timothy/0000-0001-8538-2703	National Institutes of Health [U19A170235, HL097135]; NIEHS [T32 ES010957]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES010957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was funded by National Institutes of Health Grants U19A170235 (GKH), HL097135 (TDLC and GKH), and NIEHS T32 ES010957 (EBB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejandre-Alcazar MA, 2007, DEV DYNAM, V236, P2825, DOI 10.1002/dvdy.21293; Ballou Lisa M, 2008, J Chem Biol, V1, P27, DOI 10.1007/s12154-008-0003-5; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Benhamron S, 2011, EUR J IMMUNOL, V41, P2390, DOI 10.1002/eji.201041336; Chen G, 2009, J CLIN INVEST, V119, P2914, DOI 10.1172/JCI39731; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; de Kluijver J, 2002, AM J RESP CRIT CARE, V166, P294, DOI 10.1164/rccm.2112097; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dumont F J, 1996, Life Sci, V58, P373; Fredriksson K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033984; Gessner A, 2005, J IMMUNOL, V174, P1063, DOI 10.4049/jimmunol.174.2.1063; Hamid Q, 2009, ANNU REV PHYSIOL, V71, P489, DOI 10.1146/annurev.physiol.010908.163200; Heidt S, 2008, TRANSPLANTATION, V86, P1292, DOI 10.1097/TP.0b013e3181874a36; Hesselmar B, 2000, PEDIATR ALLERGY IMMU, V11, P74, DOI 10.1034/j.1399-3038.2000.00070.x; Holgate ST, 2005, AM J RESP CRIT CARE, V172, P941, DOI 10.1164/rccm.2507007; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Jungsuwadee P, 2004, CLIN IMMUNOL, V110, P13, DOI 10.1016/j.clim.2003.09.003; Kay AB, 2006, CHEM IMMUNOL ALLERGY, V91, P59; Kearley J, 2005, J EXP MED, V202, P1539, DOI 10.1084/jem.20051166; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Kim J, 2004, AM J PHYSIOL-LUNG C, V287, pL503, DOI 10.1152/ajplung.00433.2003; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Kramer EL, 2011, J APPL PHYSIOL, V111, P1760, DOI 10.1152/japplphysiol.00737.2011; Kramer EL, 2009, AM J RESP CELL MOL, V41, P415, DOI 10.1165/rcmb.2008-0470OC; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Le Cras TD, 2004, AM J PHYSIOL-LUNG C, V287, pL718, DOI 10.1152/ajplung.00084.2004; Le Cras TD, 2011, AM J PHYSIOL-LUNG C, V300, pL414, DOI 10.1152/ajplung.00346.2010; Leech MD, 2007, J IMMUNOL, V179, P7050, DOI 10.4049/jimmunol.179.10.7050; Leverkoehne I, 2002, J HISTOCHEM CYTOCHEM, V50, P829, DOI 10.1177/002215540205000609; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Liu GW, 2010, NAT IMMUNOL, V11, P1047, DOI 10.1038/ni.1939; Lloyd CM, 2010, NAT REV IMMUNOL, V10, P838, DOI 10.1038/nri2870; Ma JX, 2011, J ALLERGY CLIN IMMUN, V127, P1447, DOI 10.1016/j.jaci.2011.01.032; Martin P, 2010, MOL CELL BIOL, V30, P4877, DOI 10.1128/MCB.00456-10; Martin P, 2010, J ALLERGY CLIN IMMUN, V126, P355, DOI 10.1016/j.jaci.2010.05.010; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Miki-Hosokawa T, 2009, J IMMUNOL, V183, P8203, DOI 10.4049/jimmunol.0900646; Mushaben EM, 2011, J IMMUNOL, V187, P5756, DOI 10.4049/jimmunol.1102133; Perkins C, 2006, J ALLERGY CLIN IMMUN, V118, P410, DOI 10.1016/j.jaci.2006.06.004; Perkins C, 2011, J EXP MED, V208, P853, DOI 10.1084/jem.20100023; Powell JD, 2010, IMMUNITY, V33, P301, DOI 10.1016/j.immuni.2010.09.002; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Saemann MD, 2009, AM J TRANSPLANT, V9, P2655, DOI 10.1111/j.1600-6143.2009.02832.x; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Saunders RN, 2001, KIDNEY INT, V59, P3, DOI 10.1046/j.1523-1755.2001.00460.x; Shinoda K, 2012, P NATL ACAD SCI USA, V109, P7409, DOI 10.1073/pnas.1118539109; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Siegle JS, 2006, AM J RESP CELL MOL, V35, P565, DOI 10.1165/rcmb.2006-0135OC; Strauss L, 2007, J IMMUNOL, V178, P320, DOI 10.4049/jimmunol.178.1.320; Taams LS, 2006, IMMUNOLOGY, V118, P1, DOI 10.1111/j.1365-2567.2006.02348.x; Ulrich K, 2008, PULM PHARMACOL THER, V21, P637, DOI 10.1016/j.pupt.2008.02.006; Zhang SL, 2011, BLOOD, V117, P1228, DOI 10.1182/blood-2010-05-287821; Zhang X, 2009, J IMMUNOL, V182, P5123, DOI 10.4049/jimmunol.0804276	56	26	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54426	10.1371/journal.pone.0054426	http://dx.doi.org/10.1371/journal.pone.0054426			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349887	Green Published, Green Submitted, gold			2022-12-25	WOS:000313738900067
J	Wang, LF; Li, J; Ruan, YY; Lu, TL; Liu, CX; Jia, MX; Yue, WH; Liu, J; Bourgeron, T; Zhang, D				Wang, Lifang; Li, Jun; Ruan, Yanyan; Lu, Tianlan; Liu, Chenxing; Jia, Meixiang; Yue, Weihua; Liu, Jing; Bourgeron, Thomas; Zhang, Dai			Sequencing ASMT Identifies Rare Mutations in Chinese Han Patients with Autism	PLOS ONE			English	Article							DE-NOVO MUTATIONS; SPECTRUM DISORDERS; MELATONIN SYNTHESIS; PROTEIN FUNCTION; MOOD DISORDERS; GENE; PATHWAY; ASSOCIATION; CHILDREN; INSOMNIA	Melatonin is involved in the regulation of circadian and seasonal rhythms and immune function. Prior research reported low melatonin levels in autism spectrum disorders (ASD). ASMT located in pseudo-autosomal region 1 encodes the last enzyme of the melatonin biosynthesis pathway. A previous study reported an association between ASD and single nucleotide polymorphisms (SNPs) rs4446909 and rs5989681 located in the promoter of ASMT. Furthermore, rare deleterious mutations were identified in a subset of patients. To investigate the association between ASMT and autism, we sequenced all ASMT exons and its neighboring region in 398 Chinese Han individuals with autism and 437 healthy controls. Although our study did not detect significant differences of genotypic distribution and allele frequencies of the common SNPs in ASMT between patients with autism and healthy controls, we identified new rare coding mutations of ASMT. Among these rare variants, 4 were exclusively detected in patients with autism including a stop mutation (p.R115W, p.V166I, p.V179G, and p.W257X). These four coding variants were observed in 6 of 398 (1.51%) patients with autism and none in 437 controls (Chi-Square test, Continuity Correction p = 0.032, two-sided). Functional prediction of impact of amino acid showed that p.R115W might affect protein function. These results indicate that ASMT might be a susceptibility gene for autism. Further studies in larger samples are needed to better understand the degree of variation in this gene as well as to understand the biochemical and clinical impacts of ASMT/melatonin deficiency.	[Wang, Lifang; Li, Jun; Ruan, Yanyan; Lu, Tianlan; Liu, Chenxing; Jia, Meixiang; Yue, Weihua; Liu, Jing; Zhang, Dai] Peking Univ, Minist Hlth, Key Lab Mental Hlth, Beijing 100871, Peoples R China; [Wang, Lifang; Li, Jun; Ruan, Yanyan; Lu, Tianlan; Liu, Chenxing; Yue, Weihua; Zhang, Dai] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [Zhang, Dai] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Bourgeron, Thomas] Inst Pasteur, CNRS, URA Genes Synapses & Cognit 2182, Paris, France; [Bourgeron, Thomas] Univ Paris Diderot, Paris, France	Peking University; Peking University; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Wang, LF (corresponding author), Peking Univ, Minist Hlth, Key Lab Mental Hlth, Beijing 100871, Peoples R China.	lifangwang@bjmu.edu.cn; daizhang@bjmu.edu.cn	Jia, Mei/GXZ-9967-2022	Bourgeron, Thomas/0000-0001-8164-9220	National Basic Research Development Program of China (973 program) [2010CB833905]; National Natural Science Foundation [30870897, 81071110]; Beijing Natural Science Foundation [7081005]	National Basic Research Development Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by research grants from the National Basic Research Development Program of China (973 program 2010CB833905), National Natural Science Foundation (grant number 30870897 and 81071110), and Beijing Natural Science Foundation (grant number: 7081005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agez L, 2009, J PINEAL RES, V46, P95, DOI 10.1111/j.1600-079X.2008.00636.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Botros HG, 2012, J PINEAL RES; Cai GQ, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-50; Chaste P, 2011, J PINEAL RES, V51, P394, DOI 10.1111/j.1600-079X.2011.00902.x; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Etain B, 2012, HUM MOL GENET, V21, P4030, DOI 10.1093/hmg/dds227; Folstein SE, 2001, NAT REV GENET, V2, P943, DOI 10.1038/35103559; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Galecki P, 2010, J PINEAL RES, V48, P311, DOI 10.1111/j.1600-079X.2010.00754.x; HALLIWELL B, 1992, ANN NEUROL, V32, pS10, DOI 10.1002/ana.410320704; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jimenez-Jorge S, 2007, J PINEAL RES, V42, P240, DOI 10.1111/j.1600-079X.2006.00411.x; Jonsson L, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-10; Kripke Daniel F, 2011, J Circadian Rhythms, V9, P8, DOI 10.1186/1740-3391-9-8; Kulman G, 2000, NEUROENDOCRINOL LETT, V21, P31; Kumar PNS, 2007, J CLIN PSYCHIAT, V68, P237, DOI 10.4088/JCP.v68n0208; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LAM RW, 1990, PSYCHIAT RES, V33, P129, DOI 10.1016/0165-1781(90)90066-E; Leblond CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002521; Maldonado MD, 2007, J PINEAL RES, V42, P1, DOI 10.1111/j.1600-079X.2006.00376.x; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Melke J, 2008, MOL PSYCHIATR, V13, P90, DOI 10.1038/sj.mp.4002016; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nir I, 1995, J AUTISM DEV DISORD, V25, P641, DOI 10.1007/BF02178193; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Pagan C, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-17; Park HJ, 2011, J MOL NEUROSCI, V45, P304, DOI 10.1007/s12031-011-9522-6; Perlis ML, 1997, J AFFECT DISORDERS, V42, P209, DOI 10.1016/S0165-0327(96)01411-5; Rutter M, 2000, J ABNORM CHILD PSYCH, V28, P3, DOI 10.1023/A:1005113900068; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Srinivasan V, 2008, NEUROIMMUNOMODULAT, V15, P93, DOI 10.1159/000148191; Srinivasan V, 2006, WORLD J BIOL PSYCHIA, V7, P138, DOI 10.1080/15622970600571822; Taupin Philippe, 2008, Int J Med Sci, V5, P127; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Toma C, 2007, MOL PSYCHIATR, V12, P977, DOI 10.1038/sj.mp.4002069; Tordjman S, 2005, BIOL PSYCHIAT, V57, P134, DOI 10.1016/j.biopsych.2004.11.003; Veenstra-Vanderweele J, 2003, J AM ACAD CHILD PSY, V42, P116, DOI 10.1097/00004583-200301000-00018; Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016	44	20	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53727	10.1371/journal.pone.0053727	http://dx.doi.org/10.1371/journal.pone.0053727			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349736	Green Published, Green Submitted, gold			2022-12-25	WOS:000313738900018
J	Tichy, H; Kallina, W				Tichy, Harald; Kallina, Wolfgang			The Evaporative Function of Cockroach Hygroreceptors	PLOS ONE			English	Article							STICK INSECT; HUMIDITY; ANTENNA; SENSILLA; MOIST; THERMORECEPTORS; PERIPLANETA; RECEPTOR	Insect hygroreceptors associate as antagonistic pairs of a moist cell and a dry cell together with a cold cell in small cuticular sensilla on the antennae. The mechanisms by which the atmospheric humidity stimulates the hygroreceptive cells remain elusive. Three models for humidity transduction have been proposed in which hygroreceptors operate either as mechanical hygrometers, evaporation detectors or psychrometers. Mechanical hygrometers are assumed to respond to the relative humidity, evaporation detectors to the saturation deficit and psychrometers to the temperature depression (the difference between wet-bulb and dry-bulb temperatures). The models refer to different ways of expressing humidity. This also means, however, that at different temperatures these different types of hygroreceptors indicate very different humidity conditions. The present study tested the adequacy of the three models on the cockroach's moist and dry cells by determining whether the specific predictions about the temperature-dependence of the humidity responses are indeed observed. While in previous studies stimulation consisted of rapid step-like humidity changes, here we changed humidity slowly and continuously up and down in a sinusoidal fashion. The low rates of change made it possible to measure instantaneous humidity values based on UV-absorption and to assign these values to the hygroreceptive sensillum. The moist cell fitted neither the mechanical hygrometer nor the evaporation detector model: the temperature dependence of its humidity responses could not be attributed to relative humidity or to saturation deficit, respectively. The psychrometer model, however, was verified by the close relationships of the moist cell's response with the wet-bulb temperature and the dry cell's response with the dry-bulb temperature. Thus, the hygroreceptors respond to evaporation and the resulting cooling due to the wetness or dryness of the air. The drier the ambient air (absolutely) and the higher the temperature, the greater the evaporative temperature depression and the power to desiccate.	[Tichy, Harald; Kallina, Wolfgang] Univ Vienna, Dept Neurobiol, Fac Life Sci, Vienna, Austria	University of Vienna	Tichy, H (corresponding author), Univ Vienna, Dept Neurobiol, Fac Life Sci, Vienna, Austria.	harald.tichy@univie.ac.at		Harald, Tichy/0000-0003-1582-5139	Austrian Science Fund [P20.197-B17]; Austrian Science Fund (FWF) [P 20196] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by a grant from the Austrian Science Fund (Project P20.197-B17) (www.fwf.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTNER H, 1985, ANNU REV ENTOMOL, V30, P273, DOI 10.1146/annurev.en.30.010185.001421; ALTNER H, 1983, CELL TISSUE RES, V234, P279, DOI 10.1007/BF00213769; Becker D, 1978, ELEKTROPHYSIOLOGISCH, P160; Crank J, 1960, MOISTURE TEXTILES, P106; Diem K, 1968, WISSENSCHAFTLICHE TA; ITOH T, 1984, ZOOL SCI, V1, P533; LOFTUS R, 1976, J COMP PHYSIOL, V111, P153, DOI 10.1007/BF00605530; LOFTUS R, 1987, J COMP PHYSIOL A, V161, P399, DOI 10.1007/BF00603965; Resch R, 1998, APPL PHYS A-MATER, V66, pS607, DOI 10.1007/s003390051209; STEINBRECHT RA, 1991, CELL TISSUE RES, V266, P441, DOI 10.1007/BF00318585; Steinbrecht RA, 1998, MICROSCOPIC ANATOMY OF INVERTEBRATES, VOL 11 A-C, P405; TICHY H, 1987, J COMP PHYSIOL A, V160, P43, DOI 10.1007/BF00613440; Tichy H, 2003, J COMP PHYSIOL A, V189, P175, DOI 10.1007/s00359-003-0397-z; Tichy H, 2010, J NEUROPHYSIOL, V103, P3274, DOI 10.1152/jn.01043.2009; TICHY H, 1979, J COMP PHYSIOL, V132, P149, DOI 10.1007/BF00610718; TICHY H, 1990, J COMP PHYSIOL A, V166, P507, DOI 10.1007/BF00192021; Tichy H, 1996, NATURWISSENSCHAFTEN, V83, P255; Tichy H., 2001, ECOLOGY SENSING, P271, DOI [10.1007/978-3-662-22644-5_14, DOI 10.1007/978-3-662-22644-5_14]; Tichy H, 2007, J NEUROPHYSIOL, V97, P3851, DOI 10.1152/jn.00097.2007; Urquhart A. R., 1960, MOISTURE TEXTILES, P14; YOKOHARI F, 1976, J COMP PHYSIOL, V106, P137, DOI 10.1007/BF00620495; YOKOHARI F, 1978, J COMP PHYSIOL, V124, P53, DOI 10.1007/BF00656391; Yokohari Fumio, 1999, P191	23	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53998	10.1371/journal.pone.0053998	http://dx.doi.org/10.1371/journal.pone.0053998			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342058	Green Published, Green Submitted, gold			2022-12-25	WOS:000313682700072
J	Wang, B; Xiao, JH; Bian, SN; Niu, LM; Murphy, RW; Huang, DW				Wang, Bo; Xiao, Jin-Hua; Bian, Sheng-Nan; Niu, Li-Ming; Murphy, Robert W.; Huang, Da-Wei			Evolution and Expression Plasticity of Opsin Genes in a Fig Pollinator, Ceratosolen solmsi	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; PCR DATA-ANALYSIS; COLOR-VISION; VISUAL PIGMENTS; LIGHT; DIVERSIFICATION; DUPLICATION; PHYLOGENY; BUTTERFLIES; RECEPTOR	Figs and fig pollinators have co-evolved species-specific systems of mutualism. So far, it was unknown how visual opsin genes of pollinators have evolved in the light conditions inside their host figs. We cloned intact full-length mRNA sequences of four opsin genes from a species of fig pollinator, Ceratosolen solmsi, and tested for selective pressure and expressional plasticity of these genes. Molecular evolutionary analysis indicated that the four opsin genes evolved under different selective constraints. Subsets of codons in the two long wavelength sensitive opsin (LW1, LW2) genes were positively selected in ancestral fig pollinators. The ultraviolet sensitive opsin (UV) gene was under strong purifying selection, whereas a relaxation of selective constrains occurred on several amino acids in the blue opsin. RT-qPCR analysis suggested that female and male fig pollinators had different expression patterns possibly due to their distinct lifestyles and different responses to light within the syconia. Co-evolutionary history with figs might have influenced the evolution and expression plasticity of opsin genes in fig pollinators.	[Wang, Bo; Xiao, Jin-Hua; Huang, Da-Wei] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Wang, Bo] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Bian, Sheng-Nan; Huang, Da-Wei] Shandong Agr Univ, Plant Protect Coll, Tai An, Shandong, Peoples R China; [Niu, Li-Ming] Chinese Acad Trop Agr Sci, Environm & Plant Protect Inst, Danzhou, Hainan, Peoples R China; [Murphy, Robert W.] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Murphy, Robert W.] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shandong Agricultural University; Chinese Academy of Tropical Agricultural Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology; Royal Ontario Museum	Huang, DW (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	huangdw619@gmail.com		Murphy, Robert/0000-0001-8555-2338	National Natural Science Foundation of China (NSFC) [31090253, 31172072, 31210103912]; Major Innovation Program of Chinese Academy of Sciences [KSCX2-EW-Z-2]; Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences; National Science Fund for Fostering Talents in Basic Research [NSFC-J0930004]; Natural Sciences and Engineering Research Council (Canada) [3148]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Major Innovation Program of Chinese Academy of Sciences; Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences; National Science Fund for Fostering Talents in Basic Research; Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This project was supported by the National Natural Science Foundation of China (NSFC grant no. 31090253, 31172072, 31210103912), partially by Major Innovation Program of Chinese Academy of Sciences (KSCX2-EW-Z-2), a grant (No. O529YX5105) from the Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences and National Science Fund for Fostering Talents in Basic Research (Special subjects in animal taxonomy, NSFC-J0930004), and by a Natural Sciences and Engineering Research Council (Canada) Discovery Grant (3148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anstett MC, 1997, TRENDS ECOL EVOL, V12, P94, DOI 10.1016/S0169-5347(96)10064-1; Astruc C, 2004, MOL PHYLOGENET EVOL, V31, P880, DOI 10.1016/j.ympev.2003.10.024; Awata H, 2009, J COMP PHYSIOL A, V195, P401, DOI 10.1007/s00359-009-0418-7; Batcha AH, 2012, NEUROBIOL DIS, V45, P887, DOI 10.1016/j.nbd.2011.12.004; Briscoe AD, 2000, J MOL EVOL, V51, P110, DOI 10.1007/s002390010071; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Briscoe AD, 2002, MOL BIOL EVOL, V19, P983, DOI 10.1093/oxfordjournals.molbev.a004158; Briscoe AD, 2010, P NATL ACAD SCI USA, V107, P3628, DOI 10.1073/pnas.0910085107; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CARULLI JP, 1994, J MOL EVOL, V38, P250, DOI 10.1007/BF00176087; Compton SG, 2010, BIOL LETTERS, V6, P838, DOI 10.1098/rsbl.2010.0389; Cook JM, 2010, ECOL ENTOMOL, V35, P54, DOI 10.1111/j.1365-2311.2009.01148.x; Cook JM, 2005, CURR BIOL, V15, pR978, DOI 10.1016/j.cub.2005.11.057; Dalal JS, 2003, VISUAL NEUROSCI, V20, P523, DOI 10.1017/S095252380320506X; Frentiu FD, 2007, P NATL ACAD SCI USA, V104, P8634, DOI 10.1073/pnas.0701447104; Fuller RC, 2011, MOL ECOL, V20, P3321, DOI 10.1111/j.1365-294X.2011.05180.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Henze MJ, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-163; Hunt DM, 2001, CELL MOL LIFE SCI, V58, P1583, DOI 10.1007/PL00000798; Karlen Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-131; Kisselev OG, 2005, EXP EYE RES, V81, P366, DOI 10.1016/j.exer.2005.06.018; Koyanagi M, 2008, J MOL EVOL, V66, P130, DOI 10.1007/s00239-008-9065-9; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lalitha S, 2000, BIOTECH SOFTWARE INT, V1, P270, DOI DOI 10.1089/152791600459894; Lopez-Vaamonde C, 2009, MOL PHYLOGENET EVOL, V52, P715, DOI 10.1016/j.ympev.2009.05.028; Maksimovic S, 2009, J EXP BIOL, V212, P3781, DOI 10.1242/jeb.031773; McLeish MJ, 2010, MOL ECOL, V19, P1483, DOI 10.1111/j.1365-294X.2010.04583.x; Mollon JD, 1999, P NATL ACAD SCI USA, V96, P4743, DOI 10.1073/pnas.96.9.4743; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Munro JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027023; Palczewski K, 2012, J BIOL CHEM, V287, P1612, DOI 10.1074/jbc.R111.301150; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Porter ML, 2012, P ROY SOC B-BIOL SCI, V279, P3, DOI 10.1098/rspb.2011.1819; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ronsted N, 2005, P ROY SOC B-BIOL SCI, V272, P2593, DOI 10.1098/rspb.2005.3249; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sasagawa H, 2003, EUR J NEUROSCI, V17, P963, DOI 10.1046/j.1460-9568.2003.02528.x; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Sekharan S, 2011, J AM CHEM SOC, V133, P19052, DOI 10.1021/ja208789h; Shichida Y, 1998, CELL MOL LIFE SCI, V54, P1299, DOI 10.1007/s000180050256; Sison-Mangus MP, 2006, J EXP BIOL, V209, P3079, DOI 10.1242/jeb.02360; Sison-Mangus MP, 2005, INTEGR COMP BIOL, V45, P1073; Spaethe J, 2004, MOL BIOL EVOL, V21, P1583, DOI 10.1093/molbev/msh162; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor SD, 2005, MOL BIOL EVOL, V22, P1165, DOI 10.1093/molbev/msi110; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Tierney SM, 2012, P ROY SOC B-BIOL SCI, V279, P794, DOI 10.1098/rspb.2011.1355; Trezise AEO, 2005, CURR BIOL, V15, pR794, DOI 10.1016/j.cub.2005.09.025; Velarde RA, 2005, INSECT BIOCHEM MOLEC, V35, P1367, DOI 10.1016/j.ibmb.2005.09.001; Wakakuwa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015015; Weiblen GD, 2002, ANNU REV ENTOMOL, V47, P299, DOI 10.1146/annurev.ento.47.091201.145213; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yang ZH, 2011, MOL BIOL EVOL, V28, P1217, DOI 10.1093/molbev/msq303; Yuan FR, 2010, MOL BIOL EVOL, V27, P2392, DOI 10.1093/molbev/msq124; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	60	20	22	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53907	10.1371/journal.pone.0053907	http://dx.doi.org/10.1371/journal.pone.0053907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342036	Green Published, gold			2022-12-25	WOS:000313682700062
J	Xu, ZQ; Chen, JP; Li, XG; Ge, JC; Pan, JL; Xu, XF				Xu, Zhiqiang; Chen, Jiaping; Li, Xuguang; Ge, Jiachun; Pan, Jianlin; Xu, Xiaofeng			Identification and Characterization of MicroRNAs in Channel Catfish (Ictalurus punctatus) by Using Solexa Sequencing Technology	PLOS ONE			English	Article							COMPUTATIONAL IDENTIFICATION; GENE-EXPRESSION; TARGETS; LET-7; MECHANISM; DISCOVERY; CELLS; RNAS	Channel catfish (Ictalurus spp.) is an economically important species in freshwater aquaculture around the world and occupies a prominent position in the aquaculture industry of the United States. MicroRNAs (miRNAs) play important roles in the regulation of almost every biological process in eukaryotes; however, there is little information available concerning miRNAs in channel catfish. In this study, a small-RNA cDNA library was constructed from 10 tissues of channel catfish, and Solexa sequencing technology was used to perform high-throughput sequencing of the library. A total of 14,919,026 raw reads, representing 161,288 unique sequences, were obtained from the small-cDNA library. After comparing the small RNA sequences with the RFam database, 4,542,396 reads that represent 25,538 unique sequences were mapped to the genome sequence of zebrafish to perform distribution analysis and to screen for candidate miRNA genes. Subsequent bioinformatic analysis identified 237 conserved miRNAs and 45 novel miRNAs in the channel catfish. Stem-loop RT-PCR was applied to validate and profile the expression of the novel miRNAs in 10 tissues. Some novel miRNAs, such as ipu-miR-129b, ipu-miR-7562 and ipu-miR-7553, were expressed in all tissues examined. However, some novel miRNAs appear to be tissue specific. Ipu-miR-7575 is predominantly expressed in stomach. Ipu-miR-7147 and ipu-miR-203c are highly expressed in heart, but are relatively weakly expressed in other tissues. Based on sequence complementarity between miRNAs and mRNA targets, potential target sequences for the 45 novel miRNAs were identified by searching for antisense hits in the reference RNA sequences of the channel catfish. These potential target sequences are involved in immune regulation, transcriptional regulation, metabolism and many other biological functions. The discovery of miRNAs in the channel catfish genome by this study contributes to a better understanding of the role miRNAs play in regulating diverse biological processes in fish and vertebrates.	[Xu, Zhiqiang; Xu, Xiaofeng] Nanjing Normal Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China; [Xu, Zhiqiang; Li, Xuguang; Ge, Jiachun; Pan, Jianlin] Freshwater Fisheries Res Inst Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Chen, Jiaping] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University; Nanjing Medical University	Xu, ZQ (corresponding author), Nanjing Normal Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China.	zhiqiangx@163.com; xuxiaofeng@njnu.edu.cn			Natural Science Foundation of Jiangsu Province [BK2011864]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by Natural Science Foundation of Jiangsu Province (BK2011864). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annibali D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040269; Arias CR, 2012, DIS AQUAT ORGAN, V100, P77, DOI 10.3354/dao02492; Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Barozai MYK, 2012, MOL BIOL REP, V39, P8867, DOI 10.1007/s11033-012-1753-2; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhardwaj Jyoti, 2010, Journal of Structural and Functional Genomics, V11, P233, DOI 10.1007/s10969-010-9098-3; Bilodeau-Bourgeois L, 2008, FISH SHELLFISH IMMUN, V24, P82, DOI 10.1016/j.fsi.2007.09.001; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012745; Chi W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023549; Cichocki F, 2011, J IMMUNOL, V187, P6171, DOI 10.4049/jimmunol.1100835; Ebhardt HA, 2009, NUCLEIC ACIDS RES, V37, P2461, DOI 10.1093/nar/gkp093; Fang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018067; FAO, 2010, YB FISH STAT SUMM TA; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Fu YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022957; Guo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021072; Guo L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011387; Issabekova A, 2012, BIOINFORMATION, V8, P513, DOI 10.6026/97320630008513; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kloosterman WP, 2006, NUCLEIC ACIDS RES, V34, P2558, DOI 10.1093/nar/gkl278; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leucht C, 2008, NAT NEUROSCI, V11, P641, DOI 10.1038/nn.2115; Li C, 2012, FISH SHELLFISH IMMUN, V32, P816, DOI 10.1016/j.fsi.2012.02.004; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Li SC, 2011, GENOMICS, V98, P453, DOI 10.1016/j.ygeno.2011.08.008; Li SC, 2010, GENOMICS, V96, P1, DOI 10.1016/j.ygeno.2010.03.009; Lu J, 2010, NUCLEIC ACIDS RES, V39, pD815; Mondol V, 2012, CURR TOP DEV BIOL, V99, P1, DOI 10.1016/B978-0-12-387038-4.00001-X; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Ou JT, 2012, FISH SHELLFISH IMMUN, V32, P345, DOI 10.1016/j.fsi.2011.11.027; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pohlenz C, 2012, FISH SHELLFISH IMMUN, V33, P543, DOI 10.1016/j.fsi.2012.06.005; Salem M, 2010, MAR BIOTECHNOL, V12, P410, DOI 10.1007/s10126-009-9232-z; Saunders HL, 2010, DEV COMP IMMUNOL, V34, P669, DOI 10.1016/j.dci.2010.01.013; Soares AR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-195; Wang XR, 2012, ONCOL LETT, V3, P955, DOI 10.3892/ol.2012.609; Wang YG, 2011, SCI TOTAL ENVIRON, V409, P4753, DOI 10.1016/j.scitotenv.2011.07.039; Whitehead A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r13; Wu Y, 2012, J RADIAT RES, V53, P516, DOI 10.1093/jrr/rrs002; Yan XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030925	47	69	354	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54174	10.1371/journal.pone.0054174	http://dx.doi.org/10.1371/journal.pone.0054174			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342099	Green Published, gold, Green Submitted			2022-12-25	WOS:000313682700093
J	Ocklenburg, S; Arning, L; Gerding, WM; Epplen, JT; Gunturkun, O; Beste, C				Ocklenburg, Sebastian; Arning, Larissa; Gerding, Wanda M.; Epplen, Joerg T.; Guentuerkuen, Onur; Beste, Christian			Cholecystokinin A Receptor (CCKAR) Gene Variation Is Associated with Language Lateralization	PLOS ONE			English	Article							SCHIZOPHRENIC-PATIENTS; HANDEDNESS; DOPAMINE; ASYMMETRY	Schizophrenia is a psychiatric disorder associated with atypical handedness and language lateralization. However, the molecular mechanisms underlying these functional changes are still poorly understood. Therefore, the present study was aimed at investigating whether variation in schizophrenia-related genes modulates individual lateralization patterns. To this end, we genotyped 16 single nucleotide polymorphisms that have previously been linked to schizophrenia on a meta-analysis level in a sample of 444 genetically unrelated healthy participants and examined the association of these polymorphisms with handedness, footedness and language lateralization. We found a significant association of the cholecystokinin-A receptor (CCKAR) gene variation rs1800857 and language lateralization assessed using the dichotic listening task. Individuals carrying the schizophrenia risk allele C of this polymorphism showed a marked reduction of the typical left-hemispheric dominance for language processing. Since the cholecystokinin A receptor is involved in dopamine release in the central nervous system, these findings suggest that genetic variation in this receptor may modulate language lateralization due to its impact on dopaminergic pathways.	[Ocklenburg, Sebastian; Guentuerkuen, Onur; Beste, Christian] Ruhr Univ Bochum, Inst Cognit Neurosci, Bochum, Germany; [Arning, Larissa; Gerding, Wanda M.; Epplen, Joerg T.] Ruhr Univ Bochum, Dept Human Genet, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Ocklenburg, S (corresponding author), Ruhr Univ Bochum, Inst Cognit Neurosci, Univ Str 150, Bochum, Germany.	sebastian.ocklenburg@rub.de	Ocklenburg, Sebastian/O-5867-2017	Ocklenburg, Sebastian/0000-0001-5882-3200; Epplen, Joerg T./0000-0002-6087-3327; Gunturkun, Onur/0000-0003-4173-5233	DFG Emmy-Noether grant [BE4045/10-1]; Cutting-Edge Grant from the Ruhr-University of Bochum	DFG Emmy-Noether grant(German Research Foundation (DFG)); Cutting-Edge Grant from the Ruhr-University of Bochum	This research was supported by a DFG Emmy-Noether grant to Christian Beste (BE4045/10-1) and a Cutting-Edge Grant from the Ruhr-University of Bochum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annett M, 2002, HANDEDNESS BRAIN ASY; Brown AS, 2011, PROG NEUROBIOL, V93, P23, DOI 10.1016/j.pneurobio.2010.09.003; Collinson SL, 2009, SCHIZOPHR RES, V112, P24, DOI 10.1016/j.schres.2009.03.034; CRAWLEY JN, 1991, TRENDS PHARMACOL SCI, V12, P232, DOI 10.1016/0165-6147(91)90558-A; de la Fuente-Fernandez R, 2000, BEHAV BRAIN RES, V112, P63, DOI 10.1016/S0166-4328(00)00165-0; Di Forti M, 2007, EUR NEUROPSYCHOPHARM, V17, pS101, DOI 10.1016/j.euroneuro.2007.02.005; Dragovic M, 2005, ACTA PSYCHIAT SCAND, V111, P410, DOI 10.1111/j.1600-0447.2005.00519.x; Elias L J, 1998, Laterality, V3, P41, DOI 10.1080/713754287; Elias LJ, 1998, NEUROPSYCHOLOGIA, V36, P37, DOI 10.1016/S0028-3932(97)00107-3; Feifel D, 2003, NEUROSCI LETT, V348, P147, DOI 10.1016/S0304-3940(03)00767-5; Gogos JA, 2006, TRENDS PHARMACOL SCI, V27, P226, DOI 10.1016/j.tips.2006.02.005; Hahn C, 2011, BRAIN COGNITION, V76, P300, DOI 10.1016/j.bandc.2011.03.015; HARTLEY LR, 1991, PHYSIOL BEHAV, V50, P881, DOI 10.1016/0031-9384(91)90409-H; HOKFELT T, 1980, NATURE, V285, P476, DOI 10.1038/285476a0; Hugdahl K, 2000, ACTA PSYCHOL, V105, P211, DOI 10.1016/S0001-6918(00)00062-7; Hugdahl Kenneth, 2008, Cogn Neuropsychiatry, V13, P166, DOI 10.1080/13546800801906808; HUPPI K, 1995, GENOMICS, V25, P727, DOI 10.1016/0888-7543(95)80018-H; Josselyn SA, 1996, PSYCHOPHARMACOLOGY, V123, P131, DOI 10.1007/BF02246170; Koefoed P, 2009, ACTA PSYCHIAT SCAND, V120, P281, DOI 10.1111/j.1600-0447.2009.01400.x; Loberg EM, 2004, PSYCHIAT RES, V128, P167, DOI 10.1016/j.psychres.2004.01.011; Loberg EM, 2002, PSYCHIAT RES, V109, P281, DOI 10.1016/S0165-1781(02)00019-7; Lux S, 2008, J ANAT, V212, P235, DOI 10.1111/j.1469-7580.2008.00855.x; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; McManus I.C., 2002, RIGHT HAND LEFT HAND; Medland SE, 2009, NEUROPSYCHOLOGIA, V47, P330, DOI 10.1016/j.neuropsychologia.2008.09.005; MELTZER HY, 1976, SCHIZOPHRENIA BULL, V2, P19, DOI 10.1093/schbul/2.1.19; Nagai T, 2011, BIOL PHARM BULL, V34, P1364, DOI 10.1248/bpb.34.1364; O'Connell G, 2011, BIOCHEM PHARMACOL, V81, P1367, DOI 10.1016/j.bcp.2010.11.009; Ocklenburg S, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00005; Ocklenburg S, 2011, BEHAV BRAIN RES, V225, P284, DOI 10.1016/j.bbr.2011.07.042; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Shulkes A, 1997, CLIN EXP PHARMACOL P, V24, P209, DOI 10.1111/j.1440-1681.1997.tb01809.x; Sommer I, 2001, BRIT J PSYCHIAT, V178, P344, DOI 10.1192/bjp.178.4.344; Tanganelli S, 2001, PEPTIDES, V22, P1229, DOI 10.1016/S0196-9781(01)00446-6; Tervaniemi M, 2003, BRAIN RES REV, V43, P231, DOI 10.1016/j.brainresrev.2003.08.004; Toirac I, 2007, PSYCHIAT GENET, V17, P47, DOI 10.1097/YPG.0b013e3280298292; Tzourio-Mazoyer N, 2010, CEREB CORTEX, V20, P1476, DOI 10.1093/cercor/bhp209; Wei J, 1999, EUR PSYCHIAT, V14, P67, DOI 10.1016/S0924-9338(99)80719-6; Westerhausen R, 2008, NEUROSCI BIOBEHAV R, V32, P1044, DOI 10.1016/j.neubiorev.2008.04.005; Zhang XY, 2000, MOL PSYCHIATR, V5, P239, DOI 10.1038/sj.mp.4000677	40	27	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53643	10.1371/journal.pone.0053643	http://dx.doi.org/10.1371/journal.pone.0053643			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341962	gold, Green Published, Green Submitted			2022-12-25	WOS:000314759400056
J	Zhu, WJ; Wei, W; Fu, YP; Cheng, JS; Xie, JT; Li, GQ; Yi, XH; Kang, ZS; Dickman, MB; Jiang, DH				Zhu, Wenjun; Wei, Wei; Fu, Yanping; Cheng, Jiasen; Xie, Jiatao; Li, Guoqing; Yi, Xianhong; Kang, Zhensheng; Dickman, Martin B.; Jiang, Daohong			A Secretory Protein of Necrotrophic Fungus Sclerotinia sclerotiorum That Suppresses Host Resistance	PLOS ONE			English	Article							WALL-DEGRADING ENZYMES; INTEGRIN-LIKE PROTEIN; OXALIC-ACID; PLASMA-MEMBRANE; CELL-WALL; ARABIDOPSIS-THALIANA; MAGNAPORTHE-ORYZAE; BOTRYTIS-CINEREA; SALICYLIC-ACID; RECEPTOR	SSITL (SS1G_14133) of Sclerotinia sclerotiorum encodes a protein with 302 amino acid residues including a signal peptide, its secretion property was confirmed with immunolocalization and immunofluorescence techniques. SSITL was classified in the integrin alpha N-terminal domain superfamily, and its 3D structure is similar to those of human integrin alpha 4-subunit and a fungal integrin-like protein. When S. sclerotiorum was inoculated to its host, high expression of SSITL was detected during the initial stages of infection (1.5-3.0 hpi). Targeted silencing of SSITL resulted in a significant reduction in virulence; on the other hand, inoculation of SSITL silenced transformant A10 initiated strong and rapid defense response in Arabidopsis, the highest expressions of defense genes PDF1.2 and PR-1 appeared at 3 hpi which was 9 hr earlier than that time when plants were inoculated with the wild-type strain of S. sclerotiorum. Systemic resistance induced by A10 was detected by analysis of the expression of PDF1.2 and PR-1, and confirmed following inoculation with Botrytis cinerea. A10 induced much larger lesions on Arabidopsis mutant ein2 and jar1, and slightly larger lesions on mutant pad4 and NahG in comparison with the wild-type plants. Furthermore, both transient and constitutive expression of SSITL in Arabidopsis suppressed the expression of PDF1.2 and led to be more susceptible to A10 and the wild-type strain of S. sclerotiorum and B. cinerea. Our results suggested that SSITL is an effector possibly and plays significant role in the suppression of jasmonic/ethylene (JA/ET) signal pathway mediated resistance at the early stage of infection.	[Zhu, Wenjun; Wei, Wei; Li, Guoqing; Jiang, Daohong] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Hubei Province, Peoples R China; [Zhu, Wenjun; Wei, Wei; Fu, Yanping; Cheng, Jiasen; Xie, Jiatao; Li, Guoqing; Yi, Xianhong; Jiang, Daohong] Huazhong Agr Univ, Prov Key Lab Plant Pathol Hubei Prov, Coll Plant Sci & Technol, Wuhan, Hubei Province, Peoples R China; [Kang, Zhensheng] NW A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Dickman, Martin B.] Texas A&M Univ, Dept Plant Pathol & Microbiol, Inst Plant Genom & Biotechnol, College Stn, TX 77843 USA	Huazhong Agricultural University; Huazhong Agricultural University; Northwest A&F University - China; Texas A&M University System; Texas A&M University College Station	Jiang, DH (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Hubei Province, Peoples R China.	daohongjiang@mail.hzau.edu.cn	Wei, Wei/L-9201-2019; Abbas, Aqleem/M-9403-2016	Wei, Wei/0000-0001-6295-6903; Abbas, Aqleem/0000-0001-9174-9700; Zhu, Wenjun/0000-0002-9026-7221	Natural Science Foundation of China [31071647]; Special Fund for Agro-scientific Research in the Public Interest [201103016]; earmarked fund for China Agriculture Research System [nycytx-00514]; National ScienceFoundation [0923918]; Binational Agricultural Research & Development Fund [US-4414-11C]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; earmarked fund for China Agriculture Research System; National ScienceFoundation(National Science Foundation (NSF)); Binational Agricultural Research & Development Fund	This research was supported by Natural Science Foundation of China (31071647), the Special Fund for Agro-scientific Research in the Public Interest (Grant NO. 201103016) and by the earmarked fund for China Agriculture Research System (nycytx-00514). This study was supported by grants from the National ScienceFoundation (0923918 to MBD) and the Binational Agricultural Research & Development Fund (US-4414-11C to MBD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asara JM, 2006, NAT PROTOC, V1, P46, DOI 10.1038/nprot.2006.7; BOLAND GJ, 1994, CAN J PLANT PATHOL, V16, P93, DOI 10.1080/07060669409500766; Bolton MD, 2006, MOL PLANT PATHOL, V7, P1, DOI 10.1111/J.1364-3703.2005.00316.X; Brutus A, 2010, P NATL ACAD SCI USA, V107, P9452, DOI 10.1073/pnas.1000675107; Century KS, 1997, SCIENCE, V278, P1963, DOI 10.1126/science.278.5345.1963; Cessna SG, 2000, PLANT CELL, V12, P2191, DOI 10.1105/tpc.12.11.2191; Cioci G, 2006, J MOL BIOL, V357, P1575, DOI 10.1016/j.jmb.2006.01.066; Coppinger P, 2004, PLANT J, V40, P225, DOI 10.1111/j.1365-313X.2004.02203.x; Correa A, 1996, PROTOPLASMA, V194, P91, DOI 10.1007/BF01273171; Dai FM, 2006, J INTEGR PLANT BIOL, V48, P44, DOI 10.1111/j.1744-7909.2006.00181.x-i1; Day B, 2006, PLANT CELL, V18, P2782, DOI 10.1105/tpc.106.044693; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; EDWARDS JE, 1986, J IMMUNOL, V137, P3577; El Oirdi M, 2011, PLANT CELL, V23, P2405, DOI 10.1105/tpc.111.083394; Kikot GE, 2009, J BASIC MICROB, V49, P231, DOI 10.1002/jobm.200800231; Ferrari S, 2003, PLANT J, V35, P193, DOI 10.1046/j.1365-313X.2003.01794.x; Gale C, 1996, P NATL ACAD SCI USA, V93, P357, DOI 10.1073/pnas.93.1.357; Gale CA, 1998, SCIENCE, V279, P1355, DOI 10.1126/science.279.5355.1355; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; GODOY G, 1990, PHYSIOL MOL PLANT P, V37, P179, DOI 10.1016/0885-5765(90)90010-U; Grant M, 2006, CURR OPIN PLANT BIOL, V9, P414, DOI 10.1016/j.pbi.2006.05.013; Guimaraes RL, 2004, PLANT PHYSIOL, V136, P3703, DOI 10.1104/pp.104.049650; Guo XM, 2007, MOL PLANT MICROBE IN, V20, P1384, DOI 10.1094/MPMI-20-11-1384; Harel A, 2006, MOL PLANT MICROBE IN, V19, P682, DOI 10.1094/MPMI-19-0682; Hostetter MK, 1999, FUNGAL GENET BIOL, V28, P135, DOI 10.1006/fgbi.1999.1165; HOSTETTER MK, 1995, BIOCHEM MOL MED, V55, P122, DOI 10.1006/bmme.1995.1042; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; KAMINSKYJ SGW, 1995, J CELL SCI, V108, P849; Kang ZhenSheng, 2007, Acta Phytopathologica Sinica, V37, P623; Khang CH, 2010, PLANT CELL, V22, P1388, DOI 10.1105/tpc.109.069666; Kim KS, 2008, MOL PLANT MICROBE IN, V21, P605, DOI 10.1094/MPMI-21-5-0605; Knepper C, 2011, PLANT PHYSIOL, V156, P286, DOI 10.1104/pp.110.169656; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Krasileva KV, 2010, PLANT CELL, V22, P2444, DOI 10.1105/tpc.110.075358; Lai ZB, 2011, PLANT J, V66, P953, DOI 10.1111/j.1365-313X.2011.04553.x; LI GQ, 2001, P INT S RAP SCI, P261; Li H, 2008, VIRUS RES, V135, P95, DOI 10.1016/j.virusres.2008.02.011; Li J, 2010, MOL CELL BIOCHEM, V343, P173, DOI 10.1007/s11010-010-0511-9; MARCANTONIO EE, 1988, J CELL BIOL, V106, P1765, DOI 10.1083/jcb.106.5.1765; MARCIANO P, 1983, PHYSIOL PLANT PATHOL, V22, P339; Mentlak TA, 2012, PLANT CELL, V24, P322, DOI 10.1105/tpc.111.092957; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; MOVAHEDI S, 1990, PHYSIOL MOL PLANT P, V36, P303, DOI 10.1016/0885-5765(90)90061-2; Mur LAJ, 2006, PLANT PHYSIOL, V140, P249, DOI 10.1104/pp.105.072348; Nagpal P, 1999, GENE, V230, P33, DOI 10.1016/S0378-1119(99)00068-2; Oliver RP, 2010, CURR OPIN PLANT BIOL, V13, P415, DOI 10.1016/j.pbi.2010.05.003; Rafiqi M, 2010, PLANT CELL, V22, P2017, DOI 10.1105/tpc.109.072983; RIOU C, 1992, APPL ENVIRON MICROB, V58, P578, DOI 10.1128/AEM.58.2.578-583.1992; Rollins JA, 2003, MOL PLANT MICROBE IN, V16, P785, DOI 10.1094/MPMI.2003.16.9.785; SCHINDLER M, 1989, J CELL BIOL, V108, P1955, DOI 10.1083/jcb.108.5.1955; Shimizu T, 2010, PLANT J, V64, P204, DOI 10.1111/j.1365-313X.2010.04324.x; Shlezinger N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002185; Spoel SH, 2007, P NATL ACAD SCI USA, V104, P18842, DOI 10.1073/pnas.0708139104; Springer TA, 1997, P NATL ACAD SCI USA, V94, P65, DOI 10.1073/pnas.94.1.65; Tan KC, 2010, FUNCT PLANT BIOL, V37, P907, DOI 10.1071/FP10067; Tucker SL, 2001, ANNU REV PHYTOPATHOL, V39, P385, DOI 10.1146/annurev.phyto.39.1.385; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Williams B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002107; Xu L, 2011, PHYTOPATHOLOGY, V101, P5104; Xu ZY, 2006, J PLANT PATHOL, V88, P89; Yamaguchi Y, 2006, P NATL ACAD SCI USA, V103, P10104, DOI 10.1073/pnas.0603729103; Yamaguchi Y, 2010, PLANT CELL, V22, P508, DOI 10.1105/tpc.109.068874; Yu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034962; Zhang L, 2010, PHYSIOL MOL PLANT P, V75, P71, DOI 10.1016/j.pmpp.2010.09.001	67	102	112	3	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53901	10.1371/journal.pone.0053901	http://dx.doi.org/10.1371/journal.pone.0053901			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342034	gold, Green Published			2022-12-25	WOS:000314759400098
J	Zhang, LP; Shao, HB; Long, XH; Liu, ZP				Zhang Liping; Shao Hongbo; Long Xiaohua; Liu Zhaopu			Gene Regulation of Iron-Deficiency Responses Is Associated with Carbon Monoxide and Heme Oxydase 1 in Chlamydomonas reinhardtii	PLOS ONE			English	Article							PHYTOCHROME-CHROMOPHORE BIOSYNTHESIS; METAL TRANSPORTER; EFFECTOR MOLECULES; CHELATE REDUCTASE; ARABIDOPSIS; METABOLISM; EXPRESSION; ACCUMULATION; FOX1; CO	Carbon monoxide (CO) as an endogenous gaseous molecule regulates a variety of biological processes in animals. However, CO regulating nutrient stress responses in green alga is largely unknown. On the other hand, heme oxydase (HO1 as a rate-limiting enzyme of the first step for heme degration and to catalyze heme into biliverdin (BV), which is concomitant with releasing of CO and ferrous ions, probably participates in the process of CO-regulating response to nutrient stress in green alga. In this paper, we described an observation that CO could regulate iron-homeostasis in iron-starving Chlamydomonas reinhardtii. Exogenous CO at 8 mu M was able to prevent the iron deficient-inducing chlorosis and improve chlorophyll accumulation. Expression pattern of FOX1, FTR1 and ferredoxin was up-regulated by CO exposure in iron-deficient mediam. treatment with external CO increasing iron accumulation in iron-deficient C. reinhardtii. Moreover, to get insights into the regulatory role of HO1, we constructed a transgenic alga overexpressing HO1 and HO1 knock-out mutants. The results show that there was no significant influence on chlorosis with HO1 overexpression of C. reinhardtii under iron-deficiency and the chlorophyll accumulation, and gene expression associated with iron deficiency of mutant were greatly improved. Otherwise, those results from HO1 knock-out mutants were opposite to HO1 overexpression mutants. Finally, CO exposure induced NO accumulation in cells. However, such an action could be blocked by NO scavenger cPTIO. These results indicate that CO/HO1 may play an important role in improving green algae adaptation to iron deficiency or cross-talking with NO under the iron deficiency.	[Zhang Liping; Shao Hongbo; Long Xiaohua; Liu Zhaopu] Nanjing Agr Univ, Coll Resources & Environm Sci, Jiangsu Key Lab Marine Biol, Nanjing, Jiangsu, Peoples R China; [Zhang Liping; Shao Hongbo] Chinese Acad Sci, Yantai Inst Costal Zone Res YIC, Key Lab Coastal Biol & Bioresources Utilizat, Yantai, Peoples R China; [Shao Hongbo] Qingdao Univ Sci & Technol, Inst Life Sci, Qingdao, Peoples R China	Nanjing Agricultural University; Chinese Academy of Sciences; Qingdao University of Science & Technology	Shao, HB (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Jiangsu Key Lab Marine Biol, Nanjing, Jiangsu, Peoples R China.	shaohongbochu@126.com; longxiaohua@njau.edu.cn; sea@njau.edu.cn			National Key Project of Scientific and Technical Supporting Programs [2011BAD13B09]; Jiangsu Provincial Key Project of Scientific and Technical Supporting Programs [BE2010305, BE2011368]; Fundamental Research Funds for the Central Universities [Y0201100249]; New Teachers' Fund for Doctor Stations, Ministry of Education [20100097120016]; Project of Special Fund for Public Welfare Industrial (Agriculture) Research of China [200903001-5]; National Natural Science Foundation of China [31201692]; One Hundred-Talent Plan of Chinese Academy of Sciences (CAS); CAS/SAFEA International Partnership Program for Creative Research Teams; Yantai Science & Technology Development Project [2011016, 2010245]; Yantai Double-hundred Talent Plan [XY-003-02]; 135 Plan Development Plan of YIC-CAS	National Key Project of Scientific and Technical Supporting Programs; Jiangsu Provincial Key Project of Scientific and Technical Supporting Programs; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); New Teachers' Fund for Doctor Stations, Ministry of Education; Project of Special Fund for Public Welfare Industrial (Agriculture) Research of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); One Hundred-Talent Plan of Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); Yantai Science & Technology Development Project; Yantai Double-hundred Talent Plan; 135 Plan Development Plan of YIC-CAS	This work has been supported jointly by the National Key Project of Scientific and Technical Supporting Programs (No. 2011BAD13B09), Jiangsu Provincial Key Project of Scientific and Technical Supporting Programs (Nos. BE2010305; BE2011368), the Fundamental Research Funds for the Central Universities (No. Y0201100249), the New Teachers' Fund for Doctor Stations, Ministry of Education (No. 20100097120016), the Project of Special Fund for Public Welfare Industrial (Agriculture) Research of China (No. 200903001-5), the National Natural Science Foundation of China (No. 31201692), One Hundred-Talent Plan of Chinese Academy of Sciences (CAS), the CAS/SAFEA International Partnership Program for Creative Research Teams, Yantai Science & Technology Development Project (No. 2011016; 2010245), Yantai Double-hundred Talent Plan (XY-003-02), and 135 Plan Development Plan of YIC-CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 2007, EUKARYOT CELL, V6, P1841, DOI 10.1128/EC.00205-07; Boczkowski J, 2006, TRENDS BIOCHEM SCI, V31, P614, DOI 10.1016/j.tibs.2006.09.001; Briat JF, 2007, CURR OPIN PLANT BIOL, V10, P276, DOI 10.1016/j.pbi.2007.04.003; Chen J, 2009, ECOTOXICOLOGY, V18, P110, DOI 10.1007/s10646-008-0264-3; Connolly EL, 2002, PLANT CELL, V14, P1347, DOI 10.1105/tpc.001263; Davis SJ, 1999, P NATL ACAD SCI USA, V96, P6541, DOI 10.1073/pnas.96.11.6541; Deng X, 2007, EUKARYOT CELL, V6, P2163, DOI 10.1128/EC.00324-07; Eckhardt U, 1998, J EXP BOT, V49, P1219, DOI 10.1093/jexbot/49.324.1219; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Graziano M, 2007, PLANT J, V52, P949, DOI 10.1111/j.1365-313X.2007.03283.x; Guo K, 2008, J EXP BOT, V59, P3443, DOI 10.1093/jxb/ern194; Hartsfield CL, 2002, ANTIOXID REDOX SIGN, V4, P301, DOI 10.1089/152308602753666352; Henriques R, 2002, PLANT MOL BIOL, V50, P587, DOI 10.1023/A:1019942200164; Kim SA, 2007, FEBS LETT, V581, P2273, DOI 10.1016/j.febslet.2007.04.043; Kong WW, 2010, PLANT BIOTECHNOL J, V8, P88, DOI 10.1111/j.1467-7652.2009.00469.x; La Fontaine S, 2002, EUKARYOT CELL, V1, P736, DOI 10.1128/EC.1.5.736-757.2002; Li LH, 2004, PLANT MOL BIOL, V54, P125, DOI 10.1023/B:PLAN.0000028774.82782.16; Lu Y, 2012, PLOS ONE, V7; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Merchant SS, 2006, BBA-MOL CELL RES, V1763, P578, DOI 10.1016/j.bbamcr.2006.04.007; Muramoto T, 1999, PLANT CELL, V11, P335, DOI 10.1105/tpc.11.3.335; Murgia I, 2002, PLANT J, V30, P521, DOI 10.1046/j.1365-313X.2002.01312.x; Paz Y, 2007, J BIOL CHEM, V282, P8658, DOI 10.1074/jbc.M609756200; Piantadosi CA, 2002, ANTIOXID REDOX SIGN, V4, P259, DOI 10.1089/152308602753666316; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; Schmidt W, 1999, NEW PHYTOL, V141, P1, DOI 10.1046/j.1469-8137.1999.00331.x; SIEGEL SM, 1962, SCIENCE, V137, P683, DOI 10.1126/science.137.3531.683; STOCKING CR, 1975, PLANT PHYSIOL, V55, P626, DOI 10.1104/pp.55.4.626; Thom SR, 1997, CHEM RES TOXICOL, V10, P1023, DOI 10.1021/tx970041h; Wang YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052436; Watts RN, 2004, BBA-MOL CELL RES, V1692, P1, DOI 10.1016/j.bbamcr.2004.02.004; Watts RN, 2003, BIOCHEM J, V369, P429, DOI 10.1042/BJ20021302; WINDER TL, 1995, PLANT PHYSIOL, V108, P1487, DOI 10.1104/pp.108.4.1487; Wu HL, 2005, PLANT CELL PHYSIOL, V46, P1505, DOI 10.1093/pcp/pci163; Xie YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049800; Zhang LP, 2008, PLANT CELL PHYSIOL, V49, P411, DOI 10.1093/pcp/pcn017	36	2	3	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53835	10.1371/journal.pone.0053835	http://dx.doi.org/10.1371/journal.pone.0053835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349749	Green Submitted, Green Published, gold			2022-12-25	WOS:000314019100033
J	Nikam, C; Jagannath, M; Narayanan, MM; Ramanabhiraman, V; Kazi, M; Shetty, A; Rodrigues, C				Nikam, Chaitali; Jagannath, Manjula; Narayanan, Manoj Mulakkapurath; Ramanabhiraman, Vinaya; Kazi, Mubin; Shetty, Anjali; Rodrigues, Camilla			Rapid Diagnosis of Mycobacterium tuberculosis with Truenat MTB: A Near-Care Approach	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; CLINICAL SPECIMENS; SPUTUM SEDIMENTS; PCR ASSAY; DNA	Background: Control of the global Tuberculosis (TB) burden is hindered by the lack of a simple and effective diagnostic test that can be utilized in resource-limited settings. Methods: We evaluated the performance of Truenat MTB (TM), a chip-based nucleic acid amplification test in the detection of Mycobacterium tuberculosis (MTB) in clinical sputum specimens from 226 patients with suspected pulmonary tuberculosis (TB). The test involved sputum processing using Trueprep-MAG (TM) (nanoparticle-based protocol run on a battery-operated device) and real-time PCR performed on the Truelab Uno (TM) analyzer (handheld, battery-operated thermal cycler). Specimens were also examined for presence of MTB using smear microscopy, liquid culture and an in-house nested PCR protocol. Results were assessed in comparison to a composite reference standard (CRS) consisting of smear and culture results, clinical treatment and follow-up, and radiology findings. Results: Based on the CRS, 191 patients had "Clinical-TB" (Definite and Probable-TB). Of which 154 patients are already on treatment, and 37 were treatment naive cases. Remaining 35 were confirmed "Non-TB" cases which are treatment naive cases. The Truenat MTB test was found to have sensitivity and specificity of 91.1% (CI: 86.1-94.7) and 100% (CI: 90.0-100) respectively, in comparison to 90.58% (CI: 85.5-94.3) and 91.43% (CI: 76.9-98.2) respectively for the in-house nested PCR protocol. Conclusion: This preliminary study shows that the Truenat MTB test allows detection of TB in approximately one hour and can be utilized in near-care settings to provide quick and accurate diagnosis.	[Nikam, Chaitali; Kazi, Mubin; Shetty, Anjali; Rodrigues, Camilla] PD Hinduja Hosp & Med Res Ctr, Dept Microbiol, Bombay, Maharashtra, India; [Jagannath, Manjula; Narayanan, Manoj Mulakkapurath; Ramanabhiraman, Vinaya] Bigtec Pvt Ltd, BigtecLabs, Bangalore, Karnataka, India		Rodrigues, C (corresponding author), PD Hinduja Hosp & Med Res Ctr, Dept Microbiol, Bombay, Maharashtra, India.	dr_crodrigues@hindujahospital.com		Mulakkapurath Narayanan, Manoj/0000-0003-0886-0980; Nikam, Chaitali/0000-0002-3834-3936	Bigtec Laboratories, Bangalore, India	Bigtec Laboratories, Bangalore, India	Bigtec Laboratories, Bangalore, India, has funded the study but the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baevis KG, 1995, J CLIN MICROBIOL, V33, P2582; BEIGE J, 1995, J CLIN MICROBIOL, V33, P90, DOI 10.1128/JCM.33.1.90-95.1995; Bennedsen J, 1996, J CLIN MICROBIOL, V34, P1407, DOI 10.1128/JCM.34.6.1407-1411.1996; Bossuyt PM, 2004, FAM PRACT, V21, P4, DOI 10.1093/fampra/cmh103; Brisson-Noel A, 1989, J GERONTOL B-PSYCHOL, V335, P1069; CLARRIDGE JE, 1993, J CLIN MICROBIOL, V31, P2049, DOI 10.1128/JCM.31.8.2049-2056.1993; Deshmukh M, 2012, INDIAN J TUBER UNPUB; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; EISENACH KD, 1991, AM REV RESPIR DIS, V144, P1160, DOI 10.1164/ajrccm/144.5.1160; HERMANS PWM, 1990, J CLIN MICROBIOL, V28, P1204, DOI 10.1128/JCM.28.6.1204-1213.1990; JONAS V, 1993, J CLIN MICROBIOL, V31, P2410, DOI 10.1128/JCM.31.9.2410-2416.1993; KELLOGG DE, 1994, BIOTECHNIQUES, V16, P1134; Kent PT, 1985, PUBLIC HLTH MYCOBACT, P36; KHANDEKAR P, 1994, INDIAN J MED RES, V100, P167; Kumar KK, 2009, PCT Pub., Patent No. [WO/2009/047805, 2009047805]; Kumar KK, 2009, PCT Pub., Patent No. [WO/2009/047804, 2009047804]; LONGO MC, 1990, GENE, V93, P125, DOI 10.1016/0378-1119(90)90145-H; Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05; MILLER N, 1994, J CLIN MICROBIOL, V32, P393, DOI 10.1128/JCM.32.2.393-397.1994; Pfyffer GE, 1996, J CLIN MICROBIOL, V34, P834, DOI 10.1128/JCM.34.4.834-841.1996; REDDI PP, 1993, INT J LEPROSY, V61, P227; SHAH JS, 1995, J CLIN MICROBIOL, V33, P1435, DOI 10.1128/JCM.33.6.1435-1441.1995; SJOBRING U, 1990, J CLIN MICROBIOL, V28, P2200; Traore H, 2006, J CLIN MICROBIOL, V44, P4384, DOI 10.1128/JCM.01332-06; Vadwai V, 2011, J CLIN MICROBIOL, V49, P2540, DOI 10.1128/JCM.02319-10; WILLIAMS DL, 1995, J CLIN MICROBIOL, V33, P1558, DOI 10.1128/JCM.33.6.1558-1561.1995; World Health Organization, 2012, FACT SHEET 104 TUB; World Health Organization, 2004, WORLD HLTH REP 2004; YAJKO DM, 1995, J CLIN MICROBIOL, V33, P1944, DOI 10.1128/JCM.33.7.1944-1947.1995	29	57	58	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e51121	10.1371/journal.pone.0051121	http://dx.doi.org/10.1371/journal.pone.0051121			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349670	Green Submitted, gold, Green Published			2022-12-25	WOS:000313943000005
J	Kobayashi, T; Yan, HM; Kurahashi, Y; Ito, Y; Maeda, H; Tada, T; Hongo, K; Nakayama, J				Kobayashi, Tatsuya; Yan, Huimin; Kurahashi, Yasuhiro; Ito, Yuki; Maeda, Hiroshi; Tada, Tsuyoshi; Hongo, Kazuhiro; Nakayama, Jun			Role of GalNAc4S-6ST in Astrocytic Tumor Progression	PLOS ONE			English	Article							ACETYLGALACTOSAMINE 4-SULFATE 6-O-SULFOTRANSFERASE; CHONDROITIN SULFATE-E; TYROSINE-PHOSPHATASE-ZETA; P-SELECTIN; CANCER; GLYCOSAMINOGLYCANS; MIDKINE; BINDING; PROTEIN	N-Acetylgalactosamine 4-sulfate 6-O-sulfotransferase (GalNAc4S-6ST) is the sulfotransferase responsible for biosynthesis of highly sulfated chondroitin sulfate CS-E. Although involvements of CS-E in neuronal cell functions have been extensively analyzed, the role of GalNAc4S-6ST in astrocytic tumor progression remains unknown. Here, we reveal that GalNAc4S-6ST transcripts were detected in astrocytic tumors derived from all 30 patients examined using quantitative reverse transcription-PCR analysis. Patients with high GalNAc4S-6ST mRNA expression had significantly worse outcome compared with patients with low expression, and multivariate survival analysis disclosed that GalNAc4S-6ST is an independent poor prognostic factor for astrocytic tumors. We then tested whether CS-E enhanced haptotaxic migration of glioblastoma U251-MG cells that endogenously express both the CS-E's scaffold tyrosine phosphatase xi (PTP xi) and GalNAc4S-6ST, in the presence of CS-E's preferred ligands, pleiotrophin (PTN) or midkine (MK), using a modified Boyden chamber method. Haptotaxic stimulation of cell migration by PTN was most robust on control siRNA-transfected U251-MG cells, while that enhancing effect was cancelled following transduction of GalNAc4S-6ST siRNA. Similar results were obtained using MK, suggesting that both PTN and MK enhance migration of U251-MG cells by binding to CS-E. We also found that PTP xi as well as PTN and MK were frequently expressed in astrocytic tumor cells. Thus, our findings indicate that GalNAc4S-6ST mRNA expressed by astrocytic tumor cells is associated with poor patient prognosis likely by enhancing CS-E-mediated tumor cell motility in the presence of PTN and/or MK.	[Kobayashi, Tatsuya; Yan, Huimin; Ito, Yuki; Nakayama, Jun] Shinshu Univ, Grad Sch Med, Dept Mol Pathol, Matsumoto, Nagano 390, Japan; [Kobayashi, Tatsuya; Hongo, Kazuhiro] Shinshu Univ, Sch Med, Dept Neurosurg, Matsumoto, Nagano 390, Japan; [Tada, Tsuyoshi] Shinshu Univ, Sch Med, Dept Med Educ, Matsumoto, Nagano 390, Japan; [Kurahashi, Yasuhiro; Maeda, Hiroshi] Seikagaku Corp, Cent Res Labs, Higashiyamato, Japan	Shinshu University; Shinshu University; Shinshu University; Seikagaku Corporation	Nakayama, J (corresponding author), Shinshu Univ, Grad Sch Med, Dept Mol Pathol, Matsumoto, Nagano 390, Japan.	jnaka@shinshu-u.ac.jp			Japan Society for the Promotion of Science [18390113]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research 18390113 from the Japan Society for the Promotion of Science (to J.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basappa, 2009, GLYCOBIOLOGY, V19, P735, DOI 10.1093/glycob/cwp041; Brown JM, 2012, P NATL ACAD SCI USA, V109, P4768, DOI 10.1073/pnas.1121318109; Clement AM, 1999, NEUROSCI LETT, V269, P125, DOI 10.1016/S0304-3940(99)00432-2; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Esko J.D., 2009, ESSENTIALS GLYCOBIOL; Ito Y, 2000, J BIOL CHEM, V275, P34728, DOI 10.1074/jbc.M909633199; Ito Y, 2007, ACTA HISTOCHEM CYTOC, V40, P53, DOI 10.1267/ahc.07004; Karumbaiah L, 2011, GLIA, V59, P981, DOI 10.1002/glia.21170; Kato Y, 2008, BIOCHEM BIOPH RES CO, V369, P1041, DOI 10.1016/j.bbrc.2008.02.130; Kawashima H, 2002, J BIOL CHEM, V277, P12921, DOI 10.1074/jbc.M200396200; Kobayashi T, 2007, CLIN CANCER RES, V13, P3868, DOI 10.1158/1078-0432.CCR-06-2730; Li F, 2008, J BIOL CHEM, V283, P34294, DOI 10.1074/jbc.M806015200; Machida E, 2001, CANCER RES, V61, P2226; MCEVER RP, 1989, J CLIN INVEST, V84, P92, DOI 10.1172/JCI114175; Monzavi-Karbassi B, 2007, INT J CANCER, V120, P1179, DOI 10.1002/ijc.22424; Muller S, 2003, ONCOGENE, V22, P6661, DOI 10.1038/sj.onc.1206763; Muramatsu T, 2002, J BIOCHEM, V132, P359, DOI 10.1093/oxfordjournals.jbchem.a003231; Ohtake S, 2001, J BIOL CHEM, V276, P43894, DOI 10.1074/jbc.M104922200; Ohtake-Niimi S, 2010, J BIOL CHEM, V285, P20793, DOI 10.1074/jbc.M109.084749; Sato Y, 2008, J NEUROCHEM, V104, P1565, DOI 10.1111/j.1471-4159.2007.05107.x; SHINMEI M, 1992, ARTHRITIS RHEUM, V35, P1304, DOI 10.1002/art.1780351110; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; ten Dam GB, 2007, AM J PATHOL, V171, P1324, DOI 10.2353/ajpath.2007.070111; The WHO, 2020, CLASSIFICATION TUMOU; Tully SE, 2004, J AM CHEM SOC, V126, P7736, DOI 10.1021/ja0484045; Ulbricht U, 2006, J NEUROCHEM, V98, P1497, DOI 10.1111/j.1471-4159.2006.04022.x; Yamamoto K, 2012, BRIT J CANCER, V106, P1214, DOI 10.1038/bjc.2012.59; YOSHIDA J, 1990, J NEURO-ONCOL, V8, P221; Zou P, 2003, GLYCOBIOLOGY, V13, P35, DOI 10.1093/glycob/cwg001	29	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54278	10.1371/journal.pone.0054278	http://dx.doi.org/10.1371/journal.pone.0054278			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349846	Green Published, Green Submitted, gold			2022-12-25	WOS:000313738900059
J	Xu, LX; Xue, HL; Song, MJ; Zhao, QH; Dong, JP; Liu, J; Guo, Y; Xu, TQ; Cao, XP; Wang, FS; Wang, SQ; Hao, SS; Yang, HF; Zhang, ZB				Xu, Laixiang; Xue, Huiliang; Song, Mingjing; Zhao, Qinghua; Dong, Jingping; Liu, Juan; Guo, Yu; Xu, Tongqin; Cao, Xiaoping; Wang, Fusheng; Wang, Shuqing; Hao, Shushen; Yang, Hefang; Zhang, Zhibin			Variation of Genetic Diversity in a Rapidly Expanding Population of the Greater Long-Tailed Hamster (Tscherskia triton) as Revealed by Microsatellites	PLOS ONE			English	Article							ARVICOLA-TERRESTRIS; DISPERSAL; TIME; FLOW	Genetic diversity is essential for persistence of animal populations over both the short- and long-term. Previous studies suggest that genetic diversity may decrease with population decline due to genetic drift or inbreeding of small populations. For oscillating populations, there are some studies on the relationship between population density and genetic diversity, but these studies were based on short- term observation or in low-density phases. Evidence from rapidly expanding populations is lacking. In this study, genetic diversity of a rapidly expanding population of the Greater long-tailed hamsters during 1984-1990, in the Raoyang County of the North China Plain was studied using DNA microsatellite markers. Results show that genetic diversity was positively correlated with population density (as measured by % trap success), and the increase in population density was correlated with a decrease of genetic differentiation between the sub-population A and B. The genetic diversity tended to be higher in spring than in autumn. Variation in population density and genetic diversity are consistent between sub-population A and B. Such results suggest that dispersal is density- and season-dependent in a rapidly expanding population of the Greater long-tailed hamster. For typically solitary species, increasing population density can increase intra-specific attack, which is a driving force for dispersal. This situation is counterbalanced by decreasing population density caused by genetic drift or inbreeding as the result of small population size. Season is a major factor influencing population density and genetic diversity. Meanwhile, roads, used to be considered as geographical isolation, have less effect on genetic differentiation in a rapidly expanding population. Evidences suggest that gene flow (Nm) is positively correlated with population density, and it is significant higher in spring than that in autumn.	[Xu, Laixiang; Xue, Huiliang; Zhao, Qinghua; Liu, Juan; Guo, Yu] Qufu Normal Univ, Coll Life Sci, Qufu, Shandong, Peoples R China; [Song, Mingjing; Dong, Jingping; Cao, Xiaoping; Wang, Fusheng; Wang, Shuqing; Hao, Shushen; Yang, Hefang; Zhang, Zhibin] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Song, Mingjing] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing 100730, Peoples R China; [Song, Mingjing] Peking Union Med Coll, Comparat Med Ctr, Beijing 100021, Peoples R China; [Xu, Tongqin] Wugong Stn Pest Monitoring & Forecasting, Raoyang Cty, Hebei Province, Peoples R China	Qufu Normal University; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Xu, LX (corresponding author), Qufu Normal Univ, Coll Life Sci, Qufu, Shandong, Peoples R China.	xulx@mail.qfnu.edu.cn			Ministry of Science and Technology [2007BC109104]; National Natural Science Foundation of China [31070332]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Ministry of Science and Technology (2007BC109104) and National Natural Science Foundation of China (31070332). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aars J, 2006, MOL ECOL, V15, P1455, DOI 10.1111/j.1365-294X.2006.02889.x; Andreassen HP, 2001, ECOLOGY, V82, P2911, DOI 10.2307/2679970; Aspi J, 2006, MOL ECOL, V15, P1561, DOI 10.1111/j.1365-294X.2006.02877.x; Berthier K, 2005, MOL ECOL, V14, P2861, DOI 10.1111/j.1365-294X.2005.02636.x; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Cena CJ, 2006, MOL ECOL, V15, P303, DOI 10.1111/j.1365-294X.2005.02637.x; Charlesworth D, 2001, CURR OPIN GENET DEV, V11, P685, DOI 10.1016/S0959-437X(00)00254-9; Clobert Jean, 2004, P307, DOI 10.1016/B978-012323448-3/50015-5; Cote SD, 2002, MOL ECOL, V11, P1923, DOI 10.1046/j.1365-294X.2002.01582.x; Dong JP, 2010, J MAMMAL, V91, P200, DOI 10.1644/09-MAMM-A-098R1.1; Estoup A, 1998, NATO ADV SCI I A-LIF, V306, P55; Francis C.Y., 1999, POPGENE VERSION 1 31; Hanski I., 1999, METAPOPULATION ECOLO; Hansson B, 2000, MOL ECOL, V9, P1529, DOI 10.1046/j.1365-294x.2000.01028.x; Ims RA, 2005, P ROY SOC B-BIOL SCI, V272, P913, DOI 10.1098/rspb.2004.3025; Ims Rolf A., 2001, P203; Keller I, 2003, P ROY SOC B-BIOL SCI, V270, P417, DOI 10.1098/rspb.2002.2247; KIMURA M, 1964, GENETICS, V49, P725; LEVENE H, 1949, ANN MATH STAT, V20, P91, DOI 10.1214/aoms/1177730093; Lewontin R.C., 1972, EVOLUTIONARY BIOL, V14, P381, DOI DOI 10.1007/978-1-4684-9063-3_14; Lin YTK, 2001, ECOL MONOGR, V71, P245, DOI 10.1890/0012-9615(2001)071[0245:TIOHQO]2.0.CO;2; MADER HJ, 1984, BIOL CONSERV, V29, P81, DOI 10.1016/0006-3207(84)90015-6; Nielsen EE, 1999, EVOLUTION, V53, P261, DOI [10.2307/2640938, 10.1111/j.1558-5646.1999.tb05351.x]; North A, 2011, EVOLUTION, V65, P1739, DOI 10.1111/j.1558-5646.2011.01254.x; Nowicki P, 2011, OECOLOGIA, V167, P657, DOI 10.1007/s00442-011-2025-x; Parn H, 2012, P ROY SOC B-BIOL SCI, V279, P144, DOI 10.1098/rspb.2011.0673; Planes S, 2002, MOL ECOL, V11, P1515, DOI 10.1046/j.1365-294X.2002.01521.x; Ranta E, 2008, P ROY SOC B-BIOL SCI, V275, P435, DOI 10.1098/rspb.2007.1546; Shikano T, 2001, HEREDITY, V86, P153, DOI 10.1046/j.1365-2540.2001.00792.x; SLATKIN M, 1989, EVOLUTION, V43, P1349, DOI 10.1111/j.1558-5646.1989.tb02587.x; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Song MJ, 2005, CAN J ZOOL, V83, P773, DOI 10.1139/Z05-060; Stenson AG, 2002, MOL ECOL, V11, P1679, DOI 10.1046/j.1365-294X.2002.01564.x; Wang M, 2001, HEREDITY, V86, P703, DOI 10.1046/j.1365-2540.2001.00889.x; Wang YQ, 2002, CHINESE SCI BULL, V47, P201, DOI 10.1360/02tb9048; Waser PM, 2006, MOL ECOL, V15, P1929, DOI 10.1111/j.1365-294X.2006.02893.x; Xie JY, 2006, INTEGR ZOOL, V1, P188, DOI 10.1111/j.1749-4877.2006.00035.x; Xu Lai-Xiang, 2002, Acta Zoologica Sinica, V48, P264; Xu LX, 2007, MOL ECOL NOTES, V7, P617, DOI 10.1111/j.1471-8286.2006.01651.x; Zhang Z., 1998, ECOLOGY MANAGEMENT R	40	7	7	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54171	10.1371/journal.pone.0054171	http://dx.doi.org/10.1371/journal.pone.0054171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349815	Green Published, Green Submitted, gold			2022-12-25	WOS:000313738900048
J	Nov, O; Shapiro, H; Ovadia, H; Tarnovscki, T; Dvir, I; Shemesh, E; Kovsan, J; Shelef, I; Carmi, Y; Voronov, E; Apte, RN; Lewis, E; Haim, Y; Konrad, D; Bashan, N; Rudich, A				Nov, Ori; Shapiro, Hagit; Ovadia, Hilla; Tarnovscki, Tanya; Dvir, Irit; Shemesh, Elad; Kovsan, Julia; Shelef, Ilan; Carmi, Yaron; Voronov, Elena; Apte, Ron N.; Lewis, Eli; Haim, Yulia; Konrad, Daniel; Bashan, Nava; Rudich, Assaf			Interleukin-1 beta Regulates Fat-Liver Crosstalk in Obesity by Auto-Paracrine Modulation of Adipose Tissue Inflammation and Expandability	PLOS ONE			English	Article							INSULIN-RESISTANCE; RECEPTOR ANTAGONIST; PORTAL THEORY; MICE; CELLS; MACROPHAGES; POPULATION; IL-1-BETA; INDUCTION; CYTOKINES	The inflammasome has been recently implicated in obesity-associated dys-metabolism. However, of its products, the specific role of IL-1 beta was clinically demonstrated to mediate only the pancreatic beta-cell demise, and in mice mainly the intra-hepatic manifestations of obesity. Yet, it remains largely unknown if IL-1 beta, a cytokine believed to mainly function locally, could regulate dysfunctional inter-organ crosstalk in obesity. Here we show that High-fat-fed (HFF) mice exhibited a preferential increase of IL-1 beta in portal compared to systemic blood. Moreover, portally-drained mesenteric fat transplantation from IL-1 beta KO donors resulted in lower pyruvate-glucose flux compared to mice receiving wild-type (WT) transplant. These results raised a putative endocrine function for visceral fat-derived IL-1 beta in regulating hepatic gluconeogenic flux. IL-1 beta KO mice on HFF exhibited only a minor or no increase in adipose expression of pro-inflammatory genes (including macrophage M1 markers), Mac2-positive crown-like structures and CD11b-F4/80-double-positive macrophages, all of which were markedly increased in WT-HFF mice. Further consistent with autocrine/paracrine functions of IL-1 beta within adipose tissue, adipose tissue macrophage lipid content was increased in WT-HFF mice, but significantly less in IL-1 beta KO mice. Ex-vivo, adipose explants co-cultured with primary hepatocytes from WT or IL-1-receptor (IL-1RI)-KO mice suggested only a minor direct effect of adipose-derived IL-1 beta on hepatocyte insulin resistance. Importantly, although IL-1 beta KOs gained weight similarly to WT-HFF, they had larger fat depots with similar degree of adipocyte hypertrophy. Furthermore, adipogenesis genes and markers (pparg, cepba, fabp4, glut4) that were decreased by HFF in WT, were paradoxically elevated in IL-1 beta KO-HFF mice. These local alterations in adipose tissue inflammation and expansion correlated with a lower liver size, less hepatic steatosis, and preserved insulin sensitivity. Collectively, we demonstrate that by promoting adipose inflammation and limiting fat tissue expandability, IL-1 beta supports ectopic fat accumulation in hepatocytes and adipose-tissue macrophages, contributing to impaired fat-liver crosstalk in nutritional obesity.	[Nov, Ori; Shapiro, Hagit; Ovadia, Hilla; Tarnovscki, Tanya; Shemesh, Elad; Kovsan, Julia; Lewis, Eli; Haim, Yulia; Bashan, Nava; Rudich, Assaf] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem, Beer Sheva, Israel; [Dvir, Irit] Sapir Acad Coll, Dept Ind Management, Chem & Life Sci Program, Hof Ashkelon, Israel; [Shemesh, Elad; Shelef, Ilan] Ben Gurion Univ Negev, Goldman Med Sch, IL-84105 Beer Sheva, Israel; [Shelef, Ilan] Soroka Acad Med Ctr, Dept Radiol, Beer Sheva, Israel; [Carmi, Yaron; Voronov, Elena; Apte, Ron N.] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel; [Konrad, Daniel] Univ Zurich, Div Pediat Endocrinol & Diabetol, Zurich, Switzerland; [Konrad, Daniel] Univ Zurich, Children Res Ctr, Univ Childrens Hosp, Zurich, Switzerland; [Konrad, Daniel] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Rudich, Assaf] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University; University of Zurich; University Children's Hospital Zurich; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Ben Gurion University	Rudich, A (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem, Beer Sheva, Israel.	rudich@bgu.ac.il	LEWIS, ELI C/F-1552-2012; Shapiro, Hagit/F-8648-2015; Shemesh, Elad/O-5039-2019	LEWIS, ELI C/0000-0002-4189-2207; Shemesh, Elad/0000-0003-1162-2991; Konrad, Daniel/0000-0001-9067-4356; Rudich, Assaf/0000-0002-1366-1444; shelef, ilan/0000-0002-8398-6455	Israel Science Foundation [1103-09]; Israeli Ministry of Health [3/5067]; Leslie and Susan Gonda (Goldschmid) Center for Diabetes Research and Education	Israel Science Foundation(Israel Science Foundation); Israeli Ministry of Health; Leslie and Susan Gonda (Goldschmid) Center for Diabetes Research and Education	This study was supported in part by grants from the Israel Science Foundation (1103-09), from the Israeli Ministry of Health (3/5067), and by the Leslie and Susan Gonda (Goldschmid) Center for Diabetes Research and Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergman RN, 2007, AM J MED, V120, pS3, DOI 10.1016/j.amjmed.2006.11.012; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Bloch-Damti A, 2006, DIABETOLOGIA, V49, P2463, DOI 10.1007/s00125-006-0349-6; Carmi Y, 2011, J IMMUNOL, V186, P3462, DOI 10.4049/jimmunol.1002901; Cawood TJ, 2006, EUR J ENDOCRINOL, V155, P395, DOI 10.1530/eje.1.02242; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Fujiki K, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-38; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hao HX, 2007, P NATL ACAD SCI USA, V104, P15466, DOI 10.1073/pnas.0705407104; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Kabir M, 2005, AM J PHYSIOL-ENDOC M, V288, pE454, DOI 10.1152/ajpendo.00203.2004; Kamari Y, 2011, J HEPATOL, V55, P1086, DOI 10.1016/j.jhep.2011.01.048; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Konrad D, 2007, DIABETOLOGIA, V50, P833, DOI 10.1007/s00125-007-0596-1; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Lagathu C, 2006, DIABETOLOGIA, V49, P2162, DOI 10.1007/s00125-006-0335-z; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Matsuki T, 2003, J EXP MED, V198, P877, DOI 10.1084/jem.20030299; McGillicuddy FC, 2011, DIABETES, V60, P1688, DOI 10.2337/db10-1278; Moschen AR, 2011, MOL MED, V17, P840, DOI 10.2119/molmed.2010.00108; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nov O, 2010, ENDOCRINOLOGY, V151, P4247, DOI 10.1210/en.2010-0340; Ovadia H, 2011, J BIOL CHEM, V286, P30433, DOI 10.1074/jbc.M111.235945; Persson H, 2008, PROTEIN ENG DES SEL, V21, P485, DOI 10.1093/protein/gzn024; Persson J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-70; Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048; Rytka JM, 2011, DIABETES, V60, P56, DOI 10.2337/db10-0697; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; Sniderman AD, 2007, INT J EPIDEMIOL, V36, P220, DOI 10.1093/ije/dyl245; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Stienstra R, 2007, J HEPATOL, V46, P869, DOI 10.1016/j.jhep.2006.11.019; Stienstra R, 2012, CELL METAB, V15, P10, DOI 10.1016/j.cmet.2011.10.011; Stienstra R, 2011, P NATL ACAD SCI USA, V108, P15324, DOI 10.1073/pnas.1100255108; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Suzawa M, 2003, NAT CELL BIOL, V5, P224, DOI 10.1038/ncb942; Trak-Smayra V, 2011, INT J EXP PATHOL, V92, P413, DOI 10.1111/j.1365-2613.2011.00793.x; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Wueest S, 2010, J CLIN INVEST, V120, P191, DOI 10.1172/JCI38388; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zeyda M, 2007, INT J OBESITY, V31, P1420, DOI 10.1038/sj.ijo.0803632	46	109	110	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53626	10.1371/journal.pone.0053626	http://dx.doi.org/10.1371/journal.pone.0053626			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341960	Green Published, gold, Green Submitted			2022-12-25	WOS:000313682700032
J	Rohrbaugh, M; Clore, A; Davis, J; Johnson, S; Jones, B; Jones, K; Kim, J; Kithuka, B; Lunsford, K; Mitchell, J; Mott, B; Ramos, E; Tchedou, MR; Acosta, G; Araujo, M; Cushing, S; Duffy, G; Graves, F; Griffin, K; Gurudatta, BV; Jackson, D; Jaimes, D; Jamison, K; Jones, K; Kelley, D; Kilgore, M; Laramore, D; Le, T; Mazhar, B; Mazhar, MM; McCrary, B; Miller, T; Moreland, C; Mullins, A; Munye, E; Okoorie, S; Pittman, E; Roberts, N; Rose, D; Rowland, A; Shagarabi, A; Smith, J; Stallworth, T; Stroud, N; Sung, E; Sung, K; Takenaka, N; Torre, E; Veira, J; Vu, K; Wagstaff, W; Wood, AM; Wu, KR; Yang, JP; Corces, VG				Rohrbaugh, Margaret; Clore, Alyssia; Davis, Julia; Johnson, Sharonta; Jones, Brian; Jones, Keith; Kim, Joanne; Kithuka, Bramwel; Lunsford, Krystal; Mitchell, Joy; Mott, Brian; Ramos, Edward; Tchedou, Maza R.; Acosta, Gilbert; Araujo, Mark; Cushing, Stuart; Duffy, Gabriel; Graves, Felicia; Griffin, Kyler; Gurudatta, B. V.; Jackson, Deaundra; Jaimes, Denis; Jamison, Kendall; Jones, Khali; Kelley, Dhaujee; Kilgore, Marquita; Laramore, Derica; Thuy Le; Mazhar, Bakhtawar; Mazhar, Muhammad M.; McCrary, Britney; Miller, Teanndras; Moreland, Celethia; Mullins, Alex; Munye, Elyas; Okoorie, Sheila; Pittman, Elisha; Roberts, Nikkita; Rose, De'Warren; Rowland, Alex; Shagarabi, Anwar; Smith, Jamela; Stallworth, Tayler; Stroud, Nicole; Sung, Elizabeth; Sung, Kai; Takenaka, Naomi; Torre, Eduardo; Veira, Jarvis; Kim Vu; Wagstaff, William; Wood, Ashley M.; Wu, Karen; Yang, Jingping; Corces, Victor G.			Identification and Characterization of Proteins Involved in Nuclear Organization Using Drosophila GFP Protein Trap Lines	PLOS ONE			English	Article							GENE DISRUPTION PROJECT; GERMLINE STEM-CELLS; CHROMATIN INSULATOR; HISTONE H3; SPERM DECONDENSATION; X-CHROMOSOME; DF31 PROTEIN; MELANOGASTER; NUCLEOPLASMIN; TRANSCRIPTION	Background: Strains from a collection of Drosophila GFP protein trap lines express GFP in the normal tissues where the endogenous protein is present. This collection can be used to screen for proteins distributed in the nucleus in a non-uniform pattern. Methodology/Principal Findings: We analyzed four lines that show peripheral or punctate nuclear staining. One of these lines affects an uncharacterized gene named CG11138. The CG11138 protein shows a punctate distribution in the nuclear periphery similar to that of Drosophila insulator proteins but does not co-localize with known insulators. Interestingly, mutations in Lamin proteins result in alterations in CG11138 localization, suggesting that this protein may be a novel component of the nuclear lamina. A second line affects the Decondensation factor 31 (Df31) gene, which encodes a protein with a unique nuclear distribution that appears to segment the nucleus into four different compartments. The X-chromosome of males is confined to one of these compartments. We also find that Drosophila Nucleoplasmin (dNlp) is present in regions of active transcription. Heat shock leads to loss of dNlp from previously transcribed regions of polytene chromosome without redistribution to the heat shock genes. Analysis of Stonewall (Stwl), a protein previously found to be necessary for the maintenance of germline stem cells, shows that Stwl is present in a punctate pattern in the nucleus that partially overlaps with that of known insulator proteins. Finally we show that Stwl, dNlp, and Df31 form part of a highly interactive network. The properties of other components of this network may help understand the role of these proteins in nuclear biology. Conclusions/Significance: These results establish screening of GFP protein trap alleles as a strategy to identify factors with novel cellular functions. Information gained from the analysis of CG11138 Stwl, dNlp, and Df31 sets the stage for future studies of these proteins.	[Rohrbaugh, Margaret; Kim, Joanne; Kithuka, Bramwel; Mott, Brian; Ramos, Edward; Acosta, Gilbert; Araujo, Mark; Gurudatta, B. V.; Kilgore, Marquita; Laramore, Derica; Sung, Elizabeth; Sung, Kai; Takenaka, Naomi; Torre, Eduardo; Wood, Ashley M.; Wu, Karen; Yang, Jingping; Corces, Victor G.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Clore, Alyssia; Moreland, Celethia; Smith, Jamela; Stallworth, Tayler; Kim Vu] S Atlanta High Sch Hlth & Med Sci, Atlanta, GA USA; [Davis, Julia; Johnson, Sharonta; Jones, Brian; Jones, Keith; Lunsford, Krystal; Mitchell, Joy; Tchedou, Maza R.; Duffy, Gabriel; Jackson, Deaundra; Jones, Khali; Miller, Teanndras; Mullins, Alex; Pittman, Elisha; Roberts, Nikkita; Rose, De'Warren; Rowland, Alex] Carver Sch Hlth Sci & Res, Atlanta, GA USA; [Cushing, Stuart; Okoorie, Sheila] Baltimore Polytech Inst, Baltimore, MD USA; [Graves, Felicia; Jamison, Kendall; Kelley, Dhaujee] Paul Laurence Dunbar High Sch, Baltimore, MD USA; [Griffin, Kyler; Mazhar, Bakhtawar; Mazhar, Muhammad M.; Munye, Elyas; Shagarabi, Anwar; Stroud, Nicole; Veira, Jarvis; Wagstaff, William] N Atlanta High Sch, Atlanta, GA USA; [Jaimes, Denis; Thuy Le] Cross Keys High Sch, Atlanta, GA USA; [McCrary, Britney] Frederick Douglass High Sch, Atlanta, GA USA	Emory University	Corces, VG (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	vcorces@emory.edu		Wood, Ashley/0000-0002-8713-601X; Corces, Victor/0000-0001-5140-4337	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	The RISE program has been supported by a Professor Award from the Howard Hughes Medical Institute to VGC. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2002, DEV GROWTH DIFFER, V44, P97; Bantignies F, 2011, TRENDS GENET, V27, P454, DOI 10.1016/j.tig.2011.06.008; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bushey AM, 2008, MOL CELL, V32, P1, DOI 10.1016/j.molcel.2008.08.017; Bushey AM, 2009, GENE DEV, V23, P1338, DOI 10.1101/gad.1798209; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Capelson M, 2005, MOL CELL, V20, P105, DOI 10.1016/j.molcel.2005.08.031; Clark KA, 1996, DEVELOPMENT, V122, P937; Cremer T, 2006, CURR OPIN CELL BIOL, V18, P307, DOI 10.1016/j.ceb.2006.04.007; CREVEL G, 1995, EMBO J, V14, P1711, DOI 10.1002/j.1460-2075.1995.tb07160.x; Crevel G, 2001, J CELL SCI, V114, P37; Drysdale Rachel, 2008, V420, P45, DOI 10.1007/978-1-59745-583-1_3; Gerasimova TI, 2007, MOL CELL, V28, P761, DOI 10.1016/j.molcel.2007.09.024; Guillebault D, 2007, J MOL BIOL, V373, P903, DOI 10.1016/j.jmb.2007.07.049; Guillemin K, 2001, NAT CELL BIOL, V3, P848, DOI 10.1038/ncb0901-848; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; HOOVER KK, 1993, GENETICS, V135, P507; Ito T, 1996, J BIOL CHEM, V271, P25041, DOI 10.1074/jbc.271.40.25041; Ivaldi MS, 2007, GENE DEV, V21, P2818, DOI 10.1101/gad.1604007; Kelso RJ, 2004, NUCLEIC ACIDS RES, V32, pD418, DOI 10.1093/nar/gkh014; Kimura M, 2008, FEBS LETT, V582, P2833, DOI 10.1016/j.febslet.2008.07.033; Legube G, 2006, GENE DEV, V20, P871, DOI 10.1101/gad.377506; Lei EP, 2006, NAT GENET, V38, P936, DOI 10.1038/ng1850; Lu ZG, 2005, P NATL ACAD SCI USA, V102, P2778, DOI 10.1073/pnas.0405374102; Maines JZ, 2007, DEVELOPMENT, V134, P1471, DOI 10.1242/dev.02810; Mao YTS, 2011, TRENDS GENET, V27, P295, DOI 10.1016/j.tig.2011.05.006; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Moshkovich N, 2011, GENE DEV, V25, P1686, DOI 10.1101/gad.16651211; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Nowak SJ, 2003, MOL CELL BIOL, V23, P6129, DOI 10.1128/MCB.23.17.6129-6138.2003; Pai CY, 2004, MOL CELL, V16, P737, DOI 10.1016/j.molcel.2004.11.004; PALMER MJ, 1993, GENETICS, V134, P545; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; PHILPOTT A, 1992, CELL, V69, P759, DOI 10.1016/0092-8674(92)90288-N; PHILPOTT A, 1991, CELL, V65, P569, DOI 10.1016/0092-8674(91)90089-H; Ramos E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016562; Schubert T, 2012, MOL CELL, V48, P434, DOI 10.1016/j.molcel.2012.08.021; Schulze SR, 2005, GENETICS, V171, P185, DOI 10.1534/genetics.105.043208; Spradling AC, 1999, GENETICS, V153, P135; Szollosi E, 2008, J PROTEOME RES, V7, P2291, DOI 10.1021/pr700720c; Wood AM, 2011, MOL CELL, V44, P29, DOI 10.1016/j.molcel.2011.07.035; Woodcock CL, 2006, CURR OPIN STRUC BIOL, V16, P213, DOI 10.1016/j.sbi.2006.02.005; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Yi X, 2009, MOL BIOL CELL, V20, P983, DOI 10.1091/mbc.E08-06-0639	46	6	6	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53091	10.1371/journal.pone.0053091	http://dx.doi.org/10.1371/journal.pone.0053091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341925	Green Published, gold			2022-12-25	WOS:000313682700021
J	Noble, MM; van Laake, G; Berumen, ML; Fulton, CJ				Noble, Mae M.; van Laake, Gregoor; Berumen, Michael L.; Fulton, Christopher J.			Community Change within a Caribbean Coral Reef Marine Protected Area following Two Decades of Local Management	PLOS ONE			English	Article							REGION-WIDE DECLINES; GREAT-BARRIER-REEF; PHASE-SHIFTS; RESERVE NETWORKS; FISH POPULATIONS; RESILIENCE; BIOMASS; RECRUITMENT; CONSERVATION; SIZE	Structural change in both the habitat and reef-associated fish assemblages within spatially managed coral reefs can provide key insights into the benefits and limitations of Marine Protected Areas (MPAs). While MPA zoning effects on particular target species are well reported, we are yet to fully resolve the various affects of spatial management on the structure of coral reef communities over decadal time scales. Here, we document mixed affects of MPA zoning on fish density, biomass and species richness over the 21 years since establishment of the Saba Marine Park (SMP). Although we found significantly greater biomass and species richness of reef-associated fishes within shallow habitats (5 meters depth) closed to fishing, this did not hold for deeper (15 m) habitats, and there was a widespread decline (38% decrease) in live hard coral cover and a 68% loss of carnivorous reef fishes across all zones of the SMP from the 1990s to 2008. Given the importance of live coral for the maintenance and replenishment of reef fishes, and the likely role of chronic disturbance in driving coral decline across the region, we explore how local spatial management can help protect coral reef ecosystems within the context of large-scale environmental pressures and disturbances outside the purview of local MPA management.	[Noble, Mae M.; Fulton, Christopher J.] Australian Natl Univ, ARC Ctr Excellence Coral Reef Studies, Res Sch Biol, Canberra, ACT, Australia; [Noble, Mae M.; van Laake, Gregoor] Saba Conservat Fdn, The Bottom, Saba, Netherlands; [Berumen, Michael L.] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Berumen, Michael L.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	Australian National University; King Abdullah University of Science & Technology; Woods Hole Oceanographic Institution	Noble, MM (corresponding author), Australian Natl Univ, ARC Ctr Excellence Coral Reef Studies, Res Sch Biol, Canberra, ACT, Australia.	mae.noble@anu.edu.au	Berumen, Michael L/F-7745-2011; Fulton, Christopher/A-5971-2008	Berumen, Michael L/0000-0003-2463-2742; Fulton, Christopher/0000-0002-1140-1999	Saba Conservation Foundation ((SCF); King Abdullah University of Science and Technology; Australian National University; Australian Research Council	Saba Conservation Foundation ((SCF); King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); Australian National University(Australian National University); Australian Research Council(Australian Research Council)	Funding was provided by the Saba Conservation Foundation ((SCF), King Abdullah University of Science and Technology, The Australian National University and Australian Research Council. The funders had no role in study design and analysis, decision to publish, or preparation of the manuscript. Staff of the SCF were involved in data collection.	Almany GR, 2009, CORAL REEFS, V28, P339, DOI 10.1007/s00338-009-0484-x; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berumen ML, 2006, CORAL REEFS, V25, P647, DOI 10.1007/s00338-006-0145-2; Berumen ML, 2012, ECOL EVOL, V2, P444, DOI 10.1002/ece3.208; Bonsack JA, 1988, 215 NOAA NMFSSEFC; Bonsack JA, 1986, 41 NOAA NMFS; Bruggemann JH, 1996, MAR ECOL PROG SER, V134, P59, DOI 10.3354/meps134059; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Cardoso SC, 2006, MAR BIODIVERS REC, V2, P1; Cheal AJ, 1997, MAR ECOL PROG SER, V158, P241, DOI 10.3354/meps158241; Cheal AJ, 2002, CORAL REEFS, V21, P131, DOI 10.1007/s00338-002-0227-8; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Coker DJ, 2012, CORAL REEFS, V31, P919, DOI 10.1007/s00338-012-0920-1; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Cote IM, 2005, PHILOS T R SOC B, V360, P385, DOI 10.1098/rstb.2004.1591; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; FROESE R, 2007, FISHBASE; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Goreau T, 2000, CONSERV BIOL, V14, P5, DOI 10.1046/j.1523-1739.2000.00011.x; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Graham NAJ, 2011, OCEANOGR MAR BIOL, V49, P105; Halford AR, 2009, GLOBAL CHANGE BIOL, V15, P3031, DOI 10.1111/j.1365-2486.2009.01972.x; Halpern BS, 2003, ECOL APPL, V13, pS117; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Huntington BE, 2011, CORAL REEFS, V30, P1077, DOI 10.1007/s00338-011-0809-4; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Jupiter SD, 2012, CORAL REEFS, V31, P321, DOI 10.1007/s00338-012-0888-x; Kerry JT, 2012, CORAL REEFS, V31, P415, DOI 10.1007/s00338-011-0859-7; Ledlie MH, 2007, CORAL REEFS, V26, P641, DOI 10.1007/s00338-007-0230-1; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; Molloy PP, 2009, J APPL ECOL, V46, P743, DOI 10.1111/j.1365-2664.2009.01662.x; Mumby PJ, 2009, CORAL REEFS, V28, P761, DOI 10.1007/s00338-009-0506-8; Nystrom M, 2008, CORAL REEFS, V27, P795, DOI 10.1007/s00338-008-0426-z; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Pollnac R, 2010, P NATL ACAD SCI USA, V107, P18262, DOI 10.1073/pnas.0908266107; POLUNIN NVC, 1993, MAR ECOL PROG SER, V100, P167, DOI 10.3354/meps100167; Precht WF, 2002, CORAL REEFS, V21, P41, DOI 10.1007/s00338-001-0209-2; ROBERTS CM, 1995, CONSERV BIOL, V9, P815, DOI 10.1046/j.1523-1739.1995.09040815.x; Roberts CM, 1995, STATUS REEF FISH COR; Russ GR, 2010, OECOLOGIA, V163, P1103, DOI 10.1007/s00442-010-1692-3; Russ Garry R., 2002, P421, DOI 10.1016/B978-012615185-5/50024-4; Russ GR, 1998, CORAL REEFS, V17, P399, DOI 10.1007/s003380050146; Sandin SA, 2012, OECOLOGIA, V168, P1079, DOI 10.1007/s00442-011-2156-0; Sea Around Us Project, 2012, GLOB CATCH DAT; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; Shahnawaz K, 2019, MED FORUM, V30, P12; Stallings CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005333; Toller W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009207; van Dijken G, 2012, STORM CARIB CARIBBEA; Westera M, 2003, J EXP MAR BIOL ECOL, V294, P145, DOI 10.1016/S0022-0981(03)00268-5; Wilkinson C, 2008, STATUS CORAL REEFS W; Williamson DH, 2004, ENVIRON CONSERV, V31, P149, DOI 10.1017/S0376892904001262; Wilson SK, 2008, J ANIM ECOL, V77, P220, DOI 10.1111/j.1365-2656.2007.01341.x; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Zeller DC, 1998, CAN J FISH AQUAT SCI, V55, P917, DOI 10.1139/cjfas-55-4-917	66	11	11	2	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54069	10.1371/journal.pone.0054069	http://dx.doi.org/10.1371/journal.pone.0054069			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342078	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400118
J	Paredes, JA; Zhou, XS; Hoglund, S; Karlsson, A				Paredes, Joao A.; Zhou, Xiaoshan; Hoglund, Stefan; Karlsson, Anna			Gene Expression Deregulation in Postnatal Skeletal Muscle of TK2 Deficient Mice Reveals a Lower Pool of Proliferating Myogenic Progenitor Cells	PLOS ONE			English	Article							MITOCHONDRIAL THYMIDINE KINASE; CARDIOMYOCYTE DNA-SYNTHESIS; RETINOBLASTOMA PROTEIN; DEOXYNUCLEOTIDE POOLS; DEPLETION MYOPATHY; MOUSE-TISSUES; STEM-CELLS; DIFFERENTIATION; INHIBITION; MTDNA	Loss of thymidine kinase 2 (TK2) causes a heterogeneous myopathic form of mitochondrial DNA (mtDNA) depletion syndrome (MDS) in humans that predominantly affects skeletal muscle tissue. In mice, TK2 deficiency also affects several tissues in addition to skeletal muscle, including brain, heart, adipose tissue, kidneys and causes death about 3 weeks after birth. We analysed skeletal muscle and heart muscle tissues of Tk2 knockout mice at postnatal development phase and observed that TK2 deficient pups grew slower and their skeletal muscles appeared significantly underdeveloped, whereas heart was close to normal in size. Both tissues showed mtDNA depletion and mitochondria with altered ultrastructure, as revealed by transmission electron microscopy. Gene expression microarray analysis showed a strong down-regulation of genes involved in cell cycle and cell proliferation in both tissues, suggesting a lower pool of undifferentiated proliferating cells. Analysis of isolated primary myoblasts from Tk2 knockout mice showed slow proliferation, less ability to differentiate and signs of premature senescence, even in absence of mtDNA depletion. Our data demonstrate that TK2 deficiency disturbs myogenic progenitor cells function in postnatal skeletal muscle and we propose this as one of the causes of underdeveloped phenotype and myopathic characteristic of the TK2 deficient mice, in addition to the progressive mtDNA depletion, mitochondrial damage and respiratory chain deficiency in post-mitotic differentiated tissue.	[Paredes, Joao A.; Zhou, Xiaoshan; Karlsson, Anna] Karolinska Univ Hosp Huddinge, Div Clin Microbiol, Dept Lab Med, Karolinska Inst, Stockholm, Sweden; [Hoglund, Stefan] Uppsala Univ, Dept Chem, BMC, Uppsala, Sweden	Karolinska Institutet; Karolinska University Hospital; Uppsala University	Paredes, JA (corresponding author), Karolinska Univ Hosp Huddinge, Div Clin Microbiol, Dept Lab Med, Karolinska Inst, Stockholm, Sweden.	joao.paredes@ki.se	Karlsson, Anders H/B-5294-2008; Karlsson, Anna/E-7945-2018	Karlsson, Anders H/0000-0003-3466-4502; Paredes, Joao/0000-0002-7788-8939	Swedish Cancer Society; Swedish Research Council; Karolinska Institute; board of research at the Karolinska Institute; research committee at the Karolinska hospital	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institute(Karolinska Institutet); board of research at the Karolinska Institute(Karolinska Institutet); research committee at the Karolinska hospital	This work was supported by grants from the Swedish Cancer Society (http://www.cancerfonden.se), the Swedish Research Council (http://www.vr.se) and the Karolinska Institute (http://www.ki.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Microarray core facility at Novum, BEA, Bioinformatics and Expression Analysis, which is supported by the board of research at the Karolinska Institute and the research committee at the Karolinska hospital. We would also like to thank Hernan Concha from the Advanced Flow Cytometry Laboratory at Centre for Infectious Diseases, Karolinska Institute, for his help during the flow cytometry analysis performed in this study.	Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012; Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143; Anversa P, 1998, CIRC RES, V83, P1, DOI 10.1161/01.RES.83.1.1; ARNER ESJ, 1992, BIOCHEM BIOPH RES CO, V188, P712, DOI 10.1016/0006-291X(92)91114-6; Bai RK, 2004, ANN NY ACAD SCI, V1011, P304, DOI 10.1196/annals.1293.029; Bartesaghi S, 2010, HUM MOL GENET, V19, P1669, DOI 10.1093/hmg/ddq043; BERK AJ, 1973, J BIOL CHEM, V248, P2722; BOGENHAGEN D, 1976, J BIOL CHEM, V251, P2938; Cam H, 2006, CANCER CELL, V10, P281, DOI 10.1016/j.ccr.2006.08.024; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Dimri GP, 1996, MOL CELL BIOL, V16, P2987; Dorado B, 2011, HUM MOL GENET, V20, P155, DOI 10.1093/hmg/ddq453; Dou QP, 1996, PROG NUCLEIC ACID RE, V53, P197, DOI 10.1016/S0079-6603(08)60145-2; DOU QP, 1994, J BIOL CHEM, V269, P1306; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eriksson S, 2002, CELL MOL LIFE SCI, V59, P1327, DOI 10.1007/s00018-002-8511-x; Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008; Gokhin DS, 2008, J EXP BIOL, V211, P837, DOI 10.1242/jeb.014340; Gotz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236; GU W, 1993, CELL, V72, P309, DOI 10.1016/0092-8674(93)90110-C; Gurer C, 2005, J VIROL, V79, P5557, DOI 10.1128/JVI.79.9.5557-5567.2005; Hoglund S, 2002, ANTIMICROB AGENTS CH, V46, P3597, DOI 10.1128/AAC.46.11.3597-3605.2002; Huang DY, 2001, BIOCHEM J, V356, P829, DOI 10.1042/0264-6021:3560829; Leanza L, 2008, J BIOL CHEM, V283, P16437, DOI 10.1074/jbc.M801572200; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Machida N, 1997, J MOL CELL CARDIOL, V29, P1895, DOI 10.1006/jmcc.1997.0427; MacLellan WR, 2000, ANNU REV PHYSIOL, V62, P289, DOI 10.1146/annurev.physiol.62.1.289; Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746; Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001; McGeachie JK, 1999, J ANAT, V194, P287, DOI 10.1046/j.1469-7580.1999.19420287.x; Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060; NAKANISHI M, 1995, P NATL ACAD SCI USA, V92, P4352, DOI 10.1073/pnas.92.10.4352; Ogryzko VV, 1997, MOL CELL BIOL, V17, P4877, DOI 10.1128/MCB.17.8.4877; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100; POULTON J, 1995, J INHERIT METAB DIS, V18, P4, DOI 10.1007/BF00711367; Rampazzo C, 2010, MUTAT RES-GEN TOX EN, V703, P2, DOI 10.1016/j.mrgentox.2010.06.002; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Rumyantsev P P, 1977, Int Rev Cytol, V51, P186; Rylova SN, 2007, BIOCHEM PHARMACOL, V74, P169, DOI 10.1016/j.bcp.2007.03.029; Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; Schultz E, 1996, DEV BIOL, V175, P84, DOI 10.1006/dbio.1996.0097; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Shaw CS, 2008, HISTOCHEM CELL BIOL, V129, P65, DOI 10.1007/s00418-007-0349-8; Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Solaroli N, 2007, GENE THER, V14, P86, DOI 10.1038/sj.gt.3302835; Soonpaa MH, 1997, AM J PHYSIOL-HEART C, V272, pH220, DOI 10.1152/ajpheart.1997.272.1.H220; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017; Tarnopolsky MA, 2007, AM J PHYSIOL-REG I, V292, pR1271, DOI 10.1152/ajpregu.00472.2006; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Ulitsky I, 2010, NAT PROTOC, V5, P303, DOI 10.1038/nprot.2009.230; Villarroya J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029691; Vitale I, 2011, CELL DEATH DIFFER, V18, P1403, DOI 10.1038/cdd.2010.145; Wang J, 1996, SCIENCE, V273, P359, DOI 10.1126/science.273.5273.359; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; ZHANG H, 1994, GENE DEV, V8, P1750, DOI 10.1101/gad.8.15.1750; Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133	62	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53698	10.1371/journal.pone.0053698	http://dx.doi.org/10.1371/journal.pone.0053698			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341978	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400069
J	Andrade, JM; Pobre, V; Arraiano, CM				Andrade, Jose Marques; Pobre, Vania; Arraiano, Cecilia Maria			Small RNA Modules Confer Different Stabilities and Interact Differently with Multiple Targets	PLOS ONE			English	Article							SMALL REGULATORY RNA; RHO-INDEPENDENT TERMINATOR; MESSENGER-RNA; ESCHERICHIA-COLI; TRANSCRIPTION TERMINATION; RIBONUCLEASE-III; PROTEIN HFQ; KEY PLAYER; OXYS RNA; BINDING	Bacterial Hfq-associated small regulatory RNAs (sRNAs) parallel animal microRNAs in their ability to control multiple target mRNAs. The small non-coding MicA RNA represses the expression of several genes, including major outer membrane proteins such as ompA, tsx and ecnB. In this study, we have characterised the RNA determinants involved in the stability of MicA and analysed how they influence the expression of its targets. Site- directed mutagenesis was used to construct MicA mutated forms. The 5'linear domain, the structured region with two stem-loops, the A/U-rich sequence or the 3' poly(U) tail were altered without affecting the overall secondary structure of MicA. The stability and the target regulation abilities of the wild-type and the different mutated forms of MicA were then compared. The 5' domain impacted MicA stability through an RNase III-mediated pathway. The two stem-loops showed different roles and disruption of stem-loop 2 was the one that mostly affected MicA stability and abundance. Moreover, STEM2 was found to be more important for the in vivo repression of both ompA and ecnB mRNAs while STEM1 was critical for regulation of tsx mRNA levels. The A/U-rich linear sequence is not the only Hfq-binding site present in MicA and the 3' poly(U) sequence was critical for sRNA stability. PNPase was shown to be an important exoribonuclease involved in sRNA degradation. In addition to the 5' domain of MicA, the stem-loops and the 3' poly(U) tail are also shown to affect target-binding. Disruption of the 3'U-rich sequence greatly affects all targets analysed. In conclusion, our results have shown that it is important to understand the "sRNA anatomy'' in order to modulate its stability. Furthermore, we have demonstrated that MicA RNA can use different modules to regulate its targets. This knowledge can allow for the engineering of non-coding RNAs that interact differently with multiple targets.	[Andrade, Jose Marques; Pobre, Vania; Arraiano, Cecilia Maria] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal	Universidade Nova de Lisboa	Arraiano, CM (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Av Republ, Oeiras, Portugal.	cecilia@itqb.unl.pt	Pobre, Vânia SF/M-4115-2013	Pobre, Vânia SF/0000-0002-4339-8472; Arraiano, Cecilia/0000-0003-1934-9301; Andrade, Jose/0000-0002-3716-2615	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [PEst-OE/EQB/LA0004/2011]; European Commission [FP7-KBBE-2011-1-289326]	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grants from Fundacao para a Ciencia e a Tecnologia (FCT), Portugal (including grant PEst-OE/EQB/LA0004/2011) and by grant FP7-KBBE-2011-1-289326 from European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 1996, BIOCHIMIE, V78, P1035, DOI 10.1016/S0300-9084(97)86727-2; Afonyushkin T, 2005, NUCLEIC ACIDS RES, V33, P1678, DOI 10.1093/nar/gki313; Altuvia S, 1998, EMBO J, V17, P6069, DOI 10.1093/emboj/17.20.6069; Amarasinghe AK, 2001, METHOD ENZYMOL, V342, P143, DOI 10.1016/S0076-6879(01)42542-0; Andrade JM, 2008, RNA, V14, P543, DOI 10.1261/rna.683308; Andrade JM, 2012, RNA, V18, P844, DOI 10.1261/rna.029413.111; Andrade JM, 2009, PROG MOL BIOL TRANSL, V85, P187, DOI 10.1016/S0079-6603(08)00805-2; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Argaman L, 2000, J MOL BIOL, V300, P1101, DOI 10.1006/jmbi.2000.3942; Arraiano CM, 2010, FEMS MICROBIOL REV, V34, P883, DOI 10.1111/j.1574-6976.2010.00242.x; ARRAIANO CM, 1988, J BACTERIOL, V170, P4625, DOI 10.1128/jb.170.10.4625-4633.1988; BABITZKE P, 1993, J BACTERIOL, V175, P229, DOI 10.1128/JB.175.1.229-239.1993; Balbontin R, 2010, MOL MICROBIOL, V78, P380, DOI 10.1111/j.1365-2958.2010.07342.x; Beisel CL, 2012, EMBO J, V31, P1961, DOI 10.1038/emboj.2012.52; Beisel CL, 2010, FEMS MICROBIOL REV, V34, P866, DOI 10.1111/j.1574-6976.2010.00241.x; Benito Y, 2000, RNA, V6, P668, DOI 10.1017/S1355838200992550; Bernhart SH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-474; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Bossi L, 2007, MOL MICROBIOL, V65, P799, DOI 10.1111/j.1365-2958.2007.05829.x; Bouvier M, 2008, MOL CELL, V32, P827, DOI 10.1016/j.molcel.2008.10.027; Brunel C, 2000, METHOD ENZYMOL, V318, P3; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Coornaert A, 2010, MOL MICROBIOL, V76, P467, DOI 10.1111/j.1365-2958.2010.07115.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davidson EA, 2005, TRENDS BIOTECHNOL, V23, P109, DOI 10.1016/j.tibtech.2005.01.006; Desnoyers G, 2009, EMBO J, V28, P1551, DOI 10.1038/emboj.2009.116; Durand S, 2010, MOL MICROBIOL, V75, P1215, DOI 10.1111/j.1365-2958.2010.07044.x; Ferrara S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036553; Folichon M, 2003, NUCLEIC ACIDS RES, V31, P7302, DOI 10.1093/nar/gkg915; Gogol EB, 2011, P NATL ACAD SCI USA, V108, P12875, DOI 10.1073/pnas.1109379108; Guillier M, 2008, NUCLEIC ACIDS RES, V36, P6781, DOI 10.1093/nar/gkn742; Hajnsdorf E, 2012, BIOCHIMIE, V94, P1544, DOI 10.1016/j.biochi.2012.02.010; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Le Derout J, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-17; Liang JC, 2011, MOL CELL, V43, P915, DOI 10.1016/j.molcel.2011.08.023; Link TM, 2009, P NATL ACAD SCI USA, V106, P19286, DOI 10.1073/pnas.0908744106; Lioliou E, 2010, NEW BIOTECHNOL, V27, P222, DOI 10.1016/j.nbt.2010.03.002; Liu JM, 2010, CURR OPIN MICROBIOL, V13, P18, DOI 10.1016/j.mib.2009.11.004; Moll I, 2003, RNA, V9, P1308, DOI 10.1261/rna.5850703; Morita T, 2005, GENE DEV, V19, P2176, DOI 10.1101/gad.1330405; Olejniczak M, 2011, BIOCHEMISTRY-US, V50, P4427, DOI 10.1021/bi102043f; Otaka H, 2011, P NATL ACAD SCI USA, V108, P13059, DOI 10.1073/pnas.1107050108; Papenfort K, 2010, P NATL ACAD SCI USA, V107, P20435, DOI 10.1073/pnas.1009784107; Papenfort K, 2009, RES MICROBIOL, V160, P278, DOI 10.1016/j.resmic.2009.03.004; Peer A, 2011, J BACTERIOL, V193, P1690, DOI 10.1128/JB.01419-10; Prevost K, 2011, GENE DEV, V25, P385, DOI 10.1101/gad.2001711; Rasmussen AA, 2005, MOL MICROBIOL, V58, P1421, DOI 10.1111/j.1365-2958.2005.04911.x; Regnier P, 2009, PROG MOL BIOL TRANSL, V85, P137, DOI 10.1016/S0079-6603(08)00804-0; Regulski Elizabeth E., 2008, V419, P53, DOI 10.1007/978-1-59745-033-1_4; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; REYNOLDS R, 1992, J MOL BIOL, V224, P53, DOI 10.1016/0022-2836(92)90575-5; Rice JB, 2011, NUCLEIC ACIDS RES, V39, P3806, DOI 10.1093/nar/gkq1219; Salvail H, 2010, P NATL ACAD SCI USA, V107, P15223, DOI 10.1073/pnas.1007805107; Sauer E, 2011, P NATL ACAD SCI US; Sauer E, 2012, P NATL ACAD SCI USA, V109, P9396, DOI 10.1073/pnas.1202521109; Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322; Sharma CM, 2007, GENE DEV, V21, P2804, DOI 10.1101/gad.447207; Sharma CM, 2009, CURR OPIN MICROBIOL, V12, P536, DOI 10.1016/j.mib.2009.07.006; Shinhara A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-428; Tijerina P, 2007, NAT PROTOC, V2, P2608, DOI 10.1038/nprot.2007.380; Udekwu KI, 2005, GENE DEV, V19, P2355, DOI 10.1101/gad.354405; Udekwu KI, 2007, NUCLEIC ACIDS RES, V35, P1279, DOI 10.1093/nar/gkl1154; Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1111/j.1365-2958.2003.03935.x; Viegas SC, 2011, NUCLEIC ACIDS RES, V39, P2918, DOI 10.1093/nar/gkq1239; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Zhang AX, 2002, MOL CELL, V9, P11, DOI 10.1016/S1097-2765(01)00437-3; Ziolkowska K, 2006, NUCLEIC ACIDS RES, V34, P709, DOI 10.1093/nar/gkj464; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	69	26	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e52866	10.1371/journal.pone.0052866	http://dx.doi.org/10.1371/journal.pone.0052866			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349691	Green Published, gold			2022-12-25	WOS:000314019100013
J	Brydges, NM; Whalley, HC; Jansen, MA; Merrifield, GD; Wood, ER; Lawrie, SM; Wynne, SM; Day, M; Fleetwood-Walker, S; Steele, D; Marshall, I; Hall, J; Holmes, MC				Brydges, Nichola M.; Whalley, Heather C.; Jansen, Maurits A.; Merrifield, Gavin D.; Wood, Emma R.; Lawrie, Stephen M.; Wynne, Sara-Madge; Day, Mark; Fleetwood-Walker, Sue; Steele, Douglas; Marshall, Ian; Hall, Jeremy; Holmes, Megan C.			Imaging Conditioned Fear Circuitry Using Awake Rodent fMRI	PLOS ONE			English	Article							JUVENILE STRESS; BRAIN; RATS; CONSEQUENCES; ACTIVATION; DISORDERS; CHILDHOOD; AMYGDALA; STIMULI; MEMORY	Functional magnetic resonance imaging (fMRI) is a powerful method for exploring emotional and cognitive brain responses in humans. However rodent fMRI has not previously been applied to the analysis of learned behaviour in awake animals, limiting its use as a translational tool. Here we have developed a novel paradigm for studying brain activation in awake rats responding to conditioned stimuli using fMRI. Using this method we show activation of the amygdala and related fear circuitry in response to a fear-conditioned stimulus and demonstrate that the magnitude of fear circuitry activation is increased following early life stress, a rodent model of affective disorders. This technique provides a new translatable method for testing environmental, genetic and pharmacological manipulations on emotional and cognitive processes in awake rodent models.	[Brydges, Nichola M.; Jansen, Maurits A.; Hall, Jeremy; Holmes, Megan C.] Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Wood, Emma R.] Univ Edinburgh, Ctr Cognit & Neural Syst, Edinburgh, Midlothian, Scotland; [Day, Mark] Bristol Myers Squibb Co, Strateg Transact Grp, Wallingford, CT 06492 USA; [Steele, Douglas] Univ Dundee, Med Res Inst, Dundee, Scotland	University of Edinburgh; University of Edinburgh; Bristol-Myers Squibb; University of Dundee	Holmes, MC (corresponding author), Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland.	megan.holmes@ed.ac.uk	Jansen, Maurits/B-3913-2012; Lawrie, Stephen MacGregor/AAD-1607-2021; Steele, Douglas/AAB-9889-2019; Whalley, Heather C/N-1886-2019	Jansen, Maurits/0000-0002-7077-0188; Lawrie, Stephen MacGregor/0000-0002-2444-5675; Steele, Douglas/0000-0002-9822-8753; Whalley, Heather C/0000-0002-4505-8869; Brydges, Nichola/0000-0003-0485-4639; Hall, Jeremy/0000-0002-0403-3278; Merrifield, Gavin/0000-0003-4652-6625	Wyeth-TMRC grant [NS-EU-136]; Scottish Senior Clinical Fellowship; University of Edinburgh Centre for Cognitive Aging and Cognitive Epidemiology, cross council Lifelong Health and Wellbeing Initiative [G0700704/84698]; Pfizer; Medical Research Council [G0801418B, MR/K026992/1, G0700704] Funding Source: researchfish; MRC [G0700704] Funding Source: UKRI	Wyeth-TMRC grant; Scottish Senior Clinical Fellowship; University of Edinburgh Centre for Cognitive Aging and Cognitive Epidemiology, cross council Lifelong Health and Wellbeing Initiative; Pfizer(Pfizer); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Wyeth-TMRC grant NS-EU-136 (IM, SF-W, MCH, JH, ERW, SML, MAJ). JH is supported by a Scottish Senior Clinical Fellowship. Further support was provided by the Dr Mortimer and Theresa Sackler Foundation JH) and the University of Edinburgh Centre for Cognitive Aging and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative (G0700704/84698)(MCG, IM and ERW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have declared that no competing interests exist. Wyeth (now Pfizer) contributed to the funding for setting up this technique, MD was previously employed by Abbott Pharmaceuticals and is now employed by Bristol-Myers Squib but there are no competing financial interests in respect to the acquisition, analysis or interpretation of the results. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Avital A, 2005, INT J NEUROPSYCHOPH, V8, P163, DOI 10.1017/S1461145704004808; Becerra L, 2011, NEUROIMAGE, V54, P1355, DOI 10.1016/j.neuroimage.2010.08.056; Bremner JD, 2001, DEV PSYCHOPATHOL, V13, P473, DOI 10.1017/S0954579401003042; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Chin CL, 2011, J PHARMACOL EXP THER, V336, P709, DOI 10.1124/jpet.110.173880; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; Ferris CF, 2005, J NEUROSCI, V25, P149, DOI 10.1523/JNEUROSCI.3156-04.2005; Governo RJM, 2008, BRIT J PHARMACOL, V153, P1558, DOI 10.1038/bjp.2008.27; Jacobson-Pick S, 2010, BEHAV BRAIN RES, V214, P268, DOI 10.1016/j.bbr.2010.05.036; Johansen JP, 2012, BIOL PSYCHIAT, V71, P1053, DOI 10.1016/j.biopsych.2011.10.023; Kim T, 2010, NEUROIMAGE, V52, P224, DOI 10.1016/j.neuroimage.2010.03.064; King JA, 2005, J NEUROSCI METH, V148, P154, DOI 10.1016/j.jneumeth.2005.04.011; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Macey PM, 2004, NEUROIMAGE, V22, P360, DOI 10.1016/j.neuroimage.2003.12.042; Meewisse ML, 2011, J TRAUMA STRESS, V24, P405, DOI 10.1002/jts.20663; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Romaniuk L, 2010, ARCH GEN PSYCHIAT, V67, P1246, DOI 10.1001/archgenpsychiatry.2010.169; Sacco T, 2010, SCIENCE, V329, P649, DOI 10.1126/science.1183165; Schweinhardt P, 2003, J NEUROSCI METH, V129, P105, DOI 10.1016/S0165-0270(03)00192-4; Shi CJ, 1999, J NEUROSCI, V19, P420, DOI 10.1523/JNEUROSCI.19-01-00420.1999; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Toledo-Rodriguez Maria, 2007, Neural Plasticity, V2007, DOI 10.1155/2007/71203; Weich S, 2009, BRIT J PSYCHIAT, V194, P392, DOI 10.1192/bjp.bp.107.042515; Yaniv D, 2004, BRAIN RES REV, V44, P179, DOI 10.1016/j.brainresrev.2003.08.008; Zhang NY, 2010, J NEUROSCI METH, V189, P186, DOI 10.1016/j.jneumeth.2010.04.001	26	34	34	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54197	10.1371/journal.pone.0054197	http://dx.doi.org/10.1371/journal.pone.0054197			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349824	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000314019100049
J	McKenzie, DJ; Estivales, G; Svendsen, JC; Steffensen, JF; Agnese, JF				McKenzie, David J.; Estivales, Guillan; Svendsen, Jon C.; Steffensen, John F.; Agnese, Jean-Francois			Local Adaptation to Altitude Underlies Divergent Thermal Physiology in Tropical Killifishes of the Genus Aphyosemion	PLOS ONE			English	Article							MITOCHONDRIAL-DNA SEQUENCES; EUROPEAN SEA BASS; METABOLIC-RATE; CLIMATE-CHANGE; PHYLOGENETIC-RELATIONSHIPS; FUNDULUS-HETEROCLITUS; SWIMMING PERFORMANCE; INTRINSIC GROWTH; DYNAMIC ACTION; PASSAGE TIME	In watersheds of equatorial West Africa, monophyletic groups of killifish species (genus Aphyosemion) occur in discrete altitudinal ranges, low altitude species (LA, sea level to similar to 350 m) or high altitude species (HA, 350 to 900 m). We investigated the hypothesis that local adaptation to altitude by the LA and HA species would be revealed as divergent effects of temperature on their physiological energetics. Two species from each group (mass similar to 350 mg) were acclimated to 19, 25 and 28 degrees C, with 19 and 28 degrees C estimated to be outside the thermal envelope for LA or HA, respectively, in the wild. Wild-caught animals (F0 generation) were compared with animals raised in captivity at 25 degrees C (F1 generation) to investigate the contribution of adaptation versus plasticity. Temperature significantly increased routine metabolic rate in all groups and generations. However, LA and HA species differed in the effects of temperature on their ability to process a meal. At 25 degrees C, the specific dynamic action (SDA) response was completed within 8 h in all groups, but acclimation to temperatures beyond the thermal envelope caused profound declines in SDA performance. At 19 degrees C, the LA required similar to 14 h to complete the SDA, whereas the HA required only similar to 7 h. The opposite effect was observed at 28 degrees C. This effect was evident in both F0 and F1. Reaction norms for effects of temperature on SDA therefore revealed a trade-off, with superior performance at warmer temperatures by LA being associated with inferior performance at cooler temperatures, and vice-versa in HA. The data indicate that divergent physiological responses to temperature in the LA and HA species reflect local adaptation to the thermal regime in their habitat, and that local adaptation to one thermal environment trades off against performance in another.	[McKenzie, David J.; Estivales, Guillan; Agnese, Jean-Francois] Univ Montpellier 2, Inst Sci Evolut, UMR5554, Montpellier, France; [McKenzie, David J.] Univ Montpellier 2, UMR5119 Ecol Syst Marins Cotiers, Montpellier, France; [Svendsen, Jon C.; Steffensen, John F.] Univ Copenhagen, Marine Biol Sect, Helsingor, Denmark	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier; University of Copenhagen	McKenzie, DJ (corresponding author), Univ Montpellier 2, Inst Sci Evolut, UMR5554, Montpellier, France.	david.mckenzie@univ-montp2.fr	McKenzie, David/AAA-5179-2021; Steffensen, John F/F-6778-2010; Svendsen, Jon/J-2716-2013; Agnèse, jean-François/J-8302-2016; McKenzie, David J./K-3090-2012	McKenzie, David/0000-0003-0961-9101; Steffensen, John F/0000-0002-4477-8039; Svendsen, Jon/0000-0002-0273-0985; Agnèse, jean-François/0000-0002-6883-551X; McKenzie, David J./0000-0003-0961-9101	Centre National pour la Recherche Scientifique; Universite Montpellier 2; Ambassade de France in Copenhagen	Centre National pour la Recherche Scientifique; Universite Montpellier 2; Ambassade de France in Copenhagen	This research was funded by the Centre National pour la Recherche Scientifique, the Universite Montpellier 2 and the Ambassade de France in Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnese JF, 2006, MOL PHYLOGENET EVOL, V40, P332, DOI 10.1016/j.ympev.2006.03.018; Agnese JF, 2009, ZOOTAXA, P43, DOI 10.11646/zootaxa.2045.1.4; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Angilletta MJ, 2003, TRENDS ECOL EVOL, V18, P234, DOI 10.1016/S0169-5347(03)00087-9; Angilletta MJ, 2002, J THERM BIOL, V27, P249, DOI 10.1016/S0306-4565(01)00094-8; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; AVERY HW, 1993, PHYSIOL ZOOL, V66, P902, DOI 10.1086/physzool.66.6.30163746; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bennett WA, 1997, T AM FISH SOC, V126, P841, DOI 10.1577/1548-8659(1997)126<0841:CTAPOO>2.3.CO;2; Billerbeck JM, 2001, EVOLUTION, V55, P1863; Bokma F, 2004, FUNCT ECOL, V18, P184, DOI 10.1111/j.0269-8463.2004.00817.x; Bozinovic F, 2011, ANNU REV ECOL EVOL S, V42, P155, DOI 10.1146/annurev-ecolsys-102710-145055; BRATTSTROM BH, 1979, AM ZOOL, V19, P345; Damme R, 1989, OECOLOGIA, V80, P516; Dillon ME, 2010, NATURE, V467, P704, DOI 10.1038/nature09407; Dupont-Prinet A, 2010, J EXP BIOL, V213, P1143, DOI 10.1242/jeb.037812; Eliason EJ, 2011, SCIENCE, V332, P109, DOI 10.1126/science.1199158; Fangue NA, 2008, PHYSIOL BIOCHEM ZOOL, V81, P389, DOI 10.1086/589109; Fangue NA, 2006, J EXP BIOL, V209, P2859, DOI 10.1242/jeb.02260; Fangue NA, 2009, PHYSIOL BIOCHEM ZOOL, V82, P776, DOI 10.1086/606030; Fraser KPP, 2007, ADV MAR BIOL, V52, P267, DOI 10.1016/S0065-2881(06)52003-6; Fry FEJ, 1971, FISH PHYSIOL, VVI, P1, DOI DOI 10.1016/S1546-5098(08)60146-6; Gomes ARC, 2005, FISH PHYSIOL, V21, P443; Huey RB, 2012, PHILOS T R SOC B, V367, P1665, DOI 10.1098/rstb.2012.0005; HUEY RB, 1993, AM NAT, V142, pS21, DOI 10.1086/285521; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Jordan AD, 2007, PHYSIOL BIOCHEM ZOOL, V80, P178, DOI 10.1086/510565; Killen SS, 2011, J ANIM ECOL, V80, P1024, DOI 10.1111/j.1365-2656.2011.01844.x; McCue MD, 2006, COMP BIOCHEM PHYS A, V144, P381, DOI 10.1016/j.cbpa.2006.03.011; McKenzie DJ, 2007, AQUACULTURE, V263, P280, DOI 10.1016/j.aquaculture.2006.10.022; Millidine KJ, 2009, P ROY SOC B-BIOL SCI, V276, P2103, DOI 10.1098/rspb.2009.0080; Murphy WJ, 1999, MOL PHYLOGENET EVOL, V11, P351, DOI 10.1006/mpev.1998.0566; Nespolo RF, 2007, J EXP BIOL, V210, P2000, DOI 10.1242/jeb.02780; NICIEZA AG, 1994, OECOLOGIA, V99, P243, DOI 10.1007/BF00627736; Norin T, 2011, J EXP BIOL, V214, P1668, DOI 10.1242/jeb.054205; Olden JD, 2010, DIVERS DISTRIB, V16, P496, DOI 10.1111/j.1472-4642.2010.00655.x; Olivry J.C., 1986, COLLECTION MONOGRAPH, V9; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Powers DA, 1998, J EXP ZOOL, V282, P71; Schulte PM, 2011, INTEGR COMP BIOL, V51, P691, DOI 10.1093/icb/icr097; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Somero George N., 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-1; Sorensen JG, 2005, J EVOLUTION BIOL, V18, P829, DOI 10.1111/j.1420-9101.2004.00876.x; STEFFENSEN JF, 1989, FISH PHYSIOL BIOCHEM, V6, P49, DOI 10.1007/BF02995809; WALDSCHMIDT SR, 1986, PHYSIOL ZOOL, V59, P376, DOI 10.1086/physzool.59.3.30156109; Wendelaar BSE, 1997, PHYSIOL REV, V77, P591	47	23	23	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54345	10.1371/journal.pone.0054345	http://dx.doi.org/10.1371/journal.pone.0054345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349857	gold, Green Submitted, Green Published			2022-12-25	WOS:000314019100058
J	Vera, E; de Jesus, BB; Foronda, M; Flores, JM; Blasco, MA				Vera, Elsa; Bernardes de Jesus, Bruno; Foronda, Miguel; Flores, Juana M.; Blasco, Maria A.			Telomerase Reverse Transcriptase Synergizes with Calorie Restriction to Increase Health Span and Extend Mouse Longevity	PLOS ONE			English	Article							LIFE-SPAN; DIETARY RESTRICTION; CELLULAR SENESCENCE; OXIDATIVE STRESS; HUMAN-DISEASE; CANCER; LENGTH; MICE; GROWTH; AGE	Caloric restriction (CR), a reduction of food intake while avoiding malnutrition, can delay the onset of cancer and age-related diseases in several species, including mice. In addition, depending of the genetic background, CR can also increase or decrease mouse longevity. This has highlighted the importance of identifying the molecular pathways that interplay with CR in modulating longevity. Significant lifespan extension in mice has been recently achieved through over-expression of the catalytic subunit of mouse telomerase (mTERT) in a cancer protective background. Given the CR cancer-protective effects in rodents, we set to address here whether CR impacts on telomere length and synergizes with mTERT to extend mouse longevity. CR significantly decreased tumor incidence in TERT transgenic (TgTERT) mice and extended their lifespan compared to wild-type (WT) controls under the same diet, indicating a synergy between TgTERT and CR in increasing mouse longevity. In addition, longitudinal telomere length measurements in peripheral blood leukocytes from individual mice showed that CR resulted in maintenance and/or elongation telomeres in a percentage of WT mice, a situation that mimics telomere dynamics in TgTERT cohorts. These results demonstrate that CR attenuates telomere erosion associated to aging and that synergizes with TERT over-expression in increasing "health span'' and extending mouse longevity.	[Vera, Elsa; Bernardes de Jesus, Bruno; Foronda, Miguel; Blasco, Maria A.] Spanish Natl Canc Res Ctr, Mol Oncol Program, Telomeres & Telomerase Grp, Madrid, Spain; [Flores, Juana M.] Univ Complutense Madrid, Fac Vet, Anim Surg & Med Dept, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Complutense University of Madrid	Blasco, MA (corresponding author), Spanish Natl Canc Res Ctr, Mol Oncol Program, Telomeres & Telomerase Grp, Melchor Fernandez Almagro 3, Madrid, Spain.	mblasco@cnio.es	Blasco, Maria A./M-1694-2014; Bernardes de Jesus, Bruno/GLQ-7625-2022	Blasco, Maria A./0000-0002-4211-233X; Bernardes de Jesus, Bruno/0000-0002-6407-3466; Foronda, Miguel/0000-0001-9590-9281; Nobrega-Pereira, Sandrina/0000-0002-9652-1382	Spanish Ministry of Science and Innovation; European Union; European Research Council; Fundacion Botin; Fundacion Lilly	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); Fundacion Botin; Fundacion Lilly	Blasco lab is funded by Spanish Ministry of Science and Innovation, European Union (GENICA and TELOMARKER), European Research Council Advanced Grant, Fundacion Botin and Fundacion Lilly. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2009, TOXICOL PATHOL, V37, P47, DOI 10.1177/0192623308329476; Argentino DP, 2005, EXP GERONTOL, V40, P27, DOI 10.1016/j.exger.2004.09.005; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Bartke A, 2005, ENDOCRINOLOGY, V146, P3718, DOI 10.1210/en.2005-0411; de Jesus BB, 2012, EMBO MOL MED, V4, P691, DOI 10.1002/emmm.201200245; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Canela A, 2007, P NATL ACAD SCI USA, V104, P5300, DOI 10.1073/pnas.0609367104; Canto C, 2009, TRENDS ENDOCRIN MET, V20, P325, DOI 10.1016/j.tem.2009.03.008; Chan SWL, 2002, ONCOGENE, V21, P553, DOI 10.1038/sj.onc.1205082; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dhahbi JM, 2004, P NATL ACAD SCI USA, V101, P5524, DOI 10.1073/pnas.0305300101; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Dunn SE, 1997, CANCER RES, V57, P4667; Elyada E, 2011, NATURE, V470, P409, DOI 10.1038/nature09673; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Ferguson VL, 2003, BONE, V33, P387, DOI 10.1016/S8756-3282(03)00199-6; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Flores I, 2006, CURR OPIN CELL BIOL, V18, P254, DOI 10.1016/j.ceb.2006.03.003; Fontana L, 2007, JAMA-J AM MED ASSOC, V297, P986, DOI 10.1001/jama.297.9.986; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Gonzalez-Suarez E, 2005, ONCOGENE, V24, P2256, DOI 10.1038/sj.onc.1208413; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Hamrick MW, 2008, J BONE MINER RES, V23, P870, DOI [10.1359/jbmr.080213, 10.1359/JBMR.080213]; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Heikkinen S, 2007, CURR PROTOC MOL BIOL, DOI DOI 10.1002/0471142727.MB29B03S77; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Hempenstall S, 2010, MECH AGEING DEV, V131, P111, DOI 10.1016/j.mad.2009.12.008; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; INGRAM DK, 1986, EXP AGING RES, V12, P155; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Liao CY, 2010, AGING CELL, V9, P92, DOI 10.1111/j.1474-9726.2009.00533.x; Longo VD, 2010, TRENDS PHARMACOL SCI, V31, P89, DOI 10.1016/j.tips.2009.11.004; Martinez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; McIlrath J, 2001, CANCER RES, V61, P912; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Pugh TD, 1999, NEUROBIOL AGING, V20, P157, DOI 10.1016/S0197-4580(99)00043-3; Sedelnikova OA, 2008, AGING CELL, V7, P89, DOI 10.1111/j.1474-9726.2007.00354.x; Spindler SR, 2010, AGEING RES REV, V9, P324, DOI 10.1016/j.arr.2009.10.003; Tomas-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034; Turturro A, 1999, J GERONTOL A-BIOL, V54, pB492, DOI 10.1093/gerona/54.11.B492; Vera E, 2012, CELL REP, V2, P732, DOI 10.1016/j.celrep.2012.08.023; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x; WEINDRUCH R, 1982, SCIENCE, V215, P1415, DOI 10.1126/science.7063854; WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	61	63	66	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53760	10.1371/journal.pone.0053760	http://dx.doi.org/10.1371/journal.pone.0053760			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349740	gold, Green Published			2022-12-25	WOS:000314019100029
J	Ruuska, M; Sahlberg, AS; Granfors, K; Penttinen, MA				Ruuska, Marja; Sahlberg, Anna S.; Granfors, Kaisa; Penttinen, Markus A.			Phosphorylation of STAT-1 Serine 727 Is Prolonged in HLA-B27-Expressing Human Monocytic Cells	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; REACTIVE ARTHRITIS; TRANSGENIC RATS; KINASE PKR; B-POCKET; ANKYLOSING-SPONDYLITIS; SALMONELLA-ENTERITIDIS; RHEUMATOID-ARTHRITIS; SIGNALING PATHWAYS; YERSINIA ANTIGENS	A tissue antigen, HLA-B27, is strongly associated with a group of rheumatic diseases called spondyloarthritides. Despite the intensive research, the exact role of HLA-B27 in the pathogenesis of these diseases is still unclear. Here we studied whether HLA-B27 modulates the phosphorylation of signal transducer and activator of transcription 1 (STAT-1) serine 727 residue and the localization of STAT-1 in Salmonella-infected human monocytic cells. In addition, we studied the role of signaling molecule double-stranded RNA activated protein kinase (PKR) in these modulatory effects. U937 human monocytic cell transfectants stably expressing wild type HLA-B27 or mutated HLA-B27 heavy chains with amino acid substitutions in the B pocket were prepared. The PMA-differentiated cells were infected with S. enteritidis. Western blotting was used to detect the phosphorylation of STAT-1, and to visualize the localization of STAT-1 in the cells confocal microscopy was used. Specific inhibitors were employed to study the role of PKR in STAT-1 phosphorylation. We discovered that the phosphorylation of STAT-1 serine 727 is prolonged in cells expressing misfolding forms of HLA-B27 after S. enteritidis infection, whereas in mock cells and in cells expressing mutated, non-misfolding HLA-B27 the phosphorylation of serine 727 is transient. Interestingly, STAT-1 serine 727 phosphorylation is partly dependent on PKR. In addition, more STAT-1 is localized in the nucleus of HLA-B27-expressing cells, even before an external trigger, when compared to mock cells. In conclusion, our results show that the phosphorylation of STAT-1 serine 727 residue is prolonged in HLA-B27-expressing monocyte-macrophage U937 cells after bacterial infection. This is of interest since the phosphorylation of serine 727 on STAT-1 is suggested to contribute to macrophage activation and promote inflammatory responses. Therefore, our results provide a mechanism which explains how the expression of an HLA-B27 molecule can impact the course of Salmonella infection and reactive arthritis.	[Ruuska, Marja; Sahlberg, Anna S.; Penttinen, Markus A.] Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland; [Ruuska, Marja; Sahlberg, Anna S.; Granfors, Kaisa] Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Turku, Finland	University of Turku; Finland National Institute for Health & Welfare	Ruuska, M (corresponding author), Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland.	marja.ruuska@utu.fi			Academy of Finland; Sigrid Juselius Foundation; Finnish Cultural Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	This study was supported by grants from the Academy of Finland (http://www.aka.fi/en-GB/A/), the Sigrid Juselius Foundation (http://www.sigridjuselius.fi/foundation/foundation/) and the Finnish Cultural Foundation (http://www.skr.fi/default.asp?docId = 12256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averbuch D, 2011, PEDIATR INFECT DIS J, V30, P352, DOI 10.1097/INF.0b013e3181fdff4a; Colbert RA, 2004, CURR MOL MED, V4, P21, DOI 10.2174/1566524043479293; COLBERT RA, 1993, P NATL ACAD SCI USA, V90, P6879, DOI 10.1073/pnas.90.14.6879; Colbert RA, 2010, IMMUNOL REV, V233, P181, DOI 10.1111/j.0105-2896.2009.00865.x; Dangoria NS, 2002, J BIOL CHEM, V277, P23459, DOI 10.1074/jbc.M110336200; Delay ML, 2009, ARTHRITIS RHEUM-US, V60, P2633, DOI 10.1002/art.24763; Ekman P, 2000, ARTHRITIS RHEUM-US, V43, P1527, DOI 10.1002/1529-0131(200007)43:7<1527::AID-ANR17>3.3.CO;2-7; Gaston JSH, 1999, ARTHRITIS RHEUM, V42, P2239; GRANFORS K, 1989, NEW ENGL J MED, V320, P216, DOI 10.1056/NEJM198901263200404; Granfors K, 1998, ARTHRITIS RHEUM, V41, P855, DOI 10.1002/1529-0131(199805)41:5<855::AID-ART12>3.0.CO;2-J; GRANFORS K, 1990, LANCET, V335, P685, DOI 10.1016/0140-6736(90)90804-E; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Ivashkiv LB, 2004, ARTHRITIS RES THER, V6, P159, DOI 10.1186/ar1197; Kovarik P, 1999, P NATL ACAD SCI USA, V96, P13956, DOI 10.1073/pnas.96.24.13956; Laitio P, 1997, EUR J IMMUNOL, V27, P1331, DOI 10.1002/eji.1830270606; LEIRISALO M, 1982, ARTHRITIS RHEUM, V25, P249, DOI 10.1002/art.1780250302; Mear JP, 1999, J IMMUNOL, V163, P6665; Mei Y, 2011, CLIN RHEUMATOL, V30, P269, DOI 10.1007/s10067-010-1647-4; Najjar I, 2010, BIOCHIMIE, V92, P425, DOI 10.1016/j.biochi.2010.02.009; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Paradowska-Gorycka A, 2010, SCAND J IMMUNOL, V71, P134, DOI 10.1111/j.1365-3083.2009.02361.x; Penttinen MA, 2004, ARTHRITIS RHEUM, V50, P2255, DOI 10.1002/art.20336; Penttinen Markus A, 2002, Curr Rheumatol Rep, V4, P518, DOI 10.1007/s11926-002-0060-7; Ruuska M, 2012, ARTHRITIS RHEUM-US, V64, P772, DOI 10.1002/art.33391; Sahlberg AS, 2012, SCAND J IMMUNOL, V75, P184, DOI 10.1111/j.1365-3083.2011.02648.x; Sahlberg AS, 2007, ARTHRITIS RHEUM, V56, P2652, DOI 10.1002/art.22746; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; SIEPER J, 1995, ARTHRITIS RHEUM, V38, P1547, DOI 10.1002/art.1780381105; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; TAUROG JD, 1988, J IMMUNOL, V141, P4020; Turner MJ, 2007, ARTHRITIS RHEUM, V56, P215, DOI 10.1002/art.22295; Turner MJ, 2005, J IMMUNOL, V175, P2438, DOI 10.4049/jimmunol.175.4.2438; Vahamiko S, 2005, ARTHRITIS RES THER, V7, P136, DOI 10.1186/ar1762; Varinou L, 2003, IMMUNITY, V19, P793, DOI 10.1016/S1074-7613(03)00322-4; Wang S, 2006, J BIOL CHEM, V281, P9439, DOI 10.1074/jbc.M504977200; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wong AHT, 1997, EMBO J, V16, P1291, DOI 10.1093/emboj/16.6.1291; Zeng L, 2011, ARTHRITIS RHEUM-US, V63, P3807, DOI 10.1002/art.30593	39	4	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e50684	10.1371/journal.pone.0050684	http://dx.doi.org/10.1371/journal.pone.0050684			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349666	Green Published, gold, Green Submitted			2022-12-25	WOS:000313943000003
J	Chu, CP; Jin, WZ; Bing, YH; Jin, QH; Kannan, H; Qiu, DL				Chu, Chun-Ping; Jin, Wen-Zhe; Bing, Yan-Hua; Jin, Qing-Hua; Kannan, Hiroshi; Qiu, De-Lai			Effects of Stresscopin on Rat Hypothalamic Paraventricular Nucleus Neurons In Vitro	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; CENTRAL-NERVOUS-SYSTEM; RECTIFIER K+ CHANNELS; FACTOR-RECEPTOR; MESSENGER-RNA; MAGNOCELLULAR NEURONS; SUPRAOPTIC NUCLEI; PYRAMIDAL CELLS; UROCORTIN-III; CRF2 RECEPTOR	The effects of stresscopin (SCP) on rat paraventricular nucleus (PVN) neurons were examined using whole-cell patch-clamp recordings and single-cell reverse-transcription multiplex polymerase chain reaction (SC-RT-mPCR) techniques. Under current-clamp conditions, bath application of SCP (100 nM) induced inhibition in 35.2% (37/105) of putative magnocellular neurons and 24.7% (20/81) of putative parvocellular neurons, and excitation in 5.7% (6/105) of putative magnocellular neurons and 18.5% (15/81) of putative parvocellular neurons. SCP-induced inhibition persisted in the presence of a mixture of TTX, a voltage-gated Na+ channel blocker, CNQX, an AMPA/kainate receptor antagonist and bicuculline, a GABA(A) receptor antagonist, whereas SCP-induced excitation of PVN neurons was reversed by the mixture. The SCP-induced inhibition of PVN neurons was abolished by bath application of antisauvagine-30, a selective CRF receptor 2 (CRF-R2) antagonist. Under voltage-clamp conditions, SCP evoked outward currents at the holding potential (-60 mV), which reversed near the potassium equilibrium potential. The SCP-evoked membrane currents were completely blocked by bath application of tertiapin-Q, a selective blocker of G protein-activated inwardly rectifying potassium (GIRK) channels. SC-RT-mPCR analysis indicated that all the SCP-sensitive PVN neurons (57 SCP-inhibited neurons, 21 SCP-excited neurons) expressed CRF-R1 and CRF-R2 mRNAs. Among SCP-hyperpolarized PVN neurons, oxytocin (OT) mRNA was detected in 91.8% of putative magnocellular neurons and 45.0% of putative parvocellular neurons. OT mRNA was also detected in 26.6% of SCP-depolarized parvocellular neurons, but not in SCP-depolarized magnocellular neurons. These results indicate that SCP inhibits a subpopulation of PVN neurons, especially OTergic magnocellular neurons, by enhancing the activity of GIRK channels via CRF-R2.	[Chu, Chun-Ping; Jin, Wen-Zhe; Bing, Yan-Hua; Qiu, De-Lai] Yanbian Univ, Cellular Funct Res Ctr, Yanji, Jilin Province, Peoples R China; [Jin, Wen-Zhe; Bing, Yan-Hua; Jin, Qing-Hua; Qiu, De-Lai] Yanbian Univ, Dept Physiol & Pathophysiol, Coll Med, Yanji, Jilin Province, Peoples R China; [Jin, Wen-Zhe] Yanbian Univ, Dept Pain, Affiliated Hosp, Yanji, Jilin Province, Peoples R China; [Kannan, Hiroshi] Kyushu Womens Univ, Fac Home Econ, Dept Nutr, Kitakyushu, Fukuoka, Japan	Yanbian University; Yanbian University; Yanbian University	Qiu, DL (corresponding author), Yanbian Univ, Cellular Funct Res Ctr, Yanji, Jilin Province, Peoples R China.	dlqiu@ybu.edu.cn			National Natural Science Foundations of China [31060138, 81260208]; Ministry of Education, Culture, Sports, Science and Technology, Japan [14370024]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the National Natural Science Foundations of China (31060138; 81260208), and in part by a Grant-in-Aid for Science Research (14370024) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blume A, 2008, EUR J NEUROSCI, V27, P1947, DOI 10.1111/j.1460-9568.2008.06184.x; Chao HX, 2012, ENDOCRINOLOGY, V153, P166, DOI 10.1210/en.2011-1312; Chen PL, 2010, AM J PHYSIOL-ENDOC M, V298, pE337, DOI 10.1152/ajpendo.00402.2009; CHEN RP, 1993, P NATL ACAD SCI USA, V90, P8967, DOI 10.1073/pnas.90.19.8967; Chu CP, 2012, NEUROSCI LETT, V511, P79, DOI 10.1016/j.neulet.2012.01.035; Chu CP, 2004, REGUL PEPTIDES, V119, P53, DOI 10.1016/j.regpep.2003.12.007; Csaki A, 2000, NEUROSCIENCE, V101, P637, DOI 10.1016/S0306-4522(00)00411-5; DESOUZA EB, 1987, J NEUROSCI, V7, P88; Fekete EM, 2007, NEUROPSYCHOPHARMACOL, V32, P1052, DOI 10.1038/sj.npp.1301214; Frank MD, 2002, TRENDS PHARMACOL SCI, V23, P71; Giesbrecht CJ, 2010, J NEUROSCI, V30, P16970, DOI 10.1523/JNEUROSCI.2306-10.2010; Hashimoto K, 2004, PEPTIDES, V25, P1711, DOI 10.1016/j.peptides.2004.05.024; Hsu SY, 2001, NAT MED, V7, P605, DOI 10.1038/87936; Jamieson PM, 2006, ENDOCRINOLOGY, V147, P4578, DOI 10.1210/en.2006-0545; Jin WL, 1999, BIOCHEMISTRY-US, V38, P14286, DOI 10.1021/bi991205r; KANNAN H, 1989, AM J PHYSIOL, V256, pR1325, DOI 10.1152/ajpregu.1989.256.6.R1325; Lawrence AJ, 2002, BRIT J PHARMACOL, V136, P896, DOI 10.1038/sj.bjp.0704783; Lewis K, 2001, P NATL ACAD SCI USA, V98, P7570, DOI 10.1073/pnas.121165198; Li C, 2002, J NEUROSCI, V22, P991, DOI 10.1523/JNEUROSCI.22-03-00991.2002; Li X, 2010, AUTON NEUROSCI-BASIC, V154, P108, DOI 10.1016/j.autneu.2009.12.004; LOVENBERG TW, 1995, ENDOCRINOLOGY, V136, P4139, DOI 10.1210/en.136.9.4139; Luther JA, 2000, J NEUROPHYSIOL, V84, P1814, DOI 10.1152/jn.2000.84.4.1814; MARTIN DS, 1991, HYPERTENSION, V18, P48, DOI 10.1161/01.HYP.18.1.48; Neumann ID, 2002, PROG BRAIN RES, V139, P147; Nicolas N, 2011, CURRENT NEUROPHARMAC, V9, P262; Nishioka T, 1998, BRAIN RES, V781, P57, DOI 10.1016/S0006-8993(97)01159-1; NORTH RA, 1989, BRIT J PHARMACOL, V98, P13, DOI 10.1111/j.1476-5381.1989.tb16855.x; Ohata H, 2004, PEPTIDES, V25, P1703, DOI 10.1016/j.peptides.2004.05.023; Park JB, 2005, FASEB J, V19, pA599; Qiu DL, 2005, J NEUROPHYSIOL, V94, P226, DOI 10.1152/jn.01325.2004; Qiu DL, 2005, NEUROSCI LETT, V374, P69, DOI 10.1016/j.neulet.2004.10.033; SAWCHENKO PE, 1983, BRAIN RES, V277, P355, DOI 10.1016/0006-8993(83)90945-9; Shirasaka T, 2007, ANESTHESIOLOGY, V107, P605, DOI 10.1097/01.anes.0000281916.65365.4e; Slugg RM, 2003, J PHYSIOL-LONDON, V551, P295, DOI 10.1113/jphysiol.2003.041319; Sun QQ, 2002, J NEUROSCI, V22, P5374; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Takigawa T, 2003, J NEUROPHYSIOL, V89, P2238, DOI 10.1152/jn.00957.2002; Takigawa T, 2002, J PHYSIOL-LONDON, V539, P67, DOI 10.1113/jphysiol.2001.012883; TASKER JG, 1993, J PHYSIOL-LONDON, V469, P179, DOI 10.1113/jphysiol.1993.sp019810; Wanat MJ, 2008, J PHYSIOL-LONDON, V586, P2157, DOI 10.1113/jphysiol.2007.150078; WEISS ML, 1990, BRAIN RES BULL, V24, P231, DOI 10.1016/0361-9230(90)90210-Q; Windle RJ, 1997, ENDOCRINOLOGY, V138, P2829, DOI 10.1210/en.138.7.2829; WONG ML, 1994, ENDOCRINOLOGY, V135, P2275, DOI 10.1210/en.135.5.2275; Wotjak CT, 2001, EUR J NEUROSCI, V13, P2273, DOI 10.1046/j.0953-816x.2001.01613.x; Zheng J, 2010, AM J PHYSIOL-GASTR L, V299, pG946, DOI 10.1152/ajpgi.00483.2009	45	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e53863	10.1371/journal.pone.0053863	http://dx.doi.org/10.1371/journal.pone.0053863			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349753	gold, Green Published, Green Submitted			2022-12-25	WOS:000313872800015
J	Moussa, M; De Jonckheere, JF; Guerlotte, J; Richard, V; Bastaraud, A; Romana, M; Talarmin, A				Moussa, Mirna; De Jonckheere, Johan F.; Guerlotte, Jerome; Richard, Vincent; Bastaraud, Alexandra; Romana, Marc; Talarmin, Antoine			Survey of Naegleria fowleri in Geothermal Recreational Waters of Guadeloupe (French West Indies)	PLOS ONE			English	Article							FREE-LIVING AMEBAS; MENINGOENCEPHALITIS; IDENTIFICATION	In 2008 a fatal case of primary amoebic meningoencephalitis, due to the amoeboflagellate Naegleria fowleri, occurred in Guadeloupe, French West Indies, after a child swam in a bath fed with geothermal water. In order to improve the knowledge on free-living amoebae in this tropical part of France, we investigated on a monthly basis, the presence of Naegleria spp. in the recreational baths, and stream waters which feed them. A total of 73 water samples, 48 sediments and 54 swabs samples were collected from 6 sampling points between June 2011 and July 2012. The water samples were filtered and the filters transferred to non-nutrient agar plates seeded with a heat-killed suspension of Escherichia coli while sediment and swab samples were placed directly on these plates. The plates were incubated at 44 degrees C for the selective isolation of thermophilic Naegleria. To identify the Naegleria isolates the internal transcribed spacers, including the 5.8S rDNA, were amplified by polymerase chain reaction and the sequence of the PCR products was determined. Thermophilic amoebae were present at nearly all collection sites. The pathogenic N. fowleri was the most frequently encountered thermophilic species followed by N. lovaniensis. The concentration of N. fowleri was rather low in most water samples, ranging from 0 to 22 per liter. Sequencing revealed that all N. fowleri isolates belonged to a common Euro-American genotype, the same as detected in the human case in Guadeloupe. These investigations need to be continued in order to counsel the health authorities about prevention measures, because these recreational thermal baths are used daily by local people and tourists.	[Moussa, Mirna; Guerlotte, Jerome; Bastaraud, Alexandra; Talarmin, Antoine] Inst Pasteur Guadeloupe, Unite Environm Sante, Les Abymes, Guadeloupe, France; [De Jonckheere, Johan F.] De Duve Inst, Brussels, Belgium; [De Jonckheere, Johan F.] Sci Inst Publ Hlth, Brussels, Belgium; [Guerlotte, Jerome] Univ Antilles Guyane, Pointe A Pitre, Guadeloupe, France; [Guerlotte, Jerome] Museum Natl Hist Nat, CNRS, UMR MNHN 7205, Paris, France; [Richard, Vincent] Inst Pasteur, Dakar, Senegal; [Romana, Marc] INSERM, U665, Pointe A Pitre, Guadeloupe, France	Universite des Antilles; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Talarmin, A (corresponding author), Inst Pasteur Guadeloupe, Unite Environm Sante, Les Abymes, Guadeloupe, France.	atalarmin@pasteur-guadeloupe.fr	Romana, Marc/K-6442-2017	Romana, Marc/0000-0002-8715-9836; Vincent, RICHARD/0000-0002-6961-1753	ACIP from the Institut Pasteur, Paris [A-01-2011]; Agence Regionale de la Sante (ARS Guadeloupe)	ACIP from the Institut Pasteur, Paris; Agence Regionale de la Sante (ARS Guadeloupe)	This research was supported by a grant ACIP (A-01-2011) from the Institut Pasteur, Paris. The authors are also grateful to the Agence Regionale de la Sante (ARS Guadeloupe) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFNOR, 2001, T90007 AFNOR NF; AFNOR, 1995, 8467 AFNOR NF EN ISO; AFNOR, 1996, 99631 AFNOR NF EN IS; AFNOR, 2009, 103041 AFNOR NF EN I; AFNOR, 2000, 7027 AFNOR NF EN ISO; AFNOR, 1996, 13395 AFNOR NF EN IS; AFNOR, 2005, 11732 AFNOR NF EN IS; AFNOR, 1997, 1484 AFNOR NF EN; AFNOR, 1984, T90003 AFNOR NF; [Anonymous], 1988, NEW KEY FRESHWATER S; [Anonymous], 1999, 14911 AFNOR NF EN; Behets J, 2007, PARASITOL RES, V100, P1249, DOI 10.1007/s00436-006-0399-1; BROWN TJ, 1983, NEW ZEAL J MAR FRESH, V17, P59, DOI 10.1080/00288330.1983.9515987; Cabanes PA, 2001, APPL ENVIRON MICROB, V67, P2927, DOI 10.1128/AEM.67.7.2927-2931.2001; CARTER RF, 1970, J PATHOL, V100, P217, DOI 10.1002/path.1711000402; CARTER SA, 1978, INT J ENVIRON STUD, V12, P199, DOI 10.1080/00207237808709782; CASSELLS JM, 1995, WATER SCI TECHNOL, V31, P119, DOI 10.1016/0273-1223(95)00251-H; CHANG SL, 1978, APPL ENVIRON MICROB, V35, P368, DOI 10.1128/AEM.35.2.368-375.1978; CURSONS RTM, 1980, APPL ENVIRON MICROB, V40, P62, DOI 10.1128/AEM.40.1.62-66.1980; De Jonckheere JF, 2002, ACTA PROTOZOOL, V41, P309; De Jonckheere JF, 1998, PROTIST, V149, P221, DOI 10.1016/S1434-4610(98)70030-6; De Jonckheere JF, 2012, EUR J PROTISTOL, V48, P178, DOI 10.1016/j.ejop.2012.01.009; De Jonckheere JF, 2011, INFECT GENET EVOL, V11, P1520, DOI 10.1016/j.meegid.2011.07.023; De Jonckheerea JF, 2005, PROTIST, V156, P89, DOI 10.1016/j.protis.2004.11.001; DEJONCKHEERE J, 1975, J HYG-CAMBRIDGE, V75, P7, DOI 10.1017/S0022172400047021; Edagawa A, 2009, PARASITOL RES, V105, P1109, DOI 10.1007/s00436-009-1528-4; Eddyani M, 2008, APPL ENVIRON MICROB, V74, P6547, DOI 10.1128/AEM.01066-08; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; GRIFFIN JL, 1983, J PROTOZOOL, V30, P403, DOI 10.1111/j.1550-7408.1983.tb02939.x; Hugo ER, 1992, PROTOCOLS PROTOZOOLO; JOHN DT, 1995, PARASITOL RES, V81, P193; LEGRAND L, 1981, EQUILIBRES CARBONIQU; MARCIANOCABRAL F, 1988, MICROBIOL REV, V52, P114, DOI 10.1128/MMBR.52.1.114-133.1988; Martinez AJ, 1997, BRAIN PATHOL, V7, P583, DOI 10.1111/j.1750-3639.1997.tb01076.x; Nicolas M, 2010, Bull Soc Pathol Exot, V103, P14, DOI 10.1007/s13149-009-0028-1; Pernin P, 1998, APPL ENVIRON MICROB, V64, P955; Schuster FL, 2004, DRUG RESIST UPDATE, V7, P41, DOI 10.1016/j.drup.2004.01.002; Sheehan KB, 2003, APPL ENVIRON MICROB, V69, P5914, DOI 10.1128/AEM.69.10.5914-5918.2003; STEVENS AR, 1980, INT J PARASITOL, V10, P51, DOI 10.1016/0020-7519(80)90064-8; TYNDALL RL, 1989, APPL ENVIRON MICROB, V55, P722, DOI 10.1128/AEM.55.3.722-732.1989; TYNDALL RL, 1984, CRIT REV ENV CONTR, V13, P195, DOI 10.1080/10643388409381707; Tyndall RL, 1985, MICROBIAL PROCESSES, P135	42	33	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54414	10.1371/journal.pone.0054414	http://dx.doi.org/10.1371/journal.pone.0054414			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349880	Green Submitted, Green Published, gold			2022-12-25	WOS:000313872800050
J	Pan-ngum, W; Blacksell, SD; Lubell, Y; Pukrittayakamee, S; Bailey, MS; de Silva, HJ; Lalloo, DG; Day, NPJ; White, LJ; Limmathurotsakul, D				Pan-ngum, Wirichada; Blacksell, Stuart D.; Lubell, Yoel; Pukrittayakamee, Sasithon; Bailey, Mark S.; de Silva, H. Janaka; Lalloo, David G.; Day, Nicholas P. J.; White, Lisa J.; Limmathurotsakul, Direk			Estimating the True Accuracy of Diagnostic Tests for Dengue Infection Using Bayesian Latent Class Models	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; RAPID IMMUNOCHROMATOGRAPHIC ASSAYS; JAPANESE ENCEPHALITIS; VIRUS-INFECTION; NS1 ANTIGEN; ANTIBODIES; GOLD; IGM	Background: Accuracy of rapid diagnostic tests for dengue infection has been repeatedly estimated by comparing those tests with reference assays. We hypothesized that those estimates might be inaccurate if the accuracy of the reference assays is not perfect. Here, we investigated this using statistical modeling. Methods/Principal Findings: Data from a cohort study of 549 patients suspected of dengue infection presenting at Colombo North Teaching Hospital, Ragama, Sri Lanka, that described the application of our reference assay (a combination of Dengue IgM antibody capture ELISA and IgG antibody capture ELISA) and of three rapid diagnostic tests (Panbio NS1 antigen, IgM antibody and IgG antibody rapid immunochromatographic cassette tests) were re-evaluated using Bayesian latent class models (LCMs). The estimated sensitivity and specificity of the reference assay were 62.0% and 99.6%, respectively. Prevalence of dengue infection (24.3%), and sensitivities and specificities of the Panbio NS1 (45.9% and 97.9%), IgM (54.5% and 95.5%) and IgG (62.1% and 84.5%) estimated by Bayesian LCMs were significantly different from those estimated by assuming that the reference assay was perfect. Sensitivity, specificity, PPV and NPV for a combination of NS1, IgM and IgG cassette tests on admission samples were 87.0%, 82.8%, 62.0% and 95.2%, respectively. Conclusions: Our reference assay is an imperfect gold standard. In our setting, the combination of NS1, IgM and IgG rapid diagnostic tests could be used on admission to rule out dengue infection with a high level of accuracy (NPV 95.2%). Further evaluation of rapid diagnostic tests for dengue infection should include the use of appropriate statistical models.	[Pan-ngum, Wirichada; Limmathurotsakul, Direk] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand; [Pan-ngum, Wirichada; Blacksell, Stuart D.; Lubell, Yoel; Day, Nicholas P. J.; White, Lisa J.; Limmathurotsakul, Direk] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Pukrittayakamee, Sasithon] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand; [Blacksell, Stuart D.; Day, Nicholas P. J.; White, Lisa J.] Univ Oxford, Nuffield Dept Clin Med, Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Bailey, Mark S.] Royal Ctr Def Med, Dept Mil Med, Birmingham, W Midlands, England; [de Silva, H. Janaka] Univ Kelaniya, Fac Med, Dept Med, Ragama, Sri Lanka; [Lalloo, David G.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Mahidol University; University of Oxford; Royal Centre for Defence Medicine; University Kelaniya; Liverpool School of Tropical Medicine; University of Liverpool	Limmathurotsakul, D (corresponding author), Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand.	direk@tropmedres.ac	White, Lisa/AAC-9396-2020; Blacksell, Stuart/D-5530-2018; Bailey, Mark S./D-3854-2013	White, Lisa/0000-0002-6523-185X; Blacksell, Stuart/0000-0001-6576-726X; Bailey, Mark S./0000-0003-4840-5093; Lalloo, David/0000-0001-7680-2200; Lubell, Yoel/0000-0002-0237-1070; pan-ngum, wirichada/0000-0002-9839-5359; Limmathurotsakul, Direk/0000-0001-7240-5320	Thailand Research Fund, Faculty of Tropical Medicine, Mahidol University [TRG5380004]; Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme; Wellcome Trust of Great Britain	Thailand Research Fund, Faculty of Tropical Medicine, Mahidol University; Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme(Wellcome Trust); Wellcome Trust of Great Britain(Wellcome Trust)	This study is supported by the Thailand Research Fund (TRG5380004), Faculty of Tropical Medicine, Mahidol University and the Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme, supported by the Wellcome Trust of Great Britain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banoo S, 2006, NAT REV MICROBIOL, pS20, DOI 10.1038/nrmicro1570; Bernatsky S, 2011, RHEUMATOL INT, V31, P549, DOI 10.1007/s00296-010-1591-2; Blacksell SD, 2006, CLIN INFECT DIS, V42, P1127, DOI 10.1086/501358; Blacksell SD, 2008, DIAGN MICR INFEC DIS, V60, P43, DOI 10.1016/j.diagmicrobio.2007.07.011; Blacksell SD, 2007, CLIN VACCINE IMMUNOL, V14, P1458, DOI 10.1128/CVI.00482-06; Blacksell SD, 2006, T ROY SOC TROP MED H, V100, P775, DOI 10.1016/j.trstmh.2005.10.018; Blacksell SD, 2012, CLIN VACCINE IMMUNOL, V19, P804, DOI 10.1128/CVI.05717-11; Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P2095, DOI 10.1128/CVI.05285-11; Deen JL, 2006, LANCET, V368, P170, DOI 10.1016/S0140-6736(06)69006-5; Dendukuri N, 2001, BIOMETRICS, V57, P158, DOI 10.1111/j.0006-341X.2001.00158.x; Ellis RD, 2006, AM J TROP MED HYG, V74, P108, DOI 10.4269/ajtmh.2006.74.108; Fry SR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001199; Hu DM, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-47; INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418; JOSEPH L, 1995, AM J EPIDEMIOL, V141, P263, DOI 10.1093/oxfordjournals.aje.a117428; Lam SK, 1998, WHO DENGUE B, V22; Limmathurotsakul D, 2012, CLIN INFECT DIS, V55, P322, DOI 10.1093/cid/cis403; Limmathurotsakul D, 2011, CLIN INFECT DIS, V52, P1024, DOI 10.1093/cid/cir080; Limmathurotsakul D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012485; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Speybroeck N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016705; Spiegelhalter D. J., 2004, STAT PRACTICE; Spiegelhalter DJ, 2004, STAT SCI, V19, P156, DOI 10.1214/088342304000000080; Strickman D, 2000, AM J TROP MED HYG, V63, P27, DOI 10.4269/ajtmh.2000.63.27; Teles FRR, 2005, REV MED VIROL, V15, P287, DOI 10.1002/rmv.461; Vaughn DW, 1999, AM J TROP MED HYG, V60, P693, DOI 10.4269/ajtmh.1999.60.693; Wang SM, 2010, J CLIN MICROBIOL, V48, P2793, DOI 10.1128/JCM.02142-09; Zhou X, 2008, STAT METHODS DIAGNOS	28	30	33	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e50765	10.1371/journal.pone.0050765	http://dx.doi.org/10.1371/journal.pone.0050765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349667	Green Published, Green Accepted, gold			2022-12-25	WOS:000313872800001
J	Friedman, J; Alm, EJ; Shapiro, BJ				Friedman, Jonathan; Alm, Eric J.; Shapiro, B. Jesse			Sympatric Speciation: When Is It Possible in Bacteria?	PLOS ONE			English	Article							THREESPINE STICKLEBACKS; ECOLOGICAL SPECIATION; BENEFICIAL MUTATIONS; POPULATION GENOMICS; ANOPHELES-GAMBIAE; MULTILOCUS MODEL; GENE-FLOW; DIVERGENCE; RECOMBINATION; DIVERSITY	According to theory, sympatric speciation in sexual eukaryotes is favored when relatively few loci in the genome are sufficient for reproductive isolation and adaptation to different niches. Here we show a similar result for clonally reproducing bacteria, but which comes about for different reasons. In simulated microbial populations, there is an evolutionary tradeoff between early and late stages of niche adaptation, which is resolved when relatively few loci are required for adaptation. At early stages, recombination accelerates adaptation to new niches (ecological speciation) by combining multiple adaptive alleles into a single genome. Later on, without assortative mating or other barriers to gene flow, recombination generates unfit intermediate genotypes and homogenizes incipient species. The solution to this tradeoff may be simply to reduce the number of loci required for speciation, or to reduce recombination between species over time. Both solutions appear to be relevant in natural microbial populations, allowing them to diverge into ecological species under similar constraints as sexual eukaryotes, despite differences in their life histories.	[Friedman, Jonathan; Alm, Eric J.; Shapiro, B. Jesse] MIT, Program Computat & Syst Biol, Cambridge, MA 02139 USA; [Alm, Eric J.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Alm, Eric J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Alm, Eric J.; Shapiro, B. Jesse] Broad Inst, Cambridge, MA USA; [Shapiro, B. Jesse] Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, Boston, MA 02115 USA; [Shapiro, B. Jesse] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Alm, EJ (corresponding author), MIT, Program Computat & Syst Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ejalm@mit.edu; bshapiro@fas.harvard.edu	Friedman, Jonathan/I-6930-2019; Shapiro, B. Jesse/U-9337-2019	Friedman, Jonathan/0000-0001-8476-8030; Shapiro, B. Jesse/0000-0001-6819-8699	National Science Foundation (NSF Grant) [DEB-0918333]; NSF Grant [0821391]; NSERC Canada Graduate Scholarship; Harvard MIDAS Center for Communicable Disease Dynamics postdoctoral fellowship; Merck-MIT fellowship	National Science Foundation (NSF Grant)(National Science Foundation (NSF)); NSF Grant(National Science Foundation (NSF)); NSERC Canada Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Harvard MIDAS Center for Communicable Disease Dynamics postdoctoral fellowship; Merck-MIT fellowship	Funding for this work was provided by the National Science Foundation (NSF Grant DEB-0918333). Computational resources were provided by NSF Grant 0821391. B.J.S. was supported by an NSERC Canada Graduate Scholarship and a Harvard MIDAS Center for Communicable Disease Dynamics postdoctoral fellowship; J.F. by a Merck-MIT fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUSH GL, 1994, TRENDS ECOL EVOL, V9, P285, DOI 10.1016/0169-5347(94)90031-0; Cadillo-Quiroz H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001265; Cohan FM, 2007, CURR BIOL, V17, pR373, DOI 10.1016/j.cub.2007.03.032; Coleman ML, 2010, P NATL ACAD SCI USA, V107, P18634, DOI 10.1073/pnas.1009480107; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Cooper TF, 2007, PLOS BIOL, V5, P1899, DOI 10.1371/journal.pbio.0050225; Cornejo OE, 2010, MOL BIOL EVOL, V27, P694, DOI 10.1093/molbev/msp287; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Denef VJ, 2010, ISME J, V4, P599, DOI 10.1038/ismej.2009.158; Denef VJ, 2010, P NATL ACAD SCI USA, V107, P2383, DOI 10.1073/pnas.0907041107; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Eppley JM, 2007, GENETICS, V177, P407, DOI 10.1534/genetics.107.072892; Falush D, 2006, PHILOS T R SOC B, V361, P2045, DOI 10.1098/rstb.2006.1925; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; Fraser C, 2007, SCIENCE, V315, P476, DOI 10.1126/science.1127573; Fraser C, 2009, SCIENCE, V323, P741, DOI 10.1126/science.1159388; Haldane J. B. S., 1932, CAUSES EVOLUTION; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; KONDRASHOV AS, 1986, THEOR POPUL BIOL, V29, P1, DOI 10.1016/0040-5809(86)90002-X; KONDRASHOV AS, 1986, BIOL J LINN SOC, V27, P201, DOI 10.1111/j.1095-8312.1986.tb01734.x; Kondrashov AS, 1999, NATURE, V400, P351, DOI 10.1038/22514; KONDRASHOV AS, 1982, GENET RES, V40, P325, DOI 10.1017/S0016672300019194; KONDRASHOV AS, 1983, THEOR POPUL BIOL, V24, P121, DOI 10.1016/0040-5809(83)90036-9; Kondrashov FA, 2001, P NATL ACAD SCI USA, V98, P12089, DOI 10.1073/pnas.211214298; Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755; Lawrence J, 1999, CURR OPIN GENET DEV, V9, P642, DOI 10.1016/S0959-437X(99)00025-8; Levin BR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000601; Majewski J, 2001, FEMS MICROBIOL LETT, V199, P161, DOI 10.1016/S0378-1097(01)00183-5; Mallet J, 2009, J EVOLUTION BIOL, V22, P2332, DOI 10.1111/j.1420-9101.2009.01816.x; Mallet J, 2006, TRENDS ECOL EVOL, V21, P386, DOI 10.1016/j.tree.2006.05.004; Mandel MJ, 2009, NATURE, V458, P215, DOI 10.1038/nature07660; Mayr E., 1942, SYSTEMATICS ORIGIN S; McKinnon JS, 2002, TRENDS ECOL EVOL, V17, P480, DOI 10.1016/S0169-5347(02)02579-X; Nadeau NJ, 2012, PHILOS T R SOC B, V367, P343, DOI 10.1098/rstb.2011.0198; Neafsey DE, 2010, SCIENCE, V330, P514, DOI 10.1126/science.1193036; Preheim SP, 2011, ENVIRON MICROBIOL, V13, P265, DOI 10.1111/j.1462-2920.2010.02328.x; Rozen DE, 2002, CURR BIOL, V12, P1040, DOI 10.1016/S0960-9822(02)00896-5; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Shapiro BJ, 2012, SCIENCE, V336, P48, DOI 10.1126/science.1218198; Shapiro BJ, 2009, TRENDS MICROBIOL, V17, P196, DOI 10.1016/j.tim.2009.02.002; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7; Via S, 2012, PHILOS T R SOC B, V367, P451, DOI 10.1098/rstb.2011.0260; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Vos M, 2011, TRENDS MICROBIOL, V19, P1, DOI 10.1016/j.tim.2010.10.003; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909; White BJ, 2010, MOL ECOL, V19, P925, DOI 10.1111/j.1365-294X.2010.04531.x; Wiedenbeck J, 2011, FEMS MICROBIOL REV, V35, P957, DOI 10.1111/j.1574-6976.2011.00292.x; Wylie CS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001108	50	27	29	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53539	10.1371/journal.pone.0053539	http://dx.doi.org/10.1371/journal.pone.0053539			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349716	Green Published, Green Submitted, gold			2022-12-25	WOS:000313738900010
J	Mei, YW; Xu, L; Kramer, HF; Tomberlin, GH; Townsend, C; Meissner, G				Mei, Yingwu; Xu, Le; Kramer, Henning F.; Tomberlin, Ginger H.; Townsend, Claire; Meissner, Gerhard			Stabilization of the Skeletal Muscle Ryanodine Receptor Ion Channel-FKBP12 Complex by the 1,4-Benzothiazepine Derivative S107	PLOS ONE			English	Article							CALCIUM-RELEASE CHANNEL; CA2+ RELEASE; SARCOPLASMIC-RETICULUM; S-NITROSYLATION; DEFECTIVE REGULATION; CALMODULIN-BINDING; FKBP12 BINDING; NITRIC-OXIDE; REDOX SENSOR; PHOSPHORYLATION	Activation of the skeletal muscle ryanodine receptor (RyR1) complex results in the rapid release of Ca2+ from the sarcoplasmic reticulum and muscle contraction. Dissociation of the small FK506 binding protein 12 subunit (FKBP12) increases RyR1 activity and impairs muscle function. The 1,4-benzothiazepine derivative JTV519, and the more specific derivative S107 (2,3,4,5,-tetrahydro-7-methoxy-4-methyl-1,4-benzothiazepine), are thought to improve skeletal muscle function by stabilizing the RyR1-FKBP12 complex. Here, we report a high degree of nonspecific and specific low affinity [H-3]S107 binding to SR vesicles. SR vesicles enriched in RyR1 bound similar to 48 [H-3]S107 per RyR1 tetramer with EC50 similar to 52 mu M and Hillslope similar to 2. The effects of S107 and FKBP12 on RyR1 were examined under conditions that altered the redox state of RyR1. S107 increased FKBP12 binding to RyR1 in SR vesicles in the presence of reduced glutathione and the NO-donor NOC12, with no effect in the presence of oxidized glutathione. Addition of 0.15 mu M FKBP12 to SR vesicles prevented FKBP12 dissociation; however, in the presence of oxidized glutathione and NOC12, FKBP12 dissociation was observed in skeletal muscle homogenates that contained 0.43 mu M myoplasmic FKBP12 and was attenuated by S107. In single channel measurements with FKBP12-depleted RyR1s, in the absence and presence of NOC12, S107 augmented the FKBP12-mediated decrease in channel activity. The data suggest that S107 can reverse the harmful effects of redox active species on SR Ca2+ release in skeletal muscle by binding to RyR1 low affinity sites.	[Mei, Yingwu; Xu, Le; Meissner, Gerhard] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Kramer, Henning F.; Tomberlin, Ginger H.; Townsend, Claire] GlaxoSmithKline Res & Dev Ltd, Res Triangle Pk, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; GlaxoSmithKline	Meissner, G (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	meissner@med.unc.edu			National Institutes of Health Grant [AR018687]; GlaxoSmithKline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR018687, R01AR018687] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline(GlaxoSmithKline); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was funded with support of the National Institutes of Health Grant AR018687 and GlaxoSmithKline. No other external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors HK, GT and CT are employed by GlaxoSmithKline Research and Development. This study was partly funded by GlaxoSmithKline. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ahern GP, 1997, BIOPHYS J, V72, P146, DOI 10.1016/S0006-3495(97)78654-5; ANDERSON K, 1994, AM J PHYSIOL, V266, pC462, DOI 10.1152/ajpcell.1994.266.2.C462; Andersson DC, 2011, CELL METAB, V14, P196, DOI 10.1016/j.cmet.2011.05.014; Aracena P, 2005, ANTIOXID REDOX SIGN, V7, P870, DOI 10.1089/ars.2005.7.870; Avila G, 2003, J BIOL CHEM, V278, P22600, DOI 10.1074/jbc.M205866200; Balshaw DM, 2001, J BIOL CHEM, V276, P20144, DOI 10.1074/jbc.M010771200; Barg S, 1997, AM J PHYSIOL-CELL PH, V272, pC1726, DOI 10.1152/ajpcell.1997.272.5.C1726; Bellinger AM, 2008, P NATL ACAD SCI USA, V105, P2198, DOI 10.1073/pnas.0711074105; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; Capes EM, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-18; DENEKE SM, 1989, AM J PHYSIOL, V257, pL163, DOI 10.1152/ajplung.1989.257.4.L163; Eu JP, 2000, CELL, V102, P499, DOI 10.1016/S0092-8674(00)00054-4; Eu JP, 2003, P NATL ACAD SCI USA, V100, P15229, DOI 10.1073/pnas.2433468100; Fauconnier J, 2011, P NATL ACAD SCI USA, V108, P13258, DOI 10.1073/pnas.1100286108; Fauconnier J, 2010, P NATL ACAD SCI USA, V107, P1559, DOI 10.1073/pnas.0908540107; Feng W, 2000, J BIOL CHEM, V275, P35902, DOI 10.1074/jbc.C000523200; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Gonzalez DR, 2007, P NATL ACAD SCI USA, V104, P20612, DOI 10.1073/pnas.0706796104; Hidalgo C, 2008, ANTIOXID REDOX SIGN, V10, P1275, DOI 10.1089/ars.2007.1886; Hunt DJ, 2007, BIOCHEM J, V404, P431, DOI 10.1042/BJ20070135; Kaftan E, 1996, CIRC RES, V78, P990, DOI 10.1161/01.RES.78.6.990; Kakizawa S, 2012, EMBO J, V31, P417, DOI 10.1038/emboj.2011.386; LAM E, 1995, J BIOL CHEM, V270, P26511, DOI 10.1074/jbc.270.44.26511; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Lehnart SE, 2008, J CLIN INVEST, V118, P2230, DOI 10.1172/JCI35346; Li YX, 2002, CIRC RES, V90, P309, DOI 10.1161/hh0302.105660; Ma JJ, 1995, BIOPHYS J, V69, P2398, DOI 10.1016/S0006-3495(95)80109-8; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Marx SO, 1998, SCIENCE, V281, P818, DOI 10.1126/science.281.5378.818; Marx SO, 2001, CIRC RES, V88, P1151, DOI 10.1161/hh1101.091268; MEISSNER G, 1983, MOL CELL BIOCHEM, V55, P65; Meissner G, 2002, FRONT BIOSCI, V7, pD2072, DOI 10.2741/meissner; Petrotchenko EV, 2011, RES REP BIOL, V2, P13, DOI 10.2147/RRB.S15776; Reid MB, 1996, NEWS PHYSIOL SCI, V11, P114, DOI 10.1152/physiologyonline.1996.11.3.114; Reiken S, 2003, J CELL BIOL, V160, P919, DOI 10.1083/jcb.200211012; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Shan J, 2010, J CLIN INVEST, V120, P4375, DOI 10.1172/JCI37649; Stange M, 2003, J BIOL CHEM, V278, P51693, DOI 10.1074/jbc.M310406200; Sun JH, 2003, J BIOL CHEM, V278, P8184, DOI 10.1074/jbc.M211940200; Sun JH, 2001, P NATL ACAD SCI USA, V98, P11158, DOI 10.1073/pnas.201289098; Sutko JL, 1997, PHARMACOL REV, V49, P53; Tang W, 2004, FASEB J, V18, P1597, DOI 10.1096/fj.04-1587fje; Terentyev D, 2008, CIRC RES, V103, P1466, DOI 10.1161/CIRCRESAHA.108.184457; TIMERMAN AP, 1995, J BIOL CHEM, V270, P2451, DOI 10.1074/jbc.270.6.2451; TIMERMAN AP, 1993, J BIOL CHEM, V268, P22992; Ward CW, 2003, FASEB J, V17, P1517, DOI 10.1096/fj.02-1083fje; Wehrens XHT, 2005, ANNU REV PHYSIOL, V67, P69, DOI 10.1146/annurev.physiol.67.040403.114521; Wehrens XHT, 2004, SCIENCE, V304, P292, DOI 10.1126/science.1094301; Xia RH, 2000, J BIOL CHEM, V275, P36556, DOI 10.1074/jbc.M007613200; Xiao BL, 2005, CIRC RES, V96, P847, DOI 10.1161/01.RES.0000163276.26083.e8; Xiao JM, 2007, J BIOL CHEM, V282, P34828, DOI 10.1074/jbc.M707423200; Xu L, 1999, J BIOL CHEM, V274, P32680, DOI 10.1074/jbc.274.46.32680; Yano M, 2003, CIRCULATION, V107, P477, DOI 10.1161/01.CIR.0000044917.74408.BE; Zable AC, 1997, J BIOL CHEM, V272, P7069, DOI 10.1074/jbc.272.11.7069; Zissimopoulos S, 2007, J BIOL CHEM, V282, P6976, DOI 10.1074/jbc.M607590200	56	24	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54208	10.1371/journal.pone.0054208	http://dx.doi.org/10.1371/journal.pone.0054208			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349825	Green Published, Green Submitted, gold			2022-12-25	WOS:000313738900052
J	Bohata, K; Koppelmann, R				Bohata, Karolina; Koppelmann, Rolf			Chaetognatha of the Namibian Upwelling Region: Taxonomy, Distribution and Trophic Position	PLOS ONE			English	Article							VERTICAL-DISTRIBUTION; POPULATION-STRUCTURE; SAGITTA-ELEGANS; CARBON ISOTOPES; DIEL MIGRATION; ZOOPLANKTON; SALINITY; NORTH; TEMPERATURE; DELTA-N-15	In October 2010, the vertical distribution, biodiversity and maturity stages of Chaetognatha species were investigated at four stations located off Walvis Bay, Namibia. Seventeen species were detected and classified as pelagic, shallow-mesopelagic, deep-mesopelagic and bathypelagic species based upon the weighted mean depth derived from their average vertical distribution. High abundances of Chaetognatha were found in the upper 100 m at all stations of the Walvis Bay transect with a maximum value of 20837 ind. 1000 m(-3) at the outer shelf station near the surface. The community was dominated by species of the Serratodentata group. Furthermore, the distribution of Chaetognatha did not seem to be influenced by low oxygen concentrations. Stable isotope ratios of carbon and nitrogen in Chaetognatha were determined for seven different areas located off northern Namibia. The values of delta N-15 ranged from 6.05 % to 11.39 %, while the delta C-13 values varied between -23.89 % and -17.03 %. The highest values for delta N-15 were observed at the Walvis Bay shelf break station. The lowest delta C-13 values were found at the Rocky Point offshore station, which was statistically different from all other areas. Stable isotopes of carbon and nitrogen were determined for four taxa (Sagitta minima, Planctonis group, Sagitta enflata, Sagitta decipiens). In this case, the delta N-15 values ranged from 6.17 % to 10.38 %, whereas the delta C-13 values varied from -22.70 % to -21.56 %. The lowest delta N-15 values were found for S. minima. The C- and N-content revealed maximum C-values for S. decipiens and maximum N-values for the Planctonis group. The C:N ratio of Chaetognatha ranged between 5.25 and 6.20. Overall, Chaetognatha are a diverse group in the pelagic food web of the Benguela Upwelling System and act as competitors of fish larvae and jelly fish by preying on copepods.	[Bohata, Karolina; Koppelmann, Rolf] Univ Hamburg, Inst Hydrobiol & Fisheries Sci, Ctr Earth Syst Res & Sustainabil, Hamburg, Germany	University of Hamburg	Bohata, K (corresponding author), Univ Hamburg, Inst Hydrobiol & Fisheries Sci, Ctr Earth Syst Res & Sustainabil, Hamburg, Germany.	karolina.bohata@uni-hamburg.de		Koppelmann, Rolf/0000-0002-0561-9617	Federal Ministry of Education and Research, Germany [FKZ 03F0497A]	Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF))	Funded by the Federal Ministry of Education and Research, Germany. Grant Number: FKZ 03F0497A (http://www.bmbf.de/en/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auel H, 2007, J EXP MAR BIOL ECOL, V352, P234, DOI 10.1016/j.jembe.2007.07.020; Bakun A, 2010, GLOBAL CHANGE BIOL, V16, P1213, DOI 10.1111/j.1365-2486.2009.02094.x; BANSE K., 1964, PROGR OCEANOGR, V2, P53, DOI 10.1016/0079-6611(64)90003-5; Batistic M, 2003, J MAR BIOL ASSOC UK, V83, P1301, DOI 10.1017/S0025315403008713; Besiktepe S, 2000, J PLANKTON RES, V22, P669, DOI 10.1093/plankt/22.4.669; Brasseur P, 1996, DEEP-SEA RES PT I, V43, P159, DOI 10.1016/0967-0637(96)00012-X; Casanova Jean-Paul, 1999, P1353; CHENEY J, 1985, DEEP-SEA RES, V32, P1041, DOI 10.1016/0198-0149(85)90061-5; CONWAY DVP, 1986, MAR BIOL, V93, P377, DOI 10.1007/BF00401105; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DURO A, 1994, J PLANKTON RES, V16, P1149, DOI 10.1093/plankt/16.9.1149; Escribano R, 2000, J MAR BIOL ASSOC UK, V80, P283, DOI 10.1017/S002531549900185X; FEIGENBAUM D, 1979, MAR BIOL, V54, P75, DOI 10.1007/BF00387053; GIBBONS MJ, 1992, S AFR J MARINE SCI, V12, P421; GIBBONS MJ, 1992, J PLANKTON RES, V14, P249, DOI 10.1093/plankt/14.2.249; Giesecke R, 2004, J PLANKTON RES, V26, P475, DOI 10.1093/plankt/fbh039; GORSKY G, 1988, J EXP MAR BIOL ECOL, V124, P133, DOI 10.1016/0022-0981(88)90116-5; GRANT GC, 1991, FISH B-NOAA, V89, P33; Hamukuaya H, 1998, S AFR J MARINE SCI, V19, P57; Hart TJ., 1960, BENGUELA CURRENT; Holmes E, 2002, DEEP-SEA RES PT I, V49, P377, DOI 10.1016/S0967-0637(01)00055-3; Hunt BPV, 2008, PROG OCEANOGR, V78, P193, DOI 10.1016/j.pocean.2008.06.001; Hutchings L, 2009, PROG OCEANOGR, V83, P15, DOI 10.1016/j.pocean.2009.07.046; IKEDA T, 1974, Memoirs of the Faculty of Fisheries Hokkaido University, V22, P1; IKEDA T, 1989, MAR BIOL, V100, P261, DOI 10.1007/BF00391967; KEHAYIAS G, 1994, MAR BIOL, V119, P647, DOI 10.1007/BF00354329; Kehayias G, 2008, J NAT HIST, V42, P633, DOI 10.1080/00222930701835597; Kehayias G, 2010, BIOLOGIA, V65, P301, DOI 10.2478/s11756-010-0024-8; Koppelmann R, J MARINE BIOL ASS UK; Kruse S, 2010, MAR ECOL PROG SER, V416, P105, DOI 10.3354/meps08773; Kusum KK, 2011, DEEP-SEA RES PT I, V58, P1163, DOI 10.1016/j.dsr.2011.08.012; Marazzo A, 1996, J PLANKTON RES, V18, P2367, DOI 10.1093/plankt/18.12.2367; MCCONNAUGHEY T, 1979, MAR BIOL, V53, P257, DOI 10.1007/BF00952434; MCGOWAN JA, 1966, LIMNOL OCEANOGR, V11, P456, DOI 10.4319/lo.1966.11.4.0456; MCLAREN IA, 1968, CAN J ZOOLOG, V46, P1267, DOI 10.1139/z68-175; Michener R, 2007, ECOL METHOD CONCEPT, pXVII; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Monteiro PMS, 2006, LAR MAR ECOSYST, V14, P71; NELSON G, 1983, PROG OCEANOGR, V12, P333, DOI 10.1016/0079-6611(83)90013-7; OMORI M, 1969, MAR BIOL, V3, P4, DOI 10.1007/BF00355587; PEARRE S, 1982, MAR ECOL PROG SER, V7, P33; PEARRE S JR, 1979, Journal of Plankton Research, V1, P29, DOI 10.1093/plankt/1.1.29; PERRY RI, 1993, CONT SHELF RES, V13, P357, DOI 10.1016/0278-4343(93)90056-4; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; PIERROTBULTS AC, 1988, CHAETOGNATHA KEYS NO; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Redfield A.C., 1934, J JOHNSTONE MEMORIAL, P177; REEVE MR, 1970, MAR BIOL, V6, P357, DOI 10.1007/BF00353669; SAUPE SM, 1989, MAR BIOL, V103, P427, DOI 10.1007/BF00399574; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; Shannon C.E., 1949, MATH THEORY INFORM; Shannon LV, 2003, LARGE MARINE ECOSYST; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; STUART V, 1991, J MAR RES, V49, P493, DOI 10.1357/002224091784995819; WIEBE PH, 1985, MAR BIOL, V87, P313, DOI 10.1007/BF00397811; Zhang WC, 2009, HYDROBIOLOGIA, V636, P257, DOI 10.1007/s10750-009-9955-x; ZO Z, 1973, LIMNOL OCEANOGR, V18, P750, DOI 10.4319/lo.1973.18.5.0750	57	13	16	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53839	10.1371/journal.pone.0053839	http://dx.doi.org/10.1371/journal.pone.0053839			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342016	Green Published, gold, Green Submitted			2022-12-25	WOS:000313682700049
J	Cross, P; St John, FAV; Khan, S; Petroczi, A				Cross, Paul; St John, Freya A. V.; Khan, Saira; Petroczi, Andrea			Innovative Techniques for Estimating Illegal Activities in a Human-Wildlife-Management Conflict	PLOS ONE			English	Article							IMPLICIT ASSOCIATION TEST; RANDOMIZED-RESPONSE; FALSE CONSENSUS; RED GROUSE; TUBERCULOSIS; PREVALENCE; BEHAVIOR; BADGERS; CATTLE; BIAS	Effective management of biological resources is contingent upon stakeholder compliance with rules. With respect to disease management, partial compliance can undermine attempts to control diseases within human and wildlife populations. Estimating non-compliance is notoriously problematic as rule-breakers may be disinclined to admit to transgressions. However, reliable estimates of rule-breaking are critical to policy design. The European badger (Meles meles) is considered an important vector in the transmission and maintenance of bovine tuberculosis (bTB) in cattle herds. Land managers in high bTB prevalence areas of the UK can cull badgers under license. However, badgers are also known to be killed illegally. The extent of illegal badger killing is currently unknown. Herein we report on the application of three innovative techniques (Randomized Response Technique (RRT); projective questioning (PQ); brief implicit association test (BIAT)) for investigating illegal badger killing by livestock farmers across Wales. RRT estimated that 10.4% of farmers killed badgers in the 12 months preceding the study. Projective questioning responses and implicit associations relate to farmers' badger killing behavior reported via RRT. Studies evaluating the efficacy of mammal vector culling and vaccination programs should incorporate estimates of non-compliance. Mitigating the conflict concerning badgers as a vector of bTB requires cross-disciplinary scientific research, departure from deep-rooted positions, and the political will to implement evidence-based management.	[Cross, Paul] Bangor Univ, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales; [St John, Freya A. V.] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury, Kent, England; [Khan, Saira; Petroczi, Andrea] Univ Kingston, Fac Sci Engn & Comp, Kingston Upon Thames KT1 2EE, Surrey, England; [Petroczi, Andrea] Univ Sheffield, Dept Psychol, Sheffield S10 2TN, S Yorkshire, England	Bangor University; University of Kent; Kingston University; University of Sheffield	Cross, P (corresponding author), Bangor Univ, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales.	paul.cross@bangor.ac.uk	Petroczi, Andrea/ABG-9863-2021	Petroczi, Andrea/0000-0002-8365-6173; St. John, Freya/0000-0002-5707-310X	British Academy, Small Research Grant programme [SG100709]	British Academy, Small Research Grant programme	This study benefited from funding from The British Academy, Small Research Grant programme (SG100709). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004570; BERK RA, 1983, AM SOCIOL REV, V48, P386, DOI 10.2307/2095230; Bourne F., 2007, BOVINE TUBERCULOSIS; BUCHMAN TA, 1982, J ACCOUNTING RES, V20, P263, DOI 10.2307/2490775; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Conner MT, 2007, PERS SOC PSYCHOL B, V33, P1727, DOI 10.1177/0146167207309194; Cross P, 2010, PREV VET MED, V96, P252, DOI 10.1016/j.prevetmed.2010.05.012; Defra, 2011, BOV TUB EV PLAN 2011; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; Donnelly CA, 2012, NATURE, V485, P582, DOI 10.1038/485582a; Friese M, 2008, EUR REV SOC PSYCHOL, V19, P285, DOI 10.1080/10463280802556958; Gallagher J, 2000, RES VET SCI, V69, P203, DOI 10.1053/rvsc.2000.0422; Gavin MC, 2010, CONSERV BIOL, V24, P89, DOI 10.1111/j.1523-1739.2009.01387.x; Golden CD, 2009, ORYX, V43, P386, DOI 10.1017/S0030605309000131; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Haynes D, 2000, MAR POLLUT BULL, V41, P279, DOI 10.1016/S0025-326X(00)00097-7; HOLE NH, 1969, NATURE, V224, P244, DOI 10.1038/224244a0; Hovardas T, 2011, ENV BEHAV; Hox J, 2004, STRUCT EQU MODELING, V11, P615, DOI 10.1207/s15328007sem1104_6; Jenkins HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009090; John FAVS, 2010, BIOL CONSERV, V143, P1025, DOI 10.1016/j.biocon.2010.01.018; Jones RD, 2005, RISK ANAL, V25, P533, DOI 10.1111/j.1539-6924.2005.00613.x; Keane A, 2008, ANIM CONSERV, V11, P75, DOI 10.1111/j.1469-1795.2008.00170.x; Laurance WF, 2004, SCIENCE, V304, P1109, DOI 10.1126/science.304.5674.1109b; Lensvelt-Mulders GJLM, 2005, SOCIOL METHOD RES, V33, P319, DOI 10.1177/0049124104268664; Lensvelt-Mulders GJLM, 2005, QUAL QUANT, V39, P253, DOI 10.1007/s11135-004-0432-3; Liberg O, 2012, P ROY SOC B-BIOL SCI, V279, P910, DOI 10.1098/rspb.2011.1275; MacDonald DW, 2006, BIOL CONSERV, V131, P268, DOI 10.1016/j.biocon.2006.05.006; Monin B, 2003, PERS SOC PSYCHOL B, V29, P559, DOI 10.1177/0146167203029005001; MUIRHEAD RH, 1974, VET REC, V95, P552, DOI 10.1136/vr.95.24.552; Nock MK, 2010, PSYCHOL SCI, V21, P511, DOI 10.1177/0956797610364762; Nosek BA, 2011, TRENDS COGN SCI, V15, P152, DOI 10.1016/j.tics.2011.01.005; Ostapczuk M, 2011, DISABIL REHABIL, V33, P399, DOI 10.3109/09638288.2010.492067; Petroczi A, 2011, SUBST ABUSE TREAT PR, V6, DOI 10.1186/1747-597X-6-20; Petroczi Andrea, 2008, J Occup Med Toxicol, V3, P19, DOI 10.1186/1745-6673-3-19; Proffitt F, 2004, SCIENCE, V303, P1955; R Core Team, 2021, R LANG ENV STAT COMP; Reid N, 2012, EUR J WILDLIFE RES, V58, P177, DOI 10.1007/s10344-011-0560-8; Richetin J, 2007, INT J PSYCHOL, V42, P166, DOI 10.1080/00207590601067078; Riordan P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028904; ROSS L, 1977, J EXP SOC PSYCHOL, V13, P279, DOI 10.1016/0022-1031(77)90049-X; Sherman JW, 2008, PSYCHOL REV, V115, P314, DOI 10.1037/0033-295X.115.2.314; SHERMAN SJ, 1983, PERS SOC PSYCHOL B, V9, P197, DOI 10.1177/0146167283092003; Solomon J., 2007, HUM DIMENS WILDL, V12, P75, DOI [10.1080/10871200701195365, DOI 10.1080/10871200701195365]; Sriram N, 2009, EXP PSYCHOL, V56, P283, DOI 10.1027/1618-3169.56.4.283; St John FAV, 2011, P ROY SOC B; St John FAV, 2011, P R SOC EDINB BIOL; Thirgood S, 2008, J APPL ECOL, V45, P1550, DOI 10.1111/j.1365-2664.2008.01519.x; Thirgood SJ, 2000, P ROY SOC B-BIOL SCI, V267, P651, DOI 10.1098/rspb.2000.1051; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Treves A, 1999, J HUM EVOL, V36, P275, DOI 10.1006/jhev.1998.0268; Uvacsek M, 2011, SCAND J MED SCI SPOR, V21, P224, DOI 10.1111/j.1600-0838.2009.01041.x; van den Hout A, 2007, COMPUT STAT DATA AN, V51, P6060, DOI 10.1016/j.csda.2006.12.002; van der Heijden PGM, 2000, SOCIOL METHOD RES, V28, P505, DOI 10.1177/0049124100028004005; Vial F, 2011, BIOL LETT; von Hippel W, 2008, PSYCHOL SCI, V19, P7, DOI 10.1111/j.1467-9280.2008.02037.x; Wilson GJ, 2011, VET MICROBIOL, V151, P43, DOI 10.1016/j.vetmic.2011.02.024; Woodroffe R, 2008, J ZOOL, V274, P28, DOI 10.1111/j.1469-7998.2007.00353.x; Woodroffe R, 2005, CONSERV BIOL SER, V9, P1; Woodroffe R, 2009, J WILDLIFE DIS, V45, P128, DOI 10.7589/0090-3558-45.1.128; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	62	14	14	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53681	10.1371/journal.pone.0053681	http://dx.doi.org/10.1371/journal.pone.0053681			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072OV	23341973	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000313682700035
J	Dalman, K; Himmelstrand, K; Olson, A; Lind, M; Brandstrom-Durling, M; Stenlid, J				Dalman, Kerstin; Himmelstrand, Kajsa; Olson, Ake; Lind, Marten; Brandstrom-Durling, Mikael; Stenlid, Jan			A Genome-Wide Association Study Identifies Genomic Regions for Virulence in the Non-Model Organism Heterobasidion annosum s.s	PLOS ONE			English	Article							FLAVIN-CONTAINING MONOOXYGENASE; MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; COMPLEX TRAITS; CALCINEURIN; PATHOGENICITY; INFERENCE; LOCI; RESISTANCE; SOFTWARE	The dense single nucleotide polymorphisms (SNP) panels needed for genome wide association (GWA) studies have hitherto been expensive to establish and use on non-model organisms. To overcome this, we used a next generation sequencing approach to both establish SNPs and to determine genotypes. We conducted a GWA study on a fungal species, analysing the virulence of Heterobasidion annosum s.s., a necrotrophic pathogen, on its hosts Picea abies and Pinus sylvestris. From a set of 33,018 single nucleotide polymorphisms (SNP) in 23 haploid isolates, twelve SNP markers distributed on seven contigs were associated with virulence (P<0.0001). Four of the contigs harbour known virulence genes from other fungal pathogens and the remaining three harbour novel candidate genes. Two contigs link closely to virulence regions recognized previously by QTL mapping in the congeneric hybrid H. irregulare x H. occidentale. Our study demonstrates the efficiency of GWA studies for dissecting important complex traits of small populations of non-model haploid organisms with small genomes.	[Dalman, Kerstin; Himmelstrand, Kajsa; Olson, Ake; Lind, Marten; Brandstrom-Durling, Mikael; Stenlid, Jan] Swedish Univ Agr Sci, Dept Forest Mycol & Plant Pathol, Uppsala BioCtr, Uppsala, Sweden	Swedish University of Agricultural Sciences	Dalman, K (corresponding author), Swedish Univ Agr Sci, Dept Forest Mycol & Plant Pathol, Uppsala BioCtr, Uppsala, Sweden.	kerstin.dalman@slu.se	Stenlid, Jan/K-5909-2019; Brandström Durling, Mikael/C-1213-2008	Brandström Durling, Mikael/0000-0001-6485-197X; Stenlid, Jan/0000-0002-5344-2094; Lind, Marten/0000-0002-3817-2823	Swedish Research Council of Environmental, Agricultural and Spatial planning (FORMAS) [229-2007-1097]; Swedish Foundation for Strategic Research (SSF) [RBb08-0011]	Swedish Research Council of Environmental, Agricultural and Spatial planning (FORMAS); Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research)	Financial support from the Swedish Research Council of Environmental, Agricultural and Spatial planning (FORMAS) grant ID 229-2007-1097 (http://www.formas.se/en/) and the Swedish Foundation for Strategic Research (SSF) number RBb08-0011 (http://www.stratresearch.se/) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrie RA, 2007, PHYTOPATHOLOGY, V97, P694, DOI 10.1094/PHYTO-97-6-0694; Aranzana MJ, 2005, PLOS GENET, V1, P531, DOI 10.1371/journal.pgen.0010060; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Choi J, 2009, FUNGAL GENET BIOL, V46, P243, DOI 10.1016/j.fgb.2008.11.010; Connelly CF, 2012, GENETICS; Cumagun CJR, 2004, PHYTOPATHOLOGY, V94, P520, DOI 10.1094/PHYTO.2004.94.5.520; Egan JD, 2009, MOL PLANT MICROBE IN, V22, P1293, DOI 10.1094/MPMI-22-10-1293; Ellison CE, 2011, P NATL ACAD SCI USA, V108, P2831, DOI 10.1073/pnas.1014971108; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Hall D, 2010, BRIEF FUNCT GENOMICS, V9, P157, DOI 10.1093/bfgp/elp048; Harel A, 2006, MOL PLANT MICROBE IN, V19, P682, DOI 10.1094/MPMI-19-0682; Hawthorne B, 1997, FUNGAL GENET NEWSL, V44, P24; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Huser A, 2009, MOL PLANT MICROBE IN, V22, P143, DOI 10.1094/MPMI-22-2-0143; Karababa M, 2006, MOL MICROBIOL, V59, P1429, DOI 10.1111/j.1365-2958.2005.05037.x; Kelly MT, 2004, MOL MICROBIOL, V53, P969, DOI 10.1111/j.1365-2958.2004.04185.x; Kim JE, 2007, CURR GENET, V51, P99, DOI 10.1007/s00294-006-0110-1; Koch M, 2006, PLANT J, V47, P629, DOI 10.1111/j.1365-313X.2006.02813.x; Korhonen K, 1998, HETEROBASIDION ANNOSUM: BIOLOGY, ECOLOGY, IMPACT AND CONTROL, P93; Korhonen K, 1998, HETEROBASIDION ANNOSUM: BIOLOGY, ECOLOGY, IMPACT AND CONTROL, P43; Ladds G, 1996, MOL MICROBIOL, V20, P35, DOI 10.1111/j.1365-2958.1996.tb02486.x; LAWTON MP, 1994, ARCH BIOCHEM BIOPHYS, V308, P254, DOI 10.1006/abbi.1994.1035; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lind M, 2005, FUNGAL GENET BIOL, V42, P519, DOI 10.1016/j.fgb.2005.03.005; Lind M, 2007, CURR GENET, V52, P35, DOI 10.1007/s00294-007-0137-y; Lind M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048347; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Muller LAH, 2011, MOL ECOL, V20, P4085, DOI 10.1111/j.1365-294X.2011.05225.x; Mylonakis E, 2004, MOL MICROBIOL, V54, P407, DOI 10.1111/j.1365-2958.2004.04310.x; Neafsey DE, 2010, GENOME RES, V20, P938, DOI 10.1101/gr.103911.109; Niemela T, 1998, HETEROBASIDION ANNOSUM: BIOLOGY, ECOLOGY, IMPACT AND CONTROL, P27; Olson A, 2001, NATURE, V411, P438, DOI 10.1038/35078147; Olson A, 2012, NEW PHYTOL, V194, P1001, DOI 10.1111/j.1469-8137.2012.04128.x; Otrosina WJ, 2010, FUNGAL BIOL-UK, V114, P16, DOI 10.1016/j.mycres.2009.09.001; Pandelova I., 2005, FUNGAL GENET NEWSL, V52; Pritchard JK, 2000, GENETICS, V155, P945; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; RAO PV, 1992, J BIOL CHEM, V267, P96; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P19; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Santoyo F, 2008, ENZYME MICROB TECH, V43, P137, DOI 10.1016/j.enzmictec.2007.11.007; Schumacher J, 2008, EUKARYOT CELL, V7, P584, DOI 10.1128/EC.00426-07; STENLID J, 1985, CAN J BOT, V63, P2268, DOI 10.1139/b85-322; Sugiura R, 2001, CELL MOL LIFE SCI, V58, P278, DOI 10.1007/PL00000855; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zerbino DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008407; Zhang HF, 2009, FEMS MICROBIOL LETT, V293, P160, DOI 10.1111/j.1574-6968.2009.01524.x; Zhang QA, 2010, J BIOL CHEM, V285, P34259, DOI 10.1074/jbc.M110.154393	54	50	54	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53525	10.1371/journal.pone.0053525	http://dx.doi.org/10.1371/journal.pone.0053525			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341945	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000313682700027
J	Ranasinghe, WKB; Xiao, L; Kovac, S; Chang, M; Michiels, C; Bolton, D; Shulkes, A; Baldwin, GS; Patel, O				Ranasinghe, Weranja K. B.; Xiao, Lin; Kovac, Suzana; Chang, Mike; Michiels, Carine; Bolton, Damien; Shulkes, Arthur; Baldwin, Graham S.; Patel, Oneel			The Role of Hypoxia-Inducible Factor 1 alpha in Determining the Properties of Castrate-Resistant Prostate Cancers	PLOS ONE			English	Article							HORMONE-REFRACTORY PROSTATE; ENDOTHELIAL GROWTH-FACTOR; FACTOR-I-ALPHA; ANDROGEN RECEPTOR; CELL-LINES; RADICAL PROSTATECTOMY; HIF-1-ALPHA SYNTHESIS; MESSENGER-RNAS; GASTRIC-CANCER; UP-REGULATION	Background: Castrate-resistant prostate cancer (CRPC) is a lethal condition in patients receiving androgen deprivation therapy for prostate cancer (PC). Despite numerous studies showing the expression of HIF1 alpha protein under normoxia in PC cell lines, the role of this normoxic HIF1 alpha expression in chemo-resistance and migration has not been investigated previously. As no method is currently available to determine which tumors will progress to CRPC, the role of HIF1 alpha in PC and its potential for predicting the development of CRPC was also investigated. Methods: The effect of HIF1 alpha protein knockdown on chemo-resistance and migration of PC3 cells was assessed by cell counting and Transwell assays, respectively. Translation efficiency of HIF1 alpha mRNA was determined in PC cells using a HIF1 alpha 5'UTR-luciferase construct. Clinical outcomes were correlated following the staining of 100 prostate tumors for HIF1 alpha expression. Results: The CRPC-like cell lines (PC3 and DU145) expressed more HIF1 alpha protein than an androgen sensitive cell line (LNCaP). Migration rate and chemo-resistance were higher in the PC3 cells and both were decreased when HIF1 alpha expression was reduced. Increased translation of HIF1 alpha mRNA may be responsible for HIF1 alpha overexpression in PC3 cells. Patients whose tumors expressed HIF1 alpha had significantly decreased metastasis-free survival and the patients who were on androgen-deprivation therapy had decreased CRPC-free survival on Kaplan-Meier analysis. On multivariate analysis HIF1 alpha was an independent risk factor for progression to metastatic PC (Hazard ratio (HR) 9.8, p = 0.017) and development of CRPC (HR 10.0, p = 0.021) in patients on androgen-deprivation therapy. Notably the tumors which did not express HIF1 alpha did not metastasize or develop CRPC. Conclusions: HIF1 alpha is likely to contribute to metastasis and chemo-resistance of CRPC and targeted reduction of HIF1 alpha may increase the responsiveness of CRPCs to chemotherapy. Expression of HIF1 alpha may be a useful screening tool for development of CRPC.	[Ranasinghe, Weranja K. B.; Xiao, Lin; Kovac, Suzana; Chang, Mike; Bolton, Damien; Shulkes, Arthur; Baldwin, Graham S.; Patel, Oneel] Univ Melbourne, Austin Hlth, Dept Surg, Heidelberg, Vic, Australia; [Ranasinghe, Weranja K. B.; Bolton, Damien] Univ Melbourne, Austin Hlth, Dept Urol, Heidelberg, Vic, Australia; [Michiels, Carine] Univ Namur, FUNDP, NARILIS NAmur Res Inst LIfe Sci, Lab Biochem & Cellular Biol URBC, Namur, Belgium	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Namur	Patel, O (corresponding author), Univ Melbourne, Austin Hlth, Dept Surg, Heidelberg, Vic, Australia.	patelo@unimelb.edu.au	Ranasinghe, Weranja/HHS-8150-2022; Ranasinghe, Weranja/AAV-5678-2021	Ranasinghe, Weranja/0000-0002-4006-0388; Xiao, Lin/0000-0001-7258-5333; Baldwin, Graham/0000-0002-0944-8747; Patel, Oneel/0000-0001-5628-7205	National Health and Medical Research Council of Australia [454322, 566555, 628390]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants 454322 (GSB), 566555 (GSB, AS) and 628390 (AS, OP, GSB) from the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimirah F, 2006, FEBS LETT, V580, P2294, DOI 10.1016/j.febslet.2006.03.041; Beltran H, 2011, EUR UROL, V60, P279, DOI 10.1016/j.eururo.2011.04.038; Berruti A, 2007, J UROLOGY, V178, P838, DOI 10.1016/j.juro.2007.05.018; Boddy JL, 2005, CLIN CANCER RES, V11, P7658, DOI 10.1158/1078-0432.CCR-05-0460; Carnell DM, 2006, INT J RADIAT ONCOL, V65, P91, DOI 10.1016/j.ijrobp.2005.11.044; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; Chau CH, 2005, CANCER BIOL THER, V4, P1222, DOI 10.4161/cbt.4.11.2091; Chen JH, 2004, CELL COMMUN ADHES, V11, P1, DOI 10.1080/15419060490471739; Chlenski A, 2001, PROSTATE, V47, P66; Chun YS, 2003, CANCER RES, V63, P8700; Dai Y, 2011, INT J RADIAT ONCOL, V81, P521, DOI 10.1016/j.ijrobp.2011.04.027; Danila DC, 2011, EUR UROL, V60, P897, DOI 10.1016/j.eururo.2011.07.011; De Armond R, 2005, BIOCHEMISTRY-US, V44, P16341, DOI 10.1021/bi051618u; Du ZX, 2003, CHINESE MED J-PEKING, V116, P1936; Ellem SJ, 2007, NAT REV CANCER, V7, P621, DOI 10.1038/nrc2174; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Figg WD, 2004, WORLD J UROL, V22, P425, DOI 10.1007/s00345-004-0443-7; Foley R, 2009, CANCER BIOL THER, V8, P118, DOI 10.4161/cbt.8.2.7086; Gravdal K, 2009, CANCER RES, V69, P4708, DOI 10.1158/0008-5472.CAN-08-4417; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Guan YL, 2010, MOL THER, V18, P188, DOI 10.1038/mt.2009.219; Hao Ping, 2004, J Huazhong Univ Sci Technolog Med Sci, V24, P593; Holland EC, 2004, ONCOGENE, V23, P3138, DOI 10.1038/sj.onc.1207590; Iyer NV, 1998, GENOMICS, V52, P159, DOI 10.1006/geno.1998.5416; Jans J, 2010, UROLOGY, V75, P786, DOI 10.1016/j.urology.2009.08.024; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kimbro KS, 2006, ENDOCR-RELAT CANCER, V13, P739, DOI 10.1677/erc.1.00728; Kirby M, 2011, INT J CLIN PRACT, V65, P1180, DOI 10.1111/j.1742-1241.2011.02799.x; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; Kosaka T, 2010, PROSTATE, V70, P162, DOI 10.1002/pros.21049; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Lee BL, 2008, CARCINOGENESIS, V29, P44, DOI 10.1093/carcin/bgm232; Lekas A, 2006, ANTICANCER RES, V26, P2989; Liu L, 2007, MOL CELL BIOCHEM, V303, P151, DOI 10.1007/s11010-007-9467-9; Marignol L, 2008, CANCER TREAT REV, V34, P313, DOI 10.1016/j.ctrv.2008.01.006; Mills CN, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-104; Minet E, 1999, BIOCHEM BIOPH RES CO, V261, P534, DOI 10.1006/bbrc.1999.0995; Mitani T, 2011, J STEROID BIOCHEM, V123, P58, DOI 10.1016/j.jsbmb.2010.10.009; Monsef N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-385; Moro L, 2008, CELL ONCOL, V30, P307, DOI 10.3233/CLO-2008-0427; Pipinikas C, 2008, BIOMARKERS, V13, P680, DOI 10.1080/13547500802591992 ; Platz EA, 2011, CANCER DISCOV, V1, P68, DOI 10.1158/2159-8274.CD-10-0020; Poon E, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001173; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Rohwer N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012038; Ross RW, 2008, CANCER-AM CANCER SOC, V112, P1247, DOI 10.1002/cncr.23304; Saramaki OR, 2001, CANCER GENET CYTOGEN, V128, P31, DOI 10.1016/S0165-4608(01)00396-X; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Singh PP, 2011, CLIN CANCER RES, V17, P4006, DOI 10.1158/1078-0432.CCR-11-0248; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Tanaka H, 2006, CANCER RES, V66, P11263, DOI 10.1158/0008-5472.CAN-06-1699; Tanaka H, 2010, NAT MED, V16, P1414, DOI 10.1038/nm.2236; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Vergis R, 2008, LANCET ONCOL, V9, P342, DOI 10.1016/S1470-2045(08)70076-7; Wang Liang, 2006, Zhonghua Nan Ke Xue, V12, P57; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Yasuda M, 2007, CANCER DETECT PREV, V31, P396, DOI 10.1016/j.cdp.2007.10.007; Yossepowitch O, 2007, EUR UROL, V51, P940, DOI 10.1016/j.eururo.2006.10.045; Zeng LH, 2007, CANCER SCI, V98, P1394, DOI 10.1111/j.1349-7006.2007.00537.x; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105; Zhang ZW, 2012, MOL CANCER THER, V11, P2410, DOI 10.1158/1535-7163.MCT-12-0157; Zhong H, 2004, CANCER DETECT PREV, V28, P88, DOI 10.1016/j.cdp.2003.12.009; Zhong H, 1999, CANCER RES, V59, P5830	63	58	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54251	10.1371/journal.pone.0054251	http://dx.doi.org/10.1371/journal.pone.0054251			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342109	Green Published, Green Submitted, gold			2022-12-25	WOS:000313682700096
J	Tamelander, T; Reigstad, M; Olli, K; Slagstad, D; Wassmann, P				Tamelander, Tobias; Reigstad, Marit; Olli, Kalle; Slagstad, Dag; Wassmann, Paul			New Production Regulates Export Stoichiometry in the Ocean	PLOS ONE			English	Article							PARTICULATE ORGANIC-CARBON; NORTH NORWEGIAN SHELF; MARGINAL ICE-ZONE; VERTICAL FLUX; TIME-SERIES; BIOGENIC MATTER; SEASONAL-VARIATION; PARTICLES; SEA; BIOGEOCHEMISTRY	The proportion in which carbon and growth-limiting nutrients are exported from the oceans' productive surface layer to the deep sea is a crucial parameter in models of the biological carbon pump. Based on >400 vertical flux observations of particulate organic carbon (POC) and nitrogen (PON) from the European Arctic Ocean we show the common assumption of constant C:N stoichiometry not to be met. Exported POC: PON ratios exceeded the classical Redfield atomic ratio of 6.625 in the entire region, with the largest deviation in the deep Central Arctic Ocean. In this part the mean exported POC: PON ratio of 9.7 (a:a) implies c. 40% higher carbon export compared to Redfield-based estimates. When spatially integrated, the potential POC export in the European Arctic was 10-30% higher than suggested by calculations based on constant POC: PON ratios. We further demonstrate that the exported POC: PON ratio varies regionally in relation to nitrate-based new production over geographical scales that range from the Arctic to the subtropics, being highest in the least productive oligotrophic Central Arctic Ocean and subtropical gyres. Accounting for variations in export stoichiometry among systems of different productivity will improve the ability of models to resolve regional patterns in carbon export and, hence, the oceans' contribution to the global carbon cycle will be predicted more accurately.	[Tamelander, Tobias; Reigstad, Marit; Wassmann, Paul] Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway; [Olli, Kalle] Univ Tartu, Inst Ecol & Earth Sci, EE-50090 Tartu, Estonia; [Slagstad, Dag] SINTEF Fisheries & Aquaculture, Trondheim, Norway	UiT The Arctic University of Tromso; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; SINTEF	Tamelander, T (corresponding author), CSIC, Inst Marine Sci, Barcelona, Catalonia, Spain.	tobtam@gmail.com	Reigstad, Marit/AFL-8306-2022; Olli, Kalle/G-5389-2010; Reigstad, Marit/B-2497-2013	Reigstad, Marit/0000-0002-8592-7192; Olli, Kalle/0000-0002-7943-5714; Reigstad, Marit/0000-0002-8592-7192	Research Council of Norway [184860/S30 MERCLIM]; Tromso forskningsstiftelse through the project CONFLUX	Research Council of Norway(Research Council of Norway); Tromso forskningsstiftelse through the project CONFLUX	This study was financed by the Research Council of Norway (http://www.forskningsradet.no) through the project 184860/S30 MERCLIM (T.T., D.S., P.W.) and by Tromso forskningsstiftelse through the project CONFLUX (M.R., D.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Salgado XA, 2002, DEEP-SEA RES PT I, V49, P1725, DOI 10.1016/S0967-0637(02)00094-8; Andreassen I, 1996, MAR ECOL PROG SER, V137, P215, DOI 10.3354/meps137215; Andreassen IJ, 1999, SARSIA, V84, P227, DOI 10.1080/00364827.1999.10420428; Babiker IS, 2004, J OCEANOGR, V60, P553, DOI 10.1023/B:JOCE.0000038348.66907.db; Bauerfeind E, 2005, J MARINE SYST, V56, P151, DOI 10.1016/j.jmarsys.2004.09.007; Bauerfeind E, 1997, J MARINE SYST, V10, P371, DOI 10.1016/S0924-7963(96)00069-3; Bhaskar PV, 2005, FEMS MICROBIOL ECOL, V53, P255, DOI 10.1016/j.femsec.2004.12.013; Boyd PW, 2007, PROG OCEANOGR, V72, P276, DOI 10.1016/j.pocean.2006.10.007; Boyd PW, 1999, DEEP-SEA RES PT II, V46, P2761, DOI 10.1016/S0967-0645(99)00083-1; Cianca A, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003788; Conte MH, 2001, DEEP-SEA RES PT II, V48, P1471, DOI 10.1016/S0967-0645(00)00150-8; Coppola L, 2002, MAR CHEM, V80, P11, DOI 10.1016/S0304-4203(02)00071-3; Duarte CM, 2000, MAR ECOL PROG SER, V206, P87, DOI 10.3354/meps206087; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196, DOI 10.4319/lo.1967.12.2.0196; Dutkiewicz S., 2009, GLOBAL BIOGEOCHEM CY, V23; Ellingsen I, 2009, OCEAN DYNAM, V59, P1095, DOI 10.1007/s10236-009-0230-5; Emerson S, 1997, NATURE, V389, P951, DOI 10.1038/40111; EPPLEY RW, 1979, NATURE, V282, P677, DOI 10.1038/282677a0; Falkowski P.G., 2013, AQUATIC PHOTOSYNTHES; Forest A, 2010, DEEP-SEA RES PT I, V57, P125, DOI 10.1016/j.dsr.2009.10.002; Gasol JM, 1997, LIMNOL OCEANOGR, V42, P1353, DOI 10.4319/lo.1997.42.6.1353; Hargrave BT, 2002, DEEP-SEA RES PT II, V49, P5227, DOI 10.1016/S0967-0645(02)00187-X; Hegseth EN, 2008, J MARINE SYST, V74, P108, DOI 10.1016/j.jmarsys.2007.11.011; Jakobsson M, 2004, ORGANIC CARBON CYCLE IN THE ARCTIC OCEAN, P1; Kawakami H, 2007, J OCEANOGR, V63, P967, DOI 10.1007/s10872-007-0081-y; Lamborg CH, 2008, DEEP-SEA RES PT II, V55, P1540, DOI 10.1016/j.dsr2.2008.04.011; Meiners K, 2003, MAR ECOL PROG SER, V248, P1, DOI 10.3354/meps248001; Neuer S, 2007, PROG OCEANOGR, V72, P1, DOI 10.1016/j.pocean.2006.08.001; Olli K, 2002, J MARINE SYST, V38, P189, DOI 10.1016/S0924-7963(02)00177-X; Olli K, 2001, PROG OCEANOGR, V51, P443, DOI 10.1016/S0079-6611(01)00079-9; Olli K, 2007, PROG OCEANOGR, V72, P84, DOI 10.1016/j.pocean.2006.08.002; Omta AW, 2009, J SEA RES, V62, P179, DOI 10.1016/j.seares.2009.06.005; OSCHLIES A, 2008, GLOBAL BIOGEOCHEM CY, V22; Reigstad M, 2007, BIOGEOCHEMISTRY, V83, P217, DOI 10.1007/s10533-007-9093-3; Reigstad M, 2008, DEEP-SEA RES PT II, V55, P2308, DOI 10.1016/j.dsr2.2008.05.007; Sakshaug E, 2004, ORGANIC CARBON CYCLE IN THE ARCTIC OCEAN, P57; Schneider B, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002184; Schneider B, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001871; Slagstad D, 1999, SARSIA, V84, P303, DOI 10.1080/00364827.1999.10420434; Sterner RW, 2008, LIMNOL OCEANOGR, V53, P1169, DOI 10.4319/lo.2008.53.3.1169; Sundfjord A, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003524; Tamelander T, 2012, MAR ECOL PROG SER, V459, P17, DOI 10.3354/meps09733; Tamelander T, 2009, POLAR BIOL, V32, P1261, DOI 10.1007/s00300-009-0622-5; THINGSTAD TF, 1995, MAR ECOL PROG SER, V117, P299, DOI 10.3354/meps117299; Tremblay JE, 2002, DEEP-SEA RES PT II, V49, P4927, DOI 10.1016/S0967-0645(02)00171-6; Tremblay JE, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004547; Wassmann P, 2006, J MARINE SYST, V59, P1, DOI 10.1016/j.jmarsys.2005.05.006; Wong CS, 2002, DEEP-SEA RES PT II, V49, P5717, DOI 10.1016/S0967-0645(02)00211-4	48	20	20	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54027	10.1371/journal.pone.0054027	http://dx.doi.org/10.1371/journal.pone.0054027			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342065	Green Published, gold			2022-12-25	WOS:000313682700077
J	Wu, DD; Chen, Y; Xu, C; Wang, K; Wang, HJ; Zheng, FY; Ma, D; Wang, GM				Wu, Dandan; Chen, Yang; Xu, Chen; Wang, Ke; Wang, Huijun; Zheng, Fengyun; Ma, Duan; Wang, Guomin			Characteristic Face: A Key Indicator for Direct Diagnosis of 22q11.2 Deletions in Chinese Velocardiofacial Syndrome Patients	PLOS ONE			English	Article							CARDIO-FACIAL SYNDROME; CHROMOSOME 22Q11.2; MICRODUPLICATION 22Q11.2; PHENOTYPE CORRELATION; CLINICAL-FEATURES; DIGEORGE-SYNDROME; CLEFT-PALATE; TBX1; ANOMALIES; SPECTRUM	Velocardiofacial syndrome (VCFS) is a disease in human with an expansive phenotypic spectrum and diverse genetic mechanisms mainly associated with copy number variations (CNVs) on 22q11.2 or other chromosomes. However, the correlations between CNVs and phenotypes remain ambiguous. This study aims to analyze the types and sizes of CNVs in VCFS patients, to define whether correlations exist between CNVs and clinical manifestations in Chinese VCFS patients. In total, 55 clinically suspected Chinese VCFS patients and 100 normal controls were detected by multiplex ligation-dependent probe amplification (MLPA). The data from MLPA and all the detailed clinical features of the objects were documented and analyzed. A total of 44 patients (80.0%) were diagnosed with CNVs on 22q11.2. Among them, 43 (78.2%) presented with 22q11.2 heterozygous deletions, of whom 40 (93.0%) had typical 3-Mb deletion, and 3 (7.0%) exhibited proximal 1.5-Mb deletion; no patient was found with atypical deletion on 22q11.2. One patient (1.8%) presented with a 3-Mb duplication mapping to the typical 3-Mb region on 22q11.2, while none of the chromosomal abnormalities in the MLPA kit were found in the other 11 patients and 100 normal controls. All the 43 patients with 22q11.2 deletions displayed characteristic face and palatal anomalies; 37 of them (86.0%) had cognitive or behavioral disorders, and 23 (53.5%) suffered from immune deficiencies; 10 patients (23.3%) manifested congenital heart diseases. Interestingly, all patients with the characteristic face had 22q11.2 heterozygous deletions, but no difference in phenotypic spectrum was observed between 3-Mb and 1.5-Mb deletions. Our data suggest that the characteristic face can be used as a key indicator for direct diagnosis of 22q11.2 deletions in Chinese VCFS patients.	[Wu, Dandan; Chen, Yang; Xu, Chen; Wang, Guomin] Shanghai Jiao Tong Univ, Shanghai Key Lab Stomatol, Dept Oral & Craniomaxillofacial Sci, Shanghai Peoples Hosp 9,Coll Stomatol,Sch Med, Shanghai 200030, Peoples R China; [Wang, Ke] Qingdao Univ, Sch Med, Affiliated Hosp, Dept Oral & Maxillofacial Surg, Qingdao 266071, Peoples R China; [Wang, Huijun; Ma, Duan] Fudan Univ, Childrens Hosp, Shanghai 200433, Peoples R China; [Zheng, Fengyun; Ma, Duan] Fudan Univ, Shanghai Med Coll, Inst Med Sci,Key Lab Mol Med, Dept Biochem & Mol Biol,Minist Educ, Shanghai 200433, Peoples R China	Shanghai Jiao Tong University; Qingdao University; Fudan University; Fudan University	Ma, D (corresponding author), Fudan Univ, Childrens Hosp, Shanghai 200433, Peoples R China.	duanma@yahoo.cn; guomin@sh163.net	wang, huimin/HDM-8421-2022; wang, hui/GRS-4730-2022; Ma, Duan/I-8330-2014		National Natural Science Foundation of China [81070813]; Nation Science Supporting Plan [2006BAI5A09]; Hospital Foundation of Shanghai Ninth People's Hospital [201212]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nation Science Supporting Plan; Hospital Foundation of Shanghai Ninth People's Hospital	This study was supported by the funds from National Natural Science Foundation of China (No. 81070813), Nation Science Supporting Plan (No. 2006BAI5A09), and Hospital Foundation of Shanghai Ninth People's Hospital (No. 201212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett AS, 2005, AM J MED GENET A, V138A, P307, DOI 10.1002/ajmg.a.30984; Conti E, 2003, EUR J HUM GENET, V11, P349, DOI 10.1038/sj.ejhg.5200956; Devriendt K, 1995, ANN GENET-PARIS, V38, P228; Driscoll DA, 2006, CLEFT PALATE-CRAN J, V43, P435; Emanuel BS, 2008, DEV DISABIL RES REV, V14, P11, DOI 10.1002/ddrr.3; Ensenauer RE, 2003, AM J HUM GENET, V73, P1027, DOI 10.1086/378818; Fernandez L, 2008, AM J MED GENET A, V146A, P1134, DOI 10.1002/ajmg.a.32256; Friedman MA, 2011, INT J PEDIATR OTORHI, V75, P1167, DOI 10.1016/j.ijporl.2011.06.013; Gong W, 2001, J Med Genet, V38, pE45, DOI 10.1136/jmg.38.12.e45; Gothelf D, 2009, J MENT HEALTH RES IN, V2, P149, DOI 10.1080/19315860902756136; GREENBERG F, 1988, AM J MED GENET, V31, P1, DOI 10.1002/ajmg.1320310102; Jalali GR, 2008, HUM MUTAT, V29, P433, DOI 10.1002/humu.20640; Kitsiou-Tzeli S, 2004, IN VIVO, V18, P603; Kobrynski LJ, 2007, LANCET, V370, P1443, DOI 10.1016/S0140-6736(07)61601-8; LIPSON AH, 1991, J MED GENET, V28, P596, DOI 10.1136/jmg.28.9.596; Looman WS, 2010, CLEFT PALATE-CRAN J, V47, P273, DOI [10.1597/09-009.1, 10.5555/09-009.1]; Lundin J, 2010, EUR J MED GENET, V53, P61, DOI 10.1016/j.ejmg.2009.11.004; McDonald-McGinn DM, 2005, AM J MED GENET A, V134A, P242, DOI 10.1002/ajmg.a.30069; McDonald-McGinn DM, 2011, MEDICINE, V90, P1, DOI 10.1097/MD.0b013e3182060469; Oh AK, 2007, CLEFT PALATE-CRAN J, V44, P62, DOI 10.1597/05-192; Ou Z, 2008, GENET MED, V10, P267, DOI 10.1097/GIM.0b013e31816b64c2; Paylor R, 2006, BIOL PSYCHIAT, V59, P1172, DOI 10.1016/j.biopsych.2006.01.018; Paylor R, 2006, P NATL ACAD SCI USA, V103, P7729, DOI 10.1073/pnas.0600206103; Portnoi MF, 2009, EUR J MED GENET, V52, P88, DOI 10.1016/j.ejmg.2009.02.008; Rauch A, 2005, J MED GENET, V42, P871, DOI 10.1136/jmg.2004.030619; Robin NH, 2005, J PEDIATR-US, V147, P90, DOI 10.1016/j.jpeds.2005.03.007; Sandrin-Garcia P, 2007, MOL CELL BIOCHEM, V303, P9, DOI 10.1007/s11010-007-9450-5; Sandrin-Garcia P, 2007, GENET MOL BIOL, V30, P21, DOI 10.1590/S1415-47572007000100006; Scambler PJ, 2000, HUM MOL GENET, V9, P2421, DOI 10.1093/hmg/9.16.2421; Shprintzen RJ, 2000, MENT RETARD DEV D R, V6, P142, DOI 10.1002/1098-2779(2000)6:2<142::AID-MRDD9>3.0.CO;2-H; SHPRINTZEN RJ, 1978, CLEFT PALATE J, V15, P56; Shprintzen RJ, 2008, DEV DISABIL RES REV, V14, P3, DOI 10.1002/ddrr.2; Tsai CH, 1999, AM J MED GENET, V82, P336, DOI 10.1002/(SICI)1096-8628(19990212)82:4<336::AID-AJMG11>3.3.CO;2-9; Van Esch H, 1999, GENET COUNSEL, V10, P59; Vorstman JAS, 2006, HUM MUTAT, V27, P814, DOI 10.1002/humu.20330; Wentzel C, 2008, EUR J MED GENET, V51, P501, DOI 10.1016/j.ejmg.2008.07.005; Xu YJ, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-169; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6; Yatsenko SA, 2004, CLIN GENET, V66, P128, DOI 10.1111/j.1399-0004.2004.00290.x; Zweier C, 2007, AM J HUM GENET, V80, P510, DOI 10.1086/511993	40	18	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54404	10.1371/journal.pone.0054404	http://dx.doi.org/10.1371/journal.pone.0054404			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342150	Green Published, Green Submitted, gold			2022-12-25	WOS:000313682700114
J	Yuan, Y; Wang, KY; Li, DZ; Pan, Y; Lv, YY; Zhao, MX; Gao, JJ				Yuan, Yue; Wang, Kaiyun; Li, Dezhi; Pan, Yu; Lv, Yuanyuan; Zhao, Meixia; Gao, JinJin			Interspecific Interactions between Phragmites australis and Spartina alterniflora along a Tidal Gradient in the Dongtan Wetland, Eastern China	PLOS ONE			English	Article							YANGTZE-RIVER ESTUARY; ENVIRONMENTAL-FACTORS; NUTRIENT LIMITATION; INVASIVE SPARTINA; SALT-MARSHES; COMPETITION; GROWTH; VEGETATION; SALINITY; FACILITATION	The invasive species Spartina alterniora Loisel was introduced to the eastern coast of China in the 1970s and 1980s for the purposes of land reclamation and the prevention of soil erosion. The resulting interspecific competition had an important influence on the distribution of native vegetation, which makes studying the patterns and mechanisms of the interactions between Spartina alterniora Loisel and the native species Phragmites australis (Cav.) Trin ex Steud in this region very important. There have been some researches on the interspecific interactions between P. australis and S. alterniora in the Dongtan wetland of Chongming, east China, most of which has focused on the comparison of their physiological characteristics. In this paper, we conducted a neighbor removal experiment along a tidal gradient to evaluate the relative competitive abilities of the two species by calculating their relative neighbor effect (RNE) index. We also looked at the influence of environmental stress and disturbance on the competitive abilities of the two species by comparing interaction strength (I) among different tidal zones both for P. australis and S. alterniora. Finally, we measured physiological characteristics of the two species to assess the physiological mechanisms behind their different competitive abilities. Both negative and positive interactions were found between P. australis and S. alterniora along the environmental gradient. When the direction of the competitive intensity index for P. australis and S. alterniora was consistent, the competitive or facilitative effect of S. alterniora on P. australis was stronger than that of P. australis on S. alterniora. The interspecific interactions of P. australis and S. alterniora varied with environmental conditions, as well as with the method used, to measure interspecific interactions.	[Yuan, Yue; Wang, Kaiyun; Li, Dezhi] E China Normal Univ, Key Lab Urbanizat & Ecol Restorat, Shanghai 200062, Peoples R China; [Li, Dezhi] E China Normal Univ, Natl Field Observat & Res Stn Tiantong Forest Eco, Ningbo, Zhejiang, Peoples R China; [Yuan, Yue; Li, Dezhi; Pan, Yu; Lv, Yuanyuan; Zhao, Meixia; Gao, JinJin] E China Normal Univ, Dept Environm Sci, Shanghai 200062, Peoples R China	East China Normal University; East China Normal University; East China Normal University	Wang, KY (corresponding author), E China Normal Univ, Key Lab Urbanizat & Ecol Restorat, Shanghai 200062, Peoples R China.	1123686641@qq.com; dzli@des.ecnu.edu.cn		Yuan, Yue/0000-0002-2124-8887	National Key Technologies Research and Development Program of China [2006BAC01A14]; project of NSFC [31170387]	National Key Technologies Research and Development Program of China(National Key Technology R&D Program); project of NSFC(National Natural Science Foundation of China (NSFC))	This work was funded by the National Key Technologies Research and Development Program of China during the 11th Five-Year Plan Period (No. 2006BAC01A14) and a project of NSFC (No. 31170387). Web site: http://program.most.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, CHIN AGR SCI B; Bertness MD, 1997, ECOLOGY, V78, P1976, DOI 10.1890/0012-9658(1997)078[1976:TROPII]2.0.CO;2; BERTNESS MD, 1994, AM NAT, V144, P363, DOI 10.1086/285681; BERTNESS MD, 1991, ECOLOGY, V72, P125, DOI 10.2307/1938908; Bockelmann AC, 2002, AQUAT BOT, V73, P211, DOI 10.1016/S0304-3770(02)00022-0; Burdick DM, 2001, ENVIRON EXP BOT, V46, P247, DOI 10.1016/S0098-8472(01)00099-5; BUTTERY BR, 1965, J ECOL, V53, P163, DOI 10.2307/2257575; Callaway RM, 2000, AM NAT, V156, P416, DOI 10.1086/303398; Celmmbers RM, 2003, CONSERV BIOL, V26, P398; Chambers RM, 2002, MAR ECOL PROG SER, V239, P83, DOI 10.3354/meps239083; Chen JQ, 2008, J PLANT ECOL, V1, P79, DOI 10.1093/jpe/rtn007; Cheng XL, 2006, SOIL BIOL BIOCHEM, V38, P3380, DOI 10.1016/j.soilbio.2006.05.016; CURTIS JT, 1951, ECOLOGY, V32, P345, DOI 10.2307/1930427; D-r Xiao, 2010, THESIS E CHINA N U; Deng ZF, 2008, ESTUAR COAST SHELF S, V76, P818, DOI 10.1016/j.ecss.2007.08.008; Emery NC, 2001, ECOLOGY, V82, P2471, DOI 10.1890/0012-9658(2001)082[2471:CASMPZ]2.0.CO;2; Franks SJ, 2003, PLANT ECOL, V168, P13, DOI 10.1023/A:1024450623205; Franks SJ, 2003, CAN J BOT, V81, P330, DOI [10.1139/B03-023, 10.1139/b03-023]; G-q Zhao, 2005, ASSESSMENT WETLAND E; Gan XJ, 2009, ESTUAR COAST SHELF S, V83, P211, DOI 10.1016/j.ecss.2009.03.026; Gao Y, 2009, ECOL RES, V24, P1033, DOI 10.1007/s11284-008-0577-y; [高宇 GAO Yu], 2007, [生态学报, Acta Ecologica Sinica], V27, P3752; Goldberg D, 1997, J ECOL, V85, P409, DOI 10.2307/2960565; Gratton C, 2005, RESTOR ECOL, V13, P358, DOI 10.1111/j.1526-100X.2005.00045.x; Gusewell S, 2005, FUNCT ECOL, V19, P582, DOI 10.1111/j.1365-2435.2005.01002.x; Hastings A, 2006, THEOR POPUL BIOL, V70, P431, DOI 10.1016/j.tpb.2006.05.003; Holomuzki JR, 2010, WETL ECOL MANAG, V18, P219, DOI 10.1007/s11273-009-9161-7; Huckle JM, 2000, J ECOL, V88, P492, DOI 10.1046/j.1365-2745.2000.00464.x; Jiang LF, 2009, ESTUAR COAST SHELF S, V81, P74, DOI 10.1016/j.ecss.2008.09.018; Kang H, 2009, GUANGXI SCI, V12, P451; Klimes L, 2000, FOLIA GEOBOT, V35, P403, DOI 10.1007/BF02803552; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; La Peyre MKG, 2001, ECOLOGY, V82, P62, DOI 10.2307/2680086; Levine JM, 2000, ECOLOGY, V81, P3431, DOI 10.1890/0012-9658(2000)081[3431:CIIASP]2.0.CO;2; Li B, 2009, ECOL ENG, V35, P511, DOI 10.1016/j.ecoleng.2008.05.013; [李富荣 LI Furong], 2007, [生态环境, Ecology and Environment], V16, P1795; [梁霞 LIANG Xia], 2006, [生态学报, Acta Ecologica Sinica], V26, P842; Ma ZJ, 2009, ENVIRON MANAGE, V43, P1187, DOI 10.1007/s00267-008-9247-7; Markham JH, 1996, FUNCT ECOL, V10, P548; Mozdzer TJ, 2010, ESTUAR COAST, V33, P784, DOI 10.1007/s12237-009-9254-9; Ngai JT, 2004, J ECOL, V92, P1001, DOI 10.1111/j.0022-0477.2004.00926.x; Quan WM, 2007, MAR ENVIRON RES, V64, P21, DOI 10.1016/j.marenvres.2006.12.005; R-h Peng, 2009, THESIS FUDAN U SHANG; READER RJ, 1994, ECOLOGY, V75, P1753, DOI 10.2307/1939634; Rebele F, 2000, PLANT ECOL, V147, P77, DOI 10.1023/A:1009808810378; Saltonstall K, 2007, AQUAT BOT, V86, P331, DOI 10.1016/j.aquabot.2006.12.003; Sammul M, 2000, OECOLOGIA, V125, P18, DOI 10.1007/PL00008887; SCHUPP EW, 1995, AM J BOT, V82, P399, DOI 10.2307/2445586; Silliman BR, 2004, CONSERV BIOL, V18, P1424, DOI 10.1111/j.1523-1739.2004.00112.x; Vasquez EA, 2006, AM J BOT, V93, P1784, DOI 10.3732/ajb.93.12.1784; Wang C, 2009, EFFECTS ENV VARIATIO; Wang Q, 2006, BIOL INVASIONS, V8, P1547, DOI 10.1007/s10530-005-5846-x; Wang Q, 2007, J NANJING U, V43, P15; Warren RS, 2001, ESTUARIES, V24, P90, DOI 10.2307/1352816; Weigelt A, 2003, J ECOL, V91, P707, DOI 10.1046/j.1365-2745.2003.00805.x; Welch Bradley A., 2006, Wetlands Ecology and Management, V14, P511, DOI 10.1007/s11273-006-9004-8; Williams AC, 2001, ECOL RES, V16, P29, DOI 10.1046/j.1440-1703.2001.00368.x; Wilson MV, 2007, J ECOL, V95, P301, DOI 10.1111/j.1365-2745.2007.01215.x; Windham L., 1999, Biological Invasions, V1, P137, DOI 10.1023/A:1010016319074; Windham L, 1999, ESTUARIES, V22, P927, DOI 10.2307/1353072; Xiao DR, 2009, ESTUAR COAST SHELF S, V83, P105, DOI 10.1016/j.ecss.2009.03.024; [肖强 Xiao Qiang], 2005, [生态学杂志, Chinese Journal of Ecology], V24, P373; Yang XG, 2008, PROG NAT SCI-MATER, V18, P901, DOI 10.1016/j.pnsc.2008.01.032; Yuan L, 2008, ACTA ECOLOGICA SINIC, V28, P5724; Zedler JB, 2004, CRIT REV PLANT SCI, V23, P431, DOI 10.1080/07352680490514673; Zeng DeHui, 2005, Acta Phytoecologica Sinica, V29, P1007; Zhao B, 2009, ECOL INDIC, V9, P346, DOI 10.1016/j.ecolind.2008.05.009; Zhao Cong-Jiao, 2008, Zhiwu Shengtai Xuebao, V32, P392, DOI 10.3773/j.issn.1005-264x.2008.02.017; Zhao YJ, 2010, HYDROBIOLOGIA, V637, P143, DOI 10.1007/s10750-009-9992-5	69	16	16	5	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53843	10.1371/journal.pone.0053843	http://dx.doi.org/10.1371/journal.pone.0053843			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342017	Green Published, gold, Green Submitted			2022-12-25	WOS:000313682700050
J	Yuzefovych, LV; Musiyenko, SI; Wilson, GL; Rachek, LI				Yuzefovych, Larysa V.; Musiyenko, Sergiy I.; Wilson, Glenn L.; Rachek, Lyudmila I.			Mitochondrial DNA Damage and Dysfunction, and Oxidative Stress Are Associated with Endoplasmic Reticulum Stress, Protein Degradation and Apoptosis in High Fat Diet-Induced Insulin Resistance Mice	PLOS ONE			English	Article							SKELETAL-MUSCLE CELLS; KINASE ACTIVATION; LIPID-CONTENT; PALMITATE; OBESITY; LIVER; EXPRESSION; AUTOPHAGY; DISEASE; RODENTS	Background: Recent studies showed a link between a high fat diet (HFD)-induced obesity and lipid accumulation in non-adipose tissues, such as skeletal muscle and liver, and insulin resistance (IR). Although the mechanisms responsible for IR in those tissues are different, oxidative stress and mitochondrial dysfunction have been implicated in the disease process. We tested the hypothesis that HFD induced mitochondrial DNA (mtDNA) damage and that this damage is associated with mitochondrial dysfunction, oxidative stress, and induction of markers of endoplasmic reticulum (ER) stress, protein degradation and apoptosis in skeletal muscle and liver in a mouse model of obesity-induced IR. Methodology/Principal Findings: C57BL/6J male mice were fed either a HFD (60% fat) or normal chow (NC) (10% fat) for 16 weeks. We found that HFD-induced IR correlated with increased mtDNA damage, mitochondrial dysfunction and markers of oxidative stress in skeletal muscle and liver. Also, a HFD causes a change in the expression level of DNA repair enzymes in both nuclei and mitochondria in skeletal muscle and liver. Furthermore, a HFD leads to activation of ER stress, protein degradation and apoptosis in skeletal muscle and liver, and significantly reduced the content of two major proteins involved in insulin signaling, Akt and IRS-1 in skeletal muscle, and Akt in liver. Basal p-Akt level was not significantly influenced by HFD feeding in skeletal muscle and liver. Conclusions/Significance: This study provides new evidence that HFD-induced mtDNA damage correlates with mitochondrial dysfunction and increased oxidative stress in skeletal muscle and liver, which is associated with the induction of markers of ER stress, protein degradation and apoptosis.	[Yuzefovych, Larysa V.; Musiyenko, Sergiy I.; Wilson, Glenn L.; Rachek, Lyudmila I.] Univ S Alabama, Dept Neurosci & Cell Biol, Mobile, AL 36688 USA	University of South Alabama	Rachek, LI (corresponding author), Univ S Alabama, Dept Neurosci & Cell Biol, Mobile, AL 36688 USA.	lrachek@jaguar1.usouthal.edu			National Institutes of Health [DK073808]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by National Institutes of Health Grants DK073808 (L.I.R.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Anderwald C, 2002, DIABETES, V51, P3025, DOI 10.2337/diabetes.51.10.3025; ANTONETTI DA, 1995, J CLIN INVEST, V95, P1383, DOI 10.1172/JCI117790; Boden G, 2001, DIABETES, V50, P1612, DOI 10.2337/diabetes.50.7.1612; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Crunkhorn S, 2007, J BIOL CHEM, V282, P15439, DOI 10.1074/jbc.M611214200; Csordas G, 2009, BBA-BIOENERGETICS, V1787, P1352, DOI 10.1016/j.bbabio.2009.06.004; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Deldicque L, 2010, AM J PHYSIOL-ENDOC M, V299, pE695, DOI 10.1152/ajpendo.00038.2010; Driggers WJ, 1997, NUCLEIC ACIDS RES, V25, P4362, DOI 10.1093/nar/25.21.4362; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Grishko V. I., 2007, FREE RADIC BIOL MED, V38, P755; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; Hoehn KL, 2009, P NATL ACAD SCI USA, V106, P17787, DOI 10.1073/pnas.0902380106; Holmstrom MH, 2012, AM J PHYSIOL-ENDOC M, V302, pE731, DOI 10.1152/ajpendo.00159.2011; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Kaneto H, 2005, J MOL MED, V83, P429, DOI 10.1007/s00109-005-0640-x; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rachek LI, 2007, ENDOCRINOLOGY, V148, P293, DOI 10.1210/en.2006-0998; Rector RS, 2010, J HEPATOL, V52, P727, DOI 10.1016/j.jhep.2009.11.030; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Sishi B, 2011, EXP PHYSIOL, V96, P179, DOI 10.1113/expphysiol.2010.054189; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Turpin SM, 2009, J PHYSIOL-LONDON, V587, P1593, DOI 10.1113/jphysiol.2008.166033; Tyrberg Bjorn, 2002, BMC Endocr Disord, V2, P2, DOI 10.1186/1472-6823-2-2; Vives-Bauza C, 2007, METHOD CELL BIOL, V80, P155, DOI 10.1016/S0091-679X(06)80007-5; Wang Y, 2008, J NUTR, V138, P1866, DOI 10.1093/jn/138.10.1866; Xu WM, 2004, NAT CELL BIOL, V6, P1129, DOI 10.1038/ncb1188; Yuzefovych L, 2010, AM J PHYSIOL-ENDOC M, V299, pE1096, DOI 10.1152/ajpendo.00238.2010; Yuzefovych LV, 2012, ENDOCRINOLOGY, V153, P92, DOI 10.1210/en.2011-1442	35	191	198	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54059	10.1371/journal.pone.0054059	http://dx.doi.org/10.1371/journal.pone.0054059			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342074	Green Submitted, Green Published, gold			2022-12-25	WOS:000313682700081
J	Christopherson, MR; Suen, G; Bramhacharya, S; Jewell, KA; Aylward, FO; Mead, D; Brumm, PJ				Christopherson, Melissa R.; Suen, Garret; Bramhacharya, Shanti; Jewell, Kelsea A.; Aylward, Frank O.; Mead, David; Brumm, Phillip J.			The Genome Sequences of Cellulomonas fimi and "Cellvibrio gilvus" Reveal the Cellulolytic Strategies of Two Facultative Anaerobes, Transfer of "Cellvibrio gilvus" to the Genus Cellulomonas, and Proposal of Cellulomonas gilvus sp nov	PLOS ONE			English	Article							PROTEIN; CELLULASE; ENZYME; PURIFICATION; FLAVIGENA; BACTERIUM; IDENTIFICATION; GROWTH; GENES; CELLOBIOHYDROLASE	Actinobacteria in the genus Cellulomonas are the only known and reported cellulolytic facultative anaerobes. To better understand the cellulolytic strategy employed by these bacteria, we sequenced the genome of the Cellulomonas fimi ATCC 484(T). For comparative purposes, we also sequenced the genome of the aerobic cellulolytic "Cellvibrio gilvus" ATCC 13127(T). An initial analysis of these genomes using phylogenetic and whole-genome comparison revealed that "Cellvibrio gilvus" belongs to the genus Cellulomonas. We thus propose to assign "Cellvibrio gilvus" to the genus Cellulomonas. A comparative genomics analysis between these two Cellulomonas genome sequences and the recently completed genome for Cellulomonas flavigena ATCC 482(T) showed that these cellulomonads do not encode cellulosomes but appear to degrade cellulose by secreting multi-domain glycoside hydrolases. Despite the minimal number of carbohydrate-active enzymes encoded by these genomes, as compared to other known cellulolytic organisms, these bacteria were found to be proficient at degrading and utilizing a diverse set of carbohydrates, including crystalline cellulose. Moreover, they also encode for proteins required for the fermentation of hexose and xylose sugars into products such as ethanol. Finally, we found relatively few significant differences between the predicted carbohydrate-active enzymes encoded by these Cellulomonas genomes, in contrast to previous studies reporting differences in physiological approaches for carbohydrate degradation. Our sequencing and analysis of these genomes sheds light onto the mechanism through which these facultative anaerobes degrade cellulose, suggesting that the sequenced cellulomonads use secreted, multidomain enzymes to degrade cellulose in a way that is distinct from known anaerobic cellulolytic strategies.	[Christopherson, Melissa R.; Suen, Garret; Bramhacharya, Shanti; Jewell, Kelsea A.; Aylward, Frank O.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Aylward, Frank O.; Mead, David; Brumm, Phillip J.] Univ Wisconsin, Dept Energy, Great Lakes Bioenergy Res Ctr, Madison, WI 53715 USA; [Mead, David] Lucigen, Middleton, WI USA; [Brumm, Phillip J.] C5 6 Technol, Middleton, WI USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison	Brumm, PJ (corresponding author), Univ Wisconsin, Dept Energy, Great Lakes Bioenergy Res Ctr, Madison, WI 53715 USA.	pbrumm@c56technologies.com	Suen, Garret/AAF-2080-2019; Jewell, Kelsea/AGG-9303-2022	Suen, Garret/0000-0002-6170-711X; MEAD, David/0000-0003-1982-9356; Aylward, Frank/0000-0002-1279-4050	DOE Great Lakes Bioenergy Research Center (GLBRC) (DOE BER Office of Science) [DE-FC02-07ER64494]; DOE BER Early Career Research Program [DE-SC0008104]; Wisconsin Bioenergy Initiative; DOE GLBRC/BACTER; Office of Science of the US Department of Energy [DE-AC02-05CH11231]; GLBRC	DOE Great Lakes Bioenergy Research Center (GLBRC) (DOE BER Office of Science)(United States Department of Energy (DOE)); DOE BER Early Career Research Program(United States Department of Energy (DOE)); Wisconsin Bioenergy Initiative; DOE GLBRC/BACTER(United States Department of Energy (DOE)); Office of Science of the US Department of Energy(United States Department of Energy (DOE)); GLBRC	This work was funded in part by the DOE Great Lakes Bioenergy Research Center (GLBRC) (DOE BER Office of Science DE-FC02-07ER64494) supporting FOA, DM, and PJB. This work was also supported by a DOE BER Early Career Research Program Award DE-SC0008104 and funding from the Wisconsin Bioenergy Initiative to GS. MRC was supported by a DOE GLBRC/BACTER Post-doctoral Research Fellowship. The work conducted by the US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under Contract No. DE-AC02-05CH11231. All work performed by employees of Lucigen or C5-6 Technologies was performed under and supported by subcontract to the GLBRC. Neither corporation was a funder of the work; no funds of either corporation was used for this research or to support the researchers during performance of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt B, 2010, STAND GENOMIC SCI, V3, P15, DOI 10.4056/sigs.1012662; AKHTAR MW, 1988, GENE, V74, P549, DOI 10.1016/0378-1119(88)90188-6; Anderson I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039331; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bacic A, 2009, CHEMISTRY, BIOCHEMISTRY, AND BIOLOGY OF (1-->3)-BETA-GLUCANS AND RELATED POLYSACCHARIDES, P1; Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; Berger E, 2007, FEMS MICROBIOL LETT, V268, P194, DOI 10.1111/j.1574-6968.2006.00583.x; BISHOP DHL, 1962, BIOCHEM J, V83, P606, DOI 10.1042/bj0830606; BREUIL C, 1976, CAN J MICROBIOL, V22, P1776, DOI 10.1139/m76-264; Buller C. S., 1990, US patent, Patent No. [4,908,310, 4908310]; CHOI WY, 1978, AUST J BIOL SCI, V31, P553, DOI 10.1071/BI9780553; Claudel-Renard C, 2003, NUCLEIC ACIDS RES, V31, P6633, DOI 10.1093/nar/gkg847; CLEMMER JE, 1986, BIOTECHNOL LETT, V8, P823, DOI 10.1007/BF01020832; Deboy RT, 2008, J BACTERIOL, V190, P5455, DOI 10.1128/JB.01701-07; DERMOUN Z, 1988, J BACTERIOL, V170, P2827, DOI 10.1128/jb.170.6.2827-2831.1988; DIN N, 1990, ARCH MICROBIOL, V153, P129, DOI 10.1007/BF00247809; Doi RH, 2004, NAT REV MICROBIOL, V2, P541, DOI 10.1038/nrmicro925; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Ewing RM, 1998, PLANT MOL BIOL, V36, P593, DOI 10.1023/A:1005947306667; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gao DH, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-5; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Graham JE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1373; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; HAGA K, 1991, AGR BIOL CHEM TOKYO, V55, P1959, DOI 10.1080/00021369.1991.10870897; Han C., 2006, P 2006 INT C BIOINF, P141; Hazlewood GP, 1998, BIOCHEM SOC T, V26, P185, DOI 10.1042/bst0260185; Himmel ME, 2010, BIOFUELS-UK, V1, P323, DOI 10.4155/bfs.09.25; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HULCHER FH, 1958, J BACTERIOL, V76, P565, DOI 10.1128/JB.76.6.565-570.1958; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Johnson PE, 1996, BIOCHEMISTRY-US, V35, P13895, DOI 10.1021/bi961186a; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Keddie KM, 1974, BERGEYS MANUAL DETER; Kenyon WJ, 2005, ANTON LEEUW INT J G, V87, P143, DOI 10.1007/s10482-004-2346-4; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lalioui L, 2005, INFECT IMMUN, V73, P3342, DOI 10.1128/IAI.73.6.3342-3350.2005; LAMED R, 1987, J BACTERIOL, V169, P3792, DOI 10.1128/jb.169.8.3792-3800.1987; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MEINKE A, 1994, MOL MICROBIOL, V12, P413, DOI 10.1111/j.1365-2958.1994.tb01030.x; Mejia-Castillo T, 2008, BIOTECHNOL LETT, V30, P681, DOI 10.1007/s10529-007-9589-x; Nataf Y, 2009, J BACTERIOL, V191, P203, DOI 10.1128/JB.01190-08; Novick RP, 2000, TRENDS MICROBIOL, V8, P148, DOI 10.1016/S0966-842X(00)01741-8; ONEILL GP, 1986, GENE, V44, P331, DOI 10.1016/0378-1119(86)90198-8; OWOLABI JB, 1988, APPL ENVIRON MICROB, V54, P518, DOI 10.1128/AEM.54.2.518-523.1988; Perez-Avalos O, 2008, CURR MICROBIOL, V57, P39, DOI 10.1007/s00284-008-9149-1; Pokusaeva K, 2011, APPL ENVIRON MICROB, V77, P1681, DOI 10.1128/AEM.01786-10; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; SAMI AJ, 1990, BIOCHEM SOC T, V18, P651, DOI 10.1042/bst0180651; Santiago-Hernandez A, 2007, J IND MICROBIOL BIOT, V34, P331, DOI 10.1007/s10295-006-0202-4; SCHAFER ML, 1965, J BACTERIOL, V89, P113, DOI 10.1128/JB.89.1.113-116.1965; SHEN H, 1995, BIOCHEM J, V311, P67, DOI 10.1042/bj3110067; Siriwardana LS, 2011, ANTON LEEUW INT J G, V99, P681, DOI 10.1007/s10482-010-9544-z; STACKEBRANDT E, 1979, INT J SYST BACTERIOL, V29, P273, DOI 10.1099/00207713-29-4-273; Stalbrand H, 1998, APPL ENVIRON MICROB, V64, P2374; STOPPOK W, 1982, APPL ENVIRON MICROB, V44, P44, DOI 10.1128/AEM.44.1.44-53.1982; STORVICK WO, 1963, BIOCHEMISTRY-US, V2, P1106, DOI 10.1021/bi00905a034; Suen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018814; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tomme P, 1996, J BACTERIOL, V178, P4216, DOI 10.1128/jb.178.14.4216-4223.1996; TROY FA, 1992, GLYCOBIOLOGY, V2, P5, DOI 10.1093/glycob/2.1.5; VLADUTTALOR M, 1986, ARCH MICROBIOL, V144, P191, DOI 10.1007/BF00410945; Watanabe H, 2001, CELL MOL LIFE SCI, V58, P1167, DOI 10.1007/PL00000931; WHITTLE DJ, 1982, GENE, V17, P139, DOI 10.1016/0378-1119(82)90066-X; Yi H, 2007, INT J SYST EVOL MICR, V57, P151, DOI 10.1099/ijs.0.64525-0; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	76	39	41	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53954	10.1371/journal.pone.0053954	http://dx.doi.org/10.1371/journal.pone.0053954			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342046	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400105
J	Dauplais, M; Lazard, M; Blanquet, S; Plateau, P				Dauplais, Marc; Lazard, Myriam; Blanquet, Sylvain; Plateau, Pierre			Neutralization by Metal Ions of the Toxicity of Sodium Selenide	PLOS ONE			English	Article							RAT PLASMA INVIVO; POSSIBLE MECHANISM; INORGANIC MERCURY; HYDROGEN-SULFIDE; CADMIUM; OXIDATION; CANCER; DETOXIFICATION; METHYLMERCURY; PREVENTION	Inert metal-selenide colloids are found in animals. They are believed to afford cross-protection against the toxicities of both metals and selenocompounds. Here, the toxicities of metal salt and sodium selenide mixtures were systematically studied using the death rate of Saccharomyces cerevisiae cells as an indicator. In parallel, the abilities of these mixtures to produce colloids were assessed. Studied metal cations could be classified in three groups: (i) metal ions that protect cells against selenium toxicity and form insoluble colloids with selenide (Ag+, Cd2+, Cu2+, Hg2+, Pb2+ and Zn2+), (ii) metal ions which protect cells by producing insoluble metal-selenide complexes and by catalyzing hydrogen selenide oxidation in the presence of dioxygen (Co2+ and Ni2+) and, finally, (iii) metal ions which do not afford protection and do not interact (Ca2+, Mg2+, Mn2+) or weakly interact (Fe2+) with selenide under the assayed conditions. When occurring, the insoluble complexes formed from divalent metal ions and selenide contained equimolar amounts of metal and selenium atoms. With the monovalent silver ion, the complex contained two silver atoms per selenium atom. Next, because selenides are compounds prone to oxidation, the stabilities of the above colloids were evaluated under oxidizing conditions. 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB), the reduction of which can be optically followed, was used to promote selenide oxidation. Complexes with cadmium, copper, lead, mercury or silver resisted dissolution by DTNB treatment over several hours. With nickel and cobalt, partial oxidation by DTNB occurred. On the other hand, when starting from ZnSe or FeSe complexes, full decompositions were obtained within a few tens of minutes. The above properties possibly explain why ZnSe and FeSe nanoparticles were not detected in animals exposed to selenocompounds.	[Dauplais, Marc; Lazard, Myriam; Blanquet, Sylvain; Plateau, Pierre] Ecole Polytech, CNRS, Biochim Lab, F-91128 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris	Plateau, P (corresponding author), Ecole Polytech, CNRS, Biochim Lab, F-91128 Palaiseau, France.	pierre.plateau@polytechnique.edu		Lazard, Myriam/0000-0002-7154-1352	CNRS; Ecole polytechnique	CNRS(Centre National de la Recherche Scientifique (CNRS)); Ecole polytechnique	This study was funded by the CNRS and the Ecole polytechnique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASETH J, 1981, SCAND J CLIN LAB INV, V41, P247, DOI 10.3109/00365518109092041; Arai T, 2004, ENVIRON SCI TECHNOL, V38, P6468, DOI 10.1021/es040367u; BLEEHEN SS, 1981, BRIT J DERMATOL, V104, P19, DOI 10.1111/j.1365-2133.1981.tb01706.x; Brozmanova J, 2010, ARCH TOXICOL, V84, P919, DOI 10.1007/s00204-010-0595-8; CHABEREK S, 1952, J AM CHEM SOC, V74, P6228, DOI 10.1021/ja01144a022; CHEN KY, 1972, ENVIRON SCI TECHNOL, V6, P529, DOI 10.1021/es60065a008; CHEN KY, 1972, J SANIT ENG DIV ASCE, V98, P215; CHEN RW, 1975, BIOINORG CHEM, V4, P125, DOI 10.1016/S0006-3061(00)81021-2; ESAKI N, 1982, J BIOL CHEM, V257, P4386; FRIEDEN E, 1985, J CHEM EDUC, V62, P917, DOI 10.1021/ed062p917; Gailer J, 2000, CHEM RES TOXICOL, V13, P1135, DOI 10.1021/tx000050h; Gailer J, 2012, J INORG BIOCHEM, V108, P128, DOI 10.1016/j.jinorgbio.2011.12.001; GASIEWICZ TA, 1976, BIOCHIM BIOPHYS ACTA, V428, P113, DOI 10.1016/0304-4165(76)90113-6; GASIEWICZ TA, 1978, CHEM-BIOL INTERACT, V23, P171, DOI 10.1016/0009-2797(78)90004-2; Glattre E, 2012, J TRACE ELEM MED BIO, V26, P168, DOI 10.1016/j.jtemb.2012.04.021; Gueldry O, 2003, EUR J BIOCHEM, V270, P2486, DOI 10.1046/j.1432-1033.2003.03620.x; HILL CH, 1975, FED PROC, V34, P2096; HILL CH, 1974, J NUTR, V104, P593, DOI 10.1093/jn/104.5.593; Jackson MI, 2008, CURR OPIN CLIN NUTR, V11, P718, DOI 10.1097/MCO.0b013e3283139674; JENSEN LS, 1975, J NUTR, V105, P769, DOI 10.1093/jn/105.6.769; Khan MAK, 2010, CHEM RES TOXICOL, V23, P1202, DOI 10.1021/tx100080s; Kobayashi Y, 2001, J CHROMATOGR B, V760, P73, DOI 10.1016/S0378-4347(01)00252-3; KOEMAN JH, 1973, NATURE, V245, P385, DOI 10.1038/245385a0; KOSTA L, 1975, NATURE, V254, P238, DOI 10.1038/254238a0; Kungolos A, 1999, ECOTOX ENVIRON SAFE, V43, P149, DOI 10.1006/eesa.1999.1767; Lailson-Brito J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042162; Letavayova L, 2008, MUTAT RES-GEN TOX EN, V652, P198, DOI 10.1016/j.mrgentox.2008.03.001; Letavayova L, 2008, MUTAT RES-FUND MOL M, V638, P1, DOI 10.1016/j.mrfmmm.2007.08.009; Manikova D, 2012, CHEM RES TOXICOL, V25, P1598, DOI 10.1021/tx300061n; MARTOJA R, 1977, CR ACAD SCI D NAT, V285, P109; MATSUMURA T, 1992, Journal of Dermatology (Tokyo), V19, P87; Muecke R, 2010, INTEGR CANCER THER, V9, P136, DOI 10.1177/1534735410367648; NAGANUMA A, 1983, TOXICOLOGY, V29, P77, DOI 10.1016/0300-483X(83)90040-9; Nakazawa E, 2011, METALLOMICS, V3, P719, DOI 10.1039/c0mt00106f; Nakazawa E, 2011, J ENVIRON MONITOR, V13, P1678, DOI 10.1039/c1em10115c; NASHEF AS, 1977, ANAL BIOCHEM, V79, P394, DOI 10.1016/0003-2697(77)90413-4; Nigro M, 1996, MAR ECOL PROG SER, V135, P137, DOI 10.3354/meps135137; NIGRO M, 1994, J MAR BIOL ASSOC UK, V74, P975, DOI 10.1017/S0025315400090226; NUTTALL KL, 1984, INORG CHIM A-BIOINOR, V91, P243, DOI 10.1016/S0020-1693(00)81844-7; NUTTALL KL, 1987, MED HYPOTHESES, V24, P217, DOI 10.1016/0306-9877(87)90107-1; Odian G, 1981, PRINCIPLES POLYM, P282; Perego P, 1997, TOXICOL APPL PHARM, V147, P312, DOI 10.1006/taap.1997.8271; Peyroche G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036343; Ralston NVC, 2010, TOXICOLOGY, V278, P112, DOI 10.1016/j.tox.2010.06.004; RAWSON AJ, 1995, ECOTOX ENVIRON SAFE, V30, P309, DOI 10.1006/eesa.1995.1035; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Richman EL, 2012, AM J CLIN NUTR, V96, P1, DOI 10.3945/ajcn.112.042119; Rickard D, 2007, CHEM REV, V107, P514, DOI 10.1021/cr0503658; Sadauskas Evaldas, 2007, Part Fibre Toxicol, V4, P10, DOI 10.1186/1743-8977-4-10; Sanmartin C, 2012, INT J MOL SCI, V13, P9649, DOI 10.3390/ijms13089649; Sasakura C, 1998, J INORG BIOCHEM, V71, P159, DOI 10.1016/S0162-0134(98)10048-X; Seby F, 2001, CHEM GEOL, V171, P173, DOI 10.1016/S0009-2541(00)00246-1; Seko Y, 1997, BIOMED ENVIRON SCI, V10, P333; Selenius M, 2010, ANTIOXID REDOX SIGN, V12, P867, DOI 10.1089/ars.2009.2884; Sigel A, 2009, METALLOTHIONEINS REL; Singh VP, 2005, METAL TOXICITY TOLER; Smith RM, 1974, CRITICAL STABILITY C, V1-6; Tarze A, 2007, J BIOL CHEM, V282, P8759, DOI 10.1074/jbc.M610078200; Tatum L, 2000, BIOL TRACE ELEM RES, V77, P241, DOI 10.1385/BTER:77:3:241; Wang L, 1997, COLLOID POLYM SCI, V275, P593, DOI 10.1007/s003960050123; WERES O, 1985, CORROSION, V41, P307, DOI 10.5006/1.3582010; WHANGER PD, 1985, ADV NUTR RES, V7, P221; Wu M, 2010, J BIOL CHEM, V285, P12055, DOI 10.1074/jbc.M109.088781; Wysocki R, 2010, FEMS MICROBIOL REV, V34, P925, DOI 10.1111/j.1574-6976.2010.00217.x; Yoneda S, 1997, BIOCHEM BIOPH RES CO, V231, P7, DOI 10.1006/bbrc.1996.6036	65	22	22	5	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54353	10.1371/journal.pone.0054353	http://dx.doi.org/10.1371/journal.pone.0054353			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342137	gold, Green Published, Green Submitted			2022-12-25	WOS:000314759400152
J	Liu, CF; Xiong, XY; Xu, W; Sun, JM; Wang, LJ; Li, JJ				Liu, Chunfeng; Xiong, Xiaoyu; Xu, Wei; Sun, Jimei; Wang, Lijie; Li, Jiujun			Serotypes and Patterns of Antibiotic Resistance in Strains Causing Invasive Pneumococcal Disease in Children Less than 5 Years of Age	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; ANTIMICROBIAL RESISTANCE; MOLECULAR EPIDEMIOLOGY; CHINESE CHILDREN; 19A	Objective: The serotypes and patterns of antibiotic resistance of Streptococcus pneumoniae (S. pneumoniae) strains that cause invasive pneumococcal disease (IPD) in infants were analyzed to provide guidance for clinical disease prevention and treatment. Methods: The clinical features of confirmed IPD were evaluated in 61 patients, less than 5 years of age, who were admitted to our hospital between January 2009 and December 2011. The serotypes and antibiotic resistance of strains of S. pneumoniae were determined using the capsular swelling method and the E-test. Results: A total of 61 invasive strains were isolated. The serotype distribution of those isolates were 19A (41.0%), 14 (19.7%), 19F (11.5%), 23F (9.8%), 8 (4.9%), 9V (4.9%), 1 (3.3%), and 4, 6B, and 20 (each 1.6%). The percentage of S. pneumoniae strains resistant to erythromycin, clindamycin, and cotrimoxazole were 100%, 86.9%, and 100%, respectively. The percentage of S. pneumoniae strains resistant to penicillin, amoxicillin/clavulanic acid, cefuroxime, ceftriaxone, cefotaxime, cefepime, and meropenem were 42.6%, 18.0%, 82.0%, 18.0%, 13.1%, 13.1%, and 36.1%, respectively. The percentage of multidrug-resistant strains was 95.6%. Strains of all serotypes isolated in this study were highly resistant to erythromycin, cotrimoxazole, and clindamycin. Strains with serotype 19A had the highest rates of resistance. Conclusions: Serotype 19A strains were most frequently isolated from children with IPD treated in our hospital. The strains causing IPD are highly resistant to antibiotics.	[Liu, Chunfeng; Xiong, Xiaoyu; Xu, Wei; Wang, Lijie; Li, Jiujun] China Med Univ, Shengjing Hosp, Dept Pediat, Shenyang, Liaoning, Peoples R China; [Sun, Jimei] China Med Univ, Shengjing Hosp, Dept Bacteriol, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University	Liu, CF (corresponding author), China Med Univ, Shengjing Hosp, Dept Pediat, Shenyang, Liaoning, Peoples R China.	zhliu258@hotmail.com			Pfizer China	Pfizer China(Pfizer)	This is a sponsored study funded by Pfizer China. The authors declare that they have no financial interests that may influnce interpretation of the results and the others. The funders had no role in study design, data collection and analysis, decision to publish, or prepareation of the manuscript.	[Anonymous], 1997, MMWR RECOMM REP, V46, P1; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P893; Centers for Disease Control and Prevention, 1997, MMWR-MORBID MORTAL W, V46, P1; Centers for Disease Control and Prevention, 2006, MMWR-MORBID MORTAL W, V55, P511; Centers for Disease Control and Prevention (CDC), 2008, MMWR-MORBID MORTAL W, V57, P1148; Choi EH, 2008, EMERG INFECT DIS, V14, P275, DOI 10.3201/eid1402.070807; CLSI, 2010, M100S16 CLSI, P56; Denham BC, 2005, J MED MICROBIOL, V54, P327, DOI 10.1099/jmm.0.45718-0; Gareia-Suarez Mdel M, 2006, JPN J INFECT DIS, V59, P299; Jauneikaite E, 2012, VACCINE, V30, P3503, DOI 10.1016/j.vaccine.2012.03.066; Liu Su-yun, 2010, Zhonghua Er Ke Za Zhi, V48, P95; Liu YD, 2008, DIAGN MICR INFEC DIS, V61, P256, DOI 10.1016/j.diagmicrobio.2008.02.004; Lonks JR, 2002, CLIN INFECT DIS, V35, P556, DOI 10.1086/341978; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Nyasulu P, 2011, PEDIATR INFECT DIS J, V30, P1075, DOI 10.1097/INF.0b013e31822cca05; Roche P, 2007, COMMUN DIS INTELL, V31, P86; SORENSEN UBS, 1993, J CLIN MICROBIOL, V31, P2097; Sun J, 2012, CHIN PEDIAT EMERG ME, V19, P368; [UNICEF WHO], 2008, WEEKLY EPIDEMIOL REC, V83, P1; Weil-Olivier C, 2012, BMC INFECT DIS, V7, P207; WHO Publication, 2012, VACCINE, V30, P4717; Xue L, 2011, CHINESE MED J-PEKING, V124, P1769, DOI 10.3760/cma.j.issn.0366-6999.2011.12.002; Xue L, 2010, CLIN INFECT DIS, V50, P741, DOI 10.1086/650534; Yao KH, 2008, VACCINE, V26, P4425, DOI 10.1016/j.vaccine.2008.06.052; Yao KH, 2011, VACCINE, V29, P2296, DOI 10.1016/j.vaccine.2011.01.027; [袁红英 YUAN Hongying], 2011, [中华医院感染学杂志, Chinese Journal of Nosocomiology], V21, P2127	26	22	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54254	10.1371/journal.pone.0054254	http://dx.doi.org/10.1371/journal.pone.0054254			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342111	gold, Green Published, Green Submitted			2022-12-25	WOS:000314759400137
J	Sequeira, KM; Tabesh, A; Sainju, RK; DeSantis, SM; Naselaris, T; Joseph, JE; Ahlman, MA; Spicer, KM; Glazier, SS; Edwards, JC; Bonilha, L				Sequeira, Karen M.; Tabesh, Ali; Sainju, Rup K.; DeSantis, Stacia M.; Naselaris, Thomas; Joseph, Jane E.; Ahlman, Mark A.; Spicer, Kenneth M.; Glazier, Steve S.; Edwards, Jonathan C.; Bonilha, Leonardo			Perfusion Network Shift during Seizures in Medial Temporal Lobe Epilepsy	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; ICTAL SPECT; MRI; ATROPHY; PET; HIPPOCAMPUS; AMYGDALA; TUTORIAL; ONSET	Background: Medial temporal lobe epilepsy (MTLE) is associated with limbic atrophy involving the hippocampus, peri-hippocampal and extra-temporal structures. While MTLE is related to static structural limbic compromise, it is unknown whether the limbic system undergoes dynamic regional perfusion network alterations during seizures. In this study, we aimed to investigate state specific (i.e. ictal versus interictal) perfusional limbic networks in patients with MTLE. Methods: We studied clinical information and single photon emission computed tomography (SPECT) images obtained with intravenous infusion of the radioactive tracer Technetium-Tc 99 m Hexamethylpropyleneamine Oxime (Tc-99 m HMPAO) during ictal and interictal state confirmed by video-electroencephalography (VEEG) in 20 patients with unilateral MTLE (12 left and 8 right MTLE). Pair-wise voxel-based analyses were used to define global changes in tracer between states. Regional tracer uptake was calculated and state specific adjacency matrices were constructed based on regional correlation of uptake across subjects. Graph theoretical measures were applied to investigate global and regional state specific network reconfigurations. Results: A significant increase in tracer uptake was observed during the ictal state in the medial temporal region, cerebellum, thalamus, insula and putamen. From network analyses, we observed a relative decreased correlation between the epileptogenic temporal region and remaining cortex during the interictal state, followed by a surge of cross-correlated perfusion in epileptogenic temporal-limbic structures during a seizure, corresponding to local network integration. Conclusions: These results suggest that MTLE is associated with a state specific perfusion and possibly functional organization consisting of a surge of limbic cross-correlated tracer uptake during a seizure, with a relative disconnection of the epileptogenic temporal lobe in the interictal period. This pattern of state specific shift in metabolic networks in MTLE may improve the understanding of epileptogenesis and neuropsychological impairments associated with MTLE.	[Sequeira, Karen M.; Sainju, Rup K.; Naselaris, Thomas; Joseph, Jane E.; Glazier, Steve S.; Edwards, Jonathan C.; Bonilha, Leonardo] Med Univ S Carolina, Comprehens Epilepsy Ctr, Div Neurol, Dept Neurosci, Charleston, SC 29425 USA; [Tabesh, Ali; Ahlman, Mark A.; Spicer, Kenneth M.] Med Univ S Carolina, Dept Radiol & Radiol Sci, Charleston, SC 29425 USA; [DeSantis, Stacia M.] Med Univ S Carolina, Dept Med, Div Biostat & Epidemiol, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Bonilha, L (corresponding author), Med Univ S Carolina, Comprehens Epilepsy Ctr, Div Neurol, Dept Neurosci, Charleston, SC 29425 USA.	bonilha@musc.edu		Sainju, Rup/0000-0002-8414-1972	South Carolina Clinical & Translational Research (SCTR) Institute through National Institutes of Health [UL1 RR029882, UL1 TR000062]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000062] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029882] Funding Source: NIH RePORTER	South Carolina Clinical & Translational Research (SCTR) Institute through National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This publication was supported in part by the South Carolina Clinical & Translational Research (SCTR) Institute, with an academic home at the Medical University of South Carolina, through National Institutes of Health Grant Numbers UL1 RR029882 and UL1 TR000062. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Amorim BJ, 2005, ARQ NEURO-PSIQUIAT, V63, P977, DOI 10.1590/S0004-282X2005000600014; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Bernasconi N, 2003, BRAIN, V126, P462, DOI 10.1093/brain/awg034; Bernasconi N, 2000, ANN NY ACAD SCI, V911, P495; Bernhardt BC, 2009, NEUROLOGY, V72, P1747, DOI 10.1212/01.wnl.0000345969.57574.f5; Bernhardt BC, 2010, NEUROLOGY, V74, P1776, DOI 10.1212/WNL.0b013e3181e0f80a; Bernhardt BC, 2011, CEREB CORTEX, V21, P2147, DOI 10.1093/cercor/bhq291; Blumenfeld H, 2004, CEREB CORTEX, V14, P892, DOI 10.1093/cercor/bhh048; Bonilha L, 2004, ARCH NEUROL-CHICAGO, V61, P1379, DOI 10.1001/archneur.61.9.1379; Bonilha L, 2003, J NEUROL NEUROSUR PS, V74, P1627, DOI 10.1136/jnnp.74.12.1627; Bonilha L, 2012, J NEUROL NEUROSUR PS, V83, P903, DOI 10.1136/jnnp-2012-302476; Brown W., 1987, SURGICAL TREATMENT E, P511; CENDES F, 1993, J COMPUT ASSIST TOMO, V17, P206, DOI 10.1097/00004728-199303000-00008; CENDES F, 1993, NEUROLOGY, V43, P719, DOI 10.1212/WNL.43.4.719; Engel J, 2003, NEUROLOGY, V60, P538, DOI 10.1212/01.WNL.0000055086.35806.2D; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Groppe DM, 2011, PSYCHOPHYSIOLOGY, V48, P1711, DOI 10.1111/j.1469-8986.2011.01273.x; Jayalakshmi Sita, 2011, Int J Mol Imaging, V2011, P803920, DOI 10.1155/2011/803920; Kaiser M, 2011, NEUROIMAGE, V57, P892, DOI 10.1016/j.neuroimage.2011.05.025; Keller SS, 2008, EPILEPSIA, V49, P741, DOI 10.1111/j.1528-1167.2007.01485.x; Keller SS, 2002, J NEUROL NEUROSUR PS, V73, P648, DOI 10.1136/jnnp.73.6.648; Kobayashi E, 2003, NEUROLOGY, V60, P405, DOI 10.1212/WNL.60.3.405; Kramer MA, 2008, EPILEPSY RES, V79, P173, DOI 10.1016/j.eplepsyres.2008.02.002; Kramer MA, 2010, J NEUROSCI, V30, P10076, DOI 10.1523/JNEUROSCI.6309-09.2010; McDonald CR, 2008, NEUROLOGY, V71, P1869, DOI 10.1212/01.wnl.0000327824.05348.3b; McDonald CR, 2008, EPILEPSY RES, V79, P130, DOI 10.1016/j.eplepsyres.2008.01.006; McDonald CR, 2008, EPILEPSIA, V49, P794, DOI 10.1111/j.1528-1167.2008.01539.x; Natsume J, 2003, NEUROLOGY, V60, P1296, DOI 10.1212/01.WNL.0000058764.34968.C2; Ortega GJ, 2008, EPILEPSIA, V49, P269, DOI 10.1111/j.1528-1167.2007.01266.x; Richardson MP, 2012, J NEUROL NEUROSUR PS, V83, P1238, DOI 10.1136/jnnp-2011-301944; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schindler KA, 2008, CHAOS, V18, DOI 10.1063/1.2966112; Sherman EMS, 2011, EPILEPSIA, V52, P857, DOI 10.1111/j.1528-1167.2011.03022.x; THEODORE WH, 1989, LANCET, V1, P502; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Paesschen W, 2007, CURR OPIN NEUROL, V20, P194, DOI 10.1097/WCO.0b013e328042baf6; Watson C, 1997, ARCH NEUROL-CHICAGO, V54, P67, DOI 10.1001/archneur.1997.00550130049015; WIESER HG, 1994, EUR NEUROL, V34, P58; Won HJ, 1999, AM J NEURORADIOL, V20, P593	40	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53204	10.1371/journal.pone.0053204	http://dx.doi.org/10.1371/journal.pone.0053204			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341932	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400036
J	Silva, LCR; Horwath, WR				Silva, Lucas C. R.; Horwath, William R.			Explaining Global Increases in Water Use Efficiency: Why Have We Overestimated Responses to Rising Atmospheric CO2 in Natural Forest Ecosystems?	PLOS ONE			English	Article							CARBON-ISOTOPE DISCRIMINATION; ELEVATED CO2; GROWTH; ENRICHMENT; ASSIMILATION; CHRONOLOGIES; PLANTS; TREES; WHEAT; PINE	Background: The analysis of tree-ring carbon isotope composition (delta C-13) has been widely used to estimate spatio-temporal variations in intrinsic water use efficiency (iWUE) of tree species. Numerous studies have reported widespread increases in iWUE coinciding with rising atmospheric CO2 over the past century. While this could represent a coherent global response, the fact that increases of similar magnitude were observed across biomes with no apparent effect on tree growth raises the question of whether iWUE calculations reflect actual physiological responses to elevated CO2 levels. Methodology/Results: Here we use Monte Carlo simulations to test if an artifact of calculation could explain observed increases in iWUE. We show that highly significant positive relationships between iWUE and CO2 occur even when simulated data (randomized delta C-13 values spanning the observed range) are used in place of actual tree-ring delta C-13 measurements. From simulated data sets we calculated non-physiological changes in iWUE from 1900 to present and across a 4000 m altitudinal range. This generated results strikingly similar to those reported in recent studies encompassing 22 species from tropical, subtropical, temperate, boreal and mediterranean ecosystems. Only 6 of 49 surveyed case studies showed increases in iWUE significantly higher than predicted from random values. Conclusions/Significance: Our results reveal that increases in iWUE estimated from tree-ring delta C-13 occur independently of changes in C-13 discrimination that characterize physiological responses to elevated CO2. Due to a correlation with CO2 concentration, which is used as an independent factor in the iWUE calculation, any tree-ring delta C-13 data set would inevitably generate increasing iWUE over time. Therefore, although consistent, previously reported trends in iWUE do not necessarily reflect a coherent global response to rising atmospheric CO2. We discuss the significance of these findings and suggest ways to distinguish real from artificial responses in future studies.	[Silva, Lucas C. R.; Horwath, William R.] Univ Calif Davis, Biogeochem & Nutrient Cycling Lab, Dept Land Air & Water Resources LAWR, Davis, CA 95616 USA	University of California System; University of California Davis	Horwath, WR (corresponding author), Univ Calif Davis, Biogeochem & Nutrient Cycling Lab, Dept Land Air & Water Resources LAWR, Davis, CA 95616 USA.	wrhorwath@ucdavis.edu	Silva, Lucas/AAA-2476-2022; Silva, Lucas C R/E-1202-2016; Silva, Lucas/GQH-8201-2022	Silva, Lucas/0000-0002-4838-327X; Silva, Lucas C R/0000-0002-4838-327X; 				Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Anderson W. T., 2005, Dendrochronologia, V23, P1, DOI 10.1016/j.dendro.2005.07.006; Andreu-Hayles L, 2011, GLOBAL CHANGE BIOL, V17, P2095, DOI 10.1111/j.1365-2486.2010.02373.x; Bloom AJ, 2002, P NATL ACAD SCI USA, V99, P1730, DOI 10.1073/pnas.022627299; Bloom AJ, 2010, SCIENCE, V328, P899, DOI 10.1126/science.1186440; Linares JC, 2012, GLOBAL CHANGE BIOL, V18, P1000, DOI 10.1111/j.1365-2486.2011.02566.x; Domec JC, 2009, PLANT CELL ENVIRON, V32, P1500, DOI 10.1111/j.1365-3040.2009.02014.x; Ewe SML, 1999, FOREST ECOL MANAG, V118, P139, DOI 10.1016/S0378-1127(98)00493-9; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; Finzi AC, 2006, ECOLOGY, V87, P15, DOI 10.1890/04-1748; Gedalof Z, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003699; Huang JG, 2007, CRIT REV PLANT SCI, V26, P265, DOI 10.1080/07352680701626978; KORNER C, 1991, OECOLOGIA, V88, P30, DOI 10.1007/BF00328400; KORNER C, 1988, OECOLOGIA, V74, P623, DOI 10.1007/BF00380063; Manly B.F.J, 2007, RANDOMIZATION BOOTST, DOI DOI 10.1201/9780429329203; McCarroll D, 2004, QUATERNARY SCI REV, V23, P771, DOI 10.1016/j.quascirev.2003.06.017; McCarroll D, 2009, GEOCHIM COSMOCHIM AC, V73, P1539, DOI 10.1016/j.gca.2008.11.041; Nock CA, 2011, GLOBAL CHANGE BIOL, V17, P1049, DOI 10.1111/j.1365-2486.2010.02222.x; Observatory ML Reports OI Co S, 2011, DATA MANAGE, P4; Penuelas J, 2008, GLOBAL CHANGE BIOL, V14, P1076, DOI 10.1111/j.1365-2486.2008.01563.x; Penuelas J, 2011, GLOBAL ECOL BIOGEOGR, V20, P597, DOI 10.1111/j.1466-8238.2010.00608.x; Silva LCR, 2013, GLOBAL ECOL BIOGEOGR, V22, P83, DOI 10.1111/j.1466-8238.2012.00783.x; Silva LCR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011543; Silva LCR, 2009, GLOBAL CHANGE BIOL, V15, P2387, DOI 10.1111/j.1365-2486.2009.01859.x	25	50	55	0	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53089	10.1371/journal.pone.0053089	http://dx.doi.org/10.1371/journal.pone.0053089			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341924	Green Submitted, Green Published, gold			2022-12-25	WOS:000314759400031
J	Tsuruyama, T; Nakai, T; Ohmori, R; Ozeki, M; Tamaki, K; Yoshikawa, K				Tsuruyama, Tatsuaki; Nakai, Tonau; Ohmori, Rei; Ozeki, Munetaka; Tamaki, Keiji; Yoshikawa, Kenichi			Dialysis Purification of Integrase-DNA Complexes Provides High-Resolution Atomic Force Microscopy Images: Dimeric Recombinant HIV-1 Integrase Binding and Specific Looping on DNA	PLOS ONE			English	Article								It remains difficult to obtain high-resolution atomic force microscopy images of HIV-1 integrase bound to DNA in a dimeric or tetrameric fashion. We therefore constructed specific target DNAs to assess HIV-1 integrase binding and purified the complex by dialysis prior to analysis. Our resulting atomic force microscopy analyses indicated precise size of binding human immunodeficiency virus type 1 (HIV-1) recombinant integrase in a tetrameric manner, inducing formation of a loop-like or figure-eight-like secondary structure in the target DNA. Our findings regarding the target DNA secondary structure provide new insights into the intermediate states of retroviral integration.	[Tsuruyama, Tatsuaki; Ohmori, Rei; Tamaki, Keiji] Kyoto Univ, Dept Anat Forens Med & Pathol Studies, Grad Sch Med, Kyoto, Japan; [Tsuruyama, Tatsuaki; Ozeki, Munetaka; Tamaki, Keiji] Kyoto Univ, Dept Forens Med & Mol Pathol, Grad Sch Med, Kyoto, Japan; [Tsuruyama, Tatsuaki] Kyoto Univ, Dept Pathol, Grad Sch Med, Kyoto, Japan; [Nakai, Tonau] Tottori Univ, Dept Mech & Aerosp Engn, Grad Sch Engn, Tottori 680, Japan; [Yoshikawa, Kenichi] Kyoto Univ, Dept Phys, Grad Sch Sci, Kyoto 606, Japan	Kyoto University; Kyoto University; Kyoto University; Tottori University; Kyoto University	Tsuruyama, T (corresponding author), Kyoto Univ, Dept Anat Forens Med & Pathol Studies, Grad Sch Med, Kyoto, Japan.	tsuruyam@kuhp.kyoto-u.ac.jp	Yoshikawa, Kenichi/N-1867-2019	Yoshikawa, Kenichi/0000-0002-2751-7136	Ministry of Education, Culture, Science and Technology, Japan; Ministry of Health, Welfare, and Labor, Japan	Ministry of Education, Culture, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Welfare, and Labor, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for Cancer Research from the Ministry of Education, Culture, Science and Technology, Japan, and by a grant from the Ministry of Health, Welfare, and Labor, Japan. The funding agencies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Magen T, 2010, J VIROL, V84, P9210, DOI 10.1128/JVI.01164-10; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Craigie R, 2002, MOBILE DNA, P613; Deprez E, 2001, P NATL ACAD SCI USA, V98, P10090, DOI 10.1073/pnas.181024498; Dolan J, 2009, J MOL BIOL, V385, P568, DOI 10.1016/j.jmb.2008.10.083; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Ivanov YD, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9809-5; Kotova S, 2010, J MOL BIOL, V399, P491, DOI 10.1016/j.jmb.2010.04.026; Kuznetsov VY, 2002, PROTEOMICS, V2, P1699, DOI 10.1002/1615-9861(200212)2:12<1699::AID-PROT1699>3.0.CO;2-R; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Ohno H, 2011, NAT NANOTECHNOL, V6, P115, DOI 10.1038/nnano.2010.268; Ren G, 2007, J MOL BIOL, V366, P286, DOI 10.1016/j.jmb.2006.11.029; Tsuruyama T, 2012, BIOCHEMISTRY-US, P306; Tsuruyama T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013841; Ueda M, 1996, PHYS REV LETT, V77, P2133, DOI 10.1103/PhysRevLett.77.2133; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; YOSHINAGA T, 1995, J VIROL, V69, P3233, DOI 10.1128/JVI.69.5.3233-3236.1995	20	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53572	10.1371/journal.pone.0053572	http://dx.doi.org/10.1371/journal.pone.0053572			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341952	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400050
J	Amigo, I; Traba, J; Gonzalez-Barroso, MM; Rueda, CB; Fernandez, M; Rial, E; Sanchez, A; Satrustegui, J; del Arco, A				Amigo, Ignacio; Traba, Javier; Mar Gonzalez-Barroso, M.; Rueda, Carlos B.; Fernandez, Margarita; Rial, Eduardo; Sanchez, Aranzazu; Satrustegui, Jorgina; del Arco, Araceli			Glucagon Regulation of Oxidative Phosphorylation Requires an Increase in Matrix Adenine Nucleotide Content through Ca2+ Activation of the Mitochondrial ATP-Mg/P-i Carrier SCaMC-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; PERMEABILITY TRANSITION; POSTNATAL-DEVELOPMENT; RESPIRATORY-CHAIN; CALCIUM; HEPATOCYTES; STIMULATION; MICE; IDENTIFICATION; ACCUMULATION	It has been known for a long time that mitochondria isolated from hepatocytes treated with glucagon or Ca2+-mobilizing agents such as phenylephrine show an increase in their adenine nucleotide (AdN) content, respiratory activity, and calcium retention capacity (CRC). Here, we have studied the role of SCaMC-3/slc25a23, the mitochondrial ATP-Mg/P-i carrier present in adult mouse liver, in the control of mitochondrial AdN levels and respiration in response to Ca2+ signals as a candidate target of glucagon actions. With the use of SCaMC-3 knock-out (KO) mice, we have found that the carrier is responsible for the accumulation of AdNs in liver mitochondria in a strictly Ca2+-dependent way with an S-0.5 for Ca2+ activation of 3.3 +/- 0.9 mu M. Accumulation of matrix AdNs allows a SCaMC-3-dependent increase in CRC. In addition, SCaMC-3-dependent accumulation of AdNs is required to acquire a fully active state 3 respiration in AdN-depleted liver mitochondria, although further accumulation of AdNs is not followed by increases in respiration. Moreover, glucagon addition to isolated hepatocytes increases oligomycin-sensitive oxygen consumption and maximal respiratory rates in cells derived from wild type, but not SCaMC-3-KO mice and glucagon administration in vivo results in an increase in AdN content, state 3 respiration and CRC in liver mitochondria in wild type but not in SCaMC-3-KO mice. These results show that SCaMC-3 is required for the increase in oxidative phosphorylation observed in liver mitochondria in response to glucagon and Ca2+-mobilizing agents, possibly by allowing a Ca2+-dependent accumulation of mitochondrial AdNs and matrix Ca2+, events permissive for other glucagon actions.	[Amigo, Ignacio; Traba, Javier; Rueda, Carlos B.; Satrustegui, Jorgina] Univ Autonoma Madrid, CSIC, Dept Biol Mol, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [Amigo, Ignacio; Traba, Javier; Rueda, Carlos B.; Satrustegui, Jorgina] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid 28049, Spain; [Mar Gonzalez-Barroso, M.; Rial, Eduardo] CSIC, Dept Med Celular & Mol, CIB, E-28040 Madrid, Spain; [Fernandez, Margarita; Sanchez, Aranzazu] Univ Complutense Madrid, Fac Farm, Dept Bioquim & Biol Mol 2, E-28040 Madrid, Spain; [del Arco, Araceli] Univ Castilla La Mancha, Area Bioquim, Ctr Reg Invest Biomed, Fac Ciencias Ambientales & Bioquim, Toledo 45071, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Complutense University of Madrid; Universidad de Castilla-La Mancha	Satrustegui, J (corresponding author), Ctr Biol Mol Severo Ochoa, Nicolas Cabrera 1, Madrid 28049, Spain.	jsatrustegui@cbm.uam.es; araceli.arco@uclm.es	Satrustegui, Jorgina/R-6732-2019; Rial, Eduardo/A-4242-2008; Sánchez, Aránzazu/H-7810-2015; Traba, Javier/AAA-9287-2020; del Arco, Araceli/R-5653-2019; Fernández, Margarita/H-9077-2015	Rial, Eduardo/0000-0001-8634-8902; Sánchez, Aránzazu/0000-0001-9145-6633; Traba, Javier/0000-0002-7855-3540; Fernández, Margarita/0000-0001-7207-2028; Amigo, Ignacio/0000-0003-0527-5954; GONZALEZ BARROSO, MARIA DEL MAR/0000-0002-0278-8298; Satrustegui Gil Delgado, Jorgina/0000-0003-3377-2667; del Arco, Araceli/0000-0002-6839-542X; Rueda, Carlos/0000-0002-3876-612X	Ministerio de Educacion y Ciencia [BFU2008-04084/BMC, BFU2011-30456]; European Union [LSHM-CT-2006-518153]; CIBERER Centro de Investigaciones Biomedicas en Red de Enfermedades Raras (an initiative of the ISCIII Instituto de Salud Carlos III); Comunidad de Madrid [S-GEN-0269-2006, S2010/BMD-2402 MITOLAB-CM]; ISCIII [PI080610]; Fundacion Ramon Areces; Ministerio de Educacion y Ciencia	Ministerio de Educacion y Ciencia(Spanish Government); European Union(European Commission); CIBERER Centro de Investigaciones Biomedicas en Red de Enfermedades Raras (an initiative of the ISCIII Instituto de Salud Carlos III); Comunidad de Madrid(Comunidad de Madrid); ISCIII(Instituto de Salud Carlos III); Fundacion Ramon Areces; Ministerio de Educacion y Ciencia(Spanish Government)	This work was supported in part by Ministerio de Educacion y Ciencia Grants BFU2008-04084/BMC and BFU2011-30456, European Union Grant LSHM-CT-2006-518153, and CIBERER Centro de Investigaciones Biomedicas en Red de Enfermedades Raras (an initiative of the ISCIII Instituto de Salud Carlos III) (to J. S.), Comunidad de Madrid Grants S-GEN-0269-2006 and S2010/BMD-2402 MITOLAB-CM (to J. S., E. R., and A. S.), by ISCIII Grant PI080610 (to A. delA), and an institutional grant from the Fundacion Ramon Areces to the Centro de Biologia Molecular Severo Ochoa.; Recipient of a Formacion de Personal Investigador fellowship from the Ministerio de Educacion y Ciencia.	Amigo I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040470; Anunciado-Koza RP, 2011, J BIOL CHEM, V286, P11659, DOI 10.1074/jbc.M110.203000; APRILLE JR, 1982, BIOCHEM BIOPH RES CO, V108, P834, DOI 10.1016/0006-291X(82)90905-6; APRILLE JR, 1980, ARCH BIOCHEM BIOPHYS, V201, P564, DOI 10.1016/0003-9861(80)90546-9; APRILLE JR, 1988, FASEB J, V2, P2547, DOI 10.1096/fasebj.2.10.3290024; APRILLE JR, 1993, J BIOENERG BIOMEMBR, V25, P473, DOI 10.1007/BF01108404; ASIMAKIS GK, 1980, ARCH BIOCHEM BIOPHYS, V203, P307, DOI 10.1016/0003-9861(80)90181-2; ASSIMACOPOULOSJEANNET F, 1986, J BIOL CHEM, V261, P8799; Balaban RS, 2012, J GEN PHYSIOL, V139, P407, DOI 10.1085/jgp.201210783; Barritt GJ, 2008, BBA-MOL CELL RES, V1783, P651, DOI 10.1016/j.bbamcr.2008.01.016; CARAFOLI E, 1965, J BIOL CHEM, V240, P2254; Chinopoulos C, 2010, FEBS J, V277, P3637, DOI 10.1111/j.1742-4658.2010.07755.x; Contreras L, 2009, J BIOL CHEM, V284, P7091, DOI 10.1074/jbc.M808066200; CROMPTON M, 1986, FEBS LETT, V204, P198, DOI 10.1016/0014-5793(86)80811-0; DAVIDSON AM, 1988, BIOCHEM J, V254, P379, DOI 10.1042/bj2540379; del Arco A, 2004, J BIOL CHEM, V279, P24701, DOI 10.1074/jbc.M401417200; DRANSFIELD DT, 1993, AM J PHYSIOL, V264, pC663, DOI 10.1152/ajpcell.1993.264.3.C663; DSOUZA MP, 1982, BIOCHIM BIOPHYS ACTA, V680, P28, DOI 10.1016/0005-2728(82)90313-9; Fiermonte G, 2004, J BIOL CHEM, V279, P30722, DOI 10.1074/jbc.M400445200; Garlid KD, 2012, J MOL CELL CARDIOL, V52, P578, DOI 10.1016/j.yjmcc.2011.12.011; Gizatullina ZZ, 2005, BBA-BIOENERGETICS, V1706, P98, DOI 10.1016/j.bbabio.2004.09.013; Gomez-Galan M, 2012, J CEREBR BLOOD F MET, V32, P306, DOI 10.1038/jcbfm.2011.129; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Haitina T, 2006, GENOMICS, V88, P779, DOI 10.1016/j.ygeno.2006.06.016; HALESTRAP AP, 1987, BIOCHIM BIOPHYS ACTA, V927, P280, DOI 10.1016/0167-4889(87)90145-5; HALESTRAP AP, 1982, BIOCHEM J, V204, P37, DOI 10.1042/bj2040037; HALESTRAP AP, 1989, BIOCHIM BIOPHYS ACTA, V973, P355, DOI 10.1016/S0005-2728(89)80378-0; HAMMAN HC, 1983, ARCH BIOCHEM BIOPHYS, V223, P85, DOI 10.1016/0003-9861(83)90574-X; HAYNES RC, 1986, J BIOL CHEM, V261, P6121; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; Jalil MA, 2005, J BIOL CHEM, V280, P31333, DOI 10.1074/jbc.M505286200; Kao CY, 1996, BIOCHEM BIOPH RES CO, V222, P64, DOI 10.1006/bbrc.1996.0698; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Gonzalez-Barroso MM, 2012, BBA-BIOENERGETICS, V1817, P1768, DOI 10.1016/j.bbabio.2012.02.019; Marmol P, 2009, J BIOL CHEM, V284, P515, DOI 10.1074/jbc.M806729200; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; MORGAN NG, 1984, P NATL ACAD SCI-BIOL, V81, P4208, DOI 10.1073/pnas.81.13.4208; NOSEK MT, 1990, J BIOL CHEM, V265, P8444; NOSEK MT, 1992, ARCH BIOCHEM BIOPHYS, V296, P691, DOI 10.1016/0003-9861(92)90628-A; PRPIC V, 1978, BIOCHEM J, V176, P705, DOI 10.1042/bj1760705; QUINLAN PT, 1983, BIOCHEM J, V214, P395, DOI 10.1042/bj2140395; Ramnanan CJ, 2011, DIABETES OBES METAB, V13, P118, DOI 10.1111/j.1463-1326.2011.01454.x; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; SOBOLL S, 1986, FEBS LETT, V205, P109, DOI 10.1016/0014-5793(86)80875-4; SUTTON R, 1978, DIFFERENTIATION, V12, P15; Traba J, 2012, CELL DEATH DIFFER, V19, P650, DOI 10.1038/cdd.2011.139; Traba J, 2008, MOL MICROBIOL, V69, P570, DOI 10.1111/j.1365-2958.2008.06300.x; Traba J, 2011, CELL MOL LIFE SCI, V68, P1183, DOI 10.1007/s00018-010-0612-3; Traba J, 2009, BIOCHEM J, V418, P125, DOI 10.1042/BJ20081262; VALCARCE C, 1991, FEBS LETT, V294, P225, DOI 10.1016/0014-5793(91)81435-B; Vives-Bauza C, 2007, METHOD CELL BIOL, V80, P155, DOI 10.1016/S0091-679X(06)80007-5; YAMAZAKI RK, 1975, J BIOL CHEM, V250, P7924	53	40	40	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7791	7802		10.1074/jbc.M112.409144	http://dx.doi.org/10.1074/jbc.M112.409144			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23344948	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000316455300034
J	Arystarkhova, E; Liu, YB; Salazar, C; Stanojevic, V; Clifford, RJ; Kaplan, JH; Kidder, GM; Sweadner, KJ				Arystarkhova, Elena; Liu, Yi B.; Salazar, Cynthia; Stanojevic, Violeta; Clifford, Rebecca J.; Kaplan, Jack H.; Kidder, Gerald M.; Sweadner, Kathleen J.			Hyperplasia of Pancreatic Beta Cells and Improved Glucose Tolerance in Mice Deficient in the FXYD2 Subunit of Na, K-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SUBUNIT; IMMUNOCYTOCHEMICAL LOCALIZATION; RENAL NA,K-ATPASE; CRYSTAL-STRUCTURE; FUNCTIONAL-ROLE; EXPRESSION; PROTEIN; MASS; PHOSPHOLEMMAN; REGULATORS	Restoration of the functional potency of pancreatic islets either through enhanced proliferation (hyperplasia) or increase in size (hypertrophy) of beta cells is a major objective for intervention in diabetes. We have obtained experimental evidence that global knock-out of a small, single-span regulatory subunit of Na,K-ATPase, FXYD2, alters glucose control. Adult Fxyd2(-/-) mice showed significantly lower blood glucose levels, no signs of peripheral insulin resistance, and improved glucose tolerance compared with their littermate controls. Strikingly, there was a substantial hyperplasia in pancreatic beta cells from the Fxyd2(-/-) mice compared with the wild type littermates, compatible with an observed increase in the level of circulating insulin. No changes were seen in the exocrine compartment of the pancreas, and the mice had only a mild, well-adapted renal phenotype. Morphometric analysis revealed an increase in beta cell mass in KO compared with WT mice. This appears to explain a phenotype of hyperinsulinemia. By RT-PCR, Western blot, and immunocytochemistry we showed the FXYD2b splice variant in pancreatic beta cells from wild type mice. Phosphorylation of Akt kinase was significantly higher under basal conditions in freshly isolated islets from Fxyd2(-/-) mice compared with their WT littermates. Inducible expression of FXYD2 in INS 832/13 cells produced a reduction in the phosphorylation level of Akt, and phosphorylation was restored in parallel with degradation of FXYD2. Thus we suggest that in pancreatic beta cells FXYD2 plays a role in Akt signaling pathways associated with cell growth and proliferation.	[Arystarkhova, Elena; Liu, Yi B.; Salazar, Cynthia; Sweadner, Kathleen J.] Massachusetts Gen Hosp, Lab Membrane Biol, Boston, MA 02114 USA; [Stanojevic, Violeta] Massachusetts Gen Hosp, Mol Endocrinol Lab, Boston, MA 02114 USA; [Clifford, Rebecca J.; Kaplan, Jack H.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Kidder, Gerald M.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6C 2V5, Canada; [Kidder, Gerald M.] Childrens Hlth Res Inst, Div Genet & Dev, London, ON N6C 2V5, Canada	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Western University (University of Western Ontario)	Arystarkhova, E (corresponding author), Massachusetts Gen Hosp, Lab Membrane Biol, Edwards 410,55 Fruit St, Boston, MA 02114 USA.	aristarkhova@helix.mgh.harvard.edu		Kaplan, Jack/0000-0002-7048-6574	National Institutes of Health [HL036271, NS045083, NS050696]; Pilot Feasibility Grant [5P30DK057521-12]; American Recovery and Reinvestment Act supplement [NS050696]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050696, R21NS045083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pilot Feasibility Grant; American Recovery and Reinvestment Act supplement; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL036271, NS045083, and NS050696. This work was also supported by Pilot Feasibility Grant 5P30DK057521-12 (Boston Area Diabetes Endocrinology Research Center) and American Recovery and Reinvestment Act supplement to Grant NS050696.	Ackermann AM, 2007, J MOL ENDOCRINOL, V38, P193, DOI 10.1677/JME-06-0053; Arystarkhova E, 1999, J BIOL CHEM, V274, P33183, DOI 10.1074/jbc.274.47.33183; Arystarkhova E, 2002, J BIOL CHEM, V277, P10162, DOI 10.1074/jbc.M111552200; Arystarkhova E, 2002, AM J PHYSIOL-RENAL, V282, pF393, DOI 10.1152/ajprenal.00146.2001; Arystarkhova E, 2007, AM J PHYSIOL-CELL PH, V292, pC1179, DOI 10.1152/ajpcell.00328.2006; Beguin P, 1997, EMBO J, V16, P4250, DOI 10.1093/emboj/16.14.4250; Bibert S, 2011, J BIOL CHEM, V286, P18562, DOI 10.1074/jbc.M110.184101; Blandino-Rosano M, 2012, CELL CYCLE, V11, P1892, DOI 10.4161/cc.20036; Brown D, 1996, HISTOCHEM CELL BIOL, V105, P261, DOI 10.1007/BF01463929; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Elghazi L, 2007, DIABETES OBES METAB, V9, P147, DOI 10.1111/j.1463-1326.2007.00783.x; Flamez D, 2010, DIABETOLOGIA, V53, P1372, DOI 10.1007/s00125-010-1714-z; Floyd RV, 2010, ANN ANAT, V192, P7, DOI 10.1016/j.aanat.2009.09.003; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Jones DH, 2005, J BIOL CHEM, V280, P19003, DOI 10.1074/jbc.M500697200; Kidder GM, 2002, CAN J PHYSIOL PHARM, V80, P110, DOI 10.1139/Y02-017; Kuster B, 2000, J BIOL CHEM, V275, P18441, DOI 10.1074/jbc.M001411200; MERCER RW, 1993, J CELL BIOL, V121, P579, DOI 10.1083/jcb.121.3.579; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Pu HX, 2001, J BIOL CHEM, V276, P20370, DOI 10.1074/jbc.M010836200; Reinhard L, 2013, CELL MOL LIFE SCI, V70, P205, DOI 10.1007/s00018-012-1039-9; Sachdeva MM, 2009, MOL ENDOCRINOL, V23, P747, DOI 10.1210/me.2008-0400; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Sweadner KJ, 2011, J BIOL CHEM, V286, P18290, DOI 10.1074/jbc.M111.241901; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Therien AG, 1999, J BIOL CHEM, V274, P12252, DOI 10.1074/jbc.274.18.12252; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Tulloch LB, 2011, J BIOL CHEM, V286, P36020, DOI 10.1074/jbc.M111.282145; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Venteo S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029852; Wetzel RK, 2004, J BIOL CHEM, V279, P41750, DOI 10.1074/jbc.M405622200; Wetzel RK, 2001, AM J PHYSIOL-RENAL, V281, pF531, DOI 10.1152/ajprenal.2001.281.3.F531; Yesil P, 2008, HISTOL HISTOPATHOL, V23, P883, DOI 10.14670/HH-23.883	37	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7077	7085		10.1074/jbc.M112.401190	http://dx.doi.org/10.1074/jbc.M112.401190			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23344951	Green Published, hybrid			2022-12-25	WOS:000316002400029
J	Aranda, A; Campo, P; Palacin, A; Dona, I; Gomez-Casado, C; Galindo, L; Diaz-Perales, A; Blanca, M				Aranda, Ana; Campo, Paloma; Palacin, Arantxa; Dona, Inmaculada; Gomez-Casado, Cristina; Galindo, Luisa; Diaz-Perales, Araceli; Blanca, Miguel			Antigenic Proteins Involved in Occupational Rhinitis and Asthma Caused by Obeche Wood (Triplochiton Scleroxylon)	PLOS ONE			English	Article							THAUMATIN-LIKE PROTEINS; CROSS-REACTIVITY; DUST EXPOSURE; IGE; IDENTIFICATION; ALLERGEN; WORKERS; POLLEN; SENSITIZATION; DETERMINANTS	Background: Obeche wood dust is a known cause of occupational asthma where an IgE-mediated mechanism has been demonstrated. Objective: To characterize the allergenic profile of obeche wood dust and evaluate the reactivity of the proteins by in vitro, ex vivo and in vivo assays in carpenters with confirmed rhinitis and/or asthma Materials and methods: An in-house obeche extract was obtained, and two IgE binding bands were purified (24 and 12 kDa) and sequenced by N-terminal identity. Specific IgE and IgG, basophil activation tests and skin prick tests (SPTs) were performed with whole extract and purified proteins. CCD binding was analyzed by ELISA inhibition studies. Results: Sixty-two subjects participated: 12 with confirmed occupational asthma/rhinitis (ORA+), 40 asymptomatic exposed (ORA-), and 10 controls. Of the confirmed subjects, 83% had a positive SPT to obeche. There was a 100% recognition by ELISA in symptomatic subjects vs. 30% and 10% in asymptomatic exposed subjects and controls respectively (p < 0.05). Two new proteins were purified, a 24 kDa protein identified as a putative thaumatin-like protein and a 12 kDa gamma-expansin. Both showed allergenic activity in vitro, with the putative thaumatin being the most active, with 92% recognition by ELISA and 100% by basophil activation test in ORA+ subjects. Cross-reactivity due to CCD was ruled out in 82% of cases. Conclusions: Two proteins of obeche wood were identified and were recognized by a high percentage of symptomatic subjects and by a small proportion of asymptomatic exposed subjects. Further studies are required to evaluate cross reactivity with other plant allergens.	[Aranda, Ana] Carlos Haya Hosp, Allergy Res Lab, Malaga, Spain; [Campo, Paloma; Dona, Inmaculada; Galindo, Luisa; Blanca, Miguel] Carlos Haya Hosp, Unidad Gest Clin Allergy, Malaga, Spain; [Palacin, Arantxa; Gomez-Casado, Cristina; Diaz-Perales, Araceli] Ctr Plant Biotechnol & Genom, Dept Biotechnol, Madrid, Spain	Hospital Carlos Haya; Hospital Carlos Haya; Universidad Politecnica de Madrid; Centro de Investigacion en Biotecnologia Genomica de Plantas (CBGP)	Campo, P (corresponding author), Carlos Haya Hosp, Unidad Gest Clin Allergy, Malaga, Spain.	campomozo@yahoo.com	Gomez-Casado, Cristina/AAE-4826-2021; Díaz-Perales, Araceli/D-8433-2016; Gomez-Casado, Cristina/K-4031-2016	Díaz-Perales, Araceli/0000-0002-1093-3627; Gomez-Casado, Cristina/0000-0002-7707-6367	Ministry of Health grant [FIS/PI071175]; Andalusian Health Division grants [PI-0182/2008]; Spanish Society of Allergy, Ministry of Science and Innovation-DGI, Spain [BIO2009-07050]; Thematic Network FIS-RIRAAF [RD07/0064]	Ministry of Health grant; Andalusian Health Division grants; Spanish Society of Allergy, Ministry of Science and Innovation-DGI, Spain; Thematic Network FIS-RIRAAF	Financial Support: Ministry of Health grant FIS/PI071175; Andalusian Health Division grants PI-0182/2008; grant from the Spanish Society of Allergy, Ministry of Science and Innovation-DGI, Spain (grant BIO2009-07050); and Thematic Network FIS-RIRAAF (RD07/0064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breiteneder H, 2004, ALLERGY, V59, P479, DOI 10.1046/j.1398-9995.2003.00421.x; BURNEY PGJ, 1989, EUR RESPIR J, V2, P940; Campo P, 2010, ANN ALLERG ASTHMA IM, V105, P24, DOI 10.1016/j.anai.2010.05.002; Ceccardi TL, 1998, PLANT MOL BIOL, V38, P775, DOI 10.1023/A:1006039016393; Chan-Yeung M, 2006, ASTHMA WORKPLACE, P505; Cosgrove DJ, 1997, P NATL ACAD SCI USA, V94, P6559, DOI 10.1073/pnas.94.12.6559; Diaz-Perales A, 2000, CLIN EXP ALLERGY, V30, P1403, DOI 10.1046/j.1365-2222.2000.00909.x; DREBORG S, 1993, ALLERGY, V48, P49, DOI 10.1111/j.1398-9995.1993.tb04756.x; Fernandez-Nieto M, 2006, INT ARCH OCC ENV HEA, V79, P483, DOI 10.1007/s00420-005-0078-z; Fernandez-Rivas M, 2006, J ALLERGY CLIN IMMUN, V118, P481, DOI 10.1016/j.jaci.2006.05.012; Ferrer A, 2001, J INVEST ALLERG CLIN, V11, P199; Gavrovic-Jankulovic M, 2002, J ALLERGY CLIN IMMUN, V110, P805, DOI 10.1067/mai.2002.128947; HINOJOSA M, 1986, CLIN ALLERGY, V16, P145, DOI 10.1111/j.1365-2222.1986.tb00758.x; Kauppinen T, 2006, ANN OCCUP HYG, V50, P549, DOI [10.1093/annhyg/mel013, 10.1093/annhyg/me1013]; Kespohl S, 2005, ALLERGY, V60, P808, DOI 10.1111/j.1398-9995.2005.00794.x; Kespohl S, 2010, CLIN EXP ALLERGY, V40, P1099, DOI 10.1111/j.1365-2222.2010.03514.x; Kespohl S, 2008, SCAND J WORK ENV HEA, V34, P387, DOI 10.5271/sjweh.1285; Kespohl S, 2012, INT ARCH ALLERGY IMM, V157, P202, DOI 10.1159/000324953; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li Y, 2002, PLANT PHYSIOL, V128, P854, DOI 10.1104/pp.010658; Malmberg PO, 1996, AM J RESP CRIT CARE, V153, P948, DOI 10.1164/ajrccm.153.3.8630578; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Palacin A, 2010, CLIN EXP ALLERGY, V40, P1422, DOI 10.1111/j.1365-2222.2010.03578.x; Perez-Rios M, 2010, ALLERGY, V65, P467, DOI 10.1111/j.1398-9995.2009.02166.x; Quirce S, 2000, J ALLERGY CLIN IMMUN, V106, P400, DOI 10.1067/mai.2000.107601; Quirce S, 2004, J ALLERGY CLIN IMMUN, V113, P361, DOI 10.1016/j.jaci.2003.11.018; REIJULA K, 1994, THORAX, V49, P622, DOI 10.1136/thx.49.6.622; Rondon C, 2007, J ALLERGY CLIN IMMUN, V119, P899, DOI 10.1016/j.jaci.2007.01.006; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Schlunssen V, 2008, ANN OCCUP HYG, V52, P227, DOI 10.1093/annhyg/men012; Skovsted TA, 2003, ALLERGY, V58, P772, DOI 10.1034/j.1398-9995.2003.00127.x; Torres MJ, 2004, CLIN EXP ALLERGY, V34, P1768, DOI 10.1111/j.1365-2222.2004.02110.x; TSE KS, 1982, CLIN ALLERGY, V12, P249, DOI 10.1111/j.1365-2222.1982.tb02525.x; Venturini M, 2004, ALLERGY, V59, P225, DOI 10.1046/j.13989995.2003.00137.x; Vidal C, 2006, ANN ALLERG ASTHMA IM, V96, P870, DOI 10.1016/S1081-1206(10)61352-X	35	16	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53926	10.1371/journal.pone.0053926	http://dx.doi.org/10.1371/journal.pone.0053926			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349765	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000314019100037
J	Li, L; Zhang, ZG; Lei, H; Wang, C; Wu, LP; Wang, JY; Fu, FY; Zhu, WG; Wu, LL				Li, Li; Zhang, Zhi-Guo; Lei, Hong; Wang, Cheng; Wu, Li-Peng; Wang, Jin-Yu; Fu, Feng-Ying; Zhu, Wei-Guo; Wu, Li-Ling			Angiotensin II Reduces Cardiac AdipoR1 Expression through AT1 Receptor/ROS/ERK1/2/c-Myc Pathway	PLOS ONE			English	Article							ADIPONECTIN RECEPTOR EXPRESSION; LEFT-VENTRICULAR HYPERTROPHY; PLASMA ADIPONECTIN; NADPH OXIDASES; RAT CARDIOMYOCYTES; INFARCTED HEART; GENE-EXPRESSION; C-MYC; HYPERTENSION; INSULIN	Adiponectin, an abundant adipose tissue-derived protein, exerts protective effect against cardiovascular disease. Adiponectin receptors (AdipoR1 and AdipoR2) mediate the beneficial effects of adiponectin on the cardiovascular system. However, the alteration of AdipoRs in cardiac remodeling is not fully elucidated. Here, we investigated the effect of angiotensin II (AngII) on cardiac AdipoRs expression and explored the possible molecular mechanism. AngII infusion into rats induced cardiac hypertrophy, reduced AdipoR1 but not AdipoR2 expression, and attenuated the phosphorylations of adenosine monophosphate-activated protein kinase and acetyl coenzyme A carboxylase, and those effects were all reversed by losartan, an AngII type 1 (AT1) receptor blocker. AngII reduced expression of AdipoR1 mRNA and protein in cultured neonatal rat cardiomyocytes, which was abolished by losartan, but not by PD123319, an AT2 receptor antagonist. The antioxidants including reactive oxygen species (ROS) scavenger NAC, NADPH oxidase inhibitor apocynin, Nox2 inhibitor peptide gp91 ds-tat, and mitochondrial electron transport chain complex I inhibitor rotenone attenuated AngII-induced production of ROS and phosphorylation of extracellular signal-regulated kinase (ERK) 1/2. AngII-reduced AdipoR1 expression was reversed by pretreatment with NAC, apocynin, gp91 ds-tat, rotenone, and an ERK1/2 inhibitor PD98059. Chromatin immunoprecipitation assay demonstrated that AngII provoked the recruitment of c-Myc onto the promoter region of AdipoR1, which was attenuated by PD98059. Moreover, AngII-induced DNA binding activity of c-Myc was inhibited by losartan, NAC, apocynin, gp91 ds-tat, rotenone, and PD98059. c-Myc small interfering RNA abolished the inhibitory effect of AngII on AdipoR1 expression. Our results suggest that AngII inhibits cardiac AdipoR1 expression in vivo and in vitro and AT1 receptor/ROS/ERK1/2/c-Myc pathway is required for the downregulation of AdipoR1 induced by AngII.	[Li, Li; Zhang, Zhi-Guo; Lei, Hong; Wang, Cheng; Wang, Jin-Yu; Wu, Li-Ling] Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China; [Li, Li; Zhang, Zhi-Guo; Lei, Hong; Wang, Cheng; Wang, Jin-Yu; Wu, Li-Ling] Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing, Peoples R China; [Wu, Li-Peng; Zhu, Wei-Guo] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China; [Fu, Feng-Ying] Minist Hlth, Key Lab Cardiovasc Mol Biol & Regulatory Peptides, Beijing, Peoples R China	Peking University; Peking University	Wu, LL (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China.	pathophy@bjmu.edu.cn	zhu, wei-guo/E-1334-2012	Zhu, Wei-Guo/0000-0001-8385-6581	National Nature Science Foundation of China [30871014, 30973316]; National Basic Research Program of China (973 Program) [2007CB512004]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by grants from the National Nature Science Foundation of China (Nos. 30871014 and 30973316) and the National Basic Research Program of China (973 Program 2007CB512004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; Afanas'ev I, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/293769; Ahuja P, 2010, J CLIN INVEST, V120, P1494, DOI 10.1172/JCI38331; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bendall JK, 2002, CIRCULATION, V105, P293, DOI 10.1161/hc0302.103712; Brandes RP, 2010, FREE RADICAL BIO MED, V49, P687, DOI 10.1016/j.freeradbiomed.2010.04.030; Chang SP, 2006, EUR J APPL PHYSIOL, V97, P189, DOI 10.1007/s00421-006-0163-3; Cui XB, 2012, CARDIOVASC RES, V93, P69, DOI 10.1093/cvr/cvr273; De Giusti VC, 2009, J MOL CELL CARDIOL, V47, P716, DOI 10.1016/j.yjmcc.2009.07.023; Delaney J, 2008, NEUROCHEM RES, V33, P545, DOI 10.1007/s11064-007-9474-y; Dikalov S, 2011, FREE RADICAL BIO MED, V51, P1289, DOI 10.1016/j.freeradbiomed.2011.06.033; Fang X, 2005, J MOL ENDOCRINOL, V35, P465, DOI 10.1677/jme.1.01877; Fu L, 2008, EUR J PHARMACOL, V584, P202, DOI 10.1016/j.ejphar.2008.01.028; Fujioka D, 2006, AM J PHYSIOL-HEART C, V290, pH2409, DOI 10.1152/ajpheart.00987.2005; Furuhashi M, 2003, HYPERTENSION, V42, P76, DOI 10.1161/01.HYP.0000078490.59735.6E; Guo ZX, 2011, J PHARM PHARMACOL, V63, P87, DOI 10.1111/j.2042-7158.2010.01157.x; Hong SJ, 2004, BLOOD PRESSURE, V13, P236, DOI 10.1080/08037050410021397; Hopkins TA, 2007, CARDIOVASC RES, V74, P11, DOI 10.1016/j.cardiores.2006.10.009; Iwashima Y, 2004, HYPERTENSION, V43, P1318, DOI 10.1161/01.HYP.0000129281.03801.4b; Kozakova M, 2008, J CLIN ENDOCR METAB, V93, P2811, DOI 10.1210/jc.2007-2580; Laskowski A, 2006, CARDIOVASC RES, V72, P112, DOI 10.1016/j.cardiores.2006.07.006; Li L, 2007, REGUL PEPTIDES, V139, P72, DOI 10.1016/j.regpep.2006.10.007; Li R, 2010, J MOL CELL CARDIOL, V49, P508, DOI 10.1016/j.yjmcc.2010.03.002; Liu S, 2011, EUR J PHARMACOL, V650, P384, DOI 10.1016/j.ejphar.2010.09.082; Looi YH, 2008, HYPERTENSION, V51, P319, DOI 10.1161/HYPERTENSIONAHA.107.101980; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; McWhinney CD, 1998, J MOL CELL CARDIOL, V30, P751, DOI 10.1006/jmcc.1998.0639; Mitsuhashi H, 2007, HYPERTENSION, V49, P1448, DOI 10.1161/HYPERTENSIONAHA.106.079509; Paakko T, 2010, ANN MED, V42, P131, DOI 10.3109/07853890903449827; Park J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023211; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Ran JM, 2006, METABOLISM, V55, P478, DOI 10.1016/j.metabol.2005.10.009; Rasmussen MS, 2006, OBESITY, V14, P28, DOI 10.1038/oby.2006.5; Gonzalez CR, 2010, PHYSIOL BEHAV, V99, P91, DOI 10.1016/j.physbeh.2009.10.015; Saito Y, 2007, AM J PHYSIOL-HEART C, V293, pH3490, DOI 10.1152/ajpheart.00310.2007; Santos CXC, 2011, FREE RADICAL BIO MED, V50, P777, DOI 10.1016/j.freeradbiomed.2011.01.003; Schauwienold D, 2003, HYPERTENSION, V41, P546, DOI 10.1161/01.HYP.0000054213.37471.84; Seddon M, 2007, HEART, V93, P903, DOI 10.1136/hrt.2005.068270; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Sun XL, 2008, FEBS LETT, V582, P3401, DOI 10.1016/j.febslet.2008.08.037; Toyz RM, 2002, BRAZ J MED BIOL RES, V35, P1001, DOI 10.1590/S0100-879X2002000900001; Tsuchida A, 2004, J BIOL CHEM, V279, P30817, DOI 10.1074/jbc.M402367200; Unger T, 2002, AM J CARDIOL, V89, p3A; Wade TE, 2009, J SURG RES, V154, P78, DOI 10.1016/j.jss.2008.05.006; Wu LP, 2008, MOL CELL BIOL, V28, P3219, DOI 10.1128/MCB.01516-07; Xiao GS, 2001, CIRC RES, V89, P1122, DOI 10.1161/hh2401.100742; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Zhang M, 2012, ANTIOXID REDOX SIGNA; Zhao YL, 2005, REGUL PEPTIDES, V128, P43, DOI 10.1016/j.regpep.2004.12.012; Zhong WG, 2006, EMBO J, V25, P3869, DOI 10.1038/sj.emboj.7601252	52	13	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e49915	10.1371/journal.pone.0049915	http://dx.doi.org/10.1371/journal.pone.0049915			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349663	Green Submitted, Green Published, gold			2022-12-25	WOS:000314019100005
J	Pal, M; Wunderlich, CM; Spohn, G; Bronneke, HS; Schmidt-Supprian, M; Wunderlich, FT				Pal, Martin; Wunderlich, Claudia M.; Spohn, Gabriele; Broenneke, Hella S.; Schmidt-Supprian, Marc; Wunderlich, F. Thomas			Alteration of JNK-1 Signaling in Skeletal Muscle Fails to Affect Glucose Homeostasis and Obesity-Associated Insulin Resistance in Mice	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ACTIVATED PROTEIN-KINASES; JUN NH2-TERMINAL KINASE; NF-KAPPA-B; METABOLIC SYNDROME; IKK-BETA; RECEPTOR; PHOSPHORYLATION; INHIBITION; STRESS	Obesity and associated metabolic disturbances, such as increased circulating fatty acids cause prolonged low grade activation of inflammatory signaling pathways in liver, skeletal muscle, adipose tissue and even in the CNS. Activation of inflammatory pathways in turn impairs insulin signaling, ultimately leading to obesity-associated type 2 diabetes mellitus. Conventional JNK-1 knock out mice are protected from high fat diet-induced insulin resistance, characterizing JNK-1-inhibition as a potential approach to improve glucose metabolism in obese patients. However, the cell type-specific role of elevated JNK-1 signaling as present during the course of obesity has not been fully elucidated yet. To investigate the functional contribution of altered JNK-1 activation in skeletal muscle, we have generated a ROSA26 insertion mouse strain allowing for Cre-activatable expression of a JNK-1 constitutive active construct (JNK(C)). To examine the consequence of skeletal muscle-restricted JNK-1 overactivation in the development of insulin resistance and glucose metabolism, JNK(C) mice were crossed to Mck-Cre mice yielding JNK(SM-C) mice. However, despite increased muscle-specific JNK activation, energy homeostasis and glucose metabolism in JNK(SM-C) mice remained largely unaltered compared to controls. In line with these findings, obese mice with skeletal muscle specific disruption of JNK-1, did not affect energy and glucose homeostasis. These experiments indicate that JNK-1 activation in skeletal muscle does not account for the major effects on diet-induced, JNK-1-mediated deterioration of insulin action and points towards a so far underappreciated role of JNK-1 in other tissues than skeletal muscle during the development of obesity-associated insulin resistance.	[Pal, Martin; Wunderlich, Claudia M.; Spohn, Gabriele; Wunderlich, F. Thomas] Univ Cologne, Inst Genet, Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [Pal, Martin; Wunderlich, Claudia M.; Spohn, Gabriele; Wunderlich, F. Thomas] CMMC, Cologne, Germany; [Broenneke, Hella S.] Cologne Excellence Cluster Cellular Stress Respon, Mouse Phenotyping Core Facil, Cologne, Germany; [Schmidt-Supprian, Marc] Max Planck Inst Biochem, Munich, Germany	Max Planck Society; University of Cologne; University of Cologne; University of Cologne; Max Planck Society	Wunderlich, FT (corresponding author), Univ Cologne, Inst Genet, Max Planck Inst Neurol Res, D-50931 Cologne, Germany.	Thomas.wunderlich@uni-koeln.de	Schmidt-Supprian, Marc/F-5893-2011; Pal, Martin/AAL-8685-2020	Schmidt-Supprian, Marc/0000-0002-8543-6166; Pal, Martin/0000-0002-1563-5426	DFG [SFB 832 A15, Z3, BR 1492/7-1]; Center for Molecular Medicine Cologne (CMMC) [D1, B2]; Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD); European Union [FP7-HEALTH-2009-241592]; Competence Network for Adipositas (Neurotarget); Federal Ministry of Education and Research [FKZ01GIO845]	DFG(German Research Foundation (DFG)); Center for Molecular Medicine Cologne (CMMC); Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD); European Union(European Commission); Competence Network for Adipositas (Neurotarget); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the DFG through SFB 832 A15 to FTW and Z3 to JCB, the Center for Molecular Medicine Cologne (CMMC) (D1 to JCB, B2 to FTW), the Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), the European Union (FP7-HEALTH-2009-241592, EurOCHIP, to JCB), the DFG (BR 1492/7-1 to JCB), and the Competence Network for Adipositas (Neurotarget) funded by the Federal Ministry of Education and Research (FKZ01GIO845 to JCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Barr RK, 2001, INT J BIOCHEM CELL B, V33, P1047, DOI 10.1016/S1357-2725(01)00093-0; Belgardt BF, P NATL ACAD SCI US, V107, P6028; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; Farese RV, 2007, J CLIN INVEST, V117, P2289, DOI 10.1172/JCI31408; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; HOTAMISLIGIL GS, 1994, J CLIN INVEST, V94, P1543, DOI 10.1172/JCI117495; Inoue H, 2006, CELL METAB, V3, P267, DOI 10.1016/j.cmet.2006.02.009; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Kyriakis JM, 1995, ANN NY ACAD SCI, V766, P303, DOI 10.1111/j.1749-6632.1995.tb26683.x; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Plomgaard P, 2005, DIABETES, V54, P2939, DOI 10.2337/diabetes.54.10.2939; Plum L, 2006, J CLIN INVEST, V116, P1886, DOI 10.1172/JCI27123; Rohl M, 2004, J CLIN INVEST, V113, P474, DOI 10.1172/JCI200418712; Sabio G, MOL CELL BIOL, V30, P106; Sabio G, GENES DEV, V24, P256; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Sabio G, 2009, CELL METAB, V10, P491, DOI 10.1016/j.cmet.2009.09.007; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Vallerie SN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003151; Wang YB, 1998, J BIOL CHEM, V273, P5423, DOI 10.1074/jbc.273.10.5423; Whitham M, J BIOL CHEM; Whitmarsh AJ, 2001, METHOD ENZYMOL, V332, P319; Wunderlich FT, 2008, P NATL ACAD SCI USA, V105, P1297, DOI 10.1073/pnas.0707849104; Zheng CJ, 1999, J BIOL CHEM, V274, P28966, DOI 10.1074/jbc.274.41.28966	38	29	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54247	10.1371/journal.pone.0054247	http://dx.doi.org/10.1371/journal.pone.0054247			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349837	gold, Green Published			2022-12-25	WOS:000313738900057
J	Herbert, C; Kubler, A; Vogele, C				Herbert, Cornelia; Kuebler, Andrea; Voegele, Claus			Risk for Eating Disorders Modulates Startle-Responses to Body Words	PLOS ONE			English	Article							ANOREXIA-NERVOSA; BULIMIA-NERVOSA; IMAGE DISTORTION; EXPOSURE; STIMULI; CUES; PREDICTORS; PERCEPTION; AMYGDALA; EMOTION	Body image disturbances are core symptoms of eating disorders (EDs). Recent evidence suggests that changes in body image may occur prior to ED onset and are not restricted to in-vivo exposure (e. g. mirror image), but also evident during presentation of abstract cues such as body shape and weight-related words. In the present study startle modulation, heart rate and subjective evaluations were examined during reading of body words and neutral words in 41 student female volunteers screened for risk of EDs. The aim was to determine if responses to body words are attributable to a general negativity bias regardless of ED risk or if activated, ED relevant negative body schemas facilitate priming of defensive responses. Heart rate and word ratings differed between body words and neutral words in the whole female sample, supporting a general processing bias for body weight and shape-related concepts in young women regardless of ED risk. Startle modulation was specifically related to eating disorder symptoms, as was indicated by significant positive correlations with self-reported body dissatisfaction. These results emphasize the relevance of examining body schema representations as a function of ED risk across different levels of responding. Peripheral-physiological measures such as the startle reflex could possibly be used as predictors of females' risk for developing EDs in the future.	[Herbert, Cornelia; Kuebler, Andrea] Univ Wurzburg, Dept Psychol 1, D-97070 Wurzburg, Germany; [Herbert, Cornelia] German Sport Univ Cologne, Inst Psychol, Cologne, Germany; [Voegele, Claus] Univ Luxembourg, Res Unit INSIDE, Luxembourg, Luxembourg	University of Wurzburg; German Sport University Cologne; University of Luxembourg	Herbert, C (corresponding author), Univ Wurzburg, Dept Psychol 1, D-97070 Wurzburg, Germany.	cornelia.herbert@psychologie.uni-wuerzburg.de	Vögele, Claus/I-5682-2013	Kubler, Andrea/0000-0003-4876-0415; Vogele, Claus/0000-0001-8086-0788	German Research Foundation (DFG); University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	The study was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATTIE I, 1989, DEV PSYCHOL, V25, P70, DOI 10.1037/0012-1649.25.1.70; Beato-Fernandez L, 2004, EUR CHILD ADOLES PSY, V13, P287, DOI 10.1007/s00787-004-0407-x; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; Bradley MM, 2006, PSYCHOPHYSIOLOGY, V43, P486, DOI 10.1111/j.1469-8986.2006.00412.x; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brewis AA, 2011, SOC SCI MED, V73, P491, DOI 10.1016/j.socscimed.2011.05.048; Dobson KS, 2004, CLIN PSYCHOL REV, V23, P1001, DOI 10.1016/j.cpr.2003.09.004; Dolcos F, 2004, NEURON, V42, P855, DOI 10.1016/S0896-6273(04)00289-2; Engel Scott G, 2006, Eat Behav, V7, P368, DOI 10.1016/j.eatbeh.2005.12.002; Friederich HC, 2006, PSYCHOL MED, V36, P1327, DOI 10.1017/S0033291706008129; GARNER DM, 1982, PSYCHOL MED, V12, P871, DOI 10.1017/S0033291700049163; GARNER DM, 1983, INT J EAT DISORDER, V2, P15, DOI 10.1002/1098-108X(198321)2:2<15::AID-EAT2260020203>3.0.CO;2-6; Gaudio S, 2012, NEUROSCI BIOBEHAV R, V79, P113; Gibson L., 2010, OXFORD HDB EATING DI, P180; Grabe S, 2008, PSYCHOL BULL, V134, P460, DOI 10.1037/0033-2909.134.3.460; Grogan S., 2008, BODY IMAGE UNDERSTAN, V2nd; Hautzinger M, 1994, BECK DEPRESSIONS INV; Hazlett EA, 2007, BIOL PSYCHIAT, V62, P250, DOI 10.1016/j.biopsych.2006.10.028; Herbert C, 2011, COGN AFFECT BEHAV NE, V11, P199, DOI 10.3758/s13415-011-0026-1; Herbert C, 2010, INT J PSYCHOPHYSIOL, V76, P64, DOI 10.1016/j.ijpsycho.2010.02.004; Hilbert A, 2002, J PSYCHOSOM RES, V52, P137, DOI 10.1016/S0022-3999(01)00314-2; Johansson Linda, 2005, Eat Behav, V6, P271, DOI 10.1016/j.eatbeh.2004.11.001; Johnson G, 1987, BULIMIA NERVOSA BIOP; Kenardy J, 2001, EUR EAT DISORD REV, V9, P242, DOI 10.1002/erv.388; Kissler J, 2007, PSYCHOL SCI, V18, P475, DOI 10.1111/j.1467-9280.2007.01924.x; Knost B, 1997, PSYCHOPHYSIOLOGY, V34, P474, DOI 10.1111/j.1469-8986.1997.tb02392.x; Lang PJ, 2010, BIOL PSYCHOL, V84, P437, DOI 10.1016/j.biopsycho.2009.10.007; Lang PJ, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P97; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; Laux L., 1981, STATE TRAIT ANGSTINV; Lee M, 2004, CLIN PSYCHOL REV, V24, P215, DOI 10.1016/j.cpr.2003.10.004; Mauler BI, 2006, J ABNORM PSYCHOL, V115, P567, DOI 10.1037/0021-843X.115.3.567; Miyake Y, 2010, NEUROIMAGE, V50, P1333, DOI 10.1016/j.neuroimage.2009.12.095; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Sanchez-Navarro JP, 2006, INT J PSYCHOPHYSIOL, V61, P34, DOI 10.1016/j.ijpsycho.2005.10.023; Seeger G, 2002, NEUROSCI LETT, V326, P25, DOI 10.1016/S0304-3940(02)00312-9; Sepulvea, 2002, PSYCHOL SPAIN, V6, P83; Shirao N, 2005, BRIT J PSYCHIAT, V186, P48, DOI 10.1192/bjp.186.1.48; Shirao N, 2003, BRAIN SCI MENT DISOR, V14, P141; Smeesters D, 2010, J CONSUM RES, V36, P930, DOI 10.1086/648688; Smeets MAM, 1999, J PSYCHOSOM RES, V46, P465, DOI 10.1016/S0022-3999(99)00005-7; Smeets MAM, 2001, INT J EAT DISORDER, V29, P409, DOI 10.1002/eat.1037; Spresser CD, 2012, BODY IMAGE, V9, P298, DOI 10.1016/j.bodyim.2011.12.005; Stice E, 2011, BEHAV RES THER, V49, P622, DOI 10.1016/j.brat.2011.06.009; Stice E, 2010, J CHILD PSYCHOL PSYC, V51, P518, DOI 10.1111/j.1469-7610.2010.02212.x; Striegel-Moore Ruth H., 1993, P144; Tuschen-Caffier B, 2003, BEHAV RES THER, V41, P573, DOI 10.1016/S0005-7967(02)00030-X; Uher R, 2005, BIOL PSYCHIAT, V58, P990, DOI 10.1016/j.biopsych.2005.06.001; Vila J, 2007, INT J PSYCHOPHYSIOL, V66, P169, DOI 10.1016/j.ijpsycho.2007.07.004; VITOUSEK KB, 1990, COGNITIVE THER RES, V14, P191, DOI 10.1007/BF01176209; Vo MLH, 2009, BEHAV RES METHODS, V41, P534, DOI 10.3758/BRM.41.2.534; Vocks S, 2007, J PSYCHOSOM RES, V62, P231, DOI 10.1016/j.jpsychores.2006.08.007; Vocks S, 2010, J PSYCHIATR NEUROSCI, V35, P163, DOI 10.1503/jpn.090048; Wagner A, 2003, NEUROREPORT, V14, P2193, DOI 10.1097/00001756-200312020-00012; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	55	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53667	10.1371/journal.pone.0053667	http://dx.doi.org/10.1371/journal.pone.0053667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072OV	23341969	Green Published, Green Submitted, gold			2022-12-25	WOS:000313682700033
J	Sapkota, Y; Ghosh, S; Lai, R; Coe, BP; Cass, CE; Yasui, Y; Mackey, JR; Damaraju, S				Sapkota, Yadav; Ghosh, Sunita; Lai, Raymond; Coe, Bradley P.; Cass, Carol E.; Yasui, Yutaka; Mackey, John R.; Damaraju, Sambasivarao			Germline DNA Copy Number Aberrations Identified as Potential Prognostic Factors for Breast Cancer Recurrence	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENE POLYMORPHISMS; NEUTRAL LOSS; UNIPARENTAL DISOMY; SUSCEPTIBILITY; RISK; HETEROZYGOSITY; COMMON; CONSEQUENCES; NUCLEOTIDE	Breast cancer recurrence (BCR) is a common treatment outcome despite curative-intent primary treatment of non-metastatic breast cancer. Currently used prognostic and predictive factors utilize tumor-based markers, and are not optimal determinants of risk of BCR. Germline-based copy number aberrations (CNAs) have not been evaluated as determinants of predisposition to experience BCR. In this study, we accessed germline DNA from 369 female breast cancer subjects who received curative-intent primary treatment following diagnosis. Of these, 155 experienced BCR and 214 did not, after a median duration of follow up after breast cancer diagnosis of 6.35 years (range = 0.60-21.78) and 8.60 years (range = 3.08-13.57), respectively. Whole genome CNA genotyping was performed on the Affymetrix SNP array 6.0 platform. CNAs were identified using the SNP-Fast Adaptive States Segmentation Technique 2 algorithm implemented in Nexus Copy Number 6.0. Six samples were removed due to poor quality scores, leaving 363 samples for further analysis. We identified 18,561 CNAs with >= 1 kb as a predefined cut-off for observed aberrations. Univariate survival analyses (log-rank tests) identified seven CNAs (two copy number gains and five copy neutral-loss of heterozygosities, CN-LOHs) showing significant differences (P < 2.01 x 10(-5)) in recurrence-free survival (RFS) probabilities with and without CNAs. We also observed three additional but distinct CN-LOHs showing significant differences in RFS probabilities (P < 2.86 x 10(-5)) when analyses were restricted to stratified cases (luminal A, n = 208) only. After adjusting for tumor stage and grade in multivariate analyses (Cox proportional hazards models), all the CNAs remained strongly associated with the phenotype of BCR. Of these, we confirmed three CNAs at 17q11.2, 11q13.1 and 6q24.1 in representative samples using independent genotyping platforms. Our results suggest further investigations on the potential use of germline DNA variations as prognostic markers in cancer-associated phenotypes.	[Sapkota, Yadav; Ghosh, Sunita; Lai, Raymond; Cass, Carol E.; Mackey, John R.; Damaraju, Sambasivarao] Cross Canc Inst, Alberta Hlth Serv, Edmonton, AB T6G 1Z2, Canada; [Sapkota, Yadav; Lai, Raymond; Damaraju, Sambasivarao] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Ghosh, Sunita; Cass, Carol E.; Mackey, John R.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Coe, Bradley P.] Univ Washington, Dept Genome Sci, Sch Med, Seattle, WA USA; [Yasui, Yutaka] Univ Alberta, Dept Publ Hlth Sci, Edmonton, AB, Canada	Alberta Health Services (AHS); University of Alberta; University of Alberta; University of Alberta; University of Washington; University of Washington Seattle; University of Alberta	Damaraju, S (corresponding author), Cross Canc Inst, Alberta Hlth Serv, Edmonton, AB T6G 1Z2, Canada.	Sambasivarao.Damaraju@albertahealthservices.ca	Yasui, Yutaka/E-2564-2015; Sapkota, Yadav/O-2142-2015; Coe, Bradley/A-2878-2009	Yasui, Yutaka/0000-0002-7717-8638; Sapkota, Yadav/0000-0001-5943-9454; Coe, Bradley/0000-0001-8471-4016	Alberta Cancer Foundation; Alberta Cancer Prevention and Legacy Fund; CBCF-Prairies/NWT Region; Alberta Cancer Research Institute (ACRI); CBCF operating grants; Alberta Cancer Board (ACB); Canadian Institute of Health Research, Canada	Alberta Cancer Foundation; Alberta Cancer Prevention and Legacy Fund; CBCF-Prairies/NWT Region; Alberta Cancer Research Institute (ACRI); CBCF operating grants; Alberta Cancer Board (ACB); Canadian Institute of Health Research, Canada(Canadian Institutes of Health Research (CIHR))	The authors would like to acknowledge Alberta Cancer Foundation, Alberta Cancer Prevention and Legacy Fund, managed by Alberta Innovates-Health Solutions and CBCF-Prairies/NWT Region for funding support to the CBCF Tumor Bank. Funding for this project was provided by Alberta Cancer Research Institute (ACRI), CBCF operating grants and Alberta Cancer Board (ACB) operating grants to SD. BPC is supported by a post-doctoral fellowship from Canadian Institute of Health Research, Canada. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein L, 2011, JNCI-J NATL CANCER I, V103, P451, DOI 10.1093/jnci/djr046; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bray J, 2010, BRIT J CANCER, V102, P1003, DOI 10.1038/sj.bjc.6605587; Canadian Cancer Society's Steering Committee, 2011, CAN CANC STAT 2011; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Grube M, 2007, DRUG METAB DISPOS, V35, P30, DOI 10.1124/dmd.106.011411; Guedj M, 2012, ONCOGENE, V31, P1196, DOI 10.1038/onc.2011.301; Henrichsen CN, 2009, HUM MOL GENET, V18, pR1, DOI 10.1093/hmg/ddp011; Koontz JI, 2001, P NATL ACAD SCI USA, V98, P6348, DOI 10.1073/pnas.101132598; Krepischi ACV, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3109; Kryh H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-443; Kuiper RP, 2010, CURR OPIN GENET DEV, V20, P282, DOI 10.1016/j.gde.2010.03.005; Lapunzina P, 2011, BIOL CELL, V103, P303, DOI 10.1042/BC20110013; Lin WY, 2011, J MED GENET, V48, P477, DOI 10.1136/jmedgenet-2011-100018; Makishima H, 2011, CLIN CANCER RES, V17, P3913, DOI 10.1158/1078-0432.CCR-10-2900; Martin DN, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-257; McShane LM, 2005, BRIT J CANCER, V93, P387, DOI 10.1038/sj.bjc.6602678; Melcher R, 2011, CARCINOGENESIS, V32, P636, DOI 10.1093/carcin/bgr011; Mohamedali A, 2007, BLOOD, V110, P3365, DOI 10.1182/blood-2007-03-079673; Nakajima T, 2008, CYTOGENET GENOME RES, V123, P156, DOI 10.1159/000184703; O'Keefe C, 2010, BLOOD, V115, P2731, DOI 10.1182/blood-2009-10-201848; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reynolds PA, 2006, J BIOL CHEM, V281, P24790, DOI 10.1074/jbc.M604175200; Saeki H, 2011, CLIN CANCER RES, V17, P1731, DOI 10.1158/1078-0432.CCR-10-1996; Sapkota Y, 2012, EUR J HUM GENET, V20, P682, DOI 10.1038/ejhg.2011.273; Sehrawat B, 2011, HUM GENET, V130, P529, DOI 10.1007/s00439-011-0973-1; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shlien A, 2010, CURR OPIN ONCOL, V22, P55, DOI 10.1097/CCO.0b013e328333dca4; Shu XO, 2012, CANCER RES, V72, P1182, DOI 10.1158/0008-5472.CAN-11-2561; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van der Leij F, 2012, SEMIN RADIAT ONCOL, V22, P100, DOI 10.1016/j.semradonc.2011.12.001; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Wang LW, 2010, CANCER RES, V70, P319, DOI 10.1158/0008-5472.CAN-09-3224; Weigel MT, 2010, ENDOCR-RELAT CANCER, V17, pR245, DOI 10.1677/ERC-10-0136; Yoshihara K, 2011, GENE CHROMOSOME CANC, V50, P167, DOI 10.1002/gcc.20841; Zickler AM, 2012, HUM MUTAT, V33, P372, DOI 10.1002/humu.21644	45	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53850	10.1371/journal.pone.0053850	http://dx.doi.org/10.1371/journal.pone.0053850			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342018	gold, Green Submitted, Green Published			2022-12-25	WOS:000313682700051
J	Schadow, S; Siebert, HC; Lochnit, G; Kordelle, J; Rickert, M; Steinmeyer, J				Schadow, Saskia; Siebert, Hans-Christian; Lochnit, Guenter; Kordelle, Jens; Rickert, Markus; Steinmeyer, Juergen			Collagen Metabolism of Human Osteoarthritic Articular Cartilage as Modulated by Bovine Collagen Hydrolysates	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; NITRIC-OXIDE; ADAMTS4 AGGRECANASE-1; DEGRADED COLLAGEN; JOINT DISEASE; II COLLAGEN; CHONDROCYTES; EXPRESSION; FRAGMENTS; MATRIX	Destruction of articular cartilage is a characteristic feature of osteoarthritis (OA). Collagen hydrolysates are mixtures of collagen peptides and have gained huge public attention as nutriceuticals used for prophylaxis of OA. Here, we evaluated for the first time whether different bovine collagen hydrolysate preparations indeed modulate the metabolism of collagen and proteoglycans from human OA cartilage explants and determined the chemical composition of oligopeptides representing collagen fragments. Using biophysical techniques, like MALDI-TOF-MS, AFM, and NMR, the molecular weight distribution and aggregation behavior of collagen hydrolysates from bovine origin (CH-Alpha (R), Peptan (TM) B 5000, Peptan (TM) B 2000) were determined. To investigate the metabolism of human femoral OA cartilage, explants were obtained during knee replacement surgery. Collagen synthesis of explants as modulated by 0-10 mg/ml collagen hydrolysates was determined using a novel dual radiolabeling procedure. Proteoglycans, NO, PGE(2), MMP-1, -3, -13, TIMP-1, collagen type II, and cell viability were determined in explant cultures. Groups of data were analyzed using ANOVA and the Friedman test (n = 5-12). The significance was set to p <= 0.05. We found that collagen hydrolysates obtained from different sources varied with respect to the width of molecular weight distribution, average molecular weight, and aggregation behavior. None of the collagen hydrolysates tested stimulated the biosynthesis of collagen. Peptan (TM) B 5000 elevated NO and PGE(2) levels significantly but had no effect on collagen or proteoglycan loss. All collagen hydrolysates tested proved not to be cytotoxic. Together, our data demonstrate for the first time that various collagen hydrolysates differ with respect to their chemical composition of collagen fragments as well as by their pharmacological efficacy on human chondrocytes. Our study underscores the importance that each collagen hydrolysate preparation should first demonstrate its pharmacological potential both in vitro and in vivo before being used for both regenerative medicine and prophylaxis of OA.	[Schadow, Saskia; Rickert, Markus; Steinmeyer, Juergen] Univ Hosp Giessen & Marburg, Dept Orthoped, Giessen, Germany; [Siebert, Hans-Christian] RI B NT Res Inst Bioinformat & Nanotechnol, Kiel, Germany; [Lochnit, Guenter] Univ Giessen, Dept Biochem, D-35390 Giessen, Germany; [Kordelle, Jens] Agaples Evangel Hosp Mittelhessen, Giessen, Germany	University Hospital of Giessen & Marburg; Justus Liebig University Giessen	Steinmeyer, J (corresponding author), Univ Hosp Giessen & Marburg, Dept Orthoped, Giessen, Germany.	Juergen.Steinmeyer@ortho.med.uni-giessen.de	Rickert, Markus/D-8731-2017	Rickert, Markus/0000-0001-7681-9918; Steinmeyer, Juergen/0000-0002-4053-503X	DRB-Foundation	DRB-Foundation	Supported in part by a grant of the DRB-Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aigner T, 2007, CURR DRUG TARGETS, V8, P325, DOI 10.2174/138945007779940070; Aigner T, 2001, ARTHRITIS RHEUM-US, V44, P2777, DOI 10.1002/1529-0131(200112)44:12<2777::AID-ART465>3.0.CO;2-H; Aigner T, 2006, ARTHRITIS RHEUM-US, V54, P3533, DOI 10.1002/art.22174; Attur M, 2008, J IMMUNOL, V181, P5082, DOI 10.4049/jimmunol.181.7.5082; Bank RA, 1997, MATRIX BIOL, V16, P233, DOI 10.1016/S0945-053X(97)90012-3; BAYLISS MT, 1978, BIOCHEM J, V176, P683, DOI 10.1042/bj1760683; Bello AE, 2006, CURR MED RES OPIN, V22, P2221, DOI 10.1185/030079906X148373; Benito-Ruiz P, 2009, INT J FOOD SCI NUTR, V60, P99, DOI 10.1080/09637480802498820; Clark KL, 2008, CURR MED RES OPIN, V24, P1485, DOI 10.1185/030079908X291967 ; Collins DH, 1949, PATHOLOGY ARTICULAR, P76; European Food Safety Authority, 2005, EFSA J, V174, P1; European Food Safety Authority (EFSA), 2011, EFSA J, V9, P2291; Fan ZY, 2005, ARTHRITIS RHEUM-US, V52, P136, DOI 10.1002/art.20725; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Fichter A, 2006, J ORTHOP RES, V24, P63, DOI 10.1002/jor.20001; FUKUDA K, 1995, INFLAMM RES, V44, P434, DOI 10.1007/BF01757700; Fukui N, 2008, ARTHRITIS RHEUM-US, V58, P154, DOI 10.1002/art.23175; Goldring MB, 2006, BEST PRACT RES CL RH, V20, P1003, DOI 10.1016/j.berh.2006.06.003; Goldring MB, 2004, CLIN ORTHOP RELAT R, pS37, DOI 10.1097/01.blo.0000144484.69656.e4; Goodwin JL, 2008, OSTEOARTHR CARTILAGE, V16, P1263, DOI 10.1016/j.joca.2008.02.011; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hashimoto G, 2001, FEBS LETT, V494, P192, DOI 10.1016/S0014-5793(01)02323-7; Henrotin Y, 2011, OSTEOARTHR CARTILAGE, V19, P1, DOI 10.1016/j.joca.2010.10.017; Hollander AP, 1995, J CLIN INVEST, V96, P2859, DOI 10.1172/JCI118357; Jennings L, 2001, CONNECT TISSUE RES, V42, P71, DOI 10.3109/03008200109014250; JUVA K, 1966, ANAL BIOCHEM, V15, P77, DOI 10.1016/0003-2697(66)90249-1; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; McAlindon TE, 2011, OSTEOARTHR CARTILAGE, V19, P399, DOI 10.1016/j.joca.2011.01.001; Moskowitz RW, 2000, SEMIN ARTHRITIS RHEU, V30, P87, DOI 10.1053/sarh.2000.9622; Naito S, 2007, PATHOL INT, V57, P703, DOI 10.1111/j.1440-1827.2007.02167.x; Oesser S, 1999, J NUTR, V129, P1891, DOI 10.1093/jn/129.10.1891; Oesser S, 2003, CELL TISSUE RES, V311, P393, DOI 10.1007/s00441-003-0702-8; Oesser S, 2008, OSTEOARTHRITIS CA S4, pS45; Raabe O, 2010, HISTOCHEM CELL BIOL, V134, P545, DOI 10.1007/s00418-010-0760-4; Roman-Blas JA, 2006, OSTEOARTHR CARTILAGE, V14, P839, DOI 10.1016/j.joca.2006.04.008; Sadowski T, 2001, INFLAMM RES, V50, P175, DOI 10.1007/s000110050742; Sadowski T, 2001, J RHEUMATOL, V28, P336; Sauerland K, 2003, OSTEOARTHR CARTILAGE, V11, P343, DOI 10.1016/S1063-4584(03)00007-4; Siebert HC, 2010, PROTEIN CELL, V1, P393, DOI 10.1007/s13238-010-0038-6; StdtzelS Eckert T, 2012, O J PHYS CH IN PRESS; Steinmeyer J, 2006, ADV DRUG DELIVER REV, V58, P168, DOI 10.1016/j.addr.2006.01.007; Steinmeyer J, 2010, J ORTHOP RES, V28, P828, DOI 10.1002/jor.21026; Stotzel S, 2012, CHEMPHYSCHEM, V13, P3117, DOI 10.1002/cphc.201200284; SWITZER BR, 1971, ANAL BIOCHEM, V39, P487, DOI 10.1016/0003-2697(71)90438-6; Vincent TL, 2008, ARTHRITIS RHEUM, V58, P1207, DOI 10.1002/art.23443; Wolf A, 2007, CELL TISSUE RES, V327, P155, DOI 10.1007/s00441-006-0251-z	46	29	29	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53955	10.1371/journal.pone.0053955	http://dx.doi.org/10.1371/journal.pone.0053955			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342047	Green Published, gold, Green Submitted			2022-12-25	WOS:000313682700067
J	Fernandez, RM; Mathieu, Y; Luzon-Toro, B; Nunez-Torres, R; Gonzalez-Meneses, A; Antinolo, G; Amiel, J; Borrego, S				Maria Fernandez, Raquel; Mathieu, Yves; Luzon-Toro, Berta; Nunez-Torres, Rocio; Gonzalez-Meneses, Antonio; Antinolo, Guillermo; Amiel, Jeanne; Borrego, Salud			Contributions of PHOX2B in the Pathogenesis of Hirschsprung Disease	PLOS ONE			English	Article							CONGENITAL CENTRAL HYPOVENTILATION; HOMEOBOX GENE PHOX2B; HOMEODOMAIN PROTEINS; GERMLINE MUTATIONS; CANDIDATE GENE; RET; FRAMESHIFT; PHENOTYPE; EXPANSION	Hirschsprung disease (HSCR) is a congenital malformation of the hindgut resulting from a disruption of neural crest cell migration during embryonic development. It has a complex genetic aetiology with several genes involved in its pathogenesis. PHOX2B plays a key function in the development of neural crest derivatives, and heterozygous mutations cause a complex dysautonomia associating HSCR, Congenital Central Hypoventilation Syndrome (CCHS) and neuroblastoma (NB) in various combinations. In order to determine the role of PHOX2B in isolated HSCR, we performed a mutational screening in a cohort of 207 Spanish HSCR patients. Our most relevant finding has been the identification of a de novo and novel deletion (c.393_410del18) in a patient with HSCR. Results of in silico and functional assays support its pathogenic effect related to HSCR. Therefore our results support that PHOX2B loss-of-function is a rare cause of HSCR phenotype.	[Maria Fernandez, Raquel; Luzon-Toro, Berta; Nunez-Torres, Rocio; Antinolo, Guillermo; Borrego, Salud] Univ Seville, Dept Genet Reprod & Fetal Med, Inst Biomed Seville, Univ Hosp Virgen del Rocio,Ctr Super Invest Cient, Seville, Spain; [Maria Fernandez, Raquel; Luzon-Toro, Berta; Nunez-Torres, Rocio; Antinolo, Guillermo; Borrego, Salud] Ctr Biomed Network Res Rare Dis, Seville, Spain; [Mathieu, Yves; Amiel, Jeanne] Hop Necker Enfants Malad, AP HP, INSERM, U781, Paris, France; [Gonzalez-Meneses, Antonio] Univ Hosp Virgen del Rocio, Dept Paediat, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Virgen del Rocio University Hospital	Borrego, S (corresponding author), Univ Seville, Dept Genet Reprod & Fetal Med, Inst Biomed Seville, Univ Hosp Virgen del Rocio,Ctr Super Invest Cient, Seville, Spain.	salud.borrego.sspa@juntadeandalucia.es	IBIS, GENETICA/P-3384-2015; amiel, jeanne/AGX-1124-2022; LUZON, BERTA/D-4884-2014; amiel, jeanne/H-3501-2017; IBIS, REPRODUCCION/P-3399-2015; Borrego, Salud/M-6314-2015	amiel, jeanne/0000-0001-5973-4728; Mathieu, Yves/0000-0003-1366-1644; Antinolo Gil, Guillermo/0000-0002-2113-074X	Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Economy and Competitiveness, Spain [PI1001290]; Regional Ministry of Innovation, Science and Enterprise of the Autonomous Government of Andalucia [CTS-7447]; Fondation pour la Recherche Medicale; Agence Nationale de la Recherche	Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Economy and Competitiveness, Spain(Spanish Government); Regional Ministry of Innovation, Science and Enterprise of the Autonomous Government of Andalucia; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Economy and Competitiveness, Spain (PI1001290) and Regional Ministry of Innovation, Science and Enterprise of the Autonomous Government of Andalucia (CTS-7447), the Fondation pour la Recherche Medicale and the Agence Nationale de la Recherche. The CIBERER is an initiative of the ISCIII, Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Amiel J, 2003, NAT GENET, V33, P459, DOI 10.1038/ng1130; Angrist M, 1996, NAT GENET, V14, P341, DOI 10.1038/ng1196-341; Benailly HK, 2003, CLIN GENET, V64, P204, DOI 10.1034/j.1399-0004.2003.00105.x; Bourdeaut F, 2005, CANCER LETT, V228, P51, DOI 10.1016/j.canlet.2005.01.055; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; de Pontual L, 2007, HUM MUTAT, V28, P790, DOI 10.1002/humu.20517; Emison ES, 2010, AM J HUM GENET, V87, P60, DOI 10.1016/j.ajhg.2010.06.007; Fitze G, 2008, AM J MED GENET A, V146A, P1486, DOI 10.1002/ajmg.a.32300; Gabriel SB, 2002, NAT GENET, V31, P89, DOI 10.1038/ng868; Garcia-Barcelo M, 2003, GUT, V52, P563, DOI 10.1136/gut.52.4.563; Hung CC, 2007, ELECTROPHORESIS, V28, P894, DOI 10.1002/elps.200600383; Jennings LJ, 2012, PEDIATR PULM, V47, P153, DOI 10.1002/ppul.21527; Leon TYY, 2009, J PEDIATR SURG, V44, P1904, DOI 10.1016/j.jpedsurg.2008.11.055; Matera I, 2004, J MED GENET, V41, P373, DOI 10.1136/jmg.2003.015412; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Ruiz-Ferrer M, 2011, J MOL MED, V89, P471, DOI 10.1007/s00109-010-0714-2; Seo H, 2002, J NEUROCHEM, V80, P905, DOI 10.1046/j.0022-3042.2002.00782.x; Trochet D, 2005, HUM MOL GENET, V14, P3697, DOI 10.1093/hmg/ddi401; Trochet D, 2009, HUM MUTAT, V30, pE421, DOI 10.1002/humu.20923; Weese-Mayer DE, 2003, AM J MED GENET A, V123A, P267, DOI 10.1002/ajmg.a.20527; Weese-Mayer DE, 2010, AM J RESP CRIT CARE, V181, P626, DOI 10.1164/rccm.200807-1069ST; WILSON DS, 1995, CURR BIOL, V5, P32, DOI 10.1016/S0960-9822(95)00010-8	23	25	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54043	10.1371/journal.pone.0054043	http://dx.doi.org/10.1371/journal.pone.0054043			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342068	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400113
J	Perez-Sieira, S; Martinez, G; Porteiro, B; Lopez, M; Vidal, A; Nogueiras, R; Dieguez, C				Perez-Sieira, Sonia; Martinez, Gloria; Porteiro, Begona; Lopez, Miguel; Vidal, Anxo; Nogueiras, Ruben; Dieguez, Carlos			Female Nur77-Deficient Mice Show Increased Susceptibility to Diet-Induced Obesity	PLOS ONE			English	Article							ORPHAN NUCLEAR RECEPTORS; BROWN ADIPOSE-TISSUE; CELL-DEATH; METABOLISM; NUR77; EXPRESSION; TARGET; NR4A1	Adipose tissue is essential in the regulation of body weight. The key process in fat catabolism and the provision of energy substrate during times of nutrient deprivation or enhanced energy demand is the hydrolysis of triglycerides and the release of fatty acids and glycerol. Nur77 is a member of the NR4A subfamily of nuclear receptors that plays an important metabolic role, modulating hepatic glucose metabolism and lipolysis in muscle. However, its endogenous role on white adipose tissue, as well as the gender dependency of these mechanisms, remains largely unknown. Male and female wild type and Nur77 deficient mice were fed with a high fat diet (45% calories from fat) for 4 months. Mice were analyzed in vivo with the indirect calorimetry system, and tissues were analyzed by real-time PCR and Western blot analysis. Female, but not male Nur77 deficient mice, gained more weight and fat mass when compared to wild type mice fed with high fat diet, which can be explained by decreased energy expenditure. The lack of Nur77 also led to a decreased pHSL/HSL ratio in white adipose tissue and increased expression of CIDEA in brown adipose tissue of female Nur77 deficient mice. Overall, these findings suggest that Nur77 is an important physiological modulator of lipid metabolism in adipose tissue and that there are gender differences in the sensitivity to deletion of the Nur77 signaling. The decreased energy expenditure and the actions of Nur77 on liver, muscle, brown and white adipose tissue contribute to the increased susceptibility to diet-induced obesity in females lacking Nur77.	[Perez-Sieira, Sonia; Martinez, Gloria; Porteiro, Begona; Lopez, Miguel; Vidal, Anxo; Nogueiras, Ruben; Dieguez, Carlos] Inst Invest Sanitarias IDIS, Dept Physiol, Sch Med, CIMUS, Santiago De Compostela, Spain; [Perez-Sieira, Sonia; Porteiro, Begona; Lopez, Miguel; Nogueiras, Ruben; Dieguez, Carlos] Univ Santiago de Compostela, CIBER Fisiopatol Obesidad & Nutr CIBERobn, Santiago De Compostela, Spain	Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universidade de Santiago de Compostela	Nogueiras, R (corresponding author), Inst Invest Sanitarias IDIS, Dept Physiol, Sch Med, CIMUS, Santiago De Compostela, Spain.	ruben.nogueiras@usc.es; carlos.dieguez@usc.es	Vidal, Anxo/B-5010-2015; Nogueiras, Ruben/AAS-9427-2021; , Begoña/AAB-3599-2021; López, Miguel/ABF-4844-2021	Vidal, Anxo/0000-0002-0866-4202; Nogueiras, Ruben/0000-0002-9976-9930; , Begoña/0000-0001-6646-5132; López, Miguel/0000-0002-7823-1648; dieguez, carlos/0000-0002-0919-4337	Ministerio de Ciencia e Innovacion [RYC-2008-02219, SAF2009-07049, RyC-2007-00211, BFU2008-02001]; Xunta de Galicia [10PXIB208164PR, 2010/14]; Fondo Investigationes Sanitarias [PS09/01880]; European Community [245009, ERC-2011-StG-OBESITY53-281408]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Fondo Investigationes Sanitarias(Instituto de Salud Carlos III); European Community(European Commission)	This work has been supported by grants from Ministerio de Ciencia e Innovacion (to RN: RYC-2008-02219; to RN: SAF2009-07049; to ML: RyC-2007-00211; to CD: BFU2008-02001), Xunta de Galicia (to ML: 10PXIB208164PR and to RN: 2010/14); Fondo Investigationes Sanitarias (to ML: PS09/01880), European Union leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 245009 and also ERC-2011-StG-OBESITY53-281408 (to RN). CIBER de Fisiopatologia de la Obesidad y Nutricion is an initiative of ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au WS, 2008, INT J OBESITY, V32, P388, DOI 10.1038/sj.ijo.0803763; Barros RPA, 2011, CELL METAB, V14, P289, DOI 10.1016/j.cmet.2011.08.005; Chao LC, 2007, MOL ENDOCRINOL, V21, P2152, DOI 10.1210/me.2007-0169; Chao LC, 2009, DIABETES, V58, P2788, DOI 10.2337/db09-0763; Chao LC, 2008, MOL ENDOCRINOL, V22, P2596, DOI 10.1210/me.2008-0161; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Czyzyk TA, 2010, FASEB J, V24, P1151, DOI 10.1096/fj.09-143610; Fu MG, 2005, MOL ENDOCRINOL, V19, P2437, DOI 10.1210/me.2004-0539; Gonzalez CR, 2009, J PHYSIOL-LONDON, V587, P3741, DOI 10.1113/jphysiol.2009.172510; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Kanzleiter T, 2005, PHYSIOL GENOMICS, V24, P37, DOI 10.1152/physiolgenomics.00204.2005; Kanzleiter T, 2010, DIABETOLOGIA, V53, P1174, DOI 10.1007/s00125-010-1703-2; Lee SJ, 2010, CELL METAB, V12, P65, DOI 10.1016/j.cmet.2010.05.003; LEE SL, 1995, SCIENCE, V269, P532, DOI 10.1126/science.7624775; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Livingstone C, 2002, CLIN SCI, V102, P151, DOI 10.1042/cs1020151; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; Maxwell MA, 2005, J BIOL CHEM, V280, P12573, DOI 10.1074/jbc.M409580200; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; Moll UM, 2006, ONCOGENE, V25, P4725, DOI 10.1038/sj.onc.1209601; Mullican SE, 2007, NAT MED, V13, P730, DOI 10.1038/nm1579; Nogueiras R, 2009, J NEUROSCI, V29, P5916, DOI 10.1523/JNEUROSCI.5977-08.2009; Pearen MA, 2006, ENDOCRINOLOGY, V147, P5217, DOI 10.1210/en.2006-0447; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Pei LM, 2006, MOL ENDOCRINOL, V20, P786, DOI 10.1210/me.2005-0331; Prior RL, 2009, MOL NUTR FOOD RES, V53, P1406, DOI 10.1002/mnfr.200900026; Sabio G, 2010, TRENDS BIOCHEM SCI, V35, P490, DOI 10.1016/j.tibs.2010.04.004; Sabio G, 2009, CELL METAB, V10, P491, DOI 10.1016/j.cmet.2009.09.007; Shi HF, 2009, FRONT NEUROENDOCRIN, V30, P396, DOI 10.1016/j.yfrne.2009.03.004; Vazquez MJ, 2008, ENDOCRINOLOGY, V149, P4534, DOI 10.1210/en.2007-1708; Velasquez DA, 2011, DIABETES, V60, P1177, DOI 10.2337/db10-0802; Veum VL, 2011, INT J OBES LOND; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang SCM, 2011, MOL ENDOCRINOL, V25, P291, DOI 10.1210/me.2010-0231; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	36	30	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53836	10.1371/journal.pone.0053836	http://dx.doi.org/10.1371/journal.pone.0053836			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342015	Green Submitted, Green Published, gold			2022-12-25	WOS:000314759400091
J	Schneeberger, K; Czirjak, GA; Voigt, CC				Schneeberger, Karin; Czirjak, Gabor A.; Voigt, Christian C.			Measures of the Constitutive Immune System Are Linked to Diet and Roosting Habits of Neotropical Bats	PLOS ONE			English	Article							BARN SWALLOWS; DISEASE RISK; BLOOD; PARASITISM; EVOLUTION; INFECTION; LEUKOCYTE; COUNTS; MICROORGANISMS; DIVERSITY	Ecological and social factors are central in the emergence and transmission of infectious diseases, thus bearing the potential for shaping a species' immune functions. Although previous studies demonstrated a link between social factors and the cellular immune system for captive mammals, it is yet poorly understood how ecological factors are connected with the different branches of the immune system in wild populations. Here, we tested how variation in aspects of the constitutive cellular and humoral immune system of free ranging bats is associated with two ecological factors that likely influence the putative risk of species to become infected by parasites and pathogens: diet and shelter. We found that white blood cell counts of 24 syntopic Neotropical bat species varied with the species' diet and body mass. Bats that included at least partially vertebrates in their diet exhibited the highest white blood cell counts, followed by phytophagous and insectivorous species, which is in agreement with the assumption that the immune system varies with the pathogen transmission risk of a trophic level. The soluble part of the constitutive immune response, assessed by an in vitro bacterial killing assay, decreased with increasing roost permanence. Our results suggest that the ecology is an important factor in the evolution of the immune system in bats and probably also other mammals.	[Schneeberger, Karin; Czirjak, Gabor A.; Voigt, Christian C.] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Schneeberger, Karin; Voigt, Christian C.] Free Univ Berlin, Dept Anim Behav, Berlin, Germany	Leibniz Institut fur Zoo und Wildtierforschung; Free University of Berlin	Schneeberger, K (corresponding author), Leibniz Inst Zoo & Wildlife Res, Berlin, Germany.	schneeberger@izw-berlin.de	Czirják, Gábor Árpád/F-5440-2011; Schneeberger, Karin/C-9836-2013	Czirják, Gábor Árpád/0000-0001-9488-0069; Schneeberger, Karin/0000-0003-2098-2542	Leibniz Institute for Zoo and Wildlife Research	Leibniz Institute for Zoo and Wildlife Research	This study was supported by funds from the Leibniz Institute for Zoo and Wildlife Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Allen LC, 2009, J COMP PHYSIOL B, V179, P315, DOI 10.1007/s00360-008-0315-3; Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; [Anonymous], 2010, R LANG ENV STAT COMP; BELL G, 1991, J ANIM ECOL, V60, P1047, DOI 10.2307/5430; Bordes F, 2009, AM NAT, V173, P467, DOI 10.1086/597227; Brown CR, 2001, P ROY SOC B-BIOL SCI, V268, P1833, DOI 10.1098/rspb.2001.1749; Buehler DM, 2008, AM NAT, V172, P783, DOI 10.1086/592865; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; Cichon M, 2001, J EVOLUTION BIOL, V14, P180, DOI 10.1046/j.1420-9101.2001.00243.x; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; Czirjak GA, 2010, MICROB ECOL, V60, P373, DOI 10.1007/s00248-010-9716-4; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; Durbin C, 2009, VET CLIN PATH, V38, P157, DOI 10.1111/j.1939-165X.2009.00110.x; Ezenwa VO, 2012, FUNCT ECOL, V26, P123, DOI 10.1111/j.1365-2435.2011.01919.x; Fogarty R, 2008, VIRUS RES, V132, P140, DOI 10.1016/j.virusres.2007.11.010; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; GREENWOOD BM, 1973, T ROY SOC TROP MED H, V67, P846, DOI 10.1016/0035-9203(73)90013-8; Hoffmann FG, 2003, MOL ECOL, V12, P3403, DOI 10.1046/j.1365-294X.2003.02009.x; Jones KE, 2002, BIOL REV, V77, P223, DOI 10.1017/S1464793101005899; Kunz TH, 2006, BAT ECOLOGY; KURIS AM, 1980, AM NAT, V116, P570, DOI 10.1086/283647; Kuzmin Ivan V, 2011, Emerg Health Threats J, V4, P7159, DOI 10.3402/ehtj.v4i0.7159; LaVal RK, 2002, MURCIELAGOS COSTA RI; LEHMANN T, 1993, PARASITOL TODAY, V9, P8, DOI 10.1016/0169-4758(93)90153-7; Li LL, 2010, J VIROL, V84, P6955, DOI 10.1128/JVI.00501-10; Liebl AL, 2009, FUNCT ECOL, V23, P1091, DOI 10.1111/j.1365-2435.2009.01592.x; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Moller AP, 2009, FUNCT ECOL, V23, P1097, DOI 10.1111/j.1365-2435.2009.01594.x; MOLLER AP, 1993, ADV STUD BEHAV, V22, P65, DOI 10.1016/S0065-3454(08)60405-2; Moller AP, 2004, J EVOLUTION BIOL, V17, P603, DOI 10.1111/j.1420-9101.2004.00694.x; Moller AP, 1998, EVOL ECOL, V12, P945, DOI 10.1023/A:1006516222343; Moore MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027430; Moore MS, 2011, THESIS BOSTON U; MORRISON DW, 1978, ECOLOGY, V59, P716, DOI 10.2307/1938775; NEWSHOLME P, 1989, BIOCHEM J, V261, P211, DOI 10.1042/bj2610211; Nunn CL, 2002, EVOLUTION, V56, P177; Nunn CL, 2003, P ROY SOC B-BIOL SCI, V270, P347, DOI 10.1098/rspb.2002.2249; Nunn CL, 2000, SCIENCE, V290, P1168, DOI 10.1126/science.290.5494.1168; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Patterson BD, 2007, J TROP ECOL, V23, P177, DOI 10.1017/S0266467406003816; Perez-Tris J, 2005, ECOL LETT, V8, P838, DOI 10.1111/j.1461-0248.2005.00788.x; Pinheiro J., 2019, NLME LINEAR NONLINEA; Previtali MA, 2012, OIKOS, V121, P1483, DOI 10.1111/j.1600-0706.2012.020215.x; Price T, 1997, PHILOS T ROY SOC B, V352, P519, DOI 10.1098/rstb.1997.0036; Saino N, 1997, P NATL ACAD SCI USA, V94, P549, DOI 10.1073/pnas.94.2.549; Santos Mery, 2003, Mammalian Species, V722, P1, DOI 10.1644/722; Schinnerl M, 2011, J ZOO WILDLIFE MED, V42, P382, DOI 10.1638/2010-0060.1; Stearns S., 1992, EVOLUTION LIFE HIST; Tieleman BI, 2005, P ROY SOC B-BIOL SCI, V272, P1715, DOI 10.1098/rspb.2005.3155; TIMM RM, 1998, OCCASIONAL PUBLICATI, V22, P1; Tvedten H, 1988, Vet Clin Pathol, V17, P4, DOI 10.1111/j.1939-165X.1988.tb00477.x; Vitone ND, 2004, EVOL ECOL RES, V6, P183; Walberg J, 2001, SEMIN AVIAN EXOT PET, V10, P72, DOI 10.1053/saep.2001.22051; Wibbelt G, 2010, BIOL LETTERS, V6, P438, DOI 10.1098/rsbl.2010.0267; Zysling DA, 2009, FUNCT ECOL, V23, P979, DOI 10.1111/j.1365-2435.2009.01572.x	59	47	47	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54023	10.1371/journal.pone.0054023	http://dx.doi.org/10.1371/journal.pone.0054023			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342064	Green Submitted, Green Published, gold			2022-12-25	WOS:000314759400111
J	Lin, SB; Shen, HX; Li, JL; Tang, SJ; Gu, YM; Chen, ZR; Hu, CB; Rice, JC; Lu, JR; Wu, LZ				Lin, Shuibin; Shen, Huangxuan; Li, Jian-Liang; Tang, Shaojun; Gu, Yumei; Chen, Zirong; Hu, Chengbin; Rice, Judd C.; Lu, Jianrong; Wu, Lizi			Proteomic and Functional Analyses Reveal the Role of Chromatin Reader SFMBT1 in Regulating Epigenetic Silencing and the Myogenic Gene Program	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCOMB GROUP; SKELETAL-MUSCLE; DNA-BINDING; DROSOPHILA-MELANOGASTER; DYNAMIC REGULATION; PCG RECRUITMENT; SATELLITE CELLS; PROTEIN; COMPLEX; COACTIVATOR	SFMBT1 belongs to the malignant brain tumor domain-containing chromatin reader family that recognizes repressive histone marks and represses transcription. The biological functions and molecular basis underlying SFMBT1-mediated transcriptional repression are poorly elucidated. Here, our proteomic analysis revealed that SFMBT1 is associated with multiple transcriptional corepressor complexes, including CtBP/LSD1/HDAC complexes, polycomb repressive complexes, and malignant brain tumor family proteins, that collectively contribute to SFMBT1 repressor activity. During myogenesis, Sfmbt1 represses myogenic differentiation of cultured and primary myoblasts. Mechanistically, Sfmbt1 interacts with MyoD and mediates epigenetic silencing of MyoD target genes via recruitment of its associated corepressors and subsequent induction of epigenetic modifications and chromatin compaction. Therefore, our study identified novel mechanisms accounting for SFMBT1-mediated transcription repression and revealed an essential role of Sfmbt1 in regulating MyoD-mediated transcriptional silencing that is required for the maintenance of undifferentiated states of myogenic progenitor cells.	[Lin, Shuibin; Shen, Huangxuan; Gu, Yumei; Chen, Zirong; Hu, Chengbin; Wu, Lizi] Univ Florida, Dept Mol Genet & Microbiol, Shands Canc Ctr, Gainesville, FL 32610 USA; [Tang, Shaojun] Univ Florida, Genet Inst, Shands Canc Ctr, Gainesville, FL 32610 USA; [Lu, Jianrong] Univ Florida, Dept Biochem & Mol Biol, Shands Canc Ctr, Gainesville, FL 32610 USA; [Shen, Huangxuan] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China; [Li, Jian-Liang] Sanford Burnham Med Res Inst Lake Nona, Orlando, FL 32827 USA; [Rice, Judd C.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Sun Yat Sen University; Sanford Burnham Prebys Medical Discovery Institute; University of Southern California	Lu, JR (corresponding author), Univ Florida, Dept Biochem & Mol Biol, Shands Canc Ctr, Gainesville, FL 32610 USA.	jrlu@ufl.edu; lzwu@ufl.edu	TANG, SHAOJUN/J-4876-2015; chen, zirong/S-4042-2016; Li, Jian-Liang/AAE-9315-2019; Li, J L/E-6100-2018; Lu, Jianrong/F-5240-2013	chen, zirong/0000-0002-0589-4619; Li, Jian-Liang/0000-0002-6487-081X; Li, J L/0000-0002-6487-081X; tang, shaojun/0000-0002-5141-0515; Lu, Jianrong/0000-0002-4969-6040; Lin, Shuibin/0000-0002-7065-614X	Muscular Dystrophy Association [MDA 4315]; University of Florida Shands Cancer Center; Florida Bankhead-Coley Cancer Research Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075094] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); University of Florida Shands Cancer Center; Florida Bankhead-Coley Cancer Research Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Muscular Dystrophy Association Grant MDA 4315 (to L. W.), by the University of Florida Shands Cancer Center Startup fund, and by the Florida Bankhead-Coley Cancer Research Program.	Arai S, 2005, EMBO J, V24, P1863, DOI 10.1038/sj.emboj.7600654; Aziz A, 2010, EPIGENETICS-US, V5, P691, DOI 10.4161/epi.5.8.13045; Basu A, 2010, J CELL BIOCHEM, V110, P62, DOI 10.1002/jcb.22487; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; Bharathy N., 2012, TRANSCRIPTION, V3, P1; Bonasio R, 2010, SEMIN CELL DEV BIOL, V21, P221, DOI 10.1016/j.semcdb.2009.09.010; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Day K, 2007, DEV BIOL, V304, P246, DOI 10.1016/j.ydbio.2006.12.026; GATEFF E, 1993, MECH DEVELOP, V41, P15, DOI 10.1016/0925-4773(93)90052-Y; Grimm C, 2009, EMBO J, V28, P1965, DOI 10.1038/emboj.2009.147; Gu Y, 2012, ONCOGENE, V31, P469, DOI 10.1038/onc.2011.247; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Luger K, 2005, CURR OPIN STRUC BIOL, V15, P188, DOI 10.1016/j.sbi.2005.03.006; Luger K, 1998, CURR OPIN STRUC BIOL, V8, P33, DOI 10.1016/S0959-440X(98)80007-9; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Philipot O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009425; Robson LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027116; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Shen HX, 2006, GENE DEV, V20, P675, DOI 10.1101/gad.1383706; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Springer ML, 2002, CURR PROTOC HUM GENE; Srinivasan L, 2004, GENE DEV, V18, P2596, DOI 10.1101/gad.1228204; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Trojer P, 2011, MOL CELL, V42, P438, DOI 10.1016/j.molcel.2011.04.004; Usui H, 2000, GENE, V248, P127, DOI 10.1016/S0378-1119(00)00131-1; Wang LJ, 2010, MOL CELL BIOL, V30, P2584, DOI 10.1128/MCB.01451-09; WISMAR J, 1995, MECH DEVELOP, V53, P141, DOI 10.1016/0925-4773(95)00431-9; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Wu SM, 2007, FEBS LETT, V581, P3289, DOI 10.1016/j.febslet.2007.06.025; Wu S, 2007, NAT STRUCT MOL BIOL, V14, P1165, DOI 10.1038/nsmb1332	38	20	24	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6238	6247		10.1074/jbc.M112.429605	http://dx.doi.org/10.1074/jbc.M112.429605			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23349461	hybrid, Green Published			2022-12-25	WOS:000315820700019
J	Yu, Y; Huang, YS; Zhang, LZ; Lin, ZB; Wang, GF				Yu, Yi; Huang, Yisheng; Zhang, Lizhen; Lin, Zhoubin; Wang, Guofu			Growth and Spectral Assessment of Yb3+-Doped KBaGd(MoO4)(3) Crystal: A Candidate for Ultrashort Pulse and Tunable Lasers	PLOS ONE			English	Article							GENERATION	In order to explore new more powerful ultrashort pulse laser and tunable laser for diode-pumping, this paper reports the growth and spectral assessment of Yb3+-doped KBaGd(MoO4)(3) crystal. An Yb3+:KBaGd(MoO4)(3) crystal with dimensions of 50x40x9 mm(3) was grown by the TSSG method from the K2Mo2O7 flux. The investigated spectral properties indicated that Yb3+:KBaGd(MoO4)(3) crystal exhibits broad absorption and emission bands, except the large emission and gain cross-sections. This feature of the broad absorption and emission bands is not only suitable for the diode pumping, but also for the production of ultrashort pulses and tunability. Therefore, Yb3+:KBaGd(MoO4)(3) crystal can be regarded as a candidate for the ultrashort pulse and tunable lasers.	[Yu, Yi; Huang, Yisheng; Zhang, Lizhen; Lin, Zhoubin; Wang, Guofu] Chinese Acad Sci, Fujian Inst Res Struct Matter, Key Lab Optoelect Mat Chem & Phys, Fuzhou 350002, Fujian, Peoples R China; [Yu, Yi] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, GF (corresponding author), Chinese Acad Sci, Fujian Inst Res Struct Matter, Key Lab Optoelect Mat Chem & Phys, Fuzhou 350002, Fujian, Peoples R China.	wgf@ms.fjirsm.ac.cn			National Natural Science Foundation of China [61108054]; National Natural Science Foundation of Fujian Province [2011J01376]; Scientific Research Foundation for Returned Scholars; Ministry of Education of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Scientific Research Foundation for Returned Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Ministry of Education of China(Ministry of Education, China)	This work is supported by the National Natural Science Foundation of China (number 61108054), the National Natural Science Foundation of Fujian Province (number 2011J01376) and Scientific Research Foundation for Returned Scholars, Ministry of Education of China, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antic-Fidancev E, 2000, J ALLOY COMPD, V300, P2, DOI 10.1016/S0925-8388(99)00695-7; Brunner F, 2000, OPT LETT, V25, P1119, DOI 10.1364/OL.25.001119; Chen YF, 2012, OPT LETT, V37, P461, DOI 10.1364/OL.37.000461; DELOACH LD, 1993, IEEE J QUANTUM ELECT, V29, P1179, DOI 10.1109/3.214504; Druon F, 2000, OPT LETT, V25, P423, DOI 10.1364/OL.25.000423; Haumesser PH, 2002, J OPT SOC AM B, V19, P2365, DOI 10.1364/JOSAB.19.002365; Haumesser PH, 2001, J PHYS-CONDENS MAT, V13, P5427, DOI 10.1088/0953-8984/13/23/303; Honninger C, 1999, APPL PHYS B-LASERS O, V69, P3, DOI 10.1007/s003400050762; Jiang HD, 2002, CHEM PHYS LETT, V357, P15, DOI 10.1016/S0009-2614(02)00409-8; KOZHEVNIKOVA NM, 1990, ZH NEORG KHIM+, V35, P3157; Kuleshov NV, 1997, OPT LETT, V22, P1317, DOI 10.1364/OL.22.001317; Li H, 2010, CRYSTENGCOMM, V12, P1307, DOI 10.1039/b914641e; Meng XM, 2011, CRYSTENGCOMM, V13, P4069, DOI 10.1039/c0ce00922a; Mougel F, 1999, J OPT SOC AM B, V16, P164, DOI 10.1364/JOSAB.16.000164; Tang LY, 2005, J CRYST GROWTH, V282, P376, DOI 10.1016/j.jcrysgro.2005.05.024; Wang GJ, 2011, CRYST GROWTH DES, V11, P3895, DOI 10.1021/cg200438p; Xiao B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040229; Xiao B, 2012, RSC ADV, V2, P5271, DOI 10.1039/c2ra00050d; Xie GQ, 2009, OPT LETT, V34, P103, DOI 10.1364/OL.34.000103; Yao G, 2008, J CRYST GROWTH, V310, P725, DOI 10.1016/j.jcrysgro.2007.11.106; Zhou M, 2009, OPT COMMUN, V282, P4109, DOI 10.1016/j.optcom.2009.07.009	21	13	14	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54450	10.1371/journal.pone.0054450	http://dx.doi.org/10.1371/journal.pone.0054450			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349892	Green Published, Green Submitted, gold			2022-12-25	WOS:000314019100068
J	Benktander, J; Angstrom, J; Karlsson, H; Teymournejad, O; Linden, S; Lebens, M; Teneberg, S				Benktander, John; Angstrom, Jonas; Karlsson, Hasse; Teymournejad, Omid; Linden, Sara; Lebens, Michael; Teneberg, Susann			The Repertoire of Glycosphingolipids Recognized by Vibrio cholerae	PLOS ONE			English	Article							RABBIT ERYTHROCYTE-MEMBRANES; TOXIN-COREGULATED PILI; HUMAN SMALL-INTESTINE; BLOOD-GROUP; ESCHERICHIA-COLI; EPITHELIAL-CELLS; EL-TOR; CERAMIDE PENTADECASACCHARIDE; HELICOBACTER-PYLORI; MASS-SPECTROMETRY	The binding of cholera toxin to the ganglioside GM1 as the initial step in the process leading to diarrhea is nowadays textbook knowledge. In contrast, the knowledge about the mechanisms for attachment of Vibrio cholerae bacterial cells to the intestinal epithelium is limited. In order to clarify this issue, a large number of glycosphingolipid mixtures were screened for binding of El Tor V. cholerae. Several specific interactions with minor complex non-acid glycosphingolipids were thereby detected. After isolation of binding-active glycosphingolipids, characterization by mass spectrometry and proton NMR, and comparative binding studies, three distinct glycosphingolipid binding patterns were defined. Firstly, V. cholerae bound to complex lacto/neolacto glycosphingolipids with the GlcNAc beta 3Gal beta 4GlcNAc sequence as the minimal binding epitope. Secondly, glycosphingolipids with a terminal Gal alpha 3Gal alpha 3Gal moiety were recognized, and the third specificity was the binding to lactosylceramide and related compounds. V. cholerae binding to lacto/neolacto glycosphingolipids, and to the other classes of binding-active compounds, remained after deletion of the chitin binding protein GbpA. Thus, the binding of V. cholerae to chitin and to lacto/neolacto containing glycosphingolipids represents two separate binding specificities.	[Benktander, John; Angstrom, Jonas; Karlsson, Hasse; Teymournejad, Omid; Linden, Sara; Teneberg, Susann] Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, Gothenburg, Sweden; [Lebens, Michael] Univ Gothenburg, Dept Med Microbiol & Immunol, Inst Biomed, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Teneberg, S (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, Gothenburg, Sweden.	Susann.Teneberg@medkem.gu.se	Lindén, Sara K/A-3271-2011	Lindén, Sara K/0000-0002-7751-9586; Lebens, Michael/0000-0001-9458-9474; Teymournejad, Omid/0000-0001-8448-7896	Swedish Research Council [342-2004-4434]; Swedish Cancer Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation	This study was supported by the Swedish Research Council, the Swedish Cancer Foundation, and governmental grants to the Sahlgrenska University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The use of the LTQ linear quadrupole ion trap mass spectrometer (obtained by a grant from the Swedish Research Council (No. 342-2004-4434) to Gunnar Hansson), and the Varian 600 MHz NMR spectrometer at the Swedish NMR Centre, Hasselblad Laboratory, Goteborg University, are gratefully acknowledged.	ANDERSSON B, 1983, J EXP MED, V158, P559, DOI 10.1084/jem.158.2.559; Angstrom J, 2004, GLYCOBIOLOGY, V14, P1, DOI 10.1093/glycob/cwh003; Bhowmick R, 2008, INFECT IMMUN, V76, P4968, DOI 10.1128/IAI.01615-07; BJORK S, 1987, J BIOL CHEM, V262, P6758; Chai WG, 2001, ANAL CHEM, V73, P651, DOI 10.1021/ac0010126; DABROWSKI J, 1982, FEBS LETT, V142, P138, DOI 10.1016/0014-5793(82)80237-8; DABROWSKI U, 1984, J BIOL CHEM, V259, P7648; EGGE H, 1985, J BIOL CHEM, V260, P4927; ESKO JD, 1999, ESSENTIALS GLYCOBIOL, P429; FINNE J, 1989, J BIOL CHEM, V264, P5720; Gastinel LN, 2001, EMBO J, V20, P638, DOI 10.1093/emboj/20.4.638; GLASS RI, 1985, AM J EPIDEMIOL, V121, P791, DOI 10.1093/oxfordjournals.aje.a114050; Guo BP, 2009, P NATL ACAD SCI USA, V106, P19280, DOI 10.1073/pnas.0905470106; HANFLAND P, 1984, EUR J BIOCHEM, V145, P531, DOI 10.1111/j.1432-1033.1984.tb08589.x; Harris JB, 2005, INFECT IMMUN, V73, P7422, DOI 10.1128/IAI.73.11.7422-7427.2005; Henry S, 1997, GLYCOCONJUGATE J, V14, P209, DOI 10.1023/A:1018541821819; HOLMGREN J, 1973, Scandinavian Journal of Infectious Diseases, V5, P77, DOI 10.3109/inf.1973.5.issue-1.15; ITO M, 1989, J BIOL CHEM, V264, P9510; IWANAGA M, 1986, MICROBIOL IMMUNOL, V30, P1075, DOI 10.1111/j.1348-0421.1986.tb03037.x; JONSON G, 1992, INFECT IMMUN, V60, P4278, DOI 10.1128/IAI.60.10.4278-4284.1992; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Karlsson H, 2010, GLYCOBIOLOGY, V20, P1103, DOI 10.1093/glycob/cwq070; Karlsson KA, 1996, BIOORGAN MED CHEM, V4, P1919, DOI 10.1016/S0968-0896(96)00174-5; KARLSSON KA, 1987, METHOD ENZYMOL, V138, P212; KARLSSON KA, 1989, ANNU REV BIOCHEM, V58, P309, DOI 10.1146/annurev.bi.58.070189.001521; Keusch JJ, 2000, J BIOL CHEM, V275, P25308, DOI 10.1074/jbc.M002629200; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; Kirn TJ, 2000, MOL MICROBIOL, V35, P896, DOI 10.1046/j.1365-2958.2000.01764.x; Lebens M, 2011, VACCINE, V29, P7505, DOI 10.1016/j.vaccine.2011.06.121; LEVINE MM, 1988, INFECT IMMUN, V56, P161, DOI 10.1128/IAI.56.1.161-167.1988; Miller-Podraza H, 2005, J BIOL CHEM, V280, P19695, DOI 10.1074/jbc.M412688200; Nair GB, 2006, J CLIN MICROBIOL, V44, P4211, DOI 10.1128/JCM.01304-06; PRIEFER UB, 1985, J BACTERIOL, V163, P324, DOI 10.1128/JB.163.1.324-330.1985; Robbe C, 2004, RAPID COMMUN MASS SP, V18, P412, DOI 10.1002/rcm.1352; Roche N, 2004, INFECT IMMUN, V72, P1519, DOI 10.1128/IAI.72.3.1519-1529.2004; SANCHEZ J, 1989, P NATL ACAD SCI USA, V86, P481, DOI 10.1073/pnas.86.2.481; Sanchez J, 2011, INDIAN J MED RES, V133, P153; Schild S, 2005, INT J MED MICROBIOL, V295, P243, DOI 10.1016/j.ijmm.2005.05.002; STROUD MR, 1991, J BIOL CHEM, V266, P8439; Tacket CO, 1998, INFECT IMMUN, V66, P692, DOI 10.1128/IAI.66.2.692-695.1998; TENEBERG S, 1994, J BIOL CHEM, V269, P8554; Teneberg S, 2004, GLYCOBIOLOGY, V14, P187, DOI 10.1093/glycob/cwh015; Wong E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002373; World Health Organization, 2008, CHOL WHO FACT SHEET	44	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e53999	10.1371/journal.pone.0053999	http://dx.doi.org/10.1371/journal.pone.0053999			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349777	Green Published, gold, Green Submitted			2022-12-25	WOS:000313943000023
J	Littleton, RM; Haworth, KJ; Tang, H; Setchell, KDR; Nelson, S; Hove, JR				Littleton, Robert M.; Haworth, Kevin J.; Tang, Hong; Setchell, Kenneth D. R.; Nelson, Sandra; Hove, Jay R.			Automated In Vivo Platform for the Discovery of Functional Food Treatments of Hypercholesterolemia	PLOS ONE			English	Article							ANTIATHEROSCLEROTIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ZEBRAFISH; EXTRACTS; VITRO; FRACTIONATION	The zebrafish is becoming an increasingly popular model system for both automated drug discovery and investigating hypercholesterolemia. Here we combine these aspects and for the first time develop an automated high-content confocal assay for treatments of hypercholesterolemia. We also create two algorithms for automated analysis of cardiodynamic data acquired by high-speed confocal microscopy. The first algorithm computes cardiac parameters solely from the frequency-domain representation of cardiodynamic data while the second uses both frequency-and time-domain data. The combined approach resulted in smaller differences relative to manual measurements. The methods are implemented to test the ability of a methanolic extract of the hawthorn plant (Crataegus laevigata) to treat hypercholesterolemia and its peripheral cardiovascular effects. Results demonstrate the utility of these methods and suggest the extract has both antihypercholesterolemic and postitively inotropic properties.	[Littleton, Robert M.; Hove, Jay R.] Univ Cincinnati, Coll Med, Dept Mol & Cellular Physiol, Cincinnati, OH 45221 USA; [Hove, Jay R.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Haworth, Kevin J.] Univ Cincinnati, Coll Med, Dept Internal Med, Div Cardiovasc Dis, Cincinnati, OH USA; [Tang, Hong; Nelson, Sandra] Univ Cincinnati, Ctr Drug Discovery, Cincinnati, OH USA; [Setchell, Kenneth D. R.] Cincinnati Childrens Hosp Med Ctr, Div Pathol & Lab Med, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Littleton, RM (corresponding author), Univ Cincinnati, Coll Med, Dept Mol & Cellular Physiol, Cincinnati, OH 45221 USA.	robert.littleton@nationwidechildrens.org	Haworth, Kevin J/D-1513-2009	Haworth, Kevin J/0000-0002-6578-2440	National Institute of Health [R01-RR023190-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR023190] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was funded through the National Institute of Health R01-RR023190-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butler MS, 2004, J NAT PROD, V67, P2141, DOI 10.1021/np040106y; Carten JD, 2009, CLIN LIPIDOL, V4, P501, DOI 10.2217/clp.09.40; Chan PK, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-11; Chang WT, 2005, AM J CHINESE MED, V33, P1, DOI 10.1142/S0192415X05002606; Clifton JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012386; Crawford AD, 2008, PLANTA MED, V74, P624, DOI 10.1055/s-2008-1034374; Fang LH, 2010, J BIOL CHEM, V285, P32343, DOI 10.1074/jbc.M110.137257; Farber SA, 2001, SCIENCE, V292, P1385, DOI 10.1126/science.1060418; Fink M, 2009, BIOTECHNIQUES, V37, P970; Jin S, 2011, FOOD CHEM TOXICOL, V49, P1521, DOI 10.1016/j.fct.2011.03.043; Jin S, 2011, J MED FOOD, V14, P247, DOI 10.1089/jmf.2009.1389; Kitambi Satish Srinivas, 2012, BMC Physiology, V12, P3, DOI 10.1186/1472-6793-12-3; Littleton RM, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-105; McCollum CW, 2011, BIRTH DEFECTS RES C, V93, P67, DOI 10.1002/bdrc.20210; Nahin Richard L, 2009, Natl Health Stat Report, P1; Nwodo UU, 2010, AFR J BIOTECHNOL, V9, P7108; Nwodo UU, 2011, MOLECULES, V16, P4818, DOI 10.3390/molecules16064818; Okoli S, 2005, AFR J BIOTECHNOL, V4, P946; Peterson RT, 2012, ANNU REV PHARMACOL, V52, P433, DOI 10.1146/annurev-pharmtox-010611-134751; Proakis J. G., 1996, DIGIT SIGNAL PROCESS; Smart EJ, 2004, P NATL ACAD SCI USA, V101, P3450, DOI 10.1073/pnas.0400441101; Stoletov K, 2009, CIRC RES, V104, P952, DOI 10.1161/CIRCRESAHA.108.189803; Taylor J. R., 1997, INTRO ERROR ANAL; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Williams CH, 2011, INT J MOL SCI, V12, P2262, DOI 10.3390/ijms12042262	26	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e52409	10.1371/journal.pone.0052409	http://dx.doi.org/10.1371/journal.pone.0052409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349685	Green Submitted, gold, Green Published			2022-12-25	WOS:000313943000007
J	Maurice, AC; Abdelkrim, J; Cisel, M; Zavodna, M; Bardin, P; Matamoro, A; Dumez, R; Machon, N				Maurice, Anne-Claire; Abdelkrim, Jawad; Cisel, Matthieu; Zavodna, Monika; Bardin, Philippe; Matamoro, Alexis; Dumez, Richard; Machon, Nathalie			Mixing Plants from Different Origins to Restore a Declining Population: Ecological Outcomes and Local Perceptions 10 Years Later	PLOS ONE			English	Article							ARENARIA-GRANDIFLORA; REINTRODUCTION; RARE; CONSEQUENCES; EXTINCTION; SUCCESS; RISKS	Populations of the Large-flowered Sandwort (Arenaria grandiflora L.) in the Fontainebleau forest (France) have declined rapidly during the last century. Despite the initiation of a protection program in 1991, less than twenty individuals remained by the late 1990s. The low fitness of these last plants, which is likely associated with genetic disorders and inbreeding depression, highlighted the need for the introduction of non-local genetic material to increase genetic diversity and thus restore Fontainebleau populations. Consequently, A. grandiflora was introduced at three distant sites in the Fontainebleau forest in 1999. Each of these populations was composed of an identical mix of individuals of both local and non-local origin that were obtained through in vitro multiplication. After establishment, the population status (number of individuals, diameter of the plants, and number of flowers) of the introduced populations was monitored. At present, two populations (one of which is much larger than the other) persist, while the third one became extinct in 2004. Analyses of the ecological parameters of the introduction sites indicated that differences in soil pH and moisture might have contributed to the differences in population dynamics. This introduction plan and its outcome attracted interest of local community, with those who supported the plan and regarded its 10-year result as a biological success (i.e., persistent populations were created), but also those who expressed reservations or disapproval of the plan and its outcome. To understand this controversy, a sociological study involving 27 semi-structured interviews was carried out. From these interviews emerged three areas of controversy: alteration of the identity of the plant, alteration of the identity of its territory, and the biological and ethical consequences of the techniques used for the experimental conservation.	[Maurice, Anne-Claire; Abdelkrim, Jawad; Cisel, Matthieu; Zavodna, Monika; Matamoro, Alexis; Machon, Nathalie] Natl Museum Nat Hist, Unite Mixte Rech 7204, Unite Conservat Especes Restaurat & Suivi Populat, Paris, France; [Maurice, Anne-Claire; Dumez, Richard] Natl Museum Nat Hist, Unite Mixte Rech 7206, Unite Ecoanthropol & Ethnobiol, Paris, France; [Bardin, Philippe] Natl Museum Nat Hist, Conservatoire Bot Natl Bassin Parisien, Paris, France	Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; Museum National d'Histoire Naturelle (MNHN)	Machon, N (corresponding author), Natl Museum Nat Hist, Unite Mixte Rech 7204, Unite Conservat Especes Restaurat & Suivi Populat, Paris, France.	machon@mnhn.fr	MAURICE, Anne-Claire/ABG-7879-2020	MAURICE, Anne-Claire/0000-0002-8444-093X; Matamoro-Vidal, Alexis/0000-0002-9316-659X	Office National des Forets (ONF); CNRS; CEMAGREF	Office National des Forets (ONF); CNRS(Centre National de la Recherche Scientifique (CNRS)); CEMAGREF	Financial support for this research came from the Office National des Forets (ONF) and an interdisciplinary program on ecological engineering of the CNRS and the CEMAGREF (call for tenders 2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnal G, 1999, PLANTES PROTEGEES IL; Aubert G., 1978, METHODES ANAL SOLS; Benhammou F, 2008, NOROIS, V208, P75; Bobbe S, 2004, COMMUNICATIONS, P203, DOI [10.3406/comm.2004.2166, DOI 10.3406/COMM.2004.2166]; Bottin L, 2007, ECOSCIENCE, V14, P410, DOI 10.2980/1195-6860(2007)14[410:RTIEPA]2.0.CO;2; Delord J, 2007, STUD HIST PHI PART C, V38, P656, DOI 10.1016/j.shpsc.2007.06.004; Edmands S, 2007, MOL ECOL, V16, P463, DOI 10.1111/j.1365-294X.2006.03148.x; Fabiani Jean-Louis, 2000, REV EURO SCI SOC, V118, P15; Falk DA., 2001, INTRO RESTORATION GE; Fenster Charles B., 1994, P34, DOI 10.1017/CBO9780511623325.004; Frankham R, 2011, CONSERV BIOL, V25, P465, DOI 10.1111/j.1523-1739.2011.01662.x; Gardner W. H., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P493; Godefroid S, 2011, BIOL CONSERV, V144, P672, DOI 10.1016/j.biocon.2010.10.003; International Union for Conservation of Nature and Natural Resources (IUCN)/SSC Re-introduction Specialist Group, 1998, IUCN GUID REINTR; Jakson P., 1995, HDB BOT GARD REINTR; Jusaitis Manfred, 2005, Ecological Management & Restoration, V6, P61, DOI 10.1111/j.1442-8903.2005.00220.x; Kephart SR, 2004, CONSERV GENET, V5, P49, DOI 10.1023/B:COGE.0000014056.65197.c4; Knapp Eric E., 1998, P345; Krauss SL, 2002, CONSERV BIOL, V16, P986, DOI 10.1046/j.1523-1739.2002.01105.x; Lambinon J, 1997, INTRO NONNATIVE PLAN; Larrere R, 2005, BIODIVERSITES OBJETS, P174; Latour B, 2001, MET CHERCH REG ANTHR; Lizet B, 1997, COLLOQ INRA, P161; Lofflin DL, 2005, AM J BOT, V92, P1691, DOI 10.3732/ajb.92.10.1691; Matthies D, 2004, OIKOS, V105, P481, DOI 10.1111/j.0030-1299.2004.12800.x; MAUNDER M, 1992, BIODIVERS CONSERV, V1, P51, DOI 10.1007/BF00700250; Mauz I, 2005, GENS CORNES CROCS; Menges ES, 2008, AUST J BOT, V56, P187, DOI 10.1071/BT07173; Micoud A, 1993, NATURES SCI SOC, V1, P202; Morgan JW, 2000, CONSERV BIOL, V14, P780, DOI 10.1046/j.1523-1739.2000.98516.x; Olivier de Sardan J-P, 2008, RIGUEUR QUALITATIF C; PAVLIK BM, 1988, BIOL CONSERV, V46, P217, DOI 10.1016/0006-3207(88)90069-9; Pelosse V, 1992, EC RURALE, V208, P101, DOI 10.3406/ecoru.1992.14462; Pelosse V, 1993, ETUD RURALES, P9; R Development Core Team, 2009, R FDN STAT COMP; Raabova J, 2009, PLANT BIOLOGY, V11, P829, DOI 10.1111/j.1438-8677.2008.00186.x; READING RP, 1993, CONSERV BIOL, V7, P569, DOI 10.1046/j.1523-1739.1993.07030569.x; Robichaux RH, 1997, CONSERV BIOL, V11, P1140, DOI 10.1046/j.1523-1739.1997.96314.x; Seddon PJ, 2007, CONSERV BIOL, V21, P303, DOI 10.1111/j.1523-1739.2006.00627.x; Skogen K, 2008, RURAL SOCIOL, V73, P105, DOI 10.1526/003601108783575916; Touraine A, 2000, J WORLD SYSTEMS RES, V6, P900, DOI DOI 10.5195/JWSR.2000.211; Vaillant S, 1723, BOT PARISIENSE OPERI; Vergeer P, 2005, PLANT BIOLOGY, V7, P509, DOI 10.1055/s-2005-865904; Vergeer P, 2004, CONSERV BIOL, V18, P812, DOI 10.1111/j.1523-1739.2004.00562.x; Vourc'h A, 1993, ETUD RURALES, P51; Weeks AR, 2011, EVOL APPL, V4, P709, DOI 10.1111/j.1752-4571.2011.00192.x; Zavodna M, 2009, MOL ECOL RESOUR, V9, P628, DOI 10.1111/j.1755-0998.2008.02482.x	47	1	1	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e50934	10.1371/journal.pone.0050934	http://dx.doi.org/10.1371/journal.pone.0050934			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349668	Green Submitted, gold, Green Published			2022-12-25	WOS:000313943000004
J	Dong, YY; Chen, FX; Yu, YB; Du, C; Qi, QQ; Liu, H; Li, YQ				Dong, Yan-Yan; Chen, Fei-Xue; Yu, Yan-Bo; Du, Chao; Qi, Qing-Qing; Liu, Han; Li, Yan-Qing			A School-Based Study with Rome III Criteria on the Prevalence of Functional Gastrointestinal Disorders in Chinese College and University Students	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; QUALITY-OF-LIFE; COLD-WATER INTAKE; PSYCHOSOCIAL FACTORS; HOSPITAL ANXIETY; DEPRESSION SCALE; NATURAL-HISTORY; UNITED-STATES; DYSPEPSIA; EPIDEMIOLOGY	Background: Functional gastrointestinal disorders, including functional dyspepsia, irritable bowel syndrome and functional constipation are very common worldwide. Objective: This research aims to estimate the prevalence and associated factors involved in functional gastrointestinal disorders in Chinese college and university students using the Rome III criteria. Methods: A total of 5000 students from Shandong University in China were asked in January-May 2012 to complete questionnaires, including the Rome III questionnaire, hospital anxiety and depression scale, and negative life events scale. Results: Based on the 4638 students who completed the questionnaire, the prevalence of functional dyspepsia, irritable bowel syndrome and functional constipation in college and university students of North China worked out to be 9.25%, 8.34% and 5.45% respectively. They were more frequent in female students. The factors of anxiety (OR 1.07; 95% CI 0.99 to 1.16, P=0.002<0.05) and depression (OR 0.55; 95% CI 0.15 to 1.05, P=0.045<0.05) indicated a high risk of causing irritable bowel syndrome. Conclusion: Functional dyspepsia, irritable bowel syndrome and functional constipation were common in college and university students of North China. Psychological disorders such as anxiety and depression provide significant risk factors for irritable bowel syndrome patients.	[Dong, Yan-Yan; Chen, Fei-Xue; Yu, Yan-Bo; Du, Chao; Qi, Qing-Qing; Liu, Han; Li, Yan-Qing] Shandong Univ, Dept Gastroenterol, Qilu Hosp, Jinan, Shandong, Peoples R China; [Dong, Yan-Yan] Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Qilu Hosp, Jinan, Shandong, Peoples R China; [Dong, Yan-Yan] Shandong Univ, Chinese Minist Hlth, Qilu Hosp, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Li, YQ (corresponding author), Shandong Univ, Dept Gastroenterol, Qilu Hosp, Jinan, Shandong, Peoples R China.	liyanqing@sdu.edu.cn	yu, yanbo/GZM-8474-2022; Liu, Han/GVT-8296-2022		Graduate Innovation Foundation of Shandong University [yyx10017]	Graduate Innovation Foundation of Shandong University	This study was supported by the Graduate Innovation Foundation of Shandong University (yyx10017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2011, GASTROENTEROL CLIN N, V40, P11, DOI 10.1016/j.gtc.2010.12.013; AGREUS L, 1995, GASTROENTEROLOGY, V109, P671, DOI 10.1016/0016-5085(95)90373-9; Chan YF, 2010, QUAL LIFE RES, V19, P865, DOI 10.1007/s11136-010-9645-1; Chang FY, 2012, ASIA PAC J CLIN NUTR, V21, P594; Chang FY, 2007, J GASTROEN HEPATOL, V22, P4, DOI 10.1111/j.1440-1746.2006.04672.x; Chang L, 2001, GASTROENTEROLOGY, V120, P1236; Dai N, 2008, DIGEST LIVER DIS, V40, P418, DOI 10.1016/j.dld.2008.01.019; Dorn SD, 2009, J CLIN GASTROENTEROL, V43, P214, DOI 10.1097/MCG.0b013e31815bd749; Drossman D, 2006, ROME 3 FUNCTIONAL GA; DROSSMAN DA, 1993, DIGEST DIS SCI, V38, P1569, DOI 10.1007/BF01303162; DROSSMAN DA, 1988, GASTROENTEROLOGY, V95, P701, DOI 10.1016/S0016-5085(88)80017-9; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; El-Serag HB, 2002, ALIMENT PHARM THER, V16, P1171, DOI 10.1046/j.1365-2036.2002.01290.x; Ersryd A, 2007, ALIMENT PHARM THERAP, V26, P953, DOI 10.1111/j.1365-2036.2007.03422.x; Faresjo A, 2007, EUR J EPIDEMIOL, V22, P473, DOI 10.1007/s10654-007-9133-2; Frank L, 2002, CLIN THER, V24, P675, DOI 10.1016/S0149-2918(02)85143-8; Golden-Kreutz DM, 2005, HEALTH PSYCHOL, V24, P288, DOI 10.1037/0278-6133.24.3.288; Gwee KA, 2004, AM J GASTROENTEROL, V99, P924, DOI 10.1111/j.1572-0241.2004.04161.x; Gwee KA, 2005, NEUROGASTROENT MOTIL, V17, P317, DOI 10.1111/j.1365-2982.2005.00627.x; Halder SLS, 2007, GASTROENTEROLOGY, V133, P799, DOI 10.1053/j.gastro.2007.06.010; Irvine EJ, 2002, AM J GASTROENTEROL, V97, P1986; Jeong LJ, 2008, WORLD J GASTROENTERO, V14, P6388, DOI 10.3748/wjg.14.6388; KATON W, 1991, AM J PSYCHIAT, V148, P34; Kawamura A, 2001, J GASTROEN HEPATOL, V16, P384, DOI 10.1046/j.1440-1746.2001.02454.x; Koloski NA, 2012, GUT, V61, P1284, DOI 10.1136/gutjnl-2011-300474; Li XJ, 2012, WORLD J GASTROENTERO, V18, P2561, DOI 10.3748/wjg.v18.i20.2561; Li YY, 2002, CHINESE MED J-PEKING, V115, P1082; Locke GR, 1998, BAILLIERE CLIN GASTR, V12, P435; Martin CR, 2004, PSYCHIAT RES, V129, P279, DOI 10.1016/j.psychres.2004.06.012; Matthews KA, 1997, AM PSYCHOL, V52, P101, DOI 10.1037/0003-066X.52.2.101; Nelhans Nick, 2010, Practitioner, V254, P22; Noh Young Wook, 2010, J Neurogastroenterol Motil, V16, P148, DOI 10.5056/jnm.2010.16.2.148; Park JM, 2011, J NEUROGASTROENTEROL, V17, P279, DOI 10.5056/jnm.2011.17.3.279; Pinto C, 2000, J Assoc Physicians India, V48, P589; Saito YA, 2002, AM J GASTROENTEROL, V97, P1910; SANDLER RS, 1990, GASTROENTEROLOGY, V99, P409, DOI 10.1016/0016-5085(90)91023-Y; Shen L, 2009, J GASTROEN HEPATOL, V24, P1885, DOI 10.1111/j.1440-1746.2009.05943.x; Sperber AD, 2007, EUR J GASTROEN HEPAT, V19, P441, DOI 10.1097/MEG.0b013e32801140e2; Stewart WF, 1999, AM J GASTROENTEROL, V94, P3530, DOI 10.1111/j.1572-0241.1999.01642.x; Tabbers MM, 2011, EUR J PEDIATR, V170, P955, DOI 10.1007/s00431-011-1515-5; Tack J, 2004, GASTROENTEROLOGY, V127, P1239, DOI 10.1053/j.gastro.2004.05.030; Talley NJ, 2007, REV GASTROENTEROL DI, V7, P97; Taylor SE, 2000, PSYCHOL REV, V107, P411, DOI 10.1037/0033-295X.107.3.411; Vodermaier A, 2011, SUPPORT CARE CANCER, V19, P1899, DOI 10.1007/s00520-011-1251-4; Wang J, 2001, CLIN EPIDEMIOLOGY; White D, 1999, BRIT J PSYCHIAT, V175, P452, DOI 10.1192/bjp.175.5.452; Xiong LS, 2004, ALIMENT PHARM THER, V19, P1217, DOI 10.1111/j.1365-2036.2004.01939.x; Yao X, 2012, J GASTROEN HEPATOL, V27, P760, DOI 10.1111/j.1440-1746.2011.06930.x; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zuo XL, 2007, J GASTROEN HEPATOL, V22, P2330, DOI 10.1111/j.1440-1746.2006.04772.x; Zuo XL, 2006, J GASTROENTEROL, V41, P311, DOI 10.1007/s00535-005-1766-x	51	43	46	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54183	10.1371/journal.pone.0054183	http://dx.doi.org/10.1371/journal.pone.0054183			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	075GQ	23349820	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872800031
J	Dupraz, S; Grassi, D; Karnas, D; Guil, AFN; Hicks, D; Quiroga, S				Dupraz, Sebastian; Grassi, Diego; Karnas, Diana; Nieto Guil, Alvaro F.; Hicks, David; Quiroga, Santiago			The Insulin-Like Growth Factor 1 Receptor Is Essential for Axonal Regeneration in Adult Central Nervous System Neurons	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; FACTOR-I; IGF-I; NEURITE REGENERATION; SURVIVAL; PIG; EXPRESSION; 3-KINASE; PROMOTE; BRAIN	Axonal regeneration is an essential condition to re-establish functional neuronal connections in the injured adult central nervous system (CNS) but efficient regrowth of severed axons has proven to be very difficult to achieve. Although significant progress has been made in identifying the intrinsic and extrinsic mechanisms involved many aspects remain unresolved. Axonal development in embryonic CNS (hippocampus) requires the obligate activation of the insulin-like growth factor 1 receptor (IGF-1R). Based on known similarities between axonal growth in fetal compared to mature CNS we decided to examine the expression of the IGF-1R using an antibody to the beta gc subunit or a polyclonal anti-peptide antibody directed to the IGF-R (C20) in an in vitro model of adult CNS axonal regeneration namely retinal ganglion cells (RGC) derived from adult rat retinas. Expression of both beta gc and the beta subunit recognized by C20 antibody were low in freshly isolated adult RGC but increased significantly after 4 days in vitro. As in embryonic axons beta gc was localised to distal regions and leading growth cones in RGC. IGF-1R-beta gc co-localised with activated p85 involved in the hosphatidylinositol-3 kinase (PI3K) signaling pathway upon stimulation with IGF-1. Blocking experiments using either an antibody which neutralises IGF-1R activation shRNA designed against the IGF-1R sequence or the PI3K pathway inhibitor LY294002 all significantly reduced axon regeneration from adult RGC in vitro (similar to 40% RGC possessed axons in controls vs 2-8% in the different blocking studies). Finally co-transfection of RGC with shRNA to silence IGF-1R together with a vector containing a constitutively active form of downstream PI3K (p110) fully restored axonal outgrowth in vitro. Hence these data demonstrate that axonal regeneration in adult CNS neurons requires re-expression and activation of IGF-1R and targeting this system may offer new therapeutic approaches to enhancing axonal regeneration following trauma.	[Dupraz, Sebastian; Grassi, Diego; Nieto Guil, Alvaro F.; Quiroga, Santiago] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, RA-5000 Cordoba, Argentina; [Dupraz, Sebastian; Grassi, Diego; Nieto Guil, Alvaro F.; Quiroga, Santiago] Consejo Nacl Invest Cient & Tecn CONICET, Ctr Invest Quim Biol Cordoba CIQUIBIC, Cordoba, Argentina; [Karnas, Diana; Hicks, David] Univ Strasbourg, Inst Neurosci Cellulaires & Integrat, CNRS, UPR 3212, Strasbourg, France	National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Quiroga, S (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, RA-5000 Cordoba, Argentina.	squiroga@fcq.unc.edu.ar	; Grassi, Davide/B-7916-2018	Grassi, Diego/0000-0002-4886-3046; Nieto Guil, Alvaro Fernando/0000-0002-9787-3486; Grassi, Davide/0000-0003-1653-3066	Mincyt-ECOS [A08S01]; FONCYT, Argentina [1733]; PICT [1442]	Mincyt-ECOS; FONCYT, Argentina(FONCyT); PICT(ANPCyT)	This work was supported by Mincyt-ECOS grant number A08S01 to SQ and DH (URL: http://www.mincyt.gov.ar/) and FONCYT, Argentina, PICT grants number 1733 and 1442 to SQ (URL: http://www.agencia.gov.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahori Y, 1997, NEUROREPORT, V8, P2265, DOI 10.1097/00001756-199707070-00034; Aras MA, 2008, CURR PROTOC NEUROSCI, V7, P7181; Bohula EA, 2003, J BIOL CHEM, V278, P15991, DOI 10.1074/jbc.M300714200; Bonnet D, 2004, BRAIN RES, V1007, P142, DOI 10.1016/j.brainres.2004.02.023; Bouquet C, 2007, ADV EXP MED BIOL, V621, P1, DOI 10.1007/978-0-387-76715-4_1; Buffo A, 2003, EUR J NEUROSCI, V18, P2146, DOI 10.1046/j.1460-9568.2003.02940.x; Burren CP, 1996, INVEST OPHTH VIS SCI, V37, P1459; Caroni P, 1997, BIOESSAYS, V19, P767, DOI 10.1002/bies.950190906; CHEN DF, 1995, P NATL ACAD SCI USA, V92, P7287, DOI 10.1073/pnas.92.16.7287; Cui Q, 2006, MOL NEUROBIOL, V33, P155, DOI 10.1385/MN:33:2:155; FORSTER V, 1999, IBRO HB S M, V18, P579; GAROFALO RS, 1989, MOL CELL BIOL, V9, P2806, DOI 10.1128/MCB.9.7.2806; Goldberg JL, 2000, ANNU REV NEUROSCI, V23, P579, DOI 10.1146/annurev.neuro.23.1.579; GONZALEZ MD, 1994, J NEUROSCI, V14, P6121; Gutierrez-Ospina G, 2002, NEUROSCI LETT, V325, P207, DOI 10.1016/S0304-3940(02)00293-8; Guy J, 1998, P NATL ACAD SCI USA, V95, P13847, DOI 10.1073/pnas.95.23.13847; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; Hayreh SS, 2009, PROG RETIN EYE RES, V28, P34, DOI 10.1016/j.preteyeres.2008.11.002; Hirsch S, 1999, ADV EXP MED BIOL, V468, P199; Homma K, 2007, NEUROCHEM INT, V50, P741, DOI 10.1016/j.neuint.2007.01.011; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; Kermer P, 2000, J NEUROSCI, V20, P722, DOI 10.1523/JNEUROSCI.20-02-00722.2000; Kim JY, 2006, EXPERT OPIN BIOL TH, V6, P735, DOI 10.1517/14712598.6.8.735; Kimpinski K, 2001, J NEUROSCI RES, V63, P486, DOI 10.1002/jnr.1043; Kinkl N, 2003, MOL CELL NEUROSCI, V23, P39, DOI 10.1016/S1044-7431(03)00070-8; Koriyama Y, 2007, NEUROCHEM INT, V50, P749, DOI 10.1016/j.neuint.2007.01.012; Kurimoto T, 2010, J NEUROSCI, V30, P15654, DOI 10.1523/JNEUROSCI.4340-10.2010; Lambooij AC, 2003, INVEST OPHTH VIS SCI, V44, P2192, DOI 10.1167/iovs.02-0410; Lebrun-Julien F, 2008, OPTOMETRY VISION SCI, V85, P417, DOI 10.1097/OPX.0b013e31817841f7; LEE WH, 1992, J NEUROSCI, V12, P4737; Luo XM, 2001, INVEST OPHTH VIS SCI, V42, P1096; Mascotti F, 1997, J NEUROSCI, V17, P1447; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Morera LP, 2012, EXP EYE RES, V101, P44, DOI 10.1016/j.exer.2012.05.010; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Ozdinler PH, 2006, NAT NEUROSCI, V9, P1371, DOI 10.1038/nn1789; QUIROGA S, 1995, P NATL ACAD SCI USA, V92, P4309, DOI 10.1073/pnas.92.10.4309; Romano C, 2007, PROG RETIN EYE RES, V26, P379, DOI 10.1016/j.preteyeres.2007.03.001; Rossi F, 2001, RESTOR NEUROL NEUROS, V19, P85; Rossi F, 2007, PROG NEUROBIOL, V81, P1, DOI 10.1016/j.pneurobio.2006.12.001; Ruberte J, 2004, J CLIN INVEST, V113, P1149, DOI 10.1172/JCI200419478; Ruiz-Ederra J, 2004, MOL VIS, V10, P83; Sapieha PS, 2006, J NEUROSCI RES, V83, P985, DOI 10.1002/jnr.20803; Sapieha PS, 2003, MOL CELL NEUROSCI, V24, P656, DOI 10.1016/S1044-7431(03)00228-8; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Sosa L, 2006, NAT NEUROSCI, V9, P993, DOI 10.1038/nn1742; Teng FYH, 2006, J NEUROCHEM, V96, P1501, DOI 10.1111/j.1471-4159.2006.03663.x; Tonges L, 2011, J NEUROCHEM, V117, P892, DOI 10.1111/j.1471-4159.2011.07257.x; Werner H, 1991, GROWTH FACTORS CYTOK, P17; Wu N, 2008, J INT MED RES, V36, P883, DOI 10.1177/147323000803600503; Yip HK, 2000, PROG RETIN EYE RES, V19, P559, DOI 10.1016/S1350-9462(00)00009-4	52	53	58	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54462	10.1371/journal.pone.0054462	http://dx.doi.org/10.1371/journal.pone.0054462			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349896	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872800055
J	He, D; Zhao, XQ; Chen, XG; Fang, Y; Singh, S; Talele, TT; Qiu, HJ; Liang, YJ; Wang, XK; Zhang, GQ; Chen, ZS; Fu, LW				He, Dan; Zhao, Xiao-qin; Chen, Xing-gui; Fang, Yi; Singh, Satyakam; Talele, Tanaji T.; Qiu, Hui-juan; Liang, Yong-ju; Wang, Xiao-kun; Zhang, Guo-qing; Chen, Zhe-sheng; Fu, Li-wu			BIRB796, the Inhibitor of p38 Mitogen-Activated Protein Kinase, Enhances the Efficacy of Chemotherapeutic Agents in ABCB1 Overexpression Cells	PLOS ONE			English	Article							MEDIATED MULTIDRUG-RESISTANCE; SUBFAMILY-B MEMBER-1; P-GLYCOPROTEIN; MAP KINASE; DRUG-RESISTANCE; CANCER-CELLS; TRANSPORTERS; BINDING; REVERSAL; PATHWAY	ATP-binding-cassette family membrane proteins play an important role in multidrug resistance. In this study, we investigated BIRB796, an orally active inhibitor of p38 mitogen-activated protein kinase, reversed MDR induced by ABCB1, ABCG2 and ABCC1. Our results showed that BIRB796 could reverse ABCB1-mediated MDR in both the drug selected and transfected ABCB1-overexpressing cell models, but did not enhance the efficacy of substrate-chemotherapeutical agents in ABCC1 or ABCG2 overexpression cells and their parental sensitive cells. Furthermore, BIRB796 increased the intracellular accumulation of the ABCB1 substrates, such as rhodamine 123 and doxorubicin. Moreover, BIRB796 bidirectionally mediated the ATPase activity of ABCB1, stimulating at low concentration, inhibiting at high concentration. However, BIRB796 did not alter the expression of ABCB1 both at protein and mRNA level. The down-regulation of p38 by siRNA neither affected the expression of ABCB1 nor the cytotoxic effect of paclitaxel on KBV200. The binding model of BIRB796 within the large cavity of the transmembrane region of ABCB1 may form the basis for future lead optimization studies. Importantly, BIRB796 also enhanced the effect of paclitaxel on the inhibition of growth of the ABCB1-overexpressing KBV200 cell xenografts in nude mice. Overall, we conclude that BIRB796 reverses ABCB1-mediated MDR by directly inhibiting its transport function. These findings may be useful for cancer combinational therapy with BIRB796 in the clinic.	[He, Dan; Zhang, Guo-qing] Xinjiang Med Univ, Affiliated Tumor Hosp, Dept Thorac Surg, Urumqi, Peoples R China; [Zhao, Xiao-qin; Chen, Xing-gui; Fang, Yi; Qiu, Hui-juan; Liang, Yong-ju; Wang, Xiao-kun; Fu, Li-wu] Sun Yat Sen Univ, State Key Lab Oncol So China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Singh, Satyakam; Talele, Tanaji T.; Chen, Zhe-sheng] St Johns Univ, Dept Pharmaceut Sci, Coll Pharm & Hlth Sci, Queens, NY USA	Xinjiang Medical University; Sun Yat Sen University; Saint John's University	Zhang, GQ (corresponding author), Xinjiang Med Univ, Affiliated Tumor Hosp, Dept Thorac Surg, Urumqi, Peoples R China.	zgqprofessor@sina.com; Fulw@mail.sysu.edu.cn	zhang, guoqing/GXG-4800-2022; Wang, Xiaokun/AAH-6815-2021; WANG, XIAOKUN/GQR-1904-2022; wang, xk/HGD-3115-2022; Fu, Liwu/AAE-8835-2020	Wang, Xiaokun/0000-0003-4148-5561; Singh, Satyakam/0000-0001-9115-3296; Chen, Zhe-Sheng/0000-0002-8289-097X	China 863 Program Foundation [2012AA02A303]; China 973 Program Foundation [2011CB504300]; China National Natural Sciences Foundation [81061160]	China 863 Program Foundation; China 973 Program Foundation; China National Natural Sciences Foundation(National Natural Science Foundation of China (NSFC))	The work was supported by China 863 Program Foundation (No. 2012AA02A303 (http://program.most.gov.cn/), China 973 Program Foundation (No. 2011CB504300, http://www.973.gov.cn/), and China National Natural Sciences Foundation (No. 81061160, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Alsayed Y, 2001, J BIOL CHEM, V276, P4012, DOI 10.1074/jbc.M007431200; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Atadja P, 1998, CANCER METAST REV, V17, P163, DOI 10.1023/A:1006046201497; Bakos E, 2007, PFLUG ARCH EUR J PHY, V453, P621, DOI 10.1007/s00424-006-0160-8; Barancik M, 2001, EUR J PHARM SCI, V14, P29, DOI 10.1016/S0928-0987(01)00139-7; Branger J, 2002, J IMMUNOL, V168, P4070, DOI 10.4049/jimmunol.168.8.4070; Chen LM, 2004, J PHARM PHARMACOL, V56, P1061, DOI 10.1211/0022357043879; Crivori P, 2006, MOL PHARMACEUT, V3, P33, DOI 10.1021/mp050071a; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Dai CL, 2008, CANCER RES, V68, P7905, DOI 10.1158/0008-5472.CAN-08-0499; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Ding PR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019329; Doyle LA, 2003, ONCOGENE, V22, P7340, DOI 10.1038/sj.onc.1206938; FOJO AT, 1987, P NATL ACAD SCI USA, V84, P265, DOI 10.1073/pnas.84.1.265; Germann UA, 1996, EUR J CANCER, V32A, P927, DOI 10.1016/0959-8049(96)00057-3; Guo XL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-375; Hideshima T, 2004, ONCOGENE, V23, P8766, DOI 10.1038/sj.onc.1208118; Jamroziak Krzysztof, 2004, Hematology, V9, P91, DOI 10.1080/10245330310001638974; Klepsch F, 2010, CURR PHARM DESIGN, V16, P1742, DOI 10.2174/138161210791163992; Klopman G, 1997, MOL PHARMACOL, V52, P323, DOI 10.1124/mol.52.2.323; Krishna Rajesh, 2001, Current Medicinal Chemistry - Anti-Cancer Agents, V1, P163, DOI 10.2174/1568011013354705; Lage H, 2006, CURR DRUG TARGETS, V7, P813, DOI 10.2174/138945006777709566; Leonard GD, 2003, ONCOLOGIST, V8, P411, DOI 10.1634/theoncologist.8-5-411; Osborn MT, 1999, ONCOGENE, V18, P5756, DOI 10.1038/sj.onc.1202943; Paillas S, 2011, CANCER RES, V71, P1041, DOI 10.1158/0008-5472.CAN-10-2726; Pajeva IK, 2009, CHEMMEDCHEM, V4, P1883, DOI 10.1002/cmdc.200900282; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Ranganathan AC, 2006, CANCER BIOL THER, V5, P729, DOI 10.4161/cbt.5.7.2968; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Regan J, 2002, J MED CHEM, V45, P2994, DOI 10.1021/jm020057r; Regan J, 2003, J MED CHEM, V46, P4676, DOI 10.1021/jm030121k; Robey RW, 2003, BRIT J CANCER, V89, P1971, DOI 10.1038/sj.bjc.6601370; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Schreiber S, 2006, CLIN GASTROENTEROL H, V4, P325, DOI 10.1016/j.cgh.2005.11.013; Shi Z, 2007, CANCER RES, V67, P11012, DOI 10.1158/0008-5472.CAN-07-2686; Shi Z, 2011, CANCER RES, V71, P3029, DOI 10.1158/0008-5472.CAN-10-3820; Tang R, 2004, LEUKEMIA, V18, P1246, DOI 10.1038/sj.leu.2403390; Tao LY, 2009, CANCER CHEMOTH PHARM, V64, P961, DOI 10.1007/s00280-009-0949-1; Teodori E, 2006, CURR DRUG TARGETS, V7, P893, DOI 10.2174/138945006777709520; Verma A, 2002, J BIOL CHEM, V277, P44988, DOI 10.1074/jbc.M207176200; WACHER VJ, 1995, MOL CARCINOGEN, V13, P129, DOI 10.1002/mc.2940130302; Wang F, 2012, MOL MED, V18, P887, DOI 10.2119/molmed.2011.00444; Wang F, 2012, CHIN J CANCER, V31, P150, DOI 10.5732/cjc.011.10310; Wilson KP, 1996, J BIOL CHEM, V271, P27696, DOI 10.1074/jbc.271.44.27696; Zhao XQ, 2012, MOL PHARM; Zheng LS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005172	47	23	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54181	10.1371/journal.pone.0054181	http://dx.doi.org/10.1371/journal.pone.0054181			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349819	gold, Green Submitted, Green Published			2022-12-25	WOS:000313872800030
J	Nobel, S; Witte, K				Noebel, Sabine; Witte, Klaudia			Public Information Influences Sperm Transfer to Females in Sailfin Molly Males	PLOS ONE			English	Article							MALE MATE CHOICE; GUPPY POECILIA-RETICULATA; MALE MATING-BEHAVIOR; SEXUAL SELECTION; GEOGRAPHIC-VARIATION; MULTIPLE PATERNITY; COMPETITION GAMES; SOCIAL INFLUENCES; JAPANESE-QUAIL; LATIPINNA COPY	In animals, including humans, the social environment can serve as a public information network in which individuals can gather public information about the quality of potential mates by observing conspecifics during sexual interactions. The observing individual itself is also a part of this information network. When recognized by the observed conspecifics as an audience, his/her presence could influence the sexual interaction between those individuals, because the observer might be considered as a potential mate or competitor. One of the most challenging questions in sexual selection to date is how the use of public information in the context of mate choice is linked to the fitness of individuals. Here, we could show that public information influences mate-choice behaviour in sailfin molly males, Poecilia latipinna, and influences the amount of sperm males transfer to a female partner. In the presence of an audience male, males spent less time with the previously preferred, larger of two females and significantly more time with the previously non-preferred, smaller female. When males could physically interact with a female and were faced with an audience male, three audience females or no audience, males transferred significantly more sperm to a female partner in the presence of an audience male than with female audience or no audience and spent less time courting his female partner. This is the first study showing that public information use turns into fitness investment, which is the crucial factor to understand the role of public information in the dynamic processes in sexual selection.	[Noebel, Sabine; Witte, Klaudia] Univ Siegen, Biol Sect, Res Grp Ecol & Behav Biol, D-57068 Siegen, Germany	Universitat Siegen	Nobel, S (corresponding author), Univ Siegen, Biol Sect, Res Grp Ecol & Behav Biol, D-57068 Siegen, Germany.	noebel@biologie.uni-siegen.de		Nobel, Sabine/0000-0002-1850-8895				Agrawal AF, 2001, BEHAV ECOL SOCIOBIOL, V51, P33, DOI 10.1007/s002650100401; Alonzo SH, 2008, ANIM BEHAV, V75, P1715, DOI 10.1016/j.anbehav.2007.09.031; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Andersson Malte, 1994; Aspbury AS, 2007, BEHAV ECOL, V18, P776, DOI 10.1093/beheco/arm044; Aspbury AS, 2004, P NATL ACAD SCI USA, V101, P15970, DOI 10.1073/pnas.0405653101; Aspbury AS, 2004, ETHOLOGY, V110, P193, DOI 10.1111/j.1439-0310.2003.00963.x; Auld HL, 2009, BEHAV PROCESS, V82, P78, DOI 10.1016/j.beproc.2009.03.004; BAKKER TCM, 1995, J EVOLUTION BIOL, V8, P129, DOI 10.1046/j.1420-9101.1995.8020129.x; BARCLAY RMR, 1982, BEHAV ECOL SOCIOBIOL, V10, P271, DOI 10.1007/BF00302816; Bierbach D, 2011, BEHAV ECOL SOCIOBIOL, V65, P1699, DOI 10.1007/s00265-011-1177-3; Birkhead TR, 1998, SPERM COMPETITION SE; Bonnie KE, 2007, ANIM BEHAV, V74, P171, DOI 10.1016/j.anbehav.2006.12.009; Bozynski CC, 2003, ANIM BEHAV, V65, P53, DOI 10.1006/anbe.2002.2024; Brennan BJ, 2008, J THEOR BIOL, V253, P561, DOI 10.1016/j.jtbi.2008.04.003; Brooks R, 1998, TRENDS ECOL EVOL, V13, P45, DOI 10.1016/S0169-5347(97)01253-6; Clutton-Brock T, 2009, ANIM BEHAV, V77, P3, DOI 10.1016/j.anbehav.2008.08.026; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Doutrelant C, 2000, BEHAVIOUR, V137, P1655, DOI 10.1163/156853900502763; Dugatkin LA, 1998, BEHAV ECOL, V9, P323, DOI 10.1093/beheco/9.4.323; Dugatkin LA, 1996, P NATL ACAD SCI USA, V93, P2770, DOI 10.1073/pnas.93.7.2770; DUGATKIN LA, 1993, BEHAV ECOL, V4, P289, DOI 10.1093/beheco/4.4.289; DUGATKIN LA, 1992, P ROY SOC B-BIOL SCI, V249, P179, DOI 10.1098/rspb.1992.0101; DUGATKIN LA, 1992, AM NAT, V139, P1384, DOI 10.1086/285392; Dzieweczynski TL, 2004, ANIM BEHAV, V68, P465, DOI 10.1016/j.anbehav.2003.08.024; Earley Ryan L., 2005, P84, DOI 10.1017/CBO9780511610363.007; Eva KW, 2006, CAN MED ASSOC J, V175, P1573, DOI 10.1503/cmaj.061367; EVANS CS, 1994, ANIM BEHAV, V47, P1159, DOI 10.1006/anbe.1994.1154; Evans Jonathan P., 2011, P197; Evans JP, 2003, BEHAV ECOL, V14, P268, DOI 10.1093/beheco/14.2.268; Evans JP, 1999, P ROY SOC B-BIOL SCI, V266, P2083, DOI 10.1098/rspb.1999.0891; Evans JP, 2001, P ROY SOC B-BIOL SCI, V268, P719, DOI 10.1098/rspb.2000.1577; Fisher HS, 2007, BIOL LETTERS, V3, P5, DOI 10.1098/rsbl.2006.0556; Frommen JG, 2009, EVOL ECOL, V23, P435, DOI 10.1007/s10682-008-9243-7; Fuller RC, 1998, P ROY SOC B-BIOL SCI, V265, P2365, DOI 10.1098/rspb.1998.0585; Galef BG, 2008, ANIM BEHAV, V75, P1117, DOI 10.1016/j.anbehav.2007.08.026; Galef BG, 1998, ANIM BEHAV, V55, P545, DOI 10.1006/anbe.1997.0616; GIBSON RM, 1992, TRENDS ECOL EVOL, V7, P229, DOI 10.1016/0169-5347(92)90050-L; Gibson RM, 1991, BEHAV ECOL, V2, P165, DOI 10.1093/beheco/2.2.165; Girndt A, 2012, ANIM BIOL, V62, P245, DOI 10.1163/157075611X618192; Godin JGJ, 2009, BEHAVIOUR, V146, P1443, DOI 10.1163/156853909X441014; Godin JGJ, 2005, ANIM BEHAV, V69, P999, DOI 10.1016/j.anbehav.2004.07.016; Goulet D, 2006, BEHAV ECOL, V17, P998, DOI 10.1093/beheco/arl032; Herb BM, 2003, BEHAVIOUR, V140, P71, DOI 10.1163/156853903763999908; Heubel KU, 2008, BEHAVIOUR, V145, P1041, DOI 10.1163/156853908784474533; Hill SE, 2006, BIOL LETT-UK, V2, P203, DOI 10.1098/rsbl.2005.0423; HOGLUND J, 1995, ANIM BEHAV, V49, P1627, DOI 10.1016/0003-3472(95)90085-3; Hoi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032806; Hubbs CL, 1932, SCIENCE, V76, P628, DOI 10.1126/science.76.1983.628; Iwasa Y, 1999, J THEOR BIOL, V200, P97, DOI 10.1006/jtbi.1999.0979; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Jennions MD, 2001, Q REV BIOL, V76, P3, DOI 10.1086/393743; KIRKPATRICK M, 1991, NATURE, V350, P33, DOI 10.1038/350033a0; KIRKPATRICK M, 1994, BEHAV ECOL SOCIOBIOL, V34, P443; KODRICBROWN A, 1993, BEHAV ECOL SOCIOBIOL, V32, P415, DOI 10.1007/BF00168825; Kokko H, 2003, P ROY SOC B-BIOL SCI, V270, P653, DOI 10.1098/rspb.2002.2235; Kokko H, 2008, J EVOLUTION BIOL, V21, P919, DOI 10.1111/j.1420-9101.2008.01540.x; LALAND KN, 1994, THEOR POPUL BIOL, V45, P1, DOI 10.1006/tpbi.1994.1001; Leaver LA, 2007, ANIM COGN, V10, P23, DOI 10.1007/s10071-006-0026-7; Lichtenberg EM, 2011, BEHAV ECOL SOCIOBIOL, V65, P763, DOI 10.1007/s00265-010-1080-3; LILEY NR, 1995, CAN J ZOOL, V73, P826, DOI 10.1139/z95-097; LOSEY GS, 1986, AM NAT, V128, P653, DOI 10.1086/284595; Loyau A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00768; MAJERUS MEN, 1986, TRENDS ECOL EVOL, V1, P1, DOI 10.1016/0169-5347(86)90056-X; Makowicz AM, 2010, BEHAV PROCESS, V85, P36, DOI 10.1016/j.beproc.2010.06.003; Makowicz AM, 2010, BEHAVIOUR, V147, P1657, DOI 10.1163/000579510X528206; Marler CA, 1997, EVOLUTION, V51, P1244, DOI 10.1111/j.1558-5646.1997.tb03971.x; McGregor Peter K., 2000, Acta Ethologica, V2, P71, DOI 10.1007/s102110000015; McGregor Peter K., 1996, P409; MCGREGOR PK, 1993, PHILOS T ROY SOC B, V340, P237, DOI 10.1098/rstb.1993.0063; McGregor PK, 2005, ANIMAL COMMUNICATION; Mennill DJ, 2002, SCIENCE, V296, P873, DOI 10.1126/science.296.5569.873; Mery F, 2009, CURR BIOL, V19, P730, DOI 10.1016/j.cub.2009.02.064; Mouterde SC, 2012, ANIM BEHAV, V83, P605, DOI 10.1016/j.anbehav.2011.11.032; Naguib M, 2004, BEHAV ECOL, V15, P1011, DOI 10.1093/beheco/arh108; Nordell SE, 1998, ECOL LETT, V1, P74; Oliveira RF, 1998, P ROY SOC B-BIOL SCI, V265, P1045, DOI 10.1098/rspb.1998.0397; OLSEN KH, 1993, GEN COMP ENDOCR, V89, P107, DOI 10.1006/gcen.1993.1014; Otter K, 1999, P ROY SOC B-BIOL SCI, V266, P1305, DOI 10.1098/rspb.1999.0779; Parker GA, 1996, P ROY SOC B-BIOL SCI, V263, P1291, DOI 10.1098/rspb.1996.0189; Parker GA, 1997, P ROY SOC B-BIOL SCI, V264, P1793, DOI 10.1098/rspb.1997.0249; Parker GA, 2010, BIOL REV, V85, P897, DOI 10.1111/j.1469-185X.2010.00140.x; PARTRIDGE L, 1983, MATE CHOICE, P227; PARZEFAL.J, 1969, BEHAVIOUR, V33, P1, DOI 10.1163/156853969X00297; Phelps SM, 2007, BEHAV ECOL, V18, P108, DOI 10.1093/beheco/arl063; Pilastro A, 2002, P NATL ACAD SCI USA, V99, P9913, DOI 10.1073/pnas.152133499; Plath M, 2008, CURR BIOL, V18, P1138, DOI 10.1016/j.cub.2008.06.067; Plath M, 2008, ANIM BEHAV, V75, P21, DOI 10.1016/j.anbehav.2007.05.013; Plath M, 2007, BEHAV ECOL, V18, P680, DOI 10.1093/beheco/arm030; Plath Martin, 2008, Communicative & Integrative Biology, V1, P199; Pollick AS, 2005, ANIM BEHAV, V70, P1273, DOI 10.1016/j.anbehav.2005.03.007; PRUETTJONES S, 1992, AM NAT, V140, P1000, DOI 10.1086/285452; Ptacek MB, 1997, EVOLUTION, V51, P1217, DOI 10.1111/j.1558-5646.1997.tb03969.x; REAL L, 1990, AM NAT, V136, P376, DOI 10.1086/285103; Ritchie MG, 2000, P ROY SOC B-BIOL SCI, V267, P327, DOI 10.1098/rspb.2000.1004; Schaus JM, 2001, BEHAV ECOL, V12, P740, DOI 10.1093/beheco/12.6.740; SCHLUPP I, 1994, SCIENCE, V263, P373, DOI 10.1126/science.8278809; Schlupp I, 1997, BEHAV ECOL, V8, P104, DOI 10.1093/beheco/8.1.104; SCHWAGMEYER PL, 1990, NATURE, V348, P62, DOI 10.1038/348062a0; Sirot E, 2001, J EVOLUTION BIOL, V14, P418, DOI 10.1046/j.1420-9101.2001.00284.x; Smith C, 2003, BEHAV ECOL SOCIOBIOL, V53, P206, DOI 10.1007/s00265-002-0576-x; Stohr S, 1998, ANIM BEHAV, V55, P893, DOI 10.1006/anbe.1997.0674; Tobler M, 2005, BIOL LETTERS, V1, P166, DOI 10.1098/rsbl.2005.0305; TRAVIS J, 1990, COPEIA, P722, DOI 10.2307/1446438; Trefry SA, 2009, ETHOLOGY, V115, P928, DOI 10.1111/j.1439-0310.2009.01675.x; Trexler JC, 1997, BEHAV ECOL SOCIOBIOL, V40, P297, DOI 10.1007/s002650050345; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Uehara T, 2005, AM NAT, V165, P403, DOI 10.1086/428301; Valone TJ, 2007, BEHAV ECOL SOCIOBIOL, V62, P1, DOI 10.1007/s00265-007-0439-6; VALONE TJ, 1989, OIKOS, V56, P357, DOI 10.2307/3565621; Vignal C, 2004, NATURE, V430, P448, DOI 10.1038/nature02645; Vukomanovic J, 2007, ETHOLOGY, V113, P579, DOI 10.1111/j.1439-0310.2007.01343.x; WADE MJ, 1990, P NATL ACAD SCI USA, V87, P5749, DOI 10.1073/pnas.87.15.5749; Waynforth D, 2007, HUM NATURE-INT BIOS, V18, P264, DOI 10.1007/s12110-007-9004-2; Webster H, 2010, ETHOLOGY, V116, P233, DOI 10.1111/j.1439-0310.2009.01729.x; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; White DJ, 2000, ANIM BEHAV, V59, P975, DOI 10.1006/anbe.1999.1402; White DJ, 1999, ANIM BEHAV, V57, P1005, DOI 10.1006/anbe.1998.1059; Widemo MS, 2006, BEHAV ECOL, V17, P255, DOI 10.1093/beheco/arj021; Witte K, 1998, BEHAV ECOL, V9, P534, DOI 10.1093/beheco/9.5.534; Witte K, 2003, ANIM BEHAV, V65, P1151, DOI 10.1006/anbe.2003.2160; Witte K, 2003, BEHAV ECOL, V14, P389, DOI 10.1093/beheco/14.3.389; Witte K, 2002, BEHAV ECOL SOCIOBIOL, V52, P194, DOI 10.1007/s00265-002-0503-1; Witte K, 2002, ANIM BEHAV, V63, P943, DOI 10.1006/anbe.2001.1982; Witte K, 2011, FISH COGNITION BEHAV, P81, DOI DOI 10.1002/9781444342536; Wong BBM, 2005, BIOL REV, V80, P559, DOI 10.1017/S1464793105006809; Wong BBM, 2009, BEHAV ECOL, V20, P278, DOI 10.1093/beheco/arp010; ZAJONC RB, 1965, SCIENCE, V149, P269, DOI 10.1126/science.149.3681.269; Ziege M, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-17	130	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53865	10.1371/journal.pone.0053865	http://dx.doi.org/10.1371/journal.pone.0053865			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342021	Green Published, Green Submitted, gold			2022-12-25	WOS:000313682700053
J	Tabong, PTN; Adongo, PB				Tabong, Philip Teg-Nefaah; Adongo, Philip Baba			Understanding the Social Meaning of Infertility and Childbearing: A Qualitative Study of the Perception of Childbearing and Childlessness in Northern Ghana	PLOS ONE			English	Article							REPRODUCTIVE HEALTH; KASSENA-NANKANA; FERTILITY; CHILDREN; COUPLES	Background: Infertility is a major medical condition that affects many married couples in sub-Saharan African and as such associated with several social meanings. This study therefore explored community's perception of childbearing and childlessness in Northern Ghana using the Upper West Region as a case study. Methods: The study was exploratory and qualitative using in-depth and key informant interviews and focus group discussions. Fifteen marriage unions with infertility (childless), forty-five couples with children, and eight key informants were purposively sampled and interviewed using a semi-structured interview guides. Three focus group discussions were also carried out, one for childless women, one for women with children and one with men with children. The data collected were transcribed, coded, arranged, and analyzed for categories and themes and finally triangulated. Results: The study revealed that infertility was caused by both social and biological factors. Socially couples could become infertile through supernatural causes such as bewitchment, and disobediences of social norms. Abortion, masturbation and use of contraceptives were also identified as causes of infertility. Most childless couples seek treatment from spiritualist, traditional healers and hospital. These sources of treatment are used simultaneously. Conclusion: Childbearing is highly valued in the community and Childlessness is highly engendered, and stigmatised in this community with manifold social consequences. In such a community therefore, the concept of reproductive choice must encompass policies that make it possible for couples to aspire to have the number of children they wish.	[Tabong, Philip Teg-Nefaah] Brong Ahafo Reg Hosp, Ghana Hlth Serv, Sunyani, Ghana; [Adongo, Philip Baba] Univ Ghana, Coll Hlth Sci, Sch Publ Hlth, Dept Social & Behav Sci, Legon, Ghana	University of Ghana	Adongo, PB (corresponding author), Univ Ghana, Coll Hlth Sci, Sch Publ Hlth, Dept Social & Behav Sci, Legon, Ghana.	philgh2001@yahoo.com	Tabong, Philip Teg-Nefaah/AAG-5478-2020	Tabong, Philip/0000-0001-9445-1643; Adongo, Philip Baba/0000-0002-0614-4756				Adongo P., 1998, AFR J REPROD HEALTH, V2, P25; Adongo PB, 1997, SOC SCI MED, V45, P1789, DOI 10.1016/S0277-9536(97)00110-X; Adongo PB, 1998, STUD FAMILY PLANN, V29, P23, DOI 10.2307/172179; [Anonymous], 2012, FERT ASS TREATM PEOP; Bharadwaj A, 2002, SEXUAL HLTH EXCHANGE, P14; Donkor Ernestina S, 2009, Afr J Reprod Health, V13, P81; Dyer SJ, 2007, J PSYCHOSOM OBST GYN, V28, P69, DOI 10.1080/01674820701409959; Dyer SJ, 2004, HUM REPROD, V19, P960, DOI 10.1093/humrep/deh195; FATHALLA MF, 1992, EARLY HUM DEV, V29, P35, DOI 10.1016/0378-3782(92)90055-L; FIANDER A, 1990, TROP DOCT, V20, P98, DOI 10.1177/004947559002000302; Fidler AT, 1999, PUBLIC HEALTH REP, V114, P494, DOI 10.1093/phr/114.6.494; Ford WCL, 2000, HUM REPROD, V15, P1703, DOI 10.1093/humrep/15.8.1703; Geelhoed DW, 2002, INT J GYNECOL OBSTET, V79, P137, DOI 10.1016/S0020-7292(02)00237-0; Gerrity D., 2001, FAMILY J, V9, P151, DOI [10.1177/1066480701092009, DOI 10.1177/1066480701092009]; Ghana Statistical Service, 2011, GHAN POP HOUS CENS R; Ghana Statistical Service (GSS) Noguchi Memorial Institute for Medical Research (NMIMR) and ORC Macro, 2004, GHAN DEM HLTH SURV 2; Gibson DM, 2002, J MENTAL HLTH COUNSE, V24, P68; Gocze PM, 2000, EUR J OBSTET GYN R B, V93, P77, DOI 10.1016/S0301-2115(00)00254-2; HAILE A, 1990, STUD FAMILY PLANN, V21, P110, DOI 10.2307/1966672; Haimes K, 2004, HUMAN REPROD, V8, P1039; HORTON R, 1993, LANCET, V342, P45, DOI 10.1016/0140-6736(93)91899-W; Larsen U, 2000, INT J EPIDEMIOL, V29, P285, DOI 10.1093/ije/29.2.285; McLachlan R, 2007, ANDROLOGY AUTRALIA, P1; MIALL CE, 1985, DEVIANT BEHAV, V6, P383, DOI 10.1080/01639625.1985.9967686; Naples NA, 2003, FEMINISM METHOD ETHN, P123; Okonofua FE, 1996, BRIT J OBSTET GYNAEC, V103, P957, DOI 10.1111/j.1471-0528.1996.tb09542.x; Roupa Z., 2009, HLTH SCI J, V3, P80; ROWE PJ, 1987, FERTIL STERIL, V47, P964; Sundby J, 1998, SOC SCI MED, V46, P891, DOI 10.1016/S0277-9536(97)00215-3; Warren C.A.B., 2015, DISCOVERING QUALITAT; Wischmann T, 2001, HUM REPROD, V16, P1753, DOI 10.1093/humrep/16.8.1753; World Health Organization (WHO), 1991, WHOMCH919	32	57	62	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54429	10.1371/journal.pone.0054429	http://dx.doi.org/10.1371/journal.pone.0054429			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072OV	23342158	Green Published, Green Submitted, gold			2022-12-25	WOS:000313682700116
J	Treguer, K; Faucheux, C; Veschambre, P; Fedou, S; Theze, N; Thiebaud, P				Treguer, Karine; Faucheux, Corinne; Veschambre, Philippe; Fedou, Sandrine; Theze, Nadine; Thiebaud, Pierre			Comparative Functional Analysis of ZFP36 Genes during Xenopus Development	PLOS ONE			English	Article							ZINC-FINGER PROTEINS; AU-RICH ELEMENT; RNA-BINDING PROTEINS; MESSENGER-RNA; TRISTETRAPROLIN; EXPRESSION; PRONEPHROS; CLONING; FAMILY; KIDNEY	ZFP36 constitutes a small family of RNA binding proteins (formerly known as the TIS11 family) that target mRNA and promote their degradation. In mammals, ZFP36 proteins are encoded by four genes and, although they show similar activities in a cellular RNA destabilization assay, there is still a limited knowledge of their mRNA targets and it is not known whether or not they have redundant functions. In the present work, we have used the Xenopus embryo, a model system allowing gain- and loss-of-function studies, to investigate, whether individual ZFP36 proteins had distinct or redundant functions. We show that overexpression of individual amphibian zfp36 proteins leads to embryos having the same defects, with alteration in somites segmentation and pronephros formation. In these embryos, members of the Notch signalling pathway such as hairy2a or esr5 mRNA are down-regulated, suggesting common targets for the different proteins. We also show that mouse Zfp36 protein overexpression gives the same phenotype, indicating an evolutionary conserved property among ZFP36 vertebrate proteins. Morpholino oligonucleotide-induced loss-of-function leads to defects in pronephros formation, reduction in tubule size and duct coiling alterations for both zfp36 and zfp36l1, indicating no functional redundancy between these two genes. Given the conservation in gene structure and function between the amphibian and mammalian proteins and the conserved mechanisms for pronephros development, our study highlights a potential and hitherto unreported role of ZFP36 gene in kidney morphogenesis.	[Treguer, Karine; Faucheux, Corinne; Veschambre, Philippe; Fedou, Sandrine; Theze, Nadine; Thiebaud, Pierre] Univ Bordeaux, Bordeaux, France; [Treguer, Karine; Faucheux, Corinne; Veschambre, Philippe; Fedou, Sandrine; Theze, Nadine; Thiebaud, Pierre] CNRS, UMR 5164, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Thiebaud, P (corresponding author), Univ Bordeaux, Bordeaux, France.	pierre.thiebaud@u-bordeaux2.fr		THIEBAUD, Pierre/0000-0003-1174-1616; Philippe, Veschambre/0000-0001-6094-6795	University Bordeaux Segalen; CNRS (Centre national de la recherche scientifique); Association Francaise contre les Myopathies; French Ministry for Research and Education; NICHD	University Bordeaux Segalen; CNRS (Centre national de la recherche scientifique)(Centre National de la Recherche Scientifique (CNRS)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); French Ministry for Research and Education; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by fundings from the University Bordeaux Segalen, the CNRS (Centre national de la recherche scientifique) and the "Association Francaise contre les Myopathies". KT was supported by a PhD fellowship from the French Ministry for Research and Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr Elizabeth Jones for the generous gift of 3G8 and 4A6 antibodies and Drs Susanne Kuhl, Muriel Perron, Eric Bellefroid, Bruno Della Gaspera, Sergei Sokol, Tomas Pieler for plasmids and advices with technical help. We thank Drs Isabelle Neant, Catherine Leclerc and Marc Moreau for their help with the pronephros animal cap inducing technique. We thank Dr Helene Boeuf for providing samples and Dr Tim Mohun for careful reading of the manuscript. The 12/101 antibody developed by J. P. Brockes was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biological Sciences. We thank the SERCOMI for its help with scanning electronic microscopy analyses and Lionel Parra Iglesias for taking care of our Xenopus colony.	Baou M, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/634520; Bell SE, 2006, DEV DYNAM, V235, P3144, DOI 10.1002/dvdy.20949; Belloc E, 2008, NATURE, V452, P1017, DOI 10.1038/nature06809; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Blackshear PJ, 2005, BIOL REPROD, V73, P297, DOI 10.1095/biolreprod.105.040527; Blackshear PJ, 2003, J BIOL CHEM, V278, P19947, DOI 10.1074/jbc.M301290200; Blomme T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r43; Carroll TJ, 1999, DEV BIOL, V214, P46, DOI 10.1006/dbio.1999.9414; Chan TC, 2000, DEV BIOL, V228, P256, DOI 10.1006/dbio.2000.9951; Chan XY, 2011, DEV BIOL, V349, P102, DOI 10.1016/j.ydbio.2010.10.001; Cheng HT, 2005, KIDNEY INT, V68, P1951, DOI 10.1111/j.1523-1755.2005.00627.x; De J, 1999, GENE, V228, P133, DOI 10.1016/S0378-1119(98)00617-9; Della Gaspera B, 2006, DEV DYNAM, V235, P524, DOI 10.1002/dvdy.20628; Dichmann DS, 2008, DEV DYNAM, V237, P1755, DOI 10.1002/dvdy.21590; DUBOIS RN, 1990, J BIOL CHEM, V265, P19185; Dudziak K, 2008, KIDNEY INT, V74, P210, DOI 10.1038/ki.2008.149; Gautier-Courteille C, 2004, DEVELOPMENT, V131, P6107, DOI 10.1242/dev.01528; Haldin CE, 2008, DEV BIOL, V322, P74, DOI 10.1016/j.ydbio.2008.07.012; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Hensey C, 1997, MECH DEVELOP, V69, P183, DOI 10.1016/S0925-4773(97)00191-3; HEXIMER SP, 1993, DNA CELL BIOL, V12, P73, DOI 10.1089/dna.1993.12.73; Hodson DJ, 2010, NAT IMMUNOL, V11, P717, DOI 10.1038/ni.1901; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Huot ME, 2005, MOL BIOL CELL, V16, P4350, DOI 10.1091/mbc.E05-04-0304; Jen WC, 1999, GENE DEV, V13, P1486, DOI 10.1101/gad.13.11.1486; Jen WC, 1997, DEVELOPMENT, V124, P1169; Kaneko T, 2003, BIOCHEM BIOPH RES CO, V308, P566, DOI 10.1016/S0006-291X(03)01419-0; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Kronnie GT, 1999, DEV GENES EVOL, V209, P443, DOI 10.1007/s004270050276; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; LAI WS, 1990, J BIOL CHEM, V265, P16556; Lai WS, 2002, J BIOL CHEM, V277, P9606, DOI 10.1074/jbc.M110395200; Leclerc C, 2008, DEV BIOL, V321, P357, DOI 10.1016/j.ydbio.2008.06.029; Liang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002880; MA QF, 1994, ONCOGENE, V9, P3329; McCright B, 2001, DEVELOPMENT, V128, P491; McLaughlin KA, 2000, DEV BIOL, V227, P567, DOI 10.1006/dbio.2000.9913; Michel SLJ, 2003, BIOCHEMISTRY-US, V42, P4626, DOI 10.1021/bi034073h; Murugan S, 2012, EXP CELL RES, V318, P1134, DOI 10.1016/j.yexcr.2012.03.008; Naye F, 2007, INT J DEV BIOL, V51, P745, DOI 10.1387/ijdb.072375fn; Naylor RW, 2009, DEVELOPMENT, V136, P3585, DOI 10.1242/dev.042606; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Ramos SBV, 2004, DEVELOPMENT, V131, P4883, DOI 10.1242/dev.01336; Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X; Saka Y, 2001, DEV BIOL, V229, P307, DOI 10.1006/dbio.2000.0101; Sato A, 2000, MECH DEVELOP, V92, P273, DOI 10.1016/S0925-4773(99)00331-7; Saulnier DME, 2002, DEV BIOL, V248, P13, DOI 10.1006/dbio.2002.0712; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; SMITH JC, 1985, DIFFERENTIATION, V29, P109, DOI 10.1111/j.1432-0436.1985.tb00302.x; Stevens CJM, 1998, INT J DEV BIOL, V42, P181; Stumpo DJ, 2004, MOL CELL BIOL, V24, P6445, DOI 10.1128/MCB.24.14.6445-6455.2004; Taelman V, 2004, DEV BIOL, V276, P47, DOI 10.1016/j.ydbio.2004.08.019; Taelman V, 2006, DEVELOPMENT, V133, P2961, DOI 10.1242/dev.02458; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tecza A, 2011, BIOL CELL, V103, P483, DOI 10.1042/BC20110032; Thompson MJ, 1996, GENE, V174, P225, DOI 10.1016/0378-1119(96)00084-4; Tran U, 2007, DEV BIOL, V307, P152, DOI 10.1016/j.ydbio.2007.04.030; Van Campenhout C, 2006, DEV BIOL, V294, P203, DOI 10.1016/j.ydbio.2006.02.040; VARNUM BC, 1989, ONCOGENE, V4, P119; VIZE PD, 1995, DEV BIOL, V171, P531, DOI 10.1006/dbio.1995.1302; Wallingford JB, 1998, DEV BIOL, V202, P103, DOI 10.1006/dbio.1998.8989; Worthington MT, 2002, J BIOL CHEM, V277, P48558, DOI 10.1074/jbc.M206505200	64	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54550	10.1371/journal.pone.0054550	http://dx.doi.org/10.1371/journal.pone.0054550			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342169	Green Published, gold, Green Submitted			2022-12-25	WOS:000313682700124
J	Vrba, L; Munoz-Rodriguez, JL; Stampfer, MR; Futscher, BW				Vrba, Lukas; Munoz-Rodriguez, Jose L.; Stampfer, Martha R.; Futscher, Bernard W.			miRNA Gene Promoters Are Frequent Targets of Aberrant DNA Methylation in Human Breast Cancer	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; FEEDBACK LOOP; EARLY EVENT; EXPRESSION; HYPERMETHYLATION; MICRORNAS; CELLS; INACTIVATION; MIR-34A; P53	miRNAs are important regulators of gene expression that are frequently deregulated in cancer, with aberrant DNA methylation being an epigenetic mechanism involved in this process. We previously identified miRNA promoter regions active in normal mammary cell types and here we analyzed which of these promoters are targets of aberrant DNA methylation in human breast cancer cell lines and breast tumor specimens. Using 5-methylcytosine immunoprecipitation coupled to miRNA tiling microarray hybridization, we performed comprehensive evaluation of DNA methylation of miRNA gene promoters in breast cancer. We found almost one third (55/167) of miRNA promoters were targets for aberrant methylation in breast cancer cell lines. Breast tumor specimens displayed DNA methylation of majority of these miRNA promoters, indicating that these changes in DNA methylation might be clinically relevant. Aberrantly methylated miRNA promoters were, similar to protein coding genes, enriched for promoters targeted by polycomb in normal cells. Detailed analysis of selected miRNA promoters revealed decreased expression of miRNA linked to increased promoter methylation for mir-31, mir-130a, let-7a-3/let-7b, mir-155, mir-137 and mir-34b/mir-34c genes. The proportion of miRNA promoters we found aberrantly methylated in breast cancer is several fold larger than that observed for protein coding genes, indicating an important role of DNA methylation in miRNA deregulation in cancer.	[Vrba, Lukas; Munoz-Rodriguez, Jose L.; Stampfer, Martha R.; Futscher, Bernard W.] Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85721 USA; [Munoz-Rodriguez, Jose L.; Futscher, Bernard W.] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Stampfer, Martha R.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Vrba, Lukas] Acad Sci Czech Republic, Inst Plant Mol Biol, Ctr Biol, Vvi, CR-37005 Ceske Budejovice, Czech Republic	Arizona Center Cancer Care; University of Arizona; University of Arizona; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Futscher, BW (corresponding author), Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85721 USA.	bfutscher@azcc.arizona.edu	Rodríguez, Jose Manuel JMMR Muñoz/A-7323-2016; Vrba, Lukas/J-9268-2015	Rodríguez, Jose Manuel JMMR Muñoz/0000-0002-4688-6420; Vrba, Lukas/0000-0003-3042-6275	Margaret E. and Fenton L. Maynard Endowment for Breast Cancer Research;  [1U01CA153086];  [P30 CA023074];  [P30 ES006694]; NATIONAL CANCER INSTITUTE [U01CA153086, P30CA023074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER	Margaret E. and Fenton L. Maynard Endowment for Breast Cancer Research; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grant 1U01CA153086; center grants P30 CA023074 and P30 ES006694; and Margaret E. and Fenton L. Maynard Endowment for Breast Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaguer F, 2010, CANCER RES, V70, P6609, DOI 10.1158/0008-5472.CAN-10-0622; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Domann FE, 2000, INT J CANCER, V85, P805, DOI 10.1002/(SICI)1097-0215(20000315)85:6<805::AID-IJC12>3.0.CO;2-5; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fury Wen, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P5531; Futscher BW, 2004, NEOPLASIA, V6, P380, DOI 10.1593/neo.04115; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Garbe JC, 2009, CANCER RES, V69, P7557, DOI 10.1158/0008-5472.CAN-09-0270; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; GUAN XY, 1994, NAT GENET, V8, P155, DOI 10.1038/ng1094-155; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hahn MA, 2008, CANCER RES, V68, P10280, DOI 10.1158/0008-5472.CAN-08-1957; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jonsson G, 2007, GENE CHROMOSOME CANC, V46, P543, DOI 10.1002/gcc.20438; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Li D, 2011, CLIN CANCER RES, V17, P1722, DOI 10.1158/1078-0432.CCR-10-1800; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Novak P, 2008, CANCER RES, V68, P8616, DOI 10.1158/0008-5472.CAN-08-1419; Novak P, 2006, CANCER RES, V66, P10664, DOI 10.1158/0008-5472.CAN-06-2761; Novak P, 2009, CANCER RES, V69, P5251, DOI 10.1158/0008-5472.CAN-08-4977; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Oshiro MM, 2003, ONCOGENE, V22, P3624, DOI 10.1038/sj.onc.1206545; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Png KJ, 2011, GENE DEV, V25, P226, DOI 10.1101/gad.1974211; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Simonini PDR, 2010, CANCER RES, V70, P9175, DOI 10.1158/0008-5472.CAN-10-1318; Suzuki H, 2010, CARCINOGENESIS, V31, P2066, DOI 10.1093/carcin/bgq203; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Vrba L, 2011, GENOME RES, V21, P2026, DOI 10.1101/gr.123935.111; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435	39	99	114	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54398	10.1371/journal.pone.0054398	http://dx.doi.org/10.1371/journal.pone.0054398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342147	Green Published, Green Submitted, gold			2022-12-25	WOS:000313682700112
J	Xu, M; Jarrell, TA; Wang, Y; Cook, SJ; Hall, DH; Emmons, SW				Xu, Meng; Jarrell, Travis A.; Wang, Yi; Cook, Steven J.; Hall, David H.; Emmons, Scott W.			Computer Assisted Assembly of Connectomes from Electron Micrographs: Application to Caenorhabditis elegans	PLOS ONE			English	Article							NERVOUS-SYSTEM; RECONSTRUCTION; VISUALIZATION; CIRCUIT; NETWORK; NEURONS	A rate-limiting step in determining a connectome, the set of all synaptic connections in a nervous system, is extraction of the relevant information from serial electron micrographs. Here we introduce a software application, Elegance, that speeds acquisition of the minimal dataset necessary, allowing the discovery of new connectomes. We have used Elegance to obtain new connectivity data in the nematode worm Caenorhabditis elegans. We analyze the accuracy that can be obtained, which is limited by unresolvable ambiguities at some locations in electron microscopic images. Elegance is useful for reconstructing connectivity in any region of neuropil of sufficiently small size.	[Xu, Meng; Jarrell, Travis A.; Wang, Yi; Cook, Steven J.; Emmons, Scott W.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Hall, David H.; Emmons, Scott W.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Emmons, SW (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA.	scott.emmons@einstein.yu.edu			United States National Institutes of Health (NIH.gov) [R21MH63223]; G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH063223] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010943] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH.gov)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the United States National Institutes of Health (NIH.gov)(R21MH63223 to SWE) and the G. Harold and Leila Y. Mathers Charitable Foundation (mathersfoundation.org) to SWE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; BRENNER S, 1974, GENETICS, V77, P71; Cardona A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000502; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; FIALA JC, 2002, MICROSC ANAL, V52, P5; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Ha HI, 2010, NEURON, V68, P1173, DOI 10.1016/j.neuron.2010.11.025; HALL DH, 1991, J NEUROSCI, V11, P1; Helmstaedter M, 2011, NAT NEUROSCI, V14, P1081, DOI 10.1038/nn.2868; Jain V, 2010, CURR OPIN NEUROBIOL, V20, P653, DOI 10.1016/j.conb.2010.07.004; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; Jeong WK, 2010, IEEE COMPUT GRAPH, V30, P58, DOI 10.1109/MCG.2010.56; Jeong WK, 2009, IEEE T VIS COMPUT GR, V15, P1505, DOI 10.1109/TVCG.2009.178; Macke JH, 2008, J NEUROSCI METH, V167, P349, DOI 10.1016/j.jneumeth.2007.07.021; Mishchenko Y, 2009, J NEUROSCI METH, V176, P276, DOI 10.1016/j.jneumeth.2008.09.006; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Schikorski T, 1997, J NEUROSCI, V17, P5858; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	22	29	29	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54050	10.1371/journal.pone.0054050	http://dx.doi.org/10.1371/journal.pone.0054050			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342070	Green Published, gold, Green Submitted			2022-12-25	WOS:000313682700079
J	Ayala, E; Carnero, AM				Ayala, Elizabeth; Carnero, Andres M.			Determinants of Burnout in Acute and Critical Care Military Nursing Personnel: A Cross-Sectional Study from Peru	PLOS ONE			English	Article							CLINICAL VALIDITY; NURSES; STRESS; REGRESSION; INVENTORY; SYMPTOMS; MODEL; STAFF	Background: Evidence on the prevalence and determinants of burnout among military acute and critical care nursing personnel from developing countries is minimal, precluding the development of effective preventive measures for this high-risk occupational group. In this context, we aimed to examine the association between the dimensions of burnout and selected socio-demographic and occupational factors in military acute/critical care nursing personnel from Lima, Peru. Methods and Findings: We conducted a cross-sectional study in 93 nurses/nurse assistants from the acute and critical care departments of a large, national reference, military hospital in Lima, Peru, using a socio-demographic/occupational questionnaire and a validated Spanish translation of the Maslach Burnout Inventory. Total scores for each of the burnout dimensions were calculated for each participant. Higher emotional exhaustion and depersonalisation scores, and lower personal achievement scores, implied a higher degree of burnout. We used linear regression to evaluate the association between each of the burnout dimensions and selected socio-demographic and occupational characteristics, after adjusting for potential confounders. The associations of the burnout dimensions were heterogeneous for the different socio-demographic and occupational factors. Higher emotional exhaustion scores were independently associated with having children (p<0.05) and inversely associated with the time working in the current department (p<0.05). Higher depersonalization scores were independently associated with being single compared with being divorced, separated or widowed (p<0.01), working in the emergency room/intensive care unit compared with the recovery room (p<0.01), and inversely associated with age (p<0.05). Finally, higher personal achievement scores were independently associated with having children (p<0.05). Conclusion: Among Peruvian military acute and critical care nursing personnel, potential screening and preventive interventions should focus on younger/less experienced nurses/nurse assistants, who are single, have children, or work in the most acute critical care areas (e. g. the emergency room/intensive care unit).	[Ayala, Elizabeth] Hosp Cent Fuerza Aerea Peru, Crit Care Dept, Lima, Peru; [Carnero, Andres M.] Univ Peruana Cayetano Heredia, Postgrad Sch, Lima, Peru	Universidad Peruana Cayetano Heredia	Carnero, AM (corresponding author), Univ Peruana Cayetano Heredia, Postgrad Sch, Lima, Peru.	andrescarnero@gmail.com		Carnero, Andres/0000-0002-9372-0378				Adeb-Saeedi J, 2002, AUST EMERG NURS J, V5, P19, DOI DOI 10.1016/S1328-2743(02)80015-3; Aiken LH, 2001, HEALTH AFFAIR, V20, P43, DOI 10.1377/hlthaff.20.3.43; Aiken LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI 10.1001/jama.288.16.1987; Azoulay E, 2009, AM J RESP CRIT CARE, V180, P853, DOI 10.1164/rccm.200810-1614OC; Bakir B, 2010, KLIN PSIKOFARMAKOL B, V20, P160, DOI 10.1080/10177833.2010.11790651; Bakker AB, 2005, J ADV NURS, V51, P276, DOI 10.1111/j.1365-2648.2005.03494.x; BARTZ C, 1986, RES NURS HEALTH, V9, P147, DOI 10.1002/nur.4770090210; Browning Laura, 2007, Psychol Health Med, V12, P248; Caceres-Bermejo GG, 2009, SANIDAD MILITAR, V65, P83; Cooper CE, 2002, J NURS ADMIN, V32, P162, DOI 10.1097/00005110-200203000-00009; Davey MM, 2009, J NURS MANAGE, V17, P312, DOI 10.1111/j.1365-2834.2008.00958.x; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Demir A, 2003, INT J NURS STUD, V40, P807, DOI 10.1016/S0020-7489(03)00077-4; DePew CL, 1999, J BURN CARE REHABIL, V20, P515; Donchin Yoel, 2002, Curr Opin Crit Care, V8, P316, DOI 10.1097/00075198-200208000-00008; Elpern EH, 2005, AM J CRIT CARE, V14, P523, DOI 10.4037/ajcc2005.14.6.523; Embriaco N, 2007, CURR OPIN CRIT CARE, V13, P482, DOI 10.1097/MCC.0b013e3282efd28a; Figueiredo-Ferraz H, 2012, PSICOTHEMA, V24, P271; Fujimoto T, 2008, J CLIN NURS, V17, P3286, DOI 10.1111/j.1365-2702.2008.02643.x; Gibbons SW, 2012, J ADV NURS, V68, P3, DOI 10.1111/j.1365-2648.2011.05708.x; Gil-Monte PR, 2005, REV SAUDE PUBL, V39, P1, DOI 10.1590/S0034-89102005000100001; Gillespie M, 2003, J CLIN NURS, V12, P842, DOI 10.1046/j.1365-2702.2003.00802.x; Halbesleben JRB, 2010, J OCCUP HEALTH PSYCH, V15, P1, DOI 10.1037/a0017634; Hayes AF, 2007, BEHAV RES METHODS, V39, P709, DOI 10.3758/BF03192961; Jennings BM, 2008, PATIENT SAFETY QUALI, P1; Kashani M, 2010, MIL MED, V175, P96, DOI 10.7205/MILMED-D-09-00092; Kelley MA, 2004, CHEST, V125, P1514, DOI 10.1378/chest.125.4.1514; Kenny Deborah J, 2008, Crit Care Nurs Clin North Am, V20, P41, DOI 10.1016/j.ccell.2007.10.013; Lambert V A, 2001, Nurs Health Sci, V3, P161, DOI 10.1046/j.1442-2018.2001.00086.x; Lang GM, 2012, J NURS SCHOLARSHIP, V44, P274, DOI 10.1111/j.1547-5069.2012.01462.x; Lang GM, 2010, MIL MED, V175, P435, DOI 10.7205/MILMED-D-09-00284; Laposa Judith M, 2003, J Emerg Nurs, V29, P23, DOI 10.1067/men.2003.7; Leiter MP, 2009, J NURS MANAGE, V17, P331, DOI 10.1111/j.1365-2834.2009.01004.x; Leiter MP, 2005, ANXIETY STRESS COPIN, V18, P131, DOI 10.1080/10615800500082473; Long JS, 2000, AM STAT, V54, P217, DOI 10.2307/2685594; Lumley T, 2002, ANNU REV PUBL HEALTH, V23, P151, DOI 10.1146/annurev.publhealth.23.100901.140546; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C., 1996, MASLACH BURNOUT INVE; McVicar A, 2003, J ADV NURS, V44, P633, DOI 10.1046/j.0309-2402.2003.02853.x; Mealer ML, 2007, AM J RESP CRIT CARE, V175, P693, DOI 10.1164/rccm.200606-735OC; Patrician PA, 2010, RES NURS HEALTH, V33, P99, DOI 10.1002/nur.20370; Pearson A, 2001, Int J Nurs Pract, V7, pS21, DOI 10.1046/j.1440-172X.2001.00330.x; Poghosyan L, 2010, RES NURS HEALTH, V33, P288, DOI 10.1002/nur.20383; Poghosyan L, 2009, INT J NURS STUD, V46, P894, DOI 10.1016/j.ijnurstu.2009.03.004; Poncet MC, 2007, AM J RESP CRIT CARE, V175, P698, DOI 10.1164/rccm.200606-806OC; ROBINSON SE, 1993, J ADV NURS, V18, P1146, DOI 10.1046/j.1365-2648.1993.18071146.x; Sahraian A, 2008, INT NURS REV, V55, P62, DOI 10.1111/j.1466-7657.2007.00582.x; Schaufeli W.B., 2003, HDB WORK HLTH PSYCHO, V2, P282, DOI DOI 10.1002/0470013400.CH19; Schaufeli WB, 2001, PSYCHOL HEALTH, V16, P565, DOI 10.1080/08870440108405527; SCHAUFELI WB, 1995, PSYCHOL REP, V76, P1083, DOI 10.2466/pr0.1995.76.3c.1083; Shirom A, 2005, INT REV IND ORGAN PS, V20, P269; Steinbrook R, 2002, NEW ENGL J MED, V346, P1757, DOI 10.1056/NEJM200205303462225; Suner-Soler R, 2013, J Psychiatr Ment Health Nurs, V20, P305, DOI 10.1111/j.1365-2850.2012.01897.x; Tekindal B, 2012, INT J NURS PRACT, V18, P68, DOI 10.1111/j.1440-172X.2011.01989.x; Vahey DC, 2004, MED CARE, V42, P57, DOI 10.1097/01.mlr.0000109126.50398.5a	55	46	52	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54408	10.1371/journal.pone.0054408	http://dx.doi.org/10.1371/journal.pone.0054408			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	087KE	23342152	Green Submitted, Green Published, gold			2022-12-25	WOS:000314759400161
J	Bar, M; Leibman, M; Schuster, S; Pitzhadza, H; Avni, A				Bar, Maya; Leibman, Meirav; Schuster, Silvia; Pitzhadza, Hilla; Avni, Adi			EHD1 Functions in Endosomal Recycling and Confers Salt Tolerance	PLOS ONE			English	Article							DOMAIN-CONTAINING PROTEINS; C-ELEGANS; VESICULAR TRAFFICKING; ENDOCYTIC PATHWAY; MAMMALIAN-CELLS; PLASMA-MEMBRANE; AUXIN TRANSPORT; ARABIDOPSIS; RECEPTOR; PLANTS	Endocytosis is a crucial process in all eukaryotic organisms including plants. We have previously shown that two Arabidopsis proteins, AtEHD1 and AtEHD2, are involved in endocytosis in plant systems. Knock-down of EHD1 was shown to have a delayed recycling phenotype in mammalians. There are many works in mammalian systems detailing the importance of the various domains in EHDs but, to date, the domains of plant EHD1 that are required for its activity have not been characterized. In this work we demonstrate that knock-down of EHD1 causes a delayed recycling phenotype and reduces Brefeldin A sensitivity in Arabidopsis seedlings. The EH domain of EHD1 was found to be crucial for the localization of EHD1 to endosomal structures. Mutant EHD1 lacking the EH domain did not localize to endosomal structures and showed a phenotype similar to that of EHD1 knock-down seedlings. Mutants lacking the coiled-coil domain, however, showed a phenotype similar to wild-type or EHD1 overexpression seedlings. Salinity stress is a major problem in current agriculture. Microarray data demonstrated that salinity stress enhances the expression of EHD1, and this was confirmed by semi quantitative RT-PCR. We demonstrate herein that transgenic plants over expressing EHD1 possess enhanced tolerance to salt stress, a property which also requires an intact EH domain.	[Bar, Maya; Leibman, Meirav; Schuster, Silvia; Pitzhadza, Hilla; Avni, Adi] Tel Aviv Univ, Dept Mol Biol & Ecol Plants, IL-69978 Tel Aviv, Israel	Tel Aviv University	Avni, A (corresponding author), Tel Aviv Univ, Dept Mol Biol & Ecol Plants, IL-69978 Tel Aviv, Israel.	Lpavni@post.tau.ac.il	Avni, Adi/R-9048-2017	Avni, Adi/0000-0003-2092-9768; Bar, Maya/0000-0002-7823-9121	Israel Science Foundation [388/12]; Manna Center for Plant Biosciences, Tel Aviv University	Israel Science Foundation(Israel Science Foundation); Manna Center for Plant Biosciences, Tel Aviv University	This work was partly supported by the Israel Science Foundation administered by the Israel Academy of Science and Humanities no. 388/12 and the Manna Center for Plant Biosciences, Tel Aviv University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar M, 2008, PLANT J, V55, P1025, DOI 10.1111/j.1365-313X.2008.03571.x; Bar M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007973; Bar M, 2009, PLANT J, V59, P600, DOI 10.1111/j.1365-313X.2009.03897.x; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Carbone R, 1997, CANCER RES, V57, P5498; Chow CM, 2008, PLANT CELL, V20, P101, DOI 10.1105/tpc.107.052001; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; de Beer T, 2000, NAT STRUCT BIOL, V7, P1018, DOI 10.1038/80924; DiFiore PP, 1997, TRENDS BIOCHEM SCI, V22, P411, DOI 10.1016/S0968-0004(97)01127-4; Dubrovsky JG, 2006, ANN BOT-LONDON, V97, P1127, DOI 10.1093/aob/mcl045; Galperin E, 2002, TRAFFIC, V3, P575, DOI 10.1034/j.1600-0854.2002.30807.x; Galperin E, 2000, GENOMICS UNPUB; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Geldner N, 2007, GENE DEV, V21, P1598, DOI 10.1101/gad.1561307; Geldner N, 2009, PLANT J, V59, P169, DOI 10.1111/j.1365-313X.2009.03851.x; George M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-3; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Gokool S, 2007, TRAFFIC, V8, P1873, DOI 10.1111/j.1600-0854.2007.00652.x; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; Irani NG, 2009, CURR OPIN PLANT BIOL, V12, P653, DOI 10.1016/j.pbi.2009.09.011; Jovic M, 2007, J CELL SCI, V120, P802, DOI 10.1242/jcs.03383; Kaye Y, 2011, PLANT PHYSIOL, V157, P229, DOI 10.1104/pp.111.176883; Kim SJ, 2011, PLANT PHYSIOL, V156, P514, DOI 10.1104/pp.110.168963; Kleine-Vehn J, 2008, ANNU REV CELL DEV BI, V24, P447, DOI 10.1146/annurev.cellbio.24.110707.175254; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Leborgne-Castel N, 2010, PROTOPLASMA, V247, P177, DOI 10.1007/s00709-010-0195-8; Lee DW, 2005, J BIOL CHEM, V280, P17213, DOI 10.1074/jbc.M412751200; Leshem Y, 2007, PLANT J, V51, P185, DOI 10.1111/j.1365-313X.2007.03134.x; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Lisboa S, 2008, PLANT CELL REP, V27, P21, DOI 10.1007/s00299-007-0437-1; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; Miller G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000448; Mintz L, 1999, GENOMICS, V59, P66, DOI 10.1006/geno.1999.5800; Muller J, 2007, PLANT PHYSIOL, V145, P293, DOI 10.1104/pp.107.102863; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Murphy AS, 2005, ANNU REV PLANT BIOL, V56, P221, DOI 10.1146/annurev.arplant.56.032604.144150; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2011, TRENDS CELL BIOL, V21, P122, DOI 10.1016/j.tcb.2010.10.003; Naslavsky N, 2009, J CELL SCI, V122, P389, DOI 10.1242/jcs.037051; Nielsen E, 2008, PLANT PHYSIOL, V147, P1516, DOI 10.1104/pp.108.121798; Olswang-Kutz Y, 2009, J CELL SCI, V122, P471, DOI 10.1242/jcs.038521; Pohl U, 2000, GENOMICS, V63, P255, DOI 10.1006/geno.1999.6087; Polo Simona, 2003, Sci STKE, V2003, pre17, DOI 10.1126/stke.2132003re17; Rapaport D, 2006, TRAFFIC, V7, P52, DOI 10.1111/j.1600-0854.2005.00359.x; Robatzek S, 2007, CELL MICROBIOL, V9, P1, DOI 10.1111/j.1462-5822.2006.00829.x; Ron M, 2004, PLANT CELL, V16, P1604, DOI 10.1105/tpc.022475; Rutherford S, 2002, CURR OPIN PLANT BIOL, V5, P518, DOI 10.1016/S1369-5266(02)00307-2; Samaj J, 2005, TRENDS CELL BIOL, V15, P425, DOI 10.1016/j.tcb.2005.06.006; Santolini E, 1999, EXP CELL RES, V253, P186, DOI 10.1006/excr.1999.4694; Sato M, 2008, EMBO J, V27, P1183, DOI 10.1038/emboj.2008.54; Sharma M, 2008, TRAFFIC, V9, P995, DOI 10.1111/j.1600-0854.2008.00732.x; Silady RA, 2008, PLANT J, V53, P29, DOI 10.1111/j.1365-313X.2007.03314.x; Takac T, 2011, J PROTEOME RES, V10, P488, DOI 10.1021/pr100690f; Teh OK, 2007, NATURE, V448, P493, DOI 10.1038/nature06023; VANENGELEN FA, 1995, TRANSGENIC RES, V4, P288, DOI 10.1007/BF01969123; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; WONG WT, 1995, P NATL ACAD SCI USA, V92, P9530, DOI 10.1073/pnas.92.21.9530; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	60	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54533	10.1371/journal.pone.0054533	http://dx.doi.org/10.1371/journal.pone.0054533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342166	Green Published, gold			2022-12-25	WOS:000314759400167
J	Bouuaert, CC; Chalmers, R				Bouuaert, Corentin Claeys; Chalmers, Ronald			Hsmar1 Transposition Is Sensitive to the Topology of the Transposon Donor and the Target	PLOS ONE			English	Article							SLEEPING-BEAUTY; RETROVIRAL INTEGRATION; DROSOPHILA-MELANOGASTER; CAENORHABDITIS-ELEGANS; DNA TRANSPOSITION; SITE PREFERENCES; SETMAR PROTEIN; IN-VITRO; EVOLUTION; ELEMENT	Hsmar1 is a member of the Tc1-mariner superfamily of DNA transposons. These elements mobilize within the genome of their host by a cut-and-paste mechanism. We have exploited the in vitro reaction provided by Hsmar1 to investigate the effect of DNA supercoiling on transposon integration. We found that the topology of both the transposon and the target affect integration. Relaxed transposons have an integration defect that can be partially restored in the presence of elevated levels of negatively supercoiled target DNA. Negatively supercoiled DNA is a better target than nicked or positively supercoiled DNA, suggesting that underwinding of the DNA helix promotes target interactions. Like other Tc1-mariner elements, Hsmar1 integrates into 5'-TA dinucleotides. The direct vicinity of the target TA provides little sequence specificity for target interactions. However, transposition within a plasmid substrate was not random and some TA dinucleotides were targeted preferentially. The distribution of intramolecular target sites was not affected by DNA topology.	[Bouuaert, Corentin Claeys; Chalmers, Ronald] Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2RD, England	University of Nottingham	Bouuaert, CC (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA.	claeysbc@mskcc.org	Claeys Bouuaert, Corentin/P-3497-2017	Claeys Bouuaert, Corentin/0000-0001-5801-7313; chalmers, ronald/0000-0002-1395-7173	Wellcome Trust [WT093160]; BBSRC	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust [grant number WT093160 to R. C.] (http://www.wellcome.ac.uk). C. C. B. was supported by a BBSRC Doctoral Training Grant (http://www.bbsrc.ac.uk/funding/studentships). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson H, 2010, GENETICA, V138, P485, DOI 10.1007/s10709-009-9434-3; Aziz RK, 2010, NUCLEIC ACIDS RES, V38, P4207, DOI 10.1093/nar/gkq140; Bouuaert CC, 2011, MOL CELL BIOL, V31, P317, DOI 10.1128/MCB.01066-10; Bouuaert CC, 2010, GENETICA, V138, P473, DOI 10.1007/s10709-009-9391-x; Bouuaert CC, 2010, NUCLEIC ACIDS RES, V38, P190, DOI 10.1093/nar/gkp891; CASADESUS J, 1989, MOL GEN GENET, V216, P204, DOI 10.1007/BF00334357; Chalmers R., 1999, ORG PROKARYOTIC GENO, P151; Cherepanov P, 2011, CURR OPIN STRUC BIOL, V21, P249, DOI 10.1016/j.sbi.2010.12.005; Cordaux R, 2006, P NATL ACAD SCI USA, V103, P8101, DOI 10.1073/pnas.0601161103; Crenes G, 2010, GENETICA, V138, P509, DOI 10.1007/s10709-009-9387-6; Crenes G, 2009, MOL GENET GENOMICS, V281, P315, DOI 10.1007/s00438-008-0414-6; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Gangadharan S, 2010, P NATL ACAD SCI USA, V107, P21966, DOI 10.1073/pnas.1016382107; Geurts AM, 2006, NUCLEIC ACIDS RES, V34, P2803, DOI 10.1093/nar/gkl301; Guimond N, 2003, MOL GENET GENOMICS, V268, P779, DOI 10.1007/s00438-002-0800-4; Guo YB, 2010, GENOME RES, V20, P239, DOI 10.1101/gr.099648.109; Ivics Z, 2011, HUM GENE THER, V22, P1043, DOI 10.1089/hum.2011.143; KELLEY MR, 1987, MOL CELL BIOL, V7, P1545, DOI 10.1128/MCB.7.4.1545; Ketting RF, 1997, NUCLEIC ACIDS RES, V25, P4041, DOI 10.1093/nar/25.20.4041; Lampe DJ, 1996, EMBO J, V15, P5470, DOI 10.1002/j.1460-2075.1996.tb00930.x; Lampe DJ, 1998, GENETICS, V149, P179; Liang Q, 2009, GENESIS, V47, P404, DOI 10.1002/dvg.20508; Liu DX, 2007, MOL CELL BIOL, V27, P1125, DOI 10.1128/MCB.01899-06; Liu DX, 2011, NUCLEIC ACIDS RES, V39, P6660, DOI 10.1093/nar/gkr309; Liu GY, 2005, J MOL BIOL, V346, P161, DOI 10.1016/j.jmb.2004.09.086; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Miskey C, 2006, NEW HUMAN MARINER TR; Miskey C, 2007, MOL CELL BIOL, V27, P4589, DOI 10.1128/MCB.02027-06; Montano SP, 2012, NATURE, V491, P413, DOI 10.1038/nature11602; Montano SP, 2011, CURR OPIN STRUC BIOL, V21, P370, DOI 10.1016/j.sbi.2011.03.004; Mularoni L, 2012, GENOME RES, V22, P693, DOI 10.1101/gr.129460.111; MULLER HP, 1994, EMBO J, V13, P4704, DOI 10.1002/j.1460-2075.1994.tb06794.x; Pace JK, 2007, GENOME RES, V17, P422, DOI 10.1101/gr.5826307; Plasterk RHA, 1999, TRENDS GENET, V15, P326, DOI 10.1016/S0168-9525(99)01777-1; Pribil PA, 2003, J MOL BIOL, V330, P247, DOI 10.1016/S0022-2836(03)00588-6; Prunell A, 1998, BIOPHYS J, V74, P2531, DOI 10.1016/S0006-3495(98)77961-5; Richardson JM, 2009, CELL, V138, P1096, DOI 10.1016/j.cell.2009.07.012; Robertson HM, 1997, GENE, V205, P203, DOI 10.1016/S0378-1119(97)00472-1; Shaheen M, 2010, GENETICA, V138, P559, DOI 10.1007/s10709-010-9452-1; Urasaki A, 2008, P NATL ACAD SCI USA, V105, P19827, DOI 10.1073/pnas.0810380105; Valenti A, 2008, NUCLEIC ACIDS RES, V36, P4587, DOI 10.1093/nar/gkn418; VANLUENEN HGAM, 1994, NUCLEIC ACIDS RES, V22, P262, DOI 10.1093/nar/22.3.262; Vigdal TJ, 2002, J MOL BIOL, V323, P441, DOI 10.1016/S0022-2836(02)00991-9	44	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53690	10.1371/journal.pone.0053690	http://dx.doi.org/10.1371/journal.pone.0053690			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341977	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400068
J	Hall, JA; Melendez, LD; Jewell, DE				Hall, Jean A.; Melendez, Lynda D.; Jewell, Dennis E.			Using Gross Energy Improves Metabolizable Energy Predictive Equations for Pet Foods Whereas Undigested Protein and Fiber Content Predict Stool Quality	PLOS ONE			English	Article							DOG FOODS; CAT FOODS; CELLULOSE; DIGESTIBILITY; MICROBIOTA	Because animal studies are labor intensive, predictive equations are used extensively for calculating metabolizable energy (ME) concentrations of dog and cat pet foods. The objective of this retrospective review of digestibility studies, which were conducted over a 7-year period and based upon Association of American Feed Control Officials (AAFCO) feeding protocols, was to compare the accuracy and precision of equations developed from these animal feeding studies to commonly used predictive equations. Feeding studies in dogs and cats (331 and 227 studies, respectively) showed that equations using modified Atwater factors accurately predict ME concentrations in dog and cat pet foods (r(2) = 0.97 and 0.98, respectively). The National Research Council (NRC) equations also accurately predicted ME concentrations in pet foods (r(2) = 0.97 for dog and cat foods). For dogs, these equations resulted in an average estimate of ME within 0.16% and 2.24% of the actual ME measured (equations using modified Atwater factors and NRC equations, respectively); for cats these equations resulted in an average estimate of ME within 1.57% and 1.80% of the actual ME measured. However, better predictions of dietary ME in dog and cat pet foods were achieved using equations based on analysis of gross energy (GE) and new factors for moisture, protein, fat and fiber. When this was done there was less than 0.01% difference between the measured ME and the average predicted ME (r(2) = 0.99 and 1.00 in dogs and cats, respectively) whereas the absolute value of the difference between measured and predicted was reduced by approximately 50% in dogs and 60% in cats. Stool quality, which was measured by stool score, was influenced positively when dietary protein digestibility was high and fiber digestibility was low. In conclusion, using GE improves predictive equations for ME content of dog and cat pet foods. Nondigestible protein and fiber content of diets predicts stool quality.	[Hall, Jean A.] Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA; [Melendez, Lynda D.; Jewell, Dennis E.] Hills Pet Nutr Inc, Pet Nutr Ctr, Topeka, KS USA	Oregon State University	Hall, JA (corresponding author), Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA.	Jean.Hall@oregonstate.edu	Jewell, Dennis/AAS-8563-2020	Jewell, Dennis/0000-0003-2305-1014	Pet Nutrition Center, Hill's Pet Nutrition, Inc., Topeka, KS	Pet Nutrition Center, Hill's Pet Nutrition, Inc., Topeka, KS	Two of the authors (LDM and DEJ) have an affiliation to the commercial funders of this research, as employees of Hill's Pet Nutrition. The work presented in this study was funded by and performed at the Pet Nutrition Center, Hill's Pet Nutrition, Inc., Topeka, KS (http://www.hillspet.com/our-company.html). There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Atwater WO, 1902, USDA FARMERS B; Earle K E, 1998, J Nutr, V128, p2798S, DOI 10.1093/jn/128.12.2798S; GIESECKE D, 1982, J NUTR, V112, P1822, DOI 10.1093/jn/112.10.1822; Gross K.L, 2010, SMALL ANIMAL CLIN NU, P49; Hang I, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-90; KENDALL PT, 1985, FELINE PRACT, V15, P38; KENDALL PT, 1982, J SCI FOOD AGR, V33, P823, DOI 10.1002/jsfa.2740330903; Kienzle E, 1998, J NUTR, V128, p2609S, DOI [10.1093/jn/128.12.2609S, 10.1093/jn/128.12.2598S, 10.1093/jn/128.12.2680S]; Kienzle E, 2002, J NUTR, V132, p1796S, DOI 10.1093/jn/132.6.1796S; Kienzle E, 2001, J ANIM PHYSIOL AN N, V85, P174, DOI 10.1046/j.1439-0396.2001.00315.x; KUHLMAN G, 1993, FELINE PRACT, V21, P16; Laflamme DP, 2001, J ANIM PHYSIOL AN N, V85, P222, DOI 10.1046/j.1439-0396.2001.00330.x; Lewis L.D., 1994, J NUTR, V124, p2716S; Lubbs DC, 2009, J ANIM PHYSIOL AN N, V93, P113, DOI 10.1111/j.1439-0396.2007.00788.x; NRC (USA), 2006, NUTR REQ DOGS CATS A; Prola L, 2010, J ANIM PHYSIOL AN N, V94, P362, DOI 10.1111/j.1439-0396.2008.00916.x; Thatcher CD., 2010, SMALL ANIMAL CLIN NU, V5th ed., P3; Wichert B, 2002, J NUTR, V132, p1728S, DOI 10.1093/jn/132.6.1728S; Yamka RM, 2007, J ANIM SCI, V85, P204, DOI 10.2527/jas.2005-336; Zentek J, 2004, J NUTR, V134, p2158S, DOI 10.1093/jn/134.8.2158S	20	36	38	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54405	10.1371/journal.pone.0054405	http://dx.doi.org/10.1371/journal.pone.0054405			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342151	Green Submitted, gold, Green Published			2022-12-25	WOS:000314759400160
J	Hung, HC; Yang, YC; Ou, HY; Wu, JS; Lu, FH; Chang, CJ				Hung, Hao-Chang; Yang, Yi-Ching; Ou, Horng-Yih; Wu, Jin-Shang; Lu, Feng-Hwa; Chang, Chih-Jen			The Association between Self-Reported Sleep Quality and Metabolic Syndrome	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; BODY-MASS INDEX; NONDIPPING HYPERTENSION; GLUCOSE-METABOLISM; NATIONAL-HEALTH; LONG SLEEPERS; RISK-FACTOR; POOR SLEEP; DURATION; ADULTS	Objectives: Short and long sleep duration are associated with metabolic syndrome. However, there is limited research on the association between sleep quality and metabolic syndrome, and thus the aim of this study is to investigate this relationship. Materials and Methods: The cross-sectional baseline data were collected from the decoded database of the Prevention Health Center of National Cheng Kung University Hospital from 2002 to 2006. The diagnosis of metabolic syndrome was according to the statement of the American Heart Association/National Heart, Lung, and Blood Institute. Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI). A higher global PSQI score indicates poorer sleep quality, and a global PSQI score greater than five differentiates poor from good sleepers. Results: Of the 3,435 subjects recruited, 899 (26.2%) had metabolic syndrome. Subjects with metabolic syndrome had higher PSQI and prevalence of poor sleepers than those without metabolic syndrome. The multivariate lineal regression analysis showed that female gender, metabolic syndrome, sleep duration, snoring, alcohol drinking, and habitual exercise were independent predictors of PSQI. When substituting metabolic syndrome with the five components, hyperglycemia and low high-density lipoprotein cholesterol (HDL-C) were positively associated with PSQI. The multivariate logistic regression analyses showed that female gender, metabolic syndrome, sleep duration, and snoring were independently associated with being poor sleepers. Of the five components, only low HDL-C was an independent predictor of being poor sleepers. Conclusions: Subjects with metabolic syndrome have higher global PSQI scores and a higher risk of being poor sleepers. Of the five components of metabolic syndrome, hyperglycemia and low HDL-C are independently associated with the global PSQI scores, while low HDL-C is an independent predictor of being poor sleepers.	[Hung, Hao-Chang; Ou, Horng-Yih] Natl Cheng Kung Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Tainan 70428, Taiwan; [Yang, Yi-Ching; Wu, Jin-Shang; Lu, Feng-Hwa; Chang, Chih-Jen] Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan 70428, Taiwan; [Yang, Yi-Ching; Wu, Jin-Shang; Lu, Feng-Hwa; Chang, Chih-Jen] Natl Cheng Kung Univ, Coll Med, Dept Family Med, Tainan 70101, Taiwan; [Ou, Horng-Yih] Natl Cheng Kung Univ, Coll Med, Dept Internal Med, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University	Chang, CJ (corresponding author), Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan 70428, Taiwan.	changcj.ncku@gmail.com	Yang, Yi-Ching/C-7033-2014	Yang, Yi-Ching/0000-0003-1391-8040; Hung, Hao-Chang/0000-0001-7584-2745	National Cheng Kung University Hospital [NCKUH-10002031, NCKUH-10102036]	National Cheng Kung University Hospital	This study was supported by grants from National Cheng Kung University Hospital (NCKUH-10002031, NCKUH-10102036). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschbach D, 2003, J CLIN ENDOCR METAB, V88, P26, DOI 10.1210/jc.2002-020827; Bidulescu A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-581; Buxton OM, 2010, DIABETES, V59, P2126, DOI 10.2337/db09-0699; Buysse DJ, 2008, J CLIN SLEEP MED, V4, P563; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cagampang FR, 2011, BRAIN BEHAV IMMUN, V25, P214, DOI 10.1016/j.bbi.2010.09.005; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Chao CY, 2011, METABOLISM, V60, P799, DOI 10.1016/j.metabol.2010.07.031; Choi KM, 2008, INT J OBESITY, V32, P1091, DOI 10.1038/ijo.2008.62; Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024; Erden I, 2010, BLOOD PRESS MONIT, V15, P184, DOI 10.1097/MBP.0b013e32833a23a0; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hall MH, 2008, SLEEP, V31, P635, DOI 10.1093/sleep/31.5.635; Huang YL, 2011, BLOOD PRESS MONIT, V16, P117, DOI [10.1097/MBP.0b013e328346a8b4, 10.1097/MBP.0b013e32834c672d]; Hung HC, 2013, CLIN ENDOCRINOL, V78, P518, DOI 10.1111/j.1365-2265.2012.04423.x; Jennings JR, 2007, SLEEP, V30, P219, DOI 10.1093/sleep/30.2.219; Knutson KL, 2006, ARCH INTERN MED, V166, P1768, DOI 10.1001/archinte.166.16.1768; Knutson KL, 2011, DIABETES CARE, V34, P1171, DOI 10.2337/dc10-1962; Knutson KL, 2010, BEST PRACT RES CL EN, V24, P731, DOI 10.1016/j.beem.2010.07.001; Kohatsu ND, 2006, ARCH INTERN MED, V166, P1701, DOI 10.1001/archinte.166.16.1701; Kronholm E, 2011, SLEEP MED, V12, P215, DOI 10.1016/j.sleep.2010.07.021; Lauderdale DS, 2009, AM J EPIDEMIOL, V170, P805, DOI 10.1093/aje/kwp230; Lo CMH, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-72; Martins RC, 2008, BRAZ J MED BIOL RES, V41, P180, DOI 10.1590/S0100-879X2006005000194; Nonogaki K, 2000, DIABETOLOGIA, V43, P533, DOI 10.1007/s001250051341; Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427; Patel SR, 2008, INT J OBESITY, V32, P1825, DOI 10.1038/ijo.2008.198; Patel SR, 2012, SLEEP, V35, P641, DOI 10.5665/sleep.1822; Rod NH, 2011, AM J EPIDEMIOL, V173, P300, DOI 10.1093/aje/kwq371; SICONOLFI SF, 1985, AM J EPIDEMIOL, V122, P101, DOI 10.1093/oxfordjournals.aje.a114068; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Spiegel K, 2004, J CLIN ENDOCR METAB, V89, P5762, DOI 10.1210/jc.2004-1003; Stamatakis KA, 2010, CHEST, V137, P95, DOI 10.1378/chest.09-0791; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; Tasali E, 2008, P NATL ACAD SCI USA, V105, P1044, DOI 10.1073/pnas.0706446105; Tsai PS, 2005, QUAL LIFE RES, V14, P1943, DOI 10.1007/s11136-005-4346-x; Van Cauter E, 2008, SLEEP MED, V9, pS23, DOI 10.1016/S1389-9457(08)70013-3; van den Berg JF, 2008, INT J OBESITY, V32, P1083, DOI 10.1038/ijo.2008.57; Vgontzas AN, 2002, ENDOCRIN METAB CLIN, V31, P15, DOI 10.1016/S0889-8529(01)00005-6; Wu MC, 2012, PREV MED, V55, P305, DOI 10.1016/j.ypmed.2012.07.013; Yilmaz MB, 2007, BLOOD PRESSURE, V16, P101, DOI 10.1080/08037050701343225	43	50	51	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54304	10.1371/journal.pone.0054304	http://dx.doi.org/10.1371/journal.pone.0054304			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342127	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400146
J	Varcoe, TJ; Boden, MJ; Voultsios, A; Salkeld, MD; Rattanatray, L; Kennaway, DJ				Varcoe, Tamara J.; Boden, Michael J.; Voultsios, Athena; Salkeld, Mark D.; Rattanatray, Leewen; Kennaway, David J.			Characterisation of the Maternal Response to Chronic Phase Shifts during Gestation in the Rat: Implications for Fetal Metabolic Programming	PLOS ONE			English	Article							MODERATE CALORIC RESTRICTION; GLUCOCORTICOID-RECEPTOR; LIGHT EXPOSURE; PHOSPHOENOLPYRUVATE CARBOXYKINASE; MELATONIN SECRETION; CIRCADIAN-RHYTHMS; GENE-EXPRESSION; ADULT DISEASE; LEPTIN; CLOCK	Disrupting maternal circadian rhythms through exposure to chronic phase shifts of the photoperiod has lifelong consequences for the metabolic homeostasis of the fetus, such that offspring develop increased adiposity, hyperinsulinaemia and poor glucose and insulin tolerance. In an attempt to determine the mechanisms by which these poor metabolic outcomes arise, we investigated the impact of chronic phase shifts (CPS) on maternal and fetal hormonal, metabolic and circadian rhythms. We assessed weight gain and food consumption of dams exposed to either CPS or control lighting conditions throughout gestation. At day 20, dams were assessed for plasma hormone and metabolite concentrations and glucose and insulin tolerance. Additionally, the expression of a range of circadian and metabolic genes was assessed in maternal, placental and fetal tissue. Control and CPS dams consumed the same amount of food, yet CPS dams gained 70% less weight during the first week of gestation. At day 20, CPS dams had reduced retroperitoneal fat pad weight (-15%), and time-of-day dependent decreases in liver weight, whereas fetal and placental weight was not affected. Melatonin secretion was not altered, yet the timing of corticosterone, leptin, glucose, insulin, free fatty acids, triglycerides and cholesterol concentrations were profoundly disrupted. The expression of gluconeogenic and circadian clock genes in maternal and fetal liver became either arrhythmic or were in antiphase to the controls. These results demonstrate that disruptions of the photoperiod can severely disrupt normal circadian profiles of plasma hormones and metabolites, as well as gene expression in maternal and fetal tissues. Disruptions in the timing of food consumption and the downstream metabolic processes required to utilise that food, may lead to reduced efficiency of growth such that maternal weight gain is reduced during early embryonic development. It is these perturbations that may contribute to the programming of poor metabolic homeostasis in the offspring.	[Varcoe, Tamara J.; Boden, Michael J.; Voultsios, Athena; Salkeld, Mark D.; Rattanatray, Leewen; Kennaway, David J.] Univ Adelaide, Robinson Inst, Adelaide, SA, Australia	Robinson Research Institute; University of Adelaide	Varcoe, TJ (corresponding author), Univ Adelaide, Robinson Inst, Adelaide, SA, Australia.	tamara.varcoe@adelaide.edu.au	Kennaway, David J/B-8955-2009; Varcoe, Tamara/H-2785-2014; Boden, Michael/L-9884-2013	Kennaway, David J/0000-0002-5864-3514; Varcoe, Tamara/0000-0002-9462-1830	Australian Government National Health and Medical Research Project Grant [APP1009877]; NHMRC	Australian Government National Health and Medical Research Project Grant(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	Experiments were funded through an Australian Government National Health and Medical Research Project Grant to DJ Kennaway and TJ Varcoe, APP1009877. DJ Kennaway is funded through a NHMRC senior research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashworth CJ, 2000, REV REPROD, V5, P18, DOI 10.1530/ror.0.0050018; Bodosi B, 2004, AM J PHYSIOL-REG I, V287, pR1071, DOI 10.1152/ajpregu.00294.2004; Bouret SG, 2010, BRAIN RES, V1350, P2, DOI 10.1016/j.brainres.2010.04.011; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; DALLMAN MF, 1992, J NEUROENDOCRINOL, V4, P517, DOI 10.1111/j.1365-2826.1992.tb00200.x; De Blasio MJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE75, DOI 10.1152/ajpendo.00689.2006; Dumont M, 2001, J BIOL RHYTHM, V16, P502, DOI 10.1177/074873001129002178; Entringer S, 2010, CURR OPIN ENDOCRINOL, V17, P507, DOI 10.1097/MED.0b013e3283405921; Ferguson SA, 2012, APPL ERGON, V43, P695, DOI 10.1016/j.apergo.2011.11.003; Ferreira DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038795; Fowden AL, 2012, PLACENTA, V33, pE1, DOI 10.1016/j.placenta.2012.09.005; Garcia AP, 2010, DIABETES OBES METAB, V12, P403, DOI 10.1111/j.1463-1326.2009.01174.x; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; HONMA K, 1992, AM J PHYSIOL, V262, pE948, DOI 10.1152/ajpendo.1992.262.6.E948; ILLNEROVA H, 1978, NEUROSCI LETT, V9, P189, DOI 10.1016/0304-3940(78)90070-8; Kalsbeek A, 2006, J BIOL RHYTHM, V21, P458, DOI 10.1177/0748730406293854; Kalsbeek A, 2012, MOL CELL ENDOCRINOL, V349, P20, DOI 10.1016/j.mce.2011.06.042; Kennaway DJ, 2000, J PINEAL RES, V28, P16, DOI 10.1034/j.1600-079x.2000.280103.x; KENNAWAY DJ, 1994, BRAIN RES BULL, V33, P639, DOI 10.1016/0361-9230(94)90227-5; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Langley-Evans SC, 2010, MED PRIN PRACT, V19, P87, DOI 10.1159/000273066; Lindsay RS, 1996, DIABETOLOGIA, V39, P1299, DOI 10.1007/s001250050573; Matsuda J, 1999, ENDOCRINOLOGY, V140, P5233, DOI 10.1210/en.140.11.5233; Mendez N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042713; Nader N, 2009, FASEB J, V23, P1572, DOI 10.1096/fj.08-117697; Nyirenda MJ, 1998, J CLIN INVEST, V101, P2174, DOI 10.1172/JCI1567; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Palou M, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-69; Schoneveld OJLM, 2004, BBA-GENE STRUCT EXPR, V1680, P114, DOI 10.1016/j.bbaexp.2004.09.004; Seckl JR, 1997, STEROIDS, V62, P89, DOI 10.1016/S0039-128X(96)00165-1; Sukumaran S, 2010, PHYSIOL GENOMICS, V42A, P141, DOI 10.1152/physiolgenomics.00106.2010; Thompson BL, 2009, NAT REV NEUROSCI, V10, P303, DOI 10.1038/nrn2598; Varcoe TJ, 2008, BRAIN RES, V1209, P19, DOI 10.1016/j.brainres.2008.02.091; Varcoe TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018504	36	50	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53800	10.1371/journal.pone.0053800	http://dx.doi.org/10.1371/journal.pone.0053800			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342007	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400085
J	Wong, MCS; Tam, WWS; Cheung, CSK; Tong, ELH; Sek, ACH; John, G; Cheung, NT; Yan, BPY; Yu, CM; Leeder, S; Griffiths, S				Wong, Martin C. S.; Tam, Wilson W. S.; Cheung, Clement S. K.; Tong, Ellen L. H.; Sek, Antonio C. H.; John, George; Cheung, N. T.; Yan, Bryan P. Y.; Yu, C. M.; Leeder, Stephen; Griffiths, Sian			Initial Antihypertensive Prescription and Switching: A 5 Year Cohort Study from 250,851 Patients	PLOS ONE			English	Article							DIAGNOSED HYPERTENSIVE PATIENTS; BLOOD-PRESSURE; UNITED-STATES; RISK-FACTORS; 33 COMMUNITIES; DRUG-THERAPY; URBAN ADULTS; HONG-KONG; DISCONTINUATION; PREVALENCE	Purpose: Adverse effects of antihypertensive therapy incur substantial cost. We evaluated whether any major classes of antihypertensive drugs were significantly associated with switching as a proxy measure of medication side effects in a large Chinese population in Hong Kong. Methods: From a clinical database, all adult patients newly prescribed an antihypertensive mono-therapy in Hong Kong between the years 2001-2003 and 2005 were included. Those who paid only one visit, died or stayed in the cohort for <180 days after the prescription, or prescribed more than one antihypertensive agent were excluded. The factors associated with switching at 180 days were evaluated by multivariate regression analyses. Age, gender, payment status, service type, district of residence, drug class, systolic and diastolic blood pressure levels were predictor variables. Results: From 250,851 subjects, 159,813 patients were eligible. A total of 6,163 (3.9%) switched their medications within 180 days. Patients prescribed thiazide diuretics had the highest switching rate (5.6%), followed by ACEIs (4.5%), CCBs (4.4%) and beta-blockers (3.2%). When compared with ACEIs, patients on thiazide diuretics were significantly more likely to be switchers (adjusted odds ratio [AOR] 1.49, 95% C. I. 1.31-1.69, p<0.001), whilst patients prescribed CCBs and beta-blockers were similarly likely to have switching. Following these patients up for 5 years showed that thiazide had the most marked increase in switching rate. Conclusions: The higher rates of switching among thiazide diuretics in this study might raise a probably greater incidence of their adverse effects in this Chinese population, yet other factors might also influence switching rates. Patients prescribed thiazide diuretics for longer term should be observed for their intolerability.	[Wong, Martin C. S.; Tam, Wilson W. S.; Griffiths, Sian] Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Cheung, Clement S. K.; Tong, Ellen L. H.; Sek, Antonio C. H.; Cheung, N. T.] Hosp Author Informat Technol Serv, Hlth Informat Sect, Hong Kong, Hong Kong, Peoples R China; [John, George] Univ Oxford, Oxford, England; [Yan, Bryan P. Y.; Yu, C. M.] Chinese Univ Hong Kong, Fac Med, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Leeder, Stephen] Univ Sydney, Menzies Ctr Hlth Policy, Sydney, NSW 2006, Australia	Chinese University of Hong Kong; University of Oxford; Chinese University of Hong Kong; University of Sydney	Tam, WWS (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China.	wilsontam@cuhk.edu.hk	TAM, Wilson W.S./H-5890-2019; Cheung, Clement Shek Kei/AAP-9969-2021; Wong, Martin/L-4568-2014; Yan, Bryan P/P-5928-2015; Tam, Wilson/K-1664-2019; Yu, Cheuk-man/P-3747-2015	TAM, Wilson W.S./0000-0003-0641-3060; Cheung, Clement Shek Kei/0000-0002-9014-8628; Wong, Martin/0000-0001-7706-9370; 				[Anonymous], 2006, POP CENS; Benetos A, 2003, J HYPERTENS, V21, P1635, DOI 10.1097/00004872-200309000-00011; Billups SJ, 2000, PHARMACOTHERAPY, V20, P941, DOI 10.1592/phco.20.11.941.35266; Brown MJ, 2006, BMJ-BRIT MED J, V332, P833, DOI 10.1136/bmj.332.7545.833; Burke TA, 2006, J HYPERTENS, V24, P1193, DOI 10.1097/01.hjh.0000226211.95936.f5; Caro JJ, 1999, CAN MED ASSOC J, V160, P31; Census and Statistics Department, GOV HONG KONG ADM RE; CHAN L, 2007, HONG KONG PRACTITION, V29, P470; Cheung NT, REALIZING BENEFITS E; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Chou CC, 2005, INT J CLIN PRACT, V59, P85, DOI 10.1111/j.1742-1241.2005.00436.x; Corrao G, 2008, J HYPERTENS, V26, P819, DOI 10.1097/HJH.0b013e3282f4edd7; Erkens JA, 2005, PHARMACOEPIDEM DR S, V14, P795, DOI 10.1002/pds.1156; Esposti LD, 2002, CLIN THER, V24, P1347, DOI 10.1016/S0149-2918(02)80039-X; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Fields LE, 2004, HYPERTENSION, V44, P398, DOI 10.1161/01.HYP.0000142248.54761.56; Flack JM, 1996, EUR HEART J, V17, P16, DOI 10.1093/eurheartj/17.suppl_A.16; Gueyffier F, 1997, ANN INTERN MED, V126, P761, DOI 10.7326/0003-4819-126-10-199705150-00002; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Kannel WB, 1996, JAMA-J AM MED ASSOC, V275, P1571, DOI 10.1001/jama.275.20.1571; Kearney PM, 2004, J HYPERTENS, V22, P11, DOI 10.1097/00004872-200401000-00003; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kim SJ, 2011, CIRC J, V75, P135, DOI 10.1253/circj.CJ-09-0948; Kokubo Y, 2009, CIRC J, V73, P1381, DOI 10.1253/circj.CJ-09-0336; Li H, 2010, J HYPERTENS, V28, P432, DOI 10.1097/HJH.0b013e328334b39e; Mazzaglia G, 2005, J HYPERTENS, V23, P2093, DOI 10.1097/01.hjh.0000186832.41125.8a; Meng XJ, 2012, CIRC J, V76, P900, DOI 10.1253/circj.CJ-11-1118; Meng XJ, 2011, J HYPERTENS, V29, P1303, DOI 10.1097/HJH.0b013e328347f79e; *NAT COLL CTR CHRO, 2006, HYP MAN AD PRIM CAR; Nicotra Federica, 2009, J Hypertens, V27, P1917, DOI 10.1097/HJH.0b013e32832d4692; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Redon J, 2007, HYPERTENSION, V49, P799, DOI 10.1161/01.HYP.0000259104.60878.43; Shafi T, 2008, HYPERTENSION, V52, P1022, DOI 10.1161/HYPERTENSIONAHA.108.119438; The Hong Kong Government, 2010, HONG KONG REF FRAM H; Tseng CH, 2008, CIRC J, V72, P1419, DOI 10.1253/circj.CJ-08-0009; Vaur L, 1999, AM J HYPERTENS, V12, P374, DOI 10.1016/S0895-7061(00)86963-0; Wong MCS, 2008, J HUM HYPERTENS, V22, P714, DOI 10.1038/jhh.2008.83; Wong MCS, 2010, J HUM HYPERTENS, V24, P669, DOI 10.1038/jhh.2009.109; Wong MCS, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-138; Wong MCS, 2011, HYPERTENS RES, V34, P888, DOI 10.1038/hr.2011.43; Wong MCS, 2009, AM J HYPERTENS, V22, P904, DOI 10.1038/ajh.2009.95; Wong Martin Cs, 2011, Asia Pac Fam Med, V10, P10, DOI 10.1186/1447-056X-10-10	43	10	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53625	10.1371/journal.pone.0053625	http://dx.doi.org/10.1371/journal.pone.0053625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341959	gold, Green Published, Green Submitted			2022-12-25	WOS:000314759400054
J	Zuriaga, E; Munoz-Sanz, JV; Molina, L; Gisbert, AD; Badenes, ML; Romero, C				Zuriaga, Elena; Munoz-Sanz, Juan V.; Molina, Laura; Gisbert, Ana D.; Badenes, Maria L.; Romero, Carlos			An S-Locus Independent Pollen Factor Confers Self-Compatibility in 'Katy' Apricot	PLOS ONE			English	Article							SPECIES SOLANUM-CHACOENSE; CRISTOBALINA SWEET CHERRY; F-BOX GENE; SKP1-LIKE PROTEIN; NICOTIANA-ALATA; PRUNUS-AVIUM; INCOMPATIBILITY ALLELES; RNASE; IDENTIFICATION; HAPLOTYPE	Loss of pollen-S function in Prunus self-compatible cultivars has been mostly associated with deletions or insertions in the S-haplotype-specific F-box (SFB) genes. However, self-compatible pollen-part mutants defective for non-S-locus factors have also been found, for instance, in the apricot (Prunus armeniaca) cv. 'Canino'. In the present study, we report the genetic and molecular analysis of another self-compatible apricot cv. termed 'Katy'. S-genotype of 'Katy' was determined as S1S2 and S-RNase PCR-typing of selfing and outcrossing populations from 'Katy' showed that pollen gametes bearing either the S-1- or the S-2-haplotype were able to overcome self-incompatibility (SI) barriers. Sequence analyses showed no SNP or indel affecting the SFB1 and SFB2 alleles from 'Katy' and, moreover, no evidence of pollen-S duplication was found. As a whole, the obtained results are compatible with the hypothesis that the loss-of-function of a S-locus unlinked factor gametophytically expressed in pollen (M'-locus) leads to SI breakdown in 'Katy'. A mapping strategy based on segregation distortion loci mapped the M'-locus within an interval of 9.4 cM at the distal end of chr.3 corresponding to similar to 1.29 Mb in the peach (Prunus persica) genome. Interestingly, pollen-part mutations (PPMs) causing self-compatibility (SC) in the apricot cvs. 'Canino' and 'Katy' are located within an overlapping region of similar to 273 Kb in chr.3. No evidence is yet available to discern if they affect the same gene or not, but molecular markers seem to indicate that both cultivars are genetically unrelated suggesting that every PPM may have arisen independently. Further research will be necessary to reveal the precise nature of 'Katy' PPM, but fine-mapping already enables SC marker-assisted selection and paves the way for future positional cloning of the underlying gene.	[Zuriaga, Elena; Munoz-Sanz, Juan V.; Molina, Laura; Gisbert, Ana D.; Badenes, Maria L.; Romero, Carlos] Inst Valenciano Invest Agr, Fruit Tree Breeding Dept, Valencia, Spain	Instituto Valenciano de Investigaciones Agrarias (IVIA)	Romero, C (corresponding author), Inst Valenciano Invest Agr, Fruit Tree Breeding Dept, Valencia, Spain.	romero_carsal@gva.es	MUÑOZ-SANZ, JUAN VICENTE/AAJ-7833-2020; Badenes, Maria Luisa/C-6606-2014; Romero, Carlos/G-6868-2015; Zuriaga, Elena/C-6985-2015; Muñoz-Sanz, Juan Vicente/T-5951-2017	MUÑOZ-SANZ, JUAN VICENTE/0000-0002-6752-7398; Badenes, Maria Luisa/0000-0001-9722-6783; Romero, Carlos/0000-0002-5316-8312; Zuriaga, Elena/0000-0001-5497-4941; Muñoz-Sanz, Juan Vicente/0000-0002-6752-7398	Ministerio de Economia y Competitividad [AGL2010-19208]	Ministerio de Economia y Competitividad(Spanish Government)	This work was supported by grants from the 'Ministerio de Economia y Competitividad', Research project AGL2010-19208. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AI YJ, 1991, MOL GEN GENET, V230, P353, DOI 10.1007/BF00280291; Alburquerque N, 2002, PLANT BREEDING, V121, P343, DOI 10.1046/j.1439-0523.2002.725292.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Belkhir K, 2004, GENETIX 4 05 LOGICIE; Bonfield J, 2004, STADEN PACKAGE VERSI; Boskovic R, 1996, EUPHYTICA, V90, P245, DOI 10.1007/BF00023865; Boskovic RI, 2010, J EXP BOT, V61, P755, DOI 10.1093/jxb/erp340; Burgos L, 1998, SEX PLANT REPROD, V11, P153, DOI 10.1007/s004970050133; Cachi AM, 2011, J EXP BOT, V62, P1847, DOI 10.1093/jxb/erq374; Chen G, 2010, J EXP BOT, V61, P2027, DOI 10.1093/jxb/erp381; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Egea J, 1996, J AM SOC HORTIC SCI, V121, P1002, DOI 10.21273/JASHS.121.6.1002; Feng JR, 2006, MOL BIOL REP, V33, P215, DOI 10.1007/s11033-006-0011-x; Marti AFI, 2009, SEX PLANT REPROD, V22, P179, DOI 10.1007/s00497-009-0102-7; Goldraij A, 2006, NATURE, V439, P805, DOI 10.1038/nature04491; Golz JF, 1999, GENETICS, V152, P1123; Golz JF, 2001, P NATL ACAD SCI USA, V98, P15372, DOI 10.1073/pnas.261571598; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Hancock CN, 2005, PLANT J, V43, P716, DOI 10.1111/j.1365-313X.2005.02490.x; Hauck NR, 2006, GENETICS, V172, P1191, DOI 10.1534/genetics.105.049395; Hosaka K, 1998, EUPHYTICA, V103, P265, DOI 10.1023/A:1018380725160; Hosaka K, 1998, EUPHYTICA, V99, P191, DOI 10.1023/A:1018353613431; Hua ZH, 2006, PLANT CELL, V18, P2531, DOI 10.1105/tpc.106.041061; Huang J, 2006, PLANT J, V46, P780, DOI 10.1111/j.1365-313X.2006.02735.x; Jung S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-130; Kakui H, 2011, PLANT J, V68, P1028, DOI 10.1111/j.1365-313X.2011.04752.x; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Kubo K, 2010, SCIENCE, V330, P796, DOI 10.1126/science.1195243; Lai Z, 2002, PLANT MOL BIOL, V50, P29, DOI 10.1023/A:1016050018779; Marchese A, 2007, J EXP BOT, V58, P4347, DOI 10.1093/jxb/erm322; Matsumoto D, 2012, PLANT PHYSIOL, V159, P1252, DOI 10.1104/pp.112.197343; McClure B, 1999, P NATL ACAD SCI USA, V96, P13548, DOI 10.1073/pnas.96.23.13548; McClure BA, 2000, ANN BOT-LONDON, V85, P113, DOI 10.1006/anbo.1999.1061; MCCLURE BA, 1989, NATURE, V342, P955, DOI 10.1038/342955a0; McClure B, 2011, ANN BOT-LONDON, V108, P647, DOI 10.1093/aob/mcr179; Movahedi S, 2011, PLANT PHYSIOL, V156, P1316, DOI 10.1104/pp.111.177865; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nettancourt, 2001, INCOMPATIBILITY INCO; Romero C, 2004, PLANT MOL BIOL, V56, P145, DOI 10.1007/s11103-004-2651-3; Russell D, 1998, STONEFRUIT CULTIVAR; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Sijacic P, 2004, NATURE, V429, P302, DOI 10.1038/nature02523; Sonneveld T, 2005, PLANT CELL, V17, P37, DOI 10.1105/tpc.104.026963; Sonneveld T, 2003, THEOR APPL GENET, V107, P1059, DOI 10.1007/s00122-003-1274-4; Tao R, 1999, J AM SOC HORTIC SCI, V124, P224, DOI 10.21273/JASHS.124.3.224; Tao R, 2007, PLANT MOL BIOL, V63, P109, DOI 10.1007/s11103-006-9076-0; Tao R, 2010, SCI HORTIC-AMSTERDAM, V124, P423, DOI 10.1016/j.scienta.2010.01.025; THOMPSON RD, 1991, MOL GEN GENET, V226, P283, DOI 10.1007/BF00273614; THOMSON D, 1995, BIOTECHNIQUES, V19, P394; Tsukamoto T, 2003, PLANT PHYSIOL, V131, P1903, DOI 10.1104/pp.102.018069; Ushijima K, 2004, PLANT J, V39, P573, DOI 10.1111/j.1365-313X.2004.02154.x; Ushijima K, 2003, PLANT CELL, V15, P771, DOI 10.1105/tpc.009290; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; Vilanova S, 2005, J AM SOC HORTIC SCI, V130, P893, DOI 10.21273/JASHS.130.6.893; Vilanova S, 2006, PLANT PHYSIOL, V142, P629, DOI 10.1104/pp.106.083865; Wang Y, 2008, PLANT PHYSIOL, V148, P1201, DOI 10.1104/pp.108.126375; Watari A, 2007, J AM SOC HORTIC SCI, V132, P396, DOI 10.21273/JASHS.132.3.396; Wu J, 2011, SEX PLANT REPROD, V24, P23, DOI 10.1007/s00497-010-0148-6; Wunsch A, 2010, PLANT CELL REP, V29, P715, DOI 10.1007/s00299-010-0857-1; Wunsch A, 2004, SEX PLANT REPROD, V17, P203, DOI 10.1007/s00497-004-0234-8; Xue YB, 1996, PLANT CELL, V8, P805, DOI 10.1105/tpc.8.5.805; Yamane H, 2003, J EXP BOT, V54, P2431, DOI 10.1093/jxb/erg271; Yamane H, 2009, J JPN SOC HORTIC SCI, V78, P137, DOI 10.2503/jjshs1.78.137; Busot GY, 2008, J EXP BOT, V59, P3187, DOI 10.1093/jxb/ern175; Zhao L, 2010, PLANT J, V62, P52, DOI 10.1111/j.1365-313X.2010.04123.x; Zhebentyayeva TN, 2008, TREE GENET GENOMES, V4, P745, DOI 10.1007/s11295-008-0147-z; Zheng XH, 2005, BIOINFORMATICS, V21, P703, DOI 10.1093/bioinformatics/bti045; Zhu CS, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-82; Zuriaga E, 2012, PLANT MOL BIOL, V79, P229, DOI 10.1007/s11103-012-9908-z	69	31	34	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53947	10.1371/journal.pone.0053947	http://dx.doi.org/10.1371/journal.pone.0053947			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342044	Green Submitted, Green Published, gold			2022-12-25	WOS:000314759400104
J	Czyz, O; Bitew, T; Cuesta-Marban, A; McMaster, CR; Mollinedo, F; Zaremberg, V				Czyz, Ola; Bitew, Teshager; Cuesta-Marban, Alvaro; McMaster, Christopher R.; Mollinedo, Faustino; Zaremberg, Vanina			Alteration of Plasma Membrane Organization by an Anticancer Lysophosphatidylcholine Analogue Induces Intracellular Acidification and Internalization of Plasma Membrane Transporters in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; LIPID RAFTS; ENDOPLASMIC-RETICULUM; ET-18-OCH3 EDELFOSINE; PHOSPHATIDIC-ACID; SNF1 KINASE; H+-ATPASE; PH; APOPTOSIS; UBIQUITIN	The lysophosphatidylcholine analogue edelfosine is a potent antitumor lipid that targets cellular membranes. The underlying mechanisms leading to cell death remain controversial, although two cellular membranes have emerged as primary targets of edelfosine, the plasma membrane (PM) and the endoplasmic reticulum. In an effort to identify conditions that enhance or prevent the cytotoxic effect of edelfosine, we have conducted genome-wide surveys of edelfosine sensitivity and resistance in Saccharomyces cerevisiae presented in this work and the accompanying paper (Cuesta-Marban, A., Botet, J., Czyz, O., Cacharro, L. M., Gajate, C., Hornillos, V., Delgado, J., Zhang, H., Amat- Guerri, F., Acuna, A. U., McMaster, C. R., Revuelta, J. L., Zaremberg, V., and Mollinedo, F. (January 23, 2013) J. Biol. Chem. 288,), respectively. Our results point to maintenance of pH homeostasis as a major player in modulating susceptibility to edelfosine with the PM proton pump Pma1p playing a main role. We demonstrate that edelfosine alters PM organization and induces intracellular acidification. Significantly, we show that edelfosine selectively reduces lateral segregation of PM proteins like Pma1p and nutrient H+ - symporters inducing their ubiquitination and internalization. The biology associated to the mode of action of edelfosine we have unveiled includes selective modification of lipid raft integrity altering pH homeostasis, which in turn regulates cell growth.	[Czyz, Ola; Bitew, Teshager; Zaremberg, Vanina] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Cuesta-Marban, Alvaro; Mollinedo, Faustino] Univ Salamanca, Consejo Super Invest Cient, Ctr Invest Canc, Inst Biol Mol & Celular Canc, E-37007 Salamanca, Spain; [McMaster, Christopher R.] Dalhousie Univ, Atlantic Res Ctr, Dept Pharmacol, Halifax, NS B3H 4H7, Canada	University of Calgary; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Dalhousie University	Mollinedo, F (corresponding author), Univ Salamanca, Consejo Super Invest Cient, Ctr Invest Canc, Inst Biol Mol & Celular Canc, Campus Miguel Unamuno, E-37007 Salamanca, Spain.	fmollin@usal.es; vzarembe@ucalgary.ca		Cuesta Marban, Alvaro/0000-0002-7144-0500; McMaster, Christopher/0000-0003-0822-5776	Natural Sciences and Engineering Research Council of Canada; University of Calgary, a Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research [14124]; Spanish Ministerio de Economia y Competitividad [SAF2008-02251, SAF2011-30518]; Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III, co-funded by the Fondo Europeo de Desarrollo Regional of the European Union [RD06/0020/1037, RD12/0036/0065]; European Community's Seventh Framework Programme [HEALTH-F2-2011-256986]; Junta de Castilla y Leon [CSI052A11-2, CSI221A12-2]; Spanish Ministerio de Ciencia e Innovacion	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Calgary, a Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Spanish Ministerio de Economia y Competitividad(Spanish Government); Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III, co-funded by the Fondo Europeo de Desarrollo Regional of the European Union; European Community's Seventh Framework Programme(European Commission); Junta de Castilla y Leon(Junta de Castilla y Leon); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported in part by a Natural Sciences and Engineering Research Council of Canada discovery grant, a seed grant from the University of Calgary, a Natural Sciences and Engineering Research Council of Canada University Faculty award (to V. Z.), Canadian Institutes of Health Research Grant 14124 (to C. R. M.), Spanish Ministerio de Economia y Competitividad Grants SAF2008-02251 and SAF2011-30518, Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III, co-funded by the Fondo Europeo de Desarrollo Regional of the European Union Grants RD06/0020/1037 and RD12/0036/0065, European Community's Seventh Framework Programme FP7-2007-2013 Grant HEALTH-F2-2011-256986, (PANACREAS), and Junta de Castilla y Leon Grants CSI052A11-2 and CSI221A12-2 (to F.M.).; Recipient of Formacion de Profesorado Universitario predoctoral fellowships from the Spanish Ministerio de Ciencia e Innovacion.	Arino J, 2010, MICROBIOL MOL BIOL R, V74, P95, DOI 10.1128/MMBR.00042-09; Bagnat M, 2001, MOL BIOL CELL, V12, P4129, DOI 10.1091/mbc.12.12.4129; Baumann NA, 2005, BIOCHEMISTRY-US, V44, P5816, DOI 10.1021/bi048296z; Bitew T, 2010, J BIOL CHEM, V285, P25731, DOI 10.1074/jbc.M110.122200; Blondel MO, 2004, MOL BIOL CELL, V15, P883, DOI 10.1091/mbc.E03-04-0202; BOGGS KP, 1995, J BIOL CHEM, V270, P7757, DOI 10.1074/jbc.270.13.7757; BOGGS KP, 1995, J BIOL CHEM, V270, P11612, DOI 10.1074/jbc.270.19.11612; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22; Brett CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017619; Carmelo V, 1996, ARCH MICROBIOL, V166, P315, DOI 10.1007/s002030050389; Casamayor A, 2012, BIOCHEM J, V444, P39, DOI 10.1042/BJ20112099; Chen R, 2011, J IMMUNOL, V186, P3215, DOI 10.4049/jimmunol.1002710; Cuesta-Marban A, 2013, J BIOL CHEM, V288, P8405, DOI 10.1074/jbc.M112.425769; Fairn GD, 2005, METHODS, V36, P102, DOI 10.1016/j.ymeth.2004.11.005; Fyrst H, 1999, BIOCHEMISTRY-US, V38, P5864, DOI 10.1021/bi9824590; Gajate C, 2000, INT J CANCER, V85, P674, DOI 10.1002/(SICI)1097-0215(20000301)85:5<674::AID-IJC13>3.0.CO;2-Z; Gajate C, 2004, J EXP MED, V200, P353, DOI 10.1084/jem.20040213; Gajate C, 2012, ONCOGENE, V31, P2627, DOI 10.1038/onc.2011.446; Gajate C, 2002, CURR DRUG METAB, V3, P491, DOI 10.2174/1389200023337225; Gajate C, 2001, BLOOD, V98, P3860, DOI 10.1182/blood.V98.13.3860; Gajate C, 2007, BLOOD, V109, P711, DOI 10.1182/blood-2006-04-016824; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Graham LA, 1998, J CELL BIOL, V142, P39, DOI 10.1083/jcb.142.1.39; Grossmann G, 2007, EMBO J, V26, P1, DOI 10.1038/sj.emboj.7601466; Grossmann G, 2008, J CELL BIOL, V183, P1075, DOI 10.1083/jcb.200806035; Hac-Wydro K, 2011, COLLOID SURFACE B, V88, P635, DOI 10.1016/j.colsurfb.2011.07.055; Hanson PJ, 2003, ECOL STUD-ANAL SYNTH, V166, P3; Huang CJ, 2011, J BIOL CHEM, V286, P10058, DOI 10.1074/jbc.M110.197889; Kaminska J, 2000, GENE, V242, P133, DOI 10.1016/S0378-1119(99)00535-1; Lauwers E, 2006, TRAFFIC, V7, P1045, DOI 10.1111/j.1600-0854.2006.00445.x; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; Marchal C, 1998, MOL CELL BIOL, V18, P314, DOI 10.1128/MCB.18.1.314; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; Mollinedo F, 1997, CANCER RES, V57, P1320; Mollinedo F, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.41; Nieto-Miguel T, 2007, CANCER RES, V67, P10368, DOI 10.1158/0008-5472.CAN-07-0278; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; Novoselova TV, 2012, EUKARYOT CELL, V11, P463, DOI 10.1128/EC.00009-12; Olivera-Couto A, 2012, MOL GENET GENOMICS, V287, P607, DOI 10.1007/s00438-012-0706-8; Orij R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r80; Orij R, 2011, BBA-GEN SUBJECTS, V1810, P933, DOI 10.1016/j.bbagen.2011.03.011; Orij R, 2009, MICROBIOL-SGM, V155, P268, DOI 10.1099/mic.0.022038-0; Pizzirusso M, 2004, MOL BIOL CELL, V15, P2401, DOI 10.1091/mbc.E03-10-0727; Pomorski T, 2004, J CELL SCI, V117, P805, DOI 10.1242/jcs.01055; Portillo F, 2005, FEBS LETT, V579, P512, DOI 10.1016/j.febslet.2004.12.019; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Serrano R, 2004, J BIOL CHEM, V279, P19698, DOI 10.1074/jbc.M313746200; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Spira F, 2012, NAT CELL BIOL, V14, P640, DOI 10.1038/ncb2487; Stringer DK, 2011, J CELL BIOL, V192, P229, DOI 10.1083/jcb.201008121; Surma MA, 2012, BBA-MOL CELL BIOL L, V1821, P1059, DOI 10.1016/j.bbalip.2011.12.008; van der Luit AH, 2002, J BIOL CHEM, V277, P39541, DOI 10.1074/jbc.M203176200; Vincent O, 2001, GENE DEV, V15, P1104, DOI 10.1101/gad.879301; Walther TC, 2006, NATURE, V439, P998, DOI 10.1038/nature04472; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wright MM, 2004, BIOCHEM CELL BIOL, V82, P18, DOI 10.1139/o03-092; Yenush L, 2005, MOL CELL BIOL, V25, P8683, DOI 10.1128/MCB.25.19.8683-8692.2005; Young BP, 2010, SCIENCE, V329, P1085, DOI 10.1126/science.1191026; Zaremberg V, 2005, J BIOL CHEM, V280, P38047, DOI 10.1074/jbc.M502849200; Zaremberg V, 2002, J BIOL CHEM, V277, P39035, DOI 10.1074/jbc.M207753200; Zhang J, 2010, CURR OPIN MICROBIOL, V13, P382, DOI 10.1016/j.mib.2010.04.004; Zhang YQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000939; Ziolkowska NE, 2012, TRENDS CELL BIOL, V22, P151, DOI 10.1016/j.tcb.2011.12.002	68	25	25	0	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8419	8432		10.1074/jbc.M112.425744	http://dx.doi.org/10.1074/jbc.M112.425744			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23344949	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000316564500040
J	Chen, QJ; Huang, SP; Chen, JJ; Zhang, SQ; Chen, Z				Chen, Quanjiao; Huang, Shengping; Chen, Jianjun; Zhang, Shaoqiong; Chen, Ze			NA Proteins of Influenza A Viruses H1N1/2009, H5N1, and H9N2 Show Differential Effects on Infection Initiation, Virus Release, and Cell-Cell Fusion	PLOS ONE			English	Article							2.2-A RESOLUTION; CROSS-PROTECTION; PLASMID DNAS; NEURAMINIDASE; HEMAGGLUTININ; GLYCOPROTEIN; GENERATION; VACCINE; LENGTH	Two surface glycoproteins of influenza virus, haemagglutinin (HA) and neuraminidase (NA), play opposite roles in terms of their interaction with host sialic acid receptors. HA attaches to sialic acid on host cell surface receptors to initiate virus infection while NA removes these sialic acids to facilitate release of progeny virions. This functional opposition requires a balance. To explore what might happen when NA of an influenza virus was replaced by one from another isolate or subtype, in this study, we generated three recombinant influenza A viruses in the background of A/PR/8/34 (PR8) (H1N1) and with NA genes obtained respectively from the 2009 pandemic H1N1 virus, a highly pathogenic avian H5N1 virus, and a lowly pathogenic avian H9N2 virus. These recombinant viruses, rPR8-H1N1NA, rPR8-H5N1NA, and rPR8-H9N2NA, were shown to have similar growth kinetics in cells and pathogenicity in mice. However, much more rPR8-H5N1NA and PR8-wt virions were released from chicken erythrocytes than virions of rPR8-H1N1NA and rPR8-H9N2NA after 1 h. In addition, in MDCK cells, rPR8-H5N1NA and rPR8-H9N2NA infected a higher percentage of cells, and induced cell-cell fusion faster and more extensively than PR8-wt and rPR8-H1N1NA did in the early phase of infection. In conclusion, NA replacement in this study did not affect virus replication kinetics but had different effects on infection initiation, virus release and fusion of infected cells. These phenomena might be partially due to NA proteins' different specificity to alpha 2-3/2-6-sialylated carbohydrate chains, but the exact mechanism remains to be explored.	[Chen, Quanjiao; Huang, Shengping; Chen, Jianjun; Zhang, Shaoqiong; Chen, Ze] Chinese Acad Sci, Ctr Emerging Infect Dis, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China; [Chen, Ze] Hunan Normal Univ, Coll Life Sci, Changsha, Hunan, Peoples R China; [Chen, Ze] Shanghai Inst Biol Prod, Shanghai, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Hunan Normal University	Chen, QJ (corresponding author), Chinese Acad Sci, Ctr Emerging Infect Dis, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China.	chenqj@wh.iov.cn; chenze2005@hotmail.com			National 973 Project [2010CB530301]; National Natural Science Foundation of China [31070141, 31100132]	National 973 Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the following research funds: National 973 Project (2010CB530301) and National Natural Science Foundation of China (31070141, 31100132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bin L, 2005, J VIROL, V79, P6763, DOI 10.1128/JVI.79.11.6763-6771.2005; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; BURMEISTER WP, 1992, EMBO J, V11, P49, DOI 10.1002/j.1460-2075.1992.tb05026.x; CASTRUCCI MR, 1993, J VIROL, V67, P759, DOI 10.1128/JVI.67.2.759-764.1993; Chen JJ, 2010, J GEN VIROL, V91, P2474, DOI 10.1099/vir.0.022681-0; Chen QJ, 2009, VIRUS GENES, V38, P30, DOI 10.1007/s11262-008-0305-2; Chen Z, 1999, J GEN VIROL, V80, P2559, DOI 10.1099/0022-1317-80-10-2559; Chen Z, 2000, VACCINE, V18, P3214, DOI 10.1016/S0264-410X(00)00149-3; Chu VC, 2004, P NATL ACAD SCI USA, V101, P18153, DOI 10.1073/pnas.0405172102; Flint M, 1999, J VIROL, V73, P6782, DOI 10.1128/JVI.73.8.6782-6790.1999; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Huang IC, 2008, J VIROL, V82, P4834, DOI 10.1128/JVI.00079-08; Iqbal M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005788; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; Mitnaul LJ, 2000, J VIROL, V74, P6015, DOI 10.1128/JVI.74.13.6015-6020.2000; Morens DM, 2007, J INFECT DIS, V195, P1018, DOI 10.1086/511989; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Neumann G, 2011, INFLUENZA OTHER RESP, V5, P157, DOI 10.1111/j.1750-2659.2011.00231.x; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ohuchi M, 2006, MICROBES INFECT, V8, P1287, DOI 10.1016/j.micinf.2005.12.008; Qiu MZ, 2006, BIOCHEM BIOPH RES CO, V343, P1124, DOI 10.1016/j.bbrc.2006.03.088; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Shtyrya Y, 2009, GLYCOCONJUGATE J, V26, P99, DOI 10.1007/s10719-008-9169-x; Sui ZW, 2010, VACCINE, V28, P7690, DOI 10.1016/j.vaccine.2010.09.019; VARGHESE JN, 1991, J MOL BIOL, V221, P473, DOI 10.1016/0022-2836(91)80068-6; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; World Health Organization, 2002, WHO MAN AN INFL DIAG; Xu XJ, 2008, J VIROL, V82, P10493, DOI 10.1128/JVI.00959-08; Zhang YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009167	35	11	13	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54334	10.1371/journal.pone.0054334	http://dx.doi.org/10.1371/journal.pone.0054334			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349854	Green Submitted, Green Published, gold			2022-12-25	WOS:000314019100057
J	Huang, YP; Rao, RPN				Huang, Yanping; Rao, Rajesh P. N.			Reward Optimization in the Primate Brain: A Probabilistic Model of Decision Making under Uncertainty	PLOS ONE			English	Article							MOTION; NEURONS	A key problem in neuroscience is understanding how the brain makes decisions under uncertainty. Important insights have been gained using tasks such as the random dots motion discrimination task in which the subject makes decisions based on noisy stimuli. A descriptive model known as the drift diffusion model has previously been used to explain psychometric and reaction time data from such tasks but to fully explain the data, one is forced to make ad-hoc assumptions such as a time-dependent collapsing decision boundary. We show that such assumptions are unnecessary when decision making is viewed within the framework of partially observable Markov decision processes (POMDPs). We propose an alternative model for decision making based on POMDPs. We show that the motion discrimination task reduces to the problems of (1) computing beliefs (posterior distributions) over the unknown direction and motion strength from noisy observations in a Bayesian manner, and (2) selecting actions based on these beliefs to maximize the expected sum of future rewards. The resulting optimal policy (belief-to-action mapping) is shown to be equivalent to a collapsing decision threshold that governs the switch from evidence accumulation to a discrimination decision. We show that the model accounts for both accuracy and reaction time as a function of stimulus strength as well as different speed-accuracy conditions in the random dots task.	[Huang, Yanping; Rao, Rajesh P. N.] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Rao, RPN (corresponding author), Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA.	rao@cs.washington.edu		Rao, Rajesh P. N./0000-0003-0682-8952	National Science Foundation (NSF) Center for Sensorimotor Neural Engineering [EEC-1028725]; NSF [0930908]; Army Research Office (ARO) [W911NF-11-1-0307]; Office of Naval Research (ONR) [N000140910097]	National Science Foundation (NSF) Center for Sensorimotor Neural Engineering; NSF(National Science Foundation (NSF)); Army Research Office (ARO); Office of Naval Research (ONR)(Office of Naval Research)	This project was supported by the National Science Foundation (NSF) Center for Sensorimotor Neural Engineering (EEC-1028725), NSF grant 0930908, Army Research Office (ARO) award W911NF-11-1-0307, and Office of Naval Research (ONR) grant N000140910097. YH is a Howard Hughes Medical Institute International Student Research fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Bogacz R, 2011, NEURAL COMPUT, V23, P817, DOI 10.1162/NECO_a_00103; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Casella G, 2001, STAT INFERENCE, V2nd; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; Cisek P, 2009, J NEUROSCI, V29, P11560, DOI 10.1523/JNEUROSCI.1844-09.2009; Daw ND, 2006, NEURAL COMPUT, V18, P1637, DOI 10.1162/neco.2006.18.7.1637; Dayan P, 2008, COGN AFFECT BEHAV NE, V8, P429, DOI 10.3758/CABN.8.4.429; Ditterich J, 2006, NEURAL NETWORKS, V19, P981, DOI 10.1016/j.neunet.2006.05.042; Doya K., 2007, BAYESIAN BRAIN PROBA; Drugowitsch J, 2012, J NEUROSCI, V32, P3612, DOI 10.1523/JNEUROSCI.4010-11.2012; Frazier PI, 2008, ADV NEURAL INFORM PR, P465; Frazier PL, 2007, ADV NEURAL INFORM PR, V20; Ghose GM, 2002, NATURE, V419, P616, DOI 10.1038/nature01057; Hanks TD, 2011, J NEUROSCI, V31, P6339, DOI 10.1523/JNEUROSCI.5613-10.2011; Huang Y., 2012, ADV NEURAL INFORM PR, V25; Kaelbling LP, 1998, ARTIF INTELL, V101, P99, DOI 10.1016/S0004-3702(98)00023-X; Knill DC, 1996, PERCEPTION BAYESIAN; LAI TL, 1988, ANN STAT, V16, P856, DOI 10.1214/aos/1176350840; Latham PE, 2007, SOCNEUROSCIABSTRACTS, V740; Law CT, 2009, NAT NEUROSCI, V12, P655, DOI 10.1038/nn.2304; Luce RD, 1986, RESPONSE TIMES THEIR; Ludwig CJH, 2009, VISION RES, V49, P2764, DOI 10.1016/j.visres.2009.08.012; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Rao R. P., 2002, PROBABILISTIC MODELS; Rao RPN, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00146; Rao RPN, 2004, NEURAL COMPUT, V16, P1, DOI 10.1162/08997660460733976; Roitman JD, 2002, J NEUROSCI, V22, P9475; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shadlen MN, 2001, J NEUROPHYSIOLOGY, V86; Shenoy P, 2012, ADV NEURAL INFORM PR, V25; Shenoy P, 2010, ADV NEURAL INFORM PR, V23; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Yu Angela J, 2008, Adv Neural Inf Process Syst, V21, P1873; Zemel RS, 1998, NEURAL COMPUTATION, P10	43	13	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53344	10.1371/journal.pone.0053344	http://dx.doi.org/10.1371/journal.pone.0053344			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349707	gold, Green Published, Green Submitted			2022-12-25	WOS:000314019100019
J	Reye, AL; Stegniy, V; Mishaeva, NP; Velhin, S; Hubschen, JM; Ignatyev, G; Muller, CP				Reye, Anna L.; Stegniy, Valentina; Mishaeva, Nina P.; Velhin, Sviataslau; Huebschen, Judith M.; Ignatyev, George; Muller, Claude P.			Prevalence of Tick-Borne Pathogens in Ixodes ricinus and Dermacentor reticulatus Ticks from Different Geographical Locations in Belarus	PLOS ONE			English	Article							BURGDORFERI SENSU-LATO; FEVER GROUP RICKETTSIAE; GROUP SFG RICKETTSIAE; ANAPLASMA-PHAGOCYTOPHILUM; BORRELIA-BURGDORFERI; BARTONELLA-HENSELAE; COXIELLA-BURNETII; BABESIA-MICROTI; IXODIDAE; SPP.	Worldwide, ticks are important vectors of human and animal pathogens. Besides Lyme Borreliosis, a variety of other bacterial and protozoal tick-borne infections are of medical interest in Europe. In this study, 553 questing and feeding Ixodes ricinus (n = 327) and Dermacentor reticulatus ticks (n = 226) were analysed by PCR for Borrelia, Rickettsia, Anaplasma, Coxiella, Francisella and Babesia species. Overall, the pathogen prevalence in ticks was 30.6% for I. ricinus and 45.6% for D. reticulatus. The majority of infections were caused by members of the spotted-fever group rickettsiae (24.4%), 9.4% of ticks were positive for Borrelia burgdorferi sensu lato, with Borrelia afzelii being the most frequently detected species (40.4%). Pathogens with low prevalence rates in ticks were Anaplasma phagocytophilum (2.2%), Coxiella burnetii (0.9%), Francisella tularensis subspecies (0.7%), Bartonella henselae (0.7%), Babesia microti (0.5%) and Babesia venatorum (0.4%). On a regional level, hotspots of pathogens were identified for A. phagocytophilum (12.5-17.2%), F. tularensis ssp. (5.5%) and C. burnetii (9.1%), suggesting established zoonotic cycles of these pathogens at least at these sites. Our survey revealed a high burden of tick-borne pathogens in questing and feeding I. ricinus and D. reticulatus ticks collected in different regions in Belarus, indicating a potential risk for humans and animals. Identified hotspots of infected ticks should be included in future surveillance studies, especially when F. tularensis ssp. and C. burnetii are involved.	[Reye, Anna L.; Huebschen, Judith M.; Muller, Claude P.] Ctr Rech Publ Sante, Natl Publ Hlth Lab, Inst Immunol, Luxembourg, Luxembourg; [Stegniy, Valentina; Mishaeva, Nina P.; Velhin, Sviataslau; Ignatyev, George] Republican Res & Pract Ctr Epidemiol & Microbiol, Clin & Expt Lab Chron Neuroinfect, Minsk, BELARUS	Luxembourg Institute of Health	Muller, CP (corresponding author), Ctr Rech Publ Sante, Natl Publ Hlth Lab, Inst Immunol, Luxembourg, Luxembourg.	Claude.Muller@CRP-SANTE.LU	Hübschen, Judith/AAF-5113-2020; Hübschen, Judith/ABA-7931-2021	Hübschen, Judith/0000-0002-5001-2128; Ignatyev, George/0000-0002-9731-3681	Ministry of Foreign Affairs of the Grand-Duchy of Luxembourg; Centre de Recherche Public de la Sante; Republic Fond of Fundamental Research of the Academy of Science of Belarus; Bourse Formation Recherche; Aides a la Formation Recherche of the Fonds National de la Recherche Luxembourg [BFR 07/038, EXT-BFR07-038 TR]	Ministry of Foreign Affairs of the Grand-Duchy of Luxembourg; Centre de Recherche Public de la Sante; Republic Fond of Fundamental Research of the Academy of Science of Belarus; Bourse Formation Recherche; Aides a la Formation Recherche of the Fonds National de la Recherche Luxembourg(Luxembourg National Research Fund)	This study was funded by the Ministry of Foreign Affairs of the Grand-Duchy of Luxembourg, the Centre de Recherche Public de la Sante and the Republic Fond of Fundamental Research of the Academy of Science of Belarus. A.L. Reye was supported by a fellowship from the Bourse Formation Recherche and the Aides a la Formation Recherche of the Fonds National de la Recherche Luxembourg (BFR 07/038; EXT-BFR07-038 TR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti A, 2005, APPL ENVIRON MICROB, V71, P6418, DOI 10.1128/AEM.71.10.6418-6422.2005; Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; Barns SM, 2005, APPL ENVIRON MICROB, V71, P5494, DOI 10.1128/AEM.71.9.5494-5500.2005; Begon Michael, 2008, P12; Bormane A, 2004, INT J MED MICROBIOL, V293, P36, DOI 10.1016/S1433-1128(04)80007-X; Casati S, 2006, ANN AGR ENV MED, V13, P65; Chmielewska-Badora J, 2012, ANN AGR ENV MED, V19, P271; Clark K, 2005, APPL ENVIRON MICROB, V71, P2616, DOI 10.1128/AEM.71.5.2616-2625.2005; De Bruin A, 2011, ZOONOSES PUBLIC HLTH; Dietrich F, 2010, APPL ENVIRON MICROB, V76, P1395, DOI 10.1128/AEM.02788-09; Dobson ADM, 2011, TICKS TICK-BORNE DIS, V2, P67, DOI 10.1016/j.ttbdis.2011.03.002; Estrada-Pena A., 2004, TICKS DOMESTIC ANIMA; Foley JE, 2010, VET MICROBIOL, V140, P332, DOI 10.1016/j.vetmic.2009.07.017; Franke J, 2010, APPL ENVIRON MICROB, V76, P6829, DOI 10.1128/AEM.01630-10; Grzeszczuk A, 2004, ANN AGR ENV MED, V11, P99; Grzeszczuk A, 2006, Adv Med Sci, V51, P283; Hubalek Z, 1997, Cent Eur J Public Health, V5, P199; Ignatovich V. F., 2001, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P14; Ishikura M, 2003, MICROBIOL IMMUNOL, V47, P823, DOI 10.1111/j.1348-0421.2003.tb03448.x; Karaban I., 2009, EpiNorth - Journal of the Network for Communicable Disease Control in Northern and Eastern Europe, V10, P48; Katargina O, 2012, CLIN MICROBIOL INFEC, V18, P40, DOI 10.1111/j.1469-0691.2010.03457.x; Kurtenbach K, 1998, INFECT IMMUN, V66, P1248, DOI 10.1128/IAI.66.3.1248-1251.1998; Lindgren E, 2006, LYME BORRELIOSIS EUR; Masuzawa T, 2008, J MED MICROBIOL, V57, P986, DOI 10.1099/jmm.0.47721-0; Matsumoto K, 2009, CLIN MICROBIOL INFEC, V15, P286, DOI 10.1111/j.1469-0691.2008.02238.x; Moniuszko A, 2011, VECTOR-BORNE ZOONOT, V11, P1399, DOI 10.1089/vbz.2010.0227; MOTIEJUNAS L, 1994, SCAND J INFECT DIS, V26, P149, DOI 10.3109/00365549409011778; Movila A, 2009, CLIN MICROBIOL INFEC, V15, P32, DOI 10.1111/j.1469-0691.2008.02152.x; Movila A, 2010, VECTOR BORNE ZOONOTI; Norman R, 1999, J THEOR BIOL, V200, P111, DOI 10.1006/jtbi.1999.0982; Podsiadly E, 2009, CLIN MICROBIOL INFEC, V15, P120, DOI 10.1111/j.1469-0691.2008.02196.x; Postic D, 1997, RES MICROBIOL, V148, P691, DOI 10.1016/S0923-2508(99)80068-0; Radzijevskaja J, 2008, INT J MED MICROBIOL, V298, P218, DOI 10.1016/j.ijmm.2008.01.008; Randolph SE, 1998, PARASITOL TODAY, V14, P186, DOI 10.1016/S0169-4758(98)01224-1; Rar VA, 2005, EMERG INFECT DIS, V11, P1708, DOI 10.3201/eid1111.041195; Rauter C, 2005, APPL ENVIRON MICROB, V71, P7203, DOI 10.1128/AEM.71.11.7203-7216.2005; REGNERY RL, 1991, J BACTERIOL, V173, P1576, DOI 10.1128/jb.173.5.1576-1589.1991; Reis C, 2011, VECTOR-BORNE ZOONOT, V11, P907, DOI 10.1089/vbz.2010.0103; Reye AL, 2010, APPL ENVIRON MICROB, V76, P2923, DOI 10.1128/AEM.03061-09; Rieg S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-167; Roux V, 1996, J CLIN MICROBIOL, V34, P2058, DOI 10.1128/JCM.34.9.2058-2065.1996; Samoylenko I, 2009, CLIN MICROBIOL INFEC, V15, P305, DOI 10.1111/j.1469-0691.2008.02249.x; Smetanova K, 2006, ANN NY ACAD SCI, V1078, P312, DOI 10.1196/annals.1374.058; Spitalska E, 2003, EUR J EPIDEMIOL, V18, P263, DOI 10.1023/A:1023330222657; Spitalska E, 2012, EXP APPL ACAROL, V57, P189, DOI 10.1007/s10493-012-9539-8; Stanczak J, 2008, INT J MED MICROBIOL, V298, P231, DOI 10.1016/j.ijmm.2007.09.006; Stanczak J, 2006, ANN NY ACAD SCI, V1078, P512, DOI 10.1196/annals.1374.100; Stanczak J, 2006, INT J MED MICROBIOL, V296, P144, DOI 10.1016/j.ijmm.2006.01.014; To H, 1996, J CLIN MICROBIOL, V34, P647, DOI 10.1128/JCM.34.3.647-651.1996; Trofimov N. M., 1998, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, V0, P21; Wojcik-Fatla A, 2006, ANN AGR ENV MED, V13, P319; Wojcik-Fatla A, 2009, ANN AGR ENV MED, V16, P151; Zeaiter Z, 2002, J CLIN MICROBIOL, V40, P1023, DOI 10.1128/JCM.40.3.1023-1030.2002; Zygner W, 2008, VET PARASITOL, V153, P139, DOI 10.1016/j.vetpar.2008.01.036	54	87	94	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54476	10.1371/journal.pone.0054476	http://dx.doi.org/10.1371/journal.pone.0054476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349900	Green Published, Green Submitted, gold			2022-12-25	WOS:000314019100071
J	Chen, ZL; Chen, WJ; Chen, H; Zhou, YY; Tang, MQ; Fu, MQ; Jin, XF				Chen, Zi-Lin; Chen, Wei-Jie; Chen, Huan; Zhou, Ying-Ying; Tang, Mei-Qin; Fu, Meng-Qi; Jin, Xiao-Feng			Prunus pananensis (Rosaceae), a New Species from Pan'an of Central Zhejiang, China	PLOS ONE			English	Article							INTERNATIONAL BOTANICAL CONGRESS	Prunus pananensis Z. L. Chen, W. J. Chen & X. F. Jin, a new species of Rosaceae from central Zhejiang, China is described and illustrated. Micromorphological characters of the indumentum on young shoots, leaves, petioles and peduncles, including scanning electron microscope [SEM] images, are provided. This new species is morphologically similar to P. schneiderianae Koehne in having its young shoots, petioles and pedicels all densely villose, but differs in having bracts persistent, styles glabrous, stipules 8-9 mm long, stamens 28-30 of per flower, and drupes glabrous. The new species is also similar to P. discoidea (Yu & C. L. Li) Yu & C. L. Li ex Z. Wei & Y. B. Chang in having 2 or 3 flowers in an umbellate inflorescence, and bracts persistent and marginally glandular, but it differs in having young shoots and petioles densely covered with yellowish-brown villose trichomes; leaves rounded or slightly cordate at base, the mid-ribs and lateral veins abaxially densely covered with yellowish-brown villose trichomes; and hypanthium ca. 3 mm long, shorter than sepals. The atpB-rbcL and trnL-F intergenic chloroplast spacers are selected for identification of the new and its similar species.	[Chen, Zi-Lin; Chen, Wei-Jie; Zhou, Ying-Ying; Tang, Mei-Qin; Fu, Meng-Qi; Jin, Xiao-Feng] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Chen, Zi-Lin] Zhejiang Dapanshan Natl Nat Reserve, Panan, Zhejiang, Peoples R China; [Chen, Huan] Zhejiang Inst Microbiol, Hangzhou, Zhejiang, Peoples R China	Hangzhou Normal University	Jin, XF (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China.	docxfjin@163.com	Chen, Huan/CAH-8180-2022		National Natural Science Foundation of China [31170183]; Science & Technology Department of Zhejiang Province [2010C33093]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Department of Zhejiang Province	This work was supported by the National Natural Science Foundation of China (Grant No. 31170183) and the project of Science & Technology Department of Zhejiang Province (Grant No. 2010C33093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bortiri E, 2002, AM J BOT, V89, P1697, DOI 10.3732/ajb.89.10.1697; Bortiri E, 2001, SYST BOT, V26, P797; Chang KS, 2007, BOT J LINN SOC, V154, P35, DOI 10.1111/j.1095-8339.2007.00631.x; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Hillier J, 2002, THE HILLIER MANUAL O; Huxley A, 1999, THE NEW ROYAL HORTIC, V3; Judd W. S., 2008, PLANT SYSTEMATICS PH; Knapp S, 2011, SYST BOT, V36, P821, DOI 10.1600/036364411X604822; Koehne E, 1913, PLANTAE WILSONIANAE, V2, P196; KRUSSMANN G, 1986, CULTIVATED BROAD LEA, V3; Lahaye R, 2008, NATURE, V1896, P1; Li C, 2003, FLORA CHINA, V9; Liu KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038880; McNeill J, 2011, TAXON, V60, P1507, DOI 10.1002/tax.605034; Mishler BD, 2000, SPECIES CONCEPTS AND PHYLOGENETIC THEORY: A DEBATE, P44; Pennisi E, 2007, SCIENCE, V318, P190, DOI 10.1126/science.318.5848.190; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Quan X, 2011, J SYST EVOL, V49, P138, DOI 10.1111/j.1759-6831.2010.00112.x; Ramos-Castro SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048822; Rehder A, 1940, MANUAL OF CULTIVATED; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Yu T.-T., 1986, FLORA REIPUBLICAE PO, V38, P41	24	4	10	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54030	10.1371/journal.pone.0054030	http://dx.doi.org/10.1371/journal.pone.0054030			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349780	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872800021
J	Khurana, N; Chauhan, H; Khurana, P				Khurana, Neetika; Chauhan, Harsh; Khurana, Paramjit			Wheat Chloroplast Targeted sHSP26 Promoter Confers Heat and Abiotic Stress Inducible Expression in Transgenic Arabidopsis Plants	PLOS ONE			English	Article							SHOCK TRANSCRIPTION FACTOR; UPSTREAM SEQUENCES; BETA-GLUCURONIDASE; CIS-ELEMENTS; GENE FUSION; PROTEIN; BINDING; TEMPERATURE; IDENTIFICATION; ACTIVATION	The small heat shock proteins (sHSPs) have been found to play a critical role in physiological stress conditions in protecting proteins from irreversible aggregation. To characterize the hloroplast targeted sHSP26 promoter in detail, deletion analysis of the promoter is carried out and analysed via transgenics in Arabidopsis. In the present study, complete assessment of the importance of CCAAT-box elements along with Heat shock elements (HSEs) in the promoter of sHSP26 was performed. Moreover, the importance of 5' untranslated region (UTR) has also been established in the promoter via Arabidopsis transgenics. An intense GUS expression was observed after heat stress in the transgenics harbouring a full-length promoter, confirming the heat-stress inducibility of the promoter. Transgenic plants without UTR showed reduced GUS expression when compared to transgenic plants with UTR as was confirmed at the RNA and protein levels by qRT-PCR and GUS histochemical assays, thus suggesting the possible involvement of some regulatory elements present in the UTR in heat-stress inducibility of the promoter. Promoter activity was also checked under different abiotic stresses and revealed differential expression in different deletion constructs. Promoter analysis based on histochemical assay, real-time qPCR and fluorimetric analysis revealed that HSEs alone could not transcribe GUS gene significantly in sHSP26 promoter and CCAAT box elements contribute synergistically to the transcription. Our results also provide insight into the importance of 5UTR of sHsp26 promoter thus emphasizing the probable role of imperfect CCAAT-box element or some novel cis-element with respect to heat stress.	[Khurana, Neetika; Chauhan, Harsh; Khurana, Paramjit] Univ Delhi, Dept Plant Mol Biol, New Delhi, India	University of Delhi	Khurana, P (corresponding author), Univ Delhi, Dept Plant Mol Biol, South Campus, New Delhi, India.	param@genomeindia.org	Chauhan, Harsh/U-8270-2019; Chauhan, Harsh/AAB-2751-2021	Chauhan, Harsh/0000-0002-1396-5464	Department of Biotechnology, Government of India, New Delhi	Department of Biotechnology, Government of India, New Delhi(Department of Biotechnology (DBT) India)	This work was financially supported by Department of Biotechnology, Government of India, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAVAYA K, 1991, GENE DEV, V5, P2117, DOI 10.1101/gad.5.11.2117; AN GH, 1987, BIOESSAYS, V7, P211, DOI 10.1002/bies.950070505; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; Carranco R, 1999, PLANT PHYSIOL, V121, P723, DOI 10.1104/pp.121.3.723; Chauhan H, 2012, PLANT CELL ENVIRON, V35, P1912, DOI 10.1111/j.1365-3040.2012.02525.x; Chauhan H, 2011, PLANT MOL BIOL, V75, P35, DOI 10.1007/s11103-010-9702-8; Chen J, 2010, J MOL BIOL, V398, P122, DOI 10.1016/j.jmb.2010.02.022; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Crone D, 2001, PLANT CELL ENVIRON, V24, P869, DOI 10.1046/j.1365-3040.2001.00727.x; Franzmann TM, 2008, MOL CELL, V29, P207, DOI 10.1016/j.molcel.2007.11.025; Freeman J, 2011, PLANT BIOTECHNOL J, V9, P788, DOI 10.1111/j.1467-7652.2011.00588.x; Ganguly M, 2011, PLANT CELL REP, V30, P1617, DOI 10.1007/s00299-011-1072-4; Hamilton EW, 2001, PLANT PHYSIOL, V126, P1266, DOI 10.1104/pp.126.3.1266; Haralampidis K, 2002, PLANT PHYSIOL, V129, P1138, DOI 10.1104/pp.004044; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Heckathorn SA, 1998, PLANT PHYSIOL, V116, P439, DOI 10.1104/pp.116.1.439; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; ISHSHALOM D, 1990, EMBO J, V9, P2657, DOI 10.1002/j.1460-2075.1990.tb07450.x; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jiang CH, 2009, PLANT CELL ENVIRON, V32, P1046, DOI 10.1111/j.1365-3040.2009.01987.x; Jung HS, 2010, PLANT PHYSIOL, V152, P453, DOI 10.1104/pp.109.149070; Karthikeyan AS, 2009, PHYSIOL PLANTARUM, V136, P10, DOI 10.1111/j.1399-3054.2009.01207.x; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; LANDSBERGER N, 1995, MOL CELL BIOL, V15, P6013; Lee BH, 2000, GENE, V245, P283, DOI 10.1016/S0378-1119(00)00043-3; LEE JH, 1995, PLANT J, V8, P603, DOI 10.1046/j.1365-313X.1995.8040603.x; Lee SY, 1998, CURR MICROBIOL, V37, P403, DOI 10.1007/s002849900400; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Lu SY, 2007, TRANSGENIC RES, V16, P177, DOI 10.1007/s11248-006-9035-1; Malik MK, 1999, PLANT J, V20, P89, DOI 10.1046/j.1365-313X.1999.00581.x; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; MORGAN WD, 1987, MOL CELL BIOL, V7, P1129, DOI 10.1128/MCB.7.3.1129; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Moriwaki M, 1999, PLANT CELL REP, V19, P96, DOI 10.1007/s002990050717; Qu LQ, 2008, J EXP BOT, V59, P2417, DOI 10.1093/jxb/ern110; RIEPING M, 1992, MOL GEN GENET, V231, P226, DOI 10.1007/BF00279795; Rossel JB, 2002, PLANT PHYSIOL, V130, P1109, DOI 10.1104/pp.005595; Santoro N, 1998, MOL CELL BIOL, V18, P6340, DOI 10.1128/MCB.18.11.6340; Sato Y, 2008, PLANT CELL REP, V27, P329, DOI 10.1007/s00299-007-0470-0; Shoji W, 2008, DEV GROWTH DIFFER, V50, P401, DOI [10.1111/j.1440-169x.2008.01038.x, 10.1111/j.1440-169X.2008.01038.x]; Siderius M. H., 1997, YEAST STRESS RESPONS, P213; Sorkina A, 2011, PLANT CELL REP, V30, P1627, DOI 10.1007/s00299-011-1073-3; Storozhenko S, 1998, PLANT PHYSIOL, V118, P1005, DOI 10.1104/pp.118.3.1005; Sun WN, 2001, PLANT J, V27, P407, DOI 10.1046/j.1365-313X.2001.01107.x; Sun YM, 2011, PLANT CELL REP, V30, P1661, DOI 10.1007/s00299-011-1075-1; TAKAHASHI T, 1992, PLANT J, V2, P751, DOI 10.1111/j.1365-313X.1992.tb00144.x; Torok Z, 2001, P NATL ACAD SCI USA, V98, P3098, DOI 10.1073/pnas.051619498; Tsuwamoto R, 2011, PLANT CELL REP, V30, P1723, DOI 10.1007/s00299-011-1080-4; Vainonen JP, 2012, BIOCHEM J, V442, P573, DOI 10.1042/BJ20111739; Volkov RA, 2005, PLANT MOL BIOL, V57, P487, DOI 10.1007/s11103-005-0339-y; Volkov RA, 2006, PLANT MOL BIOL, V61, P733, DOI 10.1007/s11103-006-0045-4; Wang DF, 2003, PLANT PHYSIOL, V133, P319, DOI 10.1104/pp.102.018309; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wu LM, 2011, PLANT CELL REP, V30, P75, DOI 10.1007/s00299-010-0945-2; XIAO H, 1991, CELL, V64, P585, DOI 10.1016/0092-8674(91)90242-Q; YABE N, 1994, PLANT CELL PHYSIOL, V35, P1207, DOI 10.1093/oxfordjournals.pcp.a078715; Yamamoto A, 2005, J BIOL CHEM, V280, P11911, DOI 10.1074/jbc.M411256200; Yokthongwattana K, 2001, PLANT CELL PHYSIOL, V42, P1389, DOI 10.1093/pcp/pce179; Yuan GF, 2010, SCI HORTIC-AMSTERDAM, V126, P103, DOI 10.1016/j.scienta.2010.06.014; ZARSKY V, 1995, PLANT CELL ENVIRON, V18, P139, DOI 10.1111/j.1365-3040.1995.tb00347.x	60	32	35	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54418	10.1371/journal.pone.0054418	http://dx.doi.org/10.1371/journal.pone.0054418			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349883	Green Submitted, Green Published, gold			2022-12-25	WOS:000313872800052
J	Pinto, LM; Dheda, K; Theron, G; Allwood, B; Calligaro, G; van Zyl-Smit, R; Peter, J; Schwartzman, K; Menzies, D; Bateman, E; Pai, M; Dawson, R				Pinto, Lancelot M.; Dheda, Keertan; Theron, Grant; Allwood, Brian; Calligaro, Gregory; van Zyl-Smit, Richard; Peter, Jonathan; Schwartzman, Kevin; Menzies, Dick; Bateman, Eric; Pai, Madhukar; Dawson, Rodney			Development of a Simple Reliable Radiographic Scoring System to Aid the Diagnosis of Pulmonary Tuberculosis	PLOS ONE			English	Article							SPUTUM SMEAR MICROSCOPY; CLINICAL PREDICTORS; RECORDING-SYSTEM; VALIDATION; INPATIENTS; PREVALENCE; DERIVATION; ASSAY; MODEL	Rationale: Chest radiography is sometimes the only method available for investigating patients with possible pulmonary tuberculosis (PTB) with negative sputum smears. However, interpretation of chest radiographs in this context lacks specificity for PTB, is subjective and is neither standardized nor reproducible. Efforts to improve the interpretation of chest radiography are warranted. Objectives: To develop a scoring system to aid the diagnosis of PTB, using features recorded with the Chest Radiograph Reading and Recording System (CRRS). Methods: Chest radiographs of outpatients with possible PTB, recruited over 3 years at clinics in South Africa were read by two independent readers using the CRRS method. Multivariate analysis was used to identify features significantly associated with culture-positive PTB. These were weighted and used to generate a score. Results: 473 patients were included in the analysis. Large upper lobe opacities, cavities, unilateral pleural effusion and adenopathy were significantly associated with PTB, had high inter-reader reliability, and received 2, 2, 1 and 2 points, respectively in the final score. Using a cut-off of 2, scores below this threshold had a high negative predictive value (91.5%, 95% CI 87.1,94.7), but low positive predictive value (49.4%, 95% CI 42.9,55.9). Among the 382 TB suspects with negative sputum smears, 229 patients had scores <2; the score correctly ruled out active PTB in 214 of these patients (NPV 93.4%; 95% CI 89.4,96.3). The score had a suboptimal negative predictive value in HIV-infected patients (NPV 86.4, 95% CI 75,94). Conclusions: The proposed scoring system is simple, and reliably ruled out active PTB in smear-negative HIV-uninfected patients, thus potentially reducing the need for further tests in high burden settings. Validation studies are now required.	[Pinto, Lancelot M.; Schwartzman, Kevin; Menzies, Dick; Pai, Madhukar] Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada; [Pinto, Lancelot M.; Menzies, Dick; Pai, Madhukar] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; [Schwartzman, Kevin; Menzies, Dick] McGill Univ, Dept Med, Div Resp, Montreal, PQ, Canada; [Dheda, Keertan; Theron, Grant; Allwood, Brian; Calligaro, Gregory; van Zyl-Smit, Richard; Peter, Jonathan; Bateman, Eric; Dawson, Rodney] Univ Cape Town, Dept Med, Div Pulmonol, Lung Inst, ZA-7925 Cape Town, South Africa	McGill University; McGill University; McGill University; University of Cape Town	Dawson, R (corresponding author), Univ Cape Town, Dept Med, Div Pulmonol, Lung Inst, ZA-7925 Cape Town, South Africa.	rodney.dawson@uct.ac.za	Theron, Grant/ABB-1167-2020; Pai, Madhukar/AAX-9901-2021; PAL, MRINAL/ABG-9676-2020; Calligaro, Greg/U-7472-2019	Theron, Grant/0000-0002-9216-2415; Pai, Madhukar/0000-0003-3667-4536; PAL, MRINAL/0000-0002-1032-272X; Calligaro, Gregory/0000-0001-7324-0775; Pinto, Lancelot/0000-0002-5418-5448; van Zyl-Smit, Richard/0000-0002-4115-5362; Peter, Jonathan/0000-0002-2658-0723	European and Developing Countries Clinical Trials Partnership (TB-Novel and Emerging Technologies for Diagnosis); European Commission; Canadian Institutes of Health Research [CIHR-MOP-89918]; Shastri Indo-Canadian Institute; Research Institute of the McGill University Health Centre; Canadian Institutes of Health Research (CIHR); Grand Challenges Canada; South African National Research Foundation Research Chairs Initiative (SARChI); European and Developing Countries Clinical Trials Partnership (Trials of Excellence in Southern Africa and TB-Novel and Emerging Technologies for Diagnosis); Medical Research Council Career Development Award	European and Developing Countries Clinical Trials Partnership (TB-Novel and Emerging Technologies for Diagnosis); European Commission(European CommissionEuropean Commission Joint Research Centre); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Shastri Indo-Canadian Institute; Research Institute of the McGill University Health Centre; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Grand Challenges Canada(CGIAR); South African National Research Foundation Research Chairs Initiative (SARChI); European and Developing Countries Clinical Trials Partnership (Trials of Excellence in Southern Africa and TB-Novel and Emerging Technologies for Diagnosis); Medical Research Council Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by grants from the The European and Developing Countries Clinical Trials Partnership (TB-Novel and Emerging Technologies for Diagnosis), European Commission (EU-FP7; Sustaining research momentum over the coming decades: mentoring the next generation of researchers for tuberculosis), and Canadian Institutes of Health Research (CIHR-MOP-89918). LMP is supported by fellowships from the Shastri Indo-Canadian Institute and the Research Institute of the McGill University Health Centre. MP is supported by a New Investigator Award by the Canadian Institutes of Health Research (CIHR), and Grand Challenges Canada. KD is supported by the South African National Research Foundation Research Chairs Initiative (SARChI), the European and Developing Countries Clinical Trials Partnership (Trials of Excellence in Southern Africa and TB-Novel and Emerging Technologies for Diagnosis) and an Medical Research Council Career Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agizew T, 2010, INT J TUBERC LUNG D, V14, P324; [Anonymous], 2011, GLOB TUB CONTR; Bock NN, 1996, AM J RESP CRIT CARE, V154, P1468, DOI 10.1164/ajrccm.154.5.8912766; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Cattamanchi A, 2011, AM J RESP CRIT CARE, V183, P547, DOI 10.1164/rccm.201008-1207OC; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Davis JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009859; Dawson R, 2010, INT J TUBERC LUNG D, V14, P52; Den Boon S, 2005, INT J TUBERC LUNG D, V9, P1088; Dheda K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009848; El-Solh AA, 1999, CHEST, V116, P968, DOI 10.1378/chest.116.4.968; ElSolh A, 1997, AM J RESP CRIT CARE, V155, P1711, DOI 10.1164/ajrccm.155.5.9154881; Koppaka R, 2004, TOMANS TUBERCULOSIS, P51; Lagrange-Xelot M, 2011, CLIN MICROBIOL INFEC, V17, P610, DOI 10.1111/j.1469-0691.2010.03259.x; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Le Minor O, 2008, JAIDS-J ACQ IMM DEF, V48, P620, DOI 10.1097/QAI.0b013e31817efb3c; Ling DI, 2011, EUR RESPIR J, V38, P649, DOI 10.1183/09031936.00181610; Moran GJ, 2009, ANN EMERG MED, V53, P625, DOI 10.1016/j.annemergmed.2008.07.027; Mylotte JM, 1997, INFECT CONT HOSP EP, V18, P554; Pinto LM, 2012, EUR RESP J; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Rakoczy KS, 2008, INFECT CONT HOSP EP, V29, P927, DOI 10.1086/590667; Solari L, 2008, INT J TUBERC LUNG D, V12, P619; Soto A, 2008, BRAZ J INFECT DIS, V12, P128, DOI 10.1590/S1413-86702008000200006; Soto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018486; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; URBANCZIK R, 1985, ZBL BAKT-INT J MED M, V260, P81; Venkatesh KK, 2011, DRUGS, V71, P1133, DOI 10.2165/11591360-000000000-00000; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Wisnivesky JP, 2000, ARCH INTERN MED, V160, P2471, DOI 10.1001/archinte.160.16.2471; Wisnivesky JP, 2005, ARCH INTERN MED, V165, P453, DOI 10.1001/archinte.165.4.453; World Health Organization, 2011, COUNTR HLTH PROF SA; Yoo SD, 2011, RESPIROLOGY, V16, P836, DOI 10.1111/j.1440-1843.2011.01981.x	33	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54235	10.1371/journal.pone.0054235	http://dx.doi.org/10.1371/journal.pone.0054235			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349835	Green Submitted, Green Published, gold			2022-12-25	WOS:000313872800033
J	Bianco, L; Alagna, F; Baldoni, L; Finnie, C; Svensson, B; Perrotta, G				Bianco, Linda; Alagna, Fiammetta; Baldoni, Luciana; Finnie, Christine; Svensson, Birte; Perrotta, Gaetano			Proteome Regulation during Olea europaea Fruit Development	PLOS ONE			English	Article							GENE-EXPRESSION; OLIVE FRUIT; OLEUROPEIN; PROTEINS; IDENTIFICATION; BIOSYNTHESIS; ACCUMULATION; INVOLVEMENT; ETHYLENE; ANNEXIN	Background: Widespread in the Mediterranean basin, Olea europaea trees are gaining worldwide popularity for the nutritional and cancer-protective properties of the oil, mechanically extracted from ripe fruits. Fruit development is a physiological process with remarkable impact on the modulation of the biosynthesis of compounds affecting the quality of the drupes as well as the final composition of the olive oil. Proteomics offers the possibility to dig deeper into the major changes during fruit development, including the important phase of ripening, and to classify temporal patterns of protein accumulation occurring during these complex physiological processes. Methodology/Principal Findings: In this work, we started monitoring the proteome variations associated with olive fruit development by using comparative proteomics coupled to mass spectrometry. Proteins extracted from drupes at three different developmental stages were separated on 2-DE and subjected to image analysis. 247 protein spots were revealed as differentially accumulated. Proteins were identified from a total of 121 spots and discussed in relation to olive drupe metabolic changes occurring during fruit development. In order to evaluate if changes observed at the protein level were consistent with changes of mRNAs, proteomic data produced in the present work were compared with transcriptomic data elaborated during previous studies. Conclusions/Significance: This study identifies a number of proteins responsible for quality traits of cv. Coratina, with particular regard to proteins associated to the metabolism of fatty acids, phenolic and aroma compounds. Proteins involved in fruit photosynthesis have been also identified and their pivotal contribution in oleogenesis has been discussed. To date, this study represents the first characterization of the olive fruit proteome during development, providing new insights into fruit metabolism and oil accumulation process.	[Bianco, Linda; Perrotta, Gaetano] TRISAIA Res Ctr, Italian Natl Agcy New Technol Energy & Sustainabl, Rotondella, Matera, Italy; [Alagna, Fiammetta; Baldoni, Luciana] CNR Inst Plant Genet, Perugia, Italy; [Finnie, Christine; Svensson, Birte] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark	Italian National Agency New Technical Energy & Sustainable Economics Development; Technical University of Denmark	Perrotta, G (corresponding author), TRISAIA Res Ctr, Italian Natl Agcy New Technol Energy & Sustainabl, Rotondella, Matera, Italy.	gaetano.perrotta@enea.it	Baldoni, Luciana/A-4411-2016; Alagna, Fiammetta/AAF-3169-2020	Baldoni, Luciana/0000-0002-3221-333X; Perrotta, Gaetano/0000-0003-2037-1063; Svensson, Birte/0000-0002-2993-8196; BALDONI, LUCIANA/0000-0002-6636-0055; Alagna, Fiammetta/0000-0003-1878-2023; Finnie, Christine/0000-0003-0657-5174	Italian Ministry of Agriculture (MIPAF)-Project OLEA; Danish Center for Advanced Food Science (LMC); Danish Research Council for Natural Sciences	Italian Ministry of Agriculture (MIPAF)-Project OLEA; Danish Center for Advanced Food Science (LMC); Danish Research Council for Natural Sciences(Danish Natural Science Research Council)	This work was supported by the Italian Ministry of Agriculture (MIPAF)-Project OLEA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Silvia Mazzuca for her precious advice on protein extraction from drupes and Birgit Andersen for the assistance with mass spectrometry. The Bruker Ultraflex II mass spectrometer was in part funded by the Danish Center for Advanced Food Science (LMC), the Typhoon scanner was granted by the Danish Research Council for Natural Sciences. We thank CRA-OLI for accessing their Olive Cultivar Collection at the experimental farm of Collececco, Spoleto (Perugia, Italy).	Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; Amemiya T, 2006, PLANTA, V223, P1272, DOI 10.1007/s00425-005-0176-x; AMIOT MJ, 1989, PHYTOCHEMISTRY, V28, P67, DOI 10.1016/0031-9422(89)85009-5; Huerta-Ocampo JA, 2012, J PROTEOMICS, V75, P2160, DOI 10.1016/j.jprot.2012.01.015; Bian W., 2011, J BOT, V2011, P1, DOI DOI 10.1155/2011/289859; Bianco L, 2009, J PROTEOMICS, V72, P586, DOI 10.1016/j.jprot.2008.11.019; BLANKE MM, 1989, PLANT CELL ENVIRON, V12, P31, DOI 10.1111/j.1365-3040.1989.tb01914.x; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Buchhaupt M, 2012, APPL MICROBIOL BIOT, V93, P159, DOI 10.1007/s00253-011-3482-1; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Carpentier SC, 2008, MASS SPECTROM REV, V27, P354, DOI 10.1002/mas.20170; Ciafardini G, 2001, ITAL J FOOD SCI, V13, P41; Clark GB, 2001, PLANT PHYSIOL, V126, P1072, DOI 10.1104/pp.126.3.1072; Coker JS, 2003, BIOTECHNIQUES, V35, P740, DOI 10.2144/03354st04; Colomer Ramon, 2006, Clin Transl Oncol, V8, P15, DOI 10.1007/s12094-006-0090-0; Conde C, 2008, J PLANT PHYSIOL, V165, P1545, DOI 10.1016/j.jplph.2008.04.018; Connor D. J., 2004, Horticultural Reviews, V31, P155, DOI 10.1002/9780470650882.ch4; Corrado G, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-86; Dierkes G, 2012, J AGR FOOD CHEM, V60, P394, DOI 10.1021/jf203406s; Esteve C, 2012, J PROTEOMICS, V75, P2396, DOI 10.1016/j.jprot.2012.02.020; Esteve C, 2011, ANAL CHIM ACTA, V690, P129, DOI 10.1016/j.aca.2011.02.005; Etienne C, 2002, PHYSIOL PLANTARUM, V114, P259, DOI 10.1034/j.1399-3054.2002.1140212.x; Faurobert M, 2007, PLANT PHYSIOL, V143, P1327, DOI 10.1104/pp.106.092817; Galla G, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-128; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Giribaldi M, 2007, PROTEOMICS, V7, P3154, DOI 10.1002/pmic.200600974; Gomez-Jimenez MC, 2010, PLANTA, V232, P629, DOI 10.1007/s00425-010-1198-6; Gutierrez-Rosales F, 2012, J AGR FOOD CHEM, V60, P4348, DOI 10.1021/jf205209y; Gutierrez-Rosales F, 2010, J AGR FOOD CHEM, V58, P12924, DOI 10.1021/jf103083u; Isaacson T, 2006, NAT PROTOC, V1, P769, DOI 10.1038/nprot.2006.102; Jimenez A, 2002, PLANTA, V214, P751, DOI 10.1007/s004250100667; Martinez-Esteso MJ, 2011, J EXP BOT, V62, P2521, DOI 10.1093/jxb/erq434; Jungblut PR, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-16; Karp NA, 2005, PROTEOMICS, V5, P3105, DOI 10.1002/pmic.200500083; Karp Natasha A, 2007, Proteomics, V7 Suppl 1, P42, DOI 10.1002/pmic.200700683; Karp NA, 2009, PROTEOMICS, V9, P388, DOI 10.1002/pmic.200800485; Katz YS, 2006, PLANT MOL BIOL, V61, P255, DOI 10.1007/s11103-006-0009-8; Konopka-Postupolska D, 2007, PROTOPLASMA, V230, P203, DOI 10.1007/s00709-006-0234-7; Larsen MR, 2000, FRESEN J ANAL CHEM, V366, P677, DOI 10.1007/s002160051562; Lelievre JM, 1997, PHYSIOL PLANTARUM, V101, P727, DOI 10.1111/j.1399-3054.1997.tb01057.x; Liu JH, 2006, JARQ-JPN AGR RES Q, V40, P51, DOI 10.6090/jarq.40.51; McCartney AW, 2004, PLANT J, V37, P156, DOI 10.1111/j.1365-313X.2004.01949.x; Nogueira SB, 2012, J PROTEOMICS, V75, P1428, DOI 10.1016/j.jprot.2011.11.015; OLIAS JM, 1993, J AGR FOOD CHEM, V41, P2368, DOI 10.1021/jf00036a029; Omar Syed Haris, 2010, Sci Pharm, V78, P133, DOI 10.3797/scipharm.0912-18; Padilla MN, 2009, J AGR FOOD CHEM, V57, P9097, DOI 10.1021/jf901777j; Paul V, 2012, J FOOD SCI TECH MYS, V49, P1, DOI 10.1007/s13197-011-0293-4; Peng XJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-26; POPOV N, 1975, ACTA BIOL MED GER, V34, P1441; Proietti P, 2006, PHOTOSYNTHETICA, V44, P275, DOI 10.1007/s11099-006-0019-4; Proust J, 1996, FEBS LETT, V383, P208, DOI 10.1016/0014-5793(96)00252-9; Rabilloud T, 2009, ELECTROPHORESIS, V30, pS174, DOI 10.1002/elps.200900050; Rabilloud T, 2009, MASS SPECTROM REV, V28, P816, DOI 10.1002/mas.20204; Rocco M, 2006, PROTEOMICS, V6, P3781, DOI 10.1002/pmic.200600128; Sanchez J, 2002, EUR J LIPID SCI TECH, V104, P564, DOI 10.1002/1438-9312(200210)104:9/10<564::AID-EJLT564>3.0.CO;2-5; SANCHEZ J, 1994, PLANT LIPID METABOLISM, P564; Seals DF, 1997, PLANT PHYSIOL, V115, P753, DOI 10.1104/pp.115.2.753; Theiss C, 2002, PLANT PHYSIOL, V128, P1470, DOI 10.1104/pp.010896; Wechter WP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-275; WILKINSON JQ, 1995, PLANT MOL BIOL, V27, P1097, DOI 10.1007/BF00020883; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; Zhang XM, 2007, PROTEOMICS, V7, P2340, DOI 10.1002/pmic.200600184	62	34	34	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53563	10.1371/journal.pone.0053563	http://dx.doi.org/10.1371/journal.pone.0053563			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349718	Green Published, Green Submitted, gold			2022-12-25	WOS:000313738900012
J	Bichet, C; Scheifler, R; Coeurdassier, M; Julliard, R; Sorci, G; Loiseau, C				Bichet, Coraline; Scheifler, Renaud; Coeurdassier, Michael; Julliard, Romain; Sorci, Gabriele; Loiseau, Claire			Urbanization, Trace Metal Pollution, and Malaria Prevalence in the House Sparrow	PLOS ONE			English	Article							TITS PARUS-MAJOR; HEAVY-METALS; GREAT TITS; CLIMATE-CHANGE; TAENIOPYGIA-GUTTATA; PLASMODIUM-RELICTUM; PASSERINE BIRDS; IMMUNE FUNCTION; AVIAN MALARIA; FEATHERS	Anthropogenic pollution poses a threat for the environment and wildlife. Trace metals (TMs) are known to have negative effects on haematological status, oxidative balance, and reproductive success in birds. These pollutants particularly increase in concentration in industrialized, urbanized and intensive agricultural areas. Pollutants can also interfere with the normal functioning of the immune system and, as such, alter the dynamics of host-parasite interactions. Nevertheless, the impact of pollution on infectious diseases has been largely neglected in natural populations of vertebrates. Here, we used a large spatial scale monitoring of 16 house sparrow (Passer domesticus) populations to identify environmental variables likely to explain variation in TMs (lead, cadmium, zinc) concentrations in the feathers. In five of these populations, we also studied the potential link between TMs, prevalence of infection with one species of avian malaria, Plasmodium relictum, and body condition. Our results show that lead concentration is associated with heavily urbanized habitats and that areas with large woodland coverage have higher cadmium and zinc feather concentrations. Our results suggest that lead concentration in the feathers positively correlates with P. relictum prevalence, and that a complex relationship links TM concentrations, infection status, and body condition. This is one of the first studies showing that environmental pollutants are associated with prevalence of an infectious disease in wildlife. The mechanisms underlying this effect are still unknown even though it is tempting to suggest that lead could interfere with the normal functioning of the immune system, as shown in other species. We suggest that more effort should be devoted to elucidate the link between pollution and the dynamics of infectious diseases.	[Bichet, Coraline; Sorci, Gabriele] Univ Bourgogne, CNRS UMR 6282, Dijon, France; [Scheifler, Renaud; Coeurdassier, Michael] Univ Franche Comte, CNRS UMR 6249, F-25030 Besancon, France; [Julliard, Romain] UMR 7204 MNHN CNRS UPMC, Paris, France; [Loiseau, Claire] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Franche-Comte; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; California State University System; San Francisco State University	Bichet, C (corresponding author), Univ Bourgogne, CNRS UMR 6282, Dijon, France.	coraline.bichet@u-bourgogne.fr	Bichet, Coraline/K-3103-2019; Jurassien, LTER Jurassian Arc Zone atelier Arc/C-1946-2016; Scheifler, Renaud/H-2971-2014	Bichet, Coraline/0000-0003-0255-4966; Scheifler, Renaud/0000-0002-9620-0204; Loiseau, Claire/0000-0002-0407-2904; Sorci, Gabriele/0000-0002-0799-3995	Region Ile de France; Region Bourgogne; Region Franche-Comte; Agence de l'Environnement et de la Maitrise de l'Energie	Region Ile de France(Region Ile-de-France); Region Bourgogne(Region Bourgogne-Franche-Comte); Region Franche-Comte(Region Bourgogne-Franche-Comte); Agence de l'Environnement et de la Maitrise de l'Energie	Financial support was provided by the Region Ile de France to CL, RJ and GS, the Region Bourgogne to GS, and the Region Franche-Comte and the Agence de l'Environnement et de la Maitrise de l'Energie to RS and MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson B, 2000, J INFECT DIS, V182, P420, DOI 10.1086/315726; Atkinson CT, 1995, PARASITOLOGY, V111, pS59, DOI 10.1017/S003118200007582X; Atkinson CT, 1991, BIRD PARASITE INTERA, P19; Atkinson CT., 1999, FIELD MANUAL WILDLIF, P193; Baos R, 2006, ENVIRON HEALTH PERSP, V114, P1497, DOI 10.1289/ehp.9099; Barbieri E, 2010, WATER ENVIRON RES, V82, P2301, DOI 10.2175/106143009X12465435982935; Bartlett JR, 2003, POULTRY SCI, V82, P1580, DOI 10.1093/ps/82.10.1580; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Biser JA, 2004, J WILDLIFE DIS, V40, P173, DOI 10.7589/0090-3558-40.2.173; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Borowska J, 2011, J INSECT PHYSIOL, V57, P760, DOI 10.1016/j.jinsphys.2011.02.012; Bossard M, 2000, CORINE LAND COVER TE, P40; Bouma MJ, 2011, TRENDS PARASITOL, V27, P421, DOI 10.1016/j.pt.2011.07.003; BRIDGER MA, 1983, ARCH ENVIRON CON TOX, V12, P45, DOI 10.1007/BF01055000; BURGER J, 1994, FUND APPL TOXICOL, V23, P553, DOI 10.1006/faat.1994.1140; BURGER J, 1994, J TOXICOL ENV HEALTH, V41, P207, DOI 10.1080/15287399409531837; Burger J., 1993, REV ENV TOXICOL, V5, P203; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Camplani A, 1999, P ROY SOC B-BIOL SCI, V266, P1111, DOI 10.1098/rspb.1999.0751; Cellier-Holzem E, 2010, INT J PARASITOL, V40, P1447, DOI 10.1016/j.ijpara.2010.04.014; CHANDRA RK, 1982, NUTR RES, V2, P721, DOI 10.1016/S0271-5317(82)80116-4; COOK JA, 1975, P SOC EXP BIOL MED, V150, P741, DOI 10.3181/00379727-150-39117; Dauwe T, 2000, ARCH ENVIRON CON TOX, V39, P541, DOI 10.1007/s002440010138; Dauwe T, 2002, ARCH ENVIRON CON TOX, V42, P88; Dauwe T, 2006, ENVIRON POLLUT, V140, P71, DOI 10.1016/j.envpol.2005.06.024; Dauwe T, 2003, ENVIRON POLLUT, V124, P429, DOI 10.1016/S0269-7491(03)00044-7; De Luca-Abbott SB, 2001, ECOTOXICOLOGY, V10, P327, DOI 10.1023/A:1012288811808; DENNEMAN WD, 1993, ENVIRON POLLUT, V82, P301, DOI 10.1016/0269-7491(93)90133-9; Fair JM, 2002, ECOTOXICOLOGY, V11, P199, DOI 10.1023/A:1015474832239; Fritsch C, 2010, CHEMOSPHERE, V81, P141, DOI 10.1016/j.chemosphere.2010.06.075; Galloway TS, 2001, ECOTOXICOLOGY, V10, P5, DOI 10.1023/A:1008939520263; Garamszegi LZ, 2011, GLOBAL CHANGE BIOL, V17, P1751, DOI 10.1111/j.1365-2486.2010.02346.x; GARDNER DE, 1977, B EUR PHYSIOPATH RES, V13, P157; Geens A, 2010, SCI TOTAL ENVIRON, V408, P1174, DOI 10.1016/j.scitotenv.2009.11.029; GRASMAN KA, 1995, ARCH ENVIRON CON TOX, V28, P161, DOI 10.1007/BF00217611; HAHN E, 1993, SCI TOTAL ENVIRON, V140, P259, DOI 10.1016/0048-9697(93)90025-2; Hawley DM, 2009, ECOTOXICOLOGY, V18, P499, DOI 10.1007/s10646-009-0307-4; HILIS DM, 1996, MOL SYSTEMATICS; Hoffman DJ, 1998, ENVIRON TOXICOL CHEM, V17, P161, DOI 10.1002/etc.5620170204; Hudson PJ, 2001, ECOLOGY WILDLIFE DIS; Isaksson C, 2009, ENVIRON RES, V109, P46, DOI 10.1016/j.envres.2008.10.006; Jager LP, 1996, J ORNITHOL, V137, P295, DOI 10.1007/BF01651071; Janssens E, 2001, ENVIRON TOXICOL CHEM, V20, P2815, DOI 10.1897/1551-5028(2001)020<2815:HMASIF>2.0.CO;2; Jaspers V, 2004, J ENVIRON MONITOR, V6, P356, DOI 10.1039/b314919f; Kenow KP, 2007, ENVIRON TOXICOL CHEM, V26, P1460, DOI 10.1897/06-442R.1; Knowles SCL, 2010, J EVOLUTION BIOL, V23, P557, DOI 10.1111/j.1420-9101.2009.01920.x; LASCHILOQUERIE A, 1987, IMMUNOPHARM IMMUNOT, V9, P235, DOI 10.3109/08923978709035212; Loiseau C, 2010, P R SOC B, V278, P1264, DOI DOI 10.1098/rspb.2010.1968; Markman S, 2011, J APPL ECOL, V48, P391, DOI 10.1111/j.1365-2664.2010.01931.x; Marzal A, 2008, J EVOLUTION BIOL, V21, P979, DOI 10.1111/j.1420-9101.2008.01545.x; Marzluff John M., 2001, P19; Mashima TY, 1998, ECOTOXICOLOGY, V7, P107, DOI 10.1023/A:1008820004249; Nain S, 2011, ECOTOX ENVIRON SAFE, V74, P787, DOI 10.1016/j.ecoenv.2010.10.045; Norte AC, 2009, IBIS, V151, P677, DOI 10.1111/j.1474-919X.2009.00960.x; Orlowski G, 2010, J ORNITHOL, V151, P279, DOI 10.1007/s10336-009-0453-8; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Palinauskas V, 2008, EXP PARASITOL, V120, P372, DOI 10.1016/j.exppara.2008.09.001; Palinauskas V, 2009, EXP PARASITOL, V123, P134, DOI 10.1016/j.exppara.2009.06.012; Pan C, 2008, B ENVIRON CONTAM TOX, V81, P558, DOI 10.1007/s00128-007-9168-9; Patz JA, 2006, P NATL ACAD SCI USA, V103, P5635, DOI 10.1073/pnas.0601493103; Roux KE, 2007, ARCH ENVIRON CON TOX, V53, P261, DOI 10.1007/s00244-006-0174-4; Scheifler R, 2006, SCI TOTAL ENVIRON, V371, P197, DOI 10.1016/j.scitotenv.2006.09.011; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; SHERMAN AR, 1992, J NUTR, V122, P604, DOI 10.1093/jn/122.suppl_3.604; Snoeijs T, 2005, ENVIRON POLLUT, V134, P123, DOI 10.1016/j.envpol.2004.07.009; Snoeijs T, 2004, ARCH ENVIRON CON TOX, V46, P399, DOI 10.1007/s00244-003-2195-6; Swaileh KM, 2006, J ENVIRON MONITOR, V8, P209, DOI 10.1039/b510635d; Thomson MC, 2006, NATURE, V439, P576, DOI 10.1038/nature04503; USEPA (US Environmental Protection Agency), 1998, EPA600R96084; Valkiunas G, 2005, AVIAN MALARIA PARASI; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; Waldenstrom J, 2004, J PARASITOL, V90, P191, DOI 10.1645/GE-3221RN; Walker CH, 2003, ECOTOXICOLOGY, V12, P307, DOI 10.1023/A:1022523331343; WEYERS B, 1988, SCI TOTAL ENVIRON, V77, P61, DOI 10.1016/0048-9697(88)90315-4; Williams RB, 2005, AVIAN PATHOL, V34, P29, DOI 10.1080/03079450400025430; Zehtindjiev P, 2008, EXP PARASITOL, V119, P99, DOI 10.1016/j.exppara.2007.12.018	76	57	59	0	154	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53866	10.1371/journal.pone.0053866	http://dx.doi.org/10.1371/journal.pone.0053866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342022	Green Published, gold, Green Submitted			2022-12-25	WOS:000313682700054
J	del Rey, M; Pericacho, M; Velasco, S; Lumbreras, E; Lopez-Novoa, JM; Hernandez-Rivas, JM; Rodriguez-Barbero, A				del Rey, Monica; Pericacho, Miguel; Velasco, Soraya; Lumbreras, Eva; Lopez-Novoa, Jose Miguel; Hernandez-Rivas, Jesus Maria; Rodriguez-Barbero, Alicia			Alteration in Endoglin-Related Angiogenesis in Refractory Cytopenia with Multilineage Dysplasia	PLOS ONE			English	Article							WORLD-HEALTH-ORGANIZATION; BONE-MARROW ANGIOGENESIS; MYELODYSPLASTIC SYNDROMES; SOLUBLE ENDOGLIN; GROWTH-FACTOR; ENDOTHELIAL-CELLS; EXPRESSION; LEUKEMIA; CLASSIFICATION; PATHOGENESIS	The functional mechanisms involved in angiogenesis and the potential role of endoglin (ENG), recently described as a new marker for this process, have not been explored in Myelodysplastic Syndromes (MDS). In order to gain insight in MDS angiogenesis a combined analysis in bone marrow (BM) of gene expression levels, angiogenesis-related soluble factors and functional angiogenesis-related studies was carried out. Ninety-seven MDS patients and forty-two normal BM samples were studied. The morphology of the capillary-like structures originated by two endothelial cells lines in the BM environment of patients with refractory cytopenia with multilineage dysplasia (RCMD) was different from those of the remaining MDS. In addition, the BM mononuclear cells from RCMD patients displayed over-expression of VEGF, HIF and FN1 while they showed reduced expression of ENG in contrast to the normal ENG expression of the remaining low-risk MDS and the high expression of ENG in high-risk MDS subtype. Moreover, higher soluble ENG and soluble FLT-1 levels in BM microenvironment were observed in RCMD cases, which distinguished them from other individuals. Therefore, the present study suggests that the patterns of angiogenesis are different between the MDS subtypes. The differences in angiogenesis observed in RCMD patients could be related to ENG abnormalities.	[del Rey, Monica; Lumbreras, Eva; Hernandez-Rivas, Jesus Maria] Univ Salamanca, CSIC, CIC, IBMCC, E-37008 Salamanca, Spain; [del Rey, Monica; Pericacho, Miguel; Lumbreras, Eva; Lopez-Novoa, Jose Miguel; Hernandez-Rivas, Jesus Maria; Rodriguez-Barbero, Alicia] Inst Invest Biomed Salamanca, IBSAL, Salamanca, Spain; [Pericacho, Miguel; Velasco, Soraya; Lopez-Novoa, Jose Miguel; Rodriguez-Barbero, Alicia] Univ Salamanca, Dept Fisiol & Farmacol, E-37008 Salamanca, Spain; [Hernandez-Rivas, Jesus Maria] Hosp Univ Salamanca, Serv Hematol, Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca	Rodriguez-Barbero, A (corresponding author), Inst Invest Biomed Salamanca, IBSAL, Salamanca, Spain.	barberoa@usal.es	Rodriguez-Barbero, Alicia/A-7583-2017; Lopez-Novoa, Jose M/A-3672-2008; Lumbreras, Eva/B-4672-2017; Pericacho, Miguel/H-1786-2016; Hernández, Jesus M/B-5459-2017	Rodriguez-Barbero, Alicia/0000-0002-6774-7147; Lumbreras, Eva/0000-0003-0359-6199; Pericacho, Miguel/0000-0003-0226-482X; Hernández, Jesus M/0000-0002-9661-9371; Lopez-Novoa, Jose M./0000-0002-6211-7269	Spanish Fondo de Investigaciones Sanitarias [FIS 09/01543]; Proyectos de Investigacion del [SACYL 355/A/09]; COST Action "EuGESMA'' [BM0801]; Obra Social Banca Civica (Caja Burgos); "Accion Transversal del Cancer''; Instituto de Salud Carlos III (ISCIII); Spanish Ministry of Science and Innovation; Cancer Research Foundation of Salamanca University; Redes de Investigacion RTICC (FIS); Junta de Castilla y Leon [SA052A06, SA029A09]; Ministerio de Ciencia e Innovacion [SAF2010-15881]; "Ayuda Predoctoral'' by the Sociedad Espanola de Hematologia y Hemoterapia; Junta de Castilla y Leon	Spanish Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Proyectos de Investigacion del; COST Action "EuGESMA''(European Cooperation in Science and Technology (COST)); Obra Social Banca Civica (Caja Burgos); "Accion Transversal del Cancer''(Instituto de Salud Carlos III); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Cancer Research Foundation of Salamanca University; Redes de Investigacion RTICC (FIS); Junta de Castilla y Leon(Junta de Castilla y Leon); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); "Ayuda Predoctoral'' by the Sociedad Espanola de Hematologia y Hemoterapia; Junta de Castilla y Leon(Junta de Castilla y Leon)	This work was partially supported by grants from the Spanish Fondo de Investigaciones Sanitarias FIS 09/01543; Proyectos de Investigacion del SACYL 355/A/09, COST Action "EuGESMA'' (BM0801), Obra Social Banca Civica (Caja Burgos) and by the "Accion Transversal del Cancer'' project, through an agreement between the Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Science and Innovation, and the Cancer Research Foundation of Salamanca University and the Redes de Investigacion RTICC (FIS). This work was also supported by grants from the Junta de Castilla y Leon (SA052A06 and SA029A09 to ARB.) and Ministerio de Ciencia e Innovacion (SAF2010-15881 to JMLN). MDR is fully supported by an "Ayuda Predoctoral'' by the Sociedad Espanola de Hematologia y Hemoterapia. The Renal and Cardiovascular Physiology Unit is an Excellence Research Group awarded by Junta de Castilla y Leon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla SA, 2006, J MED GENET, V43, P97, DOI 10.1136/jmg.2005.030833; Aguayo A, 2000, BLOOD, V96, P2240, DOI 10.1182/blood.V96.6.2240.h8002240_2240_2245; Aguayo A, 2002, CANCER-AM CANCER SOC, V95, P1923, DOI 10.1002/cncr.10900; Alexandrakis MG, 2005, LEUKEMIA RES, V29, P41, DOI 10.1016/j.leukres.2004.05.002; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bellamy WT, 2001, BLOOD, V97, P1427, DOI 10.1182/blood.V97.5.1427; Bernabeu C, 2009, BBA-MOL BASIS DIS, V1792, P954, DOI 10.1016/j.bbadis.2009.07.003; Blazquez-Medela AM, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-86; Calabro L, 2003, J CELL PHYSIOL, V194, P171, DOI 10.1002/jcp.10200; Campioni D, 2004, LEUKEMIA RES, V28, P9, DOI 10.1016/S0145-2126(03)00123-1; Candal FJ, 1996, MICROVASC RES, V52, P221, DOI 10.1006/mvre.1996.0060; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cazzola M, 2005, NEW ENGL J MED, V352, P536, DOI 10.1056/NEJMp048266; Della Porta MG, 2008, LEUKEMIA, V22, P530, DOI 10.1038/sj.leu.2405069; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; Fonsatti Ester, 2004, J Transl Med, V2, P18, DOI 10.1186/1479-5876-2-18; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Hillen F, 2007, CANCER METAST REV, V26, P489, DOI 10.1007/s10555-007-9094-7; Jerkic M, 2006, CARDIOVASC RES, V69, P845, DOI 10.1016/j.cardiores.2005.11.020; Keith T, 2007, BRIT J HAEMATOL, V137, P206, DOI 10.1111/j.1365-2141.2007.06539.x; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Longo V, 2007, LEUKEMIA, V21, P1605, DOI 10.1038/sj.leu.2404790; Lopez-Novoa JM, 2010, AM J PHYSIOL-HEART C, V299, pH959, DOI 10.1152/ajpheart.01251.2009; Lopez-Villar O, 2009, LEUKEMIA, V23, P664, DOI 10.1038/leu.2008.361; Lundberg LG, 2006, LEUKEMIA RES, V30, P247, DOI 10.1016/j.leukres.2005.07.003; Miller DW, 1999, INT J CANCER, V81, P568, DOI 10.1002/(SICI)1097-0215(19990517)81:4<568::AID-IJC11>3.3.CO;2-O; Nolte F, 2008, ANN HEMATOL, V87, P777, DOI 10.1007/s00277-008-0502-z; Peters BA, 2005, NAT MED, V11, P261, DOI 10.1038/nm1200; Pruneri G, 2002, BRIT J HAEMATOL, V118, P817, DOI 10.1046/j.1365-2141.2002.03654.x; Pruneri G, 1999, BRIT J CANCER, V81, P1398, DOI 10.1038/sj.bjc.6693515; Pruneri G, 2003, BRIT J HAEMATOL, V120, P695, DOI 10.1046/j.1365-2141.2003.04133.x; Sanchez-Elsner T, 2002, J BIOL CHEM, V277, P43799, DOI 10.1074/jbc.M207160200; Streubel B, 2004, NEW ENGL J MED, V351, P250, DOI 10.1056/NEJMoa033153; ten Dijke P, 2008, ANGIOGENESIS, V11, P79, DOI 10.1007/s10456-008-9101-9; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199; Velasco-Loyden G, 2004, J BIOL CHEM, V279, P7721, DOI 10.1074/jbc.M306499200; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Watarai M, 2002, LEUKEMIA, V16, P112, DOI 10.1038/sj.leu.2402326; Wimazal F, 2006, LEUKEMIA LYMPHOMA, V47, P451, DOI 10.1080/10428190500353083	41	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53624	10.1371/journal.pone.0053624	http://dx.doi.org/10.1371/journal.pone.0053624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341958	Green Published, Green Submitted, gold			2022-12-25	WOS:000313682700031
J	Magnusson, M; Sierra, MI; Sasidharan, R; Prashad, SL; Romero, M; Saarikoski, P; Van Handel, B; Huang, A; Li, XM; Mikkola, HKA				Magnusson, Mattias; Sierra, Maria I.; Sasidharan, Rajkumar; Prashad, Sacha L.; Romero, Melissa; Saarikoski, Pamela; Van Handel, Ben; Huang, Andy; Li, Xinmin; Mikkola, Hanna K. A.			Expansion on Stromal Cells Preserves the Undifferentiated State of Human Hematopoietic Stem Cells Despite Compromised Reconstitution Ability	PLOS ONE			English	Article							EX-VIVO EXPANSION; SELF-RENEWAL; BONE-MARROW; IN-VITRO; CORD BLOOD; MAINTENANCE; DIFFERENTIATION; QUIESCENCE; LINE; GENE	Lack of HLA-matched hematopoietic stem cells (HSC) limits the number of patients with life-threatening blood disorders that can be treated by HSC transplantation. So far, insufficient understanding of the regulatory mechanisms governing human HSC has precluded the development of effective protocols for culturing HSC for therapeutic use and molecular studies. We defined a culture system using OP9M2 mesenchymal stem cell (MSC) stroma that protects human hematopoietic stem/progenitor cells (HSPC) from differentiation and apoptosis. In addition, it facilitates a dramatic expansion of multipotent progenitors that retain the immunophenotype (CD34+CD38-CD90+) characteristic of human HSPC and proliferative potential over several weeks in culture. In contrast, transplantable HSC could be maintained, but not significantly expanded, during 2-week culture. Temporal analysis of the transcriptome of the ex vivo expanded CD34+CD38-CD90+ cells documented remarkable stability of most transcriptional regulators known to govern the undifferentiated HSC state. Nevertheless, it revealed dynamic fluctuations in transcriptional programs that associate with HSC behavior and may compromise HSC function, such as dysregulation of PBX1 regulated genetic networks. This culture system serves now as a platform for modeling human multilineage hematopoietic stem/progenitor cell hierarchy and studying the complex regulation of HSC identity and function required for successful ex vivo expansion of transplantable HSC.	[Magnusson, Mattias; Sierra, Maria I.; Sasidharan, Rajkumar; Prashad, Sacha L.; Romero, Melissa; Saarikoski, Pamela; Van Handel, Ben; Huang, Andy; Mikkola, Hanna K. A.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90024 USA; [Li, Xinmin] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Mikkola, Hanna K. A.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA; [Mikkola, Hanna K. A.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Mikkola, Hanna K. A.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Mikkola, HKA (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90024 USA.	hmikkola@mcdb.ucla.edu			CIRM New Faculty Award [RN1-00557-1]; NIH [RO1 (HL097766-01)]; Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at UCLA Innovation Award; NIH Ruth L. Kirschstein National Research Service Award (NRSA) [GM007185, T32 (HL086345)]; Whitcome fellowship; Howard Hughes Medical Institute Gilliam fellowship; Swedish Research Council; Tegger Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097766, T32HL086345] Funding Source: NIH RePORTER	CIRM New Faculty Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at UCLA Innovation Award; NIH Ruth L. Kirschstein National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitcome fellowship; Howard Hughes Medical Institute Gilliam fellowship(Howard Hughes Medical Institute); Swedish Research Council(Swedish Research CouncilEuropean Commission); Tegger Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by CIRM New Faculty Award (RN1-00557-1), NIH RO1 (HL097766-01), and Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at UCLA Innovation Award to H.K.A.M. B.V.H. and M.I.S were supported by the NIH Ruth L. Kirschstein National Research Service Award (NRSA, GM007185 and NRSA T32 (HL086345)) and S.L.P. was supported by the Whitcome fellowship and the Howard Hughes Medical Institute Gilliam fellowship. M.M. was supported by the Swedish Research Council and the Tegger Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsellem S, 2003, NAT MED, V9, P1423, DOI 10.1038/nm953; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; AUSTIN GE, 1994, LEUKEMIA LYMPHOMA, V15, P209, DOI 10.3109/10428199409049717; Ball LM, 2007, BLOOD, V110, P2764, DOI 10.1182/blood-2007-04-087056; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Bordignon C, 2006, NATURE, V441, P1100, DOI 10.1038/nature04962; Bryder D, 2000, BLOOD, V96, P1748, DOI 10.1182/blood.V96.5.1748.h8001748_1748_1755; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Buza-Vidas N, 2011, BLOOD, V118, P1291, DOI 10.1182/blood-2011-02-338046; Cai M, 2012, BLOOD, V120, P335, DOI 10.1182/blood-2012-01-403139; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Carvajal LA, 2012, GENE DEV, V26, P1533, DOI 10.1101/gad.184911.111; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; COLLINS LS, 1987, J IMMUNOL, V138, P1082; Danet GH, 2003, J CLIN INVEST, V112, P126, DOI 10.1172/JCI200317669; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; Dorrell C, 2000, BLOOD, V95, P102; Elsbach P, 1998, J LEUKOCYTE BIOL, V64, P14, DOI 10.1002/jlb.64.1.14; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; FUKUDA MN, 1995, GENE DEV, V9, P1199, DOI 10.1101/gad.9.10.1199; Gao JA, 2010, J GENET GENOMICS, V37, P475, DOI 10.1016/S1673-8527(09)60067-9; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hackney JA, 2002, P NATL ACAD SCI USA, V99, P13061, DOI 10.1073/pnas.192124499; Holyoake TL, 1999, EXP HEMATOL, V27, P1418, DOI 10.1016/S0301-472X(99)00078-8; Hope KJ, 2010, CELL STEM CELL, V7, P101, DOI 10.1016/j.stem.2010.06.007; ITOH K, 1989, EXP HEMATOL, V17, P145; Ivanovic Z, 2000, TRANSFUSION, V40, P1482, DOI 10.1046/j.1537-2995.2000.40121482.x; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Jude CD, 2008, CELL CYCLE, V7, P586, DOI 10.4161/cc.7.5.5549; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; Krosl J, 2003, IMMUNITY, V18, P561, DOI 10.1016/S1074-7613(03)00090-6; Ku CJ, 2012, BLOOD, V119, P2242, DOI 10.1182/blood-2011-07-366070; Le Blanc K, 2007, J INTERN MED, V262, P509, DOI 10.1111/j.1365-2796.2007.01844.x; Liu ZG, 2005, CELL RES, V15, P24, DOI 10.1038/sj.cr.7290259; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Mao YL, 2011, GENE DEV, V25, P131, DOI 10.1101/gad.610511; Matsumoto A, 2011, CELL STEM CELL, V9, P262, DOI 10.1016/j.stem.2011.06.014; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Miller CL, 1997, P NATL ACAD SCI USA, V94, P13648, DOI 10.1073/pnas.94.25.13648; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; Moore KA, 1997, BLOOD, V89, P4337, DOI 10.1182/blood.V89.12.4337; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Nakauchi H, 2001, ANN NY ACAD SCI, V938, P18; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Nolta JA, 2002, LEUKEMIA, V16, P352, DOI 10.1038/sj.leu.2402371; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Oostendorp RAJ, 2002, BLOOD, V99, P1183, DOI 10.1182/blood.V99.4.1183; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Pina C, 2008, CELL STEM CELL, V2, P264, DOI 10.1016/j.stem.2008.01.013; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Shimakura Y, 2000, STEM CELLS, V18, P183, DOI 10.1634/stemcells.18-3-183; Shojaei F, 2005, DEV CELL, V8, P651, DOI 10.1016/j.devcel.2005.03.004; Stanevsky A, 2009, BLOOD REV, V23, P199, DOI 10.1016/j.blre.2009.02.001; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; SUDO T, 1993, P NATL ACAD SCI USA, V90, P9125, DOI 10.1073/pnas.90.19.9125; SUTHERLAND HJ, 1989, BLOOD, V74, P1563; Teitell MA, 2006, PEDIATR RES, V59, p33R, DOI 10.1203/01.pdr.0000205155.26315.c7; Vanheusden K, 2007, STEM CELLS, V25, P107, DOI 10.1634/stemcells.2006-0256; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wettenhall JM, 2006, BIOINFORMATICS, V22, P897, DOI 10.1093/bioinformatics/btl025; Zhang CC, 2006, NAT MED, V12, P240, DOI 10.1038/nm1342; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	69	22	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53912	10.1371/journal.pone.0053912	http://dx.doi.org/10.1371/journal.pone.0053912			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342037	Green Published, gold, Green Submitted			2022-12-25	WOS:000313682700063
J	Nielsen, SE; Shafer, ABA; Boyce, MS; Stenhouse, GB				Nielsen, Scott E.; Shafer, Aaron B. A.; Boyce, Mark S.; Stenhouse, Gordon B.			Does Learning or Instinct Shape Habitat Selection?	PLOS ONE			English	Article							GRIZZLY BEARS; SITE FIDELITY; RELATEDNESS; MORTALITY; ECOSYSTEM; ALBERTA; MODELS; TESTS; DIET	Habitat selection is an important behavioural process widely studied for its population-level effects. Models of habitat selection are, however, often fit without a mechanistic consideration. Here, we investigated whether patterns in habitat selection result from instinct or learning for a population of grizzly bears (Ursus arctos) in Alberta, Canada. We found that habitat selection and relatedness were positively correlated in female bears during the fall season, with a trend in the spring, but not during any season for males. This suggests that habitat selection is a learned behaviour because males do not participate in parental care: a genetically predetermined behaviour (instinct) would have resulted in habitat selection and relatedness correlations for both sexes. Geographic distance and home range overlap among animals did not alter correlations indicating that dispersal and spatial autocorrelation had little effect on the observed trends. These results suggest that habitat selection in grizzly bears are partly learned from their mothers, which could have implications for the translocation of wildlife to novel environments.	[Nielsen, Scott E.; Shafer, Aaron B. A.] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [Shafer, Aaron B. A.; Boyce, Mark S.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Stenhouse, Gordon B.] Foothills Res Inst, Hinton, AB, Canada; [Stenhouse, Gordon B.] Alberta Sustainable Resource Dev, Fish & Wildlife Div, Hinton, AB, Canada	University of Alberta; University of Alberta	Nielsen, SE (corresponding author), Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada.	scottn@ualberta.ca	Nielsen, Scott/C-2842-2013; Nielsen, Scott/O-7482-2019; Boyce, Mark S/A-2620-2014	Nielsen, Scott/0000-0002-9754-0630; Nielsen, Scott/0000-0002-9754-0630; Boyce, Mark S/0000-0001-5811-325X; Shafer, Aaron/0000-0001-7652-225X	Natural Sciences and Engineering Research Council of Canada; Alberta Conservation Association; Foothills Research Institute Grizzly Bear Program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Conservation Association; Foothills Research Institute Grizzly Bear Program	The authors thank the Natural Sciences and Engineering Research Council of Canada, the Alberta Conservation Association, and partners from the Foothills Research Institute Grizzly Bear Program for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett A, 2011, ANIM BEHAV, V81, P1039, DOI 10.1016/j.anbehav.2011.02.011; Boyce MS, 2010, PHILOS T R SOC B, V365, P2213, DOI 10.1098/rstb.2010.0080; Breed M, 2010, NATURE ED KNOWL, V1, P10; Cattet MRL, 2003, URSUS-SERIES, V14, P88; Darwin C., 1859, ORIGIN SPECIES MEANS; Davis JM, 2004, TRENDS ECOL EVOL, V19, P411, DOI 10.1016/j.tree.2004.04.006; Dukas Reuven, 1998, P129; Edwards MA, 2009, ANIM BEHAV, V77, P23, DOI 10.1016/j.anbehav.2008.09.025; Frair JL, 2004, J APPL ECOL, V41, P201, DOI 10.1111/j.0021-8901.2004.00902.x; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; JAENIKE J, 1991, AM NAT, V137, pS67, DOI 10.1086/285140; Manly B.F.J., 2002, RESOURCE SELECTION A; MANTEL N, 1967, CANCER RES, V27, P209; Mayr E., 1942, SYSTEMATICS ORIGIN S; McLellan BN, 2011, CAN J ZOOL, V89, P546, DOI 10.1139/Z11-026; McLoughlin PD, 2005, J ANIM ECOL, V74, P701, DOI 10.1111/j.1365-2656.2005.00967.x; McLoughlin PD, 2006, P ROY SOC B-BIOL SCI, V273, P1449, DOI 10.1098/rspb.2006.3486; MINTA SC, 1992, ECOL APPL, V2, P178, DOI 10.2307/1941774; Morris DW, 2011, P ROY SOC B-BIOL SCI, V278, P2401, DOI 10.1098/rspb.2011.0604; Morris DW, 2008, ISR J ECOL EVOL, V54, P287, DOI 10.1560/IJEE.54.3-4.287; Munro RHM, 2006, J MAMMAL, V87, P1112, DOI 10.1644/05-MAMM-A-410R3.1; Mysterud A, 1998, ECOLOGY, V79, P1435, DOI 10.1890/0012-9658(1998)079[1435:FRIHUA]2.0.CO;2; Nielsen SE, 2010, BIOL CONSERV, V143, P1623, DOI 10.1016/j.biocon.2010.04.007; Nielsen SE, 2003, ECOSCIENCE, V10, P1; Nielson SE, 2002, URSUS, V13, P45; Proctor MF, 2004, CAN J ZOOL, V82, P1108, DOI 10.1139/z04-077; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Ridley M, 1999, GENOME; Rode KD, 2001, OECOLOGIA, V128, P62, DOI 10.1007/s004420100637; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schwartz C.C. S.D., 2003, WILD MAMMALS N AM BI, P556; Shafer ABA, 2012, ECOLOGY, V93, P1317; TAYLOR CE, 1978, OECOLOGIA, V37, P69, DOI 10.1007/BF00349992; WECKER SC, 1964, SCI AM, V211, P109, DOI 10.1038/scientificamerican1064-109	36	24	26	1	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53721	10.1371/journal.pone.0053721	http://dx.doi.org/10.1371/journal.pone.0053721			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341983	Green Published, gold			2022-12-25	WOS:000313682700038
J	Szalinski, CM; Guerriero, CJ; Ruiz, WG; Docter, BE; Rbaibi, Y; Pastor-Soler, NM; Apodaca, G; Puthenveedu, MA; Weisz, OA				Szalinski, Christina M.; Guerriero, Christopher J.; Ruiz, Wily G.; Docter, Brianne E.; Rbaibi, Youssef; Pastor-Soler, Nuria M.; Apodaca, Gerard; Puthenveedu, Manojkumar A.; Weisz, Ora A.			PIP5KI beta Selectively Modulates Apical Endocytosis in Polarized Renal Epithelial Cells	PLOS ONE			English	Article							CANINE KIDNEY-CELLS; CLATHRIN-COATED PITS; I PHOSPHATIDYLINOSITOL-4-PHOSPHATE 5-KINASES; POLYMERIC IMMUNOGLOBULIN RECEPTOR; LIPID KINASE FAMILY; MEDIATED ENDOCYTOSIS; PLASMA-MEMBRANE; MDCK CELLS; N-WASP; PHOSPHOINOSITIDE METABOLISM	Localized synthesis of phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5) P-2] at clathrin coated pits (CCPs) is crucial for the recruitment of adaptors and other components of the internalization machinery, as well as for regulating actin dynamics during endocytosis. PtdIns(4,5) P-2 is synthesized from phosphatidylinositol 4-phosphate by any of three phosphatidylinositol 5-kinase type I (PIP5KI) isoforms (alpha, beta or gamma). PIP5KI beta localizes almost exclusively to the apical surface in polarized mouse cortical collecting duct cells, whereas the other isoforms have a less polarized membrane distribution. We therefore investigated the role of PIP5KI isoforms in endocytosis at the apical and basolateral domains. Endocytosis at the apical surface is known to occur more slowly than at the basolateral surface. Apical endocytosis was selectively stimulated by overexpression of PIP5KI beta whereas the other isoforms had no effect on either apical or basolateral internalization. We found no difference in the affinity for PtdIns(4,5) P-2-containing liposomes of the PtdIns(4,5) P-2 binding domains of epsin and Dab2, consistent with a generic effect of elevated PtdIns(4,5) P-2 on apical endocytosis. Additionally, using apical total internal reflection fluorescence imaging and electron microscopy we found that cells overexpressing PIP5KI beta have fewer apical CCPs but more internalized coated structures than control cells, consistent with enhanced maturation of apical CCPs. Together, our results suggest that synthesis of PtdIns(4,5) P-2 mediated by PIP5KI beta is rate limiting for apical but not basolateral endocytosis in polarized kidney cells. PtdIns(4,5) P-2 may be required to overcome specific structural constraints that limit the efficiency of apical endocytosis.	[Szalinski, Christina M.; Ruiz, Wily G.; Rbaibi, Youssef; Pastor-Soler, Nuria M.; Apodaca, Gerard; Weisz, Ora A.] Univ Pittsburgh, Sch Med, Renal Electrolyte Div, Pittsburgh, PA 15260 USA; [Apodaca, Gerard; Weisz, Ora A.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA USA; [Guerriero, Christopher J.] Univ Pittsburgh, Sch Med, Dept Biol Sci, Pittsburgh, PA USA; [Docter, Brianne E.] Grand Valley State Univ, Allendale, MI 49401 USA; [Puthenveedu, Manojkumar A.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Grand Valley State University; Carnegie Mellon University	Weisz, OA (corresponding author), Univ Pittsburgh, Sch Med, Renal Electrolyte Div, Pittsburgh, PA 15260 USA.	weisz@pitt.edu	Apodaca, Gerard/HCJ-0048-2022; Puthenveedu, Manojkumar/A-3795-2016	Szalinski, Christina/0000-0002-5991-5606; Puthenveedu, Manojkumar/0000-0002-3177-4231; Guerriero, Christopher/0000-0002-1046-2300	National Institutes of Health (NIH) [R01 DK064613, DA024698, R37DK54425, T32 DK061296]; Core A of the Pittsburgh Center for Kidney Research [P30 DK079307]; Core C of the Pittsburgh Center for Kidney Research [P30 DK079307]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064613, P30DK079307, R37DK054425, R01DK084184, T32DK061296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA024698] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Core A of the Pittsburgh Center for Kidney Research; Core C of the Pittsburgh Center for Kidney Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health (NIH) grants R01 DK064613 (to OAW), DA024698 (to MAP), R37DK54425 (to GA), and by Cores A and C of the Pittsburgh Center for Kidney Research (P30 DK079307). CMS was supported in part by NIH T32 DK061296. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa Y, 2003, J CELL BIOL, V162, P647, DOI 10.1083/jcb.200212142; ANDERSON JM, 1988, J CELL BIOL, V106, P1141, DOI 10.1083/jcb.106.4.1141; Antonescu CN, 2011, MOL BIOL CELL, V22, P2588, DOI 10.1091/mbc.E11-04-0362; APODACA G, 1991, J CLIN INVEST, V87, P1877, DOI 10.1172/JCI115211; APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; Bairstow SF, 2006, J BIOL CHEM, V281, P20632, DOI 10.1074/jbc.M601465200; Barbieri MA, 2001, J BIOL CHEM, V276, P47212, DOI 10.1074/jbc.C100490200; Benesch S, 2002, J BIOL CHEM, V277, P37771, DOI 10.1074/jbc.M204145200; Benmerah A, 2007, TRAFFIC, V8, P970, DOI 10.1111/j.1600-0854.2007.00585.x; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Boulant S, 2011, NAT CELL BIOL, V13, P1124, DOI 10.1038/ncb2307; BREITFELD PP, 1989, METHOD CELL BIOL, V32, P329; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Cui SS, 2010, AM J PHYSIOL-RENAL, V298, pF335, DOI 10.1152/ajprenal.00453.2009; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Fang L, 2009, J CLIN INVEST, V119, P3278, DOI 10.1172/JCI37950; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Gong F, 2010, AM J PHYSIOL-RENAL, V298, pF1162, DOI 10.1152/ajprenal.00645.2009; GOTTLIEB TA, 1993, J CELL BIOL, V120, P695, DOI 10.1083/jcb.120.3.695; Guerriero CJ, 2006, J BIOL CHEM, V281, P15376, DOI 10.1074/jbc.M601239200; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Haucke V, 2005, BIOCHEM SOC T, V33, P1285, DOI 10.1042/BST0331285; Henkel JR, 1998, MOL BIOL CELL, V9, P2477, DOI 10.1091/mbc.9.9.2477; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; Howard C, 1998, UNBIASED STEREOLOGY; Hyman J, 2000, J CELL BIOL, V149, P537, DOI 10.1083/jcb.149.3.537; Hyman T, 2006, MOL BIOL CELL, V17, P427, DOI 10.1091/mbc.E05-05-0420; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; Ishihara H, 1996, J BIOL CHEM, V271, P23611, DOI 10.1074/jbc.271.39.23611; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; Jost M, 1998, CURR BIOL, V8, P1399, DOI 10.1016/S0960-9822(98)00022-0; Khandelwal P, 2010, EMBO J, V29, P1961, DOI 10.1038/emboj.2010.91; Krauss M, 2006, P NATL ACAD SCI USA, V103, P11934, DOI 10.1073/pnas.0510306103; LEBIVIC A, 1991, J CELL BIOL, V115, P607, DOI 10.1083/jcb.115.3.607; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Loijens JC, 1996, J BIOL CHEM, V271, P32937, DOI 10.1074/jbc.271.51.32937; Lokuta MA, 2007, MOL BIOL CELL, V18, P5069, DOI 10.1091/mbc.E07-05-0428; Mao YS, 2009, J CELL BIOL, V184, P281, DOI 10.1083/jcb.200806121; Maples CJ, 1997, J BIOL CHEM, V272, P6741, DOI 10.1074/jbc.272.10.6741; Martin-Belmonte F, 2007, CELL CYCLE, V6, P1957, DOI 10.4161/cc.6.16.4583; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Mundell SJ, 2006, TRAFFIC, V7, P1420, DOI 10.1111/j.1600-0854.2006.00469.x; Nagai M, 2003, MOL BIOL CELL, V14, P4984, DOI 10.1091/mbc.E03-06-0385; NAIM HY, 1995, J CELL BIOL, V129, P1241, DOI 10.1083/jcb.129.5.1241; Oleinikov AV, 2000, BIOCHEM J, V347, P613, DOI 10.1042/0264-6021:3470613; Oztan Asli, 2008, V440, P157, DOI 10.1007/978-1-59745-178-9_12; Padron D, 2003, J CELL BIOL, V162, P693, DOI 10.1083/jcb.200302051; Potter BA, 2006, TRAFFIC, V7, P146, DOI 10.1111/j.1600-0854.2005.00371.x; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Rappoport JZ, 2006, AM J PHYSIOL-CELL PH, V291, pC1072, DOI 10.1152/ajpcell.00160.2006; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rohde G, 2002, J CELL BIOL, V158, P209, DOI 10.1083/jcb.200203103; Rojas R, 2002, NAT REV MOL CELL BIO, V3, P944, DOI 10.1038/nrm972; Rojas R, 2001, MOL BIOL CELL, V12, P2257, DOI 10.1091/mbc.12.8.2257; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Russ J.C., 2000, PRACTICAL STEREOLOGY, V2nd ed.; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Stolt PC, 2003, STRUCTURE, V11, P569, DOI 10.1016/S0969-2126(03)00068-6; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Vasudevan KM, 2011, CURR TOP MICROBIOL, V347, P105, DOI 10.1007/82_2010_66; Volpicelli-Daley LA, 2010, J BIOL CHEM, V285, P28708, DOI 10.1074/jbc.M110.132191; Wang YF, 2008, P NATL ACAD SCI USA, V105, P14064, DOI 10.1073/pnas.0804139105; Weixel KM, 2007, J BIOL CHEM, V282, P36534, DOI 10.1074/jbc.M703970200; Wen PJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1500; Zheng J, 1996, J MOL BIOL, V255, P14, DOI 10.1006/jmbi.1996.0002; Zoncu R, 2007, P NATL ACAD SCI USA, V104, P3793, DOI 10.1073/pnas.0611733104	80	11	11	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53790	10.1371/journal.pone.0053790	http://dx.doi.org/10.1371/journal.pone.0053790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342003	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000313682700046
J	Albuquerque, D; Nobrega, C; Manco, L				Albuquerque, David; Nobrega, Clevio; Manco, Licinio			Association of FTO Polymorphisms with Obesity and Obesity-Related Outcomes in Portuguese Children	PLOS ONE			English	Article							BODY-MASS INDEX; GENOME-WIDE ASSOCIATION; EARLY-ONSET; COMMON VARIATION; FAT MASS; GENE; RISK; POPULATION; PREVALENCE; CHILDHOOD	Background: Several studies have reported an association between single nucleotide polymorphisms in the first intron of the FTO gene and body mass index (BMI) or obesity. However, this association has not yet been studied among the Portuguese population. This study aims to assess the association of three FTO polymorphisms (rs1861868, rs1421085 and rs9939609) with obesity-related outcomes in a sample of Portuguese children. Methods: We examined a total of 730 children, 256 normal-weight (55.9% girls), 320 overweight (45.3% girls) and 154 obese (53.2% girls), aging from 6 to 12-years-old, recruited randomly from public schools in the central region of Portugal. DNA samples were genotyped for the three polymorphisms by allelic discrimination TaqMan assay. Association of the FTO polymorphisms with several anthropometric traits was investigated. Additionally, we tested association with the risk of obesity using overweight and obese vs. normal-weight children. Results: We found significant associations of rs9939609 and rs1421085 polymorphisms with weight, BMI, BMI Z-score, waist circumference and hip circumference, even after age and gender adjustment (p<0.05 in all traits). For rs1861868 polymorphism, marginally significant associations were obtained with weight (p = 0.081) and BMI (p = 0.096) after adjustment for age and gender. In case-control studies, both rs9939609 and rs1421085 polymorphisms were significantly associated with obesity (OR 1.97; 95% CI, 1.08-3.59; p = 0.026; OR 2.11; 95% CI, 1.17-3.81; p = 0.013, respectively) but not with overweight (p>0.05). Haplotype analyses identified two combinations (ACA and GCA) associated with a higher risk of obesity (OR 1.53; 95% CI, 1.06-2.22; p = 0.023; OR 1.73; 95% CI, 1.06-2.87; p = 0.030, respectively). Conclusions: This study provides the first evidence for the association of FTO polymorphisms with anthropometric traits and risk of obesity in Portuguese children.	[Albuquerque, David; Manco, Licinio] Univ Coimbra, Dept Life Sci, Res Ctr Anthropol & Hlth CIAS, Coimbra, Portugal; [Nobrega, Clevio] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra	Manco, L (corresponding author), Univ Coimbra, Dept Life Sci, Res Ctr Anthropol & Hlth CIAS, Coimbra, Portugal.	lmanco@antrop.uc.pt	Manco, Licinio/M-4746-2013; Nobrega, Clévio/M-6047-2013; Albuquerque, David/S-5586-2017	Manco, Licinio/0000-0002-2636-0288; Nobrega, Clévio/0000-0002-8312-5292; Albuquerque, David/0000-0001-8899-9020	Research Centre for Anthropology and Health (CIAS); University of Coimbra; FCT [PEst-OE/SADG/UI0283/2011, SFRH/BD/68774/2010]	Research Centre for Anthropology and Health (CIAS); University of Coimbra; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was performed with the support of the Research Centre for Anthropology and Health (CIAS), University of Coimbra and FCT (PEst-OE/SADG/UI0283/2011). David Albuquerque has a PhD grant (SFRH/BD/68774/2010) from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque D, 2012, ACTA MEDICA PORT, V25, P169; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Chang YC, 2008, DIABETES, V57, P2245, DOI 10.2337/db08-0377; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cook S, 2003, ARCH PEDIAT ADOL MED, V157, P821, DOI 10.1001/archpedi.157.8.821; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fang HY, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-136; Fawcett KA, 2010, TRENDS GENET, V26, P266, DOI 10.1016/j.tig.2010.02.006; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Freathy RM, 2008, DIABETES, V57, P1419, DOI 10.2337/db07-1466; Gonzalez JR, 2012, OBESITY, V20, P909, DOI 10.1038/oby.2011.325; Grant SFA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001746; Hetherington MM, 2010, FORUM NUTR, V63, P195, DOI 10.1159/000264407; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Hotta K, 2008, J HUM GENET, V53, P546, DOI 10.1007/s10038-008-0283-1; Karns R, 2012, ANN HUM GENET, V76, P17, DOI 10.1111/j.1469-1809.2011.00686.x; Liu Y, 2010, OBESITY, V18, P1619, DOI 10.1038/oby.2009.469; Loos RJF, 2012, BEST PRACT RES CL EN, V26, P211, DOI 10.1016/j.beem.2011.11.003; Macekova S, 2012, AM J PHYS ANTHROPOL, V147, P30, DOI 10.1002/ajpa.21604; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Neel JV, 1962, B WORLD HEALTH ORGAN, V77, P694; Ohashi J, 2007, J HUM GENET, V52, P1031, DOI 10.1007/s10038-007-0198-2; Padez C, 2004, AM J HUM BIOL, V16, P670, DOI 10.1002/ajhb.20080; Paquot N, 2012, Rev Med Liege, V67, P332; Price RA, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-4; Rampersaud E, 2008, ARCH INTERN MED, V168, P1791, DOI 10.1001/archinte.168.16.1791; Rodriguez-Lopez Raquel, 2010, Endocrinol Nutr, V57, P203, DOI 10.1016/j.endonu.2010.03.002; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Song YQ, 2008, OBESITY, V16, P2472, DOI 10.1038/oby.2008.408; Tung YCL, 2011, ANN NY ACAD SCI, V1220, P162, DOI 10.1111/j.1749-6632.2010.05903.x; Weber WW, 1999, MOL DIAGN, V4, P299, DOI 10.1016/S1084-8592(99)80006-X; Zavattari P, 2011, ANN HUM GENET, V75, P648, DOI 10.1111/j.1469-1809.2011.00674.x	33	38	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54370	10.1371/journal.pone.0054370	http://dx.doi.org/10.1371/journal.pone.0054370			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342142	Green Submitted, Green Published, gold			2022-12-25	WOS:000314759400157
J	Xiang, RD; Ghanipoor-Samami, M; Johns, WH; Eindorf, T; Rutley, DL; Kruk, ZA; Fitzsimmons, CJ; Thomsen, DA; Roberts, CT; Burns, BM; Anderson, GI; Greenwood, PL; Hiendleder, S				Xiang, Ruidong; Ghanipoor-Samami, Mani; Johns, William H.; Eindorf, Tanja; Rutley, David L.; Kruk, Zbigniew A.; Fitzsimmons, Carolyn J.; Thomsen, Dana A.; Roberts, Claire T.; Burns, Brian M.; Anderson, Gail I.; Greenwood, Paul L.; Hiendleder, Stefan			Maternal and Paternal Genomes Differentially Affect Myofibre Characteristics and Muscle Weights of Bovine Fetuses at Midgestation	PLOS ONE			English	Article							MEAT QUALITY TRAITS; SKELETAL-MUSCLE; BOS-TAURUS; CARCASS TRAITS; PHENOTYPIC CHARACTERIZATION; RECIPROCAL DIFFERENCES; POLAR OVERDOMINANCE; GENETIC-PARAMETERS; EPIGENETIC CONTROL; EMBRYO-TRANSFER	Postnatal myofibre characteristics and muscle mass are largely determined during fetal development and may be significantly affected by epigenetic parent-of-origin effects. However, data on such effects in prenatal muscle development that could help understand unexplained variation in postnatal muscle traits are lacking. In a bovine model we studied effects of distinct maternal and paternal genomes, fetal sex, and non-genetic maternal effects on fetal myofibre characteristics and muscle mass. Data from 73 fetuses (Day153, 54% term) of four genetic groups with purebred and reciprocal cross Angus and Brahman genetics were analyzed using general linear models. Parental genomes explained the greatest proportion of variation in myofibre size of Musculus semitendinosus (80-96%) and in absolute and relative weights of M. supraspinatus, M. longissimus dorsi, M. quadriceps femoris and M. semimembranosus (82-89% and 56-93%, respectively). Paternal genome in interaction with maternal genome (P<0.05) explained most genetic variation in cross sectional area (CSA) of fast myotubes (68%), while maternal genome alone explained most genetic variation in CSA of fast myofibres (93%, P<0.01). Furthermore, maternal genome independently (M. semimembranosus, 88%, P<0.0001) or in combination (M. supraspinatus, 82%; M. longissimus dorsi, 93%; M. quadriceps femoris, 86%) with nested maternal weight effect (5-6%, P<0.05), was the predominant source of variation for absolute muscle weights. Effects of paternal genome on muscle mass decreased from thoracic to pelvic limb and accounted for all (M. supraspinatus, 97%, P<0.0001) or most (M. longissimus dorsi, 69%, P<0.0001; M. quadriceps femoris, 54%, P<0.001) genetic variation in relative weights. An interaction between maternal and paternal genomes (P<0.01) and effects of maternal weight (P<0.05) on expression of H19, a master regulator of an imprinted gene network, and negative correlations between H19 expression and fetal muscle mass (P<0.001), suggested imprinted genes and miRNA interference as mechanisms for differential effects of maternal and paternal genomes on fetal muscle.	[Xiang, Ruidong; Ghanipoor-Samami, Mani; Eindorf, Tanja; Rutley, David L.; Kruk, Zbigniew A.; Fitzsimmons, Carolyn J.; Thomsen, Dana A.; Anderson, Gail I.; Hiendleder, Stefan] Univ Adelaide, Sch Anim & Vet Sci, JS Davies Nonmendelian Genet Grp, Adelaide, SA 5005, Australia; [Xiang, Ruidong; Ghanipoor-Samami, Mani; Thomsen, Dana A.; Roberts, Claire T.; Hiendleder, Stefan] Univ Adelaide, Robinson Inst, Adelaide, SA 5005, Australia; [Johns, William H.; Greenwood, Paul L.] Univ New England, NSW Dept Primary Ind, Beef Ind Ctr, Armidale, NSW, Australia; [Roberts, Claire T.] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA 5005, Australia; [Burns, Brian M.] Univ Queensland, Ctr Anim Sci, Queensland Alliance Agr & Food Innovat, Rockhampton, Qld, Australia	University of Adelaide; Robinson Research Institute; University of Adelaide; NSW Department of Primary Industries; University of New England; University of Adelaide; University of Queensland	Hiendleder, S (corresponding author), Univ Adelaide, Sch Anim & Vet Sci, JS Davies Nonmendelian Genet Grp, Roseworthy Campus, Adelaide, SA 5005, Australia.	stefan.hiendleder@adelaide.edu.au	Xiang, Ruidong/A-5773-2015; Xiang, Ruidong/AAF-1071-2020; Greenwood, Paul L/G-9747-2013	Greenwood, Paul L/0000-0002-7719-8233; Roberts, Claire/0000-0002-9250-2192; Xiang, Ruidong/0000-0002-1584-7605	JS Davies Bequest; Queensland Government through the Department of Agriculture, Fisheries and Forestry's Reinvestment Fund; China Scholarship Council; University of Adelaide; Iranian Ministry of Science, Research Technology	JS Davies Bequest; Queensland Government through the Department of Agriculture, Fisheries and Forestry's Reinvestment Fund(Australian GovernmentDepartment of Agriculture and Water Resources); China Scholarship Council(China Scholarship Council); University of Adelaide; Iranian Ministry of Science, Research Technology	This work was funded by the JS Davies Bequest with support from the Queensland Government through the Department of Agriculture, Fisheries and Forestry's Reinvestment Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RX is a recipient of China scholarship and Adelaide University China Fee Scholarship provided by China Scholarship Council and The University of Adelaide. MG-S is recipient of a PhD scholarship from the Iranian Ministry of Science, Research & Technology. SH is a JS Davies Fellow. CTR is a NHMRC Senior Research Fellow (APP1020749). We would like to thank Mick Deland, John Cooper and Struan Research Centre farm staff (SARDI) for animal management, Sarah Truran and David Lines for assistance in fetus collection and Lin Lin for help with figures.	Adams GR, 2002, J APPL PHYSIOL, V93, P1159, DOI 10.1152/japplphysiol.01264.2001; Amen TS, 2007, J ANIM SCI, V85, P365, DOI 10.2527/jas.2005-754; Amen TS, 2007, J ANIM SCI, V85, P373, DOI 10.2527/jas.2005-755; Anand-Ivell R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019821; ANTHONY RV, 1986, J ANIM SCI, V62, P1375, DOI 10.2527/jas1986.6251375x; Arden NK, 1997, J BONE MINER RES, V12, P2076, DOI 10.1359/jbmr.1997.12.12.2076; Baar K, 2010, ACTA PHYSIOL, V199, P477, DOI 10.1111/j.1748-1716.2010.02121.x; Bentzinger C. F., 2012, COLD SPRING HARBOR P, V4; Boysen TJ, 2010, J ANIM SCI, V88, P3167, DOI 10.2527/jas.2009-2565; Brand-Saberi B, 2005, ANN ANAT, V187, P199, DOI 10.1016/j.aanat.2004.12.018; Budras K.-D., 2003, BOVINE ANATOMY, V1st; Byrne K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-378; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Caiment F, 2010, GENOME RES, V20, P1651, DOI 10.1101/gr.108787.110; Canavez FC, 2012, J HERED, V103, P342, DOI 10.1093/jhered/esr153; Carpenter E, 1996, J ANIM SCI, V74, P388; Chang KC, 2007, ANIMAL, V1, P681, DOI 10.1017/S1751731107702070; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cockett N, 2005, GENETICS SELECTION E, V37, P1; Cockett NE, 1996, SCIENCE, V273, P236, DOI 10.1126/science.273.5272.236; Crist CG, 2009, CELL CYCLE, V8, P3627, DOI 10.4161/cc.8.22.9960; DANIEL PM, 1977, LANCET, V2, P446; DAVIES SM, 1994, CANCER RES, V54, P2560; Davis E, 2004, CURR BIOL, V14, P1858, DOI 10.1016/j.cub.2004.09.079; Dindot SV, 2004, MAMM GENOME, V15, P966, DOI 10.1007/s00335-004-2407-z; Du M, 2010, J ANIM SCI, V88, pE51, DOI 10.2527/jas.2009-2311; Du M, 2010, BIOL REPROD, V82, P4, DOI 10.1095/biolreprod.109.077099; DWYER CM, 1994, J ANIM SCI, V72, P911, DOI 10.2527/1994.724911x; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Engellandt T, 2002, J ANIM BREED GENET, V119, P154, DOI 10.1046/j.1439-0388.2002.00323.x; FERRELL CL, 1991, J ANIM SCI, V69, P1945, DOI 10.2527/1991.6951945x; FORTIN A, 1987, J AGR SCI, V108, P141, DOI 10.1017/S0021859600064212; Gabory A, 2006, CYTOGENET GENOME RES, V113, P188, DOI 10.1159/000090831; Gabory A, 2010, BIOESSAYS, V32, P473, DOI 10.1002/bies.200900170; Ge YJ, 2011, CELL CYCLE, V10, P441, DOI 10.4161/cc.10.3.14710; Goodall JJ, 2007, ANIM GENET, V38, P154, DOI 10.1111/j.1365-2052.2007.01576.x; Greenwood PL, 2007, AUST J EXP AGR, V47, P1137, DOI 10.1071/EA06324; Greenwood PL, 2009, J ANIM SCI, V87, P3114, DOI 10.2527/jas.2009-1936; Greenwood PL, 2006, AUST J AGR RES, V57, P1, DOI 10.1071/AR04316; Greenwood PL, 1999, REPROD FERT DEVELOP, V11, P281, DOI 10.1071/RD99054; Hiendleder S, 2008, CYTOGENET GENOME RES, V120, P150, DOI 10.1159/000118756; Hiendleder S, 2004, BIOL REPROD, V70, P1196, DOI 10.1095/biolreprod.103.023028; Hiendleder S, 2004, REPROD FERT DEVELOP, V17, P204; Jackson SP, 1997, J ANIM SCI, V75, P133; Jeon JT, 1999, NAT GENET, V21, P157, DOI 10.1038/5938; Keniry A, 2012, NAT CELL BIOL, V14, P659, DOI 10.1038/ncb2521; Kim KS, 2004, MAMM GENOME, V15, P552, DOI 10.1007/s00335-004-2341-0; Koohmaraie M, 1995, J ANIM SCI, V73, P3596; Larzul C, 1997, J ANIM SCI, V75, P3126; Lee RSF, 2002, GENE, V301, P67, DOI 10.1016/S0378-1119(02)01085-5; Lin WL, 1999, MECH DEVELOP, V82, P195, DOI 10.1016/S0925-4773(99)00009-X; Mannen H, 1998, J ANIM SCI, V76, P36; Mansan Gordo DG, 2012, J ANIMAL SCI; Martyn JK, 2004, ANAT REC PART A, V281A, P1363, DOI 10.1002/ar.a.20140; McLaren RJ, 1999, MAMM GENOME, V10, P588, DOI 10.1007/s003359901050; Merrick D, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-65; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; NELDER JA, 1994, STAT COMPUT, V4, P221, DOI 10.1007/BF00156745; Neugebauer N, 2010, ANIMAL, V4, P672, DOI 10.1017/S1751731109991625; Neugebauer N, 2010, J ANIM SCI, V88, P523, DOI 10.2527/jas.2009-2026; Nezer C, 1999, NAT GENET, V21, P155, DOI 10.1038/5935; Nicoll G.B., 1998, P 6 WORLD C GEN APPL, V26, P529, DOI 10.13140/2.1.1379.9684; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Picard B, 2002, REPROD NUTR DEV, V42, P415, DOI 10.1051/rnd:2002035; Picard B, 1998, HISTOCHEM J, V30, P473, DOI 10.1023/A:1003207922944; PICARD B, 1994, J MUSCLE RES CELL M, V15, P473, DOI 10.1007/BF00122120; Rehfeldt C., 1999, BASIC APPL MYOL, V9, P235; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Relaix F, 2006, CELL MOL LIFE SCI, V63, P1221, DOI 10.1007/s00018-006-6015-9; Reverter A, 2003, AUST J AGR RES, V54, P119, DOI [10.1071/AR02086, 10.1071/AR02088]; Santos VAC, 2007, MEAT SCI, V77, P654, DOI 10.1016/j.meatsci.2007.05.019; Sawitzky M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039711; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Scott W, 2001, PHYS THER, V81, P1810, DOI 10.1093/ptj/81.11.1810; Seeman E, 1996, AM J PHYSIOL-ENDOC M, V270, pE320, DOI 10.1152/ajpendo.1996.270.2.E320; SEIDEMAN SC, 1986, MEAT SCI, V17, P55, DOI 10.1016/0309-1740(86)90083-5; SHAW RG, 1993, ECOLOGY, V74, P1638, DOI 10.2307/1939922; SIMONEAU JA, 1995, FASEB J, V9, P1091, DOI 10.1096/fasebj.9.11.7649409; Smith T, 2007, J ANIM SCI, V85, P1377, DOI 10.2527/jas.2006-653; Strydom PE, 2010, ANIMAL, V4, P653, DOI 10.1017/S1751731109991479; TOTLAND GK, 1991, ANAT EMBRYOL, V184, P441, DOI 10.1007/BF01236050; UTTARO BE, 1993, J ANIM SCI, V71, P2439, DOI 10.2527/1993.7192439x; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; WHIPPLE G, 1990, J ANIM SCI, V68, P2716; White JD, 2008, DIFFERENTIATION, V76, P283, DOI 10.1111/j.1432-0436.2007.00208.x; Wolf JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000091; Wolfe RR, 2006, AM J CLIN NUTR, V84, P475, DOI 10.1093/ajcn/84.3.475; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769; Zhu MJ, 2004, BIOL REPROD, V71, P1968, DOI 10.1095/biolreprod.104.034561; [No title captured]	92	7	7	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53402	10.1371/journal.pone.0053402	http://dx.doi.org/10.1371/journal.pone.0053402			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341941	Green Published, gold, Green Accepted			2022-12-25	WOS:000314759400043
J	Numata, Y; Morimura, T; Nakamura, S; Hirano, E; Kure, S; Goto, Y; Inoue, K				Numata, Yurika; Morimura, Toshifumi; Nakamura, Shoko; Hirano, Eriko; Kure, Shigeo; Goto, Yu-ich; Inoue, Ken			Depletion of Molecular Chaperones from the Endoplasmic Reticulum and Fragmentation of the Golgi Apparatus Associated with Pathogenesis in Pelizaeus-Merzbacher Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; PROTEOLIPID PROTEIN; CELL-DEATH; QUALITY-CONTROL; ER STRESS; MYELIN PROTEIN; POINT MUTATION; MOUSE; TRAFFICKING; CALNEXIN	Missense mutations in the proteolipid protein 1 (PLP1) gene cause a wide spectrum of hypomyelinating disorders, from mild spastic paraplegia type 2 to severe Pelizaeus-Merzbacher disease (PMD). Mutant PLP1 accumulates in the endoplasmic reticulum (ER) and induces ER stress. However, the link between the clinical severity of PMD and the cellular response induced by mutant PLP1 remains largely unknown. Accumulation of misfolded proteins in the ER generally leads to up-regulation of ER chaperones to alleviate ER stress. Here, we found that expression of the PLP1-A243V mutant, which causes severe disease, depletes some ER chaperones with a KDEL (Lys-Asp-Glu-Leu) motif, in HeLa cells, MO3.13 oligodendrocytic cells, and primary oligodendrocytes. The same PLP1 mutant also induces fragmentation of the Golgi apparatus (GA). These organelle changes are less prominent in cells with milder disease-associated PLP1 mutants. Similar changes are also observed in cells expressing another disease-causing gene that triggers ER stress, as well as in cells treated with brefeldin A, which induces ER stress and GA fragmentation by inhibiting GA to ER trafficking. We also found that mutant PLP1 disturbs localization of the KDEL receptor, which transports the chaperones with the KDEL motif from the GA to the ER. These data show that PLP1 mutants inhibit GA to ER trafficking, which reduces the supply of ER chaperones and induces GA fragmentation. We propose that depletion of ER chaperones and GA fragmentation induced by mutant misfolded proteins contribute to the pathogenesis of inherited ER stress-related diseases and affect the disease severity.	[Numata, Yurika; Morimura, Toshifumi; Nakamura, Shoko; Hirano, Eriko; Goto, Yu-ich; Inoue, Ken] NCNP, Dept Mental Retardat & Birth Defect Res, Natl Inst Neurosci, Kodaira, Tokyo 1878502, Japan; [Numata, Yurika; Kure, Shigeo] Tohoku Univ, Sch Med, Dept Pediat, Sendai, Miyagi 9808574, Japan; [Morimura, Toshifumi] Shiga Univ Med Sci, Mol Neurosci Res Ctr, Unit Neurobiol & Therapeut, Otsu, Shiga 5202192, Japan	National Center for Neurology & Psychiatry - Japan; Tohoku University; Shiga University of Medical Science	Inoue, K (corresponding author), NCNP, Dept Mental Retardat & Birth Defect Res, Natl Inst Neurosci, 4-1-1 Ogawahigashi Machi, Kodaira, Tokyo 1878502, Japan.	kinoue@ncnp.go.jp			Health and Labor Sciences Research Grants, Research on Intractable Diseases [H24-Nanchitou-Ippan-072]; Takeda Science Foundation; Ministry of Education, Culture, Sports, Science and Technology, Japan [KAKENHI: 21390103, 23659531, 23580417]; Grants-in-Aid for Scientific Research [23659531, 23580417] Funding Source: KAKEN	Health and Labor Sciences Research Grants, Research on Intractable Diseases; Takeda Science Foundation(Takeda Science Foundation (TSF)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Health and Labor Sciences Research Grants, Research on Intractable Diseases H24-Nanchitou-Ippan-072 (to K. I.), a grant from Takeda Science Foundation (to K. I.), and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, KAKENHI: 21390103 and 23659531 (to K. I.) and 23580417 (to T. M.).	Abematsu M, 2006, J NEUROSCI RES, V83, P731, DOI 10.1002/jnr.20762; Anders N, 2008, CELL MOL LIFE SCI, V65, P3433, DOI 10.1007/s00018-008-8227-7; Bernard-Marissal N, 2012, J NEUROSCI, V32, P4901, DOI 10.1523/JNEUROSCI.5431-11.2012; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Citterio C, 2008, P NATL ACAD SCI USA, V105, P2877, DOI 10.1073/pnas.0712224105; D'Antonio M, 2009, J NEUROSCI RES, V87, P3241, DOI 10.1002/jnr.22066; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dickson KM, 2002, P NATL ACAD SCI USA, V99, P9852, DOI 10.1073/pnas.152621799; Ellgaard L, 2003, CELL BIOCHEM BIOPHYS, V39, P223, DOI 10.1385/CBB:39:3:223; GENCIC S, 1990, J NEUROSCI, V10, P117; Gow A, 1998, J CELL BIOL, V140, P925, DOI 10.1083/jcb.140.4.925; Gow A, 2003, NEUROMOL MED, V4, P73, DOI 10.1385/NMM:4:1-2:73; Gow A, 1996, NAT GENET, V13, P422, DOI 10.1038/ng0896-422; GRIFFITHS G, 1994, J CELL BIOL, V127, P1557, DOI 10.1083/jcb.127.6.1557; Higa A, 2012, CELL SIGNAL, V24, P1548, DOI 10.1016/j.cellsig.2012.03.011; Inoue K, 2005, NEUROGENETICS, V6, P1, DOI 10.1007/s10048-004-0207-y; Ionasescu VV, 1997, MUSCLE NERVE, V20, P97, DOI 10.1002/(SICI)1097-4598(199701)20:1<97::AID-MUS13>3.0.CO;2-Z; Jaronen M, 2013, HUM MOL GENET, V22, P646, DOI 10.1093/hmg/dds472; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Khajavi M, 2005, AM J HUM GENET, V77, P841, DOI 10.1086/497541; KOBAYASHI H, 1994, NAT GENET, V7, P351, DOI 10.1038/ng0794-351; Koizume S, 2006, NEUROSCIENCE, V141, P1861, DOI 10.1016/j.neuroscience.2006.05.067; Lane JD, 2002, J CELL BIOL, V156, P495, DOI 10.1083/jcb.200110007; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Marie M, 2008, CELL MOL LIFE SCI, V65, P2859, DOI 10.1007/s00018-008-8355-0; Morimura T, 2005, J BIOL CHEM, V280, P16901, DOI 10.1074/jbc.M409048200; Morimura T, 2009, BRAIN RES, V1304, P26, DOI 10.1016/j.brainres.2009.09.087; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nakagomi S, 2008, NEUROBIOL DIS, V29, P221, DOI 10.1016/j.nbd.2007.08.015; Quarles RH, 2002, CELL MOL LIFE SCI, V59, P1851, DOI 10.1007/PL00012510; Roboti P, 2009, J CELL SCI, V122, P3942, DOI 10.1242/jcs.055160; SCHNEIDER A, 1992, NATURE, V358, P758, DOI 10.1038/358758a0; Shinde VM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033266; Southwood CM, 2002, NEURON, V36, P585, DOI 10.1016/S0896-6273(02)01045-0; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; SUTER U, 1992, P NATL ACAD SCI USA, V89, P4382, DOI 10.1073/pnas.89.10.4382; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; Sutterlin C, 2002, CELL, V109, P359, DOI 10.1016/S0092-8674(02)00720-1; Swanton E, 2003, EMBO J, V22, P2948, DOI 10.1093/emboj/cdg300; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Warner LE, 1999, ANNU REV MED, V50, P263, DOI 10.1146/annurev.med.50.1.263; Yamamoto K, 2001, EMBO J, V20, P3082, DOI 10.1093/emboj/20.12.3082; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yamamoto T, 1998, AM J MED GENET, V75, P439, DOI 10.1002/(SICI)1096-8628(19980203)75:4<439::AID-AJMG19>3.0.CO;2-P; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yu LH, 2012, MOL GENET METAB, V106, P108, DOI 10.1016/j.ymgme.2012.02.016; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	53	22	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7451	7466		10.1074/jbc.M112.435388	http://dx.doi.org/10.1074/jbc.M112.435388			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23344956	hybrid, Green Published			2022-12-25	WOS:000316455300003
J	Lin, RK; Ho, CW; Liu, LF; Lyu, YL				Lin, Ren-Kuo; Ho, Chia-Wen; Liu, Leroy F.; Lyu, Yi Lisa			Topoisomerase II beta Deficiency Enhances Camptothecin-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; STRAND BREAK REPAIR; DNA TOPOISOMERASE; CELL-CYCLE; CLEAVABLE COMPLEXES; GENE-EXPRESSION; TRANSCRIPTION; DEGRADATION; INVOLVEMENT; PATHWAY	Camptothecin (CPT), a topoisomerase (Top) I-targeting drug that stabilizes Top1-DNA covalent adducts, can induce S-phase-specific cytotoxicity due to the arrest of progressing replication forks. However, CPT-induced non-S-phase cytotoxicity is less well characterized. In this study, we have identified topoisomerase II beta (Top2 beta) as a specific determinant for CPT sensitivity, but not for many other cytotoxic agents, in non-S-phase cells. First, quiescent mouse embryonic fibroblasts (MEFs) lacking Top2 beta were shown to be hypersensitive to CPT with prominent induction of apoptosis. Second, ICRF-187, a Top2 catalytic inhibitor known to deplete Top2 beta, specifically sensitized MEFs to CPT. To explore the molecular basis for CPT hypersensitivity in Top2 beta-deficient cells, we found that upon CPT exposure, the RNA polymerase II large subunit (RNAP LS) became progressively depleted, followed by recovery to nearly the original level in wild-type MEFs, whereas RNAP LS remained depleted without recovery in Top2 beta-deficient cells. Concomitant with the reduction of the RNAP LS level, the p53 protein level was greatly induced. Interestingly, RNAPLS depletion has been well documented to lead to p53-dependent apoptosis. Altogether, our findings support a model in which Top2 beta deficiency promotes CPT-induced apoptosis in quiescent non-S-phase cells, possibly due to RNAP LS depletion and p53 accumulation.	[Lin, Ren-Kuo; Ho, Chia-Wen; Liu, Leroy F.; Lyu, Yi Lisa] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Lyu, YL (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, 675 Hoes Lane, Piscataway, NJ 08854 USA.	lyuyi@umdnj.edu		Liu, Leroy/0000-0001-9396-763X	National Institutes of Health Grant [R01 CA039662]; Department of Defense Idea Award [W81XWH-07-1-0407]; NATIONAL CANCER INSTITUTE [R01CA039662, P30CA072720] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Idea Award(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by an National Institutes of Health Grant R01 CA039662 (to L. F. L.) and a Department of Defense Idea Award W81XWH-07-1-0407 (to Y. L. L.).	Arima Y, 2005, J BIOL CHEM, V280, P19166, DOI 10.1074/jbc.M410691200; Austin CA, 1998, BIOESSAYS, V20, P215, DOI 10.1002/(SICI)1521-1878(199803)20:3<215::AID-BIES5>3.0.CO;2-Q; Azarova AM, 2007, P NATL ACAD SCI USA, V104, P11014, DOI 10.1073/pnas.0704002104; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; BRILL SJ, 1987, NATURE, V326, P414, DOI 10.1038/326414a0; BRILL SJ, 1988, CELL, V54, P403, DOI 10.1016/0092-8674(88)90203-6; CAPRANICO G, 1992, BIOCHIM BIOPHYS ACTA, V1132, P43, DOI 10.1016/0167-4781(92)90050-A; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Champoux JJ, 2000, ANN NY ACAD SCI, V922, P56; DARPA P, 1990, CANCER RES, V50, P6919; Das BB, 2009, EMBO J, V28, P3667, DOI 10.1038/emboj.2009.302; Desai SD, 2003, MOL CELL BIOL, V23, P2341, DOI 10.1128/MCB.23.7.2341-2350.2003; Desai SD, 1997, J BIOL CHEM, V272, P24159, DOI 10.1074/jbc.272.39.24159; Desai SD, 2001, CANCER RES, V61, P5926; Desai SD, 2008, MOL CANCER THER, V7, P1430, DOI 10.1158/1535-7163.MCT-07-2345; Durand-Dubief M, 2010, EMBO J, V29, P2126, DOI 10.1038/emboj.2010.109; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; Enokido Y, 1996, EUR J NEUROSCI, V8, P1812, DOI 10.1111/j.1460-9568.1996.tb01325.x; Fiorani P, 2004, J BIOL CHEM, V279, P21271, DOI 10.1074/jbc.M312338200; French SL, 2011, MOL CELL BIOL, V31, P482, DOI 10.1128/MCB.00589-10; Hamilton NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015387; HSIANG YH, 1988, CANCER RES, V48, P3230; HSIANG YH, 1989, CANCER RES, V49, P5077; Interthal H, 2005, EMBO J, V24, P2224, DOI 10.1038/sj.emboj.7600694; Interthal H, 2011, BIOCHEM J, V436, P559, DOI 10.1042/BJ20101841; Inukai N, 2004, J BIOL CHEM, V279, P8190, DOI 10.1074/jbc.M311412200; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; KAPOOR R, 1995, ONCOL RES, V7, P83; Katyal S, 2007, EMBO J, V26, P4720, DOI 10.1038/sj.emboj.7601869; Keramaris E, 2000, MOL CELL NEUROSCI, V15, P368, DOI 10.1006/mcne.2000.0838; Kerzendorfer C, 2010, HUM MOL GENET, V19, P1324, DOI 10.1093/hmg/ddq008; Lee KB, 2002, P NATL ACAD SCI USA, V99, P4239, DOI 10.1073/pnas.072068399; Li L, 2011, CLIN CANCER RES, V17, P4936, DOI 10.1158/1078-0432.CCR-10-1499; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Lin CP, 2008, J BIOL CHEM, V283, P21074, DOI 10.1074/jbc.M803493200; Lippert MJ, 2011, P NATL ACAD SCI USA, V108, P698, DOI 10.1073/pnas.1012363108; Liu CY, 2002, P NATL ACAD SCI USA, V99, P14970, DOI 10.1073/pnas.182557199; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Ljungman M, 1999, ONCOGENE, V18, P583, DOI 10.1038/sj.onc.1202356; Luo ZH, 2001, MUTAT RES-DNA REPAIR, V486, P259, DOI 10.1016/S0921-8777(01)00097-0; Lyu YL, 2007, CANCER RES, V67, P8839, DOI 10.1158/0008-5472.CAN-07-1649; Lyu YL, 2006, MOL CELL BIOL, V26, P7929, DOI 10.1128/MCB.00617-06; Lyu YL, 2003, P NATL ACAD SCI USA, V100, P7123, DOI 10.1073/pnas.1232376100; Morris EJ, 1996, J CELL BIOL, V134, P757, DOI 10.1083/jcb.134.3.757; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; O'Connell BC, 2010, MOL CELL, V40, P645, DOI 10.1016/j.molcel.2010.10.022; Park DS, 1997, J NEUROSCI, V17, P1256, DOI 10.1523/jneurosci.17-04-01256.1997; Pommier Y, 1999, DRUG RESIST UPDATE, V2, P307, DOI 10.1054/drup.1999.0102; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Rasheed ZA, 2003, ONCOGENE, V22, P7296, DOI 10.1038/sj.onc.1206935; Shaiu WL, 1998, MOL CELL BIOL, V18, P4358, DOI 10.1128/MCB.18.7.4358; Sordet O, 2008, J MOL BIOL, V381, P540, DOI 10.1016/j.jmb.2008.06.028; SORENSEN M, 1995, BRIT J CANCER, V72, P399, DOI 10.1038/bjc.1995.345; Sperling AS, 2011, P NATL ACAD SCI USA, V108, P12693, DOI 10.1073/pnas.1106834108; Takahashi T, 2011, P NATL ACAD SCI USA, V108, P692, DOI 10.1073/pnas.1012582108; Tsutsui K, 2001, J COMP NEUROL, V431, P228, DOI 10.1002/1096-9861(20010305)431:2<228::AID-CNE1067>3.0.CO;2-M; Wang JC, 1998, Q REV BIOPHYS, V31, P107, DOI 10.1017/S0033583598003424; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WATANABE M, 1994, NEUROSCI RES, V19, P51, DOI 10.1016/0168-0102(94)90007-8; WOESSNER RD, 1991, CELL GROWTH DIFFER, V2, P209; Wu JX, 1997, NUCLEIC ACIDS RES, V25, P4181, DOI 10.1093/nar/25.21.4181; Xiao H, 2003, P NATL ACAD SCI USA, V100, P3239, DOI 10.1073/pnas.0736401100; Zhang AL, 2006, J BIOL CHEM, V281, P35997, DOI 10.1074/jbc.M604149200; ZHANG H, 1988, P NATL ACAD SCI USA, V85, P1060, DOI 10.1073/pnas.85.4.1060; Zhang HF, 2004, CANCER RES, V64, P1114, DOI 10.1158/0008-5472.CAN-03-2858; Zhang Y, 2006, J NEUROSCI, V26, P8819, DOI 10.1523/JNEUROSCI.2593-06.2006	66	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7182	7192		10.1074/jbc.M112.415471	http://dx.doi.org/10.1074/jbc.M112.415471			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23344961	hybrid, Green Published			2022-12-25	WOS:000316002400039
J	Szczesny, P; Mykowiecka, A; Pawlowski, K; Grynberg, M				Szczesny, Pawel; Mykowiecka, Agnieszka; Pawlowski, Krzysztof; Grynberg, Marcin			Distinct Protein Classes in Human Red Cell Proteome Revealed by Similarity of Phylogenetic Profiles	PLOS ONE			English	Article							DATABASE	The minimal set of proteins necessary to maintain a vertebrate cell forms an interesting core of cellular machinery. The known proteome of human red blood cell consists of about 1400 proteins. We treated this protein complement of one of the simplest human cells as a model and asked the questions on its function and origins. The proteome was mapped onto phylogenetic profiles, i.e. vectors of species possessing homologues of human proteins. A novel clustering approach was devised, utilising similarity in the phylogenetic spread of homologues as distance measure. The clustering based on phylogenetic profiles yielded several distinct protein classes differing in phylogenetic taxonomic spread, presumed evolutionary history and functional properties. Notably, small clusters of proteins common to vertebrates or Metazoa and other multicellular eukaryotes involve biological functions specific to multicellular organisms, such as apoptosis or cell-cell signaling, respectively. Also, a eukaryote-specific cluster is identified, featuring GTP-ase signalling and ubiquitination. Another cluster, made up of proteins found in most organisms, including bacteria and archaea, involves basic molecular functions such as oxidation-reduction and glycolysis. Approximately one third of erythrocyte proteins do not fall in any of the clusters, reflecting the complexity of protein evolution in comparison to our simple model. Basically, the clustering obtained divides the proteome into old and new parts, the former originating from bacterial ancestors, the latter from inventions within multicellular eukaryotes. Thus, the model human cell proteome appears to be made up of protein sets distinct in their history and biological roles. The current work shows that phylogenetic profiles concept allows protein clustering in a way relevant both to biological function and evolutionary history.	[Szczesny, Pawel; Grynberg, Marcin] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Szczesny, Pawel] Univ Warsaw, Dept Plant Mol Biol, Inst Expt Plant Biol, Warsaw, Poland; [Pawlowski, Krzysztof] Warsaw Univ Life Sci, Fac Agr & Biol, Warsaw, Poland; [Pawlowski, Krzysztof] Polish Acad Sci, Nencki Inst Expt Biol, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw; Warsaw University of Life Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Pawlowski, K (corresponding author), Warsaw Univ Life Sci, Fac Agr & Biol, Warsaw, Poland.	k.pawlowski@nencki.gov.pl; greenb@ibb.waw.pl	Pawłowski, Krzysztof/C-2949-2013	Pawłowski, Krzysztof/0000-0002-5367-0935; Szczesny, Pawel/0000-0001-8442-0157; Grynberg, Marcin/0000-0003-1887-7209	Polish Ministry of Science and Higher Education [N N401 3126 33]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	MG and PS were supported by a grant from Polish Ministry of Science and Higher Education number N N401 3126 33 (2008-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Basu MK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-434; Bowers PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r35; D'Alessandro A, 2010, J PROTEOME RES, V9, P144, DOI 10.1021/pr900831f; D'Amici GM, 2012, NAT PROTOC, V7, P36, DOI 10.1038/nprot.2011.427; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gershon H, 1997, ARCH GERONTOL GERIAT, V24, P157, DOI 10.1016/S0167-4943(96)00748-0; Gerstein M, 1997, J MOL BIOL, V274, P562, DOI 10.1006/jmbi.1997.1412; Goodman SR, 2007, EXP BIOL MED, V232, P1391, DOI 10.3181/0706-MR-156; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jiang N, 2007, NAT IMMUNOL, V8, P1114, DOI 10.1038/ni1501; Kurland CG, 2007, BIOCHIMIE, V89, P1454, DOI 10.1016/j.biochi.2007.09.004; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Liepke C, 2003, J CHROMATOGR B, V791, P345, DOI 10.1016/S1570-0232(03)00245-9; Montel-Hagen A, 2009, CURR OPIN HEMATOL, V16, P165, DOI 10.1097/MOH.0b013e328329905c; Muller J, 2010, NUCLEIC ACIDS RES, V38, pD190, DOI 10.1093/nar/gkp951; Oliveros JC, 2007, VENNY INTERACTIVE TO; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Perez-Gordones MC, 2009, ARCH BIOCHEM BIOPHYS, V489, P55, DOI 10.1016/j.abb.2009.07.010; Sackmann E., 1995, STRUCTURE DYNAMICS M, V1, P1, DOI DOI 10.1016/S1383-8121(06)80018-7; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tsantes AE, 2006, ANTIOXID REDOX SIGN, V8, P1205, DOI 10.1089/ars.2006.8.1205; Weber RE, 2011, ACTA PHYSIOL, V202, P549, DOI 10.1111/j.1748-1716.2010.02204.x; Yutin N, 2008, MOL BIOL EVOL, V25, P1619, DOI 10.1093/molbev/msn108	25	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54471	10.1371/journal.pone.0054471	http://dx.doi.org/10.1371/journal.pone.0054471			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349899	Green Published, Green Submitted, gold			2022-12-25	WOS:000313943000040
J	Kaitaniemi, S; Gron, K; Elovaara, H; Salmi, M; Jalkanen, S; Elima, K				Kaitaniemi, Sam; Gron, Kirsi; Elovaara, Heli; Salmi, Marko; Jalkanen, Sirpa; Elima, Kati			Functional Modulation of Vascular Adhesion Protein-1 by a Novel Splice Variant	PLOS ONE			English	Article							SENSITIVE AMINE OXIDASE; SMOOTH-MUSCLE-CELLS; MESSENGER-RNA DECAY; SERUM RESPONSE FACTOR; ENDOTHELIAL-CELLS; SIGNALING PATHWAYS; LYMPHOCYTE BINDING; GENE-EXPRESSION; RECEPTOR; INFLAMMATION	Vascular Adhesion Protein-1 (VAP-1) is an endothelial adhesion molecule belonging to the primary amine oxidases. Upon inflammation it takes part in the leukocyte extravasation cascade facilitating transmigration of leukocytes into the inflamed tissue. Screening of a human lung cDNA library revealed the presence of an alternatively spliced shorter transcript of VAP-1, VAP-1 Delta 3. Here, we have studied the functional and structural characteristics of VAP-1 Delta 3, and show that the mRNA for this splice variant is expressed in most human tissues studied. In comparison to the parent molecule this carboxy-terminally truncated isoform lacks several of the amino acids important in the formation of the enzymatic groove of VAP-1. In addition, the conserved His684, which takes part in coordinating the active site copper, is missing from VAP-1 Delta 3. Assays using the prototypic amine substrates methylamine and benzylamine demonstrated that VAP-1 Delta 3 is indeed devoid of the semicarbazide-sensitive amine oxidase (SSAO) activity characteristic to VAP-1. When VAP-1 Delta 3-cDNA is transfected into cells stably expressing VAP-1, the surface expression of the full-length molecule is reduced. Furthermore, the SSAO activity of the co-transfectants is diminished in comparison to transfectants expressing only VAP-1. The observed down-regulation of both the expression and enzymatic activity of VAP-1 may result from a dominant-negative effect caused by heterodimerization between VAP-1 and VAP-1 Delta 3, which was detected in co-immunoprecipitation studies. This alternatively spliced transcript adds thus to the repertoire of potential regulatory mechanisms through which the cell-surface expression and enzymatic activity of VAP-1 can be modulated.	[Kaitaniemi, Sam; Gron, Kirsi; Elovaara, Heli; Salmi, Marko; Jalkanen, Sirpa; Elima, Kati] Univ Turku, Med Res Lab, Turku, Finland; [Kaitaniemi, Sam; Jalkanen, Sirpa] Univ Turku, Dept Microbiol & Immunol, Turku, Finland; [Salmi, Marko; Elima, Kati] Univ Turku, Dept Med Biochem & Genet, Turku, Finland	University of Turku; University of Turku; University of Turku	Elima, K (corresponding author), Univ Turku, Med Res Lab, Turku, Finland.	kati.elima@utu.fi			Academy of Finland; Sigrid Juselius Foundation; Varsinais-Suomi Regional Fund of the Finnish Cultural Foundation; Emil Aaltonen Foundation; Finnish Medical Foundation; Orion-Farmos Research Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Varsinais-Suomi Regional Fund of the Finnish Cultural Foundation; Emil Aaltonen Foundation; Finnish Medical Foundation; Orion-Farmos Research Foundation	This work was supported by the Academy of Finland, the Sigrid Juselius Foundation, the Varsinais-Suomi Regional Fund of the Finnish Cultural Foundation, the Emil Aaltonen Foundation, the Finnish Medical Foundation, and the Orion-Farmos Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airenne TT, 2005, PROTEIN SCI, V14, P1964, DOI 10.1110/ps.051438105; Belaguli NS, 1999, MOL CELL BIOL, V19, P4582; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; Davies JQ, 2007, J BIOL CHEM, V282, P27343, DOI 10.1074/jbc.M704096200; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Elovaara H, 2011, BIOCHEMISTRY-US, V50, P5507, DOI 10.1021/bi200117z; Ernberg K, 2010, ACTA CRYSTALLOGR F, V66, P1572, DOI 10.1107/S1744309110041515; Gokturk C, 2003, AM J PATHOL, V163, P1921, DOI 10.1016/S0002-9440(10)63550-X; Gomes AR, 2008, MOL CELL NEUROSCI, V37, P323, DOI 10.1016/j.mcn.2007.10.008; Griendling KK, 2000, ARTERIOSCL THROM VAS, V20, P2175, DOI 10.1161/01.ATV.20.10.2175; Harada N, 2008, AM J PHYSIOL-ENDOC M, V294, pE61, DOI 10.1152/ajpendo.00358.2007; Hiltunen MO, 2000, CIRCULATION, V102, P2262; Irjala H, 2003, EUR J IMMUNOL, V33, P815, DOI 10.1002/eji.200323859; Jaakkola K, 1999, AM J PATHOL, V155, P1953, DOI 10.1016/S0002-9440(10)65514-9; Jaakkola K, 2000, AM J PATHOL, V157, P463, DOI 10.1016/S0002-9440(10)64558-0; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; JALKANEN S, 1987, J CELL BIOL, V105, P983, DOI 10.1083/jcb.105.2.983; Junttila TT, 2003, CLIN CANCER RES, V9, P5346; Kaitaniemi S, 2009, CELL MOL LIFE SCI, V66, P2743, DOI 10.1007/s00018-009-0076-5; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Kanadia RN, 2010, GENE DEV, V24, P229, DOI 10.1101/gad.1847110; Kim E, 2008, BIOESSAYS, V30, P38, DOI 10.1002/bies.20692; Kino T, 2009, CELL MOL LIFE SCI, V66, P3435, DOI 10.1007/s00018-009-0098-z; Koskinen K, 2004, BLOOD, V103, P3388, DOI 10.1182/blood-2003-09-3275; Laitinen M, 1998, HUM GENE THER, V9, P1481, DOI 10.1089/hum.1998.9.10-1481; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lorenz M, 2007, FASEB J, V21, P1556, DOI 10.1096/fj.06-7434com; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Mathys KC, 2002, BIOCHEM BIOPH RES CO, V297, P863, DOI 10.1016/S0006-291X(02)02293-3; Matsunami H, 2004, BIOCHEMISTRY-US, V43, P2178, DOI 10.1021/bi0361923; McElvaine AT, 2006, ENDOCRINOLOGY, V147, P1884, DOI 10.1210/en.2005-1488; Mercier N, 2001, BIOCHEM J, V358, P335, DOI 10.1042/0264-6021:3580335; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Rehwinkel J, 2006, TRENDS BIOCHEM SCI, V31, P639, DOI 10.1016/j.tibs.2006.09.005; Salmi M, 1998, J IMMUNOL, V160, P5629; Salmi M, 2005, NAT REV IMMUNOL, V5, P760, DOI 10.1038/nri1705; Salmi M, 2001, IMMUNITY, V14, P265, DOI 10.1016/S1074-7613(01)00108-X; Salmi M, 2001, TRENDS IMMUNOL, V22, P211, DOI 10.1016/S1471-4906(01)01870-1; SALMI M, 1992, SCIENCE, V257, P1407, DOI 10.1126/science.1529341; Salmi M, 1996, J EXP MED, V183, P569, DOI 10.1084/jem.183.2.569; SALMI M, 1993, J EXP MED, V178, P2255, DOI 10.1084/jem.178.6.2255; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; Smith DJ, 1998, J EXP MED, V188, P17, DOI 10.1084/jem.188.1.17; Sunmonu NA, 2011, J CELL PHYSIOL, V226, P1722, DOI 10.1002/jcp.22587; Sztainberg Y, 2009, FASEB J, V23, P2186, DOI 10.1096/fj.08-128066; Tapon N, 1998, EMBO J, V17, P1395, DOI 10.1093/emboj/17.5.1395; van der Vaart Michiel, 2009, Nucl Recept Signal, V7, pe007, DOI 10.1621/nrs.07007; van Rijn RM, 2008, BIOCHEM J, V414, P121, DOI 10.1042/BJ20071583; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Zarei MM, 2001, J BIOL CHEM, V276, P16232, DOI 10.1074/jbc.M008852200; Zhang X, 2007, GENE, V400, P131, DOI 10.1016/j.gene.2007.06.008; Zorzano A, 2003, BBA-PROTEINS PROTEOM, V1647, P3, DOI 10.1016/S1570-9639(03)00039-6	54	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54151	10.1371/journal.pone.0054151	http://dx.doi.org/10.1371/journal.pone.0054151			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349812	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872800028
J	Ruiz-Villalba, A; Ziogas, A; Ehrbar, M; Perez-Pomares, JM				Ruiz-Villalba, Adrian; Ziogas, Algirdas; Ehrbar, Martin; Perez-Pomares, Jose M.			Characterization of Epicardial-Derived Cardiac Interstitial Cells: Differentiation and Mobilization of Heart Fibroblast Progenitors	PLOS ONE			English	Article							QUAIL-CHICK CHIMERA; STEM-CELLS; SUBEPICARDIAL MESENCHYME; EMBRYONIC EPICARDIUM; MESOTHELIAL CELLS; RETINOIC ACID; CONTRIBUTE; ORIGIN; MYOCARDIUM; EXPRESSION	The non-muscular cells that populate the space found between cardiomyocyte fibers are known as 'cardiac interstitial cells' (CICs). CICs are heterogeneous in nature and include different cardiac progenitor/stem cells, cardiac fibroblasts and other cell types. Upon heart damage CICs soon respond by initiating a reparative response that transforms with time into extensive fibrosis and heart failure. Despite the biomedical relevance of CICs, controversy remains on the ontogenetic relationship existing between the different cell kinds homing at the cardiac interstitium, as well as on the molecular signals that regulate their differentiation, maturation, mutual interaction and role in adult cardiac homeostasis and disease. Our work focuses on the analysis of epicardial-derived cells, the first cell type that colonizes the cardiac interstitium. We present here a characterization and an experimental analysis of the differentiation potential and mobilization properties of a new cell line derived from mouse embryonic epicardium (EPIC). Our results indicate that these cells express some markers associated with cardiovascular stemness and retain part of the multipotent properties of embryonic epicardial derivatives, spontaneously differentiating into smooth muscle, and fibroblast/myofibroblast-like cells. Epicardium-derived cells are also shown to initiate a characteristic response to different growth factors, to display a characteristic proteolytic expression profile and to degrade biological matrices in 3D in vitro assays. Taken together, these data indicate that EPICs are relevant to the analysis of epicardial-derived CICs, and are a god model for the research on cardiac fibroblasts and the role these cells play in ventricular remodeling in both ischemic or non/ischemic myocardial disease.	[Ruiz-Villalba, Adrian; Perez-Pomares, Jose M.] Univ Malaga, Fac Sci, Dept Anim Biol, E-29071 Malaga, Spain; [Ziogas, Algirdas; Ehrbar, Martin] Univ Zurich Hosp, Dept Obstet, CH-8091 Zurich, Switzerland	Universidad de Malaga; University of Zurich; University Zurich Hospital	Perez-Pomares, JM (corresponding author), Univ Malaga, Fac Sci, Dept Anim Biol, E-29071 Malaga, Spain.	jmperezp@uma.es	Perez-Pomares, Jose/G-7885-2015; Ruiz-Villalba, Adrián/AAP-6130-2020; Ehrbar, Martin/O-4130-2019; Ehrbar, Martin/F-4578-2012	Perez-Pomares, Jose/0000-0001-5487-7252; Ehrbar, Martin/0000-0003-2707-4870; Ehrbar, Martin/0000-0003-2707-4870; , Adrian/0000-0001-8063-0317	EU FP6 [LSHM-CT-2005-018630]; 'CardioNet' (EU FP7 Marie Curie Programme ITNs); Junta de Andalucia, Spain [P08-CTS-03618]; Spanish Ministry of Economy (MINECO) [BFU2009-07929, RD06/0010/0015]	EU FP6(European Commission); 'CardioNet' (EU FP7 Marie Curie Programme ITNs); Junta de Andalucia, Spain(Junta de AndaluciaEuropean Commission); Spanish Ministry of Economy (MINECO)	This work was funded by grants LSHM-CT-2005-018630 ('HeartRepair', EU FP6), 'CardioNet' (EU FP7 Marie Curie Programme ITNs), P08-CTS-03618 (Junta de Andalucia, Spain) and the Spanish Ministry of Economy (MINECO) grants BFU2009-07929 and RD06/0010/0015 (TERCEL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Guadix JA, 2011, DEVELOPMENT, V138, P1093, DOI 10.1242/dev.044594; Azambuja AP, 2010, CIRC RES, V107, P204, DOI 10.1161/CIRCRESAHA.109.214650; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Chong JJH, 2011, CELL STEM CELL, V9, P527, DOI 10.1016/j.stem.2011.10.002; Christoffels VM, 2009, NATURE, V458, pE8, DOI 10.1038/nature07916; del Monte G, 2011, CIRC RES, V108, P824, DOI 10.1161/CIRCRESAHA.110.229062; EID H, 1992, CIRC RES, V71, P40, DOI 10.1161/01.RES.71.1.40; Ferreira-Martins J, 2012, CIRC RES, V110, P701, DOI 10.1161/CIRCRESAHA.111.259507; Gittenberger-de Groot AC, 1998, CIRC RES, V82, P1043, DOI 10.1161/01.RES.82.10.1043; Goichberg P, 2011, CIRC RES, V108, P1071, DOI 10.1161/CIRCRESAHA.110.239459; Goldsmith EC, 2004, DEV DYNAM, V230, P787, DOI 10.1002/dvdy.20095; Guadix JA, 2006, DEV DYNAM, V235, P1014, DOI 10.1002/dvdy.20685; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Kandalam V, 2010, CIRC RES, V106, P796, DOI 10.1161/CIRCRESAHA.109.209189; Kanekar S, 1998, CARDIOVASC PATHOL, V7, P127, DOI 10.1016/S1054-8807(97)00119-1; Katz TC, 2012, DEV CELL, V22, P639, DOI 10.1016/j.devcel.2012.01.012; Krenning G, 2010, J CELL PHYSIOL, V225, P631, DOI 10.1002/jcp.22322; Kruithof BPT, 2006, DEV BIOL, V295, P507, DOI 10.1016/j.ydbio.2006.03.033; Laeremans H, 2010, CARDIOVASC RES, V87, P514, DOI 10.1093/cvr/cvq067; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Li P, 2011, DEVELOPMENT, V138, P1795, DOI 10.1242/dev.054338; Manner J, 1999, ANAT RECORD, V255, P212; Manner J, 2001, CELLS TISSUES ORGANS, V169, P89, DOI 10.1159/000047867; Martinez-Estrada OM, 2010, NAT GENET, V42, P89, DOI 10.1038/ng.494; Matsuura K, 2004, J BIOL CHEM, V279, P11384, DOI 10.1074/jbc.M310822200; Mellgren AM, 2008, CIRC RES, V103, P1393, DOI 10.1161/CIRCRESAHA.108.176768; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Neth P, 2006, STEM CELLS, V24, P1892, DOI 10.1634/stemcells.2005-0503; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Perez-Pomares JM, 2002, DEV BIOL, V247, P307, DOI 10.1006/dbio.2002.0706; Perez-Pomares JM, 1998, DEV BIOL, V200, P57, DOI 10.1006/dbio.1998.8949; PerezPomares JM, 1997, DEV DYNAM, V210, P96, DOI 10.1002/(SICI)1097-0177(199710)210:2<96::AID-AJA3>3.0.CO;2-4; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; Sauk JJ, 2005, FRONT BIOSCI-LANDMRK, V10, P107, DOI 10.2741/1513; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Smith CL, 2011, CIRC RES, V108, pE15, DOI 10.1161/CIRCRESAHA.110.235531; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; Torella D, 2005, TRENDS CARDIOVAS MED, V15, P229, DOI 10.1016/j.tcm.2005.06.006; Tummala PE, 1999, CIRCULATION, V100, P1223, DOI 10.1161/01.CIR.100.11.1223; van Wijk B, 2009, CIRC RES, V105, P431, DOI 10.1161/CIRCRESAHA.109.203083; VLIEGEN HW, 1991, EUR HEART J, V12, P488, DOI 10.1093/oxfordjournals.eurheartj.a059928; Wada AM, 2003, CIRC RES, V92, P525, DOI 10.1161/01.RES.0000060484.11032.0B; Wengerhoff SM, 2010, DEV DYNAM, V239, P598, DOI 10.1002/dvdy.22163; Wessels A, 2004, ANAT REC PART A, V276A, P43, DOI 10.1002/ar.a.10129; Wexler R, 2009, AM FAM PHYSICIAN, V79, P778; Wu GD, 2008, J BIOCHEM, V144, P571, DOI 10.1093/jb/mvn106; Yang MC, 2010, BIOMATERIALS, V31, P854, DOI 10.1016/j.biomaterials.2009.09.096; Zeisberg EM, 2010, CIRC RES, V107, P1304, DOI 10.1161/CIRCRESAHA.110.231910; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529; Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8	54	30	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e53694	10.1371/journal.pone.0053694	http://dx.doi.org/10.1371/journal.pone.0053694			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349729	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000313872800011
J	Simpson, SJ; Siu, KKW; Yagi, N; Whitley, JC; Lewis, RA; Frappell, PB				Simpson, Shannon J.; Siu, Karen K. W.; Yagi, Naoto; Whitley, Jane C.; Lewis, Robert A.; Frappell, Peter B.			Phase Contrast Imaging Reveals Low Lung Volumes and Surface Areas in the Developing Marsupial	PLOS ONE			English	Article							NEWBORN TAMMAR WALLABY; POSTNATAL-DEVELOPMENT; GAS-EXCHANGE; RESPIRATORY SYSTEM; MORPHOMETRIC-ANALYSIS; SETONIX-BRACHYURUS; LIQUID CLEARANCE; MACROPUS-EUGENII; METABOLIC-RATE; MOUSE LUNG	Marsupials are born with immature lungs when compared to eutherian mammals and rely, to various extents, on cutaneous gas exchange in order to meet metabolic requirements. Indeed, the fat-tailed dunnart is born with lungs in the canalicular stage of development and relies almost entirely on the skin for gas exchange at birth; consequently undergoing the majority of lung development in air. Plane radiographs and computed tomography data sets were acquired using phase contrast imaging with a synchrotron radiation source for two marsupial species, the fat-tailed dunnart and the larger tammar wallaby, during the first weeks of postnatal life. Phase contrast imaging revealed that only two lung sacs contain air after the first hour of life in the fat-tailed dunnart. While the lung of the tammar wallaby was comparatively more developed, both species demonstrated massive increases in air sac number and architectural complexity during the postnatal period. In addition, both the tammar wallaby and fat-tailed dunnart had lower lung volumes and parenchymal surface areas than were expected from morphometrically determined allometric equations relating these variables to body mass during the neonatal period. However, lung volume is predicted to scale with mass as expected after the neonatal marsupial reaches a body mass of similar to 1 g and no longer relies on the skin for gas exchange. Decreased lung volume in the marsupial neonate further supports the maxim that cutaneous gas exchange occurs in the marsupial neonate because the respiratory apparatus is not yet capable of meeting the gas exchange requirements of the newborn.	[Simpson, Shannon J.; Frappell, Peter B.] Univ Tasmania, Hobart, Tas, Australia; [Siu, Karen K. W.; Lewis, Robert A.] Monash Univ, Ctr Synchrotron Sci, Clayton, Vic 3800, Australia; [Yagi, Naoto] SPring 8 JASRI, Sayo, Hyogo, Japan; [Whitley, Jane C.] Dept Primary Ind, Attwood, Vic, Australia	University of Tasmania; Monash University; Japan Synchrotron Radiation Research Institute	Frappell, PB (corresponding author), Univ Tasmania, Hobart, Tas, Australia.	peter.frappell@utas.edu.au	simpson, shannon/C-4651-2013; Siu, Karen K W/C-1472-2008	simpson, shannon/0000-0002-4895-0975; 	Australian National Nuclear Research and Development Organisation	Australian National Nuclear Research and Development Organisation	This work was supported by Australian National Nuclear Research and Development Organisation (http://www.ansto.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTLETT D, 1977, RESP PHYSIOL, V29, P193, DOI 10.1016/0034-5687(77)90092-5; BENNETT JH, 1990, AUST J ZOOL, V37, P207, DOI 10.1071/ZO9890207; BURRI PH, 1974, ANAT REC, V178, P711, DOI 10.1002/ar.1091780405; Burri PH, 2003, RESP PHYSIOL NEUROBI, V138, P309, DOI 10.1016/S1569-9048(03)00197-6; BURRI PH, 1984, ANNU REV PHYSIOL, V46, P617, DOI 10.1146/annurev.ph.46.030184.003153; CASTLEMAN WL, 1990, AM J VET RES, V51, P789; Coxson HO, 1999, AM J RESP CRIT CARE, V159, P851, DOI 10.1164/ajrccm.159.3.9805067; DAVIES P, 1988, ANAT RECORD, V220, P281, DOI 10.1002/ar.1092200308; FARBER JP, 1972, RESP PHYSIOL, V14, P278, DOI 10.1016/0034-5687(72)90034-5; FARBER JP, 1978, RESP PHYSIOL, V35, P189, DOI 10.1016/0034-5687(78)90021-X; Frappell PB, 2006, RESP PHYSIOL NEUROBI, V154, P252, DOI 10.1016/j.resp.2006.05.001; FRAPPELL PB, 1989, RESP PHYSIOL, V76, P25, DOI 10.1016/0034-5687(89)90015-7; Frappell PB, 2000, RESP PHYSIOL, V120, P35, DOI 10.1016/S0034-5687(99)00103-6; Frappell PB, 2008, COMP BIOCHEM PHYS A, V150, P181, DOI 10.1016/j.cbpa.2008.02.017; Greenlee KJ, 2009, AM J PHYSIOL-REG I, V297, pR1343, DOI 10.1152/ajpregu.00231.2009; Gureyev TE, 2002, J SYNCHROTRON RADIAT, V9, P148, DOI 10.1107/S0909049502004971; Hooper SB, 2007, FASEB J, V21, P3329, DOI 10.1096/fj.07-8208com; Hooper SB, 2009, CLIN EXP PHARMACOL P, V36, P117, DOI 10.1111/j.1440-1681.2008.05109.x; Kaiser A, 2007, P NATL ACAD SCI USA, V104, P13198, DOI 10.1073/pnas.0611544104; Kitchen MJ, 2005, BRIT J RADIOL, V78, P1018, DOI 10.1259/bjr/13024611; Kitchen MJ, 2004, PHYS MED BIOL, V49, P4335, DOI 10.1088/0031-9155/49/18/010; KOSCH PC, 1984, J APPL PHYSIOL, V57, P1126, DOI 10.1152/jappl.1984.57.4.1126; LECHNER AJ, 1982, AM J ANAT, V163, P235, DOI 10.1002/aja.1001630304; Lewis RA, 2005, PHYS MED BIOL, V50, P5031, DOI 10.1088/0031-9155/50/21/006; Lewis RA, 2003, BRIT J RADIOL, V76, P301, DOI 10.1259/bjr/32889803; MacFarlane PM, 2002, J EXP BIOL, V205, P533; MacFarlane PM, 2001, RESP PHYSIOL, V126, P221, DOI 10.1016/S0034-5687(01)00227-4; Makanya AN, 2007, J ANAT, V211, P26, DOI 10.1111/j.1469-7580.2007.00744.x; Makanya AN, 2003, RESP PHYSIOL NEUROBI, V134, P43, DOI 10.1016/S1569-9048(02)00204-5; Miller NJ, 2001, J EXP BIOL, V204, P4031; MORTOLA JP, 1987, PHYSIOL REV, V67, P187, DOI 10.1152/physrev.1987.67.1.187; Mortola JP, 1999, NATURE, V397, P660, DOI 10.1038/17713; MORTOLA JP, 1982, J APPL PHYSIOL, V52, P1209, DOI 10.1152/jappl.1982.52.5.1209; Mund SI, 2008, DEV DYNAM, V237, P2108, DOI 10.1002/dvdy.21633; Porra L, 2004, J APPL PHYSIOL, V96, P1899, DOI 10.1152/japplphysiol.00866.2003; RIBBONS KA, 1989, RESP PHYSIOL, V75, P1, DOI 10.1016/0034-5687(89)90081-9; Runciman SIC, 1998, RESP PHYSIOL, V111, P177, DOI 10.1016/S0034-5687(97)00114-X; Runciman SIC, 1996, ANAT REC, V244, P193, DOI 10.1002/(SICI)1097-0185(199602)244:2<193::AID-AR7>3.0.CO;2-2; Runciman SIC, 1998, RESP PHYSIOL, V112, P325, DOI 10.1016/S0034-5687(98)00034-6; Runciman SIC, 1999, RESP PHYSIOL, V118, P61, DOI 10.1016/S0034-5687(99)00068-7; Schittny JC, 2008, AM J PHYSIOL-LUNG C, V294, pL246, DOI 10.1152/ajplung.00296.2007; Sera Toshihiro, 2005, Journal of Physiological Anthropology and Applied Human Science, V24, P465, DOI 10.2114/jpa.24.465; Simpson SJ, 2011, PHYSIOL BIOCHEM ZOOL, V84, P634, DOI 10.1086/662557; Socha JJ, 2008, J EXP BIOL, V211, P3409, DOI 10.1242/jeb.019877; West JB, 1995, RESP PHYSL ESSENTIAL; Westneat MW, 2003, SCIENCE, V299, P558, DOI 10.1126/science.1078008; Yagi N, 1999, MED PHYS, V26, P2190, DOI 10.1118/1.598735; ZELTNER TB, 1987, RESP PHYSIOL, V67, P269, DOI 10.1016/0034-5687(87)90058-2; ZELTNER TB, 1987, RESP PHYSIOL, V67, P247, DOI 10.1016/0034-5687(87)90057-0	49	3	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e53805	10.1371/journal.pone.0053805	http://dx.doi.org/10.1371/journal.pone.0053805			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349744	Green Published, gold			2022-12-25	WOS:000313872800013
J	Sureshan, V; Deshpande, CN; Boucher, Y; Koenig, JE; Stokes, HW; Harrop, SJ; Curmi, PMG; Mabbutt, BC				Sureshan, Visaahini; Deshpande, Chandrika N.; Boucher, Yan; Koenig, Jeremy E.; Stokes, H. W.; Harrop, Stephen J.; Curmi, Paul M. G.; Mabbutt, Bridget C.		Midwest Ctr Struct Genomics	Integron Gene Cassettes: A Repository of Novel Protein Folds with Distinct Interaction Sites	PLOS ONE			English	Article							SP-NOV.; FAMILY; INTEGRATION; METAGENOME; DIVERSITY; EVOLUTION; RESOURCE; INSIGHTS; GENOMES; SYSTEM	Mobile gene cassettes captured within integron arrays encompass a vast and diverse pool of genetic novelty. In most cases, functional annotation of gene cassettes directly recovered by cassette-PCR is obscured by their characteristically high sequence novelty. This inhibits identification of those specific functions or biological features that might constitute preferential factors for lateral gene transfer via the integron system. A structural genomics approach incorporating x-ray crystallography has been utilised on a selection of cassettes to investigate evolutionary relationships hidden at the sequence level. Gene cassettes were accessed from marine sediments (pristine and contaminated sites), as well as a range of Vibrio spp. We present six crystal structures, a remarkably high proportion of our survey of soluble proteins, which were found to possess novel folds. These entirely new structures are diverse, encompassing all-alpha, alpha+beta and alpha/beta fold classes, and many contain clear binding pocket features for small molecule substrates. The new structures emphasise the large repertoire of protein families encoded within the integron cassette metagenome and which remain to be characterised. Oligomeric association is a notable recurring property common to these new integron-derived proteins. In some cases, the protein-protein contact sites utilised in homomeric assembly could instead form suitable contact points for heterogeneous regulator/activator proteins or domains. Such functional features are ideal for a flexible molecular componentry needed to ensure responsive and adaptive bacterial functions.	[Sureshan, Visaahini; Deshpande, Chandrika N.; Mabbutt, Bridget C.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Boucher, Yan] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Koenig, Jeremy E.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Midwest Ctr Struct Genomics] Univ Toronto, Toronto, ON, Canada; [Stokes, H. W.] Univ Technol Sydney, Inst I3, Sydney, NSW 2007, Australia; [Harrop, Stephen J.; Curmi, Paul M. G.] Univ New S Wales, Sch Phys, Sydney, NSW 2052, Australia; [Curmi, Paul M. G.] St Vincents Hosp, Ctr Appl Med Res, Sydney, NSW 2010, Australia	Macquarie University; University of Alberta; Dalhousie University; University of Toronto; University of Technology Sydney; University of New South Wales Sydney; St Vincents Hospital Sydney	Mabbutt, BC (corresponding author), Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia.	bridget.mabbutt@mq.edu.au	Curmi, Paul/G-7185-2011; Boucher, Yann Felix/H-4576-2019	Curmi, Paul/0000-0001-5762-7638; Boucher, Yann Felix/0000-0002-0036-6083; Labbate, Maurizio/0000-0003-1428-3382; Deshpande, Chandrika/0000-0002-5557-519X	Midwest Center for Structural Genomics (MCSG); APA (Australian Federal Government); MQRES (Macquarie University); EIPRS (Australian Federal Government); National Health and Medical Research Council (Australia) [488502]; National Institutes of Health [GM074942, GM094568]; US Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM094568, U54GM094585, U54GM074942] Funding Source: NIH RePORTER	Midwest Center for Structural Genomics (MCSG); APA (Australian Federal Government); MQRES (Macquarie University); EIPRS (Australian Federal Government); National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Aled Edwards and Andrej Joachimiak for supporting this collaboration with the Midwest Center for Structural Genomics (MCSG). The complete list of authors from the MCSG is: R. Di Leo, O. Kagan, S. Gebert, V. Egorova, E. Evdokimova, X. Xu, M. Kudrytska, H. Cui, J. Osipiuk, C. Chang, K. Tan, M. Cuff, A. Edwards, A. Joachimiak and A. Savchenko.; The authors also thank Maurizio Labbate (University of Technology Sydney), Ian Paulsen and Robert Willows (Macquarie University) for useful discussions, and David Langley for some additional synchrotron data acquisition (Australian Synchrotron, Melbourne). VS acknowledges receipt of an APA (Australian Federal Government) scholarship. CND acknowledges receipt of a MQRES (Macquarie University) and EIPRS (Australian Federal Government) scholarship.; This work was supported by the following sources: National Health and Medical Research Council (Australia) grant 488502, National Institutes of Health grants GM074942 and GM094568, and the US Department of Energy, Office of Biological and Environmental Research (contract DE-AC02-06CH11357). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abergel C, 2007, P NATL ACAD SCI USA, V104, P6394, DOI 10.1073/pnas.0611019104; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Borek D, 2003, ACTA CRYSTALLOGR D, V59, P2031, DOI 10.1107/S0907444903020924; Boucher Y, 2007, TRENDS MICROBIOL, V15, P301, DOI 10.1016/j.tim.2007.05.004; Brown HJ, 1996, J BACTERIOL, V178, P4429, DOI 10.1128/jb.178.15.4429-4437.1996; Cherezov V, 2008, STRUCTURE, V16, P1378, DOI 10.1016/j.str.2008.05.014; Cohen O, 2011, MOL BIOL EVOL, V28, P1481, DOI 10.1093/molbev/msq333; Cole BJ, 2009, PROTEIN SCI, V18, P1602, DOI 10.1002/pro.182; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Deshpande CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016934; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; DONOVAN TJ, 1995, INT J FOOD MICROBIOL, V26, P77, DOI 10.1016/0168-1605(95)00015-C; Eisen JA, 2000, CURR OPIN GENET DEV, V10, P606, DOI 10.1016/S0959-437X(00)00143-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gao HC, 2006, INT J SYST EVOL MICR, V56, P1911, DOI 10.1099/ijs.0.64354-0; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gillings M, 2008, J BACTERIOL, V190, P5095, DOI 10.1128/JB.00152-08; HALL RM, 1995, MOL MICROBIOL, V15, P593, DOI 10.1111/j.1365-2958.1995.tb02368.x; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Holmes AJ, 2003, ENVIRON MICROBIOL, V5, P383, DOI 10.1046/j.1462-2920.2003.00429.x; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Joss MJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-118; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI [10.1107/S0907444906022657, 10.1107/S907444906022657]; KOBAYASHI TOSHIKAZU, 1963, JAPAN JOUR BACTERIOL, V18, P387; Koenig JE, 2008, ENVIRON MICROBIOL, V10, P1024, DOI 10.1111/j.1462-2920.2007.01524.x; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Labbate M, 2007, MICROBIOL-SGM, V153, P1488, DOI 10.1099/mic.0.2006/001065-0; Labbate Maurizio, 2009, V532, P103, DOI 10.1007/978-1-60327-853-9_6; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski Roman A., 2003, Journal of Structural and Functional Genomics, V4, P167, DOI 10.1023/A:1026127927612; Lehmann C, 2003, PROTEINS, V50, P249, DOI 10.1002/prot.10260; LESLIE AG, 1992, JOINT CCP4 ESF EAMCB, V26; Marri PR, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S8; Mazel D, 1998, SCIENCE, V280, P605, DOI 10.1126/science.280.5363.605; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; Michael CA, 2004, AM NAT, V164, P1, DOI 10.1086/421733; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Najmanovich R, 2008, BIOINFORMATICS, V24, pI105, DOI 10.1093/bioinformatics/btn263; Partridge SR, 2009, FEMS MICROBIOL REV, V33, P757, DOI 10.1111/j.1574-6976.2009.00175.x; PEDERSEN LC, 1995, BIOCHEMISTRY-US, V34, P13305, DOI 10.1021/bi00041a005; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; Robinson A, 2005, J MOL BIOL, V346, P1229, DOI 10.1016/j.jmb.2004.12.035; Robinson A, 2007, MOL MICROBIOL, V66, P610, DOI 10.1111/j.1365-2958.2007.05932.x; Robinson Andrew, 2008, V426, P589, DOI 10.1007/978-1-60327-058-8_39; STOKES HW, 1989, MOL MICROBIOL, V3, P1669, DOI 10.1111/j.1365-2958.1989.tb00153.x; Stokes HW, 2001, APPL ENVIRON MICROB, V67, P5240, DOI 10.1128/AEM.67.11.5240-5246.2001; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Weon HY, 2006, INT J SYST EVOL MICR, V56, P659, DOI 10.1099/ijs.0.63749-0; Wiedenbeck J, 2011, FEMS MICROBIOL REV, V35, P957, DOI 10.1111/j.1574-6976.2011.00292.x; Ye YZ, 2004, NUCLEIC ACIDS RES, V32, pW582, DOI 10.1093/nar/gkh430; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	59	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e52934	10.1371/journal.pone.0052934	http://dx.doi.org/10.1371/journal.pone.0052934			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349695	gold, Green Submitted, Green Published			2022-12-25	WOS:000313872800005
J	Okada, M; Matsuda, H; Okimura, Y				Okada, Masayoshi; Matsuda, Hiroko; Okimura, Yasuhiko			Lentiviral and Moloney Retroviral Expression of Green Fluorescent Protein in Somatotrophs In Vivo	PLOS ONE			English	Article							GROWTH-HORMONE GENE; LOCUS-CONTROL REGION; RAT ANTERIOR-PITUITARY; ORGANOTYPIC CULTURES; CELLS; VECTORS; TISSUE; PIT-1; PROLIFERATION; ACTIVATION	Previous studies have shown that the locus control region (LCR) and the promoter of the growth hormone (GH) gene can control the expression of GH. Therefore, lenti- and retro-viral vectors with these elements might be useful to monitor the activation of the GH gene and the development of newborn somatotrophs. To test this, we first constructed a lentiviral vector, which expresses green fluorescent protein (GFP) under the control of these elements, and injected them into rat pituitaries in situ and in vivo. The lentiviral vector expressed GFP specifically in the anterior lobe, and nearly all GFP-positive cells were anti-GH immunoreactive. The GFP expression was upregulated by the administration of growth hormone releasing hormone and an IGF-1 receptor blocker. Furthermore, the social isolation stress, which was shown to decrease the GH secretion, decreased the GFP expression. Second, we injected the retroviral vector into neonatal rat pituitaries in vivo. At 30 days postinjection (DPI), almost all GFP-positive cells were anti-GH positive and anti-prolactin negative as the lentiviral expression. However, GFP was transiently expressed by developing lactotrophs at 8 and 16 DPI, suggesting that our vector lacks an element(s) which suppresses the expression. Meanwhile, the retrovirally labeled cells tended to cluster with the cells of same type. An analysis of cell numbers in each cluster revealed some features of cell proliferation. These viral vectors are shown to be useful tools to monitor the activation of the GH gene and the development of somatotrophs.	[Okada, Masayoshi; Matsuda, Hiroko] Kansai Med Univ, Dept Physiol, Moriguchi, Osaka 570, Japan; [Okimura, Yasuhiko] Kobe Womens Univ, Kobe, Hyogo, Japan	Kansai Medical University	Okada, M (corresponding author), Kansai Med Univ, Dept Physiol, Moriguchi, Osaka 570, Japan.	mokada-tky@umin.ac.jp	Okada, Masayoshi/ABE-9020-2020	Okada, Masayoshi/0000-0001-8515-7143	Foundation for Growth Science	Foundation for Growth Science	This study is supported by the Foundation for Growth Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cohen LE, 1999, J CLIN INVEST, V104, P1123, DOI 10.1172/JCI7308; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; FRAWLEY LS, 1991, ENDOCR REV, V12, P337, DOI 10.1210/edrv-12-4-337; Gleiberman AS, 2008, P NATL ACAD SCI USA, V105, P6332, DOI 10.1073/pnas.0801644105; Goodman HM, 2009, BASIC MEDICAL ENDOCRINOLOGY, 4TH EDITION, P1; Guerineau NC, 1997, J NEUROSCI METH, V73, P169, DOI 10.1016/S0165-0270(97)02224-3; Ho YG, 2006, MOL CELL, V23, P365, DOI 10.1016/j.molcel.2006.05.041; JONES BK, 1995, MOL CELL BIOL, V15, P7010; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kishimoto M, 2002, J BIOL CHEM, V277, P45141, DOI 10.1074/jbc.M202991200; KUHN CM, 1978, SCIENCE, V201, P1034, DOI 10.1126/science.684424; Lin CW, 2010, NEURON, V65, P32, DOI 10.1016/j.neuron.2009.12.001; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Nagasaki H, 2006, J MOL ENDOCRINOL, V37, P39, DOI 10.1677/jme.1.01932; Niiori-Onishi A, 1999, ENDOCRINOLOGY, V140, P344, DOI 10.1210/en.140.1.344; Okada M, 2008, NEUROSCIENCE, V156, P289, DOI 10.1016/j.neuroscience.2008.07.038; Okada M, 2004, HIPPOCAMPUS, V14, P337, DOI 10.1002/hipo.10185; PERITZ LN, 1988, J BIOL CHEM, V263, P5005; PIETRZKOWSKI Z, 1992, CANCER RES, V52, P6447; Sarac MS, 2002, ENDOCRINOLOGY, V143, P2314, DOI 10.1210/en.143.6.2314; SHEPARD AR, 1994, J BIOL CHEM, V269, P1804; Shewchuk BM, 1999, J BIOL CHEM, V274, P35725, DOI 10.1074/jbc.274.50.35725; Shewchuk BM, 2002, P NATL ACAD SCI USA, V99, P11784, DOI 10.1073/pnas.182418199; Skuse D, 1996, LANCET, V348, P353, DOI 10.1016/S0140-6736(96)01358-X; Southgate TD, 2000, ENDOCRINOLOGY, V141, P3493, DOI 10.1210/en.141.9.3493; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Taniguchi Y, 2001, ANAT EMBRYOL, V204, P469, DOI 10.1007/s429-001-8003-x; WEISS RA, 1977, VIROLOGY, V76, P808, DOI 10.1016/0042-6822(77)90261-6; YEE JK, 1987, P NATL ACAD SCI USA, V84, P5197, DOI 10.1073/pnas.84.15.5197	30	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54437	10.1371/journal.pone.0054437	http://dx.doi.org/10.1371/journal.pone.0054437			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342159	gold, Green Submitted, Green Published			2022-12-25	WOS:000313682700117
J	Costechareyre, D; Chich, JF; Strub, JM; Rahbe, Y; Condemine, G				Costechareyre, Denis; Chich, Jean-Francois; Strub, Jean-Marc; Rahbe, Yvan; Condemine, Guy			Transcriptome of Dickeya dadantii Infecting Acyrthosiphon pisum Reveals a Strong Defense against Antimicrobial Peptides	PLOS ONE			English	Article							BACTERIUM ERWINIA-CHRYSANTHEMI; ESCHERICHIA-COLI; PEA APHID; PSEUDOMONAS-AERUGINOSA; VIRULENCE FACTORS; GLOBAL REGULATOR; SENSOR KINASE; SALMONELLA; EXPRESSION; PATHOGENICITY	The plant pathogenic bacterium Dickeya dadantii has recently been shown to be able to kill the aphid Acyrthosiphon pisum. While the factors required to cause plant disease are now well characterized, those required for insect pathogeny remain mostly unknown. To identify these factors, we analyzed the transcriptome of the bacteria isolated from infected aphids. More than 150 genes were upregulated and 300 downregulated more than 5-fold at 3 days post infection. No homologue to known toxin genes could be identified in the upregulated genes. The upregulated genes reflect the response of the bacteria to the conditions encountered inside aphids. While only a few genes involved in the response to oxidative stress were induced, a strong defense against antimicrobial peptides (AMP) was induced. Expression of a great number of efflux proteins and transporters was increased. Besides the genes involved in LPS modification by addition of 4-aminoarabinose (the arnBCADTEF operon) and phosphoethanolamine (pmrC, eptB) usually induced in Gram negative bacteria in response to AMPs, dltBAC and pbpG genes, which confer Gram positive bacteria resistance to AMPs by adding alanine to teichoic acids, were also induced. Both types of modification confer D. dadantii resistance to the AMP polymyxin. A. pisum harbors symbiotic bacteria and it is thought that it has a very limited immune system to maintain these populations and do not synthesize AMPs. The arnB mutant was less pathogenic to A. pisum, which suggests that, in contrast to what has been supposed, aphids do synthesize AMP.	[Costechareyre, Denis; Rahbe, Yvan; Condemine, Guy] Univ Lyon, Lyon, France; [Costechareyre, Denis; Condemine, Guy] Univ Lyon 1, F-69622 Villeurbanne, France; [Costechareyre, Denis; Condemine, Guy] CNRS, Microbiol Adaptat & Pathogenie UMR5240, Villeurbanne, France; [Costechareyre, Denis; Rahbe, Yvan; Condemine, Guy] INSA Lyon, Villeurbanne, France; [Chich, Jean-Francois] INRA, Sante Vigne & Qualite Vin UMR1131, Colmar, France; [Strub, Jean-Marc] Univ Strasbourg, CNRS, UMR7178, Lab Spectrometrie Masse BioOrgan,IPHC,DSA, Strasbourg, France; [Rahbe, Yvan] INRA, Biol Fonct Insectes & Interact UMR203, Villeurbanne, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; INRAE	Condemine, G (corresponding author), Univ Lyon, Lyon, France.	guy.condemine@insa-lyon.fr	Rahbe, Yvan/B-9389-2009	Rahbe, Yvan/0000-0002-0074-4443; Condemine, Guy/0000-0002-3256-3815; COSTECHAREYRE, Denis/0000-0002-9258-7421; Strub, Jean-Marc/0000-0001-6224-3428	ANR-Genoplante grant;  [ANR07GPLA002-Aphicibles]	ANR-Genoplante grant(French National Research Agency (ANR)); 	This study was funded by an ANR-Genoplante grant to GC, including a post-doctoral fellowship to DC, coordinated by YR (ANR07GPLA002-Aphicibles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altincicek B, 2011, DEV COMP IMMUNOL, V35, P1089, DOI 10.1016/j.dci.2011.03.017; An RS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-433; Bader MW, 2005, CELL, V122, P461, DOI 10.1016/j.cell.2005.05.030; BARDONNET N, 1991, FEMS MICROBIOL LETT, V84, P97, DOI 10.1016/0378-1097(91)90402-V; Bennett HPJ, 2005, J BACTERIOL, V187, P77, DOI 10.1128/JB.187.1.77-84.2005; Blot N, 2002, J BIOL CHEM, V277, P7936, DOI 10.1074/jbc.M109193200; Chakraborty S, 2010, J BIOL CHEM, V285, P38876, DOI 10.1074/jbc.M110.179150; Charkowski A, 2012, ANNU REV PHYTOPATHOL, V50, P425, DOI 10.1146/annurev-phyto-081211-173013; Charles H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029096; Condemine G, 2000, J BACTERIOL, V182, P1340, DOI 10.1128/JB.182.5.1340-1345.2000; Condemine G, 2007, J BACTERIOL, V189, P5955, DOI 10.1128/JB.00218-07; Costechareyre D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030702; Costechareyre D, 2010, ENVIRON MICROBIOL, V12, P3290, DOI 10.1111/j.1462-2920.2010.02305.x; FELLAY R, 1987, GENE, V52, P147, DOI 10.1016/0378-1119(87)90041-2; Fernandez L, 2010, ANTIMICROB AGENTS CH, V54, P3372, DOI 10.1128/AAC.00242-10; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Glasner JD, 2011, J BACTERIOL, V193, P2076, DOI 10.1128/JB.01513-10; Grenier AM, 2006, APPL ENVIRON MICROB, V72, P1956, DOI 10.1128/AEM.72.3.1956-1965.2006; Gunn JS, 2008, TRENDS MICROBIOL, V16, P284, DOI 10.1016/j.tim.2008.03.007; Harris F, 2009, CURR PROTEIN PEPT SC, V10, P585, DOI 10.2174/138920309789630589; Hommais F, 2008, J BACTERIOL, V190, P7508, DOI 10.1128/JB.00553-08; HugouvieuxCottePattat N, 1996, ANNU REV MICROBIOL, V50, P213, DOI 10.1146/annurev.micro.50.1.213; Khattar ZA, 2009, J BACTERIOL, V191, P7063, DOI 10.1128/JB.00892-09; Laughton AM, 2011, J INSECT PHYSIOL, V57, P830, DOI 10.1016/j.jinsphys.2011.03.015; Lebeau A, 2008, ENVIRON MICROBIOL, V10, P545, DOI 10.1111/j.1462-2920.2007.01473.x; Limmer S, 2011, P NATL ACAD SCI USA, V108, P17378, DOI 10.1073/pnas.1114907108; Llama-Palacios A, 2005, J BACTERIOL, V187, P2157, DOI 10.1128/JB.187.6.2157-2162.2005; Mahajan-Miklos S, 2000, MOL MICROBIOL, V37, P981, DOI 10.1046/j.1365-2958.2000.02056.x; Moule MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001065; Nasser W, 2001, MOL PLANT MICROBE IN, V14, P10, DOI 10.1094/MPMI.2001.14.1.10; Oshima K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023242; Perez JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000428; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pontes MH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002349; Prost LR, 2008, MOL MICROBIOL, V69, P503, DOI 10.1111/j.1365-2958.2008.06303.x; RAHBE Y, 1993, ENTOMOL EXP APPL, V67, P149, DOI 10.1007/BF02386520; RESIBOIS A, 1984, VIROLOGY, V137, P102, DOI 10.1016/0042-6822(84)90013-8; Reverchon S, 1997, J BACTERIOL, V179, P3500, DOI 10.1128/jb.179.11.3500-3508.1997; Reverchon S, 2002, J BACTERIOL, V184, P654, DOI 10.1128/JB.184.3.654-665.2002; Rio-Alvarez I, 2012, MOL PLANT MICROBE IN, V25, P523, DOI 10.1094/MPMI-09-11-0247; ROEDER DL, 1985, J BACTERIOL, V164, P51, DOI 10.1128/JB.164.1.51-56.1985; Sabater-Munoz B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r21; Sepulchre JA, 2007, J THEOR BIOL, V244, P239, DOI 10.1016/j.jtbi.2006.08.010; Shandala T, 2011, J CELL SCI, V124, P2165, DOI 10.1242/jcs.080598; Shirasu-Hiza MM, 2007, CELL MICROBIOL, V9, P2775, DOI 10.1111/j.1462-5822.2007.01042.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ulvila J., 2011, J LEUKOCYTE BIOL, V89, P649, DOI [10.1189/jlb.0410195, DOI 10.1189/jlb.0410195]; Vadyvaloo V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000783; Valecillos AM, 2006, MOL PLANT MICROBE IN, V19, P607, DOI 10.1094/MPMI-19-0607; Venkatesh B, 2006, J BACTERIOL, V188, P3088, DOI 10.1128/JB.188.8.3088-3098.2006; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Winfield MD, 2004, P NATL ACAD SCI USA, V101, P17162, DOI 10.1073/pnas.0406038101; Zwir I, 2005, P NATL ACAD SCI USA, V102, P2862, DOI 10.1073/pnas.0408238102	54	20	21	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54118	10.1371/journal.pone.0054118	http://dx.doi.org/10.1371/journal.pone.0054118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342088	Green Published, gold			2022-12-25	WOS:000314759400123
J	Daebeler, A; Gansen, M; Frenzel, P				Daebeler, Anne; Gansen, Martina; Frenzel, Peter			Methyl Fluoride Affects Methanogenesis Rather than Community Composition of Methanogenic Archaea in a Rice Field Soil	PLOS ONE			English	Article							RESTRICTION-FRAGMENT-LENGTH; STABLE-ISOTOPE FRACTIONATION; METHANE OXIDATION; ACETOCLASTIC METHANOGENESIS; CH4 PRODUCTION; MCRA GENES; INHIBITION; CARBON; RHIZOSPHERE; EMISSION	The metabolic pathways of methane formation vary with environmental conditions, but whether this can also be linked to changes in the active archaeal community structure remains uncertain. Here, we show that the suppression of aceticlastic methanogenesis by methyl fluoride (CH3F) caused surprisingly little differences in community composition of active methanogenic archaea from a rice field soil. By measuring the natural abundances of carbon isotopes we found that the effective dose for a 90% inhibition of aceticlastic methanogenesis in anoxic paddy soil incubations was <0.75% CH3F (v/v). The construction of clone libraries as well as t-RFLP analysis revealed that the active community, as indicated by mcrA transcripts (encoding the alpha subunit of methyl-coenzyme M reductase, a key enzyme for methanogenesis), remained stable over a wide range of CH3F concentrations and represented only a subset of the methanogenic community. More precisely, Methanocellaceae were of minor importance, but Methanosarcinaceae dominated the active population, even when CH3F inhibition only allowed for aceticlastic methanogenesis. In addition, we detected mcrA gene fragments of a so far unrecognised phylogenetic cluster. Transcription of this phylotype at methyl fluoride concentrations suppressing aceticlastic methanogenesis suggests that the respective organisms perform hydrogenotrophic methanogenesis. Hence, the application of CH3F combined with transcript analysis is not only a useful tool to measure and assign in situ acetate usage, but also to explore substrate usage by as yet uncultivated methanogens.	[Daebeler, Anne; Gansen, Martina; Frenzel, Peter] Max Planck Inst Terr Microbiol, Dept Biogeochem, D-35043 Marburg, Germany; [Daebeler, Anne] Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands	Max Planck Society; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Frenzel, P (corresponding author), Max Planck Inst Terr Microbiol, Dept Biogeochem, D-35043 Marburg, Germany.	frenzel@mpi-marburg.mpg.de	Daebeler, Anne/AAP-1274-2021; KNAW, NIOO-KNAW/A-4320-2012	KNAW, NIOO-KNAW/0000-0002-3835-159X; Daebeler, Anne/0000-0001-8026-3297	Deutsche Forschungsgemeinschaft; Riks Laanbroek (NIOO-KNAW)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Riks Laanbroek (NIOO-KNAW)	Work has been carried out at the Max Planck Institute for Terrestrial Microbiology, Marburg, Germany. AD's work on this project was funded by a grant of Deutsche Forschungsgemeinschaft to PF as part of the framework 'Biogeochemistry of paddy soil evolution', and further supported by Riks Laanbroek (NIOO-KNAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; BANKER BC, 1995, AGR ECOSYST ENVIRON, V53, P243, DOI 10.1016/0167-8809(94)00578-3; Bodelier PLE, 1999, APPL ENVIRON MICROB, V65, P1826; Bodelier PLE, 2000, BIOGEOCHEMISTRY, V51, P225, DOI 10.1023/A:1006438802362; Boeckx P, 1997, SOIL SCI SOC AM J, V61, P1250, DOI 10.2136/sssaj1997.03615995006100040035x; Bukovska P, 2010, J MICROBIOL METH, V82, P223, DOI 10.1016/j.mimet.2010.06.007; Cheng YQ, 2009, GEODERMA, V151, P31, DOI 10.1016/j.geoderma.2009.03.016; Chin KJ, 2004, MICROB ECOL, V47, P59, DOI 10.1007/s00248-003-2014-7; Comte J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025266; Conrad R, 2005, ORG GEOCHEM, V36, P739, DOI 10.1016/j.orggeochem.2004.09.006; Conrad R, 1999, FEMS MICROBIOL ECOL, V30, P47, DOI 10.1111/j.1574-6941.1999.tb00634.x; Conrad R, 2000, FEMS MICROBIOL ECOL, V34, P27, DOI 10.1111/j.1574-6941.2000.tb00751.x; Conrad R., 2002, FLOODED SOILS, P1316; Conrad R, 2008, GLOBAL CHANGE BIOL, V14, P657, DOI 10.1111/j.1365-2486.2007.01516.x; Conrad R, 2007, LIMNOL OCEANOGR, V52, P1393, DOI 10.4319/lo.2007.52.4.1393; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; EPP MA, 1993, J GEOPHYS RES-ATMOS, V98, P18413, DOI 10.1029/93JD01667; Frenzel P, 1996, FEMS MICROBIOL ECOL, V21, P25; GELWICKS JT, 1989, ORG GEOCHEM, V14, P441, DOI 10.1016/0146-6380(89)90009-0; Goevert D, 2009, APPL ENVIRON MICROB, V75, P2605, DOI 10.1128/AEM.02680-08; Grosskopf R, 1998, APPL ENVIRON MICROB, V64, P960; Hales BA, 1996, APPL ENVIRON MICROB, V62, P668, DOI 10.1128/AEM.62.2.668-675.1996; Heilman MA, 2001, BIOGEOCHEMISTRY, V52, P207, DOI 10.1023/A:1006427712846; HENNIGAN AN, 1994, MOL MICROBIOL, V11, P655, DOI 10.1111/j.1365-2958.1994.tb00344.x; Ho A, 2011, ENV MICROBIOL REP, V3, P738, DOI 10.1111/j.1758-2229.2011.00292.x; Janssen PH, 1997, APPL ENVIRON MICROB, V63, P4552, DOI 10.1128/AEM.63.11.4552-4557.1997; Jerman V, 2009, BIOGEOSCIENCES, V6, P1127, DOI 10.5194/bg-6-1127-2009; Jia ZJ, 2001, PLANT SOIL, V230, P211, DOI 10.1023/A:1010366631538; Junier P, 2008, APPL ENVIRON MICROB, V74, P6452, DOI 10.1128/AEM.01394-08; Kaplan CW, 2003, J MICROBIOL METH, V54, P121, DOI 10.1016/S0167-7012(03)00003-4; King GM, 1996, APPL ENVIRON MICROB, V62, P4548, DOI 10.1128/AEM.62.12.4548-4555.1996; Kotiaho M, 2010, BIOL FERT SOILS, V46, P567, DOI 10.1007/s00374-010-0461-0; Krause S, 2010, ISME J, V4, P1603, DOI 10.1038/ismej.2010.82; Kruger M, 2005, FEMS MICROBIOL ECOL, V51, P323, DOI 10.1016/j.femsec.2004.09.004; Kruger M, 2002, GLOBAL CHANGE BIOL, V8, P265, DOI 10.1046/j.1365-2486.2002.00476.x; Liu Y, 2010, HDB HYDROCARB LIPID, P595, DOI [10.1007/978-3-540-77587-4, DOI 10.1007/978-3-540-77587-4]; Lu YH, 2005, SCIENCE, V309, P1088, DOI 10.1126/science.1113435; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Lueders T, 2004, ENVIRON MICROBIOL, V6, P73, DOI 10.1046/j.1462-2920.2003.00536.x; Ma K, 2012, APPL ENVIRON MICROB, V78, P445, DOI 10.1128/AEM.06934-11; Metje M, 2005, APPL ENVIRON MICROB, V71, P8191, DOI 10.1128/AEM.71.12.8191-8200.2005; Metje M, 2007, ENVIRON MICROBIOL, V9, P954, DOI 10.1111/j.1462-2920.2006.01217.x; Moosavi SC, 1998, J GEOPHYS RES-ATMOS, V103, P29093, DOI 10.1029/97JD03519; Oksanen J., 2016, R PACKAG; OREMLAND RS, 1988, ADV MICROB ECOL, V10, P285; OREMLAND RS, 1992, APPL ENVIRON MICROB, V58, P2983, DOI 10.1128/AEM.58.9.2983-2992.1992; Penning H, 2006, APPL ENVIRON MICROB, V72, P178, DOI 10.1128/AEM.72.1.178-184.2006; Penning H, 2007, ORG GEOCHEM, V38, P2058, DOI 10.1016/j.orggeochem.2007.08.004; Popp TJ, 2000, BIOGEOCHEMISTRY, V51, P259, DOI 10.1023/A:1006452609284; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramakrishnan B, 2001, FEMS MICROBIOL ECOL, V37, P175, DOI 10.1111/j.1574-6941.2001.tb00865.x; Reiche M, 2008, FEMS MICROBIOL ECOL, V65, P88, DOI 10.1111/j.1574-6941.2008.00523.x; Ritz C, 2005, J STAT SOFTW, V12, P1; Roy R, 1997, FEMS MICROBIOL ECOL, V24, P311, DOI 10.1111/j.1574-6941.1997.tb00448.x; Sakai S, 2010, INT J SYST EVOL MICR, V60, P2918, DOI 10.1099/ijs.0.020883-0; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; vanderGon HACD, 1996, BIOL FERT SOILS, V22, P359, DOI 10.1007/BF00334584; Watanabe T, 2009, SOIL BIOL BIOCHEM, V41, P276, DOI 10.1016/j.soilbio.2008.10.025; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; WHITICAR MJ, 1986, GEOCHIM COSMOCHIM AC, V50, P693, DOI 10.1016/0016-7037(86)90346-7; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wissing L, 2011, CATENA, V87, P376, DOI 10.1016/j.catena.2011.07.007; Wu LQ, 2009, MICROB ECOL, V58, P819, DOI 10.1007/s00248-009-9554-4	64	18	18	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53656	10.1371/journal.pone.0053656	http://dx.doi.org/10.1371/journal.pone.0053656			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341965	Green Published, gold			2022-12-25	WOS:000314759400059
J	Nilsson, RE; Ross, T; Bowman, JP; Britz, ML				Nilsson, Rolf E.; Ross, Tom; Bowman, John P.; Britz, Margaret L.			MudPIT Profiling Reveals a Link between Anaerobic Metabolism and the Alkaline Adaptive Response of Listeria monocytogenes EGD-e	PLOS ONE			English	Article							ESCHERICHIA-COLI; STRINGENT RESPONSE; BACILLUS-SUBTILIS; PH HOMEOSTASIS; STRESS; GROWTH; ACID; IDENTIFICATION; STARVATION; TOLERANCE	Listeria monocytogenes is a foodborne human pathogen capable of causing life-threatening disease in susceptible populations. Previous proteomic analysis we performed demonstrated that different strains of L. monocytogenes initiate a stringent response when subjected to alkaline growth conditions. Here, using multidimensional protein identification technology (MudPIT), we show that in L. monocytogenes EGD-e this response involves an energy shift to anaerobic pathways in response to the extracellular pH environment. Importantly we show that this supports a reduction in relative lag time following an abrupt transition to low oxygen tension culture conditions. This has important implications for the packaging of fresh and ready-to-eat foods under reduced oxygen conditions in environments where potential exists for alkaline adaptation.	[Nilsson, Rolf E.; Ross, Tom; Bowman, John P.; Britz, Margaret L.] Univ Tasmania, Food Safety Ctr, Tasmanian Inst Agr, Sch Agr Sci, Hobart, Tas, Australia	University of Tasmania	Nilsson, RE (corresponding author), Univ Tasmania, Food Safety Ctr, Tasmanian Inst Agr, Sch Agr Sci, Hobart, Tas, Australia.	nilssonr@utas.edu.au	Bowman, John P/C-2414-2014; Britz, Margaret L/J-7632-2014; Bowman, John P./ABF-5108-2020	Bowman, John P/0000-0002-4528-9333; Bowman, John P./0000-0002-4528-9333; Ross, Tom/0000-0001-9916-7772	Food Safety Centre, University of Tasmania; Australian National Food Industry Strategy	Food Safety Centre, University of Tasmania; Australian National Food Industry Strategy	This work was supported by the Food Safety Centre, University of Tasmania and the Australian National Food Industry Strategy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTS B, 2004, ESSENTIAL CELL BIOL, P119; Avarbock D, 2000, BIOCHEMISTRY-US, V39, P11640, DOI 10.1021/bi001256k; BARRY AL, 1967, APPL MICROBIOL, V15, P1138, DOI 10.1128/AEM.15.5.1138-1141.1967; Beissbarth T, 2004, BIOINFORMATICS, V20, P31, DOI 10.1093/bioinformatics/bth924; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; Bremer H, 1996, MODULATION CHEM COMP; Burkholder KM, 2009, MICROBES INFECT, V11, P859, DOI 10.1016/j.micinf.2009.05.006; Chaturongakul S, 2006, APPL ENVIRON MICROB, V72, P5197, DOI 10.1128/AEM.03058-05; Christensen DP, 1999, APPL ENVIRON MICROB, V65, P2112; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; DANESHVAR MI, 1989, CAN J MICROBIOL, V35, P786, DOI 10.1139/m89-131; Delahunty C, 2005, METHODS, V35, P248, DOI 10.1016/j.ymeth.2004.08.016; Delahunty CM, 2007, BIOTECHNIQUES, V43, P563; Ebersbach T, 2010, INT J FOOD MICROBIOL, V140, P218, DOI 10.1016/j.ijfoodmicro.2010.03.030; Eisenreich W, 2006, P NATL ACAD SCI USA, V103, P2040, DOI 10.1073/pnas.0507580103; Feng HH, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/617509; Gardan R, 2003, APPL ENVIRON MICROB, V69, P3137, DOI 10.1128/AEM.69.6.3137-3143.2003; Gill AO, 2004, APPL ENVIRON MICROB, V70, P5750, DOI 10.1128/AEM.70.10.5750-5755.2004; Giotis ES, 2007, INT J FOOD MICROBIOL, V120, P250, DOI 10.1016/j.ijfoodmicro.2007.08.036; Giotis ES, 2007, APPL ENVIRON MICROB, V73, P997, DOI 10.1128/AEM.00865-06; Handke LD, 2008, J BACTERIOL, V190, P798, DOI 10.1128/JB.01115-07; Hong Y, 2010, BIOTECHNOL BIOENG, V105, P965, DOI 10.1002/bit.22606; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; ITO M, 1983, J BACTERIOL, V153, P310, DOI 10.1128/JB.153.1.310-315.1983; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Lewinson O, 2004, P NATL ACAD SCI USA, V101, P14073, DOI 10.1073/pnas.0405375101; Lungu B, 2009, ANAEROBE, V15, P7, DOI 10.1016/j.anaerobe.2008.08.001; Lungu B, 2010, FOODBORNE PATHOG DIS, V7, P499, DOI 10.1089/fpd.2009.0408; MARR AG, 1991, MICROBIOL REV, V55, P316, DOI 10.1128/MMBR.55.2.316-333.1991; Mellefont LA, 2003, INT J FOOD MICROBIOL, V83, P281, DOI 10.1016/S0168-1605(02)00377-X; Miethke M, 2006, J BACTERIOL, V188, P8655, DOI 10.1128/JB.01049-06; Nilsson RE, 2012, FOOD MICROBIOL, V30, P187, DOI 10.1016/j.fm.2011.10.004; Nilsson RE, 2011, INT J FOOD MICROBIOL, V150, P14, DOI 10.1016/j.ijfoodmicro.2011.07.012; Ofer A, 2011, J BACTERIOL, V193, P2931, DOI 10.1128/JB.01405-10; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Persky NS, 2009, MOL MICROBIOL, V73, P253, DOI 10.1111/j.1365-2958.2009.06767.x; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Romick TL, 1996, APPL ENVIRON MICROB, V62, P304, DOI 10.1128/AEM.62.1.304-307.1996; Sato A, 2005, GENES CELLS, V10, P393, DOI 10.1111/j.1365-2443.2005.00851.x; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Shabala L, 2002, INT J FOOD MICROBIOL, V75, P89, DOI 10.1016/S0168-1605(01)00740-1; Sleator RD, 2003, APPL ENVIRON MICROB, V69, P1, DOI 10.1128/AEM.69.1.1-9.2003; Sokal R. R., 2012, BIOMETRY; SVITIL AL, 1993, J BIOL CHEM, V268, P2307; Tienungoon S, 2000, APPL ENVIRON MICROB, V66, P4979, DOI 10.1128/AEM.66.11.4979-4987.2000; TRIVETT TL, 1971, J BACTERIOL, V107, P770, DOI 10.1128/JB.107.3.770-779.1971; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; Wang WX, 2003, ANAL CHEM, V75, P4818, DOI 10.1021/ac026468x; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273	49	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54157	10.1371/journal.pone.0054157	http://dx.doi.org/10.1371/journal.pone.0054157			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342094	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400126
J	Svicher, V; Cento, V; Rozera, G; Abbate, I; Santoro, MM; Armenia, D; Fabeni, L; Bruselles, A; Latini, A; Palamara, G; Micheli, V; Rizzardini, G; Gori, C; Forbici, F; Ippolito, G; Andreoni, M; Antinori, A; Ceccherini-Silberstein, F; Capobianchi, MR; Perno, CF				Svicher, Valentina; Cento, Valeria; Rozera, Gabriella; Abbate, Isabella; Santoro, Maria Mercedes; Armenia, Daniele; Fabeni, Lavinia; Bruselles, Alessandro; Latini, Alessandra; Palamara, Guido; Micheli, Valeria; Rizzardini, Giuliano; Gori, Caterina; Forbici, Federica; Ippolito, Giuseppe; Andreoni, Massimo; Antinori, Andrea; Ceccherini-Silberstein, Francesca; Capobianchi, Maria Rosaria; Perno, Carlo Federico			The Genotypic False Positive Rate Determined by V3 Population Sequencing Can Predict the Burden of HIV-1 CXCR4-using Species Detected by Pyrosequencing	PLOS ONE			English	Article							CORECEPTOR USAGE; TROPISM; MARAVIROC; LOOP; IMPACT; GP120; TOOLS; 1ST	Objective: The false-positive rate (FPR) is a percentage-score provided by Geno2Pheno-algorithm indicating the likelihood that a V3-sequence is falsely predicted as CXCR4-using. We evaluated the correlation between FPR obtained by V3 population-sequencing and the burden of CXCR4-using variants detected by V3 ultra-deep sequencing (UDPS) and Enhanced-Sensitivity Trofile assay (ESTA). Methods: 54 HIV-1 B-subtype infected-patients (all maraviroc-naive), with viremia >10,000copies/ml, were analyzed. HIV-tropism was assessed by V3 population-sequencing, UDPS (considering variants with >0.5% prevalence), and ESTA. Results: By UDPS, CCR5-using variants were detected in 53/54 patients, irrespective of FPR values, and their intra-patient prevalence progressively increased by increasing the FPR obtained by V3 population-sequencing (rho = 0.75, p = 5.0e-8). Conversely, the intra-patient prevalence of CXCR4-using variants in the 54 patients analyzed progressively decreased by increasing the FPR (rho = -0.61; p = 9.3e-6). Indeed, no CXCR4-using variants were detected in 13/13 patients with FPR>60. They were present in 7/18 (38.8%) patients with FPR 20-60 (intra-patient prevalence range: 2.1%-18.4%), in 5/7 (71.4%) with FPR 10-20, in 4/6 (66.7%) with FPR 5-10, and in 10/10(100%) with FPR<5 (intra-patient prevalence range: 12.1%-98.1%). Conclusions: FPR by V3 population-sequencing can predict the burden of CXCR4-using variants. This information can be used to optimize the management of tropism determination in clinical practice. Due to its low cost and short turnaround time, V3 population-sequencing may represent the most feasible test for HIV-1 tropism determination. More sensitive methodologies (as UDPS) might be useful when V3 population-sequencing provides a FPR >20 (particularly in the range 20-60), allowing a more careful identification of patients harboring CXCR4-using variants.	[Svicher, Valentina; Cento, Valeria; Santoro, Maria Mercedes; Armenia, Daniele; Ceccherini-Silberstein, Francesca; Perno, Carlo Federico] Univ Roma Tor Vergata, Dept Expt Med & Surg, Rome, Italy; [Rozera, Gabriella; Abbate, Isabella; Fabeni, Lavinia; Bruselles, Alessandro; Gori, Caterina; Forbici, Federica; Ippolito, Giuseppe; Antinori, Andrea; Capobianchi, Maria Rosaria; Perno, Carlo Federico] INMI L Spallanzani, Rome, Italy; [Latini, Alessandra; Palamara, Guido] San Gallicano Hosp, Rome, Italy; [Micheli, Valeria; Rizzardini, Giuliano] L Sacco Hosp Vialba, Milan, Italy; [Andreoni, Massimo] Univ Hosp Tor Vergata, Rome, Italy	University of Rome Tor Vergata; IRCCS Lazzaro Spallanzani; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); University of Milan; Luigi Sacco Hospital; University of Rome Tor Vergata; Policlin Tor Vergata	Ceccherini-Silberstein, F (corresponding author), Univ Roma Tor Vergata, Dept Expt Med & Surg, Rome, Italy.	ceccherini@med.uniroma2.it	latini, alessandra/J-8186-2018; Rozera, Gabriella/B-6874-2017; Abbate, Isabella/K-6434-2016; Micheli, Valeria/G-4927-2018; Antinori, Andrea/K-7125-2016; Andreoni, Masimo/AAL-2214-2020; Di Maio, Velia Chiara/AGH-2628-2022; Armenia, Daniele/K-2009-2016; Bruselles, Alessandro/M-6012-2019; Bruselles, Alessandro/M-7908-2017; Ippolito, Giuseppe/J-7207-2017; perno, carlo federico/O-1544-2016; FABENI, LAVINIA/J-6626-2016; Cento, Valeria/AAF-2607-2020; Ceccherini-Silberstein, Francesca/K-4762-2016; SANTORO, MARIA/K-3250-2018; gori, caterina/B-7836-2017; Forbici, Federica/B-6765-2017; Cento, Valeria/K-6636-2012	Micheli, Valeria/0000-0001-5629-3875; Antinori, Andrea/0000-0003-2121-4684; Armenia, Daniele/0000-0002-3406-7014; Bruselles, Alessandro/0000-0002-1556-4998; Bruselles, Alessandro/0000-0002-1556-4998; FABENI, LAVINIA/0000-0002-2975-8611; SANTORO, MARIA/0000-0002-6228-1114; Rozera, Gabriella/0000-0002-3590-8268; Andreoni, Massimo/0000-0002-3205-9758; SVICHER, VALENTINA/0000-0002-2377-504X; gori, caterina/0000-0002-6042-7570; Forbici, Federica/0000-0002-3954-5679; PERNO, CARLO FEDERICO/0000-0002-0825-5388; Latini, Alessandra/0000-0002-9421-6560; Ippolito, Giuseppe/0000-0002-1076-2979; Cento, Valeria/0000-0002-3272-4252; Capobianchi, Maria Rosaria/0000-0003-3465-0071; CECCHERINI SILBERSTEIN, FRANCESCA/0000-0002-6024-5101	CHAIN, Collaborative HIV and Anti-HIV Drug Resistance Network, Integrated Project [223131]; European Commission Framework 7 Program; Italian National Institute of Health (Programma Nazionale AIDS) [40H41]; Ministry of University and Scientific Research; Current and Finalized Research of the Italian Ministry of Health; AVIRALIA Foundation; Abbott; Boehringer Ingelheim; Bristol Myers Squibb; Gilead; Merck Sharp Dohme; Janssen Cilag; Pfizer; Tibotec; Roche; ViiV	CHAIN, Collaborative HIV and Anti-HIV Drug Resistance Network, Integrated Project; European Commission Framework 7 Program; Italian National Institute of Health (Programma Nazionale AIDS); Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Current and Finalized Research of the Italian Ministry of Health; AVIRALIA Foundation; Abbott(Abbott Laboratories); Boehringer Ingelheim(Boehringer Ingelheim); Bristol Myers Squibb(Bristol-Myers Squibb); Gilead(Gilead Sciences); Merck Sharp Dohme(Merck & Company); Janssen Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Pfizer(Pfizer); Tibotec; Roche(Roche Holding); ViiV	This work was supported by grants from CHAIN, Collaborative HIV and Anti-HIV Drug Resistance Network, Integrated Project no. 223131, funded by the European Commission Framework 7 Program, the Italian National Institute of Health (Programma Nazionale AIDS - 40H41), the Ministry of University and Scientific Research, Current and Finalized Research of the Italian Ministry of Health, and AVIRALIA Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. C. F. Perno has received funds for attending symposia, speaking, organizing educational activities, grant research support, consultancy and advisory board membership, from Abbott, Boehringer Ingelheim, Bristol Myers Squibb, Gilead, Merck Sharp & Dohme, Janssen Cilag, Pfizer, Tibotec, Roche, and ViiV. F. Ceccherini-Silberstein has received funds for attending symposia, speaking and organizing educational activities from Abbott, Merck Sharp & Dohme, Janssen Cilag, and ViiV. V Svicher has received funds for attending symposia, speaking and organizing educational activities from ViiV. The other authors declare that no competing interests exist. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abbate I, 2011, CLIN MICROBIOL INFEC, V17, P725, DOI 10.1111/j.1469-0691.2010.03350.x; Abbate I, 2011, J INFECT DIS, V204, P971, DOI 10.1093/infdis/jir427; Abbate I, 2011, AIDS, V25, P611, DOI 10.1097/QAD.0b013e328343489e; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; BOYD MT, 1993, J VIROL, V67, P3649, DOI 10.1128/JVI.67.6.3649-3652.1993; Cardozo T, 2007, AIDS RES HUM RETROV, V23, P415, DOI 10.1089/aid.2006.0130; Chueca N, 2009, J MED VIROL, V81, P763, DOI 10.1002/jmv.21425; Dimonte S, 2011, RETROVIROL, V12, P8, DOI DOI 10.1186/1742-4690-8-33; FOUCHIER RAM, 1995, J CLIN MICROBIOL, V33, P906, DOI 10.1128/JCM.33.4.906-911.1995; Harrigan R, 2010, REWIEVS ANTIVIRAL TH, V1, P36; Hoffman TL, 1999, MOL MEMBR BIOL, V16, P57, DOI 10.1080/096876899294760; KOITO A, 1995, VIROLOGY, V206, P878, DOI 10.1006/viro.1995.1010; MacArthur RD, 2008, CLIN INFECT DIS, V47, P236, DOI 10.1086/589289; McGovern Rachel A, 2010, J Vis Exp, DOI 10.3791/2531; Nolan KM, 2008, J VIROL, V82, P664, DOI 10.1128/JVI.01793-07; Pastore C, 2006, J VIROL, V80, P750, DOI 10.1128/JVI.80.2.750-758.2006; Poveda E, 2009, J ANTIMICROB CHEMOTH, V63, P1006, DOI 10.1093/jac/dkp063; Raymond S, 2008, AIDS, V22, pF11, DOI 10.1097/QAD.0b013e32830ebcd4; Raymond S, 2010, AIDS, V24, P2305, DOI 10.1097/QAD.0b013e32833e50bb; Regoes RR, 2005, TRENDS MICROBIOL, V13, P269, DOI 10.1016/j.tim.2005.04.005; Rozera G, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-15; Saliou A, 2011, ANTIMICROB AGENTS CH, V55, P2831, DOI 10.1128/AAC.00091-11; Svicher V, 2011, ANTIVIR RES, V90, P42, DOI 10.1016/j.antiviral.2011.02.005; Svicher V, 2010, NEW MICROBIOL, V33, P195; Swenson LC, 2011, CLIN INFECT DIS, V53, P732, DOI 10.1093/cid/cir493; Swenson LC, 2011, J INFECT DIS, V203, P237, DOI 10.1093/infdis/jiq030; Vandekerckhove LPR, 2011, LANCET INFECT DIS, V11, P394, DOI 10.1016/S1473-3099(10)70319-4; Waters L, 2008, CLIN INFECT DIS, V46, P1617, DOI 10.1086/587660	28	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53603	10.1371/journal.pone.0053603	http://dx.doi.org/10.1371/journal.pone.0053603			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341955	Green Submitted, gold, Green Published			2022-12-25	WOS:000314759400052
J	Uusitalo-Seppala, R; Huttunen, R; Aittoniemi, J; Koskinen, P; Leino, A; Vahlberg, T; Rintala, EM				Uusitalo-Seppala, Raija; Huttunen, Reetta; Aittoniemi, Janne; Koskinen, Pertti; Leino, Aila; Vahlberg, Tero; Rintala, Esa M.			Pentraxin 3 (PTX3) Is Associated with Severe Sepsis and Fatal Disease in Emergency Room Patients with Suspected Infection: A Prospective Cohort Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; LONG PENTRAXIN; INNATE IMMUNITY; SEPTIC SHOCK; PROCALCITONIN; MARKER; INFLAMMATION; RECOGNITION; RECEPTOR; CLONING	Background: Early diagnostic and prognostic stratification of patients with suspected infection is a difficult clinical challenge. We studied plasma pentraxin 3 (PTX3) upon admission to the emergency department in patients with suspected infection. Methods: The study comprised 537 emergency room patients with suspected infection: 59 with no systemic inflammatory response syndrome (SIRS) and without bacterial infection (group 1), 67 with bacterial infection without SIRS (group 2), 54 with SIRS without bacterial infection (group 3), 308 with sepsis (SIRS and bacterial infection) without organ failure (group 4) and 49 with severe sepsis (group 5). Plasma PTX3 was measured on admission using a commercial solid-phase enzyme-linked immunosorbent assay (ELISA). Results: The median PTX3 levels in groups 1-5 were 2.6 ng/ml, 4.4 ng/ml, 5.0 ng/ml, 6.1 ng/ml and 16.7 ng/ml, respectively (p<0.001). The median PTX3 concentration was higher in severe sepsis patients compared to others (16.7 vs. 4.9 ng/ml, p<0.001) and in non-survivors (day 28 case fatality) compared to survivors (14.1 vs. 5.1 ng/ml, p<0.001). A high PTX3 level predicted the need for ICU stay (p<0.001) and hypotension (p<0.001). AUC(ROC) in the prediction of severe sepsis was 0.73 (95% CI 0.66-0.81, p<0.001) and 0.69 in case fatality (95% CI 0.58-0.79, p<0.001). PTX3 at a cut-off level for 14.1 ng/ml (optimal cut-off value for severe sepsis) showed 63% sensitivity and 80% specificity. At a cut-off level 7.7 ng/ml (optimal cutoff value for case fatality) showed 70% sensitivity and 63% specificity in predicting case fatality on day 28.In multivariate models, high PTX3 remained an independent predictor of severe sepsis and case fatality after adjusting for potential confounders. Conclusions: A high PTX3 level on hospital admission predicts severe sepsis and case fatality in patients with suspected infection.	[Uusitalo-Seppala, Raija] Satakunta Cent Hosp, Dept Infect Dis, Pori, Finland; [Huttunen, Reetta] Tampere Univ Hosp, Dept Internal Med, Tampere, Finland; [Huttunen, Reetta] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Aittoniemi, Janne] Fimlab Labs, Tampere, Finland; [Koskinen, Pertti; Leino, Aila] Turku Univ, Dept Clin Chem, Turku, Finland; [Koskinen, Pertti; Leino, Aila] Turku Univ Hosp, TYKSLAB, Hosp Dist SW Finland, FIN-20520 Turku, Finland; [Vahlberg, Tero] Turku Univ, Dept Biostat, Turku, Finland; [Rintala, Esa M.] Turku Univ Hosp, Dept Hosp Hyg & Infect Control, FIN-20520 Turku, Finland	Satakunta Central Hospital; Tampere University; Tampere University Hospital; Tampere University; University of Turku; University of Turku; University of Turku; University of Turku	Uusitalo-Seppala, R (corresponding author), Satakunta Cent Hosp, Dept Infect Dis, Pori, Finland.	raija.uusitalo-seppala@satadiag.fi		Rintala, Esa/0000-0002-9289-8043	Research Fund of Satakunta Central Hospital; Tampere University Hospital; Turku University Hospital	Research Fund of Satakunta Central Hospital; Tampere University Hospital; Turku University Hospital	This work was financially supported by the Research Fund of Satakunta Central Hospital and by the Competitive Research Funding of Tampere University Hospital and Turku University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Basile A, 1997, J BIOL CHEM, V272, P8172, DOI 10.1074/jbc.272.13.8172; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Bottazzi B, 1997, J BIOL CHEM, V272, P32817, DOI 10.1074/jbc.272.52.32817; Bottazzi B, 2009, IMMUNOL REV, V227, P9, DOI 10.1111/j.1600-065X.2008.00719.x; Boyd JC, 1997, SCAND J CLIN LAB INV, V57, P46, DOI 10.1080/00365519709168308; BREVIARIO F, 1992, J BIOL CHEM, V267, P22190; Clyne B, 1999, J EMERG MED, V17, P1019, DOI 10.1016/S0736-4679(99)00135-3; de Kruif MD, 2010, J INFECTION, V60, P122, DOI 10.1016/j.jinf.2009.11.010; Diamandis EP, 2011, CLIN CANCER RES, V17, P2395, DOI 10.1158/1078-0432.CCR-10-3024; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Garlanda C, 2011, CURR PHARM DESIGN, V17, P38, DOI 10.2174/138161211795049750; He XL, 2007, AM J PHYSIOL-LUNG C, V292, pL1039, DOI 10.1152/ajplung.00490.2006; Huttunen R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017653; Introna M, 1996, Blood, V87, P1862; Karlsson S, 2007, INTENS CARE MED, V33, P435, DOI 10.1007/s00134-006-0504-z; Kumar A, 2006, J INFECT DIS, V193, P251, DOI 10.1086/498909; LEE GW, 1993, J IMMUNOL, V150, P1804; Luzzani A, 2003, CRIT CARE MED, V31, P1737, DOI 10.1097/01.CCM.0000063440.19188.ED; Mairuhu ATA, 2005, J MED VIROL, V76, P547, DOI 10.1002/jmv.20397; Manfredi AA, 2008, CURR OPIN IMMUNOL, V20, P538, DOI 10.1016/j.coi.2008.05.004; Mantovani A, 2008, J CLIN IMMUNOL, V28, P1, DOI 10.1007/s10875-007-9126-7; Marshall JC, 2009, CRIT CARE MED, V37, P2290, DOI 10.1097/CCM.0b013e3181a02afc; Mauri T, 2008, CRIT CARE MED, V36, P2302, DOI 10.1097/CCM.0b013e3181809aaf; Mauri T, 2010, INTENS CARE MED, V36, P621, DOI 10.1007/s00134-010-1752-5; Muller B, 2001, CRIT CARE MED, V29, P1404, DOI 10.1097/00003246-200107000-00017; Nakamura A, 2009, SHOCK, V31, P586, DOI 10.1097/SHK.0b013e31819716fa; Napoleone E, 2004, J LEUKOCYTE BIOL, V76, P203, DOI 10.1189/jlb.1003528; Outinen TK, 2012, EUR J CLIN MICROBIOL, V31, P957, DOI 10.1007/s10096-011-1392-x; Povoa P, 2005, CLIN MICROBIOL INFEC, V11, P101, DOI 10.1111/j.1469-0691.2004.01044.x; Silvestre J, 2009, INTENS CARE MED, V35, P909, DOI 10.1007/s00134-009-1402-y; Sprong T, 2009, SHOCK, V31, P28, DOI 10.1097/SHK.0b013e31817fd543; Tang H, 2009, INFECTION, V37, P497, DOI 10.1007/s15010-009-9034-2; Uusitalo-Seppala R, 2012, J INTERN MED, V272, P247, DOI 10.1111/j.1365-2796.2012.02569.x; Uusitalo-Seppala R, 2012, SCAND J INFECT DIS, V44, P697, DOI 10.3109/00365548.2012.677061; Uusitalo-Seppala R, 2011, SCAND J INFECT DIS, V43, P883, DOI 10.3109/00365548.2011.600325; Vanska M, 2011, HAEMATOL-HEMATOL J, V96, P1385, DOI 10.3324/haematol.2011.044925; Wagenaar JFP, 2009, J INFECTION, V58, P425, DOI 10.1016/j.jinf.2009.04.004; Yamasaki K, 2009, CLIN CHEM LAB MED, V47, P471, DOI 10.1515/CCLM.2009.110; Zambon M, 2008, J CRIT CARE, V23, P455, DOI 10.1016/j.jcrc.2007.08.003	42	62	64	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53661	10.1371/journal.pone.0053661	http://dx.doi.org/10.1371/journal.pone.0053661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341967	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400061
J	Wichmann, J; Folke, F; Torp-Pedersen, C; Lippert, F; Ketzel, M; Ellermann, T; Loft, S				Wichmann, Janine; Folke, Fredrik; Torp-Pedersen, Christian; Lippert, Freddy; Ketzel, Matthias; Ellermann, Thomas; Loft, Steffen			Out-of-Hospital Cardiac Arrests and Outdoor Air Pollution Exposure in Copenhagen, Denmark	PLOS ONE			English	Article							CASE-CROSSOVER ANALYSIS; AMERICAN-HEART-ASSOCIATION; FINE PARTICULATE MATTER; LONG-TERM EXPOSURE; MYOCARDIAL-INFARCTION; ULTRAFINE PARTICLES; AMBIENT AIR; CARDIOVASCULAR-DISEASE; VASCULAR FUNCTION; DISTRIBUTED LAG	Cardiovascular disease is the number one cause of death globally and air pollution can be a contributing cause. Acute myocardial infarction and cardiac arrest are frequent manifestations of coronary heart disease. The objectives of the study were to investigate the association between 4 657 out-of-hospital cardiac arrests (OHCA) and hourly and daily outdoor levels of PM10, PM2.5, coarse fraction of PM (PM10-2.5), ultrafine particle proxies, NOx, NO2, O-3 and CO in Copenhagen, Denmark, for the period 2000-2010. Susceptible groups by age and sex was also investigated. A case-crossover design was applied. None of the hourly lags of any of the pollutants were significantly associated with OHCA events. The strongest association with OHCA events was observed for the daily lag4 of PM2.5, lag3 of PM10, lag3 of PM10-2.5, lag3 of NOx and lag4 of CO. An IQR increase of PM2.5 and PM10 was associated with a significant increase of 4% (95% CI: 0%; 9%) and 5% (95% CI: 1%; 9%) in OHCA events with 3 days lag, respectively. None of the other daily lags or other pollutants was significantly associated with OHCA events. Adjustment for O-3 slightly increased the association between OHCA and PM2.5 and PM10. No susceptible groups were identified.	[Wichmann, Janine; Loft, Steffen] Univ Copenhagen, Environm Hlth Sect, Dept Publ Hlth, Fac Hlth Sci, Copenhagen, Denmark; [Folke, Fredrik; Torp-Pedersen, Christian] Univ Copenhagen, Dept Cardiol, Gentofte Hosp, Copenhagen, Denmark; [Lippert, Freddy] Copenhagen Emergency Med Serv, Copenhagen, Denmark; [Ketzel, Matthias; Ellermann, Thomas] Aarhus Univ, Dept Environm Sci, Roskilde, Denmark	University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Aarhus University	Wichmann, J (corresponding author), Univ Copenhagen, Environm Hlth Sect, Dept Publ Hlth, Fac Hlth Sci, Copenhagen, Denmark.	stl@sund.ku.dk	Folke, Fredrik/P-3601-2014; Ketzel, Matthias/K-4246-2015; Torp-Pedersen, Christian/E-5931-2013	Ketzel, Matthias/0000-0001-9519-1935; Loft, Steffen/0000-0001-9552-8518; Lippert, Freddy/0000-0002-2356-8809; Folke, Fredrik/0000-0002-2284-7857	Danish Environmental Protection Agency	Danish Environmental Protection Agency	The Danish Environmental Protection Agency funded the air pollution and meteorological measurements as part of the Danish Air Quality Monitoring Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RW, 2011, AM J RESP CRIT CARE, V183, P1222, DOI 10.1164/rccm.201010-1572OC; Andersen ZJ, 2007, J EXPO SCI ENV EPID, V17, P625, DOI 10.1038/sj.jes.7500546; Andersen ZJ, 2010, EUR HEART J, V31, P2034, DOI 10.1093/eurheartj/ehq188; Anderson H. R., 2007, QUANTITATIVE SYSTEMA; Bateson TF, 1999, EPIDEMIOLOGY, V10, P539, DOI 10.1097/00001648-199909000-00013; Bateson TF, 2001, EPIDEMIOLOGY, V12, P654, DOI 10.1097/00001648-200111000-00013; Bhaskaran K, 2009, HEART, V95, P1746, DOI 10.1136/hrt.2009.175018; Bosson J, 2007, RESP MED, V101, P1140, DOI 10.1016/j.rmed.2006.11.010; Brauner EV, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-13; Brauner EV, 2008, AM J RESP CRIT CARE, V177, P419, DOI 10.1164/rccm.200704-632OC; Brauner EV, 2007, ENVIRON HEALTH PERSP, V115, P1177, DOI 10.1289/ehp.9984; Brauner EV, 2009, INHAL TOXICOL, V21, P38, DOI [10.1080/08958370802304735, 10.1080/08958370802304735 ]; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Costa DL, 1997, ENVIRON HEALTH PERSP, V105, P1053, DOI 10.2307/3433509; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; Delfino RJ, 2009, ENVIRON HEALTH PERSP, V117, P1232, DOI [10.1289/journla.ehp.0800194, 10.1289/ehp.0800194]; Dennekamp M, 2010, EPIDEMIOLOGY, V21, P494, DOI 10.1097/EDE.0b013e3181e093db; Donaldson K, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-10; Ellermann T, 2011, 836 AARH U NAT ENV R; Folke F, 2009, CIRCULATION, V120, P510, DOI 10.1161/CIRCULATIONAHA.108.843755; Forastiere F, 2005, AM J RESP CRIT CARE, V172, P1549, DOI 10.1164/rccm.200412-1726OC; Ghio AJ, 2001, AM J RESP CRIT CARE, V164, P704, DOI 10.1164/ajrccm.164.4.2011089; Gilliland FD, 2004, LANCET, V363, P119, DOI 10.1016/S0140-6736(03)15262-2; Godleski J J, 2000, Res Rep Health Eff Inst, P5; Goldberg M S, 2000, Res Rep Health Eff Inst, P7; Guo YM, 2011, ENVIRON HEALTH PERSP, V119, P1719, DOI 10.1289/ehp.1103598; Hoek G, 2002, LANCET, V360, P1203, DOI 10.1016/S0140-6736(02)11280-3; Horsted TI, 2007, RESUSCITATION, V72, P214, DOI 10.1016/j.resuscitation.2006.06.029; Ibald-Mulli A, 2001, AM J PUBLIC HEALTH, V91, P571, DOI 10.2105/AJPH.91.4.571; Kodavanti UP, 2011, ENVIRON HEALTH PERSP, V119, P312, DOI 10.1289/ehp.1002386; Lee JT, 2000, ENVIRON HEALTH PERSP, V108, P1107, DOI 10.2307/3434821; Levy D, 2001, EPIDEMIOLOGY, V12, P193, DOI 10.1097/00001648-200103000-00011; Levy D, 2001, EPIDEMIOLOGY, V12, P186, DOI 10.1097/00001648-200103000-00010; Lipsett MJ, 2011, AM J RESP CRIT CARE, V184, P828, DOI 10.1164/rccm.201012-2082OC; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Mauderly JL, 2009, ENVIRON HEALTH PERSP, V117, P1, DOI 10.1289/ehp.11654; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; MORENO PR, 1994, CIRCULATION, V90, P775, DOI 10.1161/01.CIR.90.2.775; Mossman Brooke T, 2007, Part Fibre Toxicol, V4, P4, DOI 10.1186/1743-8977-4-4; Mustafic H, 2012, JAMA-J AM MED ASSOC, V307, P713, DOI 10.1001/jama.2012.126; Myerburg RJ, 2001, CARDIOVASC RES, V50, P177, DOI 10.1016/S0008-6363(01)00253-X; Nemmar A, 2002, CIRCULATION, V105, P411, DOI 10.1161/hc0402.104118; Nemmar A, 2003, AM J RESP CRIT CARE, V168, P1366, DOI 10.1164/rccm.200306-801OC; Nemmar A, 2003, CIRCULATION, V107, P1202, DOI 10.1161/01.CIR.0000053568.13058.67; O'Neill MS, 2007, OCCUP ENVIRON MED, V64, P373, DOI 10.1136/oem.2006.030023; Park SK, 2006, CIRCULATION, V114, P2798, DOI 10.1161/CIRCULATIONAHA.106.643197; Peters A, 2004, NEW ENGL J MED, V351, P1721, DOI 10.1056/NEJMoa040203; Peters A, 2001, CIRCULATION, V103, P2810; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Priori SG, 2001, EUR HEART J, V22, P1374, DOI 10.1053/euhj.2001.2824; Rayner M, 2009, EUR J CARDIOV PREV R, V16, pS43, DOI 10.1097/01.hjr.0000359235.59808.ba; Rich DQ, 2006, ENVIRON HEALTH PERSP, V114, P120, DOI 10.1289/ehp.8371; Rosenthal FS, 2008, ENVIRON HEALTH PERSP, V116, P631, DOI 10.1289/ehp.10757; Schwartz J, 2000, EPIDEMIOLOGY, V11, P320, DOI 10.1097/00001648-200005000-00016; SEATON A, 1995, LANCET, V345, P176, DOI 10.1016/S0140-6736(95)90173-6; Silverman RA, 2010, AM J EPIDEMIOL, V172, P917, DOI 10.1093/aje/kwq217; Sotoodehnia N, 2001, CARDIOVASC RES, V50, P197, DOI 10.1016/S0008-6363(01)00260-7; Spooner PM, 2001, CIRCULATION, V103, P2361; Sullivan J, 2003, AM J EPIDEMIOL, V157, P501, DOI 10.1093/aje/kwg015; Vinzents PS, 2005, ENVIRON HEALTH PERSP, V113, P1485, DOI 10.1289/ehp.7562; Wahlin P, 2001, ATMOS ENVIRON, V35, P3549, DOI 10.1016/S1352-2310(01)00066-8; Wichmann J, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-19; Wichmann J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022904; Willich SN, 1999, VASC MED, V4, P41, DOI 10.1191/135886399670596924; Working group of the Danish Cardiac Arrest Registry, 2005, STAT REP; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	66	43	44	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53684	10.1371/journal.pone.0053684	http://dx.doi.org/10.1371/journal.pone.0053684			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341975	Green Submitted, Green Published, gold			2022-12-25	WOS:000314759400066
J	Liu, XQ; Subramani, S				Liu, Xueqian; Subramani, Suresh			Unique Requirements for Mono- and Polyubiquitination of the Peroxisomal Targeting Signal Co-receptor, Pex20	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RING FINGER DOMAIN; PROTEIN IMPORT; CONSERVED CYSTEINE; SACCHAROMYCES-CEREVISIAE; MEMBRANE-PROTEIN; RECEPTOR PEX5P; UBIQUITINATION; PEX7P; PEX12P; IDENTIFICATION	In Pichia pastoris, the peroxisomal targeting signal 2 (PTS2)-dependent peroxisomal matrix protein import pathway requires the receptor, Pex7, and its co-receptor Pex20. A conserved lysine (Lys(19)) near the N terminus of Pex20 is required for its polyubiquitination and proteasomal degradation, whereas a conserved cysteine (Cys(8)) is essential for its recycling. In this study, we found that Cys(8) is required for the DTT-sensitive mono- and diubiquitination of Pex20. We also show that the PTS2 cargo receptor, Pex7, is required for Pex20 polyubiquitination. Pex4, the E2 ubiquitin-conjugation enzyme, is required for monoubiquitination of Pex20. However, it is also necessary for polyubiquitination of Pex20, making its behavior distinct from the ubiquitination described for other PTS receptors. Unlike the roles of specific RING peroxins in Pex5 ubiquitination, we found that all the RING peroxins (Pex2, Pex10, and Pex12) are required as E3 ubiquitin ligases for Pex20 mono- and polyubiquitination. A model for Pex20 ubiquitination is proposed based on these observations. This is the first description of the complete ubiquitination pathway of Pex20, which provides a better understanding of the recycling and degradation of this PTS2 cargo co-receptor.	[Liu, Xueqian; Subramani, Suresh] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Subramani, S (corresponding author), Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, Rm 3326,Bonner Hall,9500 Gilman Dr, La Jolla, CA 92093 USA.	ssubramani@ucsd.edu	liu, xueqian/N-9544-2013		National Institutes of Health MERIT (Method to Extend Research in Time) Award [DK41737]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041737, R56DK041737, R37DK041737] Funding Source: NIH RePORTER	National Institutes of Health MERIT (Method to Extend Research in Time) Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health MERIT (Method to Extend Research in Time) Award DK41737 (to S. S.).	Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Albertini M, 2001, EUR J CELL BIOL, V80, P257, DOI 10.1078/0171-9335-00164; Amemiya Y, 2008, MOL CANCER RES, V6, P1385, DOI 10.1158/1541-7786.MCR-08-0094; Baerends RJS, 2000, J BIOL CHEM, V275, P9986, DOI 10.1074/jbc.275.14.9986; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; Capili AD, 2004, J MOL BIOL, V340, P1117, DOI 10.1016/j.jmb.2004.05.035; Debelyy MO, 2011, J BIOL CHEM, V286, P28223, DOI 10.1074/jbc.M111.238600; Einwachter H, 2001, EMBO REP, V2, P1035, DOI 10.1093/embo-reports/kve228; El Magraoui F, 2012, FEBS J, V279, P2060, DOI 10.1111/j.1742-4658.2012.08591.x; Faber KN, 1998, MOL CELL BIOL, V18, P936, DOI 10.1128/MCB.18.2.936; Goh J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028220; Grou CP, 2008, J BIOL CHEM, V283, P14190, DOI 10.1074/jbc.M800402200; Grou CP, 2012, J BIOL CHEM, V287, P12815, DOI 10.1074/jbc.M112.340158; Harper CC, 2002, J BIOL CHEM, V277, P16498, DOI 10.1074/jbc.M111728200; Hazra PP, 2002, TRAFFIC, V3, P560, DOI 10.1034/j.1600-0854.2002.30806.x; Hensel A, 2011, J BIOL CHEM, V286, P43495, DOI 10.1074/jbc.M111.286104; Honsho M, 2011, J BIOCHEM, V149, P203, DOI 10.1093/jb/mvq130; KALISH JE, 1995, MOL CELL BIOL, V15, P6406; Kalish JE, 1996, EMBO J, V15, P3275, DOI 10.1002/j.1460-2075.1996.tb00692.x; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Khan BR, 2010, PLANT PHYSIOL, V154, P1602, DOI 10.1104/pp.110.162479; Krazy H, 2006, BBA-MOL CELL RES, V1763, P6, DOI 10.1016/j.bbamcr.2005.11.002; Leon S, 2006, J CELL BIOL, V172, P67, DOI 10.1083/jcb.200508096; Leon S, 2007, J BIOL CHEM, V282, P7424, DOI 10.1074/jbc.M611627200; Liu XQ, 2012, CURR OPIN CELL BIOL, V24, P484, DOI 10.1016/j.ceb.2012.05.003; Nair DM, 2004, J CELL BIOL, V167, P599, DOI 10.1083/jcb.200407119; Okumoto K, 2000, J BIOL CHEM, V275, P25700, DOI 10.1074/jbc.M003303200; Okumoto K, 1998, MOL CELL BIOL, V18, P4324, DOI 10.1128/MCB.18.7.4324; Okumoto K, 2011, TRAFFIC, V12, P1067, DOI 10.1111/j.1600-0854.2011.01217.x; Otzen M, 2005, J CELL SCI, V118, P3409, DOI 10.1242/jcs.02463; Platta H, 2004, BIOCHEM J, V384, P37, DOI 10.1042/BJ20040572; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Platta HW, 2009, MOL CELL BIOL, V29, P5505, DOI 10.1128/MCB.00388-09; Ro M, 2012, J CHILD NEUROL, V27, P1270, DOI 10.1177/0883073811435507; Schumann U, 2003, P NATL ACAD SCI USA, V100, P9626, DOI 10.1073/pnas.1633697100; Sichting M, 2003, MOL BIOL CELL, V14, P810, DOI 10.1091/mbc.E02-08-0539; Stein K, 2002, MOL CELL BIOL, V22, P6056, DOI 10.1128/MCB.22.17.6056-6069.2002; Wang XL, 2012, TRAFFIC, V13, P19, DOI 10.1111/j.1600-0854.2011.01269.x; Williams C, 2008, BIOCHEM BIOPH RES CO, V374, P620, DOI 10.1016/j.bbrc.2008.07.054; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Williams C, 2012, EMBO J, V31, P391, DOI 10.1038/emboj.2011.411; Yan M, 2008, MOL BIOL CELL, V19, P885, DOI 10.1091/mbc.E07-10-1042; Zhang L, 2006, MOL BIOL CELL, V17, P690, DOI 10.1091/mbc.E05-08-0758	43	43	45	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7230	7240		10.1074/jbc.M112.424911	http://dx.doi.org/10.1074/jbc.M112.424911			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23344950	Green Published, hybrid			2022-12-25	WOS:000316002400043
J	Alonso, M; Marimon, JM; Ercibengoa, M; Perez-Yarza, EG; Perez-Trallero, E				Alonso, Marta; Marimon, Jose M.; Ercibengoa, Maria; Perez-Yarza, Eduardo G.; Perez-Trallero, Emilio			Dynamics of Streptococcus pneumoniae Serotypes Causing Acute Otitis Media Isolated from Children with Spontaneous Middle-Ear Drainage over a 12-Year Period (1999-2010) in a Region of Northern Spain	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; MOLECULAR CHARACTERIZATION; INVASIVE DISEASE; PREVALENCE; CARRIAGE; CLONES; TRENDS	The aim of this study was to determine the serotype and clonal distribution of pneumococci causing acute otitis media (AOM) and their relationship with recurrences and mixed infections with other microorganisms under the influence of the 7-valent pneumococcal conjugate vaccine (PCV7). To do this, all pneumococcal isolates collected from the spontaneous middle-ear drainage of children,5 years old diagnosed of AOM by their pediatrician or their general practitioner from 1999 to 2010 were phenotypically characterized and the most frequent serotypes were genotyped. In the 12-year study, 818 episodes of pneumococcal AOM were detected, mostly (70.5%) in children younger than 2 years old. In 262 episodes (32%), the pneumococci were isolated with another bacterium, mainly (n = 214) Haemophilus influenzae. Mixed infections were similar in children under or over 2 years old. The most frequent serotypes were 19A (n = 227, 27.8%), 3 (n = 92, 11.2%) and 19F (n = 74, 9%). Serotypes included in the PCV7 sharply decreased from 62.4% in the pre-vaccination (1999-2001) to 2.2% in the late post-vaccination period (2008-2010). Serotype diversity steadily increased after the introduction of the PCV7 but decreased from 2008-2010 due to the predominant role of serotype 19A isolates, mostly ST276 and ST320. The prevalence of serotype 3 doubled from 6.1% (20/326) in 1999-2004 to 14.6% (72/492) in 2005-2010. Relapses mainly occurred in male infants infected with isolates with diminished antimicrobial susceptibility. Reinfections caused by isolates with the same serotype but different genotype were frequent, highlighting the need for genetic studies to differentiate among similar strains. In conclusion, the main change in pneumococcal AOM observed after the introduction of the PCV7 was the sharp decrease in vaccine serotypes. Also notable was the high burden of serotype 19A in total pneumococcal AOM before and especially after the introduction of the PCV7, as well as in relapses and reinfections.	[Alonso, Marta; Marimon, Jose M.; Ercibengoa, Maria; Perez-Trallero, Emilio] Hosp Univ Donostia, Inst Biodonostia, Dept Microbiol, San Sebastian, Spain; [Marimon, Jose M.; Perez-Trallero, Emilio] Biomed Res Ctr Network Resp Dis, San Sebastian, Spain; [Perez-Yarza, Eduardo G.] Hosp Univ Donostia, Inst Biodonostia, Dept Pediat, San Sebastian, Spain; [Perez-Yarza, Eduardo G.; Perez-Trallero, Emilio] Univ Basque Country, Fac Med, San Sebastian, Spain	Instituto de Investigacion Sanitaria Biodonostia; Instituto de Investigacion Sanitaria Biodonostia; University of Basque Country	Perez-Trallero, E (corresponding author), Hosp Univ Donostia, Inst Biodonostia, Dept Microbiol, San Sebastian, Spain.	mikrobiol@terra.es	Ercibengoa, María/ABH-9481-2020; MARIMON, JOSE MARIA/AAM-5581-2021	MARIMON, JOSE MARIA/0000-0002-2787-7094; Alonso, Marta/0000-0002-8909-4968; Perez-Yarza, Eduardo G./0000-0002-8004-7110	University of the Basque Country (UPV/EHU) [GIU 09/59]; Department of Health, Basque Country [2009-111 012]	University of the Basque Country (UPV/EHU); Department of Health, Basque Country	This work was supported in part by grants from the University of the Basque Country (UPV/EHU; grant no. GIU 09/59) and from the Department of Health, Basque Country (grant 2009-111 012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguedas A, 2010, INT J PEDIATR OTORHI, V74, P1419, DOI 10.1016/j.ijporl.2010.09.022; Block SL, 2004, PEDIATR INFECT DIS J, V23, P829, DOI 10.1097/01.inf.0000136868.91756.80; Brito DA, 2003, J CLIN MICROBIOL, V41, P2378, DOI 10.1128/JCM.41.6.2378-2384.2003; Chonmaitree T, 2008, CLIN INFECT DIS, V46, P815, DOI 10.1086/528685; CLSI, 2018, PERFORMANCE STANDARD; Couloigner V, 2012, PEDIATR INFECT DIS J, V31, P154, DOI 10.1097/INF.0b013e3182357c8d; Ercibengoa M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-69; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Fenoll A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-239; Fischer T, 2007, ACAD EMERG MED, V14, P1172, DOI 10.1197/j.aem.2007.07.011; Guevara S, 2012, VACCINE, V30, P3857, DOI 10.1016/j.vaccine.2012.04.010; Hammitt LL, 2006, J INFECT DIS, V193, P1487, DOI 10.1086/503805; Hanage WP, 2004, INFECT IMMUN, V72, P76, DOI 10.1128/IAI.72.1.76-81.2004; Hausdorff WP, 2002, PEDIATR INFECT DIS J, V21, P1008, DOI 10.1097/00006454-200211000-00007; Kaur R, 2011, PEDIATR INFECT DIS J, V30, P645, DOI 10.1097/INF.0b013e31821c2d8b; Kilpi Terhi, 2008, P301; Leibovitz E, 2004, PEDIATR INFECT DIS J, V23, P1142, DOI 10.1097/01.inf.0000148233.57296.90; Leibovitz E, 2009, PEDIATR INFECT DIS J, V28, P381, DOI 10.1097/INF.0b013e318194e783; Lujan M, 2010, EUR RESPIR J, V36, P1073, DOI 10.1183/09031936.00176309; Marimon JM, 2012, EUR J CLIN MICROBIOL, V31, P1009, DOI 10.1007/s10096-011-1399-3; Marimon JM, 2010, EUR J CLIN MICROBIOL, V29, P1035, DOI 10.1007/s10096-010-0947-6; Marimon JM, 2010, J MICROBIOL METH, V80, P274, DOI 10.1016/j.mimet.2010.01.011; Marimon JM, 2003, MICROB DRUG RESIST, V9, P133, DOI 10.1089/107662903765826714; McEllistrem MC, 2005, CLIN INFECT DIS, V40, P1738, DOI 10.1086/429908; Mintegi S, 2006, PEDIATR EMERG CARE, V22, P566, DOI 10.1097/01.pec.0000230550.79046.68; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Palmu AAI, 2004, CLIN INFECT DIS, V38, P234, DOI 10.1086/380642; Pelton SI, 2009, PEDIATR INFECT DIS J, V28, pS133, DOI 10.1097/INF.0b013e3181b6d81a; Perez-Trallero E, 2009, EUR J CLIN MICROBIOL, V28, P731, DOI 10.1007/s10096-008-0693-1; Perez-Trallero Emilio, 2012, Antimicrob Agents Chemother, V56, P3989, DOI 10.1128/AAC.00501-12; Perez-Trallero E, 2011, ANTIMICROB AGENTS CH, V55, P2729, DOI 10.1128/AAC.01546-10; Pimenta FC, 2009, J CLIN MICROBIOL, V47, P2353, DOI 10.1128/JCM.00704-09; Shouval DS, 2006, PEDIATR INFECT DIS J, V25, P602, DOI 10.1097/01.inf.0000220231.79968.f6; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Xu QF, 2011, DIAGN MICR INFEC DIS, V69, P200, DOI 10.1016/j.diagmicrobio.2010.09.019	36	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54333	10.1371/journal.pone.0054333	http://dx.doi.org/10.1371/journal.pone.0054333			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349853	Green Published, gold			2022-12-25	WOS:000314019100056
J	Shi, D; Funayama, T; Mashima, Y; Takano, Y; Shimizu, A; Yamamoto, K; Mengkegale, M; Miyazawa, A; Yasuda, N; Fukuchi, T; Abe, H; Ideta, H; Nishida, K; Nakazawa, T; Richards, JE; Fuse, N				Shi, Dong; Funayama, Tomoyo; Mashima, Yukihiko; Takano, Yoshimasa; Shimizu, Ai; Yamamoto, Kotaro; Mengkegale, MinGe; Miyazawa, Akiko; Yasuda, Noriko; Fukuchi, Takeo; Abe, Haruki; Ideta, Hidenao; Nishida, Kohji; Nakazawa, Toru; Richards, Julia E.; Fuse, Nobuo			Association of HK2 and NCK2 with Normal Tension Glaucoma in the Japanese Population	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; OXYGEN SPECIES GENERATION; AMINO-ACID SUBSTITUTIONS; GENOME-WIDE ASSOCIATION; HEXOKINASE-II GENE; MOLECULAR-GENETICS; INSULIN-RESISTANCE; NIDDM; VARIANTS; LOCI	Although family studies and genome-wide association studies have shown that genetic factors play a role in glaucoma, it has been difficult to identify the specific genetic variants involved. We tested 669 single nucleotide polymorphisms (SNPs) from the region of chromosome 2 that includes the GLC1B glaucoma locus for association with primary open-angle glaucoma (POAG) and normal tension glaucoma (NTG) in the Japanese population. We performed a two-stage case-control study. The first cohort consisted of 123 POAG cases, 121 NTG cases and 120 controls: the second cohort consisted of 187 POAG cases, 286 NTG cases, and 271 controls. Out of six SNPs showing significant association with POAG in the first round screening, seven SNPs were tested in the second round. Rs678350 in the HK2 gene coding sequence showed significant allelic (p = 0.0027 in Stage Two, 2.7XE-4 in meta-analysis) association with POAG, and significant allelic (p = 4.7XE-4 in Stage Two, 1.0XE-5 in meta-analysis) association with NTG. Although alleles in the TMEM182 gene did not show significant association with glaucoma in the second round, subjects with the A/A allele in TMEM182 rs869833 showed worse visual field mean deviation (p = 0.01). Even though rs2033008 in the NCK2 gene coding sequence did not show significant association in the first round, it had previously shown association with NTG so it was tested for association with NTG in round 2 (p = 0.0053 in Stage Two). Immunohistochemistry showed that both HK2 and NCK2 are expressed in the retinal ganglion cell layer. Once multi-testing was taken into account, only HK2 showed significant association with POAG and NTG in Stage Two. Our data also support previous reports of NCK2 association with NTG, and raise questions about what role TMEM182 might play	[Shi, Dong; Takano, Yoshimasa; Shimizu, Ai; Yamamoto, Kotaro; Mengkegale, MinGe; Miyazawa, Akiko; Nakazawa, Toru; Fuse, Nobuo] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi 980, Japan; [Shi, Dong] China Med Univ, Affiliated Hosp 4, Dept Ophthalmol, Shenyang, Liaoning, Peoples R China; [Funayama, Tomoyo] Bunkyo Univ, Fac Educ, Dept Chem, Koshigaya, Saitama, Japan; [Mashima, Yukihiko] Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, Tokyo, Japan; [Yasuda, Noriko] Tokyo Metropolitan Police Hosp, Dept Ophthalmol, Tokyo, Japan; [Fukuchi, Takeo; Abe, Haruki] Niigata Univ, Grad Sch Med & Dent Sci, Div Ophthalmol & Visual Sci, Niigata, Japan; [Ideta, Hidenao] Ideta Eye Hosp, Kumamoto, Japan; [Nishida, Kohji] Osaka Univ, Grad Sch Med, Dept Ophthalmol, Suita, Osaka, Japan; [Richards, Julia E.] Univ Michigan, WK Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Richards, Julia E.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Fuse, Nobuo] Tohoku Med Megabank Org, Dept Integrat Genom, Sendai, Miyagi, Japan	Tohoku University; China Medical University; Keio University; Niigata University; Osaka University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Fuse, N (corresponding author), Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi 980, Japan.	fusen@oph.med.tohoku.ac.jp	Shi, Dongquan/ABG-6949-2021; shi, dongquan/ABH-3078-2021	shi, dongquan/0000-0002-4769-7816; Nishida, Kohji/0000-0001-9069-3610	Ministry of Education, Science, and Culture of the Japanese Government, Tokyo, Japan [C-22591928)]; Ministry of Health, Labor and Welfare of Japan; Tohoku Medical Megabank Project; Japan-China Medical Association; National Eye Institute at the National Institutes of Health, Bethesda, MD, USA [R01-EY011671]; Research to Prevent Blindness, New York, NY, USA; NATIONAL EYE INSTITUTE [R01EY011671] Funding Source: NIH RePORTER	Ministry of Education, Science, and Culture of the Japanese Government, Tokyo, Japan; Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Tohoku Medical Megabank Project; Japan-China Medical Association; National Eye Institute at the National Institutes of Health, Bethesda, MD, USA; Research to Prevent Blindness, New York, NY, USA(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported in part by a Grant-In-Aid for Scientific Research from the Ministry of Education, Science, and Culture of the Japanese Government (C-22591928), Tokyo, Japan (NF); by a grant from the Ministry of Health, Labor and Welfare of Japan (NF); by Tohoku Medical Megabank Project (NF); by a grant from the Japan-China Medical Association (DS); by a grant R01-EY011671 from the National Eye Institute at the National Institutes of Health (JER), Bethesda, MD, USA; and a grant from Research to Prevent Blindness, New York, NY, USA (JER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2008, BRIT J OPHTHALMOL, V92, P1293, DOI 10.1136/bjo.2008.139980; Anderson DR., 1999, AUTOMATED STATIC PER; Buday L, 2002, CELL SIGNAL, V14, P723, DOI 10.1016/S0898-6568(02)00027-X; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; da-Silva WS, 2004, J BIOL CHEM, V279, P39846, DOI 10.1074/jbc.M403835200; ECHWALD SM, 1995, DIABETES, V44, P347, DOI 10.2337/diabetes.44.3.347; Funayama T, 2004, INVEST OPHTH VIS SCI, V45, P4359, DOI 10.1167/iovs.03-1403; Harada C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1190; HITCHINGS RA, 1983, BRIT J OPHTHALMOL, V67, P818, DOI 10.1136/bjo.67.12.818; HITCHINGS RA, 1992, BRIT J OPHTHALMOL, V76, P494, DOI 10.1136/bjo.76.8.494; Inagaki Y, 2006, JPN J OPHTHALMOL, V50, P128, DOI 10.1007/s10384-005-0290-0; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; LAAKSO M, 1995, DIABETOLOGIA, V38, P617, DOI 10.1007/s001250050328; LAAKSO M, 1995, DIABETES, V44, P330, DOI 10.2337/diabetes.44.3.330; Liu YT, 2011, EXP EYE RES, V93, P331, DOI 10.1016/j.exer.2011.08.007; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Nakano M, 2009, P NATL ACAD SCI USA, V106, P12838, DOI 10.1073/pnas.0906397106; Pasutto F, 2012, HUM MOL GENET, V21, P1336, DOI 10.1093/hmg/ddr572; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; QUIGLEY HA, 1993, NEW ENGL J MED, V328, P1097, DOI 10.1056/NEJM199304153281507; Ramdas WD, 2011, HUM MOL GENET, V20, P2464, DOI 10.1093/hmg/ddr120; Raymond V, 1997, AM J HUM GENET, V60, P272; Santiago APSA, 2008, BIOCHIMIE, V90, P1566, DOI 10.1016/j.biochi.2008.06.013; Sarfarazi M, 1997, HUM MOL GENET, V6, P1667, DOI 10.1093/hmg/6.10.1667; SHIOSE Y, 1991, JPN J OPHTHALMOL, V35, P133; Stoilova D, 1996, GENOMICS, V36, P142, DOI 10.1006/geno.1996.0434; Suzuki S, 2002, BIOCHEM BIOPH RES CO, V294, P1087, DOI 10.1016/S0006-291X(02)00606-X; VIDALPUIG A, 1995, DIABETES, V44, P340, DOI 10.2337/diabetes.44.3.340; Werner EB, 1996, NORMAL TENSION GLAUC; Wiggs JL, 2012, PLOS GENET, V8, P413, DOI 10.1371/journal.pgen.1002654; Wu Yu, 2008, BMC Res Notes, V1, P85, DOI 10.1186/1756-0500-1-85	31	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54115	10.1371/journal.pone.0054115	http://dx.doi.org/10.1371/journal.pone.0054115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349798	Green Published, gold, Green Submitted			2022-12-25	WOS:000314019100044
J	Kinehara, M; Kawamura, S; Tateyama, D; Suga, M; Matsumura, H; Mimura, S; Hirayama, N; Hirata, M; Uchio-Yamada, K; Kohara, A; Yanagihara, K; Furue, MK				Kinehara, Masaki; Kawamura, Suguru; Tateyama, Daiki; Suga, Mika; Matsumura, Hiroko; Mimura, Sumiyo; Hirayama, Noriko; Hirata, Mitsuhi; Uchio-Yamada, Kozue; Kohara, Arihiro; Yanagihara, Kana; Furue, Miho K.			Protein Kinase C Regulates Human Pluripotent Stem Cell Self-Renewal	PLOS ONE			English	Article							HUMAN EMBRYONIC STEM; SERUM-FREE MEDIUM; MAINTAIN PLURIPOTENCY; WNT/BETA-CATENIN; GROWTH-FACTOR; EPSILON-PKC; DIFFERENTIATION; CULTURE; MAINTENANCE; INDUCTION	Background: The self-renewal of human pluripotent stem (hPS) cells including embryonic stem and induced pluripotent stem cells have been reported to be supported by various signal pathways. Among them, fibroblast growth factor-2 (FGF-2) appears indispensable to maintain self-renewal of hPS cells. However, downstream signaling of FGF-2 has not yet been clearly understood in hPS cells. Methodology/Principal Findings: In this study, we screened a kinase inhibitor library using a high-throughput alkaline phosphatase (ALP) activity-based assay in a minimal growth factor-defined medium to understand FGF-2-related molecular mechanisms regulating self-renewal of hPS cells. We found that in the presence of FGF-2, an inhibitor of protein kinase C (PKC), GF109203X (GFX), increased ALP activity. GFX inhibited FGF-2-induced phosphorylation of glycogen synthase kinase-3 beta (GSK-3 beta), suggesting that FGF-2 induced PKC and then PKC inhibited the activity of GSK-3 beta. Addition of activin A increased phosphorylation of GSK-3 beta and extracellular signal-regulated kinase-1/2 (ERK-1/2) synergistically with FGF-2 whereas activin A alone did not. GFX negated differentiation of hPS cells induced by the PKC activator, phorbol 12-myristate 13-acetate whereas Go6976, a selective inhibitor of PKC alpha, beta, and gamma isoforms could not counteract the effect of PMA. Intriguingly, functional gene analysis by RNA interference revealed that the phosphorylation of GSK-3 beta was reduced by siRNA of PKC delta, PKC epsilon, and zeta, the phosphorylation of ERK-1/2 was reduced by siRNA of PKC epsilon and zeta, and the phosphorylation of AKT was reduced by PKCe in hPS cells. Conclusions/Significance: Our study suggested complicated cross-talk in hPS cells that FGF-2 induced the phosphorylation of phosphatidylinositol-3 kinase (PI3K)/AKT, mitogen-activated protein kinase/ERK-1/2 kinase (MEK), PKC/ERK-1/2 kinase, and PKC/GSK-3 beta. Addition of GFX with a MEK inhibitor, U0126, in the presence of FGF-2 and activin A provided a long-term stable undifferentiated state of hPS cells even though hPS cells were dissociated into single cells for passage. This study untangles the cross-talk between molecular mechanisms regulating self-renewal and differentiation of hPS cells.	[Kinehara, Masaki; Kawamura, Suguru; Tateyama, Daiki; Suga, Mika; Matsumura, Hiroko; Mimura, Sumiyo; Hirata, Mitsuhi; Yanagihara, Kana; Furue, Miho K.] Natl Inst Biomed Innovat, Dept Dis Bioresources Res, Lab Stem Cell Cultures, Osaka, Japan; [Hirayama, Noriko; Kohara, Arihiro] Natl Inst Biomed Innovat, Dept Dis Bioresources Res, Lab Cell Cultures, Osaka, Japan; [Uchio-Yamada, Kozue] Natl Inst Biomed Innovat, Dept Dis Bioresources Res, Lab Anim Models Human Dis, Osaka, Japan	National Institute of Health Sciences - Japan; National Institute of Health Sciences - Japan; National Institute of Health Sciences - Japan	Furue, MK (corresponding author), Natl Inst Biomed Innovat, Dept Dis Bioresources Res, Lab Stem Cell Cultures, Osaka, Japan.	mkfurue@nibio.go.jp		Furue, Miho/0000-0001-5032-9953	Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was supported by grants-in-aid from the Ministry of Health, Labor and Welfare of Japan to M. K. F. and A. K., the Ministry of Education, Culture, Sports, Science and Technology of Japan to M. K. F. and M. K. and the Japan Science and Technology Agency to M.K.F.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Aihara Y, 2010, INT J DEV BIOL, V54, P1287, DOI 10.1387/ijdb.103173ya; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; ANDREWS PW, 1984, HYBRIDOMA, V3, P347, DOI 10.1089/hyb.1984.3.347; Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Avery S, 2006, STEM CELLS DEV, V15, P729, DOI 10.1089/scd.2006.15.729; Barbaric I, 2010, STEM CELL RES, V5, P104, DOI 10.1016/j.scr.2010.04.006; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Boersema PJ, 2010, MOL CELL PROTEOMICS, V9, P84, DOI 10.1074/mcp.M900291-MCP200; Brandman R, 2007, J BIOL CHEM, V282, P4113, DOI 10.1074/jbc.M608521200; Cai LH, 2007, CELL RES, V17, P62, DOI 10.1038/sj.cr.7310138; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Damoiseaux R, 2009, STEM CELLS, V27, P533, DOI 10.1634/stemcells.2008-0596; Ding VMY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017538; Ding VMY, 2010, J CELL PHYSIOL, V225, P417, DOI 10.1002/jcp.22214; Doornbos RP, 1999, J BIOL CHEM, V274, P8589, DOI 10.1074/jbc.274.13.8589; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8; Dutta D, 2011, STEM CELLS, V29, P618, DOI 10.1002/stem.605; Dvorak P, 2005, STEM CELLS, V23, P1200, DOI 10.1634/stemcells.2004-0303; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Fang XJ, 2002, MOL CELL BIOL, V22, P2099, DOI 10.1128/MCB.22.7.2099-2110.2002; Feng XZ, 2012, STEM CELLS, V30, P461, DOI 10.1002/stem.1018; Furue M, 2005, IN VITRO CELL DEV-AN, V41, P19; Furue MK, 2008, P NATL ACAD SCI USA, V105, P13409, DOI 10.1073/pnas.0806136105; Furue MK, 2010, IN VITRO CELL DEV-AN, V46, P573, DOI 10.1007/s11626-010-9317-z; GOODE N, 1992, J BIOL CHEM, V267, P16878; Hayashi Y, 2007, STEM CELLS, V25, P3005, DOI 10.1634/stemcells.2007-0103; Hayashi Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014099; Hoffman LM, 2005, NAT BIOTECHNOL, V23, P699, DOI 10.1038/nbt1102; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kaidanovich-Beilin O, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00040; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; Lyssiotis CA, 2009, P NATL ACAD SCI USA, V106, P8912, DOI 10.1073/pnas.0903860106; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mochly-Rosen D, 1998, FASEB J, V12, P35; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Na J, 2010, STEM CELL RES, V5, P157, DOI 10.1016/j.scr.2010.06.002; Nakanishi M, 2009, FASEB J, V23, P114, DOI 10.1096/fj.08-111203; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Nishino K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002085; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Okamoto R, 2004, TISSUE CULTURE RES C, V23, P36; Pebay A, 2005, STEM CELLS, V23, P1541, DOI 10.1634/stemcells.2004-0338; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toyoda M, 2011, GENES CELLS, V16, P1, DOI 10.1111/j.1365-2443.2010.01459.x; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Wang XF, 2009, J BIOL CHEM, V284, P34054, DOI 10.1074/jbc.M109.052290; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	62	49	54	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54122	10.1371/journal.pone.0054122	http://dx.doi.org/10.1371/journal.pone.0054122			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349801	Green Published, gold, Green Submitted			2022-12-25	WOS:000313943000026
J	Charpentier, C; Lambert-Niclot, S; Alteri, C; Storto, A; Flandre, P; Svicher, V; Perno, F; Brun-Vezinet, F; Calvez, V; Marcelin, AG; Ceccherini-Silberstein, F; Descamps, D				Charpentier, Charlotte; Lambert-Niclot, Sidonie; Alteri, Claudia; Storto, Alexandre; Flandre, Philippe; Svicher, Valentina; Perno, Federico; Brun-Vezinet, Francoise; Calvez, Vincent; Marcelin, Anne-Genevieve; Ceccherini-Silberstein, Francesca; Descamps, Diane			Description of the L76V Resistance Protease Mutation in HIV-1 B and "Non-B" Subtypes	PLOS ONE			English	Article							NAIVE HIV-1-INFECTED PATIENTS; DRUG-RESISTANCE; TREATMENT FAILURE; TYPE-1; LOPINAVIR/RITONAVIR; PREVALENCE; PATTERNS; RITONAVIR; EFFICACY; SAFETY	Objective: To describe the prevalence of the L76V protease inhibitors resistance-associated mutation (PI-RAM) in relation with patients' characteristics and protease genotypic background in HIV-1 B-and "non-B"-infected patients. Methods: Frequency of the L76V mutation between 1998 and 2010 was surveyed in the laboratory database of 3 clinical centers. Major PI-RAMs were identified according to the IAS-USA list. Fisher's and Wilcoxon tests were used to compare variables. Results: Among the overall 29,643 sequences analyzed, the prevalence of L76V was 1.50%, while was 5.42% in PI-resistant viruses. Since 2008 the prevalence of L76V was higher in "non-B"-infected than in B-infected patients each year. Median time since diagnosis of HIV-1 infection and median time under antiretroviral-based regimen were both shorter in "non-B" than in B-infected patients (8 vs 11 years, P<0.0001; and 7 vs 8 years, P = 0.004). In addition, "non-B"-infected patients had been pre-exposed to a lower number of PI (2 vs 3, P = 0.016). The L76V was also associated with a lower number of major PI-RAMs in "non-B" vs B samples (3 vs 4, P=0.0001), and thus it was more frequent found as single major PI-RAM in "non-B" vs B subtype (10% vs 2%, P=0.014). Conclusions: We showed an impact of viral subtype on the selection of the L76V major PI-RAM with a higher prevalence in "non-B" subtypes observed since 2008. In addition, in "non-B"-infected patients this mutation appeared more rapidly and was associated with less PI-RAM.	[Charpentier, Charlotte; Storto, Alexandre; Brun-Vezinet, Francoise; Descamps, Diane] Univ Paris 07, Virol Lab, Grp Hosp Bichat Claude Bernard, AP HP,HUPNVS,PRES Sorbonne Paris Cite,EA4409, Paris, France; [Lambert-Niclot, Sidonie; Calvez, Vincent; Marcelin, Anne-Genevieve] Univ Paris 06, INSERM, UMR S943, Hop Pitie Salpetriere,AP HP,Lab Virol, Paris, France; [Alteri, Claudia; Svicher, Valentina; Perno, Federico; Ceccherini-Silberstein, Francesca] Univ Roma Tor Vergata, Dept Expt Med & Surg, Rome, Italy; [Flandre, Philippe] Univ Paris 06, INSERM, UMR S 943, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Rome Tor Vergata; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Charpentier, C (corresponding author), Univ Paris 07, Virol Lab, Grp Hosp Bichat Claude Bernard, AP HP,HUPNVS,PRES Sorbonne Paris Cite,EA4409, Paris, France.	charlotte.charpentier@bch.aphp.fr	Alteri, Claudia/AAB-9956-2019; Alteri, Claudia/J-9116-2016; Flandre, Philippe/N-6314-2017; perno, carlo federico/O-1544-2016; Charpentier, Charlotte/C-3579-2019; Marcelin, Anne-Genevieve/D-8272-2014; Ceccherini-Silberstein, Francesca/K-4762-2016; Di Maio, Velia Chiara/AGH-2628-2022	Alteri, Claudia/0000-0003-4270-5079; Alteri, Claudia/0000-0003-4270-5079; Flandre, Philippe/0000-0002-2612-3522; Marcelin, Anne-Genevieve/0000-0003-4808-8999; CECCHERINI SILBERSTEIN, FRANCESCA/0000-0002-6024-5101; PERNO, CARLO FEDERICO/0000-0002-0825-5388; SVICHER, VALENTINA/0000-0002-2377-504X	French National Agency for Research on AIDS and viral hepatitis (Agence Nationale de Recherches sur le SIDA et les hepatites virales [ANRS]); European Community [223131]; Aviralia Foundation	French National Agency for Research on AIDS and viral hepatitis (Agence Nationale de Recherches sur le SIDA et les hepatites virales [ANRS])(ANRS); European Community(European Commission); Aviralia Foundation	The study was supported by French National Agency for Research on AIDS and viral hepatitis (Agence Nationale de Recherches sur le SIDA et les hepatites virales [ANRS]) and from the European Community's Seventh Framework Programme (FP7/2007-2013) under the project "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)" (grant no. 223131) and Aviralia Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alteri C, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-111; Brenner B, 2003, AIDS, V17, pF1, DOI 10.1097/00002030-200301030-00001; Ceccherini-Silberstein F, 2004, AIDS, V18, pF11, DOI 10.1097/01.aids.0000131394.76221.02; Champenois K, 2011, J MED VIROL, V83, P1677, DOI 10.1002/jmv.22161; Charpentier C, 2012, 19 C RETR OPP INF SE; Charpentier C, 2011, AIDS RES HUM RETROV, V27, P221, DOI 10.1089/aid.2010.0103; Dam E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000345; de Mendoza C, 2008, AIDS, V22, P311, DOI 10.1097/QAD.0b013e3282f4244f; Delaugerre C, 2009, ANTIMICROB AGENTS CH, V53, P2934, DOI 10.1128/AAC.01643-08; Deshpande A, 2007, AIDS RES HUM RETROV, V23, P335, DOI 10.1089/aid.2006.0183; Ghosn J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024798; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Lambert-Niclot S, 2008, ANTIMICROB AGENTS CH, V52, P491, DOI 10.1128/AAC.00909-07; Maiga AI, 2009, ANTIVIR THER, V14, P123; Mammano F, 1998, J VIROL, V72, P7632, DOI 10.1128/JVI.72.9.7632-7637.1998; Mitsuya Y, 2007, J INFECT DIS, V196, P1177, DOI 10.1086/521624; Molina JM, 2008, LANCET, V372, P646, DOI 10.1016/S0140-6736(08)61081-8; Nijhuis M, 2007, PLOS MED, V4, P152, DOI 10.1371/journal.pmed.0040036; Nijhuis M, 2009, J INFECT DIS, V200, P698, DOI 10.1086/605329; Ortiz R, 2008, AIDS, V22, P1389, DOI 10.1097/QAD.0b013e32830285fb; Tartaglia A, 2009, ANTIMICROB AGENTS CH, V53, P1724, DOI 10.1128/AAC.01693-08; Wainberg MA, 2011, NEW ENGL J MED, V365, P637, DOI 10.1056/NEJMra1004180; Wiesmann F, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-7; Young TP, 2010, ANTIMICROB AGENTS CH, V54, P4903, DOI 10.1128/AAC.00906-10	24	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54381	10.1371/journal.pone.0054381	http://dx.doi.org/10.1371/journal.pone.0054381			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349869	gold, Green Published, Green Submitted			2022-12-25	WOS:000313872800045
J	Meng, JJ; Yu, HD; Ma, J; Wang, JH; Banerjee, S; Charboneau, R; Barke, RA; Roy, S				Meng, Jingjing; Yu, Haidong; Ma, Jing; Wang, Jinghua; Banerjee, Santanu; Charboneau, Rick; Barke, Roderick A.; Roy, Sabita			Morphine Induces Bacterial Translocation in Mice by Compromising Intestinal Barrier Function in a TLR-Dependent Manner	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; LIGHT-CHAIN KINASE; EPITHELIAL BARRIER; RECEPTOR; LIPOPOLYSACCHARIDE; SEPSIS; PHOSPHORYLATION	Opiates are among the most prescribed drugs for pain management. However, morphine use or abuse results in significant gut bacterial translocation and predisposes patients to serious infections with gut origin. The mechanism underlying this defect is still unknown. In this report, we investigated the mechanisms underlying compromised gut immune function and bacterial translocation following morphine treatment. We demonstrate significant bacterial translocation to mesenteric lymph node (MLN) and liver following morphine treatment in wild-type (WT) animals that was dramatically and significantly attenuated in Toll-like receptor (TLR2 and 4) knockout mice. We further observed significant disruption of tight junction protein organization only in the ileum but not in the colon of morphine treated WT animals. Inhibition of myosin light chain kinase (MLCK) blocked the effects of both morphine and TLR ligands, suggesting the role of MLCK in tight junction modulation by TLR. This study conclusively demonstrates that morphine induced gut epithelial barrier dysfunction and subsequent bacteria translocation are mediated by TLR signaling and thus TLRs can be exploited as potential therapeutic targets for alleviating infections and even sepsis in morphine-using or abusing populations.	[Meng, Jingjing; Roy, Sabita] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA; [Yu, Haidong; Ma, Jing; Wang, Jinghua; Banerjee, Santanu; Roy, Sabita] Univ Minnesota, Sch Med, Dept Surg, Div Infect Inflammat & Vasc Biol, Minneapolis, MN 55455 USA; [Charboneau, Rick; Barke, Roderick A.] Vet Affairs Med Ctr, Dept Surg, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Roy, S (corresponding author), Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA.	royxx002@umn.edu	ma, jing/B-5493-2013		National Institutes of Health [RO1DA031202, RO1DA12104, RO1DA022935, KO2DA15349, P50DA11806]; Minneapolis Veterans Affairs Medical Center; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022935, P50DA011806, R01DA031202, R01DA012104, K05DA033881, K02DA015349, R01DA034582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minneapolis Veterans Affairs Medical Center; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported by National Institutes of Health Grants RO1DA031202, RO1DA12104, RO1DA022935, KO2DA15349, P50DA11806 (to S. R.) and by funds from the Minneapolis Veterans Affairs Medical Center (R. A. B.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Alexander M, 2005, J SURG RES, V129, P161, DOI 10.1016/j.jss.2005.04.028; Babrowski T, 2012, ANN SURG, V255, P386, DOI 10.1097/SLA.0b013e3182331870; Bonnet MP, 2008, ANESTH ANALG, V106, P1142, DOI 10.1213/ane.0b013e318165de89; Breslow JM, 2011, J NEUROIMMUNE PHARM, V6, P551, DOI 10.1007/s11481-011-9303-6; Breslow JM, 2010, MICROB PATHOGENESIS, V49, P330, DOI 10.1016/j.micpath.2010.07.006; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; BRYANT HU, 1988, EUR J PHARMACOL, V149, P165, DOI 10.1016/0014-2999(88)90057-X; Capaldo CT, 2009, BBA-BIOMEMBRANES, V1788, P864, DOI 10.1016/j.bbamem.2008.08.027; Chabot S, 2006, J IMMUNOL, V176, P4275, DOI 10.4049/jimmunol.176.7.4275; Clarke TB, 2011, CELL HOST MICROBE, V9, P404, DOI 10.1016/j.chom.2011.04.012; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; Feng P, 2006, INFECT IMMUN, V74, P5221, DOI 10.1128/IAI.00208-06; Forsythe RM, 2002, SHOCK, V17, P180, DOI 10.1097/00024382-200203000-00004; Glattard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008791; Goldblum SE, 2011, FASEB J, V25, P144, DOI 10.1096/fj.10-158972; Greeneltch KM, 2004, BRAIN BEHAV IMMUN, V18, P476, DOI 10.1016/j.bbi.2003.12.001; Hilburger ME, 1997, J INFECT DIS, V176, P183, DOI 10.1086/514021; Huppert J, 2010, FASEB J, V24, P1023, DOI 10.1096/fj.09-141978; KUEPPERS PM, 1993, ANN SURG, V217, P286, DOI 10.1097/00000658-199303000-00011; LESLIE KA, 1994, CAN J SURG, V37, P143; Liu XXJ, 2012, DIG DIS SCI JUL; MacFarlane AS, 2000, J INFECT DIS, V181, P1350, DOI 10.1086/315403; Marchiando AM, 2010, ANNU REV PATHOL-MECH, V5, P119, DOI 10.1146/annurev.pathol.4.110807.092135; Mason KL, 2008, OVERVIEW OF GUT IMMU; Moriez R, 2005, AM J PATHOL, V167, P1071, DOI 10.1016/S0002-9440(10)61196-0; Ocasio FM, 2004, J NEUROIMMUNOL, V149, P90, DOI 10.1016/j.jneuroim.2003.12.016; Quintana JM, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-24; Regan LCA, 2012, EMERG MED J; Ripamonti C, 1991, J Palliat Care, V7, P30; Ross GR, 2008, J PHARMACOL EXP THER, V327, P561, DOI 10.1124/jpet.108.143438; Roulis M, 2011, P NATL ACAD SCI USA, V108, P5396, DOI 10.1073/pnas.1007811108; Roy S, 1999, J NEUROIMMUNOL, V95, P107, DOI 10.1016/S0165-5728(98)00265-3; Roy S, 1998, MOL BRAIN RES, V61, P190, DOI 10.1016/S0169-328X(98)00212-5; Roy S. M., 2011, J NEUROIMMUNE PHARM, P1; RUNKEL NSF, 1993, DIGEST DIS SCI, V38, P1530, DOI 10.1007/BF01308616; Schlegel N, 2010, AM J PHYSIOL-GASTR L, V298, pG774, DOI 10.1152/ajpgi.00239.2009; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P294, DOI 10.1111/j.1749-6632.2009.04062.x; Shen L, 2006, J CELL SCI, V119, P2095, DOI 10.1242/jcs.02915; Sheth P, 2007, AM J PHYSIOL-GASTR L, V293, pG308, DOI 10.1152/ajpgi.00582.2006; Shifflett DE, 2005, LAB INVEST, V85, P1308, DOI 10.1038/labinvest.3700330; Xiao WD, 2011, MOL CELL NEUROSCI, V46, P527, DOI 10.1016/j.mcn.2010.12.007	42	117	124	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54040	10.1371/journal.pone.0054040	http://dx.doi.org/10.1371/journal.pone.0054040			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349783	gold, Green Submitted, Green Published			2022-12-25	WOS:000313872800022
J	Oerlecke, I; Bauer, E; Dittmer, A; Leyh, B; Dittmer, J				Oerlecke, Ilka; Bauer, Elke; Dittmer, Angela; Leyh, Benjamin; Dittmer, Juergen			Cyclic AMP Enhances TGF beta Responses of Breast Cancer Cells by Upregulating TGF beta Receptor I Expression	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; HORMONE-RELATED PROTEIN; EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELLS; BINDING PROTEIN; BONE METASTASES; MESSENGER-RNA; CAMP; INHIBITION; PATHWAY	Cellular functions are regulated by complex networks of many different signaling pathways. The TGF beta and cAMP pathways are of particular importance in tumor progression. We analyzed the cross-talk between these pathways in breast cancer cells in 2D and 3D cultures. We found that cAMP potentiated TGF beta-dependent gene expression by enhancing Smad3 phosphorylation. Higher levels of total Smad3, as observed in 3D-cultured cells, blocked this effect. Two Smad3 regulating proteins, YAP (Yes-associated protein) and T beta RI (TGF beta receptor 1), were responsive to cAMP. While YAP had little effect on TGF beta-dependent expression and Smad3 phosphorylation, a constitutively active form of T beta RI mimicked the cAMP effect on TGF beta signaling. In 3D-cultured cells, which show much higher levels of T beta RI and cAMP, T beta RI was unresponsive to cAMP. Upregulation of T beta RI expression by cAMP was dependent on transcription. A proximal T beta RI promoter fragment was moderately, but significantly activated by cAMP suggesting that cAMP increases T beta RI expression at least partially by activating T beta RI transcription. Neither the cAMP-responsive element binding protein (CREB) nor the T beta RI-regulating transcription factor Six1 was required for the cAMP effect. An inhibitor of histone deacetylases alone or together with cAMP increased T beta RI expression by a similar extent as cAMP alone suggesting that cAMP may exert its effect by interfering with histone acetylation. Along with an additive stimulatory effect of cAMP and TGF beta on p21 expression an additive inhibitory effect of these agents on proliferation was observed. Finally, we show that mesenchymal stem cells that interact with breast cancer cells can simultaneously activate the cAMP and TGF beta pathways. In summary, these data suggest that combined effects of cAMP and TGF beta, as e.g. induced by mesenchymal stem cells, involve the upregulation of T beta RI expression on the transcriptional level, likely due to changes in histone acetylation. As a consequence, cancer cell functions such as proliferation are affected.	[Oerlecke, Ilka; Bauer, Elke; Dittmer, Angela; Leyh, Benjamin; Dittmer, Juergen] Univ Halle, Klin Gynakol, Halle, Germany	Martin Luther University Halle Wittenberg	Dittmer, J (corresponding author), Univ Halle, Klin Gynakol, Halle, Germany.	juergen.dittmer@medizin.uni-halle.de	Dittmer, Juergen/G-1160-2011		Deutsche Krebshilfe [109271]; Land Sachsen-Anhalt (Medical Faculty of the University of Halle) [FKZ VF1/A8]	Deutsche Krebshilfe(Deutsche Krebshilfe); Land Sachsen-Anhalt (Medical Faculty of the University of Halle)	The work was supported by 1. Deutsche Krebshilfe grant no. 109271 (external funding) http://www.krebshilfe.de/wir-foerdern.html), and 2. Land Sachsen-Anhalt (Wilhelm-Roux-funding) grant FKZ VF1/A8 (internal funding of the Medical Faculty of the University of Halle, no URL available, because the Wilhelm-Roux-Funding-Program is not accessible for the public outside the University). The salary for Ilka Oerlecke was payed by the University grant FKZ VF1/A8. The salary for Benjamin Leyh was payed by the Deutsche Krebshilfe grant 109271. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammanamanchi S, 2004, J BIOL CHEM, V279, P32620, DOI 10.1074/jbc.M402691200; Badve S, 2012, LANCET ONCOL, V13, pE43, DOI 10.1016/S1470-2045(11)70191-7; Beyer TA, 2012, BIOCH BIOPH IN PRESS; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Chhabra A, 2007, ONCOL REP, V18, P953; Chowdhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019335; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; Dai M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3322; de Graauw M, 2010, P NATL ACAD SCI USA, V107, P6340, DOI 10.1073/pnas.0913360107; del Valle-Perez B, 2004, FEBS LETT, V569, P105, DOI 10.1016/j.febslet.2004.05.058; Ditte P, 2011, CANCER RES, V71, P7558, DOI 10.1158/0008-5472.CAN-11-2520; Dittmer A, 2008, CANCER LETT, V260, P56, DOI 10.1016/j.canlet.2007.10.020; Dittmer A, 2006, J BIOL CHEM, V281, P14563, DOI 10.1074/jbc.M510527200; Dittmer A, 2009, CELL MOL LIFE SCI, V66, P3053, DOI 10.1007/s00018-009-0089-0; Dittmer J, 2011, BREAST CANC FOCUSING, P247; Farabaugh SM, 2012, ONCOGENE, V31, P552, DOI 10.1038/onc.2011.259; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Han J, 2012, ONCOL REP, V27, P517, DOI 10.3892/or.2011.1511; Hardt O, 2012, CANCER LETT, V325, P165, DOI 10.1016/j.canlet.2012.06.010; Heaton JH, 2001, J BIOL CHEM, V276, P3341, DOI 10.1074/jbc.M006538200; Heldin CH, 2012, FEBS LETT, V586, P1959, DOI 10.1016/j.febslet.2012.02.037; Heldin CH, 2012, CELL TISSUE RES, V347, P21, DOI 10.1007/s00441-011-1190-x; Hiraga T, 2006, CANCER RES, V66, P2067, DOI 10.1158/0008-5472.CAN-05-2012; Hua F, 2011, J CELL SCI, V124, P3235, DOI 10.1242/jcs.082875; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Iwanaga R, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3219; KALKHOVEN E, 1995, CELL GROWTH DIFFER, V6, P1151; Klopp AH, 2011, STEM CELLS, V29, P11, DOI 10.1002/stem.559; Lei XF, 2002, ONCOGENE, V21, P7514, DOI 10.1038/sj.onc.1205966; Leivonen SK, 2007, INT J CANCER, V121, P2119, DOI 10.1002/ijc.23113; Li JR, 2011, J CLIN INVEST, V121, P4655, DOI 10.1172/JCI46134; Lindemann Ralph K, 2003, Mol Cancer, V2, P20, DOI 10.1186/1476-4598-2-20; Lindemann RK, 2001, J BIOL CHEM, V276, P46661, DOI 10.1074/jbc.M105816200; Liu SL, 2011, CANCER RES, V71, P614, DOI 10.1158/0008-5472.CAN-10-0538; Liu XQ, 2006, MOL PHARMACOL, V70, P1992, DOI 10.1124/mol.106.028951; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Micalizzi DS, 2010, CANCER RES, V70, P10371, DOI 10.1158/0008-5472.CAN-10-1354; Ragazzon B, 2009, CANCER RES, V69, P7278, DOI 10.1158/0008-5472.CAN-09-1601; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Schiller M, 2010, J BIOL CHEM, V285, P409, DOI 10.1074/jbc.M109.038620; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Schmitt M, 2011, EXPERT REV MOL DIAGN, V11, P617, DOI [10.1586/ERM.11.47, 10.1586/erm.11.47]; Scollen S, 2011, CANCER EPIDEM BIOMAR, V20, P1112, DOI 10.1158/1055-9965.EPI-11-0062; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Son J, 2010, BIOCHEM BIOPH RES CO, V398, P309, DOI 10.1016/j.bbrc.2010.06.087; Sun Y, 1999, MOL CELL, V4, P499, DOI 10.1016/S1097-2765(00)80201-4; TANG WJ, 1992, CELL, V70, P869, DOI 10.1016/0092-8674(92)90236-6; Tarasewicz E, 2012, CELL CYCLE, V11, P2443, DOI 10.4161/cc.20546; THALACKER FW, 1992, BIOCHEM J, V287, P855, DOI 10.1042/bj2870855; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Wu QQ, 2008, ARTHRITIS RHEUM-US, V58, P3132, DOI 10.1002/art.23946; Xing DM, 2009, INVEST OPHTH VIS SCI, V50, P626, DOI 10.1167/iovs.08-2444; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Yoo S, 2012, Z NATURFORSCH C, V67, P222, DOI 10.5560/ZNC.2012.67c0222; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zwart W, 2007, EMBO J, V26, P3534, DOI 10.1038/sj.emboj.7601791	63	18	18	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54261	10.1371/journal.pone.0054261	http://dx.doi.org/10.1371/journal.pone.0054261			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349840	gold, Green Published, Green Submitted			2022-12-25	WOS:000313872800034
J	Fremgen, S; Williams, A; Furusawa, G; Dziewanowska, K; Settles, M; Hartzell, P				Fremgen, Sarah; Williams, Amanda; Furusawa, Gou; Dziewanowska, Katarzyna; Settles, Matthew; Hartzell, Patricia			MasABK Proteins Interact with Proteins of the Type IV Pilin System to Affect Social Motility of Myxococcus Xanthus	PLOS ONE			English	Article							GLIDING MOTILITY; PSEUDOMONAS-AERUGINOSA; CHEMOTAXIS HOMOLOGS; PILUS RETRACTION; LOCALIZATION; GENE; EXPRESSION; PREDICTION; REGULATOR; DELETIONS	Gliding motility is critical for normal development of spore-filled fruiting bodies in the soil bacterium Myxococcus xanthus. Mutations in mgl block motility and development but one mgl allele can be suppressed by a mutation in masK, the last gene in an operon adjacent to the mgl operon. Deletion of the entire 5.5 kb masABK operon crippled gliding and fruiting body development and decreased sporulation. Expression of pilAGHI, which encodes type IV pili (TFP) components essential for social (S) gliding, several cryptic pil genes, and a LuxR family protein were reduced significantly in the Delta mas mutant while expression of the myxalamide operon was increased significantly. Localization and two-hybrid analysis suggest that the three Mas proteins form a membrane complex. MasA-PhoA fusions confirmed that MasA is an integral cytoplasmic membrane protein with a approximate to 100 amino acid periplasmic domain. Results from yeast two-hybrid assays showed that MasA interacts with the lipoprotein MasB and MasK, a protein kinase and that MasB and MasK interact with one another. Additionally, yeast two-hybrid analysis revealed a physical interaction between two gene products of the mas operon, MasA and MasB, and PilA. Deletion of mas may be accompanied by compensatory mutations since complementation of the Delta mas social gliding and developmental defects required addition of both pilA and masABK.	[Fremgen, Sarah; Williams, Amanda; Furusawa, Gou; Dziewanowska, Katarzyna; Settles, Matthew; Hartzell, Patricia] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA	Idaho; University of Idaho	Hartzell, P (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.	hartzell@uidaho.edu	Settles, Matthew L/F-2031-2011	Settles, Matthew L/0000-0002-3424-1086	NIH-INBRE [P20RR016454]; IBEST Graduate Student Fellowship; National Institutes of Health (NIH) from the COBRE Program of the National Center for Research Resources [P20RR016448];  [GM075242]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016454, P20RR016448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075242] Funding Source: NIH RePORTER	NIH-INBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IBEST Graduate Student Fellowship; National Institutes of Health (NIH) from the COBRE Program of the National Center for Research Resources; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants GM075242 (to PH), P20RR016454 (NIH-INBRE) (to AW and GF), and an IBEST Graduate Student Fellowship, National Institutes of Health (NIH) Grant P20RR016448 from the COBRE Program of the National Center for Research Resources to SF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas FE, 2006, J BIOL CHEM, V281, P27712, DOI 10.1074/jbc.M604324200; Alm RA, 1996, MOL MICROBIOL, V22, P161; Astling DP, 2006, MOL MICROBIOL, V59, P45, DOI 10.1111/j.1365-2958.2005.04926.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bateman A, 2000, J MOL BIOL, V299, P1113, DOI 10.1006/jmbi.2000.3778; Bhat S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027475; Black WP, 2004, J BACTERIOL, V186, P1001, DOI 10.1128/JB.186.4.1001-1008.2004; Bode HB, 2007, CHEMBIOCHEM, V8, P2139, DOI 10.1002/cbic.200700401; Bonner PJ, 2006, J BACTERIOL, V188, P4585, DOI 10.1128/JB.00237-06; Bulyha I, 2009, MOL MICROBIOL, V74, P691, DOI 10.1111/j.1365-2958.2009.06891.x; DANA JR, 1993, J BACTERIOL, V175, P3636, DOI 10.1128/jb.175.11.3636-3647.1993; Fremgen SA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-295; Furusawa G, 2011, MOL MICROBIOL, V81, P784, DOI 10.1111/j.1365-2958.2011.07732.x; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Goldman BS, 2006, P NATL ACAD SCI USA, V103, P15200, DOI 10.1073/pnas.0607335103; Hofmann K., 1993, BIOL CHEM HOPPE SEYL, V374; Jakovljevic V, 2008, J BACTERIOL, V190, P2411, DOI 10.1128/JB.01793-07; James P, 1996, GENETICS, V144, P1425; Jelsbak L, 2005, J BACTERIOL, V187, P2105, DOI 10.1128/JB.187.6.2105-2112.2005; JIN SG, 1994, MOL MICROBIOL, V14, P1049, DOI 10.1111/j.1365-2958.1994.tb01338.x; KASHEFI K, 1995, MOL MICROBIOL, V15, P483, DOI 10.1111/j.1365-2958.1995.tb02262.x; Kearns DB, 2002, J BACTERIOL, V184, P1678, DOI 10.1128/JB.184.6.1678-1684.2002; Leonardy S, 2008, MOL BIOSYST, V4, P1009, DOI 10.1039/b806640j; Lu A, 2005, MOL MICROBIOL, V55, P206, DOI 10.1111/j.1365-2958.2004.04369.x; MANOIL C, 1986, SCIENCE, V233, P1403, DOI 10.1126/science.3529391; MANOIL C, 1985, P NATL ACAD SCI USA, V82, P8129, DOI 10.1073/pnas.82.23.8129; Mauriello EMF, 2010, EMBO J, V29, P315, DOI 10.1038/emboj.2009.356; Mauriello EMF, 2009, MOL MICROBIOL, V72, P964, DOI 10.1111/j.1365-2958.2009.06697.x; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Overgaard M, 2006, J BACTERIOL, V188, P4384, DOI 10.1128/JB.00189-06; Pasquier C, 1999, PROTEIN ENG, V12, P381, DOI 10.1093/protein/12.5.381; SHI WY, 1993, P NATL ACAD SCI USA, V90, P3378, DOI 10.1073/pnas.90.8.3378; SPORMANN AM, 1995, J BACTERIOL, V177, P5846, DOI 10.1128/jb.177.20.5846-5852.1995; STEPHENS K, 1989, J BACTERIOL, V171, P819, DOI 10.1128/jb.171.2.819-830.1989; Tanenbaum D, 2010, JCVI STANDARD OPERAT; Thomasson B, 2002, MOL MICROBIOL, V46, P1399, DOI 10.1046/j.1365-2958.2002.03258.x; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Ueki T, 1996, GENE, V183, P153, DOI 10.1016/S0378-1119(96)00546-X; Ward MJ, 2000, MOL MICROBIOL, V37, P1357, DOI 10.1046/j.1365-2958.2000.02079.x; Weimer RM, 1998, J BACTERIOL, V180, P5357, DOI 10.1128/JB.180.20.5357-5368.1998; Winther-Larsen HC, 2001, P NATL ACAD SCI USA, V98, P15276, DOI 10.1073/pnas.261574998; Wu SS, 1996, J BACTERIOL, V178, P5817, DOI 10.1128/jb.178.19.5817-5821.1996; Wu SS, 1998, MOL MICROBIOL, V29, P1249, DOI 10.1046/j.1365-2958.1998.01013.x; WU SS, 1995, MOL MICROBIOL, V18, P547, DOI 10.1111/j.1365-2958.1995.mmi_18030547.x; Wu SS, 1997, MOL MICROBIOL, V23, P109, DOI 10.1046/j.1365-2958.1997.1791550.x; Wu SS, 1997, J BACTERIOL, V179, P7748, DOI 10.1128/jb.179.24.7748-7758.1997; Xu QA, 2011, J BACTERIOL, V193, P759, DOI 10.1128/JB.00944-10; YAMAGUCHI K, 1988, CELL, V53, P423, DOI 10.1016/0092-8674(88)90162-6; Yang RF, 2004, J BACTERIOL, V186, P6168, DOI 10.1128/jb.186.18.6168-6178.2004; Yang Z, 2010, MOL MICROBIOL, V76, P1500, DOI 10.1111/j.1365-2958.2010.07180.x; Yang ZM, 1998, MOL MICROBIOL, V30, P1123, DOI 10.1046/j.1365-2958.1998.01160.x; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	55	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54557	10.1371/journal.pone.0054557	http://dx.doi.org/10.1371/journal.pone.0054557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342171	Green Submitted, gold, Green Published			2022-12-25	WOS:000313682700126
J	Levkovich, T; Poutahidis, T; Smillie, C; Varian, BJ; Ibrahim, YM; Lakritz, JR; Alm, EJ; Erdman, SE				Levkovich, Tatiana; Poutahidis, Theofilos; Smillie, Christopher; Varian, Bernard J.; Ibrahim, Yassin M.; Lakritz, Jessica R.; Alm, Eric J.; Erdman, Susan E.			Probiotic Bacteria Induce a 'Glow of Health'	PLOS ONE			English	Article							GUT MICROBIOTA; IMMUNE-SYSTEM; SKIN INFLAMMATION; HAIR-FOLLICLES; PATHOGENESIS; RESPONSES; RECEPTOR; MODELS; IL-10; CELLS	Radiant skin and hair are universally recognized as indications of good health. However, this 'glow of health' display remains poorly understood. We found that feeding of probiotic bacteria to aged mice induced integumentary changes mimicking peak health and reproductive fitness characteristic of much younger animals. Eating probiotic yogurt triggered epithelial follicular anagen-phase shift with sebocytogenesis resulting in thick lustrous fur due to a bacteria-triggered interleukin-10-dependent mechanism. Aged male animals eating probiotics exhibited increased subcuticular folliculogenesis, when compared with matched controls, yielding luxuriant fur only in probiotic-fed subjects. Female animals displayed probiotic-induced hyperacidity coinciding with shinier hair, a feature that also aligns with fertility in human females. Together these data provide insights into mammalian evolution and novel strategies for integumentary health.	[Levkovich, Tatiana; Poutahidis, Theofilos; Varian, Bernard J.; Ibrahim, Yassin M.; Lakritz, Jessica R.; Alm, Eric J.; Erdman, Susan E.] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Poutahidis, Theofilos] Aristotle Univ Thessaloniki, Pathol Lab, Fac Vet Med, GR-54006 Thessaloniki, Greece; [Alm, Eric J.] Broad Inst MIT & Harvard, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Aristotle University of Thessaloniki; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Alm, EJ (corresponding author), MIT, Div Comparat Med, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ejalm@mit.edu; serdman@mit.edu		Lakritz, Jessica/0000-0003-2510-3869; Smillie, Chris/0000-0002-7606-3433	National Institutes of Health [P30-ES002109, RO1CA108854]; NATIONAL CANCER INSTITUTE [R01CA108854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants P30-ES002109 (pilot project award to S.E.E and E.J.A) and RO1CA108854 (to S.E.E). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amico JA, 2004, PHARMACOL BIOCHEM BE, V78, P333, DOI 10.1016/j.pbb.2004.04.006; Arck P, EXP DERMATOL, V19, P401; Barber N, 1995, ETHOL SOCIOBIOL, V16, P395, DOI 10.1016/0162-3095(95)00068-2; Barth JH, 2000, LANCET, V355, P161, DOI 10.1016/S0140-6736(99)00412-2; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Cavani A, 2012, CHEM IMMUNOL ALLERGY, V96, P39, DOI 10.1159/000331870; Chapat L, 2004, EUR J IMMUNOL, V34, P2520, DOI 10.1002/eji.200425139; Cheng JB, 2004, J BIOL CHEM, V279, P37798, DOI 10.1074/jbc.M406226200; Chinen T, 2012, IMMUNOL REV, V245, P45, DOI 10.1111/j.1600-065X.2011.01083.x; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Dao H, 2007, GENDER MED, V4, P308; Di Giacinto C, 2005, J IMMUNOL, V174, P3237, DOI 10.4049/jimmunol.174.6.3237; Eurell J.A.C., 2006, DELLMANNS TXB VET HI; Fimmel S, 2007, HORM METAB RES, V39, P149, DOI 10.1055/s-2007-961815; Floch MH, 2011, J CLIN GASTROENTEROL, V45, pS168, DOI 10.1097/MCG.0b013e318230928b; Fujimura KE, 2010, EXPERT REV ANTI-INFE, V8, P435, DOI [10.1586/eri.10.14, 10.1586/ERI.10.14]; Gueniche A, 2009, EXPT DERMATOLOGY, V19; Gueniche A, 2006, EUR J DERMATOL, V16, P511, DOI 10.1684/ejd.2006.0023; Hacini-Rachinel F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004903; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Krutmann J, 2009, J DERMATOL SCI, V54, P1, DOI 10.1016/j.jdermsci.2009.01.002; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Litonjua AA, 2007, J ALLERGY CLIN IMMUN, V120, P1031, DOI 10.1016/j.jaci.2007.08.028; Liva SM, 2001, J IMMUNOL, V167, P2060, DOI 10.4049/jimmunol.167.4.2060; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; McNulty NP, SCI TRANSL MED, V3; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Muscarella F, 1996, ETHOL SOCIOBIOL, V17, P99, DOI 10.1016/0162-3095(95)00130-1; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Noverr MC, 2004, TRENDS MICROBIOL, V12, P562, DOI 10.1016/j.tim.2004.10.008; Plikus MV, 2008, J INVEST DERMATOL, V128, P1071, DOI 10.1038/sj.jid.5701180; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rebora A, 2004, J AM ACAD DERMATOL, V50, P777, DOI 10.1016/j.jaad.2003.11.073; Saulnier DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018783; SCHALL R, 1991, BIOMETRIKA, V78, P719; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Schneider MR, 2010, INT J BIOCHEM CELL B, V42, P181, DOI 10.1016/j.biocel.2009.11.017; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Suh DH, 2002, EUR J DERMATOL, V12, P139; Sundberg JP, 2005, J INVEST DERM SYMP P, V10, P264, DOI 10.1111/j.1087-0024.2005.10126.x; Tango Y, 2001, J COSMET SCI, V52, P237; THODY AJ, 1989, PHYSIOL REV, V69, P383, DOI 10.1152/physrev.1989.69.2.383; Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67; Walter J, 2011, P NATL ACAD SCI USA, V108, P4645, DOI 10.1073/pnas.1000099107; WHEELER PE, 1985, J HUM EVOL, V14, P23, DOI 10.1016/S0047-2484(85)80091-9; Williams S, 2005, SKIN PHARMACOL PHYS, V18, P247, DOI 10.1159/000086671	47	91	102	5	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53867	10.1371/journal.pone.0053867	http://dx.doi.org/10.1371/journal.pone.0053867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342023	Green Published, gold, Green Submitted			2022-12-25	WOS:000313682700055
J	Miyazawa, S				Miyazawa, Sanzo			Prediction of Contact Residue Pairs Based on Co-Substitution between Sites in Protein Structures	PLOS ONE			English	Article							DETECTING COEVOLVING POSITIONS; PACKING DENSITY; DNA-SEQUENCES; MUTATIONS; INFORMATION; ACCURATE; TREES; RECONSTRUCTION; IDENTIFICATION; COEVOLUTION	Residue-residue interactions that fold a protein into a unique three-dimensional structure and make it play a specific function impose structural and functional constraints in varying degrees on each residue site. Selective constraints on residue sites are recorded in amino acid orders in homologous sequences and also in the evolutionary trace of amino acid substitutions. A challenge is to extract direct dependences between residue sites by removing phylogenetic correlations and indirect dependences through other residues within a protein or even through other molecules. Rapid growth of protein families with unknown folds requires an accurate de novo prediction method for protein structure. Recent attempts of disentangling direct from indirect dependences of amino acid types between residue positions in multiple sequence alignments have revealed that inferred residue-residue proximities can be sufficient information to predict a protein fold without the use of known three-dimensional structures. Here, we propose an alternative method of inferring coevolving site pairs from concurrent and compensatory substitutions between sites in each branch of a phylogenetic tree. Substitution probability and physico-chemical changes (volume, charge, hydrogen-bonding capability, and others) accompanied by substitutions at each site in each branch of a phylogenetic tree are estimated with the likelihood of each substitution, and their direct correlations between sites are used to detect concurrent and compensatory substitutions. In order to extract direct dependences between sites, partial correlation coefficients of the characteristic changes along branches between sites, in which linear multiple dependences on feature vectors at other sites are removed, are calculated and used to rank coevolving site pairs. Accuracy of contact prediction based on the present coevolution score is comparable to that achieved by a maximum entropy model of protein sequences for 15 protein families taken from the Pfam release 26.0. Besides, this excellent accuracy indicates that compensatory substitutions are significant in protein evolution.	Gunma Univ, Grad Sch Engn, Kiryu, Gunma, Japan	Gunma University	Miyazawa, S (corresponding author), Gunma Univ, Grad Sch Engn, Kiryu, Gunma, Japan.	sanzo.miyazawa@gmail.com	Miyazawa, Sanzo/V-5550-2017	Miyazawa, Sanzo/0000-0002-5063-3661				ALTSCHUH D, 1988, PROTEIN ENG, V2, P193, DOI 10.1093/protein/2.3.193; Atchley WR, 2000, MOL BIOL EVOL, V17, P164, DOI 10.1093/oxfordjournals.molbev.a026229; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bazykin GA, 2004, NATURE, V429, P558, DOI 10.1038/nature02601; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Burger L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100203; Burger L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000633; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Doron-Faigenboim A, 2007, MOL BIOL EVOL, V24, P388, DOI 10.1093/molbev/msl175; Duarte JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-283; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Dutheil J, 2005, MOL BIOL EVOL, V22, P1919, DOI 10.1093/molbev/msi183; Dutheil J, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-242; Dutheil JY, 2012, BRIEF BIOINFORM, V13, P228, DOI 10.1093/bib/bbr048; Edward D, 2000, INTRO GRAPHICAL MODE; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; Fariselli P, 2001, PROTEIN ENG, V14, P835, DOI 10.1093/protein/14.11.835; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FITCH WM, 1970, BIOCHEM GENET, V4, P579, DOI 10.1007/BF00486096; Fleishman SJ, 2004, J MOL BIOL, V340, P307, DOI 10.1016/j.jmb.2004.04.064; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; GO M, 1978, INT J PEPT PROT RES, V12, P237; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gulyas-Kovacs A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036546; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lie K, 2011, PLOS ONE, V6; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Maisnier-Patin S, 2004, RES MICROBIOL, V155, P360, DOI 10.1016/j.resmic.2004.01.019; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; Minin VN, 2008, PHILOS T R SOC B, V363, P3985, DOI 10.1098/rstb.2008.0176; Minin VN, 2008, J MATH BIOL, V56, P391, DOI 10.1007/s00285-007-0120-8; Miyazawa S, 1996, J MOL BIOL, V256, P623, DOI 10.1006/jmbi.1996.0114; Miyazawa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028892; Miyazawa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017244; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Nielsen R, 2002, SYST BIOL, V51, P729, DOI 10.1080/10635150290102393; O'Brien JD, 2009, MOL BIOL EVOL, V26, P801, DOI 10.1093/molbev/msp003; Penn O, 2010, MOL BIOL EVOL, V27, P1759, DOI 10.1093/molbev/msq066; Pollock DD, 1997, PROTEIN ENG, V10, P647, DOI 10.1093/protein/10.6.647; Pollock DD, 1999, J MOL BIOL, V287, P187, DOI 10.1006/jmbi.1998.2601; Poon AFY, 2008, BIOINFORMATICS, V24, P1949, DOI 10.1093/bioinformatics/btn313; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; Romiguier J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033852; Russ WP, 2005, NATURE, V437, P579, DOI 10.1038/nature03990; Sathyapriya R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000584; SHINDYALOV IN, 1994, PROTEIN ENG, V7, P349, DOI 10.1093/protein/7.3.349; Simons KT, 1999, PROTEINS, P171; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Stamatakis A, 2012, BIOINFORMATICS, DOI DOI 10.1093/BIOINFORMATICS/BTS309:1-3; Tataru P, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-465; Taylor WR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028265; Tsai J, 1999, J MOL BIOL, V290, P253, DOI 10.1006/jmbi.1999.2829; Tuffery P, 2000, MOL BIOL EVOL, V17, P1753, DOI 10.1093/oxfordjournals.molbev.a026273; Vassura M, 2008, BIOINFORMATICS, V24, P1313, DOI 10.1093/bioinformatics/btn115; Vendruscolo M, 1997, FOLD DES, V2, P295, DOI 10.1016/S1359-0278(97)00041-2; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Wu ST, 2011, STRUCTURE, V19, P1182, DOI 10.1016/j.str.2011.05.004; Yang JS, 2007, STRUCTURE, V15, P53, DOI 10.1016/j.str.2006.11.010; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; YANOFSKY C, 1964, SCIENCE, V146, P1593, DOI 10.1126/science.146.3651.1593; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211	67	14	14	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54252	10.1371/journal.pone.0054252	http://dx.doi.org/10.1371/journal.pone.0054252			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342110	Green Published, Green Submitted, gold			2022-12-25	WOS:000313682700097
J	Denis, V; Mezaki, T; Tanaka, K; Kuo, CY; De Palmas, S; Keshavmurthy, S; Chen, CA				Denis, Vianney; Mezaki, Takuma; Tanaka, Kouki; Kuo, Chao-Yang; De Palmas, Stephane; Keshavmurthy, Shashank; Chen, Chaolun Allen			Coverage, Diversity, and Functionality of a High-Latitude Coral Community (Tatsukushi, Shikoku Island, Japan)	PLOS ONE			English	Article							RANGE SHIFTS; PHASE-SHIFTS; REEF; CLIMATE; PATTERNS; ALGAE; PRODUCTIVITY; TEMPERATURE; RESILIENCE; HERBIVORY	Background: Seawater temperature is the main factor restricting shallow-water zooxanthellate coral reefs to low latitudes. As temperatures increase, coral species and perhaps reefs may move into higher-latitude waters, increasing the chances of coral reef ecosystems surviving despite global warming. However, there is a growing need to understand the structure of these high-latitude coral communities in order to analyze their future dynamics and to detect any potential changes. Methodology/Principal Findings: The high-latitude (32.75 degrees N) community surveyed was located at Tatsukushi, Shikoku Island, Japan. Coral cover was 60 +/- 2% and was composed of 73 scleractinian species partitioned into 7 functional groups. Although only 6% of species belonged to the 'plate-like' functional group, it was the major contributor to species coverage. This was explained by the dominance of plate-like species such as Acropora hyacinthus and A. solitaryensis. Comparison with historical data suggests a relatively recent colonization/development of A. hyacinthus in this region and a potential increase in coral diversity over the last century. Low coverage of macroalgae (2% of the benthic cover) contrasted with the low abundance of herbivorous fishes, but may be reasonably explained by the high density of sea urchins (12.9 +/- 3.3 individuals m(-2)). Conclusions/Significance: The structure and composition of this benthic community are relatively remarkable for a site where winter temperature can durably fall below the accepted limit for coral reef development. Despite limited functionalities and functional redundancy, the current benthic structure might provide a base upon which a reef could eventually develop, as characterized by opportunistic and pioneer frame-building species. In addition to increasing seawater temperatures, on-going management actions and sea urchin density might also explain the observed state of this community. A focus on such 'marginal' communities should be a priority, as they can provide important insights into how tropical corals might cope with environmental changes.	[Denis, Vianney; Kuo, Chao-Yang; De Palmas, Stephane; Keshavmurthy, Shashank; Chen, Chaolun Allen] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Mezaki, Takuma; Tanaka, Kouki] Kuroshio Biol Res Fdn, Kochi, Japan; [Chen, Chaolun Allen] Acad Sinica, Taiwan Int Grad Program Biodivers, Taipei 115, Taiwan; [Chen, Chaolun Allen] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University	Chen, CA (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan.	cac@gate.sinica.edu.tw	Keshavmurthy, Shashank/C-3672-2013; , de PALMAS Stéphane/AAS-8982-2021; Denis, Vianney/E-6868-2013	Keshavmurthy, Shashank/0000-0002-2235-9132; , de PALMAS Stéphane/0000-0002-2567-1789; Denis, Vianney/0000-0002-0914-5586	Academia Sinica Thematic Grants; National Science Council postdoctoral fellowship; Academia Sinica postdoctoral fellowship	Academia Sinica Thematic Grants; National Science Council postdoctoral fellowship; Academia Sinica postdoctoral fellowship(Academia Sinica - Taiwan)	This study was partly funded by Academia Sinica Thematic Grants (2011-2013) to CAC. VD was supported by a National Science Council postdoctoral fellowship (2011-2012), and SK by Academia Sinica postdoctoral fellowship (2010-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akimichi T, 2004, CORAL REEFS JAPAN; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; BRAITHWAITE CJ, 1973, AM ASSOC PETR GEOL B, V57, P1100; Brown-Saracino J, 2007, CORAL REEFS, V26, P71, DOI 10.1007/s00338-006-0159-9; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Buddemeier R., 2004, CORAL REEFS GLOBAL C, V15, P17789; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; CARPENTER RC, 1986, ECOL MONOGR, V56, P345, DOI 10.2307/1942551; CHEN C.A., 2009, KUROSHIO SCI, V3, P15; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Choat J.H., 1991, P120; CHOAT JH, 1982, J EXP MAR BIOL ECOL, V60, P129, DOI 10.1016/0022-0981(82)90155-1; Cooper TF, 2012, SCIENCE, V335, P593, DOI 10.1126/science.1214570; COYER JA, 1993, J EXP MAR BIOL ECOL, V167, P21, DOI 10.1016/0022-0981(93)90181-M; CROSSLAND CJ, 1984, MAR ECOL PROG SER, V15, P135, DOI 10.3354/meps015135; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Ferreira CEL, 2004, J BIOGEOGR, V31, P1093, DOI 10.1111/j.1365-2699.2004.01044.x; FROESE R, 2000, FISHBASE 2000 CONCEP; Greenstein BJ, 2008, GLOBAL CHANGE BIOL, V14, P513, DOI 10.1111/j.1365-2486.2007.01506.x; Grigg R.W., 1982, Coral Reefs, V1, P29, DOI 10.1007/BF00286537; Guillemot N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026735; Harriott VJ, 1999, CORAL REEFS, V18, P281, DOI 10.1007/s003380050195; Harriott VJ, 2002, CORAL REEFS, V21, P83, DOI 10.1007/s00338-001-0201-x; HATCHER BG, 1988, TRENDS ECOL EVOL, V3, P106, DOI 10.1016/0169-5347(88)90117-6; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hongo C, 2011, MAR GEOL, V279, P162, DOI 10.1016/j.margeo.2010.10.023; Horn M.H., 1989, Oceanography and Marine Biology an Annual Review, V27, P167; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Iwase F, 1995, SCLERACTINIAN CORAL, P20; Japan Meteorological Agency, 2012, LONG TERM SEA SURF T; JOHANNES RE, 1983, MAR ECOL PROG SER, V11, P105, DOI 10.3354/meps011105; KIMURA T, 2004, STATUS CORAL REEFS W, P277; Kleypas JA, 1999, AM ZOOL, V39, P146; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Lybolt M, 2011, FRONT ECOL ENVIRON, V9, P154, DOI 10.1890/090176; Marine Parks Center, 1970, SUMM 1 MAR PARKS, V13, P8; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Micheli F, 2005, ECOL LETT, V8, P391, DOI 10.1111/j.1461-0248.2005.00731.x; Ministry of the Environment, 2012, REST PROJ TATS 2011; Ministry of the Environment, 2011, REST PROJ TATS 2010; Misaki H, 1984, MARINE PAVILLION, V13, P1; Montaggioni LF, 2005, EARTH-SCI REV, V71, P1, DOI 10.1016/j.earscirev.2005.01.002; Moothien Pillay R, 2002, FIELD GUIDE CORALS M; Nishihira M., 1995, HERMATYPIC CORALS JA; Nomura K., 2005, KUROSHIO BIOSPHERE, V2, P29; Nozawa Y, 2008, MAR ECOL PROG SER, V358, P151, DOI 10.3354/meps07342; Nozawa Y, 2011, ZOOL STUD, V50, P53; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Precht WF, 2004, FRONT ECOL ENVIRON, V2, P307; Rogelj J, 2011, NAT CLIM CHANGE, V1, P413, DOI 10.1038/NCLIMATE1258; Sakamoto TT, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023384; SAMMARCO PW, 1982, J EXP MAR BIOL ECOL, V61, P31, DOI 10.1016/0022-0981(82)90020-X; Schuhmacher H., 1988, P379; Shirai S, 1971, SEASCAPES KASHINISHI, P6; Smith LD, 2008, CORAL REEFS, V27, P197, DOI 10.1007/s00338-007-0311-1; Sugiyama T, 1937, SCI REPORTS TOHOKU I, V26, P1; TRIBBLE GW, 1986, CORAL REEFS, V4, P151, DOI 10.1007/BF00427936; Utinomi H., 1965, Publications of the Seto Marine Biological Laboratory, V13, P243; van Woesik R, 2011, MAR ECOL PROG SER, V434, P67, DOI 10.3354/meps09203; Veron J. E. N., 1992, Pacific Science, V46, P405; Veron J.E.N., 2000, CORALS WORLD, V1-3; Veron J.E.N., 1986, CORALS AUSTR INDOPAC; Veron J. E. N., 1992, HERMATYPIC CORALS JA; VERON JEN, 1992, CONT SHELF RES, V12, P835, DOI 10.1016/0278-4343(92)90047-N; VERON JEN, 1995, CORALS SPACE TIME BI; Veron John E.N., 2011, P497; Wallace C.C., 1999, STAGHORN CORALS WORL, DOI 10.1071/9780643101388; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Woodroffe Colin D., 2011, P813; YABE H., 1935, JOURN PAL, V9, P183; Yabe H, 1931, SCI REPORTS TOHOKU I, V16, P143; Yamano H, 2012, CORAL REEFS, V31, P663, DOI 10.1007/s00338-012-0893-0; Yamano H, 2001, CORAL REEFS, V20, P9; Yamano H, 2012, GEOLOGY, V40, P835, DOI 10.1130/G33293.1; Yamano H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046474	75	30	32	5	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54330	10.1371/journal.pone.0054330	http://dx.doi.org/10.1371/journal.pone.0054330			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342135	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400150
J	Pervin, S; Hewison, M; Braga, M; Tran, L; Chun, R; Karam, A; Chaudhuri, G; Norris, K; Singh, R				Pervin, Shehla; Hewison, Martin; Braga, Melissa; Lac Tran; Chun, Rene; Karam, Amer; Chaudhuri, Gautam; Norris, Keith; Singh, Rajan			Down-Regulation of Vitamin D Receptor in Mammospheres: Implications for Vitamin D Resistance in Breast Cancer and Potential for Combination Therapy	PLOS ONE			English	Article							NITRIC-OXIDE; STEM-CELLS; PROSPECTIVE IDENTIFICATION; EXPRESSION; PATHWAY; BETA; RISK; VDR; DIFFERENTIATION; POLYMORPHISMS	Vitamin D signaling in mammary cancer stem cells (MCSCs), which are implicated in the initiation and progression of breast cancer, is poorly understood. In this study, we examined vitamin D signaling in mammospheres which are enriched in MCSCs from established breast cancer cell lines. Breast cancer cells positive for aldehyde dehydrogenase (ALDH(+)) had increased ability to form mammospheres compared to ALDH(-) cells. These mammospheres expressed MCSC-specific markers and generated transplantable xenografts in nude mice. Vitamin D receptor (VDR) was significantly down-regulated in mammospheres, as well as in ALDH+ breast cancer cells. TN aggressive human breast tumors as well as transplantable xenografts obtained from SKBR3 expressed significantly lower levels of VDR but higher levels of CD44 expression. Snail was up-regulated in mammospheres isolated from breast cancer cells. Inhibition of VDR expression by siRNA led to a significant change in key EMT-specific transcription factors and increased the ability of these cells to form mammospheres. On the other hand, over-expression of VDR led to a down-regulation of Snail but increased expression of E-cad and significantly compromised the ability of cells to form mammospheres. Mammospheres were relatively insensitive to treatment with 1,25-dihydroxyvitamin D (1,25D), the active form of vitamin D, compared to more differentiated cancer cells grown in presence of serum. Treatment of H-Ras transformed HMLEHRas cells with DETA NONOate, a nitric oxide (NO)-donor led to induction of MAP-kinase phosphatase-1 (MKP-1) and dephosphorylation of ERK1/2 in the mammospheres. Combined treatment of these cells with 1,25D and a low-concentration of DETA NONOate led to a significant decrease in the overall size of mammospheres and reduced tumor volume in nude mice. Our findings therefore, suggest that combination therapy using 1,25D with drugs specifically targeting key survival pathways in MCSCs warrant testing in prospective clinical trial for treatment of aggressive breast cancer.	[Pervin, Shehla; Braga, Melissa; Lac Tran; Norris, Keith; Singh, Rajan] Charles R Drew Univ Med & Sci, Dept Internal Med, Los Angeles, CA 90059 USA; [Pervin, Shehla; Karam, Amer; Chaudhuri, Gautam; Singh, Rajan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA; [Hewison, Martin; Chun, Rene] Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthoped Surg, Los Angeles, CA 90095 USA; [Pervin, Shehla; Chaudhuri, Gautam; Singh, Rajan] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Chaudhuri, Gautam] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	Charles R. Drew University of Medicine & Science; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Pervin, S (corresponding author), Charles R Drew Univ Med & Sci, Dept Internal Med, 1621 E 120th St, Los Angeles, CA 90059 USA.	shehlapervin@cdrewu.edu; rajansingh@mednet.ucla.edu	Chun, Rene/A-9415-2010	Chun, Rene/0000-0002-0190-0807; Karam, Amer/0000-0003-1511-5583	National Institutes of Health [SC1 AG033407-01A1, 1SC1 CA165865-01A1]; MSI endowment [5S2MD000103]; NATIONAL CANCER INSTITUTE [SC1CA165865, U54CA143931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [SC1AG033407] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSI endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was supported by National Institutes of Health grants SC1 AG033407-01A1 (RS); 1SC1 CA165865-01A1 (SP) and in part by MSI endowment (5S2MD000103, sub award RS) to Charles Drew University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin SA, 2006, ANTICANCER RES, V26, P2557; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alimirah F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016024; Bai SC, 2010, J BONE MINER RES, V25, P830, DOI 10.1359/jbmr.091010; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Braga M, 2012, MOL CELL ENDOCRINOL, V350, P39, DOI 10.1016/j.mce.2011.11.019; BURAS RR, 1994, BREAST CANCER RES TR, V31, P191, DOI 10.1007/BF00666153; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Fakih MG, 2007, CLIN CANCER RES, V13, P1216, DOI 10.1158/1078-0432.CCR-06-1165; Jeanson NT, 2010, BLOOD, V116, P4126, DOI 10.1182/blood-2010-04-280552; Jensen JD, 2010, CLIN DERMATOL, V28, P644, DOI 10.1016/j.clindermatol.2010.03.026; Larriba MJ, 2010, J STEROID BIOCHEM, V121, P106, DOI 10.1016/j.jsbmb.2010.01.014; Johnson J, 2011, MOL NUTR FOOD RES, V55, P58, DOI 10.1002/mnfr.201000420; Kemmis CM, 2008, J CELL BIOCHEM, V105, P980, DOI 10.1002/jcb.21896; Kommagani R, 2006, ONCOGENE, V25, P3745, DOI 10.1038/sj.onc.1209412; Krishnan AV, 2010, J STEROID BIOCHEM, V121, P343, DOI 10.1016/j.jsbmb.2010.02.009; Krishnan AV, 2010, ENDOCRINOLOGY, V151, P32, DOI 10.1210/en.2009-0855; Larriba MJ, 2005, BRIT J CANCER, V92, P985, DOI 10.1038/sj.bjc.6602484; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Li YY, 2011, J NUTR BIOCHEM, V22, P799, DOI 10.1016/j.jnutbio.2010.11.001; Liu N, 2009, BIOL REPROD, V80, P398, DOI 10.1095/biolreprod.108.073577; Lopes N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-483; Mckay JD, 2009, CANCER EPIDEM BIOMAR, V18, P297, DOI 10.1158/1055-9965.EPI-08-0539; Mittal MK, 2008, BIOCHEM BIOPH RES CO, V372, P30, DOI 10.1016/j.bbrc.2008.04.187; Muindi JR, 2002, CLIN PHARMACOL THER, V72, P648, DOI 10.1067/mcp.2002.129305; Narvaez CJ, 2001, STEROIDS, V66, P301, DOI 10.1016/S0039-128X(00)00202-6; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Perez-Lopez FR, 2009, REPROD SCI, V16, P7, DOI 10.1177/1933719108327595; Pervin S, 2003, CANCER RES, V63, P8853; Pervin S, 2003, CANCER RES, V63, P5470; Pervin S, 2001, P NATL ACAD SCI USA, V98, P3583, DOI 10.1073/pnas.041603998; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Samuni Y, 2009, FREE RADICAL BIO MED, V47, P419, DOI 10.1016/j.freeradbiomed.2009.05.011; Sanceau J, 2002, ONCOGENE, V21, P7700, DOI 10.1038/sj.onc.1205881; Singh R, 2006, ENDOCRINOLOGY, V147, P141, DOI 10.1210/en.2004-1649; Swami Srilatha, 2011, Hormones & Cancer, V2, P190, DOI 10.1007/s12672-011-0073-7; Tavera-Mendoza LE, 2008, P NATL ACAD SCI USA, V105, P8250, DOI 10.1073/pnas.0709279105; To K, 2010, CANCER RES, V70; Toner CD, 2010, J AM DIET ASSOC, V110, P1492, DOI 10.1016/j.jada.2010.07.007; Trabert B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1833; Yin L, 2011, GYNECOL ONCOL, V121, P369, DOI 10.1016/j.ygyno.2011.01.023; Yu WD, 1998, J NATL CANCER I, V90, P134, DOI 10.1093/jnci/90.2.134; Zhang ZT, 2010, J CELL PHYSIOL, V224, P433, DOI 10.1002/jcp.22139	48	32	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53287	10.1371/journal.pone.0053287	http://dx.doi.org/10.1371/journal.pone.0053287			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341935	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400039
J	Walzer, C; Kowalczyk, C; Alexander, JM; Baur, B; Bogliani, G; Brun, JJ; Fureder, L; Guth, MO; Haller, R; Holderegger, R; Kohler, Y; Kueffer, C; Righetti, A; Spaar, R; Sutherland, WJ; Ullrich-Schneider, A; Vanpeene-Bruhier, SN; Scheurer, T				Walzer, Chris; Kowalczyk, Christine; Alexander, Jake M.; Baur, Bruno; Bogliani, Giuseppe; Brun, Jean-Jacques; Fuereder, Leopold; Guth, Marie-Odile; Haller, Ruedi; Holderegger, Rolf; Kohler, Yann; Kueffer, Christoph; Righetti, Antonio; Spaar, Reto; Sutherland, William J.; Ullrich-Schneider, Aurelia; Vanpeene-Bruhier, Sylvie N.; Scheurer, Thomas			The 50 Most Important Questions Relating to the Maintenance and Restoration of an Ecological Continuum in the European Alps	PLOS ONE			English	Article							CONSERVATION; SCIENCE; POLICY; IDENTIFICATION; MANAGEMENT; RELEVANT; NEED	The European Alps harbour a unique and species-rich biodiversity, which is increasingly impacted by habitat fragmentation through land-use changes, urbanization and expanding transport infrastructure. In this study, we identified the 50 most important questions relating to the maintenance and restoration of an ecological continuum - the connectedness of ecological processes across many scales including trophic relationship and disturbance processes and hydro-ecological flows in the European Alps. We initiated and implemented a trans-national priority setting exercise, inviting 48 institutions including researchers, conservation practitioners, NGOs, policymakers and administrators from the Alpine region. The exercise was composed of an initial call for pertinent questions, a first online evaluation of the received questions and a final discussion and selection process during a joint workshop. The participating institutions generated 484 initial questions, which were condensed to the 50 most important questions by 16 workshop participants. We suggest new approaches in tackling the issue of an ecological continuum in the Alps by analysing and classifying the characteristics of the resulting questions in a non-prioritized form as well as in a visual conceptualisation of the inter-dependencies among these questions. This priority setting exercise will support research and funding institutions in channelling their capacities and resources towards questions that need to be urgently addressed in order to facilitate significant progress in biodiversity conservation in the European Alps.	[Walzer, Chris; Kowalczyk, Christine] Univ Vet Med, Dept Integrat Biol & Evolut, Res Inst Wildlife Ecol, Vienna, Austria; [Alexander, Jake M.; Kueffer, Christoph] Swiss Fed Inst Technol Zurich, Inst Integrat Biol, Zurich, Switzerland; [Baur, Bruno] Univ Basel, Dept Environm Sci, Basel, Switzerland; [Bogliani, Giuseppe] Univ Pavia, Dept Earth & Environm Sci, I-27100 Pavia, Italy; [Brun, Jean-Jacques] Natl Res Inst Sci & Technol Environm & Agr, Unite Ecosyst Montagnards, St Martin Dheres, France; [Fuereder, Leopold] Univ Innsbruck, Inst Ecol, A-6020 Innsbruck, Austria; [Guth, Marie-Odile] Minist Ecol Sustainable Dev & Energy, Paris, France; [Haller, Ruedi] Swiss Natl Pk, Res & Geoinformat, Zernez, Switzerland; [Holderegger, Rolf] Swiss Fed Inst Forest Snow & Landscape Res, Res Unit Biodivers & Conservat Biol, CH-8903 Birmensdorf, Switzerland; [Kohler, Yann] Permanent Secretariat Alpine Convent, Task Force Protected Areas, Chambery, France; [Righetti, Antonio] Partner Innen Umweltfragen, Liebefeld, Switzerland; [Spaar, Reto] Swiss Ornithol Inst, Sempach, Switzerland; [Sutherland, William J.] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England; [Ullrich-Schneider, Aurelia] Int Commiss Protect Alps CIPRA Int, Schaan, Liechtenstein; [Vanpeene-Bruhier, Sylvie N.] Natl Res Inst Sci & Technol Environm & Agr, Aix En Provence, France; [Scheurer, Thomas] Swiss Acad Sci, Bern, Switzerland	University of Veterinary Medicine Vienna; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel; University of Pavia; INRAE; University of Innsbruck; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Swiss Ornithological Institute; University of Cambridge; INRAE	Walzer, C (corresponding author), Univ Vet Med, Dept Integrat Biol & Evolut, Res Inst Wildlife Ecol, Vienna, Austria.	chris.walzer@fiwi.at	Kueffer, Christoph/H-6091-2013; Alexander, Jake/P-2580-2014; Sutherland, William/B-1291-2013	Kueffer, Christoph/0000-0001-6701-0703; Alexander, Jake/0000-0003-2226-7913; Bogliani, Giuseppe/0000-0001-9066-6540; Vanpeene, Sylvie/0000-0003-3970-4454; Walzer, Chris/0000-0002-0437-5147; Sutherland, William/0000-0002-6498-0437	"Platform Ecological Network'' of the Alpine Convention; ECONNECT project; EU within the framework of the European Territorial Cooperation Alpine Space Programme; European Regional Development Fund; CCES-GENEREACH project of the ETH domain	"Platform Ecological Network'' of the Alpine Convention; ECONNECT project; EU within the framework of the European Territorial Cooperation Alpine Space Programme; European Regional Development Fund(European Commission); CCES-GENEREACH project of the ETH domain	Funding for this project was provided in part by the "Platform Ecological Network'' of the Alpine Convention (http://www.alpconv.org/en/organization/groups/WGEcologicalNetwork/default.html) and the ECONNECT project funded by the EU within the framework of the European Territorial Cooperation Alpine Space Programme and co-funded by the European Regional Development Fund (www.econnectproject.eu). RH was supported by the CCES-GENEREACH project of the ETH domain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beier P, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001253; Bennett G., 2004, LINKAGES PRACTICE RE; Bernstein S, 2000, EUR J INT RELAT, V6, P43, DOI 10.1177/1354066100006001003; Braunisch V, 2012, BIOL CONSERV, V153, P201, DOI 10.1016/j.biocon.2012.05.007; Cooke SJ, 2010, J FISH BIOL, V76, P2261, DOI 10.1111/j.1095-8649.2010.02666.x; Fazey I, 2005, BIOL CONSERV, V124, P63, DOI 10.1016/j.biocon.2005.01.013; Fureder L, 2011, ECONNECT POLICY RECO; Hirsch Hadorn G., 2008, HDB TRANSDISCIPLINAR, P19, DOI [DOI 10.1007/978-1-4020-6699-3_2, 10.1007/978-1-4020-6699-3]; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kohler Y, 2009, REV GEOGR ALP, V97, DOI 10.4000/rga.808; Lazarus RJ, 2009, CORNELL LAW REV, V94, P77; Lindenmayer D, 2006, HABITAT FRAGMENTATIO; Milner-Gulland EJ, 2010, ORYX, V44, P1, DOI 10.1017/S0030605309991001; Morrison S.A., 2006, CONNECTIVITY CONSERV, P536; ProClim/CASS, 1997, VIS SWISS RES RES SU; RITTEL HWJ, 1973, POLICY SCI, V4, P155, DOI 10.1007/BF01405730; Roux DJ, 2006, ECOL SOC, V11; Soule ME, 2006, CONSERV BIOL, P649; Sutherland WJ, 2009, CONSERV BIOL, V23, P557, DOI 10.1111/j.1523-1739.2009.01212.x; Sutherland WJ, 2006, J APPL ECOL, V43, P617, DOI 10.1111/j.1365-2664.2006.01188.x; Sutherland WJ, 2011, METHODS ECOL EVOL, V2, P238, DOI 10.1111/j.2041-210X.2010.00083.x; Sutherland WJ, 2010, J APPL ECOL, V47, P955, DOI 10.1111/j.1365-2664.2010.01863.x; Sutherland WJ, 2010, TRENDS ECOL EVOL, V25, P1, DOI 10.1016/j.tree.2009.10.003; Sutherland WJ, 2009, TRENDS ECOL EVOL, V24, P523, DOI 10.1016/j.tree.2009.04.008; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Walzer C, 2011, WEBS LIFE ALPINE BIO; Worboys G.L., 2010, CONNECTIVITY CONSERV; Wuelser G, 2012, SUSTAIN SCI, V7, P81, DOI 10.1007/s11625-011-0143-3	28	16	17	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53139	10.1371/journal.pone.0053139	http://dx.doi.org/10.1371/journal.pone.0053139			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341928	Green Submitted, Green Published, gold			2022-12-25	WOS:000314759400033
J	Fendri, I; Abdou, L; Trotter, V; Dedieu, L; Maamar, H; Minton, NP; Tardif, C				Fendri, Imen; Abdou, Laetitia; Trotter, Valentine; Dedieu, Luc; Maamar, Hedia; Minton, Nigel P.; Tardif, Chantal			Regulation of cel Genes of C. cellulolyticum: Identification of GlyR2, a Transcriptional Regulator Regulating cel5D Gene Expression	PLOS ONE			English	Article							SCAFFOLDING PROTEIN CIPC; CLOSTRIDIUM-CELLULOLYTICUM; SEQUENCE-ANALYSIS; ENDOGLUCANASE-A; CELLULOSOME; SYSTEM; METABOLISM; CLUSTER; OPERON	Transcription and expression regulation of some individual cel genes (cel5A, cel5I, cel5D and cel44O) of Clostridium cellulolyticum were investigated. Unlike the cip-cel operon, these genes are transcribed as monocistronic units of transcription, except cel5D. The location of the transcription initiation sites was determined using RT-PCR and the mRNA 5'-end extremities were detected using primer extension experiments. Similarly to the cip-cel operon, cel5A and cel5I expressions are regulated by a carbon catabolite repression mechanism, whereas cel44O and cel5D expressions do not seem to be submitted to this regulation. The role of the putative transcriptional regulator GlyR2 in the regulation of cel5D expression was investigated. The recombinant protein GlyR2 was produced and was shown to bind in vitro to the cel5D and glyR2 promoter regions, suggesting that besides regulating its own expression, GlyR2 may regulate cel5D expression. To test this hypothesis in vivo, an insertional glyR2 mutant was generated and the effect of this disruption on cel5D expression was evaluated. Levels of cel5D mRNAs in the mutant were 16 fold lower than that of the wild-type strain suggesting that GlyR2 acts as an activator of cel5D expression.	[Fendri, Imen; Abdou, Laetitia; Trotter, Valentine; Dedieu, Luc; Maamar, Hedia; Tardif, Chantal] IMM, CNRS UMR 7283, Chim Bacterienne Lab, Marseille, France; [Trotter, Valentine; Tardif, Chantal] Aix Marseille Univ, Marseille, France; [Minton, Nigel P.] Univ Nottingham, Sch Mol Med Sci, Ctr Biomol Sci, Clostridia Res Grp, Nottingham NG7 2RD, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University of Nottingham	Tardif, C (corresponding author), IMM, CNRS UMR 7283, Chim Bacterienne Lab, Marseille, France.	tardif@imm.cnrs.fr	Trotter, Valentine/A-9374-2018	Trotter, Valentine/0000-0002-1784-9487; FENDRI, Imen/0000-0002-4071-5444; Minton, Nigel/0000-0002-9277-1261	Centre National de la Recherche Scientifique; Biotechnology and Biological Sciences Research Council [BB/G016224/1] Funding Source: researchfish; BBSRC [BB/G016224/1] Funding Source: UKRI	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by grants from the Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou L, 2008, J BACTERIOL, V190, P1499, DOI 10.1128/JB.01160-07; Antunes A, 2012, NUCL AC RES IN PRESS; BAGNARATARDIF C, 1992, GENE, V119, P17, DOI 10.1016/0378-1119(92)90062-T; Blouzard JC, 2009, THESIS; Blouzard JC, 2007, J BACTERIOL, V189, P2300, DOI 10.1128/JB.00917-06; Blouzard JC, 2010, PROTEOMICS, V10, P541, DOI 10.1002/pmic.200900311; Desvaux M, 2001, APPL ENVIRON MICROB, V67, P3837, DOI 10.1128/AEM.67.9.3837-3845.2001; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; FAURE E, 1989, GENE, V84, P39, DOI 10.1016/0378-1119(89)90137-6; Fendri I, 2009, FEBS J, V276, P3076, DOI 10.1111/j.1742-4658.2009.07025.x; FIEROBE HP, 1991, J BACTERIOL, V173, P7956, DOI 10.1128/jb.173.24.7956-7962.1991; Fierobe HP, 1999, BIOCHEMISTRY-US, V38, P12822, DOI 10.1021/bi9911740; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Gal L, 1997, APPL ENVIRON MICROB, V63, P903, DOI 10.1128/AEM.63.3.903-909.1997; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maamar H, 2004, MOL MICROBIOL, V51, P589, DOI 10.1046/j.1365-2958.2003.03859.x; Maamar H, 2006, J BACTERIOL, V188, P2614, DOI 10.1128/JB.188.7.2614-2624.2006; Maamar H, 2003, THESIS; Martin RG, 2001, CURR OPIN MICROBIOL, V4, P132, DOI 10.1016/S1369-5274(00)00178-8; Mosbah A, 2002, J BIOMOL NMR, V23, P157, DOI 10.1023/A:1016354623398; Newcomb M, 2007, P NATL ACAD SCI USA, V104, P3747, DOI 10.1073/pnas.0700087104; Pages S, 1999, J BACTERIOL, V181, P1801; Pages S, 1996, J BACTERIOL, V178, P2279, DOI 10.1128/jb.178.8.2279-2286.1996; ReverbelLeroy C, 1996, MICROBIOL-SGM, V142, P1013, DOI 10.1099/00221287-142-4-1013; SHIMA S, 1993, APPL MICROBIOL BIOT, V38, P750, DOI 10.1007/BF00167140; Tardif C, 2001, J IND MICROBIOL BIOT, V27, P271, DOI 10.1038/sj.jim.7000081; TARDIF C, 2006, CELLULOSOME, P221; Tobes R, 2002, NUCLEIC ACIDS RES, V30, P318, DOI 10.1093/nar/30.1.318	29	4	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e44708	10.1371/journal.pone.0044708	http://dx.doi.org/10.1371/journal.pone.0044708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349658	Green Published, Green Submitted, gold			2022-12-25	WOS:000314019100001
J	Uebel, KE; Joubert, G; Wouters, E; Mollentze, WF; van Rensburg, DHCJ				Uebel, Kerry E.; Joubert, Gina; Wouters, Edwin; Mollentze, Willie F.; van Rensburg, Dingie H. C. J.			Integrating HIV Care into Primary Care Services: Quantifying Progress of an Intervention in South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT OUTCOMES; FREE STATE PROVINCE; STREAMLINING TASKS; EXPANDING ACCESS; HEALTH-SERVICES; SCALE-UP; THERAPY; COMMUNITY; STRETCH; NURSES	Background: Integration of human immunodeficiency virus (HIV) care into primary care services is one strategy proposed to achieve universal access to antiretroviral treatment (ART) for HIV-positive patients in high burden countries. There is a need for controlled studies of programmes to integrate HIV care with details of the services being integrated. Methods: A semi-quantitative questionnaire was developed in consultation with clinic staff, tested for internal consistency using Cronbach's alpha coefficients and checked for inter-observer reliability. It was used to conduct four assessments of the integration of HIV care into referring primary care clinics (mainstreaming HIV) and into the work of all nurses within ART clinics (internal integration) and the integration of pre-ART and ART care during the Streamlining Tasks and Roles to Expand Treatment and Care for HIV (STRETCH) trial in South Africa. Mean total integration and four component integration scores at intervention and control clinics were compared using one way analysis of variance (ANOVA). Repeated measures ANOVA was used to analyse changes in scores during the trial. Results: Cronbach's alpha coefficients for total integration, pre-ART and ART integration and mainstreaming HIV and internal integration scores showed good internal consistency. Mean total integration, mainstreaming HIV and ART integration scores increased significantly at intervention clinics by the third assessment. Mean pre-ART integration scores were almost maximal at the first assessment and showed no further change. There was no change in mean internal integration score. Conclusion: The questionnaire developed in this study is a valid tool with potential for monitoring integration of HIV care in other settings. The STRETCH trial interventions resulted in increased integration of HIV care, particularly ART care, by providing HIV care at referring primary care clinics, but had no effect on integrating HIV care into the work of all nurses with the ART clinic.	[Uebel, Kerry E.; Mollentze, Willie F.] Univ Orange Free State, Fac Hlth Sci, Dept Internal Med, Bloemfontein, South Africa; [Joubert, Gina] Univ Orange Free State, Fac Hlth Sci, Dept Biostat, Bloemfontein, South Africa; [Wouters, Edwin] Univ Antwerp, Dept Sociol, Antwerp, Belgium; [Wouters, Edwin] Univ Antwerp, Res Ctr Longitudinal & Life Course Studies, Antwerp, Belgium; [Wouters, Edwin; van Rensburg, Dingie H. C. J.] Univ Orange Free State, Ctr Hlth Syst Res & Dev, Bloemfontein, South Africa	University of the Free State; University of the Free State; University of Antwerp; University of Antwerp; University of the Free State	Uebel, KE (corresponding author), Univ Orange Free State, Fac Hlth Sci, Dept Internal Med, Bloemfontein, South Africa.	uebelke@fshealth.gov.za	Wouters, Edwin/AAE-1649-2021; Joubert, Gina/I-2985-2018	Wouters, Edwin/0000-0003-2268-3829; Joubert, Gina/0000-0002-3728-6925	National Research Fund of South Africa	National Research Fund of South Africa	The National Research Fund of South Africa was the source of a doctoral bursary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MA, 2009, SAMJ S AFR MED J, V99, P661; Atun R, 2010, HEALTH POLICY PLANN, V25, P1, DOI 10.1093/heapol/czp053; Barker PM, 2007, J INFECT DIS, V196, pS457, DOI 10.1086/521110; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Briggs CJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003318.pub2; Cohen R, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-23; Colvin CJ, 2010, SAMJ S AFR MED J, V100, P210, DOI 10.7196/SAMJ.4124; Dudley L, 2010, COCHRANE DB SYST REV, V7; El-Sadr WM, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000298105.79484.62; Engelbrecht MC, 2008, S AFR J ECON, V76, pS15, DOI 10.1111/j.1813-6982.2008.00164.x; English Rene G, 2008, Prim Care Respir J, V17, P156, DOI 10.3132/pcrj.2008.00044; Fairall L, 2012, LANCET, V380, P889, DOI 10.1016/S0140-6736(12)60730-2; Fairall LR, 2008, ARCH INTERN MED, V168, P86, DOI 10.1001/archinternmed.2007.10; Fairall LR, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-21; Fairall LR, 2005, BMJ-BRIT MED J, V331, P750, DOI 10.1136/bmj.331.7519.750; Fredlund VG, 2007, J INFECT DIS, V196, pS469, DOI 10.1086/521115; Friedland G, 2007, J INFECT DIS, V196, pS114, DOI 10.1086/518664; Georgeu D, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-66; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; McCoy D, 2005, AM J PUBLIC HEALTH, V95, P18, DOI 10.2105/AJPH.2004.040121; Miles K, 2007, B WORLD HEALTH ORGAN, V85, P555, DOI 10.2471/BLT.06.033076; Oakley A, 2006, BRIT MED J, V332, P413, DOI 10.1136/bmj.332.7538.413; Ooms G, 2008, GLOBALIZATION HEALTH, V4, DOI 10.1186/1744-8603-4-6; Pfeiffer J, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-3; Sanne I, 2010, LANCET, V376, P33, DOI 10.1016/S0140-6736(10)60894-X; Schneider H, 2006, REPROD HEALTH MATTER, V14, P12, DOI 10.1016/S0968-8080(06)27232-X; Shigayeva A, 2010, HEALTH POLICY PLANN, V25, pi4, DOI 10.1093/heapol/czq060; Shisana O, 2009, S AFRICAN NATL HIV P; Statistics South Africa, 2011, MIDY POP EST; Topp SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011522; Uebel KE, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-86; Uebel KE, 2010, SAMJ S AFR MED J, V100, P589, DOI 10.7196/SAMJ.3897; VARIAVA E, 2006, SOUTH AFR J HIV  JUN, P35; World Health Organisation, 2007, TASK SHIFT RAT RED T; World Health Organization, 2004, ANT THER PRIM HLTH E; World Health Organization, 2010, UN ACC SCAL PRIOR HI; World Health Organization, 2003, ANT THER PRIM HLTH C; Wouters E, 2009, SOC SCI MED, V69, P1177, DOI 10.1016/j.socscimed.2009.07.034; Wouters E, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-103; Zachariah R, 2007, T ROY SOC TROP MED H, V101, P79, DOI 10.1016/j.trstmh.2006.05.010	40	11	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54266	10.1371/journal.pone.0054266	http://dx.doi.org/10.1371/journal.pone.0054266			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077HS	23349843	Green Published, Green Submitted, gold			2022-12-25	WOS:000314019100054
J	Cohen, E; Avrahami, D; Frid, K; Canello, T; Lahad, EL; Zeligson, S; Perlberg, S; Chapman, J; Cohen, OS; Kahana, E; Lavon, I; Gabizon, R				Cohen, Eran; Avrahami, Dana; Frid, Kati; Canello, Tamar; Lahad, Ephrat Levy; Zeligson, Sharon; Perlberg, Shira; Chapman, Joab; Cohen, Oren S.; Kahana, Esther; Lavon, Iris; Gabizon, Ruth			Snord 3A: A Molecular Marker and Modulator of Prion Disease Progression	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; LIBYAN JEWS; NEURODEGENERATIVE DISEASES; PARKINSONS-DISEASE; MOUSE MODEL; PROTEIN; MUTATION; STRESS; GENE; IDENTIFICATION	Since preventive treatments for prion disease require early identification of subjects at risk, we searched for surrogate peripheral markers characterizing the asymptomatic phases of such conditions. To this effect, we subjected blood mRNA from E200K PrP CJD patients and corresponding family members to global arrays and found that the expression of Snord3A, a non-coding RNA transcript, was elevated several times in CJD patients as compared to controls, while asymptomatic carriers presented intermediate Snord3A levels. In the brains of TgMHu2ME199K mice, a mouse model mimicking for E200K CJD, Snord 3A levels were elevated in an age and disease severity dependent manner, as was the case for brains of these mice in which disease was exacerbated by copper administration. Snord3A expression was also elevated in scrapie infected mice, but not in PrP0/0 mice, indicating that while the expression levels of this transcript may reflect diverse prion etiologies, they are not related to the loss of PrPC's function. Elevation of Snord3A was consistent with the activation of ATF6, representing one of the arms of the unfolded protein response system. Indeed, SnoRNAs were associated with reduced resistance to oxidative stress, and with ER stress in general, factors playing a significant role in this and other neurodegenerative conditions. We hypothesize that in addition to its function as a disease marker, Snord3A may play an important role in the mechanism of prion disease manifestation and progression.	[Cohen, Eran; Avrahami, Dana; Frid, Kati; Canello, Tamar; Lavon, Iris; Gabizon, Ruth] Hadassah Med Ctr, Dept Neurol, Agnes Ginges Ctr Human Neurogenet, IL-91120 Jerusalem, Israel; [Lahad, Ephrat Levy; Zeligson, Sharon; Perlberg, Shira] Shaare Zedek Med Ctr, Inst Med Genet, Jerusalem, Israel; [Lahad, Ephrat Levy; Zeligson, Sharon; Perlberg, Shira] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel; [Chapman, Joab; Cohen, Oren S.] Tel Aviv Univ, Dept Neurol, Sheba Med Ctr, Sackler Fac, Tel Aviv, Israel; [Kahana, Esther] Barzilai Govt Hosp, Dept Neurol, Ashqelon, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Chaim Sheba Medical Center; Tel Aviv University; Ben Gurion University; Barzilai Medical Center	Gabizon, R (corresponding author), Hadassah Med Ctr, Dept Neurol, Agnes Ginges Ctr Human Neurogenet, Kiryat Haddasah, IL-91120 Jerusalem, Israel.	gabizonr@hadassah.org.il	Chapman, Joab/E-4598-2010; Levy-Lahad, Ephrat/F-2186-2018; Lavon, Iris/ABE-6651-2021	Levy-Lahad, Ephrat/0000-0002-2637-1921; Kahana, Esther/0000-0002-3863-3271; Chapman, Joab/0000-0002-2161-9764	Israeli Science foundation, Agnes Ginges Center for human neurogenetics	Israeli Science foundation, Agnes Ginges Center for human neurogenetics	Israeli Science foundation, Agnes Ginges Center for human neurogenetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt S, 2002, NEUROBIOL DIS, V10, P150, DOI 10.1006/nbdi.2002.0496; Avrahami D, 2011, NEUROBIOL AGING, V32, P2006, DOI 10.1016/j.neurobiolaging.2009.12.015; BASERGA SJ, 1991, EMBO J, V10, P2645, DOI 10.1002/j.1460-2075.1991.tb07807.x; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Canello T, 2012, NEUROBIOL DIS, V45, P1010, DOI 10.1016/j.nbd.2011.12.020; Canello T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000977; CHAPMAN J, 1993, J NEUROL NEUROSUR PS, V56, P1109, DOI 10.1136/jnnp.56.10.1109; Dalma-Weiszhausz DD, 2002, GENET EPIDEMIOL, V23, P4, DOI 10.1002/gepi.216; DeArmond SJ, 2002, TOXICOLOGY, V181, P9, DOI 10.1016/S0300-483X(02)00249-4; Doyle KM, 2011, J CELL MOL MED, V15, P2025, DOI 10.1111/j.1582-4934.2011.01374.x; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Freixes M, 2006, NEUROBIOL AGING, V27, P1807, DOI 10.1016/j.neurobiolaging.2005.10.006; Friedman-Levi Y, PLOS PATHOG, V7; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Hamacher M, 2007, EXPERT REV PROTEOMIC, V4, P591, DOI 10.1586/14789450.4.5.591; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hewitt PE, 2006, VOX SANG, V91, P221, DOI 10.1111/j.1423-0410.2006.00833.x; Hoozemans JJM, 2012, NEURODEGENER DIS, V10, P212, DOI 10.1159/000334536; HSIAO K, 1991, NEW ENGL J MED, V324, P1091, DOI 10.1056/NEJM199104183241604; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; KAHANA E, 1974, SCIENCE, V183, P90, DOI 10.1126/science.183.4120.90; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Kong DH, 2012, J MOL NEUROSCI, V47, P595, DOI 10.1007/s12031-011-9688-y; Lee HS, 1999, AM J HUM GENET, V64, P1063, DOI 10.1086/302340; LIPSHUTZ RJ, 1995, BIOTECHNIQUES, V19, P442; Mandel S, 2005, ANN NY ACAD SCI, V1053, P356, DOI 10.1196/annals.1344.031; Meiner Z, 1997, MEDICINE, V76, P227, DOI 10.1097/00005792-199707000-00001; Michel CI, 2011, CELL METAB, V14, P33, DOI 10.1016/j.cmet.2011.04.009; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Olanow CW, 2009, P NATL ACAD SCI USA, V106, P12571, DOI 10.1073/pnas.0906759106; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Quaglio E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019339; Riemer C, 2004, BIOCHEM BIOPH RES CO, V323, P556, DOI 10.1016/j.bbrc.2004.08.124; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; SPUDICH S, 1995, MOL MED, V1, P607, DOI 10.1007/BF03401601; Sultana R, 2009, METHODS MOL BIOL, V566, P123, DOI 10.1007/978-1-59745-562-6_9; Turner BJ, 2009, NEUROBIOL DIS, V34, P511, DOI 10.1016/j.nbd.2009.03.005; Watkins NJ, 2004, MOL CELL, V16, P789, DOI 10.1016/j.molcel.2004.11.012; Wehner KA, 2002, BRAIN RES, V945, P160, DOI 10.1016/S0006-8993(02)02750-6; Xiang W, 2004, J VIROL, V78, P11051, DOI 10.1128/JVI.78.20.11051-11060.2004; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhang M, 2010, J NEUROSCI RES, V88, P686, DOI 10.1002/jnr.22230	45	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54433	10.1371/journal.pone.0054433	http://dx.doi.org/10.1371/journal.pone.0054433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349890	gold, Green Published, Green Submitted			2022-12-25	WOS:000313943000038
J	Jourdain, I; Brzezinska, EA; Toda, T				Jourdain, Isabelle; Brzezinska, Elspeth A.; Toda, Takashi			Fission Yeast Nod1 Is a Component of Cortical Nodes Involved in Cell Size Control and Division Site Placement	PLOS ONE			English	Article							CYTOKINETIC CONTRACTILE RING; SCHIZOSACCHAROMYCES-POMBE; MITOTIC COMMITMENT; FAMILY KINASE; POLO KINASE; MYOSIN-II; MID1P; MITOSIS; GENE; MECHANISM	Most cells enter mitosis once they have reached a defined size. In the fission yeast Schizosaccharomyces pombe, mitotic entry is orchestrated by a geometry-sensing mechanism that involves the Cdk1/Cdc2-inhibiting Wee1 kinase. The factors upstream of Wee1 gather together in interphase to form a characteristic medial and cortical belt of nodes. Nodes are also considered to be precursors of the cytokinesis contractile actomyosin ring (CAR). Here we describe a new component of the interphase nodes and cytokinesis rings, which we named Nod1. Consistent with its role in cell size control at division, nod1D cells were elongated and epistatic with regulators of Wee1. Through biochemical and localisation studies, we placed Nod1 in a complex with the Rho-guanine nucleotide exchange factor Gef2. Nod1 and Gef2 mutually recruited each other in nodes and Nod1 also assembles Gef2 in rings. Like gef2 Delta, nod1 Delta cells showed a mild displacement of their division plane and this phenotype was severely exacerbated when the parallel Polo kinase pathway was also compromised. We conclude that Nod1 specifies the division site by localising Gef2 to the mitotic cell middle. Previous work showed that Gef2 in turn anchors factors that control the spatio-temporal recruitment of the actin nucleation machinery. It is believed that the actin filaments originated from the nodes pull nodes together into a single contractile ring. Surprisingly however, we found that node proteins could form pre-ring helical filaments in a cdc12-112 mutant in which nucleation of the actin ring is impaired. Furthermore, the deletion of either nod1 or gef2 created an un-expected situation where different ring components were recruited sequentially rather than simultaneously. At later stages of cytokinesis, these various rings appeared inter-fitted rather than merged. This study brings a new slant to the understanding of CAR assembly and function.	[Jourdain, Isabelle; Brzezinska, Elspeth A.; Toda, Takashi] Canc Res UK, London Res Inst, Cell Regulat Lab, London, England	Cancer Research UK	Jourdain, I (corresponding author), Canc Res UK, London Res Inst, Cell Regulat Lab, London, England.	Isabelle.Jourdain@cancer.org.uk; Takashi.Toda@cancer.org.uk		Brzezinska, Elspeth/0000-0002-6729-6825	Core grant from Cancer Research UK (United Kingdom); Cancer Research UK [15670] Funding Source: researchfish	Core grant from Cancer Research UK (United Kingdom); Cancer Research UK(Cancer Research UK)	This work was supported by a Core grant from Cancer Research UK (United Kingdom). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almonacid M, 2011, CURR BIOL, V21, P473, DOI 10.1016/j.cub.2011.02.003; Bahler J, 1998, J CELL BIOL, V143, P1603, DOI 10.1083/jcb.143.6.1603; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bathe M, 2010, TRENDS MICROBIOL, V18, P38, DOI 10.1016/j.tim.2009.10.002; Celton-Morizur S, 2006, J CELL SCI, V119, P4710, DOI 10.1242/jcs.03261; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; Coffman VC, 2009, MOL BIOL CELL, V20, P5195, DOI 10.1091/mbc.E09-05-0428; Guzman-Vendrell M, 2013, MOL CELL BIOL, V33, P418, DOI 10.1128/MCB.01286-12; Hachet O, 2008, GENE DEV, V22, P3205, DOI 10.1101/gad.1697208; Huang YY, 2008, J CELL BIOL, V183, P979, DOI 10.1083/jcb.200806151; Ikebe C, 2011, BIOSCI BIOTECH BIOCH, V75, P2364, DOI 10.1271/bbb.110558; Kanoh J, 1998, MOL BIOL CELL, V9, P3321, DOI 10.1091/mbc.9.12.3321; Laporte D, 2012, MOL BIOL CELL, V23, P3094, DOI 10.1091/mbc.E12-02-0123; Laporte D, 2011, J CELL BIOL, V192, P1005, DOI 10.1083/jcb.201008171; MacIver FH, 2003, GENE DEV, V17, P1507, DOI 10.1101/gad.256003; Martin SG, 2009, CELL CYCLE, V8, P3643, DOI 10.4161/cc.8.22.9891; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morrell JL, 2004, J CELL SCI, V117, P5293, DOI 10.1242/jcs.01409; Moseley JB, 2010, CELL, V142, P189, DOI 10.1016/j.cell.2010.07.004; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; Motegi F, 2004, J CELL BIOL, V165, P685, DOI 10.1083/jcb.200402097; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Padte NN, 2006, CURR BIOL, V16, P2480, DOI 10.1016/j.cub.2006.11.024; Paoletti A, 2000, MOL BIOL CELL, V11, P2757, DOI 10.1091/mbc.11.8.2757; PARKER LL, 1993, NATURE, V363, P736, DOI 10.1038/363736a0; Rincon SA, 2012, CYTOSKELETON, V69, P764, DOI 10.1002/cm.21056; Saha S, 2012, MOL CELL BIOCHEM, V366, P1, DOI 10.1007/s11010-012-1274-2; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Sohrmann M, 1996, GENE DEV, V10, P2707, DOI 10.1101/gad.10.21.2707; Takaine M, 2009, EMBO J, V28, P3117, DOI 10.1038/emboj.2009.252; Tanaka K, 2001, EMBO J, V20, P1259, DOI 10.1093/emboj/20.6.1259; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Vavylonis D, 2008, SCIENCE, V319, P97, DOI 10.1126/science.1151086; Wu JQ, 2006, J CELL BIOL, V174, P391, DOI 10.1083/jcb.200602032; WU L, 1993, NATURE, V363, P738, DOI 10.1038/363738a0; Ye YF, 2012, MOL BIOL CELL, V23, P1181, DOI 10.1091/mbc.E11-09-0800	37	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54142	10.1371/journal.pone.0054142	http://dx.doi.org/10.1371/journal.pone.0054142			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349808	Green Published, Green Submitted, gold			2022-12-25	WOS:000313738900044
J	Khodayari, S; Moharramipour, S; Larvor, V; Hidalgo, K; Renault, D				Khodayari, Samira; Moharramipour, Saeid; Larvor, Vanessa; Hidalgo, Kevin; Renault, David			Deciphering the Metabolic Changes Associated with Diapause Syndrome and Cold Acclimation in the Two-Spotted Spider Mite Tetranychus urticae	PLOS ONE			English	Article							EARTHWORM DENDROBAENA-OCTAEDRA; AMINO-ACID POOLS; FREEZE-TOLERANT; INSECT DIAPAUSE; CRYOPROTECTANT SYNTHESIS; SUPERCOOLING CAPACITY; OVERWINTERING LARVAE; DROSOPHILID FLY; CORN-BORER; HARDINESS	Diapause is a common feature in several arthropod species that are subject to unfavorable growing seasons. The range of environmental cues that trigger the onset and termination of diapause, in addition to associated hormonal, biochemical, and molecular changes, have been studied extensively in recent years; however, such information is only available for a few insect species. Diapause and cold hardening usually occur together in overwintering arthropods, and can be characterized by recording changes to the wealth of molecules present in the tissue, hemolymph, or whole body of organisms. Recent technological advances, such as high throughput screening and quantification of metabolites via chromatographic analyses, are able to identify such molecules. In the present work, we examined the survival ability of diapausing and non-diapausing females of the two-spotted spider mite, Tetranychus urticae, in the presence (0 or 5 degrees C) or absence of cold acclimation. Furthermore, we examined the metabolic fingerprints of these specimens via gas chromatography-mass spectrophotometry (GC-MS). Partial Least Square Discriminant Analysis (PLS-DA) of metabolites revealed that major metabolic variations were related to diapause, indicating in a clear cut-off between diapausing and non-diapausing females, regardless of acclimation state. Signs of metabolic depression were evident in diapausing females, with most amino acids and TCA cycle intermediates being significantly reduced. Out of the 40 accurately quantified metabolites, seven metabolites remained elevated or were accumulated in diapausing mites, i.e. cadaverine, gluconolactone, glucose, inositol, maltose, mannitol and sorbitol. The capacity to accumulate winter polyols during cold-acclimation was restricted to diapausing females. We conclude that the induction of increased cold hardiness in this species is associated with the diapause syndrome, rather than being a direct effect of low temperature. Our results provide novel information about biochemical events related to the cold hardening process in the two-spotted spider mite.	[Khodayari, Samira; Moharramipour, Saeid] Tarbiat Modares Univ, Fac Agr, Dept Entomol, Tehran, Iran; [Larvor, Vanessa; Hidalgo, Kevin; Renault, David] Univ Rennes 1, UMR CNRS Ecobio 6553, Rennes, France	Tarbiat Modares University; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Renault, D (corresponding author), Univ Rennes 1, UMR CNRS Ecobio 6553, Rennes, France.		Moharramipour, Saeid/AAB-7252-2019; Moharramipour, Saeid/AAE-8151-2021	Moharramipour, Saeid/0000-0001-8389-8861; Hidalgo, Kevin/0000-0001-5923-3130; RENAULT, David/0000-0003-3644-1759	Tarbiat Modares University (Tehran, Iran)	Tarbiat Modares University (Tehran, Iran)	The authors thank the Tarbiat Modares University (Tehran, Iran) that funded the experiments and the travel of S. Khodayari to France. University of Rennes 1 (Action Incitative de Recherche 2012-Collaborations Internationales) assisted the stay of S. Khodayari in France. We thank one anonymous referee, David Denlinger (Ohio State University, Columbus, USA) and Vladimir Kostal (Institute of Entomology, Biology Centre AS CR, Ceske Budejovice, Czech Republic) for helpful comments on an earlier version of the paper. We are grateful to Marie Chauris for technical assistance.; The authors thank the Tarbiat Modares University (Tehran, Iran) that funded the experiments and the travel of S. Khodayari to France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atapour M, 2009, ENVIRON ENTOMOL, V38, P260, DOI 10.1603/022.038.0132; BAUST JG, 1982, COMP BIOCHEM PHYS A, V73, P563, DOI 10.1016/0300-9629(82)90263-8; Berkvens N, 2010, J INSECT PHYSIOL, V56, P438, DOI 10.1016/j.jinsphys.2009.11.019; Calderon S, 2009, J EXP BIOL, V212, P859, DOI 10.1242/jeb.026864; Colinet H, 2012, FUNCT ECOL, V26, P711, DOI 10.1111/j.1365-2435.2012.01985.x; Colinet H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032606; Colinet H, 2010, PHYSIOL ENTOMOL, V35, P301, DOI 10.1111/j.1365-3032.2010.00743.x; COSTANZO JP, 1993, AM J PHYSIOL, V265, pR721, DOI 10.1152/ajpregu.1993.265.4.R721; DANKS HV, 1987, BIOL SURVEY CANADA M, V1; DENLINGER DL, 1986, ANNU REV ENTOMOL, V31, P239, DOI 10.1146/annurev.en.31.010186.001323; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; EVANS DE, 1981, AUST J ZOOL, V29, P483, DOI 10.1071/ZO9810483; FURUSAWA T, 1982, J COMP PHYSIOL, V147, P21, DOI 10.1007/BF00689286; GEKKO K, 1981, BIOCHEMISTRY-US, V20, P4667, DOI 10.1021/bi00519a023; Goodacre R, 2004, TRENDS BIOTECHNOL, V22, P245, DOI 10.1016/j.tibtech.2004.03.007; Goto M, 1998, J INSECT PHYSIOL, V44, P87, DOI 10.1016/S0022-1910(97)00098-X; Goto M, 2001, J INSECT PHYSIOL, V47, P709, DOI 10.1016/S0022-1910(00)00164-5; Goto M, 2001, J INSECT PHYSIOL, V47, P157, DOI 10.1016/S0022-1910(00)00099-8; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Hahn DA, 2007, J INSECT PHYSIOL, V53, P760, DOI 10.1016/j.jinsphys.2007.03.018; Hahn DA, 2011, ANNU REV ENTOMOL, V56, P103, DOI 10.1146/annurev-ento-112408-085436; Hendrix DL, 1998, COMP BIOCHEM PHYS A, V120, P487, DOI 10.1016/S1095-6433(98)10058-2; Hodkova M, 2004, EUR J ENTOMOL, V101, P445, DOI 10.14411/eje.2004.064; Holmstrup M, 2007, SOIL BIOL BIOCHEM, V39, P2640, DOI 10.1016/j.soilbio.2007.05.018; Khodayari S, 2012, J THERM BIOL, V37, P419, DOI 10.1016/j.jtherbio.2012.04.005; Kost'al V, 2000, J INSECT PHYSIOL, V46, P887, DOI 10.1016/S0022-1910(99)00195-X; Kostal V, 2007, J INSECT PHYSIOL, V53, P580, DOI 10.1016/j.jinsphys.2007.02.009; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Kostal V, 2000, J INSECT PHYSIOL, V46, P417, DOI 10.1016/S0022-1910(99)00124-9; Kostal V, 2004, J INSECT PHYSIOL, V50, P303, DOI 10.1016/j.jinsphys.2004.01.006; KOSTAL V, 1995, J INSECT PHYSIOL, V41, P627, DOI 10.1016/0022-1910(94)00124-Y; Kostal V, 2001, COMP BIOCHEM PHYS B, V130, P365, DOI 10.1016/S1096-4959(01)00441-9; Kostal V, 2008, J INSECT PHYSIOL, V54, P77, DOI 10.1016/j.jinsphys.2007.08.004; Kostal V, 2012, P NATL ACAD SCI USA, V109, P3270, DOI 10.1073/pnas.1119986109; Kostal V, 2009, INSECT BIOCHEM MOLEC, V39, P875, DOI 10.1016/j.ibmb.2009.10.004; Kruger NJ, 2003, CURR OPIN PLANT BIOL, V6, P236, DOI 10.1016/S1369-5266(03)00039-6; Laparie M, 2012, COMP BIOCHEM PHYS A, V162, P406, DOI 10.1016/j.cbpa.2012.04.022; LEE RE, 1987, J INSECT PHYSIOL, V33, P587, DOI 10.1016/0022-1910(87)90074-6; LEE RE, 1980, J INSECT PHYSIOL, V26, P135, DOI 10.1016/0022-1910(80)90053-0; LEE RE, 1987, SCIENCE, V238, P1415, DOI 10.1126/science.238.4832.1415; MacMillan HA, 2009, J INSECT PHYSIOL, V55, P243, DOI 10.1016/j.jinsphys.2008.11.015; MASAKI S, 1980, ANNU REV ENTOMOL, V25, P1, DOI 10.1146/annurev.en.25.010180.000245; Michaud MR, 2007, J COMP PHYSIOL B, V177, P753, DOI 10.1007/s00360-007-0172-5; MOREAU R, 1981, COMP BIOCHEM PHYS B, V68, P95, DOI 10.1016/0305-0491(81)90185-1; MORGAN TD, 1983, J INSECT PHYSIOL, V29, P735, DOI 10.1016/0022-1910(83)90001-X; Okasaki T, 1981, J SERICULT SIC JPN, V50, P190; OSANAI M, 1986, INSECT BIOCHEM, V16, P373, DOI 10.1016/0020-1790(86)90050-8; Overgaard J, 2007, J INSECT PHYSIOL, V53, P1218, DOI 10.1016/j.jinsphys.2007.06.012; PULLIN AS, 1989, COMP BIOCHEM PHYS A, V94, P499, DOI 10.1016/0300-9629(89)90128-X; Pullin AS, 1996, EUR J ENTOMOL, V93, P121; R Core Team, 2022, R LANG ENV STAT COMP; Ragland GJ, 2010, P NATL ACAD SCI USA, V107, P14909, DOI 10.1073/pnas.1007075107; Saeidi F, ENV ENTOMOL IN PRESS; SALT RW, 1961, ANNU REV ENTOMOL, V6, P55, DOI 10.1146/annurev.en.06.010161.000415; Salvucci ME, 2000, J THERM BIOL, V25, P353, DOI 10.1016/S0306-4565(99)00107-2; Slachta M, 2002, J INSECT PHYSIOL, V48, P1031, DOI 10.1016/S0022-1910(02)00191-9; Soudi S, 2012, J THERM BIOL, V37, P384, DOI 10.1016/j.jtherbio.2012.02.003; STOREY JM, 1990, J COMP PHYSIOL B, V160, P77; STOREY KB, 1993, J INSECT PHYSIOL, V39, P737, DOI 10.1016/0022-1910(93)90048-V; STOREY KB, 1988, PHYSIOL REV, V68, P27, DOI 10.1152/physrev.1988.68.1.27; STOREY KB, 1982, INSECT BIOCHEM, V12, P501, DOI 10.1016/0020-1790(82)90018-X; Szymanski J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007441; Tanaka K, 1997, J INSECT PHYSIOL, V43, P271, DOI 10.1016/S0022-1910(96)00091-1; Teets NM, 2012, PHYSIOL GENOMICS, V44, P764, DOI 10.1152/physiolgenomics.00042.2012; Veerman A., 1985, P279; Wang XH, 2005, J INSECT PHYSIOL, V51, P1277, DOI 10.1016/j.jinsphys.2005.07.010; Watanabe M, 1999, J INSECT PHYSIOL, V45, P167, DOI 10.1016/S0022-1910(98)00111-5; Wolschin F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006394; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; YAGINUMA T, 1979, INSECT BIOCHEM, V9, P547, DOI 10.1016/0020-1790(79)90075-1; Zhang QR, 2011, P NATL ACAD SCI USA, V108, P16922, DOI 10.1073/pnas.1113863108	71	53	53	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54025	10.1371/journal.pone.0054025	http://dx.doi.org/10.1371/journal.pone.0054025			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349779	Green Published, gold			2022-12-25	WOS:000313738900032
J	Chen, L; Zhang, XZ; Zhou, WS; Qiao, Q; Liang, HL; Li, GY; Wang, JH; Cai, F				Chen, Liang; Zhang, Xuezhen; Zhou, Wenshan; Qiao, Qin; Liang, Hualei; Li, Guangyu; Wang, Jianghua; Cai, Fei			The Interactive Effects of Cytoskeleton Disruption and Mitochondria Dysfunction Lead to Reproductive Toxicity Induced by Microcystin-LR	PLOS ONE			English	Article							INDUCED APOPTOSIS; IN-VIVO; PERMEABILITY TRANSITION; INTERMEDIATE-FILAMENTS; OXIDATIVE STRESS; DNA-DAMAGE; 3 ORGANS; RAT; LIVER; KIDNEY	The worldwide occurrence of cyanobacterial blooms evokes profound concerns. The presence of microcystins (MCs) in waters and aquatic food increases the risk to human health. Some recent studies have suggested that the gonad is the second most important target organ of MCs, however, the potential toxicity mechanisms are still unclear. For a better understanding of reproductive toxicity of MCs on animals, we conducted the present experimental investigation. Male rats were intraperitoneally injected with MC-LR for 50 d with the doses of 1 and 10 mu g/kg body weight per day. After prolonged exposure to MC-LR, the testes index significantly decreased in 10 mg/kg group. Light microscope observation indicated that the space between the seminiferous tubules was increased. Ultrastructural observation showed some histopathological characteristics, including cytoplasmic shrinkage, cell membrane blebbing, swollen mitochondria and deformed nucleus. Using Q-PCR methods, the transcriptional levels of some cytoskeletal and mitochondrial genes were determined. MC-LR exposure affected the homeostasis of the expression of cytoskeletal genes, causing possible dysfunction of cytoskeleton assembly. In MC-LR treatments, all the 8 mitochondrial genes related with oxidative phosphorylation (OXPHOS) significantly increased. The reactive oxygen species (ROS) level significantly increased in 10 mg/kg group. The mitochondria swelling and DNA damage were also determined in 10 mu g/kg group. Hormone levels of testis significantly changed. The present study verified that both cytoskeleton disruption possibly due to cytoskeletal reorganization or depolymerization and mitochondria dysfunction interact with each other through inducing of reactive oxygen species and oxidative phosphorylation, and jointly result in testis impairment after exposure to MC-LR.	[Chen, Liang; Zhang, Xuezhen; Zhou, Wenshan; Qiao, Qin; Liang, Hualei; Li, Guangyu; Wang, Jianghua] Huazhong Agr Univ, Coll Fisheries, Wuhan, Peoples R China; [Chen, Liang; Zhang, Xuezhen; Zhou, Wenshan; Qiao, Qin; Liang, Hualei; Li, Guangyu; Wang, Jianghua] Minist Agr, Key Lab Freshwater Anim Breeding, Wuhan, Peoples R China; [Cai, Fei] Xianning Univ, Coll Med, Dept Pharmacol, Xianning, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Zhang, XZ (corresponding author), Huazhong Agr Univ, Coll Fisheries, Wuhan, Peoples R China.	xuezhen@mail.hzau.edu.cn	Chen, Liang/B-4550-2015; Oliver, Brian/E-7939-2010	Chen, Liang/0000-0001-6548-5000; Oliver, Brian/0000-0002-7122-9262; Burgess, Janette/0000-0001-9868-9966	National Natural Science Foundation of China [30800160]; Natural Science Foundation for Distinguished Young Scholars of Hubei Province [2010CDA095]; Fundamental Research Funds for the Central Universities of China [2012MBDX004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation for Distinguished Young Scholars of Hubei Province; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (grant number. 30800160) and the Natural Science Foundation for Distinguished Young Scholars of Hubei Province (grant number. 2010CDA095), and the study was also supported by the Fundamental Research Funds for the Central Universities of China (grant number. 2012MBDX004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alverca E, 2009, TOXICON, V54, P283, DOI 10.1016/j.toxicon.2009.04.014; Appaix F, 2003, EXP PHYSIOL, V88, P175, DOI 10.1113/eph8802511; Boldogh IR, 2006, BBA-MOL CELL RES, V1763, P450, DOI 10.1016/j.bbamcr.2006.02.014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campos A, 2010, INT J MOL SCI, V11, P268, DOI 10.3390/ijms11010268; Chen J, 2005, TOXICON, V45, P615, DOI 10.1016/j.toxicon.2005.01.003; Chen J, 2009, TOXICOL SCI, V108, P81, DOI 10.1093/toxsci/kfp009; Chen T, 2005, MOL CELL PROTEOMICS, V4, P958, DOI 10.1074/mcp.M400185-MCP200; Chen Y, 2011, REPROD TOXICOL, V31, P551, DOI 10.1016/j.reprotox.2011.02.006; Ding WX, 2000, HEPATOLOGY, V32, P547, DOI 10.1053/jhep.2000.16183; Ding WX, 2003, FEMS MICROBIOL LETT, V220, P1, DOI 10.1016/S0378-1097(03)00100-9; Ding WX, 2002, BIOCHEM BIOPH RES CO, V291, P321, DOI 10.1006/bbrc.2002.6453; Ding WX, 2001, J TOXICOL ENV HEAL A, V64, P507, DOI 10.1080/152873901753215966; Ding WX, 2000, ENVIRON HEALTH PERSP, V108, P605, DOI 10.2307/3434879; Ding XS, 2006, TOXICON, V48, P973, DOI 10.1016/j.toxicon.2006.07.039; FALCONER IR, 1992, CHEM-BIOL INTERACT, V81, P181, DOI 10.1016/0009-2797(92)90033-H; Fiorentini C, 1999, FEBS LETT, V453, P124, DOI 10.1016/S0014-5793(99)00706-1; Frangez R, 2003, TOXICON, V41, P999, DOI 10.1016/S0041-0101(03)00072-2; Fu WY, 2009, CHEM RES TOXICOL, V22, P41, DOI 10.1021/tx800396p; Fu WY, 2005, TOXICON, V46, P171, DOI 10.1016/j.toxicon.2005.03.021; Gacsi M, 2009, TOXICOL IN VITRO, V23, P710, DOI 10.1016/j.tiv.2009.02.006; Gourlay CW, 2005, FEMS YEAST RES, V5, P1193, DOI 10.1016/j.femsyr.2005.08.001; Gupta N, 2003, TOXICOLOGY, V188, P285, DOI 10.1016/S0300-483X(03)00112-4; Hao L, 2010, TOXICON, V55, P1378, DOI 10.1016/j.toxicon.2010.02.015; Hermansky S. J., 1993, Journal of Environmental Pathology Toxicology and Oncology, V12, P101; HOOSER SB, 1991, VET PATHOL, V28, P259, DOI 10.1177/030098589102800401; HOOSER SB, 1990, VET PATHOL, V27, P9, DOI 10.1177/030098589002700102; Hoyal CR, 1998, J TOXICOL ENV HEAL B, V1, P117, DOI 10.1080/10937409809524547; La-Salete R, 2008, J APPL TOXICOL, V28, P55, DOI 10.1002/jat.1251; Lankoff A, 2004, MUTAT RES-GEN TOX EN, V559, P131, DOI 10.1016/j.mrgentox.2004.01.004; Li DS, 2011, ECOTOXICOLOGY, V20, P1018, DOI 10.1007/s10646-011-0693-2; Li GY, 2011, ENVIRON TOXICOL, V26, P111, DOI 10.1002/tox.20532; Li GY, 2011, PROTEOMICS, V11, P2003, DOI 10.1002/pmic.201000442; Li XY, 2001, ENVIRON TOXICOL, V16, P517, DOI 10.1002/tox.10012; Li Y, 2012, ENVIRON TOXICOL PHAR, V33, P318, DOI 10.1016/j.etap.2011.12.015; Li Y, 2008, REPROD TOXICOL, V26, P239, DOI 10.1016/j.reprotox.2008.09.004; Liu Y, 2010, ENVIRON TOXICOL, V25, P9, DOI 10.1002/tox.20467; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lun S, 1998, J REPROD FERTIL, V114, P131, DOI 10.1530/jrf.0.1140131; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; Majsterek I, 2004, COMP BIOCHEM PHYS C, V139, P175, DOI 10.1016/j.cca.2004.10.007; Mathe C, 2009, AQUAT TOXICOL, V92, P122, DOI 10.1016/j.aquatox.2009.02.005; Meng GM, 2011, TOXICOLOGY, V290, P218, DOI 10.1016/j.tox.2011.09.085; Mikhailov A, 2003, CHEM-BIOL INTERACT, V142, P223, DOI 10.1016/S0009-2797(02)00075-3; Milzani A, 1997, ARCH BIOCHEM BIOPHYS, V339, P267, DOI 10.1006/abbi.1996.9847; OHTA T, 1992, CARCINOGENESIS, V13, P2443, DOI 10.1093/carcin/13.12.2443; PALVA TK, 1985, FEBS LETT, V192, P267, DOI 10.1016/0014-5793(85)80122-8; Paradies G, 2002, GENE, V286, P135, DOI 10.1016/S0378-1119(01)00814-9; Sewer M, 2008, LIPIDS, V43, P1109, DOI 10.1007/s11745-008-3221-2; Toivola DM, 1998, HEPATOLOGY, V28, P116, DOI 10.1002/hep.510280117; Toivola DM, 1997, J CELL SCI, V110, P23; Toivola DM, 1999, TOXICOL IN VITRO, V13, P521, DOI 10.1016/S0887-2333(99)00024-7; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002; Wang GW, 2005, AM J PHYSIOL-HEART C, V288, pH1290, DOI 10.1152/ajpheart.00796.2004; Wang MH, 2010, CHEMOSPHERE, V81, P716, DOI 10.1016/j.chemosphere.2010.07.061; Wang Q, 2008, TOXICON, V52, P721, DOI 10.1016/j.toxicon.2008.08.004; Wang XT, 2012, TOXICON, V59, P205, DOI 10.1016/j.toxicon.2011.12.001; WICKSTROM ML, 1995, TOXICOL PATHOL, V23, P326, DOI 10.1177/019262339502300309; Xiong QA, 2010, J BIOCHEM MOL TOXIC, V24, P361, DOI 10.1002/jbt.20347; Xiong Q, 2009, TOXICON, V54, P1, DOI 10.1016/j.toxicon.2009.01.035; Zegura B, 2003, TOXICON, V41, P41, DOI 10.1016/S0041-0101(02)00207-6; Zegura B, 2004, TOXICOLOGY, V200, P59, DOI 10.1016/j.tox.2004.03.006; Zeviani M, 2005, SCI MED, V10, P154; Zhang H, 2008, FISH PHYSIOL BIOCHEM, V34, P307, DOI 10.1007/s10695-007-9189-7; Zhang H, 2007, ENVIRON TOXICOL, V22, P559, DOI 10.1002/tox.20296; Zhang HZ, 2011, TOHOKU J EXP MED, V224, P235, DOI 10.1620/tjem.224.235; Zhao SJ, 2012, PROTEOMICS, V12, P300, DOI 10.1002/pmic.201100214; Zhao YY, 2008, COMP BIOCHEM PHYS C, V148, P204, DOI 10.1016/j.cbpc.2008.05.008; Zhou Y, 2012, TOXICOL LETT, V212, P48, DOI 10.1016/j.toxlet.2012.05.001	70	130	138	4	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53949	10.1371/journal.pone.0053949	http://dx.doi.org/10.1371/journal.pone.0053949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342045	gold, Green Published, Green Submitted			2022-12-25	WOS:000313682700066
J	Machado, D; Shishido, SM; Queiroz, KCS; Oliveira, DN; Faria, ALC; Catharino, RR; Spek, CA; Ferreira, CV				Machado, Daisy; Shishido, Silvia M.; Queiroz, Karla C. S.; Oliveira, Diogo N.; Faria, Ana L. C.; Catharino, Rodrigo R.; Spek, C. Arnold; Ferreira, Carmen V.			Irradiated Riboflavin Diminishes the Aggressiveness of Melanoma In Vitro and In Vivo	PLOS ONE			English	Article							SONIC HEDGEHOG; MATRIX METALLOPROTEINASES; SIGNALING PATHWAYS; CELL MOTILITY; CANCER-CELLS; MTOR; INVASION; METASTASIS; GLI1; IDENTIFICATION	Melanoma is one of the most aggressive skin cancers due to its high capacity to metastasize. Treatment of metastatic melanomas is challenging for clinicians, as most therapeutic agents have failed to demonstrate improved survival. Thus, new candidates with antimetastatic activity are much needed. Riboavin (RF) is a component of the vitamin B complex and a potent photosensitizer. Previously, our group showed that the RF photoproducts (iRF) have potential as an antitumoral agent. Hence, we investigated the capacity of iRF on modulating melanoma B16F10 cells aggressiveness in vitro and in vivo. iRF decreases B16F10 cells survival by inhibiting mTOR as well as Src kinase. Moreover, melanoma cell migration was disrupted after treatment with iRF, mainly by inhibition of metalloproteinase (MMP) activity and expression, and by increasing TIMP expression. Interestingly, we observed that the Hedgehog (HH) pathway was inhibited by iRF. Two mediators of HH signaling, GLI1 and PTCH, were downregulated, while SUFU expression (an inhibitor of this cascade) was enhanced. Furthermore, inhibition of HH pathway signaling by cyclopamine and Gant 61 potentiated the antiproliferative action of RF. Accordingly, when a HH ligand was applied, the effect of iRF was almost completely abrogated. Our findings indicate that Hedgehog pathway is involved on the modulation of melanoma cell aggressiveness by iRF. Moreover, iRF treatment decreased pulmonary tumor formation in a murine experimental metastasis model. Research to clarify the molecular action of flavins, in vivo, is currently in progress. Taken together, the present data provides evidence that riboflavin photoproducts may provide potential candidates for improving the efficiency of melanoma treatment.	[Machado, Daisy; Shishido, Silvia M.; Ferreira, Carmen V.] Univ Estadual Campinas, Inst Biol, Dept Biochem, Lab Bioassays & Signal Transduct, Sao Paulo, Brazil; [Queiroz, Karla C. S.; Spek, C. Arnold] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Oliveira, Diogo N.; Faria, Ana L. C.; Catharino, Rodrigo R.] Univ Estadual Campinas, Fac Med Sci, Lab Innovare Biomarkers, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; University of Amsterdam; Academic Medical Center Amsterdam; Universidade Estadual de Campinas	Shishido, SM (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Biochem, Lab Bioassays & Signal Transduct, Sao Paulo, Brazil.	silvia.mika@gmail.com	Spek, Arnold/AAC-5866-2019; Catharino, Rodrigo/G-1487-2013; Machado, Daisy/A-4891-2013; de Oliveira, Diogo Noin/C-3939-2013; Machado, Daisy/ABA-3731-2020; Queiroz, Karla/L-6438-2014; Catharino, Rodrigo/AAH-4333-2021	Spek, Arnold/0000-0002-2149-4068; Catharino, Rodrigo/0000-0001-7219-2644; Machado, Daisy/0000-0002-6435-6159; de Oliveira, Diogo Noin/0000-0002-2725-476X; Machado, Daisy/0000-0002-6435-6159; Catharino, Rodrigo/0000-0001-7219-2644	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [proc. 09/00144-7, proc. 10/50356-8]; CNPq [proc. 472067/2010-9]; FAPESP; CAPES	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by a PhD scholarship for D. Machado (proc. 09/00144-7) and grant (proc. 10/50356-8) from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). C.V. Ferreira is supported by research fellowships from CNPq. The authors acknowledge financial support by the Brazilian agencies FAPESP, CNPq (proc. 472067/2010-9), and CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad I, 2004, INT J PHARMACEUT, V280, P199, DOI 10.1016/j.ijpharm.2004.05.020; Anvekar RA, 2011, FRONT ONCOL, V1, DOI 10.3389/fonc.2011.00034; Bijlsma MF, 2007, CELL SIGNAL, V19, P2596, DOI 10.1016/j.cellsig.2007.08.011; Borensztajn K, 2008, AM J PATHOL, V172, P309, DOI 10.2353/ajpath.2008.070347; Bruggemann LW, 2008, THROMB HAEMOSTASIS, V99, P787, DOI 10.1160/TH07-11-0702; Bruggemann LW, 2008, J CELL MOL MED, V12, P2622, DOI 10.1111/j.1582-4934.2008.00316.x; Carpenter RL, 2012, DISCOV MED, V13, P105; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; CHASTAIN JL, 1987, J NUTR, V117, P468, DOI 10.1093/jn/117.3.468; Neto AHC, 2010, TOXICOL IN VITRO, V24, P1911, DOI 10.1016/j.tiv.2010.07.026; Chen JS, 2009, HEPATOL RES, V39, P177, DOI 10.1111/j.1872-034X.2008.00449.x; Chen YH, 2012, J DERMATOL, V39, P339, DOI 10.1111/j.1346-8138.2011.01441.x; Das S, 2009, J BIOL CHEM, V284, P22888, DOI 10.1074/jbc.M109.021949; De Souza AC, 2006, APOPTOSIS, V11, P1761, DOI 10.1007/s10495-006-9549-2; de Souza AP, 2000, DENT MATER, V16, P103, DOI 10.1016/S0109-5641(99)00084-6; Queiroz KCD, 2007, CANCER LETT, V258, P126, DOI 10.1016/j.canlet.2007.08.024; Erve JCL, 2008, RAPID COMMUN MASS SP, V22, P3015, DOI 10.1002/rcm.3702; Eubanks LM, 2005, FEBS LETT, V579, P5361, DOI 10.1016/j.febslet.2005.08.072; Fan HR, 1999, J CELL BIOL, V147, P71, DOI 10.1083/jcb.147.1.71; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Ferguson J, 2013, ONCOGENE, V32, P86, DOI 10.1038/onc.2012.25; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gkika Maria, 2011, International Ophthalmology, V31, P309, DOI 10.1007/s10792-011-9460-x; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; Green CL, 2004, SEMIN CANCER BIOL, V14, P63, DOI 10.1016/j.semcancer.2003.11.007; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hofmann UB, 2000, J INVEST DERMATOL, V115, P337, DOI 10.1046/j.1523-1747.2000.00068.x; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hsieh A, 2011, J CELL PHYSIOL, V226, P1118, DOI 10.1002/jcp.22433; Jazirehi AR, 2012, AM J CANCER RES, V2, P178; Jerant AF, 2000, AM FAM PHYSICIAN, V62, P357; Jia JP, 2009, DEV BIOL, V330, P452, DOI 10.1016/j.ydbio.2009.04.009; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kar S, 2012, EXP CELL RES, V318, P1959, DOI 10.1016/j.yexcr.2012.05.015; LeBleu VS, 2007, EXP BIOL MED, V232, P1121, DOI 10.3181/0703-MR-72; Li CM, 2010, INT J ONCOL, V37, P1023, DOI 10.3892/ijo_00000754; Liao XY, 2009, CARCINOGENESIS, V30, P131, DOI 10.1093/carcin/bgn230; Liu L, 2006, ONCOGENE, V25, P7029, DOI 10.1038/sj.onc.1209691; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Lutzky J, 2010, SEMIN CUTAN MED SURG, V29, P249, DOI 10.1016/j.sder.2010.10.006; Marti RM, 2012, ACTAS DERMO IN PRESS; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; Meier F, 2005, FRONT BIOSCI-LANDMRK, V10, P2986, DOI 10.2741/1755; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; OHKAWA H, 1983, J BIOL CHEM, V258, P5623; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Reddy HL, 2008, TRANSFUS MED REV, V22, P133, DOI 10.1016/j.tmrv.2007.12.003; Roy R, 2009, J CLIN ONCOL, V27, P5287, DOI 10.1200/JCO.2009.23.5556; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sen Banibrata, 2011, J Signal Transduct, V2011, P865819, DOI 10.1155/2011/865819; Siegel R, 2012, CA-CANCER J CLIN, V62, P220, DOI 10.3322/caac.21149; Souzaki M, 2011, CANCER SCI, V102, P373, DOI 10.1111/j.1349-7006.2010.01779.x; Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Tas F, 2012, J ONCOL, V2012, DOI 10.1155/2012/647684; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; van den Brink GR, 2007, PHYSIOL REV, V87, P1343, DOI 10.1152/physrev.00054.2006; Van Sluis GL, 2009, BLOOD, V114, P1968, DOI 10.1182/blood-2009-04-217679; Wollensak G, 2007, J CATARACT REFR SURG, V33, P516, DOI 10.1016/j.jcrs.2006.11.015; Xiao L, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-152; Yoon JW, 2002, J BIOL CHEM, V277, P5548, DOI 10.1074/jbc.M105708200; Zhou HY, 2011, CURR PROTEIN PEPT SC, V12, P30	64	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54269	10.1371/journal.pone.0054269	http://dx.doi.org/10.1371/journal.pone.0054269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342114	Green Submitted, Green Published, gold			2022-12-25	WOS:000313682700099
J	Trihn, M; Ge, XC; Dobson, A; Kitten, T; Munro, CL; Xu, P				My Trihn; Ge, Xiuchun; Dobson, Alleson; Kitten, Todd; Munro, Cindy L.; Xu, Ping			Two-Component System Response Regulators Involved in Virulence of Streptococcus pneumoniae TIGR4 in Infective Endocarditis	PLOS ONE			English	Article							BACTERIAL-ENDOCARDITIS; IDENTIFICATION; CIAR; SANGUINIS; REGULON; GENOME	Streptococci resident in the oral cavity have been linked to infective endocarditis (IE). While other viridans streptococci are commonly studied in relation to IE, less research has been focused on Streptococcus pneumoniae. We established for the first time an animal model of S. pneumoniae IE, and examined the virulence of the TIGR4 strain in this model. We hypothesized that two-component systems (TCS) may mediate S. pneumoniae TIGR4 strain virulence in IE and examined TCS response regulator (RR) mutants of TIGR4 in vivo with the IE model. Thirteen of the 14 RR protein genes were mutagenized, excluding only the essential gene SP_1227. The requirement of the 13 RRs for S. pneumoniae competitiveness in the IE model was assessed in vivo through use of quantitative real-time PCR (qPCR) and competitive index assays. Using real-time PCR, several RR mutants were detected at significantly lower levels in infected heart valves compared with a control strain suggesting the respective RRs are candidate virulence factors for IE. The virulence reduction of the Delta ciaR mutant was further confirmed by competitive index assay. Our data suggest that CiaR is a virulence factor of S. pneumoniae strain TIGR4 for IE.	[My Trihn; Ge, Xiuchun; Dobson, Alleson; Kitten, Todd; Xu, Ping] Virginia Commonwealth Univ, VCU Philips Inst Oral & Craniofacial Mol Biol, Richmond, VA 23284 USA; [Kitten, Todd; Xu, Ping] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA; [Kitten, Todd; Xu, Ping] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Munro, Cindy L.] Univ S Florida, Coll Nursing, Tampa, FL USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; State University System of Florida; University of South Florida	Xu, P (corresponding author), Virginia Commonwealth Univ, VCU Philips Inst Oral & Craniofacial Mol Biol, Richmond, VA 23284 USA.	pxu@vcu.edu	Kitten, Todd/O-6531-2014	Kitten, Todd/0000-0001-6097-7583	National Institutes of Health [R01DE018138, R56AI085195]; Virginia Commonwealth University Presidential Research Incentive Program (PRIP) [144602-3]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI085195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018138, R01DE023078] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Commonwealth University Presidential Research Incentive Program (PRIP); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants R01DE018138 (PX) and R56AI085195 (TK) from the National Institutes of Health, and in part by the Virginia Commonwealth University Presidential Research Incentive Program (PRIP) 144602-3 (PX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddour LM, 1998, CLIN INFECT DIS, V26, P66, DOI 10.1086/516266; Bashore TM, 2006, CURR PROB CARDIOLOGY, V31, P274, DOI 10.1016/j.cpcardiol.2005.12.001; Bent CJ, 2004, J BACTERIOL, V186, P2872, DOI 10.1128/JB.186.9.2872-2879.2004; Bishop CJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-3; Biswas I, 2008, J BACTERIOL, V190, P68, DOI 10.1128/JB.00990-07; Bricker AL, 1999, FEMS MICROBIOL LETT, V172, P131, DOI 10.1016/S0378-1097(99)00027-0; Churchward G, 2007, MOL MICROBIOL, V64, P34, DOI 10.1111/j.1365-2958.2007.05649.x; Dajani AS, 1997, JAMA-J AM MED ASSOC, V277, P1794, DOI 10.1001/jama.277.22.1794; DURACK DT, 1972, BRIT J EXP PATHOL, V53, P44; Ferrieri P, 2002, CIRCULATION, V105, P2115, DOI 10.1161/01.CIR.0000013073.22415.90; Ge XC, 2008, INFECT IMMUN, V76, P2551, DOI 10.1128/IAI.00338-08; Halfmann A, 2007, MOL MICROBIOL, V66, P110, DOI 10.1111/j.1365-2958.2007.05900.x; Henriques MX, 2011, MOL MICROBIOL, V82, P515, DOI 10.1111/j.1365-2958.2011.07828.x; Ibrahim YM, 2004, J BACTERIOL, V186, P5258, DOI 10.1128/JB.186.16.5258-5266.2004; Kim Yong-Min, 2011, J Cardiovasc Ultrasound, V19, P35, DOI 10.4250/jcu.2011.19.1.35; Leday TV, 2008, INFECT IMMUN, V76, P4659, DOI 10.1128/IAI.00597-08; Liu YL, 2009, J BACTERIOL, V191, P7363, DOI 10.1128/JB.01054-09; Mascher T, 2003, J BACTERIOL, V185, P60, DOI 10.1128/JB.185.1.60-70.2003; Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x; Paik S, 2005, INFECT IMMUN, V73, P6064, DOI 10.1128/IAI.73.9.6064-6074.2005; Paterson GK, 2006, J MED MICROBIOL, V55, P355, DOI 10.1099/jmm.0.46423-0; Quach D, 2009, J BACTERIOL, V191, P2023, DOI 10.1128/JB.01216-08; Rueda Adriana M, 2010, Medicine (Baltimore), V89, P331, DOI 10.1097/MD.0b013e3181f2b824; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Strom BL, 1998, ANN INTERN MED, V129, P761, DOI 10.7326/0003-4819-129-10-199811150-00002; Tran-Winkler HJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002361; Xu P, 2007, J BACTERIOL, V189, P3166, DOI 10.1128/JB.01808-06; Xu P, 2011, SCI REP-UK, V1, DOI 10.1038/srep00125	28	5	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54320	10.1371/journal.pone.0054320	http://dx.doi.org/10.1371/journal.pone.0054320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342132	Green Published, gold, Green Submitted			2022-12-25	WOS:000313682700108
J	Sanfiorenzo, C; Ilie, MI; Belaid, A; Barlesi, F; Mouroux, J; Marquette, CH; Brest, P; Hofman, P				Sanfiorenzo, Celine; Ilie, Marius I.; Belaid, Amine; Barlesi, Fabrice; Mouroux, Jerome; Marquette, Charles-Hugo; Brest, Patrick; Hofman, Paul			Two Panels of Plasma MicroRNAs as Non-Invasive Biomarkers for Prediction of Recurrence in Resectable NSCLC	PLOS ONE			English	Article							CELL LUNG-CANCER; BREAST-CANCER; TUMOR-MARKERS; EXPRESSION; SERUM; DIAGNOSIS; SURVIVAL; PROGNOSIS; SIGNATURES; ASSOCIATION	The diagnosis of non-small cell lung carcinoma (NSCLC) at an early stage, as well as better prediction of outcome remains clinically challenging due to the lack of specific and robust non-invasive markers. The discovery of microRNAs (miRNAs), particularly those found in the bloodstream, has opened up new perspectives for tumor diagnosis and prognosis. The aim of our study was to determine whether expression profiles of specific miRNAs in plasma could accurately discriminate between NSCLC patients and controls, and whether they are able to predict the prognosis of resectable NSCLC patients. We therefore evaluated a series of seventeen NSCLC-related miRNAs by quantitative real-time (qRT)-PCR in plasma from 52 patients with I-IIIA stages NSCLC, 10 patients with chronic obstructive pulmonary disease (COPD) and 20-age, sex and smoking status-matched healthy individuals. We identified an eleven-plasma miRNA panel that could distinguish NSCLC patients from healthy subjects (AUC = 0.879). A six-plasma miRNA panel was able to discriminate between NSCLC patients and COPD patients (AUC = 0.944). Furthermore, we identified a three-miRNA plasma signature (high miR-155-5p, high miR-223- 3p, and low miR-126-3p) that significantly associated with a higher risk for progression in adenocarcinoma patients. In addition, a three-miRNA plasma panel (high miR-20a-5p, low miR-152-3p, and low miR-199a-5p) significantly predicted survival of squamous cell carcinoma patients. In conclusion, we identified two plasma miRNA expression profiles that may be useful for predicting the outcome of patients with resectable NSCLC.	[Sanfiorenzo, Celine; Ilie, Marius I.; Belaid, Amine; Mouroux, Jerome; Marquette, Charles-Hugo; Brest, Patrick; Hofman, Paul] CNRS, INSERM, Inst Res Canc & Ageing Nice IRCAN, U1081,UMR 7284,Team 3, F-06034 Nice, France; [Sanfiorenzo, Celine; Marquette, Charles-Hugo] Pasteur Hosp, Univ Hosp Ctr Nice, Dept Pneumol, Nice, France; [Sanfiorenzo, Celine; Ilie, Marius I.; Mouroux, Jerome; Marquette, Charles-Hugo; Brest, Patrick; Hofman, Paul] Univ Nice Sophia Antipolis, Fac Med, Team 3, Nice, France; [Ilie, Marius I.; Hofman, Paul] Pasteur Hosp, Univ Hosp Ctr Nice, Lab Clin & Expt Pathol, Nice, France; [Ilie, Marius I.; Hofman, Paul] Pasteur Hosp, Univ Hosp Ctr Nice, Human Biobank, Nice, France; [Barlesi, Fabrice] Aix Marseille Univ, Assistance Publ Hop Marseille, Multidisciplinary Oncol & Therapeut Innovat Dept, Marseille, France; [Mouroux, Jerome] Pasteur Hosp, Univ Hosp Ctr Nice, Dept Thorac Surg, Nice, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; CHU Nice; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Nice	Hofman, P (corresponding author), CNRS, INSERM, Inst Res Canc & Ageing Nice IRCAN, U1081,UMR 7284,Team 3, F-06034 Nice, France.	hofman.p@chu-nice.fr	Marquette, Charles Hugo/O-4084-2016; Hofman, Paul/P-7654-2018; Ilié, Marius/M-7964-2019; brest, patrick/B-7311-2012	Marquette, Charles Hugo/0000-0002-0846-9941; Hofman, Paul/0000-0003-0431-9353; Ilié, Marius/0000-0002-2014-1236; brest, patrick/0000-0002-1252-4747; Mouroux, Jerome/0000-0003-0877-4679	Canceropole PACA; Fondation ARC pour la recherche sur le cancer [ARC SL220110603478]	Canceropole PACA(Region Grand-Est); Fondation ARC pour la recherche sur le cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was partly supported by grants from the Canceropole PACA (Axe C, 2011 and 2012), and by the "Fondation ARC pour la recherche sur le cancer'' ARC SL220110603478 (PH, PB, MI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbas F, 2012, EXP LUNG RES, V38, P286, DOI 10.3109/01902148.2012.689088; Appaiah HN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2943; Blanchon F, 2006, LANCET ONCOL, V7, P829, DOI 10.1016/S1470-2045(06)70868-3; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Celli Bartolome R, 2012, Proc Am Thorac Soc, V9, P74, DOI 10.1513/pats.201107-039MS; Chen X, 2012, INT J CANCER, V130, P1620, DOI 10.1002/ijc.26177; Chirieac LR, 2010, ARCH PATHOL LAB MED, V134, P41, DOI 10.1043/1543-2165-134.1.41; Dannemann M, 2012, GENOME BIOL EVOL, V4, P552, DOI 10.1093/gbe/evs033; Donnem T, 2011, CANCER-AM CANCER SOC, V117, P3193, DOI 10.1002/cncr.25907; Donnem T, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-6; Duffy MJ, 2007, EUR J INTERN MED, V18, P175, DOI 10.1016/j.ejim.2006.12.001; Heegaard NHH, 2012, INT J CANCER, V130, P1378, DOI 10.1002/ijc.26153; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Huang W, 2012, AM J RESP CRIT CARE; Jay C, 2007, DNA CELL BIOL, V26, P293, DOI 10.1089/dna.2006.0554; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jiang F, 2010, CANCER PREV RES, V3, P1571, DOI 10.1158/1940-6207.CAPR-10-0128; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Kalscheuer S, 2008, CARCINOGENESIS, V29, P2394, DOI 10.1093/carcin/bgn209; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Landi MT, 2010, CLIN CANCER RES, V16, P430, DOI 10.1158/1078-0432.CCR-09-1736; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Leidinger P, 2011, LUNG CANCER, V74, P41, DOI 10.1016/j.lungcan.2011.02.003; Li GM, 2008, CELL RES, V18, P1, DOI 10.1038/cr.2008.9; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu Y, 2012, CARCINOGENESIS, V33, P1046, DOI 10.1093/carcin/bgs100; MARGOLIS ML, 1994, CANCER, V73, P605, DOI 10.1002/1097-0142(19940201)73:3<605::AID-CNCR2820730317>3.0.CO;2-T; McDermott AM, 2011, PHARM RES-DORDR, V28, P3016, DOI 10.1007/s11095-011-0550-2; McDoniels-Silvers AL, 2002, CLIN CANCER RES, V8, P1127; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nana-Sinkam SP, 2011, MOL ONCOL, V5, P483, DOI 10.1016/j.molonc.2011.10.003; Nisman B, 1998, CANCER-AM CANCER SOC, V82, P1850, DOI 10.1002/(SICI)1097-0142(19980515)82:10<1850::AID-CNCR6>3.0.CO;2-R; Raponi M, 2009, CANCER RES, V69, P5776, DOI 10.1158/0008-5472.CAN-09-0587; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Shen J, 2011, LAB INVEST, V91, P579, DOI 10.1038/labinvest.2010.194; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tan XG, 2011, CLIN CANCER RES, V17, P6802, DOI 10.1158/1078-0432.CCR-11-0419; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Vasilescu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007405; Wang QZ, 2009, CURR CANCER DRUG TAR, V9, P572, DOI 10.2174/156800909788486731; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Xie Y, 2010, LUNG CANCER, V67, P170, DOI 10.1016/j.lungcan.2009.04.004; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735; Zheng DL, 2011, INT J CLIN EXP PATHO, V4, P575	48	139	144	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54596	10.1371/journal.pone.0054596	http://dx.doi.org/10.1371/journal.pone.0054596			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342174	Green Submitted, Green Published, gold			2022-12-25	WOS:000313682700129
J	Chatterjee, S; Malhotra, R; Varghese, F; Bukhari, AB; Patil, A; Budrukkar, A; Parmar, V; Gupta, S; De, A				Chatterjee, Sushmita; Malhotra, Renu; Varghese, Frency; Bukhari, Amirali B.; Patil, Asawari; Budrukkar, Ashwini; Parmar, Vani; Gupta, Sudeep; De, Abhijit			Quantitative Immunohistochemical Analysis Reveals Association between Sodium Iodide Symporter and Estrogen Receptor Expression in Breast Cancer	PLOS ONE			English	Article							EMISSION COMPUTED-TOMOGRAPHY; IN-SITU HYBRIDIZATION; THYROID-CARCINOMA; GENE; TISSUE; METASTASES; QUANTIFICATION; NIS	Background: Human sodium iodide symporter (hNIS) gene over-expression is under active consideration worldwide as an alternative target molecule for breast cancer (BC) diagnosis and targeted radio-iodine treatment. However, the field demands better stratified analysis of endogenous hNIS expression across major BC subtypes. Therefore, we have analyzed subtype-specific variation of hNIS overexpression in breast tumor tissue samples by immunohistochemistry (IHC) and also report the development of a homogeneous, quantitative analysis method of digital IHC images. Methods: hNIS expression was analyzed from 108 BC tissue samples by IHC. Sub-cellular localization of hNIS protein was analyzed by dual immunofluorescence (IF) staining method using hNIS and HER2 antibodies. An ImageJ based two-step digital analysis method was developed and applied for the bias-free analysis of the images. Results: Staining of the tumor samples show 70% cases are hNIS positive indicating high incidence of hNIS positive cases in BC. More importantly, a subtype specific analysis done for the first time shows that hNIS expression is overly dominated in estrogen receptor (ER) positive cases than the receptor negative cases. Further, 56% of the ER+ve, PgR+ve, HER2-ve and 36% of ER+ve, PgR+ve, HER2+ve cases show highest intensity staining equivalent to the thyroid tissue. A significant positive correlation is also observed between hNIS and estrogen receptor expression (p = 0.0033, CI = 95%) suggesting hNIS mediated targeted radio-iodine therapy procedures may benefit both ER+ve, PgR+ve, HER2-ve as well as HER2+ve cases. Further, in a few cases, hNIS and HER2 protein localization is demonstrated by overlapping membrane co-expression. ImageJ based image analysis method shows over 70% match with manual pathological scoring method. Conclusion: The study indicates a positive link between hNIS and ER expression in BC. The quantitative IHC image analysis method reported here will further help in patient stratification and potentially benefit global clinical assessment where hNIS mediated targeted I-131 radio-ablative therapy is aimed.	[Chatterjee, Sushmita; Malhotra, Renu; Varghese, Frency; Bukhari, Amirali B.; De, Abhijit] Tata Mem Hosp, ACTREC, Funct Mol Imaging Lab, Kharghar, Navi Mumbai, India; [Patil, Asawari] Tata Mem Hosp, Bombay 400012, Maharashtra, India; [Budrukkar, Ashwini] Tata Mem Hosp, Dept Radiat Oncol, Bombay 400012, Maharashtra, India; [Parmar, Vani] Tata Mem Hosp, Dept Surg, Bombay 400012, Maharashtra, India; [Gupta, Sudeep] Tata Mem Hosp, Dept Med Oncol, Bombay 400012, Maharashtra, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Tata Memorial Hospital	De, A (corresponding author), Tata Mem Hosp, ACTREC, Funct Mol Imaging Lab, Kharghar, Navi Mumbai, India.	ade@actrec.gov.in	Bukhari, Amirali/L-5610-2014; Patil, Asawari/AAW-1878-2020; DE, ABHIJIT/AAR-5631-2021	Bukhari, Amirali/0000-0003-0543-1339; Patil, Asawari/0000-0002-8203-986X; DE, ABHIJIT/0000-0002-5818-0206	TMC-IRG; ICMR	TMC-IRG; ICMR(Indian Council of Medical Research (ICMR))	The clinical study protocol was reviewed and approved by the TMC-ACTREC Institutional Review Board. For all experiments paraffin embedded tissue blocks were used and thus patient consent was not required. Funding support on the study proposals by AD received from TMC-IRG and ICMR are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BC, 2012, THERANOSTICS, V2, P392, DOI 10.7150/thno.3722; Alotaibi H, 2006, BIOCHEM BIOPH RES CO, V345, P1487, DOI 10.1016/j.bbrc.2006.05.049; Beyer SJ, 2009, BREAST CANCER RES TR, V115, P205, DOI 10.1007/s10549-008-0059-5; Brey EM, 2003, J HISTOCHEM CYTOCHEM, V51, P575, DOI 10.1177/002215540305100503; Choudhury KR, 2010, J HISTOCHEM CYTOCHEM, V58, P95, DOI 10.1369/jhc.2009.953554; Damle AA, 2011, INDIAN J EXP BIOL, V49, P416; Dwyer RM, 2011, STEM CELLS, V29, P1149, DOI 10.1002/stem.665; Ellis CM, 2005, J CLIN PATHOL, V58, P710, DOI 10.1136/jcp.2004.023424; Haddad D, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-36; Marsee DK, 2004, CANCER GENE THER, V11, P121, DOI 10.1038/sj.cgt.7700661; Moon DH, 2001, NUCL MED BIOL, V28, P829; Niu G, 2004, J NUCL MED, V45, P445; Oh Hyun Jung, 2005, Cancer Res Treat, V37, P247, DOI 10.4143/crt.2005.37.4.247; Renier C, 2010, J NEURO-ONCOL, V96, P331, DOI 10.1007/s11060-009-9971-8; Renier C, 2009, ANN SURG ONCOL, V16, P962, DOI 10.1245/s10434-008-0280-9; Ruifrok AC, 2003, APPL IMMUNOHISTO M M, V11, P85, DOI 10.1097/00022744-200303000-00014; Ryan J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016023; Schlumberger M, 1996, J NUCL MED, V37, P598; Schlumberger MJ, 1998, NEW ENGL J MED, V338, P297, DOI 10.1056/NEJM199801293380506; Smanik PA, 1996, BIOCHEM BIOPH RES CO, V226, P339, DOI 10.1006/bbrc.1996.1358; Tandon A, 2011, INDIAN J PATHOL MICR, V54, P745, DOI 10.4103/0377-4929.91514; Tawfik OW, 2006, HISTOPATHOLOGY, V48, P258, DOI 10.1111/j.1365-2559.2005.02322.x; Tazebay UH, 2000, NAT MED, V6, P871, DOI 10.1038/78630; Tazebay UH, 2011, BREAST CANC RECENT A; Terrovitis J, 2008, J AM COLL CARDIOL, V52, P1652, DOI 10.1016/j.jacc.2008.06.051; Upadhyay G, 2003, BREAST CANCER RES TR, V77, P157, DOI 10.1023/A:1021321409159; Wapnir IL, 2004, CLIN CANCER RES, V10, P4294, DOI 10.1158/1078-0432.CCR-04-0074; Wapnir IL, 2003, J CLIN ENDOCR METAB, V88, P1880, DOI 10.1210/jc.2002-021544	28	42	46	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54055	10.1371/journal.pone.0054055	http://dx.doi.org/10.1371/journal.pone.0054055			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342072	Green Submitted, Green Published, gold			2022-12-25	WOS:000314759400115
J	Naeem, A; Amani, S				Naeem, Aabgeena; Amani, Samreen			Deciphering Structural Intermediates and Genotoxic Fibrillar Aggregates of Albumins: A Molecular Mechanism Underlying for Degenerative Diseases	PLOS ONE			English	Article							PARTIALLY FOLDED STATE; HUMAN SERUM-ALBUMIN; 1-ANILINO-8-NAPHTHALENE SULFONATE; PROTEIN AGGREGATION; GLOBULAR-PROTEIN; IN-VITRO; BINDING; ACETONITRILE; SPECTROSCOPY; TRANSITION	The misfolding and aggregation of proteins is involved in some of the most prevalent neurodegenerative disorders. The importance of human serum albumin (HSA) stems from the fact that it is involved in bio-regulatory and transport phenomena. Here the effect of acetonitrile (ACN) on the conformational stability of HSA and by comparison, ovalbumin (OVA) has been evaluated in the presence and absence of NaCl. The results show the presence of significant amount of secondary structure in HSA at 70% ACN and in OVA at 50% ACN, as evident from far-UV Circular Dichroism (CD) and Attenuated Total Reflection Fourier transformed infra red spectroscopy (ATR-FTIR). Tryptophan and 8-Anilino-1-Naphthalene-Sulphonic acid (ANS) fluorescence indicate altered tryptophan environment and high ANS binding suggesting a compact "molten globule"-like conformation with enhanced exposure of hydrophobic surface area. However, in presence of NaCl no intermediate state was observed. Detection of aggregates in HSA and OVA was possible at 90% ACN. Aggregates possess extensive beta-sheet structure as revealed by far-UV CD and ATR-FTIR. These aggregates exhibit increase Thioflavin T (Th T) fluorescence with a red shift of Congo red (CR) absorption spectrum. X-ray diffraction (XRD) and Scanning Electron Microscopy (SEM) analysis confirmed the presence of fibrillar aggregates. Single cell gel electrophoresis (SCGE) assay of these fibrillar aggregates showed the DNA damage resulting in cell necrosis confirming their genotoxic nature. Some proteins not related to any human disease form fibrils in vitro. In the present study ACN gives access to a model system to study the process of aggregation.	[Naeem, Aabgeena; Amani, Samreen] Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh 202001, Uttar Pradesh, India	Aligarh Muslim University	Naeem, A (corresponding author), Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh 202001, Uttar Pradesh, India.	aabgeenanaim@gmail.com			CSIR [37(1365)/09/EMR- II]; UGC-SRF	CSIR(Council of Scientific & Industrial Research (CSIR) - India); UGC-SRF(University Grants Commission, India)	The authors are highly thankful for the facilities available at AMU Aligarh. Financial support from CSIR [37(1365)/09/EMR- II] in the form of project is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are highly thankful for the facilities available at AMU Aligarh. USIF, AMU has been acknowledged for providing SEM facility. S. A. is the recipient of UGC-SRF.	Ahmad E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038372; Amani S, 2011, INT J BIOL MACROMOL, V49, P71, DOI 10.1016/j.ijbiomac.2011.03.014; ANFINSEN CB, 1961, P NATL ACAD SCI USA, V47, P1309, DOI 10.1073/pnas.47.9.1309; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; ARRONDO JLR, 1988, BIOCHIM BIOPHYS ACTA, V952, P261, DOI 10.1016/0167-4838(88)90125-2; Blake C, 1996, STRUCTURE, V4, P989, DOI 10.1016/S0969-2126(96)00104-9; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chapman ALP, 2003, BIOCHEM J, V375, P33, DOI 10.1042/BJ20030685; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Daniel FB, 1991, J TOXICOL-CLIN TOXIC, V29, P447; Dzwolak W, 2004, BIOPOLYMERS, V73, P463, DOI 10.1002/bip.10582; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; ENGELHARD M, 1995, PROTEIN SCI, V4, P1553, DOI 10.1002/pro.5560040813; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Fu XM, 2005, BIOCHEM BIOPH RES CO, V329, P1087, DOI 10.1016/j.bbrc.2005.01.164; Hands S, 2011, J BIOL CHEM, V286, P44512, DOI 10.1074/jbc.M111.307587; Iram A, 2013, INT J BIOL MACROMOL, V52, P286, DOI 10.1016/j.ijbiomac.2012.10.023; Juarez J, 2009, BIOPHYS J, V96, P2353, DOI 10.1016/j.bpj.2008.12.3901; KAYSEN GA, 1990, AM J NEPHROL, V10, P36, DOI 10.1159/000168192; Khan TA, 2012, AMINO ACIDS, V43, P1311, DOI 10.1007/s00726-011-1204-8; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; KRAGHHANSEN U, 1981, PHARMACOL REV, V33, P17; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; LEE JY, 1992, J BIOL CHEM, V267, P14753; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; Ma BG, 2010, STRUCTURE, V18, P819, DOI 10.1016/j.str.2010.04.004; Marcon G, 2005, J MOL BIOL, V347, P323, DOI 10.1016/j.jmb.2005.01.034; Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9; Matulis D, 1999, BIOPOLYMERS, V49, P451, DOI 10.1002/(SICI)1097-0282(199905)49:6<451::AID-BIP3>3.0.CO;2-6; Meersman F, 2002, BIOPHYS J, V82, P2635, DOI 10.1016/S0006-3495(02)75605-1; MICHAELIS HC, 1991, J TOXICOL-CLIN TOXIC, V29, P447, DOI 10.3109/15563659109025740; Muzammil S, 1999, EUR J BIOCHEM, V266, P26, DOI 10.1046/j.1432-1327.1999.00810.x; Naeem A, 2011, CELL BIOCHEM BIOPHYS, V61, P237, DOI 10.1007/s12013-011-9200-x; Naeem A, 2011, CELL BIOCHEM BIOPHYS, V59, P29, DOI 10.1007/s12013-010-9108-x; NISBET AD, 1981, EUR J BIOCHEM, V115, P335, DOI 10.1111/j.1432-1033.1981.tb05243.x; Ollesch J, 2007, APPL SPECTROSC, V61, P1025, DOI 10.1366/000370207782217680; Pertinhez TA, 2001, FEBS LETT, V495, P184, DOI 10.1016/S0014-5793(01)02384-5; Plakoutsi G, 2004, J BIOL CHEM, V279, P14111, DOI 10.1074/jbc.M312961200; Rajan RS, 2001, P NATL ACAD SCI USA, V98, P13060, DOI 10.1073/pnas.181479798; Santiago PS, 2010, LANGMUIR, V26, P9794, DOI 10.1021/la100060p; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Stathopulos PB, 2004, PROTEIN SCI, V13, P3017, DOI 10.1110/ps.04831804; STRYER L, 1968, SCIENCE, V162, P526, DOI 10.1126/science.162.3853.526; Tabner BJ, 2005, J BIOL CHEM, V280, P35789, DOI 10.1074/jbc.C500238200; Tanford C, 1968, Adv Protein Chem, V23, P121, DOI 10.1016/S0065-3233(08)60401-5; Tatsumi E, 1999, BIOSCI BIOTECH BIOCH, V63, P1285, DOI 10.1271/bbb.63.1285; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Weijers M, 2002, MACROMOLECULES, V35, P4753, DOI 10.1021/ma0120198	50	40	40	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54061	10.1371/journal.pone.0054061	http://dx.doi.org/10.1371/journal.pone.0054061			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342075	Green Submitted, gold, Green Published			2022-12-25	WOS:000314759400117
J	Raso-Barnett, L; Banky, B; Barbai, T; Becsagh, P; Timar, J; Raso, E				Raso-Barnett, Livia; Banky, Balazs; Barbai, Tamas; Becsagh, Peter; Timar, Jozsef; Raso, Erzsebet			Demonstration of a Melanoma-Specific CD44 Alternative Splicing Pattern That Remains Qualitatively Stable, but Shows Quantitative Changes during Tumour Progression	PLOS ONE			English	Article							HOMING RECEPTOR CD44; COLORECTAL-CANCER; CELL-LINES; ADHESION MOLECULES; CUTANEOUS MELANOMA; EXPRESSION; VARIANTS; GROWTH; V3; MIGRATION	The role of CD44 in the progression of human melanoma has mostly been characterised by qualitative changes in expression of its individual variable exons. These exons however, may be expressed to form a number of molecules, the alternative splice variants of CD44, which may be structurally and functionally different. Using real-time PCR measurements with variable exon specific primers we have determined that all are expressed in human melanoma. To permit comparison between different tumours we identified a stable CD44 variable exon (CD44v) expression pattern, or CD44 'fingerprint'. This was found to remain unchanged in melanoma cell lines cultured in different matrix environments. To evaluate evolution of this fingerprint during tumour progression we established a scid mouse model, in which the pure expression pattern of metastatic primary tumours, circulating cells and metastases, non-metastatic primary tumours and lung colonies could be studied. Our analyses demonstrated, that although the melanoma CD44 fingerprint is qualitatively stable, quantitative changes are observed suggesting a possible role in tumour progression.	[Raso-Barnett, Livia; Banky, Balazs; Barbai, Tamas; Becsagh, Peter; Timar, Jozsef; Raso, Erzsebet] Semmelweis Univ, Dept Tumour Progress, Inst Pathol 2, H-1085 Budapest, Hungary; [Raso-Barnett, Livia] Guys & St Thomas Hosp, Dept Cellular Pathol, London SE1 9RT, England; [Timar, Jozsef; Raso, Erzsebet] Hungarian Acad Sci, Tumour Progress Res Grp, Budapest, Hungary	Semmelweis University; Guy's & St Thomas' NHS Foundation Trust; Hungarian Academy of Sciences	Raso-Barnett, L (corresponding author), Semmelweis Univ, Dept Tumour Progress, Inst Pathol 2, H-1085 Budapest, Hungary.	rasobarnettlivia@gmail.com	Banky, Balazs/B-9670-2018; BARBAI, TAMÁS/S-5628-2017; Raso, Erzsebet/S-5619-2017	Banky, Balazs/0000-0002-4297-9072; BARBAI, TAMÁS/0000-0002-2374-6097; Raso, Erzsebet/0000-0002-4589-5771	Tarsadalmi Megujulas Operativ Program (Social Renewal Operational Programme) [(TAMOP)-4.2.1./B-09/1/KMR-2010-0001]; Egeszsegugyi Tudomanyos Tanacs (Medical Scientific Board of the Hungarian Ministry of Health) (ETT) [087-07/2009]; EGT/Norwegian Financial Mechanism [HU0125]	Tarsadalmi Megujulas Operativ Program (Social Renewal Operational Programme); Egeszsegugyi Tudomanyos Tanacs (Medical Scientific Board of the Hungarian Ministry of Health) (ETT); EGT/Norwegian Financial Mechanism	This study was supported by grants from Tarsadalmi Megujulas Operativ Program (Social Renewal Operational Programme) (TAMOP)-4.2.1./B-09/1/KMR-2010-0001, Egeszsegugyi Tudomanyos Tanacs (Medical Scientific Board of the Hungarian Ministry of Health) (ETT) 087-07/2009 and EGT/Norwegian Financial Mechanism, HU0125. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Banky B, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-83; BENNETT KL, 1995, J CELL BIOL, V128, P687, DOI 10.1083/jcb.128.4.687; BROWN PD, 1990, CANCER RES, V50, P6184; Cheng CH, 2006, GENE DEV, V20, P1715, DOI 10.1101/gad.1430906; Desai B, 2009, J CELL BIOCHEM, V108, P272, DOI 10.1002/jcb.22248; Dome B, 2001, VIRCHOWS ARCH, V439, P628; Goodison S, 1999, J CLIN PATHOL-MOL PA, V52, P189; Haruyama K, 1999, ANTICANCER RES, V19, P4421; HeroldMende C, 1996, J PATHOL, V179, P66, DOI 10.1002/(SICI)1096-9896(199605)179:1<66::AID-PATH544>3.0.CO;2-5; JACKSON DG, 1995, J CELL BIOL, V128, P673, DOI 10.1083/jcb.128.4.673; Kopp R, 2009, INT J MOL MED, V24, P677, DOI 10.3892/ijmm_00000279; MANTENHORST E, 1995, INT J CANCER, V64, P182, DOI 10.1002/ijc.2910640307; Marhaba R, 2004, J MOL HISTOL, V35, P211; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Pacifico MD, 2006, INT J CANCER, V118, P1460, DOI 10.1002/ijc.21504; Poncelet C, 2001, HUM PATHOL, V32, P1190, DOI 10.1053/hupa.2001.28935; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Ranuncolo SM, 2002, ONCOL REP, V9, P51; Recio JA, 2003, CANCER RES, V63, P1576; Reeder JA, 1998, CANCER RES, V58, P3719; RODRIGUEZ C, 1995, INT J CANCER, V64, P347, DOI 10.1002/ijc.2910640512; Ropponen KM, 1998, SCAND J GASTROENTERO, V33, P301; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; Seiter S, 1996, VIRCHOWS ARCH, V428, P141; Suzuki H, 2002, LUNG CANCER-J IASLC, V38, P137, DOI 10.1016/S0169-5002(02)00176-9; TAKACS J, 1981, ACTA MORPHOL HUNG, V29, P141; Timar J, 2005, ONCOLOGY-BASEL, V69, P185, DOI 10.1159/000088069; Tovari J, 2005, CANCER RES, V65, P7186, DOI 10.1158/0008-5472.CAN-04-2498; VANWEERING DHJ, 1993, PCR METH APPL, V3, P100; Wang SJ, 2007, HEAD NECK-J SCI SPEC, V29, P550, DOI 10.1002/hed.20544; Wong LS, 1997, BRIT J SURG, V84, P363, DOI 10.1046/j.1365-2168.1997.02582.x; Yamada Y, 2003, ONCOL REP, V10, P1919; Yang K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-16; Yoshinari C, 1999, MELANOMA RES, V9, P223, DOI 10.1097/00008390-199906000-00003; Zalewski B, 2004, WORLD J GASTROENTERO, V10, P583, DOI 10.3748/wjg.v10.i4.583	37	18	18	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53883	10.1371/journal.pone.0053883	http://dx.doi.org/10.1371/journal.pone.0053883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342032	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000314759400096
J	Takahashi, N; Nomura, T; Takahara, Y; Yamamoto, H; Shiino, T; Takeda, A; Inoue, M; Iida, A; Hara, H; Shu, T; Hasegawa, M; Sakawaki, H; Miura, T; Igarashi, T; Koyanagi, Y; Naruse, TK; Kimura, A; Matano, T				Takahashi, Naofumi; Nomura, Takushi; Takahara, Yusuke; Yamamoto, Hiroyuki; Shiino, Teiichiro; Takeda, Akiko; Inoue, Makoto; Iida, Akihiro; Hara, Hiroto; Shu, Tsugumine; Hasegawa, Mamoru; Sakawaki, Hiromi; Miura, Tomoyuki; Igarashi, Tatsuhiko; Koyanagi, Yoshio; Naruse, Taeko K.; Kimura, Akinori; Matano, Tetsuro			A Novel Protective MHC-I Haplotype Not Associated with Dominant Gag-Specific CD8(+) T-Cell Responses in SIVmac239 Infection of Burmese Rhesus Macaques	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS-REPLICATION; LYMPHOCYTE-BASED CONTROL; HLA-B; MAMU-B-ASTERISK-08-POSITIVE MACAQUES; IMMUNE CONTROL; SENDAI-VIRUS; AIDS VACCINE; VIRAL LOAD; VIREMIA; HIV	Several major histocompatibility complex class I (MHC-I) alleles are associated with lower viral loads and slower disease progression in human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) infections. Immune-correlates analyses in these MHC-I-related HIV/SIV controllers would lead to elucidation of the mechanism for viral control. Viral control associated with some protective MHC-I alleles is attributed to CD8(+) T-cell responses targeting Gag epitopes. We have been trying to know the mechanism of SIV control in multiple groups of Burmese rhesus macaques sharing MHC-I genotypes at the haplotype level. Here, we found a protective MHC-I haplotype, 90-010-Id (D), which is not associated with dominant Gag-specific CD8(+) T-cell responses. Viral loads in five D+ animals became significantly lower than those in our previous cohorts after 6 months. Most D+ animals showed predominant Nef-specific but not Gag-specific CD8(+) T-cell responses after SIV challenge. Further analyses suggested two Nef-epitope- specific CD8(+) T-cell responses exerting strong suppressive pressure on SIV replication. Another set of five D+ animals that received a prophylactic vaccine using a Gag-expressing Sendai virus vector showed significantly reduced viral loads compared to unvaccinated D+ animals at 3 months, suggesting rapid SIV control by Gag-specific CD8(+) T-cell responses in addition to Nef-specific ones. These results present a pattern of SIV control with involvement of non-Gag antigen-specific CD8(+) T-cell responses.	[Takahashi, Naofumi; Nomura, Takushi; Takahara, Yusuke; Yamamoto, Hiroyuki; Shiino, Teiichiro; Takeda, Akiko; Matano, Tetsuro] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan; [Takahashi, Naofumi; Nomura, Takushi; Takahara, Yusuke; Matano, Tetsuro] Univ Tokyo, Inst Med Sci, Tokyo, Japan; [Inoue, Makoto; Iida, Akihiro; Hara, Hiroto; Shu, Tsugumine; Hasegawa, Mamoru] DNAVEC Corp, Tsukuba, Ibaraki, Japan; [Sakawaki, Hiromi; Miura, Tomoyuki; Igarashi, Tatsuhiko; Koyanagi, Yoshio] Kyoto Univ, Inst Virus Res, Kyoto 606, Japan; [Naruse, Taeko K.; Kimura, Akinori] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pathogenesis, Tokyo, Japan	National Institute of Infectious Diseases (NIID); University of Tokyo; DNAVEC Corporation; Kyoto University; Tokyo Medical & Dental University (TMDU)	Matano, T (corresponding author), Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan.	tmatano@nih.go.jp	Naruse, Taeko/ABA-3089-2021; Kimura, Akinori/I-5989-2018	Kimura, Akinori/0000-0002-4933-2132; Inoue, Makoto/0000-0003-0804-7439	Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labor, and Welfare	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology, and grants-in-aid from the Ministry of Health, Labor, and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/00002030-200312050-00005; Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Budde ML, 2012, J VIROL, V86, P7596, DOI 10.1128/JVI.00716-12; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Crawford H, 2007, J VIROL, V81, P8346, DOI 10.1128/JVI.00465-07; Edwards BH, 2002, J VIROL, V76, P2298, DOI 10.1128/JVI.76.5.2298-2305.2002; Emu B, 2008, J VIROL, V82, P5398, DOI 10.1128/JVI.02176-07; Flores-Villanueva PO, 2001, P NATL ACAD SCI USA, V98, P5140, DOI 10.1073/pnas.071548198; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Ishii H, 2012, J VIROL, V86, P738, DOI 10.1128/JVI.06226-11; Iwamoto N, 2010, AIDS, V24, P2777, DOI 10.1097/QAD.0b013e3283402206; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kawada M, 2006, J VIROL, V80, P1949, DOI 10.1128/JVI.80.4.1949-1958.2006; Kawada M, 2008, J VIROL, V82, P10199, DOI 10.1128/JVI.01103-08; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Leslie A, 2010, J VIROL, V84, P9879, DOI 10.1128/JVI.00320-10; Li HO, 2000, J VIROL, V74, P6564, DOI 10.1128/JVI.74.14.6564-6569.2000; Loffredo JT, 2008, J VIROL, V82, P1723, DOI 10.1128/JVI.02084-07; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; Maness NJ, 2008, J VIROL, V82, P5245, DOI 10.1128/JVI.00292-08; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Matano T, 2004, J EXP MED, V199, P1709, DOI 10.1084/jem.20040432; Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Miura T, 2009, J VIROL, V83, P2743, DOI 10.1128/JVI.02265-08; Mothe BR, 2003, J VIROL, V77, P2736, DOI 10.1128/JVI.77.4.2736-2740.2003; Mudd PA, 2012, NATURE, V491, P129, DOI 10.1038/nature11443; Muhl T, 2002, J IMMUNOL, V169, P3438, DOI 10.4049/jimmunol.169.6.3438; Naruse TK, 2010, IMMUNOGENETICS, V62, P601, DOI 10.1007/s00251-010-0462-z; Nomura T, 2012, J VIROL, V86, P6481, DOI 10.1128/JVI.07077-11; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Shibata R, 1997, J INFECT DIS, V176, P362, DOI 10.1086/514053; Takeda A, 2003, J VIROL, V77, P9710, DOI 10.1128/JVI.77.17.9710-9715.2003; Tanaka-Takahashi Y, 2007, ELECTROPHORESIS, V28, P918, DOI 10.1002/elps.200600586; Tang JM, 2002, J VIROL, V76, P8276, DOI 10.1128/JVI.76.16.8276-8284.2002; Tenzer S, 2009, NAT IMMUNOL, V10, P636, DOI 10.1038/ni.1728; Valentine LE, 2009, J VIROL, V83, P11514, DOI 10.1128/JVI.01298-09; VOSS G, 1992, J VIROL METHODS, V39, P185, DOI 10.1016/0166-0934(92)90137-3; Yamamoto H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000540; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006; Zuniga R, 2006, J VIROL, V80, P3122, DOI 10.1128/JVI.80.6.3122-3125.2006	50	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54300	10.1371/journal.pone.0054300	http://dx.doi.org/10.1371/journal.pone.0054300			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342126	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400145
J	Yoda, M; Kimura, T; Tohmonda, T; Morioka, H; Matsumoto, M; Okada, Y; Toyama, Y; Horiuchi, K				Yoda, Masaki; Kimura, Tokuhiro; Tohmonda, Takahide; Morioka, Hideo; Matsumoto, Morio; Okada, Yasunori; Toyama, Yoshiaki; Horiuchi, Keisuke			Systemic Overexpression of TNF alpha-converting Enzyme Does Not Lead to Enhanced Shedding Activity In Vivo	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CUTTING EDGE; ADAM17; EGFR; EXPRESSION; RECEPTOR; TACE; DISINTEGRIN; ACTIVATION; METALLOPROTEINASE	TNF alpha-converting enzyme (TACE/ADAM17) is a membrane-bound proteolytic enzyme with a diverse set of target molecules. Most importantly, TACE is indispensable for the release and activation of pro-TNF alpha and the ligands for epidermal growth factor receptor in vivo. Previous studies suggested that the overproduction of TACE is causally related to the pathogenesis of inflammatory diseases and cancers. To test this hypothesis, we generated a transgenic line in which the transcription of exogenous Tace is driven by a CAG promoter. The Tace-transgenic mice were viable and exhibited no overt defects, and the quantitative RT-PCR and Western blot analyses confirmed that the transgenically introduced Tace gene was highly expressed in all of the tissues examined. The Tace-transgenic mice were further crossed with Tace(-/+) mice to abrogate the endogenous TACE expression, and the Tace-transgenic mice lacking endogenous Tace gene were also viable without any apparent defects. Furthermore, there was no difference in the serum TNF alpha levels after lipopolysaccharide injection between the transgenic mice and control littermates. These observations indicate that TACE activity is not necessarily dependent on transcriptional regulation and that excess TACE does not necessarily result in aberrant proteolytic activity in vivo.	[Yoda, Masaki; Kimura, Tokuhiro; Tohmonda, Takahide; Okada, Yasunori; Horiuchi, Keisuke] Keio Univ, Sch Med, Tokyo, Japan; [Yoda, Masaki; Tohmonda, Takahide; Morioka, Hideo; Matsumoto, Morio; Toyama, Yoshiaki; Horiuchi, Keisuke] Keio Univ, Sch Med, Dept Orthoped Surg, Tokyo, Japan	Keio University; Keio University	Horiuchi, K (corresponding author), Keio Univ, Sch Med, Tokyo, Japan.	horiuchi@z3.keio.jp	Toyama, Yoshiaki/K-5743-2013; Matsumoto, Morio M/L-6227-2013; Okada, Yasunori/B-5550-2014; Horiuchi, Keisuke/L-2277-2013	Okada, Yasunori/0000-0001-9208-4755; Horiuchi, Keisuke/0000-0001-7063-9609	Keio University Kanrinmaru project; MEXT KAKENHI [24390358, 23592230]; Health Labour Sciences Research Grant; Nakatomi Foundation	Keio University Kanrinmaru project; MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Health Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan); Nakatomi Foundation	This work was supported in part by Keio University Kanrinmaru project, the Nakatomi Foundation, MEXT KAKENHI (24390358 and 23592230), and the Health Labour Sciences Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blanchot-Jossic F, 2005, J PATHOL, V207, P156, DOI 10.1002/path.1814; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Ding X, 2004, WORLD J GASTROENTERO, V10, P2735, DOI 10.3748/wjg.v10.i18.2735; Dreymueller D, 2011, EUR J CELL BIOL; Duffy MJ, 2009, CLIN CANCER RES, V15, P1140, DOI 10.1158/1078-0432.CCR-08-1585; Fischer OM, 2004, MOL CELL BIOL, V24, P5172, DOI 10.1128/MCB.24.12.5172-5183.2004; Fukaya S, 2012, LAB INVEST; Hall KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031600; Horiuchi K, 2007, J IMMUNOL, V179, P6715, DOI 10.4049/jimmunol.179.10.6715; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Kenny PA, 2007, J CLIN INVEST, V117, P337, DOI 10.1172/JCI29518; Killock DJ, 2010, BIOCHEM J, V428, P293, DOI 10.1042/BJ20091611; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; McGowan PM, 2007, CLIN CANCER RES, V13, P2335, DOI 10.1158/1078-0432.CCR-06-2092; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Nelson KK, 1999, BIOCHEM J, V343, P673, DOI 10.1042/0264-6021:3430673; Ohta S, 2001, J RHEUMATOL, V28, P1756; Patel IR, 1998, J IMMUNOL, V160, P4570; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Pruessmeyer J, 2009, SEMIN CELL DEV BIOL, V20, P164, DOI 10.1016/j.semcdb.2008.09.005; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sahin Umut, 2006, V327, P99; Santiago-Josefat B, 2007, J BIOL CHEM, V282, P8325, DOI 10.1074/jbc.M608826200; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Sisto M, 2010, HISTOCHEM CELL BIOL, V134, P345, DOI 10.1007/s00418-010-0735-5; Smookler DS, 2006, J IMMUNOL, V176, P721, DOI 10.4049/jimmunol.176.2.721; Solomon KA, 1999, J IMMUNOL, V163, P4105; Swendeman S, 2008, CIRC RES, V103, P916, DOI 10.1161/CIRCRESAHA.108.184416; Xu PL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002689; Xu PL, 2010, MOL CELL, V37, P551, DOI 10.1016/j.molcel.2010.01.034; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024	39	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54412	10.1371/journal.pone.0054412	http://dx.doi.org/10.1371/journal.pone.0054412			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342154	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400163
J	Akhtar, S; Grizenkova, J; Wenborn, A; Hummerich, H; de Marco, MF; Brandner, S; Collinge, J; Lloyd, SE				Akhtar, Shaheen; Grizenkova, Julia; Wenborn, Adam; Hummerich, Holger; de Marco, Mar Fernandez; Brandner, Sebastian; Collinge, John; Lloyd, Sarah E.			Sod1 Deficiency Reduces Incubation Time in Mouse Models of Prion Disease	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; CREUTZFELDT-JAKOB-DISEASE; PROTEIN; GENE; MICE; SUSCEPTIBILITY; IDENTIFICATION; RESISTANT; PERIOD; STRAINS	Prion infections, causing neurodegenerative conditions such as Creutzfeldt-Jakob disease and kuru in humans, scrapie in sheep and BSE in cattle are characterised by prolonged and variable incubation periods that are faithfully reproduced in mouse models. Incubation time is partly determined by genetic factors including polymorphisms in the prion protein gene. Quantitative trait loci studies in mice and human genome-wide association studies have confirmed that multiple genes are involved. Candidate gene approaches have also been used and identified App, Il1-r1 and Sod1 as affecting incubation times. In this study we looked for an association between App, Il1-r1 and Sod1 representative SNPs and prion disease incubation time in the Northport heterogeneous stock of mice inoculated with the Chandler/RML prion strain. No association was seen with App, however, significant associations were seen with Il1-r1 (P = 0.02) and Sod1 (P<0.0001) suggesting that polymorphisms at these loci contribute to the natural variation observed in incubation time. Furthermore, following challenge with Chandler/RML, ME7 and MRC2 prion strains, Sod1 deficient mice showed highly significant reductions in incubation time of 20, 13 and 24%, respectively. No differences were detected in Sod1 expression or activity. Our data confirm the protective role of endogenous Sod1 in prion disease.	[Lloyd, Sarah E.] UCL, Inst Neurol, Med Res Council Prion Unit, London, England; UCL, Inst Neurol, Dept Neurodegenerat Dis, London, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; University College London; University of London; University College London	Lloyd, SE (corresponding author), UCL, Inst Neurol, Med Res Council Prion Unit, London, England.	s.lloyd@prion.ucl.ac.uk	Brandner, Sebastian/J-4562-2014	Brandner, Sebastian/0000-0002-9821-0342	UK Medical Research Council; Medical Research Council [MC_U123192748, MC_U123160652] Funding Source: researchfish; MRC [MC_U123192748, MC_U123160652] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the UK Medical Research Council (www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asante EA, 2002, EMBO J, V21, P6358, DOI 10.1093/emboj/cdf653; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; CARLSON GA, 1993, GENETICS, V133, P979; CARLSON GA, 1988, MOL CELL BIOL, V8, P5528, DOI 10.1128/MCB.8.12.5528; Collinge J, 2005, J NEUROL NEUROSUR PS, V76, P906, DOI 10.1136/jnnp.2004.048660; COLLINGE J, 1991, LANCET, V337, P1441, DOI 10.1016/0140-6736(91)93128-V; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Freixes M, 2006, NEUROBIOL AGING, V27, P1807, DOI 10.1016/j.neurobiolaging.2005.10.006; Grizenkova J, 2012, P NATL ACAD SCI USA, V109, P13722, DOI 10.1073/pnas.1208917109; Grizenkova J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015019; HITZEMANN B, 1994, J PHARMACOL EXP THER, V271, P969; Iadecola C, 1999, NAT NEUROSCI, V2, P157, DOI 10.1038/5715; Joyce PI, 2011, MAMM GENOME, V22, P420, DOI 10.1007/s00335-011-9339-1; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lee DW, 1999, FREE RADICAL RES, V30, P499, DOI 10.1080/10715769900300541; Lloyd SE, 2010, NEUROGENETICS, V11, P185, DOI 10.1007/s10048-009-0219-8; Lloyd SE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000383; Lloyd SE, 2005, CURR GENOMICS, V6, P1, DOI 10.2174/1389202053202166; Lloyd SE, 2004, J GEN VIROL, V85, P2471, DOI 10.1099/vir.0.79889-0; Lloyd SE, 2004, MAMM GENOME, V15, P383, DOI 10.1007/s00335-004-3041-5; Lloyd SE, 2002, NEUROGENETICS, V4, P77, DOI 10.1007/s10048-002-0133-9; Lloyd SE, 2001, P NATL ACAD SCI USA, V98, P6279, DOI 10.1073/pnas.101130398; Manolakou K, 2001, P NATL ACAD SCI USA, V98, P7402, DOI 10.1073/pnas.121172098; Matzuk MM, 1998, ENDOCRINOLOGY, V139, P4008, DOI 10.1210/en.139.9.4008; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; Mead S, 2012, HUM MOL GENET, V21, P1897, DOI 10.1093/hmg/ddr607; Mead S, 2009, LANCET NEUROL, V8, P57, DOI 10.1016/S1474-4422(08)70265-5; Moore RC, 1998, NAT GENET, V18, P118, DOI 10.1038/ng0298-118; Moreno CR, 2003, GENETICS, V165, P2085; Murakami K, 2011, J BIOL CHEM, V286, P44557, DOI 10.1074/jbc.M111.279208; O'Shea M, 2008, SEMIN PERINATOL, V32, P1, DOI 10.1053/j.semperi.2007.12.002; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Schultz J, 2004, AM J PATHOL, V165, P671, DOI 10.1016/S0002-9440(10)63331-7; Siskova Z, 2010, AM J PATHOL, V177, P1411, DOI 10.2353/ajpath.2010.091037; Stephenson DA, 2000, GENOMICS, V69, P47, DOI 10.1006/geno.2000.6320; Tamguney G, 2008, J GEN VIROL, V89, P1777, DOI 10.1099/vir.0.2008/001255-0; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Wadsworth JDF, 2006, BRAIN, V129, P1557, DOI 10.1093/brain/awl076; WESTAWAY D, 1987, CELL, V51, P651, DOI 10.1016/0092-8674(87)90134-6	45	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54454	10.1371/journal.pone.0054454	http://dx.doi.org/10.1371/journal.pone.0054454			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349894	Green Published, Green Submitted, gold			2022-12-25	WOS:000314019100070
J	He, YL; Liu, DD; Fang, YJ; Zhan, XQ; Yao, JJ; Mei, YA				He, Yan-Lin; Liu, Dong-Dong; Fang, Yan-Jia; Zhan, Xiao-Qin; Yao, Jin-Jing; Mei, Yan-Ai			Exposure to Extremely Low-Frequency Electromagnetic Fields Modulates Na+ Currents in Rat Cerebellar Granule Cells through Increase of AA/PGE(2) and EP Receptor-Mediated cAMP/PKA Pathway	PLOS ONE			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); ACTIVATED PROTEIN-KINASE; GATED SODIUM-CHANNELS; 50 HZ; ARACHIDONIC-ACID; NEURONAL APOPTOSIS; MAGNETIC-FIELDS; CULTURED-CELLS; IN-VITRO; RELEASE	Although the modulation of Ca2+ channel activity by extremely low-frequency electromagnetic fields (ELF-EMF) has been studied previously, few reports have addressed the effects of such fields on the activity of voltage-activated Na+ channels (Na-v). Here, we investigated the effects of ELF-EMF on Na-v activity in rat cerebellar granule cells (GCs). Our results reveal that exposing cerebellar GCs to ELF-EMF for 10-60 min significantly increased Na-v currents (I-Na) by 30-125% in a time- and intensity-dependent manner. The Na-v channel steady-state activation curve, but not the steady-state inactivation curve, was significantly shifted ( by 5.2 mV) towards hyperpolarization by ELF-EMF stimulation. This phenomenon is similar to the effect of intracellular application of arachidonic acid ( AA) and prostaglandin E-2 (PGE(2)) on I-Na in cerebellar GCs. Increases in intracellular AA, PGE(2) and phosphorylated PKA levels in cerebellar GCs were observed following ELF-EMF exposure. Western blottings indicated that the Na-V 1.2 protein on the cerebellar GCs membrane was increased, the total expression levels of Na-V 1.2 protein were not affected after exposure to ELF-EMF. Cyclooxygenase inhibitors and PGE(2) receptor (EP) antagonists were able to eliminate this ELF-EMF-induced increase in phosphorylated PKA and I-Na. In addition, ELFEMF exposure significantly enhanced the activity of PLA(2) in cerebellar GCs but did not affect COX-1 or COX-2 activity. Together, these data demonstrate for the first time that neuronal I-Na is significantly increased by ELFEMF exposure via a cPLA2 AA PGE(2) EP receptors PKA signaling pathway.	[Mei, Yan-Ai] Fudan Univ, Inst Brain Sci, Sch Life Sci, Shanghai 200433, Peoples R China; Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Mei, YA (corresponding author), Fudan Univ, Inst Brain Sci, Sch Life Sci, Shanghai 200433, Peoples R China.	yamei@fudan.edu.cn		He, Yanlin/0000-0002-5471-9016	National Basic Research Program of China [2011CB503703]; Shanghai Leading Academic Discipline Project [B111]	National Basic Research Program of China(National Basic Research Program of China); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by a grant from the National Basic Research Program of China (2011CB503703) and the Shanghai Leading Academic Discipline Project [B111]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldinucci C, 2009, TOXICOL IND HEALTH, V25, P249, DOI 10.1177/0748233709103031; Arendash GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035751; Banasiak KJ, 2004, NEUROSCIENCE, V126, P31, DOI 10.1016/S0306-4522(03)00425-1; Brash AR, 2001, J CLIN INVEST, V107, P1339, DOI 10.1172/JCI13210; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; COSTA MRC, 1984, J BIOL CHEM, V259, P8210; Cuccurazzu B, 2010, EXP NEUROL, V226, P173, DOI 10.1016/j.expneurol.2010.08.022; Cui YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032196; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; De Mattei M, 2009, OSTEOARTHR CARTILAGE, V17, P252, DOI 10.1016/j.joca.2008.06.002; Dibirdik I, 1998, J BIOL CHEM, V273, P4035, DOI 10.1074/jbc.273.7.4035; Ding YN, 2008, J CELL PHYSIOL, V215, P77, DOI 10.1002/jcp.21289; Diwakar S, 2009, J NEUROPHYSIOL, V101, P519, DOI 10.1152/jn.90382.2008; England S, 1996, J PHYSIOL-LONDON, V495, P429, DOI 10.1113/jphysiol.1996.sp021604; Fang YJ, 2011, BIOCHEM J, V438, P203, DOI 10.1042/BJ20110569; Fraser SP, 2005, CLIN CANCER RES, V11, P5381, DOI 10.1158/1078-0432.CCR-05-0327; Fulton AM, 2006, CANCER RES, V66, P9794, DOI 10.1158/0008-5472.CAN-06-2067; Gijon MA, 2000, J BIOL CHEM, V275, P20146, DOI 10.1074/jbc.M908941199; Gold MS, 1998, J NEUROSCI, V18, P10345; GONZALEZ B, 1992, P NATL ACAD SCI USA, V89, P9627, DOI 10.1073/pnas.89.20.9627; Grassi C, 2004, CELL CALCIUM, V35, P307, DOI 10.1016/j.ceca.2003.09.001; Hu CL, 2008, J NEUROCHEM, V106, P1125, DOI 10.1111/j.1471-4159.2008.05449.x; Jiao S, 2007, J NEUROCHEM, V100, P979, DOI 10.1111/j.1471-4159.2006.04261.x; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Lisi A, 2005, J CELL PHYSIOL, V204, P532, DOI 10.1002/jcp.20322; Liu Z, 2008, J NEUROCHEM, V106, P2463, DOI 10.1111/j.1471-4159.2008.05562.x; Luukkonen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018021; Marchionni I, 2006, BBA-BIOMEMBRANES, V1758, P597, DOI 10.1016/j.bbamem.2006.03.014; Morelli A, 2005, ARCH BIOCHEM BIOPHYS, V441, P191, DOI 10.1016/j.abb.2005.07.011; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Ongaro A, 2012, J CELL PHYSIOL, V227, P2461, DOI 10.1002/jcp.22981; Piacentini R, 2008, J CELL PHYSIOL, V215, P129, DOI 10.1002/jcp.21293; Ramundo-Orlando A, 2000, BIOELECTROMAGNETICS, V21, P499, DOI 10.1002/1521-186X(200010)21:7<499::AID-BEM3>3.0.CO;2-9; Ravera S, 2010, BIOELECTROMAGNETICS, V31, P270, DOI 10.1002/bem.20563; REYNOLDS JD, 1992, J DEV PHYSIOL, V18, P243; Richard D, 2002, MOL CELL BIOCHEM, V232, P133, DOI 10.1023/A:1014802005672; Rosen AD, 2003, BIOELECTROMAGNETICS, V24, P517, DOI 10.1002/bem.10124; Schaller KL, 2003, CEREBELLUM, V2, P2, DOI 10.1080/14734220309424; Smith WL, 1996, ADV IMMUNOL, V62, P167, DOI 10.1016/S0065-2776(08)60430-7; Song HS, 2010, KOREAN J PHYSIOL PHA, V14, P427, DOI 10.4196/kjpp.2010.14.6.427; Sun GY, 2004, J LIPID RES, V45, P205, DOI 10.1194/jlr.R300016-JLR200; Sun WJ, 2001, ELECTRO MAGNETOBIOL, V20, P415, DOI 10.1081/JBC-100108579; Thumm S, 1999, RADIAT ENVIRON BIOPH, V38, P195, DOI 10.1007/s004110050155; Varani K, 2010, BIOELECTROMAGNETICS; Waxman SG, 2007, NAT NEUROSCI, V10, P405, DOI 10.1038/nn1857; Yao HL, 2009, J NEUROCHEM, V108, P909, DOI 10.1111/j.1471-4159.2008.05834.x; Zahner G, 2009, BIOCHEM J, V422, P563, DOI 10.1042/BJ20090420; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200	48	30	35	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54376	10.1371/journal.pone.0054376	http://dx.doi.org/10.1371/journal.pone.0054376			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349866	Green Published, Green Submitted, gold			2022-12-25	WOS:000314019100061
J	Geiser, E; Gabrieli, JDE				Geiser, Eveline; Gabrieli, John D. E.			Influence of Rhythmic Grouping on Duration Perception: A Novel Auditory Illusion	PLOS ONE			English	Article							OMISSION EVOKED-POTENTIALS; STREAM SEGREGATION; TEMPORAL PATTERNS; TIME PERCEPTION; DISCRIMINATION; MUSICIANS; NONMUSICIANS; REPRESENTATION; SHRINKING; METER	This study investigated a potential auditory illusion in duration perception induced by rhythmic temporal contexts. Listeners with or without musical training performed a duration discrimination task for a silent period in a rhythmic auditory sequence. The critical temporal interval was presented either within a perceptual group or between two perceptual groups. We report the just-noticeable difference (difference limen, DL) for temporal intervals and the point of subjective equality (PSE) derived from individual psychometric functions based on performance of a two-alternative forced choice task. In musically untrained individuals, equal temporal intervals were perceived as significantly longer when presented between perceptual groups than within a perceptual group (109.25% versus 102.5% of the standard duration). Only the perceived duration of the between-group interval was significantly longer than its objective duration. Musically trained individuals did not show this effect. However, in both musically trained and untrained individuals, the relative difference limens for discriminating the comparison interval from the standard interval were larger in the between-groups condition than in the within-group condition (7.3% vs. 5.6% of the standard duration). Thus, rhythmic grouping affected sensitivity to duration changes in all listeners, with duration differences being harder to detect at boundaries of rhythm groups than within rhythm groups. Our results show for the first time that temporal Gestalt induces auditory duration illusions in typical listeners, but that musical experts are not susceptible to this effect of rhythmic grouping.	[Geiser, Eveline] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Geiser, E (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	egeiser@mit.edu	Gabrieli, John/AAJ-2869-2020		Ellison Medical Foundation; Swiss National Science Foundation [PA00P1_131448/1]; McGovern Institute at Massachusetts Institute of Technology	Ellison Medical Foundation(Lawrence Ellison Foundation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); McGovern Institute at Massachusetts Institute of Technology	This research was supported by a grant from the Ellison Medical Foundation. During the preparation of this manuscript EG was supported by the Swiss National Science Foundation (PA00P1_131448/1) and the McGovern Institute at Massachusetts Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolton T.L., 1894, AM J PSYCHOL, V6, P145, DOI [10.2307/1410948, DOI 10.2307/1410948]; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bregman A.S., 1990, AUDITORY SCENE ANAL; BREGMAN AS, 1978, J EXP PSYCHOL HUMAN, V4, P380, DOI 10.1037/0096-1523.4.3.380; Bregman AS, 1999, PERCEPT PSYCHOPHYS, V61, P195, DOI 10.3758/BF03206882; Desain P, 2003, PERCEPTION, V32, P341, DOI 10.1068/p3370; DRAKE C, 1993, PERCEPT PSYCHOPHYS, V53, P25, DOI 10.3758/BF03211712; Eagleman DM, 2008, CURR OPIN NEUROBIOL, V18, P131, DOI 10.1016/j.conb.2008.06.002; Ehrle N, 2005, BRAIN COGNITION, V58, P133, DOI 10.1016/j.bandc.2004.09.014; FITZGIBBONS PJ, 1974, PERCEPT PSYCHOPHYS, V16, P522, DOI 10.3758/BF03198581; Frazier L, 2006, TRENDS COGN SCI, V10, P244, DOI 10.1016/j.tics.2006.04.002; FRIBERG A, 1995, J ACOUST SOC AM, V98, P2524, DOI 10.1121/1.413218; Geiser E, 2010, EUR J NEUROSCI, V32, P1979, DOI 10.1111/j.1460-9568.2010.07462.x; Grondin S, 2001, PSYCHOL BULL, V127, P22, DOI 10.1037//0033-2909.127.1.22; Grondin S, 2009, ATTEN PERCEPT PSYCHO, V71, P1649, DOI 10.3758/APP.71.7.1649; HALPERN AR, 1982, PERCEPT PSYCHOPHYS, V31, P86, DOI 10.3758/BF03206204; HANDEL S, 1992, PERCEPT PSYCHOPHYS, V52, P497, DOI 10.3758/BF03206711; Jongsma MLA, 2005, PSYCHOPHYSIOLOGY, V42, P191, DOI 10.1111/j.1469-8986.2005.00269.x; Jongsma MLA, 2004, NEUROSCI LETT, V355, P189, DOI 10.1016/j.neulet.2003.10.070; Kanai R, 2006, J VISION, V6, P1421, DOI 10.1167/16.12.8; Kleiner M., 2007, PERC 36 ECVP S; Kolakoski W., 1965, AM MATH MON, V72, P674; KRISTOFFERSON AB, 1980, PERCEPT PSYCHOPHYS, V27, P300, DOI 10.3758/BF03206118; Matthews WJ, 2012, ATTEN PERCEPT PSYCHO, V74, P1056, DOI 10.3758/s13414-012-0282-3; McDougall R, 1903, PSYCHOL REV S, V4, P309; NAKAJIMA Y, 1991, MUSIC PERCEPT, V8, P431; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; POVEL DJ, 1981, J EXP PSYCHOL HUMAN, V7, P3, DOI 10.1037/0096-1523.7.1.3; POVEL DJ, 1985, MUSIC PERCEPT, V2, P411; Rammsayer T, 2006, MUSIC PERCEPT, V24, P37, DOI 10.1525/mp.2006.24.1.37; ROSE D, 1995, PERCEPTION, V24, P1177, DOI 10.1068/p241177; Sasaki T, 2002, PERCEPT PSYCHOPHYS, V64, P919, DOI 10.3758/BF03196796; Sasaki T, 2010, ATTEN PERCEPT PSYCHO, V72, P1404, DOI 10.3758/APP.72.5.1404; SCHULZE HH, 1989, PSYCHOL RES-PSYCH FO, V51, P10, DOI 10.1007/BF00309270; Snyder JS, 2009, J EXP PSYCHOL HUMAN, V35, P1232, DOI 10.1037/a0012741; Ten Hoopen G, 2006, MUSIC PERCEPT, V24, P1; Ten Hoopen G, 2011, ATTEN PERCEPT PSYCHO, V73, P2249, DOI 10.3758/s13414-011-0171-1; ten Hoopen G, 2008, PSYCHOLOGY OF TIME, P139, DOI 10.1016/B978-0-08046-977-5.00005-3; THORPE LA, 1989, DEV PSYCHOL, V25, P122, DOI 10.1037/0012-1649.25.1.122; Vuust P, 2005, NEUROIMAGE, V24, P560, DOI 10.1016/j.neuroimage.2004.08.039; Wertheimer M., 1938, SOURCE BOOK GESTALT, P71, DOI [10.1037/11496-005, DOI 10.1037/11496-005]	41	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54273	10.1371/journal.pone.0054273	http://dx.doi.org/10.1371/journal.pone.0054273			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	075GQ	23349845	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872800036
J	Harper, MT; van den Bosch, MTJ; Hers, I; Poole, AW				Harper, Matthew T.; van den Bosch, Marion T. J.; Hers, Ingeborg; Poole, Alastair W.			Absence of Platelet Phenotype in Mice Lacking the Motor Protein Myosin Va	PLOS ONE			English	Article							RANGE VESICLE TRANSPORT; MELANOSOME TRANSPORT; PLASMA-MEMBRANE; DENSE GRANULES; MELANOCYTES; SECRETION; RAB27A; CELLS; SLAC2-A/MELANOPHILIN; MUNC13-4	Background: The motor protein myosin Va plays an important role in the trafficking of intracellular vesicles. Mutation of the Myo5a gene causes Griscelli syndrome type 1 in humans and the dilute phenotype in mice, which are both characterised by pigment dilution and neurological defects as a result of impaired vesicle transport in melanocytes and neuroendocrine cells. The role of myosin Va in platelets is currently unknown. Rab27 has been shown to be associated with myosin Va cargo vesicles and is known to be important in platelet dense granule biogenesis and secretion, a crucial event in thrombus formation. Therefore, we hypothesised that myosin Va may regulate granule secretion or formation in platelets. Methodology/Principal Findings: Platelet function was studied in vitro using a novel Myo5a gene deletion mouse model. Myo5a(-/-) platelets were devoid of myosin Va, as determined by immunoblotting, and exhibited normal expression of surface markers. We assessed dense granule, alpha-granule and lysosomal secretion, integrin alpha(IIb)beta(3) activation, Ca2+ signalling, and spreading on fibrinogen in response to collagen-related peptide or the PAR4 agonist, AYPGKF in washed mouse platelets lacking myosin Va or wild-type platelets. Surprisingly, Myo5a(-/-) platelets showed no significant functional defects in these responses, or in the numbers of dense and a-granules expressed. Conclusion: Despite the importance of myosin Va in vesicle transport in other cells, our data demonstrate this motor protein has no non-redundant role in the secretion of dense and alpha-granules or other functional responses in platelets.	[Harper, Matthew T.; van den Bosch, Marion T. J.; Hers, Ingeborg; Poole, Alastair W.] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England	University of Bristol	Poole, AW (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England.	a.poole@bris.ac.uk	Hers, Ingeborg/ABG-3357-2020; Harper, Matthew T/G-5630-2013	Harper, Matthew T/0000-0002-4740-637X; Poole, Alastair/0000-0002-0868-297X; van den Bosch, Marion/0000-0002-4635-4416; Hers, Ingeborg/0000-0002-6467-5715	British Heart Foundation [FS/09/009/26444, FS/11/62/28934, RG/10/006/28299, PG/08/056/25325]; British Heart Foundation [PG/10/100/28658, FS/12/3/29232, FS/11/62/28934, PG/08/056/25325, RG/10/006/28299] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	Financial support for this work was from the British Heart Foundation (FS/09/009/26444, FS/11/62/28934, RG/10/006/28299, PG/08/056/25325). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahadoran P, 2001, J CELL BIOL, V152, P843, DOI 10.1083/jcb.152.4.843; Barral DC, 2002, J CLIN INVEST, V110, P247, DOI 10.1172/JCI200215058; Bond LM, 2011, MOL BIOL CELL, V22, P54, DOI 10.1091/mbc.E10-06-0553; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; Harper MT, 2010, J BIOL CHEM, V285, P19865, DOI 10.1074/jbc.M109.085654; Jacobs DT, 2009, MOL BIOL CELL, V20, P4471, DOI 10.1091/mbc.E08-08-0865; Konopatskaya O, 2011, BLOOD, V118, P416, DOI 10.1182/blood-2010-10-312199; Kuroda TS, 2003, MOL CELL BIOL, V23, P5245, DOI 10.1128/MCB.23.15.5245-5255.2003; Langford GM, 2002, TRAFFIC, V3, P859, DOI 10.1034/j.1600-0854.2002.31202.x; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Marchelletta RR, 2008, AM J PHYSIOL-CELL PH, V295, pC13, DOI 10.1152/ajpcell.00330.2007; MAUPIN P, 1994, J CELL SCI, V107, P3077; Novak EK, 2002, BLOOD, V100, P128, DOI 10.1182/blood.V100.1.128; Pastural E, 1997, NAT GENET, V16, P289, DOI 10.1038/ng0797-289; Ren QS, 2010, BLOOD, V116, P869, DOI 10.1182/blood-2010-02-270934; Rendu F, 2001, PLATELETS, V12, P261, DOI 10.1080/09537100120068170; Rodriguez OC, 2002, J CELL SCI, V115, P991; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Rudolf R, 2003, J CELL SCI, V116, P1339, DOI 10.1242/jcs.00317; Schuh M, 2011, NAT CELL BIOL, V13, P1431, DOI 10.1038/ncb2353; Shin JW, 2011, P NATL ACAD SCI USA, V108, P11458, DOI 10.1073/pnas.1017474108; Shirakawa R, 2004, J BIOL CHEM, V279, P10730, DOI 10.1074/jbc.M309426200; Tolmachova T, 2007, P NATL ACAD SCI USA, V104, P5872, DOI 10.1073/pnas.0609879104; Wagner W, 2011, NAT CELL BIOL, V13, P40, DOI 10.1038/ncb2132; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Wu XF, 1997, J CELL SCI, V110, P847; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899	28	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e53239	10.1371/journal.pone.0053239	http://dx.doi.org/10.1371/journal.pone.0053239			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349704	gold, Green Published, Green Submitted			2022-12-25	WOS:000313872800008
J	de Jong, A; Hansen, ME; Kuipers, OP; Kilstrup, M; Kok, J				de Jong, Anne; Hansen, Morten E.; Kuipers, Oscar P.; Kilstrup, Mogens; Kok, Jan			The Transcriptional and Gene Regulatory Network of Lactococcus lactis MG1363 during Growth in Milk	PLOS ONE			English	Article							BACILLUS-SUBTILIS; NUCLEOTIDE-METABOLISM; EXPRESSION; SOFTWARE; GENOMICS; REGULON; IDENTIFICATION; VISUALIZATION; ENVIRONMENT; ADAPTATION	In the present study we examine the changes in the expression of genes of Lactococcus lactis subspecies cremoris MG1363 during growth in milk. To reveal which specific classes of genes (pathways, operons, regulons, COGs) are important, we performed a transcriptome time series experiment. Global analysis of gene expression over time showed that L. lactis adapted quickly to the environmental changes. Using upstream sequences of genes with correlated gene expression profiles, we uncovered a substantial number of putative DNA binding motifs that may be relevant for L. lactis fermentative growth in milk. All available novel and literature-derived data were integrated into network reconstruction building blocks, which were used to reconstruct and visualize the L. lactis gene regulatory network. This network enables easy mining in the chrono-transcriptomics data. A freely available website at http://milkts.molgenrug.nl gives full access to all transcriptome data, to the reconstructed network and to the individual network building blocks.	[de Jong, Anne; Kuipers, Oscar P.; Kok, Jan] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Genet, Groningen, Netherlands; [Hansen, Morten E.; Kilstrup, Mogens] Tech Univ Denmark, Inst Syst Biol, Ctr Syst Microbiol, DK-2800 Lyngby, Denmark	University of Groningen; Technical University of Denmark	Kilstrup, M (corresponding author), Tech Univ Denmark, Inst Syst Biol, Ctr Syst Microbiol, DK-2800 Lyngby, Denmark.	mki@bio.dtu.dk	Kok, Jan/C-9972-2012; Kilstrup, Mogens/AAV-2030-2021; Kuipers, Oscar/B-6752-2009	Kuipers, Oscar/0000-0001-5596-7735; Kilstrup, Mogens/0000-0002-3900-723X; Ejby, Morten/0000-0003-2099-3591	Danish Dairy Research Foundation	Danish Dairy Research Foundation	Morten Ejby was supported by a grant from the Danish Dairy Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ahdesmaki M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-117; Ahdesmaki M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-233; Baerends RJS, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r37; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Beyer NH, 2003, PROTEOMICS, V3, P786, DOI 10.1002/pmic.200300416; Blom EJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-535; Bonner ER, 2001, NUCLEIC ACIDS RES, V29, P4851, DOI 10.1093/nar/29.23.4851; Brouwer RWW, 2008, BRIEF BIOINFORM, V9, P367, DOI 10.1093/bib/bbn019; Carlson JM, 2007, NUCLEIC ACIDS RES, V35, pW259, DOI 10.1093/nar/gkm310; Cretenet M, 2011, APPL ENVIRON MICROB, V77, P247, DOI 10.1128/AEM.01174-10; de Jong A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-299; den Hengst CD, 2005, J BIOL CHEM, V280, P34332, DOI 10.1074/jbc.M502349200; Doeven MK, 2005, MOL MICROBIOL, V57, P640, DOI 10.1111/j.1365-2958.2005.04698.x; Dressaire C, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S18; Fernandez M, 2006, CRIT REV MICROBIOL, V32, P155, DOI 10.1080/10408410600880643; Foucaud-Scheunemann C, 2003, FEMS MICROBIOL LETT, V224, P53, DOI 10.1016/S0378-1097(03)00419-1; GASSON MJ, 1983, J BACTERIOL, V154, P1; Guedon E, 2005, MICROBIOL-SGM, V151, P3895, DOI 10.1099/mic.0.28186-0; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jendresen CB, 2012, MICROBIOL-SGM, V158, P2026, DOI 10.1099/mic.0.059576-0; JUILLARD V, 1995, APPL ENVIRON MICROB, V61, P3024, DOI 10.1128/AEM.61.8.3024-3030.1995; Kilstrup M, 2005, FEMS MICROBIOL REV, V29, P555, DOI 10.1016/j.femsre.2005.04.006; Kilstrup M, 1998, J BACTERIOL, V180, P3907, DOI 10.1128/JB.180.15.3907-3916.1998; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Klaenhammer TR, 2007, J NUTR, V137, p748S, DOI 10.1093/jn/137.3.748S; Kohl M, 2011, METHODS MOL BIOL, V696, P291, DOI 10.1007/978-1-60761-987-1_18; Kok J, 2005, FEMS MICROBIOL REV, V29, P411, DOI 10.1016/j.femsre.2005.04.004; Larsen R, 2005, J BIOL CHEM, V280, P19319, DOI 10.1074/jbc.M413983200; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Martirani L, 2001, FEMS MICROBIOL LETT, V198, P177, DOI 10.1016/S0378-1097(01)00142-2; Notebaart RA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-296; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; Pfeiler EA, 2007, TRENDS MICROBIOL, V15, P546, DOI 10.1016/j.tim.2007.09.010; Picard F, 2009, CR BIOL, V332, P958, DOI 10.1016/j.crvi.2009.09.005; Saal LH, 2002, GENOME BIOL, V3; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Scott C, 2000, MOL MICROBIOL, V35, P1383, DOI 10.1046/j.1365-2958.2000.01799.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siezen RJ, 2011, MICROB BIOTECHNOL, V4, P383, DOI 10.1111/j.1751-7915.2011.00247.x; Singhal M, 2007, COMPUT BIOL CHEM, V31, P222, DOI 10.1016/j.compbiolchem.2007.03.006; Sperandio B, 2005, J BACTERIOL, V187, P3762, DOI 10.1128/JB.187.11.3762-3778.2005; van de Guchte M, 2002, ANTON LEEUW INT J G, V82, P187, DOI 10.1023/A:1020631532202; van Hijum Sacha A F T, 2003, Appl Bioinformatics, V2, P241; van Hijum SAFT, 2009, MICROBIOL MOL BIOL R, V73, P481, DOI 10.1128/MMBR.00037-08; van Hijum SAFT, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-77; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Zomer AL, 2007, J BACTERIOL, V189, P1366, DOI 10.1128/JB.01013-06	50	24	24	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53085	10.1371/journal.pone.0053085	http://dx.doi.org/10.1371/journal.pone.0053085			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349698	Green Published, Green Submitted, gold			2022-12-25	WOS:000313738900007
J	Arque, G; Casanovas, A; Dierssen, M				Arque, Gloria; Casanovas, Anna; Dierssen, Mara			Dyrk1A Is Dynamically Expressed on Subsets of Motor Neurons and in the Neuromuscular Junction: Possible Role in Down Syndrome	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; CEREBELLAR PHENOTYPES; SYNDROME CHILDREN; CRITICAL REGION; MOUSE MODEL; MICE; BRAIN; MNB/DYRK1A; MINIBRAIN; MOTONEURONS	Individuals with Down syndrome (DS) present important motor deficits that derive from altered motor development of infants and young children. DYRK1A, a candidate gene for DS abnormalities has been implicated in motor function due to its expression in motor nuclei in the adult brain, and its overexpression in DS mouse models leads to hyperactivity and altered motor learning. However, its precise role in the adult motor system, or its possible involvement in postnatal locomotor development has not yet been clarified. During the postnatal period we observed time-specific expression of Dyrk1A in discrete subsets of brainstem nuclei and spinal cord motor neurons. Interestingly, we describe for the first time the presence of Dyrk1A in the presynaptic terminal of the neuromuscular junctions and its axonal transport from the facial nucleus, suggesting a function for Dyrk1A in these structures. Relevant to DS, Dyrk1A overexpression in transgenic mice (TgDyrk1A) produces motor developmental alterations possibly contributing to DS motor phenotypes and modifies the numbers of motor cholinergic neurons, suggesting that the kinase may have a role in the development of the brainstem and spinal cord motor system.	[Arque, Gloria; Dierssen, Mara] Pompeu Fabra Univ, CRG, Genes & Dis Program, Barcelona, Spain; [Arque, Gloria; Dierssen, Mara] CIBER Enfermedades Raras CIBERER, Barcelona, Spain; [Casanovas, Anna] Univ Lleida, Sch Med, Dept Expt Med, Lleida, Catalonia, Spain; [Casanovas, Anna] Univ Lleida, Sch Med, IRBLLEIDA, Lleida, Catalonia, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universitat de Lleida; Universitat de Lleida	Dierssen, M (corresponding author), Pompeu Fabra Univ, CRG, Genes & Dis Program, PRBB, Barcelona, Spain.	mara.dierssen@crg.eu	Arque, Gloria/AHD-3561-2022; Llorens, Ana Maria Casanovas/C-3984-2011; Arque, Gloria/AAT-7266-2020; Dierssen, Mara/G-3552-2015	Llorens, Ana Maria Casanovas/0000-0001-8766-5555; Arque, Gloria/0000-0002-8039-3726; Dierssen, Mara/0000-0003-0853-6865	Departament d'Universitats, Recerca i Societat de la Informacio (DURSI) [09 2009SGR1313]; Fondo de Investigacion Sanitaria (FIS) [PI 082038]; Marato TV3; Jerome Lejeune Foundation; Reina Sofia Foundation; Areces Foundation; EU [LSHG-CT-2006-037627]; CureFXS ERare-EU/FIS [PS09102673];  [FCT-08-0782];  [SAF2007-60827];  [SAF2010-16427];  [SAF2007-31093-E]	Departament d'Universitats, Recerca i Societat de la Informacio (DURSI); Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); Marato TV3; Jerome Lejeune Foundation; Reina Sofia Foundation; Areces Foundation; EU(European Commission); CureFXS ERare-EU/FIS; ; ; ; 	The laboratory of MD is supported by Departament d'Universitats, Recerca i Societat de la Informacio (DURSI) (Grups consolidats 09 2009SGR1313). This work was supported by FCT-08-0782, SAF2007-60827, SAF2010-16427, SAF2007-31093-E, Fondo de Investigacion Sanitaria (FIS) (PI 082038), Marato TV3, Jerome Lejeune, Reina Sofia and Areces Foundations and EU (LSHG-CT-2006-037627; CureFXS ERare-EU/FIS PS09102673). The CIBER of Enfermedades Raras is an initiative of the ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Altafaj X, 2008, NEUROBIOL DIS; Arque G, 2009, NEUROBIOL DIS, V36, P312, DOI 10.1016/j.nbd.2009.07.027; Baxter LL, 2000, HUM MOL GENET, V9, P195, DOI 10.1093/hmg/9.2.195; BECKER L, 1991, PROG CLIN BIOL RES, V373, P133; Branchi I, 2004, J NEUROPATH EXP NEUR, V63, P429, DOI 10.1093/jnen/63.5.429; CALDERO J, 1992, NEUROSCIENCE, V48, P449, DOI 10.1016/0306-4522(92)90504-U; Casanovas A, 2001, J NEUROSCI RES, V63, P469, DOI 10.1002/jnr.1041; Chen-Hwang MC, 2002, J BIOL CHEM, V277, P17597, DOI 10.1074/jbc.M111101200; de Lagran MM, 2007, GENES BRAIN BEHAV, V6, P569, DOI 10.1111/j.1601-183X.2006.00285.x; de Lagran MM, 2004, NEUROBIOL DIS, V15, P132, DOI 10.1016/j.nbd.2003.10.002; Dierssen M, 2002, PHARMACOL BIOCHEM BE, V73, P19, DOI 10.1016/S0091-3057(02)00792-X; Dierssen M, 2012, NAT REV NEUROSCI, V13, P844, DOI 10.1038/nrn3314; Fotaki V, 2004, BEHAV NEUROSCI, V118, P815, DOI 10.1037/0735-7044.118.4.815; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Galante M, 2009, HUM MOL GENET, V18, P1449, DOI 10.1093/hmg/ddp055; Guimera J, 1996, HUM MOL GENET, V5, P1305, DOI 10.1093/hmg/5.9.1305; Hammerle B, 2003, EUR J NEUROSCI, V17, P2277, DOI 10.1046/j.1460-9568.2003.02665.x; Hammerle B, 2002, DEV BIOL, V246, P259, DOI 10.1006/dbio.2002.0675; Hammerle B, 2008, EUR J NEUROSCI, V27, P1061, DOI 10.1111/j.1460-9568.2008.06092.x; HENDERSON SE, 1981, J CHILD PSYCHOL PSYC, V22, P233, DOI 10.1111/j.1469-7610.1981.tb00549.x; Huang Y, 2004, BIOCHEMISTRY-US, V43, P10173, DOI 10.1021/bi036060+; Latash ML, 2006, PHYS THER, V86, P1151, DOI 10.1093/ptj/86.8.1151; LATASH ML, 1991, AM J MENT RETARD, V96, P189; Marti E, 2003, BRAIN RES, V964, P250, DOI 10.1016/S0006-8993(02)04069-6; MORRIS AF, 1982, J MENT DEFIC RES, V26, P41; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Olson LE, 2004, DEV DYNAM, V230, P581, DOI 10.1002/dvdy.20079; Ortiz-Abalia J, 2008, AM J HUM GENET, V83, P479, DOI 10.1016/j.ajhg.2008.09.010; Palisano RJ, 2001, ARCH PHYS MED REHAB, V82, P494, DOI 10.1053/apmr.2001.21956; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Shapiro BL, 2001, J NEURAL TRANSM-SUPP, P11; Singh D N, 1982, Prog Clin Biol Res, V84, P353; STREIT WJ, 1989, NEUROSCI LETT, V101, P143, DOI 10.1016/0304-3940(89)90521-1; Wegiel J, 2004, BRAIN RES, V1010, P69, DOI 10.1016/j.brainres.2004.03.008	36	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54285	10.1371/journal.pone.0054285	http://dx.doi.org/10.1371/journal.pone.0054285			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342120	Green Published, Green Submitted, gold			2022-12-25	WOS:000313682700103
J	Spinnler, R; Gorski, T; Stolz, K; Schuster, S; Garten, A; Beck-Sickinger, AG; Engelse, MA; de Koning, EJP; Korner, A; Kiess, W; Maedler, K				Spinnler, Robert; Gorski, Theresa; Stolz, Katharina; Schuster, Susanne; Garten, Antje; Beck-Sickinger, Annette G.; Engelse, Marten A.; de Koning, Eelco J. P.; Koerner, Antje; Kiess, Wieland; Maedler, Kathrin			The Adipocytokine Nampt and Its Product NMN Have No Effect on Beta-Cell Survival but Potentiate Glucose Stimulated Insulin Secretion	PLOS ONE			English	Article							MONOUNSATURATED FATTY-ACIDS; FACTOR-KAPPA-B; HUMAN ISLETS; ADIPONECTIN RECEPTORS; DIABETES-MELLITUS; LEPTIN; APOPTOSIS; MICE; EXPRESSION; INTERLEUKIN-1	Aims/Hypothesis: Obesity is associated with a dysregulation of beta-cell and adipocyte function. The molecular interactions between adipose tissue and beta-cells are not yet fully elucidated. We investigated, whether or not the adipocytokine Nicotinamide phosphoribosyltransferase (Nampt) and its enzymatic product Nicotinamide mononucleotide (NMN), which has been associated with obesity and type 2 diabetes mellitus (T2DM) directly influence beta-cell survival and function. Methods: The effect of Nampt and NMN on viability of INS-1E cells was assessed by WST-1 assay. Apoptosis was measured by Annexin V/PI and TUNEL assay. Activation of apoptosis signaling pathways was evaluated. Adenylate kinase release was determined to assess cytotoxicity. Chronic and acute effects of the adipocytokine Nampt and its enzymatic product NMN on insulin secretion were assessed by glucose stimulated insulin secretion in human islets. Results: While stimulation of beta-cells with the cytokines IL-1 beta, TNF alpha and IFN-gamma or palmitate significantly decreased viability, Nampt and NMN showed no direct effect on viability in INS-1E cells or in human islets, neither alone nor in the presence of pro-diabetic conditions (elevated glucose concentrations and palmitate or cytokines). At chronic conditions over 3 days of culture, Nampt and its product NMN had no effects on insulin secretion. In contrast, both Nampt and NMN potentiated glucose stimulated insulin secretion acutely during 1 h incubation of human islets. Conclusion/Interpretation: Nampt and NMN neither influenced beta-cell viability nor apoptosis but acutely potentiated glucose stimulated insulin secretion.	[Spinnler, Robert; Gorski, Theresa; Schuster, Susanne; Garten, Antje; Koerner, Antje; Kiess, Wieland] Univ Leipzig, Dept Women & Child Hlth, Ctr Pediat Res Leipzig CPL, D-04109 Leipzig, Germany; [Spinnler, Robert] Univ Leipzig, Med Ctr, IFB Adipos Dis, D-04109 Leipzig, Germany; [Stolz, Katharina; Maedler, Kathrin] Univ Bremen, Ctr Biomol Interact, D-28359 Bremen, Germany; [Beck-Sickinger, Annette G.] Univ Leipzig, Inst Biochem, Fac Biosci Pharm & Psychol, D-04109 Leipzig, Germany; [Engelse, Marten A.; de Koning, Eelco J. P.] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [de Koning, Eelco J. P.] Hubrecht Inst, Utrecht, Netherlands	Leipzig University; Leipzig University; University of Bremen; Leipzig University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Schuster, S (corresponding author), Univ Leipzig, Dept Women & Child Hlth, Ctr Pediat Res Leipzig CPL, D-04109 Leipzig, Germany.	Susanne.Schuster@medizin.uni-leipzig.de	Maedler, Kathrin/ABE-3022-2021; de Koning, Eelco JP/H-6030-2011; Körner, Antje/B-3988-2015	Maedler, Kathrin/0000-0002-7436-1197; de Koning, Eelco JP/0000-0002-1232-7022; Körner, Antje/0000-0001-6001-0356; Gaul, Susanne/0000-0003-4780-1844; Garten, Antje/0000-0002-5354-287X	Deutsche Forschungsgemeinschaft [KFO 152]; LIFE program (Leipzig Interdisciplinary Research Cluster of Genetic Factors, Clinical Phenotypes and Environment); IFB (Integrated Research and Treatment Center AdiposityDiseases); BMBF (Bundesministerium fur Bildung und Forschung); German Diabetes Society (DDG); Kompetenznetz Adipositas-Verbund LARGE [TP01]; Kompetenznetz Diabetes; National Center for Research Resources (NCRR); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Juvenile Diabetes Research Foundation (JDRF); European Consortium for Islet Transplantation (ECIT), Islets for Research Distribution Program; European Research Council [ERC 260336]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); LIFE program (Leipzig Interdisciplinary Research Cluster of Genetic Factors, Clinical Phenotypes and Environment); IFB (Integrated Research and Treatment Center AdiposityDiseases); BMBF (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); German Diabetes Society (DDG); Kompetenznetz Adipositas-Verbund LARGE; Kompetenznetz Diabetes; National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); European Consortium for Islet Transplantation (ECIT), Islets for Research Distribution Program; European Research Council(European Research Council (ERC)European Commission)	The work was supported by Deutsche Forschungsgemeinschaft KFO 152 "Atherobesity'' & Emmy Noether Programm, the LIFE program (Leipzig Interdisciplinary Research Cluster of Genetic Factors, Clinical Phenotypes and Environment), the IFB (Integrated Research and Treatment Center AdiposityDiseases), BMBF (Bundesministerium fur Bildung und Forschung), the German Diabetes Society (DDG) and the Kompetenznetz Adipositas-Verbund LARGE (TP01) and Kompetenznetz Diabetes and the European Research Council (ERC 260336). Provision of human islets were supported by the National Center for Research Resources (NCRR), the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the Juvenile Diabetes Research Foundation (JDRF) and through the European Consortium for Islet Transplantation (ECIT), Islets for Research Distribution Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Chan JL, 2003, J CLIN INVEST, V111, P1409, DOI 10.1172/JCI200317490; Cheng Q, 2011, J MOL ENDOCRINOL; Coppola A, 2009, INT J CARDIOL, V134, P414, DOI 10.1016/j.ijcard.2007.12.087; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Dahl TB, 2010, J CLIN ENDOCR METAB, V95, P3039, DOI 10.1210/jc.2009-2148; De Marinis L, 2004, J CLIN ENDOCR METAB, V89, P174, DOI 10.1210/jc.2002-021308; Drucker DJ, 2003, ENDOCRINOLOGY, V144, P5145, DOI 10.1210/en.2003-1147; Eitel K, 2002, BIOCHEM BIOPH RES CO, V299, P853, DOI 10.1016/S0006-291X(02)02752-3; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; El-Mesallamy HO, 2011, METABOLISM, V60, P63, DOI 10.1016/j.metabol.2010.04.008; Friebe D, 2011, DIABETOLOGIA, V54, P1200, DOI 10.1007/s00125-010-2042-z; Gaton PW, 2011, DIABETOLOGIA; Gu WQ, 2006, ENDOCRINE, V30, P217, DOI 10.1385/ENDO:30:2:217; Imai S, 2011, FEBS LETT, V585, P1657, DOI 10.1016/j.febslet.2011.04.060; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kharroubi I, 2003, BIOCHEM BIOPH RES CO, V312, P1118, DOI 10.1016/j.bbrc.2003.11.042; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Kieffer TJ, 1996, BIOCHEM BIOPH RES CO, V224, P522, DOI 10.1006/bbrc.1996.1059; Koerner A, 2005, BEST PRACT RES CL EN, V19, P525, DOI 10.1016/j.beem.2005.07.008; Korner A, 2007, J CLIN ENDOCR METAB, V92, P4783, DOI 10.1210/jc.2007-1304; Kulkarni RN, 1997, J CLIN INVEST, V100, P2729, DOI 10.1172/JCI119818; Lee BW, 2011, TOXICOL APPL PHARM, V252, P47, DOI 10.1016/j.taap.2011.01.018; Li YK, 2008, J BIOL CHEM, V283, P34833, DOI 10.1074/jbc.M805866200; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Maedler K, 2004, P NATL ACAD SCI USA, V101, P8138, DOI 10.1073/pnas.0305683101; Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69; Maedler K, 2008, FASEB J, V22, P1905, DOI 10.1096/fj.07-101824; Maedler K, 2009, EXPERT OPIN BIOL TH, V9, P1177, DOI 10.1517/14712590903136688; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; PUKEL C, 1988, DIABETES, V37, P133, DOI 10.2337/diabetes.37.1.133; Rakatzi I, 2004, DIABETOLOGIA, V47, P249, DOI 10.1007/s00125-003-1293-3; Ramsey KM, 2008, AGING CELL, V7, P78, DOI 10.1111/j.1474-9726.2007.00355.x; Retnakaran R, 2008, CLIN ENDOCRINOL, V69, P885, DOI 10.1111/j.1365-2265.2008.03264.x; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Romacho T, 2009, DIABETOLOGIA, V52, P2455, DOI 10.1007/s00125-009-1509-2; Sarkar SA, 2009, DIABETOLOGIA, V52, P1092, DOI 10.1007/s00125-009-1331-x; Sauter NS, 2008, ENDOCRINOLOGY, V149, P2208, DOI 10.1210/en.2007-1059; Seufert J, 2004, DIABETES, V53, pS152, DOI 10.2337/diabetes.53.2007.S152; Shu LA, 2009, HUM MOL GENET, V18, P2388, DOI 10.1093/hmg/ddp178; Staiger K, 2005, J CLIN ENDOCR METAB, V90, P6707, DOI 10.1210/jc.2005-0467; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Wang CJ, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/515136; Winzell MS, 2004, BIOCHEM BIOPH RES CO, V321, P154, DOI 10.1016/j.bbrc.2004.06.130; Xiang AH, 2010, DIABETES CARE, V33, P396, DOI 10.2337/dc09-1493; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	48	39	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54106	10.1371/journal.pone.0054106	http://dx.doi.org/10.1371/journal.pone.0054106			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342086	Green Published, Green Submitted, gold			2022-12-25	WOS:000313682700088
J	Van den Brom, R; Schimmer, B; Schneeberger, PM; Swart, WA; van der Hoek, W; Vellema, P				Van den Brom, Rene; Schimmer, Barbara; Schneeberger, Peter M.; Swart, Wim A.; van der Hoek, Wim; Vellema, Piet			Seroepidemiological Survey for Coxiella burnetii Antibodies and Associated Risk Factors in Dutch Livestock Veterinarians	PLOS ONE			English	Article							Q-FEVER INFECTION; DAIRY GOAT; OUTBREAK; NETHERLANDS; SEROPREVALENCE; SHEEP; TRANSMISSION; PNEUMONIA; WORKERS; AREA	Since 2007, Q fever has become a major public health problem in the Netherlands and goats were the most likely source of the human outbreaks in 2007, 2008 and 2009. Little was known about the consequences of these outbreaks for those professional care providers directly involved. The aim of this survey was to estimate the seroprevalence of antibodies against C. burnetii among Dutch livestock veterinarians and to determine possible risk factors. Single blood samples from 189 veterinarians, including veterinary students in their final year, were collected at a veterinary conference and a questionnaire was filled in by each participant. The blood samples were screened for IgG antibodies against phase I and phase II antigen of C. burnetii using an indirect immunofluorescent assay, and for IgM antibodies using an ELISA. Antibodies against C. burnetii were detected in 123 (65.1%) out of 189 veterinarians. Independent risk factors associated with seropositivity were number of hours with animal contact per week, number of years graduated as veterinarian, rural or sub urban living area, being a practicing veterinarian, and occupational contact with swine. Livestock veterinarians should be aware of this risk to acquire an infection with C. burnetii. Physicians should consider potential infection with C. burnetii when treating occupational risk groups, bearing in mind that the burden of disease among veterinarians remains uncertain. Vaccination of occupational risk groups should be debated.	[Van den Brom, Rene; Vellema, Piet] Anim Hlth Serv, Dept Small Ruminant Hlth, Deventer, Netherlands; [Schimmer, Barbara; van der Hoek, Wim] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Schneeberger, Peter M.] Jeroen Bosch Hosp, Dept Med Microbiol & Infect Control, Shertogenbosch, Netherlands; [Swart, Wim A.] Anim Hlth Serv, Dept Diagnost Res & Epidemiol, Deventer, Netherlands	Netherlands National Institute for Public Health & the Environment; Jeroen Bosch Ziekenhuis	Van den Brom, R (corresponding author), Anim Hlth Serv, Dept Small Ruminant Hlth, Deventer, Netherlands.	r.vd.brom@gddeventer.com		Vellema, Piet/0000-0001-9381-9063				Abe T, 2001, EUR J EPIDEMIOL, V17, P1029, DOI 10.1023/A:1020018907452; Arricau-Bouvery N, 2005, VET RES, V36, P327, DOI 10.1051/vetres:2005010; Chang CC, 2010, ZOONOSES PUBLIC HLTH, V57, pE95, DOI 10.1111/j.1863-2378.2009.01290.x; DAMOSER J, 1993, BERL MUNCH TIERARZTL, V106, P361; de Rooij MMT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032108; Derrick E. H., 1937, MED J AUSTRALIA, V2, P282; Dijkstra F, 2012, FEMS IMMUNOL MED MIC, V64, P3, DOI 10.1111/j.1574-695X.2011.00876.x; Dorko E, 2008, ANN AGR ENV MED, V15, P119; Erognul O, 2006, INT J INFECT DIS, V10, P465, DOI 10.1016/j.ijid.2006.06.005; Gardon J, 2001, J INFECT DIS, V184, P278, DOI 10.1086/322034; Gidding HF, 2009, VACCINE, V27, P2037, DOI 10.1016/j.vaccine.2009.02.007; Hatchette TF, 2001, EMERG INFECT DIS, V7, P413; Henning K, 2009, BERL MUNCH TIERARZTL, V122, P13, DOI 10.2376/0005-9366-122-13; Karagiannis I, 2009, EPIDEMIOL INFECT, V137, P1283, DOI 10.1017/S0950268808001908; LANGLEY JM, 1988, NEW ENGL J MED, V319, P354, DOI 10.1056/NEJM198808113190607; Lyytikainen O, 1998, EUR J EPIDEMIOL, V14, P193, DOI 10.1023/A:1007452503863; Marmion B, 2007, MED J AUSTRALIA, V186, P164, DOI 10.5694/j.1326-5377.2007.tb00853.x; MARRIE TJ, 1990, CAN VET J, V31, P555; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Monno R, 2009, ANN AGR ENV MED, V16, P205; Muskens J, 2007, TIJDSCHR DIERGENEESK, V132, P912; Nebreda T, 2001, ENFERM INFEC MICR CL, V19, P57, DOI 10.1016/S0213-005X(01)72561-X; Oren I, 2005, EUR J CLIN MICROBIOL, V24, P338, DOI 10.1007/s10096-005-1324-8; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; RICHARDUS JH, 1987, EPIDEMIOL INFECT, V98, P211, DOI 10.1017/S0950268800061938; Schimmer B, 2009, EUROSURVEILLANCE, V14, P14; Schimmer B, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-69; SOMMAMOREIRA RE, 1987, REV INFECT DIS, V9, P386; Stein A, 1999, CLIN INFECT DIS, V29, P617, DOI 10.1086/598643; Valencia MDS, 2000, EUR J EPIDEMIOL, V16, P469, DOI 10.1023/A:1007605414042; van den Brom R, 2012, VET REC, V170, P310, DOI 10.1136/vr.100304; van der Hoek W, 2010, NED TIJDSCHR GENEES, V154, pA1845; Van Steenbergen J E, 2007, Ned Tijdschr Geneeskd, V151, P1998; Whitney EAS, 2009, CLIN INFECT DIS, V48, P550, DOI 10.1086/596705; Wouda W, 2007, TIJDSCHR DIERGENEESK, V132, P908; Zeman D H, 1989, J Vet Diagn Invest, V1, P178	37	35	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54021	10.1371/journal.pone.0054021	http://dx.doi.org/10.1371/journal.pone.0054021			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342063	Green Submitted, gold, Green Published			2022-12-25	WOS:000313682700076
J	Alkhedir, H; Karlovsky, P; Vidal, S				Alkhedir, Hussein; Karlovsky, Petr; Vidal, Stefan			Relationship between Water Soluble Carbohydrate Content, Aphid Endosymbionts and Clonal Performance of Sitobion avenae on Cocksfoot Cultivars	PLOS ONE			English	Article							HOST-PLANT SPECIALIZATION; PEA APHID; ACYRTHOSIPHON-PISUM; AMINO-ACIDS; CEREAL APHIDS; INSECT; SYMBIONTS; POPULATIONS; DACTYLIS; SUCROSE	Aphids feed on plant phloem sap, rich in sugars but poor in essential amino acids. However, sugars cause osmotic regulation problems for aphids, which they overcome by hydrolysing the sugars in their gut and polymerising the hydrolysis products into oligosaccharides, excreted with honeydew. Aphids harbour primary bacterial endosymbionts, which supply them with essential amino acids necessary for survival. They also harbour secondary (facultative) endosymbionts (sfS), some of which have a positive impact on life history traits, although it is not yet known whether they also play a role in providing effective tolerance to differing levels of water soluble carbohydrates (WSCs). We investigated the relationship between WSC content of cocksfoot cultivars and performance of clones of the English grain aphid Sitobion avenae F. We evaluated how clone genotype and their sfS modulate performance on these different cultivars. We therefore examined the performance of genetically defined clones of S. avenae, collected from different host plants, harbouring different sfS. The performance was tested on 10 Dactylis glomerata L. cultivars with varying WSC content. D. glomerata is known as a wild host plant for S. avenae and is also commercially planted. We found that high WSCs levels are responsible for the resistance of D. glomerata cultivars to specific S. avenae clones. The minimum level of WSCs conferring resistance to D. glomerata cultivars was 1.7% dw. Cultivars with a WSC content of 2.2% or higher were resistant to S. avenae and did not allow reproduction. Our results further indicate that sfS modulate to some extend host plant cultivar adaptation in S. avenae. This is the first study revealing the importance of WSCs for aphid performance. Cocksfoot cultivars with a high content of WSCs might be therefore considered for aphid control or used for resistance breeding in this and other grass species, including cereals.	[Alkhedir, Hussein; Vidal, Stefan] Univ Gottingen, Dept Crop Sci, D-37073 Gottingen, Germany; [Karlovsky, Petr] Univ Gottingen, Dept Crop Sci Mol Phytopathol & Mycotoxin Res, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen	Vidal, S (corresponding author), Univ Gottingen, Dept Crop Sci, D-37073 Gottingen, Germany.	svidal@gwdg.de	Vidal, Stefan/AAC-3130-2020	Vidal, Stefan/0000-0002-1673-4055; Karlovsky, Petr/0000-0002-6532-5856				Ashford DA, 2000, J INSECT PHYSIOL, V46, P335, DOI 10.1016/S0022-1910(99)00186-9; Blackman R.L., 1984, APHIDS WORLDS CROPS; CHATTERTON NJ, 1990, NEW PHYTOL, V114, P167, DOI 10.1111/j.1469-8137.1990.tb00387.x; Chen DQ, 2000, ENTOMOL EXP APPL, V95, P315, DOI 10.1023/A:1004083324807; Ciepiela AP, 1999, J APPL ENTOMOL, V123, P491, DOI 10.1046/j.1439-0418.1999.00401.x; DEBARRO PJ, 1995, OECOLOGIA, V104, P379, DOI 10.1007/BF00328374; Dietrich D, 2003, ANAL BIOANAL CHEM, V376, P399, DOI 10.1007/s00216-003-1847-8; Douglas AE, 2006, PHYSIOL ENTOMOL, V31, P262, DOI 10.1111/j.1365-3032.2006.00516.x; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Douglas AE, 2006, J EXP BIOL, V209, P1395, DOI 10.1242/jeb.02148; DOWNING N, 1978, J EXP BIOL, V77, P247; Eleftherianos I, 2006, J APPL ENTOMOL, V130, P15, DOI 10.1111/j.1439-0418.2005.01017.x; Fisher DB, 2000, LONG DISTANCE TRANSP, P730; GEIGER DR, 1994, ANNU REV PLANT PHYS, V45, P235, DOI 10.1146/annurev.pp.45.060194.001315; Kehr J, 1998, PLANT J, V16, P497, DOI 10.1046/j.1365-313x.1998.00318.x; Kerepesi I, 2000, CROP SCI, V40, P482, DOI 10.2135/cropsci2000.402482x; Leonardo TE, 2004, ECOL LETT, V7, P461, DOI 10.1111/j.1461-0248.2004.00602.x; Leonardo TE, 2003, P ROY SOC B-BIOL SCI, V270, pS209, DOI 10.1098/rsbl.2003.0064; Lushai G, 2002, B ENTOMOL RES, V92, P159, DOI 10.1079/BER2001138; Massey FP, 2006, J ANIM ECOL, V75, P595, DOI 10.1111/j.1365-2656.2006.01082.x; Mayland HF, 2000, AGRON J, V92, P1203, DOI 10.2134/agronj2000.9261203x; Mika V, 2005, PLANT SOIL ENVIRON, V51, P506, DOI 10.17221/3624-PSE; Miller LA, 2001, GRASS FORAGE SCI, V56, P383, DOI 10.1046/j.1365-2494.2001.00288.x; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Price DRG, 2007, INSECT BIOCHEM MOLEC, V37, P307, DOI 10.1016/j.ibmb.2006.12.005; Rhodes JD, 1997, PHYSIOL ENTOMOL, V22, P373, DOI 10.1111/j.1365-3032.1997.tb01182.x; Rhodes JD, 1996, J EXP BIOL, V199, P1269; Russell JA, 2006, P ROY SOC B-BIOL SCI, V273, P603, DOI 10.1098/rspb.2005.3348; Sanada Y, 2004, AUST J AGR RES, V55, P1183, DOI 10.1071/AR04033; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Smith KF, 1997, GRASS FORAGE SCI, V52, P167, DOI 10.1046/j.1365-2494.1997.00067.x; Sunnucks P, 1997, MOL ECOL, V6, P1059, DOI 10.1046/j.1365-294X.1997.00280.x; Sunnucks P, 1996, GENETICS, V144, P747; Tsuchida T, 2004, SCIENCE, V303, P1989, DOI 10.1126/science.1094611; Urbanska A, 1998, ENTOMOL EXP APPL, V86, P197, DOI 10.1023/A:1003119900578; Vialatte A, 2005, P ROY SOC B-BIOL SCI, V272, P1075, DOI 10.1098/rspb.2004.3033; VICKERMAN GP, 1979, B ENTOMOL RES, V69, P1, DOI 10.1017/S0007485300017855; Wangai AW, 2000, J PHYTOPATHOL, V148, P33, DOI 10.1111/j.1439-0434.2000.tb04621.x; Wilkinson TL, 1997, J EXP BIOL, V200, P2137; WINTER H, 1992, PLANT PHYSIOL, V99, P996, DOI 10.1104/pp.99.3.996	40	23	24	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54327	10.1371/journal.pone.0054327	http://dx.doi.org/10.1371/journal.pone.0054327			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342134	Green Submitted, Green Published, gold			2022-12-25	WOS:000314759400149
J	Fares, RP; Belmeguenai, A; Sanchez, PE; Kouchi, HY; Bodennec, J; Morales, A; Georges, B; Bonnet, C; Bouvard, S; Sloviter, RS; Bezin, L				Fares, Raafat P.; Belmeguenai, Amor; Sanchez, Pascal E.; Kouchi, Hayet Y.; Bodennec, Jacques; Morales, Anne; Georges, Beatrice; Bonnet, Chantal; Bouvard, Sandrine; Sloviter, Robert S.; Bezin, Laurent			Standardized Environmental Enrichment Supports Enhanced Brain Plasticity in Healthy Rats and Prevents Cognitive Impairment in Epileptic Rats	PLOS ONE			English	Article							DEPRESSION-RELATED BEHAVIOR; PITUITARY-ADRENAL AXIS; FACTOR MESSENGER-RNA; HIPPOCAMPAL-NEURONS; HUNTINGTONS-DISEASE; GENE-EXPRESSION; MOUSE MODEL; FACTOR-I; ERYTHROPOIETIN RECEPTOR; SYNAPTIC PLASTICITY	Environmental enrichment of laboratory animals influences brain plasticity, stimulates neurogenesis, increases neurotrophic factor expression, and protects against the effects of brain insult. However, these positive effects are not constantly observed, probably because standardized procedures of environmental enrichment are lacking. Therefore, we engineered an enriched cage (the Marlau (TM) cage), which offers: (1) minimally stressful social interactions; (2) increased voluntary exercise; (3) multiple entertaining activities; (4) cognitive stimulation (maze exploration), and (5) novelty (maze configuration changed three times a week). The maze, which separates food pellet and water bottle compartments, guarantees cognitive stimulation for all animals. Compared to rats raised in groups in conventional cages, rats housed in Marlau (TM) cages exhibited increased cortical thickness, hippocampal neurogenesis and hippocampal levels of transcripts encoding various genes involved in tissue plasticity and remodeling. In addition, rats housed in Marlau (TM) cages exhibited better performances in learning and memory, decreased anxiety-associated behaviors, and better recovery of basal plasma corticosterone level after acute restraint stress. Marlau (TM) cages also insure inter-experiment reproducibility in spatial learning and brain gene expression assays. Finally, housing rats in Marlau (TM) cages after severe status epilepticus at weaning prevents the cognitive impairment observed in rats subjected to the same insult and then housed in conventional cages. By providing a standardized enriched environment for rodents during housing, the Marlau (TM) cage should facilitate the uniformity of environmental enrichment across laboratories.	[Fares, Raafat P.; Belmeguenai, Amor; Sanchez, Pascal E.; Kouchi, Hayet Y.; Bodennec, Jacques; Morales, Anne; Georges, Beatrice; Bonnet, Chantal; Bouvard, Sandrine; Bezin, Laurent] Univ Lyon, Lyon, France; [Fares, Raafat P.; Belmeguenai, Amor; Sanchez, Pascal E.; Kouchi, Hayet Y.; Bodennec, Jacques; Morales, Anne; Georges, Beatrice; Bonnet, Chantal; Bouvard, Sandrine; Bezin, Laurent] Univ Lyon 1, F-69622 Villeurbanne, France; [Fares, Raafat P.; Belmeguenai, Amor; Sanchez, Pascal E.; Kouchi, Hayet Y.; Bodennec, Jacques; Morales, Anne; Georges, Beatrice; Bonnet, Chantal; Bouvard, Sandrine; Bezin, Laurent] Lyon Neurosci Res Ctr, INSERM, U1028, Tiger Team, Lyon, France; [Fares, Raafat P.; Belmeguenai, Amor; Sanchez, Pascal E.; Kouchi, Hayet Y.; Bodennec, Jacques; Morales, Anne; Georges, Beatrice; Bonnet, Chantal; Bouvard, Sandrine; Bezin, Laurent] Lyon Neurosci Res Ctr, CNRS, UMR5292, Tiger Team, Lyon, France; [Fares, Raafat P.; Belmeguenai, Amor; Sanchez, Pascal E.; Kouchi, Hayet Y.; Bodennec, Jacques; Morales, Anne; Georges, Beatrice; Bonnet, Chantal; Bouvard, Sandrine; Bezin, Laurent] Inst EpilepsiEs, IDEE, Lyon, France; [Fares, Raafat P.] IRBA, Bretigny Sur Orge, France; [Sloviter, Robert S.] Morehouse Sch Med, Dept Neurobiol Pharmacol & Toxicol, Atlanta, GA 30310 USA	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Morehouse School of Medicine	Bezin, L (corresponding author), Univ Lyon, Lyon, France.	laurent.bezin@univ-lyon1.fr		FARES, Raafat/0000-0003-3963-381X	Centre National de la Recherche Scientifique; University Claude Bernard Lyon 1; Institut de Medecine Navale du Service de Sante des Armees [21105]; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University Claude Bernard Lyon 1; Institut de Medecine Navale du Service de Sante des Armees; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	P. E. Sanchez was a fellow from the Delegation Generale pour l'Armement, Ministere Francais de la Defense. This study was supported by grants from the Centre National de la Recherche Scientifique, the University Claude Bernard Lyon 1, and the Institut de Medecine Navale du Service de Sante des Armees (grant 21105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderson RF, 2000, BRAIN RES, V871, P210, DOI 10.1016/S0006-8993(00)02428-8; Anderson BJ, 2002, LEARN MEMORY, V9, P1, DOI 10.1101/lm.43402; Artola A, 2006, EUR J NEUROSCI, V23, P261, DOI 10.1111/j.1460-9568.2005.04552.x; Augustsson H, 2003, LAB ANIM-UK, V37, P328, DOI 10.1258/002367703322389898; Auvergne R, 2002, BRAIN RES, V954, P277, DOI 10.1016/S0006-8993(02)03355-3; Baumans V, 2005, ILAR J, V46, P162, DOI 10.1093/ilar.46.2.162; Baumans V, 2004, GENE THER, V11, pS64, DOI 10.1038/sj.gt.3302371; Baumans V, 2006, FELASA WORKING GROUP; Benaroya-Milshtein N, 2007, J IMMUNOTHER, V30, P517, DOI 10.1097/CJI.0b013e31804efc5e; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bodennec J, 2000, J LIPID RES, V41, P1524; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Burrows EL, 2011, PROG NEURO-PSYCHOPH, V35, P1376, DOI 10.1016/j.pnpbp.2010.12.011; Byts N, 2008, CELL DEATH DIFFERENT; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Cao L, 2010, CELL, V142, P52, DOI 10.1016/j.cell.2010.05.029; Carro E, 2000, J NEUROSCI, V20, P2926; Chavez JC, 2002, J NEUROSCI, V22, P8922; Chen ZY, 2007, J BIOL CHEM, V282, P25875, DOI 10.1074/jbc.M701988200; Costa DA, 2007, NEUROBIOL AGING, V28, P831, DOI 10.1016/j.neurobiolaging.2006.04.009; Cotman CW, 2007, ALZHEIMERS DEMENT, V3, pS30, DOI 10.1016/j.jalz.2007.01.013; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Cracchiolo JR, 2007, NEUROBIOL LEARN MEM, V88, P277, DOI 10.1016/j.nlm.2007.07.007; Cui MH, 2006, NEUROSCI LETT, V404, P208, DOI 10.1016/j.neulet.2006.05.048; Dhanushkodi A, 2008, NEUROSCI BIOBEHAV R, V32, P657, DOI 10.1016/j.neubiorev.2007.10.004; DIAMOND MC, 1964, J COMP NEUROL, V123, P111, DOI 10.1002/cne.901230110; Ding Q, 2006, NEUROSCIENCE, V140, P823, DOI 10.1016/j.neuroscience.2006.02.084; Du X, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.58; Duffy SN, 2001, LEARN MEMORY, V8, P26, DOI 10.1101/lm.36301; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Faherty CJ, 2005, MOL BRAIN RES, V134, P170, DOI 10.1016/j.molbrainres.2004.08.008; FALKENBERG T, 1992, NEUROSCI LETT, V138, P153, DOI 10.1016/0304-3940(92)90494-R; FARES RP, 2012, PROTOCOL EXCHANGE; Faverjon S, 2002, NEUROLOGY, V59, P1356, DOI 10.1212/01.WNL.0000033588.59005.55; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Fox C, 2006, BEHAV BRAIN RES, V175, P1, DOI 10.1016/j.bbr.2006.08.016; Francia N, 2006, EUR J NEUROSCI, V23, P711, DOI 10.1111/j.1460-9568.2006.04585.x; Frank LM, 2004, J NEUROSCI, V24, P7681, DOI 10.1523/JNEUROSCI.1958-04.2004; Hackler EA, 2007, J PHARMACOL EXP THER, V320, P1023, DOI 10.1124/jpet.106.113357; Hasselblatt M, 2006, J NEUROSURG ANESTH, V18, P132, DOI 10.1097/00008506-200604000-00007; Hattori S, 2007, BEHAV BRAIN RES, V180, P69, DOI 10.1016/j.bbr.2007.02.036; Hellemans KGC, 2004, DEV BRAIN RES, V150, P103, DOI 10.1016/j.devbrainres.2004.03.003; Hennigan A, 2007, BIOCHEM SOC T, V35, P424, DOI 10.1042/BST0350424; Herring A, 2009, EXP NEUROL, V216, P184, DOI 10.1016/j.expneurol.2008.11.027; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Hockly E, 2002, ANN NEUROL, V51, P235, DOI 10.1002/ana.10094; Hori E, 2003, HIPPOCAMPUS, V13, P190, DOI 10.1002/hipo.10062; Huang FL, 2006, J NEUROSCI, V26, P6230, DOI 10.1523/JNEUROSCI.1182-06.2006; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Kempermann G, 1999, HIPPOCAMPUS, V9, P321, DOI 10.1002/(SICI)1098-1063(1999)9:3<321::AID-HIPO11>3.0.CO;2-C; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kobilo T, 2011, LEARN MEMORY, V18, P605, DOI 10.1101/lm.2283011; Koh S, 2005, J CHILD NEUROL, V20, P796, DOI 10.1177/08830738050200100301; Kondo M, 2008, EUR J NEUROSCI, V27, P3342, DOI 10.1111/j.1460-9568.2008.06305.x; Kretz A, 2005, MOL CELL NEUROSCI, V29, P569, DOI 10.1016/j.mcn.2005.04.009; Laviola G, 2008, NEUROBIOL DIS, V31, P159, DOI 10.1016/j.nbd.2008.05.001; Liu XZ, 2003, J NEUROSCI, V23, P11505; Maiese K, 2008, PROG NEUROBIOL, V85, P194, DOI 10.1016/j.pneurobio.2008.02.002; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Manning EE, 2012, HIPPOCAMPUS, V22, P309, DOI 10.1002/hipo.20900; MCNAMARA RK, 1993, BRAIN RES REV, V18, P33, DOI 10.1016/0165-0173(93)90006-L; McOmish CE, 2008, MOL PSYCHIATR, V13, P661, DOI 10.1038/sj.mp.4002046; Meehan CL, 2007, APPL ANIM BEHAV SCI, V102, P246, DOI 10.1016/j.applanim.2006.05.031; Meijer MK, 2007, LAB ANIM-UK, V41, P161, DOI 10.1258/002367707780378168; MOHAMMED AH, 1993, BEHAV BRAIN RES, V57, P183, DOI 10.1016/0166-4328(93)90134-C; Morales A, 2006, BRAIN RES, V1109, P164, DOI 10.1016/j.brainres.2006.06.075; Nadam J, 2007, NEUROBIOL DIS, V25, P412, DOI 10.1016/j.nbd.2006.10.009; Navarro FP, 2008, J NEUROCHEM, V105, P34, DOI 10.1111/j.1471-4159.2007.05116.x; Nithianantharajah J, 2008, NEUROBIOL DIS, V29, P490, DOI 10.1016/j.nbd.2007.11.006; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Nithianantharajah J, 2011, PROG NEURO-PSYCHOPH, V35, P331, DOI 10.1016/j.pnpbp.2010.10.026; O'Kusky JR, 2000, J NEUROSCI, V20, P8435, DOI 10.1523/JNEUROSCI.20-22-08435.2000; Pang TYC, 2013, NEUROPHARMACOLOGY, V64, P515, DOI 10.1016/j.neuropharm.2012.06.029; Pang TYC, 2009, HUM MOL GENET, V18, P753, DOI 10.1093/hmg/ddn385; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pena Y, 2009, PSYCHONEUROENDOCRINO, V34, P1390, DOI 10.1016/j.psyneuen.2009.04.019; Phillips LJ, 2006, AUST NZ J PSYCHIAT, V40, P725, DOI 10.1080/j.1440-1614.2006.01877.x; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; Ransome MI, 2008, MOL CELL NEUROSCI, V38, P537, DOI 10.1016/j.mcn.2008.05.002; Rolls ET, 1999, HIPPOCAMPUS, V9, P467; ROSENZWEIG MR, 1978, BRAIN RES, V153, P563, DOI 10.1016/0006-8993(78)90340-2; Rossi C, 2006, EUR J NEUROSCI, V24, P1850, DOI 10.1111/j.1460-9568.2006.05059.x; Roy V, 2001, PHYSIOL BEHAV, V74, P313, DOI 10.1016/S0031-9384(01)00561-3; Rutten A, 2002, EUR J NEUROSCI, V16, P501, DOI 10.1046/j.1460-9568.2002.02103.x; Sanchez PE, 2009, P NATL ACAD SCI USA, V106, P9848, DOI 10.1073/pnas.0901840106; Sanchez PE, 2009, J COMP NEUROL, V514, P403, DOI 10.1002/cne.22020; SAPOLSKY RM, 1984, P NATL ACAD SCI-BIOL, V81, P6174, DOI 10.1073/pnas.81.19.6174; Schneider JS, 2001, BRAIN RES, V896, P48, DOI 10.1016/S0006-8993(00)03249-2; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; Solinas M, 2008, P NATL ACAD SCI USA, V105, P17145, DOI 10.1073/pnas.0806889105; Spires TL, 2004, EUR J NEUROSCI, V19, P2799, DOI 10.1111/j.0953-816X.2004.03374.x; Spires TL, 2004, J NEUROSCI, V24, P2270, DOI 10.1523/JNEUROSCI.1658-03.2004; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; van Dellen A, 2000, NATURE, V404, P721, DOI 10.1038/35008142; van Dellen A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-34; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Violle N, 2009, BEHAV BRAIN RES, V203, P35, DOI 10.1016/j.bbr.2009.04.015; Viviani B, 2005, J NEUROCHEM, V93, P412, DOI 10.1111/j.1471-4159.2005.03033.x; Wang CA, 2007, EPILEPSY BEHAV, V11, P303, DOI 10.1016/j.yebeh.2007.06.016; Williams JB, 2009, CANCER PREV RES, V2, P850, DOI 10.1158/1940-6207.CAPR-08-0238; Wolfer DP, 2004, NATURE, V432, P821, DOI 10.1038/432821a; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449; Zald DH, 2002, J NEUROPHYSIOL, V87, P1068, DOI 10.1152/jn.00358.2001; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; Zhao LR, 2000, NEUROSCIENCE, V97, P177, DOI 10.1016/S0306-4522(00)00023-3	106	87	87	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53888	10.1371/journal.pone.0053888	http://dx.doi.org/10.1371/journal.pone.0053888			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342033	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400097
J	King, EM; Chivers, JE; Rider, CF; Minnich, A; Giembycz, MA; Newton, R				King, Elizabeth M.; Chivers, Joanna E.; Rider, Christopher F.; Minnich, Anne; Giembycz, Mark A.; Newton, Robert			Glucocorticoid Repression of Inflammatory Gene Expression Shows Differential Responsiveness by Transactivation- and Transrepression-Dependent Mechanisms	PLOS ONE			English	Article							NF-KAPPA-B; AIRWAY EPITHELIAL-CELLS; SMOOTH-MUSCLE-CELLS; ADENOVIRAL-MEDIATED DELIVERY; ACTIVATED PROTEIN-KINASE; INDUCED LEUCINE-ZIPPER; NECROSIS-FACTOR-ALPHA; MOLECULAR-MECHANISMS; RECEPTOR-BINDING; GM-CSF	Binding of glucocorticoid to the glucocorticoid receptor (GR/NR3C1) may repress inflammatory gene transcription via direct, protein synthesis-independent processes (transrepression), or by activating transcription (transactivation) of multiple anti-inflammatory/repressive factors. Using human pulmonary A549 cells, we showed that 34 out of 39 IL-1 beta-inducible mRNAs were repressed to varying degrees by the synthetic glucocorticoid, dexamethasone. Whilst these repressive effects were GR-dependent, they did not correlate with either the magnitude of IL-1 beta-inducibility or the NF-kappa B-dependence of the inflammatory genes. This suggests that induction by IL-1 beta and repression by dexamethasone are independent events. Roles for transactivation were investigated using the protein synthesis inhibitor, cycloheximide. However, cycloheximide reduced the IL-1 beta-dependent expression of 13 mRNAs, which, along with the 5 not showing repression by dexamethasone, were not analysed further. Of the remaining 21 inflammatory mRNAs, cycloheximide significantly attenuated the dexamethasone-dependent repression of 11 mRNAs that also showed a marked time-dependence to their repression. Such effects are consistent with repression occurring via the de novo synthesis of a new product, or products, which subsequently cause repression (i.e., repression via a transactivation mechanism). Conversely, 10 mRNAs showed completely cycloheximide-independent, and time-independent, repression by dexamethasone. This is consistent with direct GR transrepression. Importantly, the inflammatory mRNAs showing attenuated repression by dexamethasone in the presence of cycloheximide also showed a significantly greater extent of repression and a higher potency to dexamethasone compared to those mRNAs showing cycloheximide-independent repression. This suggests that the repression of inflammatory mRNAs by GR transactivation-dependent mechanisms accounts for the greatest levels of repression and the most potent repression by dexamethasone. In conclusion, our data indicate roles for both transrepression and transactivation in the glucocorticoid-dependent repression of inflammatory gene expression. However, transactivation appears to account for the more potent and efficacious mechanism of repression by glucocorticoids on these IL-1 beta-induced genes.	[King, Elizabeth M.; Chivers, Joanna E.; Rider, Christopher F.; Giembycz, Mark A.; Newton, Robert] Univ Calgary, Airways Inflammat Res Grp, Snyder Inst Chron Dis, Fac Med, Calgary, AB, Canada; [Minnich, Anne] Bristol Myers Squibb Co, Clin Biomarkers Immunol, Princeton, NJ USA	University of Calgary; Bristol-Myers Squibb	Newton, R (corresponding author), Univ Calgary, Airways Inflammat Res Grp, Snyder Inst Chron Dis, Fac Med, Calgary, AB, Canada.	rnewton@ucalgary.ca	Rider, Christopher F/H-7073-2019; Newton, Robert/C-6814-2012	Rider, Christopher F/0000-0003-0399-5931; Newton, Robert/0000-0002-4919-8498	Alberta Innovates - Health Solutions (AI-HS); Canadian Institutes of Health Research (CIHR); AstraZeneca; GlaxoSmithKline; Canadian Fund for Innovation (CFI); Alberta Science and Research Authority	Alberta Innovates - Health Solutions (AI-HS); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); AstraZeneca(AstraZeneca); GlaxoSmithKline(GlaxoSmithKline); Canadian Fund for Innovation (CFI)(Canada Foundation for Innovation); Alberta Science and Research Authority	This research was supported by an Alberta Innovates - Health Solutions (AI-HS) start-up grant and operating grants from the Canadian Institutes of Health Research (CIHR), as well as funding from AstraZeneca and GlaxoSmithKline. RN was a CIHR New Investigator and is an AI-HS Scholar. EMK held an AI-HS studentship award. CFR holds an AI-HS studentship award. MAG holds a Tier 1 Canada Research Chair in Pulmonary Pharmacology. Real-time PCR was performed using an equipment and infrastructure grant from the Canadian Fund for Innovation (CFI) and the Alberta Science and Research Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Ayroldi E, 2007, J CLIN INVEST, V117, P1605, DOI 10.1172/JCI30724; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Barnes PJ, 2011, BRIT J PHARMACOL, V163, P29, DOI 10.1111/j.1476-5381.2010.01199.x; Barnes PJ, 2006, EUR J PHARMACOL, V533, P2, DOI 10.1016/j.ejphar.2005.12.052; Bartholomew W R, 1990, Immunol Ser, V52, P33; Bilodeau S, 2006, GENE DEV, V20, P2871, DOI 10.1101/gad.1444606; Brostjan C, 1996, J BIOL CHEM, V271, P19612, DOI 10.1074/jbc.271.32.19612; Catley MC, 2006, MOL PHARMACOL, V70, P697, DOI 10.1124/mol.106.023150; Catley MC, 2005, BRIT J PHARMACOL, V145, P114, DOI 10.1038/sj.bjp.0706170; Chivers JE, 2006, MOL PHARMACOL, V70, P2084, DOI 10.1124/mol.106.025841; Clark AR, 2008, J BIOL CHEM, V283, P25765, DOI 10.1074/jbc.R700053200; Clark AR, 2007, MOL CELL ENDOCRINOL, V275, P79, DOI 10.1016/j.mce.2007.04.013; Clark AR, 2012, PHARMACOL THERAPEUT, V134, P54, DOI 10.1016/j.pharmthera.2011.12.004; Commins SP, 2010, J ALLERGY CLIN IMMUN, V125, pS53, DOI 10.1016/j.jaci.2009.07.008; Cornish AL, 2009, NAT REV RHEUMATOL, V5, P554, DOI 10.1038/nrrheum.2009.178; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; Diefenbacher M, 2008, MOL ENDOCRINOL, V22, P1767, DOI 10.1210/me.2007-0574; DROUIN J, 1989, MOL CELL BIOL, V9, P5305, DOI 10.1128/MCB.9.12.5305; Eddleston J, 2007, J ALLERGY CLIN IMMUN, V119, P115, DOI 10.1016/j.jaci.2006.08.027; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; Heck S, 1997, EMBO J, V16, P4698, DOI 10.1093/emboj/16.15.4698; Hofmann TG, 2002, BIOL CHEM, V383, P1947, DOI 10.1515/BC.2002.219; Holden NS, 2007, BRIT J PHARMACOL, V152, P891, DOI 10.1038/sj.bjp.0707457; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Issa R, 2007, J IMMUNOL, V178, P7366, DOI 10.4049/jimmunol.178.11.7366; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Kaur M, 2008, MOL PHARMACOL, V73, P203, DOI 10.1124/mol.107.040121; Kelly M, 2011, BR J PHARM; King EM, 2009, J BIOL CHEM, V284, P26803, DOI 10.1074/jbc.M109.028381; King EM, 2009, J PHARMACOL EXP THER, V330, P575, DOI 10.1124/jpet.109.151423; KWON OJ, 1994, IMMUNOLOGY, V81, P389; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Luecke HF, 2005, GENE DEV, V19, P1116, DOI 10.1101/gad.1297105; Mittelstadt PR, 2001, J BIOL CHEM, V276, P29603, DOI 10.1074/jbc.M101522200; Newton R, 2000, THORAX, V55, P603, DOI 10.1136/thorax.55.7.603; Newton R, 1998, EUR J BIOCHEM, V254, P81, DOI 10.1046/j.1432-1327.1998.2540081.x; Newton R, 2002, EUR J PHARMACOL, V441, P193, DOI 10.1016/S0014-2999(01)01624-7; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; Newton R, 2010, BIOCHEM J, V427, P113, DOI 10.1042/BJ20091038; Newton R, 2010, PHARMACOL THERAPEUT, V125, P286, DOI 10.1016/j.pharmthera.2009.11.003; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Peeters BWMM, 2008, ANN NY ACAD SCI, V1148, P536, DOI 10.1196/annals.1410.072; Quante T, 2008, AM J RESP CELL MOL, V39, P208, DOI 10.1165/rcmb.2007-0014OC; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; Ray KP, 1997, BIOCHEM J, V328, P707; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; SAKAI DD, 1988, GENE DEV, V2, P1144, DOI 10.1101/gad.2.9.1144; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; Schleimer Robert P, 2004, Proc Am Thorac Soc, V1, P222, DOI 10.1513/pats.200402-018MS; So AYL, 2008, P NATL ACAD SCI USA, V105, P5745, DOI 10.1073/pnas.0801551105; Stellato Cristiana, 2004, Proc Am Thorac Soc, V1, P255, DOI 10.1513/pats.200402-015MS; Sukkar MB, 2004, AM J PHYSIOL-LUNG C, V287, pL1230, DOI 10.1152/ajplung.00014.2004; Surjit M, 2011, CELL, V145, P224, DOI 10.1016/j.cell.2011.03.027; Taube C, 2006, P NATL ACAD SCI USA, V103, P8084, DOI 10.1073/pnas.0602357103; Turpeinen T, 2010, J PHARMACOL EXP THER, V333, P310, DOI 10.1124/jpet.109.157438; Vereecke L, 2011, BIOCHEM SOC T, V39, P1086, DOI 10.1042/BST0391086; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Wang YS, 1997, J IMMUNOL, V159, P534; Webster JC, 2002, ENDOCRINOLOGY, V143, P3866, DOI 10.1210/en.2002-220188	64	57	57	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53936	10.1371/journal.pone.0053936	http://dx.doi.org/10.1371/journal.pone.0053936			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23349769	Green Submitted, Green Published, gold			2022-12-25	WOS:000314759400101
J	Mossalam, M; Soto, J; Lim, CS; Abel, ED				Mossalam, Mohanad; Soto, Jamie; Lim, Carol S.; Abel, E. Dale			Solid Phase Synthesis of Mitochondrial Triphenylphosphonium-Vitamin E Metabolite Using a Lysine Linker for Reversal of Oxidative Stress	PLOS ONE			English	Article							E-LIKE ANTIOXIDANT; TARGETED ANTIOXIDANTS; DIABETIC COMPLICATIONS; ISCHEMIA-REPERFUSION; INSULIN-RESISTANCE; ENDOTHELIAL-CELLS; CORONARY-DISEASE; ALPHA-TOCOPHEROL; KAPPA-B; APOPTOSIS	Mitochondrial targeting of antioxidants has been an area of interest due to the mitochondria's role in producing and metabolizing reactive oxygen species. Antioxidants, especially vitamin E (alpha-tocopherol), have been conjugated to lipophilic cations to increase their mitochondrial targeting. Synthetic vitamin E analogues have also been produced as an alternative to alpha-tocopherol. In this paper, we investigated the mitochondrial targeting of a vitamin E metabolite, 2,5,7,8-tetramethyl-2-(2'-carboxyethyl)-6-hydroxychroman (alpha-CEHC), which is similar in structure to vitamin E analogues. We report a fast and efficient method to conjugate the water-soluble metabolite, alpha-CEHC, to triphenylphosphonium cation via a lysine linker using solid phase synthesis. The efficacy of the final product (MitoCEHC) to lower oxidative stress was tested in bovine aortic endothelial cells. In addition the ability of MitoCEHC to target the mitochondria was examined in type 2 diabetes db/db mice. The results showed mitochondrial accumulation in vivo and oxidative stress decrease in vitro.	[Mossalam, Mohanad; Lim, Carol S.] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA; [Soto, Jamie; Abel, E. Dale] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT USA; [Soto, Jamie; Abel, E. Dale] Univ Utah, Sch Med, Div Endocrinol Metab & Diabet, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Mossalam, M (corresponding author), Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.	mohanad.mossalam@utah.edu		Abel, E. Dale/0000-0001-5290-0738	National Institutes of Health (NIH) [R21-DK073590]; National Cancer Institute of the NIH [R01-CA151847]; NATIONAL CANCER INSTITUTE [R01CA151847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK073590] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research reported in this publication was supported by the National Institutes of Health (NIH) award number R21-DK073590 to E. Dale Abel and the National Cancer Institute of the NIH under award number R01-CA151847 to Carol S. Lim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABADIE C, 1993, FREE RADICAL BIO MED, V15, P209, DOI 10.1016/0891-5849(93)90061-X; Abid MR, 2004, J BIOL CHEM, V279, P44030, DOI 10.1074/jbc.M408285200; Adlam VJ, 2005, FASEB J, V19, P1088, DOI 10.1096/fj.05-3718com; AMBROSIUS D, 1989, BIOL CHEM H-S, V370, P217, DOI 10.1515/bchm3.1989.370.1.217; Betancor-Fernandez A, 2002, FREE RADICAL RES, V36, P915, DOI 10.1080/1071576021000005357; Brennan JP, 2006, CARDIOVASC RES, V72, P313, DOI 10.1016/j.cardiores.2006.07.019; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Buchanan J, 2005, ENDOCRINOLOGY, V146, P5341, DOI 10.1210/en.2005-0938; Bugger H, 2009, DIABETES, V58, P1986, DOI 10.2337/db09-0259; CABALLERO B, 1993, NUTR REV, V51, P339, DOI 10.1111/j.1753-4887.1993.tb03761.x; Campo GM, 2001, FREE RADICAL RES, V34, P379, DOI 10.1080/10715760100300321; Chen WJ, 2006, BIOORG MED CHEM LETT, V16, P5874, DOI 10.1016/j.bmcl.2006.08.063; Cohn W, 1997, EUR J CLIN NUTR, V51, pS80; Dhanasekaran A, 2004, J BIOL CHEM, V279, P37575, DOI 10.1074/jbc.M404003200; Dray C, 2010, AM J PHYSIOL-ENDOC M, V298, pE1161, DOI 10.1152/ajpendo.00598.2009; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; Galeano M, 2001, SURGERY, V129, P467, DOI 10.1067/msy.2001.112072; Han YM, 2011, BIOORG MED CHEM LETT, V21, P747, DOI 10.1016/j.bmcl.2010.11.114; Harrison D, 2003, AM J CARDIOL, V91, p7A; Hughes G, 2005, BIOCHEM J, V389, P83, DOI 10.1042/bj20050078; Jakubowski W, 2000, CELL BIOL INT, V24, P757, DOI 10.1006/cbir.2000.0556; James AM, 2005, MECH AGEING DEV, V126, P982, DOI 10.1016/j.mad.2005.03.026; Jauslin ML, 2003, FASEB J, V17, P1972, DOI 10.1096/fj.03-0240fje; KAGAN VE, 1994, METHOD ENZYMOL, V234, P343; Kang W, 2012, BIOORG MED CHEM LETT, V22, P1187, DOI 10.1016/j.bmcl.2011.11.081; Kelly F J, 1998, J Int Fed Clin Chem, V10, P21; Kowaltowski AJ, 1999, FREE RADICAL BIO MED, V26, P463, DOI 10.1016/S0891-5849(98)00216-0; Kritharides L, 2002, ATHEROSCLEROSIS, V164, P211, DOI 10.1016/S0021-9150(02)00011-4; Kuroki T, 2003, J AM SOC NEPHROL, V14, pS216, DOI 10.1097/01.ASN.0000077405.07888.07; Laurent A, 2005, CANCER RES, V65, P948; Liley MJ, 2006, J ORG CHEM, V71, P1322, DOI 10.1021/jo051742j; Mayer-Davis EJ, 2002, DIABETES CARE, V25, P2172, DOI 10.2337/diacare.25.12.2172; Meagher E A, 2003, Prev Cardiol, V6, P85, DOI 10.1111/j.1520-037X.2003.00560.x; Moorthi RV, 2006, CLIN CHIM ACTA, V367, P132, DOI 10.1016/j.cca.2005.12.004; Mossalam M, 2008, J CONTROL RELEASE, V130, P234, DOI 10.1016/j.jconrel.2008.06.009; Mossalam M, 2012, MOL PHARMACEUT, V9, P1449, DOI 10.1021/mp3000259; Mossalam M, 2010, THER DELIV, V1, P169, DOI 10.4155/TDE.10.8; Murphy MP, 2000, ADV DRUG DELIVER REV, V41, P235, DOI 10.1016/S0169-409X(99)00069-1; Murphy MP, 2001, EXPERT OPIN BIOL TH, V1, P753, DOI 10.1517/14712598.1.5.753; Mustacich DJ, 2010, FREE RADICAL BIO MED, V48, P73, DOI 10.1016/j.freeradbiomed.2009.10.024; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Navarro A, 2008, ADV DRUG DELIVER REV, V60, P1534, DOI 10.1016/j.addr.2008.05.002; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; PAOLISSO G, 1993, AM J CLIN NUTR, V57, P650, DOI 10.1093/ajcn/57.5.650; PAOLISSO G, 1994, AM J CLIN NUTR, V59, P1291, DOI 10.1093/ajcn/59.6.1291; Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427; Paradies G, 2004, CIRC RES, V94, P53, DOI 10.1161/01.RES.0000109416.56608.64; PARTHASARATHY S, 1992, ANNU REV MED, V43, P219, DOI 10.1146/annurev.me.43.020192.001251; Persson XMT, 2010, J LIPID RES, V51, P2761, DOI 10.1194/jlr.M008011; Radosavac D, 2002, EUR J NUTR, V41, P119, DOI 10.1007/s00394-002-0365-3; Ross MF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P222, DOI 10.1007/s10541-005-0104-5; SCHULTZ M, 1995, AM J CLIN NUTR, V62, P1527, DOI 10.1093/ajcn/62.6.1527S; Sheu SS, 2006, BBA-MOL BASIS DIS, V1762, P256, DOI 10.1016/j.bbadis.2005.10.007; Singh AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032521; Smith RAJ, 1999, EUR J BIOCHEM, V263, P709, DOI 10.1046/j.1432-1327.1999.00543.x; Smith RAJ, 2003, P NATL ACAD SCI USA, V100, P5407, DOI 10.1073/pnas.0931245100; STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003; Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1; Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011	60	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53272	10.1371/journal.pone.0053272	http://dx.doi.org/10.1371/journal.pone.0053272			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341934	gold, Green Published, Green Submitted			2022-12-25	WOS:000314759400038
J	Schonrogge, K; Begg, T; Stone, GN				Schoenrogge, Karsten; Begg, Tracey; Stone, Graham N.			Native Birds and Alien Insects: Spatial Density Dependence in Songbird Predation of Invading Oak Gallwasps	PLOS ONE			English	Article							ANDRICUS-QUERCUSCALICIS HYMENOPTERA; CLIMATE-CHANGE; PARUS-MAJOR; GALL WASPS; CAMERARIA-HAMADRYADELLA; TROPHIC LEVELS; ENEMY RELEASE; TIT PREDATION; LEAF-MINER; PARASITOIDS	Revealing the interactions between alien species and native communities is central to understanding the ecological consequences of range expansion. Much has been learned through study of the communities developing around invading herbivorous insects. Much less, however, is known about the significance of such aliens for native vertebrate predators for which invaders may represent a novel food source. We quantified spatial patterns in native bird predation of invading gall-inducing Andricus wasps associated with introduced Turkey oak (Quercus cerris) at eight sites across the UK. These gallwasps are available at high density before the emergence of caterpillars that are the principle spring food of native insectivorous birds. Native birds showed positive spatial density dependence in gall attack rates at two sites in southern England, foraging most extensively on trees with highest gall densities. In a subsequent study at one of these sites, positive spatial density dependence persisted through four of five sequential week-long periods of data collection. Both patterns imply that invading galls are a significant resource for at least some native bird populations. Density dependence was strongest in southern UK bird populations that have had longest exposure to the invading gallwasps. We hypothesise that this pattern results from the time taken for native bird populations to learn how to exploit this novel resource.	[Schoenrogge, Karsten; Begg, Tracey] Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Begg, Tracey; Stone, Graham N.] Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland	UK Centre for Ecology & Hydrology (UKCEH); University of Edinburgh	Stone, GN (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.	graham.stone@ed.ac.uk	Schönrogge, Karsten/E-8818-2010; Schonrogge, Karsten/M-9935-2019	Schönrogge, Karsten/0000-0003-0122-6493; Schonrogge, Karsten/0000-0003-0122-6493; Stone, Graham/0000-0002-2737-696X	UK Natural Environment Research Council [NER/S/A/2003/11227, NE/H000135/1]; NERC [NE/H000135/1, NE/H000038/1] Funding Source: UKRI; Natural Environment Research Council [NE/H000038/1, CEH010021, NE/H000135/1, NER/B/S/2003/00856] Funding Source: researchfish	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the UK Natural Environment Research Council (http://www.nerc.ac.uk/) through grants NER/S/A/2003/11227 and NE/H000135/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askew R.R., 1982, Entomologist's Monthly Magazine, V118, P116; ASKEW RR, 1962, J ANIM ECOL, V31, P439, DOI 10.2307/2045; Bartomeus I, 2010, J ECOL, V98, P440, DOI 10.1111/j.1365-2745.2009.01629.x; BETTS MM, 1955, J ANIM ECOL, V24, P282, DOI 10.2307/1715; Both C, 2004, P ROY SOC B-BIOL SCI, V271, P1657, DOI 10.1098/rspb.2004.2770; Clavero M, 2009, BIOL CONSERV, V142, P2043, DOI 10.1016/j.biocon.2009.03.034; COLLINS M, 1983, ECOL ENTOMOL, V8, P133, DOI 10.1111/j.1365-2311.1983.tb00491.x; Conner EF, 1999, OIKOS, V87, P105, DOI 10.2307/3547001; CONNOR EF, 1993, OIKOS, V66, P515, DOI 10.2307/3544947; Crawley MJ, 1988, FUNCT ECOL, V2, P409, DOI 10.2307/2389414; Crawley M. J., 2008, R BOOK; Cronin JT, 2007, ECOLOGY, V88, P2977, DOI 10.1890/07-0253.1; Egan SP, 2007, ECOLOGY, V88, P2868, DOI 10.1890/06-1303.1; Eliason EA, 2000, ENVIRON ENTOMOL, V29, P1199, DOI 10.1603/0046-225X-29.6.1199; Gawlik DE, 2002, ECOL MONOGR, V72, P329, DOI 10.1890/0012-9615(2002)072[0329:TEOPAO]2.0.CO;2; GIBB JA, 1966, J ANIM ECOL, V35, P43, DOI 10.2307/2688; Gibb JA, 1958, IBIS, V96, P513; Gibbons D. W., 1993, NEW ATLAS BREEDING B; Girardoz S, 2007, J APPL ENTOMOL, V131, P603, DOI 10.1111/j.1439-0418.2007.01146.x; Girardoz S, 2006, AGR FOREST ENTOMOL, V8, P49, DOI 10.1111/j.1461-9555.2006.00281.x; Grabenweger G, 2010, BIOL INVASIONS, V12, P2797, DOI 10.1007/s10530-009-9685-z; Grobler BC, 2008, ECOL ENTOMOL, V33, P453, DOI 10.1111/j.1365-2311.2008.00990.x; HAILS R S, 1990, Entomologist, V109, P165; HAILS RS, 1992, J ANIM ECOL, V61, P567, DOI 10.2307/5612; HASSELL MP, 1990, PHILOS T R SOC B, V330, P203, DOI 10.1098/rstb.1990.0193; Hawkes CV, 2007, AM NAT, V170, P832, DOI 10.1086/522842; Hayward A, 2006, MOL ECOL, V15, P479, DOI 10.1111/j.1365-294X.2005.02811.x; HEADS PA, 1983, OIKOS, V41, P161, DOI 10.2307/3544259; Holmes R.T, 1990, STUD AVIAN BIOL, V13, P6; HOLMES RT, 1988, CAN J ZOOL, V66, P720, DOI 10.1139/z88-107; ITAMIES J, 1977, ANN ZOOL FENN, V14, P235; Ito M, 2005, ACTA OECOL, V27, P17, DOI 10.1016/j.actao.2004.08.005; JANSSON C, 1981, OIKOS, V37, P313, DOI 10.2307/3544122; Jordan M.J.R., 2005, International Zoo Yearbook, V39, P108; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; KREBS JR, 1977, ANIM BEHAV, V25, P30, DOI 10.1016/0003-3472(77)90064-1; Lambrechts MM, 2004, OECOLOGIA, V141, P555, DOI 10.1007/s00442-004-1681-5; LEFEBVRE L, 1995, BEHAV PROCESS, V34, P43, DOI 10.1016/0376-6357(94)00051-H; Logan M, 2020, BIOSTATISTICAL DESIG, DOI DOI 10.1002/9781444319620; McCleery RH, 1998, NATURE, V391, P30, DOI 10.1038/34073; McGeoch MA, 2005, OECOLOGIA, V144, P278, DOI 10.1007/s00442-005-0073-9; Naef-Daenzer B, 1999, J ANIM ECOL, V68, P708, DOI 10.1046/j.1365-2656.1999.00318.x; Naef-Daenzer B, 2000, ANIM BEHAV, V59, P989, DOI 10.1006/anbe.1999.1380; Naef-Daenzer L, 2004, ARDEA, V92, P229; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; NASH DR, 1995, J ANIM ECOL, V64, P225, DOI 10.2307/5757; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2016, R FDN STAT COMP; Schonrogge K, 2012, INSECT CONSERV DIVER, V5, P298, DOI 10.1111/j.1752-4598.2011.00161.x; Schonrogge K, 2000, J ANIM ECOL, V69, P841, DOI 10.1046/j.1365-2656.2000.00443.x; Schonrogge K, 1999, OIKOS, V84, P293, DOI 10.2307/3546724; Schonrogge K, 1996, ECOL ENTOMOL, V21, P71, DOI 10.1111/j.1365-2311.1996.tb00268.x; SCHONROGGE K, 1995, OIKOS, V72, P51, DOI 10.2307/3546037; Schonrogge K, 1996, OIKOS, V77, P507, DOI 10.2307/3545940; Schonrogge K, 2000, ECOL ENTOMOL, V25, P208, DOI 10.1046/j.1365-2311.2000.00244.x; Schonrogge K, 1998, P ROY SOC B-BIOL SCI, V265, P1643, DOI 10.1098/rspb.1998.0483; SHERRY DF, 1990, ANIM BEHAV, V40, P987, DOI 10.1016/S0003-3472(05)81004-8; SHERRY DF, 1984, ANIM BEHAV, V32, P937, DOI 10.1016/S0003-3472(84)80185-2; Skorka P, 2010, BIOL CONSERV, V143, P856, DOI 10.1016/j.biocon.2009.12.030; Smith DS, 2011, J EVOLUTION BIOL, V24, P422, DOI 10.1111/j.1420-9101.2010.02178.x; STEWART AJA, 2000, ECOLOGICAL CONSEQUEN, P1; STONE GN, 1993, MOL ECOL, V2, P251, DOI 10.1111/j.1365-294X.1993.tb00015.x; Stone GN, 2007, MOL ECOL, V16, P2768, DOI 10.1111/j.1365-294X.2007.03348.x; SUHONEN J, 1992, ORNIS SCAND, V23, P467, DOI 10.2307/3676678; Thomas DW, 2001, SCIENCE, V291, P2598, DOI 10.1126/science.1057487; Tremblay I, 2003, ECOLOGY, V84, P3033, DOI 10.1890/02-0663; TSCHARNTKE T, 1992, ECOLOGY, V73, P1689, DOI 10.2307/1940020; van Veen FJF, 2006, ANNU REV ENTOMOL, V51, P187, DOI 10.1146/annurev.ento.51.110104.151120; VANNOORDWIJK AJ, 1995, J ANIM ECOL, V64, P451, DOI 10.2307/5648; Veldtman R, 2004, P ROY SOC B-BIOL SCI, V271, P2439, DOI 10.1098/rspb.2004.2905; Visser ME, 2003, P ROY SOC B-BIOL SCI, V270, P367, DOI 10.1098/rspb.2002.2244; Visser ME, 2006, OECOLOGIA, V147, P164, DOI 10.1007/s00442-005-0299-6; Visser ME, 2004, ADV ECOL RES, V35, P89, DOI 10.1016/S0065-2504(04)35005-1; Visser ME, 2001, P ROY SOC B-BIOL SCI, V268, P289, DOI 10.1098/rspb.2000.1363; Walker P, 2002, DIVERS DISTRIB, V8, P335, DOI 10.1046/j.1472-4642.2002.00159.x; Wernhem C, 2002, MIGRATION ATLAS MOVE	76	8	8	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53959	10.1371/journal.pone.0053959	http://dx.doi.org/10.1371/journal.pone.0053959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342048	gold, Green Published, Green Accepted			2022-12-25	WOS:000314759400106
J	Hayama, R; Bahng, S; Karasu, ME; Marians, KJ				Hayama, Ryo; Bahng, Soon; Karasu, Mehmet E.; Marians, Kenneth J.			The MukB-ParC Interaction Affects the Intramolecular, Not Intermolecular, Activities of Topoisomerase IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CHROMOSOME CONDENSATION; DNA-REPLICATION; ELECTRON-MICROSCOPY; 13S CONDENSIN; IN-VITRO; SEGREGATION; PROTEIN; DECATENATION; DOMAIN	Proper chromosome organization is accomplished through binding of proteins such as condensins that shape the DNA and by modulation of chromosome topology by the action of topoisomerases. We found that the interaction between MukB, the bacterial condensin, and ParC, a subunit of topoisomerase IV, enhanced relaxation of negatively supercoiled DNA and knotting by topoisomerase IV, which are intramolecular DNA re-arrangements but not decatenation of multiply linked DNA dimers, which is an intermolecular DNA rearrangement required for proper segregation of daughter chromosomes. MukB DNA binding and a specific chiral arrangement of the DNA was required for topoisomerase IV stimulation because relaxation of positively supercoiled DNA was unaffected. This effect could be attributed to a more effective topological reconfiguration of the negatively supercoiled compared with positively supercoiled DNA by MukB. These data suggest that the MukB-ParC interaction may play a role in chromosome organization rather than in separation of daughter chromosomes.	[Hayama, Ryo] Weill Cornell Grad Sch Med Sci, Physiol Biophys & Syst Biol Grad Program, New York, NY 10065 USA; [Bahng, Soon; Marians, Kenneth J.] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Karasu, Mehmet E.; Marians, Kenneth J.] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY 10065 USA	Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Marians, KJ (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA.	kmarians@sloankettering.edu		Hayama, Ryo/0000-0001-8706-213X; KARASU, MEHMET ERMAN/0000-0002-1918-9152	National Institutes of Health [GM34558]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34558 (to K. J. M.)	ADAMS DE, 1992, CELL, V71, P277, DOI 10.1016/0092-8674(92)90356-H; Bhat MA, 1996, CELL, V87, P1103, DOI 10.1016/S0092-8674(00)81804-8; Bigot S, 2010, NUCLEIC ACIDS RES, V38, P3031, DOI 10.1093/nar/gkp1243; Crisona NJ, 2000, GENE DEV, V14, P2881, DOI 10.1101/gad.838900; Cuvier O, 2003, J CELL BIOL, V160, P645, DOI 10.1083/jcb.200209023; Cuylen S, 2011, NAT STRUCT MOL BIOL, V18, P894, DOI 10.1038/nsmb.2087; Gruber S, 2006, CELL, V127, P523, DOI 10.1016/j.cell.2006.08.048; Hayama Ryo, 2010, Proc Natl Acad Sci U S A, V107, P18826, DOI 10.1073/pnas.1008140107; Heller RC, 2005, MOL CELL, V17, P733, DOI 10.1016/j.molcel.2005.01.019; HIASA H, 1994, J BIOL CHEM, V269, P26959; Hiasa H, 1996, J BIOL CHEM, V271, P21529, DOI 10.1074/jbc.271.35.21529; KATO J, 1990, CELL, V63, P393, DOI 10.1016/0092-8674(90)90172-B; KATO JI, 1988, J BACTERIOL, V170, P3967, DOI 10.1128/jb.170.9.3967-3977.1988; KAVENOFF R, 1976, CHROMOSOMA, V59, P89, DOI 10.1007/BF00328479; Kimura K, 1999, CELL, V98, P239, DOI 10.1016/S0092-8674(00)81018-1; Kimura K, 1997, CELL, V90, P625, DOI 10.1016/S0092-8674(00)80524-3; Li YY, 2010, P NATL ACAD SCI USA, V107, P18832, DOI 10.1073/pnas.1008678107; Li YY, 2010, J MOL BIOL, V395, P11, DOI 10.1016/j.jmb.2009.10.040; Madabhushi R, 2009, MOL CELL, V33, P171, DOI 10.1016/j.molcel.2009.01.001; Maeshima K, 2003, DEV CELL, V4, P467, DOI 10.1016/S1534-5807(03)00092-3; MARIANS KJ, 1987, J BIOL CHEM, V262, P10362; Matoba K, 2005, BIOCHEM BIOPH RES CO, V333, P694, DOI 10.1016/j.bbrc.2005.05.163; Mossessova E, 2000, J BIOL CHEM, V275, P4099, DOI 10.1074/jbc.275.6.4099; Neuman KC, 2009, P NATL ACAD SCI USA, V106, P6986, DOI 10.1073/pnas.0900574106; NIKI H, 1991, EMBO J, V10, P183, DOI 10.1002/j.1460-2075.1991.tb07935.x; PENG H, 1993, P NATL ACAD SCI USA, V90, P8571, DOI 10.1073/pnas.90.18.8571; PENG H, 1993, J BIOL CHEM, V268, P24481; Petrushenko ZM, 2006, J BIOL CHEM, V281, P4606, DOI 10.1074/jbc.M504754200; Petrushenko ZM, 2006, J BIOL CHEM, V281, P34208, DOI 10.1074/jbc.M606723200; Petrushenko ZM, 2010, EMBO J, V29, P1126, DOI 10.1038/emboj.2009.414; She WF, 2007, J BACTERIOL, V189, P7062, DOI 10.1128/JB.00770-07; Stray JE, 2005, J BIOL CHEM, V280, P34723, DOI 10.1074/jbc.M506589200; UEMURA T, 1987, CELL, V50, P917, DOI 10.1016/0092-8674(87)90518-6; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Wang Q, 2006, J BACTERIOL, V188, P4431, DOI 10.1128/JB.00313-06; WASSERMAN SA, 1988, NATURE, V334, P448, DOI 10.1038/334448a0; Woo JS, 2009, CELL, V136, P85, DOI 10.1016/j.cell.2008.10.050; Yamanaka K, 1996, MOL GEN GENET, V250, P241	38	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7653	7661		10.1074/jbc.M112.418087	http://dx.doi.org/10.1074/jbc.M112.418087			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23349462	hybrid, Green Published			2022-12-25	WOS:000316455300022
J	Ariesandi, W; Chang, CF; Chen, TE; Chen, YR				Ariesandi, Winny; Chang, Chi-Fon; Chen, Tseng-Erh; Chen, Yun-Ru			Temperature-Dependent Structural Changes of Parkinson's Alpha-Synuclein Reveal the Role of Pre-Existing Oligomers in Alpha-Synuclein Fibrillization	PLOS ONE			English	Article							AMYLOID FIBRILS; DISEASE; FIBRILLATION; AGGREGATION; PROTEINS; PHOSPHORYLATION; IDENTIFICATION; NEUROTOXICITY; DISSOCIATION; PATHOGENESIS	Amyloid fibrils of alpha-synuclein are the main constituent of Lewy bodies deposited in substantial nigra of Parkinson's disease brains. alpha-Synuclein is an intrinsically disordered protein lacking compact secondary and tertiary structures. To enhance the understanding of its structure and function relationship, we utilized temperature treatment to study alpha-synuclein conformational changes and the subsequent effects. We found that after 1 hr of high temperature pretreatment, >80 degrees C, alpha-synuclein fibrillization was significantly inhibited. However, the temperature melting coupled with circular dichroism spectra showed that alpha-synuclein was fully reversible and the NMR studies showed no observable structural changes of alpha-synuclein after 95 degrees C treatment. By using cross-linking and analytical ultracentrifugation, rare amount of pre-existing alpha-synuclein oligomers were found to decrease after the high temperature treatment. In addition, a small portion of C-terminal truncation of alpha-synuclein also occurred. The reduction of pre-existing oligomers of alpha-synuclein may contribute to less seeding effect that retards the kinetics of amyloid fibrillization. Overall, our results showed that the pre-existing oligomeric species is a key factor contributing to alpha-synuclein fibrillization. Our results facilitate the understanding of alpha-synuclein fibrillization.	[Ariesandi, Winny; Chang, Chi-Fon; Chen, Tseng-Erh; Chen, Yun-Ru] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Ariesandi, Winny; Chen, Yun-Ru] Acad Sinica, Taiwan Int Grad Program, Taipei 115, Taiwan; [Ariesandi, Winny] Natl Tsing Hua Univ, Dept Chem, Hsinchu, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Tsing Hua University	Chen, YR (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.	yrchen@gate.sinica.edu.tw	Chen, Yun-Ru/C-9304-2014	Chen, Yun-Ru/0000-0002-6596-6338; Chang, Chi-Fon/0000-0002-2961-0748	Genomics Research Center, Academia Sinica, Taiwan; National Science Council, Taiwan [98-2320-B-001-020-MY3, 101-2320-B-001-035]	Genomics Research Center, Academia Sinica, Taiwan(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The funding for the research is from the Genomics Research Center, Academia Sinica, Taiwan and National Science Council, Taiwan (98-2320-B-001-020-MY3 and 101-2320-B-001-035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bertoncini CW, 2005, J BIOL CHEM, V280, P30649, DOI 10.1074/jbc.C500288200; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Bodner CR, 2010, BIOCHEMISTRY-US, V49, P862, DOI 10.1021/bi901723p; Bonini NM, 2005, CELL, V123, P359, DOI 10.1016/j.cell.2005.10.017; Chen WT, 2011, J BIOL CHEM, V286, P9646, DOI 10.1074/jbc.M110.177246; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Foguel D, 2003, P NATL ACAD SCI USA, V100, P9831, DOI 10.1073/pnas.1734009100; Gast K, 2003, EUR BIOPHYS J BIOPHY, V31, P586, DOI 10.1007/s00249-002-0254-y; Giehm L, 2010, J MOL BIOL, V401, P115, DOI 10.1016/j.jmb.2010.05.060; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hokenson MJ, 2004, BIOCHEMISTRY-US, V43, P4621, DOI 10.1021/bi049979h; Hong DP, 2011, FEBS LETT, V585, P561, DOI 10.1016/j.febslet.2011.01.009; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; Huang CJ, 2005, PROTEIN EXPRES PURIF, V42, P173, DOI 10.1016/j.pep.2005.02.014; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257; Kim HY, 2008, ANGEW CHEM INT EDIT, V47, P5046, DOI 10.1002/anie.200800342; Kjaergaard M, 2010, PROTEIN SCI, V19, P1555, DOI 10.1002/pro.435; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Li HT, 2006, PROTEIN PEPTIDE LETT, V13, P385, DOI 10.2174/092986606775974384; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Maiti NC, 2004, J AM CHEM SOC, V126, P2399, DOI 10.1021/ja0356176; Malm J, 2007, FEBS J, V274, P4503, DOI 10.1111/j.1742-4658.2007.05979.x; Meuvis J, 2010, BIOCHEMISTRY-US, V49, P9345, DOI 10.1021/bi1010927; Munishkina LA, 2009, CURR ALZHEIMER RES, V6, P252, DOI 10.2174/156720509788486491; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Nelson R, 2006, CURR OPIN STRUC BIOL, V16, P260, DOI 10.1016/j.sbi.2006.03.007; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Park SM, 2002, J BIOL CHEM, V277, P28512, DOI 10.1074/jbc.M111971200; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Shu Q, 2012, P NATL ACAD SCI USA, V109, P6502, DOI 10.1073/pnas.1204161109; Shulman JM, 2011, ANNU REV PATHOL-MECH, V6, P193, DOI 10.1146/annurev-pathol-011110-130242; Sidhu A, 2004, FASEB J, V18, P637, DOI 10.1096/fj.03-1112rev; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stockl M, 2008, J MOL BIOL, V375, P1394, DOI 10.1016/j.jmb.2007.11.051; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Vadysirisack DD, 2007, J BIOL CHEM, V282, P36820, DOI 10.1074/jbc.M706817200; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Wu KP, 2008, J MOL BIOL, V378, P1104, DOI 10.1016/j.jmb.2008.03.017; Yagi H, 2005, J BIOL CHEM, V280, P38609, DOI 10.1074/jbc.M508623200	53	23	24	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53487	10.1371/journal.pone.0053487	http://dx.doi.org/10.1371/journal.pone.0053487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349712	gold, Green Submitted, Green Published			2022-12-25	WOS:000314019100021
J	Otero, JM; Cimini, D; Patil, KR; Poulsen, SG; Olsson, L; Nielsen, J				Otero, Jose Manuel; Cimini, Donatella; Patil, Kiran R.; Poulsen, Simon G.; Olsson, Lisbeth; Nielsen, Jens			Industrial Systems Biology of Saccharomyces cerevisiae Enables Novel Succinic Acid Cell Factory	PLOS ONE			English	Article							SCALE METABOLIC MODEL; IN-SILICO; RECONSTRUCTION; STRAINS; GROWTH; YEAST; BIOTECHNOLOGY; VALIDATION; BIOETHANOL; PRODUCTS	Saccharomyces cerevisiae is the most well characterized eukaryote, the preferred microbial cell factory for the largest industrial biotechnology product (bioethanol), and a robust commerically compatible scaffold to be exploitted for diverse chemical production. Succinic acid is a highly sought after added-value chemical for which there is no native pre-disposition for production and accmulation in S. cerevisiae. The genome-scale metabolic network reconstruction of S. cerevisiae enabled in silico gene deletion predictions using an evolutionary programming method to couple biomass and succinate production. Glycine and serine, both essential amino acids required for biomass formation, are formed from both glycolytic and TCA cycle intermediates. Succinate formation results from the isocitrate lyase catalyzed conversion of isocitrate, and from the alpha-keto-glutarate dehydrogenase catalyzed conversion of alpha-keto-glutarate. Succinate is subsequently depleted by the succinate dehydrogenase complex. The metabolic engineering strategy identified included deletion of the primary succinate consuming reaction, Sdh3p, and interruption of glycolysis derived serine by deletion of 3-phosphoglycerate dehydrogenase, Ser3p/Ser33p. Pursuing these targets, a multi-gene deletion strain was constructed, and directed evolution with selection used to identify a succinate producing mutant. Physiological characterization coupled with integrated data analysis of transcriptome data in the metabolically engineered strain were used to identify 2nd-round metabolic engineering targets. The resulting strain represents a 30-fold improvement in succinate titer, and a 43-fold improvement in succinate yield on biomass, with only a 2.8-fold decrease in the specific growth rate compared to the reference strain. Intuitive genetic targets for either over-expression or interruption of succinate producing or consuming pathways, respectively, do not lead to increased succinate. Rather, we demonstrate how systems biology tools coupled with directed evolution and selection allows non-intuitive, rapid and substantial re-direction of carbon fluxes in S. cerevisiae, and hence show proof of concept that this is a potentially attractive cell factory for over-producing different platform chemicals.	[Otero, Jose Manuel; Olsson, Lisbeth; Nielsen, Jens] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden; [Otero, Jose Manuel; Patil, Kiran R.; Poulsen, Simon G.; Olsson, Lisbeth; Nielsen, Jens] Tech Univ Denmark, Dept Syst Biol, Ctr Microbial Biotechnol, DK-2800 Lyngby, Denmark; [Cimini, Donatella] Univ Naples 2, Dept Expt Med, Naples, Italy	Chalmers University of Technology; Technical University of Denmark; Universita della Campania Vanvitelli	Nielsen, J (corresponding author), Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden.	nielsenj@chalmers.se	Patil, Kiran R/B-9709-2009; Nielsen, Jens/Q-1347-2017	Patil, Kiran R/0000-0002-6166-8640; /0000-0002-0827-5442; Nielsen, Jens/0000-0002-9955-6003	Merck Doctoral Fellowship; Merck Research Labs, Merck Co., Inc. USA.	Merck Doctoral Fellowship; Merck Research Labs, Merck Co., Inc. USA.	This work was in part supported by a Merck Doctoral Fellowship to J.M.O. from Merck Research Labs, Merck & Co., Inc. USA. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrio JL, 2006, FEMS MICROBIOL REV, V30, P187, DOI 10.1111/j.1574-6976.2005.00009.x; Aliverdieva DA, 2006, BIOCHEMISTRY-MOSCOW+, V71, P39, DOI 10.1134/S0006297906010056; Bro C, 2006, METAB ENG, V8, P102, DOI 10.1016/j.ymben.2005.09.007; Castrillo Juan I, 2007, J Biol, V6, P4, DOI 10.1186/jbiol54; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Cimini D, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-17; Covert MW, 2001, TRENDS BIOCHEM SCI, V26, P179, DOI 10.1016/S0968-0004(00)01754-0; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Erdeniz N, 1997, GENOME RES, V7, P1174, DOI 10.1101/gr.7.12.1174; Fazio A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-341; Fisk DG, 2006, YEAST, V23, P857, DOI 10.1002/yea.1400; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; Jantama K, 2008, BIOTECHNOL BIOENG, V99, P1140, DOI 10.1002/bit.21694; Lee PC, 2002, APPL MICROBIOL BIOT, V58, P663, DOI 10.1007/s00253-002-0935-6; Lynd LR, 1999, BIOTECHNOL PROGR, V15, P777, DOI 10.1021/bp990109e; McKinlay JB, 2007, APPL MICROBIOL BIOT, V76, P727, DOI 10.1007/s00253-007-1057-y; Nielsen J, 2001, APPL MICROBIOL BIOT, V55, P263, DOI 10.1007/s002530000511; Nielsen J, 2008, FEMS YEAST RES, V8, P122, DOI 10.1111/j.1567-1364.2007.00302.x; Nookaew I, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-71; Otero JM, 2007, ADV BIOCHEM ENG BIOT, V108, P1, DOI 10.1007/10_2007_071; Paley SM, 2006, NUCLEIC ACIDS RES, V34, P3771, DOI 10.1093/nar/gkl334; Patil KR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-308; Regenberg B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r107; Sauer M, 2008, TRENDS BIOTECHNOL, V26, P100, DOI 10.1016/j.tibtech.2007.11.006; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Song H, 2006, ENZYME MICROB TECH, V39, P352, DOI 10.1016/j.enzmictec.2005.11.043; van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; Wattanachaisaereekul S, 2008, METAB ENG, V10, P246, DOI 10.1016/j.ymben.2008.04.005; Willke T, 2004, APPL MICROBIOL BIOT, V66, P131, DOI 10.1007/s00253-004-1733-0; Zeikus JG, 1999, APPL MICROBIOL BIOT, V51, P545, DOI 10.1007/s002530051431; Zelle RM, 2008, APPL ENVIRON MICROB, V74, P2766, DOI 10.1128/AEM.02591-07	36	113	121	4	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54144	10.1371/journal.pone.0054144	http://dx.doi.org/10.1371/journal.pone.0054144			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349810	Green Submitted, Green Published, gold			2022-12-25	WOS:000313943000027
J	Storz, SS; Tovin, A; Mracek, P; Alon, S; Foulkes, NS; Gothilf, Y				Storz, Sima Smadja; Tovin, Adi; Mracek, Philipp; Alon, Shahar; Foulkes, Nicholas S.; Gothilf, Yoav			Casein Kinase 1 delta Activity: A Key Element in the Zebrafish Circadian Timing System	PLOS ONE			English	Article							DROSOPHILA CLOCK GENE; DOUBLE-TIME; CKI-DELTA; EXPRESSION; PERIOD; MUTATION; PHASE; INHIBITION; RHYTHM	Zebrafish have become a popular model for studies of the circadian timing mechanism. Taking advantage of its rapid development of a functional circadian clock and the availability of light-entrainable clock-containing cell lines, much knowledge has been gained about the circadian clock system in this species. However, the post-translational modifications of clock proteins, and in particular the phosphorylation of PER proteins by Casein kinase I delta and epsilon (CK1 delta and CK1 epsilon), have so far not been examined in the zebrafish. Using pharmacological inhibitors for CK1 delta and CK1 epsilon, a pan-CK1 delta/epsilon inhibitor PF-670462, and a CK1 epsilon -selective inhibitor PF-4800567, we show that CK1 delta activity is crucial for the functioning of the circadian timing mechanism of zebrafish, while CK1 epsilon plays a minor role. The CK1 delta/epsilon inhibitor disrupted circadian rhythms of promoter activity in the circadian clock-containing zebrafish cell line, PAC-2, while the CK1 epsilon inhibitor had no effect. Zebrafish larvae that were exposed to the CK1 delta/epsilon inhibitor showed no rhythms of locomotor activity while the CK1 epsilon inhibitor had only a minor effect on locomotor activity. Moreover, the addition of the CK1 delta/epsilon inhibitor disrupted rhythms of aanat2 mRNA expression in the pineal gland. The pineal gland is considered to act as a central clock organ in fish, delivering a rhythmic hormonal signal, melatonin, which is regulated by AANAT2 enzymatic activity. Therefore, CK1 delta plays a key role in the circadian timing system of the zebrafish. Furthermore, the effect of CK1 delta inhibition on rhythmic locomotor activity may reflect its effect on the function of the central clock in the pineal gland as well as its regulation of peripheral clocks.	[Storz, Sima Smadja; Tovin, Adi; Alon, Shahar; Gothilf, Yoav] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Alon, Shahar; Gothilf, Yoav] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Mracek, Philipp; Foulkes, Nicholas S.] Karlsruhe Inst Technol, Inst Toxicol & Genet, Eggenstein Leopoldshafen, Germany	Tel Aviv University; Tel Aviv University; Helmholtz Association; Karlsruhe Institute of Technology	Storz, SS (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel.	simasmadja@gmail.com	Foulkes, Nicholas S/K-7003-2013	Foulkes, Nicholas S/0000-0002-1794-9891; Gothilf, Yoav/0000-0002-6054-4128	Israel Science Foundation, Jerusalem [1200.08]	Israel Science Foundation, Jerusalem(Israel Science Foundation)	This research was supported by Grant No 1200.08 from the Israel Science Foundation, Jerusalem. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon S, 2009, BIOINFORMATICS, V25, P559, DOI 10.1093/bioinformatics/btp031; Bae K, 2006, J BIOCHEM, V140, P609, DOI 10.1093/jb/mvj198; Brady AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025072; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; Cahill Gregory M, 2007, Methods Mol Biol, V362, P83; Camacho F, 2001, FEBS LETT, V489, P159, DOI 10.1016/S0014-5793(00)02434-0; Carr AJF, 2006, CHRONOBIOL INT, V23, P91, DOI 10.1080/07420520500464395; Cermakian N, 2000, P NATL ACAD SCI USA, V97, P4339, DOI 10.1073/pnas.97.8.4339; Dekens MPS, 2003, CURR BIOL, V13, P2051, DOI 10.1016/j.cub.2003.10.022; Etchegaray JP, 2009, MOL CELL BIOL, V29, P3853, DOI 10.1128/MCB.00338-09; Gamse JT, 2002, NAT GENET, V30, P117, DOI 10.1038/ng793; Gothilf Y, 1999, ENDOCRINOLOGY, V140, P4895, DOI 10.1210/en.140.10.4895; Hirayama J, 2005, METHOD ENZYMOL, V393, P186, DOI 10.1016/S0076-6879(05)93005-X; Hirota T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000559; Hoadley KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019755; Hurd MW, 2002, J BIOL RHYTHM, V17, P307, DOI 10.1177/074873002129002618; Jones CR, 1999, NAT MED, V5, P1062, DOI 10.1038/12502; Kaneko M, 2005, PLOS BIOL, V3, P313, DOI 10.1371/journal.pbio.0030034; Kazimi N, 1999, DEV BRAIN RES, V117, P47, DOI 10.1016/S0165-3806(99)00096-6; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Lee H, 2009, P NATL ACAD SCI USA, V106, P21359, DOI 10.1073/pnas.0906651106; Levy O, 2007, SCIENCE, V318, P467, DOI 10.1126/science.1145432; LIN S, 1994, SCIENCE, V265, P666, DOI 10.1126/science.8036514; Long A, 2012, J MED CHEM, V55, P956, DOI 10.1021/jm201387s; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Meng QJ, 2010, P NATL ACAD SCI USA, V107, P15240, DOI 10.1073/pnas.1005101107; Minamoto T, 2010, J BIOCHEM, V147, P175, DOI 10.1093/jb/mvp160; Pando MP, 2002, BIOESSAYS, V24, P419, DOI 10.1002/bies.10091; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; RALPH MR, 1988, SCIENCE, V241, P1225, DOI 10.1126/science.3413487; Reitzel AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012805; Tamai TK, 2004, CURR BIOL, V14, pR104, DOI 10.1016/j.cub.2004.01.014; Tovin A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003116; Vallone D, 2004, P NATL ACAD SCI USA, V101, P4106, DOI 10.1073/pnas.0305436101; Vallone D, 2005, ZEBRAFISH, V2, P171, DOI 10.1089/zeb.2005.2.171; Vallone Daniela, 2007, Methods Mol Biol, V362, P429; Vielhaber E, 2000, MOL CELL BIOL, V20, P4888, DOI 10.1128/MCB.20.13.4888-4899.2000; Vuilleumier R, 2006, ENDOCRINOLOGY, V147, P2273, DOI 10.1210/en.2005-1565; Walton KM, 2009, J PHARMACOL EXP THER, V330, P430, DOI 10.1124/jpet.109.151415; Weger BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017080; Whitmore D, 1998, NAT NEUROSCI, V1, P701, DOI 10.1038/3703; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; Wilcockson DC, 2011, J COMP NEUROL, V519, P562, DOI 10.1002/cne.22533; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Ziv L, 2006, P NATL ACAD SCI USA, V103, P4146, DOI 10.1073/pnas.0600571103; Ziv L, 2005, J NEUROENDOCRINOL, V17, P314, DOI 10.1111/j.1365-2826.2005.01315.x	46	21	22	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54189	10.1371/journal.pone.0054189	http://dx.doi.org/10.1371/journal.pone.0054189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349822	Green Submitted, Green Published, gold			2022-12-25	WOS:000313943000029
J	Koh, PO				Koh, Phil-Ok			Ferulic Acid Attenuates the Injury-Induced Decrease of Protein Phosphatase 2A Subunit B in Ischemic Brain Injury	PLOS ONE			English	Article							OXIDATIVE GLUTAMATE TOXICITY; PHOSPHORYLATION; RATS; EXPRESSION; APOPTOSIS; PREVENTS; ISOFORMS; DISEASE; TAU	Background: Ferulic acid provides a neuroprotective effect during cerebral ischemia through its anti-oxidant function. Protein phosphatase 2A (PP2A) is a serine and threonine phosphatase that contributes broadly to normal brain function. This study investigated whether ferulic acid regulates PP2A subunit B in a middle cerebral artery occlusion (MCAO) animal model and glutamate toxicity-induced neuronal cell death. Methodology/Principal Findings: MCAO was surgically induced to yield permanent cerebral ischemic injury in rats. The rats were treated with either vehicle or ferulic acid (100 mg/kg, i.v.) immediately after MCAO, and cerebral cortex tissues were collected 24 h after MCAO. A proteomics approach, RT-PCR, and Western blot analyses performed to identification of PP2A subunit B expression levels. Ferulic acid significantly reduced the MCAO-induced infarct volume of the cerebral cortex. A proteomics approach elucidated the reduction of PP2A subunit B in MCAO-induced animals, and ferulic acid treatment prevented the injury-induced reduction in PP2A subunit B levels. RT-PCR and Western blot analyses also showed that ferulic acid treatment attenuates the injury-induced decrease in PP2A subunit B levels. Moreover, the number of PP2A subunit B-positive cells was reduced in MCAO-induced animals, and ferulic acid prevented these decreases. In cultured neuronal cells, ferulic acid treatment protected cells against glutamate toxicity and prevented the glutamate-induced decrease in PP2A subunit B. Conclusions/Significance: These results suggest that the maintenance of PP2A subunit B by ferulic acid in ischemic brain injury plays an important role for the neuroprotective function of ferulic acid.	Gyeongsang Natl Univ, Life Sci Res Inst, Coll Vet Med, Dept Anat, Jinju, South Korea	Gyeongsang National University	Koh, PO (corresponding author), Gyeongsang Natl Univ, Life Sci Res Inst, Coll Vet Med, Dept Anat, Jinju, South Korea.	pokoh@gnu.ac.kr			National Research Foundation of Korea(NRF); Korea government(MEST) [2010-0007881]; Next-Generation BioGreen 21 Program, RDA, Republic of Korea [PJ008075]	National Research Foundation of Korea(NRF)(National Research Foundation of Korea); Korea government(MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Next-Generation BioGreen 21 Program, RDA, Republic of Korea	This work was partially supported by the National Research Foundation of Korea(NRF) grant funded by the Korea government(MEST)(No.2010 0007881) and supported by a grant from the Next-Generation BioGreen 21 Program (No.PJ008075), RDA, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen L, 2009, INT J BIOCHEM CELL B, V41, P1284, DOI 10.1016/j.biocel.2008.10.029; Cheng CY, 2008, BRAIN RES, V1209, P136, DOI 10.1016/j.brainres.2008.02.090; Cheng CY, 2008, AM J CHINESE MED, V36, P1105, DOI 10.1142/S0192415X08006570; Csortos C, 1996, J BIOL CHEM, V271, P2578, DOI 10.1074/jbc.271.5.2578; Gong CX, 2000, J BIOL CHEM, V275, P5535, DOI 10.1074/jbc.275.8.5535; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Koh PO, 2012, NEUROSCI LETT, V511, P101, DOI 10.1016/j.neulet.2012.01.049; Koh PO, 2012, NEUROSCI LETT, V507, P156, DOI 10.1016/j.neulet.2011.12.012; Koh Phil-Ok, 2011, Lab Anim Res, V27, P73, DOI 10.5625/lar.2011.27.1.73; Li SY, 2009, J VIROL, V83, P8340, DOI 10.1128/JVI.00711-09; Liu Rong, 2009, Pathophysiology, V16, P273, DOI 10.1016/j.pathophys.2009.02.008; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Maher P, 1996, J NEUROSCI, V16, P6394; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Noh HS, 2006, J NEUROSCI RES, V83, P702, DOI 10.1002/jnr.20736; SIM ATR, 1991, MOL NEUROBIOL, V5, P229, DOI 10.1007/BF02935548; Sontag E, 1996, NEURON, V17, P1201, DOI 10.1016/S0896-6273(00)80250-0; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P1080, DOI 10.1093/jnen/63.10.1080; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Srinivasan M, 2006, TOXICOLOGY, V228, P249, DOI 10.1016/j.tox.2006.09.004; Srinivasan M, 2007, J CLIN BIOCHEM NUTR, V40, P92, DOI 10.3164/jcbn.40.92; STONE SR, 1987, BIOCHEMISTRY-US, V26, P7215, DOI 10.1021/bi00397a003; Strack S, 1998, J COMP NEUROL, V392, P515; Sung JH, 2012, J VET MED SCI, V74, P1401, DOI 10.1292/jvms.12-0063; Zolnierowicz S, 2000, BIOCHEM PHARMACOL, V60, P1225, DOI 10.1016/S0006-2952(00)00424-X	25	28	28	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54217	10.1371/journal.pone.0054217	http://dx.doi.org/10.1371/journal.pone.0054217			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349830	gold, Green Published, Green Submitted			2022-12-25	WOS:000313738900053
J	Liu, CM; Teng, ZQ; McQuate, AL; Jobe, EM; Christ, CC; von Hoyningen-Huene, SJ; Reyes, MD; Polich, ED; Xing, YN; Li, Y; Guo, WX; Zhao, XY				Liu, Changmei; Teng, Zhao-Qian; McQuate, Andrea L.; Jobe, Emily M.; Christ, Christa C.; von Hoyningen-Huene, Sergei J.; Reyes, Marie D.; Polich, Eric D.; Xing, Yina; Li, Yue; Guo, Weixiang; Zhao, Xinyu			An Epigenetic Feedback Regulatory Loop Involving MicroRNA-195 and MBD1 Governs Neural Stem Cell Differentiation	PLOS ONE			English	Article							METHYL-CPG BINDING-PROTEIN-1; ADULT NEUROGENESIS; RETT-SYNDROME; MOUSE MODEL; SUPPRESSES TUMORIGENICITY; GENE-EXPRESSION; MECP2; HIPPOCAMPUS; MATURATION; NEURONS	Background: Epigenetic mechanisms, including DNA methylation, histone modification, and microRNAs, play pivotal roles in stem cell biology. Methyl-CpG binding protein 1 (MBD1), an important epigenetic regulator of adult neurogenesis, controls the proliferation and differentiation of adult neural stem/progenitor cells (aNSCs). We recently demonstrated that MBD1 deficiency in aNSCs leads to altered expression of several noncoding microRNAs (miRNAs). Methodology/Principal Findings: Here we show that one of these miRNAs, miR-195, and MBD1 form a negative feedback loop. While MBD1 directly represses the expression of miR-195 in aNSCs, high levels of miR-195 in turn repress the expression of MBD1. Both gain-of-function and loss-of-function investigations show that alterations of the MBD1-miR-195 feedback loop tip the balance between aNSC proliferation and differentiation. Conclusions/Significance: Therefore the regulatory loop formed by MBD1 and miR-195 is an important component of the epigenetic network that controls aNSC fate.	[Jobe, Emily M.; Zhao, Xinyu] Univ Wisconsin, Cellular & Mol Biol Grad Program, Madison, WI 53715 USA; [Liu, Changmei; Teng, Zhao-Qian; McQuate, Andrea L.; Christ, Christa C.; von Hoyningen-Huene, Sergei J.; Reyes, Marie D.] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA; [Jobe, Emily M.; Polich, Eric D.; Xing, Yina; Li, Yue; Guo, Weixiang; Zhao, Xinyu] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Zhao, Xinyu] Univ Wisconsin, Dept Neurosci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of New Mexico; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Zhao, XY (corresponding author), Univ Wisconsin, Cellular & Mol Biol Grad Program, Madison, WI 53715 USA.	xzhao69@wisc.edu	Li, Kevin/AAX-1664-2020; Teng, Zhao-Qian/AAD-1033-2021; Teng, Zhao-Qian/J-6260-2015	Li, Kevin/0000-0001-8198-9911; Teng, Zhao-Qian/0000-0002-7232-3381; Teng, Zhao-Qian/0000-0002-7232-3381; McQuate, Andrea/0000-0002-2052-2004; Jobe, Emily/0000-0001-8712-4767	National Institutes of Health (NIH) [MH080434, MH07897, P30HD03352, T32 GM07215]; International Rett Syndrome Foundation (IRSF); Postbaccalaureate Research and Education Program fellowships (PREP) [NIH/R25 GM075149]; Minority Access to Research Careers fellowship (MARC) [NIH/T34 GM008510]; University of Wisconsin-Madison Center for Stem Cells and Regenerative Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM075149, T32GM007215, T34GM008751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078972, R01MH080434] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Rett Syndrome Foundation (IRSF); Postbaccalaureate Research and Education Program fellowships (PREP); Minority Access to Research Careers fellowship (MARC); University of Wisconsin-Madison Center for Stem Cells and Regenerative Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the National Institutes of Health (NIH) (MH080434, MH07897) and the International Rett Syndrome Foundation (IRSF) to X.Z.; a center grant from the NIH to the Waisman Center (P30HD03352); Postbaccalaureate Research and Education Program fellowships (PREP; NIH/R25 GM075149) to C.C.C. and A.L.M.; an NIH Molecular Biosciences Training grant (MBTG: T32 GM07215) to E.M.J.; a Minority Access to Research Careers fellowship (MARC, NIH/T34 GM008510) to M.D.R; and a postdoctoral fellowship from University of Wisconsin-Madison Center for Stem Cells and Regenerative Medicine to W.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan AM, 2008, HUM MOL GENET, V17, P2047, DOI 10.1093/hmg/ddn102; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Babu H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000388; Barkho BZ, 2006, STEM CELLS DEV, V15, P407, DOI 10.1089/scd.2006.15.407; Barkho BZ, 2011, CURR STEM CELL RES T, V6, P327; Barkho BZ, 2008, STEM CELLS, V26, P3139, DOI 10.1634/stemcells.2008-0519; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Cukier HN, 2010, NEUROGENETICS, V11, P291, DOI 10.1007/s10048-009-0228-7; Dai YM, 2011, HEAD NECK-J SCI SPEC, V33, P786, DOI 10.1002/hed.21540; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Gatto S, 2010, EPIGENETICS-US, V5, P427, DOI 10.4161/epi.5.5.11999; Guo AY, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-10; Guo WX, 2012, HUM MOL GENET, V21, P681, DOI 10.1093/hmg/ddr501; Guo WX, 2011, NEURON, V70, P924, DOI 10.1016/j.neuron.2011.03.027; Guo WX, 2011, NAT MED, V17, P559, DOI 10.1038/nm.2336; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Im HI, 2010, NAT NEUROSCI, V13, P1120, DOI 10.1038/nn.2615; Jobe E, 2012, FRONTIERS N IN PRESS; Jorgensen HF, 2004, MOL CELL BIOL, V24, P3387, DOI 10.1128/MCB.24.8.3387-3395.2004; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Li H, 2005, BRAIN DEV-JPN, V27, P321, DOI 10.1016/j.braindev.2004.08.003; Li XK, 2008, J BIOL CHEM, V283, P27644, DOI 10.1074/jbc.M804899200; Li XK, 2008, STEM CELLS DEV, V17, P1043, DOI 10.1089/scd.2008.0036; Liu CM, 2010, CELL STEM CELL, V6, P433, DOI 10.1016/j.stem.2010.02.017; Liu CM, 2009, NEUROMOL MED, V11, P141, DOI 10.1007/s12017-009-8077-y; Liu G, 2009, NEUROMOLECULAR MED; Liu L, 2010, BIOCHEM BIOPH RES CO, V400, P236, DOI 10.1016/j.bbrc.2010.08.046; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo YP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000898; Mellios N, 2008, HUM MOL GENET, V17, P3030, DOI 10.1093/hmg/ddn201; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Qi JL, 2009, CELL CYCLE, V8, P3729, DOI 10.4161/cc.8.22.10033; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shen Q, 2009, NAT NEUROSCI, V12, P369, DOI 10.1038/nn0409-369; Smrt RD, 2007, NEUROBIOL DIS, V27, P77, DOI 10.1016/j.nbd.2007.04.005; Smrt RD, 2010, STEM CELLS, V28, P1060, DOI 10.1002/stem.431; Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151; Urdinguio RG, 2010, EPIGENETICS-US, V5, P656, DOI 10.4161/epi.5.7.13055; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wu H, 2010, P NATL ACAD SCI USA, V107, P18161, DOI 10.1073/pnas.1005595107; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079; Zhao C, 2009, NAT STRUCT MOL BIOL, V16, P365, DOI 10.1038/nsmb.1576; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zhao XY, 2003, P NATL ACAD SCI USA, V100, P6777, DOI 10.1073/pnas.1131928100	53	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e51436	10.1371/journal.pone.0051436	http://dx.doi.org/10.1371/journal.pone.0051436			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349673	Green Published, gold, Green Submitted			2022-12-25	WOS:000313738900003
J	Schafer, E; Tarantola, M; Polo, E; Westendorf, C; Oikawa, N; Bodenschatz, E; Geil, B; Janshoff, A				Schaefer, Edith; Tarantola, Marco; Polo, Elena; Westendorf, Christian; Oikawa, Noriko; Bodenschatz, Eberhard; Geil, Burkhard; Janshoff, Andreas			Chemotaxis of Dictyostelium discoideum: Collective Oscillation of Cellular Contacts	PLOS ONE			English	Article							CYCLIC-AMP; SIGNAL-TRANSDUCTION; AGGREGATION; CELLS; ADHESION; BEHAVIOR; NETWORK; PROPAGATION; DYNAMICS	Chemotactic responses of Dictyostelium discoideum cells to periodic self-generated signals of extracellular cAMP comprise a large number of intricate morphological changes on different length scales. Here, we scrutinized chemotaxis of single Dictyostelium discoideum cells under conditions of starvation using a variety of optical, electrical and acoustic methods. Amebas were seeded on gold electrodes displaying impedance oscillations that were simultaneously analyzed by optical video microscopy to relate synchronous changes in cell density, morphology, and distance from the surface to the transient impedance signal. We found that starved amebas periodically reduce their overall distance from the surface producing a larger impedance and higher total fluorescence intensity in total internal reflection fluorescence microscopy. Therefore, we propose that the dominant sources of the observed impedance oscillations observed on electric cell-substrate impedance sensing electrodes are periodic changes of the overall cell-substrate distance of a cell. These synchronous changes of the cell-electrode distance were also observed in the oscillating signal of acoustic resonators covered with amebas. We also found that periodic cell-cell aggregation into transient clusters correlates with changes in the cell-substrate distance and might also contribute to the impedance signal. It turned out that cell-cell contacts as well as cell-substrate contacts form synchronously during chemotaxis of Dictyostelium discoideum cells.	[Schaefer, Edith; Polo, Elena; Geil, Burkhard; Janshoff, Andreas] Univ Gottingen, Inst Phys Chem, Gottingen, Germany; [Tarantola, Marco; Westendorf, Christian; Oikawa, Noriko; Bodenschatz, Eberhard] Max Planck Inst Dynam & Self Org, Lab Fluid Dynam Pattern Format & Biocomplex LFPB, Gottingen, Germany; [Bodenschatz, Eberhard] Univ Gottingen, Inst Nonlinear Dynam, D-37073 Gottingen, Germany	University of Gottingen; Max Planck Society; University of Gottingen	Janshoff, A (corresponding author), Univ Gottingen, Inst Phys Chem, Tammannstr 6, Gottingen, Germany.	ajansho@gwdg.de	Oikawa, Noriko/S-4313-2017	Janshoff, Andreas/0000-0002-0773-2963; Westendorf, Christian/0000-0001-7663-6150; Bodenschatz, Eberhard/0000-0002-2901-0144	DFG [SFB 937]	DFG(German Research Foundation (DFG))	The work has been supported by the DFG (SFB 937). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCANTARA F, 1974, J GEN MICROBIOL, V85, P321, DOI 10.1099/00221287-85-2-321; Alonso-Latorre B, 2011, CELL MOL BIOENG, V4, P603, DOI 10.1007/s12195-011-0184-9; Anger P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.113002; Benoit M, 2000, NAT CELL BIOL, V2, P313, DOI 10.1038/35014000; Chisholm RL, 2004, NAT REV MOL CELL BIO, V5, P531, DOI 10.1038/nrm1427; Coates JC, 2001, J CELL SCI, V114, P4349; CONDEELIS J, 1993, ANNU REV CELL BIOL, V9, P411, DOI 10.1146/annurev.cb.09.110193.002211; DEVREOTES PN, 1983, DEV BIOL, V96, P405, DOI 10.1016/0012-1606(83)90178-1; DINAUER MC, 1980, J CELL BIOL, V86, P537, DOI 10.1083/jcb.86.2.537; Dormann D, 1998, BIOPHYS CHEM, V72, P21, DOI 10.1016/S0301-4622(98)00120-3; Dubertret B, 2001, NAT BIOTECHNOL, V19, P365, DOI 10.1038/86762; FAIX J, 1990, EMBO J, V9, P2709, DOI 10.1002/j.1460-2075.1990.tb07457.x; FUTRELLE RP, 1982, J CELL BIOL, V92, P807, DOI 10.1083/jcb.92.3.807; Gabriel D, 1999, J CELL SCI, V112, P3995; GERISCH G, 1974, P NATL ACAD SCI USA, V71, P2118, DOI 10.1073/pnas.71.5.2118; GIAEVER I, 1984, P NATL ACAD SCI-BIOL, V81, P3761, DOI 10.1073/pnas.81.12.3761; GIAEVER I, 1993, NATURE, V366, P591, DOI 10.1038/366591a0; Gregor T, 2010, SCIENCE, V328, P1021, DOI 10.1126/science.1183415; HARLOFF C, 1989, GENE DEV, V3, P2011, DOI 10.1101/gad.3.12a.2011; Iglesias PA, 2012, CURR OPIN CELL BIOL, V24, P245, DOI 10.1016/j.ceb.2011.11.009; Janshoff A, 2010, J ADHES SCI TECHNOL, V24, P2079, DOI 10.1163/016942410X507939; Kessin RH., 2001, DICTYOSTELIUM EVOLUT, P1; Laub MT, 1998, MOL BIOL CELL, V9, P3521, DOI 10.1091/mbc.9.12.3521; McCann CP, 2010, J CELL SCI, V123, P1724, DOI 10.1242/jcs.060137; Mehta P, 2010, CURR OPIN GENET DEV, V20, P574, DOI 10.1016/j.gde.2010.09.004; Nanjundiah V, 1998, BIOPHYS CHEM, V72, P1, DOI 10.1016/S0301-4622(98)00118-5; Parent CA, 2004, CURR OPIN CELL BIOL, V16, P4, DOI 10.1016/j.ceb.2003.11.008; Parent CA, 1996, ANNU REV BIOCHEM, V65, P411; Reiss B, 2003, LANGMUIR, V19, P1816, DOI 10.1021/la0261747; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sawai S, 2005, NATURE, V433, P323, DOI 10.1038/nature03228; Schafer E, 2011, SMALL, V7, P723, DOI 10.1002/smll.201001955; SIEGERT F, 1989, J CELL SCI, V93, P325; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Tani T, 1999, J EXP BIOL, V202, P1; Tarantola M, 2011, CHEM RES TOXICOL, V24, P1494, DOI 10.1021/tx200115q; Tarantola M, 2010, INTEGR BIOL-UK, V2, P139, DOI 10.1039/b920815a; Tarantola M, 2009, ACS NANO, V3, P213, DOI 10.1021/nn800721j; van Haastert PJM, 2007, BIOPHYS J, V93, P1787, DOI 10.1529/biophysj.107.104356; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Vicker MG, 2008, EUR J CELL BIOL, V87, P845, DOI 10.1016/j.ejcb.2008.03.010; Wang CJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002449; Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919; Weijer CJ, 2004, CURR OPIN GENET DEV, V14, P392, DOI 10.1016/j.gde.2004.06.006; Wessels D, 1998, CELL MOTIL CYTOSKEL, V41, P225, DOI 10.1002/(SICI)1097-0169(1998)41:3<225::AID-CM4>3.3.CO;2-9; WURSTER B, 1989, DIFFERENTIATION, V41, P1, DOI 10.1111/j.1432-0436.1989.tb00725.x	46	8	8	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54172	10.1371/journal.pone.0054172	http://dx.doi.org/10.1371/journal.pone.0054172			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349816	Green Published, Green Submitted, gold			2022-12-25	WOS:000313738900049
J	Warrington, NM; Wu, YY; Pennell, CE; Marsh, JA; Beilin, LJ; Palmer, LJ; Lye, SJ; Briollais, L				Warrington, Nicole M.; Wu, Yan Yan; Pennell, Craig E.; Marsh, Julie A.; Beilin, Lawrence J.; Palmer, Lyle J.; Lye, Stephen J.; Briollais, Laurent			Modelling BMI Trajectories in Children for Genetic Association Studies	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; QUALITY-OF-LIFE; OBESE CHILDREN; FTO GENE; WAIST CIRCUMFERENCE; COMMON VARIANTS; ADULT OBESITY; CHILDHOOD; LOCI	Background: The timing of associations between common genetic variants and changes in growth patterns over childhood provide insight into the development of obesity in later life. To address this question, it is important to define appropriate statistical models to allow for the detection of genetic effects influencing longitudinal childhood growth. Methods and Results: Children from The Western Australian Pregnancy Cohort (Raine; n = 1,506) Study were genotyped at 17 genetic loci shown to be associated with childhood obesity (FTO, MC4R, TMEM18, GNPDA2, KCTD15, NEGR1, BDNF, ETV5, SEC16B, LYPLAL1, TFAP2B, MTCH2, BCDIN3D, NRXN3, SH2B1, MRSA) and an obesity-risk-allele-score was calculated as the total number of 'risk alleles' possessed by each individual. To determine the statistical method that fits these data and has the ability to detect genetic differences in BMI growth profile, four methods were investigated: linear mixed effects model, linear mixed effects model with skew-t random errors, semi-parametric linear mixed models and a non-linear mixed effects model. Of the four methods, the semi-parametric linear mixed model method was the most efficient for modelling childhood growth to detect modest genetic effects in this cohort. Using this method, three of the 17 loci were significantly associated with BMI intercept or trajectory in females and four in males. Additionally, the obesity-risk-allele score was associated with increased average BMI (female: beta = 0.0049, P = 0.0181; male: beta = 0.0071, P = 0.0001) and rate of growth (female: beta = 0.0012, P = 0.0006; male: beta = 0.0008, P = 0.0068) throughout childhood. Conclusions: Using statistical models appropriate to detect genetic variants, variations in adult obesity genes were associated with childhood growth. There were also differences between males and females. This study provides evidence of genetic effects that may identify individuals early in life that are more likely to rapidly increase their BMI through childhood, which provides some insight into the biology of childhood growth.	[Warrington, Nicole M.; Pennell, Craig E.; Marsh, Julie A.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Warrington, Nicole M.; Wu, Yan Yan; Palmer, Lyle J.; Lye, Stephen J.; Briollais, Laurent] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Beilin, Lawrence J.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Palmer, Lyle J.] Ontario Inst Canc Res, Toronto, ON, Canada	University of Western Australia; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Western Australia; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Briollais, L (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	laurent@lunenfeld.ca	Study, Raine/K-4517-2013; Pennell, Craig/ABD-6902-2020; Study, Raine/G-9547-2015; Warrington, Nicole/P-4868-2014; Wu, Yanyan/H-1356-2017; Palmer, Lyle John/N-1948-2019; Briollais, Laurent/A-2941-2013; Lye, Stephen J/E-7269-2013; Palmer, Lyle John/K-3196-2014	Pennell, Craig/0000-0002-0937-6165; Warrington, Nicole/0000-0003-4195-775X; Wu, Yanyan/0000-0003-1553-1392; Palmer, Lyle John/0000-0002-1628-3055; Lye, Stephen J/0000-0002-3305-4406; Palmer, Lyle John/0000-0002-1628-3055; Marsh, Julie/0000-0001-8984-6907	University of Western Australia (UWA); Raine Medical Research Foundation; UWA Faculty of Medicine; Dentistry and Health Sciences; Telethon Institute for Child Health Research, Curtin University; Women and Infants Research Foundation; National Health and Medical Research Council of Australia [403981, 003209]; Canadian Institutes of Health Research [MOP-82893]; Australian Postgraduate Award from Australian Government of Innovation, Industry, Science and Research; Raine Study PhD Top-Up Scholarship	University of Western Australia (UWA); Raine Medical Research Foundation; UWA Faculty of Medicine; Dentistry and Health Sciences; Telethon Institute for Child Health Research, Curtin University; Women and Infants Research Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Australian Postgraduate Award from Australian Government of Innovation, Industry, Science and Research; Raine Study PhD Top-Up Scholarship	The following institutions provide funding for Core Management of the Raine Study: The University of Western Australia (UWA), Raine Medical Research Foundation, UWA Faculty of Medicine, Dentistry and Health Sciences, The Telethon Institute for Child Health Research, Curtin University and Women and Infants Research Foundation. This study was supported by project grants from the National Health and Medical Research Council of Australia (Grant ID 403981 and ID 003209; http://www.nhmrc.gov.au/) and the Canadian Institutes of Health Research (Grant ID MOP-82893; http://www.cihr-irsc.gc.ca/e/193.html). Ms. Warrington is funded by an Australian Postgraduate Award from the Australian Government of Innovation, Industry, Science and Research and a Raine Study PhD Top-Up Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzalini A, 1999, J ROY STAT SOC B, V61, P579, DOI 10.1111/1467-9868.00194; Borghi E, 2006, STAT MED, V25, P247, DOI 10.1002/sim.2227; Bradford NF, 2009, PRIMARY CARE, V36, P319, DOI 10.1016/j.pop.2009.01.002; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Cheng J, 2010, STAT MED, V29, P504, DOI 10.1002/sim.3775; Cole TJ, 2010, INT J EPIDEMIOL, V39, P1558, DOI 10.1093/ije/dyq115; Cotsapas C, 2009, HUM MOL GENET, V18, P3502, DOI 10.1093/hmg/ddp292; den Hoed M, 2010, DIABETES, V59, P2980, DOI 10.2337/db10-0370; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; DONNELLY CA, 1995, J AM STAT ASSOC, V90, P984, DOI 10.2307/2291334; Efron B., 1994, INTRO BOOTSTRAP; Elks CE, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000284; Evans S, 1996, EARLY HUM DEV, V45, P203, DOI 10.1016/0378-3782(96)01728-8; Fox CS, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S18; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; GASSER T, 1984, ANN HUM BIOL, V11, P397, DOI 10.1080/03014468400007311; GOLDSTEIN H, 1986, ANN HUM BIOL, V13, P129, DOI 10.1080/03014468600008271; Griffiths LJ, 2010, INT J PEDIATR OBES, V5, P282, DOI 10.3109/17477160903473697; Hardy R, 2010, HUM MOL GENET, V19, P545, DOI 10.1093/hmg/ddp504; Haworth CMA, 2008, OBESITY, V16, P2663, DOI 10.1038/oby.2008.434; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Hinney A, 2009, OBESITY FACTS, V2, P3, DOI 10.1159/000200020; Huang RC, 2006, INT J OBES RES; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Janssens ACJW, 2007, GENET MED, V9, P528, DOI 10.1097/GIM.0b013e31812eece0; Janssens ACJW, 2006, GENET MED, V8, P395, DOI 10.1097/01.gim.0000229689.18263.f4; Jiao H, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-51; Kindblom JM, 2009, DIABETES, V58, P867, DOI 10.2337/db08-0606; Lachos VH, 2010, STAT SINICA, V20, P303; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lawlor DA, 2005, ARCH DIS CHILD, V90, P692, DOI 10.1136/adc.2004.062919; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Liu JZ, 2010, TWIN RES HUM GENET, V13, P179, DOI 10.1375/twin.13.2.179; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Milani S, 1989, Acta Paediatr Scand Suppl, V350, P95; NEWNHAM JP, 1993, LANCET, V342, P887, DOI 10.1016/0140-6736(93)91944-H; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Paternoster L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024303; PREECE MA, 1978, ANN HUM BIOL, V5, P1, DOI 10.1080/03014467800002601; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; RICE JA, 1991, J ROY STAT SOC B MET, V53, P233; Sawyer MG, 2006, AMBUL PEDIATR, V6, P306, DOI 10.1016/j.ambp.2006.08.005; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; Song PXK, 2007, STAT SINICA, V17, P929; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Srinivasan SR, 2006, HYPERTENSION, V48, P33, DOI 10.1161/01.HYP.0000226410.11198.f4; Taal HR, 2012, NAT GENET, V44, P532, DOI 10.1038/ng.2238; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Tsiros MD, 2009, INT J OBESITY, V33, P387, DOI 10.1038/ijo.2009.42; Wang K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018939; Wardle J, 2008, AM J CLIN NUTR, V87, P398, DOI 10.1093/ajcn/87.2.398; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Williams LA, 1997, BRIT MED J, V314, P1864, DOI 10.1136/bmj.314.7098.1864; Zhao JH, 2009, OBESITY, V17, P2254, DOI 10.1038/oby.2009.159	58	24	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53897	10.1371/journal.pone.0053897	http://dx.doi.org/10.1371/journal.pone.0053897			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349760	Green Published, gold, Green Submitted			2022-12-25	WOS:000313738900025
J	Bom, RJM; van der Helm, JJ; van der Loeff, MFS; van Rooijen, MS; Heijman, T; Matser, A; de Vries, HJC; Bruisten, SM				Bom, Reinier J. M.; van der Helm, Jannie J.; van der Loeff, Maarten F. Schim; van Rooijen, Martijn S.; Heijman, Titia; Matser, Amy; de Vries, Henry J. C.; Bruisten, Sylvia M.			Distinct Transmission Networks of Chlamydia trachomatis in Men Who Have Sex with Men and Heterosexual Adults in Amsterdam, The Netherlands	PLOS ONE			English	Article							LYMPHOGRANULOMA-VENEREUM; MOLECULAR EPIDEMIOLOGY; STRAINS; INFECTIONS; GENOTYPES	Background: Genovar distributions of Chlamydia trachomatis based on ompA typing differ between men who have sex with men (MSM) and heterosexuals. We investigated clonal relationships using a high resolution typing method to characterize C. trachomatis types in these two risk groups. Methods: C. trachomatis positive samples were collected at the STI outpatient clinic in Amsterdam between 2008 and 2010 and genotyped by multilocus sequence typing. Clusters were assigned using minimum spanning trees and these were combined with epidemiological data of the hosts. Results: We typed 526 C. trachomatis positive samples: 270 from MSM and 256 from heterosexuals. Eight clusters, containing 10-128 samples were identified of which 4 consisted of samples from MSM (90%-100%), with genovars D, G, J, and L2b. The other 4 clusters consisted mainly of samples from heterosexuals (87%-100%) with genovars D, E, F, I, and J. Genetic diversity was much lower in the MSM clusters than in heterosexual clusters. Significant differences in number of sexual partners and HIV-serostatus were observed for MSM-associated clusters. Conclusions: C. trachomatis transmission patterns among MSM and heterosexuals were largely distinct. We hypothesize that these differences are due to sexual host behavior, but bacterial factors may play a role as well.	[Bom, Reinier J. M.; van Rooijen, Martijn S.; Bruisten, Sylvia M.] Publ Hlth Serv Amsterdam GGD Amsterdam, Publ Hlth Lab, Amsterdam, Netherlands; [van der Helm, Jannie J.; van der Loeff, Maarten F. Schim; van Rooijen, Martijn S.; Heijman, Titia; Matser, Amy] Publ Hlth Serv Amsterdam GGD Amsterdam, Dept Res, Amsterdam, Netherlands; [van der Helm, Jannie J.; van Rooijen, Martijn S.; Heijman, Titia; de Vries, Henry J. C.] Publ Hlth Serv Amsterdam GGD Amsterdam, STI Outpatient Clin, Amsterdam, Netherlands; [van der Loeff, Maarten F. Schim; de Vries, Henry J. C.; Bruisten, Sylvia M.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immunol Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Matser, Amy] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [de Vries, Henry J. C.] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands	Public Health Service Amsterdam; Public Health Service Amsterdam; Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam	Bruisten, SM (corresponding author), Publ Hlth Serv Amsterdam GGD Amsterdam, Publ Hlth Lab, Amsterdam, Netherlands.	sbruisten@ggd.amsterdam.nl	de Vries, Henry/K-5963-2012	de Vries, Henry/0000-0001-9784-547X; van der Helm, Jannie/0000-0002-4288-9544; Matser, Amy/0000-0003-4291-1905; Heijman, Titia/0000-0002-1944-2007	ZonMW [125010008]; Public Health Service of Amsterdam (GGD Amsterdam), The Netherlands	ZonMW(Netherlands Organization for Health Research and Development); Public Health Service of Amsterdam (GGD Amsterdam), The Netherlands(Netherlands Government)	This work was supported by ZonMW [grant number 125010008] and the Public Health Service of Amsterdam (GGD Amsterdam), The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES RC, 1987, J INFECT DIS, V156, P953, DOI 10.1093/infdis/156.6.953; BEbEar C, 2009, CLIN MICROBIOL INFEC, V15, P4, DOI 10.1111/j.1469-0691.2008.02647.x; Bom RJM, 2011, J CLIN MICROBIOL, V49, P2844, DOI 10.1128/JCM.00128-11; Choudhury B, 2006, LANCET, V368, P139, DOI 10.1016/S0140-6736(06)69003-X; Christerson L, 2012, J CLIN MICROBIOL, V50, P3548, DOI 10.1128/JCM.01713-12; Dean D, 2009, EMERG INFECT DIS, V15, P1385, DOI 10.3201/eid1509.090272; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; Heijman TLJ, 2007, SEX TRANSM DIS, V34, P508, DOI 10.1097/01.olq.0000251209.52901.c3; Hsu MC, 2006, J MED MICROBIOL, V55, P301, DOI 10.1099/jmm.0.46262-0; Ikryannikova LN, 2010, FEMS IMMUNOL MED MIC, V59, P188, DOI 10.1111/j.1574-695X.2010.00678.x; Jeffrey BM, 2010, INFECT IMMUN, V78, P2544, DOI 10.1128/IAI.01324-09; Klint M, 2007, J CLIN MICROBIOL, V45, P1410, DOI 10.1128/JCM.02301-06; Kolader ME, 2006, J CLIN MICROBIOL, V44, P2689, DOI 10.1128/JCM.02311-05; Lysen M, 2004, J CLIN MICROBIOL, V42, P1641, DOI 10.1128/JCM.42.4.1641-1647.2004; Machado ACS, 2011, J MED MICROBIOL, V60, P472, DOI 10.1099/jmm.0.026476-0; Martin-Iguacel R, 2010, EUR J CLIN MICROBIOL, V29, P917, DOI 10.1007/s10096-010-0959-2; Mossman D, 2008, SEX TRANSM DIS, V35, P614, DOI 10.1097/OLQ.0b013e31816b1b80; Nieuwenhuis RF, 2004, CLIN INFECT DIS, V39, P996, DOI 10.1086/423966; Pannekoek Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-42; Pedersen LN, 2009, FEMS IMMUNOL MED MIC, V55, P120, DOI 10.1111/j.1574-695X.2008.00526.x; Quint KD, 2010, MOL CELL PROBE, V24, P266, DOI 10.1016/j.mcp.2010.04.007; Quint KD, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-63; Tjon G, 2007, J MED VIROL, V79, P488, DOI 10.1002/jmv.20821; van de Laar TJW, 2007, J INFECT DIS, V196, P230, DOI 10.1086/518796; Van der Bij AK, 2006, CLIN INFECT DIS, V42, P186, DOI 10.1086/498904; van Houdt R, 2007, J MED VIROL, V79, P895, DOI 10.1002/jmv.20820	26	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53869	10.1371/journal.pone.0053869	http://dx.doi.org/10.1371/journal.pone.0053869			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342025	Green Submitted, Green Published, gold			2022-12-25	WOS:000313682700057
J	Raynaud, CM; Halabi, N; Elliott, DA; Pasquier, J; Elefanty, AG; Stanley, EG; Rafii, A				Raynaud, Christophe M.; Halabi, Najeeb; Elliott, David A.; Pasquier, Jennifer; Elefanty, Andrew G.; Stanley, Edouard G.; Rafii, Arash			Human Embryonic Stem Cell Derived Mesenchymal Progenitors Express Cardiac Markers but Do Not Form Contractile Cardiomyocytes	PLOS ONE			English	Article							BONE-MARROW; CARDIOMYOGENIC DIFFERENTIATION; MYOCARDIAL-INFARCTION; RAT HEARTS; IN-VITRO; TRANSPLANTATION; TISSUE; REGENERATION; GROWTH; FIBROBLASTS	Mesenchymal progenitors or stromal cells have shown promise as a therapeutic strategy for a range of diseases including heart failure. In this context, we explored the growth and differentiation potential of mesenchymal progenitors (MPs) derived in vitro from human embryonic stem cells (hESCs). Similar to MPs isolated from bone marrow, hESC derived MPs (hESC-MPs) efficiently differentiated into archetypical mesenchymal derivatives such as chondrocytes and adipocytes. Upon treatment with 5-Azacytidine or TGF-beta 1, hESC-MPs modified their morphology and up-regulated expression of key cardiac transcription factors such as NKX2-5, MEF2C, HAND2 and MYOCD. Nevertheless, NKX2-5(+) hESC-MP derivatives did not form contractile cardiomyocytes, raising questions concerning the suitability of these cells as a platform for cardiomyocyte replacement therapy. Gene profiling experiments revealed that, although hESC-MP derived cells expressed a suite of cardiac related genes, they lacked the complete repertoire of genes associated with bona fide cardiomyocytes. Our results suggest that whilst agents such as TGF-beta 1 and 5-Azacytidine can induce expression of cardiac related genes, but treated cells retain a mesenchymal like phenotype.	[Raynaud, Christophe M.; Halabi, Najeeb; Pasquier, Jennifer; Rafii, Arash] Qatar Fdn, Weill Cornell Med Coll Qatar Educ City, Stem Cell & Microenvironm Lab, Doha, Qatar; [Raynaud, Christophe M.; Halabi, Najeeb; Pasquier, Jennifer; Rafii, Arash] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA; [Elliott, David A.; Elefanty, Andrew G.; Stanley, Edouard G.] Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic, Australia; [Elliott, David A.; Elefanty, Andrew G.; Stanley, Edouard G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University; Monash University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Rafii, A (corresponding author), Qatar Fdn, Weill Cornell Med Coll Qatar Educ City, Stem Cell & Microenvironm Lab, Doha, Qatar.	jat2021@qatar-med.cornell.edu	Halabi, Najeeb/AAX-8250-2020; Elliott, David/H-3334-2012; Rafii, Arash/E-4106-2013; Stanley, Ed G/A-2985-2013; Elefanty, Andrew G/A-6066-2008; Raynaud, Christophe/AAQ-9426-2020	Halabi, Najeeb/0000-0002-9345-6132; Elliott, David/0000-0003-1052-7407; Stanley, Ed G/0000-0002-6389-3665; Raynaud, Christophe/0000-0003-1551-8075; Pasquier, Jennifer/0000-0002-2465-7942; Elefanty, Andrew/0000-0001-6448-8314	Qatar-Foundation NPRP Grant [08-663-3-140]; Qatar foundation UREP Grant [06-116-1-023]; Qatar Foundation; Qatar Technology Transfer Grant; National Health and Medical Research Council of Australia; NPRP [09-1099-3-279]	Qatar-Foundation NPRP Grant(Qatar National Research Fund (QNRF)); Qatar foundation UREP Grant(Qatar National Research Fund (QNRF)); Qatar Foundation(Qatar Foundation (QF)Qatar National Research Fund (QNRF)); Qatar Technology Transfer Grant; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NPRP	This work was funded by Qatar-Foundation NPRP Grant 08-663-3-140 and NPRP 09-1099-3-279 Qatar foundation UREP Grant 06-116-1-023, Qatar Foundation, Qatar Technology Transfer Grant and the National Health and Medical Research Council of Australia. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Qatar National Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpornmaeklong P, 2009, STEM CELLS DEV, V18, P955, DOI 10.1089/scd.2008.0310; Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; Bondue A, 2010, CIRC RES, V107, P1414, DOI 10.1161/CIRCRESAHA.110.227058; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Cashman TJ, 2012, STEM CELL REV; Chacko SM, 2009, AM J PHYSIOL-HEART C, V296, pH1263, DOI 10.1152/ajpheart.01311.2008; Chi NH, 2012, BIOMATERIALS, V33, P5541, DOI 10.1016/j.biomaterials.2012.04.030; Elliott DA, 2011, NAT METHODS, V8, P1037, DOI [10.1038/NMETH.1740, 10.1038/nmeth.1740]; Elnakish MT, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/646038; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; Fukuda K, 2003, CYTOTECHNOLOGY, V41, P165, DOI 10.1023/A:1024882908173; Fukuda K, 2002, CR BIOL, V325, P1027, DOI 10.1016/S1631-0691(02)01524-X; Fukuda K, 2001, ARTIF ORGANS, V25, P187, DOI 10.1046/j.1525-1594.2001.025003187.x; Gwak SJ, 2009, CELL BIOCHEM FUNCT, V27, P148, DOI 10.1002/cbf.1547; Hakuno D, 2002, CIRCULATION, V105, P380, DOI 10.1161/hc0302.102593; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; James D, 2010, NAT BIOTECHNOL, V28, P161, DOI 10.1038/nbt.1605; Karlsson C, 2009, STEM CELL RES; Kim YS, 2011, CELLS TISSUES ORGANS; Koninckx R, 2009, CYTOTHERAPY, V11, P778, DOI 10.3109/14653240902988818; Li XH, 2012, MOL BIOL REP, V39, P1333, DOI 10.1007/s11033-011-0867-2; Lian QZ, 2007, STEM CELLS, V25, P425, DOI 10.1634/stemcells.2006-0420; Ling SK, 2011, BIOTECHNOL PROGR, V27, P473, DOI 10.1002/btpr.558; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Mohanty S, 2011, INT J CARDIOL; Olivier EN, 2006, STEM CELLS, V24, P1914, DOI 10.1634/stemcells.2005-0648; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Ramkisoensing AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024164; Rangappa S, 2003, ANN THORAC SURG, V75, P775, DOI 10.1016/S0003-4975(02)04568-X; Richardson JD, 2012, STEM CELL REV; Shi Bei, 2011, Zhonghua Yi Xue Za Zhi, V91, P2269; Siegel G, 2012, STEM CELLS DEV; Siegel G, 2012, STEM CELLS DEV, V21, P2457, DOI 10.1089/scd.2011.0626; Snider P, 2009, CIRC RES, V105, P934, DOI 10.1161/CIRCRESAHA.109.201400; Stamm C, 2003, LANCET, V361, P45, DOI 10.1016/S0140-6736(03)12110-1; Stojkovic P, 2005, STEM CELLS, V23, P895, DOI 10.1634/stemcells.2004-0326; Stojkovic P, 2005, STEM CELLS, V23, P306, DOI 10.1634/stemcells.2004-0137; Strauer BE, 2005, J AM COLL CARDIOL, V46, P1651, DOI 10.1016/j.jacc.2005.01.069; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Tse HF, 2003, LANCET, V361, P47, DOI 10.1016/S0140-6736(03)12111-3; Xing YJ, 2012, MOL CELL BIOCHEM, V360, P279, DOI 10.1007/s11010-011-1067-z; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91; Xu CH, 2004, STEM CELLS, V22, P972, DOI 10.1634/stemcells.22-6-972; Yamada Y, 2007, STEM CELLS, V25, P1326, DOI 10.1634/stemcells.2006-0588; Yang G, 2011, CELL TRANSPLANT; Yoo KJ, 2008, CAN J SURG, V51, P269	46	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54524	10.1371/journal.pone.0054524	http://dx.doi.org/10.1371/journal.pone.0054524			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342164	Green Published, gold			2022-12-25	WOS:000313682700121
J	Blanco-Rivero, J; Sastre, E; Caracuel, L; Granado, M; Balfagon, G				Blanco-Rivero, Javier; Sastre, Esther; Caracuel, Laura; Granado, Miriam; Balfagon, Gloria			Breast Feeding Increases Vasoconstriction Induced by Electrical Field Stimulation in Rat Mesenteric Artery. Role of Neuronal Nitric Oxide and ATP	PLOS ONE			English	Article							SENSORY NERVES; RELEASE; GENDER; HYPERTENSION; ENDOTHELIUM; INNERVATION; LACTATION; RESPONSES; VESSELS; ALTERS	Objectives: The aim of this study was to investigate in rat mesenteric artery whether breast feeding (BF) affects the vasomotor response induced by electrical field stimulation (EFS), participation by different innervations in the EFS-induced response and the mechanism/s underlying these possible modifications. Methods: Experiments were performed in female Sprague-Dawley rats (3 months old), divided into three groups: Control (in oestrous phase), mothers after 21 days of BF, and mothers that had recovered their oestral cycle (After BF, in oestrous phase). Vasomotor response to EFS, noradrenaline (NA) and nitric oxide (NO) donor DEA-NO were studied. Neuronal NO synthase (nNOS) and phosphorylated nNOS (P-nNOS) protein expression were analysed and NO, superoxide anion (O-2(center dot-)), NA and ATP releases were also determined. Results: EFS-induced contraction was higher in the BF group, and was recovered after BF. 1 mu mol/L phentolamine decreased the response to EFS similarly in control and BF rats. NA vasoconstriction and release were similar in both experimental groups. ATP release was higher in segments from BF rats. 0.1 mmol/L L-NAME increased the response to EFS in both control and BF rats, but more so in control animals. BF decreased NO release and did not modify O-2(center dot-) production. Vasodilator response to DEA-NO was similar in both groups, while nNOS and P-nNOS expressions were decreased in segments from BF animals. Conclusion: Breast feeding increases EFS-induced contraction in mesenteric arteries, mainly through the decrease of neuronal NO release mediated by decreased nNOS and P-nNOS expression. Sympathetic function is increased through the increased ATP release in BF rats.	[Blanco-Rivero, Javier; Sastre, Esther; Caracuel, Laura; Granado, Miriam; Balfagon, Gloria] Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain; [Blanco-Rivero, Javier; Balfagon, Gloria] Inst Invest Sanitaria IdIPaz, Madrid, Spain	Autonomous University of Madrid	Balfagon, G (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain.	gloria.balfagon@uam.es	Blanco-Rivero, Javier/J-6118-2014; Granado, Miriam/B-8978-2017; Rivero, Javier Blanco/ABE-8749-2020	Blanco-Rivero, Javier/0000-0001-7232-2314; Granado, Miriam/0000-0001-9178-8822; Rivero, Javier Blanco/0000-0001-7232-2314; Balfagon Calvo, Gloria/0000-0001-9477-7950	Ministerio de Ciencia e Innovacion [SAF 2009-10374]; Red Cardiovascular del Fondo de Investigaciones Sanitarias [RD06/0014/0011]; FPI-UAM fellowship; Alianza 4 Universidades Program	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Red Cardiovascular del Fondo de Investigaciones Sanitarias; FPI-UAM fellowship; Alianza 4 Universidades Program	This study was supported by Ministerio de Ciencia e Innovacion (SAF 2009-10374) and Red Cardiovascular del Fondo de Investigaciones Sanitarias (RD06/0014/0011). E. Sastre received a FPI-UAM fellowship. L. Caracuel received a fellowship from Alianza 4 Universidades Program.	Altemus M, 2001, PSYCHOSOM MED, V63, P814, DOI 10.1097/00006842-200109000-00015; ALTURA BM, 1984, FED PROC, V43, P80; Balfagon G, 2004, REGUL PEPTIDES, V120, P253, DOI 10.1016/j.regpep.2004.03.016; Blanco-Rivero J, 2011, CLIN SCI, V121, P331, DOI 10.1042/CS20110072; Blanco-Rivero J, 2011, EXP PHYSIOL, V96, P275, DOI 10.1113/expphysiol.2010.055822; Blanco-Rivero J, 2011, BRIT J PHARMACOL, V162, P271, DOI 10.1111/j.1476-5381.2010.01030.x; Calderone V, 2002, J PHARM PHARMACOL, V54, P523, DOI 10.1211/0022357021778808; del Campo L, 2011, EUR J PHARMACOL, V666, P142, DOI 10.1016/j.ejphar.2011.03.056; del Campo L, 2009, J HYPERTENS, V27, P791, DOI 10.1097/HJH.0b013e32832531e6; Donald JA, 2005, COMP BIOCHEM PHYS A, V142, P188, DOI 10.1016/j.cbpa.2005.07.015; Ferrer M, 1999, LIFE SCI, V66, P337; Flinsenberg TWH, 2010, AM J PHYSIOL-REG I, V298, pR1217, DOI 10.1152/ajpregu.00839.2009; GREENBERG S, 1974, CAN J PHYSIOL PHARM, V52, P14, DOI 10.1139/y74-003; Hogarth AJ, 2007, J HUM HYPERTENS, V21, P239, DOI 10.1038/sj.jhh.1002132; Hogarth AJ, 2007, CLIN SCI, V112, P353, DOI 10.1042/CS20060288; Iizuka T, 1997, J PEDIATR-US, V131, P839, DOI 10.1016/S0022-3476(97)70030-1; KAWASAKI H, 1988, NATURE, V335, P164, DOI 10.1038/335164a0; Kowalska Joanna, 2009, Postepy Biochem, V55, P323; Lambert E, 2007, J HYPERTENS, V25, P1411, DOI 10.1097/HJH.0b013e3281053af4; LI YJ, 1992, EUR J PHARMACOL, V210, P23, DOI 10.1016/0014-2999(92)90647-M; Loesch A, 2002, HISTOL HISTOPATHOL, V17, P591, DOI 10.14670/HH-17.591; Marin J, 2000, CLIN SCI, V99, P277, DOI 10.1042/CS20000009; Marin J, 1998, BRIT J PHARMACOL, V124, P473, DOI 10.1038/sj.bjp.0701856; McNamara JP, 2001, J DAIRY SCI, V84, P1382, DOI 10.3168/jds.S0022-0302(01)70169-5; Mezzacappa ES, 2005, J PSYCHOSOM RES, V58, P351, DOI 10.1016/j.jpsychores.2004.11.004; Molinari C, 2007, ENDOCRINOLOGY, V148, P4080, DOI 10.1210/en.2006-1577; NIELSEN KC, 1971, BRAIN RES, V27, P33, DOI 10.1016/0006-8993(71)90370-2; Peaker M, 1976, Ciba Found Symp, P87; Sastre E, 2010, REV NEUROLOGIA, V50, P727, DOI 10.33588/rn.5012.2010334; Sun C, 2001, NEUROREPORT, V12, P3497, DOI 10.1097/00001756-200111160-00025; Svennersten-Sjaunja K, 2005, DOMEST ANIM ENDOCRIN, V29, P241, DOI 10.1016/j.domaniend.2005.03.006; Takala J, 1996, BRIT J ANAESTH, V77, P50, DOI 10.1093/bja/77.1.50; Xavier FE, 2004, J HYPERTENS, V22, P949, DOI 10.1097/00004872-200405000-00017; YU XJ, 1993, EUR J PHARMACOL, V241, P35	34	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53802	10.1371/journal.pone.0053802	http://dx.doi.org/10.1371/journal.pone.0053802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342008	Green Submitted, gold, Green Published			2022-12-25	WOS:000314759400086
J	Breitfeld, J; Tonjes, A; Gast, MT; Schleinitz, D; Bluher, M; Stumvoll, M; Kovacs, P; Bottcher, Y				Breitfeld, Jana; Toenjes, Anke; Gast, Marie-Therese; Schleinitz, Dorit; Blueher, Matthias; Stumvoll, Michael; Kovacs, Peter; Boettcher, Yvonne			Role of Vaspin in Human Eating Behaviour	PLOS ONE			English	Article							SELF-CONTAINED POPULATION; GENETIC-VARIATION; ASSOCIATION; SORBS	Objective: The adipokine vaspin (visceral adipose tissue derived serine protease inhibitor, serpinA12) follows a meal-related diurnal variation in humans and intracerebroventricular vaspin administration leads to acutely reduced food intake in db/db mice. We therefore hypothesized that vaspin may play a role in human eating behaviour. Materials and Methods: We measured serum vaspin concentrations in 548 subjects from a self-contained population of Sorbs (Germany) who underwent detailed metabolic testing including eating behaviour assessments using the three-factor eating questionnaire. In addition, genetic variation within vaspin was assessed by genotyping 28 single nucleotide polymorphisms (SNPs) in all study subjects. Results: Serum vaspin concentrations correlated positively with restraint, disinhibition and hunger (all P<0.05), although the correlations did not withstand further adjustments for age, gender and BMI (all P>0.05). Independent of observed correlations, genetic variants in vaspin were associated with serum vaspin levels but showed no significant association with any of the eating behaviour phenotypes after accounting for multiple testing (P >= 0.05 after adjusting for age, gender and BMI). Conclusion: Our data suggest that serum vaspin concentrations might modulate human eating behaviour, which does not seem to be affected by common genetic variation in vaspin.	[Breitfeld, Jana; Toenjes, Anke; Gast, Marie-Therese; Schleinitz, Dorit; Blueher, Matthias; Stumvoll, Michael; Kovacs, Peter] Univ Leipzig, Dept Med, D-04109 Leipzig, Germany; [Toenjes, Anke; Boettcher, Yvonne] Univ Leipzig, IFB Adipos Dis, D-04109 Leipzig, Germany	Leipzig University; Leipzig University	Kovacs, P (corresponding author), Univ Leipzig, Dept Med, D-04109 Leipzig, Germany.	peter.kovacs@medizin.uni-leipzig.de	Stumvoll, Michael/ABE-1121-2021	Stumvoll, Michael/0000-0001-6225-8240; Kovacs, Peter/0000-0002-0290-5423	Federal Ministry of Education and Research (BMBF); Boehringer Ingelheim Foundation; Integrated Research and Treatment Center IFB Adiposity Diseases [K7-38, K7-39, K7-37, K403]; Deutsche Forschungsgemeinschaft (DFG); Clinical Research Group "Atherobesity" [KFO 152, BL 833/1-1, Stu192/6-1, KO 3512/1-1, KO 3880/1-2]; German Diabetes Association; DDS Foundation; DHFD (Diabetes Hilfs- und Forschungsfonds Deutschland); LIFE - Leipzig Research Center for Civilization Diseases, Universitat Leipzig; European Union; European Regional Development Fund (ERDF); Free State of Saxony; Federal Ministry of Education and Research (BMBF), Germany [FKZ: 01EO1001]	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Boehringer Ingelheim Foundation(Boehringer Ingelheim); Integrated Research and Treatment Center IFB Adiposity Diseases; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Clinical Research Group "Atherobesity"(German Research Foundation (DFG)); German Diabetes Association; DDS Foundation; DHFD (Diabetes Hilfs- und Forschungsfonds Deutschland); LIFE - Leipzig Research Center for Civilization Diseases, Universitat Leipzig; European Union(European Commission); European Regional Development Fund (ERDF)(European Commission); Free State of Saxony; Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the Federal Ministry of Education and Research (BMBF), Boehringer Ingelheim Foundation (to P. K. and D. S.), Integrated Research and Treatment Center IFB Adiposity Diseases, K7-38, K7-39 (to Y.B.) and K7-37 and K403 (to A. T.), Deutsche Forschungsgemeinschaft (DFG), the Clinical Research Group "Atherobesity" KFO 152 (projects BL 833/1-1 to M. B., and Stu192/6-1 (MS), KO 3512/1-1 to A. K., KO 3880/1-2 to P. K., M. B. and J.B.), from the German Diabetes Association (to D. S. and P. K.), from the DDS Foundation to Y.B., DHFD (Diabetes Hilfs- und Forschungsfonds Deutschland; to M. S., P. K., M. B., A. T.), and LIFE - Leipzig Research Center for Civilization Diseases, Universitat Leipzig. LIFE is funded by means of the European Union, by the European Regional Development Fund (ERDF) and by means of the Free State of Saxony within the framework of the excellence initiative. IFB Adiposity Diseases is supported by the Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01EO1001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Breitfeld J, 2013, INT J OBESITY, V37, P861, DOI 10.1038/ijo.2012.133; Brunetti L, 2011, PEPTIDES, V32, P1866, DOI 10.1016/j.peptides.2011.08.003; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Hida K, 2005, P NATL ACAD SCI USA, V102, P10610, DOI 10.1073/pnas.0504703102; Jeong E, 2010, J CLIN ENDOCR METAB, V95, P1869, DOI 10.1210/jc.2009-1088; KAWANO K, 1992, DIABETES, V41, P1422, DOI 10.2337/diabetes.41.11.1422; Kempf K, 2010, EXP CLIN ENDOCR DIAB, V118, P184, DOI 10.1055/s-2008-1081499; Kloting N, 2011, DIABETOLOGIA, V54, P1819, DOI 10.1007/s00125-011-2137-1; Nakatsuka A, 2012, DIABETES, V61, P2823, DOI 10.2337/db12-0232; Pudel V, 1989, FRAGEBOGEN ZUM ESSVE; Teshigawara S, 2012, J CLIN ENDOCR METAB, V97, pE1202, DOI 10.1210/jc.2011-3297; Tonjes A, 2010, EUR J HUM GENET, V18, P104, DOI 10.1038/ejhg.2009.107; Tonjes A, 2009, HUM MOL GENET, V18, P4662, DOI 10.1093/hmg/ddp423; Veeramah KR, 2011, EUR J HUM GENET, V19, P995, DOI 10.1038/ejhg.2011.65; You BS, 2008, DIABETES, V57, P372, DOI 10.2337/db07-1045	16	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54140	10.1371/journal.pone.0054140	http://dx.doi.org/10.1371/journal.pone.0054140			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342091	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400125
J	Dykstra, KM; Ulengin, I; DelRose, N; Lee, TH				Dykstra, Kaitlyn M.; Ulengin, Idil; DelRose, Nicholas; Lee, Tina H.			Identification of Discrete Sites in Yip1A Necessary for Regulation of Endoplasmic Reticulum Structure	PLOS ONE			English	Article							GOLGI MEMBRANE-PROTEIN; CELLS; COMPLEX; ER; TRANSPORT; BIOGENESIS; INTERACTS; REVEALS; ORGANIZATION; REDUCTASE	The endoplasmic reticulum (ER) of specialized cells can undergo dramatic changes in structural organization, including formation of concentric whorls. We previously reported that depletion of Yip1A, an integral membrane protein conserved between yeast and mammals, caused ER whorl formation reminiscent of that seen in specialized cells. Yip1A and its yeast homologue Yip1p cycle between the ER and early Golgi, have been implicated in a number of distinct trafficking steps, and interact with a conserved set of binding partners including Yif1p/Yif1A and the Ypt1/Ypt31 Rab GTPases. Here, we carried out a mutational analysis of Yip1A to obtain insight into how it regulates ER whorl formation. Most of the Yip1A cytoplasmic domain was dispensable, whereas the transmembrane (TM) domain, especially residues within predicted TM helices 3 and 4, were sensitive to mutagenesis. Comprehensive analysis revealed two discrete functionally required determinants. One was E95 and flanking residues L92 and L96 within the cytoplasmic domain; the other was K146 and nearby residue V152 within the TM domain. Notably, the identified determinants correspond closely to two sites previously found to be essential for yeast viability (E76 and K130 in Yip1p corresponding to E95 and K146 in Yip1A, respectively). In contrast, a third site (E89) also essential for yeast viability (E70 in Yip1p) was dispensable for regulation of whorl formation. Earlier work showed that E76 (E95) was dispensable for binding Yif1p or Ypt1p/Ypt31p, whereas E70 (E89) was required. Collectively, these findings suggest that the ability of Yip1A to bind its established binding partners may be uncoupled from its ability to control ER whorl formation. In support, Yif1A knockdown did not cause ER whorl formation. Thus Yip1A may use the sites identified herein to interact with a novel binding partner to regulate ER membrane organization.	[Dykstra, Kaitlyn M.; Ulengin, Idil; DelRose, Nicholas; Lee, Tina H.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Lee, TH (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	thl@andrew.cmu.edu		Dykstra, Kaitlyn/0000-0002-8447-8364	National Institutes of Health (NIH) [R21DK088280]; ACS [CSM-112734]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK088280] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ACS(American Cancer Society); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by a National Institutes of Health (NIH) exploratory research grant R21DK088280 and an ACS research scholar grant CSM-112734. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLUWALIA N, 1992, J BIOL CHEM, V267, P10914; Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200; Barrowman J, 2003, J BIOL CHEM, V278, P19878, DOI 10.1074/jbc.M302406200; Baumann O, 2001, INT REV CYTOL, V205, P149, DOI 10.1016/S0074-7696(01)05004-5; Calero M, 2001, J BIOL CHEM, V276, P12100, DOI 10.1074/jbc.M008439200; CARR I, 1962, ANAT REC, V144, P143, DOI 10.1002/ar.1091440209; Chen CZ, 2004, GENETICS, V168, P1827, DOI 10.1534/genetics.104.032888; CHIN DJ, 1982, P NATL ACAD SCI-BIOL, V79, P1185, DOI 10.1073/pnas.79.4.1185; Dykstra KM, 2010, MOL BIOL CELL, V21, P1556, DOI 10.1091/mbc.E09-12-1002; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Heidtman M, 2005, MOL BIOL CELL, V16, P1673, DOI 10.1091/mbc.E04-10-0873; Heidtman M, 2003, J CELL BIOL, V163, P57, DOI 10.1083/jcb.200306118; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Kalies KU, 1998, J CELL BIOL, V141, P887, DOI 10.1083/jcb.141.4.887; Kano F, 2009, J CELL SCI, V122, P2218, DOI 10.1242/jcs.043414; Kapetanovich L, 2005, MOL BIOL CELL, V16, P835, DOI 10.1091/mbc.e04-09-0785; KING JC, 1974, CELL TISSUE RES, V153, P497; Koning AJ, 1996, MOL BIOL CELL, V7, P769, DOI 10.1091/mbc.7.5.769; LEE C, 1989, J CELL BIOL, V109, P2045, DOI 10.1083/jcb.109.5.2045; Lorente-Rodriguez A, 2009, J CELL SCI, V122, P1540, DOI 10.1242/jcs.042457; Matern H, 2000, EMBO J, V19, P4485, DOI 10.1093/emboj/19.17.4485; NICKERSO.PA, 1969, J CELL BIOL, V40, P859, DOI 10.1083/jcb.40.3.859; Pedrazzini E, 2000, J CELL BIOL, V148, P899, DOI 10.1083/jcb.148.5.899; Puthenveedu MA, 2004, P NATL ACAD SCI USA, V101, P1253, DOI 10.1073/pnas.0306373101; RAJASEKARAN AK, 1993, J CELL SCI, V105, P333; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Storrie B, 1998, J CELL BIOL, V143, P1505, DOI 10.1083/jcb.143.6.1505; TAKEI K, 1994, NEURON, V12, P327, DOI 10.1016/0896-6273(94)90275-5; Tang BL, 2001, J BIOL CHEM, V276, P40008, DOI 10.1074/jbc.M106189200; TERASAKI M, 1986, J CELL BIOL, V103, P1557, DOI 10.1083/jcb.103.4.1557; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; WIEST DL, 1990, J CELL BIOL, V110, P1501, DOI 10.1083/jcb.110.5.1501; Yamamoto A, 1996, J CELL SCI, V109, P1727; Yang XP, 1998, EMBO J, V17, P4954, DOI 10.1093/emboj/17.17.4954; Yoshida Y, 2008, EXP CELL RES, V314, P3427, DOI 10.1016/j.yexcr.2008.07.023	36	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54413	10.1371/journal.pone.0054413	http://dx.doi.org/10.1371/journal.pone.0054413			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342155	gold, Green Published, Green Submitted			2022-12-25	WOS:000314759400164
J	Yamada, Y; Kawabe, T				Yamada, Yuki; Kawabe, Takahiro			Localizing Non-Retinotopically Moving Objects	PLOS ONE			English	Article							DISTORTS VISUAL SPACE; REPRESENTATIONAL MOMENTUM; PERCEIVED POSITION; MENTAL EXTRAPOLATION; TARGET POSITION; HUMAN-VISION; MOTION; ATTENTION; DISPLAY; MEMORY	How does the brain determine the position of moving objects? It turns out to be rather complex to answer this question when we realize that the brain has to solve the motion correspondence problem in two kinds of reference frames: Retinotopic and non-retinotopic ones. We show that visual objects are mislocalized along a non-retinotopic motion direction. Observers viewed two successive movie frames each consisting of an outlined square and two target elements inside the square. In the non-retinotopic condition the elements as well as the square moved vertically while two bars also centripetally or centrifugally moved. In the retinotopic condition the vertical movement of them was removed from the stimuli. The task of the observers was to judge a relative position of the elements. Consequently, the elements were mislocalized in the direction of both retinotopic and non-retinotopic motion, although the mislocalization was significantly larger in the retinotopic than in the non-retinotopic conditions. The results suggest that non-retinotopic as well as retinotopic motion processing contributes to the determination of perceived positions of moving objects.	[Yamada, Yuki] Yamaguchi Univ, Res Inst Time Studies, Yamaguchi, Japan; [Yamada, Yuki] Kyushu Univ, Fac Human Environm Studies, Fukuoka 812, Japan; [Kawabe, Takahiro] NTT Commun Sci Labs, Human Informat Sci Lab, Atsugi, Kanagawa, Japan	Yamaguchi University; Kyushu University; Nippon Telegraph & Telephone Corporation	Yamada, Y (corresponding author), Yamaguchi Univ, Res Inst Time Studies, Yamaguchi, Japan.	yamadayuk@gmail.com	Yamada, Yuki/B-2671-2008	Yamada, Yuki/0000-0003-1431-568X	JSPS KAKENHI [24830054]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (Grants-in-Aid for Scientific Research) Grant Number 24830054. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin M, 2011, VISION RES, V51, P435, DOI 10.1016/j.visres.2010.12.013; Boi M, 2011, CURR BIOL, V21, P1732, DOI 10.1016/j.cub.2011.08.059; Boi M, 2011, J VISION, V11, DOI 10.1167/11.3.7; Boi M, 2009, J VISION, V9, DOI 10.1167/9.13.5; Bressler DW, 2006, VISION RES, V46, P1120, DOI 10.1016/j.visres.2005.10.012; FREYD JJ, 1984, J EXP PSYCHOL LEARN, V10, P126, DOI 10.1037/0278-7393.10.1.126; Frohlich FW., 1923, Z SINNESPHYSIOL, V54, P58; Grossberg S, 2011, ATTEN PERCEPT PSYCHO, V73, P1147, DOI 10.3758/s13414-011-0095-9; Herzog MH, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00119; Hubbard TL, 2005, PSYCHON B REV, V12, P822, DOI 10.3758/BF03196775; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Johansson G., 1950, CONFIGURATIONS EVENT; Kawabe T, 2011, ATTEN PERCEPT PSYCHO, V73, P1522, DOI 10.3758/s13414-011-0128-4; Kawabe T, 2008, J VISION, V8, DOI 10.1167/8.8.7; Kerzel D, 2005, CURR DIR PSYCHOL SCI, V14, P180, DOI 10.1111/j.0963-7214.2005.00360.x; Kerzel D, 2003, VISION RES, V43, P2623, DOI 10.1016/S0042-6989(03)00466-8; Kerzel D, 2003, COGNITION, V88, P109, DOI 10.1016/S0010-0277(03)00018-0; Kirschfeld K, 1999, VISION RES, V39, P3702, DOI 10.1016/S0042-6989(99)00089-9; MACKAY DM, 1958, NATURE, V181, P507, DOI 10.1038/181507a0; Ogmen H, 2006, VISION RES, V46, P3234, DOI 10.1016/j.visres.2006.04.007; Otto TU, 2008, J VISION, V8, DOI 10.1167/8.7.16; PANTLE A, 1976, SCIENCE, V193, P500, DOI 10.1126/science.941023; PETERSIK JT, 1979, VISION RES, V19, P143, DOI 10.1016/0042-6989(79)90044-0; Pratt J, 2008, ACTA PSYCHOL, V127, P137, DOI 10.1016/j.actpsy.2007.03.003; Shim WM, 2004, VISION RES, V44, P2393, DOI 10.1016/j.visres.2004.05.003; Suchow JW, 2011, CURR BIOL, V21, P140, DOI 10.1016/j.cub.2010.12.019; Suzuki S, 1997, J EXP PSYCHOL HUMAN, V23, P443, DOI 10.1037/0096-1523.23.2.443; Ternus J, 1926, PSYCHOL FORSCH, V7, P81, DOI 10.1007/BF02424350; Whitney D, 2000, NAT NEUROSCI, V3, P954, DOI 10.1038/78878; Whitney D, 2006, J EXP PSYCHOL HUMAN, V32, P1380, DOI 10.1037/0096-1523.32.6.1380; Yamada Y, 2011, J VISION, V11, DOI 10.1167/11.6.6	31	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53815	10.1371/journal.pone.0053815	http://dx.doi.org/10.1371/journal.pone.0053815			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342009	Green Submitted, Green Published, gold			2022-12-25	WOS:000314759400087
J	Anderson, OS; Peterson, KE; Sanchez, BN; Zhang, ZZ; Mancuso, P; Dolinoy, DC				Anderson, Olivia S.; Peterson, Karen E.; Sanchez, Brisa N.; Zhang, Zhenzhen; Mancuso, Peter; Dolinoy, Dana C.			Perinatal bisphenol A exposure promotes hyperactivity, lean body composition, and hormonal responses across the murine life course	FASEB JOURNAL			English	Article						developmental origins of health and disease; energy expenditure; glucose; insulin; metabolic homeostasis	ENDOCRINE-DISRUPTING CHEMICALS; OXYGEN-CONSUMPTION; METABOLIC SYNDROME; RECEPTOR; URINARY; BRAIN; RATS; MICE; BEHAVIOR; ASSOCIATION	The development of adult-onset diseases is influenced by perinatal exposure to altered environmental conditions. One such exposure, bisphenol A (BPA), has been associated with obesity and diabetes, and consequently labeled an obesogen. Using an isogenic murine model, we examined the effects of perinatal exposure through maternal diet to 50 ng (n=20), 50 mu g (n=21), or 50 mg (n=18) BPA/kg diet, as well as controls (n=20) on offspring energy expenditure, spontaneous activity, and body composition at 3, 6, and 9 mo of age, and hormone levels at 9 and 10 mo of age. Overall, exposed females and males exhibited increased energy expenditure (P<0.001 and 0.001, respectively) throughout the life course. In females, horizontal and vertical activity increased (P=0.07 and 0.06, respectively) throughout the life course. Generally, body composition measures were not different throughout the life course in exposed females or males (all P>0.44), although body fat and weight decreased in exposed females at particular ages (all P<0.08). Milligram-exposed females had improved glucose, insulin, adiponectin, and leptin profiles (all P<0.10). Thus, life-course analysis illustrates that BPA is associated with hyperactive and lean phenotypes. Variability across studies may be attributable to differential exposure duration and timing, dietary fat and phytoestrogen content, or lack of sophisticated phenotyping across the life course.-Anderson, O.S., Peterson, K. E., Sanchez, B.N., Zhang, Z., Mancuso, P., Dolinoy, D. C. Perinatal bisphenol A exposure promotes hyperactivity, lean body composition, and hormonal responses across the murine life course. FASEB J. 27, 1784-1792 (2013). www.fasebj.org	[Anderson, Olivia S.; Peterson, Karen E.; Mancuso, Peter; Dolinoy, Dana C.] Univ Michigan, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA; [Peterson, Karen E.] Univ Michigan, Ctr Human Growth & Dev, Ann Arbor, MI 48109 USA; [Sanchez, Brisa N.; Zhang, Zhenzhen] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Dolinoy, DC (corresponding author), Univ Michigan, 1415 Washington Hts, Ann Arbor, MI 48109 USA.	ddolinoy@umich.edu	Mancuso, Peter/AGZ-3550-2022	Mancuso, Peter/0000-0002-2559-7320	MNORC [P30 DK089503]; U.S. National Institutes of Health [R01 ES017524]; University of Michigan National Institute of Environmental Health Sciences (NIEHS) Center of Excellence grant [P30 ES017885]; University of Michigan NIEHS/Environmental Protection Agency Children's Environmental Health Formative Center grant [P20 ES018171/RD83480001]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097153, P30DK089503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES017885, R01ES017524, P20ES018171] Funding Source: NIH RePORTER	MNORC; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan National Institute of Environmental Health Sciences (NIEHS) Center of Excellence grant; University of Michigan NIEHS/Environmental Protection Agency Children's Environmental Health Formative Center grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Charles Burant, Nathan Qi, Malcolm Low, Katie Gee, and Melanie Schmidt [University of Michigan Nutrition and Obesity Research Center (MNORC) Animal Phenotyping Core] and Edmund O'Brien (Department of Environmental Health Sciences, University of Michigan) for their technical and intellectual assistance with this project. This work was supported by a pilot grant from the MNORC (P30 DK089503), as well as U.S. National Institutes of Health grant R01 ES017524, University of Michigan National Institute of Environmental Health Sciences (NIEHS) Center of Excellence grant P30 ES017885, and University of Michigan NIEHS/Environmental Protection Agency Children's Environmental Health Formative Center grant P20 ES018171/RD83480001. The authors declare no conflicts of interest.	Ahima RS, 2006, OBESITY, V14, p9S, DOI 10.1038/oby.2006.276; Alonso-Magdalena P, 2010, ENVIRON HEALTH PERSP, V118, P1243, DOI 10.1289/ehp.1001993; Anderson OS, 2012, ENVIRON MOL MUTAGEN, V53, P334, DOI 10.1002/em.21692; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Batista TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033814; Becker JB, 2005, ENDOCRINOLOGY, V146, P1650, DOI 10.1210/en.2004-1142; Ben-Jonathan N, 2009, MOL CELL ENDOCRINOL, V304, P49, DOI 10.1016/j.mce.2009.02.022; Braun JM, 2011, PEDIATRICS, V128, P873, DOI 10.1542/peds.2011-1335; Braun JM, 2009, ENVIRON HEALTH PERSP, V117, P1945, DOI 10.1289/ehp.0900979; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Decherf S, 2011, J TOXICOL ENV HEAL B, V14, P423, DOI 10.1080/10937404.2011.578561; Ferguson SA, 2011, TOXICOL SCI, V124, P149, DOI 10.1093/toxsci/kfr201; Goodell S, 1998, MECH AGEING DEV, V101, P245, DOI 10.1016/S0047-6374(97)00182-6; Gould JC, 1998, MOL CELL ENDOCRINOL, V142, P203, DOI 10.1016/S0303-7207(98)00084-7; Heindel JJ, 2009, MOL CELL ENDOCRINOL, V304, P90, DOI 10.1016/j.mce.2009.02.025; Hugo ER, 2008, ENVIRON HEALTH PERSP, V116, P1642, DOI 10.1289/ehp.11537; Institute for Laboratory Animal Resources, 1966, GUIDE CARE USE LAB A; Ishido M, 2005, REGUL PEPTIDES, V126, P145, DOI 10.1016/j.regpep.2004.08.035; Jasarevic E, 2011, P NATL ACAD SCI USA, V108, P11715, DOI 10.1073/pnas.1107958108; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jones BA, 2012, HORM BEHAV, V61, P605, DOI 10.1016/j.yhbeh.2012.02.011; Kruger T, 2008, TOXICOLOGY, V246, P112, DOI 10.1016/j.tox.2007.12.028; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kundakovic M, 2011, BRAIN BEHAV IMMUN, V25, P1084, DOI 10.1016/j.bbi.2011.02.005; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Masuo Y, 2011, J TOXICOL ENV HEAL B, V14, P346, DOI 10.1080/10937404.2011.578557; Matsuda S, 2010, CHEMOSPHERE, V78, P894, DOI 10.1016/j.chemosphere.2009.11.010; McKenzie DJ, 2007, PHILOS T R SOC B, V362, P2043, DOI 10.1098/rstb.2007.2100; Miltenberger RJ, 1997, J NUTR, V127, pS1902, DOI 10.1093/jn/127.9.1902S; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Moriyama K, 2002, J CLIN ENDOCR METAB, V87, P5185, DOI 10.1210/jc.2002-020209; Newbold RR, 2010, HORM-INT J ENDOCRINO, V9, P206, DOI 10.14310/horm.2002.1271; Osman AF, 2000, J AM COLL CARDIOL, V36, P2126, DOI 10.1016/S0735-1097(00)00985-2; Patisaul HB, 2008, BRAIN RES REV, V57, P352, DOI 10.1016/j.brainresrev.2007.06.008; Rubin BS, 2009, MOL CELL ENDOCRINOL, V304, P55, DOI 10.1016/j.mce.2009.02.023; Ryan KK, 2010, ENDOCRINOLOGY, V151, P2603, DOI 10.1210/en.2009-1218; Saal FSV, 2012, MOL CELL ENDOCRINOL, V354, P74, DOI 10.1016/j.mce.2012.01.001; Saili KS, 2012, TOXICOLOGY, V291, P83, DOI 10.1016/j.tox.2011.11.001; Sieli PT, 2011, ENVIRON HEALTH PERSP, V119, P1260, DOI 10.1289/ehp.1003385; Somm E, 2009, ENVIRON HEALTH PERSP, V117, P1549, DOI 10.1289/ehp.11342; Stern JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048790; Sui YP, 2012, ENVIRON HEALTH PERSP, V120, P399, DOI 10.1289/ehp.1104426; Takahashi O, 2003, FOOD CHEM TOXICOL, V41, P1035, DOI 10.1016/S0278-6915(03)00031-0; Takayanagi S, 2006, TOXICOL LETT, V167, P95, DOI 10.1016/j.toxlet.2006.08.012; Thomas P, 2006, J STEROID BIOCHEM, V102, P175, DOI 10.1016/j.jsbmb.2006.09.017; Trasande L, 2012, JAMA-J AM MED ASSOC, V308, P1113, DOI 10.1001/2012.jama.11461; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Viberg H, 2011, TOXICOLOGY, V290, P187, DOI 10.1016/j.tox.2011.09.006; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Wei J, 2011, ENDOCRINOLOGY, V152, P3049, DOI 10.1210/en.2011-0045; Wolstenholme JT, 2011, HORM BEHAV, V59, P296, DOI 10.1016/j.yhbeh.2010.10.001; Zhang ZF, 2011, ENVIRON SCI TECHNOL, V45, P7044, DOI 10.1021/es200976k; Zhou R, 2011, NEUROPHARMACOLOGY, V60, P789, DOI 10.1016/j.neuropharm.2011.01.031	54	78	79	0	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2013	27	4					1784	1792		10.1096/fj.12-223545	http://dx.doi.org/10.1096/fj.12-223545			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23345456	Green Submitted, Green Published			2022-12-25	WOS:000316940800046
J	Hua, PY; Zhang, LB; Guo, TT; Flanders, J; Zhang, SY				Hua, Panyu; Zhang, Libiao; Guo, Tingting; Flanders, Jon; Zhang, Shuyi			Dispersal, Mating Events and Fine-Scale Genetic Structure in the Lesser Flat-Headed Bats	PLOS ONE			English	Article							SEX-BIASED DISPERSAL; SPATIAL AUTOCORRELATION ANALYSIS; LONG-EARED BAT; TYLONYCTERIS-PACHYPUS; SWARMING SITES; HABITAT FRAGMENTATION; ROBUSTULA CHIROPTERA; POPULATION-STRUCTURE; MICROSATELLITE LOCI; SOCIAL-ORGANIZATION	Population genetic structure has important consequences in evolutionary processes and conservation genetics in animals. Fine-scale population genetic structure depends on the pattern of landscape, the permanent movement of individuals, and the dispersal of their genes during temporary mating events. The lesser flat-headed bat (Tylonycteris pachypus) is a nonmigratory Asian bat species that roosts in small groups within the internodes of bamboo stems and the habitats are fragmented. Our previous parentage analyses revealed considerable extra-group mating in this species. To assess the spatial limits and sex-biased nature of gene flow in the same population, we used 20 microsatellite loci and mtDNA sequencing of the ND2 gene to quantify genetic structure among 54 groups of adult flat-headed bats, at nine localities in South China. AMOVA and F-ST estimates revealed significant genetic differentiation among localities. Alternatively, the pairwise F-ST values among roosting groups appeared to be related to the incidence of associated extra-group breeding, suggesting the impact of mating events on fine-scale genetic structure. Global spatial autocorrelation analyses showed positive genetic correlation for up to 3 km, indicating the role of fragmented habitat and the specialized social organization as a barrier in the movement of individuals among bamboo forests. The male-biased dispersal pattern resulted in weaker spatial genetic structure between localities among males than among females, and fine-scale analyses supported that relatedness levels within internodes were higher among females than among males. Finally, only females were more related to their same sex roost mates than to individuals from neighbouring roosts, suggestive of natal philopatry in females.	[Hua, Panyu; Guo, Tingting; Zhang, Shuyi] E China Normal Univ, Inst Adv Studies Multidisciplinary Sci & Technol, Shanghai 200062, Peoples R China; [Hua, Panyu] E China Normal Univ, Shanghai Key Lab Urban Ecol Proc & Ecorestorat, Shanghai 200062, Peoples R China; [Zhang, Libiao] Guangdong Entomol Inst, Guangzhou, Guangdong, Peoples R China; [Flanders, Jon] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	East China Normal University; East China Normal University; Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences; University of Bristol	Zhang, SY (corresponding author), E China Normal Univ, Inst Adv Studies Multidisciplinary Sci & Technol, Shanghai 200062, Peoples R China.	syzhang@bio.ecnu.edu.cn		Flanders, Jon/0000-0001-7296-9601	National Science Foundation of China [30900159, 30800102, 31172077]; National Research Foundation for the Doctoral Program of Higher Education of China [20090076120018]; Shanghai Key Lab for Urban Ecological Processes and Eco-Restoration [SHUES201205]; Key Construction Program of the National '211' Project	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Research Foundation for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Shanghai Key Lab for Urban Ecological Processes and Eco-Restoration; Key Construction Program of the National '211' Project	This work was funded by the National Science Foundation of China (30900159, 30800102, 31172077), the National Research Foundation for the Doctoral Program of Higher Education of China (20090076120018), Shanghai Key Lab for Urban Ecological Processes and Eco-Restoration (SHUES201205), and a grant under the Key Construction Program of the National '211' Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archie EA, 2008, MOL ECOL, V17, P2666, DOI 10.1111/j.1365-294X.2008.03797.x; Arnold BD, 2007, AM MIDL NAT, V157, P374, DOI 10.1674/0003-0031(2007)157[374:PSASDI]2.0.CO;2; Beck NR, 2008, MOL ECOL, V17, P4346, DOI 10.1111/j.1365-294X.2008.03906.x; Belkhir K, 2004, GENETIX 4 05 LOGICIE; BRADBURY JW, 1976, BEHAV ECOL SOCIOBIOL, V1, P337, DOI 10.1007/BF00299399; Burland TM, 1999, P ROY SOC B-BIOL SCI, V266, P975, DOI 10.1098/rspb.1999.0732; Burland TM, 2001, MOL ECOL, V10, P1309, DOI 10.1046/j.1365-294X.2001.01273.x; Burland TM, 2001, BIOL REV, V76, P389, DOI 10.1017/S1464793101005747; Chen SF, 2008, J ZOOL, V274, P207, DOI 10.1111/j.1469-7998.2007.00391.x; CHESSER RK, 1991, GENETICS, V127, P437; Crochet PA, 2000, MOL ECOL, V9, P1463, DOI 10.1046/j.1365-294x.2000.01026.x; Double MC, 2005, EVOLUTION, V59, P625, DOI 10.1111/j.0014-3820.2005.tb01021.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Favre L, 1997, P ROY SOC B-BIOL SCI, V264, P127, DOI 10.1098/rspb.1997.0019; Gibbs JP, 2001, BIOL CONSERV, V100, P15, DOI 10.1016/S0006-3207(00)00203-2; Goodnight KF, 1999, MOL ECOL, V8, P1231, DOI 10.1046/j.1365-294x.1999.00664.x; Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x; Goudet J., 2001, FSTAT PROGRAM ESTIMA; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Griffin AS, 2003, SCIENCE, V302, P634, DOI 10.1126/science.1089402; Heckel G, 2002, BEHAV ECOL, V13, P750, DOI 10.1093/beheco/13.6.750; Heckel G, 1999, BEHAVIOUR, V136, P1173, DOI 10.1163/156853999501829; Hua PY, 2007, MOL ECOL NOTES, V7, P486, DOI 10.1111/j.1471-8286.2006.01629.x; Hua PY, 2011, MOL ECOL, V20, P3669, DOI 10.1111/j.1365-294X.2011.05192.x; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Johansson M, 2007, MOL ECOL, V16, P2693, DOI 10.1111/j.1365-294X.2007.03357.x; Kerth G, 2000, MOL ECOL, V9, P793, DOI 10.1046/j.1365-294x.2000.00934.x; Kerth G, 2003, CONSERV GENET, V4, P491, DOI 10.1023/A:1024771713152; Kerth G, 2002, MOL ECOL, V11, P1491, DOI 10.1046/j.1365-294X.2002.01528.x; Knutsen H, 2011, MOL ECOL, V20, P768, DOI 10.1111/j.1365-294X.2010.04979.x; MEDWAY, 1972, ZOOL J LINN SOC-LOND, V51, P33; MEDWAY L, 1970, J ZOOL, V161, P237; MEDWAY L, 1972, J ZOOL, V168, P463; Nagy M, 2007, P ROY SOC B-BIOL SCI, V274, P3019, DOI 10.1098/rspb.2007.1008; Ortega J, 2002, ETHOLOGY, V108, P1077, DOI 10.1046/j.1439-0310.2002.00836.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Peakall R, 2008, MOL ECOL, V4, P135; Petit E, 1999, P ROY SOC B-BIOL SCI, V266, P1717, DOI 10.1098/rspb.1999.0837; Petit E, 2001, EVOLUTION, V55, P635, DOI 10.1554/0014-3820(2001)055[0635:SBDIAM]2.0.CO;2; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rivers NM, 2005, MOL ECOL, V14, P4299, DOI 10.1111/j.1365-294X.2005.02748.x; Rossiter SJ, 2005, NATURE, V437, P408, DOI 10.1038/nature03965; Rossiter SJ, 2002, BEHAV ECOL SOCIOBIOL, V51, P510, DOI 10.1007/s00265-002-0467-1; Rossiter SJ, 2012, MOL ECOL, V21, P647, DOI 10.1111/j.1365-294X.2011.05391.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Simmons NB, 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Sokal RR, 1998, BIOL J LINN SOC, V65, P41, DOI 10.1111/j.1095-8312.1998.tb00350.x; Storz JF, 1999, J MAMMAL, V80, P553, DOI 10.2307/1383301; Storz JF, 2001, EVOLUTION, V55, P1215; Struebig MJ, 2011, ECOL LETT, V14, P582, DOI 10.1111/j.1461-0248.2011.01623.x; Sugg DW, 1996, TRENDS ECOL EVOL, V11, P338, DOI 10.1016/0169-5347(96)20050-3; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Veith M, 2004, HEREDITY, V93, P342, DOI 10.1038/sj.hdy.6800509; WILKINSON GS, 1984, NATURE, V308, P181, DOI 10.1038/308181a0; Yin JX, 2009, CONSERV GENET, V10, P1061, DOI 10.1007/s10592-008-9688-9; Zamudio KR, 2007, MOL ECOL, V16, P257, DOI 10.1111/j.1365-294X.2006.03139.x; Zhang L, 2007, J ZOOL, V271, P344, DOI 10.1111/j.1469-7998.2006.00210.x; Zhang LB, 2005, ACTA CHIROPTEROL, V7, P91, DOI 10.3161/1733-5329(2005)7[91:DOVITF]2.0.CO;2; Zhang LB, 2005, J MAMMAL, V86, P61, DOI 10.1644/1545-1542(2005)086<0061:DOFBTP>2.0.CO;2; Zhang Li-biao, 2004, Acta Zoologica Sinica, V50, P326; Zhang Libiao, 2011, Acta Theriologica Sinica, V31, P244	65	6	7	1	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54428	10.1371/journal.pone.0054428	http://dx.doi.org/10.1371/journal.pone.0054428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349888	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872800054
J	Boessenecker, RW; Churchill, M				Boessenecker, Robert W.; Churchill, Morgan			A Reevaluation of the Morphology, Paleoecology, and Phylogenetic Relationships of the Enigmatic Walrus Pelagiarctos	PLOS ONE			English	Article							BODY SIZES; CARNIVORA; MAMMALIA; ORIGIN; PREDATORS; EMPHASIS; CETACEA	Background: A number of aberrant walruses (Odobenidae) have been described from the Neogene of the North Pacific, including specialized suction-feeding and generalist fish-eating taxa. At least one of these fossil walruses has been hypothesized to have been a specialized predator of other marine mammals, the middle Miocene walrus Pelagiarctos thomasi from the Sharktooth Hill Bonebed of California (16.1-14.5 Ma). Methodology/Principal Findings: A new specimen of Pelagiarctos from the middle Miocene "Topanga" Formation of southern California (17.5-15 Ma) allows a reassessment of the morphology and feeding ecology of this extinct walrus. The mandibles of this new specimen are robust with large canines, bulbous premolars with prominent paraconid, metaconid, hypoconid cusps, crenulated lingual cingula with small talonid basins, M-2 present, double-rooted P-3-M-1, single-rooted P-1 and M-2, and a P-2 with a bilobate root. Because this specimen lacks a fused mandibular symphysis like Pelagiarctos thomasi, it is instead referred to Pelagiarctos sp. This specimen is more informative than the fragmentary holotype of Pelagiarctos thomasi, permitting Pelagiarctos to be included within a phylogenetic analysis for the first time. Analysis of a matrix composed of 90 cranial, dental, mandibular and postcranial characters indicates that Pelagiarctos is an early diverging walrus and sister to the late Miocene walrus Imagotaria downsi. We reevaluate the evidence for a macropredatory lifestyle for Pelagiarctos, and we find no evidence of specialization towards a macrophagous diet, suggesting that Pelagiarctos was a generalist feeder with the ability to feed on large prey. Conclusions/Significance: This new specimen of Pelagiarctos adds to the knowledge of this problematic taxon. The phylogenetic analysis conclusively demonstrates that Pelagiarctos is an early diverging walrus. Pelagiarctos does not show morphological specializations associated with macrophagy, and was likely a generalist predator, feeding on fish, invertebrates, and the occasional warm-blooded prey item.	[Boessenecker, Robert W.] Univ Otago, Dept Geol, Dunedin, Otago, New Zealand; [Boessenecker, Robert W.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; [Churchill, Morgan] Univ Wyoming, Dept Geol & Geophys, Laramie, WY 82071 USA; [Churchill, Morgan] Univ Wyoming, Program Ecol, Laramie, WY 82071 USA	University of Otago; University of California System; University of California Berkeley; University of Wyoming; University of Wyoming	Boessenecker, RW (corresponding author), Univ Otago, Dept Geol, Dunedin, Otago, New Zealand.	robert.boessenecker@otago.ac.nz			University of Otago Doctoral Scholarship; Paleontological Society Research Grant; Geological Society of America Graduate Student Research Grant; National Science Foundation (NSF)	University of Otago Doctoral Scholarship; Paleontological Society Research Grant; Geological Society of America Graduate Student Research Grant; National Science Foundation (NSF)(National Science Foundation (NSF))	RWB was supported during part of this study by a University of Otago Doctoral Scholarship. MC was supported during this study by a Paleontological Society Research Grant, a Geological Society of America Graduate Student Research Grant, and a National Science Foundation (NSF) East Asian Pacific Rim Summer Institute Fellowship. Funders webpages: http://www.otago.ac.nz/study/scholarships/database/otago014687.html; http://www.geosociety.org/grants/gradgrants.htm; http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5284; http://www.palass.org/modules.php?name = palaeo&page = 168&sec = awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Peter J., 2002, Oryctos, V4, P83; Aranda-Manteca Francisco J., 1994, Proceedings of the San Diego Society of Natural History, V29, P191; Arnason U, 2006, MOL PHYLOGENET EVOL, V41, P345, DOI 10.1016/j.ympev.2006.05.022; Barnes L.G., 1972, University of California Publications in Geological Sciences, V89, P1; Barnes L. G., 1988, CONTR SCI MUS NAT HI, V396, P1; Barnes L.G., 1971, PALEOBIOS, V11, P1; Barnes L. G., 1991, CONTR SCI MUS NAT HI, V426, P1, DOI DOI 10.7717/PEERJ.3316; Barnes L. G., 1995, ISL ARC, V3, P329, DOI DOI 10.1111/J.1440-1738.1994; Barnes L. G., 1998, PUBLICACION ESPECIAL, P26; Barnes LG, 1989, CONTRIBUTIONS SCI NA, V403, P1; Berkoff M, 1998, PALEOBIOS, V18, P1; BERTA A, 1986, Transactions of the San Diego Society of Natural History, V21, P111; Berta A., 1991, SMITHSON CONTRIB PAL, V69, P1; Berta A., 1994, SMITHSONIAN CONTRIB, V78, P1, DOI [10.5479/si.00810266.78.1, DOI 10.5479/SI.00810266.78.1]; Berta Annalisa, 1994, Proceedings of the San Diego Society of Natural History, V29, P33; Bininda-Emonds O.R.P., 1996, Bonner Zoologische Monographien, V41, P1; Bininda-Emonds ORP, 1999, BIOL REV, V74, P143, DOI 10.1017/S0006323199005307; Boessenecker RW, 2011, J VERTEBR PALEONTOL, V31, P454, DOI 10.1080/02724634.2011.550362; COHEN JE, 1993, J ANIM ECOL, V62, P67, DOI 10.2307/5483; Condon T., 1906, U OREGON B LETIN, V3, P1; Davit-Beal T, 2009, J ANAT, V214, P477, DOI 10.1111/j.1469-7580.2009.01060.x; de Muizon C, 2002, SM C PALEOB, P223; de Muizon Christian, 1993, Bulletin de l'Institut Francais d'Etudes Andines, V22, P671; Debey LB, 2013, MAR MAMMAL SCI, V29, P48, DOI 10.1111/j.1748-7692.2011.00545.x; Delisle I, 2005, MOL PHYLOGENET EVOL, V37, P192, DOI 10.1016/j.ympev.2005.04.025; Demere T.A., 1984, MIOCENE CRETACEOUS D, V54, P47; Demere TA, 2003, B AM MUS NAT HIST, P32, DOI 10.1206/0003-0090(2003)279<0032:C>2.0.CO;2; Demere TA, 2001, J VERTEBR PALEONTOL, V21, P279, DOI 10.1671/0272-4634(2001)021[0279:AROPRF]2.0.CO;2; Demere Thomas A., 2005, Bulletin of the Florida Museum of Natural History, V45, P379; Demere Thomas A., 1994, Proceedings of the San Diego Society of Natural History, V29, P77; Demere Thomas A., 1994, Proceedings of the San Diego Society of Natural History, V29, P99; Dubrovo IA, 1981, DOKLADY EARTH SCI SE, V256, P202; Fay FH, 1982, N AM FAUNA, DOI DOI 10.3996/NAFA.74.0001; Ferreira JM, 2008, POLAR BIOL, V31, P303, DOI 10.1007/s00300-007-0358-z; Fitzgerald EMG, 2006, P ROY SOC B-BIOL SCI, V273, P2955, DOI 10.1098/rspb.2006.3664; Flynn JJ, 1998, MOL PHYLOGENET EVOL, V9, P414, DOI 10.1006/mpev.1998.0504; Fulton T. L., 2009, P R SOC B, V277, P1065; GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; GORDON KR, 1984, J MORPHOL, V182, P179, DOI 10.1002/jmor.1051820206; Harris DE, 2006, NORTHEAST NAT, V13, P403, DOI 10.1656/1092-6194(2006)13[403:GAOISS]2.0.CO;2; Horikawa H., 1995, ISL ARC, V3, P309, DOI DOI 10.1111/J.1440-1738.1994.TB00118.X; Howard H, 1987, NAT HIST MUS LOS ANG, V383, P1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; ISHIYAMA M, 1987, SCANNING MICROSCOPY, V1, P1071; Kellogg R., 1922, University of California Publications in Geology, V13, P23; Kohno N, 2006, J VERTEBR PALEONTOL, V26, P411, DOI 10.1671/0272-4634(2006)26[411:ANMOMC]2.0.CO;2; KOHNO N, 1994, J VERTEBR PALEONTOL, V14, P414, DOI 10.1080/02724634.1994.10011568; Kohno N., 1995, ISL ARC, V3, P285, DOI DOI 10.1111/J.1440-1738.1994.TB00117.X; Kohno Naoki, 1996, Transactions and Proceedings of the Palaeontological Society of Japan New Series, V181, P388; Levermann Nette, 2003, BMC Ecology, V3, P1; Lindenfors P, 2002, BEHAV ECOL SOCIOBIOL, V52, P188, DOI 10.1007/s00265-002-0507-x; LOWRY LF, 1984, POLAR BIOL, V3, P11, DOI 10.1007/BF00265562; LOWRY LF, 1988, POLAR BIOL, V8, P475, DOI 10.1007/BF00264724; Mead James G., 2009, Smithsonian Contributions to Zoology, P1; Memmott J, 2000, J ANIM ECOL, V69, P1, DOI 10.1046/j.1365-2656.2000.00367.x; Meredith RW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000634; MILLER EH, 1975, CAN J ZOOL, V53, P590, DOI 10.1139/z75-073; Mitchell E., 1973, Bulletin Am Mus nat Hist, V151, P203; MITCHELL EDWARD, 1966, UNIV CALIF PUBLICATIONS GEOL SCI, V61, P1; NORES C, 1988, J ZOOL, V216, P593, DOI 10.1111/j.1469-7998.1988.tb02457.x; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pyenson ND, 2009, GEOLOGY, V37, P519, DOI 10.1130/G25509A.1; Raschke RE, 1984, MEMOIRS NATURAL HIST, V1, P61; Repenning C. A., 1977, UNITED STATE GEOLOGI, V992, P1; Rybczynski N, 2009, NATURE, V458, P1021, DOI 10.1038/nature07985; Sato JJ, 2004, ZOOL SCI, V21, P111; SCAPINO R, 1981, J MORPHOL, V167, P339, DOI 10.1002/jmor.1051670308; Scott JE, 2012, J EVOLUTION BIOL, V25, P661, DOI 10.1111/j.1420-9101.2012.02457.x; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Tedford Richard H., 2004, P169; Turner D. L., 1970, GEOLOGICAL SOC AM SP, P91, DOI DOI 10.1130/SPE124-P91; Whistler DP, 2003, B AM MUS NAT HIST, P231; Wilson JW, 2006, POLAR BIOL, V29, P905, DOI 10.1007/s00300-006-0187-5; Yerkes RF, 1979, US GEOLOGICAL SURV E, V1457, pE1	75	38	39	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54311	10.1371/journal.pone.0054311	http://dx.doi.org/10.1371/journal.pone.0054311			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342129	Green Published, Green Submitted, gold			2022-12-25	WOS:000313682700106
J	Berniker, M; O'Brien, MK; Kording, KP; Ahmed, AA				Berniker, Max; O'Brien, Megan K.; Kording, Konrad P.; Ahmed, Alaa A.			An Examination of the Generalizability of Motor Costs	PLOS ONE			English	Article							OPTIMAL FEEDBACK-CONTROL; ENERGY-COST; ADAPTATION; MECHANISMS; ERROR	Most approaches to understanding human motor control assume that people maximize their rewards while minimizing their motor efforts. This tradeoff between potential rewards and a sense of effort is quantified with a cost function. While the rewards can change across tasks, our sense of effort is assumed to remain constant and characterize how the nervous system organizes motor control. As such, when a proposed cost function compares well with data it is argued to be the underlying cause of a motor behavior, and not simply a fit to the data. Implicit in this proposition is the assumption that this cost function can then predict new motor behaviors. Here we examined this idea and asked whether an inferred cost function in one setting could explain subject's behavior in settings that differed dynamically but had identical rewards. We found that the pattern of behavior observed across settings was similar to our predictions of optimal behavior. However, we could not conclude that this behavior was consistent with a conserved sense of effort. These results suggest that the standard forms for quantifying cost may not be sufficient to accurately examine whether or not human motor behavior abides by optimality principles.	[Berniker, Max; Kording, Konrad P.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Berniker, Max; Kording, Konrad P.] Rehabil Inst Chicago, Chicago, IL 60611 USA; [O'Brien, Megan K.; Ahmed, Alaa A.] Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA; [Ahmed, Alaa A.] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA	Northwestern University; Shirley Ryan AbilityLab; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Berniker, M (corresponding author), Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA.	mbernike@northwestern.edu	Kording, Konrad P/A-1233-2007; , Alaa/GVR-7153-2022	Kording, Konrad P/0000-0001-8408-4499; OBRIEN, MEGAN/0000-0001-8069-365X	NIH [1R01NS063399]; DARPA Young Faculty Award [D12AP00253]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063399] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DARPA Young Faculty Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by NIH grant 1R01NS063399 and the DARPA Young Faculty Award D12AP00253. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RM, 1997, BIOL CYBERN, V76, P97, DOI 10.1007/s004220050324; Berniker M, 2009, P NATL ACAD SCI; Berniker M, 2011, P AMER CONTR CONF, P618; Braun DA, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00001; Bryson A.E., 2018, APPL OPTIMAL CONTROL, P90, DOI 10.1201/9781315137667-3; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243, DOI 10.1152/ajpregu.1977.233.5.R243; CHOW C K, 1971, Mathematical Biosciences, V10, P239, DOI 10.1016/0025-5564(71)90062-9; de Rugy A, 2012, J NEUROSCI, V32, P7384, DOI 10.1523/JNEUROSCI.5792-11.2012; Diedrichsen J, 2010, J NEUROSCI, V30, P5159, DOI 10.1523/JNEUROSCI.5406-09.2010; Diedrichsen J, 2007, CURR BIOL, V17, P1675, DOI 10.1016/j.cub.2007.08.051; Emken JL, 2007, J NEUROPHYSIOL, V97, P3997, DOI 10.1152/jn.01095.2006; Farahat WA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000795; Franklin DW, 2011, NEURON, V72, P425, DOI 10.1016/j.neuron.2011.10.006; Friston K, 2011, NEURON, V72, P488, DOI 10.1016/j.neuron.2011.10.018; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; HOGAN N, 1987, EXERCISE SPORT SCI R, V15, P153; HOGAN N, 1984, J NEUROSCI, V4, P2745; Huang HJ, 2012, J NEUROSCI, V32, P2182, DOI 10.1523/JNEUROSCI.4003-11.2012; Izawa J, 2008, J NEUROSCI, V28, P2883, DOI 10.1523/JNEUROSCI.5359-07.2008; Kistemaker DA, 2010, J NEUROPHYSIOL, V104, P2985, DOI 10.1152/jn.00483.2010; Kording KP, 2004, PLOS BIOL, V2, P1652, DOI 10.1371/journal.pbio.0020330; KUO AD, 1995, IEEE T BIO-MED ENG, V42, P87, DOI 10.1109/10.362914; Liu D, 2007, J NEUROSCI, V27, P9354, DOI 10.1523/JNEUROSCI.1110-06.2007; Mitrovic D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013601; Nagengast AJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000419; Nakano E, 1999, J NEUROPHYSIOL, V81, P2140, DOI 10.1152/jn.1999.81.5.2140; Schaal S, 2005, CURR OPIN NEUROBIOL, V15, P675, DOI 10.1016/j.conb.2005.10.009; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Sherback M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000708; Stengel R. F., 1994, OPTIMAL CONTROL ESTI; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; Yarrow K, 2009, NAT REV NEUROSCI, V10, P585, DOI 10.1038/nrn2672	34	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53759	10.1371/journal.pone.0053759	http://dx.doi.org/10.1371/journal.pone.0053759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341994	gold, Green Published, Green Submitted			2022-12-25	WOS:000314759400078
J	Dean, MC; Cole, TJ				Dean, M. Christopher; Cole, Tim J.			Human Life History Evolution Explains Dissociation between the Timing of Tooth Eruption and Peak Rates of Root Growth	PLOS ONE			English	Article							COMPARATIVE DENTAL DEVELOPMENT; PAN-TROGLODYTES; COMMON CHIMPANZEE; EARLIEST EVIDENCE; CROSS-STRIATIONS; EXTENSION-RATES; AGE-CHANGES; HUMAN-TEETH; ENAMEL; MOLAR	We explored the relationship between growth in tooth root length and the modern human extended period of childhood. Tooth roots provide support to counter chewing forces and so it is advantageous to grow roots quickly to allow teeth to erupt into function as early as possible. Growth in tooth root length occurs with a characteristic spurt or peak in rate sometime between tooth crown completion and root apex closure. Here we show that in Pan troglodytes the peak in root growth rate coincides with the period of time teeth are erupting into function. However, the timing of peak root velocity in modern humans occurs earlier than expected and coincides better with estimates for tooth eruption times in Homo erectus. With more time to grow longer roots prior to eruption and smaller teeth that now require less support at the time they come into function, the root growth spurt no longer confers any advantage in modern humans. We suggest that a prolonged life history schedule eventually neutralised this adaptation some time after the appearance of Homo erectus. The root spurt persists in modern humans as an intrinsic marker event that shows selection operated, not primarily on tooth tissue growth, but on the process of tooth eruption. This demonstrates the overarching influence of life history evolution on several aspects of dental development. These new insights into tooth root growth now provide an additional line of enquiry that may contribute to future studies of more recent life history and dietary adaptations within the genus Homo.	[Dean, M. Christopher] UCL, London, England; [Cole, Tim J.] UCL Inst Child Hlth, MRC Ctr Epidemiol Child Hlth, London, England	University of London; University College London; University of London; University College London	Dean, MC (corresponding author), UCL, Gower St, London, England.	ucgacrd@ucl.ac.uk	Cole, Tim J/B-7883-2008	Cole, Tim J/0000-0001-5711-8200	Leverhulme Trust [F/07 134/F]; Medical Research Council [MR/J004839/1]; MRC [MR/J004839/1] Funding Source: UKRI	Leverhulme Trust(Leverhulme Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants to MCD from The Leverhulme Trust (F/07 134/F) and TJC from the Medical Research Council (MR/J004839/1). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anderson D L, 1976, J Forensic Sci, V21, P191; ANEMONE RL, 1991, AM J PHYS ANTHROPOL, V86, P229, DOI 10.1002/ajpa.1330860211; Antoine D, 2009, J ANAT, V214, P45, DOI 10.1111/j.1469-7580.2008.01010.x; Arathi R, 2006, J INDIAN SOC PEDOD P, pS16; BERKOVITZ BK, 1971, ARCH ORAL BIOL, V16, P1033, DOI 10.1016/0003-9969(71)90208-1; BERKOVITZ BKB, 1976, J DENT RES, V55, P460, DOI 10.1177/00220345760550032601; Berkovitz BKB., 2018, ORAL ANATOMY HISTOLO, V5th ed.; Berkovitz BKB, 1989, HDB MICROSCOPIC ANAT, V6, P21; de Castro JMB, 2010, P NATL ACAD SCI USA, V107, P11739, DOI 10.1073/pnas.1006772107; Berna F, 2012, P NATL ACAD SCI USA, V109, pE1215, DOI 10.1073/pnas.1117620109; Beynon AD, 1998, J HUM EVOL, V35, P163, DOI 10.1006/jhev.1998.0230; Bogin B, 2009, AM J HUM BIOL, V21, P567, DOI 10.1002/ajhb.20895; Boughner JC, 2004, J HUM EVOL, V46, P255, DOI 10.1016/j.jhevol.2003.11.007; BOYDE A, 1979, J DENT RES, V58, P981, DOI 10.1177/00220345790580025101; BOYDE A, 1990, MG PRIMATOL, V14, P229; Boyde A, 1964, THESIS U LONDON; Boyde A., 1989, HDB MICROSCOPIC ANAT, P309; BROMAGE TG, 1991, AM J PHYS ANTHROPOL, V86, P205, DOI 10.1002/ajpa.1330860209; Cahill DR, 1988, BIOL MECHANISMS TOOT, P1; Cobb SN, 2011, J ANAT, V218, P96, DOI 10.1111/j.1469-7580.2010.01321.x; Cobb SN, 2009, FRONT ORAL BIOL, V13, P121, DOI 10.1159/000242403; Cole TJ, 2008, BIOSTATISTICS, V9, P159, DOI 10.1093/biostatistics/kxm020; Cole TJ, 2010, INT J EPIDEMIOL, V39, P1558, DOI 10.1093/ije/dyq115; Craddock HL, 2004, BRIT DENT J, V197, P385, DOI 10.1038/sj.bdj.4811712; Dean C, 2001, NATURE, V414, P628, DOI 10.1038/414628a; Dean MC, 2007, J HUM EVOL, V53, P635, DOI 10.1016/j.jhevol.2007.04.009; Dean MC, 2008, J HUM EVOL, V54, P258, DOI 10.1016/j.jhevol.2007.09.021; Dean MC, 2006, P ROY SOC B-BIOL SCI, V273, P2799, DOI 10.1098/rspb.2006.3583; Dean M Christopher, 2012, Methods Mol Biol, V915, P89, DOI 10.1007/978-1-61779-977-8_5; Dean M. Christopher, 2012, V62, P268; Dean MC, 2012, J HUM EVOL, V62, P174, DOI 10.1016/j.jhevol.2011.10.003; Dean MC, 2010, PHILOS T R SOC B, V365, P3397, DOI 10.1098/rstb.2010.0052; Dean MC, 2009, FRONT ORAL BIOL, V13, P68, DOI 10.1159/000242394; Dean M. Christopher, 2009, P101, DOI 10.1007/978-1-4020-9980-9_10; Dean MC, 2004, ANN ANAT, V186, P405; Dean MC, 1998, ARCH ORAL BIOL, V43, P1009, DOI 10.1016/S0003-9969(98)00069-7; Dean MC, 2005, 13 INT S DENT MORPH, P371; Dean MC, 1999, HUMAN GROWTH STUDIES, P11; Dean MC., 1995, STRUCTURE FUNCTION E, P239; DEMIRJIAN A, 1973, HUM BIOL, V45, P211; Ekrtrand KM, 2003, COMMUNITY DENT ORAL, V31, P344, DOI 10.1034/j.1600-0528.2003.00016.x; Estrela C, 2010, DENT PRESS J ORTHOD, V15, P44; FEASBY WH, 1981, AM J ORTHOD DENTOFAC, V80, P554, DOI 10.1016/0002-9416(81)90250-5; Fleischmannova J, 2010, J DENT RES, V89, P108, DOI 10.1177/0022034509355440; Fujiwara N, 2009, J EXP ZOOL PART B, V312B, P486, DOI 10.1002/jez.b.21268; Gleiser I, 1955, AM J PHYS ANTHROP-NE, V13, P253, DOI 10.1002/ajpa.1330130206; GORSKI JP, 1992, CRIT REV ORAL BIOL M, V3, P185, DOI 10.1177/10454411920030030201; Guatelli-Steinberg D, 2012, J HUM EVOL, V63, P475, DOI 10.1016/j.jhevol.2012.05.006; Guatelli-Steinberg D, 2009, EVOL ANTHROPOL, V18, P9, DOI 10.1002/evan.20190; Haavikko K, 1970, P FINNISH DENT SOC, V66, P104; Hallgrimsson B, 2009, EVOL BIOL, V36, P355, DOI 10.1007/s11692-009-9076-5; Harris EF, 2002, DENT ANTHR J, V16, P15, DOI 10.26575/daj.v16i1.165; Hogg RT, 2011, ANAT REC, V294, P2193, DOI 10.1002/ar.21503; JERNVALL J, 1994, INT J DEV BIOL, V38, P463; Kelley J, 2009, FRONT ORAL BIOL, V13, P128, DOI 10.1159/000242404; Kelley J, 2010, P NATL ACAD SCI USA, V107, P1035, DOI 10.1073/pnas.0906206107; KOVACS I, 1979, Ossa, V6, P181; Kovacs I., 1971, DENT MORPHOLOGY EVOL, P211; KRAEMER H C, 1982, Primates, V23, P393, DOI 10.1007/BF02381322; Kupczik K, 2008, J HUM EVOL, V54, P196, DOI 10.1016/j.jhevol.2007.09.013; Kupczik K, 2010, J HUM EVOL, V59, P525, DOI 10.1016/j.jhevol.2010.05.009; Kuykendall KL, 1996, AM J PHYS ANTHROPOL, V99, P135, DOI 10.1002/(SICI)1096-8644(199601)99:1<135::AID-AJPA8>3.0.CO;2-#; KUYKENDALL KL, 1992, AM J PHYS ANTHROPOL, V89, P379, DOI 10.1002/ajpa.1330890310; Lacruz RS, 2012, J BIOL RHYTHM, V27, P237, DOI 10.1177/0748730412442830; Le Cabec A, 2012, J HUM EVOL, V63, P667, DOI 10.1016/j.jhevol.2012.07.003; Liu SS-Y, 2001, AM J ORTHOD DENT ORT, V139, P745; Liversidge H, 1998, DENT ANTHR FUNDAMENT, P420; Liversidge HM, 2008, ANN HUM BIOL, V35, P294, DOI 10.1080/03014460801971445; Liversidge HM, 2006, ANN HUM BIOL, V33, P454, DOI 10.1080/03014460600802387; Macchiarelli R, 2006, NATURE, V444, P748, DOI 10.1038/nature05314; Marks SC, 1996, ANAT RECORD, V245, P374, DOI 10.1002/(SICI)1097-0185(199606)245:2<374::AID-AR18>3.0.CO;2-M; MARKS SC, 1984, ARCH ORAL BIOL, V29, P311, DOI 10.1016/0003-9969(84)90105-5; Moggi-Cecchi J, 1998, AM J PHYS ANTHROPOL, V106, P425, DOI 10.1002/(SICI)1096-8644(199808)106:4<425::AID-AJPA2>3.0.CO;2-I; MOORREES COENRAAD F.A., 1963, JOUR DENT RES, V42, P1490, DOI 10.1177/00220345630420062701; MOXHAM BJ, 1974, ARCH ORAL BIOL, V19, P903, DOI 10.1016/0003-9969(74)90053-3; Nielsen M, 2012, J COMP PSYCHOL, V126, P170, DOI 10.1037/a0025168; NISSEN HW, 1964, AM J PHYS ANTHROPOL, V22, P285, DOI 10.1002/ajpa.1330220315; Organ C, 2011, P NATL ACAD SCI USA, V108, P14555, DOI 10.1073/pnas.1107806108; Parner ET, 2002, J DENT RES, V81, P451, DOI 10.1177/154405910208100703; PICTON DCA, 1989, EUR J ORTHODONT, V11, P430, DOI 10.1093/oxfordjournals.ejo.a036015; Reid DJ, 2006, J HUM EVOL, V50, P329, DOI 10.1016/j.jhevol.2005.09.003; Reid DJ, 1998, J HUM EVOL, V35, P427, DOI 10.1006/jhev.1998.0248; Roberts GJ, 2008, BRIT DENT J, V204, DOI 10.1038/bdj.2008.21; Robson SL, 2008, J ANAT, V212, P394, DOI 10.1111/j.1469-7580.2008.00867.x; Roebroeks W, 2011, P NATL ACAD SCI USA, V108, P5209, DOI 10.1073/pnas.1018116108; Sadakatsu S, 1990, ERUPTION PERMANENT T, P100; Schwartz GT, 2006, INT J PRIMATOL, V27, P1201, DOI 10.1007/s10764-006-9051-2; Shackelford LL, 2012, AM J PHYS ANTHROPOL, V147, P227, DOI 10.1002/ajpa.21639; Shaweesh AI, 2012, INT J STOMATOL OCCLU, V5, P70, DOI 10.1007/s12548-012-0041-z; SHELLIS RP, 1984, ARCH ORAL BIOL, V29, P697, DOI 10.1016/0003-9969(84)90175-4; Shellis RP, 1998, J HUM EVOL, V35, P387, DOI 10.1006/jhev.1998.0260; Shinoda H, 1984, CHEM TODAY, V162, P34; Simmer JP, 2010, J DENT RES, V89, P1024, DOI 10.1177/0022034510375829; Smith B. Holly, 1993, P195; Smith BH, 2011, J HUM EVOL, V60, P34, DOI 10.1016/j.jhevol.2010.08.006; SMITH BH, 1995, ANNU REV ANTHROPOL, V24, P257, DOI 10.1146/annurev.an.24.100195.001353; SMITH BH, 1989, EVOLUTION, V43, P683, DOI 10.1111/j.1558-5646.1989.tb04266.x; SMITH BH, 1986, NATURE, V323, P327, DOI 10.1038/323327a0; Smith SL, 2009, AM J HUM BIOL, V21, P623, DOI 10.1002/ajhb.20873; Smith TM, 2007, J HUM EVOL, V52, P201, DOI 10.1016/j.jhevol.2006.09.004; Smith TM, 2006, J ANAT, V208, P125, DOI 10.1111/j.1469-7580.2006.00500.x; Spencer MA, 2003, AM J PHYS ANTHROPOL, V122, P325, DOI 10.1002/ajpa.10288; Spoor F, 2007, NATURE, V448, P688, DOI 10.1038/nature05986; STACK MV, 1967, J DENT RES, V46, P879, DOI 10.1177/00220345670460054501; Tafforeau P, 2012, J HUM EVOL, V62, P424, DOI 10.1016/j.jhevol.2012.01.001; Takeshima Takahiro, 2004, World J Orthod, V5, P332; Thesleff I, 2009, TOOTH ORGANOGENESIS, DOI [10.3824/stembook.1.37.1, DOI 10.3824/STEMBOOK.1.37.1]; Tummers M, 2003, DEVELOPMENT, V130, P1049, DOI 10.1242/dev.00332; Tummers M, 2008, EVOL DEV, V10, P187, DOI 10.1111/j.1525-142X.2008.00226.x; Ungar P.S., 2010, MAMMAL TEETH ORIGIN; Wise GE, 2002, CRIT REV ORAL BIOL M, V13, P323, DOI 10.1177/154411130201300403; Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65; Wood B., 1991, HOMINID CRANIAL REMA, V4; Zihlman A, 2004, P NATL ACAD SCI USA, V101, P10541, DOI 10.1073/pnas.0402635101; Zuckerman S, 1928, P ZOOL SOC LOND, V1928, P1	116	43	43	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54534	10.1371/journal.pone.0054534	http://dx.doi.org/10.1371/journal.pone.0054534			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342167	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400168
J	Hachinohe, M; Yamane, M; Akazawa, D; Ohsawa, K; Ohno, M; Terashita, Y; Masumoto, H				Hachinohe, Mayumi; Yamane, Midori; Akazawa, Daiki; Ohsawa, Kazuhiro; Ohno, Mayumi; Terashita, Yuzu; Masumoto, Hiroshi			A Reduction in Age-Enhanced Gluconeogenesis Extends Lifespan	PLOS ONE			English	Article							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE GENES; YEAST SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION EXTENDS; GENOME STABILITY; BUDDING YEAST; MOTHER CELLS; ACETYLATION; LONGEVITY; EXTENSION; LYSINE-56	The regulation of energy metabolism, such as calorie restriction (CR), is a major determinant of cellular longevity. Although augmented gluconeogenesis is known to occur in aged yeast cells, the role of enhanced gluconeogenesis in aged cells remains undefined. Here, we show that age-enhanced gluconeogenesis is suppressed by the deletion of the tdh2 gene, which encodes glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a protein that is involved in both glycolysis and gluconeogenesis in yeast cells. The deletion of TDH2 restores the chronological lifespan of cells with deletions of both the HST3 and HST4 genes, which encode yeast sirtuins, and represses the activation of gluconeogenesis. Furthermore, the tdh2 gene deletion can extend the replicative lifespan in a CR pathway-dependent manner. These findings demonstrate that the repression of enhanced gluconeogenesis effectively extends the cellular lifespan.	[Hachinohe, Mayumi] Natl Agr & Food Res Org NARO, Natl Food Res Inst, Tsukuba, Ibaraki, Japan; [Yamane, Midori; Akazawa, Daiki; Ohsawa, Kazuhiro; Ohno, Mayumi; Terashita, Yuzu; Masumoto, Hiroshi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan	National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; University of Tsukuba	Masumoto, H (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan.	hiroshi.masumoto.ff@u-tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government; Japan Science and Technology (JST) [23131502]	Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology (JST)(Japan Science & Technology Agency (JST))	This work was supported by Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government and Japan Science and Technology (JST) (Grant number: 23131502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberg DC., 2005, METHODS YEAST GENETI; Bitterman KJ, 2003, MICROBIOL MOL BIOL R, V67, P376, DOI 10.1128/MMBR.67.3.376-399.2003; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Burhans WC, 2009, CELL CYCLE, V8, P2300, DOI 10.4161/cc.8.14.8852; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; CUPP JR, 1992, J BIOL CHEM, V267, P16417; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Dilova I, 2007, CELL MOL LIFE SCI, V64, P752, DOI 10.1007/s00018-007-6381-y; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Easlon E, 2007, J BIOL CHEM, V282, P6161, DOI 10.1074/jbc.M607661200; Erjavec N, 2007, P NATL ACAD SCI USA, V104, P10877, DOI 10.1073/pnas.0701634104; Ewbank JJ, 1997, SCIENCE, V275, P980, DOI 10.1126/science.275.5302.980; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; GUNJA-SMITH Z, 1977, Journal of Bacteriology, V130, P818; Hachinohe M, 2011, GENES CELLS, V16, P467, DOI 10.1111/j.1365-2443.2011.01493.x; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; HASELBECK RJ, 1993, J BIOL CHEM, V268, P12116; IVY JM, 1986, MOL CELL BIOL, V6, P688, DOI 10.1128/MCB.6.2.688; Jazwinski SM, 2000, ACTA BIOCHIM POL, V47, P269, DOI 10.18388/abp.2000_4007; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; KENNEDY BK, 1994, J CELL BIOL, V127, P1985, DOI 10.1083/jcb.127.6.1985; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; Kim S, 1999, MOL BIOL CELL, V10, P3125, DOI 10.1091/mbc.10.10.3125; Klein CJL, 1998, MICROBIOL-SGM, V144, P13, DOI 10.1099/00221287-144-1-13; Klinger H, 2010, EXP GERONTOL, V45, P533, DOI 10.1016/j.exger.2010.03.016; Kobayashi T, 2004, CELL, V117, P441, DOI 10.1016/S0092-8674(04)00414-3; Lamming DW, 2005, SCIENCE, V309, P1861, DOI 10.1126/science.1113611; LILLIE SH, 1980, J BACTERIOL, V143, P1384, DOI 10.1128/JB.143.3.1384-1394.1980; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lin SS, 2001, J BIOL CHEM, V276, P36000, DOI 10.1074/jbc.M103509200; Lu SP, 2010, BBA-PROTEINS PROTEOM, V1804, P1567, DOI 10.1016/j.bbapap.2009.09.030; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; MCALISTER L, 1985, J BIOL CHEM, V260, P5013; MCALISTER L, 1985, J BIOL CHEM, V260, P5019; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Ohashi Y, 2008, MOL BIOSYST, V4, P135, DOI 10.1039/b714176a; Perrod S, 2001, EMBO J, V20, P197, DOI 10.1093/emboj/20.1.197; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; RINE J, 1987, GENETICS, V116, P9; Ritchie KB, 1999, MOL CELL BIOL, V19, P6065; RONNE H, 1995, TRENDS GENET, V11, P12, DOI 10.1016/S0168-9525(00)88980-5; Roth GS, 2001, ANN NY ACAD SCI, V928, P305; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; SCHMALIX W, 1993, J BIOL CHEM, V268, P27428; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smeal T, 1996, CELL, V84, P633, DOI 10.1016/S0092-8674(00)81038-7; Smith DL, 2007, AGING CELL, V6, P649, DOI 10.1111/j.1474-9726.2007.00326.x; SUN JY, 1994, J BIOL CHEM, V269, P18638; Tsuchiya M, 2006, AGING CELL, V5, P505, DOI 10.1111/j.1474-9726.2006.00240.x; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; WEINDRUCH W, 1998, RETARDATION AGING DI; WERNERWASHBURNE M, 1993, MICROBIOL REV, V57, P383, DOI 10.1128/MMBR.57.2.383-401.1993; Wilson WA, 2002, CELL, V111, P155, DOI 10.1016/S0092-8674(02)01043-7; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	63	15	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54011	10.1371/journal.pone.0054011	http://dx.doi.org/10.1371/journal.pone.0054011			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342062	gold, Green Published, Green Submitted			2022-12-25	WOS:000314759400110
J	Kedenge, SV; Kangwana, BP; Waweru, EW; Nyandigisi, AJ; Pandit, J; Brooker, SJ; Snow, RW; Goodman, CA				Kedenge, Sarah V.; Kangwana, Beth P.; Waweru, Evelyn W.; Nyandigisi, Andrew J.; Pandit, Jayesh; Brooker, Simon J.; Snow, Robert W.; Goodman, Catherine A.			Understanding the Impact of Subsidizing Artemisinin-Based Combination Therapies (ACTs) in the Retail Sector - Results from Focus Group Discussions in Rural Kenya	PLOS ONE			English	Article							LUMEFANTRINE TREATMENT POLICY; ARTEMETHER-LUMEFANTRINE; MALARIA TREATMENT; CASE-MANAGEMENT; 6-DOSE REGIMEN; GLOBAL SUBSIDY; AVAILABILITY; ADHERENCE; INTERVENTIONS; KNOWLEDGE	Background: There is considerable interest in the potential of private sector subsidies to increase availability and affordability of artemisinin-based combination therapies (ACTs) for malaria treatment. A cluster randomized trial of such subsidies was conducted in 3 districts in Kenya, comprising provision of subsidized packs of paediatric ACT to retail outlets, training of retail staff, and community awareness activities. The results demonstrated a substantial increase in ACT availability and coverage, though patient counselling and adherence were suboptimal. We conducted a qualitative study in order to understand why these successes and limitations occurred. Methodology/Principal Findings: Eighteen focus group discussions were conducted, 9 with retailers and 9 with caregivers, to document experiences with the intervention. Respondents were positive about intervention components, praising the focused retailer training, affordable pricing, strong promotional activities, dispensing job aids, and consumer friendly packaging, which are likely to have contributed to the positive access and coverage outcomes observed. However, many retailers still did not stock ACT, due to insufficient supplies, lack of capital and staff turnover. Advice to caregivers was poor due to insufficient time, and poor recall of instructions. Adherence by caregivers to dosing guidelines was sub-optimal, because of a wish to save tablets for other episodes, doses being required at night, stopping treatment when the child felt better, and the number and bitter taste of the tablets. Caregivers used a number of strategies to obtain paediatric ACT for older age groups. Conclusions/Significance: This study has highlighted that important components of a successful ACT subsidy intervention are regular retailer training, affordable pricing, a reliable supply chain and community mobilization emphasizing patient adherence and when to seek further care.	[Kedenge, Sarah V.; Kangwana, Beth P.; Waweru, Evelyn W.; Brooker, Simon J.; Snow, Robert W.; Goodman, Catherine A.] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Malaria Publ Hlth Grp, Nairobi, Kenya; [Nyandigisi, Andrew J.] Minist Publ Hlth & Sanitat, Div Malaria Control, Nairobi, Kenya; [Pandit, Jayesh] Pharm & Poisons Board, Nairobi, Kenya; [Brooker, Simon J.; Goodman, Catherine A.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Snow, Robert W.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England	Kenya Medical Research Institute; University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Kedenge, SV (corresponding author), Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Malaria Publ Hlth Grp, Nairobi, Kenya.	skedenge@nairobi.kemri-wellcome.org	Snow, Robert William/AFR-1436-2022; Waweru, Everlyn/AAL-4943-2020	Snow, Robert William/0000-0003-3725-6088; Waweru, Everlyn/0000-0002-4599-8973; Goodman, Catherine/0000-0002-2241-3485	Department for International Development, United Kingdom (DFID); United States Agency for International Development (USAID); Wellcome Trust, United Kingdom; Kenya Medical Research Institute (KEMRI); Wellcome Trust Master's Fellowship in Public Health and Tropical Medicine [092766]; Wellcome Trust [0811673, 092654]; United Kingdom Department for International Development	Department for International Development, United Kingdom (DFID); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Wellcome Trust, United Kingdom(Wellcome Trust); Kenya Medical Research Institute (KEMRI); Wellcome Trust Master's Fellowship in Public Health and Tropical Medicine(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission); United Kingdom Department for International Development	This work was financially supported by the Department for International Development, United Kingdom (DFID), the United States Agency for International Development (USAID), the Wellcome Trust, United Kingdom, and the Kenya Medical Research Institute (KEMRI). SVK is supported by a Wellcome Trust Master's Fellowship in Public Health and Tropical Medicine (#092766), RWS is a Principal Wellcome Trust Fellow (#079080), SJB is supported by a Research Career Development Fellowship from the Wellcome Trust (#0811673), and CAG was a member of the Consortium for Research on Equitable Health Systems, which was supported by the United Kingdom Department for International Development. SVK, BBK, SJB, RWS and CAG acknowledge support from the Wellcome Trust core grant (#092654). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuya T, 2009, AM J TROP MED HYG, V80, P905, DOI 10.4269/ajtmh.2009.80.905; Abuya TO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008937; Adeyi O, 2010, LANCET, V376, P1869, DOI 10.1016/S0140-6736(10)61189-0; Alba S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-163; Chuma J, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-15; Clinton Health Access Initiative (CHAI), 2012, PRIC SUBS INCR US PR; Fogg C, 2004, AM J TROP MED HYG, V71, P525, DOI 10.4269/ajtmh.2004.71.525; Gerstl S, 2010, T ROY SOC TROP MED H, V104, P328, DOI 10.1016/j.trstmh.2009.12.008; Goodman C, 2007, AM J TROP MED HYG, V77, P203, DOI 10.4269/ajtmh.2007.77.203; Juma E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-1; Kachur SP, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-25; Kangwana B, 2012, IMPACT RETAIL SECTOR; Kangwana B, 2010, IMPACT RETAIL SECTOR; Kangwana BB, 2009, AM J TROP MED HYG, V80, P737, DOI 10.4269/ajtmh.2009.80.737; Kangwana BP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000437; Kedenge S, 2011, IMPACT RETAIL SECTOR; Laxminarayan R, 2009, HEALTH AFFAIR, V28, P949, DOI 10.1377/hlthaff.28.4.949; Lemma H, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-349; Littrell M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-328; Mace KE, 2011, CLIN INFECT DIS, V53, P772, DOI 10.1093/cid/cir498; Marsh VM, 2004, TROP MED INT HEALTH, V9, P451, DOI 10.1111/j.1365-3156.2004.01223.x; Ministry of Public Health and Sanitation M.o.M.S., 2010, GUID DET REG PROC GE; Noor AM, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-180; O'Connell KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-326; Sabot OJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006857; Smith N, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-316; Sudoi RK, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-37; Talisuna A, 2009, LANCET, V374, P1224, DOI 10.1016/S0140-6736(09)61767-0; Tougher S, 2012, LANCET; Tren R, 2011, LANCET, V377, P810, DOI 10.1016/S0140-6736(11)60302-4; Wasunna B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-29; WHO, 2011, WORLD MALARIA REPORT 2011, P1; *WHO, 2009, WORLD MAL REP; Zurovac D, 2008, TROP MED INT HEALTH, V13, P99, DOI 10.1111/j.1365-3156.2007.01980.x; Zurovac D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-181	35	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54371	10.1371/journal.pone.0054371	http://dx.doi.org/10.1371/journal.pone.0054371			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342143	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000314759400158
J	Martin, JA				Martin H, Jose Antonio			Solving Hard Computational Problems Efficiently: Asymptotic Parametric Complexity 3-Coloring Algorithm	PLOS ONE			English	Article							4-REGULAR PLANAR GRAPHS; PERFORMANCE GUARANTEE; CO-NP; MAP	Many practical problems in almost all scientific and technological disciplines have been classified as computationally hard (NP-hard or even NP-complete). In life sciences, combinatorial optimization problems frequently arise in molecular biology, e. g., genome sequencing; global alignment of multiple genomes; identifying siblings or discovery of dysregulated pathways. In almost all of these problems, there is the need for proving a hypothesis about certain property of an object that can be present if and only if it adopts some particular admissible structure (an NP-certificate) or be absent (no admissible structure), however, none of the standard approaches can discard the hypothesis when no solution can be found, since none can provide a proof that there is no admissible structure. This article presents an algorithm that introduces a novel type of solution method to "efficiently" solve the graph 3-coloring problem; an NP-complete problem. The proposed method provides certificates (proofs) in both cases: present or absent, so it is possible to accept or reject the hypothesis on the basis of a rigorous proof. It provides exact solutions and is polynomial-time (i.e., efficient) however parametric. The only requirement is sufficient computational power, which is controlled by the parameter alpha is an element of N. Nevertheless, here it is proved that the probability of requiring a value of alpha>k to obtain a solution for a random graph decreases exponentially: P(alpha>k) <= 2(-(k+1)), making tractable almost all problem instances. Thorough experimental analyses were performed. The algorithm was tested on random graphs, planar graphs and 4-regular planar graphs. The obtained experimental results are in accordance with the theoretical expected results.	Univ Complutense Madrid, Madrid, Spain	Complutense University of Madrid	Martin, JA (corresponding author), Univ Complutense Madrid, Madrid, Spain.	jamartinh@fdi.ucm.es		Martin H, Jose Antonio/0000-0002-0874-2194	Universidad Complutense de Madrid	Universidad Complutense de Madrid	The author has declared that there is no other particular funder apart from his institution (Universidad Complutense de Madrid) through his current contract as an assistant professor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abfalter I, 2005, THESIS U WIEN; [Anonymous], 2004, J GRAPH ALGORITHMS A, DOI DOI 10.7155/JGAA.00091; APPEL K, 1977, ILLINOIS J MATH, V21, P429, DOI 10.1215/ijm/1256049011; APPEL K, 1977, ILLINOIS J MATH, V21, P491, DOI 10.1215/ijm/1256049012; Arora S, 2009, COMPUTATIONAL COMPLEXITY: A MODERN APPROACH, P1, DOI 10.1017/CBO9780511804090; Arora S., 2006, STOC'06. Proceedings of the 38th Annual ACM Symposium on Theory of Computing, P215, DOI 10.1145/1132516.1132548; BERGER B, 1990, ALGORITHMICA, V5, P459, DOI 10.1007/BF01840398; Bes JN, 2005, TOOLS ART INT 2005 I, P2, DOI [10.1109/ICTAI.2005.102, DOI 10.1109/ICTAI.2005.102]; Blum A, 1994, J ACM JACM, V41, P516; Bodirsky M, 2003, AUTOMATA LANGUAGES P, P191; Boettcher S, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066703; BOPPANA RB, 1987, INFORM PROCESS LETT, V25, P127, DOI 10.1016/0020-0190(87)90232-8; Borodin OV, 2009, J COMB THEORY B, V99, P668, DOI 10.1016/j.jctb.2008.11.001; Borodin OV, 1996, J GRAPH THEOR, V21, P183; Borodin OV, 2005, J COMB THEORY B, V93, P303, DOI 10.1016/j.jctb.2004.11.001; BROERSMA HJ, 1993, J GRAPH THEOR, V17, P613, DOI 10.1002/jgt.3190170508; Chartrand G., 2008, CHROMATIC GRAPH THEO; Cook S. A., 1971, Proceedings of the 3rd annual ACM symposium on theory of computing, P151; Culberson J, 2001, THEOR COMPUT SCI, V265, P227, DOI 10.1016/S0304-3975(01)00164-5; DAILEY DP, 1980, DISCRETE MATH, V30, P289, DOI 10.1016/0012-365X(80)90236-8; Denise A, 1996, C NUMERANTIUM, P61; Downey R, 1999, PARAMETERIZED COMPLE, V5; Erdos P., 1976, C INT TEOR COMB, V17, P19; Erdos P, 1960, PUBLICATIONS TKE MAT, V5; Flum J., 2006, TEXT THEORET COMP S, DOI 10.1007/3-540-29953-X; FORTNOW L, 1988, INFORM PROCESS LETT, V28, P249, DOI 10.1016/0020-0190(88)90199-8; Garey M.R., 1979, COMPUTERS INTRACTABI; GAREY MR, 1976, J ACM, V23, P43, DOI 10.1145/321921.321926; Goldreich O, 2008, COMPUTATIONAL COMPLEXITY: A CONCEPTUAL PERSPECTIVE, P1, DOI 10.1017/CBO9780511804106; HALLDORSSON MM, 1993, INFORM PROCESS LETT, V45, P19, DOI 10.1016/0020-0190(93)90246-6; Heawood P.J., 1898, Q J PURE APPL MATH, V29, P270; Hochstattler W, 2010, CATBOX INTERACTIVE C, DOI [10.1007/978-3-642-03822-8, DOI 10.1007/978-3-642-03822-8]; Hogg T, 1996, ARTIF INTELL, V81, P1, DOI 10.1016/0004-3702(95)00044-5; Jensen TR, 1995, WILEY INTERSCIENCE S, VXIX; Johnson D. S., 2002, Data structures, near neighbor searches, and methodology: Fifth and sixth DIMACS implementation challenges. Papers related to the DIMACS challenge on dictionaries and priority queues (1995-1996) and the DIMACS challenge on near neighbor searches (1998-1999), P215; Johnson D. S., 1974, P 5 SE C COMB GRAPH, P513; JOHNSON DS, 1974, J COMPUT SYST SCI, V9, P256, DOI 10.1016/S0022-0000(74)80044-9; Jones M, 2008, COMPUTER SCI; Karp R.M., 1972, PROC S COMPLEXITY CO, P85, DOI 10.1007/978-1-4684-2001-2_9.; Karp RM, 2011, J COMPUT SYST SCI, V77, P122, DOI 10.1016/j.jcss.2010.06.009; Khanna S, 2000, COMBINATORICA, V20, P393, DOI 10.1007/s004930070013; LEHEL J, 1981, J GRAPH THEOR, V5, P423, DOI 10.1002/jgt.3190050412; Levin L, 1973, PROBLEMY PEREDACI IN, V9, P115; Malaguti E, 2010, INT T OPER RES, V17, P1, DOI 10.1111/j.1475-3995.2009.00696.x; MANCA P, 1979, J GRAPH THEOR, V3, P357, DOI 10.1002/jgt.3190030406; Martin H JA, 2011, ABS11040510 CORR; Mizuno K, 2008, DISCRETE APPL MATH, V156, P218, DOI 10.1016/j.dam.2006.07.015; Mulet R, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.268701; Park T, 1996, J OPER RES SOC JPN, V39, P258, DOI 10.15807/jorsj.39.258; Pevzner P. A., 1995, Proceedings Third Israel Symposium on the Theory of Computing and Systems, P158, DOI 10.1109/ISTCS.1995.377035; Ramani A, 2004, DESIGN, AUTOMATION AND TEST IN EUROPE CONFERENCE AND EXHIBITION, VOLS 1 AND 2, PROCEEDINGS, P324, DOI 10.1109/DATE.2004.1268868; Selman B, 1996, ARTIF INTELL, V81, P17, DOI 10.1016/0004-3702(95)00045-3; Steinberg R., 1993, ANN DISCR M, V55, P211, DOI DOI 10.1016/S0167-5060(08)70391-1; Stockmeyer L., 1973, ACM SIGACT NEWS, V5, P19, DOI [10.1145/1008293.1008294, DOI 10.1145/1008293.1008294]; THOMASSEN C, 1994, J COMB THEORY B, V62, P268, DOI 10.1006/jctb.1994.1069; van Rossum G, 2012, PYTHON LANGUAGE WEBS; Wang WF, 2007, SCI CHINA SER A, V50, P1552, DOI 10.1007/s11425-007-0106-4; WIGDERSON A, 1983, J ACM, V30, P729, DOI 10.1145/2157.2158; Zdeborova L, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031131	60	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53437	10.1371/journal.pone.0053437	http://dx.doi.org/10.1371/journal.pone.0053437			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23349711	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400044
J	Schaap-Oziemlak, AM; Schouteden, S; Khurana, S; Verfaillie, CM				Schaap-Oziemlak, Aneta M.; Schouteden, Sarah; Khurana, Satish; Verfaillie, Catherine M.			Wnt5a Does Not Support Hematopoiesis in Stroma-Free, Serum-Free Cultures	PLOS ONE			English	Article							STEM-CELL; BETA-CATENIN; LONG-TERM; PATHWAY	Previously we reported that Wnt5a is highly expressed in the murine urogenital ridge-derived UG26-1B6 cells but not embryonic liver-derived EL08-1D2 cells. Mouse long-term repopulating hematopoietic stem cells (LTR-HSC) were maintained in non-contact UG26-1B6 cultures but not EL08-1D2 non-contact cultures, unless Wnt5a was also added to the cultures, suggesting a role for Wnt5a in the in vitro maintenance of LTR-HSC. Here, we investigated if the effect of Wnt5a on adult LTR-HSC activity is HSC-autonomous. To test the effect of Wnt5a on maintenance of LTR-HSC, we performed limiting dilution competitive transplantation assays of murine Lin-Sca1(+) c-kit(+) (LSK) cells cultured for 5 days with TPO and SCF with and without Wnt5a. The effect of Wnt5a on the generation of colony forming units (CFU) and the homing ability of LSK progeny was also tested. No effects were found of Wnt5a on total cell expansion, the number of CFU, or homing ability of day 5 LSK progeny. Furthermore, addition of Wnt5a did not improve, but may have impeded maintenance of LTR-HSC. In conclusion, our data indicate that Wnt5a does not enhance the maintenance and expansion of adult murine LTR-HSCs or committed progenitors cultured in vitro in serum-and stroma-free conditions.	[Schaap-Oziemlak, Aneta M.; Schouteden, Sarah; Khurana, Satish; Verfaillie, Catherine M.] Katholieke Univ Leuven, Interdept Stamcelinst, Louvain, Belgium	KU Leuven	Schaap-Oziemlak, AM (corresponding author), Katholieke Univ Leuven, Interdept Stamcelinst, Louvain, Belgium.	anetaoz@hotmail.com	Verfaillie, Catherine/H-5148-2013; Khurana, Satish/H-9090-2016	Verfaillie, Catherine/0000-0001-7564-4079; Khurana, Satish/0000-0001-5176-1510	FWO [G085111N]; Odysseus; CoE; K.U.Leuven [GOA/11/012]; Vanwayenberghe fund;  [NIH-PO1-CA-65493-06]; NATIONAL CANCER INSTITUTE [P01CA065493] Funding Source: NIH RePORTER	FWO(FWO); Odysseus; CoE(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); K.U.Leuven(KU Leuven); Vanwayenberghe fund; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by FWO funding (G085111N), NIH-PO1-CA-65493-06, Odysseus funding, CoE and GOA/11/012 funding from K.U.Leuven, and the Vanwayenberghe fund to CM Verfaillie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashman LK, 1999, INT J BIOCHEM CELL B, V31, P1037, DOI 10.1016/S1357-2725(99)00076-X; Austin TW, 1997, BLOOD, V89, P3624, DOI 10.1182/blood.V89.10.3624.3624_3624_3635; Buckley SM, 2011, EXP HEMATOL, V39, P114, DOI 10.1016/j.exphem.2010.09.010; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Congdon KL, 2008, STEM CELLS, V26, P1202, DOI 10.1634/stemcells.2007-0768; Corrigan PM, 2009, STEM CELLS DEV, V18, P759, DOI 10.1089/scd.2008.0270; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kestler HA, 2008, PHILOS T R SOC B, V363, P1333, DOI 10.1098/rstb.2007.2251; Luis TC, 2011, CELL STEM CELL, V9, P345, DOI 10.1016/j.stem.2011.07.017; Luis TC, 2009, BLOOD, V113, P546, DOI 10.1182/blood-2008-06-163774; Malhotra S, 2008, J IMMUNOL, V181, P3955, DOI 10.4049/jimmunol.181.6.3955; Matsunaga T, 1998, BLOOD, V92, P452, DOI 10.1182/blood.V92.2.452.414k09_452_461; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; Orelio C, 2003, BLOOD, V101, P2246, DOI 10.1182/blood-2002-07-2260; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Szilvassy SJ, 1999, BLOOD, V93, P1557, DOI 10.1182/blood.V93.5.1557; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211	21	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53669	10.1371/journal.pone.0053669	http://dx.doi.org/10.1371/journal.pone.0053669			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341970	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400063
J	Wheelock, A; Eisingerich, AB; Ananworanich, J; Gomez, GB; Hallett, TB; Dybul, MR; Piot, P				Wheelock, Ana; Eisingerich, Andreas B.; Ananworanich, Jintanat; Gomez, Gabriela B.; Hallett, Timothy B.; Dybul, Mark R.; Piot, Peter			Are Thai MSM Willing to Take PrEP for HIV Prevention? An Analysis of Attitudes, Preferences and Acceptance	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; SEXUAL-BEHAVIOR; RISK BEHAVIOR; CONDOM USE; MEN; INFECTION; ADHERENCE; STRATEGIES; EXPERIENCE; IMPACT	Objective: We aimed to understand the attitudes, preferences and acceptance of oral and parenteral PrEP among men who have sex with men (MSM) in Thailand. Background: Pre-exposure prophylaxis (PrEP), the use of antiretrovirals to prevent HIV acquisition, has shown promising results in recent trials. To assess the potential impact of this new HIV prevention method, in addition to efficacy data, we need to understand which psychosocial factors are likely to determine its uptake among members of potential user groups. Methods and Findings: Surveys of willingness to use PrEP products were administered to MSM. Spearman's rank tests were used to uncover associations between questionnaire items. Mann-Whitney tests were performed to ascertain differences between groups. Conjoint analysis was used to examine the attitudes and preferences of MSM towards PrEP attributes. Most participants were willing to consider taking PrEP (39.2% "yes, definitely'' and 49.2% "yes, probably'') and perceived PrEP as giving them new possibilities in their lives (38.5% "a lot of hope'' and 55.8% "some hope''), even after being instructed of potential side effects and costs. HIV testing was considered the most important attribute and a daily pill and longer lasting injection in the arm were the preferred routes of administration. Conclusions: Despite its multiple challenges, MSM in Thailand would be willing to take PrEP, even if they had to experience inconvenience and expense. If PrEP were to be implemented in Thailand, our findings show that its uptake could be considerable.	[Wheelock, Ana] Univ London Imperial Coll Sci Technol & Med, Ctr Patient Safety & Serv Qual, London, England; [Eisingerich, Andreas B.] Univ London Imperial Coll Sci Technol & Med, Sch Business, London, England; [Ananworanich, Jintanat] Chulalongkorn Univ, Thai Red Cross AIDS Res Ctr, Bangkok, Thailand; [Ananworanich, Jintanat] Chulalongkorn Univ, Fac Med, Bangkok 10330, Thailand; [Gomez, Gabriela B.] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Gomez, Gabriela B.] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Hallett, Timothy B.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Dybul, Mark R.] Georgetown ONeill Inst Natl & Global Hlth Law, Washington, DC USA; [Dybul, Mark R.] George W Bush Inst, Washington, DC USA; [Piot, Peter] London Sch Hyg & Trop Med, London WC1, England	Imperial College London; Imperial College London; Chulalongkorn University; Thai Red Cross Society; Chulalongkorn University; University of Amsterdam; Academic Medical Center Amsterdam; Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Wheelock, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Patient Safety & Serv Qual, London, England.	a.wheelock@imperial.ac.uk	Ananworanich, Jintanat/AAC-6348-2021; Wheelock, Ana/AAE-9248-2019	Ananworanich, Jintanat/0000-0003-1369-3224; Hallett, Timothy/0000-0002-9681-0424; Wheelock, Ana/0000-0003-0855-7252	Bill & Melinda Gates Foundation; Medical Research Council [MR/K010174/1, MR/K010174/1B, G0600719B] Funding Source: researchfish; MRC [MR/K010174/1] Funding Source: UKRI	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The sponsor of the study, the Bill & Melinda Gates Foundation, had no role in study design, data collection, data analysis, decision to publish, or write up of the paper.; We are very grateful to all those who participated in this study, and the Bill & Melinda Gates Foundation, in particular Blair Hanewall and Stephen Becker, for funding our research. We would also like to thank Emily Gray, Kate Duxbury and the Ipsos MORI team, as well as Ipsos Thailand, for their valuable input and management support throughout this study. The authors would finally like to thank Marisa Miraldo and Anam Parand (Imperial College) for their advice, and Geoffrey Garnett (Imperial College) and Joep Lange (Amsterdam Institute for Global Health and Development) for their guidance at the beginning of this study.	Amon Joseph, 2009, Sur, Rev. int. direitos human., V6, P162; AVAC, 2012, PREP DEM PROJ; Barnighausen T, 2011, LANCET INFECT DIS, V11, P942, DOI 10.1016/S1473-3099(11)70181-5; Barash EA, 2010, AIDS PATIENT CARE ST, V24, P689, DOI 10.1089/apc.2010.0173; Bekker L. G., 2012, Southern African Journal of HIV Medicine, V13, P40; Bertozzi SM, 2008, LANCET, V372, P831, DOI 10.1016/S0140-6736(08)60889-2; Beyrer C, 2011, J ACQ IMMUN DEF SYND, V57, P96; Beyrer C, 2010, EPIDEMIOL REV, V32, P137, DOI 10.1093/epirev/mxq011; Bridges John F P, 2003, Appl Health Econ Health Policy, V2, P213; Celum C, 2012, CURR OPIN INFECT DIS, V25, P51, DOI 10.1097/QCO.0b013e32834ef5ef; Chariyalertsak S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024295; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cutler DM, 2010, NEW ENGL J MED, V362, P1553, DOI 10.1056/NEJMp1002305; Eisingerich AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028238; Frost LJ, 2009, HEALTH AFFAIR, V28, P962, DOI 10.1377/hlthaff.28.4.962; Geronimus AT, 1996, J AM STAT ASSOC, V91, P529, DOI 10.2307/2291645; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gregson S, 2002, SEX TRANSM DIS, V29, P568, DOI 10.1097/00007435-200210000-00002; Hanck SE, 2008, SEX TRANSM DIS, V35, P489, DOI 10.1097/OLQ.0b013e3181653433; HANENBERG RS, 1994, LANCET, V344, P243, DOI 10.1016/S0140-6736(94)93004-X; Holt M, 2012, SEX TRANSM INFECT, V88, P258, DOI 10.1136/sextrans-2011-050312; Ickovics JR, 1997, J CLIN EPIDEMIOL, V50, P385, DOI 10.1016/S0895-4356(97)00041-3; Jackson T, 2012, AIDS BEHAV, P1; Kelesidis Theodoros, 2011, Curr HIV/AIDS Rep, V8, P94, DOI 10.1007/s11904-011-0078-4; Krakower DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033119; KROSNICK JA, 1993, AM J POLIT SCI, V37, P941, DOI 10.2307/2111580; KROSNICK JA, 1991, APPL COGNITIVE PSYCH, V5, P213, DOI 10.1002/acp.2350050305; Li A, 2009, AIDS BEHAV, V13, P318, DOI 10.1007/s10461-008-9448-3; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P77, DOI 10.1097/QAI.0b013e31818d5a27; National Institute of Allergy and Infectious Diseases (NIAID), 2011, TREAT HIV INF PEOPL; Paxton LA, 2007, LANCET, V370, P89, DOI 10.1016/S0140-6736(07)61053-8; Piot P, 2008, LANCET, V372, P845, DOI 10.1016/S0140-6736(08)60888-0; Ryan M, 2001, HLTH TECHNOL ASSESS, V5; San Francisco City Clinic, 2012, SAN FRANC PREP DEM P; Schroder KEE, 2003, ANN BEHAV MED, V26, P76, DOI 10.1207/S15324796ABM2602_02; Sudman S, 1999, J ACAD MARKET SCI, V27, P269, DOI 10.1177/0092070399272010; U.S. Food and Drug Administration, 2012, FDA APPR 1 MED RED H; UNAIDS WHO, 2011, GLOB HIV AIDS RESP E; United Nations Development Programme, 2004, THAIL RESP HIV AIDS; van Griensven F, 2005, AIDS, V19, P521, DOI 10.1097/01.aids.0000162341.50933.e8; van Griensven F., 2006, Morbidity and Mortality Weekly Report, V55, P844; van Griensven F, 2010, JAIDS-J ACQ IMM DEF, V53, P234, DOI 10.1097/QAI.0b013e3181c2fc86; Wheelock A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001234; World Health Organization, 2012, RAP ADV GUID OR PREE	44	65	66	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54288	10.1371/journal.pone.0054288	http://dx.doi.org/10.1371/journal.pone.0054288			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	087KE	23342121	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000314759400141
J	Zurcher, NR; Donnelly, N; Rogier, O; Russo, B; Hippolyte, L; Hadwin, J; Lemonnier, E; Hadjikhani, N				Zuercher, Nicole R.; Donnelly, Nick; Rogier, Ophelie; Russo, Britt; Hippolyte, Loyse; Hadwin, Julie; Lemonnier, Eric; Hadjikhani, Nouchine			It's All in the Eyes: Subcortical and Cortical Activation during Grotesqueness Perception in Autism	PLOS ONE			English	Article							FACE PERCEPTION; FUNCTIONAL NEUROANATOMY; THATCHER ILLUSION; CHILDREN; GAZE; SPECTRUM; RECOGNITION; INVERSION; BRAIN; INDIVIDUALS	Atypical face processing plays a key role in social interaction difficulties encountered by individuals with autism. In the current fMRI study, the Thatcher illusion was used to investigate several aspects of face processing in 20 young adults with high-functioning autism spectrum disorder (ASD) and 20 matched neurotypical controls. "Thatcherized" stimuli were modified at either the eyes or the mouth and participants discriminated between pairs of faces while cued to attend to either of these features in upright and inverted orientation. Behavioral data confirmed sensitivity to the illusion and intact configural processing in ASD. Directing attention towards the eyes vs. the mouth in upright faces in ASD led to (1) improved discrimination accuracy; (2) increased activation in areas involved in social and emotional processing; (3) increased activation in subcortical face-processing areas. Our findings show that when explicitly cued to attend to the eyes, activation of cortical areas involved in face processing, including its social and emotional aspects, can be enhanced in autism. This suggests that impairments in face processing in autism may be caused by a deficit in social attention, and that giving specific cues to attend to the eye-region when performing behavioral therapies aimed at improving social skills may result in a better outcome.	[Zuercher, Nicole R.; Rogier, Ophelie; Russo, Britt; Hippolyte, Loyse; Hadjikhani, Nouchine] Ecole Polytech Fed Lausanne, Brain Mind Inst, CH-1015 Lausanne, Switzerland; [Donnelly, Nick; Hadwin, Julie] Univ Southampton, Sch Psychol, Southampton, Hants, England; [Lemonnier, Eric] CHRU Brest Hop Bohars, Ctr Ressources Autisme Bretagne, Bohars, France; [Lemonnier, Eric] Univ Brest, CHRU Brest Hop Bohars, Bohars, France; [Hadjikhani, Nouchine] Harvard Univ, Sch Med, MGH HMS MIT A Martinos Ctr Biomed Imaging, Charlestown, MA USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Southampton; CHU Brest; CHU Brest; Universite de Bretagne Occidentale; Harvard University	Hadjikhani, N (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, CH-1015 Lausanne, Switzerland.	nouchine@nmr.mgh.harvard.edu	Hadjikhani, Nouchine/C-2018-2008; Zurcher, Nicole/AGF-1440-2022; lemonnier, eric/K-1084-2016	Hadjikhani, Nouchine/0000-0003-4075-3106; Zurcher, Nicole/0000-0003-0271-6304; Donnelly, Nick/0000-0002-3577-5434	Swiss National Science Foundation [PP00P3-130191]; Velux Stiftung; Centre d'Imagerie BioMedicale (CIBM) of the University of Lausanne (UNIL); Swiss Federal Institute of Technology Lausanne (EPFL); University of Geneva (UniGe); Centre Hospitalier Universitaire Vaudois (CHUV); Hopitaux Universitaires de Geneve (HUG); Leenaards Foundation; Jeantet Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Velux Stiftung; Centre d'Imagerie BioMedicale (CIBM) of the University of Lausanne (UNIL); Swiss Federal Institute of Technology Lausanne (EPFL); University of Geneva (UniGe); Centre Hospitalier Universitaire Vaudois (CHUV); Hopitaux Universitaires de Geneve (HUG); Leenaards Foundation; Jeantet Foundation	This work was supported by the Swiss National Science Foundation (PP00P3-130191 to NH) and by the Velux Stiftung; by the Centre d'Imagerie BioMedicale (CIBM) of the University of Lausanne (UNIL), the Swiss Federal Institute of Technology Lausanne (EPFL), the University of Geneva (UniGe), the Centre Hospitalier Universitaire Vaudois (CHUV), the Hopitaux Universitaires de Geneve (HUG) and the Leenaards and the Jeantet Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; BARTLETT JC, 1993, COGNITIVE PSYCHOL, V25, P281, DOI 10.1006/cogp.1993.1007; Barton JJS, 2001, BRIT J PSYCHOL, V92, P527, DOI 10.1348/000712601162329; Batki A, 2000, INFANT BEHAV DEV, V23, P223, DOI 10.1016/S0163-6383(01)00037-6; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Birmingham E, 2008, VIS COGN, V16, P341, DOI 10.1080/13506280701434532; Bouvier SE, 2006, CEREB CORTEX, V16, P183, DOI 10.1093/cercor/bhi096; Brosch T, 2008, PSYCHOL SCI, V19, P362, DOI 10.1111/j.1467-9280.2008.02094.x; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Carbon CC, 2005, PERCEPTION, V34, P1117, DOI 10.1068/p5192; Carbon CC, 2005, COGNITIVE BRAIN RES, V24, P544, DOI 10.1016/j.cogbrainres.2005.03.008; Carbon CC, 2007, PERCEPTION, V36, P1635, DOI 10.1068/p5467; Chevallier C, 2012, TRENDS COGN SCI, V16, P231, DOI 10.1016/j.tics.2012.02.007; Cornes K, 2008, THESIS U SOUTHAMPTON; Critchley HD, 2000, BRAIN, V123, P2203, DOI 10.1093/brain/123.11.2203; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; Dawson G, 2005, DEV NEUROPSYCHOL, V27, P403, DOI 10.1207/s15326942dn2703_6; de Gelder BC, 2003, P NATL ACAD SCI USA, V100, P13105, DOI 10.1073/pnas.1735530100; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Donnelly N, 2012, ATTEN PERCEPT PSYCHO, V74, P1475, DOI 10.3758/s13414-012-0330-z; Donnelly N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023340; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; Eimer M, 2000, COGNITIVE BRAIN RES, V10, P145, DOI 10.1016/S0926-6410(00)00038-0; Elsabbagh M, 2009, BIOL PSYCHIAT, V65, P31, DOI 10.1016/j.biopsych.2008.09.034; Fairhall SL, 2007, CEREB CORTEX, V17, P2400, DOI 10.1093/cercor/bhl148; Frith CD, 2012, ANNU REV PSYCHOL, V63, P287, DOI 10.1146/annurev-psych-120710-100449; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Grice SJ, 2005, CORTEX, V41, P342, DOI 10.1016/S0010-9452(08)70271-5; Hadjikhani N, 2004, NEUROIMAGE, V22, P1141, DOI 10.1016/j.neuroimage.2004.03.025; Hadjikhani N, 2002, HUM BRAIN MAPP, V16, P176, DOI 10.1002/hbm.10043; Hadjikhani N, 2007, HUM BRAIN MAPP, V28, P441, DOI 10.1002/hbm.20283; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; HILLIARD R D, 1973, Cortex, V9, P246; Ishai A, 2005, BRAIN RES BULL, V67, P87, DOI 10.1016/j.brainresbull.2005.05.027; Ishai A, 2008, NEUROIMAGE, V40, P415, DOI 10.1016/j.neuroimage.2007.10.040; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; JOHNSON M, 2005, NAT NEUROSCI REV, V6, P2; Joseph RM, 2003, J CHILD PSYCHOL PSYC, V44, P529, DOI 10.1111/1469-7610.00142; Joseph RM, 2008, J INT NEUROPSYCH SOC, V14, P947, DOI 10.1017/S1355617708081344; Kingstone A, 2004, BRAIN COGNITION, V55, P269, DOI 10.1016/j.bandc.2004.02.037; Kliemann D, 2012, J NEUROSCI, V32, P9469, DOI 10.1523/JNEUROSCI.5294-11.2012; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Kylliainen A, 2006, EUR J NEUROSCI, V24, P2679, DOI 10.1111/j.1460-9568.2006.05132.x; Kylliainen A, 2006, J AUTISM DEV DISORD, V36, P517, DOI 10.1007/s10803-006-0091-4; Lahaie A, 2006, NEUROPSYCHOLOGY, V20, P30, DOI 10.1037/0894-4105.20.1.30; LANGDELL T, 1978, J CHILD PSYCHOL PSYC, V19, P255, DOI 10.1111/j.1469-7610.1978.tb00468.x; Lopez B, 2004, VIS COGN, V11, P673, DOI 10.1080/13506280344000437; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Maddock RJ, 1999, TRENDS NEUROSCI, V22, P310, DOI 10.1016/S0166-2236(98)01374-5; Malcolm GL, 2004, PERCEPTION, V33, P1221, DOI 10.1068/p5372; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Meng M, 2012, P ROY SOC B-BIOL SCI, V279, P2052, DOI 10.1098/rspb.2011.1784; Mestry N, 2012, NEUROPSYCHOLOGIA; Mohanty A, 2009, J NEUROSCI, V29, P10563, DOI 10.1523/JNEUROSCI.1170-09.2009; Morris JP, 2007, SOC COGN AFFECT NEUR, V2, P31, DOI 10.1093/scan/nsl023; MORTON J, 1991, PSYCHOL REV, V98, P164, DOI 10.1037/0033-295X.98.2.164; Nishimura M, 2008, VIS COGN, V16, P859, DOI 10.1080/13506280701538514; Pelphrey KA, 2002, J AUTISM DEV DISORD, V32, P249, DOI 10.1023/A:1016374617369; PERRETT DI, 1988, BEHAV BRAIN RES, V29, P245, DOI 10.1016/0166-4328(88)90029-0; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Pourtois G, 2004, CEREB CORTEX, V14, P619, DOI 10.1093/cercor/bhh023; Raven J., 2004, MANUAL RAVENS PROGR; Riby DM, 2009, Q J EXP PSYCHOL, V62, P189, DOI 10.1080/17470210701855629; Ristic J, 2005, COGNITIVE BRAIN RES, V24, P715, DOI 10.1016/j.cogbrainres.2005.02.007; Rossion B, 2000, NEUROREPORT, V11, P69, DOI 10.1097/00001756-200001170-00014; Rossion Bruno, 2002, Behav Cogn Neurosci Rev, V1, P63, DOI 10.1177/1534582302001001004; Rouse H, 2004, J CHILD PSYCHOL PSYC, V45, P1246, DOI 10.1111/j.1469-7610.2004.00317.x; SCAPINELLO KF, 1970, PSYCHON SCI, V21, P329, DOI 10.3758/BF03335807; Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331; Senju A, 2005, NEUROPSYCHOLOGIA, V43, P1297, DOI 10.1016/j.neuropsychologia.2004.12.002; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sorger B, 2007, NEUROIMAGE, V35, P836, DOI 10.1016/j.neuroimage.2006.09.051; Speer LL, 2007, AUTISM, V11, P265, DOI 10.1177/1362361307076925; Sturzel F, 2000, PERCEPTION, V29, P937, DOI 10.1068/p2888; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; THOMPSON P, 1980, PERCEPTION, V9, P483, DOI 10.1068/p090483; VALENTINE T, 1988, BRIT J PSYCHOL, V79, P471, DOI 10.1111/j.2044-8295.1988.tb02747.x; Vlamings PHJM, 2009, J VISION, V9, DOI 10.1167/9.5.12; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Wechsler D., 1999, WECHSLER ABBREVIATED; Wechsler D., 2006, WECHSLER NONVERBAL S; Weigelt S, 2012, NEUROSCI BIOBEHAV R, V36, P1060, DOI 10.1016/j.neubiorev.2011.12.008; Winston JS, 2003, CURR BIOL, V13, P1824, DOI 10.1016/j.cub.2003.09.038; Woolrich M, 2008, NEUROIMAGE, V41, P286, DOI 10.1016/j.neuroimage.2008.02.042; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Worsley KJ, 2001, FUNCTIONAL MRI INTRO; Yarbus A.L., 1967, EYE MOVEMENT VISION; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; Yovel G, 2004, NEURON, V44, P889, DOI 10.1016/S0896-6273(04)00728-7	99	31	32	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54313	10.1371/journal.pone.0054313	http://dx.doi.org/10.1371/journal.pone.0054313			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	087KE	23342130	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000314759400147
J	Eissmann, K; Mueller, S; Sticht, H; Jung, SS; Zou, P; Jiang, SB; Gross, A; Eichler, J; Fleckenstein, B; Reil, H				Eissmann, Kristin; Mueller, Sebastian; Sticht, Heinrich; Jung, Susan; Zou, Peng; Jiang, Shibo; Gross, Andrea; Eichler, Jutta; Fleckenstein, Bernhard; Reil, Heide			HIV-1 Fusion Is Blocked through Binding of GB Virus C E2D Peptides to the HIV-1 gp41 Disulfide Loop	PLOS ONE			English	Article							HEPATITIS-G VIRUS; ENVELOPE GLYCOPROTEIN; ENTRY INHIBITORS; 6-HELIX BUNDLE; CORE STRUCTURE; T-LYMPHOCYTE; TYPE-1 GP41; INFECTION; PROTEIN; COINFECTION	A strategy for antiviral drug discovery is the elucidation and imitation of viral interference mechanisms. HIV-1 patients benefit from a coinfection with GB Virus C (GBV-C), since HIV-positive individuals with long-term GBV-C viraemia show better survival rates than HIV-1 patients without persisting GBV-C. A direct influence of GBV-C on HIV-1 replication has been shown in coinfection experiments. GBV-C is a human non-pathogenic member of the flaviviridae family that can replicate in T and B cells. Therefore, GBV-C shares partly the same ecological niche with HIV-1. In earlier work we have demonstrated that recombinant glycoprotein E2 of GBV-C and peptides derived from the E2 N-terminus interfere with HIV entry. In this study we investigated the underlying mechanism. Performing a virus-cell fusion assay and temperature-arrested HIV-infection kinetics, we provide evidence that the HIV-inhibitory E2 peptides interfere with late HIV-1 entry steps after the engagement of gp120 with CD4 receptor and coreceptor. Binding and competition experiments revealed that the N-terminal E2 peptides bind to the disulfide loop region of HIV-1 transmembrane protein gp41. In conjunction with computational analyses, we identified sequence similarities between the N-termini of GBV-C E2 and the HIV-1 glycoprotein gp120. This similarity appears to enable the GBV-C E2 N-terminus to interact with the HIV-1 gp41 disulfide loop, a crucial domain involved in the gp120-gp41 interface. Furthermore, the results of the present study provide initial proof of concept that peptides targeted to the gp41 disulfide loop are able to inhibit HIV fusion and should inspire the development of this new class of HIV-1 entry inhibitors.	[Eissmann, Kristin; Mueller, Sebastian; Jung, Susan; Fleckenstein, Bernhard; Reil, Heide] Univ Erlangen Nurnberg, Inst Virol, D-91054 Erlangen, Germany; [Sticht, Heinrich] Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany; [Zou, Peng; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA; [Jiang, Shibo] Fudan Univ, Key Lab Med Mol Virol, Minist Educ, Shanghai Med Coll,Inst Med Microbiol, Shanghai 200433, Peoples R China; [Jiang, Shibo] Fudan Univ, Key Lab Med Mol Virol, Minist Hlth, Shanghai Med Coll,Inst Med Microbiol, Shanghai 200433, Peoples R China	University of Erlangen Nuremberg; University of Erlangen Nuremberg; New York Blood Center; Fudan University; Fudan University	Reil, H (corresponding author), Univ Erlangen Nurnberg, Inst Virol, D-91054 Erlangen, Germany.	heide.reil@viro.med.uni-erlangen.de	Eichler, Jutta/H-7847-2018; Jiang, Shibo/L-4500-2014	Eichler, Jutta/0000-0001-6683-9456; Jiang, Shibo/0000-0001-8283-7135; Sticht, Heinrich/0000-0001-5644-045X	Akademie der Wissenschaften und Literatur zu Mainz [2 1.223]; Interdisziplinares Zentrum fur Klinische Forschung (IZKF) [Teilprojekt B16]; Deutsche Forschungsgemeinschaft [GRK1071, A5, A7]; Bayerisches Staatsministerium fur Wissenschaft; Forschung und Kunst: "Forderung der Chancengleichheit fur Frauen in Forschung und Lehre''; Sonderforschungsbereich [A5, 796, A2]; National Natural Science Foundation of China [NSFC-81173098]	Akademie der Wissenschaften und Literatur zu Mainz; Interdisziplinares Zentrum fur Klinische Forschung (IZKF); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bayerisches Staatsministerium fur Wissenschaft; Forschung und Kunst: "Forderung der Chancengleichheit fur Frauen in Forschung und Lehre''; Sonderforschungsbereich(German Research Foundation (DFG)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants of the Akademie der Wissenschaften und Literatur zu Mainz, project 2 1.223 (HR), the Interdisziplinares Zentrum fur Klinische Forschung (IZKF): Teilprojekt B16 (HR), Deutsche Forschungsgemeinschaft: GRK1071, projects A5 (KE), A7 (AG), Bayerisches Staatsministerium fur Wissenschaft, Forschung und Kunst: "Forderung der Chancengleichheit fur Frauen in Forschung und Lehre'' (KE, SJ), the Sonderforschungsbereich 796: project A2 (HS), A5 (JE), and the National Natural Science Foundation of China (NSFC-81173098) to ShJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Alter HJ, 1997, TRANSFUSION, V37, P569, DOI 10.1046/j.1537-2995.1997.37697335149.x; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Barbouche R, 2005, MOL PHARMACOL, V67, P1111, DOI 10.1124/mol.104.008276; Belyaev AS, 1998, J VIROL, V72, P868, DOI 10.1128/JVI.72.1.868-872.1998; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Caffrey M, 2001, BBA-MOL BASIS DIS, V1536, P116, DOI 10.1016/S0925-4439(01)00042-4; Caffrey M, 2011, TRENDS MICROBIOL, V19, P191, DOI 10.1016/j.tim.2011.02.001; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Deleage G, 1997, BIOCHIMIE, V79, P681, DOI 10.1016/S0300-9084(97)83524-9; Earl PL, 1997, J VIROL, V71, P2674, DOI 10.1128/JVI.71.4.2674-2684.1997; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fenouillet E, 2007, ANTIOXID REDOX SIGN, V9, P1009, DOI 10.1089/ars.2007.1639; Feucht HH, 1999, J CLIN MICROBIOL, V37, P1294, DOI 10.1128/JCM.37.5.1294-1297.1999; Feucht HH, 1997, LANCET, V349, P435, DOI 10.1016/S0140-6736(97)80062-1; George SL, 2006, J INFECT DIS, V193, P451, DOI 10.1086/499435; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; He YX, 2008, J VIROL, V82, P6349, DOI 10.1128/JVI.00319-08; HELSETH E, 1991, J VIROL, V65, P2119, DOI 10.1128/JVI.65.4.2119-2123.1991; Henderson HI, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-36; Henderson KA, 2007, STRUCTURE, V15, P1452, DOI 10.1016/j.str.2007.09.011; Heringlake S, 1998, J INFECT DIS, V177, P1723, DOI 10.1086/517431; Herrera E, 2010, J MED CHEM, V53, P6054, DOI 10.1021/jm100452c; Jacobs A, 2005, J BIOL CHEM, V280, P27284, DOI 10.1074/jbc.M414411200; Jacobs A, 2007, J BIOL CHEM, V282, P32406, DOI 10.1074/jbc.M705577200; Jiang S, 1998, J VIROL, V72, P10213, DOI 10.1128/JVI.72.12.10213-10217.1998; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Jiang SB, 2004, ANTIMICROB AGENTS CH, V48, P4349, DOI 10.1128/AAC.48.11.4349-4359.2004; Jung S, 2005, AIDS, V19, P1267, DOI 10.1097/01.aids.0000180097.50393.df; Jung S, 2007, AIDS, V21, P645, DOI 10.1097/QAD.0b013e32803277c7; Kim S, 2008, J MOL BIOL, V376, P786, DOI 10.1016/j.jmb.2007.12.001; Koedel Y, 2011, J VIROL, V85, P7037, DOI 10.1128/JVI.02366-10; Labrosse B, 2000, J VIROL, V74, P2142, DOI 10.1128/JVI.74.5.2142-2150.2000; Leary TP, 1996, J MED VIROL, V48, P60, DOI 10.1002/(SICI)1096-9071(199601)48:1&lt;60::AID-JMV10&gt;3.0.CO;2-A; Lefrere JJ, 1999, J INFECT DIS, V179, P783, DOI 10.1086/314671; Lefrere JJ, 1999, TRANSFUSION, V39, P83, DOI 10.1046/j.1537-2995.1999.39199116899.x; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linnen J, 1996, SCIENCE, V271, P505, DOI 10.1126/science.271.5248.505; Lu M, 1997, J BIOMOL STRUCT DYN, V15, P465, DOI 10.1080/07391102.1997.10508958; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; Maidana-Giret MT, 2009, AIDS, V23, P2277, DOI 10.1097/QAD.0b013e32832d7a11; Mao YD, 2012, NAT STRUCT MOL BIOL, V19, P893, DOI 10.1038/nsmb.2351; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Moenkemeyer M, 2008, J MED VIROL, V80, P1933, DOI 10.1002/jmv.21305; Mohr EL, 2009, J VIRAL HEPATITIS, V16, P757, DOI 10.1111/j.1365-2893.2009.01194.x; Munch J, 2007, CELL, V129, P263, DOI 10.1016/j.cell.2007.02.042; Munk C, 2003, AIDS RES HUM RETROV, V19, P875, DOI 10.1089/088922203322493049; Murray EJ, 2010, J VIROL, V84, P7288, DOI 10.1128/JVI.00535-10; Nattermann J, 2003, AIDS, V17, P1457, DOI 10.1097/00002030-200307040-00006; Nunnari G, 2003, ANN INTERN MED, V139, P26, DOI 10.7326/0003-4819-139-1-200307010-00009; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Rydze RT, 2012, J INFECT DIS, V206, P69, DOI 10.1093/infdis/jis312; Sanchez R, 2000, METH MOL B, V143, P97; Schwarze-Zander C, 2010, ANTIVIR THER, V15, P745, DOI 10.3851/IMP1602; SIMONS JN, 1995, NAT MED, V1, P564, DOI 10.1038/nm0695-564; Stapleton JT, 2011, J GEN VIROL, V92, P233, DOI 10.1099/vir.0.027490-0; Stapleton JT, 2003, SEMIN LIVER DIS, V23, P137; Supapol WB, 2008, J INFECT DIS, V197, P1369, DOI 10.1086/587488; Tacke M, 1997, HEPATOLOGY, V26, P1626, DOI 10.1002/hep.510260635; Tillmann HL, 2001, NEW ENGL J MED, V345, P715, DOI 10.1056/NEJMoa010398; Tilton JC, 2010, ANTIVIR RES, V85, P91, DOI 10.1016/j.antiviral.2009.07.022; Toyoda H, 1998, J ACQ IMMUN DEF SYND, V17, P209, DOI 10.1097/00042560-199803010-00004; Vahidnia F, 2012, CLIN INFECT DIS, V55, P1012, DOI 10.1093/cid/cis589; Wang JZ, 2008, J BIOL CHEM, V283, P32644, DOI 10.1074/jbc.M806099200; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Williams CF, 2004, NEW ENGL J MED, V350, P981, DOI 10.1056/NEJMoa030107; Xiang JH, 2004, LANCET, V363, P2040, DOI 10.1016/S0140-6736(04)16453-2; Xiang JH, 2001, NEW ENGL J MED, V345, P707, DOI 10.1056/NEJMoa003364; Xiang JH, 2006, P NATL ACAD SCI USA, V103, P15570, DOI 10.1073/pnas.0604728103; Xiang JH, 2012, VIROLOGY, V430, P53, DOI 10.1016/j.virol.2012.04.019; XU JY, 1991, J VIROL, V65, P4832, DOI 10.1128/JVI.65.9.4832-4838.1991; Yeo AET, 2000, ANN INTERN MED, V132, P959, DOI 10.7326/0003-4819-132-12-200006200-00006; Zhang W, 2006, HIV MED, V7, P173, DOI 10.1111/j.1468-1293.2006.00366.x; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	77	21	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54452	10.1371/journal.pone.0054452	http://dx.doi.org/10.1371/journal.pone.0054452			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349893	gold, Green Submitted, Green Published			2022-12-25	WOS:000314019100069
J	Wijaya, E; Frith, MC; Horton, P; Asai, K				Wijaya, Edward; Frith, Martin C.; Horton, Paul; Asai, Kiyoshi			Finding Protein-Coding Genes through Human Polymorphisms	PLOS ONE			English	Article							DATABASE; PREDICTION; SEQUENCE; TRANSCRIPTS; PROJECT	Human gene catalogs are fundamental to the study of human biology and medicine. But they are all based on open reading frames (ORFs) in a reference genome sequence (with allowance for introns). Individual genomes, however, are polymorphic: their sequences are not identical. There has been much research on how polymorphism affects previously-identified genes, but no research has been done on how it affects gene identification itself. We computationally predict protein-coding genes in a straightforward manner, by finding long ORFs in mRNA sequences aligned to the reference genome. We systematically test the effect of known polymorphisms with this procedure. Polymorphisms can not only disrupt ORFs, they can also create long ORFs that do not exist in the reference sequence. We found 5,737 putative protein-coding genes that do not exist in the reference, whose protein-coding status is supported by homology to known proteins. On average 10% of these genes are located in the genomic regions devoid of annotated genes in 12 other catalogs. Our statistical analysis showed that these ORFs are unlikely to occur by chance.	[Wijaya, Edward; Asai, Kiyoshi] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Wijaya, Edward; Frith, Martin C.; Horton, Paul; Asai, Kiyoshi] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Tokyo, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST)	Wijaya, E (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan.	e-wijaya@cb.k.u-tokyo.ac.jp	Edward, Wijaya/G-6209-2013; Asai, Kiyoshi/AAT-8344-2020	Asai, Kiyoshi/0000-0003-0909-4982; Frith, Martin/0000-0003-0998-2859	Japanese Ministry of Education, Sport, Science and Technology (MEXT) [221S002]	Japanese Ministry of Education, Sport, Science and Technology (MEXT)	Financial support for this study was provided by a Grant-in-Aid for Scientific Research on Innovative Areas (221S002) from Japanese Ministry of Education, Sport, Science and Technology (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson DA, 2004, NUCLEIC ACIDS RES, V32, pD23, DOI 10.1093/nar/gkh045; Blanco E, 2002, CURRENT PROTOCOLS BI; Brent MR, 2005, GENOME RES, V15, P1777, DOI 10.1101/gr.3866105; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Carvunis AR, 2012, NATURE, V487, P370, DOI 10.1038/nature11184; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cooper DN, 2010, HUM MUTAT, V31, P631, DOI 10.1002/humu.21260; Durbin R, 2011, NATURE, V470, P59; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frith Martin C, 2006, RNA Biol, V3, P40; Frith MC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1212; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Halvorsen M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001074; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110; Knowles D, 2009, GENOME RES, V21, P487; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Kozak M, 2002, GENE, V10, P1752; Mathe C, 2002, NUCLEIC ACIDS RES, V30, P4103, DOI 10.1093/nar/gkf543; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; OLIVER SG, 1992, NATURE, V357, P38, DOI 10.1038/357038a0; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; SHARP PM, 1991, YEAST, V7, P657, DOI 10.1002/yea.320070702; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shimada MK, 2009, NUCLEIC ACIDS RES, V37, pD810, DOI 10.1093/nar/gkn798; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; van Baren MJ, 2006, GENOME RES, V16, P678, DOI 10.1101/gr.4766206; Wiehe T, 2001, GENOME RES, V11, P1574, DOI 10.1101/gr.177401; Wilming LG, 2008, NUCLEIC ACIDS RES, V36, pD753, DOI 10.1093/nar/gkm987; Wilson BA, 2011, GENOME BIOL EVOL, V3, P1245, DOI 10.1093/gbe/evr099; Wu DD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002379; Yamaguchi-Kabata Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003393; Yamasaki C, 2010, NUCLEIC ACIDS RES, V38, pD626, DOI 10.1093/nar/gkp1020	46	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54210	10.1371/journal.pone.0054210	http://dx.doi.org/10.1371/journal.pone.0054210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349826	Green Submitted, Green Published, gold			2022-12-25	WOS:000314019100050
J	Tian, TH				Tian, Tianhai			Chemical Memory Reactions Induced Bursting Dynamics in Gene Expression	PLOS ONE			English	Article							EXACT STOCHASTIC SIMULATION; P53-MDM2 FEEDBACK LOOP; REGULATORY NETWORKS; BIOLOGICAL ROBUSTNESS; ESCHERICHIA-COLI; INDIVIDUAL CELLS; TOGGLE SWITCH; SINGLE-CELL; TIME DELAYS; DNA-DAMAGE	Memory is a ubiquitous phenomenon in biological systems in which the present system state is not entirely determined by the current conditions but also depends on the time evolutionary path of the system. Specifically, many memorial phenomena are characterized by chemical memory reactions that may fire under particular system conditions. These conditional chemical reactions contradict to the extant stochastic approaches for modeling chemical kinetics and have increasingly posed significant challenges to mathematical modeling and computer simulation. To tackle the challenge, I proposed a novel theory consisting of the memory chemical master equations and memory stochastic simulation algorithm. A stochastic model for single-gene expression was proposed to illustrate the key function of memory reactions in inducing bursting dynamics of gene expression that has been observed in experiments recently. The importance of memory reactions has been further validated by the stochastic model of the p53-MDM2 core module. Simulations showed that memory reactions is a major mechanism for realizing both sustained oscillations of p53 protein numbers in single cells and damped oscillations over a population of cells. These successful applications of the memory modeling framework suggested that this innovative theory is an effective and powerful tool to study memory process and conditional chemical reactions in a wide range of complex biological systems.	Monash Univ, Sch Math Sci, Melbourne, Vic 3004, Australia	Monash University	Tian, TH (corresponding author), Monash Univ, Sch Math Sci, Melbourne, Vic 3004, Australia.	Tianhai.Tian@monash.edu	Tian, Tianhai/AAU-2335-2021	Tian, Tianhai/0000-0001-6191-0209	Australian Research Council (ARC) Discovery Projects [DP1094181, DP120104460]; Australian Research Council Future Fellowship [FT100100748]	Australian Research Council (ARC) Discovery Projects(Australian Research Council); Australian Research Council Future Fellowship(Australian Research Council)	This work was supported by the Australian Research Council (ARC) Discovery Projects (DP1094181 and DP120104460). T. T. is also a recipient of the Australian Research Council Future Fellowship (FT100100748). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Agrawal S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000390; Arkin A, 1998, GENETICS, V149, P1633; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Barrio M, 2006, PLOS COMPUT BIOL, V2, P1017, DOI 10.1371/journal.pcbi.0020117; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Becskei A, 2004, NAT CELL BIOL, V6, P451, DOI 10.1038/ncb1124; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Bratsun D, 2005, P NATL ACAD SCI USA, V102, P14593, DOI 10.1073/pnas.0503858102; Burrill DR, 2010, CELL, V140, P13, DOI 10.1016/j.cell.2009.12.034; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Casadesus J, 2002, BIOESSAYS, V24, P512, DOI 10.1002/bies.10102; Chen LY, 2005, CELL, V120, P37, DOI 10.1016/j.cell.2004.11.030; Chubb JR, 2010, CURR OPIN GENET DEV, V20, P478, DOI 10.1016/j.gde.2010.06.009; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Ciliberto A, 2005, CELL CYCLE, V4, P488, DOI 10.4161/cc.4.3.1548; Dieci G, 2003, TRENDS BIOCHEM SCI, V28, P202, DOI 10.1016/S0968-0004(03)00054-9; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; HARLEY CB, 1992, EXP GERONTOL, V27, P375, DOI 10.1016/0531-5565(92)90068-B; Harper CV, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000607; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Hsu C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1687; Hume DA, 2000, BLOOD, V96, P2323, DOI 10.1182/blood.V96.7.2323.h8002323_2323_2328; Kelemen JZ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000332; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Leier A, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2919124; Loewer A, 2010, CELL, V142, P89, DOI 10.1016/j.cell.2010.05.031; Ma L, 2005, P NATL ACAD SCI USA, V102, P14266, DOI 10.1073/pnas.0501352102; Marquez-Lago TT, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-19; Monk NAM, 2003, CURR BIOL, V13, P1409, DOI 10.1016/S0960-9822(03)00494-9; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Ribeiro A, 2006, J COMPUT BIOL, V13, P1630, DOI 10.1089/cmb.2006.13.1630; Roussel MR, 2006, PHYS BIOL, V3, P274, DOI 10.1088/1478-3975/3/4/005; Schlicht R, 2008, J MATH BIOL, V57, P613, DOI 10.1007/s00285-008-0178-y; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Tan RZ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.14; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Tian TH, 2007, J COMPUT APPL MATH, V205, P696, DOI 10.1016/j.cam.2006.02.063; Tian TH, 2006, P NATL ACAD SCI USA, V103, P8372, DOI 10.1073/pnas.0507818103; Wang YV, 2007, P NATL ACAD SCI USA, V104, P12365, DOI 10.1073/pnas.0701497104; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Xu EY, 2006, MOL CELL, V23, P219, DOI 10.1016/j.molcel.2006.05.035; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zhang JJ, 2012, BIOPHYS J, V102, P1247, DOI 10.1016/j.bpj.2012.02.001; Zhu R, 2007, J THEOR BIOL, V246, P725, DOI 10.1016/j.jtbi.2007.01.021	63	12	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e52029	10.1371/journal.pone.0052029	http://dx.doi.org/10.1371/journal.pone.0052029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349679	Green Published, Green Submitted, gold			2022-12-25	WOS:000313943000006
J	Chafin, D; Theiss, A; Roberts, E; Boriee, G; Otter, M; Baird, GS				Chafin, David; Theiss, Abbey; Roberts, Esteban; Boriee, Grace; Otter, Michael; Baird, Geoffrey S.			Rapid Two-Temperature Formalin Fixation	PLOS ONE			English	Article							ANTIGEN RETRIEVAL; MICROWAVE IRRADIATION; FORMALDEHYDE FIXATION; BREAST-CANCER; TISSUE; SPECIMENS; ULTRASOUND; IMMUNOHISTOCHEMISTRY; MORPHOLOGY; STANDARDIZATION	Formalin fixation is a mainstay of modern histopathologic analysis, yet the practice is poorly standardized and a significant potential source of preanalytical errors. Concerns of workflow and turnaround time drive interest in developing shorter fixation protocols, but rapid protocols can lead to poor histomorphology or inadequate downstream assay results. Additionally, assays such as immunohistochemistry for phosphorylated epitopes have historically been challenging in the context of formalin-fixed tissue, indicating that there may be room for improvement in this process that is fundamental to the practice of anatomic pathology. With these issues in mind, we studied basic formalin biochemistry to develop a novel formalin fixation protocol that involves a pre-incubation in subambient temperature formalin prior to a brief exposure to heated formalin. This new protocol is more rapid than standard protocols yet preserves histomorphology and yields tissue that is compatible with an expanded set of downstream clinical and research assays, including immunohistochemistry for phosphorylated epitopes.	[Chafin, David; Theiss, Abbey; Roberts, Esteban; Otter, Michael] Ventana Med Syst Inc, Tucson, AZ USA; [Boriee, Grace; Baird, Geoffrey S.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Baird, Geoffrey S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	Roche Holding; Ventana Medical Systems, Inc.; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Baird, GS (corresponding author), Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.	gbaird@u.washington.edu			Ventana Medical Systems, Inc.	Ventana Medical Systems, Inc.(Roche Holding)	DC, AT, ER and MO are full-time employees of Ventana Medical. G. Baird has received research funding from Ventana Medical Systems, Inc. DC, AT, ER and MO have filed for patent protection on the 2+2 method, patent application number 2012/0214195(A1). There are no products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Allred DC, 1998, MODERN PATHOL, V11, P155; Bai YL, 2011, LAB INVEST, V91, P1253, DOI 10.1038/labinvest.2011.75; Baker AF, 2005, CLIN CANCER RES, V11, P4338, DOI 10.1158/1078-0432.CCR-05-0422; Baloglu G, 2008, APPL IMMUNOHISTO M M, V16, P485, DOI 10.1097/PAI.0b013e31815dffa6; BEROD A, 1981, J HISTOCHEM CYTOCHEM, V29, P844, DOI 10.1177/29.7.6167611; Bonnas C, 2011, INT J CANC; BOON ME, 1986, HISTOPATHOLOGY, V10, P303, DOI 10.1111/j.1365-2559.1986.tb02484.x; BOON ME, 1988, HISTOCHEM J, V20, P313, DOI 10.1007/BF01002723; BOON ME, 1991, EUR J MORPHOL, V29, P184; Boon ME, 1996, EUR J MORPHOL, V34, P375, DOI 10.1076/ejom.34.5.375.13053; Bussolati G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021043; Chen Q, 2007, ULTRASONICS, V47, P78, DOI 10.1016/j.ultras.2007.07.006; Chu WS, 2006, J HISTOCHEM CYTOCHEM, V54, P503, DOI 10.1369/jhc.5A6802.2005; Chu WS, 2005, MODERN PATHOL, V18, P850, DOI 10.1038/modpathol.3800354; Cox ML, 2006, EXP MOL PATHOL, V80, P183, DOI 10.1016/j.yexmp.2005.10.002; DAWSON IMP, 1972, HISTOCHEM J, V4, P381, DOI 10.1007/BF01005011; DETRE S, 1995, J CLIN PATHOL, V48, P876, DOI 10.1136/jcp.48.9.876; DURGUNYUCEL B, 1992, ACTA MED OKAYAMA, V46, P75; ERICSSON JL, 1967, LAB INVEST, V17, P281; Ferris AM, 2009, J NEUROSCI METH, V182, P157, DOI 10.1016/j.jneumeth.2009.06.002; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Fowler CB, 2008, LAB INVEST, V88, P785, DOI 10.1038/labinvest.2008.43; FOX CH, 1985, J HISTOCHEM CYTOCHEM, V33, P845, DOI 10.1177/33.8.3894502; Fracasso T, 2009, INT J LEGAL MED, V123, P521, DOI 10.1007/s00414-009-0368-1; Gillespie JW, 2002, AM J PATHOL, V160, P449, DOI 10.1016/S0002-9440(10)64864-X; Hafajee ZAM, 2004, PATHOLOGY, V36, P325, DOI 10.1080/00313020410001722374; Iesurum A, 2006, AM J FOREN MED PATH, V27, P178, DOI 10.1097/01.paf.0000221050.64572.01; KERNER H, 1986, HISTOPATHOLOGY, V10, P621, DOI 10.1111/j.1365-2559.1986.tb02515.x; KOK LP, 1990, HISTOCHEM J, V22, P381, DOI 10.1007/BF01003174; Leong ASY, 2011, METHODS MOL BIOL, V724, P37, DOI 10.1007/978-1-61779-055-3_3; LEONG ASY, 1985, J PATHOL, V146, P313, DOI 10.1002/path.1711460404; LEONG ASY, 1988, PATHOL ANNU, V23, P213; LEONG ASY, 1986, PATHOLOGY, V18, P222, DOI 10.3109/00313028609059463; Looi Lai-Meng, 2005, Malays J Pathol, V27, P23; Nadji M, 2005, APPL IMMUNOHISTO M M, V13, P277, DOI 10.1097/01.pai.0000146544.51771.79; O'Leary TJ, 2001, APPL IMMUNOHISTO M M, V9, P3, DOI 10.1097/00022744-200103000-00002; Pierceall WE, 2011, ANAL CELL PATHOL, V34, P159, DOI [10.1155/2011/583182, 10.3233/ACP-2011-014]; Pinhel IF, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2719; Rait VK, 2004, LAB INVEST, V84, P300, DOI 10.1038/labinvest.3700041; Rait VK, 2004, LAB INVEST, V84, P292, DOI 10.1038/labinvest.3700045; Rolls G, 2008, ASSESSING QUALITY TI; Ruijter ET, 1997, J PATHOL, V183, P369; Siddiqui S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2782; Sompuram SR, 2004, AM J CLIN PATHOL, V121, P190, DOI 10.1309/BRN7CTX1E84NWWPL; Titford M, 2012, ARCH PATHOL LAB MED, V136, P137, DOI 10.5858/arpa.2011-0363-LE; Umlas J, 2004, HUM PATHOL, V35, P1058, DOI 10.1016/j.humpath.2004.04.013; Uneyama C, 2002, J HISTOCHEM CYTOCHEM, V50, P1237, DOI 10.1177/002215540205000911; Winkelman JGM, 2002, CHEM ENG SCI, V57, P4067, DOI 10.1016/S0009-2509(02)00358-5; Zou N, 2011, BIOTECH HISTOCHEM, V86, P413, DOI 10.3109/10520295.2010.518830	49	35	42	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54138	10.1371/journal.pone.0054138	http://dx.doi.org/10.1371/journal.pone.0054138			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349806	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872800027
J	Oakenfull, RJ; Baxter, R; Knight, MR				Oakenfull, Rachael J.; Baxter, Robert; Knight, Marc R.			A C-Repeat Binding Factor Transcriptional Activator (CBF/DREB1) from European Bilberry (Vaccinium myrtillus) Induces Freezing Tolerance When Expressed in Arabidopsis thaliana	PLOS ONE			English	Article							COLD-ACCLIMATION; GENE-EXPRESSION; DNA-BINDING; GROWTH; CBF1; OVEREXPRESSION; FLUORESCENCE; PATHWAYS; STRESS; MOTIFS	Freezing stress affects all plants from temperate zones to the poles. Global climate change means such freezing events are becoming less predictable. This in turn reduces the ability of plants to predict the approaching low temperatures and cold acclimate. This has consequences for crop yields and distribution of wild plant species. C-repeat binding factors (CBFs) are transcription factors previously shown to play a vital role in the acclimation process of Arabidopsis thaliana, controlling the expression of hundreds of genes whose products are necessary for freezing tolerance. Work in other plant species cements CBFs as key determinants in the trait of freezing tolerance in higher plants. To test the function of CBFs from highly freezing tolerant plants species we cloned and sequenced CBF transcription factors from three Vaccinium species (Vaccinium myrtillus, Vaccinium uliginosum and Vaccinium vitis-idaea) which we collected in the Arctic. We tested the activity of CBF transcription factors from the three Vaccinium species by producing transgenic Arabidopsis lines overexpressing them. Only the Vaccinium myrtillus CBF was able to substantially activate COR (CBF-target) gene expression in the absence of cold. Correspondingly, only the lines expressing the Vaccinium myrtillus CBF were constitutively freezing tolerant. The basis for the differences in potency of the three Vaccinium CBFs was tested by observing cellular localisation and protein levels. All three CBFs were correctly targeted to the nucleus, but Vaccinium uliginosum CBF appeared to be relatively unstable. The reasons for lack of potency for Vaccinium vitis-idaea CBF were not due to stability or targeting, and we speculate that this was due to altered transcription factor function.	[Oakenfull, Rachael J.; Knight, Marc R.] Univ Durham, Durham Ctr Crop Improvement Technol, Durham, England; [Oakenfull, Rachael J.; Baxter, Robert; Knight, Marc R.] Univ Durham, Sch Biol & Biomed Sci, Durham, England	Durham University; Durham University	Knight, MR (corresponding author), Univ Durham, Durham Ctr Crop Improvement Technol, Durham, England.	m.r.knight@durham.ac.uk	Baxter, Robert/C-7688-2012	Baxter, Robert/0000-0002-7504-6797; Knight, Marc/0000-0002-4830-8608	UK Biotechnology and Biological Sciences Research Council; Natural Environment Research Council [NE/D005760/1] Funding Source: researchfish; NERC [NE/D005760/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The UK Biotechnology and Biological Sciences Research Council partly funded the PhD studentship of the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Achard P, 2008, PLANT CELL, V20, P2117, DOI 10.1105/tpc.108.058941; Badawi M, 2007, MOL GENET GENOMICS, V277, P533, DOI 10.1007/s00438-006-0206-9; Bokhorst S, 2012, AMBIO, V41, P246, DOI 10.1007/s13280-012-0310-5; Canella D, 2010, BBA-GENE REGUL MECH, V1799, P454, DOI 10.1016/j.bbagrm.2009.11.017; Chivasa S, 2009, PLANT J, V60, P436, DOI 10.1111/j.1365-313X.2009.03968.x; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Harberd NP, 2009, PLANT CELL, V21, P1328, DOI 10.1105/tpc.109.066969; Jaakola L, 2001, MOL BIOTECHNOL, V19, P201, DOI 10.1385/MB:19:2:201; Jacquemart AL, 1996, J ECOL, V84, P771, DOI 10.2307/2261339; Jaglo KR, 2001, PLANT PHYSIOL, V127, P910, DOI 10.1104/pp.010548; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Knight MR, 2012, NEW PHYTOL, V195, P737, DOI 10.1111/j.1469-8137.2012.04239.x; Kreyling J, 2012, OECOLOGIA, V168, P577, DOI 10.1007/s00442-011-2092-z; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Martinez-Garcia JF, 1999, PLANT J, V20, P251, DOI 10.1046/j.1365-313x.1999.00579.x; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Moffat CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035995; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Novillo F, 2004, P NATL ACAD SCI USA, V101, P3985, DOI 10.1073/pnas.0303029101; Novillo F, 2007, P NATL ACAD SCI USA, V104, P21002, DOI 10.1073/pnas.0705639105; Oxborough K, 2004, J EXP BOT, V55, P1195, DOI 10.1093/jxb/erh145; Polashock JJ, 2010, J AM SOC HORTIC SCI, V135, P40, DOI 10.21273/JASHS.135.1.40; Rinke A, 2008, GLOBAL PLANET CHANGE, V62, P173, DOI 10.1016/j.gloplacha.2008.01.004; RITCHIE JC, 1956, J ECOL, V44, P291, DOI 10.2307/2257181; RITCHIE JC, 1955, J ECOL, V43, P701, DOI 10.2307/2257030; SONESSON M, 1974, OIKOS, V25, P121, DOI 10.2307/3543633; SONESSON M, 1991, ARCTIC, V44, P95; Tahkokorpi M, 2007, ENVIRON EXP BOT, V61, P85, DOI 10.1016/j.envexpbot.2007.03.003; Taulavuori K, 2011, ENVIRON EXP BOT, V72, P397, DOI 10.1016/j.envexpbot.2011.02.009; Waadt R, 2008, PLANTA VISUALIZATION; Walworth AE, 2012, MOL BREEDING, V30, P1313, DOI 10.1007/s11032-012-9718-7; Wang QJ, 2010, PLANT CELL TISS ORG, V101, P211, DOI 10.1007/s11240-010-9678-8; Wang ZB, 2005, PLANT MOL BIOL, V58, P543, DOI 10.1007/s11103-005-6760-4; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whalley HJ, 2011, PLANT CELL, V23, P4079, DOI 10.1105/tpc.111.090480; Zhou MQ, 2011, CRIT REV BIOTECHNOL, V31, P186, DOI 10.3109/07388551.2010.505910	41	24	30	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54119	10.1371/journal.pone.0054119	http://dx.doi.org/10.1371/journal.pone.0054119			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349799	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000313738900041
J	Van Lier, J; Revlin, R; De Neys, W				Van Lier, Jens; Revlin, Russell; De Neys, Wim			Detecting Cheaters without Thinking: Testing the Automaticity of the Cheater Detection Module	PLOS ONE			English	Article							SOCIAL-EXCHANGE; SELECTION TASK; EVOLUTIONARY PSYCHOLOGY; COGNITIVE REFLECTION; WORKING-MEMORY; 2 SYSTEMS; HYPOTHESIS; INTELLIGENCE; HEURISTICS; MODULARITY	Evolutionary psychologists have suggested that our brain is composed of evolved mechanisms. One extensively studied mechanism is the cheater detection module. This module would make people very good at detecting cheaters in a social exchange. A vast amount of research has illustrated performance facilitation on social contract selection tasks. This facilitation is attributed to the alleged automatic and isolated operation of the module (i.e., independent of general cognitive capacity). This study, using the selection task, tested the critical automaticity assumption in three experiments. Experiments 1 and 2 established that performance on social contract versions did not depend on cognitive capacity or age. Experiment 3 showed that experimentally burdening cognitive resources with a secondary task had no impact on performance on the social contract version. However, in all experiments, performance on a non-social contract version did depend on available cognitive capacity. Overall, findings validate the automatic and effortless nature of social exchange reasoning.	[Van Lier, Jens] Univ Louvain, Dept Psychol, Res Fdn Flanders FWO, Louvain, Belgium; [Revlin, Russell] Univ Calif Santa Barbara, Dept Psychol, Santa Barbara, CA 93106 USA; [De Neys, Wim] Paris Descartes Univ, CNRS, LaPsyDE CNRS Unit 3521, Paris, France	University of California System; University of California Santa Barbara; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Van Lier, J (corresponding author), Univ Louvain, Dept Psychol, Res Fdn Flanders FWO, Louvain, Belgium.	jens.vanlier@ppw.kuleuven.be			KU Leuven Center of Excellence on Generalization Research [GRIP*TT;PF/10/005]	KU Leuven Center of Excellence on Generalization Research	Writing of this manuscript was partly supported by KU Leuven Center of Excellence on Generalization Research (GRIP*TT;PF/10/005). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett HC, 2006, PSYCHOL REV, V113, P628, DOI 10.1037/0033-295X.113.3.628; Barrett HC, 2006, J PERS SOC PSYCHOL, V91, P513, DOI 10.1037/0022-3514.91.3.513; BETHELLFOX CE, 1988, J EXP PSYCHOL HUMAN, V14, P12, DOI 10.1037/0096-1523.14.1.12; Carlisle E, 2005, THINK REASONING, V11, P97, DOI 10.1080/13546780442000079; COSMIDES L, 1994, AM ECON REV, V84, P327; COSMIDES L, 1989, COGNITION, V31, P187, DOI 10.1016/0010-0277(89)90023-1; Cosmides L., 2008, MORAL PSYCHOL EVOLUT, V1, P53; Cosmides L., 1992, ADAPTED MIND EVOLUTI, P163; Cosmides L, 2010, P NATL ACAD SCI USA, V107, P9007, DOI 10.1073/pnas.0914623107; De Neys W, 2006, Q J EXP PSYCHOL, V59, P1070, DOI 10.1080/02724980543000123; de Neys W, 2006, PSYCHOL SCI, V17, P428, DOI 10.1111/j.1467-9280.2006.01723.x; De Neys W, 2007, EXP PSYCHOL, V54, P128, DOI 10.1027/1618-3169.54.2.128; De Neys W, 2006, EXP PSYCHOL, V53, P123, DOI 10.1027/1618-3169.53.1.123; Ermer E, 2006, SOC NEUROSCI-UK, V1, P196, DOI 10.1080/17470910600989771; Evans J.S.B.T., 1993, HUMAN REASONING PSYC; Evans JST, 2003, TRENDS COGN SCI, V7, P454, DOI 10.1016/j.tics.2003.08.012; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Gathercole SE, 1999, TRENDS COGN SCI, V3, P410, DOI 10.1016/S1364-6613(99)01388-1; Harris PL, 2001, MEM COGNITION, V29, P757, DOI 10.3758/BF03200478; Just MA, 1996, PSYCHOL REV, V103, P773, DOI 10.1037/0033-295X.103.4.773; Kaufman SB, 2011, INTELLIGENCE, V39, P311, DOI 10.1016/j.intell.2011.05.002; Kurzban R., 2010, WHY EVERYONE ELSE IS, DOI DOI 10.1515/9781400835997; Liberman N, 1996, COGNITION, V58, P127, DOI 10.1016/0010-0277(95)00677-X; McKinnon MC, 2007, COGNITION, V102, P179, DOI 10.1016/j.cognition.2005.12.011; Miyake A, 2001, J EXP PSYCHOL GEN, V130, P621, DOI 10.1037/0096-3445.130.4.621; Over DE, 2003, CURR ISS THINK REASO, P1; POLLARD P, 1987, AM J PSYCHOL, V100, P41, DOI 10.2307/1422641; Samuels R, 1998, BRIT J PHILOS SCI, V49, P575, DOI 10.1093/bjps/49.4.575; Sloman SA, 1996, PSYCHOL BULL, V119, P3, DOI 10.1037/0033-2909.119.1.3; Sperber D, 2002, COGNITION, V85, P277, DOI 10.1016/S0010-0277(02)00125-7; Sperber D, 2000, MATE MENTALITY EVALU; Stanovich K., 1998, THINK REASONING, V4, P193, DOI DOI 10.1080/135467898394139; Stone VE, 2002, P NATL ACAD SCI USA, V99, P11531, DOI 10.1073/pnas.122352699; Sugiyama LS, 2002, P NATL ACAD SCI USA, V99, P11537, DOI 10.1073/pnas.122352999; Tentori K., 2008, MIND SOC, V7, P167, DOI DOI 10.1007/S11299-007-0045-3; Toplak ME, 2011, MEM COGNITION, V39, P1275, DOI 10.3758/s13421-011-0104-1; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Verplaetse J, 2007, EVOL HUM BEHAV, V28, P260, DOI 10.1016/j.evolhumbehav.2007.04.006; Wason P. C., 1966, NEW HORIZONS PSYCHOL, VI, P106; Yamagishi T, 2003, EVOL HUM BEHAV, V24, P290, DOI 10.1016/S1090-5138(03)00035-7; [No title captured]	42	15	15	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53827	10.1371/journal.pone.0053827	http://dx.doi.org/10.1371/journal.pone.0053827			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072OV	23342012	Green Submitted, Green Published, gold			2022-12-25	WOS:000313682700048
J	Tian, C; Ye, XL; Zhang, R; Long, J; Ren, WY; Ding, SB; Liao, D; Jin, X; Wu, HM; Xu, SQ; Ying, CJ				Tian, Chong; Ye, Xiaolei; Zhang, Rui; Long, Jia; Ren, Weiye; Ding, Shibin; Liao, Dan; Jin, Xin; Wu, Hongmei; Xu, Shunqin; Ying, Chenjiang			Green Tea Polyphenols Reduced Fat Deposits in High Fat-Fed Rats via erk1/2-PPAR gamma-Adiponectin Pathway	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; COMPLEMENT-RELATED PROTEIN; MESSENGER-RNA EXPRESSION; PPAR-GAMMA; INSULIN SENSITIVITY; METABOLIC SYNDROME; ADIPONECTIN LEVELS; HORMONE ADIPONECTIN; GENE-EXPRESSION; DOWN-REGULATION	Objective: Hypoadiponectinemia contributes to the development of obesity and related disorders such as diabetes, hyperlipidemia, and cardiovascular diseases. In this study we investigated the effects of green tea polyphenols (GTPs) on adiponectin levels and fat deposits in high fat (HF) fed rats, the mechanism of signaling pathway was explored as well. Methods and Results: Male Wistar rats were fed with high-fat diet. GTPs (0.8, 1.6, 3.2 g/L) were administered via drinking water. Serum adiponectin and insulin were measured by ELISA, mRNA levels of adiponectin and PPAR gamma in visceral adipose tissue (VAT) were determined by Real-time PCR, protein levels of PPAR gamma, phospho (p) -PPAR gamma, extracellular signal regulated kinase (erk) 1/2 and p-erk1/2 in VAT were determined by western blot. GTPs treatment attenuated the VAT accumulation, hypoadiponectinemia and the decreased mRNA level of adiponectin in VAT induced by HF. Decreased expression and increased phosphorylation of PPAR gamma (the master regulator of adiponectin), and increased activation of erk1/2 were observed in HF group, and these effects could be alleviated by GTPs treatment. To explore the underlying mechanism, VAT was cultured in DMEM with high glucose to mimic the hyperglycemia condition in vitro. Similar to the results of in vivo study, decreased adiponectin levels, decreased expression and increased phosphorylation of PPAR gamma, and elevated erk1/2 phosphorylation in cultured VAT were observed. These effects could be ameliorated by co-treatment with GTPs or PD98059 (a selective inhibitor of erk1/2). Conclusion: GTPs reduced fat deposit, ameliorated hypoadiponectinemia in HF-fed rats, and relieved high glucose-induced adiponectin decrease in VAT in vitro. The signaling pathway analysis indicated that PPAR gamma regulation mediated via erk1/2 pathway was involved.	[Tian, Chong; Zhang, Rui; Long, Jia; Ren, Weiye; Ding, Shibin; Liao, Dan; Jin, Xin; Ying, Chenjiang] Huazhong Univ Sci & Technol, Dept Nutr & Food Hyg, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China; [Tian, Chong; Zhang, Rui; Long, Jia; Ren, Weiye; Ding, Shibin; Liao, Dan; Jin, Xin; Xu, Shunqin; Ying, Chenjiang] Huazhong Univ Sci & Technol, Dept Nutr & Food Hyg, Minist Educ, Tongji Med Coll,Key Lab Environm & Hlth, Wuhan 430074, Peoples R China; [Ye, Xiaolei; Wu, Hongmei] WenZhou Med Coll, Dept Publ Hlth, Wenzhou, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Wenzhou Medical University	Ying, CJ (corresponding author), Huazhong Univ Sci & Technol, Dept Nutr & Food Hyg, Sch Publ Hlth, Wuhan 430074, Peoples R China.	yingchenjiang@yahoo.com	Ying, Chen Jiang/H-7708-2019; Tian, Chong/C-2872-2013; Ying, Chen/GRX-5695-2022; Tian, Chong/AAE-7514-2022	Ying, Chen Jiang/0000-0003-4813-5951; Tian, Chong/0000-0002-3231-9409	National Basic Research Program of China (973 Program) [2012CB722401]; National Natural Science Foundation of China [30972473, 81030051, 81172674, 81273060]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (973 Program)(Project No. 2012CB722401; http://www.973.gov.cn/Default_3.aspx), National Natural Science Foundation of China (Grant No. 30972473, 81030051,81172674, 81273060; http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Barnea M, 2006, OBESITY, V14, P2145, DOI 10.1038/oby.2006.251; Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677; Buechler C, 2011, WORLD J GASTROENTERO, V17, P2801, DOI 10.3748/wjg.v17.i23.2801; Burgermeister E, 2007, CELL CYCLE, V6, P1539, DOI 10.4161/cc.6.13.4453; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Catalano PM, 2002, AM J PHYSIOL-ENDOC M, V282, pE522, DOI 10.1152/ajpendo.00124.2001; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI200114120; Combs TP, 2002, ENDOCRINOLOGY, V143, P998, DOI 10.1210/endo.143.3.8662; Combs TP, 2003, DIABETES, V52, P268, DOI 10.2337/diabetes.52.2.268; Dastani Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002607; DeClercq V, 2011, METABOLIC SYNDROME U, P73; Diez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293; Escriva F, 2007, J ENDOCRINOL, V194, P131, DOI 10.1677/joe.1.07043; Filippatos TD, 2008, DRUG SAFETY, V31, P53, DOI 10.2165/00002018-200831010-00005; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Gayet C, 2007, BRIT J NUTR, V98, P497, DOI 10.1017/S000711450772514X; Gonzalez-Sanchez JL, 2005, OBES RES, V13, P807, DOI 10.1038/oby.2005.91; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Hosooka T, 2008, NAT MED, V14, P188, DOI 10.1038/nm1706; Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007; Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070; Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655; Kaplan JM, 2010, MOL MED, V16, P491, DOI 10.2119/molmed.2010.00063; Kasim-Karakas SE, 2006, AM J CLIN NUTR, V83, P774, DOI 10.1093/ajcn/83.4.774; Kriketos AD, 2004, DIABETES CARE, V27, P629, DOI 10.2337/diacare.27.2.629; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Kuriyama S, 2006, JAMA-J AM MED ASSOC, V296, P1255, DOI 10.1001/jama.296.10.1255; Kursawe R, 2010, OBESITY, V18, P1911, DOI 10.1038/oby.2010.23; Lara-Castro C, 2007, CURR OPIN LIPIDOL, V18, P263, DOI 10.1097/MOL.0b013e32814a645f; Lee CMY, 2007, OBES REV, V8, P191, DOI 10.1111/j.1467-789X.2006.00292.x; Li YR, 2009, J NUTR BIOCHEM, V20, P1021, DOI 10.1016/j.jnutbio.2008.12.001; Liu LR, 2011, OBESITY, V19, P2301, DOI 10.1038/oby.2011.176; Matsuzawa Y, 2010, CURR PHARM DESIGN, V16, P1896, DOI 10.2174/138161210791208893; Milan G, 2002, OBES RES, V10, P1095, DOI 10.1038/oby.2002.149; Nagao T, 2005, AM J CLIN NUTR, V81, P122; Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176; Nagao T, 2009, OBESITY, V17, P310, DOI 10.1038/oby.2008.505; Oberthuer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038481; Ohshima T, 2004, J BIOL CHEM, V279, P29551, DOI 10.1074/jbc.M403866200; Panagopoulou P, 2009, J PEDIATR ENDOCR MET, V22, P955; Park KS, 1997, DIABETES, V46, P1230, DOI 10.2337/diabetes.46.7.1230; Pories WJ, 2008, J CLIN ENDOCR METAB, V93, pS89, DOI 10.1210/jc.2008-1641; Potenza MA, 2007, AM J PHYSIOL-ENDOC M, V292, pE1378, DOI 10.1152/ajpendo.00698.2006; Qi L, 2005, DIABETES CARE, V28, P1022, DOI 10.2337/diacare.28.5.1022; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Rangwala SM, 2003, DEV CELL, V5, P657, DOI 10.1016/S1534-5807(03)00274-0; Renaldi Olly, 2009, Acta Med Indones, V41, P20; Schupp M, 2005, DIABETES, V54, P3442, DOI 10.2337/diabetes.54.12.3442; Serisier S, 2008, BRIT J NUTR, V99, P1208, DOI 10.1017/S0007114507862386; Sharabi Y, 2007, AM J HYPERTENS, V20, P206, DOI 10.1016/j.amjhyper.2006.08.002; Shiniada M, 2007, BIOSCI BIOTECH BIOCH, V71, P2079, DOI 10.1271/bbb.70174; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Wolfram S, 2005, ANN NUTR METAB, V49, P54, DOI 10.1159/000084178; Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102; Yamamoto Y, 2002, METABOLISM, V51, P1407, DOI 10.1053/meta.2002.35586; Yamane T, 2011, MOL NUTR FOOD RES, V55, pS186, DOI 10.1002/mnfr.201100144; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yang WS, 2002, DIABETES CARE, V25, P376, DOI 10.2337/diacare.25.2.376; Yatagai T, 2003, METABOLISM, V52, P1274, DOI 10.1016/S0026-0495(03)00195-1; Ying CJ, 2003, HYPERTENS RES, V26, P823, DOI 10.1291/hypres.26.823; Zaveri NT, 2006, LIFE SCI, V78, P2073, DOI 10.1016/j.lfs.2005.12.006; Zeng Q, 2007, J ATHEROSCLER THROMB, V14, P261, DOI 10.5551/jat.E498	64	76	82	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53796	10.1371/journal.pone.0053796	http://dx.doi.org/10.1371/journal.pone.0053796			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23342006	Green Published, Green Submitted, gold			2022-12-25	WOS:000314707700032
J	Makhluf, H; Buck, MD; King, K; Perry, ST; Henn, MR; Shresta, S				Makhluf, Huda; Buck, Michael D.; King, Kevin; Perry, Stuart T.; Henn, Matthew R.; Shresta, Sujan			Tracking the Evolution of Dengue Virus Strains D2S10 and D2S20 by 454 Pyrosequencing	PLOS ONE			English	Article							IN-VIVO; DISEASE; MICE; RNA	Dengue virus is the most prevalent mosquito-borne virus worldwide. In this study, we used pyrosequencing to analyze the whole viral genome of two mouse-adapted strains, D2S10 and D2S20, that induce a dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS)-like lethal disease in mice lacking the type I and/or type II interferon receptors. Previous experiments with D2S10 indicated that N124D and K128E mutations in the envelope protein were responsible for the severe disease induced in mice compared to its parental strain PL046. Here we demonstrate that D2S20 is more virulent than D2S10 and captured the presence of five key amino acid mutations - T70I, N83D, and K122I in envelope (E), and A62T in nonstructural protein 2A (NS2A) and G605V in nonstructural protein 5 (NS5) - that may account for this. These findings set the foundation for further dissection of the viral determinants responsible for dengue disease manifestations in mouse models.	[Makhluf, Huda; Buck, Michael D.; King, Kevin; Perry, Stuart T.; Shresta, Sujan] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA; [Makhluf, Huda] Natl Univ, Dept Math & Nat Sci, La Jolla, CA USA; [Henn, Matthew R.] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA	La Jolla Institute for Immunology; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Shresta, S (corresponding author), La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA.	sujan@liai.org		Buck, Michael/0000-0002-9611-1199	National Institute of Allergy and Infectious Diseases, National Institute of Health (NIH), Department of Health and Human Services from the Southeastern Regional Center of Excellence for Emerging Infectious and Biodefense [U54AI057517]; NIH [HHSN272200900042C, HHSN272200900018C]	National Institute of Allergy and Infectious Diseases, National Institute of Health (NIH), Department of Health and Human Services from the Southeastern Regional Center of Excellence for Emerging Infectious and Biodefense; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project has been funded with federal funds from the National Institute of Allergy and Infectious Diseases, National Institute of Health (NIH), Department of Health and Human Services, under grant no. U54AI057517 from the Southeastern Regional Center of Excellence for Emerging Infectious and Biodefense (SS) and NIH Contracts HHSN272200900042C (SS) and HHSN272200900018C (MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Lennon NJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r15; Macalalad AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002417; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Parameswaran P., 2012, J VIROL IN PRESS; Park GS, 2007, J VIROL, V81, P6936, DOI 10.1128/JVI.02830-06; Perry ST, 2009, J VIROL, V83, P8276, DOI 10.1128/JVI.00365-09; Prestwood TR, 2008, J VIROL, V82, P8411, DOI 10.1128/JVI.00611-08; Prestwood TR, 2012, J VIROL, V86, P12561, DOI 10.1128/JVI.06743-11; Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06; Vu TTH, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000757; World Health Organization, 2009, DENG GUID DIAGN TREA, P147, DOI DOI 10.7705/BIOMEDICA.V37I4.3370; Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004	14	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54220	10.1371/journal.pone.0054220	http://dx.doi.org/10.1371/journal.pone.0054220			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342105	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400134
J	Rada, B; Jendrysik, MA; Pang, L; Hayes, CP; Yoo, DG; Park, JJ; Moskowitz, SM; Malech, HL; Leto, TL				Rada, Balazs; Jendrysik, Meghan A.; Pang, Lan; Hayes, Craig P.; Yoo, Dae-goon; Park, Jonathan J.; Moskowitz, Samuel M.; Malech, Harry L.; Leto, Thomas L.			Pyocyanin-Enhanced Neutrophil Extracellular Trap Formation Requires the NADPH Oxidase	PLOS ONE			English	Article							AIRWAY EPITHELIAL-CELLS; CYSTIC-FIBROSIS; PSEUDOMONAS-AERUGINOSA; DUAL OXIDASE; INFECTION; SPUTUM; DECONDENSATION; ACTIVATION; MECHANISM; AUTOPHAGY	Beyond intracellular killing, a novel neutrophil-based antimicrobial mechanism has been recently discovered: entrapment and killing by neutrophil extracellular traps (NETs). NETs consist of extruded nuclear DNA webs decorated with granule proteins. Although NET formation is an important innate immune mechanism, uncontrolled NET release damages host tissues and has been linked to several diseases including cystic fibrosis (CF). The major CF airway pathogen Pseudomonas aeruginosa establishes chronic infection. Pseudomonas imbedded within biofilms is protected against the immune system, but maintains chronic inflammation that worsens disease symptoms. Aberrant NET release from recruited neutrophils was found in CF, but the underlying mechanisms remain unclear. One of the most important Pseudomonas virulence factors is pyocyanin, a redox-active pigment that has been associated with diminished lung function in CF. Here we show that pyocyanin promotes NET formation in a time-and dose-dependent manner. Most CF Pseudomonas clinical isolates tested produce pyocyanin in vitro. Pyocyanin-derived reactive oxygen species are required for its NET release. Inhibitor experiments demonstrated involvement of Jun N-terminal Kinase (JNK) and phosphatidylinositol 3-Kinase (PI3K) in pyocyanin-induced NET formation. Pyocyanin-induced NETs also require the NADPH oxidase because NET release in chronic granulomatous disease neutrophils was greatly reduced. Comparison of neutrophils from gp91phox- and p47phox-deficient patients revealed that pyocyanin-triggered NET formation is proportional to their residual superoxide production. Our studies identify pyocyanin as the first secreted bacterial toxin that enhances NET formation. The involvement of NADPH oxidase in pyocyanin-induced NET formation represents a novel mechanism of pyocyanin toxicity.	[Rada, Balazs; Jendrysik, Meghan A.; Park, Jonathan J.; Malech, Harry L.; Leto, Thomas L.] NIAID, Lab Host Def, NIH, Rockville, MD USA; [Rada, Balazs; Pang, Lan; Hayes, Craig P.; Yoo, Dae-goon] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA USA; [Moskowitz, Samuel M.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Moskowitz, Samuel M.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University System of Georgia; University of Georgia; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Rada, B (corresponding author), NIAID, Lab Host Def, NIH, Rockville, MD USA.	radab@uga.edu; tleto@niaid.nih.gov		Malech, Harry/0000-0001-5874-5775; Park, Jonathan/0000-0001-5887-3953	National Institutes of Health, National Institute of Allergy and Infectious Diseases [ZO1-AI-000614]; Public Health Service from the National Heart Lung and Blood Institute [K08HL067903]; Public Health Service from the National Institute of Allergy and Infectious Diseases [R01AI067653]; CF Foundation [MOSKOW01A0]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL067903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000614, ZIAAI000988, R01AI067653, ZIAAI000645, Z01AI000614] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Public Health Service from the National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Public Health Service from the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CF Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funds to TLL from the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases (ZO1-AI-000614), by Public Health Service grants K08HL067903 to SMM from the National Heart Lung and Blood Institute and R01AI067653 to SMM from the National Institute of Allergy and Infectious Diseases and by grant MOSKOW01A0 to SMM from the CF Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V., 2010, JOVE-J VIS EXP, V36, P1724, DOI [10.3791/1724, DOI 10.3791/1724/J0VE.C0M/VIDE0/1724]; Carlsson A, 2003, CLIN EXP RHEUMATOL, V21, pS95; Das T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046718; El Jamali A, 2010, FREE RADICAL BIO MED, V48, P798, DOI 10.1016/j.freeradbiomed.2009.12.018; Fothergill JL, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-45; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI 10.1038/NCHEMBIO.496; Hawkins PT, 2010, CURR TOP MICROBIOL, V346, P183, DOI 10.1007/82_2010_40; Hoiby N, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-32; Hoiby N, 2010, FUTURE MICROBIOL, V5, P1663, DOI [10.2217/fmb.10.125, 10.2217/FMB.10.125]; Huang J, 2009, AUTOPHAGY, V5, P887, DOI 10.4161/auto.9125; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Hunter RC, 2012, AM J RESP CELL MOL, V47, P738, DOI 10.1165/rcmb.2012-0088OC; Kim JS, 2006, CHEST, V129, P1148, DOI 10.1378/chest.129.5.1148; Koh AY, 2009, INFECT IMMUN, V77, P5300, DOI 10.1128/IAI.00501-09; Kuhns DB, 2010, NEW ENGL J MED, V363, P2600, DOI 10.1056/NEJMoa1007097; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; Lau GW, 2004, INFECT IMMUN, V72, P4275, DOI 10.1128/IAI.72.7.4275-4278.2004; Leshner M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00307; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Liu GY, 2009, TRENDS MICROBIOL, V17, P406, DOI 10.1016/j.tim.2009.06.006; Logters T, 2009, MED MICROBIOL IMMUN, V198, P211, DOI 10.1007/s00430-009-0121-x; Manzenreiter R, 2012, J CYST FIBROS, V11, P84, DOI 10.1016/j.jcf.2011.09.008; Marcos V, 2010, NAT MED, V16, P1018, DOI 10.1038/nm.2209; Martelli AM, 2011, LEUKEMIA, V25, P1064, DOI 10.1038/leu.2011.46; MULLER PK, 1989, INFECT IMMUN, V57, P2591; Rada B, 2011, MUCOSAL IMMUNOL, V4, P158, DOI 10.1038/mi.2010.62; Rada B, 2008, J IMMUNOL, V181, P4883, DOI 10.4049/jimmunol.181.7.4883; Rada B, 2009, IMMUNOL RES, V43, P198, DOI 10.1007/s12026-008-8071-8; Rada Balazs, 2008, V15, P164, DOI 10.1159/000136357; Rada BK, 2004, BLOOD, V104, P2947, DOI 10.1182/blood-2004-03-1005; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Song E, 2011, CLIN MOL ALLERGY, V9, P10, DOI [10.1186/1476-7961-9-10, DOI 10.1186/1476-7961-9-10]; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; Suri R, 2005, BIODRUGS, V19, P135, DOI 10.2165/00063030-200519030-00001; Ueyama T, 2011, J BIOL CHEM, V286, P40693, DOI 10.1074/jbc.M111.237289; Usher LR, 2002, J IMMUNOL, V168, P1861, DOI 10.4049/jimmunol.168.4.1861; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Wang Y, 2008, ENVIRON SCI TECHNOL, V42, P2380, DOI 10.1021/es702290a; Wartha F, 2007, CURR OPIN MICROBIOL, V10, P52, DOI 10.1016/j.mib.2006.12.005; Williams BJ, 2010, RESPIROLOGY, V15, P1037, DOI 10.1111/j.1440-1843.2010.01819.x; WILSON R, 1988, INFECT IMMUN, V56, P2515, DOI 10.1128/IAI.56.9.2515-2517.1988; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847; Young RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023637	48	76	80	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54205	10.1371/journal.pone.0054205	http://dx.doi.org/10.1371/journal.pone.0054205			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342104	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400133
J	Reinecke, D; Schwede, F; Genieser, HG; Seifert, R				Reinecke, Daniel; Schwede, Frank; Genieser, Hans-Gottfried; Seifert, Roland			Analysis of Substrate Specificity and Kinetics of Cyclic Nucleotide Phosphodiesterases with N '-Methylanthraniloyl-Substituted Purine and Pyrimidine 3 ',5 '-Cyclic Nucleotides by Fluorescence Spectrometry	PLOS ONE			English	Article							CYTIDINE 3',5'-MONOPHOSPHATE CCMP; ADENYLYL-CYCLASE; PROTEIN-KINASES; EDEMA FACTOR; CGMP; PURIFICATION; CMP; CALMODULIN; BINDING; IDENTIFICATION	As second messengers, the cyclic purine nucleotides adenosine 3',5'-cyclic monophosphate (cAMP) and guanosine 3',5'-cyclic monophosphate (cGMP) play an essential role in intracellular signaling. Recent data suggest that the cyclic pyrimidine nucleotides cytidine 3',5'-cyclic monophosphate (cCMP) and uridine 3',5'-cyclic monophosphate (cUMP) also act as second messengers. Hydrolysis by phosphodiesterases (PDEs) is the most important degradation mechanism for cAMP and cGMP. Elimination of cUMP and cCMP is not completely understood, though. We have shown that human PDEs hydrolyze not only cAMP and cGMP but also cyclic pyrimidine nucleotides, indicating that these enzymes may be important for termination of cCMP- and cUMP effects as well. However, these findings were acquired using a rather expensive HPLC/mass spectrometry assay, the technical requirements of which are available only to few laboratories. N'-Methylanthraniloyl-(MANT-) labeled nucleotides are endogenously fluorescent and suitable tools to study diverse protein/nucleotide interactions. In the present study, we report the synthesis of new MANT-substituted cyclic purine-and pyrimidine nucleotides that are appropriate to analyze substrate specificity and kinetics of PDEs with more moderate technical requirements. MANT-labeled nucleoside 3',5'-cyclic monophosphates (MANT-cNMPs) are shown to be substrates of various human PDEs and to undergo a significant change in fluorescence upon cleavage, thus allowing direct, quantitative and continuous determination of hydrolysis via fluorescence detection. As substrates of several PDEs, MANT-cNMPs show similar kinetics to native nucleotides, with some exceptions. Finally, they are shown to be also appropriate tools for PDE inhibitor studies.	[Reinecke, Daniel; Seifert, Roland] Hannover Med Sch, Inst Pharmacol, Hannover, Germany; [Schwede, Frank; Genieser, Hans-Gottfried] Biolog Life Sci Inst, Bremen, Germany	Hannover Medical School	Seifert, R (corresponding author), Hannover Med Sch, Inst Pharmacol, Hannover, Germany.	seifert.roland@mh-hannover.de	Seifert, Roland/G-3189-2013	Genieser, Hans-Gottfried/0000-0002-4904-5790	Deutsche Forschungsgemeinschaft [529/5-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft grant 529/5-2 to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON TR, 1982, MOL CELL ENDOCRINOL, V28, P373, DOI 10.1016/0303-7207(82)90134-4; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Beste K, 2012, N-S ARCH PHARMACOL, V385, P10; Beste KY, 2013, BIOL CHEM, V394, P261, DOI 10.1515/hsz-2012-0282; Beste KY, 2012, BIOCHEMISTRY-US, V51, P194, DOI 10.1021/bi201259y; BLOCH A, 1974, BIOCHEM BIOPH RES CO, V59, P955, DOI 10.1016/S0006-291X(74)80072-0; Borgognone A., 2012, THROMB HAEMOSTASIS, P108; Burhenne H., 2011, NAUNYN SCHMIEDEBERGS, V383; CECH SY, 1977, SCIENCE, V198, P1063, DOI 10.1126/science.22127; CHAUDHRY PS, 1988, ARCH BIOCHEM BIOPHYS, V262, P439, DOI 10.1016/0003-9861(88)90395-5; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Desch M, 2010, FEBS LETT, V584, P3979, DOI 10.1016/j.febslet.2010.07.059; Dessauer CW, 2009, MOL PHARMACOL, V76, P935, DOI 10.1124/mol.109.059345; Ding S, 2008, RAPID COMMUN MASS SP, V22, P4129, DOI 10.1002/rcm.3834; ERVENS J, 1991, BIOCHEM BIOPH RES CO, V174, P258, DOI 10.1016/0006-291X(91)90514-8; Francis Sharron H., 2009, V191, P367, DOI 10.1007/978-3-540-68964-5_16; GAION RM, 1979, BIOCHEM BIOPH RES CO, V86, P105, DOI 10.1016/0006-291X(79)90387-5; Geduhn J, 2011, J PHARMACOL EXP THER, V336, P104, DOI 10.1124/jpet.110.174219; Goettle M, 2007, MOL PHARMACOL, V72, P526, DOI 10.1124/mol.107.034413; Gottle M, 2010, BIOCHEMISTRY-US, V49, P5494, DOI 10.1021/bi100684g; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; Hammerschmidt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039848; HARDMAN JG, 1965, J BIOL CHEM, V240, P3704; HELFMAN DM, 1984, ADV CYCLIC NUCL PROT, V16, P403; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; HIRATSUKA T, 1982, J BIOL CHEM, V257, P13354; Hofmann Franz, 2009, V191, P137, DOI 10.1007/978-3-540-68964-5_8; JOHNSON JD, 1987, ANAL BIOCHEM, V162, P291, DOI 10.1016/0003-2697(87)90039-X; KINCAID RL, 1985, J BIOL CHEM, V260, P9009; KLOTZ U, 1971, N-S ARCH PHARMAKOL, V269, P117, DOI 10.1007/BF01422021; Kots Alexander Y., 2009, V191, P1, DOI 10.1007/978-3-540-68964-5_1; Mou TC, 2005, J BIOL CHEM, V280, P7253, DOI 10.1074/jbc.M409076200; NEWTON RP, 1984, BIOCHEM J, V221, P665, DOI 10.1042/bj2210665; NEWTON RP, 1986, BIOCHEM J, V236, P431, DOI 10.1042/bj2360431; Newton RP, 1999, RAPID COMMUN MASS SP, V13, P574, DOI 10.1002/(SICI)1097-0231(19990415)13:7<574::AID-RCM526>3.3.CO;2-I; Pinto C, 2011, BIOCHEM PHARMACOL, V82, P358, DOI 10.1016/j.bcp.2011.05.010; Pisareva VP, 2006, J BIOL CHEM, V281, P40224, DOI 10.1074/jbc.M607461200; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Reinecke D, 2011, FEBS LETT, V585, P3259, DOI 10.1016/j.febslet.2011.09.004; Ren JH, 1996, NUCLEIC ACIDS RES, V24, P3629, DOI 10.1093/nar/24.18.3629; RENSLAND H, 1995, BIOCHEMISTRY-US, V34, P593, DOI 10.1021/bi00002a026; Sager G, 2004, NEUROCHEM INT, V45, P865, DOI 10.1016/j.neuint.2004.03.017; Sharma IM, 2012, BIOCHEMISTRY-US, V51, P5443, DOI 10.1021/bi3003617; Sullivan SM, 2000, J BACTERIOL, V182, P3460, DOI 10.1128/JB.182.12.3460-3466.2000; Taha HM, 2009, MOL PHARMACOL, V75, P693, DOI 10.1124/mol.108.052340; Wielinga PR, 2003, J BIOL CHEM, V278, P17664, DOI 10.1074/jbc.M212723200; Wolter S, 2011, BIOCHEM BIOPH RES CO, V415, P563, DOI 10.1016/j.bbrc.2011.10.093; Zong XG, 2012, J BIOL CHEM, V287, P26506, DOI 10.1074/jbc.M112.357129	49	10	11	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54158	10.1371/journal.pone.0054158	http://dx.doi.org/10.1371/journal.pone.0054158			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342095	gold, Green Published, Green Submitted			2022-12-25	WOS:000314759400127
J	Zhou, XQ; Chen, CR; Wang, YF; Smaill, S; Clinton, P				Zhou, Xiaoqi; Chen, Chengrong; Wang, Yanfen; Smaill, Simeon; Clinton, Peter			Warming Rather Than Increased Precipitation Increases Soil Recalcitrant Organic Carbon in a Semiarid Grassland after 6 Years of Treatments	PLOS ONE			English	Article							TEMPERATURE SENSITIVITY; NITROGEN POOLS; CLIMATE-CHANGE; LABILE; MATTER; FLUXES; MINERALIZATION; DECOMPOSITION; RESPIRATION; RESPONSES	Improved understanding of changes in soil recalcitrant organic carbon (C) in response to global warming is critical for predicting changes in soil organic C (SOC) storage. Here, we took advantage of a long-term field experiment with increased temperature and precipitation to investigate the effects of warming, increased precipitation and their interactions on SOC fraction in a semiarid Inner Mongolian grassland of northern China since April 2005. We quantified labile SOC, recalcitrant SOC and stable SOC at 0-10 and 10-20 cm depths. Results showed that neither warming nor increased precipitation affected total SOC and stable SOC at either depth. Increased precipitation significantly increased labile SOC at the 0-10 cm depth. Warming decreased labile SOC (P = 0.038) and marginally but significantly increased recalcitrant SOC at the 10-20 cm depth (P = 0.082). In addition, there were significant interactive effects of warming and increased precipitation on labile SOC and recalcitrant SOC at the 0-10 cm depth (both P<0.05), indicating that that results from single factor experiments should be treated with caution because of multi-factor interactions. Given that the absolute increase of SOC in the recalcitrant SOC pool was much greater than the decrease in labile SOC, and that the mean residence time of recalcitrant SOC is much greater, our results suggest that soil C storage at 10-20 cm depth may increase with increasing temperature in this semiarid grassland.	[Zhou, Xiaoqi; Wang, Yanfen] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Zhou, Xiaoqi; Smaill, Simeon; Clinton, Peter] Scion New Zealand Forest Res Inst, Christchurch, New Zealand; [Zhou, Xiaoqi; Chen, Chengrong] Griffith Univ, Environm Futures Ctr, Nathan, Qld 4111, Australia	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Griffith University	Zhou, XQ (corresponding author), Chinese Acad Sci, Grad Univ, Beijing, Peoples R China.	zhou318@yahoo.com.cn; yfwang@gucas.ac.cn	Clinton, Peter W/D-1448-2010; chen, chengrong/K-8188-2019; Wang, Yanfen/C-6889-2013; Wang, Yuesi/AAF-3317-2019; Chen, Chengrong/B-3814-2009	chen, chengrong/0000-0001-6377-4001; Chen, Chengrong/0000-0001-6377-4001; Zhou, Xiaoqi/0000-0002-9229-1743; wang, yan fen/0000-0001-5666-9289; Smaill, Simeon/0000-0001-6242-4931; Clinton, Peter/0000-0002-8921-4835	Institute of Botany, Chinese Academy of Sciences; Chinese Academy of Sciences [2010-Biols-CAS-0103]; Chinese Academy of Agriculture [2012BAC19B04]; National Natural Science Foundation of China [30925009]; Griffith University; Postdoctoral Fellowship at Scion, New Zealand	Institute of Botany, Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Academy of Agriculture; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Griffith University(Griffith University); Postdoctoral Fellowship at Scion, New Zealand	This study was conducted as part of a comprehensive research project (Global Change Multi-factor Experiment - Duolun) sponsored by Institute of Botany, Chinese Academy of Sciences. This research was supported jointly by Chinese Academy of Sciences (No. 2010-Biols-CAS-0103), Chinese Academy of Agriculture (No. 2012BAC19B04), National Natural Science Foundation of China (30925009), Griffith University and Postdoctoral Fellowship at Scion, New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RP, 2008, SCIENCE, V321, P1481, DOI 10.1126/science.1160787; Allison SD, 2008, GLOBAL CHANGE BIOL, V14, P2898, DOI 10.1111/j.1365-2486.2008.01716.x; Allison SD, 2010, NAT GEOSCI, V3, P336, DOI 10.1038/NGEO846; [Anonymous], 2007, IPCC WORK GROUP 1 CL; Bai WM, 2010, GLOBAL CHANGE BIOL, V16, P1306, DOI 10.1111/j.1365-2486.2009.02019.x; Batjes NH, 2014, EUR J SOIL SCI, V65, P10, DOI 10.1111/ejss.12114_2; Belay-Tedla A, 2009, SOIL BIOL BIOCHEM, V41, P110, DOI 10.1016/j.soilbio.2008.10.003; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Collins HP, 2000, SOIL BIOL BIOCHEM, V32, P157, DOI 10.1016/S0038-0717(99)00136-4; Conant RT, 2008, GLOBAL CHANGE BIOL, V14, P868, DOI 10.1111/j.1365-2486.2008.01541.x; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Deng Q, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041493, 10.1371/journal.pone.0038737]; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Fissore C, 2008, GLOBAL CHANGE BIOL, V14, P193, DOI 10.1111/j.1365-2486.2007.01478.x; Fissore C, 2009, GLOBAL CHANGE BIOL, V15, P2295, DOI 10.1111/j.1365-2486.2009.01903.x; Giardina CP, 2000, NATURE, V404, P858, DOI 10.1038/35009076; Hartley IP, 2008, SOIL BIOL BIOCHEM, V40, P1567, DOI 10.1016/j.soilbio.2008.01.007; Karhu K, 2010, ECOLOGY, V91, P370, DOI 10.1890/09-0478.1; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; Liu WX, 2009, GLOBAL CHANGE BIOL, V15, P184, DOI 10.1111/j.1365-2486.2008.01728.x; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Niinisto SM, 2004, GLOBAL CHANGE BIOL, V10, P1363, DOI 10.1111/j.1365-2486.2004.00799.x; Niu SL, 2008, NEW PHYTOL, V177, P209, DOI 10.1111/j.1469-8137.2007.02237.x; Rey A, 2006, GLOBAL CHANGE BIOL, V12, P1894, DOI 10.1111/j.1365-2486.2006.01230.x; Rovira P, 2007, SOIL BIOL BIOCHEM, V39, P202, DOI 10.1016/j.soilbio.2006.07.021; Smith P, 2010, NATURE, V464, P499, DOI 10.1038/464499a; Song B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033217; Townsend AR, 1997, BIOGEOCHEMISTRY, V38, P1, DOI 10.1023/A:1017942918708; Trumbore SE, 1996, SCIENCE, V272, P393, DOI 10.1126/science.272.5260.393; Yang HJ, 2011, GLOBAL CHANGE BIOL, V17, P452, DOI 10.1111/j.1365-2486.2010.02253.x; Zhou XQ, 2012, BIOL FERT SOILS, V48, P859, DOI 10.1007/s00374-012-0686-1; Zhou XQ, 2012, APPL SOIL ECOL, V53, P49, DOI 10.1016/j.apsoil.2011.11.002; Zhou XQ, 2011, J SOIL SEDIMENT, V11, P762, DOI 10.1007/s11368-011-0353-4	33	13	14	25	159	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53761	10.1371/journal.pone.0053761	http://dx.doi.org/10.1371/journal.pone.0053761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341995	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400079
J	Clauset, A				Clauset, Aaron			How Large Should Whales Be?	PLOS ONE			English	Article							BODY-SIZE; METABOLIC-RATE; COPES RULE; MASS; EXTINCTION; EVOLUTION; DISTRIBUTIONS; DYNAMICS; PATTERNS; MAMMALS	The evolution and distribution of species body sizes for terrestrial mammals is well-explained by a macroevolutionary tradeoff between short-term selective advantages and long-term extinction risks from increased species body size, unfolding above the 2 g minimum size induced by thermoregulation in air. Here, we consider whether this same tradeoff, formalized as a constrained convection-reaction-diffusion system, can also explain the sizes of fully aquatic mammals, which have not previously been considered. By replacing the terrestrial minimum with a pelagic one, at roughly 7000 g, the terrestrial mammal tradeoff model accurately predicts, with no tunable parameters, the observed body masses of all extant cetacean species, including the 175,000,000 g Blue Whale. This strong agreement between theory and data suggests that a universal macroevolutionary tradeoff governs body size evolution for all mammals, regardless of their habitat. The dramatic sizes of cetaceans can thus be attributed mainly to the increased convective heat loss is water, which shifts the species size distribution upward and pushes its right tail into ranges inaccessible to terrestrial mammals. Under this macroevolutionary tradeoff, the largest expected species occurs where the rate at which smaller-bodied species move up into large-bodied niches approximately equals the rate at which extinction removes them.	[Clauset, Aaron] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Clauset, Aaron] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Clauset, Aaron] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; The Santa Fe Institute	Clauset, A (corresponding author), Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA.	aaron.clauset@colorado.edu		CLAUSET, AARON/0000-0002-3529-8746	Santa Fe Institute	Santa Fe Institute	This work was supported by the Santa Fe Institute. http://www.santafe.edu. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlborn BK, 1999, AM J PHYS, V67, P920, DOI 10.1119/1.19150; Ahlborn BK, 2000, J NON-EQUIL THERMODY, V25, P87, DOI 10.1515/JNETDY.2000.006; Allen CR, 2006, ECOL LETT, V9, P630, DOI 10.1111/j.1461-0248.2006.00902.x; Alroy J, 1998, SCIENCE, V280, P731, DOI 10.1126/science.280.5364.731; Alroy J, 2000, PALEOBIOLOGY, V26, P319, DOI 10.1666/0094-8373(2000)026<0319:UTDOTW>2.0.CO;2; Alroy J, 2000, PALEOBIOLOGY, V26, P707, DOI 10.1666/0094-8373(2000)026<0707:NMFQMP>2.0.CO;2; Berg, 2018, RANDOM WALKS BIOL; Best Robin C., 1993, Mammalian Species, V426, P1; Borsa P, 2006, CR BIOL, V329, P277, DOI 10.1016/j.crvi.2006.01.004; Brown J. H., 1995, MACROECOLOGY; Brown JH, 1996, AM NAT, V147, P1092, DOI 10.1086/285895; Clapham Phillip J., 1999, Mammalian Species, V604, P1; Clauset A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.038103; Clauset A, 2008, SCIENCE, V321, P399, DOI 10.1126/science.1157534; Clauset A, 2009, AM NAT, V173, P256, DOI 10.1086/595760; Cranford TW, 1999, MAR MAMMAL SCI, V15, P1133, DOI 10.1111/j.1748-7692.1999.tb00882.x; Culik BM, 2004, MARINE MAMMAL ACTION, V177; Davidson AD, 2012, P NATL ACAD SCI USA, V109, P3395, DOI 10.1073/pnas.1121469109; DOWNHOWER JF, 1988, NATURE, V335, P675, DOI 10.1038/335675b0; Goldbogen JA, 2012, FUNCT ECOL, V26, P216, DOI 10.1111/j.1365-2435.2011.01905.x; Hunt G, 2007, P NATL ACAD SCI USA, V104, P18404, DOI 10.1073/pnas.0704088104; Jefferson T. A., 1994, HDB MARINE MAMMALS, V5, P335; Jefferson T.A, 1993, FAO SPECIES IDENTIFI; Jefferson Thomas A., 1997, Mammalian Species, V553, P1; Jefferson Thomas A., 1993, Mammalian Species, V425, P1; Jefferson Thomas A., 2003, Mammalian Species, V726, P1, DOI 10.1644/726; Jefferson Thomas A., 1994, Mammalian Species, V470, P1; Jefferson Thomas A., 2001, Mammalian Species, V655, P1, DOI 10.1644/1545-1410(2001)655<0001:SC>2.0.CO;2; Jefferson Thomas A., 2004, Mammalian Species, P1; Kozlowski J, 2002, FUNCT ECOL, V16, P419, DOI 10.1046/j.1365-2435.2002.00646.x; Krapivsky P., 2010, KINETIC VIEW STAT PH; Liow LH, 2008, P NATL ACAD SCI USA, V105, P6097, DOI 10.1073/pnas.0709763105; LOMOLINO MV, 1985, AM NAT, V125, P310, DOI 10.1086/284343; Long C. A., 1968, Transactions of the Kansas Academy of Science, V71, P201, DOI 10.2307/3627372; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; McNab BK, 2009, P NATL ACAD SCI USA, V106, P12184, DOI 10.1073/pnas.0904000106; MCSHEA DW, 1994, EVOLUTION, V48, P1747, DOI 10.1111/j.1558-5646.1994.tb02211.x; Mead JG, 1982, SMITHSONIAN CONTRIBU; NAGORSEN D, 1985, Mammalian Species, P1, DOI 10.2307/3503937; Newcomer Michael W., 1996, Mammalian Species, V531, P1; PEARSON OP, 1948, SCIENCE, V108, P44, DOI 10.1126/science.108.2793.44; Perrin WF, 2004, NOMTMNMFSSWFSC364 NO; Perrin William F., 2001, Mammalian Species, V683, P1, DOI 10.1644/1545-1410(2001)683<0001:SA>2.0.CO;2; Perrin William F., 2002, Mammalian Species, V702, P1, DOI 10.1644/1545-1410(2002)702<0001:SF>2.0.CO;2; Perrin William F., 1998, Mammalian Species, V599, P1; Potvin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044854; RAUP DM, 1977, AM SCI, V65, P50; REEVES R R, 1980, Mammalian Species, P1, DOI 10.2307/3503952; SEBENS KP, 1987, ANNU REV ECOL SYST, V18, P371, DOI 10.1146/annurev.es.18.110187.002103; Smith FA, 2003, ECOLOGY, V84, P3403, DOI 10.1890/02-9003; Smith FA, 2011, PHILOS T R SOC B, V366, P2364, DOI 10.1098/rstb.2011.0067; Stacey Pam J., 1999, Mammalian Species, V616, P1; Stacey Pam J., 1994, Mammalian Species, V456, P1; STANLEY SM, 1975, P NATL ACAD SCI USA, V72, P646, DOI 10.1073/pnas.72.2.646; STANLEY SM, 1973, EVOLUTION, V27, P1, DOI 10.1111/j.1558-5646.1973.tb05912.x; STEWART B E, 1989, Mammalian Species, P1, DOI 10.2307/3504210; Uhen MD, 1998, EVOLUTION TERTIARY M, V2, P566; Van Valkenburgh B, 2004, SCIENCE, V306, P101, DOI 10.1126/science.1102417; Van Waerebeek Koen, 2004, Aquatic Mammals, V30, P56, DOI 10.1578/AM.30.1.2004.56; West GB, 2002, P NATL ACAD SCI USA, V99, P2473, DOI 10.1073/pnas.012579799; White EP, 2007, TRENDS ECOL EVOL, V22, P323, DOI 10.1016/j.tree.2007.03.007; Wilson GP, 2012, NATURE, V483, P457, DOI 10.1038/nature10880	63	23	23	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53967	10.1371/journal.pone.0053967	http://dx.doi.org/10.1371/journal.pone.0053967			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23342050	gold, Green Published, Green Submitted			2022-12-25	WOS:000313552400065
J	Vakorin, VA; Misic, B; Krakovska, O; Bezgin, G; McIntosh, AR				Vakorin, Vasily A.; Misic, Bratislav; Krakovska, Olga; Bezgin, Gleb; McIntosh, Anthony R.			Confounding Effects of Phase Delays on Causality Estimation	PLOS ONE			English	Article							STATISTICAL ASSESSMENT; GRANGER CAUSALITY; EEG; SYNCHRONIZATION; CONNECTIVITY	Linear and non-linear techniques for inferring causal relations between the brain signals representing the underlying neuronal systems have become a powerful tool to extract the connectivity patterns in the brain. Typically these tools employ the idea of Granger causality, which is ultimately based on the temporal precedence between the signals. At the same time, phase synchronization between coupled neural ensembles is considered a mechanism implemented in the brain to integrate relevant neuronal ensembles to perform a cognitive or perceptual task. Phase synchronization can be studied by analyzing the effects of phase-locking between the brain signals. However, we should expect that there is no one-to-one mapping between the observed phase lag and the time precedence as specified by physically interacting systems. Specifically, phase lag observed between two signals may interfere with inferring causal relations. This could be of critical importance for the coupled non-linear oscillating systems, with possible time delays in coupling, when classical linear cross-spectrum strategies for solving phase ambiguity are not efficient. To demonstrate this, we used a prototypical model of coupled non-linear systems, and compared three typical pipelines of inferring Granger causality, as established in the literature. Specifically, we compared the performance of the spectral and information-theoretic Granger pipelines as well as standard Granger causality in their relations to the observed phase differences for frequencies at which the signals become synchronized to each other. We found that an information-theoretic approach, which takes into account different time lags between the past of one signal and the future of another signal, was the most robust to phase effects.	[Vakorin, Vasily A.; Misic, Bratislav; Bezgin, Gleb; McIntosh, Anthony R.] Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada; [Misic, Bratislav; McIntosh, Anthony R.] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Krakovska, Olga] York Univ, Dept Chem, Toronto, ON M3J 2R7, Canada	University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; York University - Canada	Vakorin, VA (corresponding author), Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada.	vvakorin@research.baycrest.org	Vakorin, Vasily/AAY-3249-2021	Vakorin, Vasily/0000-0003-0489-1552; McIntosh, Anthony/0000-0002-1784-5662	J.S. McDonnell Foundation	J.S. McDonnell Foundation	This research was supported by research grants from the J.S. McDonnell Foundation to Dr. Anthony R. McIntosh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blinowska KJ, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.050902; Brovelli A., 2004, PNAS, V101; Buzsaki G., 2006, RHYTHMS BRAIN; Chao Zenas C, 2010, Front Neuroeng, V3, P3, DOI 10.3389/fneng.2010.00003; Chavez M, 2003, J NEUROSCI METH, V124, P113, DOI 10.1016/S0165-0270(02)00367-9; Deco G, 2009, P NATL ACAD SCI USA, V106, P10302, DOI 10.1073/pnas.0901831106; Florin E, 2010, NEUROIMAGE, V50, P577, DOI 10.1016/j.neuroimage.2009.12.050; GEWEKE J, 1982, J AM STAT ASSOC, V77, P304, DOI 10.2307/2287238; Ghosh A, 2008, COGN NEURODYNAMICS, V2, P115, DOI 10.1007/s11571-008-9044-2; GOTMAN J, 1981, EPILEPSIA, V22, P453, DOI 10.1111/j.1528-1157.1981.tb06156.x; GOTMAN J, 1983, ELECTROEN CLIN NEURO, V56, P501, DOI 10.1016/0013-4694(83)90235-3; Gourevitch B, 2006, BIOL CYBERN, V95, P349, DOI 10.1007/s00422-006-0098-0; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hadjipapas A, 2009, NEUROIMAGE, V44, P1290, DOI 10.1016/j.neuroimage.2008.10.035; HAKEN H, 1996, PRINCIPLES BRAIN FUN, DOI [10.1007/978-3-642-79570-1_11, DOI 10.1007/978-3-642-79570-1_11]; Hinrichs H, 2006, NEUROIMAGE, V31, P1051, DOI 10.1016/j.neuroimage.2006.01.038; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Keil A, 2009, HUM BRAIN MAPP, V30, P532, DOI 10.1002/hbm.20521; Lachaux EP, 1991, HUMAN BRAIN MAPPING, V8, P194; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Nagasaka Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022561; Nunez P.L., 1995, NEOCORTICAL DYNAMICS; Oppenheim A.V.B., 2001, DISCRETE TIME SIGNAL, VVolume 2; Palus M, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.046211; Palus M, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.056211; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; PRICHARD D, 1995, PHYSICA D, V84, P476, DOI 10.1016/0167-2789(95)00041-2; Rosenblum MG, 1996, PHYS REV LETT, V76, P1804, DOI 10.1103/PhysRevLett.76.1804; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Seth A., 2007, SCHOLARPEDIA, V2, P1667, DOI [DOI 10.4249/SCHOLARPEDIA.1667, 10.4249/ scholarpedia.1667]; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Small M, 2002, PHYSICA, V164; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Tass P, 1998, PHYS REV LETT, V81, P3291, DOI 10.1103/PhysRevLett.81.3291; Vakorin VA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00096; Vakorin VA, 2010, NEUROIMAGE, V49, P1593, DOI 10.1016/j.neuroimage.2009.08.027; Vakorin VA, 2009, J NEUROSCI METH, V184, P152, DOI 10.1016/j.jneumeth.2009.07.014; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; Wibral M, 2011, PROG BIOPHYS MOL BIO, V105, P80, DOI 10.1016/j.pbiomolbio.2010.11.006; Zeitler M, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.065203	41	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e53588	10.1371/journal.pone.0053588	http://dx.doi.org/10.1371/journal.pone.0053588			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349720	Green Published, Green Submitted, gold			2022-12-25	WOS:000313943000013
J	Lee, JM; Lee, J; Kim, T; Lee, SK				Lee, Jae Myung; Lee, Junhyeong; Kim, Taesung; Lee, Sung Kuk			Switchable Gene Expression in Escherichia coli Using a Miniaturized Photobioreactor	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; HETEROLOGOUS PROTEINS; PHAGE-LAMBDA; BACTERIA; LIGHT; PROMOTER; SYSTEM; ACTIVATION; CELLS; K-12	We present a light-switchable gene expression system for both inducible and switchable control of gene expression at a single cell level in Escherichia coli using a previously constructed light-sensing system. The lambda cl repressor gene with an LVA degradation tag was expressed under the control of the ompC promoter on the chromosome. The green fluorescent protein (GFP) gene fused to a lambda repressor-repressible promoter was used as a reporter. This light-switchable system allows rapid and reversible induction or repression of expression of the target gene at any desired time. This system also ensures homogenous expression across the entire cell population. We also report the design of a miniaturized photobioreactor to be used in combination with the light-switchable gene expression system. The miniaturized photobioreactor helps to reduce unintended induction of the light receptor due to environmental disturbances and allows precise control over the duration of induction. This system would be a good tool for switchable, homogenous, strong, and highly regulatable expression of target genes over a wide range of induction times. Hence, it could be applied to study gene function, optimize metabolic pathways, and control biological systems both spatially and temporally.	[Lee, Jae Myung; Lee, Junhyeong; Kim, Taesung; Lee, Sung Kuk] Ulsan Natl Inst Sci & Technol UNIST, Sch Nanobiosci & Chem Engn, Ulsan, South Korea; [Kim, Taesung] UNIST, Sch Mech & Adv Mat Engn, Ulsan, South Korea; [Lee, Sung Kuk] UNIST, Sch Urban & Environm Engn, Ulsan, South Korea	Ulsan National Institute of Science & Technology (UNIST); Ulsan National Institute of Science & Technology (UNIST); Ulsan National Institute of Science & Technology (UNIST)	Kim, T (corresponding author), Ulsan Natl Inst Sci & Technol UNIST, Sch Nanobiosci & Chem Engn, Ulsan, South Korea.	tskim@unist.ac.kr; sklee@unist.ac.kr	Lee, Junhyeong/F-8245-2013; Lee, Sung K/HGC-6832-2022; Kim, Taesung/E-9308-2010; Lee, Sung K/E-6525-2010	Lee, Junhyeong/0000-0002-1826-1116; Kim, Taesung/0000-0001-9827-7531; 	National Research Foundation of Korea (NRF); Korean Government (MEST) [NRF-2009-C1AAA0012009-0093479, NRF-2010-0006436]; Next-Generation BioGreen 21 Program (SSAC) [PJ0099058]; Rural Development Administration, Republic of Korea	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Next-Generation BioGreen 21 Program (SSAC)(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grants funded by the Korean Government (MEST) (NRF-2009-C1AAA0012009-0093479, NRF-2010-0006436) and by the Next-Generation BioGreen 21 Program (SSAC, grant PJ0099058), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Brieke C, 2012, ANGEW CHEM INT EDIT, V51, P8446, DOI 10.1002/anie.201202134; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Cho HS, 2012, BIOTECHNOL BIOENG, V109, P2612, DOI 10.1002/bit.24532; Chou CJ, 2010, CHEMBIOCHEM, V11, P972, DOI 10.1002/cbic.201000041; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Drepper T, 2011, APPL MICROBIOL BIOT, V90, P23, DOI 10.1007/s00253-011-3141-6; Gambetta GA, 2001, P NATL ACAD SCI USA, V98, P10566, DOI 10.1073/pnas.191375198; Jana S, 2005, APPL MICROBIOL BIOT, V67, P289, DOI 10.1007/s00253-004-1814-0; Joseph S, 2001, MOL CLONING LAB MANU; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; Lee SK, 2005, APPL ENVIRON MICROB, V71, P6856, DOI 10.1128/AEM.71.11.6856-6862.2005; Lee SK, 2006, BIOTECHNOL BIOENG, V93, P912, DOI 10.1002/bit.20784; Levskaya A, 2005, NATURE, V438, P441, DOI 10.1038/nature04405; Menart V, 2003, BIOTECHNOL BIOENG, V83, P181, DOI 10.1002/bit.10660; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Na D, 2010, BIOINFORMATICS, V26, P2633, DOI 10.1093/bioinformatics/btq458; Ohlendorf R, 2012, J MOL BIOL, V416, P534, DOI 10.1016/j.jmb.2012.01.001; Rinas U, 1996, BIOTECHNOL PROGR, V12, P196, DOI 10.1021/bp9600039; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; Tabor JJ, 2011, J MOL BIOL, V405, P315, DOI 10.1016/j.jmb.2010.10.038; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Valdez-Cruz NA, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-18; Young DD, 2007, ANGEW CHEM INT EDIT, V46, P4290, DOI 10.1002/anie.200700057; Zhou L, 2012, METAB ENG, V14, P560, DOI 10.1016/j.ymben.2012.05.004	28	50	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e52382	10.1371/journal.pone.0052382	http://dx.doi.org/10.1371/journal.pone.0052382			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349683	Green Published, Green Submitted, gold			2022-12-25	WOS:000313738900005
J	Ammirante, P; Russo, FA; Good, A; Fels, DI				Ammirante, Paolo; Russo, Frank A.; Good, Arla; Fels, Deborah I.			Feeling Voices	PLOS ONE			English	Article							GLOTTAL CHARACTERISTICS; SUMMATION; SPEAKERS	Two experiments investigated deaf individuals' ability to discriminate between same-sex talkers based on vibrotactile stimulation alone. Nineteen participants made same/different judgments on pairs of utterances presented to the lower back through voice coils embedded in a conforming chair. Discrimination of stimuli matched for F0, duration, and perceived magnitude was successful for pairs of spoken sentences in Experiment 1 (median percent correct = 83%) and pairs of vowel utterances in Experiment 2 (median percent correct = 75%). Greater difference in spectral tilt between "different" pairs strongly predicted their discriminability in both experiments. The current findings support the hypothesis that discrimination of complex vibrotactile stimuli involves the cortical integration of spectral information filtered through frequency-tuned skin receptors.	[Ammirante, Paolo; Russo, Frank A.; Good, Arla] Ryerson Univ, Dept Psychol, Toronto, ON, Canada; [Fels, Deborah I.] Ryerson Univ, Ctr Learning Technol, Toronto, ON, Canada	Toronto Metropolitan University; Toronto Metropolitan University	Russo, FA (corresponding author), Ryerson Univ, Dept Psychol, Toronto, ON, Canada.	russo@ryerson.ca	Russo, Frank A./H-3748-2019	Russo, Frank A./0000-0002-2939-6358	Natural Sciences and Engineering Research Council of Canada [341583-07),]; Network of Centres of Excellence [: G-NI-10-Ry-01]; Graphics, Animation and New Media (GRAND) Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Network of Centres of Excellence; Graphics, Animation and New Media (GRAND) Canada	This research was supported by a Discovery grant awarded to the second author from the Natural Sciences and Engineering Research Council of Canada (Reference #: 341583-07), and Graphics, Animation and New Media (GRAND) Canada, a federally funded Network of Centres of Excellence (Reference #: G-NI-10-Ry-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, PROFILE ANAL AUDITOR; Birnbaum D.M., 2007, P INT COMP MUS C COP, P397; Boersma P., 2010, PRAAT DOING PHONETIC; BOLANOWSKI SJ, 1988, J ACOUST SOC AM, V84, P1680, DOI 10.1121/1.397184; BROOKS PL, 1985, J ACOUST SOC AM, V77, P1576, DOI 10.1121/1.392000; Brooks PL, 1985, J REHABIL ENG, V22, P119; Brooks PL, 1985, J REHABIL ENG, V22, P129; Chasin M., 2009, HEARING LOSS MUSICIA; DiCanio CT, 2009, J INT PHON ASSOC, V39, P162, DOI 10.1017/S0025100309003879; Gault RH, 1924, J ABNORMAL PSYCHOL S, V19, DOI DOI 10.1037/H0065752; Gordon M, 2001, J PHONETICS, V29, P383, DOI 10.1006/jpho.2001.0147; Hanson HM, 1997, J ACOUST SOC AM, V101, P466, DOI 10.1121/1.417991; Hanson HM, 1999, J ACOUST SOC AM, V106, P1064, DOI 10.1121/1.427116; Karam M, 2009, IEEE T HAPTICS, V2, P160, DOI 10.1109/ToH.2009.32; Kramer SE, 2008, INT J AUDIOL, V47, pS124, DOI 10.1080/14992020802310887; Macmillan N. A., 2005, DETECTION THEORY USE; MARKS LE, 1979, SENS PROCESS, V3, P188; Price E., 2008, ACM INT C P SERIES G, V322, P267; REED CM, 1985, J ACOUST SOC AM, V77, P247, DOI 10.1121/1.392266; Russo FA, 2012, J EXP PSYCHOL HUMAN, V38, P822, DOI 10.1037/a0029046; VERRILLO RT, 1975, PERCEPT PSYCHOPHYS, V18, P128, DOI 10.3758/BF03204100; Vy QV, 2009, LECT NOTES COMPUT SC, V5727, P916, DOI 10.1007/978-3-642-03658-3_110	22	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53585	10.1371/journal.pone.0053585	http://dx.doi.org/10.1371/journal.pone.0053585			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341954	Green Published, Green Submitted, gold			2022-12-25	WOS:000313682700030
J	Aroca-Aguilar, JD; Martinez-Redondo, F; Martin-Gil, A; Pintor, J; Coca-Prados, M; Escribano, J				Aroca-Aguilar, Jose-Daniel; Martinez-Redondo, Francisco; Martin-Gil, Alba; Pintor, Jesus; Coca-Prados, Miguel; Escribano, Julio			Bicarbonate-Dependent Secretion and Proteolytic Processing of Recombinant Myocilin	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; MUTATIONS; CLEAVAGE; GENE; IDENTIFICATION; TRAFFICKING; PROTEINS; PH	Myocilin is an extracellular glycoprotein of poorly understood function. Mutations of this protein are involved in glaucoma, an optic neuropathy characterized by a progressive and irreversible visual loss and frequently associated with elevated intraocular pressure. We previously showed that recombinant myocilin undergoes an intracellular proteolytic processing by calpain II which cleaves the central region of the protein, releasing one N- and one C-terminal fragment. Myocilin cleavage is reduced by glaucoma mutations and it has been proposed to participate in intraocular pressure modulation. To identify possible factors regulating the proteolytic processing of recombinant myocilin, we used a cellular model in which we analyzed how different culture medium parameters (i.e., culture time, cell density, pH, bicarbonate concentration, etc.) affect the presence of the extracellular C-terminal fragment. Extracellular bicarbonate depletion associated with culture medium acidification produced a reversible intracellular accumulation of full-length recombinant myocilin and incremented its intracellular proteolytic processing, raising the extracellular C-terminal fragment percentage. It was also determined that myocilin intracellular accumulation depends on its N- terminal region. These data suggest that aqueous humor bicarbonate variations could also modulate the secretion and cleavage of myocilin present in ocular tissues.	[Aroca-Aguilar, Jose-Daniel; Martinez-Redondo, Francisco; Escribano, Julio] Univ Castilla La Mancha, Fac Med, Inst Invest Discapacidades Neurol IDINE, Lab Genet Mol Humana, Albacete, Spain; [Martin-Gil, Alba; Pintor, Jesus] Univ Complutense Madrid, Dept Bioquim & Biol Mol 4, EU Opt, Madrid, Spain; [Coca-Prados, Miguel] Fdn Invest Oftalmol, Inst Oftalmol Fernandez Vega, Oviedo, Spain; [Coca-Prados, Miguel] Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06510 USA	Universidad de Castilla-La Mancha; Complutense University of Madrid; Yale University	Escribano, J (corresponding author), Univ Castilla La Mancha, Fac Med, Inst Invest Discapacidades Neurol IDINE, Lab Genet Mol Humana, Albacete, Spain.	julio.escribano@uclm.es	Aroca-Aguilar, Jose Daniel/R-5513-2019; Aroca-Aguilar, J.Daniel/B-7842-2008; Escribano, Julio/D-9742-2015; Martin-Gil, Alba/C-8176-2019	Aroca-Aguilar, Jose Daniel/0000-0001-6487-1612; Aroca-Aguilar, J.Daniel/0000-0001-6487-1612; Escribano, Julio/0000-0002-8919-8134; Pintor, Jesus/0000-0002-9191-7679; Martin-Gil, Alba/0000-0001-8641-2169	Spanish Ministry of Science and Innovation; Regional Ministry of Health; Regional Ministry of Science and Technology of the Board of the Communities of "Castilla-La Mancha" [SAF2008-02228, GCS-2006_C/12, PAI-05-002, PCI08-0036, RD07/0062/0004, RD07/0062/0014]; Regional Ministry of Science and Technology of the Board of the Communities of "Instituto de Salud Carlos III" [SAF2008-02228, GCS-2006_C/12, PAI-05-002, PCI08-0036, RD07/0062/0004, RD07/0062/0014]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Regional Ministry of Health; Regional Ministry of Science and Technology of the Board of the Communities of "Castilla-La Mancha"; Regional Ministry of Science and Technology of the Board of the Communities of "Instituto de Salud Carlos III"	This study was funded by research grants from the Spanish Ministry of Science and Innovation, the Regional Ministry of Health and the Regional Ministry of Science and Technology of the Board of the Communities of "Castilla-La Mancha", and "Instituto de Salud Carlos III" (SAF2008-02228; GCS-2006_C/12; PAI-05-002 and PCI08-0036; RD07/0062/0004 and RD07/0062/0014). MC-P is "Catedratico Rafael del Pino" in the "Fundacion de Investigacion Oftalmologica, Instituto Oftalmologico Fernandez-Vega", Oviedo, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroca-Aguilar JD, 2005, J BIOL CHEM, V280, P21043, DOI 10.1074/jbc.M501340200; Aroca-Aguilar JD, 2011, INVEST OPHTH VIS SCI, V52, P179, DOI 10.1167/iovs.09-4866; Aroca-Aguilar JD, 2010, INVEST OPHTH VIS SCI, V51, P72, DOI 10.1167/iovs.09-4118; Aroca-Aguilar JD, 2008, MOL VIS, V14, P2097; Caballero M, 2000, BBA-MOL BASIS DIS, V1502, P447, DOI 10.1016/S0925-4439(00)00068-5; Campos-Mollo E, 2007, MOL VIS, V13, P1666; Dismuke WM, 2012, BIOCHEMISTRY-US, V51, P3606, DOI 10.1021/bi300073r; Fautsch MP, 2004, MOL VIS, V10, P417; Fautsch MP, 2001, INVEST OPHTH VIS SCI, V42, P2324; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Glunde K, 2003, NEOPLASIA, V5, P533, DOI 10.1016/S1476-5586(03)80037-4; Hardy KM, 2005, J BIOL CHEM, V280, P28917, DOI 10.1074/jbc.M504803200; Huang W, 2000, Ophthalmic Genet, V21, P155, DOI 10.1076/1381-6810(200009)21:3;1-Z;FT155; Jacobson N, 2001, HUM MOL GENET, V10, P117, DOI 10.1093/hmg/10.2.117; Kennedy KD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036301; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lu DW, 2001, J OCUL PHARMACOL TH, V17, P343, DOI 10.1089/108076801753162753; NEURATH H, 1991, ENZYME, V45, P239, DOI 10.1159/000468898; Ortego J, 1997, FEBS LETT, V413, P349, DOI 10.1016/S0014-5793(97)00934-4; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Russell P, 2001, INVEST OPHTH VIS SCI, V42, P983; Sanchez-Sanchez F, 2007, J BIOL CHEM, V282, P27810, DOI 10.1074/jbc.M609608200; Stamer WD, 2006, EXP EYE RES, V83, P1386, DOI 10.1016/j.exer.2006.07.018; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Tsai PSJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032603; YAMAMOTO F, 1992, EXP EYE RES, V55, P279, DOI 10.1016/0014-4835(92)90192-U	26	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54385	10.1371/journal.pone.0054385	http://dx.doi.org/10.1371/journal.pone.0054385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342144	Green Published, gold, Green Submitted			2022-12-25	WOS:000313682700109
J	Otalora-Luna, F; Lapointe, SL; Dickens, JC				Otalora-Luna, Fernando; Lapointe, Stephen L.; Dickens, Joseph C.			Olfactory Cues Are Subordinate to Visual Stimuli in a Neotropical Generalist Weevil	PLOS ONE			English	Article							DIAPREPES-ABBREVIATUS COLEOPTERA; COLORADO-POTATO-BEETLE; AGGREGATION PHEROMONE; MANDUCA-SEXTA; BUMBLE-BEES; CURCULIONIDAE; BEHAVIOR; INSECTS; ORIENTATION; FIELD	The tropical root weevil Diaprepes abbreviatus is a major pest of multiple crops in the Caribbean Islands and has become a serious constraint to citrus production in the United States. Recent work has identified host and conspecific volatiles that mediate host- and mate-finding by D. abbreviatus. The interaction of light, color, and odors has not been studied in this species. The responses of male and female D. abbreviatus to narrow bandwidths of visible light emitted by LEDs offered alone and in combination with olfactory stimuli were studied in a specially-designed multiple choice arena combined with a locomotion compensator. Weevils were more attracted to wavelengths close to green and yellow compared with blue or ultraviolet, but preferred red and darkness over green. Additionally, dim green light was preferred over brighter green. Adult weevils were also attracted to the odor of its citrus host + conspecifics. However, the attractiveness of citrus + conspecific odors disappeared in the presence of a green light. Photic stimulation induced males but not females to increase their speed. In the presence of light emitted by LEDs, turning speed decreased and path straightness increased, indicating that weevils tended to walk less tortuously. Diaprepes abbreviatus showed a hierarchy between chemo- and photo-taxis in the series of experiments presented herein, where the presence of the green light abolished upwind anemotaxis elicited by the pheromone + host plant odor. Insight into the strong responses to visual stimuli of chemically stimulated insects may be provided when the amount of information supplied by vision and olfaction is compared, as the information transmission capacity of compound eyes is estimated to be several orders of magnitude higher compared with the olfactory system. Subordination of olfactory responses by photic stimuli should be considered in the design of strategies aimed at management of such insects.	[Otalora-Luna, Fernando] IVIC, Ctr Multidisciplinario Ciencias, Lab Ecol Sensorial, Parroquia Jaji, Edo Merida, Venezuela; [Lapointe, Stephen L.] Agr Res Serv, USDA, US Hort Res Lab, Ft Pierce, FL USA; [Otalora-Luna, Fernando; Dickens, Joseph C.] Agr Res Serv, USDA, Invas Insect Biocontrol & Behav Lab, Beltsville, MD USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Otalora-Luna, F (corresponding author), IVIC, Ctr Multidisciplinario Ciencias, Lab Ecol Sensorial, Parroquia Jaji, Edo Merida, Venezuela.	fotalora@ivic.gob.ve	Luna, Fernando Otálora/R-9992-2019; Dickens, Dick/AGY-7295-2022	Luna, Fernando Otálora/0000-0002-5313-2184; 				Adair RC, 1998, FLA ENTOMOL, V81, P225, DOI 10.2307/3496091; Balkenius A, 2006, J COMP PHYSIOL A, V192, P431, DOI 10.1007/s00359-005-0081-6; Batschelet E, 1981, CIRCULAR STAT BIOL; BEAVERS JB, 1982, ENVIRON ENTOMOL, V11, P436, DOI 10.1093/ee/11.2.436; BEAVERS JB, 1979, FLA ENTOMOL, V62, P136, DOI 10.2307/3494091; Bell WJ, 1991, SEARCHING BEHAV BEHA, DOI DOI 10.1371/journal.pone.0086271; Bouyssy A, 1987, PHYS SCI VIE PHYS SE, V1, P129; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Cleveland WS, 1994, ELEMENTS GRAPHING DA; Dickens JC, 2006, J APPL ENTOMOL, V130, P26, DOI 10.1111/j.1439-0418.2005.01014.x; Dusenbery D.B., 1992, SENSORY ECOLOGY ORGA; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Goyret J, 2007, J EXP BIOL, V210, P1398, DOI 10.1242/jeb.02752; GRAHAM K, 1959, NATURE, V184, P283, DOI 10.1038/184283b0; Hammock JA, 2007, ARTHROPOD-PLANT INTE, V1, P27, DOI 10.1007/s11829-007-9005-4; Harari AR, 1997, J CHEM ECOL, V23, P857, DOI 10.1023/B:JOEC.0000006416.96240.aa; Hausmann C, 2004, ENVIRON ENTOMOL, V33, P1410, DOI 10.1603/0046-225X-33.5.1410; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; JONES IF, 1984, J ECON ENTOMOL, V77, P334, DOI 10.1093/jee/77.2.334; KITCHING RL, 1982, RES POPUL ECOL, V24, P224, DOI 10.1007/BF02515573; KRAMER E, 1976, PHYSIOL ENTOMOL, V1, P27, DOI 10.1111/j.1365-3032.1976.tb00883.x; Kulahci IG, 2008, P R SOC B, V275, P797, DOI 10.1098/rspb.2007.1176; Kunze J, 2001, BEHAV ECOL, V12, P447, DOI 10.1093/beheco/12.4.447; Landolt PJ, 1997, ANNU REV ENTOMOL, V42, P371, DOI 10.1146/annurev.ento.42.1.371; Lapointe SL, 1999, FLA ENTOMOL, V82, P291, DOI 10.2307/3496582; Lapointe SL., 2004, MANEJO INTEGRADO PLA, V71, P106; Lapointe SL, 2007, ENVIRON ENTOMOL, V36, P73, DOI 10.1603/0046-225X(2007)36[73:EOLTOM]2.0.CO;2; Lapointe SL, 2012, J CHEM ECOL, V38, P408, DOI 10.1007/s10886-012-0096-8; Lapointe SL, 2010, ENVIRON ENTOMOL, V39, P670, DOI 10.1603/EN09304; Lapointe SL, 2009, J ECON ENTOMOL, V102, P992, DOI 10.1603/029.102.0318; MCMAHON T, 1973, SCIENCE, V179, P1201, DOI 10.1126/science.179.4079.1201; Omura H, 2005, OECOLOGIA, V142, P588, DOI 10.1007/s00442-004-1761-6; Otalora-Luna F, 2004, J COMP PHYSIOL A, V190, P847, DOI 10.1007/s00359-004-0540-5; Otalora-Luna F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020990; Otalora-Luna F, 2009, ARTHROPOD-PLANT INTE, V3, P63, DOI 10.1007/s11829-009-9058-7; Patt JM, 2007, ENVIRON ENTOMOL, V36, P142, DOI 10.1603/0046-225X(2007)36[142:OAVSAH]2.0.CO;2; PROKOPY RJ, 1983, ANNU REV ENTOMOL, V28, P337, DOI 10.1146/annurev.en.28.010183.002005; Raguso RA, 2002, ANIM BEHAV, V64, P685, DOI 10.1006/anbe.2002.4010; Reddy GVP, 2004, TRENDS PLANT SCI, V9, P253, DOI 10.1016/j.tplants.2004.03.009; Roderick GK, 2003, ANN ENTOMOL SOC AM, V96, P631, DOI 10.1603/0013-8746(2003)096[0631:SPICPB]2.0.CO;2; Ruxton GD, 2008, BEHAV ECOL, V19, P690, DOI 10.1093/beheco/arn020; SCHROEDER WJ, 1981, ENVIRON ENTOMOL, V10, P898, DOI 10.1093/ee/10.6.898; SHOREY H. H., 1965, ANN ENTOMOL SOC AMER, V58, P833, DOI 10.1093/aesa/58.6.833; Simpson SE, 1996, ENVIRON ENTOMOL, V25, P333, DOI 10.1093/ee/25.2.333; Sokal RR, 1995, BIOMETRY; Teder T, 2005, OIKOS, V108, P321, DOI 10.1111/j.0030-1299.2005.13609.x; TURRELL F. M., 1961, BOT GAZ, V123, P10, DOI 10.1086/336123	47	19	19	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53120	10.1371/journal.pone.0053120	http://dx.doi.org/10.1371/journal.pone.0053120			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341926	Green Submitted, Green Published, gold			2022-12-25	WOS:000313682700022
J	Caignard, G; Lucas-Hourani, M; Dhondt, KP; Labernardiere, JL; Petit, T; Jacob, Y; Horvat, B; Tangy, F; Vidalain, PO				Caignard, Gregory; Lucas-Hourani, Marianne; Dhondt, Kevin P.; Labernardiere, Jean-Louis; Petit, Thierry; Jacob, Yves; Horvat, Branka; Tangy, Frederic; Vidalain, Pierre-Olivier			The V Protein of Tioman Virus Is Incapable of Blocking Type I Interferon Signaling in Human Cells	PLOS ONE			English	Article							UBIQUITIN LIGASE COMPLEXES; AMINO-ACID SUBSTITUTION; BINDING-PROTEIN; HUMAN INFECTION; RNA HELICASE; NIPAH-VIRUS; DNA-BINDING; RIG-I; PARAMYXOVIRUS; STAT1	The capacity of a virus to cross species barriers is determined by the development of bona fide interactions with cellular components of new hosts, and in particular its ability to block IFN-alpha/beta antiviral signaling. Tioman virus (TioV), a close relative of mumps virus (MuV), has been isolated in giant fruit bats in Southeast Asia. Nipah and Hendra viruses, which are present in the same bat colonies, are highly pathogenic in human. Despite serological evidences of close contacts between TioV and human populations, whether TioV is associated to some human pathology remains undetermined. Here we show that in contrast to the V protein of MuV, the V protein of TioV (TioV-V) hardly interacts with human STAT2, does not degrade STAT1, and cannot block IFN-alpha/beta signaling in human cells. In contrast, TioV-V properly binds to human STAT3 and MDA5, and thus interferes with IL-6 signaling and IFN-beta promoter induction in human cells. Because STAT2 binding was previously identified as a host restriction factor for some Paramyxoviridae, we established STAT2 sequence from giant fruit bats, and binding to TioV-V was tested. Surprisingly, TioV-V interaction with STAT2 from giant fruit bats is also extremely weak and barely detectable. Altogether, our observations question the capacity of TioV to appropriately control IFN-alpha/beta signaling in both human and giant fruit bats that are considered as its natural host.	[Caignard, Gregory; Lucas-Hourani, Marianne; Labernardiere, Jean-Louis; Tangy, Frederic; Vidalain, Pierre-Olivier] Inst Pasteur, Unite Genom Virale & Vaccinat, CNRS, URA 3015,Virol Dept, Paris, France; [Dhondt, Kevin P.; Horvat, Branka] Ecole Normale Super Lyon, INSERM, U758, F-69364 Lyon, France; [Horvat, Branka] Univ Lyon 1, F-69365 Lyon, France; [Petit, Thierry] Zoo Palmyre, Les Mathes, France; [Jacob, Yves] Inst Pasteur, Unite Genet Papillomavirus & Canc Humain, Dept Virol, Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Tangy, F (corresponding author), Inst Pasteur, Unite Genom Virale & Vaccinat, CNRS, URA 3015,Virol Dept, Paris, France.	ftangy@pasteur.fr; vidalain@pasteur.fr	Labernardière, Jean-Louis/AAT-2605-2020; Vidalain, Pierre-Olivier/F-9778-2019; Horvat, Branka/M-3504-2014	Vidalain, Pierre-Olivier/0000-0003-3082-7407; Horvat, Branka/0000-0003-0578-7765; Dhondt, Kevin P./0000-0001-8729-4213; Caignard, Gregory/0000-0001-7021-0749; Jacob, Yves/0000-0001-9125-2374	Fondation Recherche Medicale; Institut Carnot Pasteur-MI; DGA-INSERM; INSERM; Agence Nationale de Recherche, Microbiologie, Immunologie et Maladies Emergentes (ANR MIME)	Fondation Recherche Medicale; Institut Carnot Pasteur-MI; DGA-INSERM; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de Recherche, Microbiologie, Immunologie et Maladies Emergentes (ANR MIME)(French National Research Agency (ANR))	GC is supported by Fondation Recherche Medicale and Institut Carnot Pasteur-MI and KD is supported by DGA-INSERM. Work in BSL4 was supported by grants from INSERM and Agence Nationale de Recherche, Microbiologie, Immunologie et Maladies Emergentes (ANR MIME) to BH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Andrejeva J, 2002, J VIROL, V76, P11379, DOI 10.1128/JVI.76.22.11379-11386.2002; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Breed AC, 2010, EMERG INFECT DIS, V16, P1997, DOI 10.3201/eid1612.100879; Brussow H, 2009, ENVIRON MICROBIOL, V11, P2778, DOI 10.1111/j.1462-2920.2009.01962.x; Caignard G, 2009, VIROLOGY, V383, P112, DOI 10.1016/j.virol.2008.10.014; Caignard G, 2007, VIROLOGY, V368, P351, DOI 10.1016/j.virol.2007.06.037; Capraro GA, 2008, VIROLOGY, V376, P416, DOI 10.1016/j.virol.2008.03.034; Chant K, 1998, EMERG INFECT DIS, V4, P273, DOI 10.3201/eid0402.980215; Chatziandreou N, 2002, VIROLOGY, V293, P234, DOI 10.1006/viro.2001.1302; Childs KS, 2009, J VIROL, V83, P1465, DOI 10.1128/JVI.01768-08; Childs K, 2007, VIROLOGY, V359, P190, DOI 10.1016/j.virol.2006.09.023; Childs K, 2012, J VIROL, V86, P3411, DOI 10.1128/JVI.06405-11; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 2001, VIROLOGY, V283, P215, DOI 10.1006/viro.2000.0882; Crameri G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008266; Devaux P, 2011, J VIROL, V85, P348, DOI 10.1128/JVI.00802-10; Didcock L, 1999, J VIROL, V73, P9928, DOI 10.1128/JVI.73.12.9928-9933.1999; Hagmaier K, 2006, J GEN VIROL, V87, P3649, DOI 10.1099/vir.0.82261-0; Iehle C, 2007, EMERG INFECT DIS, V13, P159, DOI 10.3201/eid1301.060791; Karron RA., 2007, FIELDS VIROLOGY, V5, P1497; Kraus TA, 2008, VIROLOGY, V371, P196, DOI 10.1016/j.virol.2007.10.001; Kubota T, 2001, BIOCHEM BIOPH RES CO, V283, P255, DOI 10.1006/bbrc.2001.4764; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Lin GY, 1998, VIROLOGY, V249, P189, DOI 10.1006/viro.1998.9317; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; Mendoza JA, 2006, J VIROL, V80, P12420, DOI 10.1128/JVI.02576-05; Nishio M, 2005, J VIROL, V79, P14756, DOI 10.1128/JVI.79.23.14756-14768.2005; Nishio M, 2002, VIROLOGY, V300, P92, DOI 10.1006/viro.2002.1509; Parisien JP, 2009, J VIROL, V83, P7252, DOI 10.1128/JVI.00153-09; Parisien JP, 2002, J VIROL, V76, P6435, DOI 10.1128/JVI.76.13.6435-6441.2002; Parisien JP, 2002, J VIROL, V76, P4190, DOI 10.1128/JVI.76.9.4190-4198.2002; Parisien JP, 2001, VIROLOGY, V283, P230, DOI 10.1006/viro.2001.0856; Pellet J, 2010, NUCLEIC ACIDS RES, V38, pD371, DOI 10.1093/nar/gkp1000; Poole E, 2002, VIROLOGY, V303, P33, DOI 10.1006/viro.2002.1737; Precious B, 2005, J VIROL, V79, P13434, DOI 10.1128/JVI.79.21.13434-13441.2005; Precious BL, 2007, VIROLOGY, V368, P114, DOI 10.1016/j.virol.2007.06.024; Puri M, 2009, J VIROL, V83, P6347, DOI 10.1128/JVI.00596-09; Ramachandran A, 2009, J INTERF CYTOK RES, V29, P531, DOI 10.1089/jir.2009.0070; Rodriguez JJ, 2003, J VIROL, V77, P11842, DOI 10.1128/JVI.77.21.11842-11845.2003; Schaap-Nutt A, 2011, J VIROL, V85, P4007, DOI 10.1128/JVI.02542-10; Schaap-Nutt A, 2010, VIROLOGY, V406, P65, DOI 10.1016/j.virol.2010.07.011; SELVEY LA, 1995, MED J AUSTRALIA, V162, P642, DOI 10.5694/j.1326-5377.1995.tb126050.x; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Ulane CM, 2005, J VIROL, V79, P10180, DOI 10.1128/JVI.79.16.10180-10189.2005; Ulane CM, 2003, J VIROL, V77, P6385, DOI 10.1128/JVI.77.11.6385-6393.2003; Ulane CM, 2002, VIROLOGY, V304, P160, DOI 10.1006/viro.2002.1773; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Virtue ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022488; Wansley EK, 2002, J VIROL, V76, P10109, DOI 10.1128/JVI.76.20.10109-10121.2002; Wild TF, 2009, PATHOL BIOL, V57, P188, DOI 10.1016/j.patbio.2008.04.006; Yaiw KC, 2008, ARCH VIROL, V153, P865, DOI 10.1007/s00705-008-0059-0; Yaiw KC, 2007, J INFECT DIS, V196, P884, DOI 10.1086/520817; Yokosawa N, 2002, J VIROL, V76, P12683, DOI 10.1128/JVI.76.24.12683-12690.2002; Yoneyama M, 1996, J BIOCHEM-TOKYO, V120, P160; Young DF, 2000, VIROLOGY, V269, P383, DOI 10.1006/viro.2000.0240; Young DF, 2001, J VIROL, V75, P3363, DOI 10.1128/JVI.75.7.3363-3370.2001; Zhou P, 2011, J IMMUNOL, V186, P3138, DOI 10.4049/jimmunol.1003115	59	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53881	10.1371/journal.pone.0053881	http://dx.doi.org/10.1371/journal.pone.0053881			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342031	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400095
J	Calmon, MF; Mota, MTD; Babeto, E; Candido, NM; Girol, AP; Mendiburu, CF; Bonilha, JL; Silvestre, RVD; Rosa, BM; Thome, JA; Medeiros, GHA; Soares, FA; Guimaraes, GC; de Arruda, JGF; Oliani, SM; Villa, LL; Vassallo, J; Rahal, P				Calmon, Marilia Freitas; de Oliveira Mota, Manlio Tasso; Babeto, Erica; Candido, Natalia Maria; Girol, Ana Paula; Mendiburu, Carlos Fabian; Bonilha, Jane Lopes; Duarte Silvestre, Rodrigo Vellasco; Rosa, Bruno Miziara; Thome, Jorge Alberto; Americo Medeiros, Gustavo Hernandez; Soares, Fernando Augusto; Guimaraes, Gustavo Cardoso; Ferraz de Arruda, Jose Germano; Oliani, Sonia Maria; Villa, Luisa Lina; Vassallo, Jose; Rahal, Paula			Overexpression of ANXA1 in Penile Carcinomas Positive for High-Risk HPVs	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; HUMAN-PAPILLOMAVIRUS; ANNEXIN-I; INTRAEPITHELIAL NEOPLASIA; DIFFERENTIAL EXPRESSION; PROSTATE-CANCER; PROTEIN; A1; P16(INK4A); TUMOR	The incidence of penile cancer varies between populations but is rare in developed nations. Penile cancer is associated with a number of established risk factors and associated diseases including phimosis with chronic inflammation, human papillomavirus (HPV) infection, poor hygiene and smoking. The objective of this study was to identify genes related to this type of cancer. The detection of HPV was analyzed in 47 penile squamous cell carcinoma samples. HPV DNA was detected in 48.9% of penile squamous cell carcinoma cases. High-risk HPV were present in 42.5% of cases and low-risk HPV were detected in 10.6% of penile squamous cell carcinomas. The RaSH approach identified differential expression of Annexin A1 (ANXA1), p16, RPL6, PBEF1 and KIAA1033 in high-risk HPV positive penile carcinoma; ANXA1 and p16 were overexpressed in penile squamous cells positive for high-risk HPVs compared to normal penile samples by qPCR. ANXA1 and p16 proteins were significantly more expressed in the cells from high-risk HPV-positive penile carcinoma as compared to HPV-negative tumors (p<0.0001) independently of the subtype of the carcinoma. Overexpression of ANXA1 might be mediated by HPV E6 in penile squamous cell carcinoma of patients with high-risk HPVs, suggesting that this gene plays an important role in penile cancer.	[Calmon, Marilia Freitas; de Oliveira Mota, Manlio Tasso; Babeto, Erica; Candido, Natalia Maria; Girol, Ana Paula; Oliani, Sonia Maria; Rahal, Paula] Sao Paulo State Univ, Sao Paulo, Brazil; [Mendiburu, Carlos Fabian; Rosa, Bruno Miziara; Thome, Jorge Alberto] Inst Anat Pathol & Cytopathol, Sao Paulo, Brazil; [Bonilha, Jane Lopes; Ferraz de Arruda, Jose Germano] Coll Med Rio Preto, Sao Paulo, Brazil; [Duarte Silvestre, Rodrigo Vellasco] Univ Hosp Joao de Berros Barreto, Belem, Para, Brazil; [Americo Medeiros, Gustavo Hernandez; Soares, Fernando Augusto; Guimaraes, Gustavo Cardoso; Vassallo, Jose] Hosp AC Camargo Fund Antonio Prudente, Sao Paulo, Brazil; [Villa, Luisa Lina] Univ Sao Paulo, Sch Med, Dept Radiol & Basic Oncol, Sao Paulo, Brazil; [Villa, Luisa Lina] Coll Med Sci Santa Casa Sao Paulo, Sao Paulo, Brazil	Universidade Estadual Paulista; A.C.Camargo Cancer Center; Universidade de Sao Paulo	Rahal, P (corresponding author), Sao Paulo State Univ, Sao Paulo, Brazil.	rahalp@yahoo.com.br	de Oliveira Mota, Mânlio Tasso/E-2619-2013; Candido, Natalia M./H-5703-2013; Papilomavirus, Inct/I-2406-2013; Rahal, Paula/D-3871-2012; GUIMARAES, GUSTAVO CARDOSO/H-3595-2012; Calmon, Marilia Freitas/H-3150-2012; VASSALLO, JOSE/AAP-4600-2021; USP, Oncologia/F-9053-2014; Girol, Ana P/O-1716-2013; Oliani, Sonia Maria/E-3476-2012; VILLA, LUISA/AAH-4761-2019	de Oliveira Mota, Mânlio Tasso/0000-0003-0236-5356; Rahal, Paula/0000-0001-5693-6148; GUIMARAES, GUSTAVO CARDOSO/0000-0002-1317-2114; Calmon, Marilia Freitas/0000-0001-5203-0103; VASSALLO, JOSE/0000-0002-2192-4865; Girol, Ana P/0000-0002-8760-8945; Oliani, Sonia Maria/0000-0003-0918-2130; VILLA, LUISA/0000-0003-4074-2335; Soares, Fernando/0000-0002-1212-9093; Soares, Fernando Augusto/0000-0003-1647-7842	FAPESP [2009/11203-4, 2009/52088-3]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Source of funding: FAPESP. Grant numbers: 2009/11203-4 and 2009/52088-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 1997, CLIN EXP METASTAS, V15, P151, DOI 10.1023/A:1018452810915; Alldridge LC, 1999, J BIOL CHEM, V274, P37620, DOI 10.1074/jbc.274.53.37620; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Armed Forces Institute of Pathology (U.S.) National Research Council (U.S.)], ATLAS TUMOR PATHOLOG; Backes DM, 2009, CANCER CAUSE CONTROL, V20, P449, DOI 10.1007/s10552-008-9276-9; Bai XF, 2004, WORLD J GASTROENTERO, V10, P1466; Barnholtz-Sloan JS, 2007, UROL ONCOL-SEMIN ORI, V25, P361, DOI 10.1016/j.urolonc.2006.08.029; Begum S, 2007, CLIN CANCER RES, V13, P1186, DOI 10.1158/1078-0432.CCR-06-1690; Bleeker MCG, 2009, WORLD J UROL, V27, P141, DOI 10.1007/s00345-008-0302-z; Calmon MF, 2011, THESCIENTIFICWORLDJO, V11, P269, DOI 10.1100/tsw.2011.24; Calmon MF, 2009, NEOPLASIA, V11, P1329, DOI 10.1593/neo.91110; Cubilla AL, 2011, AM J SURG PATHOL, V35, P253, DOI 10.1097/PAS.0b013e318203cdba; de Coupade C, 2000, HEPATOLOGY, V31, P371, DOI 10.1002/hep.510310217; Dorovkov MV, 2004, J BIOL CHEM, V279, P50643, DOI 10.1074/jbc.C400441200; Edge SB, 2010, AJCC CANC STAGING MA; Favorito LA, 2008, INT BRAZ J UROL, V34, P587, DOI 10.1590/S1677-55382008000500007; Ferrandiz-Pulido C, 2012, J AM ACAD DERMATOL; Ferreux E, 2003, J PATHOL, V201, P109, DOI 10.1002/path.1394; Fregonesi PAG, 2003, J HISTOCHEM CYTOCHEM, V51, P1291; Hannon R, 2002, FASEB J, V16, P253, DOI 10.1096/fj.02-0239fje; Hippo Y, 2001, CANCER RES, V61, P889; Howie HL, 2009, VIROLOGY, V384, P324, DOI 10.1016/j.virol.2008.11.017; Hu N, 2004, CLIN CANCER RES, V10, P6013, DOI 10.1158/1078-0432.CCR-04-0317; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P4918, DOI 10.1128/MCB.13.8.4918; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; JOHNSON MD, 1989, HUM PATHOL, V20, P772, DOI 10.1016/0046-8177(89)90071-3; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; Kang JS, 2002, CLIN CANCER RES, V8, P117; Lu DW, 2003, MODERN PATHOL, V16, P692, DOI 10.1097/01.MP.0000077417.08371.CE; Masaki T, 1996, HEPATOLOGY, V24, P72, DOI 10.1053/jhep.1996.v24.pm0008707286; Miralles-Guri C, 2009, J CLIN PATHOL, V62, P870, DOI 10.1136/jcp.2008.063149; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Nam EJ, 2007, GYNECOL ONCOL, V104, P207, DOI 10.1016/j.ygyno.2006.07.043; Nam Eun Ji, 2008, J Gynecol Oncol, V19, P162, DOI 10.3802/jgo.2008.19.3.162; Nguyen M, 2002, J VIROL, V76, P13039, DOI 10.1128/JVI.76.24.13039-13048.2002; Paschalidis N, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-33; Paweletz CP, 2000, CANCER RES, V60, P6293; Pedrero JMG, 2004, AM J PATHOL, V164, P73, DOI 10.1016/S0002-9440(10)63098-2; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Protzel C, 2011, WORLD J UROL, V29, P393, DOI 10.1007/s00345-010-0575-x; Prowse DM, 2008, BRIT J DERMATOL, V158, P261, DOI 10.1111/j.1365-2133.2007.08305.x; Raiol T, 2011, INTERVIROLOGY, V54, P146, DOI 10.1159/000320199; Rodrigo JP, 2005, AM J RHINOL, V19, P483, DOI 10.1177/194589240501900511; Senba M, 2009, ACTA VIROL, V53, P43, DOI 10.4149/av_2009_01_43; Shen DJ, 2006, HUM PATHOL, V37, P1583, DOI 10.1016/j.humpath.2006.06.001; Shimoji T, 2009, J CELL BIOCHEM, V106, P1123, DOI 10.1002/jcb.22096; Shirakura M, 2007, J VIROL, V81, P1174, DOI 10.1128/JVI.01684-06; Silistino-Souza R, 2007, INT J CANCER, V120, P2582, DOI 10.1002/ijc.22639; SLEBOS RJC, 1994, P NATL ACAD SCI USA, V91, P5320, DOI 10.1073/pnas.91.12.5320; Song SY, 1999, J VIROL, V73, P5887, DOI 10.1128/JVI.73.7.5887-5893.1999; Tewari M, 2007, ASIAN J SURG, V30, P126, DOI 10.1016/S1015-9584(09)60145-7; Thomas M, 2008, ONCOGENE, V27, P7018, DOI 10.1038/onc.2008.351; Villota C, 2012, J BIOL CHEM, V287, P21303, DOI 10.1074/jbc.M111.326694; Xia SH, 2002, ONCOGENE, V21, P6641, DOI 10.1038/sj.onc.1205818; Xin W, 2003, AM J PATHOL, V162, P255, DOI 10.1016/S0002-9440(10)63816-3; Yi M, 2009, P NATL ACAD SCI USA, V106, P17886, DOI 10.1073/pnas.0901324106	56	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53260	10.1371/journal.pone.0053260	http://dx.doi.org/10.1371/journal.pone.0053260			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341933	Green Submitted, gold, Green Published			2022-12-25	WOS:000314759400037
J	Livingston, DP; Henson, CA; Tuong, TD; Wise, ML; Tallury, SP; Duke, SH				Livingston, David P., III; Henson, Cynthia A.; Tuong, Tan D.; Wise, Mitchell L.; Tallury, Shyamalrau P.; Duke, Stanley H.			Histological Analysis and 3D Reconstruction of Winter Cereal Crowns Recovering from Freezing: A Unique Response in Oat (Avena sativa L.)	PLOS ONE			English	Article							LOW-TEMPERATURE; INJURY; TOLERANCE; BARLEY; GENES; PLANT; ACCLIMATION; ARABIDOPSIS; MICROSCOPY; TRANSPORT	The crown is the below ground portion of the stem of a grass which contains meristematic cells that give rise to new shoots and roots following winter. To better understand mechanisms of survival from freezing, a histological analysis was performed on rye, wheat, barley and oat plants that had been frozen, thawed and allowed to resume growth under controlled conditions. Extensive tissue disruption and abnormal cell structure was noticed in the center of the crown of all 4 species with relatively normal cells on the outside edge of the crown. A unique visual response was found in oat in the shape of a ring of cells that stained red with Safranin. A tetrazolium analysis indicated that tissues immediately inside this ring were dead and those outside were alive. Fluorescence microscopy revealed that the barrier fluoresced with excitation between 405 and 445 nm. Three dimensional reconstruction of a cross sectional series of images indicated that the red staining cells took on a somewhat spherical shape with regions of no staining where roots entered the crown. Characterizing changes in plants recovering from freezing will help determine the genetic basis for mechanisms involved in this important aspect of winter hardiness.	[Livingston, David P., III; Tuong, Tan D.] ARS, USDA, Raleigh, NC USA; [Livingston, David P., III; Tuong, Tan D.; Tallury, Shyamalrau P.] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Henson, Cynthia A.; Wise, Mitchell L.] ARS, USDA, Cereal Crops Res Unit, Madison, WI USA; [Henson, Cynthia A.; Wise, Mitchell L.; Duke, Stanley H.] Univ Wisconsin, Dept Agron, Madison, WI 53706 USA	United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University; United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison	Livingston, DP (corresponding author), ARS, USDA, Raleigh, NC USA.	dpl@ncsu.edu			USDA	USDA(United States Department of Agriculture (USDA))	The study was supported by USDA in-house funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONI R, 1991, PLANTA, V184, P123, DOI 10.1007/BF00208245; Beckman CH, 2000, PHYSIOL MOL PLANT P, V57, P101, DOI 10.1006/pmpp.2000.0287; Briggs DE, 2009, J I BREWING, V115, P41, DOI 10.1002/j.2050-0416.2009.tb00343.x; Brouwer DJ, 2000, CROP SCI, V40, P1387, DOI 10.2135/cropsci2000.4051387x; CATTIVELLI L, 1990, PLANT PHYSIOL, V93, P1504, DOI 10.1104/pp.93.4.1504; Cook D, 2004, P NATL ACAD SCI USA, V101, P15243, DOI 10.1073/pnas.0406069101; EAGLES CF, 1993, NEW PHYTOL, V123, P477, DOI 10.1111/j.1469-8137.1993.tb03759.x; GUY CL, 1990, ANNU REV PLANT PHYS, V41, P187, DOI 10.1146/annurev.pp.41.060190.001155; Hannah MA, 2006, PLOS GENET, V1, P79; HOUDE M, 1995, PLANT J, V8, P583, DOI 10.1046/j.1365-313X.1995.8040583.x; Hughes MA, 1996, J EXP BOT, V47, P291, DOI 10.1093/jxb/47.3.291; Johansen DA., 1940, PLANT MICROTECHNIQUE, P49; Kitin P, 2010, PLANT PHYSIOL, V154, P887, DOI 10.1104/pp.110.156224; Krishnamurthy KV, 1999, METHODS CELL WALL CY, P40; Livingston DP, 2010, J MICROSC-OXFORD, V240, P122, DOI 10.1111/j.1365-2818.2010.03393.x; Livingston DP, 2009, CROP SCI, V49, P1837, DOI 10.2135/cropsci2009.02.0077; Livingston DP, 2006, CAN J BOT, V84, P199, DOI 10.1139/B05-147; Livingston DP, 2005, CROP SCI, V45, P1545, DOI 10.2135/cropsci2004.0579; Livingston DP, 1996, CROP SCI, V36, P1568, DOI 10.2135/cropsci1996.0011183X003600060027x; MARSHALL D, 1988, PHYTOPATHOLOGY, V78, P952, DOI 10.1094/Phyto-78-952; MCDOWELL EM, 1976, ARCH PATHOL LAB MED, V100, P405; OLIEN CR, 1981, CRYOBIOLOGY, V18, P404, DOI 10.1016/0011-2240(81)90114-0; OLIEN CR, 1976, CROP SCI, V16, P201, DOI 10.2135/cropsci1976.0011183X001600020009x; PALTA JP, 1993, ADVANCES IN PLANT COLD HARDINESS, P143; PALTA JP, 1980, PHYSIOL PLANTARUM, V50, P169, DOI 10.1111/j.1399-3054.1980.tb04446.x; PALTA JP, 1977, PLANT PHYSIOL, V60, P393, DOI 10.1104/pp.60.3.393; Pearce RS, 2004, LIFE IN THE FROZEN STATE, P171, DOI 10.1201/9780203647073.ch5; Pearce RS, 1998, PLANT PHYSIOL, V117, P787, DOI 10.1104/pp.117.3.787; PETERS J, 2000, CONTRIBUTION AOSA, V29; Ruzin S. E., 1999, PLANT MICROTECHNIQUE, P87; SHANDS HL, 1961, OATS OAT IMPROVEMENT, P465; Steponkus PL, 1998, P NATL ACAD SCI USA, V95, P14570, DOI 10.1073/pnas.95.24.14570; STEPONKUS PL, 1967, PLANT PHYSIOL, V42, P1423, DOI 10.1104/pp.42.10.1423; TANINO KK, 1985, CAN J BOT, V63, P432, DOI 10.1139/b85-053; Thomashow MF, 1998, PLANT PHYSIOL, V118, P1, DOI 10.1104/pp.118.1.1; ZAMECNIK J, 1994, PLANT SOIL, V167, P149, DOI 10.1007/BF01587610	36	16	17	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53468	10.1371/journal.pone.0053468	http://dx.doi.org/10.1371/journal.pone.0053468			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341944	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400046
J	Pongratz, G; Hochrinner, H; Straub, RH; Lang, S; Brunnler, T				Pongratz, Georg; Hochrinner, Hannah; Straub, Rainer H.; Lang, Stefanie; Bruennler, Tanja			B Cell Activating Factor of the Tumor Necrosis Factor Family (BAFF) Behaves as an Acute Phase Reactant in Acute Pancreatitis	PLOS ONE			English	Article							SEVERITY; PROCALCITONIN; PREDICTION; MANAGEMENT	Objective: To determine if B cell activating factor of the tumor necrosis factor family (BAFF) acts as an acute phase reactant and predicts severity of acute pancreatitis. Methods: 40 patients with acute pancreatitis were included in this single center cohort pilot study. Whole blood and serum was analyzed on day of admission and nine consecutive days for BAFF, c-reactive protein (CRP), interleukin-6 (IL-6), procalcitonin (PCT), and leucocyte numbers. Different severity Scores (Ranson, APACHE II, SAPS II, SAPS III) and the clinical course of the patient (treatment, duration of stay, duration ICU) were recorded. Results: Serum BAFF correlates with CRP, an established marker of severity in acute pancreatitis at day of admission with a timecourse profil similar to IL-6 over the first nine days. Serum BAFF increases with Ranson score (Kruskal-Wallis: Chi2 = 10.8; p = 0.03) similar to CRP (Kruskal-Wallis: Chi2 = 9.4; p = 0.05). Serum BAFF, IL-6, and CRP levels are elevated in patients that need intensive care for more than seven days and in patients with complicated necrotizing pancreatitis. Discriminant analysis and receiver operator characteristics show that CRP (wilks-lambda = 0.549; ROC: AUC 0.948) and BAFF (wilks-lambda = 0.907; ROC: AUC 0.843) serum levels at day of admission best predict severe necrotizing pancreatitis or death, outperforming IL-6, PCT, and number of leucocytes. Conclusion: This study establishes for the first time BAFF as an acute phase reactant with predictive value for the course of acute pancreatitis. BAFF outperforms established markers in acute pancreatitis, like IL-6 and PCT underscoring the important role of BAFF in the acute inflammatory response.	[Pongratz, Georg; Hochrinner, Hannah; Straub, Rainer H.; Lang, Stefanie; Bruennler, Tanja] Univ Hosp Regensburg, Dept Internal Med 1, Regensburg, Germany; [Bruennler, Tanja] Hosp Order St John God Regensburg, Emergency Ctr, Regensburg, Germany	University of Regensburg	Pongratz, G (corresponding author), Univ Hosp Regensburg, Dept Internal Med 1, Regensburg, Germany.	georg.pongratz@ukr.de	Pongratz, Georg/F-5472-2016	Pongratz, Georg/0000-0002-2185-8458; Straub, Rainer H/0000-0003-1165-4555	University Hospital Regensburg; Deutsche Forschungsgemeinschaft [PO 801/4-1]	University Hospital Regensburg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	In part internal institutional funding, University Hospital Regensburg. In part Deutsche Forschungsgemeinschaft (PO 801/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CAlero I, 2010, DISCOV MED, V10, P416; Davidson A, 2010, CURR OPIN IMMUNOL, V22, P732, DOI 10.1016/j.coi.2010.09.010; Dervenis C, 1999, INT J PANCREATOL, V25, P195; Fabris M, 2007, SCAND J GASTROENTERO, V42, P1434, DOI 10.1080/00365520701452225; Kylanpaa-Back ML, 2001, CRIT CARE MED, V29, P63, DOI 10.1097/00003246-200101000-00016; Kylanpaa-Back ML, 2001, BRIT J SURG, V88, P222, DOI 10.1046/j.1365-2168.2001.01673.x; Lam QLK, 2008, P NATL ACAD SCI USA, V105, P14993, DOI 10.1073/pnas.0806044105; Lied GA, 2011, SCAND J IMMUNOL, V73, P1, DOI 10.1111/j.1365-3083.2010.02470.x; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Mayer JM, 2002, BRIT J SURG, V89, P163, DOI 10.1046/j.1365-2168.2002.01972.x; Muller CA, 2000, GUT, V46, P233, DOI 10.1136/gut.46.2.233; Nagatani K, 2007, ARTHRITIS RHEUM-US, V56, P3554, DOI 10.1002/art.22929; Pongratz G, 2010, CLIN EXP RHEUMATOL, V28, P813; RANSON JHC, 1977, J SURG RES, V22, P79, DOI 10.1016/0022-4804(77)90045-2; RANSON JHC, 1974, SURG GYNECOL OBSTET, V139, P69; Werner J, 2003, PANCREATOLOGY, V3, P115, DOI 10.1159/000070079; WILSON C, 1990, BRIT J SURG, V77, P1260, DOI 10.1002/bjs.1800771120; Yamanishi H, 2011, PANCREAS, V40, P840, DOI 10.1097/MPA.0b013e3182143b10	18	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54297	10.1371/journal.pone.0054297	http://dx.doi.org/10.1371/journal.pone.0054297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342125	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400144
J	Villamon, E; Berbegall, AP; Piqueras, M; Tadeo, I; Castel, V; Djos, A; Martinsson, T; Navarro, S; Noguera, R				Villamon, Eva; Berbegall, Ana P.; Piqueras, Marta; Tadeo, Irene; Castel, Victoria; Djos, Anna; Martinsson, Tommy; Navarro, Samuel; Noguera, Rosa			Genetic Instability and Intratumoral Heterogeneity in Neuroblastoma with MYCN Amplification Plus 11q Deletion	PLOS ONE			English	Article							IMPROVED SURVIVAL PROBABILITY; CHROMOSOME INSTABILITY; RISK; TUMORS; GAIN; DDX1; EXPRESSION; CLASSIFICATION; IDENTIFICATION; ACCUMULATION	Background/Aim: Genetic analysis in neuroblastoma has identified the profound influence of MYCN amplification and 11q deletion in patients' prognosis. These two features of high-risk neuroblastoma usually occur as mutually exclusive genetic markers, although in rare cases both are present in the same tumor. The purpose of this study was to characterize the genetic profile of these uncommon neuroblastomas harboring both these high-risk features. Methods: We selected 18 neuroblastomas with MNA plus 11q loss detected by FISH. Chromosomal aberrations were analyzed using Multiplex Ligation-dependent Probe Amplification and Single Nucleotide Polymorphism array techniques. Results and Conclusion: This group of tumors has approximately the same high frequency of aberrations as found earlier for 11q deleted tumors. In some cases, DNA instability generates genetic heterogeneity, and must be taken into account in routine genetic diagnosis.	[Villamon, Eva; Berbegall, Ana P.; Piqueras, Marta; Navarro, Samuel; Noguera, Rosa] Univ Valencia, Dept Pathol, Sch Med, Valencia, Spain; [Tadeo, Irene] Hosp Clin Univ Valencia, Res Fdn, Valencia, Spain; [Castel, Victoria] Hosp Univ La Fe, Pediat Oncol Unit, Valencia, Spain; [Djos, Anna; Martinsson, Tommy] Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Clin Genet, Sahlgrenska Acad, Gothenburg, Sweden	University of Valencia; Hospital Clinic Universitari de Valencia; Hospital Universitari i Politecnic La Fe; Sahlgrenska University Hospital; University of Gothenburg	Noguera, R (corresponding author), Univ Valencia, Dept Pathol, Sch Med, Valencia, Spain.	rosa.noguera@uv.es	Villamon, Eva/A-6574-2016; Berbegall, Ana/AAB-2258-2020; Navarro, Samuel/AAD-2021-2020; Piqueras, Marta/ABH-1866-2020; Martinsson, Tommy/J-4140-2013; Tadeo, Irene/M-1639-2016	Berbegall, Ana/0000-0002-8798-3286; Navarro, Samuel/0000-0001-5016-5653; Piqueras, Marta/0000-0002-3748-7444; Martinsson, Tommy/0000-0002-9403-3123; Tadeo, Irene/0000-0003-3690-5007; Djos, Anna/0000-0002-5250-2163; Villamon, Eva/0000-0003-0636-3358; Castel, Victoria/0000-0002-3792-0615	ISCIII ERDF [RD06/0020/0102, PI10/0015]; FAECC [396/2009]; Swedish Cancer Society [09/1217]; Children's Cancer Foundation [08/098]	ISCIII ERDF; FAECC; Swedish Cancer Society(Swedish Cancer Society); Children's Cancer Foundation	This study was supported by the grants: RD06/0020/0102 and PI10/0015 (ISCIII & ERDF); 396/2009 (FAECC); 09/1217 (Swedish Cancer Society); and 08/098 (Children's Cancer Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros IM, 2003, J CLIN ONCOL, V21, P2077, DOI 10.1200/JCO.2003.03.025; Ambros IM, 2011, CLIN CANCER RES, V17, P792, DOI 10.1158/1078-0432.CCR-10-0830; Ambros PF, 2009, BRIT J CANCER, V100, P1471, DOI 10.1038/sj.bjc.6605014; Ambros PF, 2001, MED PEDIATR ONCOL, V37, P492, DOI 10.1002/mpo.1242; Ambros PF, 2001, MED PEDIATR ONCOL, V36, P1; Ando K, 2008, INT J CANCER, V123, P2087, DOI 10.1002/ijc.23776; Assie G, 2008, AM J HUM GENET, V82, P903, DOI 10.1016/j.ajhg.2008.01.012; Blumrich A, 2011, HUM MOL GENET, V20, P1488, DOI 10.1093/hmg/ddr027; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Buckley PG, 2010, CLIN CANCER RES, V16, P2971, DOI 10.1158/1078-0432.CCR-09-3215; Capasso M, 2009, NAT GENET, V41, P718, DOI 10.1038/ng.374; Caren H, 2010, P NATL ACAD SCI USA, V107, P4323, DOI 10.1073/pnas.0910684107; Caren H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-353; Carr J, 2006, CANCER RES, V66, P2138, DOI 10.1158/0008-5472.CAN-05-2623; Coco S, 2012, INT J CANCER, V131, P1591, DOI 10.1002/ijc.27432; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; De Brouwer S, 2010, CLIN CANCER RES, V16, P4353, DOI 10.1158/1078-0432.CCR-09-2660; De Preter K, 2005, J CLIN ONCOL, V23, P3167, DOI 10.1200/JCO.2005.05.346; Defferrari R, 2007, CANCER LETT, V256, P56, DOI 10.1016/j.canlet.2007.05.010; Fieuw A, 2012, INT J CANCER, V130, P2599, DOI 10.1002/ijc.26317; Fischer M, 2010, ONCOGENE, V29, P865, DOI 10.1038/onc.2009.390; Fix A, 2008, GENE CHROMOSOME CANC, V47, P819, DOI 10.1002/gcc.20583; Gagos S, 2005, INT J BIOCHEM CELL B, V37, P1014, DOI 10.1016/j.biocel.2005.01.003; Henrich KO, 2011, CANCER RES, V71, P3142, DOI 10.1158/0008-5472.CAN-10-3014; Hoebeeck J, 2007, INT J CANCER, V120, P533, DOI 10.1002/ijc.22326; Janoueix-Lerosey I, 2009, J CLIN ONCOL, V27, P1026, DOI 10.1200/JCO.2008.16.0630; Jeison M, 2010, AM J PATHOL, V176, P2616, DOI 10.2353/ajpath.2010.090624; Kaneko S, 2007, J CANCER RES CLIN, V133, P185, DOI 10.1007/s00432-006-0156-y; Kerbl R, 2002, MED PEDIATR ONCOL, V38, P109, DOI 10.1002/mpo.1281.abs; Kryh H, 2011, INT J ONCOL, V39, P1063, DOI 10.3892/ijo.2011.1120; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; McArdle L, 2004, CARCINOGENESIS, V25, P1599, DOI 10.1093/carcin/bgh173; Melegh Z, 2005, VIRCHOWS ARCH, V446, P517, DOI 10.1007/s00428-005-1204-8; Michels E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-173; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Morales La Madrid A, 2012, PEDIAT BLOOD CANC; Noguera R, 2003, CANCER GENET CYTOGEN, V140, P157, DOI 10.1016/S0165-4608(02)00677-5; Piqueras M, 2011, BRIT J CANCER, V105, P89, DOI 10.1038/bjc.2011.188; Piqueras M, 2011, HISTOPATHOLOGY, V59, P22, DOI 10.1111/j.1365-2559.2011.03899.x; Schleiermacher G, 2011, BRIT J CANCER, V105, P1940, DOI 10.1038/bjc.2011.472; Schleiermacher G, 2010, J CLIN ONCOL, V28, P3122, DOI 10.1200/JCO.2009.26.7955; Shimada H, 2001, CANCER, V92, P2451, DOI 10.1002/1097-0142(20011101)92:9<2451::AID-CNCR1595>3.0.CO;2-S; Spitz R, 2006, CLIN CANCER RES, V12, P3368, DOI 10.1158/1078-0432.CCR-05-2495; Stigliani S, 2012, NEOPLASIA, V14, P823, DOI 10.1593/neo.121114; Theissen J, 2009, CLIN CANCER RES, V15, P2085, DOI 10.1158/1078-0432.CCR-08-1648; Thompson PM, 2001, CANCER RES, V61, P679; de Souza DRV, 2011, PEDIATR BLOOD CANCER, V56, P749, DOI 10.1002/pbc.22823; Vandesompele J, 2008, INT J CANCER, V122, P1177, DOI 10.1002/ijc.23156; Villamon E, 2011, HISTOL HISTOPATHOL, V26, P343, DOI 10.14670/HH-26.343; Weber A, 2004, J CLIN ONCOL, V22, P2681, DOI 10.1200/JCO.2004.07.192; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809	51	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53740	10.1371/journal.pone.0053740	http://dx.doi.org/10.1371/journal.pone.0053740			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341988	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400073
J	Wang, MH; Wang, QS; Pan, YC				Wang, Minghui; Wang, Qishan; Pan, Yuchun			From QTL to QTN: Candidate Gene Set Approach and a Case Study in Porcine IGF1-FoxO Pathway	PLOS ONE			English	Article							GENOME ASSOCIATION; TOOL SET; GROWTH; PREDICTION; INSIGHTS; DISEASE; TRAITS; SNPS	Unraveling the genetic background of economic traits is a major goal in modern animal genetics and breeding. Both candidate gene analysis and QTL mapping have previously been used for identifying genes and chromosome regions related to studied traits. However, most of these studies may be limited in their ability to fully consider how multiple genetic factors may influence a particular phenotype of interest. If possible, taking advantage of the combined effect of multiple genetic factors is expected to be more powerful than analyzing single sites, as the joint action of multiple loci within a gene or across multiple genes acting in the same gene set will likely have a greater influence on phenotypic variation. Thus, we proposed a pipeline of gene set analysis that utilized information from multiple loci to improve statistical power. We assessed the performance of this approach by both simulated and a real IGF1-FoxO pathway data set. The results showed that our new method can identify the association between genetic variation and phenotypic variation with higher statistical power and unravel the mechanisms of complex traits in a point of gene set. Additionally, the proposed pipeline is flexible to be extended to model complex genetic structures that include the interactions between different gene sets and between gene sets and environments.	[Wang, Minghui; Wang, Qishan; Pan, Yuchun] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China; [Wang, Minghui; Wang, Qishan; Pan, Yuchun] Shanghai Key Lab Anim Biotechnol, Shanghai, Peoples R China	Shanghai Jiao Tong University	Pan, YC (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China.	panyuchun1963@yahoo.com.cn	Wang, Minghui/G-4939-2015		National Natural Science Foundation of China [31072003, 31000992, 31272414]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant Nos. 31072003, 31000992, and 31272414). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Dentice M, 2010, J CLIN INVEST, V120, P4021, DOI 10.1172/JCI43670; Durrant C, 2004, AM J HUM GENET, V75, P35, DOI 10.1086/422174; Fan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014726; Garcia-Gamez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021158; Gauderman WJ, 2007, GENET EPIDEMIOL, V31, P383, DOI 10.1002/gepi.20219; Gilmour AR, 2009, ASREML USER GUIDE RE; Ginja C, 2009, J HERED, V100, P148, DOI 10.1093/jhered/esn080; HENDERSON CR, 1985, J ANIM SCI, V60, P111, DOI 10.2527/jas1985.601111x; Hribal ML, 2003, J CELL BIOL, V162, P535, DOI 10.1083/jcb.200212107; Hu ZL, 2007, NUCLEIC ACIDS RES, V35, pD604, DOI 10.1093/nar/gkl946; John JMM, 2011, EUR J HUM GENET, V19, P696, DOI 10.1038/ejhg.2011.17; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Liang Yulan, 2006, Functional & Integrative Genomics, V6, P1, DOI 10.1007/s10142-005-0006-z; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Calle ML, 2010, BIOINFORMATICS, V26, P2198, DOI 10.1093/bioinformatics/btq352; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Meidtner K, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-76; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ron M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-183; Rothschild MF, 1997, PROBE, V8, P13; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Short TH, 1997, J ANIM SCI, V75, P3138; Soroceanu L, 2007, P NATL ACAD SCI USA, V104, P3466, DOI 10.1073/pnas.0611271104; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang MH, 2011, MAMM GENOME, V22, P272, DOI 10.1007/s00335-011-9322-x; Wang QS, 2012, ANIM SCI J, V83, P279, DOI 10.1111/j.1740-0929.2011.00952.x; Wernersson R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-70; Williamson DL, 2010, J GERONTOL A-BIOL, V65, P335, DOI 10.1093/gerona/glq005; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	38	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53452	10.1371/journal.pone.0053452	http://dx.doi.org/10.1371/journal.pone.0053452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341942	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400045
J	Cheng, LM; Sage, EH; Yan, Q				Cheng, Lamei; Sage, E. Helene; Yan, Qi			SPARC Fusion Protein Induces Cellular Adhesive Signaling	PLOS ONE			English	Article							GROWTH-FACTOR; EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; FOCAL ADHESIONS; MELANOMA-CELLS; DNA-SYNTHESIS; LENS CAPSULE; IN-VITRO; BINDING; ATTACHMENT	Secreted protein, acidic and rich in cysteine (SPARC) has been described as a counteradhesive matricellular protein with a diversity of biological functions associated with morphogenesis, remodeling, cellular migration, and proliferation. We have produced mouse SPARC with a FLAG-tag at the N-terminus of SPARC (Flag-SPARC, FSP) in a Bac-to-Bac baculoviral expression system. After affinity purification, this procedure yields SPARC of high purity, with an electrophoretic mobility of similar to 44 kDa under reducing conditions, and similar to 38-39 kDa under non-reducing conditions. Unexpectedly, FSP adsorbed to plastic supported cell attachment and spreading, in a calcium-dependent manner. The adhesive activity of native FSP was inhibited by prior incubation with anti-SPARC IgG. Cell adhesion to FSP induced the formation of filopodia and lamellipodia but not focal adhesions that were prominent on cells that were attached to fibronectin. In addition, FSP induced the tyrosine phosphorylation of FAK and paxillin in attached epithelial cells. Erk1/2 and Rac were also activated in cells attached to FSP, but at a lower level in comparison to cells on fibronectin. This study provides new insight into the biological functions of SPARC, a matricellular protein with important roles in cell-extracellualr matrix interactions.	[Cheng, Lamei; Sage, E. Helene; Yan, Qi] Benaroya Res Inst, Seattle, WA USA; [Sage, E. Helene; Yan, Qi] Univ Washington, Sch Med, Dept Biol Struct, Seattle, WA 98195 USA; [Cheng, Lamei] Cent S Univ, Inst Reprod & Stem Cell Engn, Changsha, Hunan, Peoples R China	Benaroya Research Institute; University of Washington; University of Washington Seattle; Central South University	Yan, Q (corresponding author), Benaroya Res Inst, Seattle, WA USA.	qyanresearch@gmail.com	; Brestic, Marian/A-8263-2012	Brestic, Marian/0000-0002-6597-7838; Brestic, Marian/0000-0003-3470-6100	National Institutes of Health [EY014150, GM40711]; NATIONAL EYE INSTITUTE [R01EY014150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant EY014150 and GM40711. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassuk JA, 1996, INT J BIOCHEM CELL B, V28, P1031, DOI 10.1016/1357-2725(96)00036-2; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Bradshaw Amy D., 2000, Molecular Cell Biology Research Communications, V3, P345, DOI 10.1006/mcbr.2000.0237; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Chlenski A, 2010, SEMIN CELL DEV BIOL, V21, P55, DOI 10.1016/j.semcdb.2009.11.018; ENGEL J, 1987, BIOCHEMISTRY-US, V26, P6958, DOI 10.1021/bi00396a015; FUNK SE, 1993, J CELL PHYSIOL, V154, P53, DOI 10.1002/jcp.1041540108; Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334; Girard JP, 1996, J BIOL CHEM, V271, P4511; Haber CL, 2008, INT J CANCER, V122, P1465, DOI 10.1002/ijc.23216; Hanks SK, 2003, FRONT BIOSCI-LANDMRK, V8, pD982, DOI 10.2741/1114; HARLAN JM, 1983, LAB INVEST, V48, P269; Huynh MH, 2011, DEV GENES EVOL, V220, P315, DOI 10.1007/s00427-010-0349-x; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; Kzhyshkowska J, 2006, J IMMUNOL, V176, P5825, DOI 10.4049/jimmunol.176.10.5825; Liu PJ, 2008, MOL BIOL CELL, V19, P248, DOI 10.1091/mbc.E07-05-0510; McClung HM, 2012, CARCINOGENESIS, V33, P275, DOI 10.1093/carcin/bgr276; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; Nagaraju GPC, 2011, CANCER TREAT REV, V37, P559, DOI 10.1016/j.ctrv.2010.12.001; NISCHT R, 1991, EUR J BIOCHEM, V200, P529, DOI 10.1111/j.1432-1033.1991.tb16214.x; RAINES EW, 1992, P NATL ACAD SCI USA, V89, P1281, DOI 10.1073/pnas.89.4.1281; Rempel SA, 2001, J NEURO-ONCOL, V53, P149, DOI 10.1023/A:1012201300188; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; ROBERTS DD, 1987, J CELL BIOL, V104, P131, DOI 10.1083/jcb.104.1.131; SAGE H, 1989, J CELL BIOL, V109, P341, DOI 10.1083/jcb.109.1.341; Schaller MD, 1996, J ENDOCRINOL, V150, P1, DOI 10.1677/joe.0.1500001; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; SRIRAMARAO P, 1993, J CELL SCI, V105, P1001; Tai IT, 2008, DRUG RESIST UPDATE, V11, P231, DOI 10.1016/j.drup.2008.08.005; TUSZYNSKI GP, 1987, SCIENCE, V236, P1570, DOI 10.1126/science.2438772; VARANI J, 1986, EXP CELL RES, V167, P376, DOI 10.1016/0014-4827(86)90178-3; Yan Q, 2005, INVEST OPHTH VIS SCI, V46, P4652, DOI 10.1167/iovs.05-0460; Yan Q, 2005, GRAEF ARCH CLIN EXP, V243, P1253, DOI 10.1007/s00417-005-1181-2; Yan Q, 2002, J CELL SCI, V115, P2747	35	68	73	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e53202	10.1371/journal.pone.0053202	http://dx.doi.org/10.1371/journal.pone.0053202			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349702	gold, Green Published, Green Submitted			2022-12-25	WOS:000313943000011
J	Zhang, Q; Zhu, YX; Zhou, WB; Gao, L; Yuan, L; Han, X				Zhang, Qiang; Zhu, Yunxia; Zhou, Wenbo; Gao, Lu; Yuan, Li; Han, Xiao			Serotonin Receptor 2C and Insulin Secretion	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; BETA-CELLS; PANCREATIC-ISLETS; 5-HT RECEPTORS; IN-VIVO; MICE; ACID; BIOSYNTHESIS; EXPRESSION; DOPAMINE	Type 2 diabetes mellitus (T2DM) describes a group of metabolic disorders characterized by defects in insulin secretion and insulin sensitivity. Insulin secretion from pancreatic beta-cells is an important factor in the etiology of T2DM, though the complex regulation and mechanisms of insulin secretion from beta-cells remains to be fully elucidated. High plasma levels of serotonin (5-hydroxytryptamine; 5-HT) have been reported in T2DM patients, though the potential effect on insulin secretion is unclear. However, it is known that the 5-HT receptor 2C (5-HT2CR) agonist, mCPP, decreases plasma insulin concentration in mice. As such, we aimed to investigate the expression of the 5-HT2CR in pancreatic islets of diabetic mice and the role of 5-HT2CR signaling in insulin secretion from pancreatic beta-cells. We found that 5-HT2CR expression was significantly increased in pancreatic islets of db/db mice. Furthermore, treatment with a 5-HT2CR antagonist (SB242084) increased insulin secretion from pancreatic islets isolated from db/db mice in a dose-dependent manner, but had no effect in islets from control mice. The effect of a 5-HT2CR agonist (mCPP) and antagonist (SB242084) were further studied in isolated pancreatic islets from mice and Min-6 cells. We found that mCPP significantly inhibited insulin secretion in Min-6 cells and isolated islets in a dose-dependent manner, which could be reversed by SB242084 or RNA interference against 5-HT2CR. We also treated Min-6 cells with palmitic acid for 24 h, and found that the expression of 5-HT2CR increased in a dose-dependent manner; furthermore, the inhibition of insulin secretion in Min-6 cells induced by palmitic acid could be reversed by SB242084 or RNA interference against 5-HT2CR. Taken together, our data suggests that increased expression of 5-HT2CR in pancreatic beta-cells might inhibit insulin secretion. This unique observation increases our understanding of T2DM and suggests new avenues for potential treatment.	[Zhang, Qiang; Zhu, Yunxia; Zhou, Wenbo; Gao, Lu; Yuan, Li; Han, Xiao] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Qiang; Zhu, Yunxia; Zhou, Wenbo; Gao, Lu; Yuan, Li; Han, Xiao] Nanjing Med Univ, Key Lab Human Funct Genom Jiangsu Prov, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Yuan, L (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	Yuanli621@sohu.com; hanxiao@njmu.edu.cn	Zhu, Yunxia/G-6273-2014		National Basic Research Program of China (973 Program) [2011CB504003, 2012CB524901]; National Natural Science Foundation of China [30971403]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by grants from the National Basic Research Program of China (973 Program, 2011CB504003 and 2012CB524901, to XH, http://www.973.gov.cn), and the National Natural Science Foundation of China (30971403, http://www.nsfc.gov.cn) and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; Andreazzi AE, 2011, EXP DIABETES RES, DOI 10.1155/2011/947917; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Baruah MP, 2012, RECENT PATENTS ENDOC, V6, P129, DOI 10.2174/187221412800604563; de Souza SL, 2008, EUR J NEUROSCI, V27, P1400, DOI 10.1111/j.1460-9568.2008.06105.x; Deeney JT, 2007, FEBS LETT, V581, P4080, DOI 10.1016/j.febslet.2007.07.052; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Di Giovanni G, 2000, SYNAPSE, V35, P53, DOI 10.1002/(SICI)1098-2396(200001)35:1<53::AID-SYN7>3.0.CO;2-2; Du J, 2010, PHARMAZIE, V65, P231, DOI 10.1691/ph.2010.9607; Erdmann J, 2012, HORM METAB RES, V44, P60, DOI 10.1055/s-0031-1295414; Farag YMK, 2011, NEPHROL DIAL TRANSPL, V26, P28, DOI 10.1093/ndt/gfq576; GRAHAMES.DG, 1967, BIOCHEM J, V105, P351, DOI 10.1042/bj1050351; Han X, 2001, DIABETES, V50, P1047, DOI 10.2337/diabetes.50.5.1047; Hara K, 2011, DIABETES RES CLIN PR, V94, P167, DOI 10.1016/j.diabres.2011.06.020; Harvey JA, 2004, PSYCHOPHARMACOLOGY, V172, P435, DOI 10.1007/s00213-003-1687-4; HASHIMOTO Y, 1985, BIOCHIM BIOPHYS ACTA, V841, P283, DOI 10.1016/0304-4165(85)90070-4; Hattersley AT, 2004, J CLIN INVEST, V114, P314, DOI 10.1172/jcj200422506; Hay-Schmidt A, 2000, P ROY SOC B-BIOL SCI, V267, P1071, DOI 10.1098/rspb.2000.1111; Heisler LK, 2006, NEURON, V51, P239, DOI 10.1016/j.neuron.2006.06.004; Holness MJ, 2011, CURR DIABETES REV, V7, P336, DOI 10.2174/157339911797415602; Huang XF, 2004, MOL BRAIN RES, V127, P39, DOI 10.1016/j.molbrainres.2004.05.008; Iwasawa Takamasa, 2002, J Cardiol, V40, P19; Jiang ZE, 2011, KOREAN J PHYSIOL PHA, V15, P307, DOI 10.4196/kjpp.2011.15.5.307; Kinoshita M, 2010, MOL ENDOCRINOL, V24, P1978, DOI 10.1210/me.2010-0054; Kolar J, 2005, J PINEAL RES, V39, P333, DOI 10.1111/j.1600-079X.2005.00276.x; Kong Kok Choi, 2011, Commun Integr Biol, V4, P489, DOI 10.4161/cib.4.4.15716; LECHIN F, 1975, ACTA PHYSIOL LAT AM, V25, P339; Marchetti P, 2010, ADV EXP MED BIOL, V654, P501, DOI 10.1007/978-90-481-3271-3_22; Monti JM, 2011, SLEEP MED REV, V15, P269, DOI 10.1016/j.smrv.2010.11.003; Moore MC, 2004, DIABETES, V53, P14, DOI 10.2337/diabetes.53.1.14; Nekrep N, 2008, DEVELOPMENT, V135, P2151, DOI 10.1242/dev.015859; Nichols DE, 2008, CHEM REV, V108, P1614, DOI 10.1021/cr078224o; Nonogaki K, 1998, NAT MED, V4, P1152, DOI 10.1038/2647; Nonogaki K, 2006, ENDOCRINOLOGY, V147, P5893, DOI 10.1210/en.2006-0418; Pozzi L, 2002, J NEUROCHEM, V82, P93, DOI 10.1046/j.1471-4159.2002.00947.x; PRISCO S, 1994, J PHARMACOL EXP THER, V271, P83; QUICKEL KE, 1971, ENDOCRINOLOGY, V89, P1295, DOI 10.1210/endo-89-5-1295; RAJAN AS, 1990, DIABETES CARE, V13, P340, DOI 10.2337/diacare.13.3.340; Rodriguez-Diaz R, 2011, CELL METAB, V14, P45, DOI 10.1016/j.cmet.2011.05.008; Roep BO, 2007, NATURE, V450, P799, DOI 10.1038/450799a; Saini V, 2010, WORLD J DIABETES, V1, P68, DOI 10.4239/wjd.v1.i3.68; Schraenen A, 2010, DIABETOLOGIA, V53, P2589, DOI 10.1007/s00125-010-1913-7; Stumvoll M, 2008, LANCET, V371, P2153, DOI 10.1016/S0140-6736(08)60932-0; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Vickers SP, 1999, PSYCHOPHARMACOLOGY, V143, P309, DOI 10.1007/s002130050952; Watanabe H, 2010, ENDOCRINOLOGY, V151, P4776, DOI 10.1210/en.2009-1349; Watanabe RLH, 2010, CELL MOL NEUROBIOL, V30, P1025, DOI 10.1007/s10571-010-9533-9; Weiger WA, 1997, BIOL REV, V72, P61, DOI 10.1017/S0006323196004975; Xu Y, 2008, NEURON, V60, P582, DOI 10.1016/j.neuron.2008.09.033; ZHANG HJ, 1989, DIABETES, V38, P44, DOI 10.2337/diabetes.38.1.44; Zhou L, 2007, CELL METAB, V6, P398, DOI 10.1016/j.cmet.2007.10.008; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042	52	147	153	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54250	10.1371/journal.pone.0054250	http://dx.doi.org/10.1371/journal.pone.0054250			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349838	Green Published, Green Submitted, gold			2022-12-25	WOS:000313738900058
J	Zhu, Y; Pires, KMP; Whitehead, KJ; Olsen, CD; Wayment, B; Zhang, YC; Bugger, H; Ilkun, O; Litwin, SE; Thomas, G; Kozma, SC; Abel, ED				Zhu, Yi; Pires, Karla M. P.; Whitehead, Kevin J.; Olsen, Curtis D.; Wayment, Benjamin; Zhang, Yi Cheng; Bugger, Heiko; Ilkun, Olesya; Litwin, Sheldon E.; Thomas, George; Kozma, Sara C.; Abel, E. Dale			Mechanistic Target of Rapamycin (Mtor) Is Essential for Murine Embryonic Heart Development and Growth	PLOS ONE			English	Article							GENE-EXPRESSION; MAMMALIAN TARGET; CARDIAC-FUNCTION; IN-VIVO; COMPLEX; MOUSE; MUSCLE; RICTOR; PHOSPHORYLATION; PROLIFERATION	Mechanistic target of rapamycin (Mtor) is required for embryonic inner cell mass proliferation during early development. However, Mtor expression levels are very low in the mouse heart during embryogenesis. To determine if Mtor plays a role during mouse cardiac development, cardiomyocyte specific Mtor deletion was achieved using alpha myosin heavy chain (alpha-MHC) driven Cre recombinase. Initial mosaic expression of Cre between embryonic day (E) 10.5 and E11.5 eliminated a subset of cardiomyocytes with high Cre activity by apoptosis and reduced overall cardiac proliferative capacity. The remaining cardiomyocytes proliferated and expanded normally. However loss of 50% of cardiomyocytes defined a threshold that impairs the ability of the embryonic heart to sustain the embryo's circulatory requirements. As a result 92% of embryos with cardiomyocyte Mtor deficiency died by the end of gestation. Thus Mtor is required for survival and proliferation of cardiomyocytes in the developing heart.	[Zhu, Yi; Pires, Karla M. P.; Zhang, Yi Cheng; Bugger, Heiko; Ilkun, Olesya; Abel, E. Dale] Univ Utah, Sch Med, Div Endocrinol Metab & Diabet, Salt Lake City, UT 84112 USA; [Zhu, Yi; Pires, Karla M. P.; Zhang, Yi Cheng; Bugger, Heiko; Ilkun, Olesya; Abel, E. Dale] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT USA; [Zhu, Yi; Abel, E. Dale] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT USA; [Whitehead, Kevin J.; Olsen, Curtis D.; Wayment, Benjamin; Litwin, Sheldon E.] Univ Utah, Sch Med, Div Cardiol, Salt Lake City, UT USA; [Pires, Karla M. P.] Univ Estado Rio De Janeiro, Lab Morphometry & Cardiovasc Morphol, Inst Biol, Biomed Ctr, Rio De Janeiro, Brazil; [Thomas, George; Kozma, Sara C.] Univ Cincinnati, Coll Med, Dept Internal Med, Metab Dis Inst,Div Hematol Oncol, Cincinnati, OH USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Universidade do Estado do Rio de Janeiro; University System of Ohio; University of Cincinnati	Abel, ED (corresponding author), Univ Utah, Sch Med, Div Endocrinol Metab & Diabet, Salt Lake City, UT 84112 USA.	dale.abel@hmbg.utah.edu	Thomas, George/K-9235-2014; Bugger, Heiko/ABA-4180-2021	Thomas, George/0000-0003-3518-8149; Zhang, Yi/0000-0003-2228-0341; Slakeski, Nada/0000-0001-9776-6018; Abel, E. Dale/0000-0001-5290-0738; Reynolds, Eric/0000-0002-6618-4856; Dashper, Stuart/0000-0003-0106-8691; Bugger, Heiko/0000-0002-3524-0405	 [U01HL087947];  [R01DK092065]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027506] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL087947, U54HL112311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK091317, R01DK092065] Funding Source: NIH RePORTER	; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	EDA was funded by U01HL087947, R01DK092065. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altunkaynak ME, 2011, ANAT HISTOL EMBRYOL, V40, P402, DOI 10.1111/j.1439-0264.2011.01085.x; Belke DD, 2002, J CLIN INVEST, V109, P629, DOI 10.1172/JCI200213946; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Cybulski N, 2009, P NATL ACAD SCI USA, V106, P9902, DOI 10.1073/pnas.0811321106; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Gaussin V, 2002, P NATL ACAD SCI USA, V99, P2878, DOI 10.1073/pnas.042390499; Hentges KE, 2001, P NATL ACAD SCI USA, V98, P13796, DOI 10.1073/pnas.241184198; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kilkenny C, 2011, J CEREBR BLOOD F MET, V31, P991, DOI 10.1038/jcbfm.2010.220; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lazorchak AS, 2010, MOL CELL, V39, P433, DOI 10.1016/j.molcel.2010.07.031; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; LYONS GE, 1990, J CELL BIOL, V111, P2427, DOI 10.1083/jcb.111.6.2427; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shen WH, 2008, J BIOL CHEM, V283, P13842, DOI 10.1074/jbc.M801510200; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Valencik ML, 2001, TRANSGENIC RES, V10, P269, DOI 10.1023/A:1016601928465; Wang Q, 2003, J AM CHEM SOC, V125, P3192, DOI 10.1021/ja021381e; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Yin ZR, 2008, CIRCULATION, V117, P1414, DOI 10.1161/CIRCULATIONAHA.107.759233; Zhang DH, 2010, J CLIN INVEST, V120, P2805, DOI 10.1172/JCI43008	28	88	90	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54221	10.1371/journal.pone.0054221	http://dx.doi.org/10.1371/journal.pone.0054221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342106	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400135
J	Shi, JR; Jiang, BB; Qiu, YL; Guan, J; Jain, M; Cao, X; Bauer, M; Su, LH; Burkly, LC; Leone, TC; Kelly, DP; Liao, RL				Shi, Jianru; Jiang, Bingbing; Qiu, Yiling; Guan, Jian; Jain, Mohit; Cao, Xin; Bauer, Michael; Su, Lihe; Burkly, Linda C.; Leone, Teresa C.; Kelly, Daniel P.; Liao, Ronglih			PGC1 alpha Plays a Critical Role in TWEAK-Induced Cardiac Dysfunction	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR; MULTIFUNCTIONAL CYTOKINE; PGC-1 COACTIVATORS; WEAK INDUCER; RECEPTOR; PGC-1-ALPHA; METABOLISM; APOPTOSIS; BINDS; FN14	Background: Inflammatory cytokines play an important role in the pathogenesis of heart failure. We have recently found the cytokine TWEAK (tumor necrosis factor (TNF)-like weak inducer of apoptosis), a member of the TNF superfamily, to be increased in patients with cardiomyopathy and result in the development of heart failure when overexpressed in mice. The molecular mechanisms underlying TWEAK-induced cardiac pathology, however, remain unknown. Methodology and Critical Finding: Using mouse models of elevated circulating TWEAK levels, established through intravenous injection of adenovirus expressing TWEAK or recombinant TWEAK protein, we find that TWEAK induces a progressive dilated cardiomyopathy with impaired contractile function in mice. Moreover, TWEAK treatment is associated with decreased expression of peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC1 alpha) and genes required for mitochondrial oxidative phosphorylation, which precede the onset of cardiac dysfunction. TWEAK-induced downregulation of PGC1 alpha requires expression of its cell surface receptor, fibroblast growth factor-inducible 14 (Fn14). We further find that TWEAK downregulates PGC1 alpha gene expression via the TNF receptor-associated factor 2 (TRAF2) and NFkB signaling pathways. Maintaining PGC1 alpha levels through adenoviral-mediated gene expression is sufficient to protect against TWEAK-induced cardiomyocyte dysfunction. Conclusion: Collectively, our data suggest that TWEAK induces cardiac dysfunction via downregulation of PGC1 alpha, through FN14-TRAF2-NF kappa B-dependent signaling. Selective targeting of the FN14-TRAF2-NF kappa B-dependent signaling pathway or augmenting PGC1 alpha levels may serve as novel therapeutic strategies for cardiomyopathy and heart failure.	[Shi, Jianru; Jiang, Bingbing; Qiu, Yiling; Guan, Jian; Jain, Mohit; Cao, Xin; Bauer, Michael; Liao, Ronglih] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc,Cardiac Muscle Res Lab, Boston, MA 02115 USA; [Su, Lihe] Biogen Idec Inc, Dept Prot Biochem, Cambridge, MA USA; [Burkly, Linda C.] Biogen Idec Inc, Dept Immunol, Cambridge, MA USA; [Leone, Teresa C.; Kelly, Daniel P.] Sanford Burnham Med Res Inst Lake Nona, Cardiovasc Pathobiol Program, Orlando, FL USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Biogen; Biogen; Sanford Burnham Prebys Medical Discovery Institute	Liao, RL (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc,Cardiac Muscle Res Lab, Boston, MA 02115 USA.	rliao@rics.bwh.harvard.edu	Qiu, Yiling/C-7138-2013; Kelly, Daniel/ABG-2056-2021	Liao, Ronglih/0000-0002-9598-9020; Bai, Chunxue/0000-0001-5798-3130	National Institute of Health [HL099073, HL086967, HL093147, R01HL058493, R01HL101189, R01DK045416, K08 HL107451]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101189, R01HL058493, R01HL086967, K08HL107451, R01HL099073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045416] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in part, by National Institute of Health research grants HL099073 HL086967 and HL093147 (R.L.), R01HL058493, R01HL101189, and R01DK045416 (D.P.K.) grants. M.J. is the recipient of NIH mentored award (K08 HL107451). J.S. and M.B. were supported by a postdoctoral fellowship from American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Guardia D, 2010, CARDIOVASC RES, V87, P449, DOI 10.1093/cvr/cvq080; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Bauer M, 2011, CIRC RES, V108, P908, DOI 10.1161/CIRCRESAHA.110.239574; Brown SAN, 2003, BIOCHEM J, V371, P395, DOI 10.1042/BJ20021730; Brown SAN, 2010, J BIOL CHEM, V285, P17432, DOI 10.1074/jbc.M110.131979; Burkly LC, 2007, CYTOKINE, V40, P1, DOI 10.1016/j.cyto.2007.09.007; Burkly LC, 2011, IMMUNOL REV, V244, P99, DOI 10.1111/j.1600-065X.2011.01054.x; Campbell S, 2006, J IMMUNOL, V176, P1889, DOI 10.4049/jimmunol.176.3.1889; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Chorianopoulos E, 2010, ATHEROSCLEROSIS, V211, P322, DOI 10.1016/j.atherosclerosis.2010.02.016; Enwere EK, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003086; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Finck BN, 2007, CIRCULATION, V115, P2540, DOI 10.1161/CIRCULATIONAHA.107.670588; Girgenrath M, 2006, EMBO J, V25, P5826, DOI 10.1038/sj.emboj.7601441; Horowitz JD, 2010, CURR OPIN CARDIOL, V25, P329, DOI 10.1097/HCO.0b013e328339f191; Jain M, 2009, CIRCULATION, V119, P2058, DOI 10.1161/CIRCULATIONAHA.108.837286; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Kumar A, 2012, CURR OPIN CLIN NUTR, V15, P233, DOI 10.1097/MCO.0b013e328351c3fc; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Liao Ronglih, 2007, V139, P251; Moreno JA, 2011, J AM SOC NEPHROL, V22, P1315, DOI 10.1681/ASN.2010101073; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Roos C, 2010, J IMMUNOL, V185, P1593, DOI 10.4049/jimmunol.0903555; Rowe GC, 2010, CIRC RES, V107, P825, DOI 10.1161/CIRCRESAHA.110.223818; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; Schilling J, 2011, J MOL CELL CARDIOL, V51, P578, DOI 10.1016/j.yjmcc.2010.09.021; Shi JR, 2010, P NATL ACAD SCI USA, V107, P4188, DOI 10.1073/pnas.0912263107; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Weinberg JM, 2011, KIDNEY INT, V79, P151, DOI 10.1038/ki.2010.435; Wiley SR, 2003, CYTOKINE GROWTH F R, V14, P241, DOI 10.1016/S1359-6101(03)00019-4; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Yepes M, 2006, DRUG NEWS PERSPECT, V19, P589, DOI 10.1358/dnp.2006.19.10.1068005	35	43	51	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54054	10.1371/journal.pone.0054054	http://dx.doi.org/10.1371/journal.pone.0054054			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342071	Green Submitted, Green Published, gold			2022-12-25	WOS:000313682700080
J	Iyer, S; Killingback, T; Sundaram, B; Wang, Z				Iyer, Swami; Killingback, Timothy; Sundaram, Bala; Wang, Zhen			Attack Robustness and Centrality of Complex Networks	PLOS ONE			English	Article							SCALE-FREE NETWORKS; ERROR; TOLERANCE	Many complex systems can be described by networks, in which the constituent components are represented by vertices and the connections between the components are represented by edges between the corresponding vertices. A fundamental issue concerning complex networked systems is the robustness of the overall system to the failure of its constituent parts. Since the degree to which a networked system continues to function, as its component parts are degraded, typically depends on the integrity of the underlying network, the question of system robustness can be addressed by analyzing how the network structure changes as vertices are removed. Previous work has considered how the structure of complex networks change as vertices are removed uniformly at random, in decreasing order of their degree, or in decreasing order of their betweenness centrality. Here we extend these studies by investigating the effect on network structure of targeting vertices for removal based on a wider range of non-local measures of potential importance than simply degree or betweenness. We consider the effect of such targeted vertex removal on model networks with different degree distributions, clustering coefficients and assortativity coefficients, and for a variety of empirical networks.	[Iyer, Swami] Univ Massachusetts, Dept Comp Sci, Boston, MA 02125 USA; [Killingback, Timothy] Univ Massachusetts, Dept Math, Boston, MA 02125 USA; [Sundaram, Bala; Wang, Zhen] Univ Massachusetts, Dept Phys, Boston, MA 02125 USA	University of Massachusetts System; University of Massachusetts Boston; University of Massachusetts System; University of Massachusetts Boston; University of Massachusetts System; University of Massachusetts Boston	Killingback, T (corresponding author), Univ Massachusetts, Dept Math, Harbor Campus, Boston, MA 02125 USA.	timothy.killingback@umb.edu	Sundaram, Bala/A-6532-2010; Alam, Hunain/H-2984-2019	Sundaram, Bala/0000-0002-1728-704X; Alam, Hunain/0000-0002-6183-3677				Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Allesina S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000494; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BEAUCHAMP MA, 1965, BEHAV SCI, V10, P161, DOI 10.1002/bs.3830100205; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Callaway DS, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.041902; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Crucitti P, 2004, PHYSICA A, V340, P388, DOI 10.1016/j.physa.2004.04.031; Crucitti P, 2003, PHYSICA A, V320, P622, DOI 10.1016/S0378-4371(02)01545-5; Dym H, 2007, LINEAR ALGEBRA ACTIO, V78; Faust K, 2000, SOCIAL NETWORK ANAL; FREDMAN ML, 1987, J ACM, V34, P596, DOI 10.1145/28869.28874; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Holme Petter, 2002, Phys Rev E Stat Nonlin Soft Matter Phys, V65, P066109; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; Newman M, 2008, MATH NETWORKS; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Peixoto TP, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.118703; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Schneider CM, 2011, P NATL ACAD SCI USA, V108, P3838, DOI 10.1073/pnas.1009440108; STAUFFER D, 1994, INTRO PERCOLATION TH; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Wasserman S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Xulvi-Brunet R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066102	37	287	296	8	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59613	10.1371/journal.pone.0059613	http://dx.doi.org/10.1371/journal.pone.0059613			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23341946	Green Submitted, Green Published, gold			2022-12-25	WOS:000317717300025
J	Chen, H; Wu, N; Wang, YF; Zhu, D; Zhu, QA; Yang, G; Gao, YH; Fang, XQ; Wang, X; Peng, CH				Chen, Huai; Wu, Ning; Wang, Yanfen; Zhu, Dan; Zhu, Qiu'an; Yang, Gang; Gao, Yongheng; Fang, Xiuqin; Wang, Xu; Peng, Changhui			Inter-Annual Variations of Methane Emission from an Open Fen on the Qinghai-Tibetan Plateau: A Three-Year Study	PLOS ONE			English	Article							NITROUS-OXIDE; EXPERIMENTAL DROUGHT; CARBON-DIOXIDE; SOIL EMISSIONS; ALPINE WETLAND; NITRIC-OXIDE; RICE FIELDS; FLUXES; CLIMATE; CHINA	The study aimed to understand the inter-annual variations of methane (CH4) emissions from an open fen on the Qinghai-Tibetan Plateau (QTP) from 2005 to 2007. The weighted mean CH4 emission rate was 8.37 +/- 11.32 mg CH4 m(-2) h(-1) during the summers from 2005 to 2007, falling in the range of CH4 fluxes reported by other studies, with significant inter-annual and spatial variations. The CH4 emissions of the year of 2006 (2.11 +/- 3.48 mg CH4 m(-2) h(-1)) were 82% lower than the mean value of the years 2005 and 2007 (13.91 +/- 17.80 mg CH4 m(-2) h(-1) and 9.44 +/- 14.32 mg CH4 m(-2) h(-1), respectively), responding to the inter-annual changes of standing water depths during the growing season of the three years. Significant drawdown of standing water depth is believed to cause such significant reduction in CH4 emissions from wetlands in the year 2006, probably through changing the methanogen composition and decreasing its community size as well as activating methanotrophs to enhance CH4 oxidation. Our results are helpful to understand the inter-annual variations of CH4 emission and provide a more reasonable regional budget of CH4 emission from wetlands on the QTP and even for world-wide natural wetlands under climate change.	[Chen, Huai; Wu, Ning; Zhu, Dan] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China; [Chen, Huai; Zhu, Qiu'an; Yang, Gang; Peng, Changhui] NW A&F Univ, Lab Ecol Forecasting & Global Change, Coll Forestry, Yangling, Peoples R China; [Wang, Yanfen] Univ Chinese Acad Sci, Beijing, Peoples R China; [Gao, Yongheng] Chinese Acad Sci, Inst Mt Hazards & Environm, Chengdu, Peoples R China; [Fang, Xiuqin; Peng, Changhui] Univ Quebec Montreal, Inst Environm Sci, Montreal, PQ, Canada; [Wang, Xu] Chinese Acad Forestry, Res Inst Trop Forestry, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Northwest A&F University - China; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Mountain Hazards & Environment, CAS; University of Quebec; University of Quebec Montreal; Chinese Academy of Forestry; Research Institute of Tropical Forestry, CAF	Chen, H (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China.	chenhuai81@gmail.com; wuning@cib.ac.cn	Chen, Huai/AAI-1024-2020; Wang, Yanfen/C-6889-2013; Furnham, Adrian/ABB-2072-2020; yang, gang/F-9553-2013; Chen, Huai/A-7418-2015; Wang, Yuesi/AAF-3317-2019; Chen, Huai/A-7418-2015	Chen, Huai/0000-0001-7650-289X; Chen, Huai/0000-0001-7650-289X; Chen, Huai/0000-0001-6208-1481; wang, yan fen/0000-0001-5666-9289; Yang, Gang/0000-0003-2576-013X	National Natural Science Foundation of China [31100348]; Natural Science Foundation Project of CQ CSTC [2009BB7182]; Natural Sciences and Engineering Research Council of Canada (NSERC); China QianRen programme	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); China QianRen programme	This study was supported by the National Natural Science Foundation of China (No. 31100348), Natural Science Foundation Project of CQ CSTC (2009BB7182), Natural Sciences and Engineering Research Council of Canada (NSERC) discovery grant, and the China QianRen programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai ZC, 2000, J GEOPHYS RES-ATMOS, V105, P17231, DOI 10.1029/2000JD900014; Chen H, 2009, SCI TOTAL ENVIRON, V407, P1097, DOI 10.1016/j.scitotenv.2008.10.038; Chen H, 2010, ENVIRON MONIT ASSESS, V164, P21, DOI 10.1007/s10661-009-0871-3; Chen H, 2009, ATMOS ENVIRON, V43, P4995, DOI 10.1016/j.atmosenv.2009.07.001; Chen H, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD012410; Chen H, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2006JD008072; Chen YH, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006058; Davidson EA, 2004, GLOBAL CHANGE BIOL, V10, P718, DOI 10.1111/j.1365-2486.2004.00762.x; Davidson EA, 2008, GLOBAL CHANGE BIOL, V14, P2582, DOI 10.1111/j.1365-2486.2008.01694.x; Denman KL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; Ding WX, 2004, ATMOS ENVIRON, V38, P751, DOI 10.1016/j.atmosenv.2003.10.016; Ding WX, 2002, ATMOS ENVIRON, V36, P5149, DOI 10.1016/S1352-2310(02)00647-7; Dowrick DJ, 2006, GEODERMA, V132, P384, DOI 10.1016/j.geoderma.2005.06.003; Estop-Aragones C, 2012, SOIL BIOL BIOCHEM, V47, P1, DOI 10.1016/j.soilbio.2011.12.008; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; FREEMAN C, 1993, BIOGEOCHEMISTRY, V19, P51; Freeman C, 2002, SOIL BIOL BIOCHEM, V34, P61, DOI 10.1016/S0038-0717(01)00154-7; Hirota M, 2005, ATMOS ENVIRON, V39, P5255, DOI 10.1016/j.atmosenv.2005.05.036; Hirota M, 2004, SOIL BIOL BIOCHEM, V36, P737, DOI 10.1016/j.soilbio.2003.12.009; HUTCHINSON GL, 1981, SOIL SCI SOC AM J, V45, P311, DOI 10.2136/sssaj1981.03615995004500020017x; Jin HJ, 1999, CHINESE SCI BULL, V44, P2282, DOI 10.1007/BF02885940; Kang SC, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/015101; Kato T, 2011, ATMOS ENVIRON, V45, P5632, DOI 10.1016/j.atmosenv.2011.03.010; Kim SY, 2008, SOIL BIOL BIOCHEM, V40, P2874, DOI 10.1016/j.soilbio.2008.08.004; Knorr KH, 2008, SOIL BIOL BIOCHEM, V40, P1781, DOI 10.1016/j.soilbio.2008.03.019; Knorr KH, 2009, SOIL BIOL BIOCHEM, V41, P1187, DOI 10.1016/j.soilbio.2009.02.030; Li L, 2010, ARCT ANTARCT ALP RES, V42, P449, DOI 10.1657/1938-4246-42.4.449; Middelburg JJ, 2002, BIOGEOCHEMISTRY, V59, P95, DOI 10.1023/A:1015515130419; MOSIER A, 1991, NATURE, V350, P330, DOI 10.1038/350330a0; Ringeval B, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2008GB003354; SHANNON RD, 1994, BIOGEOCHEMISTRY, V27, P35, DOI 10.1007/BF00002570; Singh S.N., 2000, CHEMOSPHERE GLOB CHA, V2, DOI [10.1016/S1465- 9972(99)00046-X, DOI 10.1016/S1465-9972(99)00046-X]; Tian JQ, 2012, EUROPEAN J SOIL BIOL, DOI [10.1016/j.ej-sobi.2012.1007.1003, DOI 10.1016/J.EJSOBI.2012.1007.1003]; [王德宣 Wang Dexuan], 2002, [地球科学进展, Advance in Earth Sciences], V17, P877; Wang MH, 1987, SCI GEOGRAPHICA SINI, V18, P145; Wu N, 1997, ERDE, V128, P67; Wu QB, 2010, GLOBAL PLANET CHANGE, V72, P32, DOI 10.1016/j.gloplacha.2010.03.001; Xiang SA, 2009, ECOL ENG, V35, P553, DOI 10.1016/j.ecoleng.2008.02.016; Xu BQ, 2001, SCI CHINA SER D, V44, P689, DOI 10.1007/BF02907198; Xu ZX, 2008, HYDROL PROCESS, V22, P3056, DOI 10.1002/hyp.6892; Yan XY, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003182; Zhang Y, 2011, ENVIRON MONIT ASSESS, V180, P189, DOI 10.1007/s10661-010-1781-0	42	72	78	3	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53878	10.1371/journal.pone.0053878	http://dx.doi.org/10.1371/journal.pone.0053878			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342029	gold, Green Published			2022-12-25	WOS:000314759400093
J	Schoning, JM; Cerny, N; Prohaska, S; Wittenbrink, MM; Smith, NH; Bloemberg, G; Pewsner, M; Schiller, I; Origgi, FC; Ryser-Degiorgis, MP				Schoening, Janne Marie; Cerny, Nadine; Prohaska, Sarah; Wittenbrink, Max M.; Smith, Noel H.; Bloemberg, Guido; Pewsner, Mirjam; Schiller, Irene; Origgi, Francesco C.; Ryser-Degiorgis, Marie-Pierre			Surveillance of Bovine Tuberculosis and Risk Estimation of a Future Reservoir Formation in Wildlife in Switzerland and Liechtenstein	PLOS ONE			English	Article							BADGER MELES-MELES; BOAR SUS-SCROFA; SUBMAXILLARY LYMPH-NODES; MOUNTAIN NATIONAL-PARK; WHITE-TAILED DEER; MYCOBACTERIUM-BOVIS; RED DEER; RHODOCOCCUS-EQUI; AFRICAN BUFFALO; CERVUS-ELAPHUS	Bovine tuberculosis (bTB) caused by Mycobacterium bovis or M. caprae has recently (re-) emerged in livestock and wildlife in all countries bordering Switzerland (CH) and the Principality of Liechtenstein (FL). Comprehensive data for Swiss and Liechtenstein wildlife are not available so far, although two native species, wild boar (Sus scrofa) and red deer (Cervus elaphus elaphus), act as bTB reservoirs elsewhere in continental Europe. Our aims were (1) to assess the occurrence of bTB in these wild ungulates in CH/FL and to reinforce scanning surveillance in all wild mammals; (2) to evaluate the risk of a future bTB reservoir formation in wild boar and red deer in CH/FL. Tissue samples collected from 2009 to 2011 from 434 hunted red deer and wild boar and from eight diseased ungulates with tuberculosis-like lesions were tested by direct real-time PCR and culture to detect mycobacteria of the Mycobacterium tuberculosis complex (MTBC). Identification of suspicious colonies was attempted by real-time PCR, genotyping and spoligotyping. Information on risk factors for bTB maintenance within wildlife populations was retrieved from the literature and the situation regarding identified factors was assessed for our study areas. Mycobacteria of the MTBC were detected in six out of 165 wild boar (3.6%; 95% CI: 1.4-7.8) but none of the 269 red deer (0%; 0-1.4). M. microti was identified in two MTBC-positive wild boar, while species identification remained unsuccessful in four cases. Main risk factors for bTB maintenance worldwide, including different causes of aggregation often resulting from intensive wildlife management, are largely absent in CH and FL. In conclusion, M. bovis and M. caprae were not detected but we report for the first time MTBC mycobacteria in Swiss wild boar. Present conditions seem unfavorable for a reservoir emergence, nevertheless increasing population numbers of wild ungulates and offal consumption may represent a risk.	[Schoening, Janne Marie; Pewsner, Mirjam; Origgi, Francesco C.; Ryser-Degiorgis, Marie-Pierre] Univ Bern, Vetsuisse Fac, Ctr Fish & Wildlife Hlth FIWI, Bern, Switzerland; [Cerny, Nadine; Prohaska, Sarah; Wittenbrink, Max M.] Univ Zurich, Vetsuisse Fac, IVB, Zurich, Switzerland; [Smith, Noel H.] AHVLA, New Haw, Surrey, England; [Bloemberg, Guido] Univ Zurich, Fac Med, IMM, Zurich, Switzerland; [Schiller, Irene] Div Anim Hlth, Fed Vet Off, Bern, Switzerland	University of Bern; University of Zurich; University of Geneva; University of Zurich	Ryser-Degiorgis, MP (corresponding author), Univ Bern, Vetsuisse Fac, Ctr Fish & Wildlife Hlth FIWI, Bern, Switzerland.	marie-pierre.ryser@vetsuisse.unibe.ch	Bloemberg, Guido/AAC-4914-2020; Smith, Noel H/C-6708-2011; Ryser-Degiorgis, Marie-Pierre/AAN-5249-2020	Ryser-Degiorgis, Marie-Pierre/0000-0003-1062-870X; Baker, Joseph/0000-0002-5686-1737; Schorer, Jorg/0000-0002-4888-7048	Swiss Federal Veterinary Office (FVO) [1.10.07]; Universitiy of Bern; Universitiy of Zurich	Swiss Federal Veterinary Office (FVO); Universitiy of Bern; Universitiy of Zurich	The study was funded by the Swiss Federal Veterinary Office (FVO; www.bvet.admin.ch; contract nr. 1.10.07;), with a contribution of the Universities of Bern and Zurich (salary of mentors, infrastructure). It is always part of contracts with the FVO that study results should be published, as the FVO wants to encourage the large distribution of research results. However, the FVO has no influence on the studies' outcome or on the prepared manuscripts.	Acevedo P, 2007, EPIDEMIOL INFECT, V135, P519, DOI 10.1017/S0950268806007059; Acevedo-Whitehouse K, 2005, MOL ECOL, V14, P3209, DOI 10.1111/j.1365-294X.2005.02656.x; Amanfu W, 2006, TUBERCULOSIS, V86, P330, DOI 10.1016/j.tube.2006.01.007; Aranaz A, 2003, INT J SYST EVOL MICR, V53, P1785, DOI 10.1099/ijs.0.02532-0; Ashford RW, 2003, EMERG INFECT DIS, V9, P1495; Ashford RW, 1997, BELG J ZOOL, V127, P85; Ayele WY, 2004, INT J TUBERC LUNG D, V8, P924; Balseiro A, 2009, VET REC, V164, P468, DOI 10.1136/vr.164.15.468; Balseiro A, 2011, VET J, V90, pe21; Blanchong JA, 2007, BIOL LETT-UK, V3, P103, DOI 10.1098/rsbl.2006.0547; Boadella M, 2011, J VET DIAGN INVEST, V23, P77, DOI 10.1177/104063871102300111; Bollo E, 2000, J VET MED B, V47, P337, DOI 10.1046/j.1439-0450.2000.00354.x; Bouakaze C, 2011, J CLIN MICROBIOL, V49, P3292, DOI 10.1128/JCM.00744-11; BOUVIER G., 1957, Schweizer Archiv fur Tierheilkunde, V99, P461; Bouvier G, 1963, B OFF INT EPIZOOT, V59, P433; Briones V, 2000, EMERG INFECT DIS, V6, P189, DOI 10.3201/eid0602.000214; Buijtels PCA, 2005, J MICROBIOL METH, V62, P83, DOI 10.1016/j.mimet.2005.01.010; Cadmus S, 2006, J CLIN MICROBIOL, V44, P29, DOI 10.1128/JCM.44.1.29-34.2006; Carstensen Michelle, 2011, Veterinary Medicine International, P413240, DOI 10.4061/2011/413240; Casaubon J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-204; Cassidy JP, 2006, VET MICROBIOL, V112, P151, DOI 10.1016/j.vetmic.2005.11.031; Castillo L, 2011, PREV VET MED, V98, P58, DOI 10.1016/j.prevetmed.2010.11.008; Causse M, 2011, J CLIN MICROBIOL, V49, P3065, DOI 10.1128/JCM.00491-11; Cavanagh R, 2002, J CLIN MICROBIOL, V40, P3281, DOI 10.1128/JCM.40.9.3281-3285.2002; CHEESEMAN CL, 1981, J APPL ECOL, V18, P795, DOI 10.2307/2402370; CLIFTONHADLEY RS, 1995, EPIDEMIOL INFECT, V114, P179, DOI 10.1017/S0950268800052031; COLEMAN JD, 1994, NEW ZEAL VET J, V42, P128, DOI 10.1080/00480169.1994.35802; Contzen M, 2011, ZOONOSES PUBLIC HLTH, V58, P479, DOI 10.1111/j.1863-2378.2011.01396.x; Corner LAL, 2011, J COMP PATHOL, V144, P1, DOI 10.1016/j.jcpa.2010.10.003; Corner LAL, 2006, VET MICROBIOL, V112, P303, DOI 10.1016/j.vetmic.2005.11.015; Cousins DV, 2003, INT J SYST EVOL MICR, V53, P1305, DOI 10.1099/ijs.0.02401-0; Cvetnic Z, 2007, INT J TUBERC LUNG D, V11, P652; Cvetnic Z, 2007, ACTA VET HUNG, V55, P1, DOI 10.1556/AVet.55.2007.1.1; de Jong E, 2009, J CLIN MICROBIOL, V47, P3038, DOI 10.1128/JCM.00772-09; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; De Vos V, 2001, ONDERSTEPOORT J VET, V68, P119; Delahay RJ, 2000, J ANIM ECOL, V69, P428, DOI 10.1046/j.1365-2656.2000.00406.x; Dini V, 2004, J MT ECOL, V7, P145; Dondo A., 2007, Epidemiologie et Sante Animale, P35; Entstrasser-Muller C, 2011, TBC OBEREN LECHTAL G; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2597; European Food Safety Authority European Centre for Disease Prevention and Control, 2011, EFSA J, V9, DOI DOI 10.2903/J.EFSA.2011.2090.2090; Frank W, 2009, WIEN KLIN WOCHENSCHR, V121, P282, DOI 10.1007/s00508-009-1164-0; Gallagher J, 2000, RES VET SCI, V69, P203, DOI 10.1053/rvsc.2000.0422; Gavier-Widen D, 2009, NEW ZEAL VET J, V57, P122, DOI 10.1080/00480169.2009.36891; GEORGII B, 1983, OECOLOGIA, V58, P238, DOI 10.1007/BF00399224; Gerstmair E, 2011, THESIS LUDWIG MAXIMI; Gortazar C, 2012, MAMMAL REV, V42, P193, DOI 10.1111/j.1365-2907.2011.00191.x; Gortazar C, 2011, VET MICROBIOL, V151, P170, DOI 10.1016/j.vetmic.2011.02.041; GRIFFIN JFT, 1994, VET MICROBIOL, V40, P193, DOI 10.1016/0378-1135(94)90055-8; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; Hickling G. J., 2002, 3363 MICH DEP NAT RE, P1; Johnston WT, 2005, BIOL LETT-UK, V1, P53, DOI 10.1098/rsbl.2004.0249; Joly DO, 2004, J ANIM ECOL, V73, P623, DOI 10.1111/j.0021-8790.2004.00836.x; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kim JH, 2011, J CLIN MICROBIOL, V49, P173, DOI 10.1128/JCM.00694-10; Komijn RE, 1999, J CLIN MICROBIOL, V37, P1254, DOI 10.1128/JCM.37.5.1254-1259.1999; Komijn RE, 2007, VET MICROBIOL, V120, P352, DOI 10.1016/j.vetmic.2006.10.031; Kremer K, 1998, J CLIN MICROBIOL, V36, P2793, DOI 10.1128/JCM.36.9.2793-2794.1998; Kuiken T, 2011, REV SCI TECH OIE, V30, P755; Lees VW, 2004, CAN VET J, V45, P28; Lees VW, 2003, CAN VET J, V44, P830; Leuenberger R, 2004, THESIS U BASEL SWITZ; LoBue PA, 2010, INT J TUBERC LUNG D, V14, P1075; Makrai L, 2005, J CLIN MICROBIOL, V43, P1246, DOI 10.1128/JCM.43.3.1246-1250.2005; Makrai L, 2008, VET MICROBIOL, V131, P318, DOI 10.1016/j.vetmic.2008.04.009; Marsan A., 1995, IBEX J MT ECOL, V3, P219; Martin-Atance P, 2005, J WILDLIFE DIS, V41, P435, DOI 10.7589/0090-3558-41.2.435; Martin-Hernando MP, 2007, TUBERCULOSIS, V87, P360, DOI 10.1016/j.tube.2007.02.003; Michel AL, 2006, VET MICROBIOL, V112, P91, DOI 10.1016/j.vetmic.2005.11.035; Michel AL, 2007, BMC VET RES, V3, P23, DOI DOI 10.1186/1746-6148-3-23; Miller R, 2003, J WILDLIFE DIS, V39, P84, DOI 10.7589/0090-3558-39.1.84; Morris RS, 1995, NEW ZEAL VET J, V43, P256, DOI 10.1080/00480169./1995.35904; Naranjo V, 2008, VET MICROBIOL, V127, P1, DOI 10.1016/j.vetmic.2007.10.002; Nishi JS, 2006, VET MICROBIOL, V112, P325, DOI 10.1016/j.vetmic.2005.11.013; NORTON JH, 1984, AUST VET J, V61, P75, DOI 10.1111/j.1751-0813.1984.tb15521.x; Nugent G, 2011, VET MICROBIOL, V151, P34, DOI 10.1016/j.vetmic.2011.02.023; O'Brien DJ, 2008, J WILDLIFE DIS, V44, P802, DOI 10.7589/0090-3558-44.4.802; O'Brien DJ, 2011, VET MICROBIOL, V151, P179, DOI 10.1016/j.vetmic.2011.02.042; O'Brien DJ, 2006, VET MICROBIOL, V112, P313, DOI 10.1016/j.vetmic.2005.11.014; Oevermann A, 2004, J CLIN MICROBIOL, V42, P1818, DOI 10.1128/JCM.42.4.1818-1821.2004; Power AG, 2004, AM NAT, V164, pS79, DOI 10.1086/424610; Prodinger WM, 2002, J CLIN MICROBIOL, V40, P2270, DOI 10.1128/JCM.40.6.2270-2272.2002; Rodriguez E, 2009, INT J TUBERC LUNG D, V13, P1536; Rodwell TC, 2001, J WILDLIFE DIS, V37, P258, DOI 10.7589/0090-3558-37.2.258; Rogers LM, 1997, J ZOOL, V242, P705, DOI 10.1111/j.1469-7998.1997.tb05821.x; Rohonczy EB, 1996, CAN J VET RES, V60, P108; Santos N, 2009, J WILDLIFE DIS, V45, P1048, DOI 10.7589/0090-3558-45.4.1048; Schiller I, 2010, TRANSBOUND EMERG DIS, V57, P205, DOI 10.1111/j.1865-1682.2010.01148.x; Schiller I, 2011, VET MICROBIOL, V151, P153, DOI 10.1016/j.vetmic.2011.02.039; Schmitt SM, 1997, J WILDLIFE DIS, V33, P749, DOI 10.7589/0090-3558-33.4.749; Shitaye JE, 2006, VET MED-CZECH, V51, P497, DOI 10.17221/5584-VETMED; Shury Todd K, 2011, Vet Med Int, V2011, P591980, DOI 10.4061/2011/591980; Sleeman DP, 2009, EUR J WILDLIFE RES, V55, P333, DOI 10.1007/s10344-008-0244-1; Smith NH, 2009, J CLIN MICROBIOL, V47, P2551, DOI 10.1128/JCM.00638-09; Smith NH, 2011, INFECT GENET EVOL; Sobrino R, 2008, VET REC, V163, P159, DOI 10.1136/vr.163.5.159; Taylor C, 2006, VET REC, V159, P59, DOI 10.1136/vr.159.2.59-a; Thrusfield M, 2001, VET REC, V148, P567, DOI 10.1136/vr.148.18.567; van Soolingen D, 1998, J CLIN MICROBIOL, V36, P1840, DOI 10.1128/JCM.36.7.1840-1845.1998; Vicente J, 2007, J ANIM ECOL, V76, P348, DOI 10.1111/j.1365-2656.2006.01199.x; Vicente J, 2007, OECOLOGIA, V152, P655, DOI 10.1007/s00442-007-0690-6; Vicente J, 2007, VET RES, V38, P451, DOI 10.1051/vetres:2007002; Vieira-Pinto M, 2011, EUR J WILDLIFE RES, V57, P1189, DOI 10.1007/s10344-011-0532-z; Witmer G, 2010, J WILDLIFE DIS, V46, P368, DOI 10.7589/0090-3558-46.2.368; Wobeser G, 2009, CAN VET J, V50, P1169; Wu N, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-116; Wu N, 2011, J WILDLIFE DIS, V47, P868, DOI 10.7589/0090-3558-47.4.868; Wyss D, 2000, VET REC, V147, P713; Zanella G, 2008, VET REC, V163, P43, DOI 10.1136/vr.163.2.43; Zanella G, 2008, J WILDLIFE DIS, V44, P99, DOI 10.7589/0090-3558-44.1.99; Zanolari P, 2009, J VET INTERN MED, V23, P1266, DOI 10.1111/j.1939-1676.2009.0377.x	112	62	67	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54253	10.1371/journal.pone.0054253	http://dx.doi.org/10.1371/journal.pone.0054253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23637745	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000313943000032
J	Zhu, LH; Zhao, XC; Lai, LM; Wang, JJ; Jiang, LH; Ding, JZ; Liu, NX; Yu, YJ; Li, JS; Xiao, NW; Zheng, YR; Rimmington, GM				Zhu, Linhai; Zhao, Xuechun; Lai, Liming; Wang, Jianjian; Jiang, Lianhe; Ding, Jinzhi; Liu, Nanxi; Yu, Yunjiang; Li, Junsheng; Xiao, Nengwen; Zheng, Yuanrun; Rimmington, Glyn M.			Soil TPH Concentration Estimation Using Vegetation Indices in an Oil Polluted Area of Eastern China	PLOS ONE			English	Article							RED-EDGE; REFLECTANCE; LEAF; RESPONSES; FOREST; PREDICTION; PETROLEUM; RATIOS; RADAR; METAL	Assessing oil pollution using traditional field-based methods over large areas is difficult and expensive. Remote sensing technologies with good spatial and temporal coverage might provide an alternative for monitoring oil pollution by recording the spectral signals of plants growing in polluted soils. Total petroleum hydrocarbon concentrations of soils and the hyperspectral canopy reflectance were measured in wetlands dominated by reeds (Phragmites australis) around oil wells that have been producing oil for approximately 10 years in the Yellow River Delta, eastern China to evaluate the potential of vegetation indices and red edge parameters to estimate soil oil pollution. The detrimental effect of oil pollution on reed communities was confirmed by the evidence that the aboveground biomass decreased from 1076.5 g m(-2) to 5.3 g m(-2) with increasing total petroleum hydrocarbon concentrations ranging from 9.45 mg kg(-1) to 652 mg kg(-1). The modified chlorophyll absorption ratio index (MCARI) best estimated soil TPH concentration among 20 vegetation indices. The linear model involving MCARI had the highest coefficient of determination (R-2 = 0.73) and accuracy of prediction (RMSE = 104.2 mg kg(-1)). For other vegetation indices and red edge parameters, the R-2 and RMSE values ranged from 0.64 to 0.71 and from 120.2 mg kg(-1) to 106.8 mg kg(-1) respectively. The traditional broadband normalized difference vegetation index (NDVI), one of the broadband multispectral vegetation indices (BMVIs), produced a prediction (R-2 = 0.70 and RMSE = 110.1 mg kg(-1)) similar to that of MCARI. These results corroborated the potential of remote sensing for assessing soil oil pollution in large areas. Traditional BMVIs are still of great value in monitoring soil oil pollution when hyperspectral data are unavailable.	[Zhu, Linhai; Zhao, Xuechun; Lai, Liming; Wang, Jianjian; Jiang, Lianhe; Ding, Jinzhi; Liu, Nanxi; Zheng, Yuanrun] Chinese Acad Sci, Inst Bot, W China Subalpine Bot Garden, Key Lab Resource Plants,Beijing Bot Garden, Beijing, Peoples R China; [Zhu, Linhai; Zhao, Xuechun] Univ Chinese Acad Sci, Beijing, Peoples R China; [Yu, Yunjiang; Li, Junsheng; Xiao, Nengwen] Chinese Res Inst Environm Sci, Beijing, Peoples R China; [Rimmington, Glyn M.] Wichita State Univ, Global Learning Coll Engn, Wichita, KS USA	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Research Academy of Environmental Sciences; Wichita State University	Zheng, YR (corresponding author), Chinese Acad Sci, Inst Bot, W China Subalpine Bot Garden, Key Lab Resource Plants,Beijing Bot Garden, Beijing, Peoples R China.	zhengyr@ibcas.ac.cn	Ding, Jinzhi/AAE-3421-2019; liming, lai/HGB-0743-2022; Xiao, Nengwen/ACW-1426-2022; Zhu, Linhai/B-8551-2011	Ding, Jinzhi/0000-0003-3664-2702; Zhu, Linhai/0000-0001-7064-9022; Xiao, NengWen/0000-0002-7482-135X	National Key Technology R&D Program of China [2008BAC43B01]	National Key Technology R&D Program of China(National Key Technology R&D Program)	This work was supported by the National Key Technology R&D Program of China (2008BAC43B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin JM, 2003, FOREST ECOL MANAG, V176, P575, DOI 10.1016/S0378-1127(02)00314-6; Bannari A., 1995, REV VEG INDICES, V13, P95, DOI [10.1080/02757259509532298, DOI 10.1080/02757259509532298]; Baret F., 1989, P 12 CAN S REM SENS, V3, P1355; Blackburn GA, 1998, INT J REMOTE SENS, V19, P657, DOI 10.1080/014311698215919; Broge NH, 2001, REMOTE SENS ENVIRON, V76, P156, DOI 10.1016/S0034-4257(00)00197-8; CARTER GA, 1994, INT J REMOTE SENS, V15, P697, DOI 10.1080/01431169408954109; CARTER GA, 1993, AM J BOT, V80, P239, DOI 10.2307/2445346; Chaineau CH, 2003, WATER AIR SOIL POLL, V144, P419, DOI 10.1023/A:1022935600698; [陈建 CHEN Jian], 2011, [地理科学进展, Progress in Geography], V30, P585; Cho MA, 2006, REMOTE SENS ENVIRON, V101, P181, DOI 10.1016/j.rse.2005.12.011; Clevers JGPW, 2004, INT J REMOTE SENS, V25, P3883, DOI 10.1080/01431160310001654473; COLWELL J E, 1974, Remote Sensing of Environment, V3, P175, DOI 10.1016/0034-4257(74)90003-0; Culbertson JB, 2008, J APPL ECOL, V45, P1284, DOI 10.1111/j.1365-2664.2008.01477.x; Daughtry CST, 2000, REMOTE SENS ENVIRON, V74, P229, DOI 10.1016/S0034-4257(00)00113-9; DEMETRIADESSHAH TH, 1990, REMOTE SENS ENVIRON, V33, P55, DOI 10.1016/0034-4257(90)90055-Q; Fodrie FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021609; GATES DM, 1965, APPL OPTICS, V4, P11, DOI 10.1364/AO.4.000011; GOETZ AFH, 1985, SCIENCE, V228, P1147, DOI 10.1126/science.228.4704.1147; Guyot G., 1988, J CHEM INF MODEL, P279; Haboudane D, 2004, REMOTE SENS ENVIRON, V90, P337, DOI 10.1016/j.rse.2003.12.013; Haboudane D, 2002, REMOTE SENS ENVIRON, V81, P416, DOI 10.1016/S0034-4257(02)00018-4; HORLER DNH, 1983, INT J REMOTE SENS, V4, P273, DOI 10.1080/01431168308948546; HUETE A R, 1988, Remote Sensing of Environment, V25, P295; Ji GD, 2004, ENVIRON INT, V30, P509, DOI 10.1016/j.envint.2003.10.003; Ji GD, 2007, ECOL ENG, V29, P272, DOI 10.1016/j.ecoleng.2006.04.002; KAUFMAN YJ, 1992, IEEE T GEOSCI REMOTE, V30, P261, DOI 10.1109/36.134076; KNIPLING E B, 1970, Remote Sensing of Environment, V1, P155; Kooistra L, 2004, ENVIRON POLLUT, V127, P281, DOI 10.1016/S0269-7491(03)00266-5; Kooistra L, 2003, INT J REMOTE SENS, V24, P4995, DOI 10.1080/0143116031000080769; [刘五星 LIU Wuxing], 2007, [土壤, Soils], V39, P247; MAJOR DJ, 1990, INT J REMOTE SENS, V11, P727, DOI 10.1080/01431169008955053; Mason DC, 2012, IEEE T GEOSCI REMOTE, V50, P3041, DOI 10.1109/TGRS.2011.2178030; MILLER JR, 1990, INT J REMOTE SENS, V11, P1755, DOI 10.1080/01431169008955128; Nie M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017961; Osuji LC, 2004, CHEM BIODIVERS, V1, P1569, DOI 10.1002/cbdv.200490117; Penuelas J, 1998, TRENDS PLANT SCI, V3, P151, DOI 10.1016/S1360-1385(98)01213-8; Peterson CH, 2003, SCIENCE, V302, P2082, DOI 10.1126/science.1084282; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pezeshki SR, 2000, ENVIRON POLLUT, V108, P129, DOI 10.1016/S0269-7491(99)00244-4; Pu RL, 2003, IEEE T GEOSCI REMOTE, V41, P916, DOI 10.1109/TGRS.2003.813555; Qiu GY, 1998, J HYDROL, V210, P93, DOI 10.1016/S0022-1694(98)00174-7; Ren L., 2000, AGROENVIRONMENTAL PR, V19, P360; ROCK BN, 1988, REMOTE SENS ENVIRON, V24, P109, DOI 10.1016/0034-4257(88)90008-9; Rondeaux G, 1996, REMOTE SENS ENVIRON, V55, P95, DOI 10.1016/0034-4257(95)00186-7; Rosso PH, 2005, ENVIRON POLLUT, V137, P241, DOI 10.1016/j.envpol.2005.02.025; Rouse J.W., 1973, 3 EARTH RESOURCES TE, DOI DOI 10.1002/MRM.26868; SHIELDS PG, 1993, CANCER RES, V53, P3486; Smith KL, 2004, REMOTE SENS ENVIRON, V92, P207, DOI 10.1016/j.rse.2004.06.002; Thenkabail PS, 2000, REMOTE SENS ENVIRON, V71, P158, DOI 10.1016/S0034-4257(99)00067-X; WOOLLEY JT, 1971, PLANT PHYSIOL, V47, P656, DOI 10.1104/pp.47.5.656; 许学工, 2001, [北京大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Pekinensis], V37, P111	51	91	96	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54028	10.1371/journal.pone.0054028	http://dx.doi.org/10.1371/journal.pone.0054028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342066	Green Submitted, gold, Green Published			2022-12-25	WOS:000313682700078
J	Bauer, M; Metzler, R				Bauer, Maximilian; Metzler, Ralf			In Vivo Facilitated Diffusion Model	PLOS ONE			English	Article							REPRESSOR-OPERATOR INTERACTION; ANOMALOUS DIFFUSION; PROTEIN TRANSLOCATION; DRIVEN MECHANISMS; NUCLEIC-ACIDS; DNA; KINETICS; SEARCH; CONFINEMENT; DYNAMICS	Under dilute in vitro conditions transcription factors rapidly locate their target sequence on DNA by using the facilitated diffusion mechanism. However, whether this strategy of alternating between three-dimensional bulk diffusion and one-dimensional sliding along the DNA contour is still beneficial in the crowded interior of cells is highly disputed. Here we use a simple model for the bacterial genome inside the cell and present a semi-analytical model for the in vivo target search of transcription factors within the facilitated diffusion framework. Without having to resort to extensive simulations we determine the mean search time of a lac repressor in a living E. coli cell by including parameters deduced from experimental measurements. The results agree very well with experimental findings, and thus the facilitated diffusion picture emerges as a quantitative approach to gene regulation in living bacteria cells. Furthermore we see that the search time is not very sensitive to the parameters characterizing the DNA configuration and that the cell seems to operate very close to optimal conditions for target localization. Local searches as implied by the colocalization mechanism are only found to mildly accelerate the mean search time within our model.	[Bauer, Maximilian; Metzler, Ralf] Univ Potsdam, Inst Phys & Astron, Potsdam, Germany; [Bauer, Maximilian] Tech Univ Munich, Dept Phys, Garching, Germany; [Metzler, Ralf] Tampere Univ Technol, Dept Phys, FIN-33101 Tampere, Finland	University of Potsdam; Technical University of Munich; Tampere University	Metzler, R (corresponding author), Univ Potsdam, Inst Phys & Astron, Potsdam, Germany.	rmetzler@uni-potsdam.de	Metzler, Ralf/J-9088-2013; Stefanadis, Christodoulos/ABH-2232-2020	Metzler, Ralf/0000-0002-6013-7020; Liao, Ronglih/0000-0002-9598-9020; Stefanadis, Christodoulos/0000-0001-5974-6454; Cheng, Susan/0000-0002-4977-036X	Academy of Finland (FiDiPro scheme); German Federal Ministry for Education and Research	Academy of Finland (FiDiPro scheme)(Academy of Finland); German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by Academy of Finland (FiDiPro scheme): www.aka.fi/eng; and German Federal Ministry for Education and Research: www.bmbf.de/en/index.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks DS, 2005, BIOPHYS J, V89, P2960, DOI 10.1529/biophysj.104.051078; Barkai E, 2012, PHYS TODAY, V65, P29, DOI 10.1063/PT.3.1677; Bauer M, 2012, BIOPHYS J, V102, P2321, DOI 10.1016/j.bpj.2012.04.008; Benichou O, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.038102; Benichou O, 2010, NAT CHEM, V2, P472, DOI [10.1038/nchem.622, 10.1038/NCHEM.622]; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Bonnet I, 2008, NUCLEIC ACIDS RES, V36, P4118, DOI 10.1093/nar/gkn376; Buenemann M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013806; Coppey M, 2004, BIOPHYS J, V87, P1640, DOI 10.1529/biophysj.104.045773; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Foffano G, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.021919; Fritsche M, 2012, NUCLEIC ACIDS RES, V40, P972, DOI 10.1093/nar/gkr779; Golding I, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.098102; Gowers DM, 2005, P NATL ACAD SCI USA, V102, P15883, DOI 10.1073/pnas.0505378102; Guigas G, 2008, BIOPHYS J, V94, P90, DOI 10.1529/biophysj.107.117044; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; Hellmann M, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/58004; Jeon JH, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.048103; Jun S, 2010, NAT REV MICROBIOL, V8, P600, DOI 10.1038/nrmicro2391; Jung Y, 2012, SOFT MATTER, V8, P2095, DOI 10.1039/c1sm05706e; Junier I, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000678; Kim J, 2004, NUCLEIC ACIDS RES, V32, P1982, DOI 10.1093/nar/gkh512; Kolesov G, 2007, P NATL ACAD SCI USA, V104, P13948, DOI 10.1073/pnas.0700672104; Kolomeisky AB, 2011, PHYS CHEM CHEM PHYS, V13, P2088, DOI 10.1039/c0cp01966f; Konopka MC, 2006, J BACTERIOL, V188, P6115, DOI 10.1128/JB.01982-05; Koslover EF, 2011, BIOPHYS J, V101, P856, DOI 10.1016/j.bpj.2011.06.066; Kuhn T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022962; Lomholt MA, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.200603; Lomholt MA, 2009, P NATL ACAD SCI USA, V106, P8204, DOI 10.1073/pnas.0903293106; MADRAS N, 1990, J STAT PHYS, V58, P159, DOI 10.1007/BF01020290; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; Meyer B, 2010, PHYS REV E, V83; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Mirny L, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434013; Morelli MJ, 2011, BIOPHYS J, V101, P2882, DOI 10.1016/j.bpj.2011.10.053; Postow L, 2004, GENE DEV, V18, P1766, DOI 10.1101/gad.1207504; Reingruber J, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/6/065103; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; Rocha EPC, 2008, ANNU REV GENET, V42, P211, DOI 10.1146/annurev.genet.42.110807.091653; Romantsov T, 2007, BIOPHYS J, V92, P2875, DOI 10.1529/biophysj.106.095729; Sereshki LE, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/20008; Sheinman M, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/2/026601; Sheinman M, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/016003; Slutsky M, 2004, BIOPHYS J, V87, P4021, DOI 10.1529/biophysj.104.050765; Sokolov IM, 2005, BIOPHYS J, V89, P895, DOI 10.1529/biophysj.104.057612; Umbarger MA, 2011, MOL CELL, V44, P252, DOI 10.1016/j.molcel.2011.09.010; van den Broek B, 2008, P NATL ACAD SCI USA, V105, P15738, DOI 10.1073/pnas.0804248105; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; von Smoluchowski M, 1916, PHYS Z, V17, P557; Wang YM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.048302; Weber SC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.238102; Weiss M, 2004, BIOPHYS J, V87, P3518, DOI 10.1529/biophysj.104.044263; WINTER RB, 1981, BIOCHEMISTRY-US, V20, P6961, DOI 10.1021/bi00527a030; Wunderlich Z, 2008, NUCLEIC ACIDS RES, V36, P3570, DOI 10.1093/nar/gkn173; Zhou HX, 2011, P NATL ACAD SCI USA, V108, P8651, DOI 10.1073/pnas.1101555108	55	80	81	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e53956	10.1371/journal.pone.0053956	http://dx.doi.org/10.1371/journal.pone.0053956			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349772	Green Submitted, Green Published, gold			2022-12-25	WOS:000313872800019
J	Cheng, HL; Furnham, A				Cheng, Helen; Furnham, Adrian			Correlates of Adult Binge Drinking: Evidence from a British Cohort	PLOS ONE			English	Article							HEALTH-RELATED BEHAVIORS; ALCOHOL-CONSUMPTION; PERSONALITY; INTELLIGENCE; CHILDHOOD; ANXIETY	Objective: To investigate whether parental social class and cognitive ability in childhood, as well as social and psychological factors, particularly personality traits, are independently associated with binge drinking in 50 year old adults assessed in a longitudinal birth cohort study. Method: 17,415 babies born in Great Britain in 1958 and followed up at 11, 33, and 50 years of age. Their binge drinking alcohol abuse at aged 50 was the outcome measure. Results: 6,478 participants with data on parental social class, childhood cognitive ability, educational qualifications at age 33, personality traits, psychological distress, occupational levels, and alcohol consumption (all measured at age 50) were included in the study. Using logistic regression analyses, results showed that parental social class, childhood intelligence, educational qualifications, occupational levels, personality traits (Extraversion and Disagreeableness), as well as psychological distress, were all significantly and independently associated with adult excessive alcohol use. Men tended to binge drink more than women (22% in men and 9.8% in women). Conclusion: Both social and psychological factors influence adult excessive alcohol consumption. Personality traits play a more important role than previously understood. There appears to be a distinction between the frequency and dose level of alcohol consumption.	[Cheng, Helen; Furnham, Adrian] UCL, Dept Psychol, London, England; [Furnham, Adrian] BI Norwegian Business Sch, Oslo, Norway	University of London; University College London; BI Norwegian Business School	Furnham, A (corresponding author), UCL, Dept Psychol, London, England.	a.furnham@ucl.ac.uk	Chen, Huai/AAI-1024-2020; Wang, Yanfen/C-6889-2013; Furnham, Adrian/ABB-2072-2020; yang, gang/F-9553-2013; Chen, Huai/A-7418-2015; Wang, Yuesi/AAF-3317-2019; Chen, Huai/A-7418-2015	Chen, Huai/0000-0001-7650-289X; Chen, Huai/0000-0001-7650-289X; Chen, Huai/0000-0001-6208-1481; wang, yan fen/0000-0001-5666-9289; Yang, Gang/0000-0003-2576-013X				Batty GD, 2007, ANN EPIDEMIOL, V17, P278, DOI 10.1016/j.annepidem.2006.07.010; Batty GD, 2008, AM J PUBLIC HEALTH, V98, P2237, DOI 10.2105/AJPH.2007.109488; Batty GD, 2004, BMJ-BRIT MED J, V329, P585, DOI 10.1136/bmj.329.7466.585; Bogg T, 2004, PSYCHOL BULL, V130, P887, DOI 10.1037/0033-2909.130.6.887; Chambless DL, 1987, J ANXIETY DIORD, V1, P29; Ciarrochi J, 2012, INTELLIGENCE, V40, P317, DOI 10.1016/j.intell.2012.03.003; Cook M, 1998, PERS INDIV DIFFER, V24, P641, DOI 10.1016/S0191-8869(97)00214-6; Davie R, 1972, BIRTH 7; Douglas James W.B, 1964, HOME SCH; Ferri E., 2003, CHANGING BRITAIN CHA; Fogelman K., 1976, BRITAINS 16 YEAR OLD; Friedman HS, 2008, BRAIN BEHAV IMMUN, V22, P668, DOI 10.1016/j.bbi.2007.09.004; FRIEDMAN HS, 1993, J PERS SOC PSYCHOL, V65, P176, DOI 10.1037/0022-3514.65.1.176; Furnham A, 2003, BINGE DRINKING; Furnham A., 2008, PERSONALITY INTELLIG; George SM, 2010, PERS INDIV DIFFER, V49, P204, DOI 10.1016/j.paid.2010.03.036; Goldberg L.R., 1999, PERSONALITY PSYCHOL, V7, P7, DOI DOI 10.1016/J.JRP.2014.05.003; Gratzer D, 2004, J AFFECT DISORDERS, V79, P209, DOI 10.1016/S0165-0327(02)00355-5; Gunn RL, 2013, ADDICT BEHAV, V38, P2352, DOI 10.1016/j.addbeh.2013.02.009; Kanazawa S, 2012, INTELLIGENCE PARADOX; Kanazawa S, 2010, REV GEN PSYCHOL, V14, P382, DOI 10.1037/a0021526; Leete R, 1977, POPULATION TRENDS, V8, P1; Leino J, 2011, SCAND J PUBLIC HEALT, V39, P749, DOI 10.1177/1403494811421056; Leon DA, 2009, INTELLIGENCE, V37, P520, DOI 10.1016/j.intell.2008.11.004; MARSH C, 1986, KEY VARIABLES SOCIAL; MARTIN NG, 1989, BEHAV GENET, V19, P97, DOI 10.1007/BF01065886; Plewis I, 2004, NATL CHILD DEV STUDY; Ronksley Paul E, 2011, BMJ, V342, pd671, DOI 10.1136/bmj.d671; Rutter M., 1976, CYCLES DISADVANTAGE; Swendsen JD, 1998, COMPR PSYCHIAT, V39, P176, DOI 10.1016/S0010-440X(98)90058-X; Terracciano A, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-22; Wilkinson R., 2003, Social determinants of health: the solid facts	32	72	78	3	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78838	10.1371/journal.pone.0078838	http://dx.doi.org/10.1371/journal.pone.0078838			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	23342029	Green Submitted, Green Published, gold			2022-12-25	WOS:000327254700054
J	Cheng, YC; Hsieh, FY; Chiang, MC; Scotting, PJ; Shih, HY; Lin, SJ; Wu, HL; Lee, HT				Cheng, Yi-Chuan; Hsieh, Fu-Yu; Chiang, Ming-Chang; Scotting, Paul J.; Shih, Hung-Yu; Lin, Sheng-Jia; Wu, Hui-Lan; Lee, Han-Ting			Akt1 Mediates Neuronal Differentiation in Zebrafish via a Reciprocal Interaction with Notch Signaling	PLOS ONE			English	Article							THREONINE PROTEIN-KINASE; IN-VITRO; NERVOUS-SYSTEM; MOLECULAR-CLONING; CELLS; NEUROGENESIS; ACTIVATION; MICE; TRANSCRIPTION; LEUKEMIA	Akt1 is well known for its role in regulating cell proliferation, differentiation, and apoptosis and is implicated in tumors and several neurological disorders. However, the role of Akt1 in neural development has not been well defined. We have isolated zebrafish akt1 and shown that this gene is primarily transcribed in the developing nervous system, and its spatiotemporal expression pattern suggests a role in neural differentiation. Injection of akt1 morpholinos resulted in loss of neuronal precursors with a concomitant increase in post-mitotic neurons, indicating that knockdown of Akt1 is sufficient to cause premature differentiation of neurons. A similar phenotype was observed in embryos deficient for Notch signaling. Both the ligand (deltaA) and the downstream target of Notch (her8a) were downregulated in akt1 morphants, indicating that Akt1 is required for Delta-Notch signaling. Furthermore, akt1 expression was downregulated in Delta-Notch signaling-deficient embryos and could be induced by constitutive activation of Notch signaling. In addition, knockdown of Akt1 was able to nullify the inhibition of neuronal differentiation caused by constitutive activation of Notch signaling. Taken together, these results provide in vivo evidence that Akt1 interacts with Notch signaling reciprocally and provide an explanation of why Akt1 is essential for the inhibition of neuronal differentiation.	[Cheng, Yi-Chuan; Hsieh, Fu-Yu; Shih, Hung-Yu; Lin, Sheng-Jia; Wu, Hui-Lan; Lee, Han-Ting] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Chiang, Ming-Chang] Fu Jen Catholic Univ, Dept Life Sci, New Taipei City, Taiwan; [Scotting, Paul J.] Univ Nottingham, Ctr Genet & Genom, Childrens Brain Tumour Res Ctr, Queens Med Ctr, Nottingham NG7 2RD, England	Chang Gung University; Fu Jen Catholic University; University of Nottingham	Cheng, YC (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Tao Yuan, Taiwan.	yccheng@mail.cgu.edu.tw	Lin, Sheng-Jia/AGC-3315-2022	Lin, Sheng-Jia/0000-0002-7559-6529; ozturk, nail can/0000-0001-9459-2120; Shih, Hung-Yu/0000-0002-3490-1750	Chang Gung Memorial Hospital [CMRPD170513]; National Science Council of Taiwan [96-2745-B-182-003-URD]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from Chang Gung Memorial Hospital (CMRPD170513) and the National Science Council of Taiwan (96-2745-B-182-003-URD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Bang OS, 2001, J CELL SCI, V114, P81; Beaulieu JM, 2007, TRENDS PHARMACOL SCI, V28, P166, DOI 10.1016/j.tips.2007.02.006; Bedogni B, 2008, J CLIN INVEST, V118, P3660, DOI 10.1172/JCI36157; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Burke RE, 2007, PHARMACOL THERAPEUT, V114, P261, DOI 10.1016/j.pharmthera.2007.02.002; Calzavara E, 2008, J CELL BIOCHEM, V103, P1405, DOI 10.1002/jcb.21527; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cheng YC, 2000, DEV BRAIN RES, V121, P233, DOI 10.1016/S0165-3806(00)00049-3; Cheng YC, 2004, DEV CELL, V6, P539, DOI 10.1016/S1534-5807(04)00097-8; CHITNIS AB, 1995, MOL CELL NEUROSCI, V6, P311, DOI 10.1006/mcne.1995.1024; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Chung PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019394; COFFER PJ, 1991, EUR J BIOCHEM, V201, P475, DOI 10.1111/j.1432-1033.1991.tb16305.x; Dottori M, 2008, STEM CELLS, V26, P1146, DOI 10.1634/stemcells.2007-1118; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jiang YJ, 1996, DEVELOPMENT, V123, P205; Jo HS, 2012, EMBO J, V31, P817, DOI 10.1038/emboj.2011.443; JONES PF, 1991, P NATL ACAD SCI USA, V88, P4171, DOI 10.1073/pnas.88.10.4171; Kumar CC, 2005, ONCOGENE, V24, P7493, DOI 10.1038/sj.onc.1209087; Lai WS, 2006, P NATL ACAD SCI USA, V103, P16906, DOI 10.1073/pnas.0604994103; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Ma JH, 2010, J CLIN INVEST, V120, P103, DOI 10.1172/JCI37964; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martelli AM, 2006, LEUKEMIA, V20, P911, DOI 10.1038/sj.leu.2404245; Mckenzie G, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-10; Namikawa K, 2000, J NEUROSCI, V20, P2875; Oishi K, 2009, P NATL ACAD SCI USA, V106, P13064, DOI 10.1073/pnas.0808400106; Palomero T, 2008, CELL CYCLE, V7, P965, DOI 10.4161/cc.7.8.5753; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Peng Y, 2004, J BIOL CHEM, V279, P28509, DOI 10.1074/jbc.M402294200; Ries V, 2006, P NATL ACAD SCI USA, V103, P18757, DOI 10.1073/pnas.0606401103; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Saji M, 2011, ONCOGENE, V30, P4307, DOI 10.1038/onc.2011.136; Shao ZL, 2006, CIRC RES, V98, P111, DOI 10.1161/01.RES.0000197781.20524.b9; Sinor AD, 2004, J NEUROSCI, V24, P8531, DOI 10.1523/JNEUROSCI.1470-04.2004; Song J, 2008, FEBS LETT, V582, P1693, DOI 10.1016/j.febslet.2008.04.024; STAAL SP, 1977, P NATL ACAD SCI USA, V74, P3065, DOI 10.1073/pnas.74.7.3065; Stambolic V, 2006, TRENDS CELL BIOL, V16, P461, DOI 10.1016/j.tcb.2006.07.001; Takamiya M, 2006, DEV DYNAM, V235, P978, DOI 10.1002/dvdy.20720; Taylor JS, 2001, PHILOS T R SOC B, V356, P1661, DOI 10.1098/rstb.2001.0975; Vojtek AB, 2003, MOL CELL BIOL, V23, P4417, DOI 10.1128/MCB.23.13.4417-4427.2003; Wang L, 2006, J CEREBR BLOOD F MET, V26, P556, DOI 10.1038/sj.jcbfm.9600215; Wettstein DA, 1997, DEVELOPMENT, V124, P693; Xu QL, 1995, DEVELOPMENT, V121, P4005; Yang ZZ, 2005, MOL CELL BIOL, V25, P10407, DOI 10.1128/MCB.25.23.10407-10418.2005; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhang JH, 2011, J BIOL CHEM, V286, P8055, DOI 10.1074/jbc.M110.192641; Zhao NJ, 2010, ONCOL REP, V23, P1443, DOI 10.3892/or_00000782; Zhou FQ, 2006, PHILOS T R SOC B, V361, P1575, DOI 10.1098/rstb.2006.1882	59	51	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54262	10.1371/journal.pone.0054262	http://dx.doi.org/10.1371/journal.pone.0054262			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23544149	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400138
J	Wu, JY; Chen, CH; Wang, CZ; Ho, ML; Yeh, ML; Wang, YH				Wu, Jyun-Yi; Chen, Chia-Hsin; Wang, Chau-Zen; Ho, Mei-Ling; Yeh, Ming-Long; Wang, Yan-Hsiung			Low-Power Laser Irradiation Suppresses Inflammatory Response of Human Adipose-Derived Stem Cells by Modulating Intracellular Cyclic AMP Level and NF-kappa B Activity	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; TOLL-LIKE RECEPTORS; THERAPY LLLT; SIGNALING PATHWAY; RAT; NM; FIBROBLASTS; MECHANISMS; PROTEIN; MUSCLE	Mesenchymal stem cell (MSC)-based tissue regeneration is a promising therapeutic strategy for treating damaged tissues. However, the inflammatory microenvironment that exists at a local injury site might restrict reconstruction. Low-power laser irradiation (LPLI) has been widely applied to retard the inflammatory reaction. The purpose of this study was to investigate the anti-inflammatory effect of LPLI on human adipose-derived stem cells (hADSCs) in an inflammatory environment. We showed that the hADSCs expressed Toll-like Receptors (TLR) 1, TLR2, TLR3, TLR4, and TLR6 and that lipopolysaccharide (LPS) significantly induced the production of pro-inflammatory cytokines (Cyclooxygenase-2 (Cox-2), Interleukin-1b (IL-1b), Interleukin-6 (IL-6), and Interleukin-8 (IL-8)). LPLI markedly inhibited LPS-induced, pro-inflammatory cytokine expression at an optimal dose of 8 J/cm(2). The inhibitory effect triggered by LPLI might occur through an increase in the intracellular level of cyclic AMP (cAMP), which acts to down-regulate nuclear factor kappa B (NF-kappa B) transcriptional activity. These data collectively provide insight for further investigations of the potential application of anti-inflammatory treatment followed by stem cell therapy.	[Wu, Jyun-Yi; Yeh, Ming-Long] Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 70101, Taiwan; [Chen, Chia-Hsin] Kaohsiung Med Univ Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan; [Chen, Chia-Hsin] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Phys Med & Rehabil, Kaohsiung, Taiwan; [Chen, Chia-Hsin] Kaohsiung Municipal Tatung Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan; [Wang, Chau-Zen; Ho, Mei-Ling; Wang, Yan-Hsiung] Kaohsiung Med Univ, Coll Med, Orthopaed Res Ctr, Kaohsiung, Taiwan; [Wang, Chau-Zen; Ho, Mei-Ling] Kaohsiung Med Univ, Dept Physiol, Coll Med, Kaohsiung, Taiwan; [Wang, Chau-Zen; Ho, Mei-Ling] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Wang, Yan-Hsiung] Kaohsiung Med Univ, Sch Dent, Coll Dent Med, Kaohsiung, Taiwan	National Cheng Kung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University	Yeh, ML (corresponding author), Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 70101, Taiwan.	mlyeh@mail.ncku.edu.tw; yhwang@kmu.edu.tw	Wang, Yan-Hsiung/ABD-4004-2020	Wang, Yan-Hsiung/0000-0001-8161-7472; Ho, Mei-Ling/0000-0001-8064-8488; Chen, Chia-Hsin/0000-0002-6557-9848	National Health Research Institutes [NHRI-EX101-9914EC]; Kaohsiung Municipal Ta-Tung Hospital [KMTTH-99-013]; Kaohsiung Medical University of Taiwan [KMU-Q099018]	National Health Research Institutes(National Health Research Institutes, Japan); Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University of Taiwan	This study was supported by a grant from the National Health Research Institutes (NHRI-EX101-9914EC), a grant from the Kaohsiung Municipal Ta-Tung Hospital (KMTTH-99-013), and a grant from the Kaohsiung Medical University (KMU-Q099018) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimbire F, 2008, INFLAMMATION, V31, P189, DOI 10.1007/s10753-008-9064-4; Aimbire F, 2008, INT IMMUNOPHARMACOL, V8, P603, DOI 10.1016/j.intimp.2007.12.007; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Behfar A, 2007, J EXP MED, V204, P405, DOI 10.1084/jem.20061916; Bortone F, 2008, INT IMMUNOPHARMACOL, V8, P206, DOI 10.1016/j.intimp.2007.09.004; Boschi ES, 2008, LASER SURG MED, V40, P500, DOI 10.1002/lsm.20658; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Cho HH, 2006, STEM CELLS, V24, P2744, DOI 10.1634/stemcells.2006-0189; Correa F, 2007, PHOTOMED LASER SURG, V25, P245, DOI 10.1089/pho.2007.2079; Crisostomo PR, 2007, SHOCK, V28, P375, DOI 10.1097/shk.0b013e318058a817; de Lima FM, 2011, LASER MED SCI, V26, P389, DOI 10.1007/s10103-010-0874-x; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Garcia-Gomez I, 2010, EXPERT OPIN BIOL TH, V10, P1453, DOI 10.1517/14712598.2010.519333; Gerlo S, 2011, CELL MOL LIFE SCI, V68, P3823, DOI 10.1007/s00018-011-0757-8; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; KARU TI, 1985, DOKL AKAD NAUK SSSR+, V281, P1242; Lombardo E, 2009, TISSUE ENG PT A, V15, P1579, DOI 10.1089/ten.tea.2008.0340; Martin P, 2003, CURR BIOL, V13, P1122, DOI 10.1016/S0960-9822(03)00396-8; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Parry GCN, 1997, J IMMUNOL, V159, P5450; Pires D, 2011, LASER MED SCI, V26, P85, DOI 10.1007/s10103-010-0811-z; Rizzi CF, 2006, LASER SURG MED, V38, P704, DOI 10.1002/lsm.20371; Sakurai Y, 2000, EUR J ORAL SCI, V108, P29, DOI 10.1034/j.1600-0722.2000.00783.x; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; Wu JY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046393, 10.1371/journal.pone.0044027]; Xiong Fang, 2007, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V15, P449; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhu YX, 2008, CELL BIOCHEM FUNCT, V26, P664, DOI 10.1002/cbf.1488; Zungu IL, 2009, PHOTOCHEM PHOTOBIOL, V85, P987, DOI 10.1111/j.1751-1097.2008.00523.x	33	54	59	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54067	10.1371/journal.pone.0054067	http://dx.doi.org/10.1371/journal.pone.0054067			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23825677	Green Published, gold			2022-12-25	WOS:000313682700083
J	Iyer, SV; Dange, PP; Alam, H; Sawant, SS; Ingle, AD; Borges, AM; Shirsat, NV; Dalal, SN; Vaidya, MM				Iyer, Sapna V.; Dange, Prerana P.; Alam, Hunain; Sawant, Sharada S.; Ingle, Arvind D.; Borges, Anita M.; Shirsat, Neelam V.; Dalal, Sorab N.; Vaidya, Milind M.			Understanding the Role of Keratins 8 and 18 in Neoplastic Potential of Breast Cancer Derived Cell Lines	PLOS ONE			English	Article							INTERMEDIATE-FILAMENTS; EPITHELIAL-CELLS; CYTOKERATIN EXPRESSION; E-CADHERIN; DIFFERENTIATION; GENE; CARCINOMAS; VIMENTIN; INTEGRIN; INVASION	Background: Breast cancer is a complex disease which cannot be defined merely by clinical parameters like lymph node involvement and histological grade, or by routinely used biomarkers like estrogen receptor (ER), progesterone receptor (PGR) and epidermal growth factor receptor 2 (HER2) in diagnosis and prognosis. Breast cancer originates from the epithelial cells. Keratins (K) are cytoplasmic intermediate filament proteins of epithelial cells and changes in the expression pattern of keratins have been seen during malignant transformation in the breast. Expression of the K8/18 pair is seen in the luminal cells of the breast epithelium, and its role in prognostication of breast cancer is not well understood. Methodology/Principal Findings: In this study, we have modulated K8 expression to understand the role of the K8/18 pair in three different breast epithelium derived cell lines: non-transformed MCF10A, transformed but poorly invasive MDA MB 468 and highly invasive MDA MB 435. The up-regulation of K8 in the invasive MDA MB 435 cell line resulted in a significant decrease in proliferation, motility, in-vitro invasion, tumor volume and lung metastasis. The down-regulation of K8 in MDA MB 468 resulted in a significant increase in transformation potential, motility and invasion in-vitro, while MCF10A did not show any changes in cell transformation assays. Conclusions/Significance: These results indicate the role of K8/18 in modulating invasion in breast cancer - its presence correlating with less invasive phenotype and absence correlating with highly invasive, dedifferentiated phenotype. These data may have important implications for prognostication of breast cancer.	[Iyer, Sapna V.; Dange, Prerana P.; Alam, Hunain; Sawant, Sharada S.; Ingle, Arvind D.; Shirsat, Neelam V.; Dalal, Sorab N.; Vaidya, Milind M.] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Kharghar, Navi Mumbai, India; [Borges, Anita M.] SL Raheja Hosp, Asian Inst Oncol, Dept Histopathol, Bombay, Maharashtra, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital	Vaidya, MM (corresponding author), Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Kharghar, Navi Mumbai, India.	mvaidya@actrec.gov.in	Sundaram, Bala/A-6532-2010; Alam, Hunain/H-2984-2019	Sundaram, Bala/0000-0002-1728-704X; Alam, Hunain/0000-0002-6183-3677	Department of Biotechnology (DBT)	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India)	This work was supported by grants from Department of Biotechnology (DBT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTSTAETTER T, 1986, METHOD ENZYMOL, V134, P355; Alam H, 2011, MOL BIOL CELL, V22, P4068, DOI 10.1091/mbc.E10-08-0703; Alam H, 2011, J CELL SCI, V124, P2096, DOI 10.1242/jcs.073585; BAUMAN PA, 1994, P NATL ACAD SCI USA, V91, P5311, DOI 10.1073/pnas.91.12.5311; BLOBEL GA, 1984, VIRCHOWS ARCH B, V45, P407, DOI 10.1007/BF02889883; Bordeleau F, 2010, MOL BIOL CELL, V21, P1698, DOI 10.1091/mbc.E09-05-0373; Buhler H, 2005, MOL CANCER RES, V3, P365, DOI 10.1158/1541-7786.MCR-04-0117; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; CASANOVA L, 1995, J CELL SCI, V108, P811; CLAUSEN H, 1986, J INVEST DERMATOL, V86, P249, DOI 10.1111/1523-1747.ep12285369; Cortes Gutierrez Elva I, 2005, Ginecol Obstet Mex, V73, P111; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853; Fillies T, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-10; FRANKE WW, 1981, J MOL BIOL, V153, P933, DOI 10.1016/0022-2836(81)90460-5; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Galvin S, 1989, Adv Dermatol, V4, P277; Gonzalez A, 2012, APPL MICROBIOL BIOTE; Gosavi P, 2011, CELL MOL LIFE SCI, V68, P1439, DOI 10.1007/s00018-010-0531-3; Green KJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000125; HENDRIX MJC, 1992, JNCI-J NATL CANCER I, V84, P165, DOI 10.1093/jnci/84.3.165; Hendrix MJC, 1996, CANCER METAST REV, V15, P507, DOI 10.1007/BF00054016; HEYDEN A, 1992, J ORAL PATHOL MED, V21, P7, DOI 10.1111/j.1600-0714.1992.tb00960.x; Hinestrosa MC, 2007, NAT REV CANCER, V7, P309, DOI 10.1038/nrc2113; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Khapare N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038561; Magin TM, 1998, J CELL BIOL, V140, P1441, DOI 10.1083/jcb.140.6.1441; Malzahn K, 1998, VIRCHOWS ARCH, V433, P119, DOI 10.1007/s004280050226; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; MOLL R, 1987, ACTA HISTOCHEM, P37; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; MOLL R, 1990, J CELL BIOL, V111, P567, DOI 10.1083/jcb.111.2.567; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Morini M, 2000, INT J CANCER, V87, P336, DOI 10.1002/1097-0215(20000801)87:3<336::AID-IJC5>3.0.CO;2-3; Oshima RG, 1996, CANCER METAST REV, V15, P445, DOI 10.1007/BF00054012; Oshima RG, 2002, CELL DEATH DIFFER, V9, P486, DOI 10.1038/sj.cdd.4400988; OUHAYOUN JP, 1985, DIFFERENTIATION, V30, P123; Owens DW, 2003, BIOESSAYS, V25, P748, DOI 10.1002/bies.10316; Paramio JM, 2002, BIOESSAYS, V24, P836, DOI 10.1002/bies.10140; Ramesh S, 1999, BRIT J CANCER, V81, P1392, DOI 10.1038/sj.bjc.6693437; Ranganathan K, 2006, J ORAL PATHOL MED, V35, P25, DOI 10.1111/j.1600-0714.2005.00366.x; Raul U, 2004, INT J CANCER, V111, P662, DOI 10.1002/ijc.20349; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Sawaf M H, 1991, J Biol Buccale, V19, P187; SCHAAFSMA HE, 1993, J PATHOL, V170, P77, DOI 10.1002/path.1711700113; Schaller G, 1996, CLIN CANCER RES, V2, P1879; Schaller G, 1999, Zentralbl Gynakol, V121, P126; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Singhai R, 2011, N AM J MED SCI, V3, P227, DOI 10.4297/najms.2011.3227; SOULE HD, 1990, CANCER RES, V50, P6075; Tagliabue E, 1998, CLIN CANCER RES, V4, P407; Tao GZ, 2003, J CELL SCI, V116, P4629, DOI 10.1242/jcs.00782; TAYLORPAPADIMITRIOU J, 1989, J CELL SCI, V94, P403; Thomas PA, 1999, CLIN CANCER RES, V5, P2698; Vaidya MM, 1996, ORAL ONCOL, V32B, P333, DOI 10.1016/0964-1955(96)00012-7; Vaidya MM, 1998, ORAL ONCOL, V34, P261, DOI 10.1016/S1368-8375(97)00095-X; VAIDYA MM, 1989, J ORAL PATHOL MED, V18, P282, DOI 10.1111/j.1600-0714.1989.tb00398.x; VANMUIJEN GNP, 1987, EXP CELL RES, V171, P331, DOI 10.1016/0014-4827(87)90166-2; Woelfle U, 2004, CLIN CANCER RES, V10, P2670, DOI 10.1158/1078-0432.CCR-03-0114; Xiang RH, 2002, CANCER RES, V62, P2637	60	287	296	8	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53532	10.1371/journal.pone.0053532	http://dx.doi.org/10.1371/journal.pone.0053532			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23341946	gold, Green Submitted, Green Published			2022-12-25	WOS:000314707700020
J	Chen, SR; Zou, LY; Li, L; Wu, T				Chen, Shaoru; Zou, Liyi; Li, Li; Wu, Tie			The Protective Effect of Glycyrrhetinic Acid on Carbon Tetrachloride-Induced Chronic Liver Fibrosis in Mice via Upregulation of Nrf2	PLOS ONE			English	Article							EXTRACELLULAR-SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; FREE-RADICALS; LIPID-PEROXIDATION; MONOAMINE-OXIDASE; REACTIVE OXYGEN; HEPATITIS-C; MOUSE-LIVER; DNA-DAMAGE; RAT-LIVER	This study was designed to investigate the potentially protective effects of glycyrrhetinic acid (GA) and the role of transcription factor nuclear factor-erythroid 2(NF-E2)-related factor 2 (Nrf2) signaling in the regulation of Carbon Tetrachloride (CCl4)-induced chronic liver fibrosis in mice. The potentially protective effects of GA on CCl4-induced chronic liver fibrosis in mice were depicted histologically and biochemically. Firstly, histopathological changes including regenerative nodules, inflammatory cell infiltration and fibrosis were induced by CCl4. Then, CCl4 administration caused a marked increase in the levels of serum aminotransferases (GOT, GPT), serum monoamine oxidase (MAO) and lipid peroxidation (MDA) as well as MAO in the mice liver homogenates. Also, decreased nuclear Nrf2 expression, mRNA levels of its target genes such as superoxide dismutase 3 (SOD3), catalase (CAT), glutathione peroxidase 2 (GPX2), and activity of cellular antioxidant enzymes were found after CCl4 exposure. All of these phenotypes were markedly reversed by the treatment of the mice with GA. In addition, GA exhibited the antioxidant effects in vitro by on FeCl2-ascorbate induced lipid peroxidation in mouse liver homogenates, and on DPPH scavenging activity. Taken together, these results suggested that GA can protect the liver from oxidative stress in mice, presumably through activating the nuclear translocation of Nrf2, enhancing the expression of its target genes and increasing the activity of the antioxidant enzymes. Therefore, GA may be an effective hepatoprotective agent and viable candidate for treating liver fibrosis and other oxidative stress-related diseases.	[Chen, Shaoru; Zou, Liyi; Li, Li; Wu, Tie] Pharm GuangDong Med Coll, Dongguan, Guangdong, Peoples R China	Guangdong Medical University	Wu, T (corresponding author), Pharm GuangDong Med Coll, Dongguan, Guangdong, Peoples R China.	wutie2@163.com			GuangDong foundation for basic research [2010B06050]	GuangDong foundation for basic research	This work was supported by the GuangDong foundation for basic research (grant 2010B06050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablise M, 2004, CHEM PHARM BULL, V52, P1436, DOI 10.1248/cpb.52.1436; Aslan M, 2004, CURR ALZHEIMER RES, V1, P111, DOI 10.2174/1567205043332162; Banning A, 2005, MOL CELL BIOL, V25, P4914, DOI 10.1128/MCB.25.12.4914-4923.2005; Bardag-Gorce F, 2011, EXP MOL PATHOL, V90, P123, DOI 10.1016/j.yexmp.2010.10.013; Bartsch H, 2006, LANGENBECK ARCH SURG, V391, P499, DOI 10.1007/s00423-006-0073-1; BRATTIN W J, 1985, Journal of Free Radicals in Biology and Medicine, V1, P27, DOI 10.1016/0748-5514(85)90026-1; Brautbar N, 2002, INT J HYG ENVIR HEAL, V205, P479, DOI 10.1078/1438-4639-00175; BRENT JA, 1993, J TOXICOL-CLIN TOXIC, V31, P173, DOI 10.3109/15563659309000384; Brigelius-Flohe R, 1999, FREE RADICAL BIO MED, V27, P951, DOI 10.1016/S0891-5849(99)00173-2; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; Cederbaum AI, 2009, ARCH TOXICOL, V83, P519, DOI 10.1007/s00204-009-0432-0; Chen J, 2011, SHANDONG MED J, V51, P12; Cho HY, 2006, ANTIOXID REDOX SIGN, V8, P76, DOI 10.1089/ars.2006.8.76; Choi HK, 2009, TOXICOL APPL PHARM, V240, P377, DOI 10.1016/j.taap.2009.07.030; CHU FF, 1993, J BIOL CHEM, V268, P2571; Copple IM, 2008, TOXICOLOGY, V246, P24, DOI 10.1016/j.tox.2007.10.029; Edmondson DE, 2004, CURR MED CHEM, V11, P1983, DOI 10.2174/0929867043364784; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fan J, 1997, Zhonghua Nei Ke Za Zhi, V36, P808; Farombi EO, 2008, FOOD CHEM TOXICOL, V46, P1279, DOI 10.1016/j.fct.2007.09.095; FOLZ RJ, 1994, GENOMICS, V22, P162, DOI 10.1006/geno.1994.1357; Friedman SL, 2003, SCHIFFS DIS LIVER, P409; Goldring CEP, 2004, HEPATOLOGY, V39, P1267, DOI 10.1002/hep.20183; Gong XL, 2008, STRAIT PHARM J, V20, P4; GRESSNER AM, 1982, J CLIN CHEM CLIN BIO, V20, P509; Guyton A.C., 2006, TXB MED PHYSL, P859; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Hare MLC, 1928, BIOCHEM J, V22, P968, DOI 10.1042/bj0220968; He SX, 2006, WORLD J GASTROENTERO, V12, P3924, DOI 10.3748/wjg.v12.i24.3924; Hong YA, 2010, ACTA PHARMACOL SIN, V31, P1421, DOI 10.1038/aps.2010.101; Ivanov AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024957; Jeong WS, 2006, ANTIOXID REDOX SIGN, V8, P99, DOI 10.1089/ars.2006.8.99; Jia N, 2007, TOXICOLOGY, V237, P1, DOI 10.1016/j.tox.2007.04.015; Jiang T, 2009, TOXICOL APPL PHARM, V240, P8, DOI 10.1016/j.taap.2009.06.010; Jin M, 2009, MED RECAPIT, V15, P1712; JU HS, 1990, ACTA PHARM SINIC, V11, P466; [阚周密 KAN Zhoumi], 2007, [天津医药, Tianjin Medical Journal], V35, P361; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; KARLSSON K, 1988, BIOCHEM J, V255, P223; KARLSSON K, 1994, LAB INVEST, V70, P705; Kim HJ, 2008, FOOD CHEM TOXICOL, V46, P3407, DOI 10.1016/j.fct.2008.08.012; Kim HK, 2009, FOOD SCI BIOTECHNOL, V18, P1186; Kobashi K, 1984, Patent No. [JP: 5914799, 5914799]; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lai MMC, 2002, GASTROENTEROLOGY, V122, P568, DOI 10.1053/gast.2002.31474; Li CY, 2006, J FOOD SCI BIOTECHNO, V25, P1673; Li L, 2011, EXP TOXICOL PATHOL, V4, P1; Luo Ye, 2008, Practical Pharmacy and Clinical Remedies, V11, P182; Makino T, 2008, DRUG METAB DISPOS, V36, P1438, DOI 10.1124/dmd.108.021089; Mann Giovanni E., 2007, Shengli Xuebao, V59, P117; MARKLUND SL, 1982, P NATL ACAD SCI-BIOL, V79, P7634, DOI 10.1073/pnas.79.24.7634; Mizrahi Meir, 2008, Harefuah, V147, P381; Molyneux P., 2004, SJST, V26, P211, DOI DOI 10.1287/ISRE.6.2.144; Moro T, 2008, LIFE SCI, V83, P531, DOI 10.1016/j.lfs.2008.07.023; Mulcahy RT, 1997, J BIOL CHEM, V272, P7445, DOI 10.1074/jbc.272.11.7445; NANJI AA, 1995, J LIPID RES, V36, P736; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Patel R, 2008, FREE RADICAL BIO MED, V44, P1897, DOI 10.1016/j.freeradbiomed.2008.02.006; PIERCE RA, 1987, J BIOL CHEM, V262, P1652; Poli Giuseppe, 2000, Molecular Aspects of Medicine, V21, P49, DOI 10.1016/S0098-2997(00)00004-2; Recknagel R.O., 2020, HEPATOTOXICOLOGY, P401; RECKNAGEL RO, 1989, PHARMACOL THERAPEUT, V43, P139, DOI 10.1016/0163-7258(89)90050-8; Reisman SA, 2009, TOXICOL SCI, V108, P35, DOI 10.1093/toxsci/kfn267; [任明 Ren Ming], 2010, [中国病理生理杂志, Chinese Journal of Pathophysiology], V26, P2222; Sikorska K, 2011, HEPATOB PANCREAT DIS, V10, P270, DOI 10.1016/S1499-3872(11)60045-3; Singh B, 2012, CARCINOGENESIS, V33, P2601, DOI 10.1093/carcin/bgs300; SLATER TF, 1984, BIOCHEM J, V222, P1; Slotkin TA, 1999, BRAIN RES BULL, V50, P373, DOI 10.1016/S0361-9230(99)00110-0; Tanigawa S, 2007, FREE RADICAL BIO MED, V42, P1690, DOI 10.1016/j.freeradbiomed.2007.02.017; Thompson K, 1998, HEPATOLOGY, V28, P1597, DOI 10.1002/hep.510280620; Tipton KF, 2004, CURR MED CHEM, V11, P1965, DOI 10.2174/0929867043364810; TSUKAMOTO H, 1995, J GASTROEN HEPATOL, V10, pS50, DOI 10.1111/j.1440-1746.1995.tb01798.x; Van Rossum TGJ, 1998, ALIMENT PHARM THER, V12, P199; Wang JY, 2001, WORLD J GASTROENTERO, V7, P115; Wang YP, 2010, WORLD J GASTROENTERO, V16, P2657, DOI 10.3748/wjg.v16.i21.2657; WILLIAMS AT, 1990, SEMIN LIVER DIS, V10, P279, DOI 10.1055/s-2008-1040483; Wu KC, 2012, TOXICOL APPL PHARM, V263, P14, DOI 10.1016/j.taap.2012.05.017; Xu WH, 2008, LAB INVEST, V88, P1068, DOI 10.1038/labinvest.2008.75; Yang YS, 2008, FOOD CHEM TOXICOL, V46, P380, DOI 10.1016/j.fct.2007.08.016; Zhang Qi-sheng, 2005, Zhonghua Gan Zang Bing Za Zhi, V13, P664; Zhu H, 2012, J DIGEST DIS, V13, P133, DOI 10.1111/j.1751-2980.2011.00569.x; Zhu W, 2000, FREE RADICAL BIO MED, V29, P870, DOI 10.1016/S0891-5849(00)00396-8	82	187	196	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53662	10.1371/journal.pone.0053662	http://dx.doi.org/10.1371/journal.pone.0053662			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341968	gold, Green Published, Green Submitted			2022-12-25	WOS:000314759400062
J	Zhu, JY; Yang, P; Zhang, Z; Wu, GX; Yang, B				Zhu, Jia-Ying; Yang, Pu; Zhang, Zhong; Wu, Guo-Xing; Yang, Bin			Transcriptomic Immune Response of Tenebrio molitor Pupae to Parasitization by Scleroderma guani	PLOS ONE			English	Article							GENE-EXPRESSION; HELIOTHIS-VIRESCENS; INNATE IMMUNITY; PIERIS-RAPAE; RECOGNITION PROTEINS; MOLECULAR-CLONING; TRICHOPLUSIA-NI; STORAGE PROTEIN; ENZYME-ACTIVITY; VENOM PROTEINS	Background: Host and parasitoid interaction is one of the most fascinating relationships of insects, which is currently receiving an increasing interest. Understanding the mechanisms evolved by the parasitoids to evade or suppress the host immune system is important for dissecting this interaction, while it was still poorly known. In order to gain insight into the immune response of Tenebrio molitor to parasitization by Scleroderma guani, the transcriptome of T. molitor pupae was sequenced with focus on immune-related gene, and the non-parasitized and parasitized T. molitor pupae were analyzed by digital gene expression (DGE) analysis with special emphasis on parasitoid-induced immune-related genes using Illumina sequencing. Methodology/Principal Findings: In a single run, 264,698 raw reads were obtained. De novo assembly generated 71,514 unigenes with mean length of 424 bp. Of those unigenes, 37,373 (52.26%) showed similarity to the known proteins in the NCBI nr database. Via analysis of the transcriptome data in depth, 430 unigenes related to immunity were identified. DGE analysis revealed that parasitization by S. guani had considerable impacts on the transcriptome profile of T. molitor pupae, as indicated by the significant up-or down-regulation of 3,431 parasitism-responsive transcripts. The expression of a total of 74 unigenes involved in immune response of T. molitor was significantly altered after parasitization. Conclusions/Significance: obtained T. molitor transcriptome, in addition to establishing a fundamental resource for further research on functional genomics, has allowed the discovery of a large group of immune genes that might provide a meaningful framework to better understand the immune response in this species and other beetles. The DGE profiling data provides comprehensive T. molitor immune gene expression information at the transcriptional level following parasitization, and sheds valuable light on the molecular understanding of the host-parasitoid interaction.	[Zhu, Jia-Ying; Yang, Bin] SW Forestry Univ, Key Lab Forest Disaster Warning & Control Yunnan, Kunming, Peoples R China; [Yang, Pu] Chinese Acad Forestry, Res Inst Resource Insects, Kunming, Peoples R China; [Zhang, Zhong] Taishan Med Univ, Dept Pathogen Biol, Tai An, Shandong, Peoples R China; [Wu, Guo-Xing] Yunnan Agr Univ, Coll Plant Protect, Kunming, Peoples R China	Chinese Academy of Forestry; Research Institute of Resources Insects, CAF; Shandong First Medical University & Shandong Academy of Medical Sciences; Yunnan Agricultural University	Zhu, JY (corresponding author), SW Forestry Univ, Key Lab Forest Disaster Warning & Control Yunnan, Kunming, Peoples R China.	jyzhu001@gmail.com	Yang, Pu/L-1442-2019; Yang, Bin/AAW-9583-2021	Yang, Bin/0000-0002-9290-7288; li, wan feng/0000-0003-0834-5479	Key Project of Chinese Ministry of Education [211171]; Applied Basic Research Programs of Yunnan Province [2010CD063]; National Natural Science Foundation of China [31260449]	Key Project of Chinese Ministry of Education(Ministry of Education, China); Applied Basic Research Programs of Yunnan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Key Project of Chinese Ministry of Education (211171), Applied Basic Research Programs of Yunnan Province (2010CD063), and National Natural Science Foundation of China (31260449). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latief M, 2008, INSECT BIOCHEM MOLEC, V38, P136, DOI 10.1016/j.ibmb.2007.10.001; Agaisse H, 2004, IMMUNOL REV, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; Asgari S, 2004, J INSECT PHYSIOL, V50, P687, DOI 10.1016/j.jinsphys.2004.05.003; Asgari S, 2011, ANNU REV ENTOMOL, V56, P313, DOI 10.1146/annurev-ento-120709-144849; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Axen A, 1997, EUR J BIOCHEM, V247, P614, DOI 10.1111/j.1432-1033.1997.00614.x; Badisco L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017274; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Barat-Houari M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-160; Beckage NE, 2004, ANNU REV ENTOMOL, V49, P299, DOI 10.1146/annurev.ento.49.061802.123324; Benassi V, 2000, ARCH INSECT BIOCHEM, V43, P64, DOI 10.1002/(SICI)1520-6327(200002)43:2&lt;64::AID-ARCH2&gt;3.0.CO;2-I; Burmester T, 1999, EUR J ENTOMOL, V96, P213; Carton Y, 2008, INSECT SCI, V15, P67, DOI 10.1111/j.1744-7917.2008.00188.x; Carvalho RA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-695; Chen Jun, 2000, Chinese Journal of Biological Control, V16, P166; Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corona M, 2006, INSECT MOL BIOL, V15, P687, DOI 10.1111/j.1365-2583.2006.00695.x; Coudron TA, 1997, COMP BIOCHEM PHYS B, V116, P197, DOI 10.1016/S0305-0491(96)00217-9; COUDRON TA, 1994, ARCH INSECT BIOCHEM, V26, P97, DOI 10.1002/arch.940260204; Coustau C, 1996, INSECT MOL BIOL, V5, P167, DOI 10.1111/j.1365-2583.1996.tb00050.x; Dong K, 1996, ARCH INSECT BIOCHEM, V32, P237, DOI 10.1002/(SICI)1520-6327(1996)32:2&lt;237::AID-ARCH7&gt;3.0.CO;2-V; Doucet D, 2008, ARCH INSECT BIOCHEM, V67, P188, DOI 10.1002/arch.20227; Dziarski R, 2004, MOL IMMUNOL, V40, P877, DOI 10.1016/j.molimm.2003.10.011; Eleftherianos I, 2011, J INNATE IMMUN, V3, P28, DOI 10.1159/000321931; Etebari K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-446; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Fang Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026888; Fearon DT, 1977, NATURE, V388, P323, DOI DOI 10.1038/40967; Feldhaar H, 2008, MICROBES INFECT, V10, P1082, DOI 10.1016/j.micinf.2008.07.010; Hall M, 1999, P NATL ACAD SCI USA, V96, P1965, DOI 10.1073/pnas.96.5.1965; HARA S, 1995, J BIOL CHEM, V270, P29923, DOI 10.1074/jbc.270.50.29923; Hartzer KL, 2005, ARCH INSECT BIOCHEM, V59, P67, DOI 10.1002/arch.20056; HAYAKAWA Y, 1994, J BIOL CHEM, V269, P14536; HOFFMANN JA, 1995, CURR OPIN IMMUNOL, V7, P4, DOI 10.1016/0952-7915(95)80022-0; Hughes Austin L, 2012, Immunogenetics, V64, P549, DOI 10.1007/s00251-012-0610-8; Keeling CI, 2012, INSECT BIOCHEM MOLEC, V42, P525, DOI 10.1016/j.ibmb.2012.03.010; Kraaijeveld AR, 2009, ADV PARASIT, V70, P257, DOI 10.1016/S0065-308X(09)70010-7; KUNKEL JG, 1990, ARCH INSECT BIOCHEM, V13, P117, DOI 10.1002/arch.940130111; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li XR, 2011, INT J BIOL SCI, V7, P848, DOI 10.7150/ijbs.7.848; Lourenco AP, 2009, ARCH INSECT BIOCHEM, V71, P70, DOI 10.1002/arch.20301; Mahadav A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-342; Marmaras VJ, 2009, CELL SIGNAL, V21, P186, DOI 10.1016/j.cellsig.2008.08.014; Moreau SJM, 2005, INSECT BIOCHEM MOLEC, V35, P1209, DOI 10.1016/j.ibmb.2005.07.003; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nappi A, 2009, ADV PARASIT, V70, P99, DOI 10.1016/S0065-308X(09)70004-1; Nicolas E, 1996, DEV COMP IMMUNOL, V20, P175, DOI 10.1016/0145-305X(96)00017-1; Ourth DD, 2005, BIOCHEM BIOPH RES CO, V335, P1085, DOI 10.1016/j.bbrc.2005.07.189; Pal S, 2009, FLY, V3, P121, DOI 10.4161/fly.8827; Pennacchio F, 2006, ANNU REV ENTOMOL, V51, P233, DOI 10.1146/annurev.ento.51.110104.151029; Pick C, 2009, FEBS J, V276, P1930, DOI 10.1111/j.1742-4658.2009.06918.x; Provost B, 2011, INSECT BIOCHEM MOLEC, V41, P582, DOI 10.1016/j.ibmb.2011.03.010; Qin X, 1982, SCI SILVAE SINICAE, V18, P209; Quicke D. L. J., 1997, PARASITIC WASPS; Ribou AC, 2012, P ROY SOC B-BIOL SCI, V279, P2196, DOI 10.1098/rspb.2011.2422; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Scharlaken B, 2008, DEV COMP IMMUNOL, V32, P883, DOI 10.1016/j.dci.2008.01.010; Schlenke TA, 2007, PLOS PATHOG, V3, P1486, DOI 10.1371/journal.ppat.0030158; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Schmidt O, 2006, ARCH INSECT BIOCHEM, V61, P107, DOI 10.1002/arch.20110; Schmidt O, 1989, Subcell Biochem, V15, P91; SHELBY KS, 1994, J GEN VIROL, V75, P2285, DOI 10.1099/0022-1317-75-9-2285; Shelby KS, 1997, INSECT BIOCHEM MOLEC, V27, P263, DOI 10.1016/S0965-1748(96)00095-1; Shelby KS, 1999, J INSECT PHYSIOL, V45, P507, DOI 10.1016/S0022-1910(98)00144-9; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Song KH, 2008, J INSECT PHYSIOL, V54, P1271, DOI 10.1016/j.jinsphys.2008.06.010; Stanley D, 2009, J INNATE IMMUN, V1, P282, DOI 10.1159/000210371; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Takeda T, 2006, PESTIC BIOCHEM PHYS, V86, P15, DOI 10.1016/j.pestbp.2005.11.012; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; TELFER WH, 1991, ANNU REV ENTOMOL, V36, P205, DOI 10.1146/annurev.en.36.010191.001225; Tian YY, 2009, DEV COMP IMMUNOL, V33, P772, DOI 10.1016/j.dci.2009.01.002; Wertheim B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r94; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yu XQ, 2004, DEV COMP IMMUNOL, V28, P891, DOI 10.1016/j.dci.2004.02.005; Yu XQ, 2002, INSECT BIOCHEM MOLEC, V32, P1287, DOI 10.1016/S0965-1748(02)00091-7; Zagrobelny M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-574; Zhang L, 1980, SCI SILVAE SINICAE, V16, P41; Zhang YH, 2012, GENOMICS, V100, P35, DOI 10.1016/j.ygeno.2012.05.002; Zhang ZT, 2012, DEV COMP IMMUNOL, V38, P262, DOI 10.1016/j.dci.2012.05.003; Zhu JY, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/491748; Zhu JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032291; Zhu JY, 2011, J ZHEJIANG UNIV-SC B, V12, P103, DOI 10.1631/jzus.B1000275; Zhu JY, 2009, INSECT SCI, V16, P227, DOI 10.1111/j.1744-7917.2009.01252.x; Zhu JY, 2009, J ZHEJIANG UNIV-SC B, V10, P445, DOI 10.1631/jzus.B0820314; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177	90	198	208	5	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54411	10.1371/journal.pone.0054411	http://dx.doi.org/10.1371/journal.pone.0054411			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23301042	Green Submitted, Green Published, gold			2022-12-25	WOS:000314759400162
J	Zhu, JF; Zhang, LF; Li, WF; Han, SY; Yang, WH; Qi, LW				Zhu, Jianfeng; Zhang, Lifeng; Li, Wanfeng; Han, Suying; Yang, Wenhua; Qi, Liwang			Reference Gene Selection for Quantitative Real-time PCR Normalization in Caragana intermedia under Different Abiotic Stress Conditions	PLOS ONE			English	Article							RT-PCR; HOUSEKEEPING GENES; TRANSCRIPTION FACTOR; INTERNAL CONTROL; EXPRESSION NORMALIZATION; VALIDATION; ARABIDOPSIS; IDENTIFICATION; DROUGHT; RICE	Quantitative real-time reverse transcription polymerase chain reaction (qPCR), a sensitive technique for gene expression analysis, depends on the stability of the reference genes used for data normalization. Caragana intermedia, a native desert shrub with strong drought-resistance, sand-fixing capacity and high forage value that is widespread in the desert land of west and northwest China, has not been investigated regarding the identification of reference genes suitable for the normalization of qPCR data. In this study, 10 candidate reference genes were analyzed in C. intermedia subjected to different abiotic (osmotic, salt, cold and heat) stresses, in two distinct plant organs (roots and leaves). The expression stability of these genes was assessed using geNorm, NormFinder and BestKeeper algorithms. The best-ranked reference genes differed across the different sets of samples, but UNK2, PP2A and SAND were the most stable across all tested samples. UNK2 and SAND would be appropriate for normalizing gene expression data for salt-treated roots, whereas the combination of UNK2, SAND and EF-1 alpha would be appropriate for salt-treated leaves. UNK1, UNK2 and PP2A would be appropriate for PEG-treated (osmotic) roots, whereas the combination of TIP41 and PP2A was the most suitable for PEG-treated leaves. SAND, PP2A and TIP41 exhibited the most stable expression in heat-treated leaves. In cold-treated leaves, SAND and EF-1 alpha were the most stably expressed. To further validate the suitability of the reference genes identified in this study, the expression levels of DREB1 and DREB2 (homologs of AtDREB1 and AtDREB2) were studied in parallel. This study is the first systematic analysis for the selection of superior reference genes for qPCR in C. intermedia under different abiotic stress conditions, and will benefit future studies on gene expression in C. intermedia and other species of the leguminous genus Caragana.	[Zhu, Jianfeng; Zhang, Lifeng; Li, Wanfeng; Yang, Wenhua; Qi, Liwang] Chinese Acad Forestry, Res Inst Forestry, Cell Biol Lab, Beijing, Peoples R China; [Han, Suying] Chinese Acad Forestry, Res Inst Forest Ecol & Protect, Key Lab, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF	Qi, LW (corresponding author), Chinese Acad Forestry, Res Inst Forestry, Cell Biol Lab, Beijing, Peoples R China.	lwqi@caf.ac.cn	Yang, Pu/L-1442-2019; Yang, Bin/AAW-9583-2021	Yang, Bin/0000-0002-9290-7288; li, wan feng/0000-0003-0834-5479	National Basic Research Program of China [2009CB119106]; National High Technology Research and Development Program of China [2011AA100203]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the National Basic Research Program of China (2009CB119106) and the National High Technology Research and Development Program of China (2011AA100203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Chi XY, 2012, MOL GENET GENOMICS, V287, P167, DOI 10.1007/s00438-011-0665-5; Coito Joao L, 2012, BMC Res Notes, V5, P220, DOI 10.1186/1756-0500-5-220; Condori Jose, 2011, BMC Res Notes, V4, P392, DOI 10.1186/1756-0500-4-392; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Demidenko NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019434; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Faccioli P, 2007, PLANT MOL BIOL, V63, P679, DOI 10.1007/s11103-006-9116-9; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Guo WH, 2010, AGROFOREST SYST, V80, P423, DOI 10.1007/s10457-010-9337-4; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Huang JL, 2010, PLANT PHYSIOL, V153, P1526, DOI 10.1104/pp.110.157370; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Kakar K, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-18; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Klie Maik, 2011, BMC Res Notes, V4, P518, DOI 10.1186/1756-0500-4-518; Koo SC, 2010, PLANT J, V62, P807, DOI 10.1111/j.1365-313X.2010.04192.x; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Mahoney DJ, 2004, PHYSIOL GENOMICS, V18, P226, DOI 10.1152/physiolgenomics.00067.2004; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Migocka M, 2011, MOL BREEDING, V28, P343, DOI 10.1007/s11032-010-9487-0; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Perez R, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-79; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Portieles R, 2010, PLANT BIOTECHNOL J, V8, P678, DOI 10.1111/j.1467-7652.2010.00501.x; Qiu JL, 2008, EMBO J, V27, P2214, DOI 10.1038/emboj.2008.147; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Ren XZ, 2010, PLANT J, V63, P417, DOI 10.1111/j.1365-313X.2010.04248.x; Shi SQ, 2010, PLANT CELL ENVIRON, V33, P149, DOI 10.1111/j.1365-3040.2009.02065.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Wang XM, 2011, MOL BIOL REP, V38, P2801, DOI 10.1007/s11033-010-0425-3; Xu ZZ, 2007, PLANT SOIL, V301, P87, DOI 10.1007/s11104-007-9424-0; Zhong HY, 2011, PLANT CELL REP, V30, P641, DOI 10.1007/s00299-010-0992-8	44	198	208	5	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53196	10.1371/journal.pone.0053196	http://dx.doi.org/10.1371/journal.pone.0053196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301042	gold, Green Published, Green Submitted			2022-12-25	WOS:000313320900067
J	Zhao, Z; Su, TJ; Chesters, D; Wang, SD; Ho, SYW; Zhu, CD; Chen, XL; Zhang, CT				Zhao, Zhe; Su, Tian-juan; Chesters, Douglas; Wang, Shi-di; Ho, Simon Y. W.; Zhu, Chao-dong; Chen, Xiao-lin; Zhang, Chun-tian			The Mitochondrial Genome of Elodia flavipalpis Aldrich (Diptera: Tachinidae) and the Evolutionary Timescale of Tachinid Flies	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; DNA CONTROL REGION; TRANSFER-RNA GENE; CALYPTRATAE DIPTERA; MOLECULAR PHYLOGENY; FRUIT-FLY; AGROMYZIDAE; PHYLOGEOGRAPHY; REARRANGEMENT; ORGANIZATION	Tachinid flies are natural enemies of many lepidopteran and coleopteran pests of forests, crops, and fruit trees. In order to address the lack of genetic data in this economically important group, we sequenced the complete mitochondrial genome of the Palaearctic tachinid fly Elodia flavipalpis Aldrich, 1933. Usually found in Northern China and Japan, this species is one of the primary natural enemies of the leaf-roller moths (Tortricidae), which are major pests of various fruit trees. The 14,932-bp mitochondrial genome was typical of Diptera, with 13 protein-coding genes, 22 tRNA genes, and 2 rRNA genes. However, its control region is only 105 bp in length, which is the shortest found so far in flies. In order to estimate dipteran evolutionary relationships, we conducted a phylogenetic analysis of 58 mitochondrial genomes from 23 families. Maximum-likelihood and Bayesian methods supported the monophyly of both Tachinidae and superfamily Oestroidea. Within the subsection Calyptratae, Muscidae was inferred as the sister group to Oestroidea. Within Oestroidea, Calliphoridae and Sarcophagidae formed a sister clade to Oestridae and Tachinidae. Using a Bayesian relaxed clock calibrated with fossil data, we estimated that Tachinidae originated in the middle Eocene.	[Zhao, Zhe; Wang, Shi-di; Zhang, Chun-tian] Shenyang Normal Univ, Liaoning Key Lab Evolut & Biodivers, Shenyang, Liaoning, Peoples R China; [Zhao, Zhe; Su, Tian-juan; Chesters, Douglas; Zhu, Chao-dong; Chen, Xiao-lin] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Ho, Simon Y. W.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	Shenyang Normal University; Chinese Academy of Sciences; Institute of Zoology, CAS; University of Sydney	Zhu, CD (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	zhucd@ioz.ac.cn; xlchen@ioz.ac.cn; chuntianzhang@yahoo.cn	Chesters, Douglas/AAF-7926-2019; ZHU, Chao-Dong/E-5961-2011; Ho, Simon YW/A-8417-2008; Su, Tianjuan/AAJ-6290-2021	ZHU, Chao-Dong/0000-0002-9347-3178; Ho, Simon YW/0000-0002-0361-2307; 	Knowledge Innovation Program of Chinese Academy of Sciences [KSXC2-EW-B-02]; Public Welfare Project from the Ministry of Agriculture, China [201103024]; National Science Foundation, China [30870268, 31172048, J0930004, 31093430, 31272279]; National Special Science and Technology Foundation of China [2012FY111100]; NHLBI NIH HHS [R01 HL97979, R01 HL097979] Funding Source: Medline	Knowledge Innovation Program of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Public Welfare Project from the Ministry of Agriculture, China; National Science Foundation, China(National Natural Science Foundation of China (NSFC)); National Special Science and Technology Foundation of China; NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported mainly by a grant from the Knowledge Innovation Program of Chinese Academy of Sciences (grant KSXC2-EW-B-02), Public Welfare Project from the Ministry of Agriculture, China (grant 201103024), and the National Science Foundation, China (grants 30870268, 31172048, J0930004) to Chao-dong Zhu; the National Science Foundation, China (grants 31093430, 31272279) to Chun-tian Zhang; National Special Science and Technology Foundation of China (2012FY111100) to Xiao-lin Chen and Chao-dong Zhu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aldrich JM, 1933, P ENTOMOLOGICAL SOC, V35, P21; Beard C.B., 1993, Insect Molecular Biology, V2, P103, DOI 10.1111/j.1365-2583.1993.tb00131.x; Beckenbach AT, 2012, GENOME BIOL EVOL, V4, P89, DOI 10.1093/gbe/evr131; Beckenbach AT, 2009, GENOME BIOL EVOL, V1, P278, DOI 10.1093/gbe/evp027; Behura SK, 2011, INSECT BIOCHEM MOLEC, V41, P770, DOI 10.1016/j.ibmb.2011.05.006; Boore JL, 2005, METHOD ENZYMOL, V395, P311, DOI 10.1016/S0076-6879(05)95019-2; Cameron SL, 2007, SYST ENTOMOL, V32, P40, DOI 10.1111/j.1365-3113.2006.00355.x; Chao CM, 2009, FAUNA HEBEI PROVINCE, p[1, 555]; Chatterjee S, 2005, GENETICA, V125, P1, DOI 10.1007/s10709-004-6192-0; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Griffiths G.C.D., 1972, Series Ent, V8, P1; Grimaldi David, 2005, pi; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Han HY, 2000, BIOCHEM SYST ECOL, V28, P501, DOI 10.1016/S0305-1978(99)00097-6; HENNIG W, 1976, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), P1; Jiang ST, 2009, INT J BIOL SCI, V5, P351; Junqueira ACM, 2004, GENE, V339, P7, DOI 10.1016/j.gene.2004.06.031; Krzeminski Wieslaw, 1994, Acta Zoologica Cracoviensia, V37, P95; Krzywinski J, 2006, MOL PHYLOGENET EVOL, V39, P417, DOI 10.1016/j.ympev.2006.01.006; Krzywinski J, 2011, MOL PHYLOGENET EVOL, V58, P469, DOI 10.1016/j.ympev.2011.01.003; Kutty SN, 2010, SYST ENTOMOL, V35, P614, DOI 10.1111/j.1365-3113.2010.00536.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lessinger AC, 2000, MED VET ENTOMOL, V14, P71, DOI 10.1046/j.1365-2915.2000.00209.x; Lessinger AC, 2004, GENE, V339, P1, DOI 10.1016/j.gene.2004.06.041; Lessinger AC, 2000, INSECT MOL BIOL, V9, P521, DOI 10.1046/j.1365-2583.2000.00215.x; Lewis DL, 1995, INSECT MOL BIOL, V4, P263, DOI 10.1111/j.1365-2583.1995.tb00032.x; LIU YQ, 2002, FAUNA SINICA INSECT, V27, P315; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Matsumoto Y, 2009, MED VET ENTOMOL, V23, P47, DOI 10.1111/j.1365-2915.2008.00789.x; McAlpine JF, 1989, MONOGRAPH, V3, P1397; MITCHELL SE, 1993, GENOME, V36, P1058, DOI 10.1139/g93-141; Moreno M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-127; Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627; Nardi F, 2010, MOL PHYLOGENET EVOL, V57, P678, DOI 10.1016/j.ympev.2010.08.008; Nelson LA, 2012, GENE, V511, P131, DOI 10.1016/j.gene.2012.09.103; Nelson LA, 2012, MITOCHONDR DNA, V23, P42, DOI 10.3109/19401736.2011.644042; Nelson LA, 2011, MITOCHONDR DNA, V22, P197, DOI 10.3109/19401736.2011.632896; Nirmala X, 2001, INSECT MOL BIOL, V10, P475, DOI 10.1046/j.0962-1075 .2001.00286.x; O'Hara JE, 2009, ZOOTAXA, P1; O'Hara JE, 2010, WORLD GENERA TACHINI; Oliveira MT, 2006, J MED ENTOMOL, V43, P636, DOI 10.1603/0022-2585(2006)43[636:IATTCR]2.0.CO;2; Oliveira MT, 2007, J MOL EVOL, V64, P519, DOI 10.1007/s00239-006-0099-6; Oliveira MT, 2008, MOL PHYLOGENET EVOL, V48, P850, DOI 10.1016/j.ympev.2008.05.022; PAPE T, 1992, Tijdschrift voor Entomologie, V135, P43; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A., 2007, TRACER V1 4; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Scheffer SJ, 2006, ANN ENTOMOL SOC AM, V99, P991, DOI 10.1603/0013-8746(2006)99[991:MPOTVP]2.0.CO;2; Shao YJ, 2012, MOL BIOL REP, V39, P11023, DOI 10.1007/s11033-012-2005-1; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Singh VK, 1998, BIOTECHNIQUES, V24, P318, DOI 10.2144/98242pf02; Spanos L, 2000, INSECT MOL BIOL, V9, P139, DOI 10.1046/j.1365-2583.2000.00165.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stireman JO, 2002, SYST ENTOMOL, V27, P409, DOI 10.1046/j.1365-3113.2002.00187.x; Tachi T, 2010, SYST ENTOMOL, V35, P148, DOI 10.1111/j.1365-3113.2009.00497.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Torres TT, 2009, NUCLEIC ACIDS RES, V37, P7509, DOI 10.1093/nar/gkp856; von Tschirnhaus Michael, 2009, Denisia, P171; Wang S., 2009, MOL BIOL REP, V38, P687; Weigl S, 2010, MED VET ENTOMOL, V24, P329, DOI 10.1111/j.1365-2915.2010.00873.x; Wiegmann BM, 2003, SYST BIOL, V52, P745, DOI [10.1080/10635150390250965, 10.1093/sysbio/52.6.745]; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; Winkler IS, 2010, J PALEONTOL, V84, P935, DOI 10.1666/09-163.1; Yang F, 2011, GENE, V485, P7, DOI 10.1016/j.gene.2011.05.030; Ye Jun, 2010, Plant Quarantine (Shanghai), V24, P11; Yeates DK, 2007, ZOOTAXA, P565, DOI 10.11646/zootaxa.1668.1.27; Yu DJ, 2007, GENE, V396, P66, DOI 10.1016/j.gene.2007.02.023; Zhao JL, 2011, MOL BIOL REP, V38, P3757, DOI 10.1007/s11033-010-0491-6; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	71	141	147	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61814	10.1371/journal.pone.0061814	http://dx.doi.org/10.1371/journal.pone.0061814			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23349680	gold, Green Submitted, Green Published			2022-12-25	WOS:000318008400098
J	Liu, XQ; Zhou, CL; Li, YJ; Ji, Y; Xu, GP; Wang, XT; Yan, JL				Liu, Xiaoqi; Zhou, Changlong; Li, Yanjing; Ji, Ye; Xu, Gongping; Wang, Xintao; Yan, Jinglong			SDF-1 Promotes Endochondral Bone Repair during Fracture Healing at the Traumatic Brain Injury Condition	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HEAD-INJURY; ENHANCED OSTEOGENESIS; IN-VITRO; MYOCARDIAL-INFARCTION; MARROW; GROWTH; MIGRATION; MODEL; RATS	Purposes: The objective of this study was to investigate the role of stromal cell-derived factor-1 (SDF-1) and its receptor, CXCR4, on bone healing and whether SDF-1 contributes to accelerating bone repair in traumatic brain injury (TBI)/fracture model. Materials and Methods: Real-time polymerase chain reaction and immunohistochemical analysis were used to detect the expression of SDF-1 during the repair of femoral bone in TBI/fracture model. The TBI/fracture model was treated with anti-SDF-1 neutralizing antibody or AMD3100, an antagonist for CXCR4, and evaluated by histomorphometry. In vitro and in vivo migration assays were used to evaluate the functional effect of SDF-1 on primary mesenchymal stem cells. Results: The expression of SDF1 and CXCR4 messenger RNA was increased during the bone healing in TBI/fracture model but was less increased in fracture only model. High expression of SDF-1 protein was observed in the surrounding tissue of the damaged bone. Treated with anti-SDF-1 antibody or AMD3100 could inhibit new bone formation. SDF-1 increased mesenchymal stem cell chemotaxis in vitro in a dose-dependent manner. The in vivo migration study demonstrated that mesenchymal stem cells recruited by SDF-1 participate in endochondral bone repair. Conclusion: The SDF-1/CXCR4 axis plays a crucial role in the accelerating fracture healing under the condition of TBI and contributes to endochondral bone repair.	[Liu, Xiaoqi; Zhou, Changlong; Li, Yanjing; Ji, Ye; Xu, Gongping; Wang, Xintao; Yan, Jinglong] Harbin Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Harbin, Peoples R China	Harbin Medical University	Yan, JL (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Harbin, Peoples R China.	yanjlhyd@hotmail.com		John, Ciny/0000-0003-3688-0751; Liu, Geoffrey/0000-0002-2603-7296	National Natural Science Foundation of China [100334]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China (100334) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Beeton CA, 2004, J BONE JOINT SURG BR, V86B, P912, DOI 10.1302/0301-620x.86b6.14176; BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Castano-Izquierdo H, 2007, J BIOMED MATER RES A, V82A, P129, DOI 10.1002/jbm.a.31082; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Guo ZK, 2006, STEM CELLS, V24, P992, DOI 10.1634/stemcells.2005-0224; HaraIrie F, 1996, BONE, V18, P29, DOI 10.1016/8756-3282(95)00425-4; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; Jung Y, 2006, BONE, V38, P497, DOI 10.1016/j.bone.2005.10.003; Khare G N, 1995, Indian J Med Sci, V49, P281; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Kucia M, 2004, BLOOD CELL MOL DIS, V32, P52, DOI 10.1016/j.bcmd.2003.09.025; Liu XQ, 2012, BIOTECHNOL LETT, V34, P387, DOI 10.1007/s10529-011-0757-7; Ma J, 2005, BASIC RES CARDIOL, V100, P217, DOI 10.1007/s00395-005-0521-z; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mori T, 2004, MOL CANCER THER, V3, P29; Otfinowski Janusz, 1993, Patologia Polska, V44, P133; RENFREE KJ, 1994, SPINE, V19, P740, DOI 10.1097/00007632-199404000-00002; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; SPENCER RF, 1990, S AFR J SURG, V28, P51; SPENCER RF, 1987, J BONE JOINT SURG BR, V69, P525, DOI 10.1302/0301-620X.69B4.3611151; Sun YX, 2005, J BONE MINER RES, V20, P318, DOI 10.1359/JBMR.041109; Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144; Tiyapatanaputi P, 2004, J ORTHOP RES, V22, P1254, DOI 10.1016/j.orthres.2004.03.017; Togel F, 2005, KIDNEY INT, V67, P1772, DOI 10.1111/j.1523-1755.2005.00275.x; Tsur A, 1996, BRAIN INJURY, V10, P259, DOI 10.1080/026990596124430; Wieczorek G, 2003, CELL TISSUE RES, V311, P227, DOI 10.1007/s00441-002-0671-3; WILDBURGER R, 1995, EUR J CLIN CHEM CLIN, V33, P693; WILDBURGER R, 1994, BONE MINER, V27, P183, DOI 10.1016/S0169-6009(08)80192-4; WILDBURGER R, 1994, RES EXP MED, V194, P247, DOI 10.1007/BF02576386; Wildburger R, 1998, J ENDOCRINOL INVEST, V21, P78, DOI 10.1007/BF03350319; Zhang G, 2007, TISSUE ENG, V13, P2063, DOI 10.1089/ten.2006.0013	35	100	110	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54077	10.1371/journal.pone.0054077	http://dx.doi.org/10.1371/journal.pone.0054077			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	24130878	Green Published, gold, Green Submitted			2022-12-25	WOS:000314019100041
J	Li, S; Jin, XK; Guo, XN; Yu, AQ; Wu, MH; Tan, SJ; Zhu, YT; Li, WW; Wang, Q				Li, Shuang; Jin, Xing-Kun; Guo, Xiao-Nv; Yu, Ai-Qing; Wu, Min-Hao; Tan, Shang-Jian; Zhu, You-Ting; Li, Wei-Wei; Wang, Qun			A Double WAP Domain-Containing Protein Es-DWD1 from Eriocheir sinensis Exhibits Antimicrobial and Proteinase Inhibitory Activities	PLOS ONE			English	Article							WHEY ACIDIC PROTEIN; CHINESE MITTEN CRAB; CRUSTIN-LIKE GENE; C-TYPE LECTIN; MOLECULAR-CLONING; WHITE SHRIMP; ALPHA-2-MACROGLOBULIN ALPHA-2-M; RECOMBINANT EXPRESSION; ANTIBACTERIAL PROTEINS; PEPTIDE	Whey acidic proteins (WAP) belong to a large gene family of antibacterial peptides, which are critical in the host immune response against microbial invasion. The common feature of these proteins is a single WAP domain maintained by at least one four-disulfide core (4-DSC) structure rich in cysteine residues. In this study, a double WAP domain (DWD)-containing protein, Es-DWD1, was first cloned from the Chinese mitten crab (Eriocheir sinensis). The full-length Es-DWD1cDNA was 1193 bp, including a 411 bp open reading frame (ORF) encoding 136 amino acids with a signal peptide of 22 amino acids in the N-terminus. A comparison with other reported invertebrate and vertebrate sequences revealed the presence of WAP domains characteristic of WAP superfamilies. As determined by quantitative real-time RT-PCR, Es-DWD1 transcripts were ubiquitously expressed in all tissues, but it was upregulated in hemocytes post-challenge with pathogen-associated molecular patterns (PAMPs). The mature recombinant Es-DWD1 (rEs-DWD1) protein exhibited different binding activities to bacteria and fungus. Moreover, rEs-DWD1 could exert agglutination activities against Bacillus subtilis and Pichia pastoris and demonstrated inhibitory activities against the growth of Staphylococcus aureus, Aeromonas hydrophila and P. pastoris. Furthermore, rEs-DWD1 showed a specific protease inhibitory activity in B. subtilis. Coating of rEs-DWD1 onto agarose beads enhanced encapsulation of the beads by crab hemocytes. Collectively, the results suggest that Es-DWD1 is a double WAP domain containing protein with antimicrobial and proteinase inhibitory activities, which play significant roles in the immunity of crustaceans.	[Li, Shuang; Jin, Xing-Kun; Guo, Xiao-Nv; Yu, Ai-Qing; Wu, Min-Hao; Tan, Shang-Jian; Zhu, You-Ting; Li, Wei-Wei; Wang, Qun] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China	East China Normal University	Wang, Q (corresponding author), E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China.	qwang@bio.ecnu.edu.cn	Wang, Qun/I-7778-2013; Zhang, Quanfa/H-1922-2011; LI, WEIWEI/J-3538-2013; Jin, Xingkun/H-4366-2013; Li, Siyue/DCN-3040-2022; Li, Siyue/E-8297-2012	Wang, Qun/0000-0001-7929-7692; Jin, Xingkun/0000-0003-2454-1621; Li, Siyue/0000-0002-3097-6819; Li, Siyue/0000-0002-3097-6819; li, si yue/0000-0002-4550-892X	National Natural Science Foundation of China [31172393]; National Science and Technology Support Program of China [2012BAD26B04-04]; Innovation Program of Shanghai Municipal Education Commission [13zz031]; National Research Foundation for the Doctoral Program of Higher Education of China [20110076110016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program of China; Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); National Research Foundation for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This research was supported by grants from the National Natural Science Foundation of China (No. 31172393), the National Science and Technology Support Program of China (2012BAD26B04-04), the Innovation Program of Shanghai Municipal Education Commission (13zz031) and the National Research Foundation for the Doctoral Program of Higher Education of China (20110076110016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amparyup P, 2008, DEV COMP IMMUNOL, V32, P1497, DOI 10.1016/j.dci.2008.06.005; Amparyup P, 2008, MOL IMMUNOL, V45, P1085, DOI 10.1016/j.molimm.2007.07.031; ARAKI K, 1989, BIOCHEM BIOPH RES CO, V164, P496, DOI 10.1016/0006-291X(89)91747-6; AVIDOR Y, 1953, J BACTERIOL, V66, P1, DOI 10.1002/path.1700660103; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Chen A, 2008, FISH SHELLFISH IMMUN, V25, P775, DOI 10.1016/j.fsi.2008.02.017; CORONEL CE, 1990, J BIOL CHEM, V265, P6854; Davey GC, 2001, GENE, V263, P121, DOI 10.1016/S0378-1119(00)00587-4; DEAR TN, 1988, CANCER RES, V48, P5203; Du ZQ, 2009, COMP BIOCHEM PHYS B, V154, P203, DOI 10.1016/j.cbpb.2009.06.004; Du ZQ, 2010, FISH SHELLFISH IMMUN, V28, P134, DOI 10.1016/j.fsi.2009.10.009; DYAR MT, 1946, J BACTERIOL, V51, P149, DOI 10.1128/JB.51.2.149-167.1946; Gollas-Galvan T, 2003, COMP BIOCHEM PHYS C, V134, P431, DOI 10.1016/S1532-0456(03)00002-4; Gowda NM, 2008, J INVERTEBR PATHOL, V99, P141, DOI 10.1016/j.jip.2008.04.003; Hagiwara K, 2003, J IMMUNOL, V170, P1973, DOI 10.4049/jimmunol.170.4.1973; HALL M, 1989, FEBS LETT, V254, P111, DOI 10.1016/0014-5793(89)81019-1; Hauton C, 2006, MOL IMMUNOL, V43, P1490, DOI 10.1016/j.molimm.2005.07.029; He L, PLOS ONE, V20127; HENNIGHAUSEN LG, 1982, NUCLEIC ACIDS RES, V10, P2677, DOI 10.1093/nar/10.8.2677; Hiemstra PS, 1996, INFECT IMMUN, V64, P4520, DOI 10.1128/IAI.64.11.4520-4524.1996; Jia YP, 2008, AQUACULTURE, V284, P246, DOI 10.1016/j.aquaculture.2008.07.046; Jiang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011175; Jimenez-Vega F, 2005, DEV COMP IMMUNOL, V29, P385, DOI 10.1016/j.dci.2004.10.001; Jimenez-Vega F, 2007, FISH SHELLFISH IMMUN, V23, P1119, DOI 10.1016/j.fsi.2007.06.006; JOHANSSON MW, 1994, EUR J BIOCHEM, V223, P389, DOI 10.1111/j.1432-1033.1994.tb19005.x; Krusong K, 2012, DEV COMP IMMUNOL, V36, P208, DOI 10.1016/j.dci.2011.08.002; Li FM, 2012, DEV COMP IMMUNOL, V36, P183, DOI 10.1016/j.dci.2011.07.003; Liang ZC, 1997, P NATL ACAD SCI USA, V94, P6682, DOI 10.1073/pnas.94.13.6682; LIANG ZC, 1995, COMP BIOCHEM PHYS B, V112, P385, DOI 10.1016/0305-0491(95)00105-0; Lin YC, 2008, DEV COMP IMMUNOL, V32, P317, DOI 10.1016/j.dci.2007.07.002; Lin YC, 2007, MOL IMMUNOL, V44, P1065, DOI 10.1016/j.molimm.2006.08.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mu CK, 2011, FISH SHELLFISH IMMUN, V31, P142, DOI 10.1016/j.fsi.2011.04.013; Mu CK, 2010, DEV COMP IMMUNOL, V34, P734, DOI 10.1016/j.dci.2010.02.001; Nile CJ, 2006, MOL IMMUNOL, V43, P388, DOI 10.1016/j.molimm.2005.02.015; Pech LL, 1996, J CELL SCI, V109, P2053; Ranganathan S, 1999, J MOL GRAPH MODEL, V17, P106, DOI 10.1016/S1093-3263(99)00023-6; Rattanachai A, 2004, FISH SHELLFISH IMMUN, V16, P599, DOI 10.1016/j.fsi.2003.09.011; Ren Q, 2009, FISH SHELLFISH IMMUN, V27, P739, DOI 10.1016/j.fsi.2009.09.007; Sallenave JM, 2002, BIOCHEM SOC T, V30, P111, DOI 10.1042/BST0300111; Smith VJ, 2008, DEV COMP IMMUNOL, V32, P758, DOI 10.1016/j.dci.2007.12.002; Smith VJ, 2011, BIOCHEM SOC T, V39, P1403, DOI 10.1042/BST0391403; Smith VJ, 2001, ADV EXP MED BIOL, V484, P95; Snedecor G., 1971, STAT METHODS; SODERHALL K, 1983, DEV COMP IMMUNOL, V7, P229, DOI 10.1016/0145-305X(83)90004-6; Somprasong N, 2006, DEV COMP IMMUNOL, V30, P998, DOI 10.1016/j.dci.2006.01.004; Sperstad SV, 2009, DEV COMP IMMUNOL, V33, P583, DOI 10.1016/j.dci.2008.10.010; Supungul P, 2002, MAR BIOTECHNOL, V4, P487, DOI 10.1007/s10126-002-0043-8; Tomee JFC, 1997, J INFECT DIS, V176, P740, DOI 10.1086/514098; Van Harreveld A, 1936, P SOC EXP BIOL MED, V34, P428; Vargas-Albores F, 2004, COMP BIOCHEM PHYS B, V138, P415, DOI 10.1016/j.cbpc.2004.05.007; Wang W, 2004, RES MICROBIOL, V155, P630, DOI 10.1016/j.resmic.2004.04.010; WIEDOW O, 1990, J BIOL CHEM, V265, P14791; Wu HX, 2004, J INVERTEBR PATHOL, V86, P59, DOI 10.1016/j.jip.2004.03.010; Yang JL, 2010, DEV COMP IMMUNOL, V34, P1274, DOI 10.1016/j.dci.2010.07.004; Yang WL, 2005, CHIN J FRESHWATER FI, V35, P62; Yenugu S, 2004, BIOL REPROD, V71, P1484, DOI 10.1095/biolreprod.104.031567; Yu YH, 2007, J IMMUNOL, V179, P8425, DOI 10.4049/jimmunol.179.12.8425; Zhang JQ, 2007, J BIOTECHNOL, V127, P605, DOI 10.1016/j.jbiotec.2006.08.013; Zhang Shu-yong, 2002, Virologica Sinica, V17, P263	61	177	190	4	181	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e73563	10.1371/journal.pone.0073563	http://dx.doi.org/10.1371/journal.pone.0073563			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967346	gold, Green Published, Green Submitted			2022-12-25	WOS:000323115800122
J	Zhao, ZG; Zhang, JW; He, J; Zeng, GH				Zhao, Zhigang; Zhang, Jingwei; He, Jun; Zeng, Guohua			Clinical Utility of the UPOINT Phenotype System in Chinese Males with Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS): A Prospective Study	PLOS ONE			English	Article							SEXUAL DYSFUNCTION; ERECTILE DYSFUNCTION; SYMPTOM INDEX; MEN; PREVALENCE; CLASSIFICATION; MULTICENTER; MECHANISMS; DISEASE; IMPACT	Background: Recent data showed that a six-domain UPOINT is a flexible and responsive new classification system that has the clinical applicability in CP/CPPS. However, the utility of UPOINT algorithm in men in China with CP/CPPS has not been comprehensively studied. For international validation and adoption, we evaluated this clinical phenotype system for a large cohort of Chinese CP/CPPS patients and correlated it with patient symptoms and erectile dysfunction (ED). We also investigated the addition of an ED domain in regard to symptom correlation. Methods: A total of 389 Chinese males with CP/CPPS were prospectively collected and classified in each domain of the UPOINT system. Symptom severity was measured using the NIH-CPSI and IPSS. The erectile function was evaluated using the IIEF-5. Clinically relevant associations were calculated. Results: The percentage of patients positive for each domain was 54.0%, 42.1%, 41.9%, 20.8%, 26.7%, and 40.4% for the Urinary, Psychosocial, Organ-specific, Infection, Neurological/systemic, and Tenderness, respectively. There were significant correlations between the number of positive UPOINT domains and total NIH-CPSI (r = 0.706, p<0.001), IPSS (r = 0.682, p<0.001) and IIEF-5 scores (r = 0.631, P = 0.007) in Chinese cohort. Except for patients age, symptom duration was associated with a significantly greater number of positive domains (r = 0.638, P = 0.005). After adding an ED domain to create a modified UPOINT system, the correlation between the number of phenotypic domains and symptom severity was improved (0.706 to 0.844, p<0.001). Conclusions: The clinical applicability of using UPOINT phenotyping system has been validated in the Chinese patients with CP/CPPS. In our cohort, the number of positive domains was also correlated with ED symptoms and the significant association between the number of UPOINT domains and NIH-CPSI scores was further refined by adding a domain for ED. Our findings presented here support the utility of using ED as a stand-alone item in the UPOINT domain.	[Zhao, Zhigang; Zhang, Jingwei; He, Jun; Zeng, Guohua] Guangzhou Med Univ, Affiliated Hosp 1, Guangdong Prov Key Lab Urol, Dept Urol & Androl,Minimally Invas Surg Ctr, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University	Zeng, GH (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Guangdong Prov Key Lab Urol, Dept Urol & Androl,Minimally Invas Surg Ctr, Guangzhou, Guangdong, Peoples R China.	zgzhaodr@yahoo.com.cn	Chesters, Douglas/AAF-7926-2019; ZHU, Chao-Dong/E-5961-2011; Ho, Simon YW/A-8417-2008; Su, Tianjuan/AAJ-6290-2021	ZHU, Chao-Dong/0000-0002-9347-3178; Ho, Simon YW/0000-0002-0361-2307; 	NHLBI NIH HHS [R01 HL97979, R01 HL097979] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson RU, 2006, J UROLOGY, V176, P1534, DOI 10.1016/j.juro.2006.06.010; Bartoletti R, 2007, J UROLOGY, V178, P2411, DOI 10.1016/j.juro.2007.08.046; Calhoun EA, 2004, ARCH INTERN MED, V164, P1231; Chou YH., 2011, INCONT PELVIC FLOOR, V5, P31; Chung SD, 2012, BJU INT, V110, P726, DOI 10.1111/j.1464-410X.2011.10807.x; Collins MM, 2001, J GEN INTERN MED, V16, P656; Davis SNP, 2009, J SEX MARITAL THER, V35, P182, DOI 10.1080/00926230802716310; Eryildirim B, 2010, INT J IMPOT RES, V22, P349, DOI 10.1038/ijir.2010.26; Gonen M, 2005, J ANDROL, V26, P601, DOI 10.2164/jandrol.04159; Hedelin HH, 2009, SCAND J UROL NEPHROL, V43, P373, DOI 10.3109/00365590903164514; Krieger JN, 1999, JAMA-J AM MED ASSOC, V282, P236, DOI 10.1001/jama.282.3.236; Krieger JN, 2002, UROLOGY, V60, P959, DOI 10.1016/S0090-4295(02)01963-5; Lee SWH, 2008, UROLOGY, V71, P79, DOI 10.1016/j.urology.2007.08.043; Liang CZ, 2009, J UROLOGY, V182, P558, DOI 10.1016/j.juro.2009.04.011; Liang CZ, 2004, BJU INT, V93, P568, DOI 10.1111/j.1464-410X.2003.04662.x; Litwin MS, 1999, J UROLOGY, V162, P369, DOI 10.1016/S0022-5347(05)68562-X; Magri V, 2010, J UROLOGY, V184, P2339, DOI 10.1016/j.juro.2010.08.025; Magri Vittorio, 2008, Arch Ital Urol Androl, V80, P172; Muller Alexander, 2006, Curr Urol Rep, V7, P307, DOI 10.1007/s11934-996-0010-4; Perlmutter AE, 2011, INTERNET J UROLOGY, V9, P1, DOI [10.5580/c54, DOI 10.5580/C54]; Pontari MA, 2004, J UROLOGY, V172, P839, DOI 10.1097/01.ju.0000136002.76898.04; Pontari MA, 2008, J UROLOGY, V179, pS61, DOI 10.1016/j.juro.2008.03.139; Propert KJ, 2006, QUAL LIFE RES, V15, P299, DOI 10.1007/s11136-005-1317-1; Propert KJ, 2006, J UROLOGY, V175, P619, DOI 10.1016/S0022-5347(05)00233-8; Rosen RC, 1999, INT J IMPOT RES, V11, P319, DOI 10.1038/sj.ijir.3900472; Samplaski MK, 2011, UROLOGY, V78, P653, DOI 10.1016/j.urology.2011.04.016; Schaeffer AJ, 2006, 6 INT C NEW DEV PROS, P343; Shoskes DA, 2009, PROSTATE CANCER P D, V12, P177, DOI 10.1038/pcan.2008.42; Shoskes DA, 2012, CURR UROL REP, V13, P263, DOI 10.1007/s11934-012-0254-0; Shoskes DA, 2011, J UROLOGY, V186, P907, DOI 10.1016/j.juro.2011.04.063; Shoskes DA, 2010, UROLOGY, V75, P1249, DOI 10.1016/j.urology.2010.01.021; Shoskes DA, 2009, UROLOGY, V73, P538, DOI 10.1016/j.urology.2008.09.074; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Tan HM, 2012, J SEX MED, V9, P663, DOI 10.1111/j.1743-6109.2011.02582.x; Trinchieri Alberto, 2007, Arch Ital Urol Androl, V79, P67; Tuncel A, 2006, INT UROL NEPHROL, V38, P583, DOI 10.1007/s11255-006-0087-1; Wagenlehner FME, 2009, EUR UROL, V56, P544, DOI 10.1016/j.eururo.2009.05.046	37	141	147	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e52044	10.1371/journal.pone.0052044	http://dx.doi.org/10.1371/journal.pone.0052044			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349680	Green Published, gold, Green Submitted			2022-12-25	WOS:000313738900004
J	Li, SY; Xia, XL; Tan, X; Zhang, QF				Li, Siyue; Xia, Xiaoling; Tan, Xiang; Zhang, Quanfa			Effects of Catchment and Riparian Landscape Setting on Water Chemistry and Seasonal Evolution of Water Quality in the Upper Han River Basin, China	PLOS ONE			English	Article							MAJOR-ELEMENT CHEMISTRY; LAND-USE; ALPINE/SUBALPINE BASINS; ION COMPOSITIONS; GEOCHEMISTRY; COVER; NITROGEN; IMPACT; FLUXES; RATES	Six-year (2005-2010) evolution of water chemistry (Cl-, NO3-, SO42-, HCO3-, Na+, K+, Ca2+ and Mg2+) and their interactions with morphological properties (i.e., slope and area), land cover, and hydrological seasonality were examined to identify controlling factors and processes governing patterns of stream water quality in the upper Han River, China. Correlation analysis and stepwise multiple regression models revealed significant correlations between ions (i.e., Cl-, SO42-, Na+ and K+) and land cover (i.e., vegetation and bare land) over the entire catchment in both high-and low-flow periods, and in the buffer zone the correlation was much more stronger in the low-flow period. Catchment with steeper slope (>15 degrees) was negatively correlated with major ions, largely due to multicollinearity of basin characteristics. Land cover within the buffer zone explained slightly less of major elements than at catchment scale in the rainy season, whereas in the dry season, land cover along the river networks in particular this within 100 m riparian zone much better explained major elements rather than this over the entire catchment. Anthropogenic land uses (i.e., urban and agriculture) however could not explain water chemical variables, albeit EC, TDS, anthropogenic markers (Cl-, NO3-, SO42), Na+, K+ and Ca2+ significantly increased during 2005-2010, which was corroborated by principal component analyses (PCA) that indicated anthropogenic inputs. Observations demonstrated much higher solute concentrations in the industrial-polluted river. Our results suggested that seasonal evolution of water quality in combined with spatial analysis at multiple scales should be a vital part of identifying the controls on spatio-temporal patterns of water quality.	[Li, Siyue; Xia, Xiaoling; Tan, Xiang; Zhang, Quanfa] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS	Li, SY (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Peoples R China.	lisiyue@wbgcas.cn; qzhang@wbgcas.cn	Wang, Qun/I-7778-2013; Zhang, Quanfa/H-1922-2011; LI, WEIWEI/J-3538-2013; Jin, Xingkun/H-4366-2013; Li, Siyue/DCN-3040-2022; Li, Siyue/E-8297-2012	Wang, Qun/0000-0001-7929-7692; Jin, Xingkun/0000-0003-2454-1621; Li, Siyue/0000-0002-3097-6819; Li, Siyue/0000-0002-3097-6819; li, si yue/0000-0002-4550-892X	National Natural Science Foundation of China [31100347, 31130010]; Youth Innovation Promotion Association; Chinese Academy of Sciences, China [Y129431C06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association; Chinese Academy of Sciences, China(Chinese Academy of Sciences)	The research is funded by the National Natural Science Foundation of China (31100347 and 31130010) and Youth Innovation Promotion Association, the Chinese Academy of Sciences, China (Y129431C06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RB, 2000, NATURE, V403, P758, DOI 10.1038/35001562; Anshumali, 2007, APPL GEOCHEM, V22, P1736, DOI 10.1016/j.apgeochem.2007.03.045; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Chang H, 2008, WATER RES, V42, P3285, DOI 10.1016/j.watres.2008.04.006; Chen JS, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002325; Chen JS, 2002, CHEM GEOL, V187, P231, DOI 10.1016/S0009-2541(02)00032-3; Chinese Ministry of Health, 2006, GB5749 CHIN MIN HLTH; Clow DW, 2000, WATER RESOUR RES, V36, P49, DOI 10.1029/1999WR900294; Dodds WK, 1998, WATER RES, V32, P1455, DOI 10.1016/S0043-1354(97)00370-9; Gaillardet J, 1999, CHEM GEOL, V159, P3, DOI 10.1016/S0009-2541(99)00031-5; Garcia-Esteves J, 2007, APPL GEOCHEM, V22, P230, DOI 10.1016/j.apgeochem.2006.09.013; GIBBS RJ, 1970, SCIENCE, V170, P1088, DOI 10.1126/science.170.3962.1088; HU MH, 1982, NATURE, V298, P550, DOI 10.1038/298550a0; HUNSAKER CT, 1995, BIOSCIENCE, V45, P193, DOI 10.2307/1312558; Iqbal J, 2011, J HAZARD MATER, V192, P887, DOI 10.1016/j.jhazmat.2011.05.105; Johnson LB, 1997, FRESHWATER BIOL, V37, P193, DOI 10.1046/j.1365-2427.1997.d01-539.x; Li SY, 2009, J HAZARD MATER, V162, P1340, DOI 10.1016/j.jhazmat.2008.06.059; Li SY, 2008, CATENA, V75, P216, DOI 10.1016/j.catena.2008.06.005; Li SY, 2009, J HAZARD MATER, V170, P605, DOI 10.1016/j.jhazmat.2009.05.022; Li SY, 2009, CHEM GEOL, V264, P89, DOI 10.1016/j.chemgeo.2009.02.021; Li SY, 2008, APPL GEOCHEM, V23, P3535, DOI 10.1016/j.apgeochem.2008.08.012; Li SY, 2009, J HAZARD MATER, V165, P317, DOI 10.1016/j.jhazmat.2008.09.123; MEYBECK M, 1987, AM J SCI, V287, P401, DOI 10.2475/ajs.287.5.401; Meybeck M, 2005, TREATISE GEOCHEM, V5, P207; Meynendonckx J, 2006, HYDROL EARTH SYST SC, V10, P913, DOI 10.5194/hess-10-913-2006; OSBORNE LL, 1988, J ENVIRON MANAGE, V26, P9; PEIERLS BL, 1991, NATURE, V350, P386, DOI 10.1038/350386b0; Pratt B, 2012, J HAZARD MATER, V209, P48, DOI 10.1016/j.jhazmat.2011.12.068; PROSPERO JM, 1989, NATURE, V339, P687, DOI 10.1038/339687a0; Sliva L, 2001, WATER RES, V35, P3462, DOI 10.1016/S0043-1354(01)00062-8; STALLARD RF, 1983, J GEOPHYS RES-OCEANS, V88, P9671, DOI 10.1029/JC088iC14p09671; Stark JM, 1997, NATURE, V385, P61, DOI 10.1038/385061a0; Sueker JK, 2001, HYDROL PROCESS, V15, P2749, DOI 10.1002/hyp.265; Varol M, 2011, J HAZARD MATER, V195; Varol M, 2012, CATENA, V92, P11, DOI 10.1016/j.catena.2011.11.013; WHO, 2006, GUID DRINK WAT QUAL, V1; Wu WH, 2008, CHEM GEOL, V249, P307, DOI 10.1016/j.chemgeo.2008.01.025; ZHANG J, 1995, J HYDROL, V168, P173, DOI 10.1016/0022-1694(94)02635-O; Zhang LA, 2011, APPL GEOCHEM, V26, P293, DOI 10.1016/j.apgeochem.2010.12.002; Zhang SR, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000493	40	177	190	4	181	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53163	10.1371/journal.pone.0053163	http://dx.doi.org/10.1371/journal.pone.0053163			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23967346	Green Published, Green Submitted, gold			2022-12-25	WOS:000314019100016
J	Zhang, XY; Sun, Q; Shan, M; Niu, M; Liu, T; Xia, BS; Liang, XS; Wei, W; Sun, SS; Zhang, YX; Liu, XS; Song, QB; Yang, YM; Ma, YY; Liu, Y; Yang, L; Ren, YL; Zhang, GQ; Pang, D				Zhang, Xianyu; Sun, Qian; Shan, Ming; Niu, Ming; Liu, Tong; Xia, Bingshu; Liang, Xiaoshuan; Wei, Wei; Sun, Shanshan; Zhang, Youxue; Liu, Xiaolong Sean; Song, Qingbin; Yang, Yanmei; Ma, Yuyan; Liu, Yang; Yang, Long; Ren, Yanlv; Zhang, Guoqiang; Pang, Da			Promoter Hypermethylation of ARID1A Gene Is Responsible for Its Low mRNA Expression in Many Invasive Breast Cancers	PLOS ONE			English	Article							CLEAR-CELL CARCINOMA; SOMATIC MUTATIONS; SWI/SNF COMPLEXES; PROTEIN P270; EPIGENETICS; COMPONENT	ARID1A (AT-rich interactive domain 1A) has recently been identified as a tumor suppressor gene. Its mRNA expression is significantly low in many breast cancers; this is often associated with more aggressive phenotypes. However, the underlying molecular mechanism for its low expression has not been fully understood. This study was undertaken to evaluate the contribution of gene copy number variation, mutations, promoter methylation and histone modification to ARID1A's low expression. 38 pairs of breast invasive ductal carcinomas and their normal breast tissue counterparts from the same patients were randomly selected for gene expression and copy number variation detection. Promoter methylation and histone modification levels were evaluated by MeDIP-qPCR and ChIP-qPCR, respectively. PCR product Sanger sequencing was carried out to detect the exon mutation rate. Twenty-two out of 38 invasive ductal carcinomas in the study (57.9%) revealed ARID1A mRNA low expression by realtime RT-PCR. The relative promoter methylation level was, significantly higher in ARID1A mRNA low expression group compared with its high expression group (p<0.001). In the low expression group, nineteen out of 22 invasive ductal carcinomas (86.4%) exhibited ARID1A promoter hypermthylation. In addition, the promoter hypermethylation was accompanied with repressive histone modification (H3K27Me3). Although five out of 38 invasive ductal carcinomas (13.2%) exhibited loss of ARID1A gene copy number by realtime PCR and nine exon novel mutations are seen from eight out of 33 invasive ductal carcinomas (24.2%), there was no statistically significant difference in both ARID1A mRNA low and high expression groups (p = 0.25, and p = 0.68, respectively). We demonstrate that promoter hypermethylation was the main culprit for ARID1A mRNA low expression in invasive ductal carcinomas. The influence of mutation and copy number variation on the expression were statistically insignificant at mRNA level, and were, therefore, not considered the main causes for ARID1A mRNA low expression in invasive breast cancer.	[Zhang, Xianyu; Sun, Qian; Shan, Ming; Niu, Ming; Liu, Tong; Xia, Bingshu; Liang, Xiaoshuan; Wei, Wei; Sun, Shanshan; Zhang, Youxue; Ren, Yanlv; Zhang, Guoqiang; Pang, Da] Harbin Med Univ, Dept Breast Surg, Affiliated Hosp 3, Harbin, Heilongjiang, Peoples R China; [Liu, Xiaolong Sean] Harbin Med Univ, Dept Pathol, Affiliated Hosp 3, Harbin, Heilongjiang, Peoples R China; [Song, Qingbin] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Yang, Yanmei; Ma, Yuyan; Pang, Da] Heilongjiang Inst Canc Res, Key Lab, Harbin, Heilongjiang, Peoples R China; [Yang, Long] Life Technol Corp, ICFC Custom Serv, Beijing, Peoples R China	Harbin Medical University; Harbin Medical University; Icahn School of Medicine at Mount Sinai; Thermo Fisher Scientific	Pang, D (corresponding author), Harbin Med Univ, Dept Breast Surg, Affiliated Hosp 3, Harbin, Heilongjiang, Peoples R China.	pangda@ems.hrbmu.edu.cn	Zhang, Guo-Qiang/AAG-6817-2019; Liu, Wei/N-4465-2017	Zhang, Guo-Qiang/0000-0001-6439-019X; LIU, TONG/0000-0001-9234-1328; Liu, Wei/0000-0001-9819-3178; Wu, Chongming/0000-0003-2898-370X	National Natural Science Foundation of China [81172498/H1622]; Harbin Science and Technology bureau [2011RFXYS056]; Postgraduate Innovation Research Fund of Heilongjiang Province [YJSCX2011-332-HLJ]; Research initiation Fund of the Third Affiliated Hospital of Harbin Medical University [JJ2010-24]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Harbin Science and Technology bureau; Postgraduate Innovation Research Fund of Heilongjiang Province; Research initiation Fund of the Third Affiliated Hospital of Harbin Medical University	This work was supported by National Natural Science Foundation of China (81172498/H1622), Harbin Science and Technology bureau (2011RFXYS056), Postgraduate Innovation Research Fund of Heilongjiang Province (YJSCX2011-332-HLJ) and Research initiation Fund of the Third Affiliated Hospital of Harbin Medical University (JJ2010-24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cornen S., 2012, ONCOGENE; Dallas PB, 2000, MOL CELL BIOL, V20, P3137, DOI 10.1128/MCB.20.9.3137-3146.2000; Dallas PB, 1998, MOL CELL BIOL, V18, P3596, DOI 10.1128/MCB.18.6.3596; DeCristofaro MF, 2001, J CELL PHYSIOL, V186, P136; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Jones S, 2012, HUM MUTAT, V33, P100, DOI 10.1002/humu.21633; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Katagiri A, 2012, MODERN PATHOL, V25, P282, DOI 10.1038/modpathol.2011.161; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mamo A, 2012, ONCOGENE, V31, P2090, DOI 10.1038/onc.2011.386; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nagl NG, 2005, CANCER RES, V65, P9236, DOI 10.1158/0008-5472.CAN-05-1225; Nagl NG, 2007, EMBO J, V26, P752, DOI 10.1038/sj.emboj.7601541; Shain AH, 2012, P NATL ACAD SCI USA, V109, pE252, DOI 10.1073/pnas.1114817109; Tsai HC, 2011, CELL RES, V21, P502, DOI 10.1038/cr.2011.24; Wang XM, 2004, INT J CANCER, V112, P636, DOI 10.1002/ijc.20450; Wiegand KC, 2011, J PATHOL, V224, P328, DOI 10.1002/path.2911; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Zhang XY, 2012, CANCER EPIDEMIOL, V36, P288, DOI 10.1016/j.canep.2011.07.006	21	709	730	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e53931	10.1371/journal.pone.0053931	http://dx.doi.org/10.1371/journal.pone.0053931			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349767	Green Published, Green Submitted, gold			2022-12-25	WOS:000313943000021
J	Yang, Y; Wang, Q				Yang, Yong; Wang, Qi			The Earliest Fleshy Cone of Ephedra from the Early Cretaceous Yixian Formation of Northeast China	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; GNETALES; AGE; CHLOROPLAST; FOSSIL; MORPHOLOGY; ANGIOSPERM; DISPERSAL; DIVERSITY; PORTUGAL	Bracts of female cones of extant gymnosperm Ephedra (Joint fir) are either colorful and fleshy (section Ephedra), or dry-winged and membranous (section Alatae), or dry and coriaceous (section Asarca), which have played a crucial role in long-distance seed dispersal that is responsible for a wide distribution of the genus in semiarid and arid areas of Eurasia, North Africa, North America, and South America. Recent molecular systematic studies on Ephedra have suggested that the fleshy bracts in character evolution may be plesiomorphic relative to the dry, membranous and coriaceous bracts. However, little is known about when the fleshy bracts of Ephedra have made their debut in the geological past. Herein, we describe a novel, fleshy bract-bearing female cone macrofossil from the Early Cretaceous (ca. 120-125 Ma) Yixian Formation in Liaoning, northeastern China. This cone bears three ellipsoid seeds subtended by only one whorl of fleshy bracts. Each seed has a thin outer envelope and an inner integument that extends upward and passes through the opening of the outer envelope, forming a thin and straight micropylar tube. Such a syndrome shows the closest similarity to an extant triovulate species Ephedra intermedia in the section Ephedra, but the latter bears a whorl of terminal fertile bracts and more than one whorl of inferior sterile bracts, and a thick outer envelope. Hence, we establish a new fossil species Ephedra carnosa. Our discovery provides the first direct macrofossil evidence for the previous molecular systematics of Ephedra, implying that the origin of fleshy bracts in Ephedra should not have been later than that of the membranous and coriaceous bracts by at least the Early Cretaceous.	[Yang, Yong; Wang, Qi] Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS	Wang, Q (corresponding author), Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Beijing, Peoples R China.	happyking@ibcas.ac.cn	Yang, Yong/S-1202-2019	Kang, Hong-Yo/0000-0003-0626-5037; Fu, Hung-Chun/0000-0002-0660-9349	National Natural Science Foundation of China [30970177, 30600035, 40830209, 40972015]; State Key Laboratory of Systematic and Evolutionary Botany, Institute of Botany, Chinese Academy of Sciences [56176G1044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Systematic and Evolutionary Botany, Institute of Botany, Chinese Academy of Sciences(Chinese Academy of Sciences)	The study was supported by the National Natural Science Foundation of China (no. 30970177, 30600035, 40830209, 40972015), the State Key Laboratory of Systematic and Evolutionary Botany, Institute of Botany, Chinese Academy of Sciences (no. 56176G1044) to WQ and YY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2007, STRELITZIA, V20, P1; Barrett PM, 2000, TRENDS ECOL EVOL, V15, P99, DOI 10.1016/S0169-5347(99)01782-6; Caveney S, 2001, AM J BOT, V88, P1199, DOI 10.2307/3558330; Cladera Gerardo, 2007, Revista del Museo Argentino de Ciencias Naturales, V9, P49; Duan SY, 1998, SCI CHINA SER D, V41, P14, DOI 10.1007/BF02932415; Friis E. M., 2011, EARLY FLOWERS ANGIOS; Friis EM, 2007, NATURE, V450, P549, DOI 10.1038/nature06278; Friis EM, 2009, AM J BOT, V96, P252, DOI 10.3732/ajb.0800113; Fu LK, 1999, FLORA CHINA, P97; Gifford E.M., 1989, COMP MORPHOLOGY VASC; Gradstein FM, 2004, EPISODES, V27, P83, DOI 10.18814/epiiugs/2004/v27i2/002; Guo S.X., 2000, ACTA PALAEONTOLOGICA, V39, P81; Hollander JL, 2010, EVOL ECOL, V24, P333, DOI 10.1007/s10682-009-9309-1; Hollander JL, 2009, INT J PLANT SCI, V170, P323, DOI 10.1086/596334; Huang JL, 2005, MOL PHYLOGENET EVOL, V35, P48, DOI 10.1016/j.ympev.2004.12.020; Huang JL, 2003, MOL BIOL EVOL, V20, P435, DOI 10.1093/molbev/msg049; Ickert-Bond SM, 2004, SYST BOT, V29, P834, DOI 10.1600/0363644042451143; Ickert-Bond SM, 2011, INT J PLANT SCI, V172, P36, DOI 10.1086/657299; Ickert-Bond SM, 2009, J SYST EVOL, V47, P444, DOI 10.1111/j.1759-6831.2009.00053.x; KRASSILOV V, 1982, Palaeontographica Abteilung B Palaeophytologie, V181, P1; Krassilov VA, 2009, PALEONTOL J+, V43, P1272, DOI 10.1134/S0031030109100098; KRASSILOV VA, 1986, REV PALAEOBOT PALYNO, V47, P9, DOI 10.1016/0034-6667(86)90003-5; Kubitzki K., 1990, FAMILIES GENERA VASC, V1, P378; Kunzmann L, 2009, REV PALAEOBOT PALYNO, V158, P193, DOI 10.1016/j.revpalbo.2009.09.001; Leslie AB, 2011, PALEOBIOLOGY, V37, P587, DOI 10.1666/10049.1; Liu HM, 2008, TAXON, V57, P577, DOI 10.2307/25066023; Pearson HHW, 1929, GNETALES; Price RA, 1996, INT J PLANT SCI, V157, pS40, DOI 10.1086/297402; Ridley H., 1930, J ECOL, DOI DOI 10.2307/2255951; Rydin C, 2006, PLANT SYST EVOL, V262, P239, DOI 10.1007/s00606-006-0481-2; Rydin C, 2004, P NATL ACAD SCI USA, V101, P16571, DOI 10.1073/pnas.0407588101; Rydin C, 2006, ANN BOT-LONDON, V98, P123, DOI 10.1093/aob/mcl078; Rydin C, 2010, BOT J LINN SOC, V163, P387, DOI 10.1111/j.1095-8339.2010.01066.x; Rydin C, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-183; Rydin C, 2009, INT J PLANT SCI, V170, P1031, DOI 10.1086/605116; Stapf O., 1889, MATHEMATISCH NATURWI, V56, P1; Stevenson D.W., 1993, FLORA N AM, V2, P428; Sun G, 1998, SCIENCE, V282, P1692, DOI 10.1126/science.282.5394.1692; Sun G, 2001, EARLY ANGIOSPERMS TH; Swisher CC, 2002, CHINESE SCI BULL, V47, P135; Swisher CC, 1999, NATURE, V400, P58, DOI 10.1038/21872; Yang Y, 2005, BOT BULL ACAD SINICA, V46, P363; Yang Y, 2005, AM J BOT, V92, P231, DOI 10.3732/ajb.92.2.231; Yang Y, 2004, AM J BOT, V91, P361, DOI 10.3732/ajb.91.3.361; Yang Y, 2001, ACTA BOT SIN, V43, P1011; Yang Y., 2002, CHIN ACAD SCI, P1; Yang Y, 2007, TAXON, V56, P1271, DOI 10.2307/25065920; Yang Yong, 2011, Journal of Tropical and Subtropical Botany, V19, P1; [杨永 Yang Yong], 2011, [地质论评, Geological Review], V57, P9; Yang Yong, 2010, Taiwania, V55, P346; Zhou ZH, 2002, NATURE, V418, P405, DOI 10.1038/nature00930; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420; Zhou ZG, 2006, GEOL J, V41, P377, DOI 10.1002/gj.1045; 王鑫, 2010, [科学通报, Chinese Science Bulletin], V55, P675	54	37	38	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53652	10.1371/journal.pone.0053652	http://dx.doi.org/10.1371/journal.pone.0053652			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	24244503	gold, Green Published, Green Submitted			2022-12-25	WOS:000314759400058
J	Zhang, ZZ; Wang, W; Li, WL				Zhang, Zhengzhi; Wang, Wei; Li, Wanlong			Genetic Interactions Underlying the Biosynthesis and Inhibition of beta-Diketones in Wheat and Their Impact on Glaucousness and Cuticle Permeability	PLOS ONE			English	Article							CUTICULAR WAX BIOSYNTHESIS; FATTY-ACID ELONGASE; DROUGHT TOLERANCE; EPICUTICULAR WAXES; CONDENSING ENZYME; ABC TRANSPORTER; CELL EXPANSION; COA REDUCTASE; PISUM-SATIVUM; SURFACE WAXES	Cuticular wax composition greatly impacts plant responses to dehydration. Two parallel pathways exist in Triticeae for manipulating wax composition: the acyl elongation, reduction, and decarbonylation pathway that is active at the vegetative stage and yields primary alcohols and alkanes, and the beta-diketone pathway that predominates at the reproductive stage and synthesizes beta-diketones. Variation in glaucousness during the reproductive stage of wheat is mainly controlled by the wax production genes, W1 and W2, and wax inhibitor genes, Iw1 and Iw2. Little is known about the metabolic and physiological effects of the genetic interactions among these genes and their roles in shifting wax composition during plant development. We characterized the effect of W1, W2, Iw1, and Iw2 and analyzed their interaction using a set of six near-isogenic lines (NILs) by metabolic, molecular and physiological approaches. Loss of functional alleles of both W genes or the presence of either Iw gene depletes beta-diketones and results in the nonglaucous phenotype. Elimination of beta-diketones is compensated for by an increase in aldehydes and primary alcohols in the Iw NILs. Accordingly, transcription of CER4-6, which encodes an alcohol-forming fatty acyl-CoA reductase, was elevated 120-fold in Iw1/Iw2. CER4-6 was transcribed at much higher levels in seedlings than in adult plants, and showed little difference between the glaucous and nonglaucous NILs, suggesting that Iw2 counteracts the developmental repression of CER4-6 at the reproductive stage. While W1 and W2 redundantly function in beta-diketone biosynthesis, a combination of both functional alleles led to the beta-diketone hydroxylation. Consistent with this, transcription of MAH1-9, which encodes a mid-chain alkane hydroxylase, increased seven-fold only in W1W2. In parallel with the hydroxyl-beta-diketone production patterns, glaucousness was intensified and cuticle permeability was reduced significantly in W1W2 compared to the other NILs. This suggests that both W1 and W2 are required for enhancing drought tolerance.	[Zhang, Zhengzhi; Wang, Wei; Li, Wanlong] S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA; [Li, Wanlong] S Dakota State Univ, Dept Plant Sci, Brookings, SD 57007 USA	South Dakota State University; South Dakota State University	Li, WL (corresponding author), S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA.	wanlong.li@sdstate.edu	zhang, zhengzhi/I-5403-2016; Wu, Jian/AAU-5221-2020; Vu, Gia-Phong/HCH-7906-2022; Zhang, Zhanhui/AAX-9545-2021; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wong, Matthew Man-Kin/0000-0003-3296-3277; Wu, Jianguo/0000-0002-8326-2895; ALZAHARNA, Mazen/0000-0002-1111-958X; Wu, Jian/0000-0002-3394-1507; Cheung, Hon-Yeung/0000-0002-6750-3628; Chiu, Sung Kay/0000-0002-9927-7346	South Dakota Agricultural Experiment Station; South Dakota Wheat Commission; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091536, R01AI041927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014842] Funding Source: NIH RePORTER	South Dakota Agricultural Experiment Station; South Dakota Wheat Commission; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding for this research was provided by South Dakota Agricultural Experiment Station and South Dakota Wheat Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2004, PLANT CELL, V16, P2463, DOI 10.1105/tpc.104.022897; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bach L, 2008, P NATL ACAD SCI USA, V105, P14727, DOI 10.1073/pnas.0805089105; BARBER HN, 1968, PHYTOCHEMISTRY, V7, P2089, DOI 10.1016/S0031-9422(00)85661-7; Beaudoin F, 2009, PLANT PHYSIOL, V150, P1174, DOI 10.1104/pp.109.137497; Bennett D, 2012, THEOR APPL GENET, V124, P697, DOI 10.1007/s00122-011-1740-3; Bernard A, 2012, PLANT CELL, V24, P3106, DOI 10.1105/tpc.112.099796; BIANCHI G, 1984, CEREAL CHEM, V61, P45; BIANCHI G, 1986, J AGR FOOD CHEM, V34, P429, DOI 10.1021/jf00069a012; Bianchi G., 1995, WAXES CHEM MOL BIOL, P175; Bird D, 2007, PLANT J, V52, P485, DOI 10.1111/j.1365-313X.2007.03252.x; Bonaventure G, 2003, PLANT CELL, V15, P1020, DOI 10.1105/tpc.008946; Broun P, 2004, P NATL ACAD SCI USA, V101, P4706, DOI 10.1073/pnas.0305574101; CHEESBROUGH TM, 1984, P NATL ACAD SCI-BIOL, V81, P6613, DOI 10.1073/pnas.81.21.6613; Cominelli E, 2008, PLANT J, V53, P53, DOI 10.1111/j.1365-313X.2007.03310.x; DeBono A, 2009, PLANT CELL, V21, P1230, DOI 10.1105/tpc.108.064451; Dietrich CR, 2005, PLANT J, V42, P844, DOI 10.1111/j.1365-313X.2005.02418.x; Dudnikov AJ, 2012, MOL BIOL REP, V39, P2355, DOI 10.1007/s11033-011-0986-9; Fiebig A, 2000, PLANT CELL, V12, P2001, DOI 10.1105/tpc.12.10.2001; Greer S, 2007, PLANT PHYSIOL, V145, P653, DOI 10.1104/pp.107.107300; Hansen JD, 1997, PLANT PHYSIOL, V113, P1091, DOI 10.1104/pp.113.4.1091; Hooker TS, 2007, PLANT CELL, V19, P904, DOI 10.1105/tpc.106.049304; Hooker TS, 2002, PLANT PHYSIOL, V129, P1568, DOI 10.1104/pp.003707; Javelle M, 2011, PLANT PHYSIOL, V157, P790, DOI 10.1104/pp.111.182147; Javelle M, 2010, PLANT PHYSIOL, V154, P273, DOI 10.1104/pp.109.150540; JENKS M. A., 2010, HORTICULTURAL REV, V23, P1, DOI [10.1002/9780470650752.ch1, DOI 10.1002/9780470650752.CH1]; JOHNSON DA, 1983, CROP SCI, V23, P318, DOI 10.2135/cropsci1983.0011183X002300020033x; KOLATTUKUDY PE, 1980, SCIENCE, V208, P990, DOI 10.1126/science.208.4447.990; Kosma DK, 2010, PLANT J, V63, P31, DOI 10.1111/j.1365-313X.2010.04229.x; Lam P, 2012, PLANT PHYSIOL, V159, P1385, DOI 10.1104/pp.112.199646; Li F, 2008, PLANT PHYSIOL, V148, P97, DOI 10.1104/pp.108.123471; Liu Q, 2007, EUPHYTICA, V155, P71, DOI 10.1007/s10681-006-9302-5; Liu SZ, 2009, GENETICS, V183, P1215, DOI 10.1534/genetics.109.108936; Lolle SJ, 1997, DEV BIOL, V189, P311, DOI 10.1006/dbio.1997.8671; Long XY, 2010, PLANT MOL BIOL, V74, P307, DOI 10.1007/s11103-010-9666-8; MIKKELSEN JD, 1978, CARLSBERG RES COMMUN, V43, P15, DOI 10.1007/BF02906546; Millar AA, 1999, PLANT CELL, V11, P825, DOI 10.1105/tpc.11.5.825; Monneveux P, 2004, J AGRON CROP SCI, V190, P395, DOI 10.1111/j.1439-037X.2004.00116.x; Moose SP, 1996, GENE DEV, V10, P3018, DOI 10.1101/gad.10.23.3018; Nawrath Christiane, 2002, Arabidopsis Book, V1, pe0021, DOI 10.1199/tab.0021; NELSON JC, 1995, GENOME, V38, P516, DOI 10.1139/g95-067; Panikashvili D, 2007, PLANT PHYSIOL, V145, P1345, DOI 10.1104/pp.107.105676; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003; Raffaele S, 2008, PLANT CELL, V20, P752, DOI 10.1105/tpc.107.054858; Richards R.A., 1984, P 6 INT WHEAT GEN S, P447; RICHARDS RA, 1986, AUST J PLANT PHYSIOL, V13, P465, DOI 10.1071/PP9860465; Richardson A, 2007, PLANTA, V226, P1459, DOI 10.1007/s00425-007-0585-0; Rowland O, 2006, PLANT PHYSIOL, V142, P866, DOI 10.1104/pp.106.086785; Samuels L, 2008, ANNU REV PLANT BIOL, V59, P683, DOI 10.1146/annurev.arplant.59.103006.093219; Schnurr JA, 2002, PLANT PHYSIOL, V129, P1700, DOI 10.1104/pp.003251; Seo PJ, 2011, PLANT CELL, V23, P1138, DOI 10.1105/tpc.111.083485; Seo PJ, 2009, PLANT PHYSIOL, V151, P275, DOI 10.1104/pp.109.144220; Shepherd T, 2006, NEW PHYTOL, V171, P469, DOI 10.1111/j.1469-8137.2006.01826.x; Simmonds JR, 2008, EUPHYTICA, V159, P333, DOI 10.1007/s10681-007-9514-3; Sturaro M, 2005, PLANT PHYSIOL, V138, P478, DOI 10.1104/pp.104.058164; Suh MC, 2005, PLANT PHYSIOL, V139, P1649, DOI 10.1104/pp.105.070805; Tacke E, 1995, PLANT J, V8, P907, DOI 10.1046/j.1365-313X.1995.8060907.x; Todd J, 1999, PLANT J, V17, P119, DOI 10.1046/j.1365-313X.1999.00352.x; Tsunewaki K, 1999, GENES GENET SYST, V74, P33, DOI 10.1266/ggs.74.33; TULLOCH AP, 1980, CAN J BOT, V58, P2602, DOI 10.1139/b80-302; TULLOCH AP, 1973, PHYTOCHEMISTRY, V12, P2225, DOI 10.1016/0031-9422(73)85124-6; Vailleau F, 2002, P NATL ACAD SCI USA, V99, P10179, DOI 10.1073/pnas.152047199; Vioque J, 1997, ARCH BIOCHEM BIOPHYS, V340, P64, DOI 10.1006/abbi.1997.9932; von Wettstein-Knowles P., 1995, WAXES CHEM MOL BIOL, P91; VONWETTSTEINKNOWLES P, 1980, CARLSBERG RES COMMUN, V45, P125, DOI 10.1007/BF02906514; VONWETTSTEINKNOWLES P, 1972, PLANTA, V106, P113, DOI 10.1007/BF00383991; Xu XJ, 2002, PLANT PHYSIOL, V128, P924, DOI 10.1104/pp.010621; Xu XJ, 1997, PLANT PHYSIOL, V115, P501, DOI 10.1104/pp.115.2.501; Xue GP, 2006, PLANT MOL BIOL, V61, P863, DOI 10.1007/s11103-006-0055-2; Yu DM, 2008, PLANTA, V228, P675, DOI 10.1007/s00425-008-0770-9; Zhang JY, 2007, PLANT MOL BIOL, V64, P265, DOI 10.1007/s11103-007-9150-2; Zhang JY, 2005, PLANT J, V42, P689, DOI 10.1111/j.1365-313X.2005.02405.x; Zheng HQ, 2005, PLANT CELL, V17, P1467, DOI 10.1105/tpc.104.030155	75	243	268	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54129	10.1371/journal.pone.0054129	http://dx.doi.org/10.1371/journal.pone.0054129			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349804	Green Published, gold, Green Submitted			2022-12-25	WOS:000313738900042
J	Zhang, ZH; Liu, ZH; Cui, ZT; Hu, YM; Wang, B; Tang, JH				Zhang, Zhanhui; Liu, Zonghua; Cui, Zitian; Hu, Yanmin; Wang, Bin; Tang, Jihua			Genetic Analysis of Grain Filling Rate Using Conditional QTL Mapping in Maize	PLOS ONE			English	Article							KERNEL WATER RELATIONS; WEIGHT RESPONSE; SINK; GROWTH; EXPRESSION; ENDOSPERM; TEMPERATURE; DISSECTION; DURATION; ENCODES	The grain filling rate (GFR) is an important dynamic trait that determines the final grain yield and is controlled by a network of genes and environment factors. To determine the genetic basis of the GFR, a conditional quantitative trait locus (QTL) analysis method was conducted using time-related phenotypic values of the GFR collected from a set of 243 immortalized F-2 (IF2) population, which were evaluated at two locations over 2 years. The GFR gradually rose in the 0-15 days after pollination (DAP) and 16-22 DAP, reaching a maximum at 23-29 DAP, and then gradually decreasing. The variation of kernel weight (KW) was mainly decided by the GFR, and not by the grain filling duration (GFD). Thirty-three different unconditional QTLs were identified for the GFR at the six sampling stages over 2 years. Among them, QTLs qGFR7b, qGFR9 and qGFR6d were identified at the same stages at two locations over 2 years. In addition, 14 conditional QTLs for GFR were detected at five stages. The conditional QTL qGFR7c was identified at stage V|IV (37-43 DAP) at two locations over 2 years, and qGFR7b was detected at the sixth stage (44-50 DAP) in all four environments, except at Anyang location in 2009. QTLs qQTL7b and qQTL6f were identified by unconditional and conditional QTL mapping at the same stages, and might represent major QTLs for regulating the GFR in maize in the IF2 population. Moreover, most of the QTLs identified were co-located with QTLs from previous studies that were associated with GFR, enzyme activities of starch synthesis, soluble carbohydrates, and grain filling related genes. These results indicated that the GFR is regulated by many genes, which are specifically expressed at different grain filling stages, and the specific expression of the genes between 16-35 DAP might be very important for deciding the final kernel weight.	[Zhang, Zhanhui; Liu, Zonghua; Cui, Zitian; Hu, Yanmin; Wang, Bin; Tang, Jihua] Henan Agr Univ, Coll Agron, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China	Henan Agricultural University	Tang, JH (corresponding author), Henan Agr Univ, Coll Agron, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China.	tangjihua1@163.com	zhang, zhengzhi/I-5403-2016; Wu, Jian/AAU-5221-2020; Vu, Gia-Phong/HCH-7906-2022; Zhang, Zhanhui/AAX-9545-2021; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wong, Matthew Man-Kin/0000-0003-3296-3277; Wu, Jianguo/0000-0002-8326-2895; ALZAHARNA, Mazen/0000-0002-1111-958X; Wu, Jian/0000-0002-3394-1507; Cheung, Hon-Yeung/0000-0002-6750-3628; Chiu, Sung Kay/0000-0002-9927-7346	National Project 973 of China [2012CB723001]; National High Technology Research and Development Program of China [2012AA10A305]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091536, R01AI041927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014842] Funding Source: NIH RePORTER	National Project 973 of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a grant from the National Project 973 of China (2012CB723001) and the National High Technology Research and Development Program of China (2012AA10A305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blewley JD, 1985, SEEDS PHYSL DEV GERM, P41; Borras L, 2006, FIELD CROP RES, V95, P223, DOI 10.1016/j.fcr.2005.03.001; Borras L, 2004, FIELD CROP RES, V86, P131, DOI 10.1016/j.fcr.2003.08.002; Borras L, 2003, ANN BOT-LONDON, V91, P857, DOI 10.1093/aob/mcg090; Borras L, 2001, CROP SCI, V41, P1816, DOI 10.2135/cropsci2001.1816; Borras L, 2009, CROP SCI, V49, P999, DOI 10.2135/cropsci2008.08.0475; Borras L, 2010, FIELD CROP RES, V118, P1, DOI 10.1016/j.fcr.2010.04.010; Carlson SJ, 1999, PLANT PHYSIOL, V121, P1025, DOI 10.1104/pp.121.3.1025; CAVALIERI AJ, 1985, CROP SCI, V25, P856, DOI 10.2135/cropsci1985.0011183X002500050031x; Cheng WH, 1996, PLANT CELL, V8, P971, DOI 10.1105/tpc.8.6.971; Gambin BL, 2007, FIELD CROP RES, V101, P1, DOI 10.1016/j.fcr.2006.09.001; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Guo M, 2010, PLANT CELL, V22, P1057, DOI 10.1105/tpc.109.073676; Gupta PK, 2006, GENOME, V49, P565, DOI 10.1139/G06-063; Hua JP, 2002, GENETICS, V162, P1885; Li ShaoChang, 2003, Acta Agronomica Sinica, V29, P775; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Lid SE, 2002, P NATL ACAD SCI USA, V99, P5460, DOI 10.1073/pnas.042098799; Liu ZH, 2011, MOL BREEDING, V27, P25, DOI 10.1007/s11032-010-9410-8; Liu ZongHua, 2007, Acta Agronomica Sinica, V33, P782; Loffler CM, 2005, CROP SCI, V45, P1708, DOI 10.2135/cropsci2004.0370; Maitz M, 2000, PLANT J, V23, P29, DOI 10.1046/j.1365-313x.2000.00747.x; MUCHOW RC, 1990, FIELD CROP RES, V23, P145, DOI 10.1016/0378-4290(90)90109-O; Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292; PRIOUL JL, 1994, PLANT PHYSIOL, V104, P179, DOI 10.1104/pp.104.1.179; SAS Institute, 2009, SAS STAT 9 2 US GUID; SEKA D, 1995, CROP SCI, V35, P74, DOI 10.2135/cropsci1995.0011183X003500010013x; SEKA D, 1995, CROP SCI, V35, P80, DOI 10.2135/cropsci1995.0011183X003500010014x; Setter TL, 2001, J EXP BOT, V52, P1401, DOI 10.1093/jexbot/52.360.1401; Stewart DW, 1998, AGRON J, V90, P73, DOI 10.2134/agronj1998.00021962009000010014x; Takai T, 2005, J EXP BOT, V56, P2107, DOI 10.1093/jxb/eri209; Tang JH, 2010, THEOR APPL GENET, V120, P333, DOI 10.1007/s00122-009-1213-0; Thevenot C, 2005, J EXP BOT, V56, P945, DOI 10.1093/jxb/eri087; Vilhar B, 2002, PLANT PHYSIOL, V129, P23, DOI 10.1104/pp.001826; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang GL, 1999, FIELD CROP RES, V61, P211, DOI 10.1016/S0378-4290(98)00163-4; Wilhelm EP, 1999, CROP SCI, V39, P1733, DOI 10.2135/cropsci1999.3961733x; Wu W, 2002, THEOR APPL GENET, V105, P1043, DOI 10.1007/s00122-002-1052-8; Wu WR, 1999, GENETICS, V151, P297; Yan HB, 2009, THEOR APPL GENET, V119, P815, DOI 10.1007/s00122-009-1091-5; Yang JC, 2010, J EXP BOT, V61, P1, DOI 10.1093/jxb/erp348; ZENG ZB, 1994, GENETICS, V136, P1457; Zheng H, 2001, J MAIZE SCI, V9, P69; ZHU J, 1995, GENETICS, V141, P1633	44	243	268	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56344	10.1371/journal.pone.0056344	http://dx.doi.org/10.1371/journal.pone.0056344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23349804	Green Submitted, Green Published, gold			2022-12-25	WOS:000315159200037
J	Kim, SO; Sakchaisri, K; Thimmegowda, NR; Soung, NK; Jang, JH; Kim, YS; Lee, KS; Kwon, YT; Asami, Y; Ahn, JS; Erikson, RL; Kim, BY				Kim, Sun-Ok; Sakchaisri, Krisada; Thimmegowda, N. R.; Soung, Nak Kyun; Jang, Jae-Hyuk; Kim, Young Sang; Lee, Kyung Sang; Kwon, Yong Tae; Asami, Yukihiro; Ahn, Jong Seog; Erikson, Raymond Leo; Kim, Bo Yeon			STK295900, a Dual Inhibitor of Topoisomerase 1 and 2, Induces G(2) Arrest in the Absence of DNA Damage	PLOS ONE			English	Article							CDC25 PHOSPHATASES; CELL-CYCLE; I INHIBITORS; G2/M TRANSITION; CANCER-THERAPY; HISTONE H3; PHOSPHORYLATION; CHECKPOINT; CAMPTOTHECIN; MECHANISM	STK295900, a small synthetic molecule belonging to a class of symmetric bibenzimidazoles, exhibits antiproliferative activity against various human cancer cell lines from different origins. Examining the effect of STK295900 in HeLa cells indicates that it induces G(2) phase arrest without invoking DNA damage. Further analysis shows that STK295900 inhibits DNA relaxation that is mediated by topoisomerase 1 (Top 1) and topoisomerase 2 (Top 2) in vitro. In addition, STK295900 also exhibits protective effect against DNA damage induced by camptothecin. However, STK295900 does not affect etoposide-induced DNA damage. Moreover, STK295900 preferentially exerts cytotoxic effect on cancer cell lines while camptothecin, etoposide, and Hoechst 33342 affected both cancer and normal cells. Therefore, STK295900 has a potential to be developed as an anticancer chemotherapeutic agent.	[Kim, Sun-Ok; Sakchaisri, Krisada; Thimmegowda, N. R.; Soung, Nak Kyun; Jang, Jae-Hyuk; Ahn, Jong Seog; Kim, Bo Yeon] Korea Res Inst Biosci & Biotechnol KRIBB, Ochang, Cheongwon, South Korea; [Kim, Sun-Ok; Kim, Young Sang] Chungnam Natl Univ, Coll Nat Sci, Dept Biochem, Taejon, South Korea; [Lee, Kyung Sang] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA; [Kwon, Yong Tae] Seoul Natl Univ, World Class Univ, Grad Sch Convergence Sci & Technol, Seoul, South Korea; [Kwon, Yong Tae] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Kwon, Yong Tae] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA USA; [Kwon, Yong Tae] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Asami, Yukihiro] RIKEN Adv Sci Inst, Dept Biol Chem, Wako, Saitama, Japan; [Erikson, Raymond Leo] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungnam National University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Seoul National University (SNU); Seoul National University (SNU); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; RIKEN; Harvard University	Ahn, JS (corresponding author), Korea Res Inst Biosci & Biotechnol KRIBB, Ochang, Cheongwon, South Korea.	jsahn@kribb.re.kr; bykim@kribb.re.kr	Damschroder, Laura/A-1142-2007; Appelbaum, Paul/AFU-3908-2022	Appelbaum, Paul/0000-0002-1940-0042; timmusk, s/0000-0001-8465-1043; Damschroder, Laura/0000-0002-3657-8459; Ryan, Kerry/0000-0002-0582-3693; Asami, Yukihiro/0000-0003-1821-9169; De Vries, Raymond/0000-0003-3087-3040	World Class Institute [2009-002]; Global RD Center (GRDC); World Class University [R31-2008-000-10103-0]; KRIBB Research Initiative program; Ministry of Education, Science and Technology (MEST) of Korea	World Class Institute; Global RD Center (GRDC); World Class University; KRIBB Research Initiative program; Ministry of Education, Science and Technology (MEST) of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the World Class Institute (2009-002), Global R&D Center (GRDC), World Class University (R31-2008-000-10103-0) programs and a grant from KRIBB Research Initiative program funded by the Ministry of Education, Science and Technology (MEST) of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Balmain A, 2002, CELL, V108, P145, DOI 10.1016/S0092-8674(02)00622-0; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bonnet J, 2008, BIOCHEM BIOPH RES CO, V370, P483, DOI 10.1016/j.bbrc.2008.03.117; Bower JJ, 2010, ONCOGENE, V29, P4787, DOI 10.1038/onc.2010.232; Bulavin DV, 2003, NAT CELL BIOL, V5, P545, DOI 10.1038/ncb994; Cai XM, 2009, CANCER TREAT REV, V35, P437, DOI 10.1016/j.ctrv.2009.02.004; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; CHEN AY, 1993, P NATL ACAD SCI USA, V90, P8131, DOI 10.1073/pnas.90.17.8131; Chiu CC, 2005, CANCER LETT, V223, P249, DOI 10.1016/j.canlet.2004.10.049; Clifford B, 2003, CANCER RES, V63, P4074; Dale AG, 2012, BIOCHEMISTRY; DOWNES CS, 1994, NATURE, V372, P467, DOI 10.1038/372467a0; Foijer F, 2006, CELL CYCLE, V5, P831, DOI 10.4161/cc.5.8.2687; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; He L, 2007, CELL SIGNAL, V19, P1713, DOI 10.1016/j.cellsig.2007.03.006; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Jin S, 2000, BIOORG MED CHEM LETT, V10, P719, DOI 10.1016/S0960-894X(00)00087-1; JORDAN MA, 1992, J CELL SCI, V102, P401; Kellogg DR, 2003, J CELL SCI, V116, P4883, DOI 10.1242/jcs.00908; Kim BY, 2005, CARCINOGENESIS, V26, P1395, DOI 10.1093/carcin/bgi081; Kristjansdottir K, 2004, CHEM BIOL, V11, P1043, DOI 10.1016/j.chembiol.2004.07.007; Larsen AK, 2003, PHARMACOL THERAPEUT, V99, P167, DOI 10.1016/S0163-7258(03)00058-5; Mann J, 2001, J MED CHEM, V44, P138, DOI 10.1021/jm000297b; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Narasimhan B, 2012, MED CHEM RES, V21, P269, DOI 10.1007/s00044-010-9533-9; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Patel S, 2000, MOL PHARMACOL, V58, P560, DOI 10.1124/mol.58.3.560; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rudolph J, 2007, BIOCHEMISTRY-US, V46, P3595, DOI 10.1021/bi700026j; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Smits VAJ, 2001, BBA-GENE STRUCT EXPR, V1519, P1, DOI 10.1016/S0167-4781(01)00204-4; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Trembley JH, 1996, CELL GROWTH DIFFER, V7, P903; TSAO YP, 1992, CANCER RES, V52, P1823; Uto K, 2004, EMBO J, V23, P3386, DOI 10.1038/sj.emboj.7600328; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7	46	111	116	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53908	10.1371/journal.pone.0053908	http://dx.doi.org/10.1371/journal.pone.0053908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349762	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000314019100036
J	Zhang, ZG; Vu, GP; Gong, H; Xia, C; Chen, YC; Liu, FY; Wu, JG; Lu, SW				Zhang, Zhigang; Vu, Gia-Phong; Gong, Hao; Xia, Chuan; Chen, Yuan-Chuan; Liu, Fenyong; Wu, Jianguo; Lu, Sangwei			Engineered External Guide Sequences Are Highly Effective in Inhibiting Gene Expression and Replication of Hepatitis B Virus in Cultured Cells	PLOS ONE			English	Article							P-MEDIATED INHIBITION; RNASE-P; ATTENUATED SALMONELLA; MESSENGER-RNA; CLEAVAGE; TYPHIMURIUM; STABILITY; SELECTION; DELIVERY; VECTORS	External guide sequences (EGSs) are RNA molecules that consist of a sequence complementary to a target mRNA and recruit intracellular ribonuclease P (RNase P), a tRNA processing enzyme, for specific degradation of the target mRNA. We have previously used an in vitro selection procedure to generate EGS variants that efficiently induce human RNase P to cleave a target mRNA in vitro. In this study, we constructed EGSs from a variant to target the overlapping region of the S mRNA, pre-S/L mRNA, and pregenomic RNA (pgRNA) of hepatitis B virus (HBV), which are essential for viral replication and infection. The EGS variant was about 50-fold more efficient in inducing human RNase P to cleave the mRNA in vitro than the EGS derived from a natural tRNA. Following Salmonella-mediated gene delivery, the EGSs were expressed in cultured HBV-carrying cells. A reduction of about 97% and 75% in the level of HBV RNAs and proteins and an inhibition of about 6,000- and 130-fold in the levels of capsid-associated HBV DNA were observed in cells treated with Salmonella vectors carrying the expression cassette for the variant and the tRNA-derived EGS, respectively. Our study provides direct evidence that the EGS variant is more effective in blocking HBV gene expression and DNA replication than the tRNA-derived EGS. Furthermore, these results demonstrate the feasibility of developing Salmonella-mediated gene delivery of highly active EGS RNA variants as a novel approach for gene-targeting applications such as anti-HBV therapy.	[Zhang, Zhigang; Xia, Chuan; Liu, Fenyong; Wu, Jianguo] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hunan, Peoples R China; [Vu, Gia-Phong; Chen, Yuan-Chuan; Liu, Fenyong; Lu, Sangwei] Univ Calif Berkeley, Program Comparat Biochem, Berkeley, CA 94720 USA; [Gong, Hao; Liu, Fenyong; Lu, Sangwei] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	Wuhan University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Liu, FY (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hunan, Peoples R China.	liu_fy@berkeley.edu; jwu@whu.edu.cn; sangwei@berkeley.edu	zhang, zhengzhi/I-5403-2016; Wu, Jian/AAU-5221-2020; Vu, Gia-Phong/HCH-7906-2022; Zhang, Zhanhui/AAX-9545-2021; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wong, Matthew Man-Kin/0000-0003-3296-3277; Wu, Jianguo/0000-0002-8326-2895; ALZAHARNA, Mazen/0000-0002-1111-958X; Wu, Jian/0000-0002-3394-1507; Cheung, Hon-Yeung/0000-0002-6750-3628; Chiu, Sung Kay/0000-0002-9927-7346	National Basic Research Program of China (973 Program) [2011CB504800, 2012CB518900]; National Natural Science Foundation of China [31100128, 81030031, 31230005, 812111146]; NIH [RO1-AI041927, RO1-AI091536, RO1-DE014842]; University of California at Berkeley; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091536, R01AI041927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014842] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California at Berkeley; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research has been supported by grants from National Basic Research Program of China (973 Program; No. 2011CB504800 and 2012CB518900), National Natural Science Foundation of China (No. 31100128, 81030031, 31230005, and 812111146) and NIH (RO1-AI041927, RO1-AI091536, and RO1-DE014842). G. V. and Y. C. were partially supported by a predoctoral Block grant from University of California at Berkeley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman S., 1999, RNA WORLD, P351; ARES M, 1990, GENE DEV, V4, P2132, DOI 10.1101/gad.4.12a.2132; Belongia E A, 2008, NIH Consens State Sci Statements, V25, P1; Block TM, 2013, ANTIVIR RES, V98, P27, DOI 10.1016/j.antiviral.2013.01.006; Cai DW, 2012, ANTIMICROB AGENTS CH, V56, P4277, DOI 10.1128/AAC.00473-12; Chen YN, 2011, FASEB J, V25, P4511, DOI 10.1096/fj.11-187781; Clairmont C, 2000, J INFECT DIS, V181, P1996, DOI 10.1086/315497; Darji A, 1997, CELL, V91, P765, DOI 10.1016/S0092-8674(00)80465-1; Evans D, 2006, TRENDS BIOCHEM SCI, V31, P333, DOI 10.1016/j.tibs.2006.04.007; FORSTER AC, 1990, SCIENCE, V249, P783, DOI 10.1126/science.1697102; Giladi H, 2003, MOL THER, V8, P769, DOI 10.1016/S1525-0016(03)00244-2; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; Gong H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002120; GOPALAN V, 2006, RNA WORLD; Grillot-Courvalin C, 1999, CURR OPIN BIOTECH, V10, P477, DOI 10.1016/S0958-1669(99)00013-0; GUERRIERTAKADA C, 1995, P NATL ACAD SCI USA, V92, P11115, DOI 10.1073/pnas.92.24.11115; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Hnatyszyn HJ, 2001, GENE THER, V8, P1863, DOI 10.1038/sj.gt.3301606; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; JOYCE GF, 1992, SCI AM, V267, P90, DOI 10.1038/scientificamerican1292-90; Kawa D, 1998, RNA, V4, P1397, DOI 10.1017/S1355838298980918; Kazantsev AV, 2006, NAT REV MICROBIOL, V4, P729, DOI 10.1038/nrmicro1491; Khan SA, 1998, MOL MICROBIOL, V29, P571, DOI 10.1046/j.1365-2958.1998.00952.x; LEVINE MM, 1987, J CLIN INVEST, V79, P888, DOI 10.1172/JCI112899; Li HJ, 2006, RNA, V12, P63, DOI 10.1261/rna.2184706; Liu FY, 2010, PROTEIN REV, V10, P257, DOI 10.1007/978-1-4419-1142-1_14; LIU FY, 1994, CELL, V77, P1093, DOI 10.1016/0092-8674(94)90448-0; LIU FY, 1995, GENE DEV, V9, P471, DOI 10.1101/gad.9.4.471; Loessner H, 2006, FEMS MICROBIOL LETT, V265, P81, DOI 10.1111/j.1574-6968.2006.00470.x; Ma M, 2000, NAT BIOTECHNOL, V18, P58, DOI 10.1038/71924; Marvin MC, 2009, J CELL BIOCHEM, V108, P1244, DOI 10.1002/jcb.22367; McCaffrey AP, 2003, NAT BIOTECHNOL, V21, P639, DOI 10.1038/nbt824; Paglia P, 2000, GENE THER, V7, P1725, DOI 10.1038/sj.gt.3301290; Plehn-Dujowich D, 1998, P NATL ACAD SCI USA, V95, P7327, DOI 10.1073/pnas.95.13.7327; PYLE AM, 1990, P NATL ACAD SCI USA, V87, P8187, DOI 10.1073/pnas.87.21.8187; Scherer LJ, 2003, NAT BIOTECHNOL, V21, P1457, DOI 10.1038/nbt915; Seegar C., 2007, FIELDS VIROLOGY, P2978; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Su J, 2009, INFECT IMMUN, V77, P667, DOI 10.1128/IAI.01027-08; SZOSTAK JW, 1992, TRENDS BIOCHEM SCI, V17, P89, DOI 10.1016/0968-0004(92)90242-2; Uprichard SL, 2005, P NATL ACAD SCI USA, V102, P773, DOI 10.1073/pnas.0409028102; Werner M, 1998, RNA, V4, P847, DOI 10.1017/S1355838298980323; Xia C, 2013, MOL THER, V21, P995, DOI 10.1038/mt.2013.37; Yang Nan, 2008, Cancer Biol Ther, V7, P145; YUAN Y, 1994, SCIENCE, V263, P1269, DOI 10.1126/science.8122108; YUAN Y, 1992, P NATL ACAD SCI USA, V89, P8006, DOI 10.1073/pnas.89.17.8006; ZAUG AJ, 1995, RNA, V1, P363; Zhang L, 2007, CANCER RES, V67, P5859, DOI 10.1158/0008-5472.CAN-07-0098; Zhou TH, 2002, J BIOL CHEM, V277, P30112, DOI 10.1074/jbc.M200183200; Zhu JM, 2004, P NATL ACAD SCI USA, V101, P9073, DOI 10.1073/pnas.0403164101	51	243	268	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65268	10.1371/journal.pone.0065268	http://dx.doi.org/10.1371/journal.pone.0065268			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23349804	Green Submitted, gold, Green Published			2022-12-25	WOS:000320322400011
J	Kim, SYH; Kim, HM; Ryan, KA; Appelbaum, PS; Knopman, DS; Damschroder, L; De Vries, R				Kim, Scott Y. H.; Kim, H. Myra; Ryan, Kerry A.; Appelbaum, Paul S.; Knopman, David S.; Damschroder, Laura; De Vries, Raymond			How Important Is 'Accuracy' of Surrogate Decision-Making for Research Participation?	PLOS ONE			English	Article							DEMENTIA-RESEARCH; ADVANCE DIRECTIVES; CARE RESEARCH; CONSENT; DELIBERATION; BIOETHICS; CAPACITY; DISEASE; MAKERS; FAMILY	Background: There is a longstanding concern about the accuracy of surrogate consent in representing the health care and research preferences of those who lose their ability to decide for themselves. We sought informed, deliberative views of the older general public (>= 50 years old) regarding their willingness to participate in dementia research and to grant leeway to future surrogates to choose an option contrary to their stated wishes. Methodology/Principal Findings: 503 persons aged 50+ recruited by random digit dialing were randomly assigned to one of three groups: deliberation, education, or control. The deliberation group attended an all-day education/peer deliberation session; the education group received written information only. Participants were surveyed at baseline, after the deliberation session (or equivalent time), and one month after the session, regarding their willingness to participate in dementia research and to give leeway to surrogates, regarding studies of varying risk-benefit profiles (a lumbar puncture study, a drug randomized controlled trial, a vaccine randomized controlled trial, and an early phase gene transfer trial). At baseline, 48% (gene transfer scenario) to 92% (drug RCT) were willing to participate in future dementia research. A majority of respondents (57-71% depending on scenario) were willing to give leeway to future surrogate decision-makers. Democratic deliberation increased willingness to participate in all scenarios, to grant leeway in 3 of 4 scenarios (lumbar puncture, vaccine, and gene transfer), and to enroll loved ones in research in all scenarios. On average, respondents were more willing to volunteer themselves for research than to enroll their loved ones. Conclusions/Significance: Most people were willing to grant leeway to their surrogates, and this willingness was either sustained or increased after democratic deliberation, suggesting that the attitude toward leeway is a reliable opinion. Eliciting a person's current preferences about future research participation should also involve eliciting his or her leeway preferences.	[Kim, Scott Y. H.; Ryan, Kerry A.; De Vries, Raymond] Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA; [Kim, Scott Y. H.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Kim, H. Myra] Univ Michigan, Ctr Stat Consultat & Res, Ann Arbor, MI 48109 USA; [Appelbaum, Paul S.] Columbia Univ, Dept Psychiat, Div Law Eth & Psychiat, New York, NY USA; [Appelbaum, Paul S.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Knopman, David S.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Damschroder, Laura] Ann Arbor VA Med Ctr, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Columbia University; New York State Psychiatry Institute; Mayo Clinic	Kim, SYH (corresponding author), Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA.	scottkim@med.umich.edu	Damschroder, Laura/A-1142-2007; Appelbaum, Paul/AFU-3908-2022	Appelbaum, Paul/0000-0002-1940-0042; timmusk, s/0000-0001-8465-1043; Damschroder, Laura/0000-0002-3657-8459; Ryan, Kerry/0000-0002-0582-3693; Asami, Yukihiro/0000-0003-1821-9169; De Vries, Raymond/0000-0003-3087-3040	National Institute of Health [R01AG029550]; Greenwall Foundation Faculty Scholars Award in Bioethics; Janssen Pharmaceuticals	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Greenwall Foundation Faculty Scholars Award in Bioethics; Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	Supported by National Institute of Health R01AG029550 and the Greenwall Foundation Faculty Scholars Award in Bioethics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Scott Kim, H. Myra Kim, Kerry Ryan, Paul Appelbaum, Laura Damschroder, and Raymond De Vries have declared that they have no competing interests. David Knopman has read the journal's policy and has the following conflicts: he serves as Deputy Editor for Neurology (R); serves on a Data Safety Monitoring Board for Lilly Pharmaceuticals; is an investigator in clinical trials sponsored by Janssen Pharmaceuticals, and receives research support from the National Institute of Health. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ciroldi M, 2007, INTENS CARE MED, V33, P807, DOI 10.1007/s00134-007-0582-6; Coppolino M, 2001, CHEST, V119, P603, DOI 10.1378/chest.119.2.603; De Vries R, 2011, J EMPIR RES HUM RES, V6, P3, DOI 10.1525/jer.2011.6.3.3; Fagerlin A, 2004, HASTINGS CENT REP, V34, P30, DOI 10.2307/3527683; Hawkins NA, 2005, GERONTOLOGIST, V45, P107, DOI 10.1093/geront/45.1.107; Karlawish J, 2009, AM J PSYCHIAT, V166, P182, DOI 10.1176/appi.ajp.2008.08050645; Kim SYH, 2011, NEUROLOGY, V77, P2097, DOI 10.1212/WNL.0b013e31823648cb; Kim SYH, 2009, NEUROLOGY, V72, P149, DOI 10.1212/01.wnl.0000339039.18931.a2; Kim SYH, 2011, ARCH GEN PSYCHIAT, V68, P214, DOI 10.1001/archgenpsychiatry.2010.191; Kim SYH, 2010, ALZHEIMERS DEMENT, V6, P342, DOI 10.1016/j.jalz.2009.06.001; Kim SYH, 2009, J EMPIR RES HUM RES, V4, P3, DOI 10.1525/jer.2009.4.4.3; Kim SYH, 2001, AM J PSYCHIAT, V158, P712, DOI 10.1176/appi.ajp.158.5.712; Kirchhoff KT, 2010, J AM GERIATR SOC, V58, P1233, DOI 10.1111/j.1532-5415.2010.02760.x; Okonkwo O, 2007, NEUROLOGY, V69, P1528, DOI 10.1212/01.wnl.0000277639.90611.d9; Puchalski CM, 2000, J AM GERIATR SOC, V48, pS84, DOI 10.1111/j.1532-5415.2000.tb03146.x; SEHGAL A, 1992, JAMA-J AM MED ASSOC, V267, P59, DOI 10.1001/jama.267.1.59; Shalowitz DI, 2006, ARCH INTERN MED, V166, P493, DOI 10.1001/archinte.166.5.493; Stocking CB, 2006, NEUROLOGY, V66, P1361, DOI 10.1212/01.wnl.0000216424.66098.55; Wendler D, 2002, AM J PSYCHIAT, V159, P585, DOI 10.1176/appi.ajp.159.4.585	19	111	116	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54790	10.1371/journal.pone.0054790	http://dx.doi.org/10.1371/journal.pone.0054790			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	085JH	23349762	Green Submitted, Green Published, gold			2022-12-25	WOS:000314610600042
J	Liu, AH; Gao, F; Kanno, Y; Jordan, MC; Kamiya, Y; Seo, M; Ayele, BT				Liu, Aihua; Gao, Feng; Kanno, Yuri; Jordan, Mark C.; Kamiya, Yuji; Seo, Mitsunori; Ayele, Belay T.			Regulation of Wheat Seed Dormancy by After-Ripening Is Mediated by Specific Transcriptional Switches That Induce Changes in Seed Hormone Metabolism and Signaling	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA SEEDS; ACTIVATED PROTEIN-KINASES; ABSCISIC-ACID; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; GIBBERELLIN METABOLISM; CONJUGATE HYDROLASES; FLORAL DEVELOPMENT; JASMONIC ACID; CROSS-TALK	Treatments that promote dormancy release are often correlated with changes in seed hormone content and/or sensitivity. To understand the molecular mechanisms underlying the role of after-ripening (seed dry storage) in triggering hormone related changes and dormancy decay in wheat (Triticum aestivum), temporal expression patterns of genes related to abscisic acid (ABA), gibberellin (GA), jasmonate and indole acetic acid (IAA) metabolism and signaling, and levels of the respective hormones were examined in dormant and after-ripened seeds in both dry and imbibed states. After-ripening mediated developmental switch from dormancy to germination appears to be associated with declines in seed sensitivity to ABA and IAA, which are mediated by transcriptional repressions of PROTEIN PHOSPHATASE 2C, SNF1-RELATED PROTEIN KINASE2, ABA INSENSITIVE5 and LIPID PHOSPHATE PHOSPHTASE2, and AUXIN RESPONSE FACTOR and RELATED TO UBIQUITIN1 genes. Transcriptomic analysis of wheat seed responsiveness to ABA suggests that ABA inhibits the germination of wheat seeds partly by repressing the transcription of genes related to chromatin assembly and cell wall modification, and activating that of GA catabolic genes. After-ripening induced seed dormancy decay in wheat is also associated with the modulation of seed IAA and jasmonate contents. Transcriptional control of members of the ALLENE OXIDE SYNTHASE, 3-KETOACYL COENZYME A THIOLASE, LIPOXYGENASE and 12-OXOPHYTODIENOATE REDUCTASE gene families appears to regulate seed jasmonate levels. Changes in the expression of GA biosynthesis genes, GA 20-OXIDASE and GA 3-OXIDASE, in response to after-ripening implicate this hormone in enhancing dormancy release and germination. These findings have important implications in the dissection of molecular mechanisms underlying regulation of seed dormancy in cereals.	[Liu, Aihua; Gao, Feng; Ayele, Belay T.] Univ Manitoba, Dept Plant Sci, Winnipeg, MB R3T 2N2, Canada; [Jordan, Mark C.] Agr & Agri Food Canada, Cereal Res Ctr, Winnipeg, MB, Canada; [Kanno, Yuri; Kamiya, Yuji; Seo, Mitsunori] RIKEN Plant Sci Ctr, Yokohama, Kanagawa, Japan	University of Manitoba; Agriculture & Agri Food Canada; RIKEN	Ayele, BT (corresponding author), Univ Manitoba, Dept Plant Sci, Winnipeg, MB R3T 2N2, Canada.	b_ayele@umanitoba.ca	Seo, Mitsunori/N-9603-2015; Kamiya, Yuji/F-9420-2010; kanno, yuri/C-9211-2017; Ponnusamy, Murugavel/X-5699-2018	Kamiya, Yuji/0000-0003-4415-520X; Ponnusamy, Murugavel/0000-0001-5558-8719; Seo, Mitsunori/0000-0001-8325-7984	Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085065] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada to BTA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An YQ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-105; Appleford NEJ, 2006, PLANTA, V223, P568, DOI 10.1007/s00425-005-0104-0; Ayele BT, 2012, J PLANT GROWTH REGUL, V31, P235, DOI 10.1007/s00344-011-9234-8; Barrero JM, 2012, NEW PHYTOL, V193, P376, DOI 10.1111/j.1469-8137.2011.03938.x; Barrero JM, 2009, PLANT PHYSIOL, V150, P1006, DOI 10.1104/pp.109.137901; Bassel GW, 2011, P NATL ACAD SCI USA, V108, P9709, DOI 10.1073/pnas.1100958108; BERESTETZKY V, 1991, BIOCHEM PHYSIOL PFL, V187, P13, DOI 10.1016/S0015-3796(11)80178-2; Berger S, 1996, PLANT PHYSIOL, V111, P525, DOI 10.1104/pp.111.2.525; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; BIALEK K, 1989, PLANT PHYSIOL, V91, P775, DOI 10.1104/pp.91.2.775; BIALEK K, 1992, PLANT PHYSIOL, V100, P509, DOI 10.1104/pp.100.1.509; BIALEK K, 1992, PLANT PHYSIOL, V100, P2002, DOI 10.1104/pp.100.4.2002; Blazejczyk M, 2007, FLEXARRAY VERSION 1; Brady SM, 2003, PLANT J, V34, P67, DOI 10.1046/j.1365-313X.2003.01707.x; Cadman CSC, 2006, PLANT J, V46, P805, DOI 10.1111/j.1365-313X.2006.02738.x; Cao DN, 2006, PLANT PHYSIOL, V142, P509, DOI 10.1104/pp.106.082289; Carrera E, 2008, PLANT J, V53, P214, DOI 10.1111/j.1365-313X.2007.03331.x; Chen KG, 2010, ACTA PHYSIOL PLANT, V32, P789, DOI 10.1007/s11738-010-0464-3; Chibani K, 2006, PLANT PHYSIOL, V142, P1493, DOI 10.1104/pp.106.087452; Chono M, 2006, J EXP BOT, V57, P2421, DOI 10.1093/jxb/erj215; del Pozo JC, 1999, P NATL ACAD SCI USA, V96, P15342, DOI 10.1073/pnas.96.26.15342; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dill A, 2004, PLANT CELL, V16, P1392, DOI 10.1105/tpc.020958; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Ellis C, 2002, PLANTA, V215, P549, DOI 10.1007/s00425-002-0787-4; Finch-Savage WE, 2007, PLANT J, V51, P60, DOI 10.1111/j.1365-313X.2007.03118.x; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Finkelstein RR, 2002, CURR OPIN PLANT BIOL, V5, P26, DOI 10.1016/S1369-5266(01)00225-4; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Gao F, 2012, PLANT BIOTECHNOL J, V10, P465, DOI 10.1111/j.1467-7652.2012.00682.x; Gomez-Cadenas A, 1999, P NATL ACAD SCI USA, V96, P1767, DOI 10.1073/pnas.96.4.1767; Gubler F, 2005, CURR OPIN PLANT BIOL, V8, P183, DOI 10.1016/j.pbi.2005.01.011; Gubler F, 2008, PLANT PHYSIOL, V147, P886, DOI 10.1104/pp.107.115469; Heitz T, 2012, J BIOL CHEM, V287, P6296, DOI 10.1074/jbc.M111.316364; Henderson JT, 2004, PLANT PHYSIOL, V134, P995, DOI 10.1104/pp.103.030148; HILHORST HWM, 1995, SEED SCI RES, V5, P61, DOI 10.1017/S0960258500002634; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; Jacobsen JV, 2002, PHYSIOL PLANTARUM, V115, P428, DOI 10.1034/j.1399-3054.2002.1150313.x; JACOBSEN SE, 1993, PLANT CELL, V5, P887, DOI 10.1105/tpc.5.8.887; Jones HD, 1997, PLANT J, V12, P911, DOI 10.1046/j.1365-313X.1997.12040911.x; Kaneko M, 2004, PLANT CELL, V16, P33, DOI 10.1105/tpc.017327; Kanno Y, 2010, PLANT CELL PHYSIOL, V51, P1988, DOI 10.1093/pcp/pcq158; Katagiri T, 2005, PLANT J, V43, P107, DOI 10.1111/j.1365-313X.2005.02431.x; Kazan K, 2008, PLANT PHYSIOL, V146, P1459, DOI 10.1104/pp.107.115717; Kermode AR, 2005, J PLANT GROWTH REGUL, V24, P319, DOI 10.1007/s00344-005-0110-2; Kline KG, 2010, PLANT PHYSIOL, V154, P479, DOI 10.1104/pp.110.160846; KOORNNEEF M, 1980, THEOR APPL GENET, V58, P257, DOI 10.1007/BF00265176; Kucera B, 2005, SEED SCI RES, V15, P281, DOI 10.1079/SSR2005218; Lackman P, 2011, P NATL ACAD SCI USA, V108, P5891, DOI 10.1073/pnas.1103010108; LeClere S, 2002, J BIOL CHEM, V277, P20446, DOI 10.1074/jbc.M111955200; Lefebvre V, 2006, PLANT J, V45, P309, DOI 10.1111/j.1365-313X.2005.02622.x; LEYSER HMO, 1993, NATURE, V364, P161, DOI 10.1038/364161a0; Li CJ, 2012, PLANT CELL ENVIRON, V35, P952, DOI 10.1111/j.1365-3040.2011.02464.x; Lim PO, 2010, J EXP BOT, V61, P1419, DOI 10.1093/jxb/erq010; Linkies A, 2012, PLANT CELL REP, V31, P253, DOI 10.1007/s00299-011-1180-1; Liu PP, 2007, PLANT J, V52, P133, DOI 10.1111/j.1365-313X.2007.03218.x; Liu YX, 2007, PLANT CELL, V19, P433, DOI 10.1105/tpc.106.049221; LIU YQ, 1994, PLANTA, V194, P368, DOI 10.1007/BF00197537; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ljung K, 2002, PLANT MOL BIOL, V50, P309, DOI 10.1023/A:1016024017872; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; MCCARTY DR, 1991, CELL, V66, P895, DOI 10.1016/0092-8674(91)90436-3; MCCARTY DR, 1989, PLANT CELL, V1, P523, DOI 10.1105/tpc.1.5.523; McGinnis KM, 2003, PLANT CELL, V15, P1120, DOI 10.1105/tpc.010827; McKibbin RS, 2002, P NATL ACAD SCI USA, V99, P10203, DOI 10.1073/pnas.152318599; MORRIS CF, 1989, PLANT PHYSIOL, V90, P643, DOI 10.1104/pp.90.2.643; Nag R, 2005, PLANT MOL BIOL, V59, P821, DOI 10.1007/s11103-005-1387-z; Nakamura S, 2001, J EXP BOT, V52, P875, DOI 10.1093/jexbot/52.357.875; Nakashima K, 2009, PLANT PHYSIOL, V149, P88, DOI 10.1104/pp.108.129791; Nambara E, 2010, SEED SCI RES, V20, P55, DOI 10.1017/S0960258510000012; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; Okamoto M, 2006, PLANT PHYSIOL, V141, P97, DOI 10.1104/pp.106.079475; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Penfield S, 2006, CURR BIOL, V16, P2366, DOI 10.1016/j.cub.2006.10.057; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Preston J, 2009, PLANT CELL PHYSIOL, V50, P1786, DOI 10.1093/pcp/pcp121; Rampey RA, 2004, PLANT PHYSIOL, V135, P978, DOI 10.1104/pp.104.039677; Rikiishi K, 2010, J CEREAL SCI, V51, P292, DOI 10.1016/j.jcs.2010.01.003; ROUSSELIN P, 1992, THEOR APPL GENET, V85, P213, DOI 10.1007/BF00222862; Saavedra L, 2009, PLANT CELL PHYSIOL, V50, P595, DOI 10.1093/pcp/pcp018; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schruff MC, 2006, DEVELOPMENT, V133, P251, DOI 10.1242/dev.02194; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Seo M, 2006, PLANT J, V48, P354, DOI 10.1111/j.1365-313X.2006.02881.x; Simpson G. M., 1990, SEED DORMANCY GRASSE; Steber CM, 1998, GENETICS, V149, P509; Sun TP, 2004, ANNU REV PLANT BIOL, V55, P197, DOI 10.1146/annurev.arplant.55.031903.141753; Tanaka M, 2008, PLANT PHYSIOL, V146, P149, DOI 10.1104/pp.107.111674; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Townley-Smith TF, 2008, CAN J PLANT SCI, V88, P347, DOI 10.4141/CJPS07004; Tyler L, 2004, PLANT PHYSIOL, V135, P1008, DOI 10.1104/pp.104.039578; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Ullah H, 2002, PLANT PHYSIOL, V129, P897, DOI 10.1104/pp.005017; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Rodriguez MV, 2009, ANN BOT-LONDON, V104, P975, DOI 10.1093/aob/mcp184; WALKERSIMMONS M, 1987, PLANT PHYSIOL, V84, P61, DOI 10.1104/pp.84.1.61; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Yao Z, 2012, J PLANT PHYSIOL, V169, P1477, DOI 10.1016/j.jplph.2012.06.001; Yildiz K, 2007, ASIAN J CHEM, V19, P1098; Yoshida T, 2006, PLANT PHYSIOL, V140, P115, DOI 10.1104/pp.105.070128; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Zhang XR, 2005, GENE DEV, V19, P1532, DOI 10.1101/gad.1318705	104	328	350	30	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56570	10.1371/journal.pone.0056570	http://dx.doi.org/10.1371/journal.pone.0056570			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23468976	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200108
J	Liu, EK; Yan, CR; Mei, XR; Zhang, YQ; Fan, TL				Liu, Enke; Yan, Changrong; Mei, Xurong; Zhang, Yanqing; Fan, Tinglu			Long-Term Effect of Manure and Fertilizer on Soil Organic Carbon Pools in Dryland Farming in Northwest China	PLOS ONE			English	Article							DIFFERENT CROPPING SYSTEMS; SEQUESTRATION RATES; DEPTH DISTRIBUTION; LOESS PLATEAU; MATTER; TILLAGE; MANAGEMENT; FRACTIONS; DYNAMICS; QUALITY	An understanding of the dynamics of soil organic carbon (SOC) as affected by farming practices is imperative for maintaining soil productivity and mitigating global warming. The objectives of this study were to investigate the effects of long-term fertilization on SOC and SOC fractions for the whole soil profile (0-100 cm) in northwest China. The study was initiated in 1979 in Gansu, China and included six treatments: unfertilized control (CK), nitrogen fertilizer (N), nitrogen and phosphorus (P) fertilizers (NP), straw plus N and P fertilizers (NP+S), farmyard manure (FYM), and farmyard manure plus N and P fertilizers (NP+FYM). Results showed that SOC concentration in the 0-20 cm soil layer increased with time except in the CK and N treatments. Long-term fertilization significantly influenced SOC concentrations and storage to 60 cm depth. Below 60 cm, SOC concentrations and storages were statistically not significant between all treatments. The concentration of SOC at different depths in 0-60 cm soil profile was higher under NP+FYM follow by under NP+S, compared to under CK. The SOC storage in 0-60 cm in NP+FYM, NP+S, FYM and NP treatments were increased by 41.3%, 32.9%, 28.1% and 17.9%, respectively, as compared to the CK treatment. Organic manure plus inorganic fertilizer application also increased labile soil organic carbon pools in 0-60 cm depth. The average concentration of particulate organic carbon (POC), dissolved organic carbon (DOC) and microbial biomass carbon (MBC) in organic manure plus inorganic fertilizer treatments (NP+S and NP+FYM) in 0-60 cm depth were increased by 64.9-91.9%, 42.5-56.9%, and 74.7-99.4%, respectively, over the CK treatment. The POC, MBC and DOC concentrations increased linearly with increasing SOC content. These results indicate that long-term additions of organic manure have the most beneficial effects in building carbon pools among the investigated types of fertilization.	[Liu, Enke; Yan, Changrong; Mei, Xurong; Zhang, Yanqing] Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Beijing 100193, Peoples R China; [Liu, Enke; Yan, Changrong; Mei, Xurong; Zhang, Yanqing] Minist Agr Peoples Republ China MOA, Key Lab Dryland Farming g Agr, Beijing, Peoples R China; [Fan, Tinglu] Gansu Acad Agr Sci, Dryland Agr Inst, Lanzhou, Gansu, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS; Ministry of Agriculture & Rural Affairs	Yan, CR (corresponding author), Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Beijing 100193, Peoples R China.	yancr@ieda.org.cn; zhangyq@ieda.org.cn	Seo, Mitsunori/N-9603-2015; Kamiya, Yuji/F-9420-2010; kanno, yuri/C-9211-2017; Ponnusamy, Murugavel/X-5699-2018	Kamiya, Yuji/0000-0003-4415-520X; Ponnusamy, Murugavel/0000-0001-5558-8719; Seo, Mitsunori/0000-0001-8325-7984	National Basic Research Program of China (973 Program) [2012CB955904]; Chinese National Scientific Foundation [31000253, 31170490]; National Key Technologies RD Program [2012BAD09B01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085065] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese National Scientific Foundation; National Key Technologies RD Program(National Key Technology R&D Program); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Basic Research Program of China (973 Program) (No.2012CB955904), the Chinese National Scientific Foundation (No. 31000253, 31170490), the 12th five-year plan of the National Key Technologies R&D Program (No. 2012BAD09B01). The authors declare that no additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black C.A, 1965, AM SOC AGRON MADISON, P482; Blair N, 2006, SOIL TILL RES, V91, P39, DOI 10.1016/j.still.2005.11.001; Bronson KF, 1998, ADV SOIL S, P35; CAMBARDELLA CA, 1992, SOIL SCI SOC AM J, V56, P777, DOI 10.2136/sssaj1992.03615995005600030017x; Chakraborty A, 2011, BIOL FERT SOILS, V47, P227, DOI 10.1007/s00374-010-0509-1; Chan KY, 1997, SOIL SCI SOC AM J, V61, P1376, DOI 10.2136/sssaj1997.03615995006100050013x; Chapman H.D., 1965, METHODS SOIL ANAL 2, P891; Doran JW, 1996, ADV AGRON, V56, P1, DOI 10.1016/S0065-2113(08)60178-9; Dou F, 2008, SOIL SCI SOC AM J, V72, P1445, DOI 10.2136/sssaj2007.0230; Dou F, 2007, SOIL TILL RES, V94, P530, DOI 10.1016/j.still.2006.10.001; FAO-UNESCO, 1988, SOIL MAP WORLD; Gami SK, 2009, SOIL TILL RES, V106, P95, DOI 10.1016/j.still.2009.10.003; Gong W, 2009, GEODERMA, V149, P318, DOI 10.1016/j.geoderma.2008.12.010; GOYAL S, 1992, SOIL BIOL BIOCHEM, V24, P1081, DOI 10.1016/0038-0717(92)90056-4; GREGORICH EG, 1994, CAN J SOIL SCI, V74, P367, DOI 10.4141/cjss94-051; Halvorson AD, 2002, SOIL SCI SOC AM J, V66, P906, DOI 10.2136/sssaj2002.0906; Haynes RJ, 2005, ADV AGRON, V85, P221, DOI 10.1016/S0065-2113(04)85005-3; Janzen HH, 1997, DEV SOIL SCI, V25, P277; Jiang PK, 2006, FOREST ECOL MANAG, V236, P30, DOI 10.1016/j.foreco.2006.06.010; Kalbitz K, 2000, SOIL SCI, V165, P277, DOI 10.1097/00010694-200004000-00001; Kanchikerimath M, 2001, AGR ECOSYST ENVIRON, V86, P155, DOI 10.1016/S0167-8809(00)00280-2; Liang BC, 1998, BIOL FERT SOILS, V26, P88, DOI 10.1007/s003740050348; Liang Q, 2012, NUTR CYCL AGROECOSYS, V92, P21, DOI 10.1007/s10705-011-9469-6; Lorenz K, 2005, ADV AGRON, V88, P35, DOI 10.1016/S0065-2113(05)88002-2; Lou YL, 2011, CATENA, V87, P386, DOI 10.1016/j.catena.2011.07.006; LYNCH JM, 1980, SOIL BIOL BIOCHEM, V12, P547, DOI 10.1016/0038-0717(80)90033-4; Majumder B, 2008, SOIL SCI SOC AM J, V72, P775, DOI 10.2136/sssaj2006.0378; Marschner P, 2003, SOIL BIOL BIOCHEM, V35, P453, DOI 10.1016/S0038-0717(02)00297-3; Melero S, 2009, SOIL TILL RES, V104, P292, DOI 10.1016/j.still.2009.04.001; Nayak AK, 2012, FIELD CROP RES, V127, P129, DOI 10.1016/j.fcr.2011.11.011; OCIO JA, 1991, SOIL BIOL BIOCHEM, V23, P655, DOI 10.1016/0038-0717(91)90079-Y; Ouedraogo E, 2007, SOIL TILL RES, V94, P64, DOI 10.1016/j.still.2006.07.001; Powlson DS, 2012, AGR ECOSYST ENVIRON, V146, P23, DOI 10.1016/j.agee.2011.10.004; Puget P, 2001, SOIL SCI SOC AM J, V65, P771, DOI 10.2136/sssaj2001.653771x; Purakayastha TJ, 2008, GEODERMA, V144, P370, DOI 10.1016/j.geoderma.2007.12.006; Rudrappa L, 2006, SOIL TILL RES, V88, P180, DOI 10.1016/j.still.2005.05.008; Sa JCD, 2009, SOIL TILL RES, V103, P46, DOI 10.1016/j.still.2008.09.003; Saviozzi A, 2001, PLANT SOIL, V233, P251, DOI 10.1023/A:1010526209076; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Su YZ, 2006, NUTR CYCL AGROECOSYS, V75, P285, DOI 10.1007/s10705-006-9034-x; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Verma S, 2007, BIOL FERT SOILS, V44, P235, DOI 10.1007/s00374-007-0207-9; West TO, 2002, SOIL SCI SOC AM J, V66, P1930, DOI 10.2136/sssaj2002.1930; Wu TY, 2005, J PLANT NUTR SOIL SC, V168, P100, DOI 10.1002/jpln.200321295; Xing N., 2001, STUDY DRYLAND AGR N; Xu MG, 2011, BIOL FERT SOILS, V47, P745, DOI 10.1007/s00374-011-0579-8; Zhang WJ, 2009, NUTR CYCL AGROECOSYS, V84, P59, DOI 10.1007/s10705-008-9226-7; Zhang X, 1998, HYDROL PROCESS, V12, P171, DOI 10.1002/(SICI)1099-1085(199801)12:1&lt;171::AID-HYP570&gt;3.0.CO;2-L	48	328	350	30	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56536	10.1371/journal.pone.0056536	http://dx.doi.org/10.1371/journal.pone.0056536			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23468976	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200099
J	Liu, N; He, S; Ma, L; Ponnusamy, M; Tang, JH; Tolbert, E; Bayliss, G; Zhao, TC; Yan, HD; Zhuang, SG				Liu, Na; He, Song; Ma, Li; Ponnusamy, Murugavel; Tang, Jinhua; Tolbert, Evelyn; Bayliss, George; Zhao, Ting C.; Yan, Haidong; Zhuang, Shougang			Blocking the Class I Histone Deacetylase Ameliorates Renal Fibrosis and Inhibits Renal Fibroblast Activation via Modulating TGF-Beta and EGFR Signaling	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CHRONIC KIDNEY-DISEASE; OBSTRUCTIVE NEPHROPATHY; INTERSTITIAL FIBROSIS; MOLECULAR-MECHANISMS; CARDIAC-HYPERTROPHY; FACTOR RECEPTOR; ANGIOTENSIN-II; SOLID TUMORS; INJURY	Background: Histone deacetylase (HDAC) inhibitors are promising anti-fibrosis drugs; however, nonselective inhibition of class I and class II HDACs does not allow a detailed elucidation of the individual HDAC functions in renal fibrosis. In this study, we investigated the effect of MS-275, a selective class I HDAC inhibitor, on the development of renal fibrosis in a murine model of unilateral ureteral obstruction (UUO) and activation of cultured renal interstitial fibroblasts. Methods/Findings: The UUO model was established by ligation of the left ureter and the contralateral kidney was used as a control. At seven days after UUO injury, kidney developed fibrosis as indicated by deposition of collagen fibrils and increased expression of collagen I, fibronectin and alpha-smooth muscle actin (alpha-SMA). Administration of MS-275 inhibited all these fibrotic responses and suppressed UUO-induced production of transforming growth factor-beta1 (TGF- beta), increased expression of TGF-beta receptor I, and phosphorylation of Smad-3. MS-275 was also effective in suppressing phosphorylation and expression of epidermal growth factor receptor (EGFR) and its downstream signaling molecule, signal transducer and activator of transcription-3. Moreover, class I HDAC inhibition reduced the number of renal tubular cells arrested in the G2/M phase of the cell cycle, a cellular event associated with TGF-beta1overproduction. In cultured renal interstitial fibroblasts, MS-275 treatment inhibited TGF-beta induced phosphorylation of Smad-3, differentiation of renal fibroblasts to myofibroblasts and proliferation of myofibroblasts. Conclusions and Significance: These results demonstrate that class I HDACs are critically involved in renal fibrogenesis and renal fibroblast activation through modulating TGF-beta and EGFR signaling and suggest that blockade of class I HDAC may be a useful treatment for renal fibrosis.	[Liu, Na; Tang, Jinhua; Yan, Haidong; Zhuang, Shougang] Tongji Univ, Sch Med, Shanghai E Hosp, Dept Nephrol, Shanghai 200092, Peoples R China; [Liu, Na; He, Song; Ma, Li; Ponnusamy, Murugavel; Tang, Jinhua; Tolbert, Evelyn; Bayliss, George; Zhuang, Shougang] Brown Univ, Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA; [Liu, Na; He, Song; Ma, Li; Ponnusamy, Murugavel; Tang, Jinhua; Tolbert, Evelyn; Bayliss, George; Zhuang, Shougang] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [He, Song] Shekou Peoples Hosp, Dept Lab Med, Shenzhen, Guangdong, Peoples R China; [Zhao, Ting C.] Boston Univ, Sch Med, Roger William Med Ctr, Dept Surg, Providence, RI USA	Tongji University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Boston University; Roger Williams Medical Center	Yan, HD (corresponding author), Tongji Univ, Sch Med, Shanghai E Hosp, Dept Nephrol, Shanghai 200092, Peoples R China.	yhdcmu@sina.com; szhuang@lifespan.org	Seo, Mitsunori/N-9603-2015; Kamiya, Yuji/F-9420-2010; kanno, yuri/C-9211-2017; Ponnusamy, Murugavel/X-5699-2018	Kamiya, Yuji/0000-0003-4415-520X; Ponnusamy, Murugavel/0000-0001-5558-8719; Seo, Mitsunori/0000-0001-8325-7984	National Institutes of Health [DK-085065]; national nature science foundation of China [81270778, 81170638, 81200492]; Pudong New District Foundation of China [PWZxk2010-02]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); national nature science foundation of China(National Natural Science Foundation of China (NSFC)); Pudong New District Foundation of China; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (DK-085065 to SZ), the national nature science foundation of China (81270778 to SZ, 81170638 to HY, 81200492 to NL), and Pudong New District Foundation of China (PWZxk2010-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Bogaard HJ, 2011, AM J RESP CRIT CARE, V183, P1402, DOI 10.1164/rccm.201007-1106OC; Bonner JC, 2004, CYTOKINE GROWTH F R, V15, P255, DOI 10.1016/j.cytogfr.2004.03.006; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Bruzzese F, 2011, J CELL PHYSIOL, V226, P2378, DOI 10.1002/jcp.22574; Cavasin MA, 2012, CIRC RES, V110, P739, DOI 10.1161/CIRCRESAHA.111.258426; Chen JC, 2012, J AM SOC NEPHROL, V23, P215, DOI 10.1681/ASN.2011070645; Choi Y, 2008, EXP MOL MED, V40, P574, DOI 10.3858/emm.2008.40.5.574; Dalgard CL, 2008, CLIN CANCER RES, V14, P3113, DOI 10.1158/1078-0432.CCR-07-4836; Deribe YL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000576; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Fraczek J, 2009, J CELL MOL MED, V13, P2990, DOI 10.1111/j.1582-4934.2009.00831.x; Gao YS, 2010, J BIOL CHEM, V285, P11219, DOI 10.1074/jbc.M109.042754; Gilbert RE, 2011, KIDNEY INT, V79, P1312, DOI 10.1038/ki.2011.39; Glasgow E, 2008, ENDOCR-RELAT CANCER, V15, P59, DOI 10.1677/ERC-07-0168; Hemmatazad H, 2009, ARTHRITIS RHEUM-US, V60, P1519, DOI 10.1002/art.24494; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; Kim HJ, 2011, AM J TRANSL RES, V3, P166; Knipstein J, 2011, EXPERT OPIN INV DRUG, V20, P1455, DOI 10.1517/13543784.2011.613822; Kook H, 2003, J CLIN INVEST, V112, P863, DOI 10.1172/JCI200319137; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Lan HY, 2011, CONTRIB NEPHROL, V170, P75, DOI 10.1159/000324949; Lautrette A, 2005, NAT MED, V11, P867, DOI 10.1038/nm1275; Liu N, 2012, J AM SOC NEPHROL, V23, P854, DOI 10.1681/ASN.2011050493; Liu N, 2011, J AM SOC NEPHROL, V22, P1064, DOI 10.1681/ASN.2010090956; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Lopez-Hernandez FJ, 2012, CELL TISSUE RES, V347, P141, DOI 10.1007/s00441-011-1275-6; Ma L, 2010, P NATL ACAD SCI USA, V107, P19314, DOI 10.1073/pnas.1010253107; Mannaerts I, 2010, HEPATOLOGY, V51, P603, DOI 10.1002/hep.23334; Marumo T, 2010, AM J PHYSIOL-RENAL, V298, pF133, DOI 10.1152/ajprenal.00400.2009; Miyajima A, 2000, KIDNEY INT, V58, P2301, DOI 10.1046/j.1523-1755.2000.00414.x; MORI S, 1995, J BIOL CHEM, V270, P29447, DOI 10.1074/jbc.270.49.29447; Noronha IL, 2002, NEPHROL DIAL TRANSPL, V17, P363, DOI 10.1093/ndt/17.3.363; Pang MY, 2010, J PHARMACOL EXP THER, V335, P266, DOI 10.1124/jpet.110.168385; Pang MY, 2010, KIDNEY INT, V78, P257, DOI 10.1038/ki.2010.154; Pang MY, 2009, AM J PHYSIOL-RENAL, V297, pF996, DOI 10.1152/ajprenal.00282.2009; Prince HM, 2009, CLIN CANCER RES, V15, P3958, DOI 10.1158/1078-0432.CCR-08-2785; Qi W, 2008, INT J BIOCHEM CELL B, V40, P9, DOI 10.1016/j.biocel.2007.01.006; Ryan QC, 2005, J CLIN ONCOL, V23, P3912, DOI 10.1200/JCO.2005.02.188; Singh BN, 2010, EXPERT REV ANTICANC, V10, P935, DOI [10.1586/era.10.62, 10.1586/ERA.10.62]; Tan JH, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-5; Tang XL, 2007, CELL, V131, P93, DOI 10.1016/j.cell.2007.07.034; Terzi F, 2000, J CLIN INVEST, V106, P225, DOI 10.1172/JCI8315; Thiagalingam S, 2003, ANN NY ACAD SCI, V983, P84, DOI 10.1111/j.1749-6632.2003.tb05964.x; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Van Beneden K, 2011, J AM SOC NEPHROL, V22, P1863, DOI 10.1681/ASN.2010111196; Walkinshaw DR, 2008, J CELL BIOCHEM, V104, P1541, DOI 10.1002/jcb.21746; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166	52	328	350	30	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54001	10.1371/journal.pone.0054001	http://dx.doi.org/10.1371/journal.pone.0054001			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23468976	Green Submitted, Green Published, gold			2022-12-25	WOS:000313682700073
J	Li, YY; Xie, J; Wu, SY; Xia, J; Zhang, PF; Liu, C; Zhang, P; Huang, X				Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi			Protein Kinase Regulated by dsRNA Downregulates the Interferon Production in Dengue Virus- and dsRNA-Stimulated Human Lung Epithelial Cells	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; PKR-DEPENDENT ACTIVATION; CELLULAR ACTIVATOR; RIG-I; BINDING PROTEIN; ADAPTER IPS-1; INDUCTION; INFECTION; TRANSLATION	Background: Dengue virus (DENV) is found in the tropical and subtropical regions and affects millions of people annually. Currently, no specific vaccine or antiviral treatment against dengue virus is available. Innate immunity has been shown to be important for host resistance to DENV infection. Although protein kinase regulated by double-stranded RNA (PKR) has been found to promote the innate signaling in response to infection by several viruses, its role in the innate response to DENV infection is still unclear. Our study aimed to investigate the role of PKR in DENV-induced innate immune responses. Methodology/Principal Findings: By RNAi, silencing of PKR significantly enhanced the expression of interferon (IFN)-beta in DENV infected human lung epithelial A549 cells. Western blot and immunofluorescence microscopy data showed that PKR knockdown upregulated the activation of innate signaling cascades including p38 and JNK mitogen-activated protein kinases (MAPKs), interferon regulatory factor-3 and NF-kappa B, following DENV2 infection. Likewise, a negative regulatory effect of PKR on the IFN production was also observed in poly(IC) challenged cells. Moreover, the PKR knockdown-mediated IFN induction was attenuated by RIG-I or IPS-1 silencing. Finally, overexpression of a catalytically inactive PKR mutant (K296R), but not of a mutant lacking dsRNA binding activity (K64E) or the double mutant (K64EK296R), reversed the IFN induction mediated by PKR knockdown, suggesting that the dsRNA binding activity is required for PKR to downregulate IFN production. Conclusions/Significance: PKR acts as a negative regulator of IFN induction triggered by DENVs and poly(IC), and this regulation relies on its dsRNA binding activity. These findings reveal a novel regulatory role for PKR in innate immunity, suggesting that PKR might be a promising target for anti-DENV treatments.	[Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi] Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhang, P (corresponding author), Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou 510275, Guangdong, Peoples R China.	zhangp36@mail.sysu.edu.cn; huangxi6@mail.sysu.edu.cn	Liu, Hongliang/P-3444-2014; Scott, Colin/A-4682-2009; Oakeshott, John/B-5365-2009; Teese, Mark George/B-4307-2008; Chen, Huaping/O-3096-2014	Liu, Hongliang/0000-0001-7639-0904; Scott, Colin/0000-0001-6110-6982; Oakeshott, John/0000-0001-8324-7874; Tollefsbol, Trygve/0000-0002-0284-1511; Li, Yong/0000-0002-3595-6673; Li, Yongwen/0000-0001-6102-2949; Teese, Mark George/0000-0002-8003-4918; HUANG, XI/0000-0002-4829-8390; Song, Yajun/0000-0002-6628-2747; Chen, Huaping/0000-0002-9835-5138; Yang, Xianwei/0000-0003-4388-9674	National Natural Science Foundation of China [30972763, 81261160323, 81171576, 30901345, U0832006]; Guangdong innovative research team program [2009010058]; Guangdong Province Universities and Colleges Pearl River School Funded Scheme [2009]; Guangdong Natural Science Foundation [10251008901000013]; National Basic Research Program of China [2010CB530004]; Doctoral Fund of Ministry of Education of China [20100171110047]; Fundamental Research Funds for the Central Universities of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong innovative research team program; Guangdong Province Universities and Colleges Pearl River School Funded Scheme; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); National Basic Research Program of China(National Basic Research Program of China); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (30972763, 81261160323, 81171576, 30901345, U0832006), Guangdong innovative research team program (NO. 2009010058), Guangdong Province Universities and Colleges Pearl River School Funded Scheme (NO. 2009), Guangdong Natural Science Foundation (10251008901000013), National Basic Research Program of China (2010CB530004), Doctoral Fund of Ministry of Education of China (20100171110047), Fundamental Research Funds for the Central Universities of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Arnaud N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002289; Arnaud N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010575; Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888; Barry G, 2009, J GEN VIROL, V90, P1382, DOI 10.1099/vir.0.007336-0; Bonnet MC, 2006, CELL SIGNAL, V18, P1865, DOI 10.1016/j.cellsig.2006.02.010; Bonnet MC, 2000, MOL CELL BIOL, V20, P4532, DOI 10.1128/MCB.20.13.4532-4542.2000; Boonyaratanakornkit J, 2011, J VIROL, V85, P1495, DOI 10.1128/JVI.01297-10; Brown MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034055; Cheung BKW, 2005, J IMMUNOL, V175, P7218, DOI 10.4049/jimmunol.175.11.7218; COLTHURST DR, 1987, EUR J BIOCHEM, V166, P357, DOI 10.1111/j.1432-1033.1987.tb13523.x; Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000; Diamond MS, 2001, VIROLOGY, V289, P297, DOI 10.1006/viro.2001.1114; Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gil J, 2000, APOPTOSIS, V5, P107, DOI 10.1023/A:1009664109241; Gil J, 2004, MOL CELL BIOL, V24, P4502, DOI 10.1128/MCB.24.10.4502-4512.2004; Gilfoy FD, 2007, J VIROL, V81, P11148, DOI 10.1128/JVI.00446-07; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Ito T, 1999, J BIOL CHEM, V274, P15427, DOI 10.1074/jbc.274.22.15427; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999; Katze Michael G., 1995, Trends in Microbiology, V3, P75, DOI 10.1016/S0966-842X(00)88880-0; Kok KH, 2011, CELL HOST MICROBE, V9, P299, DOI 10.1016/j.chom.2011.03.007; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; Langland JO, 1999, BIOCHEMISTRY-US, V38, P6361, DOI 10.1021/bi982410u; Lee YR, 2007, VIRUS RES, V126, P216, DOI 10.1016/j.virusres.2007.03.003; McAllister CS, 2012, J BIOL CHEM, V287, P36384, DOI 10.1074/jbc.M112.390039; McAllister CS, 2010, J VIROL, V84, P380, DOI 10.1128/JVI.02630-08; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Nakayama Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000966; Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926; Patel CV, 2000, J BIOL CHEM, V275, P37993, DOI 10.1074/jbc.M004762200; Pereira RMS, 2010, FASEB J, V24, P617, DOI 10.1096/fj.09-140053; Pfaller CK, 2011, CURR OPIN IMMUNOL, V23, P573, DOI 10.1016/j.coi.2011.08.009; Pindel A, 2011, J INTERF CYTOK RES, V31, P59, DOI 10.1089/jir.2010.0099; Porterfield J S, 1980, Med Trop (Mars), V40, P493; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; RUSSELL PK, 1967, J IMMUNOL, V99, P291; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Sadler AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000311; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; Schulz O, 2010, CELL HOST MICROBE, V7, P354, DOI 10.1016/j.chom.2010.04.007; Sen A, 2011, J VIROL, V85, P3717, DOI 10.1128/JVI.02634-10; Silva AM, 2004, J BIOL CHEM, V279, P37670, DOI 10.1074/jbc.M406554200; Srivastava SP, 1998, J BIOL CHEM, V273, P2416, DOI 10.1074/jbc.273.4.2416; Thomas Stephen J, 2003, Adv Virus Res, V61, P235, DOI 10.1016/S0065-3527(03)61006-7; Tissari J, 2005, J IMMUNOL, V174, P4289, DOI 10.4049/jimmunol.174.7.4289; Umareddy I, 2008, J GEN VIROL, V89, P3052, DOI 10.1099/vir.0.2008/001594-0; Weber F, 2006, J INTERF CYTOK RES, V26, P1, DOI 10.1089/jir.2006.26.1; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Xu Z, 2000, MOL CELL BIOL, V20, P5285, DOI 10.1128/MCB.20.14.5285-5299.2000; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07; Zhang P, 2009, J VIROL, V83, P5718, DOI 10.1128/JVI.00224-09; Zhang P, 2008, J BIOL CHEM, V283, P34580, DOI 10.1074/jbc.M807029200	63	321	342	10	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55108	10.1371/journal.pone.0055108	http://dx.doi.org/10.1371/journal.pone.0055108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23342141	Green Published, Green Submitted, gold			2022-12-25	WOS:000315210400065
